data_6amv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6amv _Structure_validation_residue.Date_analyzed 2017-09-22 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.6 t90 . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 121.205 0.526 . . . . 75.120000000000005 109.804 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.51 -22.69 34.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.889 0.876 . . . . 71.030000000000001 111.104 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 m -78.95 7.32 7.42 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.241 1.416 . . . . 54.420000000000002 113.021 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.39 -18.18 65.02 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.464 1.106 . . . . 74.019999999999996 112.315 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -20.35 26.2 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.319 0.648 . . . . 72.310000000000002 110.916 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.47 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 12.7 m120 -78.45 -12.31 60.0 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.322 0.649 . . . . 55.119999999999997 110.377 170.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.05 -50.45 70.59 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.679 0.792 . . . . 74.140000000000001 110.623 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.407 HD11 ' CG ' ' A' ' 219' ' ' HIS . 84.8 mt -112.12 30.15 7.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.486 0.714 . . . . 75.450000000000003 110.063 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.473 0.722 0 C-N-CA 122.663 0.385 . . . . 75.140000000000001 110.562 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.105 0.479 . . . . 70.299999999999997 110.848 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.7 tp -76.78 138.42 39.88 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.75 -0.594 . . . . 71.530000000000001 109.455 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.7 m-85 -108.11 173.45 6.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.588 1.155 . . . . 73.219999999999999 110.06 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.6 147.55 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 125.221 1.409 . . . . 65.239999999999995 109.64 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.21 120.15 25.45 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.219 1.008 . . . . 74.530000000000001 110.205 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.3 -42.26 68.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.329 0.651 . . . . 64.409999999999997 111.161 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.51 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.8 m-85 -124.54 158.4 33.05 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.41 -0.813 . . . . 75.129999999999995 109.223 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 120.71 24.27 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.502 -1.296 . . . . 72.25 107.502 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.8 t80 -123.01 138.28 54.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.903 0.881 . . . . 73.019999999999996 108.712 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.48 134.18 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.76 -0.83 . . . . 75.120000000000005 108.76 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.6 117.18 4.62 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.078 0.862 . . . . 74.319999999999993 110.631 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 p -67.82 -38.33 83.12 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.654 0.782 . . . . 65.319999999999993 110.887 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.72 -175.95 14.28 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-N 115.717 -0.674 . . . . 72.140000000000001 111.826 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.79 -31.85 67.02 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.546 0.739 . . . . 74.549999999999997 110.661 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -75.52 -18.06 59.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.803 1.241 . . . . 64.049999999999997 112.115 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 57.2 p -95.63 171.25 8.79 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.48 -0.563 . . . . 75.310000000000002 109.48 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.9 tp -126.94 136.7 52.64 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.275 0.56 . . . . 75.230000000000004 111.735 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -82.25 117.03 22.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.726 -1.125 . . . . 62.130000000000003 109.042 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.587 HG12 ' HB3' ' A' ' 91' ' ' PHE . 20.7 pt -110.08 144.26 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.388 0.675 . . . . 74.409999999999997 110.104 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.3 m -95.76 140.23 30.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.424 -0.807 . . . . 65.040000000000006 108.845 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.29 125.99 25.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.318 0.647 . . . . 75.200000000000003 111.356 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.45 76.67 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 123.88 0.738 . . . . 60.049999999999997 113.605 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -82.11 138.34 34.79 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.46 0.63 . . . . 74.109999999999999 111.434 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -79.95 112.81 17.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.837 -0.801 . . . . 74.340000000000003 108.837 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.505 ' HB3' HG21 ' A' ' 123' ' ' THR . 0.4 OUTLIER -122.83 167.78 13.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.951 0.9 . . . . 74.230000000000004 110.024 -177.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -121.74 119.43 31.72 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.935 -0.478 . . . . 74.209999999999994 111.035 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.585 HG11 ' HB1' ' A' ' 119' ' ' ALA . 43.5 t -86.54 134.55 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.246 1.018 . . . . 75.230000000000004 109.881 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.54 HD12 ' HG3' ' A' ' 120' ' ' GLU . 46.1 mt -105.89 -31.49 8.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.467 1.107 . . . . 75.140000000000001 110.126 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.01 145.48 4.71 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 115.835 -0.62 . . . . 61.119999999999997 112.375 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.51 ' CD2' ' HB3' ' A' ' 119' ' ' ALA . 45.5 m-85 -85.68 169.74 13.17 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.436 0.694 . . . . 74.329999999999998 110.886 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -85.66 -176.26 5.97 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.213 -0.903 . . . . 74.420000000000002 110.694 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -52.83 -35.18 56.79 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.754 1.221 . . . . 74.430000000000007 114.17 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -112.12 2.63 16.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.855 0.462 . . . . 72.129999999999995 112.171 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.452 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.79 30.56 72.59 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.398 0.919 . . . . 72.200000000000003 115.398 173.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.03 -35.96 18.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.285 0.543 . . . . 74.510000000000005 110.716 173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 35.3 m95 -131.0 151.66 51.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.743 0.817 . . . . 74.129999999999995 111.72 -171.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.585 ' HB1' HG11 ' A' ' 109' ' ' VAL . . . -133.54 137.09 45.39 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.534 1.134 . . . . 72.040000000000006 111.026 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.54 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.8 tp10 -66.81 114.45 5.68 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 106.854 -1.536 . . . . 75.030000000000001 106.854 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.15 162.13 33.8 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.184 0.516 . . . . 73.230000000000004 111.299 -170.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.46 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . 9.8 pt20 -132.8 128.96 37.9 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.414 -0.812 . . . . 73.219999999999999 111.122 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.505 HG21 ' HB3' ' A' ' 107' ' ' LEU . 45.8 p -116.61 179.1 4.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 74.319999999999993 109.757 173.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -70.68 -16.35 62.79 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 109.513 -0.551 . . . . 75.549999999999997 109.513 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -78.78 -20.16 50.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.918 1.287 . . . . 74.439999999999998 110.984 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.68 -140.4 10.15 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 122.051 -0.118 . . . . 74.439999999999998 112.941 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' A' ' 122' ' ' GLN . 61.6 tp60 -128.67 155.83 44.4 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.348 1.059 . . . . 74.329999999999998 109.667 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.56 169.4 15.36 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.025 -0.43 . . . . 74.25 112.025 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -77.75 134.53 38.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.241 0.616 . . . . 75.310000000000002 111.668 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.483 HG23 HD11 ' A' ' 135' ' ' ILE . 5.9 m -132.0 143.26 48.26 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 124.308 1.043 . . . . 75.420000000000002 108.807 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 92.9 Cg_endo -80.4 143.04 15.19 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 C-N-CA 122.018 1.812 . . . . 75.439999999999998 114.075 -173.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -39.61 -44.73 1.52 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.583 1.953 . . . . 74.310000000000002 114.229 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 38.1 p-10 -79.04 -1.91 37.89 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.198 0.999 . . . . 74.25 113.132 -171.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.51 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 28.8 m-85 -113.14 -0.63 14.61 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.026 0.93 . . . . 74.219999999999999 111.308 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 130' ' ' VAL . 21.0 pt -135.37 170.48 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.182 0.993 . . . . 64.25 110.667 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -163.4 155.39 15.14 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.812 -1.181 . . . . 64.430000000000007 107.812 170.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.8 Cg_endo -60.44 153.53 59.88 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.679 1.586 . . . . 73.310000000000002 111.632 171.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.1 -8.44 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.107 0.956 . . . . 70.329999999999998 110.356 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.94 -18.61 55.86 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.336 1.054 . . . . 73.129999999999995 111.248 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.2 p -87.01 170.43 11.57 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.853 0.835 . . . . 75.200000000000003 113.024 -170.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.36 -23.79 26.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.512 -1.222 . . . . 74.299999999999997 110.931 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.64 -29.81 70.3 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.322 1.049 . . . . 75.140000000000001 111.447 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -60.08 -19.28 52.34 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.614 0.765 . . . . 72.340000000000003 112.904 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -86.66 141.86 28.64 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.544 0.737 . . . . 72.329999999999998 109.749 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.1 m -58.9 -40.64 85.1 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.07 0.856 . . . . 64.430000000000007 112.182 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -62.53 -38.5 90.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.122 0.889 . . . . 73.140000000000001 112.336 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -76.6 112.37 13.07 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.728 -0.841 . . . . 73.219999999999999 108.728 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -109.07 -14.83 14.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.073 0.549 . . . . 70.400000000000006 111.517 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.78 -127.25 15.49 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 118.18 -1.344 . . . . 43.119999999999997 112.3 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.55 95.2 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.984 2.456 . . . . 75.219999999999999 112.591 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 77.3 t -137.78 119.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.605 0.762 . . . . 64.5 109.575 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.8 m -71.78 159.35 34.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.289 0.635 . . . . 71.329999999999998 109.32 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 78.0 ttt180 -59.04 -38.07 78.46 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 119.435 -0.317 . . . . 74.310000000000002 111.415 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -63.49 -36.88 85.21 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.362 0.665 . . . . 71.409999999999997 111.209 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.36 -30.27 67.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.16 0.584 . . . . 71.209999999999994 110.408 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.26 63.18 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 51.509999999999998 111.647 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 22.5 mm-40 -65.66 -43.11 90.38 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.119 -0.697 . . . . 74.310000000000002 109.119 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.483 ' HE1' ' HB2' ' A' ' 239' ' ' ARG . 17.0 t80 -62.73 -41.47 99.19 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.315 -1.311 . . . . 74.5 111.201 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 239' ' ' ARG . 28.7 mt -61.48 -44.13 97.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.59 0.756 . . . . 61.539999999999999 111.478 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.0 mt -98.3 17.96 17.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.199 0.6 . . . . 72.420000000000002 112.59 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.0 p -69.35 -36.24 76.68 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.444 0.64 . . . . 74.219999999999999 110.694 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 p -106.42 15.81 25.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.342 1.057 . . . . 74.209999999999994 110.8 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.86 140.48 23.3 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.37 -0.377 . . . . 63.119999999999997 112.379 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.7 pt -86.81 -179.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.405 0.682 . . . . 74.0 111.431 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.6 112.33 3.13 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.679 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.6 10.88 39.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.392 -0.822 . . . . 72.209999999999994 112.94 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.4 m -75.54 143.31 42.52 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.634 0.717 . . . . 62.140000000000001 110.619 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 183' ' ' SER . 24.1 p90 -149.72 163.78 37.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.063 0.459 . . . . 74.230000000000004 111.937 -171.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 183' ' ' SER . 4.0 pp -161.72 152.69 18.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.873 -1.058 . . . . 73.540000000000006 109.482 175.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.583 HG22 HG12 ' A' ' 182' ' ' ILE . 59.5 t -107.64 126.73 63.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.424 -0.954 . . . . 55.210000000000001 108.424 168.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.521 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 13.1 ptt180 -114.97 147.29 40.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.182 -1.044 . . . . 74.200000000000003 108.182 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.89 145.99 40.68 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 107.741 -1.207 . . . . 72.340000000000003 107.741 166.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.4 t -78.55 121.64 24.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.169 -0.678 . . . . 74.109999999999999 109.169 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.25 -34.3 77.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.306 1.042 . . . . 74.219999999999999 110.485 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 p -83.18 -15.87 48.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.72 0.808 . . . . 72.340000000000003 111.788 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.8 m -142.2 86.03 10.43 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.423 0.689 . . . . 73.519999999999996 110.079 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.09 135.54 69.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.33 2.687 . . . . 73.239999999999995 112.529 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.15 -28.86 12.07 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.472 -0.331 . . . . 61.509999999999998 112.594 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -81.41 117.11 21.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.182 0.491 . . . . 74.329999999999998 110.193 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.602 HH11 HD11 ' A' ' 214' ' ' LEU . 99.4 mtt180 -130.03 157.6 41.9 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.908 0.883 . . . . 75.409999999999997 110.974 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.4 m -143.61 146.24 33.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.944 -1.026 . . . . 61.310000000000002 109.454 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.583 HG12 HG22 ' A' ' 170' ' ' VAL . 42.8 mt -100.81 108.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 107.394 -1.335 . . . . 73.439999999999998 107.394 169.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.459 ' HB2' ' HG ' ' A' ' 169' ' ' LEU . 14.9 m -87.38 106.81 18.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.243 -1.391 . . . . 65.310000000000002 107.243 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 193' ' ' TYR . 62.4 tp -115.47 110.95 20.03 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.78 -0.822 . . . . 74.5 108.78 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.429 ' HB2' HG21 ' A' ' 190' ' ' VAL . 75.9 ttt180 -89.61 122.77 33.07 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.316 0.646 . . . . 75.209999999999994 110.486 173.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -143.7 144.13 31.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.655 1.182 . . . . 72.450000000000003 108.352 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 61.11 21.93 12.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.422 1.089 . . . . 70.120000000000005 112.358 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.29 11.45 82.17 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 114.358 0.503 . . . . 60.219999999999999 114.358 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -120.14 134.5 55.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.49 0.716 . . . . 74.409999999999997 109.744 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 185' ' ' ARG . 91.0 t -88.65 118.24 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.304 -0.628 . . . . 74.439999999999998 109.304 174.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.37 157.42 16.92 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.147 0.979 . . . . 72.439999999999998 108.564 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -132.76 124.15 27.55 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.976 -0.75 . . . . 74.140000000000001 108.976 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' A' ' 184' ' ' LEU . 89.8 m-85 -113.83 141.24 47.56 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.415 1.086 . . . . 72.310000000000002 108.714 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -85.21 124.36 31.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.398 0.279 . . . . 73.129999999999995 110.391 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.2 mt -84.71 99.6 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.132 -1.433 . . . . 73.040000000000006 107.132 166.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -78.46 119.71 22.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.963 -1.017 . . . . 72.450000000000003 108.37 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -94.15 108.5 20.35 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.908 -0.775 . . . . 75.0 108.908 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.48 157.57 16.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.952 0.901 . . . . 62.020000000000003 110.886 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -61.85 -30.94 71.19 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.293 1.037 . . . . 75.129999999999995 113.395 -170.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -85.0 -11.5 55.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.803 0.841 . . . . 73.299999999999997 111.925 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.0 11.15 14.38 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.451 -0.638 . . . . 74.310000000000002 114.352 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -75.5 152.16 37.88 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 118.082 0.941 . . . . 71.099999999999994 110.983 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -113.56 142.6 45.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.327 -0.99 . . . . 73.519999999999996 108.327 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.615 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.8 p90 -165.0 137.0 4.31 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.52 0.512 . . . . 73.349999999999994 110.872 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.3 t -79.12 -45.73 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.832 -0.803 . . . . 72.430000000000007 108.832 166.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -101.29 135.93 41.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.763 -1.108 . . . . 71.219999999999999 110.696 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.5 t -64.14 -22.46 66.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.287 1.035 . . . . 74.219999999999999 112.267 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -81.47 -29.98 33.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.941 0.896 . . . . 73.109999999999999 111.176 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 17.1 m -123.17 99.01 6.14 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.026 0.53 . . . . 65.200000000000003 110.176 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.615 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 47.3 mtt180 -112.35 120.29 41.19 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.818 0.847 . . . . 74.120000000000005 109.632 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.62 156.0 20.75 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.083 0.953 . . . . 72.420000000000002 109.085 -171.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -69.32 -42.74 74.98 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 70.5 p -120.95 155.04 35.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.92 0.867 . . . . 75.420000000000002 111.904 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.602 HD11 HH11 ' A' ' 180' ' ' ARG . 1.3 tt -65.38 -24.61 67.28 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 114.352 -1.295 . . . . 75.230000000000004 109.559 172.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.33 93.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.41 0.684 . . . . 75.439999999999998 110.766 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.19 -34.81 75.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.83 0.852 . . . . 71.319999999999993 111.15 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.04 -54.92 39.08 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.09 0.556 . . . . 74.040000000000006 111.025 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.61 -41.09 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 123.655 0.597 . . . . 75.140000000000001 111.011 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.407 ' CG ' HD11 ' A' ' 74' ' ' LEU . 17.0 t-80 -55.63 -58.0 9.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.441 0.696 . . . . 61.340000000000003 111.362 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -64.17 -33.7 76.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.125 -0.943 . . . . 74.239999999999995 110.813 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.537 ' HB3' HD12 ' A' ' 228' ' ' LEU . 11.1 m-70 -88.28 -10.78 48.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.797 -0.638 . . . . 73.5 112.081 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 89.1 p -93.92 -20.28 20.16 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.756 0.423 . . . . 61.420000000000002 111.255 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 37.7 p -81.98 -48.12 11.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.873 -0.417 . . . . 74.230000000000004 109.873 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' A' ' 226' ' ' ASP . 33.2 m -128.72 158.92 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.636 0.732 . . . . 74.209999999999994 112.303 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.97 16.0 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.759 2.024 . . . . 61.509999999999998 115.217 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.562 ' HB2' HG21 ' A' ' 224' ' ' VAL . 28.9 t70 -42.64 31.69 0.0 OUTLIER 'General case' 0 CA--C 1.601 2.925 1 C-N-CA 131.88 4.072 . . . . 72.510000000000005 119.351 -157.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.86 -1.94 9.25 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 119.486 -2.009 . . . . 74.120000000000005 112.604 -168.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 221' ' ' HIS . 45.1 mt -95.59 160.3 14.57 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.584 1.153 . . . . 70.420000000000002 110.216 168.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.11 -35.55 72.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 120.895 0.379 . . . . 73.420000000000002 110.322 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -149.18 173.52 13.35 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.506 0.722 . . . . 73.549999999999997 110.094 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -67.42 143.17 56.41 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.172 0.589 . . . . 72.319999999999993 110.675 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.58 96.56 0.12 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.74 0.816 . . . . 64.329999999999998 109.275 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -89.45 -66.14 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.184 -0.916 . . . . 75.239999999999995 110.681 -169.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 167' ' ' SER . 43.0 t80 -114.81 121.77 34.92 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 123.852 0.861 . . . . 73.519999999999996 109.725 -170.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.36 123.71 5.61 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.09 1.86 . . . . 75.219999999999999 111.722 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.02 130.95 95.06 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.971 -0.751 . . . . 75.150000000000006 108.971 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.03 179.78 6.18 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.833 2.355 . . . . 75.400000000000006 112.413 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.78 150.92 48.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 75.329999999999998 109.575 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.483 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . 13.7 ptt180 -92.51 -60.49 1.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 111.838 0.31 . . . . 75.239999999999995 111.838 -174.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -109.47 138.45 45.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 73.530000000000001 110.482 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.1 113.64 47.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.256 -1.757 . . . . 72.319999999999993 106.256 159.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.493 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 35.8 Cg_exo -61.01 123.87 13.76 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.51 2.14 . . . . 72.120000000000005 112.709 -173.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 61.2 m -73.47 119.1 17.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.827 0.451 . . . . 74.340000000000003 110.558 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.3 t -98.62 127.04 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.281 1.032 . . . . 62.399999999999999 108.38 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.08 114.52 28.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.095 0.407 . . . . 74.310000000000002 111.51 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.8 21.89 38.57 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 116.426 1.331 . . . . 71.030000000000001 116.426 160.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.478 HG23 ' NE1' ' A' ' 118' ' ' TRP . 27.2 m -82.3 127.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 117.732 0.766 . . . . 74.420000000000002 111.913 -173.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 t -85.18 117.83 69.59 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 104.85 -2.278 . . . . 72.540000000000006 104.85 152.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo . . . . . 0 C--N 1.371 1.749 0 C-N-CA 120.92 1.08 . . . . 75.040000000000006 113.917 -159.081 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 6.2 t90 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 122.151 0.977 . . . . 75.409999999999997 109.272 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -79.14 -23.92 43.68 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.24 -1.345 . . . . 71.400000000000006 109.426 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.517 ' HB2' ' HD1' ' A' ' 144' ' ' HIS . 82.6 p -78.03 4.54 12.0 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.967 0.907 . . . . 74.430000000000007 112.337 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.96 -37.62 78.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.949 0.5 . . . . 75.340000000000003 110.987 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.49 -31.16 62.1 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.072 0.463 . . . . 63.109999999999999 109.943 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.51 -5.81 57.24 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.042 0.937 . . . . 72.5 111.06 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.0 tp -66.19 -49.71 66.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.296 1.038 . . . . 75.219999999999999 111.36 -173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -103.61 20.97 16.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.999 0.52 . . . . 71.409999999999997 110.661 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 C-N-CA 122.65 0.38 . . . . 72.340000000000003 110.854 174.546 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.867 0.365 . . . . 71.340000000000003 111.524 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.6 tp -86.59 133.37 33.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.467 -0.938 . . . . 72.140000000000001 108.467 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -110.42 171.51 7.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.777 0.831 . . . . 75.239999999999995 109.14 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.19 138.71 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.473 1.109 . . . . 74.420000000000002 109.273 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 135' ' ' ILE . . . -82.68 111.14 18.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.966 0.906 . . . . 64.120000000000005 109.594 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.46 -38.06 68.34 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.699 0.799 . . . . 72.329999999999998 110.937 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.47 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 37.1 m-85 -122.54 140.91 52.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.341 -1.3 . . . . 72.209999999999994 107.574 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -84.34 150.07 25.63 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.734 -0.469 . . . . 72.450000000000003 109.734 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.611 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.9 t80 -139.84 143.52 36.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.051 0.94 . . . . 71.140000000000001 108.642 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.97 133.2 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.564 -1.273 . . . . 63.030000000000001 107.564 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 129.8 41.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.319 0.648 . . . . 52.520000000000003 111.345 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 p -88.35 -38.96 14.7 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.776 0.83 . . . . 75.150000000000006 109.678 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.76 -170.32 12.66 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.344 -0.844 . . . . 45.200000000000003 112.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.74 -35.1 60.3 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.682 0.793 . . . . 65.510000000000005 110.581 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -63.07 -29.32 70.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.054 0.942 . . . . 72.239999999999995 111.871 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.5 p -90.38 154.43 19.68 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.845 0.858 . . . . 65.540000000000006 109.491 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.664 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 58.6 tp -125.12 136.9 54.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.003 0.521 . . . . 71.310000000000002 110.467 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -75.23 131.39 40.35 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.958 0.503 . . . . 74.540000000000006 110.063 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.694 HG22 HG23 ' A' ' 123' ' ' THR . 19.3 pt -128.47 167.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.77 0.828 . . . . 73.409999999999997 111.215 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -123.11 152.36 41.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.363 1.065 . . . . 75.010000000000005 109.568 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.72 122.37 16.22 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.429 -0.582 . . . . 75.329999999999998 109.429 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.4 72.03 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-O 119.537 -0.591 . . . . 73.329999999999998 113.894 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -83.76 125.4 31.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.678 0.739 . . . . 72.109999999999999 110.745 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -78.3 133.86 37.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.277 -0.638 . . . . 72.109999999999999 109.277 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.617 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.77 147.03 34.86 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.574 0.75 . . . . 74.040000000000006 110.715 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -94.81 105.58 17.52 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.961 -0.755 . . . . 73.329999999999998 108.961 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.563 HG12 ' HB1' ' A' ' 119' ' ' ALA . 60.6 t -82.67 105.18 12.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.517 -0.92 . . . . 70.310000000000002 108.517 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.518 HD22 ' HG2' ' A' ' 120' ' ' GLU . 2.6 mm? -65.68 -52.88 48.06 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.162 0.914 . . . . 74.510000000000005 108.594 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.7 155.69 22.53 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.605 -0.725 . . . . 65.239999999999995 114.104 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.592 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 96.9 m-85 -88.15 163.54 16.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.801 0.84 . . . . 75.200000000000003 109.786 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -71.43 -172.57 0.77 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 120.803 0.335 . . . . 72.510000000000005 111.338 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -47.71 -41.1 22.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.858 1.263 . . . . 74.219999999999999 114.144 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -114.52 3.62 14.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.306 0.854 . . . . 74.439999999999998 113.306 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.14 32.86 47.02 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.921 0.728 . . . . 44.539999999999999 114.921 174.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.85 -65.65 0.71 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.437 0.695 . . . . 63.140000000000001 110.736 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.648 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 34.4 m95 -114.4 165.86 12.28 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 75.109999999999999 109.33 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' A' ' 109' ' ' VAL . . . -135.08 131.08 36.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.764 1.226 . . . . 74.049999999999997 111.384 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.518 ' HG2' HD22 ' A' ' 110' ' ' LEU . 24.0 tt0 -68.6 103.05 1.61 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.198 -1.038 . . . . 72.400000000000006 108.198 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.4 140.52 48.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.979 0.912 . . . . 74.299999999999997 109.85 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.475 ' HG3' HD21 ' A' ' 110' ' ' LEU . 55.8 mt-30 -105.51 105.39 15.41 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.575 -0.898 . . . . 72.099999999999994 108.575 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.694 HG23 HG22 ' A' ' 101' ' ' ILE . 68.5 p -99.88 -176.37 3.23 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.816 1.246 . . . . 74.310000000000002 110.357 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.88 -18.37 64.12 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.529 -0.76 . . . . 75.409999999999997 110.231 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.64 -3.46 59.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.664 1.186 . . . . 72.109999999999999 111.714 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.53 -138.39 13.27 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-O 119.513 -0.604 . . . . 75.0 111.815 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -129.73 143.51 50.85 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.724 0.762 . . . . 75.329999999999998 110.096 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.664 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.5 -172.28 43.46 Favored Glycine 0 C--O 1.225 -0.428 0 N-CA-C 110.972 -0.851 . . . . 64.420000000000002 110.972 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 40.9 m95 -107.34 125.19 50.88 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.323 0.561 . . . . 74.239999999999995 110.505 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.426 HG13 HG21 ' A' ' 101' ' ' ILE . 29.7 m -130.52 140.42 38.6 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.433 1.493 . . . . 71.349999999999994 109.091 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 9.3 Cg_exo -72.15 147.96 49.25 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 122.731 2.287 . . . . 71.049999999999997 114.414 -171.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 m -37.2 -51.59 1.02 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.415 1.886 . . . . 73.439999999999998 114.189 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -75.11 -3.18 31.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.546 0.738 . . . . 74.349999999999994 112.809 -171.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -94.47 -23.21 17.82 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.493 0.717 . . . . 74.450000000000003 111.577 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 109' ' ' VAL . 11.4 pt -123.32 173.77 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.794 0.838 . . . . 71.420000000000002 111.346 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.3 t -160.97 153.63 17.43 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.039 -1.097 . . . . 73.319999999999993 108.039 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.24 147.76 93.61 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 121.59 1.527 . . . . 62.119999999999997 110.981 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.82 -6.9 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 CA-C-O 121.499 0.666 . . . . 64.409999999999997 110.885 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -79.29 -13.15 59.84 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.346 0.658 . . . . 73.329999999999998 112.076 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.0 p -88.53 174.82 7.87 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.336 0.588 . . . . 63.32 112.418 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -84.03 -22.68 31.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.047 -0.979 . . . . 74.230000000000004 110.475 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.23 -22.09 66.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.964 0.905 . . . . 75.099999999999994 112.121 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -63.28 -13.74 41.76 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.529 0.566 . . . . 63.43 112.529 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.517 ' HD1' ' HB2' ' A' ' 69' ' ' SER . 95.8 m-70 -94.25 150.65 20.1 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.76 0.824 . . . . 74.310000000000002 110.425 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.8 p -67.66 -38.82 84.3 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 124.272 0.983 . . . . 74.319999999999993 111.635 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.475 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 41.9 p-90 -60.38 -48.96 79.48 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.82 0.7 . . . . 74.040000000000006 111.958 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.48 96.88 2.99 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.125 -0.694 . . . . 74.0 109.125 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -91.57 -2.38 57.15 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.616 -0.72 . . . . 74.010000000000005 111.078 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.54 -161.82 42.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.158 -0.801 . . . . 63.43 112.588 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.33 98.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.4 2.733 . . . . 75.430000000000007 112.564 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 53.5 t -122.94 135.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 114.674 -1.148 . . . . 75.420000000000002 109.9 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.7 p -75.37 156.72 35.17 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.366 0.666 . . . . 62.130000000000003 109.489 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 71.1 ttt180 -62.71 -36.92 84.52 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 118.78 -0.629 . . . . 71.450000000000003 111.361 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -55.42 -43.94 75.8 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.559 0.695 . . . . 73.140000000000001 110.484 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.43 70.22 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.406 -1.27 . . . . 70.439999999999998 111.321 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.5 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.084 0.554 . . . . 74.510000000000005 111.402 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.2 mm-40 -68.98 -30.17 68.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.146 0.578 . . . . 73.140000000000001 110.009 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.73 -47.32 84.09 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.202 0.601 . . . . 75.420000000000002 110.329 171.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.6 mt -60.48 -35.33 75.65 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.987 0.515 . . . . 72.420000000000002 110.679 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 73.9 mt -105.74 21.32 17.45 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.539 -0.755 . . . . 75.319999999999993 113.036 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.8 p -88.61 -35.13 17.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.453 -0.943 . . . . 74.219999999999999 108.453 165.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.7 p -95.97 12.89 28.82 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.94 -1.027 . . . . 64.019999999999996 111.702 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.0 -175.59 40.97 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 112.493 -0.243 . . . . 73.140000000000001 112.493 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.3 pt -131.18 -174.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.363 1.065 . . . . 72.530000000000001 110.036 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -58.72 122.32 13.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 74.030000000000001 110.799 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.78 9.57 68.25 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.84 -0.618 . . . . 71.349999999999994 113.66 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 48.8 m -88.9 127.85 35.66 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.975 0.887 . . . . 61.149999999999999 110.035 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -132.41 -178.33 4.87 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.772 0.714 . . . . 75.209999999999994 112.793 -172.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.0 pp -164.69 155.97 15.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.048 0.939 . . . . 75.140000000000001 109.633 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.669 HG21 HG12 ' A' ' 182' ' ' ILE . 88.1 t -116.37 134.36 60.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.356 -0.979 . . . . 72.519999999999996 108.356 167.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 15.4 ptt180 -130.26 149.39 51.98 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.522 -0.763 . . . . 70.340000000000003 110.077 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -93.11 150.44 20.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.076 1.35 . . . . 74.439999999999998 108.036 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.8 t -79.5 123.51 27.63 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.819 -0.437 . . . . 74.010000000000005 109.819 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.98 -36.14 72.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.284 1.033 . . . . 74.409999999999997 111.2 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.0 p -78.39 -31.09 48.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.409 0.683 . . . . 74.430000000000007 111.566 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.4 m -140.04 89.43 11.19 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.192 0.597 . . . . 75.120000000000005 109.764 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.38 132.7 53.44 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.068 2.512 . . . . 72.400000000000006 112.819 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.52 -27.82 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.842 0.734 . . . . 72.409999999999997 112.388 -175.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -86.87 114.56 23.62 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.817 -0.808 . . . . 73.519999999999996 108.817 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -125.96 148.45 49.25 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.235 0.54 . . . . 73.239999999999995 110.914 -172.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.6 p -144.42 148.88 35.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.782 -1.099 . . . . 74.200000000000003 109.923 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.669 HG12 HG21 ' A' ' 170' ' ' VAL . 41.6 mt -102.25 149.71 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.264 -1.384 . . . . 74.299999999999997 107.264 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -125.29 120.85 32.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.105 -1.443 . . . . 75.430000000000007 107.105 170.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 67.7 tp -114.04 114.11 25.69 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.921 0.782 . . . . 73.420000000000002 110.52 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 29.3 ttt85 -77.48 113.85 15.71 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 109.761 -0.459 . . . . 75.109999999999999 109.761 166.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -142.06 138.68 31.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.206 1.402 . . . . 74.129999999999995 107.477 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 58.74 22.14 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.426 1.09 . . . . 72.310000000000002 111.984 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.93 86.7 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 114.226 0.45 . . . . 72.030000000000001 114.226 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -108.17 147.62 31.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.925 0.89 . . . . 75.010000000000005 108.685 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.32 105.58 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.384 0.674 . . . . 72.109999999999999 109.827 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.35 116.46 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.486 1.115 . . . . 74.349999999999994 109.333 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -91.59 118.95 31.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.826 0.451 . . . . 52.109999999999999 110.751 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.561 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.4 m-85 -94.77 151.17 19.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.185 0.994 . . . . 71.430000000000007 108.782 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -104.71 122.72 46.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.415 -0.587 . . . . 74.420000000000002 109.415 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.2 mt -90.98 105.87 16.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.084 -0.71 . . . . 73.519999999999996 109.084 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.91 140.3 29.63 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.412 0.685 . . . . 71.010000000000005 110.033 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 42.6 m -98.36 119.05 36.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.655 1.182 . . . . 70.019999999999996 107.854 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 174.45 6.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.978 0.911 . . . . 73.329999999999998 110.569 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 61.0 p -66.01 -25.63 67.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.373 0.669 . . . . 54.520000000000003 111.937 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.36 -17.21 29.29 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.143 0.577 . . . . 75.299999999999997 111.0 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.55 6.0 23.81 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-O 119.352 -0.693 . . . . 74.209999999999994 114.493 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -70.96 128.6 36.54 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.915 0.857 . . . . 74.540000000000006 112.097 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.21 143.12 34.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.783 0.833 . . . . 75.099999999999994 108.924 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.511 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.2 p90 -165.9 146.84 6.79 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.506 0.504 . . . . 71.329999999999998 111.624 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 217' ' ' LEU . 78.0 t -89.39 -42.44 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.561 -0.903 . . . . 73.030000000000001 108.561 165.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.2 m -104.87 129.32 53.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.95 -1.023 . . . . 73.310000000000002 109.155 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -67.14 -18.54 65.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.305 0.642 . . . . 64.349999999999994 111.739 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -70.29 -26.56 63.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.608 1.163 . . . . 63.32 110.942 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 51.1 p -137.46 107.66 6.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.535 0.734 . . . . 72.400000000000006 109.93 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.511 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.2 mtt180 -116.56 133.82 55.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.303 1.041 . . . . 75.409999999999997 108.881 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 143.67 50.97 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.365 0.666 . . . . 75.040000000000006 109.945 -170.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -67.91 -22.29 65.09 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.974 0.51 . . . . 73.329999999999998 112.066 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.2 p -130.89 155.14 47.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.121 0.962 . . . . 71.129999999999995 112.05 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -28.19 69.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 113.631 -1.622 . . . . 73.439999999999998 109.327 173.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.79 94.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.733 0.813 . . . . 72.439999999999998 110.945 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.407 0.683 . . . . 73.319999999999993 111.15 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.475 HD11 HG21 ' A' ' 205' ' ' VAL . 17.8 tp -55.2 -54.37 44.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 123.552 0.533 . . . . 70.310000000000002 111.158 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.88 -46.79 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 124.038 0.836 . . . . 74.140000000000001 110.703 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -61.74 -48.05 82.45 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.544 0.527 . . . . 73.129999999999995 111.968 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.02 -47.04 78.86 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.939 -0.573 . . . . 75.150000000000006 109.609 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.641 ' HB3' HD13 ' A' ' 228' ' ' LEU . 15.9 m-70 -82.76 -1.45 51.59 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 112.296 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.8 p -94.14 -40.83 9.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.919 0.488 . . . . 74.349999999999994 110.913 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.7 p -69.63 -38.3 77.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.321 -0.399 . . . . 71.450000000000003 111.019 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 226' ' ' ASP . 17.6 m -132.97 162.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.669 0.747 . . . . 64.349999999999994 112.237 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.34 15.71 0.92 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 127.219 2.208 . . . . 73.349999999999994 113.988 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.621 ' HB2' HG21 ' A' ' 224' ' ' VAL . 23.4 t70 -44.2 33.44 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.464 1 C-N-CA 132.357 4.263 . . . . 74.329999999999998 119.519 -156.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.28 2.14 9.16 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.243 -1.536 . . . . 72.349999999999994 112.63 -171.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.641 HD13 ' HB3' ' A' ' 221' ' ' HIS . 14.5 mt -94.5 165.58 12.47 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 125.701 1.6 . . . . 74.109999999999999 109.972 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.1 tt -56.38 -42.05 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 109.982 -0.377 . . . . 73.040000000000006 109.982 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.9 t -160.91 177.39 10.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.995 0.918 . . . . 70.540000000000006 109.693 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 68.3 p -61.85 150.12 38.26 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.451 1.1 . . . . 75.530000000000001 113.106 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.561 HD21 ' HE1' ' A' ' 193' ' ' TYR . 86.5 mt -83.65 92.44 7.68 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.384 -0.969 . . . . 74.200000000000003 108.384 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -78.76 -51.32 9.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.504 0.557 . . . . 72.329999999999998 112.504 -161.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.4 OUTLIER -148.16 150.22 34.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.843 -1.169 . . . . 74.430000000000007 107.843 169.109 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -96.0 153.29 1.41 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.384 2.722 . . . . 73.109999999999999 114.149 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.51 128.38 88.1 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 114.653 -1.158 . . . . 73.010000000000005 109.53 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.58 -173.79 1.45 Allowed 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 123.006 2.47 . . . . 74.340000000000003 113.31 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.47 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 74.1 mmtt -67.3 133.27 49.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.867 0.867 . . . . 73.099999999999994 109.523 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.465 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 13.5 ptt180 -86.49 -66.72 0.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.538 0.94 . . . . 75.340000000000003 113.538 -167.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.465 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 9.1 t30 -114.98 158.03 22.61 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.984 0.514 . . . . 74.340000000000003 111.323 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.91 114.62 41.09 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 108.115 -1.068 . . . . 72.540000000000006 108.115 166.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.56 123.12 12.87 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.018 2.478 . . . . 74.409999999999997 112.167 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 5.1 m -72.95 103.64 3.82 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.651 -0.704 . . . . 72.420000000000002 111.268 -167.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.484 HG23 ' HG2' ' A' ' 131' ' ' PRO . 25.0 t -93.39 127.92 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.261 -1.014 . . . . 75.209999999999994 108.261 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -104.44 111.18 23.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.426 -0.321 . . . . 71.099999999999994 110.331 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.84 -39.39 0.24 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 118.245 2.058 . . . . 71.200000000000003 118.245 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.3 123.55 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.818 1.044 . . . . 74.439999999999998 113.818 -157.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.1 t -82.04 129.31 64.84 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 106.01 -1.848 . . . . 70.299999999999997 106.01 157.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.371 1.74 0 C-N-CA 121.484 1.456 . . . . 73.129999999999995 113.957 -154.217 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 2.1 t90 . . . . . 0 CA--C 1.55 0.958 0 CA-C-O 121.506 0.669 . . . . 74.420000000000002 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.6 p-10 -63.98 -24.18 67.62 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.355 1.062 . . . . 71.310000000000002 110.236 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.5 m -67.34 3.04 1.37 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.871 1.269 . . . . 75.299999999999997 112.796 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.8 -40.28 83.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.401 1.08 . . . . 74.430000000000007 111.508 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 7.9 pt-20 -68.53 -39.14 81.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.829 0.452 . . . . 75.109999999999999 110.146 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.467 HD21 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -81.12 -10.29 59.68 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.254 -0.884 . . . . 75.120000000000005 111.025 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.3 tp -62.78 -52.75 61.98 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.313 0.645 . . . . 75.549999999999997 110.122 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.9 mt -104.34 20.92 17.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.04 0.536 . . . . 74.439999999999998 110.624 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 122.94 0.496 . . . . 72.319999999999993 111.278 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 CA--C 1.554 1.13 0 CA-C-O 120.502 0.191 . . . . 75.409999999999997 110.767 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.2 tp -84.14 135.28 34.45 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.699 -0.625 . . . . 73.349999999999994 109.462 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -119.22 174.23 6.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.238 1.415 . . . . 75.349999999999994 109.734 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.62 139.41 35.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.959 1.303 . . . . 74.329999999999998 108.338 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 107' ' ' LEU . . . -76.09 130.8 38.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.619 0.768 . . . . 72.409999999999997 109.344 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.0 mt -91.26 -26.91 18.77 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.395 0.678 . . . . 63.43 110.728 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.14 165.64 21.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.504 0.721 . . . . 75.519999999999996 110.362 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 3.4 m-20 -89.18 120.21 30.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.191 -0.913 . . . . 71.340000000000003 108.915 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.529 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.5 t80 -114.96 148.14 39.13 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.282 -1.007 . . . . 72.25 108.282 173.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.6 t -122.92 134.54 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.19 -1.041 . . . . 70.230000000000004 108.19 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.3 124.54 22.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.804 . . . . 74.450000000000003 111.573 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 p -141.32 18.56 2.24 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.076 0.95 . . . . 73.230000000000004 111.213 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.25 -179.28 24.08 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.944 -0.863 . . . . 54.149999999999999 110.944 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.93 -38.84 76.33 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.985 0.514 . . . . 64.200000000000003 111.516 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.472 HD22 ' HG2' ' A' ' 249' ' ' PRO . 27.0 p-10 -105.47 -3.19 22.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.977 0.511 . . . . 75.310000000000002 112.305 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.407 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 73.6 p -72.47 164.57 26.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.728 0.64 . . . . 73.310000000000002 112.728 -170.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.581 HD23 ' HG1' ' A' ' 123' ' ' THR . 67.3 tp -147.18 136.31 22.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.022 0.529 . . . . 75.319999999999993 110.744 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.4 m -80.0 117.6 20.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.307 0.643 . . . . 71.319999999999993 110.615 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.593 HG23 HG23 ' A' ' 123' ' ' THR . 22.6 pt -117.72 157.04 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.167 0.587 . . . . 74.109999999999999 111.009 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.8 m -111.31 151.54 28.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.566 1.146 . . . . 75.200000000000003 109.064 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HZ1' ' HB2' ' A' ' 103' ' ' LYS . 4.0 ttmp? -60.05 125.62 24.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.231 0.612 . . . . 71.310000000000002 110.414 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.62 -7.23 82.41 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.611 . . . . 54.049999999999997 113.751 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -69.57 124.39 23.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.366 0.583 . . . . 71.430000000000007 111.058 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -73.86 134.94 43.35 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.348 -0.612 . . . . 63.140000000000001 109.348 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.595 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.0 159.05 44.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.8 0.84 . . . . 74.530000000000001 110.457 -175.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 56.7 ttm-85 -115.43 109.97 18.64 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.881 0.472 . . . . 74.230000000000004 110.578 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 119' ' ' ALA . 25.5 t -70.61 112.18 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.56 0.695 . . . . 73.150000000000006 109.127 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.08 -41.83 58.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.042 -0.981 . . . . 70.140000000000001 108.364 175.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.77 158.33 16.79 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.843 0.714 . . . . 64.099999999999994 113.639 171.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.764 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 59.9 m-85 -88.16 164.89 15.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 70.209999999999994 111.666 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.7 -172.56 3.37 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.972 0.909 . . . . 73.219999999999999 111.162 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.24 -35.43 11.97 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 115.158 1.54 . . . . 73.540000000000006 115.158 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -110.5 -15.43 13.9 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.136 0.574 . . . . 74.299999999999997 111.791 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.764 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 87.97 30.19 18.26 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 114.631 0.613 . . . . 73.209999999999994 114.631 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.45 -38.05 17.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.516 0.658 . . . . 75.530000000000001 111.79 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 18.1 m95 -125.52 146.25 49.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.163 0.585 . . . . 74.129999999999995 110.559 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -129.72 136.5 49.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 74.129999999999995 110.927 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.641 ' HG2' HE21 ' A' ' 127' ' ' GLN . 27.1 tt0 -69.41 103.79 2.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.11 -1.07 . . . . 74.409999999999997 108.11 173.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.7 138.42 39.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.108 0.563 . . . . 75.549999999999997 111.135 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 61.3 tt0 -97.75 104.89 16.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.903 -1.147 . . . . 74.310000000000002 107.903 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.595 HG22 ' HB3' ' A' ' 107' ' ' LEU . 68.5 p -111.09 172.07 7.1 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.753 0.821 . . . . 72.5 110.86 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -14.53 62.97 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 114.718 -1.128 . . . . 74.319999999999993 110.031 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.1 -26.66 30.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.18 0.992 . . . . 64.439999999999998 111.539 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 136.22 -158.68 24.07 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 120.158 -0.245 . . . . 75.019999999999996 112.533 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.641 HE21 ' HG2' ' A' ' 120' ' ' GLU . 66.5 tp60 -101.82 137.39 40.18 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.208 0.504 . . . . 74.010000000000005 111.377 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 165.9 162.67 17.76 Favored Glycine 0 C--N 1.347 1.143 0 C-N-CA 121.403 -0.427 . . . . 63.520000000000003 113.399 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 43.1 m95 -77.15 133.69 38.9 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.319 1.047 . . . . 74.140000000000001 112.19 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.3 m -136.28 146.32 55.64 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 125.108 1.363 . . . . 70.530000000000001 108.552 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 73.4 Cg_endo -76.06 150.05 33.25 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.1 1.867 . . . . 71.200000000000003 114.888 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -39.23 -49.06 1.87 Allowed 'General case' 0 C--N 1.366 1.308 0 C-N-CA 126.243 1.817 . . . . 61.299999999999997 113.516 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -79.22 -0.85 33.78 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.082 0.771 . . . . 73.219999999999999 113.082 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -98.76 -13.38 20.22 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.85 0.86 . . . . 74.519999999999996 111.487 170.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.73 177.25 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.26 1.024 . . . . 75.25 110.451 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.4 t -161.75 151.91 14.3 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 108.463 -0.939 . . . . 73.450000000000003 108.463 170.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.03 148.15 86.69 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.705 1.603 . . . . 62.450000000000003 111.679 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 36.9 t -71.27 -7.76 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-O 121.688 0.756 . . . . 74.310000000000002 109.893 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -75.45 -20.26 58.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.078 0.951 . . . . 74.0 111.746 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.5 p -91.83 174.41 7.35 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.448 0.699 . . . . 75.25 111.607 -172.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.28 -20.04 32.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 71.129999999999995 110.569 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.5 -19.13 65.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.086 0.955 . . . . 75.299999999999997 111.992 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -62.68 -21.43 65.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.499 0.72 . . . . 74.340000000000003 112.658 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -78.47 139.75 38.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.285 0.634 . . . . 75.420000000000002 110.143 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.9 p -59.65 -41.94 91.66 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.187 0.995 . . . . 71.230000000000004 111.906 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -67.01 -38.66 86.35 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.834 0.709 . . . . 73.239999999999995 112.229 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.5 118.51 20.71 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.179 -0.674 . . . . 74.140000000000001 109.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -112.63 -1.46 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.122 0.569 . . . . 73.530000000000001 112.273 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.55 -162.23 49.0 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 118.807 -0.996 . . . . 75.099999999999994 112.794 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.38 95.9 0.15 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.988 2.459 . . . . 72.430000000000007 112.721 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 82.3 t -119.93 149.72 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.996 1.318 . . . . 70.120000000000005 109.002 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 45.6 m -85.66 166.8 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.525 0.73 . . . . 65.450000000000003 110.598 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -60.04 -50.92 71.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.988 0.515 . . . . 74.439999999999998 110.975 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -58.24 -39.75 79.95 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.0 0.92 . . . . 74.430000000000007 111.7 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.4 75.48 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.907 -0.588 . . . . 73.319999999999993 110.801 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.496 ' HA ' HD13 ' A' ' 159' ' ' LEU . . . -57.34 -39.21 75.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.585 0.707 . . . . 71.540000000000006 111.505 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -83.7 -19.04 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.254 -0.884 . . . . 73.5 111.971 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -24.69 43.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.839 0.745 . . . . 73.200000000000003 110.936 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.83 HD23 ' HA ' ' A' ' 239' ' ' ARG . 42.7 mt -69.77 -43.66 71.76 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.013 -0.994 . . . . 74.310000000000002 110.007 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 75.4 mt -94.8 22.77 6.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.844 -1.071 . . . . 71.400000000000006 112.285 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.7 p -74.23 -41.68 60.96 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.099 0.476 . . . . 75.239999999999995 110.152 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 p -111.99 15.06 20.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.183 0.993 . . . . 65.200000000000003 112.247 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.29 168.73 52.2 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 121.908 -0.187 . . . . 61.240000000000002 113.235 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 pt -101.8 -176.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.641 0.776 . . . . 65.299999999999997 111.056 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -63.31 125.35 23.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.459 -0.791 . . . . 75.200000000000003 109.853 172.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.451 ' HA2' HD13 ' A' ' 184' ' ' LEU . . . 90.56 10.79 63.08 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 119.313 -0.715 . . . . 63.240000000000002 113.181 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 68.4 m -82.17 116.01 21.53 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.364 1.082 . . . . 64.040000000000006 111.627 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 183' ' ' SER . 12.9 p90 -132.25 168.47 17.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.448 0.642 . . . . 73.530000000000001 111.494 -171.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.32 155.88 25.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.355 -1.293 . . . . 73.530000000000001 108.584 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.648 HG23 HG12 ' A' ' 182' ' ' ILE . 77.5 t -112.33 125.04 69.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.028 -1.101 . . . . 74.530000000000001 108.028 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 36.3 ptt85 -114.81 161.65 17.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.039 -1.097 . . . . 75.340000000000003 108.039 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 155.24 23.11 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.9 t -79.79 126.41 30.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.049 0.54 . . . . 75.209999999999994 109.794 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -63.42 -34.87 78.69 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 123.948 0.78 . . . . 74.25 110.265 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 p -82.01 -19.38 40.57 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.626 0.77 . . . . 63.119999999999997 111.989 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -143.86 98.78 5.21 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.901 0.48 . . . . 72.200000000000003 111.176 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.53 136.35 75.33 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.089 2.526 . . . . 74.219999999999999 112.638 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.33 -29.53 6.07 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.135 -0.484 . . . . 62.539999999999999 113.546 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -75.83 117.3 17.42 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.384 -0.599 . . . . 74.140000000000001 109.384 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -122.29 145.79 47.9 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.658 0.742 . . . . 75.420000000000002 110.288 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.1 m -132.49 144.52 50.51 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.523 -1.217 . . . . 73.109999999999999 108.291 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.648 HG12 HG23 ' A' ' 170' ' ' VAL . 31.9 mt -99.68 148.56 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.787 -1.56 . . . . 74.5 106.787 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -123.9 108.71 12.73 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.336 -1.357 . . . . 74.409999999999997 107.336 172.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.451 HD13 ' HA2' ' A' ' 166' ' ' GLY . 67.3 tp -105.93 142.75 35.11 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.367 -0.605 . . . . 73.319999999999993 109.367 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.5 ttt85 -117.53 119.38 34.85 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.525 1.13 . . . . 75.049999999999997 109.486 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -140.97 136.27 32.01 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.061 1.344 . . . . 63.149999999999999 107.84 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 58.18 21.23 7.83 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.637 1.175 . . . . 74.329999999999998 111.62 -170.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.17 -9.5 74.73 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.185 0.434 . . . . 52.409999999999997 114.185 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 57.4 mtp85 -96.18 140.12 31.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.522 0.661 . . . . 75.219999999999999 110.177 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.15 108.42 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.691 0.796 . . . . 72.109999999999999 110.81 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.82 150.6 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.278 1.431 . . . . 74.549999999999997 108.51 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 86.0 m-70 -125.45 127.13 46.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.469 0.307 . . . . 73.340000000000003 110.174 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.44 ' HE1' HD23 ' A' ' 232' ' ' LEU . 5.9 m-85 -101.06 149.29 24.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.899 0.88 . . . . 74.439999999999998 109.287 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -97.99 117.25 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.708 -0.849 . . . . 72.5 108.708 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.7 mt -82.2 99.83 5.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.299 -1.371 . . . . 74.049999999999997 107.299 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -75.04 110.6 9.47 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.555 -1.276 . . . . 73.099999999999994 107.555 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.7 m -89.28 106.4 18.42 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.956 -0.757 . . . . 72.450000000000003 108.956 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.429 ' HB3' ' HE1' ' A' ' 204' ' ' TYR . . . -63.06 148.68 47.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.909 0.884 . . . . 75.049999999999997 110.743 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.3 p -65.5 -23.81 66.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.255 0.622 . . . . 75.329999999999998 112.13 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -78.24 -18.6 55.16 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.862 0.465 . . . . 72.439999999999998 110.986 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.61 14.77 12.06 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.869 -0.406 . . . . 63.520000000000003 114.012 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -92.15 139.0 31.07 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.779 0.789 . . . . 74.25 110.949 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.13 143.03 29.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.956 -1.128 . . . . 70.420000000000002 107.956 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.5 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.5 p90 -163.39 135.45 5.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.221 0.326 . . . . 74.319999999999993 111.675 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.4 t -82.94 -34.02 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.315 -0.995 . . . . 74.239999999999995 108.315 161.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.9 m -99.48 119.91 38.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.446 1.099 . . . . 71.549999999999997 110.344 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.6 t -59.12 -34.15 71.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.805 1.242 . . . . 75.340000000000003 112.634 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.22 -2.86 58.85 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.968 0.907 . . . . 74.340000000000003 111.836 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.5 m -135.05 85.63 2.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.068 0.547 . . . . 73.319999999999993 109.527 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.5 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 43.5 mtt180 -93.59 120.49 33.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.929 0.891 . . . . 75.319999999999993 109.286 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -107.44 149.68 27.64 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.533 0.733 . . . . 74.450000000000003 109.351 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -62.36 -44.13 97.18 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.523 0.514 . . . . 70.420000000000002 110.161 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.4 p -125.68 160.5 29.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.637 0.732 . . . . 62.549999999999997 111.785 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.24 -25.92 68.27 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.728 -1.124 . . . . 71.200000000000003 109.317 171.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.13 86.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.039 0.936 . . . . 72.109999999999999 111.395 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -72.02 -30.71 65.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.131 -0.94 . . . . 74.049999999999997 111.346 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.8 tp -57.12 -55.49 34.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.306 0.379 . . . . 75.299999999999997 110.351 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.2 -41.96 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.752 0.658 . . . . 72.25 111.254 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -61.87 -55.1 33.24 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.452 0.47 . . . . 75.420000000000002 111.445 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -61.52 -38.08 86.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.443 0.697 . . . . 73.230000000000004 110.866 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.709 ' HB3' HD11 ' A' ' 228' ' ' LEU . 18.6 m170 -88.65 -6.41 57.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.793 -0.639 . . . . 73.510000000000005 112.386 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.0 p -91.07 -31.89 16.09 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 110.22 -0.289 . . . . 74.430000000000007 110.22 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 40.4 p -76.71 -40.63 48.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.206 -0.452 . . . . 72.439999999999998 111.351 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.616 HG23 ' HB2' ' A' ' 226' ' ' ASP . 18.3 m -134.84 158.45 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.331 0.652 . . . . 71.540000000000006 111.623 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.45 14.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 126.932 2.093 . . . . 71.219999999999999 114.424 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.616 ' HB2' HG23 ' A' ' 224' ' ' VAL . 36.4 t70 -42.92 32.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.78 1 C-N-CA 132.07 4.148 . . . . 73.319999999999993 119.761 -155.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.22 -1.8 9.71 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.22 -1.55 . . . . 71.299999999999997 112.112 -168.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.2 mt -92.07 162.8 14.21 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.691 1.196 . . . . 74.040000000000006 109.434 168.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.49 -42.57 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 121.046 0.45 . . . . 74.430000000000007 110.42 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -161.36 -179.23 7.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.106 0.962 . . . . 74.140000000000001 109.127 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 49.0 p -70.08 143.99 52.27 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.471 0.708 . . . . 65.430000000000007 112.346 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.44 HD23 ' HE1' ' A' ' 193' ' ' TYR . 49.3 mt -72.21 145.66 47.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.649 -1.241 . . . . 75.319999999999993 107.649 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -147.26 -78.66 0.16 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.323 0.965 . . . . 73.129999999999995 111.534 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 167' ' ' SER . 11.5 t80 -83.41 124.06 76.17 Favored Pre-proline 0 C--O 1.208 -1.09 0 C-N-CA 124.284 1.034 . . . . 73.129999999999995 108.445 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -86.6 139.3 5.69 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.291 1.994 . . . . 73.25 112.122 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.25 151.9 90.14 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.408 0.683 . . . . 74.219999999999999 109.778 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.06 176.83 9.52 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.508 2.139 . . . . 72.209999999999994 112.118 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.62 154.57 40.2 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.129 0.572 . . . . 75.439999999999998 110.285 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.83 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -69.9 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.723 1.008 . . . . 75.209999999999994 113.723 -158.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.442 ' H ' ' HG2' ' A' ' 239' ' ' ARG . 65.3 t30 -120.45 159.33 25.34 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.012 -1.055 . . . . 75.200000000000003 108.561 159.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.458 ' NZ ' ' HB2' ' A' ' 90' ' ' ASP . 98.6 mttt -73.43 115.64 43.33 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 107.686 -1.227 . . . . 65.219999999999999 107.686 160.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.49 127.44 21.83 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.042 2.495 . . . . 74.409999999999997 112.587 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 26.0 m -80.49 116.43 20.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.84 -0.43 . . . . 62.240000000000002 109.84 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.37 111.89 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.643 0.777 . . . . 74.420000000000002 108.964 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.9 112.8 20.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.541 -0.299 . . . . 75.140000000000001 110.692 -166.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 70.47 -41.51 0.51 Allowed Glycine 0 CA--C 1.542 1.737 0 N-CA-C 117.436 1.735 . . . . 71.239999999999995 117.436 163.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.61 135.4 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 117.687 0.743 . . . . 72.549999999999997 112.667 -157.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -82.8 130.08 59.47 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 105.757 -1.942 . . . . 74.049999999999997 105.757 157.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.472 ' HG2' HD22 ' A' ' 97' ' ' ASN . 12.2 Cg_exo . . . . . 0 C--N 1.365 1.419 0 C-N-CA 121.575 1.516 . . . . 54.420000000000002 113.829 -153.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.781 ' HB2' ' HG3' ' A' ' 235' ' ' PRO . 11.6 t90 . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 121.949 0.881 . . . . 74.209999999999994 109.021 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.7 p-10 -64.53 -24.18 67.52 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.367 -0.833 . . . . 64.439999999999998 110.012 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.7 p -69.69 3.67 2.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.863 1.265 . . . . 71.349999999999994 112.775 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.6 -20.96 66.13 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.816 0.446 . . . . 74.510000000000005 110.664 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 14.4 pt-20 -63.33 -42.46 98.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.056 0.542 . . . . 75.239999999999995 109.816 168.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -72.39 -16.5 61.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.469 1.108 . . . . 71.109999999999999 110.924 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 tp -63.53 -51.4 65.61 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.675 0.79 . . . . 64.430000000000007 110.632 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.6 mt -103.13 4.17 36.68 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 111.41 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 122.667 0.387 . . . . 72.239999999999995 110.93 175.183 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 t30 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 121.242 0.544 . . . . 74.230000000000004 110.069 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.6 tp -79.4 139.12 37.81 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.327 -0.397 . . . . 74.219999999999999 110.033 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -118.62 171.54 8.12 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.729 1.212 . . . . 75.230000000000004 109.723 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.35 131.48 22.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.502 1.121 . . . . 74.340000000000003 109.406 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.74 114.11 6.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.542 1.137 . . . . 74.230000000000004 109.889 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 78.0 mt -73.92 -32.63 63.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.516 0.726 . . . . 64.349999999999994 110.496 173.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.53 163.78 21.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.606 -1.179 . . . . 63.340000000000003 108.69 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.15 149.69 23.75 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.803 -0.814 . . . . 75.200000000000003 108.803 166.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.615 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.2 t80 -132.96 141.52 48.38 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.809 -1.182 . . . . 74.439999999999998 107.809 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.24 133.47 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.321 -0.992 . . . . 72.409999999999997 108.321 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.25 132.51 53.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.51 0.724 . . . . 52.229999999999997 111.108 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 p -129.39 -41.12 1.4 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.186 0.995 . . . . 74.140000000000001 111.065 -172.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.88 23.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.307 -0.406 . . . . 72.109999999999999 112.524 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.26 -43.57 10.88 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.638 0.719 . . . . 74.25 111.067 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.433 HD22 ' HD2' ' A' ' 249' ' ' PRO . 6.6 p30 -108.24 10.84 27.73 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.613 0.765 . . . . 71.329999999999998 112.123 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.0 p -73.14 150.35 42.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.347 0.659 . . . . 74.200000000000003 110.122 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.607 HD22 ' HG1' ' A' ' 123' ' ' THR . 58.1 tp -130.32 127.73 40.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.089 0.556 . . . . 74.040000000000006 110.824 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -74.27 133.14 42.62 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.221 0.609 . . . . 75.129999999999995 111.619 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.615 HG12 ' HB3' ' A' ' 91' ' ' PHE . 11.4 pt -130.28 166.84 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.208 1.003 . . . . 74.140000000000001 111.1 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.9 m -109.84 155.89 21.08 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.577 1.151 . . . . 74.430000000000007 110.329 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -58.95 127.84 34.24 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.162 0.585 . . . . 64.519999999999996 110.196 171.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.83 3.88 84.68 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.388 0.515 . . . . 64.340000000000003 114.388 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' OE2' ' HB ' ' A' ' 123' ' ' THR . 38.1 tt0 -73.45 142.48 46.86 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.053 0.541 . . . . 64.430000000000007 110.516 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -93.1 132.28 37.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.454 -0.573 . . . . 75.409999999999997 109.454 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.48 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -143.46 163.44 33.11 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.012 0.925 . . . . 72.450000000000003 110.511 -177.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -123.79 108.05 12.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.771 0.428 . . . . 72.409999999999997 110.345 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 119' ' ' ALA . 41.3 t -73.65 117.86 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.197 0.522 . . . . 73.530000000000001 110.47 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.8 mt -84.08 -60.3 2.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.822 -1.081 . . . . 74.450000000000003 109.079 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.4 141.1 9.01 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 120.853 -0.689 . . . . 51.229999999999997 112.942 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.627 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 20.5 m-85 -88.41 154.54 20.29 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.413 0.685 . . . . 74.219999999999999 109.781 171.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -78.54 -174.9 4.06 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.527 -1.215 . . . . 71.420000000000002 111.857 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -50.01 -31.65 13.36 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.185 1.394 . . . . 71.25 114.253 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -112.8 3.08 16.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.836 0.68 . . . . 71.219999999999999 112.836 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.49 19.65 74.74 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.974 0.75 . . . . 73.549999999999997 114.974 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.46 -12.13 18.79 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.453 0.701 . . . . 73.200000000000003 112.806 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 44.7 m95 -134.34 144.87 48.52 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.535 0.734 . . . . 72.010000000000005 110.248 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.516 ' HB3' HG13 ' A' ' 109' ' ' VAL . . . -132.98 129.7 38.55 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.716 0.807 . . . . 63.439999999999998 110.962 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.83 97.43 2.24 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 106.814 -1.55 . . . . 74.239999999999995 106.814 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.08 144.49 33.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.393 0.677 . . . . 75.340000000000003 111.434 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -93.76 103.37 15.51 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.78 -1.192 . . . . 72.239999999999995 107.78 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.607 ' HG1' HD22 ' A' ' 99' ' ' LEU . 38.5 p -97.36 174.56 6.63 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.003 0.921 . . . . 74.129999999999995 109.979 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -63.83 -23.21 67.26 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.189 0.518 . . . . 74.5 110.187 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -79.19 -29.35 42.87 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.598 1.159 . . . . 74.209999999999994 111.036 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 139.86 -170.03 24.43 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 112.282 -0.327 . . . . 63.229999999999997 112.282 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -97.33 135.93 38.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.463 0.632 . . . . 73.209999999999994 111.224 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.454 ' N ' HD21 ' A' ' 99' ' ' LEU . . . 170.6 172.28 36.79 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.328 -0.709 . . . . 63.149999999999999 111.328 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -85.19 124.02 31.35 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.344 0.572 . . . . 72.310000000000002 112.076 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.523 HG23 HD12 ' A' ' 135' ' ' ILE . 17.2 m -126.99 143.39 46.71 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.09 1.356 . . . . 72.510000000000005 108.445 170.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 66.2 Cg_endo -88.13 149.61 6.82 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.257 1.971 . . . . 73.219999999999999 115.33 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 m -46.67 -28.09 1.37 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.607 1.963 . . . . 75.540000000000006 115.592 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.531 HD22 HG22 ' A' ' 244' ' ' VAL . 32.0 p-10 -81.95 -16.32 50.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.478 0.311 . . . . 75.450000000000003 111.769 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.425 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 30.1 m-85 -94.48 -23.53 17.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 72.109999999999999 111.688 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.523 HD12 HG23 ' A' ' 130' ' ' VAL . 20.4 pt -123.56 168.01 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.071 0.549 . . . . 72.099999999999994 112.282 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.456 ' HG1' ' HB2' ' A' ' 142' ' ' GLU . 13.3 t -159.75 151.3 16.54 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.964 0.906 . . . . 74.400000000000006 108.643 174.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.7 147.24 95.53 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 121.745 1.63 . . . . 73.230000000000004 111.724 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.29 -11.56 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.738 0.78 . . . . 73.239999999999995 110.767 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -80.26 -13.53 59.13 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.146 0.578 . . . . 75.549999999999997 111.648 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.2 p -89.16 165.16 14.65 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.253 0.621 . . . . 64.120000000000005 110.973 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.9 mt -80.35 -21.35 42.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.804 0.842 . . . . 71.239999999999995 110.817 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.456 ' HB2' ' HG1' ' A' ' 136' ' ' THR . 1.2 mp0 -63.83 -17.16 62.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.843 1.257 . . . . 74.409999999999997 111.68 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -61.54 -20.22 63.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.957 0.903 . . . . 73.239999999999995 112.976 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.47 144.55 25.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.167 0.587 . . . . 70.430000000000007 111.276 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -60.95 -41.5 96.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.596 1.158 . . . . 72.040000000000006 111.869 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -67.26 -33.07 74.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.649 0.779 . . . . 74.430000000000007 112.556 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -77.59 116.31 18.05 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.69 -0.856 . . . . 73.209999999999994 108.69 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.416 ' ND1' HD12 ' A' ' 159' ' ' LEU . 33.0 m170 -113.33 -2.71 13.94 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.36 0.504 . . . . 73.430000000000007 112.36 -175.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.9 -136.25 25.43 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 118.543 -1.143 . . . . 72.519999999999996 113.091 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.79 90.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.53 2.82 . . . . 74.549999999999997 112.71 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.6 t -132.31 133.73 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 75.549999999999997 108.963 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -89.79 175.53 7.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.862 0.865 . . . . 73.409999999999997 109.87 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 2.6 tmt_? -58.75 -45.92 88.6 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.76 0.424 . . . . 73.450000000000003 110.261 175.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -63.44 -35.12 79.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.714 0.805 . . . . 72.209999999999994 111.547 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.83 -30.34 62.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.058 -0.519 . . . . 70.329999999999998 110.95 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.7 71.23 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.009 0.524 . . . . 74.340000000000003 111.063 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 12.0 mm-40 -62.86 -48.28 79.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.251 0.62 . . . . 70.430000000000007 109.503 170.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.54 -41.21 69.45 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.077 1.751 . . . . 63.119999999999997 111.669 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.582 HD23 ' HB3' ' A' ' 239' ' ' ARG . 59.0 mt -68.1 -55.43 12.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.036 0.934 . . . . 74.209999999999994 111.684 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -84.89 16.02 3.62 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.576 0.584 . . . . 74.120000000000005 112.576 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.6 p -65.0 -40.34 94.8 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.405 0.621 . . . . 74.150000000000006 110.397 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.9 p -98.29 18.89 15.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.34 1.056 . . . . 73.230000000000004 111.0 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.46 162.97 32.31 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.243 -0.435 . . . . 73.299999999999997 112.56 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.1 -176.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.39 1.076 . . . . 70.299999999999997 110.039 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -67.47 123.2 19.75 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.422 -0.585 . . . . 74.340000000000003 109.422 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.78 5.98 57.36 Favored Glycine 0 C--O 1.25 1.155 0 CA-C-O 119.555 -0.581 . . . . 75.299999999999997 113.187 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 52.6 m -83.88 131.69 34.85 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 119.188 -0.434 . . . . 73.219999999999999 110.5 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.58 168.07 20.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.409 0.623 . . . . 65.340000000000003 111.557 -172.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.16 158.72 27.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 114.326 -1.306 . . . . 74.140000000000001 108.979 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 182' ' ' ILE . 98.9 t -119.31 137.69 52.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 N-CA-C 108.338 -0.986 . . . . 72.519999999999996 108.338 168.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.617 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 0.4 OUTLIER -122.26 146.86 46.89 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.009 -0.996 . . . . 73.519999999999996 109.634 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.1 tp10 -97.15 139.64 32.84 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.005 1.322 . . . . 71.310000000000002 108.207 164.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.4 t -83.82 123.14 29.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 72.519999999999996 109.093 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -81.88 -26.55 34.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.28 0.562 . . . . 65.239999999999995 109.799 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.8 m -64.49 -39.12 93.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.281 1.033 . . . . 73.150000000000006 110.213 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 47.5 m -137.51 91.3 14.19 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.035 -1.098 . . . . 71.319999999999993 108.035 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.68 134.38 60.31 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.98 2.453 . . . . 74.340000000000003 112.679 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.06 -27.23 21.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.483 -0.78 . . . . 75.400000000000006 112.549 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -85.22 116.9 23.84 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.538 -0.912 . . . . 71.329999999999998 108.538 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 99.4 mtt180 -123.38 159.5 28.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.477 0.656 . . . . 64.140000000000001 111.668 -170.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.421 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 18.8 m -149.0 152.51 36.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.914 -1.039 . . . . 71.120000000000005 109.516 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.578 HG12 HG23 ' A' ' 170' ' ' VAL . 25.3 mt -102.72 149.08 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.389 -1.337 . . . . 72.400000000000006 107.389 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.2 m -126.43 114.6 18.39 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.311 -0.996 . . . . 64.420000000000002 108.311 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.404 HD21 HG23 ' A' ' 230' ' ' THR . 41.7 tp -113.03 113.5 25.54 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.088 0.404 . . . . 73.040000000000006 109.911 175.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 44.4 ttt180 -77.82 115.3 17.46 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.324 0.583 . . . . 73.409999999999997 110.013 166.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -139.03 144.65 38.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.613 1.565 . . . . 75.239999999999995 107.361 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 58.3 21.07 7.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.04 0.936 . . . . 75.209999999999994 111.919 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.82 -0.37 89.62 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 119.418 -0.657 . . . . 43.149999999999999 114.535 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 55.8 mtp180 -115.36 150.42 36.35 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 117.893 0.846 . . . . 75.010000000000005 109.672 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 62.0 t -100.82 118.94 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.146 0.578 . . . . 75.319999999999993 110.541 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -108.21 117.47 34.23 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.184 0.993 . . . . 74.340000000000003 108.634 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -91.42 122.32 33.91 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.022 0.529 . . . . 75.510000000000005 110.503 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.497 ' HE1' HD22 ' A' ' 232' ' ' LEU . 6.6 m-85 -94.36 149.08 21.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.43 1.092 . . . . 74.209999999999994 108.291 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -101.21 127.5 47.75 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.087 -0.708 . . . . 74.120000000000005 109.087 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.51 101.05 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.83 -1.174 . . . . 71.209999999999994 107.83 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -88.11 144.51 26.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.934 1.294 . . . . 73.230000000000004 109.062 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -111.46 116.86 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.55 -0.537 . . . . 75.010000000000005 109.55 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.34 168.15 13.09 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.715 0.806 . . . . 73.219999999999999 110.652 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.6 m -62.81 -28.02 69.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.931 0.892 . . . . 74.420000000000002 112.368 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -90.19 -0.04 57.42 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.063 0.945 . . . . 75.209999999999994 111.969 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 92.09 12.74 58.53 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 114.081 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -83.23 128.09 34.2 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.453 0.627 . . . . 73.450000000000003 111.016 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -81.45 148.14 29.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.648 0.779 . . . . 75.439999999999998 109.288 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.532 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 47.3 p90 -168.21 147.11 4.51 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.361 0.413 . . . . 64.319999999999993 111.115 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 217' ' ' LEU . 66.0 t -89.65 -41.05 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.38 -0.97 . . . . 74.400000000000006 108.38 164.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.407 ' HG ' ' HA3' ' A' ' 227' ' ' GLY . 46.6 m -104.94 130.17 53.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.091 0.956 . . . . 65.400000000000006 110.029 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.5 t -66.03 -20.59 66.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 74.140000000000001 112.959 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -76.87 -28.64 55.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.615 0.766 . . . . 73.019999999999996 110.666 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.4 m -124.6 98.09 5.58 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.233 0.613 . . . . 74.420000000000002 110.137 -172.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.532 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.4 mtt180 -112.08 144.36 41.58 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.973 0.909 . . . . 72.129999999999995 109.284 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.95 151.7 52.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.773 0.829 . . . . 70.129999999999995 108.985 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.33 -40.6 77.49 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.988 -0.375 . . . . 72.140000000000001 109.988 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -121.42 160.69 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.042 0.925 . . . . 64.230000000000004 112.353 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.429 HD12 HG11 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -66.8 -27.74 67.81 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.714 -1.584 . . . . 74.140000000000001 109.431 171.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.76 96.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.492 0.717 . . . . 63.140000000000001 110.782 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -68.78 -38.78 80.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.068 0.947 . . . . 73.219999999999999 111.165 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.475 HD13 HG22 ' A' ' 205' ' ' VAL . 16.6 tp -55.12 -56.9 14.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.037 0.535 . . . . 65.439999999999998 110.712 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.62 -38.22 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.545 0.738 . . . . 73.409999999999997 111.774 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -61.37 -57.96 10.17 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.784 0.326 . . . . 75.129999999999995 111.177 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -64.14 -28.15 69.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.805 -0.634 . . . . 75.099999999999994 111.028 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.651 ' HB3' HD12 ' A' ' 228' ' ' LEU . 11.6 m170 -91.13 -10.85 40.41 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.88 0.472 . . . . 64.010000000000005 112.186 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 98.3 p -87.62 -29.19 21.4 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 110.181 -0.303 . . . . 70.25 110.181 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 59.0 p -77.27 -50.38 12.99 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.021 0.528 . . . . 74.329999999999998 110.74 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.588 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.7 m -126.4 157.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 121.667 0.746 . . . . 74.230000000000004 111.942 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.63 17.74 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 127.552 2.341 . . . . 74.310000000000002 114.538 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.588 ' HB2' HG23 ' A' ' 224' ' ' VAL . 32.0 t70 -42.47 28.66 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.581 1 C-N-CA 132.619 4.368 . . . . 75.239999999999995 119.497 -152.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.407 ' HA3' ' HG ' ' A' ' 206' ' ' SER . . . 123.11 -5.4 9.55 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 119.835 -1.79 . . . . 71.030000000000001 112.169 -165.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -89.62 160.87 16.43 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.831 1.252 . . . . 73.120000000000005 109.792 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.07 -34.35 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 116.272 -0.422 . . . . 73.200000000000003 110.855 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.404 HG23 HD21 ' A' ' 184' ' ' LEU . 3.8 t -162.3 178.49 8.65 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.865 0.866 . . . . 73.209999999999994 109.796 173.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 50.1 p -73.07 142.39 47.59 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.873 0.469 . . . . 73.25 111.184 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.497 HD22 ' HE1' ' A' ' 193' ' ' TYR . 46.8 mt -73.36 134.74 44.19 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.474 -0.935 . . . . 73.129999999999995 108.474 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -140.26 -68.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 119.982 1.264 . . . . 73.430000000000007 112.508 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 167' ' ' SER . 16.6 t80 -80.1 120.82 80.89 Favored Pre-proline 0 C--O 1.212 -0.915 0 N-CA-C 107.861 -1.162 . . . . 74.530000000000001 107.861 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.781 ' HG3' ' HB2' ' A' ' 67' ' ' TRP . 58.5 Cg_endo -86.69 144.02 7.42 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.012 1.808 . . . . 71.200000000000003 112.736 173.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.54 149.09 80.85 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 108.878 -0.786 . . . . 72.530000000000001 108.878 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -88.26 174.59 4.34 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.359 2.039 . . . . 75.030000000000001 111.661 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 75.6 mmtt -59.57 138.1 57.82 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.127 -0.694 . . . . 74.329999999999998 109.127 175.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.582 ' HB3' HD23 ' A' ' 159' ' ' LEU . 15.9 ptt180 -62.69 -67.4 0.42 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.758 1.021 . . . . 74.019999999999996 113.758 -157.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.571 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 7.9 t30 -119.03 165.19 14.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.844 0.747 . . . . 73.129999999999995 110.004 164.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 82.4 mttt -65.27 136.19 96.36 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 110.16 -0.311 . . . . 63.109999999999999 110.16 163.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 7.4 Cg_exo -72.58 126.96 11.96 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.945 2.43 . . . . 73.530000000000001 112.901 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 99.1 m -84.6 124.28 31.26 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.833 -0.802 . . . . 74.319999999999993 108.833 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.531 HG22 HD22 ' A' ' 133' ' ' ASN . 4.3 t -99.84 139.21 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.392 -0.966 . . . . 74.150000000000006 108.392 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.3 114.82 28.98 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.712 0.405 . . . . 75.5 111.822 -161.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.62 62.19 Favored Glycine 0 C--N 1.362 1.997 0 N-CA-C 115.827 1.091 . . . . 72.209999999999994 115.827 163.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.425 HG23 ' NE1' ' A' ' 118' ' ' TRP . 9.3 p -105.6 130.06 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 114.605 1.335 . . . . 74.219999999999999 114.605 -161.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.0 m -86.42 118.89 71.03 Favored Pre-proline 0 N--CA 1.48 1.066 0 N-CA-C 105.236 -2.135 . . . . 73.129999999999995 105.236 148.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.433 ' HD2' HD22 ' A' ' 97' ' ' ASN . 82.9 Cg_exo . . . . . 0 C--N 1.385 2.476 0 C-N-CA 122.115 1.877 . . . . 65.25 113.97 -162.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 9.3 t90 . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 121.403 0.62 . . . . 71.540000000000006 111.344 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -81.45 -20.94 39.24 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.664 -0.698 . . . . 75.340000000000003 110.538 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.8 p -73.21 1.03 10.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.243 0.617 . . . . 75.219999999999999 112.1 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -71.55 -18.9 62.23 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.37 0.668 . . . . 70.230000000000004 111.431 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.87 -32.92 71.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.614 0.721 . . . . 64.450000000000003 110.678 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -85.9 -9.09 57.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.701 -1.136 . . . . 73.019999999999996 110.978 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 215' ' ' ALA . 37.7 tp -70.57 -46.4 63.57 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.467 0.707 . . . . 64.299999999999997 109.457 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.91 52.22 1.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.439 0.638 . . . . 74.439999999999998 110.076 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.546 0 CA-C-N 115.245 -0.889 . . . . 72.400000000000006 109.972 175.336 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 p30 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.528 0.204 . . . . 73.0 111.109 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.53 139.17 44.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 74.530000000000001 108.676 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -118.97 172.95 7.18 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.008 1.323 . . . . 71.540000000000006 109.928 -176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.94 141.54 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 125.246 1.418 . . . . 72.019999999999996 108.985 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.33 129.57 35.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.35 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 143' ' ' LYS . 82.4 mt -87.25 -26.54 23.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.14 0.976 . . . . 65.099999999999994 112.483 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.2 m-85 -134.24 153.19 52.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.011 0.524 . . . . 72.310000000000002 110.227 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.33 119.11 21.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.091 -0.707 . . . . 71.200000000000003 109.091 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.544 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.5 t80 -117.62 126.14 52.0 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.388 -0.967 . . . . 74.400000000000006 108.388 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.45 133.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.857 -1.164 . . . . 75.349999999999994 107.857 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.66 116.46 14.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.719 0.408 . . . . 73.409999999999997 111.304 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.9 p -115.77 77.22 1.07 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.637 0.775 . . . . 74.109999999999999 108.941 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 140.58 -175.89 21.77 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.41 -0.814 . . . . 72.040000000000006 111.535 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -89.31 -42.03 11.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.407 0.683 . . . . 70.040000000000006 112.031 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.6 -26.73 60.94 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.705 0.802 . . . . 73.030000000000001 110.571 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 77.8 p -72.7 143.19 48.15 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.229 0.611 . . . . 74.0 110.241 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.487 HD21 ' N ' ' A' ' 128' ' ' GLY . 56.1 tp -132.55 132.05 42.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.195 0.598 . . . . 74.239999999999995 109.932 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.3 m -70.81 130.03 40.63 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.468 0.707 . . . . 72.239999999999995 110.914 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.544 HG12 ' HB3' ' A' ' 91' ' ' PHE . 23.3 pt -133.6 150.26 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.773 0.829 . . . . 74.439999999999998 110.313 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -102.45 146.82 27.54 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.942 0.897 . . . . 71.530000000000001 109.319 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -67.94 114.37 6.44 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.542 -0.54 . . . . 74.430000000000007 109.542 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.58 -9.62 32.65 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 123.327 0.489 . . . . 60.119999999999997 112.382 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 37.5 tt0 -77.9 137.89 38.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.972 0.909 . . . . 72.109999999999999 111.334 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.43 133.39 35.94 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.432 0.693 . . . . 74.239999999999995 110.2 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.428 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.6 OUTLIER -149.08 161.59 41.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.667 1.187 . . . . 74.150000000000006 110.117 -174.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -120.34 118.74 31.17 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.88 -0.513 . . . . 73.019999999999996 110.256 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 119' ' ' ALA . 55.5 t -73.35 121.34 23.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.56 0.695 . . . . 71.109999999999999 110.02 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.427 HD23 ' HG3' ' A' ' 122' ' ' GLN . 23.6 mt -84.58 -51.95 6.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.967 -1.469 . . . . 71.540000000000006 108.874 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.95 149.39 12.35 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.883 -0.599 . . . . 75.209999999999994 112.784 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.527 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 51.6 m-85 -85.3 168.26 14.85 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.399 0.68 . . . . 74.030000000000001 110.605 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -82.21 -172.87 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.379 -0.828 . . . . 45.200000000000003 109.842 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -53.84 -42.32 68.38 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.836 0.854 . . . . 74.430000000000007 112.945 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -112.43 13.6 20.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.933 0.716 . . . . 72.430000000000007 112.933 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.8 21.07 76.45 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 115.685 1.034 . . . . 72.219999999999999 115.685 170.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -77.28 -54.5 6.4 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.611 0.706 . . . . 75.219999999999999 110.571 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.848 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 20.4 m95 -110.95 152.9 26.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.809 0.844 . . . . 70.340000000000003 111.55 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.529 ' HB2' HG11 ' A' ' 109' ' ' VAL . . . -129.53 140.46 51.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.688 1.195 . . . . 75.209999999999994 109.981 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 38.4 tt0 -75.82 130.04 37.96 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.956 -1.127 . . . . 72.219999999999999 107.956 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.34 144.55 44.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.526 0.731 . . . . 74.310000000000002 110.003 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.427 ' HG3' HD23 ' A' ' 110' ' ' LEU . 47.8 mt-30 -96.51 107.8 20.27 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.763 -1.199 . . . . 72.349999999999994 107.763 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.428 HG22 ' HB3' ' A' ' 107' ' ' LEU . 34.6 p -106.42 -177.04 3.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.111 0.964 . . . . 73.430000000000007 111.395 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -71.83 -10.42 59.75 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.504 -0.771 . . . . 74.099999999999994 110.828 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -101.44 16.42 25.7 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.52 1.128 . . . . 65.310000000000002 110.585 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.79 -122.68 7.06 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.218 -0.768 . . . . 74.120000000000005 112.044 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.83 152.45 47.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 118.032 0.916 . . . . 73.25 110.849 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.487 ' N ' HD21 ' A' ' 99' ' ' LEU . . . 153.8 172.55 21.99 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 111.575 -0.61 . . . . 55.399999999999999 111.575 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 66.0 m95 -80.15 131.81 35.8 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.225 0.61 . . . . 70.450000000000003 112.561 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.41 HG21 HD12 ' A' ' 135' ' ' ILE . 34.3 m -136.8 141.89 36.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 125.645 1.578 . . . . 74.129999999999995 109.215 168.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.848 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.1 Cg_endo -77.92 151.26 27.5 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.438 2.092 . . . . 73.409999999999997 115.284 -172.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -36.63 -50.54 0.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.628 1.971 . . . . 60.32 113.856 170.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -74.22 -7.96 54.53 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.417 0.687 . . . . 72.120000000000005 112.352 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.42 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 13.6 m-85 -104.03 -4.92 22.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.88 0.872 . . . . 73.049999999999997 112.118 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 130' ' ' VAL . 6.3 pt -135.24 168.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 124.003 0.921 . . . . 74.540000000000006 111.826 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.9 t -163.54 155.98 15.46 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 108.334 -0.987 . . . . 74.200000000000003 108.334 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.55 151.77 44.37 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.108 1.872 . . . . 74.530000000000001 113.029 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.51 -5.66 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.166 0.507 . . . . 75.450000000000003 110.209 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.4 -20.21 23.07 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.625 -0.672 . . . . 74.319999999999993 110.881 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.1 p -80.9 172.49 13.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.328 0.585 . . . . 63.200000000000003 111.742 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.5 mt -84.67 -25.02 28.73 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.785 0.834 . . . . 75.120000000000005 111.291 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.5 -24.01 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.474 1.11 . . . . 75.200000000000003 112.092 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.481 ' HA ' HD22 ' A' ' 88' ' ' LEU . 23.1 pttm -64.2 -26.16 68.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.39 0.676 . . . . 73.439999999999998 112.476 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -75.15 148.35 39.7 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.61 -0.723 . . . . 72.310000000000002 110.159 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 235' ' ' PRO . 16.9 m -60.52 -41.09 93.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.115 0.885 . . . . 72.010000000000005 111.552 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -67.18 -48.32 68.28 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.324 0.65 . . . . 74.400000000000006 112.549 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -75.66 112.53 12.12 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.538 -0.541 . . . . 75.109999999999999 109.538 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.438 ' HB2' HG22 ' A' ' 151' ' ' VAL . 32.6 m170 -102.39 -1.98 29.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.379 0.672 . . . . 75.230000000000004 111.612 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.34 -151.26 36.27 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 118.887 -0.952 . . . . 74.310000000000002 112.232 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.62 114.29 1.93 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.053 2.502 . . . . 65.519999999999996 111.407 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 54.0 t -142.72 137.85 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 125.398 1.479 . . . . 60.210000000000001 108.863 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.2 p -82.58 170.22 15.42 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.627 0.771 . . . . 64.239999999999995 110.95 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -59.7 -48.47 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.932 0.893 . . . . 73.349999999999994 110.389 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.35 -44.37 84.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.466 1.107 . . . . 72.340000000000003 111.465 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.78 76.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.973 -1.012 . . . . 71.129999999999995 111.518 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.77 82.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.447 0.699 . . . . 53.200000000000003 111.636 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -78.64 -25.49 45.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.565 -0.743 . . . . 74.409999999999997 112.709 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -24.88 59.71 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.943 0.792 . . . . 74.230000000000004 110.678 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.824 HD22 ' HA ' ' A' ' 239' ' ' ARG . 69.0 mt -71.92 -48.97 41.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.963 -1.017 . . . . 75.109999999999999 110.056 170.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 63.8 mt -89.23 19.49 4.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.044 -0.98 . . . . 75.409999999999997 112.642 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.3 p -90.42 -34.11 15.76 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.091 -1.077 . . . . 71.420000000000002 108.091 157.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.5 m -92.05 2.49 56.53 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.949 1.299 . . . . 74.340000000000003 111.892 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.1 -178.07 40.43 Favored Glycine 0 C--N 1.351 1.386 0 C-N-CA 122.771 0.224 . . . . 74.310000000000002 112.839 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -107.62 177.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.241 1.016 . . . . 72.439999999999998 110.31 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.05 131.26 46.09 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.84 6.42 72.5 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.079 -0.845 . . . . 73.310000000000002 113.695 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.5 m -81.39 136.18 35.7 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.217 1.008 . . . . 73.409999999999997 110.524 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -142.8 163.12 33.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.303 0.573 . . . . 73.219999999999999 111.218 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.64 145.32 22.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.83 -1.077 . . . . 75.5 108.666 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.636 HG22 HG12 ' A' ' 182' ' ' ILE . 83.2 t -103.48 126.73 57.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.947 -1.131 . . . . 74.510000000000005 107.947 169.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.613 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.5 ptt85 -115.71 160.98 19.35 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.177 0.991 . . . . 74.409999999999997 109.06 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -114.35 150.29 34.8 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.259 -1.756 . . . . 70.239999999999995 106.259 167.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -67.96 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.299 -0.63 . . . . 74.319999999999993 109.299 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.07 -31.33 71.74 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.822 0.849 . . . . 71.239999999999995 111.176 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.8 p -97.17 -5.31 37.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.135 0.974 . . . . 64.120000000000005 112.008 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -149.88 102.84 3.21 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 122.719 0.408 . . . . 71.209999999999994 111.189 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.23 146.81 70.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.551 2.167 . . . . 73.319999999999993 111.833 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.69 -28.36 3.55 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 123.069 0.366 . . . . 73.219999999999999 113.403 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.91 114.45 18.83 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -130.8 156.54 44.83 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.52 0.676 . . . . 75.5 111.12 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.8 m -147.2 150.86 35.73 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.833 -1.076 . . . . 74.030000000000001 109.241 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.636 HG12 HG22 ' A' ' 170' ' ' VAL . 22.6 mt -103.81 151.57 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.54 -1.281 . . . . 75.319999999999993 107.54 170.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -124.73 121.98 36.18 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.678 -1.23 . . . . 70.530000000000001 107.678 168.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.2 tp -115.65 114.36 24.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.36 0.664 . . . . 75.25 110.377 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.682 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 56.1 ttt85 -76.3 111.53 11.84 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.551 0.74 . . . . 74.109999999999999 109.033 164.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -139.44 139.58 37.11 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.991 1.316 . . . . 72.530000000000001 107.791 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 59.7 21.76 10.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.47 1.108 . . . . 74.420000000000002 111.782 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.75 -12.31 59.75 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.628 -0.714 . . . . 61.039999999999999 113.85 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -98.96 146.73 25.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.237 0.615 . . . . 75.329999999999998 110.211 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 115.24 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.08 0.552 . . . . 74.409999999999997 110.405 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -101.47 137.96 39.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.487 1.115 . . . . 63.100000000000001 108.807 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.54 120.04 41.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.889 0.376 . . . . 73.209999999999994 110.74 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.479 ' HE1' HD22 ' A' ' 232' ' ' LEU . 5.8 m-85 -95.59 152.31 18.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.224 1.009 . . . . 74.25 108.738 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -104.7 115.81 30.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.401 -0.592 . . . . 73.329999999999998 109.401 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -85.73 101.96 10.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.849 -1.167 . . . . 72.129999999999995 107.849 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -84.04 107.21 16.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.403 -1.271 . . . . 65.099999999999994 108.382 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -74.52 112.65 10.91 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.862 -1.162 . . . . 75.340000000000003 107.862 164.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.94 160.97 19.45 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.682 0.393 . . . . 54.130000000000003 110.704 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.0 p -62.43 -28.36 69.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.59 0.756 . . . . 74.340000000000003 111.07 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -89.76 -5.2 57.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.245 1.018 . . . . 73.230000000000004 111.128 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 106.58 -6.82 38.79 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 114.787 0.675 . . . . 73.310000000000002 114.787 168.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.13 127.47 32.68 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.887 0.843 . . . . 75.420000000000002 111.646 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.71 142.68 30.55 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.099 0.96 . . . . 73.209999999999994 109.051 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.604 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 39.9 p90 -164.71 139.74 5.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.214 0.321 . . . . 75.120000000000005 111.686 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.0 t -84.64 -37.84 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.559 -0.904 . . . . 75.120000000000005 108.559 163.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.426 ' HG ' ' HA3' ' A' ' 227' ' ' GLY . 24.2 m -101.23 126.91 48.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 109.771 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.9 t -69.7 -16.72 63.39 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.421 0.689 . . . . 65.430000000000007 112.129 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -92.66 -15.3 26.94 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.776 1.23 . . . . 73.219999999999999 110.99 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.2 m -133.93 95.46 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.746 0.818 . . . . 73.420000000000002 109.116 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.604 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -111.59 134.77 52.94 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.87 0.868 . . . . 75.150000000000006 109.527 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.0 151.97 43.1 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.104 0.961 . . . . 72.109999999999999 108.538 -170.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -69.47 -34.2 74.01 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.601 0.563 . . . . 74.439999999999998 110.692 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.3 p -126.76 152.58 46.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.73 0.812 . . . . 73.420000000000002 111.718 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.84 -24.44 67.75 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 114.674 -1.148 . . . . 75.329999999999998 109.215 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 73' ' ' LEU . . . -59.16 -49.12 79.06 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.976 0.91 . . . . 72.200000000000003 111.275 173.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -65.33 -36.8 85.14 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.526 0.73 . . . . 75.299999999999997 111.325 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.9 tp -56.43 -56.76 17.22 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.495 0.497 . . . . 74.010000000000005 111.102 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.44 -41.5 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.317 0.647 . . . . 75.099999999999994 110.897 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.11 -52.25 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.741 0.416 . . . . 75.409999999999997 111.524 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -65.44 -40.61 93.46 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.203 0.601 . . . . 74.450000000000003 109.85 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.63 ' HB3' HD13 ' A' ' 228' ' ' LEU . 12.3 m-70 -86.6 -4.54 59.19 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.446 -0.797 . . . . 74.400000000000006 111.917 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 89.9 p -91.98 -35.31 14.05 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 110.181 -0.303 . . . . 64.519999999999996 110.181 167.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.2 m -68.4 -49.63 58.7 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.306 0.574 . . . . 71.409999999999997 110.216 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -128.18 161.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.006 -0.997 . . . . 72.329999999999998 110.161 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.47 19.61 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.377 1.871 . . . . 72.299999999999997 114.637 -174.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.579 ' HB2' HG22 ' A' ' 224' ' ' VAL . 10.9 t70 -43.02 31.64 0.0 OUTLIER 'General case' 0 CA--C 1.598 2.8 1 C-N-CA 132.319 4.247 . . . . 75.25 120.203 -153.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.426 ' HA3' ' HG ' ' A' ' 206' ' ' SER . . . 125.22 0.82 8.04 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 121.259 -0.9 . . . . 75.540000000000006 112.583 -167.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.63 HD13 ' HB3' ' A' ' 221' ' ' HIS . 11.0 mt -95.06 165.61 12.34 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 126.169 1.788 . . . . 75.400000000000006 110.025 168.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.99 -41.92 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-N 116.604 -0.271 . . . . 61.229999999999997 110.314 168.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -157.41 -179.78 8.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.104 0.561 . . . . 71.239999999999995 110.969 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.0 p -63.55 137.1 57.99 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.837 1.255 . . . . 73.25 112.243 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.479 HD22 ' HE1' ' A' ' 193' ' ' TYR . 75.7 mt -72.62 111.03 7.42 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.949 -0.76 . . . . 73.310000000000002 108.949 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -106.87 -44.54 4.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.948 0.722 . . . . 75.409999999999997 112.948 -163.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -130.84 125.24 21.22 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.15 0.98 . . . . 75.430000000000007 109.138 -169.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.425 ' HB2' ' HB2' ' A' ' 145' ' ' SER . 76.1 Cg_endo -81.56 129.17 6.39 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 122.234 1.956 . . . . 73.349999999999994 112.121 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.36 151.94 85.62 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.852 0.861 . . . . 74.129999999999995 110.113 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.71 170.3 17.12 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.966 2.444 . . . . 74.25 112.593 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.9 154.02 35.08 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.044 0.937 . . . . 75.219999999999999 110.917 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.824 ' HA ' HD22 ' A' ' 159' ' ' LEU . 18.8 ptt180 -81.66 -60.34 2.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.541 0.941 . . . . 74.439999999999998 113.541 -168.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.534 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 64.9 t30 -108.69 153.92 22.75 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.701 0.8 . . . . 73.430000000000007 109.122 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 84.2 tttt -87.4 114.77 60.25 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.204 -1.776 . . . . 75.340000000000003 106.204 159.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 31.7 Cg_exo -62.21 144.39 95.52 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.373 2.715 . . . . 63.130000000000003 113.151 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.4 m -94.66 134.72 36.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.283 0.633 . . . . 74.109999999999999 110.86 -172.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -90.43 125.82 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 64.310000000000002 108.664 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -109.81 115.9 30.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.689 0.395 . . . . 75.239999999999995 110.988 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 75.94 -48.27 2.34 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 119.277 2.471 . . . . 61.340000000000003 119.277 155.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 31.2 m -99.48 144.1 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 114.366 1.247 . . . . 74.120000000000005 114.366 -157.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.0 t -82.34 115.83 60.16 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 104.405 -2.443 . . . . 72.340000000000003 104.405 149.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.663 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 11.3 Cg_endo . . . . . 0 N--CA 1.496 1.655 0 C-N-CA 122.94 2.427 . . . . 71.049999999999997 116.858 -152.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 3.3 t90 . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.917 0.865 . . . . 74.329999999999998 109.213 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 23.8 p-10 -65.43 -21.82 66.7 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.982 -1.008 . . . . 74.010000000000005 109.46 165.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.4 p -77.47 5.41 8.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.573 1.549 . . . . 73.120000000000005 112.782 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.55 -25.4 68.03 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.202 0.456 . . . . 75.030000000000001 111.167 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.5 pt-20 -62.63 -43.45 98.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.26 0.624 . . . . 71.420000000000002 110.502 168.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -82.47 -2.97 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.48 1.112 . . . . 73.150000000000006 111.331 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.0 tp -52.33 -49.18 64.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.005 0.922 . . . . 75.150000000000006 110.274 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.5 mt -95.58 83.26 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.779 -1.193 . . . . 71.010000000000005 107.779 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-N 115.098 -0.956 . . . . 74.430000000000007 113.054 -168.538 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.55 0.977 0 N-CA-C 110.862 -0.051 . . . . 75.409999999999997 110.862 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.61 HD23 ' HD3' ' A' ' 106' ' ' LYS . 35.7 tp -80.65 125.52 30.12 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.22 172.49 6.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.727 1.211 . . . . 73.329999999999998 108.178 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.57 137.22 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.276 1.031 . . . . 72.150000000000006 108.836 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.2 123.66 26.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.62 0.768 . . . . 73.230000000000004 109.968 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.03 -32.86 45.13 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 74.519999999999996 110.982 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.581 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 55.9 m-85 -126.54 160.14 31.47 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.068 0.547 . . . . 73.0 110.792 -174.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.7 120.38 23.93 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.477 -0.934 . . . . 75.349999999999994 108.477 166.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.721 ' HB3' HG12 ' A' ' 101' ' ' ILE . 93.8 t80 -113.14 132.53 55.42 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.71 -0.848 . . . . 74.439999999999998 108.71 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -93.92 128.59 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.328 -0.99 . . . . 74.409999999999997 108.328 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.3 114.56 6.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.408 -0.59 . . . . 74.219999999999999 109.408 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.9 p -98.69 -0.83 42.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.735 0.814 . . . . 73.310000000000002 111.431 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.9 166.26 24.92 Favored Glycine 0 C--O 1.244 0.742 0 N-CA-C 110.703 -0.959 . . . . 70.329999999999998 110.703 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -70.87 -39.16 73.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.103 0.478 . . . . 73.010000000000005 110.45 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -79.95 -24.53 40.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 63.520000000000003 111.809 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 p -76.25 166.7 23.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.678 0.391 . . . . 74.200000000000003 110.829 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -134.96 133.47 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.042 0.537 . . . . 74.409999999999997 110.629 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.6 m -74.61 141.75 44.66 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.793 0.837 . . . . 74.420000000000002 110.177 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.721 HG12 ' HB3' ' A' ' 91' ' ' PHE . 14.1 pt -128.5 156.51 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.174 0.59 . . . . 73.120000000000005 110.412 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 7.2 m -108.03 152.45 24.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.159 0.984 . . . . 74.340000000000003 109.938 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -60.04 110.69 1.26 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.636 0.774 . . . . 73.140000000000001 109.13 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.85 8.33 63.64 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.688 -0.507 . . . . 51.530000000000001 113.646 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.2 tt0 -76.23 120.89 22.13 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.478 0.639 . . . . 72.25 110.355 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.61 ' HD3' HD23 ' A' ' 84' ' ' LEU . 64.6 mttp -78.69 127.7 32.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.274 0.629 . . . . 74.329999999999998 109.474 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.45 150.68 40.89 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.364 1.066 . . . . 75.450000000000003 110.351 -171.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -100.99 118.86 37.83 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.056 0.543 . . . . 75.420000000000002 109.939 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.48 HG12 ' HB1' ' A' ' 119' ' ' ALA . 56.5 t -84.97 118.22 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.617 0.722 . . . . 74.420000000000002 109.862 172.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.615 HD12 ' HG3' ' A' ' 120' ' ' GLU . 18.9 mt -85.37 -13.99 47.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.142 1.377 . . . . 72.409999999999997 110.889 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.25 4.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.491 -1.043 . . . . 71.319999999999993 110.491 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.476 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 62.3 m-85 -88.71 173.28 8.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.543 0.687 . . . . 73.540000000000006 110.625 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -78.36 -179.53 6.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.663 -1.153 . . . . 74.310000000000002 110.844 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -45.72 -41.47 10.66 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.167 1.387 . . . . 71.25 113.766 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -114.24 12.07 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.612 0.968 . . . . 73.420000000000002 113.612 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.56 10.63 85.71 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 116.249 1.26 . . . . 75.109999999999999 116.249 168.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.85 -42.21 28.08 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.987 0.894 . . . . 72.120000000000005 111.655 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 21.1 m95 -119.66 157.38 28.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.707 0.803 . . . . 74.219999999999999 110.36 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.48 ' HB1' HG12 ' A' ' 109' ' ' VAL . . . -135.24 145.69 47.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.662 0.785 . . . . 72.329999999999998 110.361 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.615 ' HG3' HD12 ' A' ' 110' ' ' LEU . 13.2 tp10 -79.22 113.55 17.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.578 -1.638 . . . . 74.420000000000002 106.578 164.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -134.08 140.35 46.57 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.08 0.466 . . . . 71.120000000000005 111.233 -171.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -104.11 106.57 17.12 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.363 1.065 . . . . 72.099999999999994 108.705 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.633 HG23 HG23 ' A' ' 101' ' ' ILE . 50.8 p -97.98 175.1 6.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.2 1.0 . . . . 71.420000000000002 109.482 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -65.15 -22.72 66.96 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.84 -0.429 . . . . 74.040000000000006 109.84 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.32 -21.16 56.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.514 1.126 . . . . 74.409999999999997 111.802 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.07 -139.89 9.3 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.311 0.505 . . . . 63.439999999999998 113.589 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -130.37 127.86 40.24 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.982 0.913 . . . . 72.439999999999998 109.898 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 169.37 -173.18 43.71 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 123.256 0.347 . . . . 73.040000000000006 112.723 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -85.56 126.86 34.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.321 0.648 . . . . 74.430000000000007 112.339 -172.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -133.84 144.07 50.2 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.097 0.959 . . . . 74.120000000000005 108.618 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 2.2 Cg_endo -83.04 142.64 11.09 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.532 2.154 . . . . 72.420000000000002 114.385 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.46 ' HB3' ' CE2' ' A' ' 112' ' ' TYR . 69.2 p -40.92 -44.57 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.867 1.667 . . . . 75.329999999999998 113.707 167.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' ' 242' ' ' PRO . 27.8 p30 -77.94 -6.59 54.87 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.243 -0.89 . . . . 74.400000000000006 112.558 -172.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.581 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 30.2 m-85 -103.58 -10.0 18.8 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.371 0.668 . . . . 70.329999999999998 111.719 170.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.9 pt -126.32 178.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 124.099 0.959 . . . . 75.319999999999993 110.812 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.2 t -160.96 149.99 13.57 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.125 0.97 . . . . 65.420000000000002 108.71 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.559 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 24.3 Cg_endo -61.51 150.07 86.88 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.801 1.667 . . . . 73.140000000000001 111.548 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.1 t -71.32 -15.95 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 CA-C-O 120.955 0.407 . . . . 73.219999999999999 110.598 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -76.28 -17.94 59.22 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.449 0.699 . . . . 75.109999999999999 112.326 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.559 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 59.9 p -71.53 163.75 27.15 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.632 0.729 . . . . 73.5 112.648 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.41 -23.43 40.37 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.241 -0.891 . . . . 74.230000000000004 109.261 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.88 -15.48 63.09 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.607 1.163 . . . . 73.519999999999996 112.678 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -66.72 -24.08 66.19 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.919 0.39 . . . . 71.010000000000005 111.187 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -79.09 134.8 36.73 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.375 0.67 . . . . 72.129999999999995 109.788 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.7 p -59.12 -43.8 91.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.514 1.134 . . . . 74.239999999999995 111.745 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -62.88 -39.05 93.27 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.059 0.85 . . . . 72.349999999999994 112.467 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -77.76 110.83 12.97 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.128 -0.693 . . . . 75.409999999999997 109.128 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -107.03 -6.68 17.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.196 0.598 . . . . 73.140000000000001 111.155 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.57 -133.08 25.26 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.639 -1.09 . . . . 61.109999999999999 113.041 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.34 100.65 0.22 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.941 2.427 . . . . 74.010000000000005 112.006 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 55.9 t -138.71 131.74 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.747 1.219 . . . . 74.420000000000002 108.912 -175.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.3 p -84.7 171.57 12.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 64.340000000000003 109.987 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -62.07 -43.81 98.04 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.95 -0.548 . . . . 63.229999999999997 111.069 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -54.22 -43.44 70.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.731 0.645 . . . . 75.340000000000003 110.938 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.456 ' HB3' HG11 ' A' ' 151' ' ' VAL . . . -67.93 -38.45 82.88 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.282 -0.872 . . . . 74.400000000000006 111.155 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.3 -42.45 88.32 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.588 0.755 . . . . 65.150000000000006 111.732 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 67.5 mm-40 -59.85 -46.57 88.86 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.669 0.787 . . . . 74.439999999999998 109.421 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.533 ' HE1' ' HD2' ' A' ' 239' ' ' ARG . 42.3 t80 -62.01 -46.26 89.98 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.308 -1.314 . . . . 75.430000000000007 111.932 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.03 -40.33 84.71 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.912 0.885 . . . . 74.420000000000002 111.142 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.73 18.01 13.89 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.747 -0.661 . . . . 73.549999999999997 112.367 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 96.8 p -63.84 -41.23 97.87 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.083 0.856 . . . . 75.239999999999995 111.167 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 p -100.7 13.32 35.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.439 0.696 . . . . 70.310000000000002 111.299 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 151.87 41.69 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 123.117 0.26 . . . . 75.230000000000004 113.223 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.6 pt -101.96 -175.39 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.968 0.907 . . . . 75.530000000000001 110.898 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -52.7 122.2 8.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.63 0.772 . . . . 74.129999999999995 110.414 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.444 ' HA2' HD13 ' A' ' 184' ' ' LEU . . . 88.4 10.25 68.38 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.019 -0.879 . . . . 62.420000000000002 113.528 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 61.7 m -83.76 115.68 22.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.221 1.011 . . . . 72.519999999999996 111.282 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.465 ' HB3' HD11 ' A' ' 184' ' ' LEU . 11.1 p90 -130.22 167.08 19.0 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.202 0.525 . . . . 75.230000000000004 112.083 -170.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.27 146.79 24.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.717 -1.129 . . . . 74.340000000000003 108.609 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.595 HG23 HG12 ' A' ' 182' ' ' ILE . 78.3 t -107.65 135.56 45.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.152 -1.055 . . . . 73.230000000000004 108.152 171.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.498 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 19.8 ptt85 -134.62 160.22 38.79 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.273 1.029 . . . . 75.430000000000007 109.811 -175.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -117.56 155.35 29.95 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.163 -1.051 . . . . 75.450000000000003 108.163 164.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -80.11 125.75 30.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.14 -0.689 . . . . 55.420000000000002 109.14 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.12 -39.77 65.48 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.339 0.656 . . . . 74.120000000000005 109.619 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.9 p -75.07 -13.29 60.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.41 0.684 . . . . 73.540000000000006 111.74 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 35.3 m -141.72 80.55 15.77 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.511 0.724 . . . . 71.5 109.502 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -59.42 131.26 39.69 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.867 2.378 . . . . 72.319999999999993 112.292 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.45 -29.24 10.77 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.855 -0.611 . . . . 72.430000000000007 112.24 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -80.93 115.89 20.63 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.076 -0.713 . . . . 72.109999999999999 109.076 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -116.26 150.09 38.15 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.55 0.691 . . . . 71.400000000000006 111.077 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.9 m -150.08 153.66 36.8 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.583 -1.19 . . . . 73.439999999999998 109.886 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.595 HG12 HG23 ' A' ' 170' ' ' VAL . 30.0 mt -110.78 149.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.486 -0.931 . . . . 74.540000000000006 108.486 172.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 36.3 m -123.11 108.28 12.69 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.666 -1.235 . . . . 73.420000000000002 107.666 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.476 HD23 ' OH ' ' A' ' 193' ' ' TYR . 70.0 tp -106.78 128.04 53.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.915 0.486 . . . . 64.439999999999998 110.069 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -102.36 129.17 48.75 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.098 0.959 . . . . 74.200000000000003 109.085 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -150.17 131.32 14.45 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.602 1.561 . . . . 72.140000000000001 107.174 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 63.72 23.99 13.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.087 0.955 . . . . 71.439999999999998 111.736 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.04 81.04 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.012 0.365 . . . . 51.119999999999997 114.012 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -105.77 128.27 53.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.929 0.892 . . . . 74.120000000000005 109.432 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.2 t -93.63 111.99 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.195 0.598 . . . . 75.430000000000007 110.465 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -96.53 147.81 23.47 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.725 1.21 . . . . 73.540000000000006 109.589 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -121.86 117.48 26.61 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.305 0.574 . . . . 74.209999999999994 110.445 -171.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 9.1 m-30 -96.07 148.21 22.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.76 1.224 . . . . 72.430000000000007 109.42 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.98 117.58 34.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.696 -0.854 . . . . 73.439999999999998 108.696 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 mt -84.08 100.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 N-CA-C 107.304 -1.369 . . . . 70.420000000000002 107.304 172.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -82.95 131.44 35.19 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.077 0.951 . . . . 73.5 108.769 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.7 m -97.33 121.76 39.59 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.767 -0.827 . . . . 73.040000000000006 108.767 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.71 174.31 8.56 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.277 0.631 . . . . 65.5 110.705 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.2 p -62.83 -32.68 73.94 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.655 0.782 . . . . 75.010000000000005 111.737 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.85 -14.9 27.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.742 0.817 . . . . 74.519999999999996 110.891 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.93 13.69 13.42 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 118.983 -0.898 . . . . 75.340000000000003 114.252 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.16 125.69 27.5 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.039 0.92 . . . . 75.510000000000005 110.798 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -84.87 141.16 30.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.51 -0.922 . . . . 73.430000000000007 108.51 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.544 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 31.4 p90 -165.55 137.5 4.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.325 0.391 . . . . 75.340000000000003 111.506 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 217' ' ' LEU . 73.1 t -84.19 -36.72 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.573 -0.899 . . . . 64.219999999999999 108.573 163.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.5 m -100.99 127.44 47.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.859 -1.064 . . . . 74.510000000000005 109.962 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.2 t -63.67 -22.59 66.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.235 1.014 . . . . 74.140000000000001 111.909 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -82.87 -29.15 29.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.723 1.209 . . . . 73.340000000000003 110.859 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.6 m -126.33 99.02 5.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.33 0.652 . . . . 71.209999999999994 110.531 -175.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.544 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -97.34 133.46 41.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.871 0.868 . . . . 74.340000000000003 109.592 174.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.69 151.49 38.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.684 0.793 . . . . 73.319999999999993 109.327 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -73.09 -42.76 62.65 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.917 -0.401 . . . . 72.409999999999997 109.917 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 44.0 p -118.7 159.05 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.741 0.781 . . . . 75.239999999999995 112.248 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.06 -27.71 68.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.462 -1.245 . . . . 65.420000000000002 109.847 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.88 95.83 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.51 0.724 . . . . 74.109999999999999 110.629 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.11 -39.92 75.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.879 0.871 . . . . 72.109999999999999 110.865 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 205' ' ' VAL . 15.3 tp -55.38 -56.07 24.29 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.848 0.718 . . . . 73.430000000000007 111.23 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.1 -42.35 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 123.797 0.686 . . . . 73.209999999999994 111.001 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.84 -55.57 30.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.016 0.823 . . . . 75.109999999999999 111.339 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -68.29 -34.77 76.77 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.41 -0.814 . . . . 71.430000000000007 111.214 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.599 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.8 m170 -87.64 -9.56 53.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.812 0.445 . . . . 71.140000000000001 112.083 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 90.7 p -90.51 -33.72 15.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.947 0.499 . . . . 71.120000000000005 110.231 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.1 p -72.98 -49.51 28.59 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.717 -0.674 . . . . 74.230000000000004 111.169 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 226' ' ' ASP . 35.5 m -123.77 159.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.833 0.825 . . . . 74.129999999999995 112.459 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.15 16.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 128.205 2.602 . . . . 64.230000000000004 115.246 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.534 ' HB2' HG22 ' A' ' 224' ' ' VAL . 32.6 t70 -40.02 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 131.676 3.99 . . . . 70.519999999999996 119.852 -150.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.06 -3.22 10.68 Favored Glycine 0 N--CA 1.469 0.898 0 O-C-N 118.985 -2.322 . . . . 63.5 112.042 -165.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.1 mt -90.13 163.64 14.77 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.93 1.692 . . . . 74.310000000000002 109.231 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.76 -38.91 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 120.756 0.313 . . . . 71.540000000000006 110.881 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -158.02 -178.0 6.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.099 0.959 . . . . 73.230000000000004 109.938 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.5 p -67.41 144.01 55.99 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.588 0.755 . . . . 73.430000000000007 112.183 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.44 HD22 ' HE1' ' A' ' 193' ' ' TYR . 76.8 mt -75.4 90.21 2.67 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 107.565 -1.272 . . . . 74.310000000000002 107.565 169.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -121.71 9.35 10.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.054 -1.029 . . . . 73.129999999999995 113.673 -158.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -159.17 122.95 2.07 Favored Pre-proline 0 C--O 1.22 -0.493 0 N-CA-C 106.957 -1.497 . . . . 74.140000000000001 106.957 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.2 139.3 6.06 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 122.214 1.942 . . . . 75.340000000000003 112.592 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.46 124.8 89.16 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.181 -1.044 . . . . 53.049999999999997 108.181 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.13 -176.98 3.34 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.321 2.014 . . . . 72.439999999999998 113.218 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -76.85 118.74 19.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.034 -0.985 . . . . 74.420000000000002 109.318 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 240' ' ' ASN . 6.3 ptt180 -76.53 -53.65 7.79 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.591 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.542 ' N ' ' HG3' ' A' ' 239' ' ' ARG . 10.5 t30 -108.72 122.54 47.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.778 1.029 . . . . 70.319999999999993 113.778 -158.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 89' ' ' TYR . 97.2 mttt -79.8 113.46 37.88 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.183 -1.414 . . . . 75.140000000000001 107.183 159.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.637 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 25.5 Cg_exo -68.84 153.36 73.01 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.789 2.326 . . . . 73.209999999999994 113.601 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 24.5 m -73.44 139.94 46.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.725 -0.671 . . . . 74.329999999999998 110.993 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 52.0 t -95.65 113.51 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.99 -1.115 . . . . 62.049999999999997 107.99 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.421 ' O ' HG11 ' A' ' 247' ' ' VAL . 7.9 m-85 -102.94 110.85 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 119.256 -0.402 . . . . 73.450000000000003 110.414 -173.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.47 25.11 48.82 Favored Glycine 0 N--CA 1.477 1.373 0 N-CA-C 118.078 1.991 . . . . 73.319999999999993 118.078 160.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 245' ' ' TYR . 33.7 m -101.1 134.04 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 119.065 1.433 . . . . 65.340000000000003 113.421 -172.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -83.38 118.35 71.31 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 103.508 -2.775 . . . . 74.420000000000002 103.508 142.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo . . . . . 0 C--N 1.375 1.94 0 C-N-CA 121.501 1.467 . . . . 64.200000000000003 113.753 -152.419 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.404 ' NE1' ' HB2' ' A' ' 69' ' ' SER . 11.7 t90 . . . . . 0 C--O 1.238 0.462 0 N-CA-C 109.007 -0.738 . . . . 74.540000000000006 109.007 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 24.1 p-10 -84.2 -8.97 58.9 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.718 -0.674 . . . . 70.109999999999999 110.868 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 144' ' ' HIS . 23.8 m -61.17 -4.3 1.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.778 1.399 . . . . 72.430000000000007 114.778 -165.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.51 -34.36 69.0 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.45 0.7 . . . . 75.310000000000002 111.145 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 12.7 pt-20 -65.32 -46.59 79.72 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.444 0.698 . . . . 73.25 110.589 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.04 -5.34 59.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.147 0.979 . . . . 71.219999999999999 111.014 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.441 ' HA ' ' HE2' ' A' ' 144' ' ' HIS . 18.9 tp -76.22 -49.68 16.5 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.429 1.091 . . . . 73.519999999999996 109.111 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.5 mt -104.45 36.7 2.31 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.229 -0.896 . . . . 74.319999999999993 109.529 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.955 0 C-N-CA 124.412 1.085 . . . . 70.150000000000006 112.677 -175.578 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.158 0.504 . . . . 74.439999999999998 110.607 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.4 ' HB2' ' NH2' ' A' ' 108' ' ' ARG . 26.1 tp -79.67 127.54 32.3 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.714 -0.847 . . . . 70.510000000000005 108.714 165.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.4 174.9 5.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.028 1.331 . . . . 73.109999999999999 109.165 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.12 135.12 32.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.726 0.81 . . . . 74.409999999999997 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.07 5.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.967 0.907 . . . . 75.239999999999995 110.373 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.9 -30.71 64.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.688 0.795 . . . . 73.310000000000002 110.735 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.0 m-85 -123.91 141.23 52.22 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.922 -1.036 . . . . 73.409999999999997 109.019 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -73.53 146.89 44.49 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.14 0.576 . . . . 71.329999999999998 109.524 168.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.427 ' HE2' ' HB ' ' A' ' 98' ' ' THR . 86.1 t80 -154.14 107.66 2.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.278 0.631 . . . . 74.530000000000001 109.361 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.49 137.03 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.111 -1.07 . . . . 75.310000000000002 108.111 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 115.53 10.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.035 0.534 . . . . 75.420000000000002 110.528 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.1 p -88.63 -25.5 22.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.288 0.635 . . . . 72.140000000000001 109.654 171.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.19 157.84 15.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-N 115.227 -0.897 . . . . 72.5 111.242 173.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.1 -34.69 75.49 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.722 0.809 . . . . 51.539999999999999 109.735 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -76.51 -26.91 55.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.356 -1.293 . . . . 74.0 112.3 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.427 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 67.0 p -82.77 155.36 24.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.425 -0.583 . . . . 75.109999999999999 109.425 173.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.544 ' HB3' HG13 ' A' ' 130' ' ' VAL . 67.2 tp -113.65 136.21 53.08 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.9 0.48 . . . . 74.340000000000003 111.741 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.7 m -74.55 117.09 15.97 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.794 0.837 . . . . 74.430000000000007 110.482 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.619 HG23 HG21 ' A' ' 123' ' ' THR . 22.0 pt -124.53 147.22 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.714 0.805 . . . . 75.340000000000003 111.343 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 57.5 m -89.88 145.65 24.99 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.262 1.025 . . . . 74.420000000000002 109.474 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -62.08 114.34 3.35 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.985 0.514 . . . . 72.230000000000004 109.749 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 7.05 61.68 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 119.648 -0.529 . . . . 74.340000000000003 113.457 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 88.4 tt0 -83.85 135.09 34.64 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.437 0.618 . . . . 64.409999999999997 110.371 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -85.02 138.59 32.35 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.225 0.61 . . . . 74.420000000000002 109.617 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.603 ' HB3' HG23 ' A' ' 123' ' ' THR . 0.3 OUTLIER -147.6 135.11 20.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.238 1.015 . . . . 62.310000000000002 109.935 -174.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.4 ' NH2' ' HB2' ' A' ' 84' ' ' LEU . 53.0 ttm-85 -99.15 115.9 30.12 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 122.306 -0.246 . . . . 73.450000000000003 110.624 -172.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 119' ' ' ALA . 74.0 t -76.36 122.97 31.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.8 0.687 . . . . 64.209999999999994 110.39 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.432 HD11 ' HG3' ' A' ' 122' ' ' GLN . 20.9 mt -90.81 -36.96 13.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.927 1.291 . . . . 75.140000000000001 109.448 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.46 148.77 9.66 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.421 -0.809 . . . . 72.450000000000003 112.373 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.597 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 22.0 m-85 -95.37 156.92 16.12 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 74.519999999999996 110.839 176.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -70.83 -178.39 1.87 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.434 -0.803 . . . . 72.420000000000002 110.791 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -55.29 -27.72 48.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.959 1.096 . . . . 73.109999999999999 113.959 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.02 -2.69 15.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.144 0.578 . . . . 74.329999999999998 112.436 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.63 20.98 75.85 Favored Glycine 0 C--N 1.349 1.305 0 N-CA-C 114.478 0.551 . . . . 62.299999999999997 114.478 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.49 -61.42 1.72 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 117.381 0.591 . . . . 72.310000000000002 110.152 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 62.6 m95 -92.3 145.48 24.45 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.735 0.414 . . . . 72.299999999999997 110.896 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 112' ' ' TYR . . . -130.66 139.19 50.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.667 1.187 . . . . 72.040000000000006 110.679 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.2 98.75 5.97 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 107.779 -1.193 . . . . 72.230000000000004 107.779 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . . . -105.46 134.8 47.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.678 0.791 . . . . 61.140000000000001 109.694 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.432 ' HG3' HD11 ' A' ' 110' ' ' LEU . 90.2 mt-30 -93.59 113.14 25.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.945 -0.761 . . . . 73.530000000000001 108.945 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.619 HG21 HG23 ' A' ' 101' ' ' ILE . 57.4 p -98.22 179.5 4.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.144 0.978 . . . . 75.329999999999998 110.589 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -72.51 -18.76 61.63 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.908 -1.042 . . . . 74.129999999999995 110.005 170.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -80.38 -12.5 59.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.384 1.073 . . . . 74.409999999999997 111.278 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.72 -172.75 14.48 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.618 -0.193 . . . . 74.230000000000004 112.618 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -85.67 136.29 33.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.255 0.622 . . . . 74.239999999999995 110.756 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -173.38 -177.77 42.86 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.99 -0.55 . . . . 72.219999999999999 112.49 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -107.2 125.21 50.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.837 0.455 . . . . 71.420000000000002 111.58 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.561 HG21 HD13 ' A' ' 135' ' ' ILE . 26.8 m -138.6 148.9 60.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 125.129 1.372 . . . . 75.030000000000001 109.461 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 90.3 Cg_endo -95.0 151.91 1.71 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.956 2.437 . . . . 64.400000000000006 115.538 -170.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.1 m -41.54 -38.5 1.34 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.424 1.89 . . . . 74.219999999999999 115.133 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -71.78 -13.37 61.68 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 122.113 -0.367 . . . . 75.209999999999994 111.175 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.433 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 15.5 m-85 -104.08 -25.26 13.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.007 0.923 . . . . 74.140000000000001 112.363 170.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 130' ' ' VAL . 32.7 pt -128.21 144.95 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 118.669 0.668 . . . . 75.200000000000003 112.486 -173.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.429 ' HG1' ' HB2' ' A' ' 142' ' ' GLU . 15.3 t -137.5 148.57 62.11 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 108.866 -0.79 . . . . 70.319999999999993 108.866 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.25 141.2 88.55 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.532 2.155 . . . . 72.439999999999998 110.948 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.05 -3.26 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.425 0 CA-C-O 121.056 0.455 . . . . 73.329999999999998 111.355 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.402 ' N ' HD21 ' A' ' 139' ' ' ASN . 0.9 OUTLIER -90.77 -8.54 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.379 0.672 . . . . 72.140000000000001 112.11 174.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.7 p -75.97 -177.27 3.8 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.155 0.582 . . . . 72.510000000000005 111.901 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.7 mt -86.85 -30.93 21.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.828 0.451 . . . . 72.340000000000003 110.082 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.429 ' HB2' ' HG1' ' A' ' 136' ' ' THR . 2.1 mp0 -64.34 -23.83 67.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.403 1.081 . . . . 75.430000000000007 111.8 -174.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -6.17 9.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.911 0.884 . . . . 74.129999999999995 112.425 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 73' ' ' LEU . 85.1 m-70 -97.21 155.47 16.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.887 0.875 . . . . 74.319999999999993 110.585 171.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.5 p -66.99 -41.51 86.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.501 1.12 . . . . 74.010000000000005 111.745 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -66.04 -41.67 90.56 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.113 0.783 . . . . 74.140000000000001 113.113 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 26.4 t80 -78.06 112.55 15.11 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.955 -0.387 . . . . 73.430000000000007 109.955 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.411 ' HB2' HG23 ' A' ' 151' ' ' VAL . 30.6 m170 -104.41 -5.29 21.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.376 0.51 . . . . 52.340000000000003 112.376 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.34 -141.73 30.37 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 118.506 -1.163 . . . . 75.299999999999997 112.673 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.59 94.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.596 2.864 . . . . 73.230000000000004 112.919 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.662 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.8 t -138.53 137.09 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.916 1.286 . . . . 61.310000000000002 109.702 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.4 p -89.4 176.26 6.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.394 1.078 . . . . 65.530000000000001 110.882 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -60.1 -49.29 78.21 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.984 0.513 . . . . 73.430000000000007 110.122 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -59.56 -41.56 90.43 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.194 0.934 . . . . 75.230000000000004 111.192 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -65.84 -44.82 84.36 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.307 -0.86 . . . . 73.439999999999998 111.522 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.56 89.63 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.56 -0.745 . . . . 75.310000000000002 111.123 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -80.68 -21.6 41.16 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.47 -0.786 . . . . 63.450000000000003 111.977 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.431 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -78.23 -25.63 47.03 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.992 0.814 . . . . 74.430000000000007 110.388 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 239' ' ' ARG . 62.2 mt -70.74 -42.48 70.45 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.518 0.675 . . . . 72.549999999999997 110.484 169.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.443 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 66.9 mt -94.37 22.44 6.05 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.757 -1.11 . . . . 75.430000000000007 111.388 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 99.1 p -74.06 -43.8 56.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.148 0.499 . . . . 73.430000000000007 110.164 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.7 p -112.05 19.56 17.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.633 0.773 . . . . 64.430000000000007 110.464 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.96 149.8 48.2 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.98 -0.555 . . . . 74.230000000000004 111.724 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.7 pt -87.35 169.82 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-O 121.166 0.508 . . . . 74.519999999999996 110.527 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -70.96 109.25 4.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.077 -0.511 . . . . 75.219999999999999 109.632 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.87 10.07 19.42 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.087 0.851 . . . . 72.349999999999994 112.863 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.0 m -86.22 131.99 34.11 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.089 0.944 . . . . 62.409999999999997 110.583 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 183' ' ' SER . 8.6 p90 -139.29 166.95 23.18 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.385 0.539 . . . . 74.439999999999998 111.569 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -162.62 147.63 12.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.916 -1.038 . . . . 73.040000000000006 108.483 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.691 HG22 HG12 ' A' ' 182' ' ' ILE . 99.2 t -105.32 124.53 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.56 -1.274 . . . . 74.530000000000001 107.56 169.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.662 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 44.7 ptt85 -114.68 159.99 19.86 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.456 1.102 . . . . 71.239999999999995 108.663 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.65 141.79 47.73 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.757 -1.201 . . . . 62.149999999999999 107.757 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.0 t -83.51 130.73 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.26 0.624 . . . . 71.230000000000004 110.003 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.05 -33.01 33.79 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.718 0.636 . . . . 75.329999999999998 109.973 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.8 p -72.45 -31.81 65.76 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.494 -0.775 . . . . 75.549999999999997 110.955 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.6 m -121.8 95.1 48.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.476 0.71 . . . . 72.030000000000001 109.293 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.57 114.44 2.54 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.39 2.727 . . . . 64.400000000000006 113.31 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.16 -15.15 61.83 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.755 -0.657 . . . . 75.219999999999999 112.964 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -79.16 116.6 19.53 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.505 0.653 . . . . 72.439999999999998 109.975 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -110.22 144.65 38.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.477 0.656 . . . . 72.140000000000001 110.46 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.6 m -138.43 150.67 46.71 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.834 0.854 . . . . 74.409999999999997 109.043 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.691 HG12 HG22 ' A' ' 170' ' ' VAL . 22.3 mt -101.87 150.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.54 -1.282 . . . . 74.340000000000003 107.54 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -124.87 108.24 11.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.778 -1.193 . . . . 75.319999999999993 107.778 168.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.455 HD22 ' OH ' ' A' ' 193' ' ' TYR . 56.7 tp -107.49 111.12 23.26 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.325 -0.62 . . . . 74.340000000000003 109.325 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -79.55 122.37 26.4 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.521 -0.548 . . . . 73.25 109.521 168.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -149.92 145.25 26.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.848 1.659 . . . . 74.319999999999993 107.458 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 59.45 21.79 10.23 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 124.255 1.022 . . . . 64.409999999999997 111.557 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.47 -7.15 62.11 Favored Glycine 0 C--N 1.358 1.765 0 CA-C-N 116.176 -0.465 . . . . 75.030000000000001 113.956 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -104.49 138.64 40.56 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.196 0.999 . . . . 75.340000000000003 108.581 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.33 103.81 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.397 0.544 . . . . 73.310000000000002 110.395 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.26 115.47 27.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.885 0.874 . . . . 75.040000000000006 109.65 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.63 118.25 30.84 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.194 0.598 . . . . 75.510000000000005 110.371 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.494 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 11.1 m-85 -94.33 148.49 22.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.447 1.099 . . . . 72.409999999999997 109.532 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -107.02 112.93 26.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 74.310000000000002 108.727 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.18 101.49 8.82 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 N-CA-C 108.8 -0.815 . . . . 75.219999999999999 108.8 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -80.79 121.81 26.39 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.662 -1.154 . . . . 73.420000000000002 108.931 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.2 m -93.39 113.88 26.15 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.917 0.887 . . . . 71.439999999999998 108.78 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.25 167.32 14.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.7 0.8 . . . . 74.019999999999996 110.799 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.9 p -62.45 -24.69 67.57 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.881 0.872 . . . . 74.049999999999997 112.195 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -96.87 -16.66 20.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.62 0.768 . . . . 74.230000000000004 111.516 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.87 9.94 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.217 -0.768 . . . . 70.409999999999997 114.81 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.72 124.71 26.54 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.32 1.06 . . . . 73.319999999999993 110.551 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -88.26 140.88 29.03 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.846 -0.798 . . . . 74.340000000000003 108.846 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.579 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 44.8 p90 -162.63 135.59 5.8 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.769 0.668 . . . . 75.400000000000006 110.516 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 217' ' ' LEU . 53.9 t -70.81 -53.28 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.902 -0.777 . . . . 74.129999999999995 108.902 165.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.3 m -107.06 136.15 47.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.629 -1.168 . . . . 74.439999999999998 109.744 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.8 t -60.4 -26.59 66.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.45 1.1 . . . . 71.230000000000004 112.942 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.39 -23.3 61.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.747 0.819 . . . . 73.409999999999997 111.479 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.2 m -134.4 101.17 4.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.182 0.593 . . . . 71.319999999999993 110.364 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.579 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.1 mtm180 -110.07 138.07 46.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.162 0.985 . . . . 75.230000000000004 110.197 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.87 149.22 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.623 -0.88 . . . . 72.239999999999995 108.623 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -68.66 -31.96 71.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 75.400000000000006 110.76 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -132.1 157.36 44.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 112.074 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -27.55 69.03 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.731 -1.122 . . . . 75.109999999999999 109.506 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.99 -45.44 86.79 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.553 0.741 . . . . 72.219999999999999 110.898 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.6 -34.83 72.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.527 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 205' ' ' VAL . 16.0 tp -56.98 -58.64 7.27 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.752 0.421 . . . . 64.239999999999995 110.873 174.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.22 -40.65 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.246 0.618 . . . . 74.239999999999995 111.165 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -57.13 -61.47 2.44 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.822 0.701 . . . . 74.340000000000003 111.566 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -71.9 -29.16 64.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.849 -0.614 . . . . 73.340000000000003 111.262 -171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.504 ' HB3' HD12 ' A' ' 228' ' ' LEU . 12.7 m170 -87.55 -9.88 53.17 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.675 0.39 . . . . 73.319999999999993 112.049 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.0 p -88.43 -35.33 17.14 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.98 0.355 . . . . 74.010000000000005 110.114 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 65.8 p -70.28 -46.65 63.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.631 0.372 . . . . 71.129999999999995 111.048 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.733 HG22 ' HB2' ' A' ' 226' ' ' ASP . 22.8 m -132.01 165.14 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.353 0.661 . . . . 71.450000000000003 111.973 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.62 15.41 0.37 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 126.714 2.005 . . . . 64.129999999999995 114.208 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.733 ' HB2' HG22 ' A' ' 224' ' ' VAL . 23.8 t70 -44.65 36.23 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.723 1 C-N-CA 132.429 4.292 . . . . 75.109999999999999 119.561 -157.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 124.1 -7.08 8.73 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.537 -0.727 . . . . 74.430000000000007 112.493 -170.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 221' ' ' HIS . 14.4 mt -94.65 162.45 13.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.116 1.366 . . . . 74.209999999999994 110.059 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.76 -35.26 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.604 0.24 . . . . 74.150000000000006 110.786 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.5 t -159.06 -179.22 7.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.996 0.519 . . . . 74.219999999999999 110.677 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.2 p -66.13 137.24 56.9 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.622 1.169 . . . . 73.219999999999999 112.311 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.44 96.69 1.19 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.75 0.82 . . . . 73.349999999999994 109.051 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -97.53 -82.61 0.41 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.818 -0.551 . . . . 64.25 111.99 -170.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -75.22 120.72 82.99 Favored Pre-proline 0 C--N 1.351 0.647 0 N-CA-C 108.857 -0.794 . . . . 74.400000000000006 108.857 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.88 127.7 7.97 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.038 1.825 . . . . 73.120000000000005 111.275 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.95 140.94 88.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 108.851 -0.796 . . . . 74.409999999999997 108.851 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.76 176.58 9.34 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.488 2.125 . . . . 74.140000000000001 113.051 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -63.53 140.7 58.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.897 0.879 . . . . 75.109999999999999 109.654 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.597 ' HE ' HG22 ' A' ' 151' ' ' VAL . 20.8 ptt85 -90.49 -61.31 1.71 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.524 0.935 . . . . 75.310000000000002 113.524 -165.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.405 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.8 t30 -109.08 128.84 55.32 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.595 0.758 . . . . 74.140000000000001 109.614 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 90.8 mttt -76.94 113.26 28.6 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.092 -1.447 . . . . 74.349999999999994 107.092 164.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 39.0 Cg_exo -63.15 132.65 37.31 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.534 2.156 . . . . 74.239999999999995 112.46 -172.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 89.5 m -69.25 123.84 22.22 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.404 0.682 . . . . 72.319999999999993 110.284 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.65 111.74 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.405 -0.961 . . . . 74.519999999999996 108.405 172.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.56 112.37 25.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.303 0.641 . . . . 72.319999999999993 111.917 -169.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 69.34 -38.18 0.34 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 117.366 1.706 . . . . 71.040000000000006 117.366 165.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.33 129.33 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 117.833 0.817 . . . . 73.219999999999999 112.771 -158.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.9 t -83.35 135.82 43.7 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 107.339 -1.356 . . . . 75.409999999999997 107.339 168.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 C--N 1.387 2.562 0 C-N-CA 122.126 1.884 . . . . 75.129999999999995 115.265 -156.246 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.1 t90 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 74.299999999999997 109.625 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 26.2 p-10 -66.97 -33.95 76.7 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.419 -0.81 . . . . 73.409999999999997 110.826 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 p -72.0 6.21 2.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.698 1.199 . . . . 74.510000000000005 112.72 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 83.5 tttt -70.28 -21.24 62.98 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.75 0.42 . . . . 75.430000000000007 111.13 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.568 ' HG3' HD21 ' A' ' 72' ' ' ASN . 13.3 pt-20 -73.0 -38.11 66.72 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.474 -0.565 . . . . 73.450000000000003 109.474 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.568 HD21 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -77.43 -13.59 59.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.23 0.612 . . . . 75.230000000000004 111.075 176.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 60.3 tp -59.14 -50.32 74.5 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.684 0.794 . . . . 73.129999999999995 110.692 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 mt -108.06 23.8 13.94 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.78 -0.645 . . . . 72.099999999999994 110.922 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 123.073 0.549 . . . . 70.319999999999993 111.533 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.933 0.397 . . . . 73.010000000000005 111.681 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.5 tp -100.11 139.52 35.66 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.65 -0.656 . . . . 72.239999999999995 110.315 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -116.5 172.3 7.29 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.362 1.065 . . . . 73.319999999999993 109.101 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.08 139.99 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.732 1.213 . . . . 74.430000000000007 109.538 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.32 117.26 20.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.207 1.003 . . . . 73.230000000000004 110.249 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.444 HD13 ' HZ3' ' A' ' 238' ' ' LYS . 69.9 mt -81.07 -31.7 34.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.09 0.956 . . . . 75.209999999999994 111.564 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.43 141.61 51.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.036 0.934 . . . . 74.540000000000006 108.921 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.99 120.2 24.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.158 -0.682 . . . . 71.409999999999997 109.158 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.2 t80 -115.43 142.87 46.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.786 0.834 . . . . 64.109999999999999 109.469 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.72 135.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.737 -0.838 . . . . 63.109999999999999 108.737 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.42 119.22 10.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.701 0.8 . . . . 75.510000000000005 111.035 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.3 p -94.4 10.94 32.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.428 1.091 . . . . 74.409999999999997 111.324 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.78 179.45 43.47 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.108 -0.496 . . . . 73.310000000000002 112.034 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.14 -34.81 63.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.892 0.877 . . . . 74.430000000000007 110.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' ND2' ' HD2' ' A' ' 249' ' ' PRO . 32.4 p-10 -90.37 -4.05 57.33 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.043 -0.981 . . . . 75.400000000000006 112.262 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.9 p -96.76 168.51 10.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.457 0.703 . . . . 72.299999999999997 109.936 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.58 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 66.1 tp -135.93 136.29 40.33 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.084 0.553 . . . . 73.049999999999997 111.38 -172.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -83.9 120.14 25.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.573 0.749 . . . . 70.239999999999995 110.073 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.751 HG22 HG23 ' A' ' 123' ' ' THR . 20.2 pt -117.43 152.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 123.171 0.588 . . . . 75.450000000000003 111.614 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -98.53 146.44 25.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.362 1.065 . . . . 72.310000000000002 109.601 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -70.17 118.59 13.19 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.907 0.483 . . . . 74.439999999999998 109.701 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.78 -11.5 56.21 Favored Glycine 0 N--CA 1.472 1.052 0 C-N-CA 123.197 0.427 . . . . 74.420000000000002 112.845 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.11 135.65 44.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.65 0.78 . . . . 73.319999999999993 110.97 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -85.92 142.46 28.83 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.572 -0.899 . . . . 74.040000000000006 108.572 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.628 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.15 150.4 34.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.25 0.62 . . . . 62.210000000000001 111.119 -176.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -95.4 106.41 18.46 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.687 -0.688 . . . . 73.409999999999997 109.287 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.583 HG11 ' HB2' ' A' ' 119' ' ' ALA . 42.1 t -86.75 107.88 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.621 -0.511 . . . . 74.439999999999998 109.621 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.605 HD23 ' HG3' ' A' ' 122' ' ' GLN . 2.1 mm? -69.52 -23.22 63.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.349 1.059 . . . . 75.409999999999997 110.935 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.7 166.42 13.61 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.276 -0.42 . . . . 75.140000000000001 112.46 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.566 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 61.1 m-85 -86.6 173.12 9.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.841 0.829 . . . . 74.140000000000001 111.794 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -90.05 -178.66 5.49 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.208 -1.36 . . . . 64.25 110.97 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -53.26 -34.3 56.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.611 1.165 . . . . 71.030000000000001 113.11 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -105.35 -19.67 13.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 119.183 -0.436 . . . . 74.25 111.368 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.21 34.68 22.9 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.548 0.579 . . . . 71.109999999999999 114.548 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.55 -29.82 14.7 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.023 0.412 . . . . 73.310000000000002 111.057 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 60.6 m95 -128.75 156.02 44.2 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.16 0.984 . . . . 74.25 111.15 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.583 ' HB2' HG11 ' A' ' 109' ' ' VAL . . . -137.22 141.31 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.305 1.042 . . . . 73.319999999999993 110.263 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.483 ' HG2' HD21 ' A' ' 110' ' ' LEU . 40.7 tt0 -74.82 118.43 17.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.859 -1.163 . . . . 63.350000000000001 107.859 170.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.52 151.33 48.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.25 0.62 . . . . 75.430000000000007 111.307 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.605 ' HG3' HD23 ' A' ' 110' ' ' LEU . 56.4 mt-30 -115.05 116.43 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.148 0.979 . . . . 74.400000000000006 108.95 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.751 HG23 HG22 ' A' ' 101' ' ' ILE . 67.0 p -114.6 -178.51 3.39 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.349 1.059 . . . . 72.409999999999997 110.885 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.498 ' HB3' ' HZ2' ' A' ' 124' ' ' LYS . 1.1 mmmp? -68.66 -16.53 63.86 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.553 -0.748 . . . . 74.430000000000007 110.29 172.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -84.33 -20.46 32.01 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.202 1.001 . . . . 73.120000000000005 111.074 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.31 -168.43 14.84 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.096 -0.402 . . . . 55.240000000000002 112.096 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.27 145.45 28.83 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.35 0.575 . . . . 71.349999999999994 111.593 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.39 -161.91 27.65 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.713 -0.955 . . . . 31.43 110.713 177.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -110.94 136.24 50.25 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.797 0.798 . . . . 74.129999999999995 111.463 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.442 HG11 ' CG2' ' A' ' 101' ' ' ILE . 34.2 m -137.8 140.28 29.13 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.063 1.345 . . . . 73.109999999999999 109.252 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 8.8 Cg_exo -72.85 146.4 42.33 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.44 2.093 . . . . 74.120000000000005 114.38 -172.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 m -38.09 -50.96 1.4 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.469 1.907 . . . . 61.119999999999997 114.194 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 131' ' ' PRO . 12.7 p-10 -73.3 -3.65 28.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.375 1.07 . . . . 74.519999999999996 113.103 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -106.73 -9.39 16.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.858 0.863 . . . . 75.120000000000005 111.313 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.482 HD12 HG23 ' A' ' 109' ' ' VAL . 18.0 pt -130.8 168.59 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.137 0.975 . . . . 73.329999999999998 111.832 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 t -163.06 155.9 16.29 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 124.08 0.952 . . . . 62.340000000000003 108.672 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.74 142.71 91.65 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 121.795 1.663 . . . . 72.040000000000006 111.442 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.4 t -69.72 -11.37 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.796 0.807 . . . . 75.409999999999997 109.848 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -73.8 -18.36 60.97 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.523 1.129 . . . . 53.439999999999998 112.568 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.6 p -92.69 -178.25 4.8 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.318 0.858 . . . . 73.230000000000004 113.318 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.8 mt -83.5 -21.19 32.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.257 1.023 . . . . 74.409999999999997 111.689 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.54 -20.95 63.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.684 0.394 . . . . 73.200000000000003 111.792 -172.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -65.33 -15.99 63.12 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 112.266 0.469 . . . . 74.420000000000002 112.266 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -83.22 138.47 33.6 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.401 0.68 . . . . 75.319999999999993 109.28 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 p -65.11 -39.88 93.76 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.611 0.765 . . . . 72.329999999999998 112.203 -177.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.42 ' HE1' HD11 ' A' ' 73' ' ' LEU . 32.2 p-90 -67.78 -30.16 69.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.848 0.859 . . . . 72.219999999999999 112.87 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -80.58 102.99 10.13 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.742 -0.466 . . . . 75.230000000000004 109.742 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -99.72 -4.1 31.47 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.992 0.517 . . . . 75.439999999999998 111.788 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.8 -139.79 26.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 118.708 -1.051 . . . . 62.25 112.793 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.92 101.51 0.39 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.813 2.342 . . . . 74.010000000000005 112.399 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 76.7 t -132.3 141.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.77 0.828 . . . . 74.319999999999993 109.801 -175.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.6 p -87.72 172.65 9.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.924 0.89 . . . . 73.25 110.369 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 68.8 ttt180 -61.71 -45.51 93.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.243 -0.28 . . . . 63.539999999999999 110.243 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.5 -45.56 80.94 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.042 0.838 . . . . 64.299999999999997 111.019 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.593 ' HB1' HH12 ' A' ' 239' ' ' ARG . . . -71.65 -26.45 62.55 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.289 -0.869 . . . . 71.239999999999995 111.699 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.27 -43.27 52.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.27 0.628 . . . . 74.310000000000002 111.243 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 26.7 mm-40 -60.79 -36.19 78.38 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.722 0.809 . . . . 74.129999999999995 110.059 174.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -67.75 -47.29 69.67 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.704 -1.134 . . . . 73.209999999999994 111.205 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.33 -38.44 68.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.284 0.634 . . . . 73.010000000000005 111.307 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.9 mt -100.93 6.79 43.75 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.952 0.723 . . . . 73.109999999999999 112.952 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 90.6 p -59.17 -35.31 73.32 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 119.075 0.852 . . . . 70.5 111.166 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -102.86 18.92 20.37 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.495 1.118 . . . . 73.25 110.89 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.11 133.29 11.68 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 123.644 0.64 . . . . 74.109999999999999 113.057 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -79.54 -177.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.946 0.898 . . . . 51.100000000000001 111.837 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.96 116.43 3.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.601 0.761 . . . . 71.129999999999995 110.656 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.16 11.8 55.7 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.629 -0.714 . . . . 73.019999999999996 113.094 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.1 m -76.38 135.24 39.48 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 118.082 0.941 . . . . 74.510000000000005 110.622 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 183' ' ' SER . 33.6 p90 -142.22 168.13 20.47 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 118.782 0.719 . . . . 71.010000000000005 111.34 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 pp -159.29 152.67 22.52 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.337 -0.986 . . . . 73.140000000000001 108.337 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.679 HG21 HG12 ' A' ' 182' ' ' ILE . 89.4 t -110.91 142.05 24.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 N-CA-C 109.092 -0.707 . . . . 70.409999999999997 109.092 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.453 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.3 ptt85 -135.37 159.21 42.3 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.288 -1.323 . . . . 74.439999999999998 108.95 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.655 ' HG2' ' HG2' ' A' ' 180' ' ' ARG . 10.7 mt-10 -113.93 162.14 16.76 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.523 -0.918 . . . . 73.219999999999999 108.523 164.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -84.02 133.79 34.65 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.99 -0.744 . . . . 74.409999999999997 108.99 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -71.17 -43.73 66.89 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.722 -0.473 . . . . 74.450000000000003 109.722 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.5 p -76.25 -15.76 59.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.112 0.565 . . . . 71.420000000000002 112.145 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.5 m -139.54 82.99 17.57 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.141 0.577 . . . . 74.519999999999996 109.865 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.64 125.94 18.57 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.958 2.439 . . . . 72.109999999999999 111.531 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.42 -29.58 8.98 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.752 -0.539 . . . . 53.0 111.752 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -75.77 116.89 16.94 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.02 -0.733 . . . . 72.049999999999997 109.02 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.655 ' HG2' ' HG2' ' A' ' 172' ' ' GLU . 98.3 mtt180 -124.01 145.89 48.9 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 123.954 0.902 . . . . 75.010000000000005 110.121 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 64.3 m -142.27 146.46 35.14 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.221 -0.9 . . . . 71.319999999999993 109.668 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.679 HG12 HG21 ' A' ' 170' ' ' VAL . 34.6 mt -103.32 150.17 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.084 -1.45 . . . . 72.010000000000005 107.084 169.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.1 m -125.45 108.09 11.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.661 -1.237 . . . . 71.430000000000007 107.661 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 25.5 tp -107.72 110.16 21.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.658 0.663 . . . . 75.430000000000007 110.216 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.524 ' HB2' HG22 ' A' ' 190' ' ' VAL . 20.5 ttt180 -79.95 120.89 24.77 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.673 0.749 . . . . 75.299999999999997 110.773 168.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -140.59 135.51 31.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 113.816 -1.538 . . . . 73.5 107.446 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 60.14 22.4 11.67 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.799 0.84 . . . . 63.539999999999999 112.087 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.15 -10.77 73.05 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.142 0.417 . . . . 45.210000000000001 114.142 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -103.5 139.04 39.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.314 0.646 . . . . 73.209999999999994 109.908 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' A' ' 185' ' ' ARG . 48.1 t -99.3 110.33 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.897 0.479 . . . . 73.329999999999998 110.433 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -95.05 117.03 29.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.979 1.311 . . . . 73.030000000000001 109.133 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -96.54 122.94 39.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.947 0.499 . . . . 75.120000000000005 110.723 -172.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.468 ' HE1' HD21 ' A' ' 232' ' ' LEU . 8.2 m-30 -94.82 147.36 23.43 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.097 0.959 . . . . 75.040000000000006 109.795 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -99.24 117.65 34.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.132 -1.062 . . . . 74.540000000000006 108.132 173.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 180' ' ' ARG . 56.8 mt -82.4 100.59 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 107.649 -1.241 . . . . 73.439999999999998 107.649 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.28 119.81 15.96 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.051 -0.977 . . . . 72.209999999999994 109.206 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 m -87.71 110.47 20.46 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.677 -0.692 . . . . 73.200000000000003 109.16 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.25 157.3 10.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.167 0.987 . . . . 61.0 111.383 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.6 p -64.43 -31.79 73.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.641 0.776 . . . . 73.200000000000003 112.101 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -82.58 -13.92 55.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.319 0.648 . . . . 72.329999999999998 111.316 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.32 9.77 19.04 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.401 0.52 . . . . 65.5 114.401 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -79.66 164.09 24.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.686 0.743 . . . . 73.409999999999997 110.735 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -115.73 147.36 41.0 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.601 0.761 . . . . 75.420000000000002 109.172 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.594 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.6 p90 -170.3 140.06 1.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.027 0.829 . . . . 72.510000000000005 111.728 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.35 -44.38 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.733 -0.84 . . . . 63.130000000000003 108.733 165.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 43.1 m -92.7 130.83 38.2 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.941 -1.027 . . . . 71.140000000000001 109.992 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -72.27 -17.11 61.91 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.416 0.686 . . . . 74.099999999999994 111.884 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.47 -1.51 57.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.038 0.535 . . . . 64.450000000000003 111.399 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.36 101.86 3.53 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.769 0.428 . . . . 73.519999999999996 111.426 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.594 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 74.2 mtt180 -101.36 153.68 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.219 0.608 . . . . 72.530000000000001 110.32 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.4 154.72 47.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.411 0.684 . . . . 75.329999999999998 109.952 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -72.21 -44.74 62.48 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.233 -0.655 . . . . 63.240000000000002 109.233 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 156.41 31.39 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-O 121.938 0.875 . . . . 75.450000000000003 111.564 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.438 HD23 HD23 ' A' ' 217' ' ' LEU . 0.8 OUTLIER -64.55 -26.6 68.49 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-N 114.012 -1.449 . . . . 73.099999999999994 110.065 175.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.26 96.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.576 0.75 . . . . 70.140000000000001 111.331 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.84 -33.19 70.4 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.375 0.67 . . . . 72.5 111.154 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.438 HD23 HD23 ' A' ' 214' ' ' LEU . 15.3 tp -53.36 -57.23 11.31 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.729 0.643 . . . . 74.209999999999994 110.034 171.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 53.4 t -63.88 -37.83 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 O-C-N 123.802 0.689 . . . . 74.219999999999999 112.035 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -65.14 -51.89 58.46 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.853 0.358 . . . . 74.319999999999993 111.189 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -64.23 -35.11 79.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 75.150000000000006 110.776 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.623 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.5 m170 -85.72 -9.33 57.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.284 0.476 . . . . 72.430000000000007 112.284 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.4 p -90.93 -29.73 17.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.727 0.411 . . . . 73.549999999999997 110.761 170.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.7 p -75.48 -49.51 18.57 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.852 0.358 . . . . 75.140000000000001 110.735 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.3 m -125.7 154.23 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.979 0.895 . . . . 73.420000000000002 111.694 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.62 13.88 7.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.627 1.971 . . . . 71.150000000000006 113.694 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -46.77 34.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 131.182 3.793 . . . . 55.25 119.855 -159.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.58 -0.67 6.37 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 119.28 0.945 . . . . 74.430000000000007 112.941 -167.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.2 mt -92.33 161.92 14.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.434 1.094 . . . . 75.540000000000006 110.52 163.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.83 -42.19 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 122.564 0.345 . . . . 74.25 110.432 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -161.69 170.9 18.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.665 0.786 . . . . 71.120000000000005 110.102 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.3 p -61.29 139.36 58.17 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.456 1.102 . . . . 63.530000000000001 112.687 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.468 HD21 ' HE1' ' A' ' 193' ' ' TYR . 79.5 mt -68.17 99.55 0.91 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.033 0.933 . . . . 74.510000000000005 109.161 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -94.44 -50.24 5.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.329 0.492 . . . . 73.439999999999998 112.329 -163.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 167' ' ' SER . 15.5 t80 -130.77 124.16 20.62 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.936 1.294 . . . . 72.030000000000001 108.127 -171.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -84.95 146.91 10.4 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.256 1.97 . . . . 72.420000000000002 112.17 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -74.63 130.15 82.25 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.437 -1.32 . . . . 75.420000000000002 107.437 172.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.35 173.8 12.77 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.076 1.85 . . . . 73.310000000000002 112.5 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HZ3' HD13 ' A' ' 88' ' ' LEU . 34.0 mmtp -68.19 109.12 3.42 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.882 -0.784 . . . . 74.349999999999994 108.882 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.603 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 8.7 ptt180 -75.51 -68.3 0.58 Allowed 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.559 0.948 . . . . 73.319999999999993 113.559 -158.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.603 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 66.8 t30 -111.29 137.75 48.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.788 -0.57 . . . . 70.219999999999999 110.128 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -74.49 112.69 18.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 106.3 -1.741 . . . . 71.420000000000002 106.3 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.23 127.28 16.4 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.346 2.031 . . . . 64.329999999999998 111.568 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 84.8 m -61.53 110.76 1.56 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.969 0.907 . . . . 74.230000000000004 111.182 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.22 106.96 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 107.685 -1.228 . . . . 64.109999999999999 107.685 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.73 120.77 43.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.128 0.971 . . . . 73.209999999999994 112.777 -163.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.07 63.74 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 116.352 1.301 . . . . 64.409999999999997 116.352 161.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.63 122.42 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 123.187 0.595 . . . . 72.239999999999995 110.874 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.9 t -81.3 116.73 64.65 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 104.834 -2.284 . . . . 72.439999999999998 104.834 161.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.501 ' HD2' ' ND2' ' A' ' 97' ' ' ASN . 99.3 Cg_exo . . . . . 0 C--N 1.378 2.11 0 C-N-CA 122.677 2.252 . . . . 74.349999999999994 116.226 -148.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.8 t90 . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 108.51 -0.922 . . . . 74.409999999999997 108.51 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 30.1 p-10 -94.38 -34.01 12.94 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.888 0.475 . . . . 74.430000000000007 110.68 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.3 p -71.25 2.94 4.05 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.959 0.903 . . . . 75.099999999999994 113.3 -171.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.08 -22.07 64.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.658 . . . . 72.209999999999994 110.636 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 10.9 pt-20 -65.76 -30.79 71.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.688 0.795 . . . . 74.540000000000006 110.673 172.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -84.17 -10.34 57.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.128 0.971 . . . . 74.549999999999997 110.928 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.5 tp -65.12 -48.91 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.807 0.843 . . . . 73.420000000000002 111.686 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.51 12.39 29.6 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 73.540000000000006 110.971 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 123.179 0.591 . . . . 63.0 111.471 179.792 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 111.754 0.279 . . . . 70.329999999999998 111.754 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.0 tp -84.23 127.29 33.86 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 121.258 0.552 . . . . 64.120000000000005 110.035 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -110.49 174.95 5.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.625 1.57 . . . . 74.239999999999995 108.652 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.66 141.56 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.744 1.218 . . . . 74.329999999999998 109.46 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.4 137.03 38.47 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.609 0.763 . . . . 72.310000000000002 110.079 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.518 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 73.1 mt -103.97 -20.85 13.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.942 0.897 . . . . 72.219999999999999 111.475 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.98 149.19 49.99 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.021 0.928 . . . . 73.430000000000007 109.552 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.4 119.58 19.69 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.515 -0.92 . . . . 74.349999999999994 108.515 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -129.8 133.6 47.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.222 -0.659 . . . . 73.549999999999997 109.222 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.9 136.23 37.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.534 -1.284 . . . . 74.450000000000003 107.534 169.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.65 136.07 50.81 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.349 1.06 . . . . 62.219999999999999 111.218 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -131.33 26.88 4.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.014 0.925 . . . . 70.310000000000002 112.254 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.46 -165.74 26.36 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.071 -0.513 . . . . 73.230000000000004 112.014 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.73 -42.51 19.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.143 0.577 . . . . 75.430000000000007 112.304 -172.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -101.05 5.07 42.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.632 0.373 . . . . 72.239999999999995 111.767 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -76.27 172.31 13.09 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.698 0.799 . . . . 73.519999999999996 112.044 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.531 HD23 ' HG1' ' A' ' 123' ' ' THR . 39.5 tp -147.02 130.54 16.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 73.299999999999997 110.138 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -80.77 127.79 32.91 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.336 0.654 . . . . 62.219999999999999 109.86 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.627 HG21 HG21 ' A' ' 123' ' ' THR . 19.5 pt -126.72 154.22 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.549 0.74 . . . . 75.239999999999995 111.684 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -100.68 147.33 26.13 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.616 -1.175 . . . . 73.310000000000002 108.743 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.67 114.16 4.78 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.551 -0.537 . . . . 75.230000000000004 109.551 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.84 -1.34 44.99 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 115.924 -0.58 . . . . 74.109999999999999 113.124 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -79.65 127.18 31.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.951 0.501 . . . . 74.209999999999994 110.493 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -79.3 135.35 36.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.484 0.714 . . . . 74.140000000000001 109.435 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.652 ' HB3' HG23 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.64 147.87 30.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.651 0.78 . . . . 71.430000000000007 111.26 -174.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -104.93 109.51 21.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.854 0.461 . . . . 75.420000000000002 110.731 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.521 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.4 t -73.05 125.23 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.608 0.363 . . . . 72.239999999999995 110.162 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.9 mt -96.28 -36.76 10.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.877 1.271 . . . . 75.530000000000001 110.237 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.1 144.68 6.89 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.76 -0.655 . . . . 73.200000000000003 111.982 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 119' ' ' ALA . 29.5 m-85 -89.62 171.11 9.91 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.853 0.835 . . . . 63.340000000000003 111.616 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -68.98 161.02 29.81 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 113.784 -1.553 . . . . 74.099999999999994 108.021 169.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -54.29 -28.52 42.62 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.998 0.919 . . . . 74.329999999999998 113.141 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -106.11 -3.62 21.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.078 0.951 . . . . 73.299999999999997 111.847 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.72 33.38 58.05 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-O 119.818 -0.434 . . . . 72.319999999999993 113.981 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.611 ' HB3' ' HD1' ' A' ' 118' ' ' TRP . 37.6 mt-10 -70.23 -65.69 0.69 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.261 0.531 . . . . 71.219999999999999 110.544 171.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.773 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 23.5 m95 -119.65 167.09 12.37 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.277 1.031 . . . . 74.430000000000007 110.176 -171.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.554 ' HB3' ' CE2' ' A' ' 112' ' ' TYR . . . -141.7 131.56 24.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.462 1.105 . . . . 73.040000000000006 109.95 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.76 101.8 4.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . . . -104.64 144.69 31.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.35 0.66 . . . . 73.329999999999998 110.586 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -95.6 105.17 17.13 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.109 -1.071 . . . . 75.040000000000006 108.109 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.652 HG23 ' HB3' ' A' ' 107' ' ' LEU . 62.3 p -97.94 173.53 7.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.618 1.167 . . . . 74.0 110.152 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -68.69 -21.79 64.4 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.503 -0.772 . . . . 73.219999999999999 109.777 174.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.979 1.312 . . . . 75.299999999999997 111.474 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.11 -170.48 24.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.139 -0.384 . . . . 71.150000000000006 112.139 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -102.33 135.05 44.62 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.415 0.686 . . . . 74.129999999999995 110.554 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 172.34 -175.38 45.54 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 111.261 -0.735 . . . . 34.340000000000003 111.261 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -94.84 132.67 39.4 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.268 0.627 . . . . 74.299999999999997 112.023 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.525 HG21 HD11 ' A' ' 135' ' ' ILE . 36.0 m -137.72 139.98 28.41 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.75 1.62 . . . . 71.340000000000003 108.816 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 7.7 Cg_exo -71.21 145.35 48.73 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.598 2.198 . . . . 75.540000000000006 113.953 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -38.2 -50.75 1.44 Allowed 'General case' 0 C--N 1.369 1.444 0 C-N-CA 125.405 1.482 . . . . 72.230000000000004 112.763 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -80.66 12.38 3.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.442 1.097 . . . . 74.299999999999997 112.882 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -115.58 -16.13 11.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.36 1.064 . . . . 74.430000000000007 111.481 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 130' ' ' VAL . 21.3 pt -128.91 171.69 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.766 0.826 . . . . 73.109999999999999 111.511 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.8 t -161.71 153.24 15.75 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.649 -0.871 . . . . 71.430000000000007 108.649 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 36.8 Cg_endo -64.08 154.53 69.99 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.685 1.59 . . . . 73.430000000000007 112.067 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.4 t -72.59 -6.96 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-O 121.937 0.875 . . . . 74.450000000000003 110.382 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.54 -19.78 35.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.826 0.85 . . . . 60.350000000000001 111.401 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.6 p -88.42 171.84 9.81 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.338 0.655 . . . . 73.030000000000001 111.738 -172.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.41 -21.55 30.75 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.001 0.92 . . . . 74.109999999999999 110.668 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.86 -17.12 63.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.471 1.108 . . . . 74.109999999999999 111.761 -172.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.417 ' HA ' HD22 ' A' ' 88' ' ' LEU . 23.4 pttm -62.46 -12.53 22.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.66 0.784 . . . . 74.420000000000002 112.371 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -96.68 150.89 20.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.112 0.965 . . . . 74.310000000000002 110.303 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 p -67.33 -43.86 80.52 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.097 0.959 . . . . 73.129999999999995 111.5 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -57.85 -39.77 78.52 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 124.281 0.988 . . . . 74.5 111.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -77.83 112.67 14.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.062 -0.718 . . . . 73.099999999999994 109.062 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -108.53 -2.71 18.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.024 0.53 . . . . 75.430000000000007 111.695 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.41 -145.69 25.51 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 118.88 -0.955 . . . . 75.219999999999999 113.22 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.74 91.75 0.3 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.357 2.705 . . . . 71.140000000000001 111.85 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.21 144.14 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.724 1.21 . . . . 74.120000000000005 109.005 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.4 p -88.2 167.25 13.75 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.575 0.75 . . . . 74.450000000000003 109.835 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -60.05 -46.79 88.38 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.901 0.48 . . . . 73.340000000000003 111.702 -173.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -65.53 -35.31 80.49 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 123.754 0.659 . . . . 71.430000000000007 111.115 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.33 67.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.091 0.556 . . . . 64.319999999999993 110.87 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.617 ' HA ' HD12 ' A' ' 159' ' ' LEU . . . -68.35 -43.86 76.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.604 0.716 . . . . 33.43 110.885 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.24 -21.31 60.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.2 -0.909 . . . . 73.010000000000005 110.647 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -72.48 -42.35 65.01 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.594 0.757 . . . . 75.219999999999999 110.353 170.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 156' ' ' ALA . 21.5 mt -56.66 -37.33 70.66 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.276 0.631 . . . . 75.540000000000006 110.674 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 19.6 17.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.415 -0.811 . . . . 75.200000000000003 112.602 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 -35.86 51.22 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.759 -0.83 . . . . 72.239999999999995 108.759 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.5 p -94.54 -15.16 24.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.67 1.188 . . . . 74.219999999999999 111.586 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.18 148.65 50.28 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 123.267 0.355 . . . . 54.100000000000001 113.455 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.4 -178.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.767 . . . . 72.230000000000004 111.398 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.26 123.2 19.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.146 -0.479 . . . . 65.25 109.88 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.31 7.89 61.73 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.311 -0.716 . . . . 62.310000000000002 113.052 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.5 m -83.71 133.46 34.8 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 118.26 1.03 . . . . 75.239999999999995 110.479 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -139.37 166.34 24.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.095 0.474 . . . . 74.120000000000005 111.146 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -158.5 150.62 21.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.906 -1.043 . . . . 75.409999999999997 109.17 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.635 HG23 HG12 ' A' ' 182' ' ' ILE . 99.6 t -110.33 140.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 108.596 -0.89 . . . . 72.030000000000001 108.596 167.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.499 ' HD3' ' HB3' ' A' ' 156' ' ' ALA . 52.2 ptt85 -142.6 161.43 38.08 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.045 -0.979 . . . . 75.340000000000003 109.621 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.48 154.67 27.79 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.196 -1.409 . . . . 74.400000000000006 107.196 165.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -79.63 119.2 22.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 72.299999999999997 109.649 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.46 -37.02 85.69 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.609 -0.723 . . . . 73.510000000000005 109.886 168.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 -40.52 97.9 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.273 1.029 . . . . 75.120000000000005 111.659 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.4 m -143.47 94.84 6.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.648 0.779 . . . . 63.130000000000003 109.598 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -59.19 146.91 92.98 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.217 2.611 . . . . 73.129999999999995 112.812 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.06 -30.62 8.3 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.49 -0.777 . . . . 64.409999999999997 112.268 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.82 115.16 15.22 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 109.451 -0.574 . . . . 65.019999999999996 109.451 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -119.68 140.93 49.88 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.292 0.637 . . . . 74.430000000000007 109.441 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 71.1 m -145.24 147.39 32.36 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.065 0.946 . . . . 74.099999999999994 109.864 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.635 HG12 HG23 ' A' ' 170' ' ' VAL . 38.0 mt -102.74 147.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.221 -1.4 . . . . 74.299999999999997 107.221 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.6 m -124.3 113.0 17.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.519 -1.289 . . . . 65.349999999999994 107.519 172.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.0 112.34 24.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.048 0.539 . . . . 75.310000000000002 109.871 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.438 ' HB2' HG22 ' A' ' 190' ' ' VAL . 54.3 ttt180 -79.73 116.5 19.94 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 109.43 -0.581 . . . . 72.140000000000001 109.43 166.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -142.11 141.44 32.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.144 1.377 . . . . 75.329999999999998 107.938 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 54.55 31.05 14.19 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.403 1.081 . . . . 65.420000000000002 111.603 -173.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.24 -11.25 50.74 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-N 115.466 -0.788 . . . . 72.109999999999999 114.228 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -104.72 139.5 39.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.585 0.754 . . . . 74.150000000000006 110.129 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 185' ' ' ARG . 51.7 t -95.68 107.26 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.848 0.459 . . . . 73.319999999999993 110.511 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -93.1 132.38 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.471 1.108 . . . . 73.109999999999999 109.211 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -107.52 119.8 40.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.14 0.576 . . . . 71.219999999999999 110.636 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.501 ' HE1' HD22 ' A' ' 232' ' ' LEU . 7.8 m-85 -94.55 146.65 23.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.411 1.084 . . . . 73.120000000000005 109.192 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -100.38 114.72 28.47 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.217 -0.66 . . . . 72.430000000000007 109.217 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mt -85.15 101.06 9.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.198 -1.038 . . . . 73.519999999999996 108.198 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.93 121.27 23.94 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.948 -1.024 . . . . 65.219999999999999 108.641 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.7 m -94.23 118.7 31.95 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.343 -0.984 . . . . 75.450000000000003 108.343 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.9 169.54 14.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.867 0.867 . . . . 72.530000000000001 110.621 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.7 p -66.3 -28.51 68.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.839 0.456 . . . . 72.209999999999994 110.918 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.79 -11.3 42.54 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.542 0.737 . . . . 63.25 110.946 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.27 -0.31 25.21 Favored Glycine 0 C--N 1.356 1.683 0 CA-C-O 119.104 -0.831 . . . . 64.409999999999997 115.166 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.408 ' HE2' ' OD1' ' A' ' 212' ' ' ASN . 98.3 mttt -69.36 131.94 45.6 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.398 1.099 . . . . 72.129999999999995 112.155 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -89.22 142.94 27.21 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.037 -1.097 . . . . 70.019999999999996 108.037 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.503 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.1 p90 -167.48 138.0 2.92 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.57 0.543 . . . . 74.340000000000003 111.993 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.0 t -89.17 -30.8 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.583 -0.895 . . . . 72.230000000000004 108.583 163.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 14.7 m -93.2 115.58 28.2 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.26 -1.015 . . . . 74.430000000000007 108.26 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.3 t -56.98 -38.14 72.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.481 0.712 . . . . 74.310000000000002 111.863 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.34 -29.6 30.91 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.751 0.82 . . . . 64.430000000000007 111.15 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 58.9 m -102.2 91.28 4.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.062 0.545 . . . . 74.540000000000006 110.289 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.503 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 87.1 mtt180 -91.1 140.62 29.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.511 0.724 . . . . 73.5 109.688 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.2 m-85 -125.75 141.87 51.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.878 -0.786 . . . . 74.219999999999999 108.878 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.408 ' OD1' ' HE2' ' A' ' 202' ' ' LYS . 71.4 m-20 -64.75 -38.83 92.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.533 0.521 . . . . 72.319999999999993 110.132 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 63.7 p -123.88 155.33 38.26 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.072 0.939 . . . . 74.299999999999997 111.757 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.02 -24.29 66.72 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 113.869 -1.514 . . . . 74.510000000000005 109.496 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.65 94.83 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.857 0.863 . . . . 73.150000000000006 110.964 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 47.4 mt-10 -72.52 -36.8 68.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.489 0.716 . . . . 75.129999999999995 111.263 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.2 tp -53.91 -57.1 12.22 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.584 0.553 . . . . 73.409999999999997 110.492 173.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.64 -37.48 80.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 O-C-N 123.736 0.648 . . . . 74.209999999999994 111.413 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.981 0.355 . . . . 75.340000000000003 111.163 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -57.34 -36.83 71.66 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.142 0.901 . . . . 73.129999999999995 109.988 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.649 ' HB3' HD13 ' A' ' 228' ' ' LEU . 12.9 m170 -87.29 -12.28 47.04 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 112.513 0.56 . . . . 73.129999999999995 112.513 -175.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.6 p -98.16 -11.12 23.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.89 0.476 . . . . 74.329999999999998 110.575 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.8 p -87.66 -43.16 12.15 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 110.1 -0.334 . . . . 72.409999999999997 110.1 171.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 226' ' ' ASP . 29.1 m -137.46 172.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.461 0.648 . . . . 73.120000000000005 112.71 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.97 14.51 1.37 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.866 2.066 . . . . 71.510000000000005 114.106 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.576 ' HB2' HG21 ' A' ' 224' ' ' VAL . 28.0 t70 -42.66 29.8 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 1 C-N-CA 131.799 4.039 . . . . 73.340000000000003 120.073 -152.249 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.49 1.1 10.13 Favored Glycine 0 N--CA 1.483 1.825 0 O-C-N 120.071 -1.643 . . . . 72.129999999999995 112.192 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.649 HD13 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -92.83 161.96 14.3 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.082 1.353 . . . . 75.319999999999993 109.525 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.52 -37.4 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 N-CA-C 110.177 -0.305 . . . . 74.349999999999994 110.177 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -161.28 169.2 22.58 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.79 0.836 . . . . 70.439999999999998 110.388 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 27.8 m -61.31 135.9 57.87 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.372 1.069 . . . . 75.420000000000002 111.266 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.501 HD22 ' HE1' ' A' ' 193' ' ' TYR . 74.9 mt -69.5 128.11 35.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 74.0 109.701 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -113.39 -78.71 0.58 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.921 0.489 . . . . 73.310000000000002 111.765 -171.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 167' ' ' SER . 33.2 t80 -94.03 124.92 54.74 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.387 1.075 . . . . 75.430000000000007 109.444 -173.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.99 127.56 4.76 Favored 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 122.272 1.981 . . . . 74.430000000000007 111.477 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.59 124.52 87.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.273 0.629 . . . . 75.120000000000005 109.499 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.33 175.47 9.3 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.975 2.45 . . . . 74.230000000000004 113.11 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.518 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 72.1 mmtt -69.1 130.33 42.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.371 -0.831 . . . . 72.349999999999994 109.106 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -83.47 -59.13 2.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.518 0.562 . . . . 73.230000000000004 112.518 -168.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -108.6 132.75 53.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.784 1.234 . . . . 74.420000000000002 110.136 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -81.32 114.92 53.02 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 106.77 -1.567 . . . . 74.030000000000001 106.77 163.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.33 123.64 14.09 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.782 2.322 . . . . 65.239999999999995 111.897 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 20.8 m -74.73 100.21 3.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.818 0.447 . . . . 73.329999999999998 110.071 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.32 106.54 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 107.245 -1.391 . . . . 65.150000000000006 107.245 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.3 107.54 19.12 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.395 -0.224 . . . . 72.420000000000002 110.395 -161.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.27 11.74 7.18 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.76 1.464 . . . . 72.219999999999999 116.76 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -75.32 130.06 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 118.465 1.133 . . . . 75.510000000000005 112.722 -164.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 m -87.65 115.55 63.29 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.378 -2.082 . . . . 52.240000000000002 105.378 144.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 C--N 1.367 1.509 0 C-N-CA 121.006 1.138 . . . . 72.400000000000006 114.952 -169.503 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 1.2 t90 . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 121.967 0.889 . . . . 74.519999999999996 110.931 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -69.78 -31.75 69.85 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.218 -1.355 . . . . 72.219999999999999 109.428 166.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.9 p -80.21 6.28 12.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.921 1.288 . . . . 74.140000000000001 113.048 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.3 -48.16 82.66 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.871 0.468 . . . . 74.150000000000006 110.983 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -71.78 -24.97 61.84 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.217 0.607 . . . . 73.540000000000006 111.172 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.452 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 15.6 m120 -88.38 -2.46 58.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.706 0.802 . . . . 71.109999999999999 111.671 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.1 tp -61.84 -47.98 82.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.012 0.925 . . . . 65.329999999999998 111.304 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.02 36.1 2.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.142 0.977 . . . . 74.439999999999998 109.87 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 123.529 0.731 . . . . 72.049999999999997 110.938 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.3 p30 . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 112.073 0.397 . . . . 72.510000000000005 112.073 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.1 tp -83.54 120.07 25.48 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.827 -0.805 . . . . 71.239999999999995 108.827 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -109.06 175.2 5.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.33 1.452 . . . . 72.329999999999998 108.717 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.34 135.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.756 1.222 . . . . 61.32 109.213 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.72 112.98 9.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.98 0.912 . . . . 75.340000000000003 110.404 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.19 -31.55 38.76 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.249 0.62 . . . . 75.049999999999997 111.32 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.511 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 55.3 m-85 -126.34 141.71 51.8 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.33 1.052 . . . . 74.030000000000001 108.758 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.96 122.98 27.38 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.83 -0.804 . . . . 72.140000000000001 108.83 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.45 ' HB3' HG12 ' A' ' 101' ' ' ILE . 78.5 t80 -111.66 135.47 52.2 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.524 -0.917 . . . . 72.109999999999999 108.524 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.95 130.17 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.278 -1.379 . . . . 74.319999999999993 107.278 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.96 132.62 53.29 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.119 0.887 . . . . 72.420000000000002 111.669 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -95.34 13.29 26.19 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.34 1.056 . . . . 62.539999999999999 111.189 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.21 -171.65 44.05 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.1 -0.5 . . . . 70.219999999999999 112.014 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -69.93 -41.85 74.06 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.736 0.814 . . . . 74.430000000000007 112.759 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -82.99 -25.92 31.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.951 0.9 . . . . 75.150000000000006 111.522 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -75.72 158.37 32.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.297 0.639 . . . . 74.319999999999993 109.733 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.575 HD22 ' HG1' ' A' ' 123' ' ' THR . 53.2 tp -127.82 137.37 52.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.807 0.443 . . . . 73.349999999999994 111.49 -169.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -86.61 118.02 25.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.881 0.872 . . . . 74.420000000000002 110.168 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 123' ' ' THR . 31.7 pt -122.12 162.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.812 0.845 . . . . 71.439999999999998 110.349 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -129.16 152.52 48.66 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 72.140000000000001 109.358 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -57.67 136.87 56.89 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.858 0.863 . . . . 74.409999999999997 112.143 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.5 67.77 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 123.586 0.612 . . . . 22.030000000000001 113.993 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.09 130.24 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.284 0.542 . . . . 73.099999999999994 111.237 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.13 123.21 28.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.141 0.977 . . . . 71.420000000000002 109.107 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.73 ' HB3' HG21 ' A' ' 123' ' ' THR . 0.4 OUTLIER -133.69 146.34 50.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.519 0.728 . . . . 74.219999999999999 110.857 -175.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -96.96 112.62 24.29 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.199 0.6 . . . . 71.25 110.447 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 119' ' ' ALA . 55.5 t -79.9 117.33 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.447 0.641 . . . . 74.310000000000002 109.671 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.453 HD13 ' HG3' ' A' ' 120' ' ' GLU . 29.6 mt -89.64 -19.35 24.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.069 1.348 . . . . 75.019999999999996 110.88 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.51 147.42 5.05 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.146 -0.934 . . . . 73.540000000000006 111.375 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.614 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 23.3 m-85 -87.42 178.58 6.78 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.561 0.745 . . . . 75.439999999999998 111.033 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.62 HD22 ' HB2' ' A' ' 117' ' ' GLU . 9.9 p30 -90.54 -174.0 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 71.510000000000005 110.918 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -44.75 -45.31 9.87 Favored 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 126.318 1.847 . . . . 73.340000000000003 114.389 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -115.86 7.81 14.6 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.15 0.58 . . . . 70.510000000000005 111.92 174.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.614 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 71.74 30.77 65.7 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 116.939 1.536 . . . . 53.149999999999999 116.939 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.62 ' HB2' HD22 ' A' ' 113' ' ' ASN . 22.4 mt-10 -68.48 -42.96 77.92 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 119.028 1.414 . . . . 72.549999999999997 109.972 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 51.4 m95 -123.05 159.57 28.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 75.099999999999994 110.204 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.491 ' HB2' HG13 ' A' ' 109' ' ' VAL . . . -135.37 138.52 43.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.185 0.994 . . . . 74.109999999999999 110.022 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HG3' HD13 ' A' ' 110' ' ' LEU . 9.1 tp10 -69.36 98.06 1.03 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 106.786 -1.561 . . . . 75.120000000000005 106.786 168.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.91 140.65 38.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.486 0.714 . . . . 75.439999999999998 110.854 -173.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -114.5 107.66 15.81 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.178 -0.919 . . . . 74.519999999999996 108.748 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.73 HG21 ' HB3' ' A' ' 107' ' ' LEU . 72.4 p -116.15 175.52 5.51 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.101 1.361 . . . . 74.409999999999997 110.491 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -75.6 -10.4 59.41 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.6 -0.727 . . . . 74.329999999999998 110.466 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -76.93 -22.74 52.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.819 0.848 . . . . 74.530000000000001 110.355 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.78 -160.48 23.24 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 112.233 -0.347 . . . . 43.149999999999999 112.233 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -104.09 137.82 41.49 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.983 0.913 . . . . 72.140000000000001 109.625 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.416 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 164.46 178.08 37.62 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 121.083 -0.579 . . . . 54.350000000000001 112.971 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -90.24 128.54 36.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.862 0.865 . . . . 71.140000000000001 112.19 -170.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 10.9 m -132.17 143.62 49.69 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.137 0.975 . . . . 74.5 108.936 171.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 6.2 Cg_exo -76.14 146.4 28.68 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 C-N-CA 122.685 2.257 . . . . 71.540000000000006 113.977 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -41.52 -46.92 3.66 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.882 1.673 . . . . 60.210000000000001 113.173 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 9.2 p-10 -75.35 2.52 11.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.661 0.784 . . . . 74.349999999999994 112.871 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.42 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -109.21 -9.63 15.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.681 0.792 . . . . 73.329999999999998 111.507 171.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.2 pt -132.26 175.86 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.904 0.882 . . . . 65.349999999999994 110.782 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -162.54 151.7 12.88 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.562 -0.903 . . . . 74.310000000000002 108.562 170.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.7 Cg_endo -60.11 149.56 84.07 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 121.636 1.557 . . . . 74.140000000000001 111.414 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.5 t -73.41 -7.05 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.465 0 CA-C-O 121.617 0.722 . . . . 72.409999999999997 110.119 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -79.49 -8.32 59.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.274 1.03 . . . . 74.450000000000003 112.173 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.2 p -95.6 171.45 8.67 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.499 0.666 . . . . 63.119999999999997 112.612 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.2 mt -85.28 -20.11 30.55 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.806 -1.088 . . . . 74.329999999999998 111.365 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.82 -21.44 66.48 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.684 0.794 . . . . 73.519999999999996 112.008 -172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.58 -13.59 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.241 0.616 . . . . 72.319999999999993 112.5 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -90.71 141.75 28.47 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.403 0.681 . . . . 73.219999999999999 109.969 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.6 m -58.5 -39.96 81.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.722 1.209 . . . . 73.109999999999999 112.39 -175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -70.11 -30.51 67.73 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 74.430000000000007 112.811 -175.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -82.55 117.65 22.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.558 -0.534 . . . . 74.209999999999994 109.558 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -112.12 -6.48 14.14 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.272 0.629 . . . . 74.530000000000001 111.681 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.83 -141.22 34.36 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 118.345 -1.253 . . . . 73.530000000000001 112.89 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -59.65 94.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.561 2.841 . . . . 72.319999999999993 113.144 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.634 HG23 HH12 ' A' ' 239' ' ' ARG . 85.6 t -133.93 132.02 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 70.120000000000005 108.905 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.4 p -78.57 173.01 12.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.446 0.699 . . . . 63.210000000000001 110.408 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -60.41 -43.6 96.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.299 0.639 . . . . 75.129999999999995 109.964 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.9 -46.59 88.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.925 0.89 . . . . 61.219999999999999 111.091 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.39 -26.4 63.69 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.028 0.531 . . . . 70.510000000000005 111.441 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.32 62.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.911 0.484 . . . . 64.329999999999998 110.671 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.08 -21.61 61.48 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.764 -0.653 . . . . 65.129999999999995 110.597 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.64 -49.06 72.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.499 0.719 . . . . 74.450000000000003 109.728 170.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.85 -39.22 80.65 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.595 -0.73 . . . . 74.349999999999994 110.947 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.8 -3.71 55.8 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.823 1.046 . . . . 64.540000000000006 113.823 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 61.3 p -69.47 -34.21 74.03 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.767 1.167 . . . . 65.420000000000002 110.239 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 p -90.02 9.1 29.3 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.234 1.014 . . . . 72.129999999999995 110.867 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -105.45 156.61 16.61 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 123.996 0.808 . . . . 55.229999999999997 111.723 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 26.8 pt -103.83 -176.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 124.955 1.302 . . . . 74.099999999999994 112.006 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.53 121.25 11.07 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.65 -0.705 . . . . 74.439999999999998 110.02 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.31 10.36 58.36 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 119.394 -0.67 . . . . 71.340000000000003 113.343 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.7 m -86.09 128.71 34.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.713 1.256 . . . . 74.340000000000003 111.148 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 183' ' ' SER . 13.3 p90 -135.52 167.24 21.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.077 0.551 . . . . 71.530000000000001 111.458 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.4 pp -164.22 143.54 7.62 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.008 -0.996 . . . . 75.129999999999995 108.926 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.647 HG21 HG12 ' A' ' 182' ' ' ILE . 90.8 t -98.13 137.86 24.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.439 -0.948 . . . . 74.239999999999995 108.439 167.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.487 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.8 ptt85 -134.3 160.67 37.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.962 1.305 . . . . 74.200000000000003 109.108 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.33 151.42 33.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.977 -1.49 . . . . 74.329999999999998 106.977 165.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 t -84.98 123.21 30.27 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.703 -0.851 . . . . 72.049999999999997 108.703 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.59 -35.6 73.11 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.565 -0.531 . . . . 61.5 109.565 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 p -71.64 -34.86 70.14 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.402 -0.817 . . . . 75.129999999999995 111.111 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.3 m -124.25 90.66 50.54 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 123.405 0.682 . . . . 64.540000000000006 109.943 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.28 127.56 24.43 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.499 2.8 . . . . 75.140000000000001 112.947 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.51 -28.32 15.45 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.915 -0.584 . . . . 75.340000000000003 112.969 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.431 ' HB3' ' NH1' ' A' ' 194' ' ' ARG . 79.2 mm-40 -69.03 115.03 7.86 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.293 -0.632 . . . . 75.299999999999997 109.293 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -119.82 149.22 42.42 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 109.882 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.2 m -148.0 152.12 36.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.806 -1.088 . . . . 74.219999999999999 109.704 -172.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.647 HG12 HG21 ' A' ' 170' ' ' VAL . 23.6 mt -102.47 150.05 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 106.511 -1.663 . . . . 72.239999999999995 106.511 166.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -125.93 107.1 10.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.708 -1.219 . . . . 71.200000000000003 107.708 171.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 168' ' ' PHE . 56.9 tp -107.5 110.91 22.95 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.538 0.608 . . . . 73.430000000000007 109.785 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 190' ' ' VAL . 59.1 ttt180 -80.66 121.36 25.76 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.054 0.542 . . . . 74.120000000000005 109.799 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.1 145.73 31.53 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.506 1.522 . . . . 74.549999999999997 107.688 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 57.97 22.39 8.75 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.931 0.892 . . . . 62.43 112.333 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.94 -9.4 72.33 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.333 -0.704 . . . . 74.019999999999996 114.538 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -113.35 150.37 32.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.291 1.045 . . . . 74.129999999999995 109.99 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . 41.8 t -99.08 111.24 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.851 0.46 . . . . 73.430000000000007 110.672 -177.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -93.73 112.22 24.05 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.278 -1.008 . . . . 55.420000000000002 108.278 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -89.64 124.49 34.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.714 -0.676 . . . . 75.209999999999994 109.209 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.439 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.0 m-85 -93.65 146.37 23.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.371 -0.974 . . . . 75.239999999999995 108.371 172.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 179' ' ' GLN . 6.8 tpp180 -106.41 120.64 42.42 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.994 -1.113 . . . . 72.099999999999994 107.994 175.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mt -79.03 100.3 3.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.05 -1.092 . . . . 70.099999999999994 108.05 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 196' ' ' ASN . 0.8 OUTLIER -80.37 145.34 32.08 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.476 -0.935 . . . . 74.540000000000006 108.476 177.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.6 m -105.87 136.78 44.9 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.122 0.969 . . . . 75.420000000000002 109.355 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.96 178.23 8.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.073 0.949 . . . . 75.200000000000003 110.15 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 p -65.68 -33.48 75.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.128 0.571 . . . . 75.209999999999994 111.706 -174.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.24 -13.53 28.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.643 0.377 . . . . 71.5 111.086 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 115.57 15.12 7.7 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 115.886 1.115 . . . . 63.340000000000003 115.886 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -68.99 141.51 54.89 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.291 1.045 . . . . 74.439999999999998 111.654 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.47 141.58 28.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.66 0.784 . . . . 74.310000000000002 109.153 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.574 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.1 p90 -164.98 148.01 8.39 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.54 0.525 . . . . 73.420000000000002 111.72 175.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.43 -40.36 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.174 -1.047 . . . . 75.340000000000003 108.174 164.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.0 m -99.9 125.13 45.84 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.011 -0.995 . . . . 71.430000000000007 108.831 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -62.81 -28.23 69.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.481 0.712 . . . . 61.32 111.41 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.87 -25.17 62.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.633 1.173 . . . . 74.129999999999995 110.55 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.5 m -129.45 89.94 2.92 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.58 0.752 . . . . 75.519999999999996 110.328 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 94.3 mtt180 -103.3 134.31 46.91 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.328 -0.619 . . . . 74.239999999999995 109.328 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -119.38 151.15 38.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.97 0.908 . . . . 74.5 108.602 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -74.04 -28.09 61.25 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.573 0.546 . . . . 74.349999999999994 110.468 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.8 p -132.74 156.01 47.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.876 0.87 . . . . 74.409999999999997 112.144 -177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.14 -25.88 64.6 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 114.272 -1.331 . . . . 73.349999999999994 109.427 172.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.14 96.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.4 0.68 . . . . 72.140000000000001 110.675 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.71 -41.88 87.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.47 0.708 . . . . 71.409999999999997 111.336 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.7 tp -52.49 -57.13 10.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 123.52 0.512 . . . . 74.109999999999999 111.157 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.84 -46.39 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.641 0.588 . . . . 74.519999999999996 111.415 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -55.72 -55.68 29.34 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.56 0.744 . . . . 75.310000000000002 111.447 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -67.82 -37.84 82.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.991 -1.004 . . . . 75.409999999999997 110.622 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.611 ' HB3' HD13 ' A' ' 228' ' ' LEU . 15.9 m170 -86.63 -4.41 59.17 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.544 0.572 . . . . 74.400000000000006 112.544 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.7 p -93.95 -35.11 12.8 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.595 0.358 . . . . 73.400000000000006 110.706 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 47.5 p -74.81 -42.13 58.64 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 116.061 -0.518 . . . . 74.040000000000006 111.855 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.703 HG23 ' HB2' ' A' ' 226' ' ' ASP . 31.6 m -128.35 158.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.334 0.654 . . . . 64.150000000000006 111.131 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.14 15.34 0.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.46 1.904 . . . . 74.439999999999998 114.027 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.703 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.9 t70 -44.47 33.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 1 C-N-CA 132.556 4.343 . . . . 64.329999999999998 119.386 -153.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.34 -0.82 9.61 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 120.07 -1.644 . . . . 64.150000000000006 112.049 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.611 HD13 ' HB3' ' A' ' 221' ' ' HIS . 15.4 mt -92.19 161.65 14.64 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.725 1.21 . . . . 75.040000000000006 109.768 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.9 tt -57.61 -37.01 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 O-C-N 123.419 0.449 . . . . 74.010000000000005 110.673 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -161.5 176.23 11.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.162 0.985 . . . . 71.349999999999994 109.682 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -64.29 145.47 55.96 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.853 0.861 . . . . 74.439999999999998 111.931 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.439 HD21 ' HE1' ' A' ' 193' ' ' TYR . 66.8 mt -75.54 119.48 19.65 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 108.606 -0.887 . . . . 70.109999999999999 108.606 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -113.19 -80.05 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.514 0.597 . . . . 73.540000000000006 112.206 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.7 t80 -87.14 120.0 71.22 Favored Pre-proline 0 C--O 1.208 -1.124 0 C-N-CA 124.266 1.027 . . . . 74.349999999999994 108.438 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.33 136.03 9.79 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 121.632 1.555 . . . . 74.140000000000001 110.947 171.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.87 136.6 96.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 108.9 -0.778 . . . . 74.430000000000007 108.9 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.49 171.94 16.03 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.01 1.807 . . . . 73.439999999999998 112.987 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.511 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 73.7 mmtt -70.33 108.54 4.26 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.053 -1.091 . . . . 73.200000000000003 108.053 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.634 HH12 HG23 ' A' ' 151' ' ' VAL . 15.6 ptt-85 -68.83 -62.92 1.18 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.838 1.051 . . . . 72.209999999999994 113.838 -160.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -110.29 154.58 23.26 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.923 0.889 . . . . 75.450000000000003 109.814 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.21 112.66 27.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 106.188 -1.782 . . . . 74.340000000000003 106.188 158.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.468 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 39.3 Cg_exo -60.52 124.54 15.3 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.752 2.301 . . . . 63.539999999999999 112.965 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 16.6 m -65.46 123.56 19.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.502 0.721 . . . . 72.010000000000005 111.179 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.37 124.5 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 108.356 -0.979 . . . . 74.400000000000006 108.356 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -102.46 114.89 29.48 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.462 0.542 . . . . 75.140000000000001 112.462 -164.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.74 44.08 91.7 Favored Glycine 0 N--CA 1.482 1.712 0 O-C-N 124.046 0.841 . . . . 61.509999999999998 115.124 163.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -103.45 124.36 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 114.228 1.196 . . . . 62.140000000000001 114.228 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.3 t -86.09 119.09 71.48 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 104.057 -2.572 . . . . 63.240000000000002 104.057 143.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--N 1.389 2.692 0 CA-C-N 120.965 1.38 . . . . 74.219999999999999 113.0 -158.707 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.401 ' HB2' ' HG3' ' A' ' 235' ' ' PRO . 8.9 t90 . . . . . 0 CA--C 1.543 0.704 0 CA-C-O 121.894 0.855 . . . . 71.540000000000006 109.463 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.446 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.9 p30 -72.51 -14.84 61.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.158 -0.928 . . . . 73.340000000000003 110.848 174.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.6 p -84.0 4.92 27.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.959 0.904 . . . . 75.340000000000003 112.073 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -67.21 -22.71 65.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.764 0.425 . . . . 73.120000000000005 111.021 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.7 pt-20 -68.49 -39.65 81.22 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.161 0.505 . . . . 63.539999999999999 109.837 168.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.523 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 8.8 m120 -75.2 -10.24 59.29 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.198 -0.91 . . . . 71.5 110.972 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.28 -50.93 69.75 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.045 0.938 . . . . 74.510000000000005 110.572 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.62 23.79 13.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.369 0.668 . . . . 75.530000000000001 110.639 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 122.842 0.457 . . . . 75.239999999999995 111.355 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 112.055 0.391 . . . . 75.140000000000001 112.055 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.412 HD21 ' HD3' ' A' ' 106' ' ' LYS . 30.5 tp -81.85 128.13 33.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.22 -0.659 . . . . 75.319999999999993 109.22 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -111.66 172.96 6.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.819 1.247 . . . . 74.129999999999995 108.684 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.75 138.21 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.279 1.032 . . . . 72.530000000000001 109.434 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.87 131.28 41.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 63.109999999999999 110.336 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.479 HD11 ' NZ ' ' A' ' 238' ' ' LYS . 77.5 mt -98.7 -26.56 14.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 74.439999999999998 111.329 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.428 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 48.6 m-85 -125.53 148.66 48.82 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.966 0.906 . . . . 74.340000000000003 108.739 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.482 ' HB2' ' HZ2' ' A' ' 241' ' ' LYS . 5.6 m-20 -72.2 136.33 46.37 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.61 -0.885 . . . . 74.230000000000004 108.61 170.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.596 ' HB3' HG12 ' A' ' 101' ' ' ILE . 82.3 t80 -129.79 133.36 46.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.534 -1.284 . . . . 74.25 107.534 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -103.65 137.14 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 107.248 -1.39 . . . . 65.030000000000001 107.248 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.28 114.23 3.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.242 0.617 . . . . 74.040000000000006 110.942 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -86.91 -51.44 6.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.852 0.861 . . . . 63.43 109.64 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.92 -177.14 38.04 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 115.279 -0.873 . . . . 71.019999999999996 112.261 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.62 -32.88 60.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.772 0.829 . . . . 74.209999999999994 111.645 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.433 HD22 ' HG2' ' A' ' 249' ' ' PRO . 29.3 p-10 -92.32 -20.43 21.1 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.034 0.534 . . . . 71.129999999999995 111.689 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 78.0 p -71.1 154.16 41.97 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.549 0.53 . . . . 75.319999999999993 109.834 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.566 HD23 ' HG1' ' A' ' 123' ' ' THR . 49.5 tp -128.28 124.36 36.4 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.731 0.412 . . . . 71.340000000000003 111.417 -164.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 m -68.36 117.71 10.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.566 0.746 . . . . 74.349999999999994 110.848 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.596 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -119.24 154.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.475 0.71 . . . . 75.120000000000005 111.739 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 21.6 m -99.18 147.87 24.67 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.333 -1.303 . . . . 74.200000000000003 109.108 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.93 125.77 26.45 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.74 -0.467 . . . . 74.340000000000003 109.74 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.0 1.66 79.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 116.1 -0.5 . . . . 54.229999999999997 113.278 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 80.9 tt0 -84.9 121.24 27.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.381 0.59 . . . . 74.329999999999998 110.071 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.412 ' HD3' HD21 ' A' ' 84' ' ' LEU . 56.8 mttp -73.87 142.82 46.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.379 0.672 . . . . 74.120000000000005 110.155 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB3' HG23 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.33 150.01 32.85 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.452 1.101 . . . . 75.430000000000007 110.142 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -100.15 108.36 20.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.039 -0.726 . . . . 65.209999999999994 109.039 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 119' ' ' ALA . 69.7 t -74.84 119.99 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.174 -0.676 . . . . 63.340000000000003 109.174 174.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.67 HD12 ' HG3' ' A' ' 122' ' ' GLN . 14.2 mt -82.07 -54.08 5.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.267 -1.333 . . . . 64.239999999999995 108.019 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.38 152.92 22.68 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.886 -1.052 . . . . 74.510000000000005 112.978 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.761 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 44.9 m-85 -89.29 174.72 7.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.903 0.881 . . . . 75.439999999999998 111.609 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.35 -173.59 4.8 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.13 0.972 . . . . 75.030000000000001 110.389 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -50.7 -39.47 51.43 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 113.741 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -111.16 2.08 17.62 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.453 0.701 . . . . 64.340000000000003 111.563 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.761 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.18 30.35 73.71 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.421 0.928 . . . . 74.209999999999994 115.421 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.48 -27.49 14.86 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.81 0.805 . . . . 75.319999999999993 110.889 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 28.2 m95 -114.38 152.18 31.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.317 1.047 . . . . 74.219999999999999 109.81 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -137.22 148.21 46.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.262 0.625 . . . . 60.020000000000003 111.26 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -96.64 118.86 34.03 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.434 -1.321 . . . . 73.209999999999994 107.434 166.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -132.8 151.12 52.07 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.141 0.976 . . . . 64.439999999999998 111.026 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.67 ' HG3' HD12 ' A' ' 110' ' ' LEU . 98.4 mt-30 -100.58 105.23 16.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.828 0.851 . . . . 75.099999999999994 109.243 175.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.583 HG23 ' HB3' ' A' ' 107' ' ' LEU . 40.9 p -98.4 176.5 5.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.743 1.217 . . . . 74.150000000000006 110.649 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -64.76 -20.32 66.29 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.588 -0.733 . . . . 74.530000000000001 110.728 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -80.49 -32.1 37.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.882 0.873 . . . . 63.240000000000002 111.185 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 144.73 -168.78 26.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.829 -0.428 . . . . 51.100000000000001 112.153 -171.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -104.32 132.25 50.77 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.268 0.627 . . . . 63.5 110.414 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.461 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 177.83 -165.49 35.12 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 111.775 -0.53 . . . . 72.129999999999995 111.775 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -100.12 121.75 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.598 0.962 . . . . 72.549999999999997 113.598 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.69 136.76 28.36 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.246 1.418 . . . . 71.25 108.487 170.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 81.8 Cg_endo -85.45 155.21 10.65 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 122.074 1.85 . . . . 72.120000000000005 114.887 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -38.77 -47.23 1.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 126.199 1.8 . . . . 74.430000000000007 114.443 173.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -77.58 0.02 24.65 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.794 0.838 . . . . 74.439999999999998 112.665 -172.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 12.1 m-85 -105.6 -18.54 14.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.16 0.984 . . . . 74.319999999999993 111.459 171.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 109' ' ' VAL . 12.7 pt -123.97 175.67 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.889 0.876 . . . . 72.420000000000002 111.672 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.0 t -161.41 150.82 13.69 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 123.797 0.839 . . . . 72.409999999999997 109.818 172.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.26 145.48 96.07 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.667 1.578 . . . . 73.349999999999994 111.853 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 41.7 t -73.78 -4.63 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 124.018 0.927 . . . . 73.420000000000002 110.797 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -91.26 -18.61 24.11 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 73.239999999999995 111.905 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 99.6 p -91.71 179.09 5.73 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.866 0.467 . . . . 64.329999999999998 111.607 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.0 mt -84.45 -22.75 30.22 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.812 0.845 . . . . 73.099999999999994 111.665 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -66.97 -17.98 65.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.508 0.723 . . . . 72.310000000000002 112.173 -171.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -64.09 -13.56 48.43 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.272 0.629 . . . . 72.329999999999998 112.104 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -97.53 148.58 23.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.163 0.985 . . . . 73.400000000000006 109.859 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.2 p -64.98 -41.41 95.45 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.094 0.871 . . . . 72.209999999999994 111.582 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -60.92 -38.44 85.78 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.023 0.749 . . . . 63.119999999999997 113.023 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.93 100.51 11.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.529 -0.915 . . . . 74.430000000000007 108.529 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.46 ' HB2' HG21 ' A' ' 151' ' ' VAL . 77.1 m80 -96.41 8.78 43.17 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.277 0.473 . . . . 74.549999999999997 112.277 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 151' ' ' VAL . . . 69.27 -145.54 42.83 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 118.631 -1.094 . . . . 74.299999999999997 112.498 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.92 106.17 0.91 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.801 2.334 . . . . 71.340000000000003 111.963 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 14.5 t -123.12 131.96 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.642 0.777 . . . . 75.109999999999999 110.236 -177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 151' ' ' VAL . 66.2 p -77.83 152.75 33.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.827 -0.805 . . . . 74.230000000000004 108.827 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -55.81 -38.63 70.23 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.124 0.416 . . . . 75.450000000000003 112.124 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -58.08 -45.21 87.53 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.966 0.791 . . . . 74.129999999999995 111.138 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.82 75.75 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.677 -0.692 . . . . 55.030000000000001 111.179 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.15 68.95 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.463 0.649 . . . . 72.200000000000003 111.524 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -75.83 -19.72 58.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.306 0.642 . . . . 72.450000000000003 110.926 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -67.21 -44.3 79.92 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.653 0.781 . . . . 73.519999999999996 110.28 168.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 239' ' ' ARG . 53.5 mt -60.19 -38.08 82.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.34 0.656 . . . . 74.340000000000003 111.187 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.98 20.72 10.74 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.464 -0.789 . . . . 74.010000000000005 112.321 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.0 p -66.35 -40.96 90.15 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.926 0.393 . . . . 72.230000000000004 110.977 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.4 p -104.96 14.61 29.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.277 1.031 . . . . 73.209999999999994 111.399 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.63 163.91 50.25 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 114.404 0.522 . . . . 75.209999999999994 114.404 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 17.9 pt -109.18 -175.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.618 1.167 . . . . 74.150000000000006 111.223 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 4.5 m-20 -56.64 123.81 16.16 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.295 -0.866 . . . . 74.450000000000003 110.432 171.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.45 ' HA2' HD13 ' A' ' 184' ' ' LEU . . . 88.01 10.98 68.3 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.755 -0.657 . . . . 54.409999999999997 113.393 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.7 m -81.0 118.13 22.21 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.434 1.117 . . . . 72.340000000000003 110.296 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.509 ' HB3' HD11 ' A' ' 184' ' ' LEU . 13.7 p90 -129.6 171.45 12.6 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.391 0.615 . . . . 75.349999999999994 112.557 -168.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.74 146.7 6.93 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 113.884 -1.507 . . . . 73.109999999999999 109.336 171.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.681 HG22 HG12 ' A' ' 182' ' ' ILE . 93.7 t -100.39 131.87 47.09 Favored 'Isoleucine or valine' 0 C--O 1.261 1.659 0 N-CA-C 108.567 -0.901 . . . . 75.019999999999996 108.567 167.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.62 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt85 -116.5 133.83 55.56 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.645 -1.161 . . . . 73.109999999999999 109.115 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.473 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.6 tp10 -84.95 145.72 27.61 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.4 1.08 . . . . 71.340000000000003 108.2 166.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.5 t -83.02 126.69 32.82 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.339 -0.615 . . . . 74.120000000000005 109.339 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.47 -40.99 93.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.028 0.531 . . . . 71.239999999999995 109.929 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.8 p -70.09 -25.76 63.66 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 73.519999999999996 111.307 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 66.5 m -145.43 91.88 5.69 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 122.678 0.391 . . . . 73.230000000000004 111.68 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.79 136.18 68.59 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.44 2.093 . . . . 73.200000000000003 111.625 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.23 -24.7 31.2 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 112.127 -173.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -95.78 114.76 26.52 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.743 -0.836 . . . . 71.129999999999995 108.743 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.608 HH11 HD12 ' A' ' 214' ' ' LEU . 94.4 mtt180 -131.29 157.15 44.07 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.221 0.608 . . . . 72.329999999999998 110.947 -171.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.5 m -145.36 147.85 32.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.636 0.774 . . . . 74.299999999999997 109.227 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.681 HG12 HG22 ' A' ' 170' ' ' VAL . 24.6 mt -103.96 125.84 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.923 -0.769 . . . . 75.200000000000003 108.923 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 14.5 m -96.72 110.21 22.7 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.691 -1.226 . . . . 73.340000000000003 107.691 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 168' ' ' PHE . 54.8 tp -116.54 111.79 20.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.22 1.008 . . . . 74.329999999999998 109.739 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -81.59 127.69 33.14 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.178 0.991 . . . . 75.329999999999998 111.087 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 88.5 t80 -143.03 136.76 28.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.258 1.423 . . . . 74.510000000000005 107.947 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 53.78 29.18 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.208 1.003 . . . . 75.25 112.499 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.34 -12.6 64.28 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.035 -0.869 . . . . 73.099999999999994 114.669 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -97.81 146.43 25.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.212 1.006 . . . . 72.319999999999993 109.608 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.99 112.69 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 122.572 0.349 . . . . 75.409999999999997 110.1 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -97.94 143.87 28.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.716 1.207 . . . . 74.450000000000003 109.11 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -130.13 118.29 21.24 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.354 0.524 . . . . 75.120000000000005 110.227 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.667 ' HH ' HD11 ' A' ' 228' ' ' LEU . 0.6 OUTLIER -121.24 131.72 54.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.497 0.719 . . . . 75.109999999999999 111.045 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 21.4 tpp85 -70.72 131.27 43.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.428 1.091 . . . . 75.030000000000001 111.519 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.58 104.95 11.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.184 -1.043 . . . . 72.409999999999997 108.184 166.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -78.35 138.05 38.35 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.908 -0.775 . . . . 72.329999999999998 108.908 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -111.05 117.25 32.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.66 -0.867 . . . . 73.230000000000004 108.66 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.66 171.49 11.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.537 0.735 . . . . 74.049999999999997 111.258 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 12.8 p -64.52 -26.62 68.5 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.928 0.891 . . . . 74.230000000000004 112.639 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -81.75 -14.47 56.41 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.567 0.747 . . . . 74.140000000000001 111.828 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.44 11.19 39.33 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 119.802 -0.443 . . . . 72.310000000000002 113.432 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -79.39 132.61 36.45 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 116.901 0.35 . . . . 75.209999999999994 110.922 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.24 146.92 26.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.537 -0.912 . . . . 73.340000000000003 108.537 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.2 p90 -170.27 142.77 2.26 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.379 0.425 . . . . 75.209999999999994 111.128 176.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -89.49 -35.85 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.469 -0.937 . . . . 72.549999999999997 108.469 163.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.468 ' HG ' ' HA3' ' A' ' 227' ' ' GLY . 15.6 m -105.5 124.34 49.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.062 0.945 . . . . 74.310000000000002 109.474 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.4 t -65.03 -21.9 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.367 0.667 . . . . 74.510000000000005 111.435 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -66.18 -26.6 67.48 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.275 1.43 . . . . 71.109999999999999 111.459 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.3 m -144.22 106.67 4.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.192 0.597 . . . . 61.25 110.248 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.514 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 84.5 mtt180 -104.23 143.37 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.347 1.059 . . . . 74.420000000000002 109.206 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.62 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 6.3 m-85 -125.84 136.34 52.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.05 0.54 . . . . 71.040000000000006 110.073 -167.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -57.51 -34.34 68.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.956 0.902 . . . . 74.340000000000003 111.031 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.3 p -131.2 154.4 48.45 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 122.016 0.912 . . . . 75.310000000000002 111.582 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.608 HD12 HH11 ' A' ' 180' ' ' ARG . 0.8 OUTLIER -62.65 -23.98 67.38 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.008 -1.451 . . . . 73.140000000000001 109.309 170.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.92 94.21 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.753 0.821 . . . . 75.340000000000003 111.005 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 53.9 mt-10 -72.92 -35.01 66.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.999 0.519 . . . . 60.329999999999998 111.021 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.35 -57.31 11.75 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.414 0.446 . . . . 74.319999999999993 110.053 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.88 -37.72 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 123.839 0.712 . . . . 64.239999999999995 111.54 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -63.32 -59.22 5.0 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.081 0.238 . . . . 74.239999999999995 111.572 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -63.47 -33.02 74.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.352 0.408 . . . . 73.129999999999995 110.942 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.621 ' HB3' HD13 ' A' ' 228' ' ' LEU . 16.5 m170 -88.96 -7.19 56.5 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.433 0.531 . . . . 65.450000000000003 112.433 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -88.23 -35.77 17.13 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.199 0.454 . . . . 70.400000000000006 110.273 168.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 54.0 p -68.98 -47.45 65.57 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.503 -0.771 . . . . 75.150000000000006 110.765 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -131.67 164.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.835 0.826 . . . . 63.299999999999997 112.445 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.33 13.87 1.08 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.864 2.066 . . . . 70.120000000000005 114.69 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.519 ' HB2' HG21 ' A' ' 224' ' ' VAL . 28.5 t70 -42.18 30.57 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 131.56 3.944 . . . . 64.439999999999998 119.409 -152.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.468 ' HA3' ' HG ' ' A' ' 206' ' ' SER . . . 123.37 1.49 9.26 Favored Glycine 0 N--CA 1.486 2.031 0 O-C-N 120.065 -1.647 . . . . 75.329999999999998 112.354 -170.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.667 HD11 ' HH ' ' A' ' 193' ' ' TYR . 9.6 mt -91.87 163.97 13.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.174 1.389 . . . . 73.340000000000003 108.839 169.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 11.4 tt -61.57 -35.98 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-O 120.67 0.271 . . . . 70.200000000000003 110.808 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -157.48 -179.07 7.82 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.513 0.725 . . . . 75.299999999999997 110.322 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.8 p -67.32 146.94 53.59 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.748 0.819 . . . . 72.0 111.68 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 80.8 mt -79.03 92.44 4.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 108.874 -0.788 . . . . 74.439999999999998 108.874 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -88.93 -65.1 1.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.686 0.795 . . . . 75.140000000000001 112.231 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -108.75 120.9 44.79 Favored Pre-proline 0 C--O 1.216 -0.68 0 C-N-CA 124.749 1.22 . . . . 74.439999999999998 109.451 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.401 ' HG3' ' HB2' ' A' ' 67' ' ' TRP . 66.3 Cg_endo -84.51 129.96 4.39 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.009 1.806 . . . . 74.230000000000004 111.965 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -69.22 135.71 89.09 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.058 0.543 . . . . 64.450000000000003 110.664 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.407 ' O ' HD22 ' A' ' 159' ' ' LEU . 10.6 Cg_exo -72.27 172.74 14.26 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.825 2.35 . . . . 75.109999999999999 111.999 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.479 ' NZ ' HD11 ' A' ' 88' ' ' LEU . 33.7 mmtp -71.27 145.59 49.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.02 0.528 . . . . 72.430000000000007 111.478 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.58 ' HB3' HD23 ' A' ' 159' ' ' LEU . 20.8 ptt-85 -82.68 -63.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.248 0.833 . . . . 72.420000000000002 113.248 -163.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.491 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.0 t30 -113.39 130.51 56.28 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.015 0.926 . . . . 74.200000000000003 110.707 -174.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.482 ' HZ2' ' HB2' ' A' ' 90' ' ' ASP . 97.4 mttt -77.73 113.41 32.12 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 107.484 -1.302 . . . . 74.209999999999994 107.484 164.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.65 124.44 13.68 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.892 2.394 . . . . 71.329999999999998 113.556 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 88.2 m -76.9 123.4 26.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.983 -0.747 . . . . 75.439999999999998 108.983 173.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 47.9 t -92.58 114.54 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.384 -0.969 . . . . 74.310000000000002 108.384 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -95.2 112.33 24.05 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.565 -0.255 . . . . 75.209999999999994 111.306 -167.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.68 5.92 2.23 Favored Glycine 0 CA--C 1.542 1.773 0 N-CA-C 118.28 2.072 . . . . 54.039999999999999 118.28 161.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.43 143.81 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.63 1.715 . . . . 73.040000000000006 111.615 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.6 t -77.54 128.91 78.7 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.592 -1.262 . . . . 72.430000000000007 107.592 167.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.433 ' HG2' HD22 ' A' ' 97' ' ' ASN . 78.5 Cg_exo . . . . . 0 C--N 1.385 2.483 0 C-N-CA 122.703 2.269 . . . . 75.319999999999993 113.737 -167.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.9 t90 . . . . . 0 C--O 1.242 0.678 0 N-CA-C 108.932 -0.766 . . . . 73.329999999999998 108.932 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -65.93 -25.13 67.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.853 -1.067 . . . . 74.219999999999999 110.419 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.5 m -75.3 4.45 7.11 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.967 1.307 . . . . 74.5 113.155 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -69.99 -33.82 72.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.332 0.515 . . . . 73.439999999999998 110.902 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.75 -36.12 43.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.947 0.499 . . . . 63.43 110.126 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -74.03 -7.28 51.89 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.626 0.77 . . . . 60.009999999999998 111.523 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.75 -23.95 67.57 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.63 1.172 . . . . 74.129999999999995 111.322 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.55 14.3 20.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.927 0.891 . . . . 74.239999999999995 110.968 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.156 0.582 . . . . 73.019999999999996 111.307 177.691 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 CA--C 1.565 1.528 0 CA-C-O 121.59 0.709 . . . . 72.340000000000003 111.156 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.545 HD22 ' HD3' ' A' ' 106' ' ' LYS . 36.4 tp -85.07 131.41 34.46 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.368 -0.833 . . . . 74.299999999999997 110.339 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.0 m-85 -111.24 172.64 6.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.507 1.123 . . . . 74.310000000000002 108.443 173.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.41 137.22 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.215 1.006 . . . . 75.329999999999998 109.376 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.75 122.17 21.97 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.515 0.726 . . . . 74.349999999999994 110.8 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.4 mt -76.69 -35.87 57.6 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.708 0.803 . . . . 72.519999999999996 110.811 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 20.1 m-85 -124.31 168.21 13.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.2 -0.909 . . . . 73.510000000000005 109.888 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.65 117.71 24.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.207 -1.035 . . . . 75.150000000000006 108.207 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.644 ' HB3' HG12 ' A' ' 101' ' ' ILE . 61.3 t80 -106.46 131.55 53.51 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.374 -1.343 . . . . 74.129999999999995 107.374 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.14 133.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.871 -0.788 . . . . 70.239999999999995 108.871 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.33 123.2 20.56 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.279 0.631 . . . . 44.450000000000003 109.871 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 p -86.23 -16.31 38.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.601 0.76 . . . . 65.099999999999994 110.997 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -158.83 -173.7 27.58 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.621 -0.718 . . . . 75.400000000000006 111.483 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -69.46 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.964 0.905 . . . . 75.140000000000001 111.669 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -73.68 -27.5 61.26 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.58 1.152 . . . . 75.109999999999999 112.131 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.2 p -93.36 169.11 10.62 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.723 0.809 . . . . 65.409999999999997 109.744 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.535 HD22 ' HG1' ' A' ' 123' ' ' THR . 65.6 tp -136.06 128.8 30.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.696 0.398 . . . . 74.319999999999993 111.424 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 m -72.79 116.61 13.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.678 HG21 HG22 ' A' ' 123' ' ' THR . 27.1 pt -120.72 149.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.356 0.662 . . . . 72.209999999999994 110.04 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.4 m -102.12 142.2 33.75 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.306 -0.861 . . . . 71.219999999999999 110.256 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -59.2 114.45 2.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.735 0.814 . . . . 73.439999999999998 110.291 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.83 0.12 39.2 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.688 -0.687 . . . . 72.430000000000007 112.78 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.17 121.16 27.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.287 0.544 . . . . 63.229999999999997 111.294 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.545 ' HD3' HD22 ' A' ' 84' ' ' LEU . 62.7 mttp -70.83 130.39 41.56 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.797 0.839 . . . . 74.219999999999999 109.009 169.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.698 ' HB3' HG21 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.14 138.38 31.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.392 0.677 . . . . 74.409999999999997 110.464 -176.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.5 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 40.9 ttm180 -89.49 108.56 19.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.928 0.491 . . . . 75.450000000000003 110.068 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.547 HG13 ' HB1' ' A' ' 119' ' ' ALA . 4.6 t -78.61 117.88 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.347 0.659 . . . . 73.25 110.099 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.3 mt -90.3 -49.12 6.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.101 0.96 . . . . 75.129999999999995 110.229 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.67 144.56 9.47 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 115.38 -0.827 . . . . 71.450000000000003 111.606 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.511 ' CD2' ' HB3' ' A' ' 119' ' ' ALA . 25.0 m-85 -87.86 168.77 12.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.655 0.782 . . . . 74.540000000000006 111.252 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -88.71 -172.19 3.62 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.681 -1.145 . . . . 73.420000000000002 110.982 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -41.95 -44.72 3.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.838 1.655 . . . . 74.219999999999999 114.506 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -114.34 6.42 16.07 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.174 0.805 . . . . 73.310000000000002 113.174 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.56 16.14 80.59 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.252 -0.749 . . . . 61.219999999999999 114.711 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.77 -66.85 0.81 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.92 0.86 . . . . 74.299999999999997 109.668 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 70.1 m95 -90.68 131.91 36.1 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.926 0.49 . . . . 73.329999999999998 111.187 -168.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.547 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -124.5 139.14 54.16 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.208 1.003 . . . . 74.409999999999997 109.7 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.62 ' HG2' HE21 ' A' ' 127' ' ' GLN . 25.4 tt0 -73.44 110.41 7.7 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.115 -1.069 . . . . 74.209999999999994 108.115 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -101.61 143.78 31.15 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.591 0.756 . . . . 75.239999999999995 109.513 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 35.4 tt0 -102.66 104.5 14.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.138 -1.392 . . . . 74.430000000000007 107.504 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.698 HG21 ' HB3' ' A' ' 107' ' ' LEU . 58.7 p -112.17 166.83 10.91 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.282 1.033 . . . . 75.329999999999998 110.391 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -72.51 -17.49 61.73 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.796 -1.093 . . . . 74.25 109.536 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -75.23 -27.44 59.51 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.632 1.173 . . . . 75.510000000000005 111.088 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.16 -155.06 25.37 Favored Glycine 0 C--N 1.358 1.799 0 CA-C-O 120.246 -0.197 . . . . 75.540000000000006 112.969 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.62 HE21 ' HG2' ' A' ' 120' ' ' GLU . 56.8 tp60 -116.29 137.66 51.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.425 0.613 . . . . 75.319999999999993 110.516 -174.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 161.98 170.87 27.33 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 120.249 -0.976 . . . . 74.319999999999993 114.215 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -87.49 129.87 34.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.418 0.687 . . . . 74.230000000000004 111.783 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -137.68 145.2 47.75 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 74.310000000000002 109.106 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 18.3 Cg_endo -87.47 151.81 7.75 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 122.402 2.068 . . . . 63.200000000000003 114.917 -170.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.0 m -40.47 -30.79 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.133 2.173 . . . . 74.400000000000006 114.69 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.473 HD22 HG21 ' A' ' 244' ' ' VAL . 29.6 p30 -78.97 -27.02 43.42 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.111 0.565 . . . . 74.120000000000005 112.191 -175.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.455 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -91.4 -16.23 27.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.542 0.737 . . . . 75.010000000000005 112.05 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.6 pt -122.8 176.32 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.724 0.81 . . . . 73.049999999999997 111.122 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.0 m -160.03 136.67 6.54 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.649 1.18 . . . . 72.319999999999993 109.083 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 29.1 Cg_endo -59.98 134.9 59.42 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 121.942 1.762 . . . . 73.340000000000003 111.488 173.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.04 -7.33 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.557 0.743 . . . . 72.129999999999995 110.637 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -75.93 -23.44 55.45 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.292 0.637 . . . . 73.409999999999997 111.811 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.3 p -94.59 173.92 7.37 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.173 0.511 . . . . 74.239999999999995 111.91 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 mt -82.79 -19.51 37.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.341 1.056 . . . . 74.340000000000003 111.37 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.66 -18.89 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.207 1.003 . . . . 65.310000000000002 112.19 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -62.58 -25.55 68.13 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.174 0.589 . . . . 73.030000000000001 111.772 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -78.04 136.97 38.02 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.504 -0.771 . . . . 73.510000000000005 110.226 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 m -57.36 -36.58 71.38 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.212 1.005 . . . . 75.239999999999995 112.311 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.411 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 42.7 p-90 -67.72 -28.8 67.97 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.917 0.761 . . . . 71.349999999999994 112.621 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.416 ' O ' ' HE2' ' A' ' 238' ' ' LYS . 20.9 t80 -89.14 98.59 11.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.774 -0.824 . . . . 74.209999999999994 108.774 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.537 ' HB2' HG22 ' A' ' 151' ' ' VAL . 65.8 m80 -91.69 -9.04 45.3 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.752 0.421 . . . . 74.439999999999998 111.788 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.04 -126.91 9.02 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 118.317 -1.269 . . . . 62.530000000000001 113.175 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -69.24 88.31 0.48 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 123.25 2.633 . . . . 73.0 112.185 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 43.4 t -126.95 133.46 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.946 0.898 . . . . 74.439999999999998 109.494 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 p -86.46 171.1 11.36 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.025 0.93 . . . . 72.099999999999994 109.808 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -62.16 -42.31 99.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 110.002 -0.37 . . . . 74.329999999999998 110.002 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.27 -48.26 76.94 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.235 0.959 . . . . 73.409999999999997 110.867 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.3 69.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.236 0.614 . . . . 73.310000000000002 111.735 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.39 75.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 63.450000000000003 111.311 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.97 -20.98 47.81 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.544 -0.753 . . . . 71.230000000000004 110.677 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -37.12 81.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.111 0.964 . . . . 71.0 110.084 170.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.551 HD22 ' HB3' ' A' ' 239' ' ' ARG . 67.4 mt -68.97 -51.69 36.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.99 0.516 . . . . 75.530000000000001 110.673 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.455 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 80.7 mt -83.75 11.95 6.69 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.563 0.579 . . . . 70.439999999999998 112.563 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.7 p -62.05 -37.47 85.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.904 0.482 . . . . 75.519999999999996 111.663 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.5 m -111.28 18.62 19.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.678 0.791 . . . . 74.420000000000002 110.739 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 152.06 41.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 112.818 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.8 pt -87.74 -177.67 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.313 0.645 . . . . 64.349999999999994 110.533 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -62.48 125.68 24.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.899 -0.591 . . . . 61.329999999999998 110.472 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.53 ' HA3' ' HB3' ' A' ' 233' ' ' HIS . . . 84.22 10.92 79.45 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.05 -0.977 . . . . 52.340000000000003 113.29 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.6 m -67.67 139.16 56.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.272 1.036 . . . . 63.229999999999997 109.703 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.458 ' HB3' HD13 ' A' ' 184' ' ' LEU . 18.1 p90 -149.17 166.49 28.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.804 0.729 . . . . 73.549999999999997 111.76 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.1 pp -161.84 135.6 6.53 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.841 -1.072 . . . . 75.530000000000001 109.724 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.654 HG22 HG12 ' A' ' 182' ' ' ILE . 74.5 t -91.66 141.55 14.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 N-CA-C 108.3 -1.0 . . . . 75.129999999999995 108.3 167.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.568 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 46.0 ptt85 -144.95 153.38 41.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.242 -0.89 . . . . 72.329999999999998 109.983 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -115.2 148.45 39.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.224 1.009 . . . . 70.319999999999993 108.393 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.8 t -78.67 125.4 29.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.07 0.548 . . . . 74.25 110.103 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.12 -41.77 88.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.172 0.989 . . . . 71.5 110.489 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 57.8 p -80.53 -25.17 38.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.496 0.718 . . . . 74.140000000000001 111.806 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.7 m -124.6 95.63 42.47 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.511 0.724 . . . . 72.519999999999996 110.668 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.81 139.61 81.09 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.211 2.608 . . . . 74.25 112.215 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.64 -28.38 4.9 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.279 -0.419 . . . . 71.450000000000003 113.06 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -75.67 116.18 16.11 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 117.062 0.431 . . . . 65.439999999999998 110.345 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.64 HH11 HD13 ' A' ' 214' ' ' LEU . 89.5 mtt180 -126.12 150.75 48.01 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.087 0.955 . . . . 75.349999999999994 109.281 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.4 m -149.41 153.75 37.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.098 0.959 . . . . 75.409999999999997 109.494 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.654 HG12 HG22 ' A' ' 170' ' ' VAL . 26.7 mt -110.9 149.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.107 -1.071 . . . . 71.510000000000005 108.107 172.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 55.0 m -121.75 115.4 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.34 -1.355 . . . . 41.100000000000001 107.34 169.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 168' ' ' PHE . 14.7 tp -108.45 112.76 25.33 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.569 0.622 . . . . 73.140000000000001 109.956 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 23.3 ttt180 -81.68 112.02 18.48 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 109.752 -0.462 . . . . 74.310000000000002 109.752 165.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -136.36 143.96 44.35 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 106.85 -1.537 . . . . 74.230000000000004 106.85 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 61.38 21.21 11.8 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.178 0.991 . . . . 75.319999999999993 111.815 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.07 1.35 68.22 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.976 -0.347 . . . . 75.109999999999999 113.759 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 71.6 mtp180 -105.66 139.31 40.45 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.683 1.193 . . . . 74.109999999999999 109.251 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.9 t -100.13 105.61 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.051 0.453 . . . . 74.239999999999995 110.147 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -90.98 120.15 31.74 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.862 1.265 . . . . 74.219999999999999 109.229 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -95.32 120.69 36.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.62 0.368 . . . . 72.450000000000003 110.462 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -96.95 147.28 24.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.739 1.215 . . . . 74.510000000000005 109.854 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 19.7 tpp180 -101.84 113.17 26.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.323 0.649 . . . . 72.310000000000002 109.277 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.1 mt -82.63 102.12 8.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.828 -1.175 . . . . 74.340000000000003 107.828 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -78.34 107.86 11.27 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.799 -1.091 . . . . 74.409999999999997 108.513 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.8 m -79.44 109.11 13.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.301 -1.0 . . . . 74.239999999999995 108.301 170.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.64 167.7 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.383 0.673 . . . . 64.209999999999994 110.731 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 21.7 p -60.83 -26.3 67.25 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.27 1.028 . . . . 75.200000000000003 113.186 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -94.29 -18.08 22.0 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.482 0.713 . . . . 71.219999999999999 111.502 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.5 10.78 16.39 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-O 119.535 -0.591 . . . . 72.150000000000006 113.662 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 96.3 mttt -76.68 127.26 32.45 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.643 0.721 . . . . 74.019999999999996 110.239 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.24 145.53 24.93 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.679 -0.86 . . . . 75.349999999999994 108.679 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.605 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 43.8 p90 -163.36 129.81 3.3 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.421 0.45 . . . . 75.310000000000002 111.162 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 60.1 t -72.87 -41.79 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.807 -0.812 . . . . 74.200000000000003 108.807 164.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.4 m -107.48 129.24 54.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.73 -1.123 . . . . 52.100000000000001 110.049 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.1 t -61.58 -26.88 68.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.54 0.736 . . . . 72.219999999999999 111.654 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -70.39 -27.91 64.68 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.764 1.225 . . . . 75.420000000000002 110.873 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.8 m -134.13 100.35 4.68 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.38 0.672 . . . . 74.319999999999993 109.766 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.605 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 58.2 mtt180 -105.93 128.72 53.98 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.97 0.908 . . . . 75.040000000000006 108.801 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.504 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 7.2 m-85 -115.13 139.68 49.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.698 0.799 . . . . 74.239999999999995 109.921 -167.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.633 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 6.7 m-80 -67.03 -31.28 71.71 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.167 0.917 . . . . 73.129999999999995 110.267 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.7 p -132.29 156.66 46.16 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.155 0.982 . . . . 74.140000000000001 111.497 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.64 HD13 HH11 ' A' ' 180' ' ' ARG . 0.7 OUTLIER -66.77 -24.37 66.19 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 114.916 -1.038 . . . . 74.140000000000001 109.772 173.023 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.39 79.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.621 0.768 . . . . 72.420000000000002 110.496 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 35.5 mt-10 -70.25 -36.93 74.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.059 0.943 . . . . 74.329999999999998 111.536 177.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 12.6 tp -54.91 -61.3 2.4 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.508 0.505 . . . . 75.099999999999994 110.956 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.2 -38.93 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.827 0.451 . . . . 73.519999999999996 111.093 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -61.51 -57.08 13.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.811 0.445 . . . . 75.010000000000005 111.146 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -67.88 -29.74 68.93 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.243 -0.435 . . . . 72.099999999999994 111.016 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.611 ' HB3' HD13 ' A' ' 228' ' ' LEU . 11.9 m170 -87.6 -11.51 48.39 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.26 0.467 . . . . 71.420000000000002 112.26 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.4 p -93.78 -27.14 16.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.742 0.417 . . . . 53.109999999999999 110.967 173.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.6 p -77.81 -48.25 16.98 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.831 -0.622 . . . . 75.209999999999994 110.535 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.636 HG21 ' HB2' ' A' ' 226' ' ' ASP . 15.8 m -129.77 163.89 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.566 0.698 . . . . 75.140000000000001 111.797 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.21 16.65 0.23 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 127.373 2.269 . . . . 45.439999999999998 114.236 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.636 ' HB2' HG21 ' A' ' 224' ' ' VAL . 36.1 t70 -43.84 33.81 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.606 1 C-N-CA 132.645 4.378 . . . . 73.109999999999999 119.231 -159.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.41 -0.9 10.43 Favored Glycine 0 N--CA 1.474 1.199 0 O-C-N 120.741 -1.224 . . . . 74.230000000000004 112.335 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.611 HD13 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -94.71 164.75 12.82 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.759 1.624 . . . . 74.310000000000002 109.878 169.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 9.6 tt -66.5 -39.35 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.036 0.446 . . . . 72.310000000000002 109.921 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.4 m -151.7 154.73 36.9 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 74.019999999999996 110.377 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.1 p -57.38 139.58 52.63 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.79 1.236 . . . . 63.240000000000002 112.475 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.44 HD22 HD12 ' A' ' 184' ' ' LEU . 86.8 mt -68.14 100.1 0.97 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.557 0.743 . . . . 73.439999999999998 109.007 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.53 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 24.3 t60 -96.45 -78.39 0.47 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.898 0.879 . . . . 74.150000000000006 111.643 -165.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -94.0 123.64 58.67 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.385 0.674 . . . . 74.310000000000002 110.11 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.4 130.88 8.24 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.539 2.159 . . . . 75.150000000000006 111.765 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.59 82.48 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 109.063 -0.717 . . . . 71.219999999999999 109.063 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.21 167.01 16.07 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.409 2.073 . . . . 73.239999999999995 112.261 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 32.4 mmtp -63.45 138.12 58.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.494 0.718 . . . . 74.319999999999993 110.252 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.551 ' HB3' HD22 ' A' ' 159' ' ' LEU . 14.7 ptt-85 -72.73 -63.28 1.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.341 1.237 . . . . 73.209999999999994 114.341 -160.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.512 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 53.6 t30 -112.87 146.48 38.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.992 0.917 . . . . 72.230000000000004 110.314 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 94.8 mttt -77.82 114.45 41.61 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 107.638 -1.245 . . . . 74.450000000000003 107.638 161.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.444 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 26.2 Cg_exo -64.44 127.41 18.94 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.16 2.573 . . . . 63.130000000000003 113.181 -171.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.4 m -76.87 117.2 18.24 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.102 0.561 . . . . 72.439999999999998 109.537 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.473 HG21 HD22 ' A' ' 133' ' ' ASN . 4.0 t -96.91 112.85 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.268 -1.012 . . . . 75.030000000000001 108.268 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -88.07 114.2 24.45 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.743 0.646 . . . . 73.040000000000006 112.743 -160.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.74 42.41 94.39 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 124.577 1.173 . . . . 74.319999999999993 114.438 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m -104.23 132.72 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 113.29 0.848 . . . . 62.299999999999997 113.29 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.8 t -83.98 120.11 74.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 105.083 -2.192 . . . . 70.439999999999998 105.083 148.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--N 1.373 1.851 0 C-N-CA 122.525 2.15 . . . . 64.310000000000002 113.996 -162.667 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.408 ' HH2' HD23 ' A' ' 73' ' ' LEU . 20.6 t90 . . . . . 0 C--O 1.244 0.801 0 CA-C-O 121.518 0.675 . . . . 75.329999999999998 110.315 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -77.8 -31.11 51.63 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.455 -1.248 . . . . 70.450000000000003 111.135 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.7 p -76.14 9.42 2.53 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.555 1.142 . . . . 75.230000000000004 111.98 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -41.61 -43.32 2.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.429 1.492 . . . . 74.310000000000002 113.302 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.64 -27.77 68.63 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.746 0.818 . . . . 72.120000000000005 112.703 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.487 ' HB2' ' HE1' ' A' ' 144' ' ' HIS . 12.8 m120 -86.11 -0.92 56.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.98 0.912 . . . . 72.019999999999996 111.373 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.408 HD23 ' HH2' ' A' ' 67' ' ' TRP . 59.3 tp -57.51 -52.91 63.49 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 122.604 0.362 . . . . 74.140000000000001 110.396 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.55 45.14 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.019 0.927 . . . . 72.129999999999995 110.18 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.889 0 C-N-CA 123.249 0.619 . . . . 73.239999999999995 110.779 -177.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 112.975 0.732 . . . . 74.150000000000006 112.975 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 tp -100.37 123.65 44.86 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.805 0.812 . . . . 73.219999999999999 109.751 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -113.19 173.1 6.56 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.516 1.526 . . . . 73.430000000000007 109.491 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 p -136.72 132.44 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.069 1.347 . . . . 75.040000000000006 108.805 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.06 116.69 9.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.291 1.036 . . . . 74.420000000000002 110.025 173.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.6 mt -81.48 -36.07 29.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.76 0.824 . . . . 72.209999999999994 110.638 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.427 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 36.8 m-85 -122.85 143.91 49.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.967 -1.015 . . . . 75.510000000000005 108.819 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -74.23 134.3 42.68 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.843 -0.799 . . . . 63.439999999999998 108.843 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.614 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.0 t80 -134.87 138.33 44.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.093 0.957 . . . . 74.209999999999994 109.015 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.8 134.16 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.006 -1.479 . . . . 72.340000000000003 107.006 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.1 128.27 36.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.865 0.866 . . . . 74.340000000000003 110.996 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 p -110.1 8.96 24.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.799 0.84 . . . . 72.540000000000006 111.725 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.9 -179.46 32.81 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.8 -0.52 . . . . 74.540000000000006 111.8 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.34 -21.49 39.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.575 0.75 . . . . 74.140000000000001 112.767 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -107.12 -7.92 16.68 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 111.852 0.315 . . . . 63.229999999999997 111.852 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.6 p -75.97 177.96 6.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.873 0.469 . . . . 74.219999999999999 111.217 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.535 HD22 ' HG1' ' A' ' 123' ' ' THR . 57.0 tp -142.65 145.53 33.55 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.825 -0.547 . . . . 74.439999999999998 110.985 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 m -94.11 120.49 34.43 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.936 0.895 . . . . 73.420000000000002 109.304 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.629 HG23 HG21 ' A' ' 123' ' ' THR . 15.8 pt -113.82 148.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.629 0.771 . . . . 74.040000000000006 111.079 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.9 m -94.92 143.96 26.05 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.714 0.806 . . . . 73.230000000000004 109.312 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.01 120.75 11.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.54 0.736 . . . . 74.010000000000005 109.923 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.95 -9.23 68.1 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.643 -0.532 . . . . 63.399999999999999 113.607 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.7 143.44 51.33 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.591 0.757 . . . . 65.420000000000002 111.461 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.33 134.88 35.09 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.87 0.868 . . . . 74.420000000000002 109.192 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.475 ' HB3' HG23 ' A' ' 123' ' ' THR . 0.4 OUTLIER -145.33 142.79 29.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 75.319999999999993 109.847 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -97.08 109.66 22.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.188 -0.671 . . . . 73.430000000000007 109.188 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.504 HG11 ' HB1' ' A' ' 119' ' ' ALA . 19.1 t -72.67 126.4 33.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-O 121.699 0.761 . . . . 71.450000000000003 109.363 171.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.5 mt -88.63 -59.13 2.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.456 -1.702 . . . . 72.400000000000006 109.203 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.63 142.93 8.79 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.359 -0.382 . . . . 54.399999999999999 112.531 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.594 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 30.8 m-85 -86.4 168.12 14.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.513 1.125 . . . . 74.200000000000003 111.25 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -94.09 -171.58 2.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.088 1.355 . . . . 74.109999999999999 111.002 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -47.22 -36.35 8.75 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.924 1.689 . . . . 74.209999999999994 115.025 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -109.57 -6.18 15.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.543 0.337 . . . . 71.129999999999995 111.357 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.72 25.2 75.81 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.392 0.433 . . . . 74.099999999999994 113.451 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.47 -7.15 21.14 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.44 0.696 . . . . 74.239999999999995 112.296 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 33.4 m95 -140.48 134.33 30.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.67 0.788 . . . . 75.140000000000001 109.57 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.531 ' HB3' ' CD2' ' A' ' 112' ' ' TYR . . . -134.0 148.24 51.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 74.310000000000002 110.639 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.86 113.63 19.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.857 -1.164 . . . . 73.519999999999996 107.857 167.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.59 145.36 45.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.262 0.625 . . . . 62.119999999999997 110.95 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.44 103.53 15.49 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 109.03 -0.73 . . . . 73.25 109.03 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.629 HG21 HG23 ' A' ' 101' ' ' ILE . 75.7 p -86.36 168.44 13.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.356 0.662 . . . . 74.439999999999998 109.248 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -74.1 -11.2 60.24 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.671 -0.695 . . . . 75.239999999999995 110.57 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -79.99 -33.08 39.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.731 0.812 . . . . 72.219999999999999 110.19 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.58 -161.52 31.83 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 111.415 -0.674 . . . . 73.109999999999999 111.415 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -128.91 149.28 50.84 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.786 0.793 . . . . 74.5 110.597 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.06 178.35 35.87 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.706 0.629 . . . . 55.43 111.576 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -84.3 122.93 29.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.614 0.766 . . . . 75.140000000000001 111.989 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.415 HG23 HD11 ' A' ' 135' ' ' ILE . 19.8 m -128.61 145.21 55.16 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 124.992 1.317 . . . . 75.019999999999996 109.361 173.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.2 Cg_endo -84.3 146.61 11.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.287 1.991 . . . . 73.409999999999997 114.705 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 m -40.03 -41.85 1.29 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.191 1.796 . . . . 63.240000000000002 113.968 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -76.39 -17.91 59.13 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.175 -0.921 . . . . 74.219999999999999 112.657 -170.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.462 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 24.7 m-85 -92.28 -18.4 23.44 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.19 0.596 . . . . 73.329999999999998 111.713 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 130' ' ' VAL . 19.4 pt -120.24 -179.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.553 1.141 . . . . 72.099999999999994 110.408 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.9 t -162.5 151.08 12.35 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 118.428 -0.796 . . . . 71.450000000000003 108.872 166.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.72 145.71 97.21 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 121.49 1.46 . . . . 74.209999999999994 109.831 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.55 -4.38 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 121.778 0.799 . . . . 71.430000000000007 111.462 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.88 -22.74 49.31 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.777 0.831 . . . . 73.010000000000005 111.186 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.5 p -81.32 176.43 9.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.832 0.825 . . . . 75.019999999999996 111.705 -167.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.438 HD13 HD12 ' A' ' 214' ' ' LEU . 38.8 mt -85.78 -26.32 25.86 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.847 -1.07 . . . . 74.209999999999994 110.605 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.521 ' HG3' ' HD2' ' A' ' 147' ' ' TYR . 1.6 mp0 -64.47 -20.41 66.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.79 1.236 . . . . 75.319999999999993 111.966 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -63.75 -4.69 3.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.732 0.813 . . . . 75.019999999999996 113.095 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.487 ' HE1' ' HB2' ' A' ' 72' ' ' ASN . 42.4 m-70 -117.73 159.29 23.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.998 0.919 . . . . 73.120000000000005 110.728 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -42.94 89.29 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.447 1.099 . . . . 71.219999999999999 112.14 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 56.3 p-90 -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.364 0.875 . . . . 74.140000000000001 113.364 -172.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.521 ' HD2' ' HG3' ' A' ' 142' ' ' GLU . 21.0 t80 -85.34 106.76 16.97 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.705 0.684 . . . . 75.140000000000001 110.356 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.506 ' HB3' HG21 ' A' ' 151' ' ' VAL . 3.2 m80 -89.27 -14.04 36.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.982 0.913 . . . . 74.400000000000006 112.0 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.48 -140.62 23.79 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.035 -1.425 . . . . 71.329999999999998 112.197 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.62 88.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.535 2.823 . . . . 72.439999999999998 112.891 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 155' ' ' ALA . 37.6 t -140.14 128.05 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.849 1.659 . . . . 73.549999999999997 108.807 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.1 p -84.27 175.13 9.62 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 124.061 0.945 . . . . 70.409999999999997 109.997 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -60.08 -40.95 91.32 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.984 -0.531 . . . . 73.420000000000002 111.158 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -53.26 -51.33 62.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.199 0.937 . . . . 75.120000000000005 110.317 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.516 ' HB2' HG11 ' A' ' 151' ' ' VAL . . . -62.57 -46.35 88.72 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.057 -1.429 . . . . 54.100000000000001 111.168 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.464 ' HB3' ' HD3' ' A' ' 171' ' ' ARG . . . -56.86 -37.13 70.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.453 0.701 . . . . 43.310000000000002 112.184 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -68.83 -43.8 74.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.176 0.99 . . . . 74.219999999999999 111.155 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.415 ' OH ' ' HD2' ' A' ' 239' ' ' ARG . 0.1 OUTLIER -71.74 -22.83 61.56 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.328 0.585 . . . . 73.219999999999999 112.214 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 239' ' ' ARG . 55.8 mt -75.67 -43.59 46.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.872 -1.058 . . . . 74.209999999999994 112.579 174.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.527 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 96.4 mt -83.21 -20.65 34.22 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.045 -0.525 . . . . 74.319999999999993 111.466 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.44 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 86.6 p -64.3 -27.77 69.26 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 108.599 -0.889 . . . . 73.140000000000001 108.599 167.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.5 m -90.41 16.63 8.46 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.516 1.127 . . . . 73.430000000000007 111.468 175.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.29 178.52 17.3 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.381 0.515 . . . . 72.439999999999998 112.688 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.3 pt -100.17 175.77 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.479 1.111 . . . . 74.439999999999998 112.241 -176.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -72.22 116.1 12.25 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.663 -0.698 . . . . 73.450000000000003 109.549 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.07 6.18 34.47 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.508 -0.769 . . . . 73.329999999999998 112.534 -167.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 66.1 m -85.26 135.36 33.96 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 117.979 0.889 . . . . 65.129999999999995 111.124 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.8 p90 -139.46 158.31 44.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.747 0.419 . . . . 74.129999999999995 110.661 -176.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.69 137.11 15.83 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.871 -0.788 . . . . 73.540000000000006 108.871 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.696 HG22 HG12 ' A' ' 182' ' ' ILE . 59.9 t -92.28 136.5 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.791 -1.189 . . . . 74.329999999999998 107.791 168.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.464 ' HD3' ' HB3' ' A' ' 156' ' ' ALA . 41.2 ptt85 -136.36 143.21 43.93 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.012 0.925 . . . . 63.399999999999999 108.643 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.89 117.11 30.4 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.764 -1.569 . . . . 74.340000000000003 106.764 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -53.44 120.58 6.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.197 0.999 . . . . 72.310000000000002 111.409 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.6 -29.3 69.88 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.684 0.754 . . . . 75.310000000000002 109.665 168.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -67.55 -32.61 73.5 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.678 -1.146 . . . . 73.329999999999998 111.446 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -148.09 94.77 4.24 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 123.929 0.892 . . . . 74.519999999999996 109.829 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.27 146.6 88.45 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.845 2.363 . . . . 75.439999999999998 111.899 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.15 -28.72 3.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.491 -0.616 . . . . 72.450000000000003 114.104 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -76.24 115.85 16.37 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 117.665 0.733 . . . . 73.010000000000005 110.078 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -113.93 140.5 48.34 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.006 0.922 . . . . 75.510000000000005 109.29 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.1 m -145.92 148.61 32.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.344 1.057 . . . . 71.420000000000002 108.977 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.696 HG12 HG22 ' A' ' 170' ' ' VAL . 14.2 mt -101.03 144.3 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.745 -1.576 . . . . 75.310000000000002 106.745 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -124.68 109.24 12.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.968 -1.493 . . . . 75.219999999999999 106.968 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.7 tp -106.59 113.96 27.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.038 0.535 . . . . 74.340000000000003 110.361 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.527 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 18.0 ttt180 -76.4 117.85 18.48 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.442 -0.947 . . . . 74.299999999999997 108.442 162.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -140.77 139.8 34.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 107.448 -1.315 . . . . 71.519999999999996 107.448 168.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 62.01 22.12 12.85 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.356 1.062 . . . . 74.129999999999995 112.472 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 1.91 89.66 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.331 -0.395 . . . . 75.129999999999995 113.369 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -111.96 140.12 46.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.152 0.981 . . . . 74.310000000000002 108.463 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.33 106.77 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-O 121.371 0.605 . . . . 70.219999999999999 110.657 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -90.86 145.69 24.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 73.510000000000005 108.805 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -125.02 117.92 25.07 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.083 0.468 . . . . 75.420000000000002 110.265 -173.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.574 ' HE1' HD23 ' A' ' 232' ' ' LEU . 3.0 m-85 -95.31 137.0 34.97 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.974 -1.121 . . . . 72.329999999999998 107.974 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -94.77 122.17 37.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.03 -1.1 . . . . 75.519999999999996 108.03 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 59.4 mt -84.65 101.99 9.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.583 -0.895 . . . . 75.340000000000003 108.583 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -76.18 139.52 41.27 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.856 -1.065 . . . . 71.010000000000005 109.094 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -118.39 117.3 28.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.639 0.776 . . . . 73.329999999999998 109.514 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.97 161.05 16.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.748 1.219 . . . . 75.530000000000001 110.464 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 70.0 p -64.41 -27.16 68.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.726 0.81 . . . . 71.420000000000002 112.258 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -83.84 -19.1 35.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.001 0.52 . . . . 73.340000000000003 111.032 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.48 14.3 10.72 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-O 119.014 -0.881 . . . . 64.319999999999993 115.004 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 34.7 mtmm -71.82 129.87 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.218 1.009 . . . . 71.430000000000007 111.09 173.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.93 142.85 26.91 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 71.230000000000004 108.294 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.532 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.9 p90 -169.76 137.73 1.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.097 0.873 . . . . 74.319999999999993 110.756 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -78.66 -46.02 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.435 -0.95 . . . . 75.549999999999997 108.435 164.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.1 m -98.56 124.58 43.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.437 -1.256 . . . . 74.030000000000001 108.764 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 31.4 t -65.97 -21.58 66.42 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.766 0.826 . . . . 65.340000000000003 112.051 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.13 -26.63 53.38 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.97 0.908 . . . . 74.409999999999997 110.163 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -125.42 98.41 5.6 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.798 0.839 . . . . 74.5 109.272 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.532 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 70.5 mtt180 -111.47 118.91 37.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.843 0.857 . . . . 74.219999999999999 110.179 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.87 147.84 34.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.703 0.801 . . . . 72.530000000000001 109.166 -169.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 7.9 m-80 -66.41 -38.88 88.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.265 0.626 . . . . 74.239999999999995 110.341 -175.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.8 p -124.32 154.57 40.1 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.652 0.781 . . . . 61.450000000000003 111.28 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.438 HD12 HD13 ' A' ' 141' ' ' LEU . 1.8 tt -65.21 -23.84 67.19 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.129 0.972 . . . . 63.530000000000001 109.377 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.57 80.36 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.789 0.836 . . . . 74.450000000000003 111.242 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.52 -30.74 64.75 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.378 -0.828 . . . . 72.329999999999998 111.551 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.21 -53.54 56.96 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 123.507 0.505 . . . . 75.120000000000005 110.744 171.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.77 -43.3 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.111 0.565 . . . . 75.239999999999995 110.475 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -55.15 -56.75 16.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.957 0.903 . . . . 75.430000000000007 111.248 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -65.58 -33.16 75.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.688 -1.142 . . . . 72.129999999999995 111.047 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.639 ' HB3' HD13 ' A' ' 228' ' ' LEU . 12.1 m170 -92.21 -10.58 38.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.015 0.526 . . . . 74.409999999999997 112.024 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 77.2 p -97.75 -11.68 23.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.279 0.632 . . . . 63.310000000000002 110.747 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 35.8 p -87.31 -52.07 5.6 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 122.399 0.28 . . . . 74.219999999999999 110.636 167.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.9 162.95 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 122.135 0.969 . . . . 65.319999999999993 113.204 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.84 11.76 17.01 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.616 1.966 . . . . 73.439999999999998 114.42 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -47.73 32.07 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 130.729 3.611 . . . . 75.430000000000007 120.065 -157.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.07 6.38 4.91 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.649 -1.282 . . . . 63.329999999999998 112.911 -167.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.639 HD13 ' HB3' ' A' ' 221' ' ' HIS . 14.9 mt -94.11 161.9 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.722 1.209 . . . . 74.010000000000005 109.067 161.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.4 tt -59.46 -40.09 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-O 120.736 0.303 . . . . 74.230000000000004 110.239 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -159.37 171.96 18.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.851 0.861 . . . . 72.200000000000003 109.904 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 34.0 m -68.73 138.38 54.84 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.144 0.978 . . . . 75.400000000000006 111.606 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.574 HD23 ' HE1' ' A' ' 193' ' ' TYR . 63.8 mt -71.9 131.41 42.94 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.199 0.999 . . . . 63.439999999999998 109.412 177.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -121.4 -77.98 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 118.65 0.659 . . . . 73.420000000000002 111.223 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.556 ' HH ' ' HD3' ' A' ' 237' ' ' PRO . 33.4 t80 -85.92 121.48 72.99 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 123.531 0.733 . . . . 73.329999999999998 109.366 -175.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.61 126.95 4.82 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.181 1.921 . . . . 72.329999999999998 111.519 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.73 145.7 98.97 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.813 0.845 . . . . 72.239999999999995 110.159 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.556 ' HD3' ' HH ' ' A' ' 234' ' ' TYR . 83.5 Cg_endo -81.44 167.17 17.48 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.524 2.15 . . . . 72.540000000000006 112.015 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 32.8 mmtp -69.45 150.12 47.56 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.442 0.697 . . . . 74.219999999999999 110.118 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.68 ' HB3' HD22 ' A' ' 159' ' ' LEU . 13.7 ptt180 -91.38 -64.18 1.16 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.249 0.833 . . . . 73.299999999999997 113.249 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.448 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 61.7 t30 -111.31 134.27 53.02 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.713 0.805 . . . . 73.040000000000006 109.743 -175.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -75.58 110.97 12.03 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 105.457 -2.053 . . . . 74.150000000000006 105.457 160.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.2 146.66 38.42 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.429 2.752 . . . . 74.430000000000007 115.732 -166.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.8 m -80.55 120.69 24.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.22 0.608 . . . . 75.299999999999997 110.78 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.41 108.01 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 108.023 -1.102 . . . . 73.549999999999997 108.023 170.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -108.33 111.75 23.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.192 0.597 . . . . 71.120000000000005 109.879 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 61.46 24.07 63.37 Favored Glycine 0 C--N 1.355 1.639 0 O-C-N 124.187 0.93 . . . . 70.420000000000002 114.871 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.4 116.99 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.328 0.651 . . . . 75.310000000000002 110.676 -174.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.9 t -87.99 120.44 70.74 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 105.829 -1.915 . . . . 72.439999999999998 105.829 151.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 N--CA 1.497 1.686 0 C-N-CA 121.771 1.647 . . . . 75.329999999999998 114.793 -159.919 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.2 t90 . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.411 0.624 . . . . 73.310000000000002 109.995 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -83.32 -31.52 26.78 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.627 -1.169 . . . . 74.340000000000003 109.805 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.6 p -69.58 3.48 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.153 0.981 . . . . 73.150000000000006 112.712 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.76 -25.04 67.09 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.419 0.688 . . . . 73.239999999999995 110.329 169.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.575 ' HG3' HD21 ' A' ' 72' ' ' ASN . 17.0 pt-20 -58.82 -36.81 75.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.588 0.755 . . . . 74.409999999999997 110.248 171.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.575 HD21 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -86.15 -7.04 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.945 1.298 . . . . 45.530000000000001 111.569 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.81 -49.42 70.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.246 0.618 . . . . 70.430000000000007 110.157 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.2 mt -112.84 18.45 18.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.384 0.674 . . . . 75.150000000000006 110.906 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.119 0 C-N-CA 122.906 0.482 . . . . 52.130000000000003 110.842 177.819 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 112.205 0.446 . . . . 75.239999999999995 112.205 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.34 120.15 25.04 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.93 -0.767 . . . . 75.299999999999997 108.93 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.91 174.22 5.98 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.758 1.223 . . . . 74.239999999999995 109.066 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.32 138.41 40.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.97 1.308 . . . . 74.400000000000006 108.66 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.49 116.84 18.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 75.239999999999995 109.968 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.41 HD13 ' HZ2' ' A' ' 238' ' ' LYS . 69.6 mt -79.4 -29.98 42.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.283 0.633 . . . . 74.519999999999996 110.864 175.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 87.4 m-85 -126.64 140.82 52.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.867 -1.06 . . . . 75.439999999999998 108.529 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -72.84 134.19 44.77 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.176 -1.046 . . . . 65.019999999999996 108.176 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.551 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.9 t80 -131.22 111.23 11.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.316 -0.994 . . . . 73.430000000000007 108.316 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.99 137.15 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.542 -1.281 . . . . 74.430000000000007 107.542 172.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.01 117.12 2.96 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.129 0.972 . . . . 75.340000000000003 112.497 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.8 p -88.5 4.99 44.67 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.918 0.887 . . . . 72.329999999999998 111.646 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.85 -175.39 33.84 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.245 -0.742 . . . . 72.209999999999994 111.245 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -79.39 -38.21 35.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.22 0.608 . . . . 72.099999999999994 110.508 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -83.25 -15.46 50.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.24 1.016 . . . . 71.439999999999998 111.458 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.7 p -77.24 177.24 8.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.967 0.507 . . . . 75.030000000000001 111.183 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 56.3 tp -134.31 132.22 39.3 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.814 0.446 . . . . 74.019999999999996 111.154 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 58.0 m -77.9 116.9 18.76 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.864 -0.607 . . . . 61.100000000000001 109.771 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 91' ' ' PHE . 15.2 pt -119.9 153.89 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.951 0.901 . . . . 75.219999999999999 110.137 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -106.9 145.87 31.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.106 0.562 . . . . 72.450000000000003 109.506 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -67.34 109.68 3.24 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 122.857 0.463 . . . . 75.019999999999996 110.156 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.18 -11.93 33.94 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 116.371 -0.377 . . . . 71.230000000000004 112.358 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -77.52 137.73 38.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.331 0.652 . . . . 73.319999999999993 110.443 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -84.55 145.23 28.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.816 0.847 . . . . 75.099999999999994 109.371 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.33 146.74 32.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.337 0.655 . . . . 71.439999999999998 110.301 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -92.49 109.65 21.05 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.112 -1.069 . . . . 73.239999999999995 108.112 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.56 HG13 ' HB3' ' A' ' 119' ' ' ALA . 74.8 t -85.21 122.92 38.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.979 -0.748 . . . . 74.120000000000005 108.979 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.403 HD12 HE21 ' A' ' 122' ' ' GLN . 17.3 mt -90.87 -21.91 21.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.814 1.246 . . . . 74.099999999999994 109.959 -174.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.92 152.69 6.39 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.639 -0.534 . . . . 62.030000000000001 112.668 174.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 47.1 m-85 -86.56 165.22 16.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.372 0.606 . . . . 74.549999999999997 110.81 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -86.91 -172.3 3.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.609 1.164 . . . . 73.409999999999997 111.077 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -58.61 -34.12 70.77 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.886 0.875 . . . . 72.409999999999997 112.53 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -102.5 -4.09 25.89 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.239 0.616 . . . . 74.450000000000003 111.741 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 63.49 26.84 70.02 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.59 -0.561 . . . . 71.540000000000006 114.44 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.19 -12.98 19.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.34 0.57 . . . . 72.329999999999998 111.49 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.429 ' CZ2' HG11 ' A' ' 244' ' ' VAL . 79.6 m95 -137.65 151.43 48.27 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.984 0.914 . . . . 74.430000000000007 109.967 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' A' ' 112' ' ' TYR . . . -135.35 140.22 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.581 0.752 . . . . 63.329999999999998 110.312 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.415 ' HG2' ' NE2' ' A' ' 127' ' ' GLN . 40.7 tt0 -77.19 99.87 5.59 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.684 -1.598 . . . . 72.319999999999993 106.684 169.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.98 161.7 24.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.275 0.63 . . . . 74.120000000000005 110.668 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.403 HE21 HD12 ' A' ' 110' ' ' LEU . 8.5 pt20 -132.11 123.64 27.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.25 0.548 . . . . 74.400000000000006 111.929 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.2 p -98.05 -176.95 3.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.958 1.303 . . . . 64.5 109.853 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 11.0 mptt -66.91 -22.27 65.96 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.762 -1.108 . . . . 71.420000000000002 109.514 172.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -75.96 -19.69 58.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.931 1.293 . . . . 74.310000000000002 110.9 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.62 -160.85 24.16 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.076 0.235 . . . . 64.120000000000005 112.873 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 128' ' ' GLY . 64.7 tp60 -98.59 158.34 15.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.917 0.887 . . . . 72.230000000000004 110.378 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 166.29 -163.42 36.86 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.234 -0.439 . . . . 63.149999999999999 112.416 169.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -102.76 131.64 49.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.906 0.882 . . . . 70.109999999999999 110.618 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 m -130.66 139.37 35.41 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.196 0.998 . . . . 73.340000000000003 108.947 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.94 141.32 16.67 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.522 2.148 . . . . 63.200000000000003 113.577 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.5 m -42.6 -44.74 4.34 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.614 1.566 . . . . 72.340000000000003 113.981 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.564 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 26.5 p-10 -78.25 6.09 8.95 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.895 0.878 . . . . 74.019999999999996 112.329 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.4 -14.29 12.2 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.3 1.04 . . . . 75.200000000000003 111.274 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.46 173.2 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.507 0.723 . . . . 75.310000000000002 112.034 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.8 t -161.56 153.33 16.1 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.602 1.161 . . . . 74.150000000000006 107.889 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.71 148.4 91.81 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.507 1.472 . . . . 74.510000000000005 111.634 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.2 t -73.46 -4.01 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 CA-C-O 121.711 0.767 . . . . 73.430000000000007 110.179 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -80.02 -19.99 46.41 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.697 0.799 . . . . 74.239999999999995 111.49 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.0 p -86.41 174.52 8.95 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.172 0.589 . . . . 64.129999999999995 112.129 -171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.59 -22.38 30.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.738 0.815 . . . . 64.299999999999997 111.516 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.47 -18.1 64.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.74 0.816 . . . . 75.349999999999994 111.611 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -60.74 -12.94 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.412 0.685 . . . . 73.010000000000005 112.744 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -95.44 158.18 15.57 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.029 0.931 . . . . 71.25 110.535 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.5 p -70.11 -42.79 72.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.588 0.755 . . . . 73.140000000000001 111.254 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.497 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 48.9 p-90 -61.98 -39.61 92.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.051 0.76 . . . . 75.409999999999997 113.051 -176.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -82.83 105.78 14.12 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.956 -0.387 . . . . 62.32 109.956 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -99.32 -3.55 33.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.292 0.637 . . . . 53.130000000000003 111.952 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.13 -148.86 33.45 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.754 -1.025 . . . . 73.409999999999997 113.102 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.34 106.76 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.792 2.328 . . . . 52.439999999999998 112.042 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.7 t -135.79 139.63 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.533 1.533 . . . . 72.439999999999998 109.152 -174.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.6 p -90.23 170.33 10.38 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 65.430000000000007 109.873 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.19 -29.81 70.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.795 0.27 . . . . 74.299999999999997 110.583 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -55.94 -53.84 51.98 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.275 0.63 . . . . 73.030000000000001 110.125 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' A' ' 151' ' ' VAL . . . -72.5 -27.88 62.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.844 -1.071 . . . . 75.510000000000005 111.725 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.41 61.97 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.111 0.564 . . . . 74.25 111.586 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -63.71 -38.17 90.09 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.731 . . . . 72.349999999999994 110.433 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.46 -45.81 92.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.903 -1.044 . . . . 74.340000000000003 110.753 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.67 -48.82 79.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.597 0.759 . . . . 75.400000000000006 111.772 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.17 11.18 24.15 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.709 1.003 . . . . 74.099999999999994 113.709 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.8 p -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.725 0.693 . . . . 54.409999999999997 109.991 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.1 p -94.0 10.1 34.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.57 0.748 . . . . 71.420000000000002 111.145 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -76.52 157.92 48.3 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.21 -0.45 . . . . 74.319999999999993 113.274 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.2 pt -100.74 176.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.878 0.871 . . . . 73.430000000000007 111.074 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.99 110.08 5.48 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.089 -0.708 . . . . 75.319999999999993 109.089 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.62 7.96 23.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.505 -0.608 . . . . 64.209999999999994 112.723 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.3 m -83.86 122.43 28.7 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.463 0.632 . . . . 73.340000000000003 111.014 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -129.53 164.82 22.95 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.475 0.579 . . . . 74.239999999999995 111.16 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.94 138.65 14.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.478 -0.934 . . . . 74.030000000000001 108.478 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 182' ' ' ILE . 72.5 t -98.27 138.8 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.136 -1.061 . . . . 72.239999999999995 108.136 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.565 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 2.1 ppt_? -146.7 162.38 38.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.881 0.873 . . . . 74.239999999999995 108.83 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -107.57 150.0 27.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.427 -1.323 . . . . 62.020000000000003 107.427 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t -68.33 125.1 25.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.454 -0.573 . . . . 63.310000000000002 109.454 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.25 -38.93 71.78 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.479 1.112 . . . . 73.219999999999999 111.154 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.3 m -102.88 5.92 38.81 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.605 0.762 . . . . 73.219999999999999 112.254 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.7 m -148.1 88.77 5.39 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 122.888 0.475 . . . . 61.509999999999998 110.532 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.55 134.47 35.67 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.69 2.26 . . . . 75.409999999999997 111.961 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.27 -28.54 13.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.934 -0.575 . . . . 72.109999999999999 112.378 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -88.91 116.98 27.58 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.844 -0.798 . . . . 75.400000000000006 108.844 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 77.5 mtt180 -119.16 159.35 24.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.284 0.564 . . . . 73.120000000000005 110.525 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.542 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 40.2 m -148.4 152.43 36.97 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.266 -0.879 . . . . 72.310000000000002 110.278 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.656 HG12 HG21 ' A' ' 170' ' ' VAL . 33.9 mt -104.18 150.48 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.373 -1.343 . . . . 72.450000000000003 107.373 170.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.0 m -122.94 108.18 12.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.186 -1.412 . . . . 64.549999999999997 107.186 170.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.95 110.49 22.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.319 -0.623 . . . . 73.25 109.319 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.503 ' HB2' HG23 ' A' ' 190' ' ' VAL . 35.6 ttt180 -78.3 115.68 18.19 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.982 -0.747 . . . . 75.319999999999993 108.982 166.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -140.34 138.25 34.74 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.552 1.158 . . . . 63.130000000000003 108.446 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 56.08 30.89 17.12 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.297 1.039 . . . . 72.409999999999997 112.033 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 75.96 12.95 83.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.87 -0.605 . . . . 74.510000000000005 114.264 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -122.0 136.56 54.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 73.530000000000001 109.391 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 185' ' ' ARG . 60.3 t -96.54 106.47 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 122.921 0.488 . . . . 75.120000000000005 110.252 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.02 136.48 33.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.593 1.157 . . . . 73.319999999999993 109.381 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -112.51 119.0 36.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.132 0.491 . . . . 64.420000000000002 110.231 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.524 ' HE1' HD22 ' A' ' 232' ' ' LEU . 10.6 m-30 -95.63 142.2 28.23 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.994 -1.003 . . . . 74.420000000000002 109.053 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 7.1 tpp180 -93.88 109.79 21.48 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.121 -0.696 . . . . 74.310000000000002 109.121 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 54.9 mt -85.7 101.95 10.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.079 -1.082 . . . . 71.439999999999998 108.079 170.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.06 116.46 19.37 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.051 -0.722 . . . . 75.400000000000006 109.051 170.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 m -87.66 112.92 22.85 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.786 -0.82 . . . . 73.439999999999998 108.786 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.487 ' HB1' ' HB2' ' A' ' 202' ' ' LYS . . . -67.13 157.65 33.13 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.232 0.613 . . . . 70.109999999999999 110.401 174.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.8 p -65.61 -20.93 66.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.005 0.922 . . . . 72.209999999999994 113.122 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.37 -14.96 39.25 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.1 0.56 . . . . 73.409999999999997 110.891 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.23 11.99 14.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.508 -0.607 . . . . 41.200000000000003 113.868 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.487 ' HB2' ' HB1' ' A' ' 198' ' ' ALA . 67.9 mttm -71.56 155.36 40.64 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.873 0.837 . . . . 74.439999999999998 110.563 171.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.43 143.41 49.25 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.011 -1.107 . . . . 64.420000000000002 108.011 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.589 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 52.9 p90 -162.83 133.79 4.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.403 0.44 . . . . 73.450000000000003 111.994 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 52.9 t -82.14 -36.32 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.466 -0.788 . . . . 72.010000000000005 109.432 168.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.481 ' HG ' ' HA3' ' A' ' 227' ' ' GLY . 16.0 m -105.47 124.64 49.89 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.006 -1.109 . . . . 75.040000000000006 108.006 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.2 m -62.25 -25.62 67.93 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 74.439999999999998 112.771 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -80.69 -31.32 36.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.876 . . . . 73.510000000000005 110.775 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 50.6 m -109.47 88.47 2.75 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.484 0.713 . . . . 71.310000000000002 109.933 -173.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.589 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 64.8 mtt180 -100.67 127.11 47.18 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.873 -0.788 . . . . 73.340000000000003 108.873 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.95 148.55 38.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.476 -0.935 . . . . 70.219999999999999 108.476 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -68.06 -37.45 81.32 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.555 0.534 . . . . 64.409999999999997 110.146 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 67.0 p -127.98 158.68 37.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.829 0.852 . . . . 74.109999999999999 112.031 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.9 -22.23 62.29 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.879 -1.055 . . . . 75.140000000000001 109.917 175.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.39 97.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.392 0.677 . . . . 74.150000000000006 110.348 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.28 -37.06 71.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.103 -0.953 . . . . 73.519999999999996 111.403 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.2 tp -55.04 -57.87 9.96 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.366 0.416 . . . . 64.099999999999994 110.963 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.46 -48.76 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.226 0.61 . . . . 71.239999999999995 110.976 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -57.84 -55.04 39.99 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.012 0.82 . . . . 74.329999999999998 111.071 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -65.13 -33.43 75.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.093 0.557 . . . . 63.229999999999997 111.576 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.691 ' HB3' HD13 ' A' ' 228' ' ' LEU . 14.0 m170 -89.76 -8.54 51.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.095 0.406 . . . . 73.140000000000001 112.095 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 84.5 p -93.59 -24.81 17.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.764 0.426 . . . . 43.420000000000002 110.209 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.9 p -81.31 -47.11 13.75 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.769 0.428 . . . . 73.400000000000006 110.856 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.582 HG23 ' HB2' ' A' ' 226' ' ' ASP . 23.5 m -128.17 164.37 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.043 0.925 . . . . 74.150000000000006 112.356 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.95 14.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 127.184 2.194 . . . . 72.319999999999993 114.125 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.582 ' HB2' HG23 ' A' ' 224' ' ' VAL . 35.4 t70 -45.41 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.356 1 C-N-CA 131.816 4.046 . . . . 74.040000000000006 119.614 -158.219 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.481 ' HA3' ' HG ' ' A' ' 206' ' ' SER . . . 124.52 -1.79 8.77 Favored Glycine 0 N--CA 1.486 1.977 0 O-C-N 120.808 -1.183 . . . . 71.340000000000003 112.48 -169.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 221' ' ' HIS . 11.7 mt -93.9 163.15 13.62 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.753 1.221 . . . . 74.109999999999999 110.016 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.7 tt -56.96 -40.45 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 120.824 0.345 . . . . 71.439999999999998 110.369 166.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -162.76 177.33 9.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.595 0.758 . . . . 72.409999999999997 110.69 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -66.15 136.24 55.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 73.310000000000002 111.686 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.524 HD22 ' HE1' ' A' ' 193' ' ' TYR . 49.2 mt -69.36 138.73 53.94 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 108.332 -0.988 . . . . 72.510000000000005 108.332 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -132.25 -77.63 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.962 1.255 . . . . 73.420000000000002 111.675 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 167' ' ' SER . 17.9 t80 -80.7 123.0 82.82 Favored Pre-proline 0 C--O 1.209 -1.049 0 CA-C-O 118.307 -0.854 . . . . 72.019999999999996 108.753 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 146' ' ' TRP . 8.3 Cg_endo -88.36 132.89 2.68 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.288 1.992 . . . . 72.430000000000007 111.609 171.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.77 131.94 93.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.484 0.714 . . . . 75.140000000000001 109.782 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.92 177.76 7.99 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.674 2.249 . . . . 71.439999999999998 113.116 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 32.7 mmtp -79.0 126.6 30.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.463 0.705 . . . . 73.430000000000007 109.349 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.487 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 15.3 ptt180 -93.14 -62.45 1.38 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.545 0.943 . . . . 75.120000000000005 113.545 -160.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.487 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 57.4 t30 -109.26 132.31 54.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.235 0.614 . . . . 73.340000000000003 111.09 -167.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -68.84 112.4 11.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 107.179 -1.415 . . . . 74.549999999999997 107.179 163.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.564 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 8.0 Cg_exo -74.61 124.59 8.93 Favored 'Trans proline' 0 C--N 1.364 1.395 0 C-N-CA 122.218 1.946 . . . . 74.030000000000001 112.098 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 87.7 m -64.96 123.27 19.0 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.318 0.647 . . . . 74.439999999999998 110.744 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.429 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 64.1 t -79.69 125.95 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 108.658 -0.868 . . . . 72.530000000000001 108.658 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -98.17 113.0 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 117.711 0.232 . . . . 64.230000000000004 111.096 -168.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 58.1 6.37 2.92 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 118.675 2.23 . . . . 75.340000000000003 118.675 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.419 HG23 ' HE1' ' A' ' 118' ' ' TRP . 17.1 m -106.53 123.07 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.943 1.371 . . . . 72.329999999999998 113.781 -170.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 t -82.89 122.94 78.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 106.326 -1.731 . . . . 73.409999999999997 106.326 157.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 C--N 1.367 1.534 0 C-N-CA 121.423 1.415 . . . . 74.140000000000001 115.212 -157.146 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 6.7 t90 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.274 -0.639 . . . . 73.420000000000002 109.274 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -76.84 -29.48 55.93 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 116.229 -0.441 . . . . 73.030000000000001 110.519 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -73.21 5.03 3.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.019 1.328 . . . . 74.129999999999995 113.095 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.53 -17.71 64.96 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.676 1.19 . . . . 73.140000000000001 112.922 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -26.84 19.51 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.255 0.622 . . . . 74.129999999999995 110.957 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.92 -5.63 55.94 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.62 0.768 . . . . 75.310000000000002 110.4 169.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.408 HD11 ' HE1' ' A' ' 146' ' ' TRP . 62.4 tp -60.72 -54.09 49.48 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.961 0.505 . . . . 73.019999999999996 109.869 174.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.02 84.3 1.9 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.98 -1.119 . . . . 71.109999999999999 107.98 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.725 0 CA-C-N 115.378 -0.828 . . . . 72.319999999999993 111.774 -173.41 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.447 0.642 . . . . 74.010000000000005 110.073 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 106' ' ' LYS . 38.5 tp -88.46 121.37 30.77 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 114.636 -1.165 . . . . 72.409999999999997 108.084 171.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.56 173.19 6.42 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.5 1.12 . . . . 72.230000000000004 108.704 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -131.18 135.81 58.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 124.424 1.089 . . . . 65.510000000000005 108.109 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.69 107.06 6.55 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.062 0.945 . . . . 73.25 109.405 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 143' ' ' LYS . 79.0 mt -69.29 -23.92 63.89 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.475 0.71 . . . . 74.209999999999994 111.528 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 77.0 m-85 -135.77 155.67 50.0 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 75.140000000000001 109.954 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.434 ' HB2' ' HE2' ' A' ' 241' ' ' LYS . 10.9 m-20 -70.87 156.09 40.0 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.908 -0.775 . . . . 73.420000000000002 108.908 167.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.578 ' HB3' HG12 ' A' ' 101' ' ' ILE . 71.1 t80 -149.3 124.32 10.03 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.133 -1.432 . . . . 72.319999999999993 107.133 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.4 135.34 27.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.789 -1.56 . . . . 62.409999999999997 106.789 169.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.48 117.46 3.11 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.964 0.79 . . . . 71.219999999999999 111.475 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.2 p -88.03 15.14 7.72 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.159 0.984 . . . . 64.239999999999995 110.991 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.47 179.54 46.06 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.912 -0.875 . . . . 74.319999999999993 110.912 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.09 -24.97 58.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.215 0.606 . . . . 72.319999999999993 111.444 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.46 HD22 ' HD2' ' A' ' 249' ' ' PRO . 43.6 p-10 -89.06 -17.56 29.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.724 0.809 . . . . 74.150000000000006 111.561 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.7 p -88.97 158.96 17.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.187 0.595 . . . . 75.040000000000006 110.508 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -121.63 134.15 54.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.215 0.606 . . . . 72.030000000000001 110.98 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.8 m -79.94 132.6 36.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.628 0.771 . . . . 71.450000000000003 110.512 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.679 HG23 HG23 ' A' ' 123' ' ' THR . 6.7 pt -129.22 154.49 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.617 0.767 . . . . 74.450000000000003 111.098 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.5 m -102.93 145.87 29.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.726 1.21 . . . . 51.420000000000002 109.922 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HE3' ' O ' ' A' ' 88' ' ' LEU . 42.3 tttt -70.63 108.15 4.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.252 0.621 . . . . 73.329999999999998 109.75 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.95 29.24 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-N 115.832 -0.622 . . . . 64.219999999999999 112.559 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 54.0 tt0 -74.2 144.99 44.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.787 0.835 . . . . 74.219999999999999 111.314 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HB3' HD13 ' A' ' 84' ' ' LEU . 43.0 mmtm -92.74 129.61 38.61 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.36 0.664 . . . . 64.430000000000007 109.843 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.578 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.3 OUTLIER -132.18 136.13 46.84 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.835 0.854 . . . . 75.129999999999995 109.505 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -95.15 109.66 21.72 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.902 -0.777 . . . . 74.120000000000005 108.902 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.512 HG12 ' HB1' ' A' ' 119' ' ' ALA . 42.5 t -77.22 134.35 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 123.644 0.59 . . . . 72.439999999999998 110.278 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.4 mt -102.75 -31.21 10.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.943 1.297 . . . . 74.530000000000001 109.906 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.32 142.94 3.93 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.5 -0.611 . . . . 75.409999999999997 113.331 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.545 ' CD2' ' HB3' ' A' ' 119' ' ' ALA . 33.6 m-85 -86.92 167.34 14.38 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.944 0.898 . . . . 63.420000000000002 110.857 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -88.49 -178.79 5.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.839 . . . . 71.530000000000001 110.565 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -55.42 -34.58 64.54 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.949 1.3 . . . . 75.239999999999995 113.625 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -111.38 9.29 21.5 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.071 0.548 . . . . 74.120000000000005 112.051 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.62 33.11 86.37 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 115.134 0.813 . . . . 63.200000000000003 115.134 172.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.65 -38.68 12.3 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.088 0.444 . . . . 73.549999999999997 111.924 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 66.9 m95 -129.9 147.37 51.65 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.44 0.696 . . . . 75.200000000000003 111.174 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.545 ' HB3' ' CD2' ' A' ' 112' ' ' TYR . . . -128.58 150.82 50.04 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.027 1.331 . . . . 73.299999999999997 109.3 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -87.21 115.76 24.83 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.952 -1.129 . . . . 64.299999999999997 107.952 166.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.51 168.68 10.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.432 0.693 . . . . 72.129999999999995 110.918 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -120.95 110.84 16.77 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.647 0.779 . . . . 74.239999999999995 110.364 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.679 HG23 HG23 ' A' ' 101' ' ' ILE . 82.7 p -100.63 177.58 4.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.347 1.059 . . . . 75.219999999999999 109.933 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.01 -18.3 64.02 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 110.753 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.79 -24.69 55.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.163 0.985 . . . . 73.430000000000007 111.035 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.34 -146.9 17.63 Favored Glycine 0 C--N 1.363 2.055 0 CA-C-N 117.706 0.23 . . . . 72.409999999999997 112.906 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -130.59 139.82 50.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.498 0.719 . . . . 71.109999999999999 109.946 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.21 -174.03 41.05 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.257 -0.737 . . . . 74.540000000000006 111.257 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -87.83 121.81 30.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.344 0.658 . . . . 71.340000000000003 112.41 -170.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.509 HG22 HD11 ' A' ' 135' ' ' ILE . 5.2 m -122.7 142.72 38.33 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.13 1.372 . . . . 75.239999999999995 108.726 173.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 10.6 Cg_endo -88.48 146.91 6.15 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 C-N-CA 122.241 1.961 . . . . 75.230000000000004 114.767 -172.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.4 m -41.35 -44.3 2.73 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.512 1.925 . . . . 75.200000000000003 114.551 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.573 HD21 ' HB2' ' A' ' 242' ' ' PRO . 22.4 p-10 -73.28 -4.16 31.41 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.012 0.525 . . . . 72.340000000000003 112.192 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.46 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 9.7 m-85 -106.44 -22.57 12.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.787 0.835 . . . . 74.349999999999994 111.475 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 130' ' ' VAL . 27.6 pt -123.28 164.65 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.325 0.65 . . . . 75.450000000000003 112.442 -172.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.2 t -160.41 149.55 13.91 Favored Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.126 -0.94 . . . . 74.150000000000006 109.166 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.12 145.98 40.5 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.517 2.145 . . . . 73.310000000000002 112.377 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 t -75.68 -3.73 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.576 0.703 . . . . 63.200000000000003 111.149 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.84 -2.78 43.34 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.601 -0.687 . . . . 63.43 112.297 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.8 p -78.25 171.58 14.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.2 0.524 . . . . 75.340000000000003 111.828 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.38 -27.71 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.882 -0.599 . . . . 74.239999999999995 109.66 165.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.6 -16.21 64.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.311 1.044 . . . . 73.129999999999995 112.139 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.507 ' HA ' HD21 ' A' ' 88' ' ' LEU . 16.7 pttm -69.49 -31.71 70.15 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.815 0.446 . . . . 75.120000000000005 111.742 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.01 133.8 51.57 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.721 0.809 . . . . 74.430000000000007 110.23 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.0 p -55.59 -32.55 63.16 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 74.420000000000002 112.702 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.408 ' HE1' HD11 ' A' ' 73' ' ' LEU . 25.7 p-90 -81.13 -32.42 33.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.222 0.609 . . . . 73.310000000000002 112.59 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -84.24 107.6 16.64 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.3 -0.63 . . . . 73.310000000000002 109.3 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.77 -5.57 24.73 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.494 0.717 . . . . 71.239999999999995 111.51 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.24 -130.62 21.72 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 118.065 -1.408 . . . . 75.430000000000007 112.941 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.623 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 32.2 Cg_exo -58.63 86.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.821 3.014 . . . . 74.230000000000004 113.603 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.97 132.48 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.285 1.034 . . . . 74.349999999999994 109.681 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.0 p -87.68 175.07 8.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.755 1.222 . . . . 72.420000000000002 110.193 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -61.85 -44.94 95.83 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.483 0.313 . . . . 74.5 110.508 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.23 -48.46 80.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.978 0.911 . . . . 74.140000000000001 110.295 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.3 77.95 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.853 -1.067 . . . . 72.340000000000003 111.419 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.95 -52.47 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.278 0.631 . . . . 73.420000000000002 111.935 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.512 ' HG2' HG13 ' A' ' 190' ' ' VAL . 43.2 mt-10 -68.8 -25.89 64.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.646 0.779 . . . . 75.310000000000002 110.677 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.23 -43.68 90.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.884 0.874 . . . . 70.120000000000005 111.373 170.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.3 mt -65.0 -34.6 78.83 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.285 0.564 . . . . 75.400000000000006 110.532 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 90.0 mt -89.72 2.23 55.08 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.324 -0.853 . . . . 74.540000000000006 112.807 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -61.98 -34.42 76.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.841 0.746 . . . . 71.349999999999994 111.471 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.6 p -101.73 11.08 39.4 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.631 0.772 . . . . 72.420000000000002 111.065 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.04 153.98 40.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.183 -0.462 . . . . 73.510000000000005 113.094 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.59 -176.89 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 124.259 1.024 . . . . 75.209999999999994 111.599 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 108.14 1.66 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.574 -0.739 . . . . 65.430000000000007 110.403 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 105.54 12.32 26.91 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.475 -0.625 . . . . 75.209999999999994 112.429 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' A' ' 185' ' ' ARG . 74.2 m -71.21 144.85 49.98 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 117.519 0.659 . . . . 72.140000000000001 111.209 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.2 p90 -157.52 164.35 37.45 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 122.799 0.44 . . . . 74.439999999999998 110.423 -174.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.07 146.4 12.44 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.647 -0.871 . . . . 72.230000000000004 108.647 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.631 HG22 HG12 ' A' ' 182' ' ' ILE . 91.4 t -96.62 126.67 49.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 108.889 -0.782 . . . . 62.420000000000002 108.889 167.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -116.08 143.4 45.52 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.959 1.303 . . . . 73.120000000000005 107.883 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.76 149.29 38.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.755 0.822 . . . . 75.5 108.922 171.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 t -83.76 125.47 31.95 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.242 -0.651 . . . . 74.140000000000001 109.242 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 150' ' ' PRO . 18.4 tp10 -77.71 -34.31 52.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.195 0.598 . . . . 73.010000000000005 109.392 172.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.0 p -75.22 -16.36 60.48 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.549 0.74 . . . . 74.450000000000003 111.186 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -147.37 79.16 9.84 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 123.768 0.827 . . . . 74.409999999999997 109.185 172.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.65 133.57 55.11 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.169 2.579 . . . . 72.209999999999994 112.406 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.73 -29.59 10.66 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.885 -0.598 . . . . 73.349999999999994 111.92 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -73.64 115.02 12.56 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 108.632 -0.877 . . . . 71.140000000000001 108.632 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.423 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.7 mtt85 -128.47 146.17 50.89 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.725 0.81 . . . . 73.340000000000003 109.098 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.9 m -140.51 148.84 41.69 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.385 1.074 . . . . 72.439999999999998 109.009 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.631 HG12 HG22 ' A' ' 170' ' ' VAL . 34.4 mt -101.51 148.44 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 106.734 -1.58 . . . . 75.5 106.734 168.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 24.6 m -123.46 109.35 13.73 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.203 -1.406 . . . . 74.510000000000005 107.203 171.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.445 HD11 HD21 ' A' ' 232' ' ' LEU . 20.5 tp -103.59 112.39 25.29 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.808 0.731 . . . . 74.040000000000006 109.614 177.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 23.8 ttt180 -80.47 111.17 16.62 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.471 0.653 . . . . 74.209999999999994 109.482 165.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -137.25 134.71 36.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.214 -1.357 . . . . 74.430000000000007 107.433 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 61.91 22.48 13.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.538 1.135 . . . . 74.329999999999998 111.547 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.34 85.94 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.938 -0.573 . . . . 65.129999999999995 113.006 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -105.01 130.77 53.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.132 0.973 . . . . 74.25 108.798 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.512 HG13 ' HG2' ' A' ' 157' ' ' GLU . 58.7 t -96.46 115.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.897 -0.409 . . . . 74.310000000000002 109.897 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -100.08 148.82 24.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.953 1.301 . . . . 72.219999999999999 107.747 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -119.63 116.41 25.95 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.377 0.535 . . . . 73.519999999999996 110.608 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.412 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 8.6 m-30 -93.89 149.48 21.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.434 1.094 . . . . 75.129999999999995 108.216 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -106.29 114.05 27.94 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.896 -0.409 . . . . 72.200000000000003 109.896 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 48.2 mt -87.42 102.75 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.315 -0.994 . . . . 75.510000000000005 108.315 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -87.17 132.52 33.84 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.101 -0.954 . . . . 63.299999999999997 108.72 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.6 m -100.76 106.77 18.21 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.979 -1.119 . . . . 75.299999999999997 107.979 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.07 159.56 3.29 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.686 0.794 . . . . 64.409999999999997 110.525 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.5 p -63.3 -22.31 66.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.063 0.945 . . . . 64.109999999999999 113.236 -172.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -93.79 -0.62 55.78 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.692 0.797 . . . . 75.349999999999994 111.44 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 100.17 14.05 34.55 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.601 -0.555 . . . . 74.219999999999999 114.068 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -88.15 127.03 35.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 117.852 0.826 . . . . 73.340000000000003 111.426 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -87.03 146.18 26.2 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.339 1.056 . . . . 74.109999999999999 108.545 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 39.7 p90 -165.43 140.41 5.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.374 0.421 . . . . 74.400000000000006 110.648 173.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.449 HG22 HD12 ' A' ' 217' ' ' LEU . 76.1 t -85.18 -43.04 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.229 -1.026 . . . . 74.299999999999997 108.229 163.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.2 m -104.79 129.95 52.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.526 -1.216 . . . . 73.329999999999998 109.099 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.5 t -67.66 -14.65 63.12 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.07 0.948 . . . . 64.129999999999995 112.693 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.44 -17.0 59.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.695 1.198 . . . . 55.030000000000001 111.729 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.2 m -149.57 112.17 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.902 0.481 . . . . 70.319999999999993 110.638 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 98.4 mtt180 -102.97 124.17 47.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.06 0.944 . . . . 75.510000000000005 109.021 175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -106.87 145.95 31.56 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.071 0.948 . . . . 75.25 109.284 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.49 -39.77 88.9 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.733 0.645 . . . . 75.540000000000006 110.159 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 69.2 p -126.49 151.62 47.57 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.985 -1.007 . . . . 74.040000000000006 111.482 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 195' ' ' ILE . 0.7 OUTLIER -62.94 -24.63 67.96 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.333 -1.303 . . . . 75.25 109.842 172.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.34 86.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.215 1.006 . . . . 61.520000000000003 111.602 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.37 -35.86 71.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.363 0.665 . . . . 74.120000000000005 111.274 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.449 HD12 HG22 ' A' ' 205' ' ' VAL . 12.4 tp -55.15 -56.18 22.8 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.635 0.584 . . . . 73.25 110.762 174.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.6 -39.44 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.81 -0.632 . . . . 72.310000000000002 111.041 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -61.26 -53.12 60.89 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.287 0.367 . . . . 71.299999999999997 110.661 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -62.03 -38.6 89.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.413 -0.812 . . . . 75.430000000000007 110.643 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.671 ' HB3' HD13 ' A' ' 228' ' ' LEU . 12.0 m170 -88.17 -5.18 58.56 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.112 -0.494 . . . . 74.099999999999994 112.258 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.7 p -95.31 -24.28 16.82 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.819 0.448 . . . . 72.010000000000005 110.837 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.7 p -81.74 -38.86 25.04 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 122.749 0.42 . . . . 72.219999999999999 111.274 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.589 HG21 ' HB2' ' A' ' 226' ' ' ASP . 27.4 m -135.52 162.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.984 0.897 . . . . 72.510000000000005 112.142 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.69 15.07 1.11 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.71 2.004 . . . . 72.120000000000005 114.231 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.589 ' HB2' HG21 ' A' ' 224' ' ' VAL . 33.7 t70 -43.36 33.65 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 131.634 3.974 . . . . 64.010000000000005 119.145 -156.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.55 -5.35 9.28 Favored Glycine 0 N--CA 1.478 1.459 0 O-C-N 120.738 -1.226 . . . . 70.010000000000005 112.846 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 221' ' ' HIS . 10.6 mt -91.3 162.23 14.7 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.121 1.368 . . . . 75.400000000000006 109.785 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -61.25 -36.07 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-O 120.843 0.354 . . . . 75.519999999999996 110.075 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -162.33 175.42 11.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.953 0.901 . . . . 62.409999999999997 109.427 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.6 p -61.88 148.42 43.49 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.454 1.102 . . . . 75.230000000000004 112.202 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.445 HD21 HD11 ' A' ' 184' ' ' LEU . 52.7 mt -75.13 145.93 41.78 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.873 0.869 . . . . 73.430000000000007 108.689 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -137.35 -72.29 0.43 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.799 0.727 . . . . 75.010000000000005 111.949 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.456 ' HH ' ' HD3' ' A' ' 237' ' ' PRO . 62.2 t80 -95.26 122.85 58.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.401 0.68 . . . . 73.340000000000003 109.775 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 71.1 Cg_endo -82.1 139.33 10.63 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.538 2.159 . . . . 62.439999999999998 111.058 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.19 141.79 95.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.061 0.545 . . . . 65.109999999999999 110.426 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.456 ' HD3' ' HH ' ' A' ' 234' ' ' TYR . 90.4 Cg_endo -79.49 136.37 12.38 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.339 2.026 . . . . 75.239999999999995 111.852 -177.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.24 102.73 2.18 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.563 -1.273 . . . . 73.340000000000003 107.563 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.604 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 17.7 ptt180 -73.38 -66.93 0.63 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 115.182 1.549 . . . . 71.049999999999997 115.182 -154.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.604 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 25.2 t-20 -113.75 150.14 33.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.039 0.536 . . . . 74.140000000000001 110.495 -172.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 90' ' ' ASP . 85.5 mttt -70.12 115.71 36.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.098 -1.075 . . . . 71.430000000000007 108.098 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 133' ' ' ASN . 23.6 Cg_exo -63.78 137.58 59.19 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.643 2.228 . . . . 73.319999999999993 111.933 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 25.5 m -68.81 122.29 18.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.151 0.58 . . . . 62.5 111.547 -172.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.417 HG13 ' CZ2' ' A' ' 118' ' ' TRP . 58.0 t -92.34 128.27 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.594 -1.261 . . . . 74.200000000000003 107.594 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -104.01 112.48 25.48 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.214 0.461 . . . . 74.430000000000007 111.159 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.71 8.28 3.99 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 118.366 2.106 . . . . 74.0 118.366 159.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.66 129.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 119.256 1.528 . . . . 65.530000000000001 111.865 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 t -73.5 121.67 85.72 Favored Pre-proline 0 C--N 1.355 0.818 0 N-CA-C 106.431 -1.692 . . . . 74.25 106.431 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HD2' HD22 ' A' ' 97' ' ' ASN . 82.0 Cg_exo . . . . . 0 C--N 1.374 1.872 0 C-N-CA 122.791 2.327 . . . . 73.310000000000002 116.452 -153.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.614 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 12.0 t90 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 120.799 0.333 . . . . 72.430000000000007 110.464 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -64.97 -17.06 64.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.568 0.747 . . . . 73.349999999999994 110.823 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.425 ' HA ' ' HB2' ' A' ' 72' ' ' ASN . 20.0 m -77.49 4.0 12.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.524 1.129 . . . . 74.219999999999999 112.169 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -75.52 -47.78 25.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.708 0.803 . . . . 74.019999999999996 110.358 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.9 -24.55 64.32 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 120.836 0.351 . . . . 64.239999999999995 110.424 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 69' ' ' SER . 10.7 m120 -89.43 -6.43 56.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.007 0.923 . . . . 75.209999999999994 111.634 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.22 -52.15 64.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.346 1.058 . . . . 65.409999999999997 112.219 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.91 16.14 26.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.605 0.762 . . . . 71.239999999999995 110.36 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 C-N-CA 123.35 0.66 . . . . 61.350000000000001 112.035 -177.248 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 CA--C 1.553 1.066 0 CA-C-O 120.658 0.266 . . . . 74.540000000000006 111.099 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.433 HD12 ' HB3' ' A' ' 106' ' ' LYS . 26.2 tp -96.16 126.83 41.65 Favored 'General case' 0 C--N 1.357 0.917 0 CA-C-O 121.65 0.738 . . . . 71.430000000000007 110.085 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -113.95 173.71 6.3 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.417 1.487 . . . . 75.230000000000004 108.257 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.47 139.19 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.088 0.955 . . . . 73.049999999999997 109.04 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HA ' HG23 ' A' ' 135' ' ' ILE . . . -74.4 120.4 19.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.213 0.605 . . . . 70.430000000000007 110.137 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 143' ' ' LYS . 83.8 mt -86.03 -34.97 20.6 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.462 0.705 . . . . 73.040000000000006 110.704 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.409 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 68.9 m-85 -123.78 146.19 48.5 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.131 -0.941 . . . . 74.219999999999999 108.879 -175.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB2' ' HZ1' ' A' ' 241' ' ' LYS . 6.8 m-20 -74.1 144.76 44.83 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.734 0.646 . . . . 74.5 109.409 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.582 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.6 t80 -142.18 140.5 32.4 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.437 -0.949 . . . . 73.230000000000004 108.437 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 68.0 t -110.99 134.82 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 108.209 -1.034 . . . . 74.310000000000002 108.209 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.68 116.27 2.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.167 0.987 . . . . 72.109999999999999 111.239 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.8 p -107.91 26.03 10.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.227 1.011 . . . . 64.400000000000006 110.209 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.27 177.52 43.49 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.086 -0.961 . . . . 64.230000000000004 110.929 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.71 -38.18 54.78 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.007 0.523 . . . . 72.239999999999995 111.254 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -84.32 -23.33 30.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.966 0.506 . . . . 74.530000000000001 111.152 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.6 p -72.92 153.99 40.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.151 0.58 . . . . 73.439999999999998 111.521 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.507 HD21 ' HG1' ' A' ' 123' ' ' THR . 61.8 tp -127.06 129.05 47.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.388 0.675 . . . . 72.230000000000004 110.968 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -69.66 130.56 42.71 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.692 0.797 . . . . 74.519999999999996 109.997 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.635 HG21 HG23 ' A' ' 123' ' ' THR . 22.0 pt -129.25 147.5 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 74.540000000000006 110.67 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -106.93 140.58 39.52 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.84 -1.17 . . . . 65.439999999999998 107.84 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -62.45 147.43 48.71 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 123.5 0.5 . . . . 75.310000000000002 110.271 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.74 -28.74 10.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.984 -0.342 . . . . 71.140000000000001 112.794 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.3 146.01 33.19 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.229 0.515 . . . . 74.299999999999997 111.04 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.433 ' HB3' HD12 ' A' ' 84' ' ' LEU . 39.9 mmtm -90.02 142.68 27.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.129 0.971 . . . . 74.200000000000003 109.696 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -145.57 146.1 31.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.861 0.865 . . . . 73.040000000000006 110.115 -178.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -99.65 107.06 19.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.811 0.444 . . . . 75.540000000000006 110.063 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 119' ' ' ALA . 53.5 t -79.02 119.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.873 -0.788 . . . . 70.430000000000007 108.873 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.8 -8.68 11.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.94 -0.573 . . . . 75.420000000000002 111.055 -175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.83 140.74 6.48 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 121.263 -0.494 . . . . 52.219999999999999 112.885 171.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -97.03 174.92 6.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.918 0.887 . . . . 75.109999999999999 110.439 172.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -96.09 -173.16 2.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.987 -1.006 . . . . 72.140000000000001 110.445 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -52.44 -39.38 60.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.657 1.183 . . . . 72.340000000000003 114.115 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -108.14 6.62 27.0 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.814 0.446 . . . . 72.209999999999994 112.092 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.66 12.15 45.73 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 115.361 0.904 . . . . 53.219999999999999 115.361 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.76 -7.71 33.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.6 0.76 . . . . 75.310000000000002 111.636 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.458 ' HZ2' HG12 ' A' ' 244' ' ' VAL . 39.2 m95 -127.52 145.38 50.87 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.97 -1.122 . . . . 72.230000000000004 107.97 167.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -148.02 125.78 11.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.274 -0.876 . . . . 73.030000000000001 109.219 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 37.9 tt0 -67.34 123.29 19.95 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 108.268 -1.012 . . . . 71.409999999999997 108.268 171.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . . . -126.98 145.71 50.6 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.76 0.824 . . . . 75.409999999999997 110.215 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -101.92 100.31 10.59 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.12 -1.067 . . . . 75.010000000000005 108.12 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.635 HG23 HG21 ' A' ' 101' ' ' ILE . 67.0 p -82.27 165.85 20.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.309 0.644 . . . . 74.530000000000001 109.831 173.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.46 ' HB3' ' HZ2' ' A' ' 124' ' ' LYS . 0.3 OUTLIER -66.34 -20.45 66.09 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 121.462 0.649 . . . . 75.510000000000005 109.445 175.139 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -79.38 -29.94 42.3 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.087 1.355 . . . . 74.099999999999994 112.297 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.33 -165.3 36.59 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 119.872 -0.405 . . . . 62.109999999999999 112.588 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -128.03 144.75 51.11 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.033 0.916 . . . . 74.209999999999994 110.367 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.13 178.42 36.0 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 112.589 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 75.1 m95 -75.07 118.4 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.324 1.05 . . . . 73.209999999999994 112.49 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.2 m -118.14 152.47 50.53 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 124.23 1.012 . . . . 54.299999999999997 108.428 174.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.12 129.07 17.59 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 121.772 1.648 . . . . 73.010000000000005 111.206 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 m -64.4 -25.84 68.19 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.099 0.96 . . . . 75.129999999999995 112.295 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -80.41 -5.48 56.57 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.236 1.015 . . . . 74.549999999999997 111.875 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.409 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 4.1 m-85 -96.87 -13.98 22.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.072 0.949 . . . . 75.299999999999997 110.944 173.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.5 HG23 ' HA ' ' A' ' 87' ' ' ALA . 16.1 pt -125.83 172.34 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.752 0.821 . . . . 73.510000000000005 110.585 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.401 HG23 ' HB2' ' A' ' 142' ' ' GLU . 2.5 m -159.63 142.35 10.15 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.403 1.081 . . . . 71.120000000000005 108.959 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.72 139.64 58.1 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.161 1.908 . . . . 75.239999999999995 112.237 170.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.8 t -70.19 -6.05 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 121.603 0.716 . . . . 73.200000000000003 109.966 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -85.85 -21.16 28.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.831 0.852 . . . . 71.319999999999993 112.756 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.3 p -102.11 179.01 4.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.383 0.673 . . . . 62.310000000000002 112.576 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.74 -22.24 37.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.429 1.092 . . . . 73.140000000000001 112.177 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.401 ' HB2' HG23 ' A' ' 136' ' ' THR . 3.1 mp0 -69.5 -13.87 62.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.075 0.95 . . . . 74.450000000000003 112.223 -172.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.529 ' HA ' HD22 ' A' ' 88' ' ' LEU . 22.2 pttm -69.88 -11.38 60.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.49 0.716 . . . . 72.120000000000005 112.175 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -87.05 143.37 27.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.293 0.637 . . . . 73.200000000000003 110.582 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 p -68.13 -33.29 74.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.29 1.036 . . . . 75.530000000000001 112.765 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -71.17 -33.28 69.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 75.109999999999999 111.46 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -78.43 112.79 15.82 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.52 -0.918 . . . . 74.400000000000006 108.52 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.46 -20.13 13.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.5 0.72 . . . . 75.510000000000005 111.345 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.95 -150.27 42.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 118.545 -1.142 . . . . 72.209999999999994 111.974 -174.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.03 100.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.66 2.907 . . . . 73.319999999999993 113.437 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.9 t -131.93 150.13 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.954 1.302 . . . . 75.200000000000003 108.94 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.3 p -90.95 175.19 7.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.368 0.667 . . . . 71.319999999999993 111.434 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -60.69 3.13 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.494 1.117 . . . . 70.430000000000007 110.886 -177.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.1 -29.03 70.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.936 0.895 . . . . 75.120000000000005 111.255 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.59 83.35 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 123.786 0.679 . . . . 65.329999999999998 110.944 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.78 -44.41 93.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.807 0.692 . . . . 73.329999999999998 110.84 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.99 -44.58 82.84 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.538 -0.755 . . . . 75.140000000000001 111.337 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.11 -44.46 88.68 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.592 -1.186 . . . . 74.030000000000001 111.888 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 237' ' ' PRO . 87.0 mt -59.8 -39.5 85.2 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.19 0.996 . . . . 73.129999999999995 111.571 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 90.8 mt -81.05 -27.53 35.71 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.283 -0.871 . . . . 74.530000000000001 112.074 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.9 p -68.39 -10.02 52.22 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 118.379 0.536 . . . . 51.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.9 p -103.55 21.16 16.57 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.62 1.168 . . . . 71.310000000000002 111.122 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.71 -178.15 15.19 Favored Glycine 0 C--N 1.353 1.499 0 C-N-CA 123.347 0.499 . . . . 51.149999999999999 113.79 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.4 pt -96.79 178.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.381 1.072 . . . . 74.439999999999998 112.06 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.47 112.46 5.31 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.158 -1.052 . . . . 71.319999999999993 108.158 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.59 24.89 Favored Glycine 0 CA--C 1.528 0.89 0 O-C-N 123.742 0.651 . . . . 74.329999999999998 112.746 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.436 ' O ' HD11 ' A' ' 184' ' ' LEU . 73.3 m -76.56 139.96 40.9 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.567 0.684 . . . . 75.430000000000007 110.868 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.2 p90 -148.78 163.53 37.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.068 0.461 . . . . 75.109999999999999 110.538 -175.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 4.1 pp -157.73 149.71 22.16 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.359 -0.837 . . . . 72.310000000000002 108.961 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.712 HG21 HG12 ' A' ' 182' ' ' ILE . 93.9 t -109.0 120.78 61.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.114 -1.069 . . . . 75.230000000000004 108.114 168.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.501 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 24.2 ptt85 -114.54 164.51 13.9 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.651 1.18 . . . . 71.25 108.452 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.16 160.84 20.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.98 0.912 . . . . 72.219999999999999 108.697 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.7 t -79.68 124.18 28.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.498 -0.556 . . . . 62.43 109.498 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.52 -36.24 83.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.85 0.86 . . . . 71.400000000000006 110.54 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.1 p -69.75 -31.27 69.14 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.897 0.879 . . . . 60.43 112.071 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 m -150.91 119.43 3.5 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.034 0.534 . . . . 75.239999999999995 110.305 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.8 154.4 74.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.832 2.355 . . . . 75.129999999999995 112.198 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.16 -31.22 8.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.004 -0.543 . . . . 65.230000000000004 112.316 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.59 112.19 17.72 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.93 -1.137 . . . . 72.129999999999995 107.93 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.52 ' H ' ' NH2' ' A' ' 194' ' ' ARG . 98.4 mtt180 -124.28 127.32 47.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.553 0.741 . . . . 74.430000000000007 110.068 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.1 m -125.28 145.51 49.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.74 0.816 . . . . 52.229999999999997 110.206 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.712 HG12 HG21 ' A' ' 170' ' ' VAL . 20.9 mt -100.12 143.93 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 107.696 -1.224 . . . . 75.329999999999998 107.696 173.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.2 m -125.61 109.84 13.12 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 176.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 167' ' ' SER . 32.0 tp -105.35 112.91 26.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.956 0.503 . . . . 74.25 110.994 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 76.1 ttt180 -78.25 110.97 13.73 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.54 -0.911 . . . . 71.140000000000001 108.54 163.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -133.1 125.88 30.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.009 1.324 . . . . 75.329999999999998 108.718 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 58.54 30.84 20.33 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.339 1.055 . . . . 71.040000000000006 110.433 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.431 ' HA2' ' HE ' ' A' ' 185' ' ' ARG . . . 79.84 -13.23 25.47 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-N 114.678 -1.146 . . . . 74.400000000000006 113.824 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 58.0 mtp85 -93.63 125.53 38.3 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.289 0.636 . . . . 75.409999999999997 109.406 -171.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.93 106.56 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.104 0.562 . . . . 73.430000000000007 110.847 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -96.51 131.99 42.56 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.586 1.154 . . . . 74.519999999999996 108.796 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -110.39 117.82 34.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.213 0.53 . . . . 75.109999999999999 111.439 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.461 ' HE1' HD22 ' A' ' 232' ' ' LEU . 2.8 m-30 -95.33 138.71 32.64 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 124.767 1.227 . . . . 70.140000000000001 108.768 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.52 ' NH2' ' H ' ' A' ' 180' ' ' ARG . 1.8 tpm_? -112.0 109.04 18.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 106.873 -1.528 . . . . 73.439999999999998 106.873 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -68.8 103.56 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 123.55 0.531 . . . . 74.049999999999997 110.759 -171.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -68.85 143.44 54.55 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.671 0.788 . . . . 75.340000000000003 110.414 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.6 m -119.99 118.78 31.57 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.506 0.722 . . . . 75.450000000000003 109.702 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.35 159.83 33.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.668 0.787 . . . . 74.400000000000006 109.907 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.5 m -62.24 -22.83 66.28 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.632 0.975 . . . . 75.230000000000004 113.632 -170.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -90.24 -13.98 34.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.96 0.904 . . . . 51.109999999999999 112.03 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.42 12.9 12.48 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 114.501 0.561 . . . . 63.329999999999998 114.501 176.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -74.16 146.45 43.46 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.941 0.87 . . . . 74.109999999999999 111.254 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.4 150.3 24.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.931 0.892 . . . . 73.109999999999999 109.269 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 28.7 p90 -173.14 130.16 0.47 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.993 0.808 . . . . 74.420000000000002 109.492 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 217' ' ' LEU . 79.2 t -70.8 -53.78 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.092 -1.077 . . . . 73.319999999999993 108.092 163.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.6 m -103.08 138.99 39.19 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.674 -1.603 . . . . 74.010000000000005 110.147 -170.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.0 t -68.55 -10.46 55.86 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.041 0.936 . . . . 73.340000000000003 112.45 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.0 -29.36 61.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.306 1.042 . . . . 71.340000000000003 112.423 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.31 116.56 7.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.611 0.364 . . . . 75.340000000000003 110.219 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.51 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 95.7 mtt180 -97.98 132.2 43.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.696 0.798 . . . . 73.349999999999994 109.305 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -113.11 156.67 22.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.196 0.998 . . . . 72.329999999999998 109.371 -173.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -78.43 -29.83 47.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.726 -0.67 . . . . 74.209999999999994 109.844 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 35.2 p -137.34 159.15 42.76 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.852 0.834 . . . . 71.409999999999997 112.153 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.46 HD12 HG12 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -64.14 -31.64 72.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.809 1.243 . . . . 75.420000000000002 110.099 177.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.88 -37.83 80.47 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.09 0.556 . . . . 64.25 111.299 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -77.79 -32.17 52.3 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.706 -0.679 . . . . 70.430000000000007 111.335 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 205' ' ' VAL . 18.3 tp -54.69 -55.52 28.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.894 -0.41 . . . . 73.230000000000004 109.894 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.72 -44.38 98.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 O-C-N 124.251 0.969 . . . . 65.409999999999997 110.453 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -61.09 -57.7 11.46 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 123.451 0.469 . . . . 73.409999999999997 111.982 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -62.32 -38.75 90.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.052 -0.522 . . . . 75.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.632 ' HB3' HD13 ' A' ' 228' ' ' LEU . 16.2 m170 -84.84 -6.59 59.35 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.518 0.562 . . . . 74.010000000000005 112.518 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 86.7 p -95.75 -29.25 14.36 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.742 0.417 . . . . 75.310000000000002 111.16 172.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 38.0 p -81.55 -43.19 19.06 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.323 -0.398 . . . . 72.319999999999993 110.72 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 226' ' ' ASP . 28.9 m -126.65 160.84 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.405 0.682 . . . . 75.430000000000007 111.644 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.78 13.83 1.55 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.372 1.869 . . . . 70.319999999999993 114.624 -170.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.5 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.2 t70 -41.95 29.63 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 131.207 3.803 . . . . 74.239999999999995 120.148 -151.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.14 9.97 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 120.573 -1.329 . . . . 75.329999999999998 112.579 -169.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.632 HD13 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -90.56 162.56 14.95 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.762 1.225 . . . . 73.109999999999999 108.79 166.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.83 -36.57 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.474 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.2 t -159.84 -178.71 7.25 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.562 0.745 . . . . 74.420000000000002 110.483 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.5 p -66.99 143.34 56.85 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.114 0.965 . . . . 74.099999999999994 111.844 175.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.461 HD22 ' HE1' ' A' ' 193' ' ' TYR . 41.8 mt -74.89 146.44 41.88 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 107.802 -1.184 . . . . 73.510000000000005 107.802 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -147.72 -45.68 0.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 120.134 1.334 . . . . 72.209999999999994 113.833 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -112.55 133.31 21.87 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.323 0.649 . . . . 74.25 109.445 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 67.5 Cg_endo -87.39 124.45 2.01 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.388 2.059 . . . . 74.549999999999997 110.259 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.413 ' HB2' HD21 ' A' ' 160' ' ' LEU . . . -62.39 144.36 95.29 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.002 -0.74 . . . . 75.530000000000001 109.002 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.457 ' O ' HD23 ' A' ' 159' ' ' LEU . 86.8 Cg_endo -75.81 -178.82 4.61 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.242 1.961 . . . . 74.230000000000004 112.718 -177.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -85.48 138.12 32.44 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.637 -1.245 . . . . 74.329999999999998 107.637 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.405 ' HB3' HD21 ' A' ' 159' ' ' LEU . 15.0 ptt180 -90.42 -57.33 2.87 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.351 0.978 . . . . 74.299999999999997 111.257 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -106.78 136.68 46.18 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.156 0.583 . . . . 73.150000000000006 110.443 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.407 ' HZ1' ' HB2' ' A' ' 90' ' ' ASP . 95.8 mttt -82.85 116.96 66.92 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.076 -1.453 . . . . 74.340000000000003 107.076 162.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.03 127.63 15.21 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.896 3.064 . . . . 75.409999999999997 113.901 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.5 m -75.1 122.01 22.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.939 0.495 . . . . 74.010000000000005 111.13 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.458 HG12 ' HZ2' ' A' ' 118' ' ' TRP . 95.2 t -94.2 120.99 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.281 -1.007 . . . . 73.239999999999995 108.281 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -105.17 112.53 25.69 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.608 -0.516 . . . . 71.230000000000004 109.608 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.54 -28.44 0.22 Allowed Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.514 2.166 . . . . 73.230000000000004 118.514 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.1 m -72.03 132.0 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 118.856 1.328 . . . . 75.510000000000005 114.359 -160.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.8 t -73.45 122.99 88.99 Favored Pre-proline 0 C--N 1.355 0.83 0 N-CA-C 106.288 -1.745 . . . . 70.040000000000006 106.288 160.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 C--N 1.375 1.944 0 C-N-CA 121.833 1.688 . . . . 72.200000000000003 113.838 -158.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.2 t90 . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.167 0.508 . . . . 74.430000000000007 111.376 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 29.7 p-10 -88.09 -22.66 24.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.684 -0.689 . . . . 72.040000000000006 109.264 165.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.4 m -67.64 2.85 1.63 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.776 1.23 . . . . 74.329999999999998 113.381 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -70.01 -26.96 64.3 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.995 0.518 . . . . 72.310000000000002 110.997 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 13.2 pt-20 -77.54 -21.64 52.27 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.095 0.474 . . . . 74.040000000000006 110.327 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -91.66 -2.34 57.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.818 1.247 . . . . 62.509999999999998 110.827 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.31 -47.76 80.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.241 1.017 . . . . 75.530000000000001 111.733 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.1 mt -99.15 26.6 5.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.421 0.688 . . . . 72.340000000000003 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.19 0.596 . . . . 74.209999999999994 111.724 178.408 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.036 0.446 . . . . 75.049999999999997 111.47 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 tp -89.55 122.12 32.41 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.734 -0.839 . . . . 74.340000000000003 108.734 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -108.87 174.52 5.83 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.811 1.244 . . . . 71.439999999999998 109.099 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.96 138.88 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.109 1.364 . . . . 72.439999999999998 108.957 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.02 114.18 14.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 75.25 110.517 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.24 -35.62 66.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.288 0.635 . . . . 72.129999999999995 111.071 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 32.5 m-85 -122.96 143.96 49.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.512 -0.921 . . . . 75.510000000000005 108.512 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 6.3 p-10 -70.42 148.05 48.79 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 109.178 -0.675 . . . . 74.549999999999997 109.178 167.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.6 t80 -147.17 141.57 26.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.127 -1.064 . . . . 72.219999999999999 108.127 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.7 139.97 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.236 -1.024 . . . . 72.019999999999996 108.236 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.22 115.72 3.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.536 0.734 . . . . 75.209999999999994 111.009 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -93.24 -55.93 3.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.328 1.051 . . . . 75.430000000000007 109.704 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.54 -173.44 38.32 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.398 -0.819 . . . . 65.030000000000001 113.452 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.68 -38.94 80.73 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.278 1.031 . . . . 75.239999999999995 111.759 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -98.95 -12.85 20.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.906 0.882 . . . . 74.319999999999993 112.036 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.4 p -72.33 135.04 45.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.784 -0.451 . . . . 64.319999999999993 109.784 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.602 ' HB3' HG13 ' A' ' 130' ' ' VAL . 66.4 tp -103.42 130.91 50.85 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.411 0.684 . . . . 73.319999999999993 110.394 -174.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -70.94 125.74 27.67 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.722 -0.844 . . . . 74.430000000000007 108.722 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.591 HG21 HG21 ' A' ' 123' ' ' THR . 22.8 pt -125.47 144.86 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.604 0.762 . . . . 74.209999999999994 110.08 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 10.1 m -88.72 144.94 25.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.676 -0.861 . . . . 74.150000000000006 108.676 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 62.5 tttp -65.69 110.97 2.97 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.796 0.438 . . . . 63.509999999999998 110.616 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.13 -10.88 55.28 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.013 -0.54 . . . . 61.409999999999997 112.931 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.5 tt0 -71.27 130.84 42.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.784 0.834 . . . . 75.420000000000002 110.533 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -77.27 147.63 36.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.953 -0.758 . . . . 74.219999999999999 108.953 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -147.98 142.2 26.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.798 0.439 . . . . 65.329999999999998 111.222 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 19.6 tpp180 -89.12 107.26 18.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.526 -0.761 . . . . 72.510000000000005 109.214 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.504 HG11 ' HB1' ' A' ' 119' ' ' ALA . 77.7 t -88.81 102.59 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.443 -0.577 . . . . 64.319999999999993 109.443 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.528 HD22 ' HG3' ' A' ' 122' ' ' GLN . 2.2 mm? -67.53 -41.06 84.96 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.17 -0.923 . . . . 74.25 110.153 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.45 151.15 11.6 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.321 -0.854 . . . . 64.319999999999993 112.201 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.567 ' CE2' ' HB3' ' A' ' 119' ' ' ALA . 56.7 m-85 -88.35 174.45 8.15 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.791 0.836 . . . . 71.239999999999995 110.633 174.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -80.22 -176.34 5.54 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.614 -0.721 . . . . 71.0 109.217 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -54.63 -36.59 64.68 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.043 0.937 . . . . 75.420000000000002 113.296 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -112.48 10.46 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.077 0.769 . . . . 74.340000000000003 113.077 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.52 26.14 74.52 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.978 0.751 . . . . 70.310000000000002 114.978 171.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -80.81 -65.74 0.97 Allowed 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 109.027 -0.731 . . . . 71.329999999999998 109.027 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 73.8 m95 -90.59 150.94 21.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.015 0.926 . . . . 71.200000000000003 111.082 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.567 ' HB3' ' CE2' ' A' ' 112' ' ' TYR . . . -137.64 132.2 32.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.959 0.903 . . . . 71.120000000000005 110.641 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -76.85 107.48 9.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.889 -0.782 . . . . 70.219999999999999 108.889 167.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . . . -112.52 149.71 32.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.989 0.916 . . . . 62.030000000000001 110.89 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.528 ' HG3' HD22 ' A' ' 110' ' ' LEU . 56.1 mt-30 -112.39 123.15 49.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.899 0.879 . . . . 74.5 109.498 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.591 HG21 HG21 ' A' ' 101' ' ' ILE . 44.1 p -124.01 174.78 7.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.716 1.207 . . . . 74.230000000000004 110.824 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -58.05 -27.31 63.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.68 1.192 . . . . 73.400000000000006 110.696 167.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.79 -30.87 59.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.525 1.13 . . . . 72.120000000000005 111.299 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 138.03 -177.23 20.16 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.188 -0.229 . . . . 51.229999999999997 112.921 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -86.79 138.9 31.21 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.921 0.488 . . . . 70.430000000000007 109.948 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -178.33 -173.48 43.75 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.243 -0.743 . . . . 71.439999999999998 111.243 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.405 ' HE3' ' HB3' ' A' ' 118' ' ' TRP . 32.7 m95 -110.76 120.79 43.57 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.513 0.725 . . . . 74.329999999999998 111.426 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 99' ' ' LEU . 31.0 m -127.99 143.33 47.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 125.207 1.403 . . . . 73.209999999999994 108.969 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 4.6 Cg_endo -86.07 156.25 9.84 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.385 2.057 . . . . 72.319999999999993 114.39 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.3 m -36.5 -40.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 127.038 2.135 . . . . 64.319999999999993 114.691 170.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -65.98 -22.21 66.45 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.326 0.65 . . . . 71.400000000000006 111.977 -172.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.433 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 38.1 m-85 -98.6 -20.04 17.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.806 0.842 . . . . 73.150000000000006 112.387 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -122.8 171.11 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.332 0.653 . . . . 73.540000000000006 112.249 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.4 t -161.3 153.9 17.19 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.353 -0.98 . . . . 72.010000000000005 108.353 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.23 149.36 45.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 121.743 1.629 . . . . 74.209999999999994 112.351 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.88 -12.63 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.94 0.876 . . . . 75.409999999999997 109.852 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -87.22 -6.15 58.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.082 0.953 . . . . 73.25 111.516 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.3 p -89.11 174.26 7.98 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.924 0.489 . . . . 70.239999999999995 111.553 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.17 -23.63 30.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.507 -0.77 . . . . 72.030000000000001 110.849 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.64 -22.19 64.42 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.828 0.851 . . . . 74.409999999999997 111.929 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -59.55 -22.14 61.27 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.054 0.541 . . . . 75.439999999999998 111.91 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -82.55 139.59 33.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.522 0.729 . . . . 74.340000000000003 110.399 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.6 p -60.02 -42.17 93.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.695 1.198 . . . . 64.439999999999998 112.353 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -65.99 -38.42 88.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.734 0.813 . . . . 75.439999999999998 112.568 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.12 109.96 15.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.386 -0.598 . . . . 71.140000000000001 109.386 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.401 ' HB2' HG23 ' A' ' 151' ' ' VAL . 28.5 m170 -104.71 -9.78 17.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.009 0.524 . . . . 74.409999999999997 111.832 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.54 -132.26 27.14 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 118.208 -1.329 . . . . 72.540000000000006 112.294 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.88 95.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.254 2.636 . . . . 73.230000000000004 112.764 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.593 HG22 ' HE ' ' A' ' 239' ' ' ARG . 46.9 t -136.95 126.94 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.431 1.093 . . . . 62.030000000000001 108.956 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.6 p -76.29 172.51 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.307 0.643 . . . . 71.530000000000001 110.762 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -62.8 -48.46 79.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.739 0.416 . . . . 73.299999999999997 109.903 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -59.17 -35.88 74.32 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.113 0.883 . . . . 72.230000000000004 111.089 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -67.64 -47.84 68.41 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.602 -0.726 . . . . 72.450000000000003 111.182 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.36 86.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.409 -0.814 . . . . 73.319999999999993 110.798 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -81.94 -20.27 39.01 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.154 -0.93 . . . . 74.340000000000003 111.914 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.426 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -81.03 -24.7 37.7 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.156 0.889 . . . . 74.510000000000005 111.063 174.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 239' ' ' ARG . 65.4 mt -71.35 -46.24 60.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 74.519999999999996 110.12 168.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 40.4 mt -92.47 20.33 6.33 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.128 -0.942 . . . . 74.239999999999995 111.935 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.6 p -90.4 -37.66 13.83 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.392 -0.596 . . . . 64.430000000000007 109.392 166.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.0 p -96.38 -11.64 25.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.458 0.703 . . . . 63.509999999999998 111.179 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.67 166.21 35.66 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 123.439 0.462 . . . . 64.340000000000003 113.89 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 pt -98.35 -178.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.83 0.852 . . . . 73.349999999999994 111.703 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -68.03 125.66 27.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.97 -0.559 . . . . 72.319999999999993 109.98 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.93 9.65 65.66 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-O 119.084 -0.842 . . . . 73.219999999999999 112.794 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.8 m -75.56 135.76 40.56 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 118.093 0.947 . . . . 75.349999999999994 110.396 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 183' ' ' SER . 17.1 p90 -147.28 162.96 37.88 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.708 0.403 . . . . 72.5 110.63 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -160.51 148.33 16.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.537 -0.756 . . . . 71.400000000000006 109.324 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.634 HG23 HG12 ' A' ' 182' ' ' ILE . 70.8 t -101.55 125.17 55.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.168 -1.049 . . . . 72.340000000000003 108.168 169.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.549 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt180 -115.67 151.11 35.66 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.255 1.022 . . . . 71.329999999999998 108.418 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.96 149.96 36.51 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.573 -1.269 . . . . 73.549999999999997 107.573 165.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.6 t -81.04 120.85 25.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.111 0.564 . . . . 73.150000000000006 110.37 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.72 -36.03 77.82 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.152 0.981 . . . . 73.329999999999998 109.862 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.3 m -68.47 -34.04 75.24 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.631 0.773 . . . . 64.530000000000001 111.642 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.5 m -140.98 91.6 8.93 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.381 0.673 . . . . 72.420000000000002 110.969 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.1 124.93 17.46 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.158 2.572 . . . . 72.219999999999999 112.545 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.58 -28.92 11.84 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.815 -0.436 . . . . 63.310000000000002 112.76 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -74.38 116.69 15.34 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.844 -0.799 . . . . 75.129999999999995 108.844 173.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.49 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 72.3 mtt85 -123.84 144.35 49.79 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.462 0.705 . . . . 74.519999999999996 109.252 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.1 m -138.26 146.28 42.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.063 -0.971 . . . . 74.099999999999994 108.561 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.634 HG12 HG23 ' A' ' 170' ' ' VAL . 28.5 mt -100.41 149.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 106.589 -1.634 . . . . 74.510000000000005 106.589 168.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.1 m -124.52 120.07 30.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.474 -1.306 . . . . 73.219999999999999 107.474 170.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.6 tp -114.07 112.01 22.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.828 0.74 . . . . 74.420000000000002 110.399 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 32.9 ttt85 -78.07 114.44 16.96 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 109.258 -0.645 . . . . 72.340000000000003 109.258 165.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -136.9 132.3 34.31 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.08 -1.082 . . . . 75.530000000000001 108.08 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 59.36 28.59 17.98 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.7 1.2 . . . . 64.540000000000006 111.488 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.19 -9.81 56.14 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.889 -0.596 . . . . 72.120000000000005 114.034 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -96.49 124.1 40.37 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.085 0.954 . . . . 74.150000000000006 108.781 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.82 108.08 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 120.913 0.387 . . . . 74.120000000000005 110.104 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.99 151.07 21.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.56 1.144 . . . . 74.319999999999993 108.706 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -128.15 116.75 20.42 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.593 -0.521 . . . . 72.319999999999993 109.593 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.496 ' HE1' HD22 ' A' ' 232' ' ' LEU . 4.5 m-85 -95.74 149.59 21.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.412 1.085 . . . . 74.040000000000006 108.74 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -107.26 116.12 31.38 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.039 0.536 . . . . 74.409999999999997 109.577 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 45.3 mt -81.92 105.28 11.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.564 -0.902 . . . . 73.319999999999993 108.564 172.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -90.57 144.62 25.59 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.918 0.887 . . . . 71.049999999999997 109.288 173.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.8 m -98.39 128.97 45.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.903 0.881 . . . . 53.229999999999997 109.163 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 160.56 31.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.619 0.768 . . . . 71.420000000000002 109.951 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 40.9 p -62.64 -24.44 67.6 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.864 0.69 . . . . 73.010000000000005 112.864 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.07 -17.31 27.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.416 0.686 . . . . 75.349999999999994 111.372 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.55 14.02 9.17 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.451 0.94 . . . . 75.319999999999993 115.451 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -68.87 156.05 39.14 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.244 1.022 . . . . 74.439999999999998 110.492 170.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 146.8 34.2 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.413 -0.958 . . . . 63.340000000000003 108.413 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 30.7 p90 -167.97 141.52 3.32 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.681 0.613 . . . . 73.230000000000004 112.069 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.402 ' HB ' ' CE1' ' A' ' 221' ' ' HIS . 75.4 t -88.89 -31.87 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.186 -0.915 . . . . 72.540000000000006 108.87 162.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.7 m -105.54 123.04 47.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.301 1.04 . . . . 73.420000000000002 109.383 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -66.54 -24.7 66.41 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.163 0.585 . . . . 74.349999999999994 111.735 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.72 -15.18 57.15 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.41 1.084 . . . . 75.439999999999998 110.577 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.5 m -133.67 89.42 2.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.772 0.829 . . . . 74.549999999999997 109.338 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.47 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 52.9 mtt180 -97.11 120.04 36.71 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.725 0.81 . . . . 75.239999999999995 109.288 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.22 146.86 32.19 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.642 -0.873 . . . . 75.329999999999998 108.642 -174.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.21 -30.2 70.61 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 123.764 0.665 . . . . 72.209999999999994 111.622 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 75.2 p -132.08 158.79 40.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.32 0.648 . . . . 75.439999999999998 111.902 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.77 -28.56 67.71 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.471 1.108 . . . . 75.120000000000005 109.688 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.47 83.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.312 0.645 . . . . 73.310000000000002 110.668 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -77.33 -28.3 53.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.677 0.791 . . . . 72.209999999999994 111.666 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 12.4 tp -58.33 -57.64 12.02 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.541 0.336 . . . . 75.409999999999997 110.254 170.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.54 -38.28 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.892 0.745 . . . . 63.32 110.739 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.15 -56.33 23.49 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.789 0.681 . . . . 73.019999999999996 111.301 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -65.21 -33.54 76.25 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.406 0.682 . . . . 73.310000000000002 110.844 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.684 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.6 m170 -89.29 -8.39 53.46 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.138 -0.483 . . . . 71.209999999999994 112.115 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.6 p -97.52 -22.89 16.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.041 0.537 . . . . 72.310000000000002 110.775 170.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 44.6 p -82.25 -43.2 17.9 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.796 0.439 . . . . 54.340000000000003 111.051 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.526 HG23 ' HB2' ' A' ' 226' ' ' ASP . 32.0 m -130.32 167.71 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.844 0.83 . . . . 73.420000000000002 111.57 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -80.48 13.93 2.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.839 2.056 . . . . 52.439999999999998 114.549 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.526 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.6 t70 -40.98 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 131.18 3.792 . . . . 73.530000000000001 119.82 -150.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.48 -3.94 10.22 Favored Glycine 0 N--CA 1.481 1.639 0 O-C-N 119.438 -2.039 . . . . 72.349999999999994 112.133 -166.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.684 HD11 ' HB3' ' A' ' 221' ' ' HIS . 9.8 mt -89.59 162.49 15.62 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 125.139 1.375 . . . . 75.099999999999994 109.285 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.8 tt -57.5 -39.17 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-O 120.588 0.232 . . . . 75.219999999999999 110.499 168.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -162.64 175.62 11.2 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.492 0.717 . . . . 73.349999999999994 110.906 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.8 p -60.42 144.55 50.76 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.613 1.165 . . . . 73.409999999999997 112.209 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.496 HD22 ' HE1' ' A' ' 193' ' ' TYR . 78.4 mt -77.65 116.4 18.17 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.692 0.797 . . . . 64.209999999999994 109.353 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -104.94 -79.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.787 0.435 . . . . 74.450000000000003 111.308 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 167' ' ' SER . 46.3 t80 -90.39 121.52 68.38 Favored Pre-proline 0 C--O 1.213 -0.844 0 C-N-CA 123.7 0.8 . . . . 70.319999999999993 109.486 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.21 134.32 10.26 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.001 1.8 . . . . 71.219999999999999 111.228 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.17 151.35 92.42 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.492 0.717 . . . . 64.120000000000005 109.573 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -85.45 169.15 9.74 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.446 2.097 . . . . 73.120000000000005 113.873 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -59.05 119.19 6.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.006 0.922 . . . . 72.340000000000003 109.041 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.593 ' HE ' HG22 ' A' ' 151' ' ' VAL . 22.9 ptt85 -78.94 -59.67 2.69 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.794 1.035 . . . . 74.140000000000001 113.794 -161.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -106.98 122.0 45.58 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.84 0.856 . . . . 65.209999999999994 109.0 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.69 113.75 22.57 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 106.953 -1.499 . . . . 74.209999999999994 106.953 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.58 129.32 17.58 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.812 2.341 . . . . 74.519999999999996 112.521 -166.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.8 m -68.81 113.5 6.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.312 -0.858 . . . . 71.329999999999998 110.667 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.56 117.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.601 -1.259 . . . . 74.200000000000003 107.601 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -96.03 110.39 22.64 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 118.927 -0.558 . . . . 75.430000000000007 110.707 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 63.42 -38.19 0.08 OUTLIER Glycine 0 CA--C 1.55 2.26 0 N-CA-C 118.639 2.216 . . . . 60.200000000000003 118.639 166.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.96 125.51 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.809 0.844 . . . . 75.25 113.226 -154.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.4 t -86.83 142.66 34.51 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 107.389 -1.338 . . . . 72.049999999999997 107.389 150.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 C--N 1.375 1.968 0 CA-C-N 120.834 1.334 . . . . 75.299999999999997 114.019 -167.561 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 5.4 t90 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 121.585 0.707 . . . . 73.439999999999998 109.611 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -85.65 -17.79 35.08 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.966 -1.015 . . . . 74.540000000000006 110.249 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.0 p -87.42 5.42 38.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.952 0.901 . . . . 74.239999999999995 111.684 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -64.34 -30.32 71.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.745 0.418 . . . . 73.319999999999993 111.553 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.555 ' HG3' HD21 ' A' ' 72' ' ' ASN . 11.6 pt-20 -65.24 -33.16 75.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.166 -0.47 . . . . 75.310000000000002 110.482 172.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.555 HD21 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -75.97 -17.95 59.51 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.575 0.75 . . . . 74.319999999999993 111.369 177.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.4 tp -55.48 -51.66 66.22 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.093 0.557 . . . . 74.109999999999999 110.73 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.11 14.84 23.71 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.448 0.699 . . . . 74.409999999999997 111.213 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 C-N-CA 122.477 0.311 . . . . 72.519999999999996 111.261 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.429 0.157 . . . . 73.109999999999999 110.945 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -86.6 130.85 34.33 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 109.202 -0.666 . . . . 74.549999999999997 109.202 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -108.82 174.12 6.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.568 1.147 . . . . 75.230000000000004 108.975 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.44 139.36 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.666 1.186 . . . . 63.43 108.616 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.5 127.51 32.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.515 0.726 . . . . 71.340000000000003 110.739 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 143' ' ' LYS . 91.2 mt -83.55 -32.82 25.64 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.773 0.829 . . . . 74.140000000000001 111.916 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.426 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 25.8 m-85 -125.05 157.18 36.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.253 0.621 . . . . 74.219999999999999 109.485 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.62 119.16 23.93 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.384 -0.969 . . . . 71.530000000000001 108.384 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.597 ' HB3' HG12 ' A' ' 101' ' ' ILE . 79.7 t80 -119.03 138.62 52.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.532 -0.914 . . . . 72.040000000000006 108.532 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -104.95 131.08 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.437 -0.949 . . . . 73.010000000000005 108.437 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.26 56.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.23 0.612 . . . . 62.43 111.092 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -86.83 -42.94 12.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.414 0.686 . . . . 52.109999999999999 109.689 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.76 -167.77 11.17 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.584 -0.734 . . . . 71.099999999999994 112.561 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.92 -37.87 85.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.129 0.972 . . . . 71.239999999999995 110.835 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -66.91 -21.01 66.01 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.259 -1.337 . . . . 74.340000000000003 112.222 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.0 p -100.39 -179.15 4.03 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.842 0.857 . . . . 73.129999999999995 110.484 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.638 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 62.9 tp -144.31 139.69 28.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.917 0.487 . . . . 75.239999999999995 111.073 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 m -85.35 132.9 34.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.442 0.697 . . . . 74.430000000000007 109.7 174.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.597 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -133.01 148.8 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 120.953 0.406 . . . . 75.099999999999994 111.621 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.8 m -99.3 150.23 22.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.076 0.95 . . . . 75.040000000000006 108.73 174.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -64.84 126.92 29.47 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.739 -0.467 . . . . 73.129999999999995 109.739 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.02 -14.13 64.19 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.127 -0.488 . . . . 75.120000000000005 112.575 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 39.2 tt0 -74.76 128.0 34.5 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.794 0.838 . . . . 73.349999999999994 110.774 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.88 134.68 35.08 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.412 0.685 . . . . 71.120000000000005 110.325 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 0.4 OUTLIER -146.21 136.86 24.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.817 0.847 . . . . 74.319999999999993 110.631 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -96.65 115.12 26.9 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.506 0.323 . . . . 72.420000000000002 110.602 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.508 HG11 ' HB2' ' A' ' 119' ' ' ALA . 52.7 t -74.58 110.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.424 0.63 . . . . 75.5 109.707 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.67 -32.13 60.04 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.246 -1.343 . . . . 74.099999999999994 110.044 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.54 155.34 11.17 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.231 -0.895 . . . . 72.129999999999995 111.878 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.594 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 43.0 m-85 -87.47 175.5 7.93 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.472 0.654 . . . . 72.219999999999999 111.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -85.38 -173.05 4.47 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.935 -1.029 . . . . 74.420000000000002 110.928 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -44.38 -44.17 8.12 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.472 1.509 . . . . 74.310000000000002 114.296 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -112.61 0.28 15.37 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.911 0.708 . . . . 75.409999999999997 112.911 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 81.83 22.69 59.24 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 115.313 0.885 . . . . 74.25 115.313 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.48 -65.44 1.0 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.98 0.89 . . . . 72.329999999999998 110.012 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 49.2 m95 -92.3 150.4 20.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.194 0.598 . . . . 74.510000000000005 111.369 -174.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.534 ' HB1' ' CE2' ' A' ' 112' ' ' TYR . . . -133.3 137.34 45.94 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.438 1.095 . . . . 71.439999999999998 110.193 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -78.37 98.8 6.11 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.292 -1.003 . . . . 73.409999999999997 108.292 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . . . -105.42 139.98 39.23 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.414 0.685 . . . . 64.129999999999995 110.339 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -102.27 105.7 16.39 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.216 -0.661 . . . . 71.310000000000002 109.216 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.456 HG21 HG23 ' A' ' 101' ' ' ILE . 69.4 p -80.4 168.42 19.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.952 0.783 . . . . 75.450000000000003 109.731 171.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -67.33 -8.19 30.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.607 -0.724 . . . . 75.420000000000002 111.537 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -91.4 -30.78 16.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.937 0.895 . . . . 74.019999999999996 110.958 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.28 174.68 24.64 Favored Glycine 0 C--N 1.36 1.886 0 N-CA-C 114.204 0.442 . . . . 73.450000000000003 114.204 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -86.62 142.49 28.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.809 0.843 . . . . 73.239999999999995 110.99 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -176.81 -170.01 38.8 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-N 114.945 -1.025 . . . . 75.230000000000004 110.646 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -109.77 129.34 55.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.817 0.808 . . . . 74.030000000000001 111.41 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 99' ' ' LEU . 27.6 m -136.07 145.21 51.43 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 124.698 1.199 . . . . 75.230000000000004 109.188 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 47.4 Cg_endo -88.44 156.35 6.57 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 122.541 2.161 . . . . 65.319999999999993 114.312 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 m -38.33 -43.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.611 1.964 . . . . 74.319999999999993 114.137 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.481 HD21 ' HB2' ' A' ' 242' ' ' PRO . 36.4 p-10 -72.23 -11.33 60.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.097 0.559 . . . . 75.120000000000005 112.057 -174.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 28.7 m-85 -105.9 -13.5 15.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.983 0.913 . . . . 74.310000000000002 112.581 176.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 130' ' ' VAL . 16.8 pt -130.98 172.83 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.373 0.669 . . . . 71.439999999999998 111.696 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -162.01 152.02 14.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 108.428 -0.953 . . . . 75.329999999999998 108.428 172.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.23 149.52 44.73 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.04 1.826 . . . . 71.420000000000002 112.065 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.17 -23.36 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.093 0.473 . . . . 73.340000000000003 110.531 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -69.69 -18.61 63.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.941 0.896 . . . . 64.409999999999997 112.291 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.2 p -77.93 166.16 23.21 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.157 0.799 . . . . 74.340000000000003 113.157 -167.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -84.52 -19.73 32.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.815 -1.084 . . . . 73.540000000000006 110.663 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -71.13 -24.15 62.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.294 1.037 . . . . 75.349999999999994 111.35 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.508 ' HA ' HD22 ' A' ' 88' ' ' LEU . 21.3 pttm -62.08 -18.64 61.37 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.44 0.696 . . . . 75.400000000000006 112.868 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -76.7 149.28 36.42 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.472 0.709 . . . . 72.310000000000002 110.418 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.4 p -61.72 -43.24 99.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.95 0.9 . . . . 73.230000000000004 111.456 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -68.89 -34.56 75.61 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.062 0.851 . . . . 74.299999999999997 113.103 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.92 113.92 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.148 -0.686 . . . . 75.140000000000001 109.148 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.412 ' HD2' ' HD3' ' A' ' 238' ' ' LYS . 29.8 m170 -110.94 3.59 18.93 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.633 0.605 . . . . 75.209999999999994 112.633 -175.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.58 -148.04 38.03 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-O 118.861 -0.966 . . . . 64.150000000000006 112.771 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.81 97.54 0.23 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.02 2.48 . . . . 74.319999999999993 111.952 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 61.0 t -131.89 129.28 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.666 0.787 . . . . 73.340000000000003 110.003 -175.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -79.36 172.34 13.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.55 0.74 . . . . 60.420000000000002 110.392 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -60.35 -47.62 85.27 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.645 0.378 . . . . 71.219999999999999 110.803 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -57.09 -41.59 79.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.652 0.781 . . . . 65.5 111.89 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.418 ' HB2' HG11 ' A' ' 151' ' ' VAL . . . -72.14 -34.25 68.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.763 0.425 . . . . 71.439999999999998 111.325 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.25 91.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.484 0.659 . . . . 75.540000000000006 110.915 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -79.6 -21.23 45.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.418 -0.81 . . . . 71.430000000000007 110.88 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -64.61 -42.06 95.78 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.221 0.608 . . . . 71.420000000000002 109.623 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.56 HD21 ' HA ' ' A' ' 239' ' ' ARG . 85.8 mt -64.76 -44.51 89.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.521 0.728 . . . . 70.219999999999999 111.692 174.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.5 13.72 13.15 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.959 -0.564 . . . . 74.239999999999995 112.17 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -65.39 -42.11 92.99 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.476 0.655 . . . . 72.209999999999994 110.002 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.3 p -102.58 19.61 18.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.59 1.156 . . . . 74.549999999999997 110.494 176.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.35 152.95 36.65 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.883 -0.599 . . . . 72.409999999999997 112.269 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 pt -102.31 -177.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.147 0.979 . . . . 74.200000000000003 110.709 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.41 120.95 10.29 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.176 0.59 . . . . 72.420000000000002 110.247 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.17 10.52 62.34 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.795 -0.639 . . . . 61.219999999999999 113.168 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 73.9 m -77.73 128.4 33.99 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.782 0.791 . . . . 72.319999999999993 110.044 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -139.69 164.34 30.2 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.381 0.61 . . . . 74.219999999999999 111.454 -170.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 236' ' ' ALA . 4.5 pp -160.2 154.92 24.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.464 -1.244 . . . . 75.549999999999997 108.968 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.602 HG21 HG12 ' A' ' 182' ' ' ILE . 87.5 t -110.14 127.93 66.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.533 -0.914 . . . . 75.140000000000001 108.533 168.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.542 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 20.4 ptt85 -115.66 155.36 27.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.41 -1.268 . . . . 75.230000000000004 108.514 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.52 147.46 40.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.257 -1.016 . . . . 74.439999999999998 108.257 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -87.33 129.08 35.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.687 -0.486 . . . . 70.239999999999995 109.687 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -80.7 -40.06 26.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.485 -0.779 . . . . 75.439999999999998 109.518 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.7 m -66.54 -33.07 74.85 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.999 0.92 . . . . 62.310000000000002 111.097 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -118.51 95.53 48.9 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 123.764 0.826 . . . . 74.349999999999994 109.529 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -58.14 126.55 21.89 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.322 2.681 . . . . 74.430000000000007 113.278 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.62 -27.52 8.66 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 116.242 -0.435 . . . . 62.530000000000001 113.152 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -66.65 136.3 55.35 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.353 0.661 . . . . 74.129999999999995 110.548 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -135.17 158.29 44.75 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.717 0.807 . . . . 72.230000000000004 109.793 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.4 m -147.37 150.1 34.05 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.432 1.093 . . . . 72.019999999999996 108.93 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.602 HG12 HG21 ' A' ' 170' ' ' VAL . 35.8 mt -103.93 149.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.954 -1.128 . . . . 73.420000000000002 107.954 173.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.2 m -125.09 110.85 14.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.286 -1.005 . . . . 74.209999999999994 108.286 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.1 tp -110.0 112.85 25.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.152 0.581 . . . . 74.120000000000005 110.104 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.502 ' HB2' HG21 ' A' ' 190' ' ' VAL . 39.1 ttt180 -78.47 114.79 17.69 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.268 0.556 . . . . 75.420000000000002 110.048 165.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.44 141.62 37.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.153 -1.385 . . . . 72.329999999999998 107.763 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 57.07 28.67 15.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.922 0.889 . . . . 75.099999999999994 111.575 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.42 -9.46 54.78 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-N 115.797 -0.638 . . . . 72.420000000000002 114.043 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -104.5 140.05 38.53 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.834 0.854 . . . . 74.340000000000003 109.839 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.502 HG21 ' HB2' ' A' ' 185' ' ' ARG . 48.9 t -98.77 106.51 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.852 0.461 . . . . 73.439999999999998 110.457 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -91.16 141.62 28.62 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.016 0.926 . . . . 75.140000000000001 109.115 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -114.88 118.58 33.9 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.713 0.405 . . . . 75.010000000000005 110.019 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.444 ' HE1' HD23 ' A' ' 232' ' ' LEU . 6.4 m-30 -94.02 149.78 20.93 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.05 0.94 . . . . 74.5 108.738 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -101.07 127.45 47.6 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.792 -0.818 . . . . 74.430000000000007 108.792 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 101.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.826 -1.176 . . . . 75.099999999999994 107.826 171.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -79.02 132.92 36.81 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.501 -0.772 . . . . 72.200000000000003 109.045 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.8 m -93.76 113.74 25.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.293 -1.003 . . . . 72.430000000000007 108.293 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.11 159.17 33.43 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.559 0.537 . . . . 71.120000000000005 111.257 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.5 p -66.8 -27.91 67.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.578 -0.737 . . . . 74.209999999999994 110.94 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.3 -1.05 48.33 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.985 0.914 . . . . 73.129999999999995 111.343 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 98.26 -7.92 62.36 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.822 -0.432 . . . . 75.310000000000002 114.116 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.33 133.49 34.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.652 0.726 . . . . 73.420000000000002 111.745 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.6 147.87 27.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.855 0.862 . . . . 75.019999999999996 108.913 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.3 p90 -166.53 151.46 7.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.967 0.413 . . . . 73.129999999999995 111.876 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 221' ' ' HIS . 59.8 t -99.19 -35.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.577 -0.897 . . . . 75.420000000000002 108.577 165.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -103.78 125.76 50.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.095 0.958 . . . . 73.510000000000005 109.252 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.9 t -63.01 -30.15 71.38 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 72.409999999999997 112.207 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.58 -26.9 61.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.624 0.769 . . . . 72.230000000000004 111.099 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.1 m -121.85 96.68 5.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 74.340000000000003 110.063 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.548 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.0 mtt180 -100.02 140.66 33.93 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.789 0.836 . . . . 75.150000000000006 109.195 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.572 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 3.1 m-85 -127.0 140.55 52.23 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.374 0.67 . . . . 72.230000000000004 109.818 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.19 -27.03 63.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.241 0.616 . . . . 74.329999999999998 110.289 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -133.29 153.72 51.32 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.813 0.845 . . . . 72.099999999999994 110.745 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.472 HD13 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -67.54 -21.52 65.46 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.128 -0.942 . . . . 75.310000000000002 109.708 172.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.01 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.9 0.88 . . . . 72.409999999999997 110.398 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.3 mt-10 -69.42 -37.04 77.25 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.289 -0.868 . . . . 74.420000000000002 111.338 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.17 -57.86 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.374 0.421 . . . . 71.310000000000002 111.152 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.9 -40.3 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.892 0.477 . . . . 73.0 111.355 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -59.15 -54.44 46.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.381 0.672 . . . . 74.340000000000003 111.004 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -63.76 -38.21 90.25 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.797 0.839 . . . . 72.450000000000003 110.925 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.676 ' HB3' HD13 ' A' ' 228' ' ' LEU . 11.0 m-70 -85.8 -8.24 58.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.922 0.489 . . . . 72.420000000000002 112.002 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.8 p -93.66 -28.9 15.72 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.627 0.371 . . . . 54.450000000000003 110.308 169.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.6 p -77.65 -40.71 40.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.322 0.249 . . . . 75.120000000000005 111.113 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.58 157.56 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.72 . . . . 74.340000000000003 111.487 -176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.59 10.24 18.57 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.08 1.752 . . . . 74.310000000000002 113.874 -173.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -45.96 32.78 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 130.799 3.64 . . . . 75.430000000000007 120.428 -155.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 127.84 -1.11 6.8 Favored Glycine 0 N--CA 1.464 0.564 0 O-C-N 120.925 -1.109 . . . . 50.100000000000001 112.788 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 221' ' ' HIS . 12.5 mt -91.58 161.38 14.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.51 1.124 . . . . 75.129999999999995 109.753 165.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -60.77 -36.37 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 120.816 0.341 . . . . 75.299999999999997 110.485 171.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.2 t -162.77 178.77 8.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.885 0.874 . . . . 75.530000000000001 109.471 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.5 p -63.78 143.77 57.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.24 0.616 . . . . 73.219999999999999 112.039 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.444 HD23 ' HE1' ' A' ' 193' ' ' TYR . 54.4 mt -69.5 138.15 53.12 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 108.159 -1.052 . . . . 75.150000000000006 108.159 169.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -135.95 -76.7 0.43 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.85 0.75 . . . . 75.120000000000005 112.238 -170.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -84.21 122.43 75.62 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.912 -0.773 . . . . 72.109999999999999 108.912 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.05 126.4 6.37 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 122.251 1.968 . . . . 64.420000000000002 111.918 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 169' ' ' LEU . . . -74.11 135.8 76.47 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.891 -0.781 . . . . 74.340000000000003 108.891 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.5 177.76 8.36 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.632 2.222 . . . . 52.5 112.322 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.412 ' HD3' ' HD2' ' A' ' 148' ' ' HIS . 72.5 mmtt -63.52 157.12 24.41 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.752 0.821 . . . . 74.209999999999994 109.971 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.56 ' HA ' HD21 ' A' ' 159' ' ' LEU . 29.3 ptt180 -91.13 -62.56 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.06 0.763 . . . . 74.109999999999999 113.06 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.546 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 24.8 t-20 -110.68 158.56 18.47 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.821 0.848 . . . . 74.109999999999999 108.794 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 114.55 57.37 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 106.131 -1.803 . . . . 74.400000000000006 106.131 156.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.481 ' HB2' HD21 ' A' ' 133' ' ' ASN . 36.6 Cg_endo -62.79 124.9 14.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.41 2.074 . . . . 72.420000000000002 112.19 -169.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 33.8 m -71.29 117.8 13.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.819 0.847 . . . . 75.420000000000002 110.646 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.43 HG12 ' CZ2' ' A' ' 118' ' ' TRP . 24.6 t -98.62 125.17 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.077 -1.083 . . . . 74.329999999999998 108.077 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.18 115.55 30.45 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.573 -0.251 . . . . 74.230000000000004 110.563 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.63 -3.36 0.25 Allowed Glycine 0 CA--C 1.54 1.626 0 N-CA-C 118.409 2.123 . . . . 63.409999999999997 118.409 161.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 11.9 m -91.53 122.99 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.372 1.586 . . . . 75.239999999999995 112.222 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 25.3 t -72.97 123.88 90.09 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 106.874 -1.528 . . . . 75.209999999999994 106.874 165.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo . . . . . 0 C--N 1.378 2.092 0 C-N-CA 122.321 2.014 . . . . 65.150000000000006 115.104 -153.795 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.3 t90 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 109.962 -0.385 . . . . 75.239999999999995 109.962 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -84.2 -36.08 23.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.314 0.646 . . . . 74.349999999999994 111.355 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.9 p -77.53 7.26 5.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.954 0.902 . . . . 72.120000000000005 112.702 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -62.04 -39.49 92.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.766 1.226 . . . . 73.409999999999997 111.21 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.0 -34.13 71.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 110.274 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -73.28 -12.86 61.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.398 0.679 . . . . 65.209999999999994 110.989 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.1 tp -67.29 -51.68 49.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.801 0.84 . . . . 72.030000000000001 111.868 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.4 mt -112.46 22.04 15.06 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.741 0.416 . . . . 72.219999999999999 110.133 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 62.409999999999997 112.036 177.071 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.7 t30 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.057 0.456 . . . . 73.319999999999993 110.744 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.9 tp -77.34 131.56 38.16 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.634 -0.666 . . . . 75.310000000000002 109.527 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -115.54 173.12 6.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.446 1.099 . . . . 74.329999999999998 109.84 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.73 138.96 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.003 1.321 . . . . 45.310000000000002 108.84 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HB1' HD23 ' A' ' 107' ' ' LEU . . . -79.72 138.23 37.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.511 0.724 . . . . 73.439999999999998 110.349 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 143' ' ' LYS . 82.7 mt -104.01 -35.48 8.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.728 0.811 . . . . 75.299999999999997 110.987 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.458 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 44.0 m-85 -122.48 140.93 52.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.194 -0.912 . . . . 74.5 108.874 -173.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HB2' ' HZ2' ' A' ' 241' ' ' LYS . 3.5 m-20 -68.5 124.87 24.75 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.984 -0.747 . . . . 75.310000000000002 108.984 171.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.624 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.2 t80 -114.24 139.45 49.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.261 -1.015 . . . . 74.310000000000002 108.261 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.97 131.82 59.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.523 -1.288 . . . . 74.340000000000003 107.523 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.71 119.13 4.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.839 0.855 . . . . 72.450000000000003 111.709 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.5 p -84.28 -27.31 27.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.498 0.719 . . . . 74.129999999999995 111.158 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -141.38 -169.62 11.96 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.805 -0.918 . . . . 71.540000000000006 110.805 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.68 -44.63 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.005 0.431 . . . . 74.439999999999998 111.257 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.473 HD22 ' HD2' ' A' ' 249' ' ' PRO . 26.5 p-10 -71.47 -24.68 62.04 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.151 -0.931 . . . . 63.439999999999998 111.657 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.0 p -79.99 160.28 25.96 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.332 0.653 . . . . 64.400000000000006 110.775 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.7 tp -133.44 136.4 45.16 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.968 0.507 . . . . 73.319999999999993 111.371 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 m -75.48 134.0 40.93 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.544 0.738 . . . . 63.420000000000002 111.312 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.624 HG12 ' HB3' ' A' ' 91' ' ' PHE . 21.8 pt -127.22 166.77 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.167 0.587 . . . . 74.329999999999998 111.818 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.0 m -126.42 157.19 39.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.727 -1.124 . . . . 62.240000000000002 110.479 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -47.29 119.57 2.71 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.227 1.011 . . . . 74.010000000000005 111.808 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.91 8.61 78.29 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 115.129 0.811 . . . . 71.239999999999995 115.129 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -68.53 122.24 18.06 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.268 0.627 . . . . 71.140000000000001 110.764 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -75.92 128.76 35.75 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.128 -0.693 . . . . 74.439999999999998 109.128 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.46 HD23 ' HB1' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -147.91 166.94 26.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.71 0.804 . . . . 75.329999999999998 110.783 -173.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -122.72 117.44 25.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.927 0.491 . . . . 75.230000000000004 110.151 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.531 HG11 ' HB1' ' A' ' 119' ' ' ALA . 41.6 t -81.05 112.38 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.196 0.598 . . . . 74.120000000000005 110.139 175.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.5 -35.17 40.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.442 -0.799 . . . . 71.420000000000002 109.965 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.98 147.56 6.09 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.437 0.461 . . . . 44.140000000000001 112.87 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.522 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 47.2 m-85 -86.95 162.78 17.49 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.381 0.672 . . . . 74.450000000000003 111.458 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -81.69 -173.73 4.6 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.302 -0.863 . . . . 71.200000000000003 110.361 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -52.5 -36.95 56.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.28 1.432 . . . . 74.040000000000006 113.838 -170.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -112.17 -3.76 14.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.471 0.708 . . . . 62.350000000000001 111.853 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 72.61 33.97 60.34 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.54 -0.589 . . . . 71.329999999999998 114.566 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -84.91 -38.39 19.44 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.402 0.601 . . . . 74.400000000000006 110.717 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 70.3 m95 -123.0 154.13 38.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.57 0.748 . . . . 74.439999999999998 110.561 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.531 ' HB1' HG11 ' A' ' 109' ' ' VAL . . . -134.35 132.4 39.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.027 0.931 . . . . 74.219999999999999 109.991 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.4 114.22 7.44 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 106.172 -1.788 . . . . 73.310000000000002 106.172 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.31 150.85 49.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 64.030000000000001 111.028 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -106.38 116.38 31.83 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.522 -1.288 . . . . 74.040000000000006 107.522 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.502 HG21 HG23 ' A' ' 101' ' ' ILE . 22.9 p -116.96 174.43 6.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.434 0.694 . . . . 74.120000000000005 110.167 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -62.85 -24.24 67.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.311 0.645 . . . . 74.129999999999995 110.22 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.06 -27.57 60.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.497 0.719 . . . . 74.519999999999996 111.608 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.75 -125.1 2.21 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 121.408 -0.425 . . . . 75.049999999999997 113.538 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -134.94 140.42 45.71 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.757 0.823 . . . . 70.450000000000003 110.499 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.51 176.87 23.09 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 113.709 0.243 . . . . 75.219999999999999 113.709 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -80.87 120.6 24.91 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.127 0.971 . . . . 74.030000000000001 112.28 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.434 HG23 HD12 ' A' ' 135' ' ' ILE . 4.2 m -121.79 139.63 30.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.312 1.045 . . . . 65.430000000000007 108.638 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 3.1 Cg_exo -76.05 143.45 25.86 Favored 'Trans proline' 0 CA--C 1.561 1.863 0 C-N-CA 122.631 2.221 . . . . 74.310000000000002 114.46 -172.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -39.54 -49.61 2.14 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.85 1.66 . . . . 64.430000000000007 113.469 168.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 18.6 p-10 -76.3 7.18 4.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.777 0.831 . . . . 73.019999999999996 112.581 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.501 ' HB3' HD13 ' A' ' 101' ' ' ILE . 16.5 m-85 -115.87 -9.12 11.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.349 1.06 . . . . 74.349999999999994 111.568 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 130' ' ' VAL . 10.8 pt -132.37 171.43 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.96 0.904 . . . . 75.109999999999999 111.215 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -164.17 152.18 10.91 Favored Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.479 -0.772 . . . . 74.150000000000006 109.151 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -58.15 157.85 24.02 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.441 2.094 . . . . 74.530000000000001 113.791 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.55 -8.28 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 123.271 0.628 . . . . 65.209999999999994 111.783 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -102.11 0.82 35.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 72.040000000000006 111.866 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.9 p -77.1 168.11 20.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.13 0.572 . . . . 63.109999999999999 112.197 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.22 -24.65 27.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.149 -0.478 . . . . 72.049999999999997 110.352 167.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.4 -23.59 66.34 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.366 0.666 . . . . 73.019999999999996 111.599 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.65 ' HA ' HD22 ' A' ' 88' ' ' LEU . 20.9 pttm -62.49 -18.21 61.38 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.761 0.663 . . . . 73.430000000000007 112.522 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.99 141.98 30.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.648 -0.705 . . . . 75.430000000000007 110.512 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 p -62.67 -40.14 96.14 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.379 1.049 . . . . 73.319999999999993 111.13 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -66.14 -37.58 86.05 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.163 0.801 . . . . 75.409999999999997 113.163 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 38.9 t80 -76.41 113.6 14.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.854 -0.424 . . . . 75.239999999999995 109.854 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -109.23 -5.24 15.98 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.086 0.554 . . . . 74.049999999999997 112.473 -177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.67 -145.68 42.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 118.652 -1.082 . . . . 71.239999999999995 112.843 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.35 94.88 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.06 2.507 . . . . 75.219999999999999 112.996 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 49.0 t -135.74 126.98 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.994 1.318 . . . . 74.319999999999993 109.257 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.9 p -83.92 175.44 9.58 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.912 0.885 . . . . 72.540000000000006 110.323 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -60.75 -40.4 92.29 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 119.467 -0.301 . . . . 75.239999999999995 110.934 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -53.54 -49.88 66.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.183 0.593 . . . . 71.099999999999994 110.923 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.477 ' HB2' HG13 ' A' ' 151' ' ' VAL . . . -71.0 -26.18 63.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.224 -0.898 . . . . 62.32 111.634 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.4 -46.45 60.22 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.067 0.547 . . . . 64.209999999999994 111.821 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.6 mm-40 -68.72 -32.91 73.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.559 -0.534 . . . . 73.450000000000003 109.559 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.08 -47.82 82.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.115 0.966 . . . . 72.209999999999994 110.664 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.425 HD11 HD22 ' A' ' 169' ' ' LEU . 12.9 mt -58.54 -45.43 88.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.875 0.87 . . . . 72.409999999999997 111.487 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.42 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 97.9 mt -92.99 8.0 41.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.749 0.648 . . . . 74.219999999999999 112.749 -176.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.4 p -64.05 -37.26 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 118.713 0.688 . . . . 70.409999999999997 110.377 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.4 p -101.93 18.44 20.6 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.138 0.975 . . . . 73.549999999999997 111.504 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.21 165.26 32.68 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.285 -0.416 . . . . 74.519999999999996 112.409 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.34 -179.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.58 0.752 . . . . 75.010000000000005 111.213 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.57 125.81 24.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.316 -0.856 . . . . 74.549999999999997 110.026 169.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.435 ' HA2' HD13 ' A' ' 184' ' ' LEU . . . 90.02 9.67 65.46 Favored Glycine 0 C--O 1.242 0.651 0 CA-C-O 119.192 -0.782 . . . . 64.319999999999993 113.022 -177.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.8 m -87.68 116.87 26.11 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 117.669 0.734 . . . . 75.120000000000005 110.526 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.419 ' HB3' HD11 ' A' ' 184' ' ' LEU . 21.0 p90 -128.24 167.92 16.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.936 0.495 . . . . 75.420000000000002 111.118 -172.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.425 HD22 HD11 ' A' ' 159' ' ' LEU . 4.3 pp -159.56 142.35 13.95 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.579 -0.737 . . . . 73.099999999999994 109.622 174.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.657 HG21 HG12 ' A' ' 182' ' ' ILE . 74.2 t -100.27 115.3 41.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.988 -1.116 . . . . 75.040000000000006 107.988 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.583 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 41.9 ptt85 -115.91 143.1 45.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.566 0.746 . . . . 74.25 109.074 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -94.1 149.15 21.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.534 -0.913 . . . . 72.400000000000006 108.534 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 t -76.28 127.5 33.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.176 0.59 . . . . 72.129999999999995 109.585 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.0 -31.46 70.3 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.685 -0.689 . . . . 75.25 109.419 171.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 34.0 m -66.17 -34.81 78.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.924 0.89 . . . . 73.510000000000005 111.132 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.9 p -148.21 93.41 4.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.084 0.553 . . . . 71.120000000000005 110.841 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.14 138.23 85.35 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.895 2.396 . . . . 73.400000000000006 112.379 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.84 -29.93 10.74 Favored Glycine 0 C--N 1.345 1.029 0 C-N-CA 123.324 0.488 . . . . 74.439999999999998 111.959 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -82.72 117.72 22.85 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.822 -0.807 . . . . 74.439999999999998 108.822 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.505 0.669 . . . . 75.099999999999994 110.446 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 61.4 m -140.52 149.28 42.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.775 1.23 . . . . 71.310000000000002 108.588 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.657 HG12 HG21 ' A' ' 170' ' ' VAL . 25.9 mt -102.42 146.3 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.684 -1.228 . . . . 72.299999999999997 107.684 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 46.3 m -124.29 107.98 11.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.881 -1.155 . . . . 71.219999999999999 107.881 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.435 HD13 ' HA2' ' A' ' 166' ' ' GLY . 45.5 tp -105.45 114.25 28.31 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.087 0.555 . . . . 75.439999999999998 110.507 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.42 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -76.92 116.72 17.84 Favored 'General case' 0 C--O 1.254 1.321 0 CA-C-O 121.43 0.633 . . . . 73.019999999999996 109.946 166.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -139.59 138.52 36.27 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.498 1.519 . . . . 73.549999999999997 107.462 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 59.67 22.02 10.74 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.927 0.891 . . . . 62.530000000000001 111.887 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.61 -12.63 55.69 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.345 -0.389 . . . . 72.420000000000002 113.869 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -98.99 144.93 27.59 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.547 0.739 . . . . 74.209999999999994 109.463 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.8 t -103.31 110.19 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.066 0.46 . . . . 74.209999999999994 110.532 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -96.94 124.51 40.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.849 1.259 . . . . 74.109999999999999 109.513 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -98.66 119.09 36.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.31 0.644 . . . . 73.450000000000003 111.286 -172.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.548 ' HE1' HD21 ' A' ' 232' ' ' LEU . 4.9 m-85 -95.42 150.72 19.98 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.574 -0.899 . . . . 75.5 108.574 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -106.81 125.3 50.83 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.276 -0.639 . . . . 73.450000000000003 109.276 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.4 mt -85.39 102.41 11.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.428 -0.953 . . . . 74.430000000000007 108.428 172.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -85.38 147.14 26.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.823 -1.08 . . . . 74.530000000000001 109.666 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -108.68 135.69 49.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.475 0.71 . . . . 75.450000000000003 109.648 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.9 176.88 7.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.578 0.751 . . . . 72.150000000000006 110.227 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.0 p -65.7 -28.91 69.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.208 0.603 . . . . 72.129999999999995 112.379 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -91.85 -17.34 25.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 75.319999999999993 110.243 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.11 9.21 16.1 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.914 -0.937 . . . . 72.219999999999999 114.847 175.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.72 130.21 45.36 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.3 1.05 . . . . 73.140000000000001 111.58 176.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -86.54 141.12 29.28 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.876 -1.157 . . . . 71.030000000000001 107.876 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.611 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.1 p90 -167.44 132.11 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.579 0.55 . . . . 73.239999999999995 110.961 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 217' ' ' LEU . 70.6 t -77.62 -38.0 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.688 -0.856 . . . . 74.329999999999998 108.688 164.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.7 m -105.54 123.38 47.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.625 -1.17 . . . . 64.129999999999995 109.513 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -64.24 -25.16 67.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.488 0.715 . . . . 74.310000000000002 112.489 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -77.3 -24.38 50.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.625 0.77 . . . . 75.409999999999997 110.946 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.8 m -129.68 100.43 5.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.186 0.594 . . . . 75.340000000000003 109.679 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.611 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 77.7 mtt180 -107.22 138.8 42.73 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 74.530000000000001 109.209 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -124.34 146.65 48.7 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.85 -37.56 87.84 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.933 0.771 . . . . 73.5 110.381 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -127.81 157.43 40.45 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.738 0.815 . . . . 74.430000000000007 111.609 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.81 -25.32 67.18 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.689 -1.141 . . . . 75.219999999999999 109.741 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.85 97.35 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.447 0.699 . . . . 72.349999999999994 111.019 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.38 -34.42 67.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.438 0.695 . . . . 75.010000000000005 111.48 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.488 HD13 ' HD1' ' A' ' 221' ' ' HIS . 14.9 tp -56.48 -54.57 44.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.815 0.446 . . . . 75.310000000000002 111.141 174.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.68 -38.41 82.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 O-C-N 123.776 0.673 . . . . 64.430000000000007 110.677 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -58.29 -57.31 13.46 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 75.329999999999998 111.253 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -63.14 -39.61 95.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.722 -0.672 . . . . 73.230000000000004 111.1 -176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.699 ' HB3' HD13 ' A' ' 228' ' ' LEU . 41.8 m80 -85.45 -6.09 59.24 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.323 0.49 . . . . 65.230000000000004 112.323 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 91.6 p -98.07 -14.42 20.49 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.027 0.376 . . . . 64.200000000000003 111.12 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 50.7 p -83.63 -40.05 19.49 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 110.23 -0.285 . . . . 73.150000000000006 110.23 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 226' ' ' ASP . 16.1 m -138.6 167.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 113.36 0.874 . . . . 73.219999999999999 113.36 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -81.53 13.24 3.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.983 2.113 . . . . 74.340000000000003 113.659 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.565 ' HB2' HG21 ' A' ' 224' ' ' VAL . 35.8 t70 -41.95 33.67 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 1 C-N-CA 132.091 4.156 . . . . 71.319999999999993 118.744 -158.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 126.35 -5.52 7.67 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 120.068 -1.645 . . . . 63.009999999999998 112.986 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.699 HD13 ' HB3' ' A' ' 221' ' ' HIS . 14.1 mt -90.45 161.09 15.7 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.447 1.099 . . . . 71.109999999999999 109.484 174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.7 tt -56.74 -36.36 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-O 120.958 0.409 . . . . 72.140000000000001 110.418 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.3 t -161.03 170.9 19.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.292 0.637 . . . . 65.349999999999994 110.189 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 29.5 m -63.1 138.33 58.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.513 1.125 . . . . 70.430000000000007 111.889 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.548 HD21 ' HE1' ' A' ' 193' ' ' TYR . 65.1 mt -73.43 135.06 44.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.263 -0.643 . . . . 73.209999999999994 109.263 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.82 -76.16 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.524 0.602 . . . . 73.430000000000007 110.809 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 167' ' ' SER . 19.9 t80 -85.4 121.39 73.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 108.393 -0.966 . . . . 75.129999999999995 108.393 -177.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.05 125.06 3.98 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.364 2.043 . . . . 75.519999999999996 111.396 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.1 134.53 94.5 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.773 -0.649 . . . . 60.149999999999999 110.076 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.67 -179.15 4.85 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.603 2.202 . . . . 74.439999999999998 111.988 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.34 152.07 45.96 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.151 0.58 . . . . 74.430000000000007 109.587 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -88.92 -62.21 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.532 0.567 . . . . 74.409999999999997 112.532 -172.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -111.24 149.05 31.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.283 0.633 . . . . 74.349999999999994 110.74 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.537 ' HZ2' ' HB2' ' A' ' 90' ' ' ASP . 99.9 mttt -83.57 114.88 56.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 106.807 -1.553 . . . . 75.010000000000005 106.807 160.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.519 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 19.5 Cg_exo -65.27 122.52 10.26 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.085 1.857 . . . . 62.229999999999997 111.817 -168.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.0 m -72.24 112.43 8.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.948 0.499 . . . . 75.109999999999999 110.233 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.29 106.69 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.571 -1.27 . . . . 75.439999999999998 107.571 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -85.5 114.82 22.82 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.702 0.401 . . . . 64.129999999999995 111.776 -161.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.12 0.42 0.71 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.645 1.818 . . . . 73.420000000000002 117.645 164.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.48 HG22 ' HE1' ' A' ' 118' ' ' TRP . 24.1 m -96.99 122.82 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.174 1.487 . . . . 65.340000000000003 112.801 -169.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.4 t -78.66 135.33 60.23 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 113.793 -1.549 . . . . 73.25 107.377 160.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.473 ' HD2' HD22 ' A' ' 97' ' ' ASN . 33.1 Cg_exo . . . . . 0 C--N 1.379 2.177 0 C-N-CA 121.137 1.225 . . . . 73.019999999999996 112.645 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 t90 . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 121.348 0.594 . . . . 73.219999999999999 110.516 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -82.76 -20.73 35.34 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.755 -0.657 . . . . 72.209999999999994 110.074 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 m -70.79 3.15 3.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.306 1.443 . . . . 75.120000000000005 112.886 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.89 -24.4 66.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.794 0.838 . . . . 74.430000000000007 111.612 175.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -81.85 -36.58 28.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.034 0.534 . . . . 71.209999999999994 110.126 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.81 -5.81 49.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.949 0.9 . . . . 62.409999999999997 110.528 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.3 tp -58.96 -51.01 71.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.685 1.194 . . . . 75.329999999999998 111.522 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.75 -53.2 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.014 0.526 . . . . 72.209999999999994 110.37 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.625 0.77 . . . . 75.25 111.897 -173.962 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.612 -0.144 . . . . 74.329999999999998 110.612 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -57.53 148.38 24.05 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 73.25 111.295 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -111.88 163.87 13.73 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.52 0.728 . . . . 74.129999999999995 109.653 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 138.58 46.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 124.423 1.089 . . . . 73.030000000000001 108.619 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.452 ' HB1' HD22 ' A' ' 107' ' ' LEU . . . -76.33 115.27 15.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.776 0.83 . . . . 74.409999999999997 109.481 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.525 HD13 ' HZ1' ' A' ' 238' ' ' LYS . 68.8 mt -71.98 -38.52 69.69 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.272 0.558 . . . . 74.450000000000003 110.698 175.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.55 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 6.0 m-85 -125.18 151.81 45.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.981 -1.008 . . . . 74.030000000000001 108.769 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.46 125.49 29.43 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.973 -0.751 . . . . 73.230000000000004 108.973 166.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.606 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.5 t80 -106.35 135.01 48.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.797 -1.186 . . . . 71.450000000000003 107.797 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -102.04 134.96 41.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.23 -1.026 . . . . 74.439999999999998 108.23 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.8 134.88 57.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.02 0.928 . . . . 70.329999999999998 111.822 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.5 p -98.82 -53.22 3.35 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.022 0.929 . . . . 74.430000000000007 109.071 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.73 176.28 33.45 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.116 -0.947 . . . . 61.119999999999997 111.747 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.59 -21.41 57.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.839 0.855 . . . . 72.439999999999998 111.521 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -93.55 -26.09 17.28 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.763 0.825 . . . . 72.420000000000002 111.656 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.3 p -73.03 134.83 44.78 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.111 -0.7 . . . . 74.409999999999997 109.111 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.638 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 63.6 tp -104.55 125.72 50.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.453 0.701 . . . . 72.450000000000003 110.561 -167.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -70.35 132.25 45.36 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.952 0.783 . . . . 74.329999999999998 109.842 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.712 HG22 HG23 ' A' ' 123' ' ' THR . 9.8 pt -119.13 148.82 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.728 -0.471 . . . . 71.239999999999995 109.728 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -86.3 149.48 25.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.625 0.77 . . . . 74.430000000000007 109.354 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.73 113.35 6.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.71 0.404 . . . . 74.120000000000005 110.318 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.79 61.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.379 -0.373 . . . . 73.310000000000002 112.927 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 36.6 tt0 -73.09 135.48 44.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.708 0.803 . . . . 75.120000000000005 111.801 -175.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -80.03 126.54 31.18 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.554 -0.906 . . . . 72.540000000000006 108.554 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.452 HD22 ' HB1' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -148.16 153.59 39.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.244 0.545 . . . . 72.420000000000002 110.8 -174.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -108.56 130.23 55.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.833 0.853 . . . . 73.439999999999998 108.965 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 119' ' ' ALA . 53.3 t -88.03 130.52 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.213 -1.032 . . . . 72.420000000000002 108.213 168.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' A' ' 120' ' ' GLU . 36.0 mt -92.67 -29.19 16.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.221 1.009 . . . . 74.209999999999994 109.623 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.54 145.36 4.44 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.207 -0.906 . . . . 74.109999999999999 111.547 175.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.678 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 62.3 m-85 -86.23 160.34 19.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.212 0.506 . . . . 74.219999999999999 110.033 173.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -83.34 -172.43 4.14 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 73.230000000000004 110.539 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -52.34 -41.46 63.04 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.268 1.027 . . . . 73.109999999999999 113.504 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -95.46 -2.41 48.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.407 0.683 . . . . 74.519999999999996 111.341 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 60.51 22.5 59.17 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.029 0.772 . . . . 61.100000000000001 115.029 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.02 -16.54 18.66 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.396 0.679 . . . . 74.010000000000005 110.82 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 56.2 m95 -131.53 143.4 50.35 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.068 0.947 . . . . 73.530000000000001 110.026 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.49 ' HB1' ' CD2' ' A' ' 112' ' ' TYR . . . -123.28 149.04 45.29 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.462 1.105 . . . . 74.519999999999996 110.042 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HG2' HD11 ' A' ' 110' ' ' LEU . 38.6 tt0 -82.85 107.73 15.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.469 -1.678 . . . . 72.329999999999998 106.469 164.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.45 152.53 40.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.419 0.628 . . . . 74.040000000000006 112.141 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -112.57 103.98 12.05 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.346 -1.297 . . . . 73.349999999999994 108.171 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.712 HG23 HG22 ' A' ' 101' ' ' ILE . 39.5 p -101.62 176.25 5.29 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.111 0.964 . . . . 75.430000000000007 110.206 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -71.56 -14.29 62.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.943 0.497 . . . . 70.439999999999998 110.265 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -85.28 -18.05 35.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.321 1.049 . . . . 73.340000000000003 111.187 172.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.25 -165.23 23.2 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-O 120.3 -0.167 . . . . 73.409999999999997 113.347 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -92.22 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.203 0.601 . . . . 72.340000000000003 111.393 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 176.01 -161.12 29.51 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.52 0.512 . . . . 54.350000000000001 112.443 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -112.11 120.46 41.9 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.34 0.656 . . . . 73.430000000000007 111.635 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.76 143.5 47.84 Favored Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 124.015 0.926 . . . . 73.340000000000003 109.923 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 83.1 Cg_endo -84.69 145.44 10.31 Favored 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 121.943 1.762 . . . . 75.109999999999999 114.827 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -38.68 -46.48 1.23 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.281 1.832 . . . . 74.540000000000006 114.526 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.482 HD21 ' HB2' ' A' ' 242' ' ' PRO . 30.0 p-10 -75.03 -7.66 54.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.857 0.863 . . . . 74.200000000000003 113.014 -169.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.55 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 29.4 m-85 -103.64 -10.61 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.388 0.675 . . . . 75.219999999999999 111.904 174.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.0 pt -123.78 170.84 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.92 0.888 . . . . 75.120000000000005 110.636 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 3.4 m -158.45 137.98 8.46 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.721 0.808 . . . . 71.129999999999995 109.941 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.53 136.71 47.55 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 121.686 1.591 . . . . 72.219999999999999 110.897 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.29 -11.79 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.167 0.987 . . . . 75.140000000000001 110.378 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -21.19 63.29 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.166 0.987 . . . . 74.219999999999999 112.177 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.413 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 91.7 p -109.61 -179.63 3.87 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.867 0.867 . . . . 64.129999999999995 111.852 -173.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.94 -22.84 36.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.535 1.134 . . . . 75.120000000000005 112.32 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.78 -12.4 61.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.943 0.897 . . . . 70.340000000000003 112.245 -173.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 140' ' ' SER . 20.8 pttm -63.82 -11.68 29.31 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.818 0.847 . . . . 74.219999999999999 111.911 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -99.63 146.64 26.24 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.867 0.867 . . . . 71.209999999999994 110.895 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -64.64 -33.94 77.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.156 -0.929 . . . . 70.040000000000006 112.517 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -72.93 -35.13 66.95 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.569 0.747 . . . . 75.430000000000007 112.471 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -80.29 103.02 9.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.825 -0.806 . . . . 73.310000000000002 108.825 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.455 ' HB2' HG22 ' A' ' 151' ' ' VAL . 52.8 m170 -95.59 -9.18 32.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.06 0.544 . . . . 72.230000000000004 112.056 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 -135.06 17.88 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-O 118.273 -1.293 . . . . 65.219999999999999 112.727 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.33 93.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.697 2.931 . . . . 74.329999999999998 113.127 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 75.4 t -139.64 132.39 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.915 1.286 . . . . 75.230000000000004 109.252 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.1 p -89.86 175.8 7.07 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.263 1.025 . . . . 74.340000000000003 109.896 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -58.2 -50.14 74.59 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.289 0.236 . . . . 74.329999999999998 111.111 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -55.49 -44.96 77.02 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.845 0.858 . . . . 60.439999999999998 111.145 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.58 84.33 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.397 -0.82 . . . . 55.32 110.751 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.0 80.41 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.946 0.898 . . . . 62.509999999999998 112.052 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -83.83 -21.16 32.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.757 -0.656 . . . . 75.209999999999994 111.759 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.402 ' OH ' ' HD2' ' A' ' 239' ' ' ARG . 0.1 OUTLIER -82.8 -19.36 37.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.27 0.557 . . . . 74.230000000000004 111.311 172.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 239' ' ' ARG . 51.6 mt -74.96 -42.97 56.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.344 -0.843 . . . . 64.129999999999995 110.669 168.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.538 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 89.0 mt -92.67 20.69 6.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.281 -0.872 . . . . 75.209999999999994 111.451 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 92.5 p -72.55 -40.19 66.9 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.679 -0.489 . . . . 65.030000000000001 109.679 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.4 p -100.63 3.65 42.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.201 1.0 . . . . 75.530000000000001 112.271 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.11 159.05 53.04 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.124 0.265 . . . . 72.040000000000006 113.469 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.77 -178.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 74.430000000000007 110.799 174.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -61.92 118.49 7.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.367 0.667 . . . . 72.340000000000003 109.814 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.78 12.03 59.75 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.292 -0.726 . . . . 73.430000000000007 113.444 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.0 m -76.06 133.04 40.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.182 0.991 . . . . 74.430000000000007 110.184 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.476 ' HB3' HD11 ' A' ' 184' ' ' LEU . 27.0 p90 -141.81 166.44 24.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.237 0.541 . . . . 73.030000000000001 111.187 -171.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -162.6 151.29 14.75 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.617 -1.174 . . . . 72.340000000000003 108.135 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.648 HG23 HG12 ' A' ' 182' ' ' ILE . 85.9 t -103.51 128.9 56.24 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 N-CA-C 108.101 -1.074 . . . . 63.340000000000003 108.101 169.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.616 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.0 ptt85 -114.97 143.26 45.44 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.731 -1.122 . . . . 75.25 108.313 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -114.95 130.21 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.329 -1.36 . . . . 74.409999999999997 107.329 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -62.67 127.56 31.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.66 0.384 . . . . 71.099999999999994 110.409 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.86 -43.5 98.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.173 0.589 . . . . 73.120000000000005 110.004 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.0 p -68.71 -27.09 65.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.838 0.855 . . . . 74.140000000000001 111.409 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.3 m -137.19 79.5 37.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.043 0.537 . . . . 74.109999999999999 110.582 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.42 137.32 73.53 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.629 2.219 . . . . 75.129999999999995 111.529 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.14 -29.57 12.23 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.809 -0.632 . . . . 64.099999999999994 111.668 -174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -81.38 114.93 20.48 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.95 -0.759 . . . . 75.510000000000005 108.95 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -129.29 147.77 51.16 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.847 0.859 . . . . 74.5 109.465 -173.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -148.54 150.97 34.3 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.142 0.977 . . . . 63.439999999999998 108.542 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.648 HG12 HG23 ' A' ' 170' ' ' VAL . 16.8 mt -103.23 121.87 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.224 -1.028 . . . . 74.519999999999996 108.224 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -93.82 127.25 39.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.646 -1.242 . . . . 74.109999999999999 107.646 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.525 ' HB2' ' HH ' ' A' ' 193' ' ' TYR . 61.9 tp -131.96 110.36 10.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.173 0.589 . . . . 71.019999999999996 109.511 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.538 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 21.7 ttt180 -79.7 113.81 18.14 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.076 0.55 . . . . 75.219999999999999 109.829 168.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -139.72 137.0 34.77 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.219 -1.4 . . . . 75.040000000000006 107.219 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 62.14 21.44 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.17 0.988 . . . . 74.239999999999995 111.624 -174.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 9.98 86.58 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.91 -0.586 . . . . 71.409999999999997 113.677 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -117.66 134.45 54.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.415 1.086 . . . . 75.319999999999993 109.487 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.58 115.56 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.735 0.414 . . . . 74.319999999999993 110.592 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -102.94 128.79 49.6 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.624 1.17 . . . . 75.109999999999999 108.696 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -110.37 110.13 20.8 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.316 0.646 . . . . 75.530000000000001 109.393 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.525 ' HH ' ' HB2' ' A' ' 184' ' ' LEU . 0.2 OUTLIER -115.23 122.89 47.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.553 0.741 . . . . 73.120000000000005 110.545 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.76 135.04 53.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.55 1.14 . . . . 72.239999999999995 111.301 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.49 103.44 12.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.303 -0.999 . . . . 74.310000000000002 108.303 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -66.16 112.73 4.07 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.59 0.756 . . . . 72.540000000000006 109.172 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.8 m -97.45 105.46 17.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.436 0.695 . . . . 73.209999999999994 109.133 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.1 155.75 26.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.033 0.933 . . . . 72.519999999999996 110.771 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.8 p -69.19 -13.73 62.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.489 0.922 . . . . 74.120000000000005 113.489 -170.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.11 -16.42 31.52 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.391 0.676 . . . . 73.439999999999998 111.141 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 111.72 14.45 11.33 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.72 -0.489 . . . . 73.510000000000005 113.763 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -78.52 138.71 38.54 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.167 0.484 . . . . 71.439999999999998 110.89 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.29 143.76 32.24 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.977 -1.12 . . . . 63.520000000000003 107.977 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.6 p90 -170.81 136.45 1.17 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.546 0.529 . . . . 75.239999999999995 111.525 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.441 HG23 ' HD1' ' A' ' 193' ' ' TYR . 63.7 t -79.89 -42.06 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.639 -0.875 . . . . 74.450000000000003 108.639 166.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.469 ' HG ' ' HA3' ' A' ' 227' ' ' GLY . 15.2 m -100.17 126.98 46.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.24 1.016 . . . . 74.310000000000002 109.605 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -63.16 -24.73 68.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.559 0.743 . . . . 74.439999999999998 112.12 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -77.09 -30.68 55.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.674 1.19 . . . . 62.149999999999999 111.233 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -120.87 100.62 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.575 0.75 . . . . 74.219999999999999 109.157 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.3 mtt180 -110.13 126.01 53.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.011 0.924 . . . . 75.129999999999995 109.514 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.529 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.5 m-85 -116.03 149.33 39.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.537 0.735 . . . . 75.129999999999995 110.043 -168.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.03 -44.33 72.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.403 -0.591 . . . . 75.239999999999995 109.403 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.1 p -117.93 154.95 31.05 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.955 0.883 . . . . 73.239999999999995 111.722 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.465 HD12 HG13 ' A' ' 170' ' ' VAL . 1.1 tt -65.47 -23.23 66.86 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.723 -1.126 . . . . 74.099999999999994 109.899 174.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.07 93.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.383 0.673 . . . . 61.299999999999997 110.662 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.2 mt-10 -68.04 -36.8 80.5 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 110.82 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 tp -54.04 -57.88 9.4 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.767 0.667 . . . . 74.120000000000005 110.407 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.01 -38.4 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 123.755 0.659 . . . . 72.349999999999994 110.716 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -62.94 -59.05 5.37 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.921 0.488 . . . . 75.400000000000006 111.55 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.26 -32.94 74.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.028 0.531 . . . . 75.319999999999993 111.063 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.657 ' HB3' HD12 ' A' ' 228' ' ' LEU . 17.4 m170 -89.44 -4.72 57.87 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.629 0.603 . . . . 73.150000000000006 112.629 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.2 p -96.24 -28.07 14.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.868 0.467 . . . . 74.329999999999998 110.807 168.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 52.7 p -77.29 -40.36 44.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.356 -0.384 . . . . 74.239999999999995 110.504 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 226' ' ' ASP . 16.5 m -134.5 161.44 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.304 1.049 . . . . 73.319999999999993 112.437 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.23 16.62 0.74 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.26 2.224 . . . . 73.219999999999999 114.442 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.541 ' HB2' HG22 ' A' ' 224' ' ' VAL . 28.1 t70 -44.37 25.31 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.617 1 C-N-CA 132.266 4.227 . . . . 54.229999999999997 119.821 -155.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.469 ' HA3' ' HG ' ' A' ' 206' ' ' SER . . . 123.95 6.22 7.16 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 120.114 -1.616 . . . . 64.310000000000002 111.823 -165.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.657 HD12 ' HB3' ' A' ' 221' ' ' HIS . 6.7 mt -95.23 163.67 13.17 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.749 1.22 . . . . 75.430000000000007 109.363 167.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 8.4 tt -65.89 -34.0 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-O 121.229 0.537 . . . . 74.140000000000001 109.834 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.405 HG21 HD21 ' A' ' 184' ' ' LEU . 6.4 t -159.67 170.67 21.08 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.592 0.757 . . . . 75.200000000000003 109.664 177.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.2 p -63.96 142.09 58.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.363 0.665 . . . . 62.140000000000001 111.385 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.42 112.21 4.5 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 108.686 -0.857 . . . . 74.299999999999997 108.686 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -104.75 -57.88 1.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.299999999999997 112.007 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -119.27 122.77 29.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.789 0.836 . . . . 74.420000000000002 109.54 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.2 123.33 4.99 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.449 2.099 . . . . 72.510000000000005 111.132 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -68.32 142.06 94.25 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 109.072 -0.714 . . . . 74.099999999999994 109.072 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.66 176.35 7.12 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.605 2.203 . . . . 74.319999999999993 112.943 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.525 ' HZ1' HD13 ' A' ' 88' ' ' LEU . 33.1 mmtp -71.41 155.7 40.33 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.394 -0.821 . . . . 64.409999999999997 109.974 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.829 ' HB3' HD21 ' A' ' 159' ' ' LEU . 16.7 ptt-85 -91.89 -60.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.578 0.584 . . . . 62.149999999999999 112.578 -167.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -110.89 155.06 23.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.348 1.059 . . . . 65.140000000000001 109.872 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.67 114.77 59.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.663 -1.606 . . . . 62.25 106.663 156.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.482 ' HB2' HD21 ' A' ' 133' ' ' ASN . 27.9 Cg_endo -61.59 124.88 15.49 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.595 2.197 . . . . 74.420000000000002 112.352 -171.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.4 m -72.4 112.83 8.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.543 -0.753 . . . . 72.400000000000006 110.833 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.07 111.77 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 107.416 -1.327 . . . . 73.310000000000002 107.416 171.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.74 111.05 22.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.157 -0.312 . . . . 74.230000000000004 110.157 -166.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 60.22 -14.13 0.04 OUTLIER Glycine 0 CA--C 1.542 1.764 0 N-CA-C 118.185 2.034 . . . . 53.210000000000001 118.185 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.3 m -89.52 122.96 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.376 1.588 . . . . 75.040000000000006 112.882 -164.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 36.4 t -82.61 140.02 44.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 106.928 -1.508 . . . . 74.400000000000006 106.928 159.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo . . . . . 0 C--N 1.382 2.325 0 CA-C-N 120.723 1.294 . . . . 74.340000000000003 112.793 -163.193 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.1 ttm . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 108.976 -0.75 . . . . 75.219999999999999 108.976 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.7 66.05 3.67 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.337 0.398 . . . . 62.32 112.787 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -113.74 140.5 48.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.882 0.873 . . . . 73.010000000000005 109.617 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -95.8 106.01 24.82 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.607 0.763 . . . . 63.049999999999997 109.163 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.01 155.32 22.95 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.952 2.435 . . . . 73.549999999999997 112.73 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.54 73.73 2.56 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.148 -0.781 . . . . 70.129999999999995 111.148 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -65.95 -58.2 6.09 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.91 0.884 . . . . 75.239999999999995 113.072 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -159.7 129.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.32 0.648 . . . . 70.109999999999999 109.758 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.8 tt -75.99 -67.93 0.63 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.916 0.886 . . . . 73.340000000000003 109.493 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.35 -141.57 7.32 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 121.573 -0.346 . . . . 72.299999999999997 112.622 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.425 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 10.9 t70 -83.98 129.22 34.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.6 0.76 . . . . 74.109999999999999 108.978 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -127.88 -175.55 3.51 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.736 0.815 . . . . 74.329999999999998 110.964 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.57 177.82 6.45 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.942 0.897 . . . . 75.430000000000007 109.76 173.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 1.8 mpt_? -106.27 113.02 63.8 Favored Pre-proline 0 N--CA 1.477 0.875 0 C-N-CA 124.043 0.937 . . . . 64.049999999999997 109.488 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -82.22 174.68 9.77 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.924 2.416 . . . . 70.439999999999998 111.913 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.0 p -122.18 75.35 1.22 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.025 0.53 . . . . 64.439999999999998 111.001 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.54 105.83 55.78 Favored Pre-proline 0 N--CA 1.483 1.196 0 N-CA-C 108.981 -0.748 . . . . 71.439999999999998 108.981 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -80.43 92.81 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.614 2.209 . . . . 75.400000000000006 111.774 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.09 124.4 24.9 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.354 0.662 . . . . 72.450000000000003 109.914 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.4 tp -141.75 134.12 28.03 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.627 0.771 . . . . 75.120000000000005 109.713 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -160.14 136.83 9.05 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.903 0.881 . . . . 75.319999999999993 110.231 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.06 149.92 47.72 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.902 0.881 . . . . 71.400000000000006 109.681 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.401 HD11 ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -169.57 148.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 107.506 -1.294 . . . . 73.099999999999994 107.506 176.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' N ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -78.31 94.11 4.78 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.433 -0.58 . . . . 73.019999999999996 109.433 -178.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.52 79.24 0.34 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.685 -0.689 . . . . 65.420000000000002 112.201 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.65 166.18 25.91 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.941 0.896 . . . . 64.129999999999995 110.048 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.96 90.95 0.46 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.875 -0.49 . . . . 72.519999999999996 111.875 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -144.53 138.24 27.4 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.483 0.713 . . . . 74.5 110.247 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -115.06 92.07 3.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.233 1.013 . . . . 74.310000000000002 109.747 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.74 88.08 3.31 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 105.976 -1.861 . . . . 71.310000000000002 105.976 159.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.1 m -133.75 143.09 48.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.716 0.807 . . . . 72.030000000000001 111.161 -164.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.6 t -156.96 -172.43 4.04 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.336 1.054 . . . . 75.329999999999998 108.959 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.412 ' H ' ' HD2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -125.21 148.01 48.82 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.306 1.042 . . . . 73.129999999999995 110.349 -173.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -128.87 -41.87 1.44 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.54 0.336 . . . . 75.329999999999998 110.729 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.84 -167.37 34.79 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.532 -0.758 . . . . 74.450000000000003 113.441 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.44 67.6 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.729 -1.348 . . . . 60.350000000000001 109.729 -175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -63.27 128.51 22.86 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 123.589 2.859 . . . . 74.340000000000003 114.604 -165.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -176.66 -159.55 0.06 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.547 1.139 . . . . 74.25 109.872 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.3 m -45.41 156.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.698 1.599 . . . . 74.420000000000002 114.156 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -97.1 170.18 9.3 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.658 0.783 . . . . 73.109999999999999 111.049 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.0 t -123.74 -97.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 108.153 -1.055 . . . . 74.019999999999996 108.153 165.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.1 t80 179.38 69.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.569 -0.9 . . . . 74.400000000000006 108.569 -172.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 p -161.42 161.4 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 124.401 1.08 . . . . 73.230000000000004 108.855 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.517 ' HA ' HG21 ' A' ' 52' ' ' VAL . 10.8 pt-20 -128.03 134.69 49.24 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.9 1.074 . . . . 75.019999999999996 113.9 -171.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.601 ' HD1' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER 173.01 -157.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.769 1.627 . . . . 74.400000000000006 109.093 168.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -91.22 -175.55 4.31 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.365 0.666 . . . . 65.310000000000002 110.431 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . . . 74.79 118.88 0.05 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.364 1.466 . . . . 70.230000000000004 112.618 170.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.09 82.59 6.99 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.64 0.776 . . . . 72.319999999999993 110.434 -169.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' HG2' ' HD3' ' A' ' 50' ' ' ARG . 7.5 tt0 -115.63 -66.18 1.11 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.435 -0.95 . . . . 73.129999999999995 108.435 169.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.499 ' HD3' ' HG2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -114.06 120.67 38.21 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 106.709 -1.589 . . . . 71.040000000000006 106.709 174.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -49.01 156.53 2.12 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.996 2.464 . . . . 73.219999999999999 113.553 165.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.517 HG21 ' HA ' ' A' ' 44' ' ' GLU . 9.6 p -70.8 159.5 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 123.935 0.894 . . . . 73.310000000000002 111.625 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.63 115.17 5.53 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.814 -1.18 . . . . 70.439999999999998 107.814 165.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.2 t -61.1 -9.92 5.4 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.662 1.356 . . . . 75.239999999999995 114.662 -165.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.43 -48.57 74.83 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.472 0.654 . . . . 74.329999999999998 110.489 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.13 137.47 51.99 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.897 0.879 . . . . 72.439999999999998 109.017 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.8 78.31 30.75 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.886 -1.153 . . . . 71.409999999999997 107.886 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -84.58 -24.07 2.49 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.519 2.146 . . . . 75.219999999999999 112.424 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -142.48 -36.54 0.4 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.809 1.244 . . . . 75.540000000000006 109.728 -174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.53 -14.66 29.98 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 114.381 0.513 . . . . 72.340000000000003 114.381 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -125.96 -161.1 1.02 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.327 0.651 . . . . 73.140000000000001 110.284 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 p -169.6 119.3 0.65 Allowed 'General case' 0 C--O 1.246 0.899 0 C-N-CA 124.016 0.927 . . . . 73.150000000000006 110.537 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.755 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 27.6 tt0 -161.6 -48.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.255 1.022 . . . . 75.349999999999994 110.061 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.601 ' HB3' ' HD1' ' A' ' 45' ' ' HIS . . . -63.01 -15.58 56.91 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.781 1.03 . . . . 73.109999999999999 113.781 -172.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.51 -15.82 55.77 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.32 0.648 . . . . 74.329999999999998 112.327 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.496 ' NH2' ' HA ' ' A' ' 63' ' ' GLU . 33.8 mtm105 -118.64 -35.34 3.74 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.085 0.954 . . . . 74.329999999999998 110.274 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -159.69 89.67 0.9 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.9 0.88 . . . . 75.120000000000005 109.804 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.51 -22.69 34.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.889 0.876 . . . . 71.030000000000001 111.104 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 m -78.95 7.32 7.42 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.241 1.416 . . . . 54.420000000000002 113.021 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.39 -18.18 65.02 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.464 1.106 . . . . 74.019999999999996 112.315 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -20.35 26.2 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.319 0.648 . . . . 72.310000000000002 110.916 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.47 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 12.7 m120 -78.45 -12.31 60.0 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.322 0.649 . . . . 55.119999999999997 110.377 170.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.05 -50.45 70.59 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.679 0.792 . . . . 74.140000000000001 110.623 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.407 HD11 ' CG ' ' A' ' 219' ' ' HIS . 84.8 mt -112.12 30.15 7.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.486 0.714 . . . . 75.450000000000003 110.063 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 72' ' ' ASN . . . -72.05 -25.78 61.93 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.663 0.385 . . . . 75.140000000000001 110.562 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.31 -136.24 16.96 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 118.96 -0.911 . . . . 71.310000000000002 110.869 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.13 175.6 0.32 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.551 2.167 . . . . 63.32 112.406 166.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 1.7 m -71.46 175.64 5.34 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 116.267 -0.424 . . . . 70.409999999999997 111.227 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.77 -48.95 66.44 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.089 0.956 . . . . 64.049999999999997 112.981 -164.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -132.76 -41.08 0.94 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.91 0.484 . . . . 60.539999999999999 110.598 169.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 78' ' ' SER . 18.1 t70 -92.19 118.69 68.26 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 115.345 -0.843 . . . . 72.239999999999995 110.922 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.24 -13.3 39.05 Favored 'Trans proline' 0 CA--C 1.559 1.736 0 C-N-CA 122.937 2.425 . . . . 72.239999999999995 114.832 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -110.69 20.42 17.64 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.435 0.694 . . . . 70.299999999999997 110.848 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.7 tp -76.78 138.42 39.88 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.75 -0.594 . . . . 71.530000000000001 109.455 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.7 m-85 -108.11 173.45 6.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.588 1.155 . . . . 73.219999999999999 110.06 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.6 147.55 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 125.221 1.409 . . . . 65.239999999999995 109.64 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.21 120.15 25.45 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.219 1.008 . . . . 74.530000000000001 110.205 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.3 -42.26 68.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.329 0.651 . . . . 64.409999999999997 111.161 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.51 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.8 m-85 -124.54 158.4 33.05 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.41 -0.813 . . . . 75.129999999999995 109.223 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 120.71 24.27 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.502 -1.296 . . . . 72.25 107.502 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.8 t80 -123.01 138.28 54.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.903 0.881 . . . . 73.019999999999996 108.712 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.48 134.18 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.76 -0.83 . . . . 75.120000000000005 108.76 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.6 117.18 4.62 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.078 0.862 . . . . 74.319999999999993 110.631 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 p -67.82 -38.33 83.12 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.654 0.782 . . . . 65.319999999999993 110.887 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.72 -175.95 14.28 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-N 115.717 -0.674 . . . . 72.140000000000001 111.826 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.79 -31.85 67.02 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.546 0.739 . . . . 74.549999999999997 110.661 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -75.52 -18.06 59.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.803 1.241 . . . . 64.049999999999997 112.115 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 57.2 p -95.63 171.25 8.79 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.48 -0.563 . . . . 75.310000000000002 109.48 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.9 tp -126.94 136.7 52.64 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.275 0.56 . . . . 75.230000000000004 111.735 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -82.25 117.03 22.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.726 -1.125 . . . . 62.130000000000003 109.042 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.587 HG12 ' HB3' ' A' ' 91' ' ' PHE . 20.7 pt -110.08 144.26 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.388 0.675 . . . . 74.409999999999997 110.104 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.3 m -95.76 140.23 30.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.424 -0.807 . . . . 65.040000000000006 108.845 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.29 125.99 25.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.318 0.647 . . . . 75.200000000000003 111.356 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.45 76.67 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 123.88 0.738 . . . . 60.049999999999997 113.605 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -82.11 138.34 34.79 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.46 0.63 . . . . 74.109999999999999 111.434 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -79.95 112.81 17.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.837 -0.801 . . . . 74.340000000000003 108.837 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.505 ' HB3' HG21 ' A' ' 123' ' ' THR . 0.4 OUTLIER -122.83 167.78 13.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.951 0.9 . . . . 74.230000000000004 110.024 -177.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -121.74 119.43 31.72 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.935 -0.478 . . . . 74.209999999999994 111.035 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.585 HG11 ' HB1' ' A' ' 119' ' ' ALA . 43.5 t -86.54 134.55 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.246 1.018 . . . . 75.230000000000004 109.881 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.54 HD12 ' HG3' ' A' ' 120' ' ' GLU . 46.1 mt -105.89 -31.49 8.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.467 1.107 . . . . 75.140000000000001 110.126 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.01 145.48 4.71 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 115.835 -0.62 . . . . 61.119999999999997 112.375 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.51 ' CD2' ' HB3' ' A' ' 119' ' ' ALA . 45.5 m-85 -85.68 169.74 13.17 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.436 0.694 . . . . 74.329999999999998 110.886 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -85.66 -176.26 5.97 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.213 -0.903 . . . . 74.420000000000002 110.694 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -52.83 -35.18 56.79 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.754 1.221 . . . . 74.430000000000007 114.17 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -112.12 2.63 16.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.855 0.462 . . . . 72.129999999999995 112.171 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.452 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.79 30.56 72.59 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.398 0.919 . . . . 72.200000000000003 115.398 173.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.03 -35.96 18.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.285 0.543 . . . . 74.510000000000005 110.716 173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 35.3 m95 -131.0 151.66 51.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.743 0.817 . . . . 74.129999999999995 111.72 -171.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.585 ' HB1' HG11 ' A' ' 109' ' ' VAL . . . -133.54 137.09 45.39 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.534 1.134 . . . . 72.040000000000006 111.026 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.54 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.8 tp10 -66.81 114.45 5.68 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 106.854 -1.536 . . . . 75.030000000000001 106.854 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.15 162.13 33.8 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.184 0.516 . . . . 73.230000000000004 111.299 -170.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.46 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . 9.8 pt20 -132.8 128.96 37.9 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.414 -0.812 . . . . 73.219999999999999 111.122 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.505 HG21 ' HB3' ' A' ' 107' ' ' LEU . 45.8 p -116.61 179.1 4.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 74.319999999999993 109.757 173.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -70.68 -16.35 62.79 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 109.513 -0.551 . . . . 75.549999999999997 109.513 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -78.78 -20.16 50.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.918 1.287 . . . . 74.439999999999998 110.984 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.68 -140.4 10.15 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 122.051 -0.118 . . . . 74.439999999999998 112.941 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' A' ' 122' ' ' GLN . 61.6 tp60 -128.67 155.83 44.4 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.348 1.059 . . . . 74.329999999999998 109.667 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.56 169.4 15.36 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.025 -0.43 . . . . 74.25 112.025 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -77.75 134.53 38.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.241 0.616 . . . . 75.310000000000002 111.668 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.483 HG23 HD11 ' A' ' 135' ' ' ILE . 5.9 m -132.0 143.26 48.26 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 124.308 1.043 . . . . 75.420000000000002 108.807 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 92.9 Cg_endo -80.4 143.04 15.19 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 C-N-CA 122.018 1.812 . . . . 75.439999999999998 114.075 -173.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -39.61 -44.73 1.52 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.583 1.953 . . . . 74.310000000000002 114.229 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 38.1 p-10 -79.04 -1.91 37.89 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.198 0.999 . . . . 74.25 113.132 -171.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.51 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 28.8 m-85 -113.14 -0.63 14.61 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.026 0.93 . . . . 74.219999999999999 111.308 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 130' ' ' VAL . 21.0 pt -135.37 170.48 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.182 0.993 . . . . 64.25 110.667 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -163.4 155.39 15.14 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.812 -1.181 . . . . 64.430000000000007 107.812 170.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.8 Cg_endo -60.44 153.53 59.88 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.679 1.586 . . . . 73.310000000000002 111.632 171.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.1 -8.44 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.107 0.956 . . . . 70.329999999999998 110.356 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.94 -18.61 55.86 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.336 1.054 . . . . 73.129999999999995 111.248 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.2 p -87.01 170.43 11.57 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.853 0.835 . . . . 75.200000000000003 113.024 -170.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.36 -23.79 26.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.512 -1.222 . . . . 74.299999999999997 110.931 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.64 -29.81 70.3 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.322 1.049 . . . . 75.140000000000001 111.447 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -60.08 -19.28 52.34 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.614 0.765 . . . . 72.340000000000003 112.904 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -86.66 141.86 28.64 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.544 0.737 . . . . 72.329999999999998 109.749 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.1 m -58.9 -40.64 85.1 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.07 0.856 . . . . 64.430000000000007 112.182 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -62.53 -38.5 90.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.122 0.889 . . . . 73.140000000000001 112.336 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -76.6 112.37 13.07 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.728 -0.841 . . . . 73.219999999999999 108.728 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -109.07 -14.83 14.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.073 0.549 . . . . 70.400000000000006 111.517 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.78 -127.25 15.49 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 118.18 -1.344 . . . . 43.119999999999997 112.3 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.55 95.2 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.984 2.456 . . . . 75.219999999999999 112.591 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 77.3 t -137.78 119.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.605 0.762 . . . . 64.5 109.575 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.8 m -71.78 159.35 34.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.289 0.635 . . . . 71.329999999999998 109.32 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 78.0 ttt180 -59.04 -38.07 78.46 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 119.435 -0.317 . . . . 74.310000000000002 111.415 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -63.49 -36.88 85.21 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.362 0.665 . . . . 71.409999999999997 111.209 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.36 -30.27 67.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.16 0.584 . . . . 71.209999999999994 110.408 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.26 63.18 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 51.509999999999998 111.647 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 22.5 mm-40 -65.66 -43.11 90.38 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.119 -0.697 . . . . 74.310000000000002 109.119 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.483 ' HE1' ' HB2' ' A' ' 239' ' ' ARG . 17.0 t80 -62.73 -41.47 99.19 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.315 -1.311 . . . . 74.5 111.201 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 239' ' ' ARG . 28.7 mt -61.48 -44.13 97.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.59 0.756 . . . . 61.539999999999999 111.478 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.0 mt -98.3 17.96 17.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.199 0.6 . . . . 72.420000000000002 112.59 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.0 p -69.35 -36.24 76.68 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.444 0.64 . . . . 74.219999999999999 110.694 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 p -106.42 15.81 25.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.342 1.057 . . . . 74.209999999999994 110.8 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.86 140.48 23.3 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.37 -0.377 . . . . 63.119999999999997 112.379 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.7 pt -86.81 -179.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.405 0.682 . . . . 74.0 111.431 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.6 112.33 3.13 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.679 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.6 10.88 39.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.392 -0.822 . . . . 72.209999999999994 112.94 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.4 m -75.54 143.31 42.52 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.634 0.717 . . . . 62.140000000000001 110.619 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 183' ' ' SER . 24.1 p90 -149.72 163.78 37.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.063 0.459 . . . . 74.230000000000004 111.937 -171.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 183' ' ' SER . 4.0 pp -161.72 152.69 18.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.873 -1.058 . . . . 73.540000000000006 109.482 175.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.583 HG22 HG12 ' A' ' 182' ' ' ILE . 59.5 t -107.64 126.73 63.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.424 -0.954 . . . . 55.210000000000001 108.424 168.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.521 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 13.1 ptt180 -114.97 147.29 40.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.182 -1.044 . . . . 74.200000000000003 108.182 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.89 145.99 40.68 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 107.741 -1.207 . . . . 72.340000000000003 107.741 166.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.4 t -78.55 121.64 24.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.169 -0.678 . . . . 74.109999999999999 109.169 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.25 -34.3 77.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.306 1.042 . . . . 74.219999999999999 110.485 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 p -83.18 -15.87 48.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.72 0.808 . . . . 72.340000000000003 111.788 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.8 m -142.2 86.03 10.43 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.423 0.689 . . . . 73.519999999999996 110.079 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.09 135.54 69.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.33 2.687 . . . . 73.239999999999995 112.529 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.15 -28.86 12.07 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.472 -0.331 . . . . 61.509999999999998 112.594 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -81.41 117.11 21.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.182 0.491 . . . . 74.329999999999998 110.193 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.602 HH11 HD11 ' A' ' 214' ' ' LEU . 99.4 mtt180 -130.03 157.6 41.9 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.908 0.883 . . . . 75.409999999999997 110.974 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.4 m -143.61 146.24 33.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.944 -1.026 . . . . 61.310000000000002 109.454 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.583 HG12 HG22 ' A' ' 170' ' ' VAL . 42.8 mt -100.81 108.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 107.394 -1.335 . . . . 73.439999999999998 107.394 169.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.459 ' HB2' ' HG ' ' A' ' 169' ' ' LEU . 14.9 m -87.38 106.81 18.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.243 -1.391 . . . . 65.310000000000002 107.243 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 193' ' ' TYR . 62.4 tp -115.47 110.95 20.03 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.78 -0.822 . . . . 74.5 108.78 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.429 ' HB2' HG21 ' A' ' 190' ' ' VAL . 75.9 ttt180 -89.61 122.77 33.07 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.316 0.646 . . . . 75.209999999999994 110.486 173.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -143.7 144.13 31.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.655 1.182 . . . . 72.450000000000003 108.352 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 61.11 21.93 12.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.422 1.089 . . . . 70.120000000000005 112.358 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.29 11.45 82.17 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 114.358 0.503 . . . . 60.219999999999999 114.358 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -120.14 134.5 55.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.49 0.716 . . . . 74.409999999999997 109.744 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 185' ' ' ARG . 91.0 t -88.65 118.24 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.304 -0.628 . . . . 74.439999999999998 109.304 174.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.37 157.42 16.92 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.147 0.979 . . . . 72.439999999999998 108.564 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -132.76 124.15 27.55 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.976 -0.75 . . . . 74.140000000000001 108.976 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' A' ' 184' ' ' LEU . 89.8 m-85 -113.83 141.24 47.56 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.415 1.086 . . . . 72.310000000000002 108.714 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -85.21 124.36 31.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.398 0.279 . . . . 73.129999999999995 110.391 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.2 mt -84.71 99.6 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.132 -1.433 . . . . 73.040000000000006 107.132 166.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -78.46 119.71 22.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.963 -1.017 . . . . 72.450000000000003 108.37 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -94.15 108.5 20.35 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.908 -0.775 . . . . 75.0 108.908 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.48 157.57 16.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.952 0.901 . . . . 62.020000000000003 110.886 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -61.85 -30.94 71.19 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.293 1.037 . . . . 75.129999999999995 113.395 -170.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -85.0 -11.5 55.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.803 0.841 . . . . 73.299999999999997 111.925 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.0 11.15 14.38 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.451 -0.638 . . . . 74.310000000000002 114.352 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -75.5 152.16 37.88 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 118.082 0.941 . . . . 71.099999999999994 110.983 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -113.56 142.6 45.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.327 -0.99 . . . . 73.519999999999996 108.327 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.615 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.8 p90 -165.0 137.0 4.31 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.52 0.512 . . . . 73.349999999999994 110.872 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.3 t -79.12 -45.73 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.832 -0.803 . . . . 72.430000000000007 108.832 166.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -101.29 135.93 41.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.763 -1.108 . . . . 71.219999999999999 110.696 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.5 t -64.14 -22.46 66.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.287 1.035 . . . . 74.219999999999999 112.267 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -81.47 -29.98 33.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.941 0.896 . . . . 73.109999999999999 111.176 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 17.1 m -123.17 99.01 6.14 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.026 0.53 . . . . 65.200000000000003 110.176 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.615 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 47.3 mtt180 -112.35 120.29 41.19 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.818 0.847 . . . . 74.120000000000005 109.632 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.62 156.0 20.75 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.083 0.953 . . . . 72.420000000000002 109.085 -171.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -69.32 -42.74 74.98 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 70.5 p -120.95 155.04 35.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.92 0.867 . . . . 75.420000000000002 111.904 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.602 HD11 HH11 ' A' ' 180' ' ' ARG . 1.3 tt -65.38 -24.61 67.28 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 114.352 -1.295 . . . . 75.230000000000004 109.559 172.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.33 93.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.41 0.684 . . . . 75.439999999999998 110.766 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.19 -34.81 75.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.83 0.852 . . . . 71.319999999999993 111.15 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.04 -54.92 39.08 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.09 0.556 . . . . 74.040000000000006 111.025 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.61 -41.09 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 123.655 0.597 . . . . 75.140000000000001 111.011 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.407 ' CG ' HD11 ' A' ' 74' ' ' LEU . 17.0 t-80 -55.63 -58.0 9.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.441 0.696 . . . . 61.340000000000003 111.362 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -64.17 -33.7 76.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.125 -0.943 . . . . 74.239999999999995 110.813 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.537 ' HB3' HD12 ' A' ' 228' ' ' LEU . 11.1 m-70 -88.28 -10.78 48.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.797 -0.638 . . . . 73.5 112.081 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 89.1 p -93.92 -20.28 20.16 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.756 0.423 . . . . 61.420000000000002 111.255 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 37.7 p -81.98 -48.12 11.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.873 -0.417 . . . . 74.230000000000004 109.873 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' A' ' 226' ' ' ASP . 33.2 m -128.72 158.92 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.636 0.732 . . . . 74.209999999999994 112.303 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.97 16.0 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.759 2.024 . . . . 61.509999999999998 115.217 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.562 ' HB2' HG21 ' A' ' 224' ' ' VAL . 28.9 t70 -42.64 31.69 0.0 OUTLIER 'General case' 0 CA--C 1.601 2.925 1 C-N-CA 131.88 4.072 . . . . 72.510000000000005 119.351 -157.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.86 -1.94 9.25 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 119.486 -2.009 . . . . 74.120000000000005 112.604 -168.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 221' ' ' HIS . 45.1 mt -95.59 160.3 14.57 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.584 1.153 . . . . 70.420000000000002 110.216 168.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.11 -35.55 72.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 120.895 0.379 . . . . 73.420000000000002 110.322 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -149.18 173.52 13.35 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.506 0.722 . . . . 73.549999999999997 110.094 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -67.42 143.17 56.41 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.172 0.589 . . . . 72.319999999999993 110.675 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.58 96.56 0.12 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.74 0.816 . . . . 64.329999999999998 109.275 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -89.45 -66.14 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.184 -0.916 . . . . 75.239999999999995 110.681 -169.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 167' ' ' SER . 43.0 t80 -114.81 121.77 34.92 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 123.852 0.861 . . . . 73.519999999999996 109.725 -170.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.36 123.71 5.61 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.09 1.86 . . . . 75.219999999999999 111.722 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.02 130.95 95.06 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.971 -0.751 . . . . 75.150000000000006 108.971 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.03 179.78 6.18 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.833 2.355 . . . . 75.400000000000006 112.413 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.78 150.92 48.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 75.329999999999998 109.575 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.483 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . 13.7 ptt180 -92.51 -60.49 1.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 111.838 0.31 . . . . 75.239999999999995 111.838 -174.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -109.47 138.45 45.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 73.530000000000001 110.482 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.1 113.64 47.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.256 -1.757 . . . . 72.319999999999993 106.256 159.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.493 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 35.8 Cg_exo -61.01 123.87 13.76 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.51 2.14 . . . . 72.120000000000005 112.709 -173.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 61.2 m -73.47 119.1 17.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.827 0.451 . . . . 74.340000000000003 110.558 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.3 t -98.62 127.04 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.281 1.032 . . . . 62.399999999999999 108.38 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.08 114.52 28.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.095 0.407 . . . . 74.310000000000002 111.51 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.8 21.89 38.57 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 116.426 1.331 . . . . 71.030000000000001 116.426 160.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.478 HG23 ' NE1' ' A' ' 118' ' ' TRP . 27.2 m -82.3 127.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 117.732 0.766 . . . . 74.420000000000002 111.913 -173.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 t -85.18 117.83 69.59 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 104.85 -2.278 . . . . 72.540000000000006 104.85 152.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.99 -59.23 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 120.92 1.08 . . . . 75.040000000000006 113.917 -159.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -128.86 -18.53 3.79 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.368 0.667 . . . . 74.439999999999998 109.576 159.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -77.62 105.99 9.13 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 115.192 -0.913 . . . . 73.430000000000007 111.164 -158.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -117.71 -43.59 2.78 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.549 -1.278 . . . . 74.319999999999993 107.549 157.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 11' ' ' ASP . 29.3 ttmt -112.65 -15.98 12.9 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.767 1.227 . . . . 75.140000000000001 111.295 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -50.42 135.45 22.17 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.632 1.173 . . . . 73.219999999999999 113.555 -163.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.251 1.164 0 N-CA-C 108.457 -0.942 . . . . 74.439999999999998 108.457 -179.905 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.494 -0.558 . . . . 75.299999999999997 109.494 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.55 106.41 0.2 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.102 -0.799 . . . . 74.299999999999997 111.102 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -69.58 110.77 4.99 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.251 0.621 . . . . 74.329999999999998 110.246 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -113.12 154.29 45.16 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 124.183 0.993 . . . . 75.209999999999994 109.602 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -68.38 -164.12 0.1 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.107 2.538 . . . . 74.040000000000006 112.483 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.06 90.25 0.02 OUTLIER Glycine 0 C--N 1.354 1.569 0 C-N-CA 123.137 0.399 . . . . 73.310000000000002 112.838 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 1.3 tpmt? -75.29 116.26 15.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.61 0.764 . . . . 75.010000000000005 110.474 -171.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.31 124.89 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.041 0.536 . . . . 74.219999999999999 109.74 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.4 119.46 27.69 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.076 -1.083 . . . . 75.319999999999993 108.076 173.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.38 111.22 3.93 Favored Glycine 0 C--N 1.345 1.03 0 O-C-N 123.56 0.537 . . . . 72.319999999999993 113.303 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.69 156.71 22.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.569 1.147 . . . . 75.230000000000004 109.773 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -54.19 118.25 3.91 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.198 0.599 . . . . 74.319999999999993 111.934 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -145.15 -169.57 3.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.386 0.674 . . . . 65.340000000000003 111.52 -166.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 139.0 67.54 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.824 1.25 . . . . 75.450000000000003 112.903 -173.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -59.73 127.3 23.07 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.69 2.927 . . . . 75.230000000000004 114.084 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.0 t -101.22 -8.84 21.82 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.008 0.923 . . . . 75.200000000000003 110.254 173.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 mp 47.72 65.9 6.39 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.098 1.359 . . . . 74.329999999999998 110.762 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.63 -23.98 2.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.619 2.213 . . . . 72.219999999999999 114.072 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 62.56 175.07 0.14 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.947 1.299 . . . . 71.140000000000001 112.316 -170.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -156.99 -54.06 0.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.887 -1.153 . . . . 75.349999999999994 107.887 176.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 71.66 -68.97 0.2 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.008 1.323 . . . . 72.430000000000007 111.2 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.536 ' HE2' ' HZ3' ' A' ' 24' ' ' LYS . 9.1 t80 57.74 -71.5 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 126.404 1.882 . . . . 73.430000000000007 114.732 166.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mt 76.13 112.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.705 2.002 . . . . 74.109999999999999 111.214 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.554 ' H ' ' HB2' ' A' ' 112' ' ' TYR . 24.1 mmtm -140.3 160.83 39.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.909 0.883 . . . . 74.420000000000002 110.02 168.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.2 104.23 1.41 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.688 -0.687 . . . . 65.400000000000006 111.604 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -141.36 -176.92 4.9 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.725 0.81 . . . . 74.25 109.633 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.86 -169.96 42.97 Favored Glycine 0 C--O 1.241 0.549 0 N-CA-C 111.082 -0.807 . . . . 61.219999999999999 111.082 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -143.32 137.23 28.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.439 -0.578 . . . . 72.239999999999995 109.439 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.466 ' HD2' ' HG2' ' A' ' 150' ' ' PRO . 19.5 mmt85 -86.69 168.34 13.66 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.1 0.96 . . . . 75.439999999999998 110.045 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 52.99 87.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.072 0.949 . . . . 73.230000000000004 113.217 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 p -72.35 164.47 26.27 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.128 -0.693 . . . . 51.409999999999997 109.128 167.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.54 ' HA ' HH21 ' A' ' 33' ' ' ARG . 15.1 m -68.68 166.88 16.39 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 121.092 0.472 . . . . 73.430000000000007 111.656 -176.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.54 HH21 ' HA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -108.79 78.98 1.18 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.909 0.385 . . . . 75.209999999999994 111.34 -177.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -163.68 131.54 3.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.043 0.937 . . . . 61.539999999999999 108.833 165.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.07 -143.7 5.89 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.524 -0.63 . . . . 62.219999999999999 111.524 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.58 132.48 1.52 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-O 118.863 -0.965 . . . . 75.299999999999997 112.292 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.63 178.55 6.9 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.611 2.207 . . . . 63.420000000000002 112.392 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -132.57 147.03 52.34 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.809 -0.811 . . . . 73.400000000000006 108.809 174.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.448 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 71.7 m -127.38 95.72 4.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.341 0.656 . . . . 73.310000000000002 111.007 -177.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.531 ' H ' ' HA ' ' A' ' 65' ' ' ALA . 15.5 m120 -81.55 -179.08 7.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.277 1.031 . . . . 65.450000000000003 111.042 169.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.6 m -97.23 -169.43 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.985 0.914 . . . . 75.230000000000004 111.077 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 83.24 118.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 126.334 1.854 . . . . 73.5 112.741 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 62' ' ' SER . 8.6 p -156.73 143.27 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.944 1.298 . . . . 72.25 109.452 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -165.69 153.08 10.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.869 0.467 . . . . 74.25 110.451 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 83.1 t60 77.57 -50.14 0.52 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.558 1.943 . . . . 73.409999999999997 111.961 177.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.39 136.61 58.03 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.113 -1.069 . . . . 74.219999999999999 108.113 172.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.89 110.39 10.77 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.445 0.906 . . . . 75.409999999999997 113.445 -164.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.9 tt -138.78 120.79 15.59 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.375 -1.343 . . . . 74.510000000000005 107.375 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -67.73 103.99 1.54 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.428 1.091 . . . . 52.530000000000001 112.144 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.504 ' HB3' ' HD2' ' A' ' 51' ' ' PRO . 80.6 mtt85 -126.1 177.75 1.81 Allowed Pre-proline 0 CA--C 1.565 1.526 0 C-N-CA 125.065 1.346 . . . . 71.349999999999994 109.297 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 50' ' ' ARG . 21.1 Cg_exo -37.61 132.94 0.65 Allowed 'Trans proline' 0 C--N 1.398 3.177 0 C-N-CA 123.944 3.096 . . . . 75.329999999999998 114.621 171.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -67.15 148.67 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 113.635 0.976 . . . . 73.230000000000004 113.635 -169.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.5 -161.16 0.81 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.271 1.028 . . . . 74.530000000000001 110.093 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -72.22 -52.36 16.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.032 0.533 . . . . 73.530000000000001 111.4 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -110.46 -83.21 0.57 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.525 -0.546 . . . . 74.319999999999993 109.525 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -95.19 146.77 24.09 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.931 0.492 . . . . 75.209999999999994 109.856 172.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.03 103.85 10.3 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 106.564 -1.643 . . . . 73.209999999999994 106.564 173.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.58 -52.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 121.962 1.774 . . . . 54.32 112.735 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.408 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 25.6 mm-40 -159.28 -43.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.883 0.873 . . . . 74.049999999999997 110.166 -168.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.91 18.03 79.22 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.525 0.515 . . . . 71.019999999999996 112.5 -170.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -161.37 131.81 5.08 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 106.94 -1.504 . . . . 74.519999999999996 106.94 -176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.54 ' HA ' ' HB ' ' A' ' 43' ' ' VAL . 20.2 m -90.52 147.03 23.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.757 0.823 . . . . 73.219999999999999 113.218 -166.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.533 ' HG3' HG21 ' A' ' 43' ' ' VAL . 32.5 mt-10 -101.94 -28.58 12.31 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.797 0.839 . . . . 75.310000000000002 111.212 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.67 21.23 0.4 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.255 0.622 . . . . 62.039999999999999 112.023 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.531 ' HA ' ' H ' ' A' ' 40' ' ' ASN . . . -48.98 -52.89 22.36 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.736 1.614 . . . . 75.400000000000006 111.589 174.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -166.84 19.94 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 O-C-N 124.549 1.156 . . . . 75.319999999999993 109.229 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -93.45 70.94 4.33 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 122.151 0.977 . . . . 75.409999999999997 109.272 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -79.14 -23.92 43.68 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.24 -1.345 . . . . 71.400000000000006 109.426 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.517 ' HB2' ' HD1' ' A' ' 144' ' ' HIS . 82.6 p -78.03 4.54 12.0 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.967 0.907 . . . . 74.430000000000007 112.337 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.96 -37.62 78.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.949 0.5 . . . . 75.340000000000003 110.987 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.49 -31.16 62.1 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.072 0.463 . . . . 63.109999999999999 109.943 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.51 -5.81 57.24 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.042 0.937 . . . . 72.5 111.06 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.0 tp -66.19 -49.71 66.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.296 1.038 . . . . 75.219999999999999 111.36 -173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -103.61 20.97 16.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.999 0.52 . . . . 71.409999999999997 110.661 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.46 -22.27 25.04 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.65 0.38 . . . . 72.340000000000003 110.854 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.03 -134.27 21.48 Favored Glycine 0 C--N 1.356 1.684 0 CA-C-O 119.014 -0.881 . . . . 74.209999999999994 112.349 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.464 ' HB3' ' ND2' ' A' ' 139' ' ' ASN . 36.2 Cg_exo -60.52 -174.67 0.1 Allowed 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.831 3.02 . . . . 74.200000000000003 113.558 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 m -64.11 169.72 4.2 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.93 -0.577 . . . . 71.099999999999994 109.725 166.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.91 -41.84 88.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 122.978 0.511 . . . . 71.030000000000001 111.557 -173.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -127.81 -35.18 2.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.049 0.54 . . . . 75.010000000000005 111.928 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -88.92 122.38 69.03 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.124 0.787 . . . . 75.209999999999994 113.124 -167.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HA ' HD22 ' A' ' 139' ' ' ASN . 92.9 Cg_endo -81.42 -8.54 12.67 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.567 2.178 . . . . 74.230000000000004 111.653 164.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -109.52 6.81 24.38 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.081 0.953 . . . . 71.340000000000003 111.524 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.6 tp -86.59 133.37 33.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.467 -0.938 . . . . 72.140000000000001 108.467 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -110.42 171.51 7.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.777 0.831 . . . . 75.239999999999995 109.14 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.19 138.71 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.473 1.109 . . . . 74.420000000000002 109.273 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 135' ' ' ILE . . . -82.68 111.14 18.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.966 0.906 . . . . 64.120000000000005 109.594 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.46 -38.06 68.34 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.699 0.799 . . . . 72.329999999999998 110.937 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.47 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 37.1 m-85 -122.54 140.91 52.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.341 -1.3 . . . . 72.209999999999994 107.574 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -84.34 150.07 25.63 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.734 -0.469 . . . . 72.450000000000003 109.734 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.611 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.9 t80 -139.84 143.52 36.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.051 0.94 . . . . 71.140000000000001 108.642 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.97 133.2 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.564 -1.273 . . . . 63.030000000000001 107.564 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 129.8 41.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.319 0.648 . . . . 52.520000000000003 111.345 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 p -88.35 -38.96 14.7 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.776 0.83 . . . . 75.150000000000006 109.678 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.76 -170.32 12.66 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.344 -0.844 . . . . 45.200000000000003 112.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.74 -35.1 60.3 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.682 0.793 . . . . 65.510000000000005 110.581 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.465 ' HA ' ' HE3' ' A' ' 254' ' ' TRP . 24.2 p-10 -63.07 -29.32 70.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.054 0.942 . . . . 72.239999999999995 111.871 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.5 p -90.38 154.43 19.68 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.845 0.858 . . . . 65.540000000000006 109.491 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.664 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 58.6 tp -125.12 136.9 54.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.003 0.521 . . . . 71.310000000000002 110.467 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -75.23 131.39 40.35 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.958 0.503 . . . . 74.540000000000006 110.063 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.694 HG22 HG23 ' A' ' 123' ' ' THR . 19.3 pt -128.47 167.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.77 0.828 . . . . 73.409999999999997 111.215 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -123.11 152.36 41.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.363 1.065 . . . . 75.010000000000005 109.568 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.72 122.37 16.22 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.429 -0.582 . . . . 75.329999999999998 109.429 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.4 72.03 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-O 119.537 -0.591 . . . . 73.329999999999998 113.894 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -83.76 125.4 31.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.678 0.739 . . . . 72.109999999999999 110.745 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -78.3 133.86 37.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.277 -0.638 . . . . 72.109999999999999 109.277 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.617 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.77 147.03 34.86 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.574 0.75 . . . . 74.040000000000006 110.715 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -94.81 105.58 17.52 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.961 -0.755 . . . . 73.329999999999998 108.961 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.563 HG12 ' HB1' ' A' ' 119' ' ' ALA . 60.6 t -82.67 105.18 12.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.517 -0.92 . . . . 70.310000000000002 108.517 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.518 HD22 ' HG2' ' A' ' 120' ' ' GLU . 2.6 mm? -65.68 -52.88 48.06 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.162 0.914 . . . . 74.510000000000005 108.594 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.7 155.69 22.53 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.605 -0.725 . . . . 65.239999999999995 114.104 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.592 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 96.9 m-85 -88.15 163.54 16.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.801 0.84 . . . . 75.200000000000003 109.786 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -71.43 -172.57 0.77 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 120.803 0.335 . . . . 72.510000000000005 111.338 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -47.71 -41.1 22.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.858 1.263 . . . . 74.219999999999999 114.144 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -114.52 3.62 14.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.306 0.854 . . . . 74.439999999999998 113.306 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.14 32.86 47.02 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.921 0.728 . . . . 44.539999999999999 114.921 174.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.85 -65.65 0.71 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.437 0.695 . . . . 63.140000000000001 110.736 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.648 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 34.4 m95 -114.4 165.86 12.28 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 75.109999999999999 109.33 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' A' ' 109' ' ' VAL . . . -135.08 131.08 36.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.764 1.226 . . . . 74.049999999999997 111.384 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.518 ' HG2' HD22 ' A' ' 110' ' ' LEU . 24.0 tt0 -68.6 103.05 1.61 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.198 -1.038 . . . . 72.400000000000006 108.198 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.4 140.52 48.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.979 0.912 . . . . 74.299999999999997 109.85 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.475 ' HG3' HD21 ' A' ' 110' ' ' LEU . 55.8 mt-30 -105.51 105.39 15.41 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.575 -0.898 . . . . 72.099999999999994 108.575 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.694 HG23 HG22 ' A' ' 101' ' ' ILE . 68.5 p -99.88 -176.37 3.23 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.816 1.246 . . . . 74.310000000000002 110.357 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.88 -18.37 64.12 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.529 -0.76 . . . . 75.409999999999997 110.231 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.64 -3.46 59.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.664 1.186 . . . . 72.109999999999999 111.714 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.53 -138.39 13.27 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-O 119.513 -0.604 . . . . 75.0 111.815 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -129.73 143.51 50.85 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.724 0.762 . . . . 75.329999999999998 110.096 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.664 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.5 -172.28 43.46 Favored Glycine 0 C--O 1.225 -0.428 0 N-CA-C 110.972 -0.851 . . . . 64.420000000000002 110.972 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 40.9 m95 -107.34 125.19 50.88 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.323 0.561 . . . . 74.239999999999995 110.505 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.426 HG13 HG21 ' A' ' 101' ' ' ILE . 29.7 m -130.52 140.42 38.6 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.433 1.493 . . . . 71.349999999999994 109.091 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 9.3 Cg_exo -72.15 147.96 49.25 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 122.731 2.287 . . . . 71.049999999999997 114.414 -171.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 m -37.2 -51.59 1.02 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.415 1.886 . . . . 73.439999999999998 114.189 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -75.11 -3.18 31.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.546 0.738 . . . . 74.349999999999994 112.809 -171.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -94.47 -23.21 17.82 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.493 0.717 . . . . 74.450000000000003 111.577 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 109' ' ' VAL . 11.4 pt -123.32 173.77 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.794 0.838 . . . . 71.420000000000002 111.346 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.3 t -160.97 153.63 17.43 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.039 -1.097 . . . . 73.319999999999993 108.039 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.24 147.76 93.61 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 121.59 1.527 . . . . 62.119999999999997 110.981 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.82 -6.9 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 CA-C-O 121.499 0.666 . . . . 64.409999999999997 110.885 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 77' ' ' PRO . 5.1 m120 -79.29 -13.15 59.84 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.346 0.658 . . . . 73.329999999999998 112.076 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.0 p -88.53 174.82 7.87 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.336 0.588 . . . . 63.32 112.418 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -84.03 -22.68 31.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.047 -0.979 . . . . 74.230000000000004 110.475 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.23 -22.09 66.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.964 0.905 . . . . 75.099999999999994 112.121 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -63.28 -13.74 41.76 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.529 0.566 . . . . 63.43 112.529 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.517 ' HD1' ' HB2' ' A' ' 69' ' ' SER . 95.8 m-70 -94.25 150.65 20.1 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.76 0.824 . . . . 74.310000000000002 110.425 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.8 p -67.66 -38.82 84.3 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 124.272 0.983 . . . . 74.319999999999993 111.635 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.475 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 41.9 p-90 -60.38 -48.96 79.48 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.82 0.7 . . . . 74.040000000000006 111.958 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.48 96.88 2.99 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.125 -0.694 . . . . 74.0 109.125 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -91.57 -2.38 57.15 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.616 -0.72 . . . . 74.010000000000005 111.078 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.54 -161.82 42.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.158 -0.801 . . . . 63.43 112.588 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.466 ' HG2' ' HD2' ' A' ' 29' ' ' ARG . 52.2 Cg_exo -58.33 98.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.4 2.733 . . . . 75.430000000000007 112.564 174.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 53.5 t -122.94 135.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 114.674 -1.148 . . . . 75.420000000000002 109.9 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.7 p -75.37 156.72 35.17 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.366 0.666 . . . . 62.130000000000003 109.489 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 71.1 ttt180 -62.71 -36.92 84.52 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 118.78 -0.629 . . . . 71.450000000000003 111.361 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -55.42 -43.94 75.8 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.559 0.695 . . . . 73.140000000000001 110.484 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.43 70.22 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.406 -1.27 . . . . 70.439999999999998 111.321 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.5 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.084 0.554 . . . . 74.510000000000005 111.402 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.2 mm-40 -68.98 -30.17 68.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.146 0.578 . . . . 73.140000000000001 110.009 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.73 -47.32 84.09 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.202 0.601 . . . . 75.420000000000002 110.329 171.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.6 mt -60.48 -35.33 75.65 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.987 0.515 . . . . 72.420000000000002 110.679 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 73.9 mt -105.74 21.32 17.45 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.539 -0.755 . . . . 75.319999999999993 113.036 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.8 p -88.61 -35.13 17.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.453 -0.943 . . . . 74.219999999999999 108.453 165.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.7 p -95.97 12.89 28.82 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.94 -1.027 . . . . 64.019999999999996 111.702 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.0 -175.59 40.97 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 112.493 -0.243 . . . . 73.140000000000001 112.493 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.3 pt -131.18 -174.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.363 1.065 . . . . 72.530000000000001 110.036 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -58.72 122.32 13.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 74.030000000000001 110.799 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.78 9.57 68.25 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.84 -0.618 . . . . 71.349999999999994 113.66 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 48.8 m -88.9 127.85 35.66 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.975 0.887 . . . . 61.149999999999999 110.035 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -132.41 -178.33 4.87 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.772 0.714 . . . . 75.209999999999994 112.793 -172.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.0 pp -164.69 155.97 15.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.048 0.939 . . . . 75.140000000000001 109.633 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.669 HG21 HG12 ' A' ' 182' ' ' ILE . 88.1 t -116.37 134.36 60.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.356 -0.979 . . . . 72.519999999999996 108.356 167.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 15.4 ptt180 -130.26 149.39 51.98 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.522 -0.763 . . . . 70.340000000000003 110.077 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -93.11 150.44 20.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.076 1.35 . . . . 74.439999999999998 108.036 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.8 t -79.5 123.51 27.63 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.819 -0.437 . . . . 74.010000000000005 109.819 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.98 -36.14 72.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.284 1.033 . . . . 74.409999999999997 111.2 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.0 p -78.39 -31.09 48.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.409 0.683 . . . . 74.430000000000007 111.566 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.4 m -140.04 89.43 11.19 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.192 0.597 . . . . 75.120000000000005 109.764 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.38 132.7 53.44 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.068 2.512 . . . . 72.400000000000006 112.819 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.52 -27.82 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.842 0.734 . . . . 72.409999999999997 112.388 -175.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -86.87 114.56 23.62 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.817 -0.808 . . . . 73.519999999999996 108.817 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -125.96 148.45 49.25 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.235 0.54 . . . . 73.239999999999995 110.914 -172.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.6 p -144.42 148.88 35.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.782 -1.099 . . . . 74.200000000000003 109.923 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.669 HG12 HG21 ' A' ' 170' ' ' VAL . 41.6 mt -102.25 149.71 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.264 -1.384 . . . . 74.299999999999997 107.264 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -125.29 120.85 32.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.105 -1.443 . . . . 75.430000000000007 107.105 170.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 67.7 tp -114.04 114.11 25.69 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.921 0.782 . . . . 73.420000000000002 110.52 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 29.3 ttt85 -77.48 113.85 15.71 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 109.761 -0.459 . . . . 75.109999999999999 109.761 166.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -142.06 138.68 31.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.206 1.402 . . . . 74.129999999999995 107.477 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 58.74 22.14 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.426 1.09 . . . . 72.310000000000002 111.984 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.93 86.7 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 114.226 0.45 . . . . 72.030000000000001 114.226 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -108.17 147.62 31.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.925 0.89 . . . . 75.010000000000005 108.685 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.32 105.58 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.384 0.674 . . . . 72.109999999999999 109.827 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.35 116.46 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.486 1.115 . . . . 74.349999999999994 109.333 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -91.59 118.95 31.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.826 0.451 . . . . 52.109999999999999 110.751 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.561 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.4 m-85 -94.77 151.17 19.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.185 0.994 . . . . 71.430000000000007 108.782 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -104.71 122.72 46.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.415 -0.587 . . . . 74.420000000000002 109.415 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.2 mt -90.98 105.87 16.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.084 -0.71 . . . . 73.519999999999996 109.084 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.91 140.3 29.63 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.412 0.685 . . . . 71.010000000000005 110.033 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 42.6 m -98.36 119.05 36.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.655 1.182 . . . . 70.019999999999996 107.854 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 174.45 6.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.978 0.911 . . . . 73.329999999999998 110.569 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 61.0 p -66.01 -25.63 67.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.373 0.669 . . . . 54.520000000000003 111.937 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.36 -17.21 29.29 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.143 0.577 . . . . 75.299999999999997 111.0 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.55 6.0 23.81 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-O 119.352 -0.693 . . . . 74.209999999999994 114.493 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -70.96 128.6 36.54 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.915 0.857 . . . . 74.540000000000006 112.097 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.21 143.12 34.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.783 0.833 . . . . 75.099999999999994 108.924 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.511 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.2 p90 -165.9 146.84 6.79 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.506 0.504 . . . . 71.329999999999998 111.624 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 217' ' ' LEU . 78.0 t -89.39 -42.44 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.561 -0.903 . . . . 73.030000000000001 108.561 165.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.2 m -104.87 129.32 53.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.95 -1.023 . . . . 73.310000000000002 109.155 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -67.14 -18.54 65.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.305 0.642 . . . . 64.349999999999994 111.739 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -70.29 -26.56 63.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.608 1.163 . . . . 63.32 110.942 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 51.1 p -137.46 107.66 6.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.535 0.734 . . . . 72.400000000000006 109.93 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.511 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.2 mtt180 -116.56 133.82 55.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.303 1.041 . . . . 75.409999999999997 108.881 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 143.67 50.97 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.365 0.666 . . . . 75.040000000000006 109.945 -170.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -67.91 -22.29 65.09 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.974 0.51 . . . . 73.329999999999998 112.066 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.2 p -130.89 155.14 47.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.121 0.962 . . . . 71.129999999999995 112.05 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -28.19 69.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 113.631 -1.622 . . . . 73.439999999999998 109.327 173.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.79 94.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.733 0.813 . . . . 72.439999999999998 110.945 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.407 0.683 . . . . 73.319999999999993 111.15 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.475 HD11 HG21 ' A' ' 205' ' ' VAL . 17.8 tp -55.2 -54.37 44.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 123.552 0.533 . . . . 70.310000000000002 111.158 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.88 -46.79 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 124.038 0.836 . . . . 74.140000000000001 110.703 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -61.74 -48.05 82.45 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.544 0.527 . . . . 73.129999999999995 111.968 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.02 -47.04 78.86 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.939 -0.573 . . . . 75.150000000000006 109.609 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.641 ' HB3' HD13 ' A' ' 228' ' ' LEU . 15.9 m-70 -82.76 -1.45 51.59 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 112.296 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.8 p -94.14 -40.83 9.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.919 0.488 . . . . 74.349999999999994 110.913 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.7 p -69.63 -38.3 77.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.321 -0.399 . . . . 71.450000000000003 111.019 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 226' ' ' ASP . 17.6 m -132.97 162.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.669 0.747 . . . . 64.349999999999994 112.237 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.34 15.71 0.92 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 127.219 2.208 . . . . 73.349999999999994 113.988 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.621 ' HB2' HG21 ' A' ' 224' ' ' VAL . 23.4 t70 -44.2 33.44 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.464 1 C-N-CA 132.357 4.263 . . . . 74.329999999999998 119.519 -156.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.28 2.14 9.16 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.243 -1.536 . . . . 72.349999999999994 112.63 -171.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.641 HD13 ' HB3' ' A' ' 221' ' ' HIS . 14.5 mt -94.5 165.58 12.47 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 125.701 1.6 . . . . 74.109999999999999 109.972 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.1 tt -56.38 -42.05 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 109.982 -0.377 . . . . 73.040000000000006 109.982 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.9 t -160.91 177.39 10.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.995 0.918 . . . . 70.540000000000006 109.693 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 68.3 p -61.85 150.12 38.26 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.451 1.1 . . . . 75.530000000000001 113.106 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.561 HD21 ' HE1' ' A' ' 193' ' ' TYR . 86.5 mt -83.65 92.44 7.68 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.384 -0.969 . . . . 74.200000000000003 108.384 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -78.76 -51.32 9.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.504 0.557 . . . . 72.329999999999998 112.504 -161.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.4 OUTLIER -148.16 150.22 34.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.843 -1.169 . . . . 74.430000000000007 107.843 169.109 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -96.0 153.29 1.41 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.384 2.722 . . . . 73.109999999999999 114.149 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.51 128.38 88.1 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 114.653 -1.158 . . . . 73.010000000000005 109.53 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.58 -173.79 1.45 Allowed 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 123.006 2.47 . . . . 74.340000000000003 113.31 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.47 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 74.1 mmtt -67.3 133.27 49.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.867 0.867 . . . . 73.099999999999994 109.523 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.465 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 13.5 ptt180 -86.49 -66.72 0.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.538 0.94 . . . . 75.340000000000003 113.538 -167.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.465 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 9.1 t30 -114.98 158.03 22.61 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.984 0.514 . . . . 74.340000000000003 111.323 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.91 114.62 41.09 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 108.115 -1.068 . . . . 72.540000000000006 108.115 166.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.56 123.12 12.87 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.018 2.478 . . . . 74.409999999999997 112.167 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 5.1 m -72.95 103.64 3.82 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.651 -0.704 . . . . 72.420000000000002 111.268 -167.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.484 HG23 ' HG2' ' A' ' 131' ' ' PRO . 25.0 t -93.39 127.92 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.261 -1.014 . . . . 75.209999999999994 108.261 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -104.44 111.18 23.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.426 -0.321 . . . . 71.099999999999994 110.331 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.84 -39.39 0.24 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 118.245 2.058 . . . . 71.200000000000003 118.245 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.3 123.55 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.818 1.044 . . . . 74.439999999999998 113.818 -157.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.1 t -82.04 129.31 64.84 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 106.01 -1.848 . . . . 70.299999999999997 106.01 157.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.08 -55.61 0.98 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.484 1.456 . . . . 73.129999999999995 113.957 -154.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -129.46 -17.3 3.75 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.943 0.897 . . . . 74.340000000000003 111.243 161.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.431 ' CD1' ' HB2' ' A' ' 254' ' ' TRP . 73.7 m-85 -86.39 108.97 18.71 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.0 1.111 . . . . 75.209999999999994 114.0 -158.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -104.41 -23.53 13.17 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.225 -0.898 . . . . 72.310000000000002 108.764 159.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -94.04 9.38 37.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.05 0.94 . . . . 72.109999999999999 112.247 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.465 ' HE3' ' HA ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -94.38 157.88 15.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.493 0.588 . . . . 75.430000000000007 110.008 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 C--O 1.25 1.117 0 N-CA-C 107.49 -1.3 . . . . 71.540000000000006 107.49 173.693 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.139 -0.689 . . . . 72.519999999999996 109.139 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.8 78.06 0.51 Allowed Glycine 0 C--N 1.353 1.526 0 O-C-N 123.645 0.59 . . . . 74.420000000000002 112.732 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -132.86 175.74 9.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.837 1.255 . . . . 73.329999999999998 109.319 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -71.32 136.3 84.15 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 109.162 -0.681 . . . . 73.439999999999998 109.162 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -52.69 108.28 0.25 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.029 2.486 . . . . 75.140000000000001 112.615 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.61 134.92 35.64 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.303 -0.862 . . . . 65.340000000000003 112.036 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -82.48 67.71 8.64 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.825 0.85 . . . . 74.5 108.903 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.6 m -87.64 130.77 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.761 -1.108 . . . . 72.219999999999999 109.514 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.79 150.71 23.21 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.336 -0.986 . . . . 74.239999999999995 108.336 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.79 114.53 0.62 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.064 -0.814 . . . . 72.25 111.064 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -151.94 111.24 3.92 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.636 -0.875 . . . . 74.409999999999997 108.636 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -136.32 -179.23 5.55 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.047 0.939 . . . . 51.409999999999997 108.931 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 164.0 39.07 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.993 -0.743 . . . . 75.019999999999996 108.993 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.43 142.84 25.13 Favored Pre-proline 0 N--CA 1.487 1.375 0 CA-C-N 118.088 0.404 . . . . 74.5 110.802 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.49 93.11 0.58 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.951 2.434 . . . . 54.43 111.714 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.2 p -81.49 116.53 21.32 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.225 0.61 . . . . 74.549999999999997 110.19 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -155.48 113.35 2.24 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.638 -1.245 . . . . 71.099999999999994 107.638 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.12 155.77 59.13 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 123.377 2.718 . . . . 75.530000000000001 112.977 -172.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -127.14 153.69 45.7 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.354 0.662 . . . . 64.239999999999995 111.621 -170.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.3 mt -101.83 131.36 48.2 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.893 0.877 . . . . 73.319999999999993 110.011 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.494 ' HA ' ' OH ' ' A' ' 251' ' ' TYR . 0.6 OUTLIER -80.4 147.64 30.91 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 117.575 0.17 . . . . 74.109999999999999 110.845 177.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -112.92 149.26 33.44 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.4 0.68 . . . . 75.230000000000004 109.685 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.56 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 37.7 pt -112.96 177.29 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.43 0.692 . . . . 74.25 110.879 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt 78.31 142.35 0.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 126.243 1.817 . . . . 73.310000000000002 112.29 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.488 ' HA3' ' HD1' ' A' ' 112' ' ' TYR . . . 137.66 150.63 5.74 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.097 -0.956 . . . . 52.130000000000003 111.97 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.712 ' HA ' ' HZ ' ' A' ' 85' ' ' PHE . . . -147.44 98.43 2.99 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.197 0.599 . . . . 71.109999999999999 111.414 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 28' ' ' LYS . . . 61.35 -179.3 3.56 Favored Glycine 0 C--N 1.364 2.104 0 O-C-N 123.662 0.601 . . . . 74.450000000000003 113.33 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 27' ' ' GLY . 4.0 mmtm -162.08 -104.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.762 1.225 . . . . 73.310000000000002 109.102 169.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.72 90.94 3.46 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.462 -0.94 . . . . 73.200000000000003 108.462 -175.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -81.42 63.77 5.87 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.306 1.051 . . . . 63.109999999999999 108.264 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.2 p -84.86 156.71 21.17 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 114.052 -1.431 . . . . 53.43 111.291 -170.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.7 m -76.27 179.44 5.76 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.028 -0.987 . . . . 65.239999999999995 111.551 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.628 ' HB3' ' HB3' ' A' ' 240' ' ' ASN . 0.2 OUTLIER -161.41 142.25 11.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.526 -1.657 . . . . 75.519999999999996 106.526 178.246 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -86.98 119.74 27.51 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.416 0.553 . . . . 61.420000000000002 109.776 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.38 -152.15 6.84 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.241 -0.436 . . . . 74.5 113.079 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.4 96.03 0.21 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.363 -0.687 . . . . 62.329999999999998 111.865 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -83.9 156.84 13.55 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.062 2.508 . . . . 74.140000000000001 112.029 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -147.28 145.33 29.35 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.702 0.401 . . . . 75.120000000000005 110.37 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.478 ' SG ' ' HG3' ' A' ' 237' ' ' PRO . 94.7 m -131.21 155.74 46.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.105 0.962 . . . . 72.049999999999997 111.014 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -150.48 -176.9 5.67 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 107.479 -1.304 . . . . 73.019999999999996 107.479 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.5 t 79.66 118.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 125.09 1.356 . . . . 72.299999999999997 110.243 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -77.42 172.52 13.2 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.372 0.669 . . . . 74.439999999999998 110.389 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.58 HG21 ' HB1' ' A' ' 65' ' ' ALA . 43.6 t -121.52 -174.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.816 1.246 . . . . 55.350000000000001 107.957 -175.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' N ' HG13 ' A' ' 43' ' ' VAL . 9.6 tp10 -133.9 138.4 45.53 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.331 0.652 . . . . 75.109999999999999 110.292 168.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.489 ' HD1' ' HB2' ' A' ' 61' ' ' LEU . 22.5 t-160 -164.15 -93.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.654 0.782 . . . . 72.209999999999994 110.434 166.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 162.48 153.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.473 1.509 . . . . 75.140000000000001 108.07 -166.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.14 158.8 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.178 1.391 . . . . 73.319999999999993 113.027 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -157.34 173.03 17.55 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.375 0.67 . . . . 75.25 110.225 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.08 -55.46 0.45 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.946 -1.131 . . . . 51.119999999999997 107.946 174.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.558 ' HD2' HD22 ' A' ' 165' ' ' ASN . 0.0 OUTLIER -119.9 86.69 36.82 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 106.989 -1.486 . . . . 74.510000000000005 106.989 170.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.56 141.89 51.92 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.88 2.387 . . . . 64.510000000000005 112.99 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 m -82.36 -14.7 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-O 121.149 0.5 . . . . 64.219999999999999 110.583 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.53 101.28 3.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.52 1.128 . . . . 75.549999999999997 108.209 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.0 m -85.71 71.81 10.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.919 0.888 . . . . 72.430000000000007 109.918 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -173.81 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.264 1.425 . . . . 73.209999999999994 108.676 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -167.98 124.94 1.11 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 124.441 1.096 . . . . 73.129999999999995 108.458 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.69 105.92 56.33 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.607 0.763 . . . . 75.409999999999997 109.333 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.99 -36.64 58.58 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.489 2.126 . . . . 73.140000000000001 111.501 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.415 ' HB3' ' H ' ' A' ' 43' ' ' VAL . 5.0 pm0 -91.77 -45.87 8.19 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.863 -1.062 . . . . 74.340000000000003 111.091 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.56 -107.58 1.45 Allowed Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.695 -0.962 . . . . 73.319999999999993 110.695 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.489 ' HB2' ' HD1' ' A' ' 45' ' ' HIS . 96.3 mt -77.41 90.22 3.82 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 109.303 -0.629 . . . . 74.120000000000005 109.303 168.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.5 t -67.51 105.35 1.81 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.945 1.298 . . . . 74.450000000000003 111.606 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.525 ' H ' HG11 ' A' ' 43' ' ' VAL . 11.1 pt-20 -144.19 -48.01 0.27 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.103 1.149 . . . . 73.409999999999997 114.103 -171.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.7 -48.61 80.97 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.399 0.888 . . . . 73.420000000000002 113.399 -168.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.58 ' HB1' HG21 ' A' ' 43' ' ' VAL . . . -86.52 -9.79 55.43 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.16 0.584 . . . . 73.109999999999999 112.219 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.44 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -102.08 -63.74 1.13 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.358 0.663 . . . . 74.409999999999997 109.62 -176.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.42 46.12 1.19 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.372 1.069 . . . . 74.420000000000002 109.615 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.6 p-10 -63.98 -24.18 67.62 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.355 1.062 . . . . 71.310000000000002 110.236 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.5 m -67.34 3.04 1.37 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.871 1.269 . . . . 75.299999999999997 112.796 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.8 -40.28 83.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.401 1.08 . . . . 74.430000000000007 111.508 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 7.9 pt-20 -68.53 -39.14 81.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.829 0.452 . . . . 75.109999999999999 110.146 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.467 HD21 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -81.12 -10.29 59.68 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.254 -0.884 . . . . 75.120000000000005 111.025 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.3 tp -62.78 -52.75 61.98 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.313 0.645 . . . . 75.549999999999997 110.122 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.9 mt -104.34 20.92 17.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.04 0.536 . . . . 74.439999999999998 110.624 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 72' ' ' ASN . . . -70.72 -32.75 70.06 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.94 0.496 . . . . 72.319999999999993 111.278 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.6 -134.44 22.4 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-O 118.785 -1.008 . . . . 43.450000000000003 110.856 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 31.3 Cg_exo -58.63 -175.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.85 2.367 . . . . 74.310000000000002 113.096 167.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.437 ' OG ' ' HB ' ' A' ' 138' ' ' VAL . 7.0 m -72.94 170.74 14.15 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 122.808 0.443 . . . . 74.019999999999996 110.406 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.65 -50.57 29.4 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 111.92 0.341 . . . . 70.299999999999997 111.92 -170.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -131.2 -38.46 1.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.278 0.631 . . . . 75.230000000000004 110.883 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 24.0 m-20 -91.35 111.03 46.76 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 117.972 -1.013 . . . . 63.140000000000001 112.003 -174.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -58.31 -26.69 78.17 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.439 2.093 . . . . 73.510000000000005 112.217 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -96.41 20.45 10.53 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.386 0.674 . . . . 75.409999999999997 110.767 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.2 tp -84.14 135.28 34.45 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.699 -0.625 . . . . 73.349999999999994 109.462 175.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.712 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 5.3 m-85 -119.22 174.23 6.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.238 1.415 . . . . 75.349999999999994 109.734 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.62 139.41 35.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.959 1.303 . . . . 74.329999999999998 108.338 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 107' ' ' LEU . . . -76.09 130.8 38.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.619 0.768 . . . . 72.409999999999997 109.344 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.0 mt -91.26 -26.91 18.77 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.395 0.678 . . . . 63.43 110.728 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.14 165.64 21.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.504 0.721 . . . . 75.519999999999996 110.362 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 3.4 m-20 -89.18 120.21 30.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.191 -0.913 . . . . 71.340000000000003 108.915 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.529 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.5 t80 -114.96 148.14 39.13 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.282 -1.007 . . . . 72.25 108.282 173.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.6 t -122.92 134.54 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.19 -1.041 . . . . 70.230000000000004 108.19 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.3 124.54 22.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.804 . . . . 74.450000000000003 111.573 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 p -141.32 18.56 2.24 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.076 0.95 . . . . 73.230000000000004 111.213 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.25 -179.28 24.08 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.944 -0.863 . . . . 54.149999999999999 110.944 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.93 -38.84 76.33 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.985 0.514 . . . . 64.200000000000003 111.516 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.472 HD22 ' HG2' ' A' ' 249' ' ' PRO . 27.0 p-10 -105.47 -3.19 22.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.977 0.511 . . . . 75.310000000000002 112.305 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.407 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 73.6 p -72.47 164.57 26.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.728 0.64 . . . . 73.310000000000002 112.728 -170.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.581 HD23 ' HG1' ' A' ' 123' ' ' THR . 67.3 tp -147.18 136.31 22.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.022 0.529 . . . . 75.319999999999993 110.744 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.4 m -80.0 117.6 20.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.307 0.643 . . . . 71.319999999999993 110.615 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.593 HG23 HG23 ' A' ' 123' ' ' THR . 22.6 pt -117.72 157.04 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.167 0.587 . . . . 74.109999999999999 111.009 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.8 m -111.31 151.54 28.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.566 1.146 . . . . 75.200000000000003 109.064 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HZ1' ' HB2' ' A' ' 103' ' ' LYS . 4.0 ttmp? -60.05 125.62 24.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.231 0.612 . . . . 71.310000000000002 110.414 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.62 -7.23 82.41 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.611 . . . . 54.049999999999997 113.751 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -69.57 124.39 23.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.366 0.583 . . . . 71.430000000000007 111.058 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -73.86 134.94 43.35 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.348 -0.612 . . . . 63.140000000000001 109.348 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.595 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.0 159.05 44.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.8 0.84 . . . . 74.530000000000001 110.457 -175.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 56.7 ttm-85 -115.43 109.97 18.64 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.881 0.472 . . . . 74.230000000000004 110.578 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 119' ' ' ALA . 25.5 t -70.61 112.18 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.56 0.695 . . . . 73.150000000000006 109.127 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.08 -41.83 58.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.042 -0.981 . . . . 70.140000000000001 108.364 175.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 23' ' ' ILE . . . 172.77 158.33 16.79 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.843 0.714 . . . . 64.099999999999994 113.639 171.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.764 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 59.9 m-85 -88.16 164.89 15.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 70.209999999999994 111.666 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.7 -172.56 3.37 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.972 0.909 . . . . 73.219999999999999 111.162 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.24 -35.43 11.97 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 115.158 1.54 . . . . 73.540000000000006 115.158 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -110.5 -15.43 13.9 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.136 0.574 . . . . 74.299999999999997 111.791 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.764 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 87.97 30.19 18.26 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 114.631 0.613 . . . . 73.209999999999994 114.631 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.45 -38.05 17.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.516 0.658 . . . . 75.530000000000001 111.79 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 18.1 m95 -125.52 146.25 49.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.163 0.585 . . . . 74.129999999999995 110.559 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -129.72 136.5 49.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 74.129999999999995 110.927 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.641 ' HG2' HE21 ' A' ' 127' ' ' GLN . 27.1 tt0 -69.41 103.79 2.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.11 -1.07 . . . . 74.409999999999997 108.11 173.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.7 138.42 39.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.108 0.563 . . . . 75.549999999999997 111.135 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 61.3 tt0 -97.75 104.89 16.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.903 -1.147 . . . . 74.310000000000002 107.903 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.595 HG22 ' HB3' ' A' ' 107' ' ' LEU . 68.5 p -111.09 172.07 7.1 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.753 0.821 . . . . 72.5 110.86 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -14.53 62.97 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 114.718 -1.128 . . . . 74.319999999999993 110.031 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.1 -26.66 30.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.18 0.992 . . . . 64.439999999999998 111.539 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 136.22 -158.68 24.07 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 120.158 -0.245 . . . . 75.019999999999996 112.533 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.641 HE21 ' HG2' ' A' ' 120' ' ' GLU . 66.5 tp60 -101.82 137.39 40.18 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.208 0.504 . . . . 74.010000000000005 111.377 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 165.9 162.67 17.76 Favored Glycine 0 C--N 1.347 1.143 0 C-N-CA 121.403 -0.427 . . . . 63.520000000000003 113.399 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 43.1 m95 -77.15 133.69 38.9 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.319 1.047 . . . . 74.140000000000001 112.19 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.3 m -136.28 146.32 55.64 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 125.108 1.363 . . . . 70.530000000000001 108.552 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 73.4 Cg_endo -76.06 150.05 33.25 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.1 1.867 . . . . 71.200000000000003 114.888 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -39.23 -49.06 1.87 Allowed 'General case' 0 C--N 1.366 1.308 0 C-N-CA 126.243 1.817 . . . . 61.299999999999997 113.516 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -79.22 -0.85 33.78 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.082 0.771 . . . . 73.219999999999999 113.082 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -98.76 -13.38 20.22 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.85 0.86 . . . . 74.519999999999996 111.487 170.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.73 177.25 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.26 1.024 . . . . 75.25 110.451 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.4 t -161.75 151.91 14.3 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 108.463 -0.939 . . . . 73.450000000000003 108.463 170.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.03 148.15 86.69 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.705 1.603 . . . . 62.450000000000003 111.679 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.437 ' HB ' ' OG ' ' A' ' 78' ' ' SER . 36.9 t -71.27 -7.76 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-O 121.688 0.756 . . . . 74.310000000000002 109.893 173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 5.3 m120 -75.45 -20.26 58.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.078 0.951 . . . . 74.0 111.746 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.5 p -91.83 174.41 7.35 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.448 0.699 . . . . 75.25 111.607 -172.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.28 -20.04 32.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 71.129999999999995 110.569 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.5 -19.13 65.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.086 0.955 . . . . 75.299999999999997 111.992 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -62.68 -21.43 65.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.499 0.72 . . . . 74.340000000000003 112.658 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -78.47 139.75 38.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.285 0.634 . . . . 75.420000000000002 110.143 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.9 p -59.65 -41.94 91.66 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.187 0.995 . . . . 71.230000000000004 111.906 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -67.01 -38.66 86.35 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.834 0.709 . . . . 73.239999999999995 112.229 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.5 118.51 20.71 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.179 -0.674 . . . . 74.140000000000001 109.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -112.63 -1.46 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.122 0.569 . . . . 73.530000000000001 112.273 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.55 -162.23 49.0 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 118.807 -0.996 . . . . 75.099999999999994 112.794 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.38 95.9 0.15 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.988 2.459 . . . . 72.430000000000007 112.721 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 82.3 t -119.93 149.72 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.996 1.318 . . . . 70.120000000000005 109.002 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 45.6 m -85.66 166.8 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.525 0.73 . . . . 65.450000000000003 110.598 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -60.04 -50.92 71.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.988 0.515 . . . . 74.439999999999998 110.975 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -58.24 -39.75 79.95 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.0 0.92 . . . . 74.430000000000007 111.7 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.4 75.48 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.907 -0.588 . . . . 73.319999999999993 110.801 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.496 ' HA ' HD13 ' A' ' 159' ' ' LEU . . . -57.34 -39.21 75.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.585 0.707 . . . . 71.540000000000006 111.505 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -83.7 -19.04 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.254 -0.884 . . . . 73.5 111.971 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -24.69 43.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.839 0.745 . . . . 73.200000000000003 110.936 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.83 HD23 ' HA ' ' A' ' 239' ' ' ARG . 42.7 mt -69.77 -43.66 71.76 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.013 -0.994 . . . . 74.310000000000002 110.007 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 75.4 mt -94.8 22.77 6.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.844 -1.071 . . . . 71.400000000000006 112.285 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.7 p -74.23 -41.68 60.96 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.099 0.476 . . . . 75.239999999999995 110.152 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 p -111.99 15.06 20.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.183 0.993 . . . . 65.200000000000003 112.247 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.29 168.73 52.2 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 121.908 -0.187 . . . . 61.240000000000002 113.235 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 pt -101.8 -176.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.641 0.776 . . . . 65.299999999999997 111.056 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.558 HD22 ' HD2' ' A' ' 50' ' ' ARG . 4.4 m-20 -63.31 125.35 23.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.459 -0.791 . . . . 75.200000000000003 109.853 172.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.451 ' HA2' HD13 ' A' ' 184' ' ' LEU . . . 90.56 10.79 63.08 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 119.313 -0.715 . . . . 63.240000000000002 113.181 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 68.4 m -82.17 116.01 21.53 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.364 1.082 . . . . 64.040000000000006 111.627 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 183' ' ' SER . 12.9 p90 -132.25 168.47 17.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.448 0.642 . . . . 73.530000000000001 111.494 -171.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.32 155.88 25.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.355 -1.293 . . . . 73.530000000000001 108.584 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.648 HG23 HG12 ' A' ' 182' ' ' ILE . 77.5 t -112.33 125.04 69.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.028 -1.101 . . . . 74.530000000000001 108.028 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 36.3 ptt85 -114.81 161.65 17.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.039 -1.097 . . . . 75.340000000000003 108.039 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 155.24 23.11 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.9 t -79.79 126.41 30.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.049 0.54 . . . . 75.209999999999994 109.794 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -63.42 -34.87 78.69 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 123.948 0.78 . . . . 74.25 110.265 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 p -82.01 -19.38 40.57 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.626 0.77 . . . . 63.119999999999997 111.989 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -143.86 98.78 5.21 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.901 0.48 . . . . 72.200000000000003 111.176 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.53 136.35 75.33 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.089 2.526 . . . . 74.219999999999999 112.638 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.33 -29.53 6.07 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.135 -0.484 . . . . 62.539999999999999 113.546 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -75.83 117.3 17.42 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.384 -0.599 . . . . 74.140000000000001 109.384 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -122.29 145.79 47.9 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.658 0.742 . . . . 75.420000000000002 110.288 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.1 m -132.49 144.52 50.51 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.523 -1.217 . . . . 73.109999999999999 108.291 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.648 HG12 HG23 ' A' ' 170' ' ' VAL . 31.9 mt -99.68 148.56 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.787 -1.56 . . . . 74.5 106.787 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -123.9 108.71 12.73 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.336 -1.357 . . . . 74.409999999999997 107.336 172.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.451 HD13 ' HA2' ' A' ' 166' ' ' GLY . 67.3 tp -105.93 142.75 35.11 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.367 -0.605 . . . . 73.319999999999993 109.367 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.5 ttt85 -117.53 119.38 34.85 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.525 1.13 . . . . 75.049999999999997 109.486 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -140.97 136.27 32.01 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.061 1.344 . . . . 63.149999999999999 107.84 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 58.18 21.23 7.83 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.637 1.175 . . . . 74.329999999999998 111.62 -170.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.17 -9.5 74.73 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.185 0.434 . . . . 52.409999999999997 114.185 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 57.4 mtp85 -96.18 140.12 31.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.522 0.661 . . . . 75.219999999999999 110.177 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.15 108.42 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.691 0.796 . . . . 72.109999999999999 110.81 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.82 150.6 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.278 1.431 . . . . 74.549999999999997 108.51 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 86.0 m-70 -125.45 127.13 46.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.469 0.307 . . . . 73.340000000000003 110.174 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.44 ' HE1' HD23 ' A' ' 232' ' ' LEU . 5.9 m-85 -101.06 149.29 24.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.899 0.88 . . . . 74.439999999999998 109.287 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -97.99 117.25 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.708 -0.849 . . . . 72.5 108.708 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.7 mt -82.2 99.83 5.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.299 -1.371 . . . . 74.049999999999997 107.299 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -75.04 110.6 9.47 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.555 -1.276 . . . . 73.099999999999994 107.555 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.7 m -89.28 106.4 18.42 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.956 -0.757 . . . . 72.450000000000003 108.956 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.429 ' HB3' ' HE1' ' A' ' 204' ' ' TYR . . . -63.06 148.68 47.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.909 0.884 . . . . 75.049999999999997 110.743 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.3 p -65.5 -23.81 66.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.255 0.622 . . . . 75.329999999999998 112.13 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -78.24 -18.6 55.16 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.862 0.465 . . . . 72.439999999999998 110.986 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.61 14.77 12.06 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.869 -0.406 . . . . 63.520000000000003 114.012 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -92.15 139.0 31.07 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.779 0.789 . . . . 74.25 110.949 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.13 143.03 29.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.956 -1.128 . . . . 70.420000000000002 107.956 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.5 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.5 p90 -163.39 135.45 5.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.221 0.326 . . . . 74.319999999999993 111.675 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.4 t -82.94 -34.02 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.315 -0.995 . . . . 74.239999999999995 108.315 161.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.9 m -99.48 119.91 38.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.446 1.099 . . . . 71.549999999999997 110.344 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.6 t -59.12 -34.15 71.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.805 1.242 . . . . 75.340000000000003 112.634 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.22 -2.86 58.85 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.968 0.907 . . . . 74.340000000000003 111.836 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.5 m -135.05 85.63 2.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.068 0.547 . . . . 73.319999999999993 109.527 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.5 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 43.5 mtt180 -93.59 120.49 33.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.929 0.891 . . . . 75.319999999999993 109.286 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -107.44 149.68 27.64 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.533 0.733 . . . . 74.450000000000003 109.351 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -62.36 -44.13 97.18 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.523 0.514 . . . . 70.420000000000002 110.161 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.4 p -125.68 160.5 29.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.637 0.732 . . . . 62.549999999999997 111.785 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.24 -25.92 68.27 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.728 -1.124 . . . . 71.200000000000003 109.317 171.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.13 86.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.039 0.936 . . . . 72.109999999999999 111.395 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -72.02 -30.71 65.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.131 -0.94 . . . . 74.049999999999997 111.346 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.8 tp -57.12 -55.49 34.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.306 0.379 . . . . 75.299999999999997 110.351 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.2 -41.96 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.752 0.658 . . . . 72.25 111.254 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -61.87 -55.1 33.24 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.452 0.47 . . . . 75.420000000000002 111.445 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -61.52 -38.08 86.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.443 0.697 . . . . 73.230000000000004 110.866 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.709 ' HB3' HD11 ' A' ' 228' ' ' LEU . 18.6 m170 -88.65 -6.41 57.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.793 -0.639 . . . . 73.510000000000005 112.386 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.0 p -91.07 -31.89 16.09 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 110.22 -0.289 . . . . 74.430000000000007 110.22 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 40.4 p -76.71 -40.63 48.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.206 -0.452 . . . . 72.439999999999998 111.351 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.616 HG23 ' HB2' ' A' ' 226' ' ' ASP . 18.3 m -134.84 158.45 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.331 0.652 . . . . 71.540000000000006 111.623 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.45 14.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 126.932 2.093 . . . . 71.219999999999999 114.424 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.616 ' HB2' HG23 ' A' ' 224' ' ' VAL . 36.4 t70 -42.92 32.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.78 1 C-N-CA 132.07 4.148 . . . . 73.319999999999993 119.761 -155.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.22 -1.8 9.71 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.22 -1.55 . . . . 71.299999999999997 112.112 -168.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.2 mt -92.07 162.8 14.21 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.691 1.196 . . . . 74.040000000000006 109.434 168.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.49 -42.57 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 121.046 0.45 . . . . 74.430000000000007 110.42 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -161.36 -179.23 7.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.106 0.962 . . . . 74.140000000000001 109.127 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 49.0 p -70.08 143.99 52.27 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.471 0.708 . . . . 65.430000000000007 112.346 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.44 HD23 ' HE1' ' A' ' 193' ' ' TYR . 49.3 mt -72.21 145.66 47.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.649 -1.241 . . . . 75.319999999999993 107.649 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.425 ' CE1' ' HB3' ' A' ' 61' ' ' LEU . 15.8 t60 -147.26 -78.66 0.16 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.323 0.965 . . . . 73.129999999999995 111.534 -175.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 167' ' ' SER . 11.5 t80 -83.41 124.06 76.17 Favored Pre-proline 0 C--O 1.208 -1.09 0 C-N-CA 124.284 1.034 . . . . 73.129999999999995 108.445 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -86.6 139.3 5.69 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.291 1.994 . . . . 73.25 112.122 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.25 151.9 90.14 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.408 0.683 . . . . 74.219999999999999 109.778 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.478 ' HG3' ' SG ' ' A' ' 39' ' ' CYS . 92.6 Cg_endo -76.06 176.83 9.52 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.508 2.139 . . . . 72.209999999999994 112.118 177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.62 154.57 40.2 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.129 0.572 . . . . 75.439999999999998 110.285 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.83 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -69.9 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.723 1.008 . . . . 75.209999999999994 113.723 -158.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.628 ' HB3' ' HB3' ' A' ' 33' ' ' ARG . 65.3 t30 -120.45 159.33 25.34 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.012 -1.055 . . . . 75.200000000000003 108.561 159.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.458 ' NZ ' ' HB2' ' A' ' 90' ' ' ASP . 98.6 mttt -73.43 115.64 43.33 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 107.686 -1.227 . . . . 65.219999999999999 107.686 160.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.49 127.44 21.83 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.042 2.495 . . . . 74.409999999999997 112.587 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 26.0 m -80.49 116.43 20.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.84 -0.43 . . . . 62.240000000000002 109.84 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.37 111.89 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.643 0.777 . . . . 74.420000000000002 108.964 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.9 112.8 20.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.541 -0.299 . . . . 75.140000000000001 110.692 -166.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 70.47 -41.51 0.51 Allowed Glycine 0 CA--C 1.542 1.737 0 N-CA-C 117.436 1.735 . . . . 71.239999999999995 117.436 163.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.61 135.4 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 117.687 0.743 . . . . 72.549999999999997 112.667 -157.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -82.8 130.08 59.47 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 105.757 -1.942 . . . . 74.049999999999997 105.757 157.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.472 ' HG2' HD22 ' A' ' 97' ' ' ASN . 12.2 Cg_exo -68.55 -57.21 0.15 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 121.575 1.516 . . . . 54.420000000000002 113.829 -153.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -129.76 -24.41 2.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.054 0.454 . . . . 71.400000000000006 110.437 164.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.494 ' OH ' ' HA ' ' A' ' 21' ' ' HIS . 82.2 m-85 -99.79 139.81 34.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.807 1.039 . . . . 74.530000000000001 113.807 -159.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.445 ' HB3' ' HD2' ' A' ' 253' ' ' LYS . 19.1 t70 -119.45 -31.99 4.46 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.922 1.289 . . . . 74.120000000000005 110.614 166.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 252' ' ' ASP . 1.2 mptp? -110.73 13.81 22.35 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.169 0.803 . . . . 74.340000000000003 113.169 -168.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.448 ' CE3' ' HA ' ' A' ' 97' ' ' ASN . 68.3 t90 -70.91 111.74 6.55 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.208 0.913 . . . . 73.299999999999997 110.766 -171.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 CA--C 1.558 1.284 0 C-N-CA 125.803 1.641 . . . . 72.329999999999998 112.468 179.747 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.542 0.21 . . . . 62.100000000000001 110.565 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.88 153.77 5.96 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.349 -0.387 . . . . 70.209999999999994 112.207 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -80.71 68.75 7.05 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.995 0.902 . . . . 72.010000000000005 109.677 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -141.14 140.68 21.52 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.582 1.553 . . . . 73.540000000000006 107.34 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.61 136.65 77.21 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.453 2.102 . . . . 64.450000000000003 112.175 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.13 110.14 3.37 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.219 -0.352 . . . . 71.519999999999996 112.219 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.22 112.18 23.15 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.86 -0.793 . . . . 75.109999999999999 108.86 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -64.94 -27.32 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 122.875 0.47 . . . . 74.030000000000001 111.404 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.4 mt 62.0 -176.23 0.13 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.752 1.221 . . . . 71.430000000000007 112.157 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.74 -142.96 10.13 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.768 -0.933 . . . . 70.129999999999995 110.768 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.94 141.49 40.46 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.352 -0.61 . . . . 71.219999999999999 109.352 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -78.18 149.34 33.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.172 0.589 . . . . 73.099999999999994 110.292 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -76.64 179.28 6.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.757 0.823 . . . . 74.319999999999993 111.94 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -56.94 168.04 0.94 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 124.821 1.248 . . . . 74.519999999999996 113.367 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 253' ' ' LYS . 1.2 Cg_exo -32.01 119.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 124.565 3.51 . . . . 71.340000000000003 116.477 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.0 m -108.45 20.73 18.23 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.834 -1.075 . . . . 71.340000000000003 109.817 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 255' ' ' GLU . 0.6 OUTLIER 37.26 85.67 0.15 Allowed Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 127.027 2.131 . . . . 74.430000000000007 115.918 173.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HA ' ' A' ' 254' ' ' TRP . 75.6 Cg_exo -56.42 152.49 39.5 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.846 2.364 . . . . 64.209999999999994 112.4 159.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.76 85.62 7.29 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.217 0.607 . . . . 55.109999999999999 111.326 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HA ' ' HZ2' ' A' ' 254' ' ' TRP . 10.5 mp 53.17 -87.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.695 1.598 . . . . 74.439999999999998 114.128 169.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 86.37 145.92 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 126.707 2.003 . . . . 72.299999999999997 111.364 -168.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -140.67 126.32 19.1 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.627 0.771 . . . . 71.409999999999997 109.923 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.4 pt -147.8 -171.45 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 124.99 1.316 . . . . 75.510000000000005 108.268 172.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -130.0 128.23 41.6 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 123.226 0.61 . . . . 74.530000000000001 109.848 171.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.3 166.07 26.51 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.63 -0.588 . . . . 52.310000000000002 111.63 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 85' ' ' PHE . . . -144.92 156.25 43.88 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.802 0.441 . . . . 75.120000000000005 111.831 -176.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.26 -177.55 36.67 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 112.401 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' HE3' ' HD2' ' A' ' 137' ' ' PRO . 9.2 ptpp? -171.6 169.28 6.09 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.965 0.906 . . . . 75.329999999999998 110.358 176.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 132' ' ' SER . 9.4 ptm180 -165.76 -171.17 1.99 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.106 0.963 . . . . 75.049999999999997 109.646 165.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.77 -171.74 2.64 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.825 0.85 . . . . 73.530000000000001 111.505 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.9 t -163.28 159.44 22.67 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.514 1.126 . . . . 74.319999999999993 108.6 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.5 p -140.41 110.65 6.62 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.074 0.55 . . . . 72.319999999999993 111.122 -168.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -133.11 -149.46 0.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.584 1.154 . . . . 74.019999999999996 108.602 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -151.94 130.94 12.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.209 0.604 . . . . 72.209999999999994 110.077 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.26 -115.28 0.33 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.171 -1.171 . . . . 45.439999999999998 110.171 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.7 81.47 0.04 OUTLIER Glycine 0 C--N 1.346 1.134 0 CA-C-O 119.411 -0.661 . . . . 45.25 112.114 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.56 159.87 35.36 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.679 2.252 . . . . 75.120000000000005 112.599 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -133.76 150.81 51.47 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.696 1.198 . . . . 75.109999999999999 109.828 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.0 t -152.85 141.83 21.23 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.423 0.689 . . . . 72.209999999999994 109.887 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.0 OUTLIER -160.62 126.5 3.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.787 0.835 . . . . 52.109999999999999 110.005 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.76 -159.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.331 1.052 . . . . 75.450000000000003 108.915 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -60.52 143.31 53.91 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.326 0.651 . . . . 73.140000000000001 111.49 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.2 m -85.08 -177.63 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.756 0.822 . . . . 73.340000000000003 109.777 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.536 ' HB3' ' HD1' ' A' ' 45' ' ' HIS . 0.4 OUTLIER -145.3 -74.05 0.24 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.568 0.622 . . . . 73.519999999999996 111.867 -179.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.536 ' HD1' ' HB3' ' A' ' 44' ' ' GLU . 0.9 OUTLIER -158.88 -160.6 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 122.162 -0.336 . . . . 75.510000000000005 111.368 -166.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 70.84 -177.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.241 1.016 . . . . 75.340000000000003 112.94 172.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.71 167.46 13.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.28 1.032 . . . . 73.019999999999996 110.185 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.92 -174.32 2.52 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.739 0.816 . . . . 74.400000000000006 109.921 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.547 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -117.09 6.97 12.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.815 0.846 . . . . 73.420000000000002 110.22 169.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 165' ' ' ASN . 48.9 ttt85 -173.29 106.51 0.31 Allowed Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.938 1.295 . . . . 71.329999999999998 107.935 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.54 153.66 30.7 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.809 2.339 . . . . 71.329999999999998 110.784 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.17 -175.88 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.892 0 C-N-CA 122.785 0.434 . . . . 73.0 110.527 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.1 116.91 3.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.276 0.63 . . . . 63.509999999999998 109.803 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 m -63.57 -23.47 67.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.261 1.025 . . . . 71.439999999999998 112.134 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.08 -30.38 70.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.613 1.165 . . . . 71.120000000000005 111.429 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.459 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 59.8 m-85 -128.65 39.18 3.85 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.887 0.875 . . . . 74.420000000000002 110.164 -174.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.84 97.51 17.76 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 123.504 0.722 . . . . 64.349999999999994 110.071 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 56' ' ' PHE . 4.6 Cg_exo -88.95 -50.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.317 2.678 . . . . 75.109999999999999 112.866 169.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -84.42 -58.32 2.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.595 0.758 . . . . 74.540000000000006 110.496 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.27 -79.6 0.9 Allowed Glycine 0 C--N 1.35 1.331 0 N-CA-C 111.002 -0.839 . . . . 63.43 111.002 -173.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.52 127.25 32.03 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.859 -0.793 . . . . 74.140000000000001 108.859 171.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.4 m -143.98 31.77 1.26 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.465 0.706 . . . . 71.450000000000003 109.756 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -48.5 74.4 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.356 -0.838 . . . . 73.019999999999996 110.488 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.72 -24.16 53.09 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.035 0.534 . . . . 71.019999999999996 111.213 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.9 -26.87 67.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.225 0.536 . . . . 65.230000000000004 111.129 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.562 HH22 ' HD3' ' A' ' 237' ' ' PRO . 15.7 mmm180 -114.46 -15.46 12.06 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.535 1.134 . . . . 73.400000000000006 111.768 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.781 ' HB2' ' HG3' ' A' ' 235' ' ' PRO . 11.6 t90 -150.6 53.04 0.88 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.949 0.881 . . . . 74.209999999999994 109.021 -169.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.7 p-10 -64.53 -24.18 67.52 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.367 -0.833 . . . . 64.439999999999998 110.012 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.7 p -69.69 3.67 2.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.863 1.265 . . . . 71.349999999999994 112.775 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.6 -20.96 66.13 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.816 0.446 . . . . 74.510000000000005 110.664 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 14.4 pt-20 -63.33 -42.46 98.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.056 0.542 . . . . 75.239999999999995 109.816 168.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -72.39 -16.5 61.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.469 1.108 . . . . 71.109999999999999 110.924 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 tp -63.53 -51.4 65.61 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.675 0.79 . . . . 64.430000000000007 110.632 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.6 mt -103.13 4.17 36.68 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 111.41 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.61 -30.27 62.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.667 0.387 . . . . 72.239999999999995 110.93 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.75 -136.51 27.65 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.118 -0.823 . . . . 70.120000000000005 111.59 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HA ' HD21 ' A' ' 139' ' ' ASN . 15.5 Cg_exo -67.02 151.36 82.11 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.57 2.18 . . . . 74.510000000000005 111.636 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 20.2 m -66.96 141.01 57.76 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.716 -0.475 . . . . 73.439999999999998 109.716 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -57.61 -44.5 85.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.483 1.113 . . . . 73.230000000000004 113.357 -168.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -113.11 -38.87 4.34 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.548 0.214 . . . . 71.530000000000001 111.424 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 78' ' ' SER . 57.4 m-20 -94.07 107.04 25.64 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 123.451 0.7 . . . . 74.150000000000006 111.607 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.28 -11.64 7.22 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.689 2.259 . . . . 62.240000000000002 112.477 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -110.73 19.58 18.48 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.822 0.849 . . . . 74.230000000000004 110.069 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.6 tp -79.4 139.12 37.81 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.327 -0.397 . . . . 74.219999999999999 110.033 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 7.2 m-85 -118.62 171.54 8.12 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.729 1.212 . . . . 75.230000000000004 109.723 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.35 131.48 22.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.502 1.121 . . . . 74.340000000000003 109.406 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.74 114.11 6.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.542 1.137 . . . . 74.230000000000004 109.889 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 78.0 mt -73.92 -32.63 63.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.516 0.726 . . . . 64.349999999999994 110.496 173.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.53 163.78 21.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.606 -1.179 . . . . 63.340000000000003 108.69 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.15 149.69 23.75 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.803 -0.814 . . . . 75.200000000000003 108.803 166.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.615 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.2 t80 -132.96 141.52 48.38 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.809 -1.182 . . . . 74.439999999999998 107.809 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.24 133.47 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.321 -0.992 . . . . 72.409999999999997 108.321 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.25 132.51 53.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.51 0.724 . . . . 52.229999999999997 111.108 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 p -129.39 -41.12 1.4 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.186 0.995 . . . . 74.140000000000001 111.065 -172.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.88 23.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.307 -0.406 . . . . 72.109999999999999 112.524 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.26 -43.57 10.88 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.638 0.719 . . . . 74.25 111.067 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB2' ' HE3' ' A' ' 254' ' ' TRP . 6.6 p30 -108.24 10.84 27.73 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.613 0.765 . . . . 71.329999999999998 112.123 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.0 p -73.14 150.35 42.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.347 0.659 . . . . 74.200000000000003 110.122 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.607 HD22 ' HG1' ' A' ' 123' ' ' THR . 58.1 tp -130.32 127.73 40.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.089 0.556 . . . . 74.040000000000006 110.824 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -74.27 133.14 42.62 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.221 0.609 . . . . 75.129999999999995 111.619 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.615 HG12 ' HB3' ' A' ' 91' ' ' PHE . 11.4 pt -130.28 166.84 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.208 1.003 . . . . 74.140000000000001 111.1 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.9 m -109.84 155.89 21.08 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.577 1.151 . . . . 74.430000000000007 110.329 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -58.95 127.84 34.24 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.162 0.585 . . . . 64.519999999999996 110.196 171.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.83 3.88 84.68 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.388 0.515 . . . . 64.340000000000003 114.388 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' OE2' ' HB ' ' A' ' 123' ' ' THR . 38.1 tt0 -73.45 142.48 46.86 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.053 0.541 . . . . 64.430000000000007 110.516 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -93.1 132.28 37.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.454 -0.573 . . . . 75.409999999999997 109.454 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.48 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -143.46 163.44 33.11 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.012 0.925 . . . . 72.450000000000003 110.511 -177.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -123.79 108.05 12.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.771 0.428 . . . . 72.409999999999997 110.345 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 119' ' ' ALA . 41.3 t -73.65 117.86 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.197 0.522 . . . . 73.530000000000001 110.47 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.8 mt -84.08 -60.3 2.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.822 -1.081 . . . . 74.450000000000003 109.079 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.4 141.1 9.01 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 120.853 -0.689 . . . . 51.229999999999997 112.942 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.627 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 20.5 m-85 -88.41 154.54 20.29 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.413 0.685 . . . . 74.219999999999999 109.781 171.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -78.54 -174.9 4.06 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.527 -1.215 . . . . 71.420000000000002 111.857 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -50.01 -31.65 13.36 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.185 1.394 . . . . 71.25 114.253 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -112.8 3.08 16.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.836 0.68 . . . . 71.219999999999999 112.836 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.49 19.65 74.74 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.974 0.75 . . . . 73.549999999999997 114.974 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.46 -12.13 18.79 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.453 0.701 . . . . 73.200000000000003 112.806 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 44.7 m95 -134.34 144.87 48.52 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.535 0.734 . . . . 72.010000000000005 110.248 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.516 ' HB3' HG13 ' A' ' 109' ' ' VAL . . . -132.98 129.7 38.55 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.716 0.807 . . . . 63.439999999999998 110.962 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.83 97.43 2.24 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 106.814 -1.55 . . . . 74.239999999999995 106.814 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.08 144.49 33.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.393 0.677 . . . . 75.340000000000003 111.434 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -93.76 103.37 15.51 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.78 -1.192 . . . . 72.239999999999995 107.78 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.607 ' HG1' HD22 ' A' ' 99' ' ' LEU . 38.5 p -97.36 174.56 6.63 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.003 0.921 . . . . 74.129999999999995 109.979 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -63.83 -23.21 67.26 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.189 0.518 . . . . 74.5 110.187 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -79.19 -29.35 42.87 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.598 1.159 . . . . 74.209999999999994 111.036 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 139.86 -170.03 24.43 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 112.282 -0.327 . . . . 63.229999999999997 112.282 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -97.33 135.93 38.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.463 0.632 . . . . 73.209999999999994 111.224 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.454 ' N ' HD21 ' A' ' 99' ' ' LEU . . . 170.6 172.28 36.79 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.328 -0.709 . . . . 63.149999999999999 111.328 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -85.19 124.02 31.35 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.344 0.572 . . . . 72.310000000000002 112.076 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.523 HG23 HD12 ' A' ' 135' ' ' ILE . 17.2 m -126.99 143.39 46.71 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.09 1.356 . . . . 72.510000000000005 108.445 170.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 66.2 Cg_endo -88.13 149.61 6.82 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.257 1.971 . . . . 73.219999999999999 115.33 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.601 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 2.4 m -46.67 -28.09 1.37 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.607 1.963 . . . . 75.540000000000006 115.592 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.531 HD22 HG22 ' A' ' 244' ' ' VAL . 32.0 p-10 -81.95 -16.32 50.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.478 0.311 . . . . 75.450000000000003 111.769 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.425 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 30.1 m-85 -94.48 -23.53 17.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 72.109999999999999 111.688 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.523 HD12 HG23 ' A' ' 130' ' ' VAL . 20.4 pt -123.56 168.01 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.071 0.549 . . . . 72.099999999999994 112.282 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.456 ' HG1' ' HB2' ' A' ' 142' ' ' GLU . 13.3 t -159.75 151.3 16.54 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.964 0.906 . . . . 74.400000000000006 108.643 174.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.423 ' HD2' ' HE3' ' A' ' 28' ' ' LYS . 24.3 Cg_endo -60.7 147.24 95.53 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 121.745 1.63 . . . . 73.230000000000004 111.724 174.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.29 -11.56 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.738 0.78 . . . . 73.239999999999995 110.767 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.419 HD21 ' HA ' ' A' ' 77' ' ' PRO . 10.2 m120 -80.26 -13.53 59.13 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.146 0.578 . . . . 75.549999999999997 111.648 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.2 p -89.16 165.16 14.65 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.253 0.621 . . . . 64.120000000000005 110.973 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.9 mt -80.35 -21.35 42.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.804 0.842 . . . . 71.239999999999995 110.817 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.456 ' HB2' ' HG1' ' A' ' 136' ' ' THR . 1.2 mp0 -63.83 -17.16 62.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.843 1.257 . . . . 74.409999999999997 111.68 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -61.54 -20.22 63.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.957 0.903 . . . . 73.239999999999995 112.976 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.47 144.55 25.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.167 0.587 . . . . 70.430000000000007 111.276 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -60.95 -41.5 96.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.596 1.158 . . . . 72.040000000000006 111.869 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -67.26 -33.07 74.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.649 0.779 . . . . 74.430000000000007 112.556 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -77.59 116.31 18.05 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.69 -0.856 . . . . 73.209999999999994 108.69 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.416 ' ND1' HD12 ' A' ' 159' ' ' LEU . 33.0 m170 -113.33 -2.71 13.94 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.36 0.504 . . . . 73.430000000000007 112.36 -175.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.9 -136.25 25.43 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 118.543 -1.143 . . . . 72.519999999999996 113.091 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.79 90.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.53 2.82 . . . . 74.549999999999997 112.71 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.6 t -132.31 133.73 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 75.549999999999997 108.963 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -89.79 175.53 7.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.862 0.865 . . . . 73.409999999999997 109.87 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 2.6 tmt_? -58.75 -45.92 88.6 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.76 0.424 . . . . 73.450000000000003 110.261 175.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -63.44 -35.12 79.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.714 0.805 . . . . 72.209999999999994 111.547 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.83 -30.34 62.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.058 -0.519 . . . . 70.329999999999998 110.95 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.7 71.23 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.009 0.524 . . . . 74.340000000000003 111.063 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 12.0 mm-40 -62.86 -48.28 79.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.251 0.62 . . . . 70.430000000000007 109.503 170.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.54 -41.21 69.45 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.077 1.751 . . . . 63.119999999999997 111.669 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.582 HD23 ' HB3' ' A' ' 239' ' ' ARG . 59.0 mt -68.1 -55.43 12.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.036 0.934 . . . . 74.209999999999994 111.684 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -84.89 16.02 3.62 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.576 0.584 . . . . 74.120000000000005 112.576 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.6 p -65.0 -40.34 94.8 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.405 0.621 . . . . 74.150000000000006 110.397 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.9 p -98.29 18.89 15.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.34 1.056 . . . . 73.230000000000004 111.0 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.46 162.97 32.31 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.243 -0.435 . . . . 73.299999999999997 112.56 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.1 -176.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.39 1.076 . . . . 70.299999999999997 110.039 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 50' ' ' ARG . 40.2 m-20 -67.47 123.2 19.75 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.422 -0.585 . . . . 74.340000000000003 109.422 175.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.78 5.98 57.36 Favored Glycine 0 C--O 1.25 1.155 0 CA-C-O 119.555 -0.581 . . . . 75.299999999999997 113.187 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 52.6 m -83.88 131.69 34.85 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 119.188 -0.434 . . . . 73.219999999999999 110.5 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.58 168.07 20.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.409 0.623 . . . . 65.340000000000003 111.557 -172.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.16 158.72 27.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 114.326 -1.306 . . . . 74.140000000000001 108.979 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 182' ' ' ILE . 98.9 t -119.31 137.69 52.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 N-CA-C 108.338 -0.986 . . . . 72.519999999999996 108.338 168.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.617 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 0.4 OUTLIER -122.26 146.86 46.89 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.009 -0.996 . . . . 73.519999999999996 109.634 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.1 tp10 -97.15 139.64 32.84 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.005 1.322 . . . . 71.310000000000002 108.207 164.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.4 t -83.82 123.14 29.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 72.519999999999996 109.093 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -81.88 -26.55 34.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.28 0.562 . . . . 65.239999999999995 109.799 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.8 m -64.49 -39.12 93.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.281 1.033 . . . . 73.150000000000006 110.213 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 47.5 m -137.51 91.3 14.19 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.035 -1.098 . . . . 71.319999999999993 108.035 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.68 134.38 60.31 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.98 2.453 . . . . 74.340000000000003 112.679 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.06 -27.23 21.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.483 -0.78 . . . . 75.400000000000006 112.549 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -85.22 116.9 23.84 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.538 -0.912 . . . . 71.329999999999998 108.538 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 99.4 mtt180 -123.38 159.5 28.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.477 0.656 . . . . 64.140000000000001 111.668 -170.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.421 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 18.8 m -149.0 152.51 36.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.914 -1.039 . . . . 71.120000000000005 109.516 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.578 HG12 HG23 ' A' ' 170' ' ' VAL . 25.3 mt -102.72 149.08 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.389 -1.337 . . . . 72.400000000000006 107.389 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.2 m -126.43 114.6 18.39 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.311 -0.996 . . . . 64.420000000000002 108.311 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.404 HD21 HG23 ' A' ' 230' ' ' THR . 41.7 tp -113.03 113.5 25.54 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.088 0.404 . . . . 73.040000000000006 109.911 175.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 44.4 ttt180 -77.82 115.3 17.46 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.324 0.583 . . . . 73.409999999999997 110.013 166.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -139.03 144.65 38.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.613 1.565 . . . . 75.239999999999995 107.361 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 58.3 21.07 7.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.04 0.936 . . . . 75.209999999999994 111.919 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.82 -0.37 89.62 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 119.418 -0.657 . . . . 43.149999999999999 114.535 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 55.8 mtp180 -115.36 150.42 36.35 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 117.893 0.846 . . . . 75.010000000000005 109.672 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 62.0 t -100.82 118.94 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.146 0.578 . . . . 75.319999999999993 110.541 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -108.21 117.47 34.23 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.184 0.993 . . . . 74.340000000000003 108.634 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -91.42 122.32 33.91 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.022 0.529 . . . . 75.510000000000005 110.503 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.497 ' HE1' HD22 ' A' ' 232' ' ' LEU . 6.6 m-85 -94.36 149.08 21.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.43 1.092 . . . . 74.209999999999994 108.291 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -101.21 127.5 47.75 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.087 -0.708 . . . . 74.120000000000005 109.087 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.51 101.05 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.83 -1.174 . . . . 71.209999999999994 107.83 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -88.11 144.51 26.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.934 1.294 . . . . 73.230000000000004 109.062 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -111.46 116.86 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.55 -0.537 . . . . 75.010000000000005 109.55 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.34 168.15 13.09 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.715 0.806 . . . . 73.219999999999999 110.652 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.6 m -62.81 -28.02 69.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.931 0.892 . . . . 74.420000000000002 112.368 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -90.19 -0.04 57.42 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.063 0.945 . . . . 75.209999999999994 111.969 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 92.09 12.74 58.53 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 114.081 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -83.23 128.09 34.2 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.453 0.627 . . . . 73.450000000000003 111.016 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -81.45 148.14 29.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.648 0.779 . . . . 75.439999999999998 109.288 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.532 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 47.3 p90 -168.21 147.11 4.51 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.361 0.413 . . . . 64.319999999999993 111.115 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 217' ' ' LEU . 66.0 t -89.65 -41.05 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.38 -0.97 . . . . 74.400000000000006 108.38 164.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.407 ' HG ' ' HA3' ' A' ' 227' ' ' GLY . 46.6 m -104.94 130.17 53.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.091 0.956 . . . . 65.400000000000006 110.029 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.5 t -66.03 -20.59 66.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 74.140000000000001 112.959 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -76.87 -28.64 55.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.615 0.766 . . . . 73.019999999999996 110.666 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.4 m -124.6 98.09 5.58 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.233 0.613 . . . . 74.420000000000002 110.137 -172.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.532 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.4 mtt180 -112.08 144.36 41.58 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.973 0.909 . . . . 72.129999999999995 109.284 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.95 151.7 52.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.773 0.829 . . . . 70.129999999999995 108.985 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.33 -40.6 77.49 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.988 -0.375 . . . . 72.140000000000001 109.988 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -121.42 160.69 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.042 0.925 . . . . 64.230000000000004 112.353 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.429 HD12 HG11 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -66.8 -27.74 67.81 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.714 -1.584 . . . . 74.140000000000001 109.431 171.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.76 96.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.492 0.717 . . . . 63.140000000000001 110.782 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -68.78 -38.78 80.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.068 0.947 . . . . 73.219999999999999 111.165 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.475 HD13 HG22 ' A' ' 205' ' ' VAL . 16.6 tp -55.12 -56.9 14.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.037 0.535 . . . . 65.439999999999998 110.712 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.62 -38.22 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.545 0.738 . . . . 73.409999999999997 111.774 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -61.37 -57.96 10.17 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.784 0.326 . . . . 75.129999999999995 111.177 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -64.14 -28.15 69.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.805 -0.634 . . . . 75.099999999999994 111.028 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.651 ' HB3' HD12 ' A' ' 228' ' ' LEU . 11.6 m170 -91.13 -10.85 40.41 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.88 0.472 . . . . 64.010000000000005 112.186 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 98.3 p -87.62 -29.19 21.4 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 110.181 -0.303 . . . . 70.25 110.181 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 59.0 p -77.27 -50.38 12.99 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.021 0.528 . . . . 74.329999999999998 110.74 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.588 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.7 m -126.4 157.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 121.667 0.746 . . . . 74.230000000000004 111.942 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.63 17.74 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 127.552 2.341 . . . . 74.310000000000002 114.538 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.588 ' HB2' HG23 ' A' ' 224' ' ' VAL . 32.0 t70 -42.47 28.66 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.581 1 C-N-CA 132.619 4.368 . . . . 75.239999999999995 119.497 -152.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.407 ' HA3' ' HG ' ' A' ' 206' ' ' SER . . . 123.11 -5.4 9.55 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 119.835 -1.79 . . . . 71.030000000000001 112.169 -165.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -89.62 160.87 16.43 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.831 1.252 . . . . 73.120000000000005 109.792 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.07 -34.35 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 116.272 -0.422 . . . . 73.200000000000003 110.855 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.404 HG23 HD21 ' A' ' 184' ' ' LEU . 3.8 t -162.3 178.49 8.65 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.865 0.866 . . . . 73.209999999999994 109.796 173.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 50.1 p -73.07 142.39 47.59 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.873 0.469 . . . . 73.25 111.184 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.497 HD22 ' HE1' ' A' ' 193' ' ' TYR . 46.8 mt -73.36 134.74 44.19 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.474 -0.935 . . . . 73.129999999999995 108.474 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -140.26 -68.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 119.982 1.264 . . . . 73.430000000000007 112.508 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 167' ' ' SER . 16.6 t80 -80.1 120.82 80.89 Favored Pre-proline 0 C--O 1.212 -0.915 0 N-CA-C 107.861 -1.162 . . . . 74.530000000000001 107.861 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.781 ' HG3' ' HB2' ' A' ' 67' ' ' TRP . 58.5 Cg_endo -86.69 144.02 7.42 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.012 1.808 . . . . 71.200000000000003 112.736 173.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.54 149.09 80.85 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 108.878 -0.786 . . . . 72.530000000000001 108.878 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.562 ' HD3' HH22 ' A' ' 66' ' ' ARG . 44.3 Cg_endo -88.26 174.59 4.34 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.359 2.039 . . . . 75.030000000000001 111.661 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 75.6 mmtt -59.57 138.1 57.82 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.127 -0.694 . . . . 74.329999999999998 109.127 175.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.582 ' HB3' HD23 ' A' ' 159' ' ' LEU . 15.9 ptt180 -62.69 -67.4 0.42 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.758 1.021 . . . . 74.019999999999996 113.758 -157.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.571 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 7.9 t30 -119.03 165.19 14.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.844 0.747 . . . . 73.129999999999995 110.004 164.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 82.4 mttt -65.27 136.19 96.36 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 110.16 -0.311 . . . . 63.109999999999999 110.16 163.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 7.4 Cg_exo -72.58 126.96 11.96 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.945 2.43 . . . . 73.530000000000001 112.901 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 99.1 m -84.6 124.28 31.26 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.833 -0.802 . . . . 74.319999999999993 108.833 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.531 HG22 HD22 ' A' ' 133' ' ' ASN . 4.3 t -99.84 139.21 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.392 -0.966 . . . . 74.150000000000006 108.392 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.3 114.82 28.98 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.712 0.405 . . . . 75.5 111.822 -161.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.62 62.19 Favored Glycine 0 C--N 1.362 1.997 0 N-CA-C 115.827 1.091 . . . . 72.209999999999994 115.827 163.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.425 HG23 ' NE1' ' A' ' 118' ' ' TRP . 9.3 p -105.6 130.06 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 114.605 1.335 . . . . 74.219999999999999 114.605 -161.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.0 m -86.42 118.89 71.03 Favored Pre-proline 0 N--CA 1.48 1.066 0 N-CA-C 105.236 -2.135 . . . . 73.129999999999995 105.236 148.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.433 ' HD2' HD22 ' A' ' 97' ' ' ASN . 82.9 Cg_exo -50.61 -58.01 1.93 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.115 1.877 . . . . 65.25 113.97 -162.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -129.37 -27.5 2.42 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.18 -1.044 . . . . 74.230000000000004 108.18 140.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -100.06 149.38 23.55 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 113.518 -1.674 . . . . 75.530000000000001 112.722 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.49 -17.07 12.75 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.611 -1.631 . . . . 72.140000000000001 108.556 161.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -111.6 3.51 17.99 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.724 1.379 . . . . 72.310000000000002 114.724 -165.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 18' ' ' PRO . 7.4 t90 -93.65 154.77 17.64 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.41 1.005 . . . . 73.329999999999998 111.269 -176.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 10.1 tp10 . . . . . 0 C--O 1.251 1.157 0 CA-C-N 115.315 -0.857 . . . . 73.129999999999995 109.438 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.818 0.342 . . . . 75.099999999999994 110.825 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.31 117.14 0.7 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.928 -0.578 . . . . 73.25 111.716 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.47 112.89 15.97 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.468 0.707 . . . . 74.340000000000003 110.092 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.79 120.32 62.0 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.211 0.605 . . . . 62.240000000000002 109.564 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.08 144.02 91.74 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.517 2.145 . . . . 72.439999999999998 111.784 168.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.71 141.49 12.98 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.989 -0.551 . . . . 64.5 112.619 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.536 ' HD2' HG11 ' A' ' 247' ' ' VAL . 15.7 ptpt -80.97 137.28 36.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.531 0.732 . . . . 63.329999999999998 110.156 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.73 -42.73 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.237 0.615 . . . . 74.310000000000002 111.099 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pp -176.68 -178.9 0.93 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.613 1.165 . . . . 71.040000000000006 110.242 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.47 62.85 0.18 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.957 -0.565 . . . . 64.140000000000001 111.921 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.43 106.58 2.57 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.108 -0.701 . . . . 54.329999999999998 109.108 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.466 ' HG2' ' HG3' ' A' ' 13' ' ' ARG . 58.0 tt0 -159.53 145.68 16.19 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.539 1.136 . . . . 74.209999999999994 108.037 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.511 ' HB2' ' HB3' ' A' ' 96' ' ' ASP . 59.6 mtt180 68.1 159.67 0.16 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.435 1.094 . . . . 71.120000000000005 110.566 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -100.95 156.44 35.14 Favored Pre-proline 0 CA--C 1.556 1.18 0 CA-C-O 118.771 -0.633 . . . . 73.319999999999993 110.452 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -39.65 106.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 124.854 3.702 . . . . 74.200000000000003 114.959 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.7 m -95.2 91.19 6.17 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.831 -0.803 . . . . 73.010000000000005 108.831 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.74 112.82 8.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.36 1.064 . . . . 70.25 110.579 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -83.41 -171.8 1.19 Allowed 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.758 2.305 . . . . 75.319999999999993 112.536 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.02 112.18 9.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.198 0.599 . . . . 64.109999999999999 109.393 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.2 tp -166.09 150.45 7.99 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.083 0.953 . . . . 71.099999999999994 108.964 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.421 ' HA ' HD22 ' A' ' 110' ' ' LEU . 57.4 t-80 -143.41 134.1 25.13 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.898 0.479 . . . . 72.239999999999995 110.511 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -147.39 -166.32 2.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.788 1.235 . . . . 74.439999999999998 109.523 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 tt -143.1 152.27 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.56 1.144 . . . . 75.310000000000002 109.474 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HE2' ' HA2' ' A' ' 111' ' ' GLY . 35.3 mmtm -136.18 173.74 11.38 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.206 1.003 . . . . 73.450000000000003 110.196 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 82' ' ' PRO . . . 166.36 108.85 0.21 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.96 -0.856 . . . . 63.43 110.96 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.93 155.45 48.9 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.799 0.84 . . . . 75.439999999999998 110.658 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.98 136.04 2.63 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-O 119.747 -0.474 . . . . 51.420000000000002 112.279 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -157.85 158.01 34.31 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.638 0.775 . . . . 74.140000000000001 110.825 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.64 171.21 12.38 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.621 1.169 . . . . 71.230000000000004 109.072 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.65 124.3 9.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.01 -1.107 . . . . 73.109999999999999 108.01 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 t -68.54 114.48 6.98 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.754 0.821 . . . . 73.140000000000001 111.837 -171.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -82.98 -168.96 2.28 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.457 1.103 . . . . 64.120000000000005 110.658 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -86.76 -152.46 0.18 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.897 0.879 . . . . 75.430000000000007 111.035 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -137.81 112.77 9.07 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.168 -1.049 . . . . 74.150000000000006 108.168 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.79 125.78 1.12 Allowed Glycine 0 C--N 1.346 1.097 0 C-N-CA 121.336 -0.459 . . . . 65.340000000000003 113.292 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 205' ' ' VAL . . . 163.88 155.44 8.27 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.303 -0.72 . . . . 74.420000000000002 111.534 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -90.55 -165.42 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.534 2.822 . . . . 72.5 113.416 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -149.94 110.0 4.13 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.323 1.049 . . . . 71.329999999999998 109.369 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.0 m -145.97 160.79 41.35 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.98 1.312 . . . . 61.009999999999998 108.729 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.64 ' HA ' ' HB1' ' A' ' 225' ' ' ALA . 24.7 t-20 -156.58 133.65 10.46 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.621 0.646 . . . . 74.219999999999999 111.327 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.417 ' H ' ' HB1' ' A' ' 225' ' ' ALA . 13.8 p -148.89 142.81 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.267 1.427 . . . . 73.420000000000002 107.518 176.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.92 159.11 36.87 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.515 1.126 . . . . 72.519999999999996 109.36 -171.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.405 HG11 ' H ' ' A' ' 44' ' ' GLU . 15.2 t -87.46 173.39 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 C-N-CA 124.892 1.277 . . . . 64.540000000000006 109.65 -176.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 12.9 pt-20 -150.01 148.25 28.82 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.487 0.715 . . . . 55.109999999999999 111.621 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 178.97 -76.76 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.506 1.522 . . . . 72.049999999999997 109.391 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -131.46 159.44 38.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.202 1.001 . . . . 75.310000000000002 109.661 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.73 113.43 20.89 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.154 0.582 . . . . 74.099999999999994 110.908 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.81 97.93 2.41 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.605 -1.628 . . . . 73.310000000000002 106.605 171.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.508 ' HG3' ' H ' ' A' ' 50' ' ' ARG . 4.4 tp-100 61.95 -153.96 0.35 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.916 1.287 . . . . 72.430000000000007 109.441 -174.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.641 ' HG2' ' HB3' ' A' ' 57' ' ' GLU . 10.4 mpt_? 69.31 158.89 0.15 Allowed Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 124.88 1.272 . . . . 75.349999999999994 112.526 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.11 -173.36 0.89 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.53 2.153 . . . . 71.25 111.667 163.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -65.55 99.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.718 0.77 . . . . 73.329999999999998 109.098 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.18 -164.98 0.6 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.452 -0.795 . . . . 65.219999999999999 110.825 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -51.34 -44.09 61.94 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.165 0.983 . . . . 64.239999999999995 109.508 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . 16.2 t70 -126.79 -85.89 0.6 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 106.608 -1.627 . . . . 64.519999999999996 106.608 162.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -151.52 120.89 6.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.045 1.338 . . . . 74.340000000000003 107.393 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.641 ' HB3' ' HG2' ' A' ' 50' ' ' ARG . 36.8 tt0 -88.95 125.72 61.56 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 122.463 0.305 . . . . 73.239999999999995 110.373 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -86.36 -34.09 0.16 Allowed 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.726 2.284 . . . . 73.329999999999998 114.23 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -155.5 -38.77 0.09 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.979 0.912 . . . . 74.219999999999999 109.648 -172.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.51 -70.5 2.83 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.646 -0.706 . . . . 72.140000000000001 112.454 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.647 HD23 ' HA ' ' A' ' 233' ' ' HIS . 51.3 mt -83.17 153.0 25.0 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.104 0.962 . . . . 73.310000000000002 111.712 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -98.01 42.41 1.09 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.254 1.022 . . . . 75.219999999999999 109.015 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.04 -35.4 81.06 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.367 -1.288 . . . . 75.329999999999998 111.363 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.13 -24.63 67.98 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.646 0.778 . . . . 73.120000000000005 112.042 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.69 -46.14 22.78 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.545 0.738 . . . . 71.450000000000003 111.85 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -125.51 -53.56 1.58 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.831 0.452 . . . . 75.040000000000006 111.782 -173.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -79.2 71.91 5.74 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.405 0.682 . . . . 71.540000000000006 111.344 -169.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -81.45 -20.94 39.24 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.664 -0.698 . . . . 75.340000000000003 110.538 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.8 p -73.21 1.03 10.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.243 0.617 . . . . 75.219999999999999 112.1 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -71.55 -18.9 62.23 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.37 0.668 . . . . 70.230000000000004 111.431 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.87 -32.92 71.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.614 0.721 . . . . 64.450000000000003 110.678 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -85.9 -9.09 57.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.701 -1.136 . . . . 73.019999999999996 110.978 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 215' ' ' ALA . 37.7 tp -70.57 -46.4 63.57 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.467 0.707 . . . . 64.299999999999997 109.457 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.91 52.22 1.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.439 0.638 . . . . 74.439999999999998 110.076 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 78' ' ' SER . . . -95.02 -49.03 5.72 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.245 -0.889 . . . . 72.400000000000006 109.972 175.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.83 -138.33 44.43 Favored Glycine 0 C--N 1.356 1.682 0 N-CA-C 110.418 -1.073 . . . . 71.319999999999993 110.418 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -65.91 116.78 4.17 Favored 'Trans proline' 0 C--N 1.367 1.531 0 CA-C-N 119.628 1.714 . . . . 72.329999999999998 108.459 159.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 46.6 t -121.63 176.04 5.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.611 0.764 . . . . 64.019999999999996 110.913 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -72.12 -13.02 61.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.121 0.968 . . . . 73.510000000000005 108.763 167.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -78.7 29.72 0.2 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.441 1.496 . . . . 75.150000000000006 112.18 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' HB2' ' ND2' ' A' ' 83' ' ' ASN . 6.4 m-20 -45.39 149.48 0.99 Allowed Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 126.002 1.721 . . . . 65.019999999999996 112.989 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 57.3 Cg_endo -63.52 -0.26 2.31 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.42 2.746 . . . . 75.310000000000002 115.518 -171.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 81' ' ' ASP . 10.1 p30 -69.89 -23.8 63.3 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.578 0.351 . . . . 73.0 111.109 172.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.53 139.17 44.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 74.530000000000001 108.676 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -118.97 172.95 7.18 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.008 1.323 . . . . 71.540000000000006 109.928 -176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.94 141.54 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 125.246 1.418 . . . . 72.019999999999996 108.985 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.33 129.57 35.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.35 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 143' ' ' LYS . 82.4 mt -87.25 -26.54 23.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.14 0.976 . . . . 65.099999999999994 112.483 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.2 m-85 -134.24 153.19 52.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.011 0.524 . . . . 72.310000000000002 110.227 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.33 119.11 21.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.091 -0.707 . . . . 71.200000000000003 109.091 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.544 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.5 t80 -117.62 126.14 52.0 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.388 -0.967 . . . . 74.400000000000006 108.388 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.45 133.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.857 -1.164 . . . . 75.349999999999994 107.857 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.66 116.46 14.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.719 0.408 . . . . 73.409999999999997 111.304 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.9 p -115.77 77.22 1.07 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.637 0.775 . . . . 74.109999999999999 108.941 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 140.58 -175.89 21.77 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.41 -0.814 . . . . 72.040000000000006 111.535 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 30.9 p-10 -89.31 -42.03 11.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.407 0.683 . . . . 70.040000000000006 112.031 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.6 -26.73 60.94 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.705 0.802 . . . . 73.030000000000001 110.571 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 77.8 p -72.7 143.19 48.15 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.229 0.611 . . . . 74.0 110.241 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.487 HD21 ' N ' ' A' ' 128' ' ' GLY . 56.1 tp -132.55 132.05 42.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.195 0.598 . . . . 74.239999999999995 109.932 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.3 m -70.81 130.03 40.63 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.468 0.707 . . . . 72.239999999999995 110.914 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.544 HG12 ' HB3' ' A' ' 91' ' ' PHE . 23.3 pt -133.6 150.26 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.773 0.829 . . . . 74.439999999999998 110.313 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -102.45 146.82 27.54 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.942 0.897 . . . . 71.530000000000001 109.319 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -67.94 114.37 6.44 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.542 -0.54 . . . . 74.430000000000007 109.542 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.58 -9.62 32.65 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 123.327 0.489 . . . . 60.119999999999997 112.382 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 37.5 tt0 -77.9 137.89 38.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.972 0.909 . . . . 72.109999999999999 111.334 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.43 133.39 35.94 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.432 0.693 . . . . 74.239999999999995 110.2 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.428 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.6 OUTLIER -149.08 161.59 41.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.667 1.187 . . . . 74.150000000000006 110.117 -174.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -120.34 118.74 31.17 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.88 -0.513 . . . . 73.019999999999996 110.256 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 119' ' ' ALA . 55.5 t -73.35 121.34 23.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.56 0.695 . . . . 71.109999999999999 110.02 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.427 HD23 ' HG3' ' A' ' 122' ' ' GLN . 23.6 mt -84.58 -51.95 6.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.967 -1.469 . . . . 71.540000000000006 108.874 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.432 ' HA2' ' HE2' ' A' ' 24' ' ' LYS . . . -170.95 149.39 12.35 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.883 -0.599 . . . . 75.209999999999994 112.784 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.527 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 51.6 m-85 -85.3 168.26 14.85 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.399 0.68 . . . . 74.030000000000001 110.605 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -82.21 -172.87 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.379 -0.828 . . . . 45.200000000000003 109.842 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -53.84 -42.32 68.38 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.836 0.854 . . . . 74.430000000000007 112.945 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -112.43 13.6 20.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.933 0.716 . . . . 72.430000000000007 112.933 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.8 21.07 76.45 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 115.685 1.034 . . . . 72.219999999999999 115.685 170.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -77.28 -54.5 6.4 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.611 0.706 . . . . 75.219999999999999 110.571 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.848 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 20.4 m95 -110.95 152.9 26.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.809 0.844 . . . . 70.340000000000003 111.55 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.529 ' HB2' HG11 ' A' ' 109' ' ' VAL . . . -129.53 140.46 51.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.688 1.195 . . . . 75.209999999999994 109.981 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 38.4 tt0 -75.82 130.04 37.96 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.956 -1.127 . . . . 72.219999999999999 107.956 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.34 144.55 44.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.526 0.731 . . . . 74.310000000000002 110.003 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.427 ' HG3' HD23 ' A' ' 110' ' ' LEU . 47.8 mt-30 -96.51 107.8 20.27 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.763 -1.199 . . . . 72.349999999999994 107.763 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.428 HG22 ' HB3' ' A' ' 107' ' ' LEU . 34.6 p -106.42 -177.04 3.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.111 0.964 . . . . 73.430000000000007 111.395 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -71.83 -10.42 59.75 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.504 -0.771 . . . . 74.099999999999994 110.828 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -101.44 16.42 25.7 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.52 1.128 . . . . 65.310000000000002 110.585 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.79 -122.68 7.06 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.218 -0.768 . . . . 74.120000000000005 112.044 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.83 152.45 47.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 118.032 0.916 . . . . 73.25 110.849 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.487 ' N ' HD21 ' A' ' 99' ' ' LEU . . . 153.8 172.55 21.99 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 111.575 -0.61 . . . . 55.399999999999999 111.575 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 66.0 m95 -80.15 131.81 35.8 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.225 0.61 . . . . 70.450000000000003 112.561 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.41 HG21 HD12 ' A' ' 135' ' ' ILE . 34.3 m -136.8 141.89 36.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 125.645 1.578 . . . . 74.129999999999995 109.215 168.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.848 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.1 Cg_endo -77.92 151.26 27.5 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.438 2.092 . . . . 73.409999999999997 115.284 -172.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -36.63 -50.54 0.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.628 1.971 . . . . 60.32 113.856 170.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -74.22 -7.96 54.53 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.417 0.687 . . . . 72.120000000000005 112.352 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.42 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 13.6 m-85 -104.03 -4.92 22.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.88 0.872 . . . . 73.049999999999997 112.118 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 130' ' ' VAL . 6.3 pt -135.24 168.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 124.003 0.921 . . . . 74.540000000000006 111.826 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.9 t -163.54 155.98 15.46 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 108.334 -0.987 . . . . 74.200000000000003 108.334 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.55 151.77 44.37 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.108 1.872 . . . . 74.530000000000001 113.029 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.51 -5.66 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.166 0.507 . . . . 75.450000000000003 110.209 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.4 -20.21 23.07 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.625 -0.672 . . . . 74.319999999999993 110.881 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.1 p -80.9 172.49 13.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.328 0.585 . . . . 63.200000000000003 111.742 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.5 mt -84.67 -25.02 28.73 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.785 0.834 . . . . 75.120000000000005 111.291 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.5 -24.01 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.474 1.11 . . . . 75.200000000000003 112.092 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.481 ' HA ' HD22 ' A' ' 88' ' ' LEU . 23.1 pttm -64.2 -26.16 68.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.39 0.676 . . . . 73.439999999999998 112.476 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -75.15 148.35 39.7 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.61 -0.723 . . . . 72.310000000000002 110.159 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 235' ' ' PRO . 16.9 m -60.52 -41.09 93.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.115 0.885 . . . . 72.010000000000005 111.552 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -67.18 -48.32 68.28 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.324 0.65 . . . . 74.400000000000006 112.549 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -75.66 112.53 12.12 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.538 -0.541 . . . . 75.109999999999999 109.538 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.438 ' HB2' HG22 ' A' ' 151' ' ' VAL . 32.6 m170 -102.39 -1.98 29.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.379 0.672 . . . . 75.230000000000004 111.612 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.34 -151.26 36.27 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 118.887 -0.952 . . . . 74.310000000000002 112.232 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.62 114.29 1.93 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.053 2.502 . . . . 65.519999999999996 111.407 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 54.0 t -142.72 137.85 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 125.398 1.479 . . . . 60.210000000000001 108.863 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.2 p -82.58 170.22 15.42 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.627 0.771 . . . . 64.239999999999995 110.95 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -59.7 -48.47 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.932 0.893 . . . . 73.349999999999994 110.389 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.35 -44.37 84.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.466 1.107 . . . . 72.340000000000003 111.465 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.78 76.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.973 -1.012 . . . . 71.129999999999995 111.518 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.77 82.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.447 0.699 . . . . 53.200000000000003 111.636 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -78.64 -25.49 45.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.565 -0.743 . . . . 74.409999999999997 112.709 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -24.88 59.71 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.943 0.792 . . . . 74.230000000000004 110.678 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.824 HD22 ' HA ' ' A' ' 239' ' ' ARG . 69.0 mt -71.92 -48.97 41.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.963 -1.017 . . . . 75.109999999999999 110.056 170.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 63.8 mt -89.23 19.49 4.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.044 -0.98 . . . . 75.409999999999997 112.642 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.3 p -90.42 -34.11 15.76 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.091 -1.077 . . . . 71.420000000000002 108.091 157.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.5 m -92.05 2.49 56.53 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.949 1.299 . . . . 74.340000000000003 111.892 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.1 -178.07 40.43 Favored Glycine 0 C--N 1.351 1.386 0 C-N-CA 122.771 0.224 . . . . 74.310000000000002 112.839 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -107.62 177.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.241 1.016 . . . . 72.439999999999998 110.31 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.05 131.26 46.09 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.84 6.42 72.5 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.079 -0.845 . . . . 73.310000000000002 113.695 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.5 m -81.39 136.18 35.7 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.217 1.008 . . . . 73.409999999999997 110.524 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -142.8 163.12 33.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.303 0.573 . . . . 73.219999999999999 111.218 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.64 145.32 22.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.83 -1.077 . . . . 75.5 108.666 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.636 HG22 HG12 ' A' ' 182' ' ' ILE . 83.2 t -103.48 126.73 57.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.947 -1.131 . . . . 74.510000000000005 107.947 169.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.613 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.5 ptt85 -115.71 160.98 19.35 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.177 0.991 . . . . 74.409999999999997 109.06 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -114.35 150.29 34.8 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.259 -1.756 . . . . 70.239999999999995 106.259 167.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -67.96 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.299 -0.63 . . . . 74.319999999999993 109.299 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.07 -31.33 71.74 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.822 0.849 . . . . 71.239999999999995 111.176 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.8 p -97.17 -5.31 37.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.135 0.974 . . . . 64.120000000000005 112.008 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -149.88 102.84 3.21 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 122.719 0.408 . . . . 71.209999999999994 111.189 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.23 146.81 70.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.551 2.167 . . . . 73.319999999999993 111.833 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.69 -28.36 3.55 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 123.069 0.366 . . . . 73.219999999999999 113.403 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.91 114.45 18.83 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -130.8 156.54 44.83 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.52 0.676 . . . . 75.5 111.12 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.8 m -147.2 150.86 35.73 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.833 -1.076 . . . . 74.030000000000001 109.241 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.636 HG12 HG22 ' A' ' 170' ' ' VAL . 22.6 mt -103.81 151.57 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.54 -1.281 . . . . 75.319999999999993 107.54 170.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -124.73 121.98 36.18 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.678 -1.23 . . . . 70.530000000000001 107.678 168.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.2 tp -115.65 114.36 24.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.36 0.664 . . . . 75.25 110.377 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.682 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 56.1 ttt85 -76.3 111.53 11.84 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.551 0.74 . . . . 74.109999999999999 109.033 164.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -139.44 139.58 37.11 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.991 1.316 . . . . 72.530000000000001 107.791 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 59.7 21.76 10.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.47 1.108 . . . . 74.420000000000002 111.782 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.75 -12.31 59.75 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.628 -0.714 . . . . 61.039999999999999 113.85 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -98.96 146.73 25.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.237 0.615 . . . . 75.329999999999998 110.211 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 115.24 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.08 0.552 . . . . 74.409999999999997 110.405 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -101.47 137.96 39.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.487 1.115 . . . . 63.100000000000001 108.807 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.54 120.04 41.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.889 0.376 . . . . 73.209999999999994 110.74 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.479 ' HE1' HD22 ' A' ' 232' ' ' LEU . 5.8 m-85 -95.59 152.31 18.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.224 1.009 . . . . 74.25 108.738 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -104.7 115.81 30.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.401 -0.592 . . . . 73.329999999999998 109.401 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -85.73 101.96 10.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.849 -1.167 . . . . 72.129999999999995 107.849 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -84.04 107.21 16.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.403 -1.271 . . . . 65.099999999999994 108.382 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -74.52 112.65 10.91 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.862 -1.162 . . . . 75.340000000000003 107.862 164.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.94 160.97 19.45 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.682 0.393 . . . . 54.130000000000003 110.704 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.0 p -62.43 -28.36 69.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.59 0.756 . . . . 74.340000000000003 111.07 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -89.76 -5.2 57.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.245 1.018 . . . . 73.230000000000004 111.128 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 106.58 -6.82 38.79 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 114.787 0.675 . . . . 73.310000000000002 114.787 168.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.13 127.47 32.68 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.887 0.843 . . . . 75.420000000000002 111.646 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.71 142.68 30.55 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.099 0.96 . . . . 73.209999999999994 109.051 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.604 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 39.9 p90 -164.71 139.74 5.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.214 0.321 . . . . 75.120000000000005 111.686 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.462 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 72.0 t -84.64 -37.84 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.559 -0.904 . . . . 75.120000000000005 108.559 163.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.426 ' HG ' ' HA3' ' A' ' 227' ' ' GLY . 24.2 m -101.23 126.91 48.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 109.771 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.9 t -69.7 -16.72 63.39 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.421 0.689 . . . . 65.430000000000007 112.129 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -92.66 -15.3 26.94 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.776 1.23 . . . . 73.219999999999999 110.99 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.2 m -133.93 95.46 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.746 0.818 . . . . 73.420000000000002 109.116 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.604 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -111.59 134.77 52.94 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.87 0.868 . . . . 75.150000000000006 109.527 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.0 151.97 43.1 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.104 0.961 . . . . 72.109999999999999 108.538 -170.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -69.47 -34.2 74.01 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.601 0.563 . . . . 74.439999999999998 110.692 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.3 p -126.76 152.58 46.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.73 0.812 . . . . 73.420000000000002 111.718 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.84 -24.44 67.75 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 114.674 -1.148 . . . . 75.329999999999998 109.215 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 73' ' ' LEU . . . -59.16 -49.12 79.06 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.976 0.91 . . . . 72.200000000000003 111.275 173.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -65.33 -36.8 85.14 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.526 0.73 . . . . 75.299999999999997 111.325 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.9 tp -56.43 -56.76 17.22 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.495 0.497 . . . . 74.010000000000005 111.102 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.44 -41.5 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.317 0.647 . . . . 75.099999999999994 110.897 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.11 -52.25 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.741 0.416 . . . . 75.409999999999997 111.524 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -65.44 -40.61 93.46 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.203 0.601 . . . . 74.450000000000003 109.85 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.63 ' HB3' HD13 ' A' ' 228' ' ' LEU . 12.3 m-70 -86.6 -4.54 59.19 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.446 -0.797 . . . . 74.400000000000006 111.917 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 89.9 p -91.98 -35.31 14.05 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 110.181 -0.303 . . . . 64.519999999999996 110.181 167.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.2 m -68.4 -49.63 58.7 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.306 0.574 . . . . 71.409999999999997 110.216 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -128.18 161.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.006 -0.997 . . . . 72.329999999999998 110.161 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 40' ' ' ASN . . . -74.47 19.61 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.377 1.871 . . . . 72.299999999999997 114.637 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.579 ' HB2' HG22 ' A' ' 224' ' ' VAL . 10.9 t70 -43.02 31.64 0.0 OUTLIER 'General case' 0 CA--C 1.598 2.8 1 C-N-CA 132.319 4.247 . . . . 75.25 120.203 -153.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.426 ' HA3' ' HG ' ' A' ' 206' ' ' SER . . . 125.22 0.82 8.04 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 121.259 -0.9 . . . . 75.540000000000006 112.583 -167.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.63 HD13 ' HB3' ' A' ' 221' ' ' HIS . 11.0 mt -95.06 165.61 12.34 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 126.169 1.788 . . . . 75.400000000000006 110.025 168.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.99 -41.92 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-N 116.604 -0.271 . . . . 61.229999999999997 110.314 168.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -157.41 -179.78 8.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.104 0.561 . . . . 71.239999999999995 110.969 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.0 p -63.55 137.1 57.99 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.837 1.255 . . . . 73.25 112.243 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.479 HD22 ' HE1' ' A' ' 193' ' ' TYR . 75.7 mt -72.62 111.03 7.42 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.949 -0.76 . . . . 73.310000000000002 108.949 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.647 ' HA ' HD23 ' A' ' 61' ' ' LEU . 13.4 t60 -106.87 -44.54 4.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.948 0.722 . . . . 75.409999999999997 112.948 -163.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -130.84 125.24 21.22 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.15 0.98 . . . . 75.430000000000007 109.138 -169.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.425 ' HB2' ' HB2' ' A' ' 145' ' ' SER . 76.1 Cg_endo -81.56 129.17 6.39 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 122.234 1.956 . . . . 73.349999999999994 112.121 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.36 151.94 85.62 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.852 0.861 . . . . 74.129999999999995 110.113 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.71 170.3 17.12 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.966 2.444 . . . . 74.25 112.593 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.9 154.02 35.08 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.044 0.937 . . . . 75.219999999999999 110.917 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.824 ' HA ' HD22 ' A' ' 159' ' ' LEU . 18.8 ptt180 -81.66 -60.34 2.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.541 0.941 . . . . 74.439999999999998 113.541 -168.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.534 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 64.9 t30 -108.69 153.92 22.75 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.701 0.8 . . . . 73.430000000000007 109.122 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 84.2 tttt -87.4 114.77 60.25 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.204 -1.776 . . . . 75.340000000000003 106.204 159.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 31.7 Cg_exo -62.21 144.39 95.52 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.373 2.715 . . . . 63.130000000000003 113.151 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.4 m -94.66 134.72 36.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.283 0.633 . . . . 74.109999999999999 110.86 -172.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -90.43 125.82 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 64.310000000000002 108.664 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -109.81 115.9 30.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.689 0.395 . . . . 75.239999999999995 110.988 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 75.94 -48.27 2.34 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 119.277 2.471 . . . . 61.340000000000003 119.277 155.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.536 HG11 ' HD2' ' A' ' 7' ' ' LYS . 31.2 m -99.48 144.1 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 114.366 1.247 . . . . 74.120000000000005 114.366 -157.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.0 t -82.34 115.83 60.16 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 104.405 -2.443 . . . . 72.340000000000003 104.405 149.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.663 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 11.3 Cg_endo -53.78 -53.2 6.85 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.94 2.427 . . . . 71.049999999999997 116.858 -152.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -123.23 -11.46 7.97 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.989 0.916 . . . . 64.450000000000003 110.226 165.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.536 ' HA ' ' HB3' ' A' ' 254' ' ' TRP . 32.1 t80 -85.1 93.11 8.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.681 0.753 . . . . 74.549999999999997 111.444 -154.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -128.85 -45.48 1.29 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.936 1.294 . . . . 74.409999999999997 108.414 146.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -81.17 -34.55 32.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.191 0.597 . . . . 73.150000000000006 109.528 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 251' ' ' TYR . 38.8 t-105 -60.0 147.82 37.64 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 114.692 -1.14 . . . . 75.219999999999999 110.597 -175.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 C--O 1.246 0.902 0 N-CA-C 106.837 -1.542 . . . . 74.150000000000006 106.837 176.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 mtm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.037 -0.727 . . . . 74.099999999999994 109.037 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.93 43.64 0.02 OUTLIER Glycine 0 C--N 1.349 1.28 0 O-C-N 123.343 0.402 . . . . 64.120000000000005 112.234 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -68.05 112.44 5.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.302 0.641 . . . . 75.319999999999993 110.233 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -122.73 90.9 49.83 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 123.307 0.643 . . . . 74.140000000000001 109.889 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.9 177.14 9.24 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.73 2.286 . . . . 71.319999999999993 111.949 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.77 117.88 0.62 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.325 -0.71 . . . . 72.129999999999995 111.325 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.96 135.49 37.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.785 0.834 . . . . 72.420000000000002 109.9 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.02 96.95 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 124.097 0.959 . . . . 73.230000000000004 109.552 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.59 175.22 10.75 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.908 0.883 . . . . 73.430000000000007 110.395 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.0 155.31 17.89 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.314 -0.715 . . . . 64.299999999999997 111.314 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.03 160.02 44.18 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.853 -1.166 . . . . 74.019999999999996 107.853 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -158.43 105.89 1.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.76 0.79 . . . . 73.340000000000003 111.422 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -110.6 138.59 46.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.696 -1.224 . . . . 74.239999999999995 107.696 164.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.555 ' HD2' HD12 ' A' ' 17' ' ' LEU . 33.2 mmt180 -119.21 81.66 21.69 Favored Pre-proline 0 N--CA 1.484 1.273 0 C-N-CA 123.397 0.679 . . . . 75.409999999999997 109.939 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 255' ' ' GLU . 6.4 Cg_exo -75.57 -66.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.797 2.332 . . . . 74.109999999999999 110.706 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.9 m -154.75 116.97 4.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.215 1.006 . . . . 72.209999999999994 108.511 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.555 HD12 ' HD2' ' A' ' 14' ' ' ARG . 5.9 mp -75.2 129.99 81.38 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.955 0.902 . . . . 75.129999999999995 109.653 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.54 160.59 6.85 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.477 2.785 . . . . 72.209999999999994 114.685 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.21 178.11 2.47 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.353 1.061 . . . . 74.439999999999998 112.683 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.4 HD23 ' OD1' ' A' ' 83' ' ' ASN . 7.8 mp -63.3 120.82 12.31 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.603 -0.726 . . . . 75.140000000000001 110.999 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -150.19 121.36 7.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.814 -1.55 . . . . 72.439999999999998 106.814 169.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.647 ' HB3' ' H ' ' A' ' 112' ' ' TYR . 47.2 p90 -161.5 149.56 15.29 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.709 0.633 . . . . 75.409999999999997 112.709 -169.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 115' ' ' ASN . 34.6 pt -131.21 176.74 8.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 115.066 -0.97 . . . . 73.120000000000005 108.816 168.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -94.84 105.8 17.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.608 0.763 . . . . 74.540000000000006 110.1 -174.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.0 168.7 20.64 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.573 -1.011 . . . . 70.150000000000006 110.573 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.95 -177.62 3.45 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 117.495 0.647 . . . . 55.210000000000001 111.338 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.421 ' N ' HD21 ' A' ' 133' ' ' ASN . . . -131.67 -178.03 15.25 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 110.799 -0.92 . . . . 61.350000000000001 110.799 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.86 167.45 28.08 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 117.251 0.525 . . . . 74.120000000000005 111.923 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.63 167.97 7.71 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.36 1.464 . . . . 75.329999999999998 108.68 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.99 -92.53 0.13 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.61 0.764 . . . . 71.25 111.928 -172.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.7 p -89.86 128.63 36.22 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.271 0.628 . . . . 73.349999999999994 110.844 -165.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 10.7 p 178.75 148.51 0.2 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.006 1.722 . . . . 73.209999999999994 107.495 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.36 144.58 22.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.09 0.471 . . . . 75.540000000000006 110.122 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -131.32 155.83 46.53 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.413 -0.958 . . . . 75.400000000000006 108.413 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.95 -115.15 1.66 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.347 -1.101 . . . . 73.040000000000006 110.347 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.93 -173.13 31.22 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.895 0.409 . . . . 74.25 112.095 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -87.1 -165.84 0.27 Allowed 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.208 2.605 . . . . 71.099999999999994 111.283 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -125.87 173.94 8.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.287 0.635 . . . . 73.140000000000001 110.897 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.7 t -155.52 -144.68 0.14 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 108.395 -0.965 . . . . 65.540000000000006 108.395 -171.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -102.22 168.5 9.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.477 0.711 . . . . 70.219999999999999 110.304 173.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.61 HG21 ' HG3' ' A' ' 63' ' ' GLU . 7.5 p -122.74 149.04 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.13 0.972 . . . . 75.540000000000006 109.525 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -68.7 153.33 43.97 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.34 0.656 . . . . 74.319999999999993 110.29 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.4 m -56.42 110.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 123.882 0.873 . . . . 72.109999999999999 112.068 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.18 -171.97 2.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.086 0.954 . . . . 65.439999999999998 109.54 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -139.26 139.23 37.34 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.048 0.539 . . . . 75.319999999999993 111.287 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.24 -29.48 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.536 0.734 . . . . 72.230000000000004 109.503 175.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 60.24 -152.84 0.39 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.995 0.918 . . . . 75.409999999999997 112.454 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 71.54 171.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.115 1.366 . . . . 74.230000000000004 112.068 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.85 114.9 4.35 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.48 0.712 . . . . 73.140000000000001 111.505 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.456 ' HG3' ' HA3' ' A' ' 60' ' ' GLY . 2.6 ptp180 179.25 146.33 0.38 Allowed Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 125.57 1.548 . . . . 75.450000000000003 108.937 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.55 90.25 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.763 2.308 . . . . 73.209999999999994 112.373 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.516 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 27.1 m -81.39 172.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.932 0.893 . . . . 73.299999999999997 111.169 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.81 164.69 16.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.416 0.686 . . . . 74.219999999999999 110.983 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.5 t -67.42 135.64 53.46 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.26 0.624 . . . . 75.430000000000007 110.253 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t70 69.1 -78.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.593 1.183 . . . . 71.439999999999998 111.083 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -79.16 137.3 37.4 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.778 0.431 . . . . 75.319999999999993 110.497 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -104.6 102.55 34.92 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.435 0.694 . . . . 74.319999999999993 109.744 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.62 -68.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 121.833 1.689 . . . . 74.310000000000002 109.653 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -173.58 21.0 0.01 OUTLIER 'General case' 0 C--N 1.36 1.035 0 O-C-N 123.91 0.756 . . . . 74.140000000000001 112.868 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 52' ' ' VAL . . . 72.08 -76.28 0.74 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.888 -0.396 . . . . 54.25 114.048 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 pp -49.18 129.26 17.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.152 1.381 . . . . 74.420000000000002 111.127 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.478 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 33.2 p -99.81 126.94 45.99 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.378 0.671 . . . . 72.420000000000002 111.177 -170.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.61 ' HG3' HG21 ' A' ' 41' ' ' VAL . 45.4 mt-10 -74.38 -54.17 8.15 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.761 0.663 . . . . 72.329999999999998 109.812 173.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.21 -20.29 6.65 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.326 1.051 . . . . 74.310000000000002 113.544 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.9 -62.99 1.32 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.288 1.035 . . . . 70.299999999999997 111.84 174.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -113.04 7.09 17.95 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.95 0.9 . . . . 72.239999999999995 110.945 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -144.45 45.36 1.41 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.917 0.865 . . . . 74.329999999999998 109.213 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 23.8 p-10 -65.43 -21.82 66.7 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.982 -1.008 . . . . 74.010000000000005 109.46 165.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.4 p -77.47 5.41 8.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.573 1.549 . . . . 73.120000000000005 112.782 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.55 -25.4 68.03 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.202 0.456 . . . . 75.030000000000001 111.167 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.5 pt-20 -62.63 -43.45 98.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.26 0.624 . . . . 71.420000000000002 110.502 168.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -82.47 -2.97 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.48 1.112 . . . . 73.150000000000006 111.331 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.0 tp -52.33 -49.18 64.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.005 0.922 . . . . 75.150000000000006 110.274 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.5 mt -95.58 83.26 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.779 -1.193 . . . . 71.010000000000005 107.779 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.77 -57.04 3.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.098 -0.956 . . . . 74.430000000000007 113.054 -168.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.11 -137.92 20.56 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.07 -0.85 . . . . 62.409999999999997 111.031 -169.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.76 176.83 5.5 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.636 2.224 . . . . 75.519999999999996 112.349 171.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 m -80.38 178.24 8.44 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.713 0.805 . . . . 63.340000000000003 110.632 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -60.39 -52.12 66.59 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.895 0.702 . . . . 72.329999999999998 112.895 -167.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -136.91 -40.12 0.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.289 0.636 . . . . 71.200000000000003 110.527 163.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 13.7 m-20 -92.05 124.11 60.92 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 115.326 -0.852 . . . . 75.230000000000004 111.785 -176.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.19 -17.15 50.13 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.102 1.868 . . . . 74.439999999999998 111.345 164.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.4 ' OD1' HD23 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -86.44 2.51 47.49 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.109 0.964 . . . . 75.409999999999997 110.862 177.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.61 HD23 ' HD3' ' A' ' 106' ' ' LYS . 35.7 tp -80.65 125.52 30.12 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.22 172.49 6.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.727 1.211 . . . . 73.329999999999998 108.178 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.57 137.22 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.276 1.031 . . . . 72.150000000000006 108.836 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.2 123.66 26.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.62 0.768 . . . . 73.230000000000004 109.968 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.03 -32.86 45.13 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 74.519999999999996 110.982 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.581 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 55.9 m-85 -126.54 160.14 31.47 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.068 0.547 . . . . 73.0 110.792 -174.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.7 120.38 23.93 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.477 -0.934 . . . . 75.349999999999994 108.477 166.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.721 ' HB3' HG12 ' A' ' 101' ' ' ILE . 93.8 t80 -113.14 132.53 55.42 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.71 -0.848 . . . . 74.439999999999998 108.71 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -93.92 128.59 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.328 -0.99 . . . . 74.409999999999997 108.328 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.3 114.56 6.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.408 -0.59 . . . . 74.219999999999999 109.408 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.9 p -98.69 -0.83 42.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.735 0.814 . . . . 73.310000000000002 111.431 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.9 166.26 24.92 Favored Glycine 0 C--O 1.244 0.742 0 N-CA-C 110.703 -0.959 . . . . 70.329999999999998 110.703 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -70.87 -39.16 73.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.103 0.478 . . . . 73.010000000000005 110.45 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -79.95 -24.53 40.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 63.520000000000003 111.809 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 p -76.25 166.7 23.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.678 0.391 . . . . 74.200000000000003 110.829 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -134.96 133.47 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.042 0.537 . . . . 74.409999999999997 110.629 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.6 m -74.61 141.75 44.66 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.793 0.837 . . . . 74.420000000000002 110.177 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.721 HG12 ' HB3' ' A' ' 91' ' ' PHE . 14.1 pt -128.5 156.51 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.174 0.59 . . . . 73.120000000000005 110.412 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 7.2 m -108.03 152.45 24.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.159 0.984 . . . . 74.340000000000003 109.938 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -60.04 110.69 1.26 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.636 0.774 . . . . 73.140000000000001 109.13 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.85 8.33 63.64 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.688 -0.507 . . . . 51.530000000000001 113.646 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.2 tt0 -76.23 120.89 22.13 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.478 0.639 . . . . 72.25 110.355 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.61 ' HD3' HD23 ' A' ' 84' ' ' LEU . 64.6 mttp -78.69 127.7 32.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.274 0.629 . . . . 74.329999999999998 109.474 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.45 150.68 40.89 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.364 1.066 . . . . 75.450000000000003 110.351 -171.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -100.99 118.86 37.83 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.056 0.543 . . . . 75.420000000000002 109.939 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.48 HG12 ' HB1' ' A' ' 119' ' ' ALA . 56.5 t -84.97 118.22 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.617 0.722 . . . . 74.420000000000002 109.862 172.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.615 HD12 ' HG3' ' A' ' 120' ' ' GLU . 18.9 mt -85.37 -13.99 47.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.142 1.377 . . . . 72.409999999999997 110.889 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.25 4.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.491 -1.043 . . . . 71.319999999999993 110.491 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.647 ' H ' ' HB3' ' A' ' 22' ' ' PHE . 62.3 m-85 -88.71 173.28 8.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.543 0.687 . . . . 73.540000000000006 110.625 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -78.36 -179.53 6.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.663 -1.153 . . . . 74.310000000000002 110.844 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -45.72 -41.47 10.66 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.167 1.387 . . . . 71.25 113.766 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.45 ' HA ' HD11 ' A' ' 23' ' ' ILE . 31.4 p-10 -114.24 12.07 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.612 0.968 . . . . 73.420000000000002 113.612 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.56 10.63 85.71 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 116.249 1.26 . . . . 75.109999999999999 116.249 168.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.85 -42.21 28.08 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.987 0.894 . . . . 72.120000000000005 111.655 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 21.1 m95 -119.66 157.38 28.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.707 0.803 . . . . 74.219999999999999 110.36 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.48 ' HB1' HG12 ' A' ' 109' ' ' VAL . . . -135.24 145.69 47.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.662 0.785 . . . . 72.329999999999998 110.361 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' HG3' HD12 ' A' ' 110' ' ' LEU . 13.2 tp10 -79.22 113.55 17.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.578 -1.638 . . . . 74.420000000000002 106.578 164.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -134.08 140.35 46.57 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.08 0.466 . . . . 71.120000000000005 111.233 -171.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -104.11 106.57 17.12 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.363 1.065 . . . . 72.099999999999994 108.705 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.633 HG23 HG23 ' A' ' 101' ' ' ILE . 50.8 p -97.98 175.1 6.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.2 1.0 . . . . 71.420000000000002 109.482 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -65.15 -22.72 66.96 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.84 -0.429 . . . . 74.040000000000006 109.84 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.32 -21.16 56.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.514 1.126 . . . . 74.409999999999997 111.802 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.07 -139.89 9.3 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.311 0.505 . . . . 63.439999999999998 113.589 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -130.37 127.86 40.24 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.982 0.913 . . . . 72.439999999999998 109.898 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 169.37 -173.18 43.71 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 123.256 0.347 . . . . 73.040000000000006 112.723 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CH2' ' HB3' ' A' ' 250' ' ' ASN . 91.3 m95 -85.56 126.86 34.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.321 0.648 . . . . 74.430000000000007 112.339 -172.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -133.84 144.07 50.2 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.097 0.959 . . . . 74.120000000000005 108.618 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 2.2 Cg_endo -83.04 142.64 11.09 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.532 2.154 . . . . 72.420000000000002 114.385 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.46 ' HB3' ' CE2' ' A' ' 112' ' ' TYR . 69.2 p -40.92 -44.57 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.867 1.667 . . . . 75.329999999999998 113.707 167.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' ' 242' ' ' PRO . 27.8 p30 -77.94 -6.59 54.87 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.243 -0.89 . . . . 74.400000000000006 112.558 -172.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.581 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 30.2 m-85 -103.58 -10.0 18.8 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.371 0.668 . . . . 70.329999999999998 111.719 170.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.9 pt -126.32 178.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 124.099 0.959 . . . . 75.319999999999993 110.812 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.2 t -160.96 149.99 13.57 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.125 0.97 . . . . 65.420000000000002 108.71 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.559 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 24.3 Cg_endo -61.51 150.07 86.88 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.801 1.667 . . . . 73.140000000000001 111.548 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.1 t -71.32 -15.95 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 CA-C-O 120.955 0.407 . . . . 73.219999999999999 110.598 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -76.28 -17.94 59.22 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.449 0.699 . . . . 75.109999999999999 112.326 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.559 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 59.9 p -71.53 163.75 27.15 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.632 0.729 . . . . 73.5 112.648 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.41 -23.43 40.37 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.241 -0.891 . . . . 74.230000000000004 109.261 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.88 -15.48 63.09 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.607 1.163 . . . . 73.519999999999996 112.678 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -66.72 -24.08 66.19 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.919 0.39 . . . . 71.010000000000005 111.187 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -79.09 134.8 36.73 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.375 0.67 . . . . 72.129999999999995 109.788 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.7 p -59.12 -43.8 91.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.514 1.134 . . . . 74.239999999999995 111.745 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -62.88 -39.05 93.27 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.059 0.85 . . . . 72.349999999999994 112.467 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -77.76 110.83 12.97 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.128 -0.693 . . . . 75.409999999999997 109.128 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -107.03 -6.68 17.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.196 0.598 . . . . 73.140000000000001 111.155 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.57 -133.08 25.26 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.639 -1.09 . . . . 61.109999999999999 113.041 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.34 100.65 0.22 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.941 2.427 . . . . 74.010000000000005 112.006 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 55.9 t -138.71 131.74 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.747 1.219 . . . . 74.420000000000002 108.912 -175.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.3 p -84.7 171.57 12.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 64.340000000000003 109.987 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -62.07 -43.81 98.04 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.95 -0.548 . . . . 63.229999999999997 111.069 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -54.22 -43.44 70.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.731 0.645 . . . . 75.340000000000003 110.938 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.456 ' HB3' HG11 ' A' ' 151' ' ' VAL . . . -67.93 -38.45 82.88 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.282 -0.872 . . . . 74.400000000000006 111.155 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.3 -42.45 88.32 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.588 0.755 . . . . 65.150000000000006 111.732 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 67.5 mm-40 -59.85 -46.57 88.86 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.669 0.787 . . . . 74.439999999999998 109.421 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.533 ' HE1' ' HD2' ' A' ' 239' ' ' ARG . 42.3 t80 -62.01 -46.26 89.98 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.308 -1.314 . . . . 75.430000000000007 111.932 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.03 -40.33 84.71 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.912 0.885 . . . . 74.420000000000002 111.142 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.73 18.01 13.89 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.747 -0.661 . . . . 73.549999999999997 112.367 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 96.8 p -63.84 -41.23 97.87 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.083 0.856 . . . . 75.239999999999995 111.167 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 p -100.7 13.32 35.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.439 0.696 . . . . 70.310000000000002 111.299 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 151.87 41.69 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 123.117 0.26 . . . . 75.230000000000004 113.223 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.6 pt -101.96 -175.39 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.968 0.907 . . . . 75.530000000000001 110.898 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -52.7 122.2 8.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.63 0.772 . . . . 74.129999999999995 110.414 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.444 ' HA2' HD13 ' A' ' 184' ' ' LEU . . . 88.4 10.25 68.38 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.019 -0.879 . . . . 62.420000000000002 113.528 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 61.7 m -83.76 115.68 22.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.221 1.011 . . . . 72.519999999999996 111.282 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.465 ' HB3' HD11 ' A' ' 184' ' ' LEU . 11.1 p90 -130.22 167.08 19.0 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.202 0.525 . . . . 75.230000000000004 112.083 -170.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.27 146.79 24.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.717 -1.129 . . . . 74.340000000000003 108.609 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.595 HG23 HG12 ' A' ' 182' ' ' ILE . 78.3 t -107.65 135.56 45.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.152 -1.055 . . . . 73.230000000000004 108.152 171.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.498 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 19.8 ptt85 -134.62 160.22 38.79 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.273 1.029 . . . . 75.430000000000007 109.811 -175.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -117.56 155.35 29.95 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.163 -1.051 . . . . 75.450000000000003 108.163 164.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -80.11 125.75 30.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.14 -0.689 . . . . 55.420000000000002 109.14 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.12 -39.77 65.48 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.339 0.656 . . . . 74.120000000000005 109.619 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.9 p -75.07 -13.29 60.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.41 0.684 . . . . 73.540000000000006 111.74 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 35.3 m -141.72 80.55 15.77 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.511 0.724 . . . . 71.5 109.502 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -59.42 131.26 39.69 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.867 2.378 . . . . 72.319999999999993 112.292 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.45 -29.24 10.77 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.855 -0.611 . . . . 72.430000000000007 112.24 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -80.93 115.89 20.63 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.076 -0.713 . . . . 72.109999999999999 109.076 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -116.26 150.09 38.15 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.55 0.691 . . . . 71.400000000000006 111.077 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.9 m -150.08 153.66 36.8 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.583 -1.19 . . . . 73.439999999999998 109.886 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.595 HG12 HG23 ' A' ' 170' ' ' VAL . 30.0 mt -110.78 149.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.486 -0.931 . . . . 74.540000000000006 108.486 172.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 36.3 m -123.11 108.28 12.69 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.666 -1.235 . . . . 73.420000000000002 107.666 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.476 HD23 ' OH ' ' A' ' 193' ' ' TYR . 70.0 tp -106.78 128.04 53.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.915 0.486 . . . . 64.439999999999998 110.069 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -102.36 129.17 48.75 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.098 0.959 . . . . 74.200000000000003 109.085 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -150.17 131.32 14.45 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.602 1.561 . . . . 72.140000000000001 107.174 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 63.72 23.99 13.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.087 0.955 . . . . 71.439999999999998 111.736 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.04 81.04 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.012 0.365 . . . . 51.119999999999997 114.012 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -105.77 128.27 53.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.929 0.892 . . . . 74.120000000000005 109.432 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.2 t -93.63 111.99 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.195 0.598 . . . . 75.430000000000007 110.465 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -96.53 147.81 23.47 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.725 1.21 . . . . 73.540000000000006 109.589 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -121.86 117.48 26.61 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.305 0.574 . . . . 74.209999999999994 110.445 -171.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 9.1 m-30 -96.07 148.21 22.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.76 1.224 . . . . 72.430000000000007 109.42 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.98 117.58 34.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.696 -0.854 . . . . 73.439999999999998 108.696 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 mt -84.08 100.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 N-CA-C 107.304 -1.369 . . . . 70.420000000000002 107.304 172.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -82.95 131.44 35.19 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.077 0.951 . . . . 73.5 108.769 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.7 m -97.33 121.76 39.59 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.767 -0.827 . . . . 73.040000000000006 108.767 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.71 174.31 8.56 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.277 0.631 . . . . 65.5 110.705 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.2 p -62.83 -32.68 73.94 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.655 0.782 . . . . 75.010000000000005 111.737 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.85 -14.9 27.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.742 0.817 . . . . 74.519999999999996 110.891 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.93 13.69 13.42 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 118.983 -0.898 . . . . 75.340000000000003 114.252 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.16 125.69 27.5 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.039 0.92 . . . . 75.510000000000005 110.798 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -84.87 141.16 30.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.51 -0.922 . . . . 73.430000000000007 108.51 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.544 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 31.4 p90 -165.55 137.5 4.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.325 0.391 . . . . 75.340000000000003 111.506 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 217' ' ' LEU . 73.1 t -84.19 -36.72 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.573 -0.899 . . . . 64.219999999999999 108.573 163.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.5 m -100.99 127.44 47.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.859 -1.064 . . . . 74.510000000000005 109.962 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.2 t -63.67 -22.59 66.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.235 1.014 . . . . 74.140000000000001 111.909 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -82.87 -29.15 29.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.723 1.209 . . . . 73.340000000000003 110.859 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.6 m -126.33 99.02 5.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.33 0.652 . . . . 71.209999999999994 110.531 -175.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.544 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -97.34 133.46 41.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.871 0.868 . . . . 74.340000000000003 109.592 174.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.69 151.49 38.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.684 0.793 . . . . 73.319999999999993 109.327 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -73.09 -42.76 62.65 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.917 -0.401 . . . . 72.409999999999997 109.917 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 44.0 p -118.7 159.05 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.741 0.781 . . . . 75.239999999999995 112.248 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.06 -27.71 68.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.462 -1.245 . . . . 65.420000000000002 109.847 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.88 95.83 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.51 0.724 . . . . 74.109999999999999 110.629 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.11 -39.92 75.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.879 0.871 . . . . 72.109999999999999 110.865 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 205' ' ' VAL . 15.3 tp -55.38 -56.07 24.29 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.848 0.718 . . . . 73.430000000000007 111.23 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.1 -42.35 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 123.797 0.686 . . . . 73.209999999999994 111.001 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.84 -55.57 30.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.016 0.823 . . . . 75.109999999999999 111.339 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -68.29 -34.77 76.77 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.41 -0.814 . . . . 71.430000000000007 111.214 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.599 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.8 m170 -87.64 -9.56 53.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.812 0.445 . . . . 71.140000000000001 112.083 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 90.7 p -90.51 -33.72 15.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.947 0.499 . . . . 71.120000000000005 110.231 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.1 p -72.98 -49.51 28.59 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.717 -0.674 . . . . 74.230000000000004 111.169 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 226' ' ' ASP . 35.5 m -123.77 159.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.833 0.825 . . . . 74.129999999999995 112.459 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.15 16.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 128.205 2.602 . . . . 64.230000000000004 115.246 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.534 ' HB2' HG22 ' A' ' 224' ' ' VAL . 32.6 t70 -40.02 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 131.676 3.99 . . . . 70.519999999999996 119.852 -150.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.06 -3.22 10.68 Favored Glycine 0 N--CA 1.469 0.898 0 O-C-N 118.985 -2.322 . . . . 63.5 112.042 -165.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.1 mt -90.13 163.64 14.77 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.93 1.692 . . . . 74.310000000000002 109.231 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.76 -38.91 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 120.756 0.313 . . . . 71.540000000000006 110.881 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -158.02 -178.0 6.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.099 0.959 . . . . 73.230000000000004 109.938 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.5 p -67.41 144.01 55.99 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.588 0.755 . . . . 73.430000000000007 112.183 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.44 HD22 ' HE1' ' A' ' 193' ' ' TYR . 76.8 mt -75.4 90.21 2.67 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 107.565 -1.272 . . . . 74.310000000000002 107.565 169.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -121.71 9.35 10.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.054 -1.029 . . . . 73.129999999999995 113.673 -158.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -159.17 122.95 2.07 Favored Pre-proline 0 C--O 1.22 -0.493 0 N-CA-C 106.957 -1.497 . . . . 74.140000000000001 106.957 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.2 139.3 6.06 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 122.214 1.942 . . . . 75.340000000000003 112.592 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.46 124.8 89.16 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.181 -1.044 . . . . 53.049999999999997 108.181 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.13 -176.98 3.34 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.321 2.014 . . . . 72.439999999999998 113.218 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -76.85 118.74 19.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.034 -0.985 . . . . 74.420000000000002 109.318 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 240' ' ' ASN . 6.3 ptt180 -76.53 -53.65 7.79 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.591 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.542 ' N ' ' HG3' ' A' ' 239' ' ' ARG . 10.5 t30 -108.72 122.54 47.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.778 1.029 . . . . 70.319999999999993 113.778 -158.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 89' ' ' TYR . 97.2 mttt -79.8 113.46 37.88 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.183 -1.414 . . . . 75.140000000000001 107.183 159.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.637 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 25.5 Cg_exo -68.84 153.36 73.01 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.789 2.326 . . . . 73.209999999999994 113.601 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 24.5 m -73.44 139.94 46.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.725 -0.671 . . . . 74.329999999999998 110.993 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 52.0 t -95.65 113.51 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.99 -1.115 . . . . 62.049999999999997 107.99 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.421 ' O ' HG11 ' A' ' 247' ' ' VAL . 7.9 m-85 -102.94 110.85 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 119.256 -0.402 . . . . 73.450000000000003 110.414 -173.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.47 25.11 48.82 Favored Glycine 0 N--CA 1.477 1.373 0 N-CA-C 118.078 1.991 . . . . 73.319999999999993 118.078 160.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 245' ' ' TYR . 33.7 m -101.1 134.04 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 119.065 1.433 . . . . 65.340000000000003 113.421 -172.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -83.38 118.35 71.31 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 103.508 -2.775 . . . . 74.420000000000002 103.508 142.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.64 -59.5 0.83 Allowed 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 121.501 1.467 . . . . 64.200000000000003 113.753 -152.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.507 ' HB3' ' CH2' ' A' ' 129' ' ' TRP . 10.2 t30 -129.89 -19.99 3.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.016 0.526 . . . . 74.510000000000005 109.8 151.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -72.9 98.83 2.54 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.977 -0.556 . . . . 74.430000000000007 110.984 -154.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -123.01 -48.95 1.98 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.361 1.064 . . . . 75.510000000000005 108.933 162.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.615 ' HZ2' ' HB3' ' A' ' 253' ' ' LYS . 5.4 ttpm? -111.8 -14.99 13.48 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 114.262 -1.336 . . . . 72.439999999999998 110.735 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -56.89 153.35 11.15 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.685 0.794 . . . . 73.319999999999993 110.342 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.419 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 7.7 pt-20 . . . . . 0 CA--C 1.56 1.338 0 CA-C-O 117.638 -1.173 . . . . 72.329999999999998 110.288 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 110.107 -0.331 . . . . 74.209999999999994 110.107 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.54 33.94 0.02 OUTLIER Glycine 0 C--N 1.345 1.076 0 CA-C-N 116.409 -0.36 . . . . 62.200000000000003 112.529 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -159.03 132.88 7.52 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.317 0.647 . . . . 73.019999999999996 109.883 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -107.92 106.63 58.97 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.026 0.931 . . . . 73.230000000000004 109.506 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.2 77.93 1.95 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.573 2.182 . . . . 74.129999999999995 111.45 169.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.67 -21.69 79.47 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.508 -0.769 . . . . 61.100000000000001 113.459 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -79.44 3.44 18.5 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.617 0.767 . . . . 75.120000000000005 111.092 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.41 96.78 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 N-CA-C 109.495 -0.557 . . . . 75.310000000000002 109.495 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.59 82.07 7.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.387 0.675 . . . . 73.510000000000005 110.199 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.87 -175.5 35.67 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.976 -0.556 . . . . 72.430000000000007 112.056 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -103.06 142.91 33.3 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.587 0.355 . . . . 72.230000000000004 110.315 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -135.97 21.64 3.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.108 0.963 . . . . 62.399999999999999 110.63 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -70.9 166.5 21.02 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.858 0.463 . . . . 75.099999999999994 109.937 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 59.84 74.86 0.53 Allowed Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.045 0.938 . . . . 75.239999999999995 109.203 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.13 160.07 48.3 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.35 2.033 . . . . 74.319999999999993 112.152 -172.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.1 m -76.08 138.83 41.06 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.371 0.669 . . . . 71.150000000000006 109.901 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 pp -81.54 153.91 71.06 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.038 0.535 . . . . 75.010000000000005 110.251 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.16 162.6 28.56 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.032 1.821 . . . . 71.030000000000001 112.582 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.05 160.26 14.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.793 0.837 . . . . 71.219999999999999 109.665 172.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.57 124.0 48.84 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 109.045 -0.724 . . . . 65.049999999999997 109.045 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -95.26 143.13 26.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.106 0.562 . . . . 75.420000000000002 110.342 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -91.23 154.44 19.28 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.82 0.848 . . . . 74.519999999999996 109.845 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 tt -63.98 146.35 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 124.447 1.099 . . . . 72.340000000000003 112.201 -175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -125.96 91.97 3.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.918 1.287 . . . . 74.439999999999998 109.262 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.64 -0.09 73.08 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.831 -0.622 . . . . 52.109999999999999 113.781 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.0 102.57 11.04 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 117.727 0.764 . . . . 65.25 110.37 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.73 149.86 19.75 Favored Glycine 0 C--N 1.348 1.25 0 O-C-N 123.624 0.577 . . . . 44.240000000000002 112.59 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 11.5 mmpt? -91.55 169.93 10.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.471 1.108 . . . . 73.140000000000001 111.244 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -107.74 -76.92 0.6 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.977 0.511 . . . . 75.420000000000002 110.429 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.79 85.96 1.24 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.724 0.81 . . . . 75.310000000000002 109.78 -175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.3 p -169.68 32.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.055 1.742 . . . . 74.120000000000005 106.995 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.6 m -101.96 169.86 8.5 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 113.865 -1.516 . . . . 64.319999999999993 112.343 -164.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.455 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -163.38 160.63 23.8 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.347 -0.842 . . . . 74.310000000000002 109.41 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -96.46 132.85 41.6 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.147 -0.686 . . . . 70.409999999999997 109.147 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.19 -36.64 1.77 Allowed Glycine 0 C--N 1.344 0.987 0 O-C-N 123.886 0.741 . . . . 33.530000000000001 112.091 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.69 135.16 2.53 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 118.461 -1.188 . . . . 74.319999999999993 111.468 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.56 124.5 12.92 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.145 2.563 . . . . 73.430000000000007 112.806 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -117.56 140.98 48.9 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.973 0.909 . . . . 72.329999999999998 110.028 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.9 m -84.28 -178.52 6.96 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.083 0.953 . . . . 72.319999999999993 111.158 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 85.65 156.98 0.09 Allowed 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 126.527 1.931 . . . . 73.420000000000002 111.09 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.572 HG12 HD21 ' A' ' 250' ' ' ASN . 23.4 m -130.93 141.95 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.13 0.972 . . . . 75.200000000000003 110.177 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -127.69 -166.77 1.66 Allowed 'General case' 0 C--O 1.246 0.876 0 C-N-CA 124.688 1.195 . . . . 74.540000000000006 108.443 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -167.13 139.93 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.164 0.585 . . . . 74.439999999999998 110.578 172.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -164.25 167.78 19.57 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.611 1.164 . . . . 74.010000000000005 109.745 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -128.35 131.54 48.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.79 0.836 . . . . 73.099999999999994 108.79 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.67 -77.73 0.59 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.128 -1.064 . . . . 63.009999999999998 108.128 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.73 -175.78 0.95 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.602 0.761 . . . . 73.439999999999998 110.661 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 1.1 pt? -146.26 -175.9 4.95 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.476 1.11 . . . . 73.430000000000007 110.236 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 71.99 142.49 0.06 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.273 1.429 . . . . 73.329999999999998 112.342 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.1 mmt-85 -130.96 143.12 48.12 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.161 0.985 . . . . 75.420000000000002 108.777 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.73 110.46 1.28 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.701 2.267 . . . . 74.209999999999994 111.477 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.3 p -88.33 125.37 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 109.261 -0.644 . . . . 75.019999999999996 109.261 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.25 155.44 28.56 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.197 0.599 . . . . 72.120000000000005 110.303 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.3 p -64.54 -30.18 71.21 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.008 0.818 . . . . 73.409999999999997 109.473 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.83 81.17 4.26 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.178 -0.919 . . . . 73.150000000000006 109.537 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -151.48 159.2 44.28 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.251 1.02 . . . . 74.209999999999994 108.614 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.7 109.87 3.38 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.859 0.864 . . . . 73.310000000000002 108.904 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.2 -32.7 97.53 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.181 2.587 . . . . 74.319999999999993 113.918 -171.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.442 HE22 ' HA ' ' A' ' 159' ' ' LEU . 24.8 tp60 -90.31 -38.52 13.32 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.4 0.68 . . . . 74.349999999999994 110.949 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.56 45.47 22.93 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.02 -1.232 . . . . 61.25 110.02 -163.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.96 136.82 58.2 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.332 1.053 . . . . 64.310000000000002 111.337 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -127.61 175.38 8.31 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.72 0.808 . . . . 75.329999999999998 110.508 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 30.62 0.71 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.86 1.264 . . . . 70.030000000000001 111.82 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.85 10.69 0.65 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.283 1.033 . . . . 73.519999999999996 113.366 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.56 -18.55 64.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.249 1.02 . . . . 70.109999999999999 111.904 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -95.71 125.73 40.49 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.339 0.656 . . . . 70.019999999999996 109.684 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.404 ' NE1' ' HB2' ' A' ' 69' ' ' SER . 11.7 t90 -142.4 86.41 1.96 Allowed 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.007 -0.738 . . . . 74.540000000000006 109.007 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 24.1 p-10 -84.2 -8.97 58.9 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.718 -0.674 . . . . 70.109999999999999 110.868 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 144' ' ' HIS . 23.8 m -61.17 -4.3 1.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.778 1.399 . . . . 72.430000000000007 114.778 -165.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.51 -34.36 69.0 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.45 0.7 . . . . 75.310000000000002 111.145 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 12.7 pt-20 -65.32 -46.59 79.72 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.444 0.698 . . . . 73.25 110.589 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.04 -5.34 59.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.147 0.979 . . . . 71.219999999999999 111.014 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.441 ' HA ' ' HE2' ' A' ' 144' ' ' HIS . 18.9 tp -76.22 -49.68 16.5 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.429 1.091 . . . . 73.519999999999996 109.111 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.5 mt -104.45 36.7 2.31 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.229 -0.896 . . . . 74.319999999999993 109.529 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.63 92.02 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.412 1.085 . . . . 70.150000000000006 112.677 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.3 -140.37 35.49 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 119.123 -0.821 . . . . 63.409999999999997 111.989 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -67.95 120.09 7.09 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.095 1.863 . . . . 71.400000000000006 109.843 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 m -120.54 157.23 29.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.426 0.69 . . . . 72.319999999999993 111.404 -172.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -65.74 -25.43 67.28 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.421 1.088 . . . . 63.32 108.687 167.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.32 39.49 0.15 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.03 2.132 . . . . 75.510000000000005 113.018 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -42.59 151.99 0.36 Allowed Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 126.592 1.957 . . . . 64.0 113.523 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -51.96 -25.71 22.79 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.953 3.102 . . . . 63.509999999999998 115.753 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -75.54 -21.63 57.77 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.158 0.504 . . . . 74.439999999999998 110.607 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.4 ' HB2' ' NH2' ' A' ' 108' ' ' ARG . 26.1 tp -79.67 127.54 32.3 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.714 -0.847 . . . . 70.510000000000005 108.714 165.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.4 174.9 5.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.028 1.331 . . . . 73.109999999999999 109.165 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.12 135.12 32.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.726 0.81 . . . . 74.409999999999997 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.07 5.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.967 0.907 . . . . 75.239999999999995 110.373 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.9 -30.71 64.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.688 0.795 . . . . 73.310000000000002 110.735 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.0 m-85 -123.91 141.23 52.22 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.922 -1.036 . . . . 73.409999999999997 109.019 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -73.53 146.89 44.49 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.14 0.576 . . . . 71.329999999999998 109.524 168.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.427 ' HE2' ' HB ' ' A' ' 98' ' ' THR . 86.1 t80 -154.14 107.66 2.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.278 0.631 . . . . 74.530000000000001 109.361 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.49 137.03 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.111 -1.07 . . . . 75.310000000000002 108.111 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 115.53 10.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.035 0.534 . . . . 75.420000000000002 110.528 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.1 p -88.63 -25.5 22.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.288 0.635 . . . . 72.140000000000001 109.654 171.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.19 157.84 15.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-N 115.227 -0.897 . . . . 72.5 111.242 173.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 255' ' ' GLU . 4.2 m-20 -69.1 -34.69 75.49 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.722 0.809 . . . . 51.539999999999999 109.735 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -76.51 -26.91 55.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.356 -1.293 . . . . 74.0 112.3 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.427 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 67.0 p -82.77 155.36 24.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.425 -0.583 . . . . 75.109999999999999 109.425 173.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.544 ' HB3' HG13 ' A' ' 130' ' ' VAL . 67.2 tp -113.65 136.21 53.08 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.9 0.48 . . . . 74.340000000000003 111.741 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.7 m -74.55 117.09 15.97 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.794 0.837 . . . . 74.430000000000007 110.482 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.619 HG23 HG21 ' A' ' 123' ' ' THR . 22.0 pt -124.53 147.22 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.714 0.805 . . . . 75.340000000000003 111.343 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 57.5 m -89.88 145.65 24.99 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.262 1.025 . . . . 74.420000000000002 109.474 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -62.08 114.34 3.35 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.985 0.514 . . . . 72.230000000000004 109.749 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 7.05 61.68 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 119.648 -0.529 . . . . 74.340000000000003 113.457 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 88.4 tt0 -83.85 135.09 34.64 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.437 0.618 . . . . 64.409999999999997 110.371 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -85.02 138.59 32.35 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.225 0.61 . . . . 74.420000000000002 109.617 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.603 ' HB3' HG23 ' A' ' 123' ' ' THR . 0.3 OUTLIER -147.6 135.11 20.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.238 1.015 . . . . 62.310000000000002 109.935 -174.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.4 ' NH2' ' HB2' ' A' ' 84' ' ' LEU . 53.0 ttm-85 -99.15 115.9 30.12 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 122.306 -0.246 . . . . 73.450000000000003 110.624 -172.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 119' ' ' ALA . 74.0 t -76.36 122.97 31.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.8 0.687 . . . . 64.209999999999994 110.39 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.432 HD11 ' HG3' ' A' ' 122' ' ' GLN . 20.9 mt -90.81 -36.96 13.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.927 1.291 . . . . 75.140000000000001 109.448 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.46 148.77 9.66 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.421 -0.809 . . . . 72.450000000000003 112.373 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.597 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 22.0 m-85 -95.37 156.92 16.12 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 74.519999999999996 110.839 176.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -70.83 -178.39 1.87 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.434 -0.803 . . . . 72.420000000000002 110.791 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -55.29 -27.72 48.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.959 1.096 . . . . 73.109999999999999 113.959 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.02 -2.69 15.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.144 0.578 . . . . 74.329999999999998 112.436 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.63 20.98 75.85 Favored Glycine 0 C--N 1.349 1.305 0 N-CA-C 114.478 0.551 . . . . 62.299999999999997 114.478 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.49 -61.42 1.72 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 117.381 0.591 . . . . 72.310000000000002 110.152 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 62.6 m95 -92.3 145.48 24.45 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.735 0.414 . . . . 72.299999999999997 110.896 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 112' ' ' TYR . . . -130.66 139.19 50.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.667 1.187 . . . . 72.040000000000006 110.679 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.2 98.75 5.97 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 107.779 -1.193 . . . . 72.230000000000004 107.779 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . . . -105.46 134.8 47.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.678 0.791 . . . . 61.140000000000001 109.694 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.432 ' HG3' HD11 ' A' ' 110' ' ' LEU . 90.2 mt-30 -93.59 113.14 25.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.945 -0.761 . . . . 73.530000000000001 108.945 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.619 HG21 HG23 ' A' ' 101' ' ' ILE . 57.4 p -98.22 179.5 4.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.144 0.978 . . . . 75.329999999999998 110.589 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -72.51 -18.76 61.63 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.908 -1.042 . . . . 74.129999999999995 110.005 170.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -80.38 -12.5 59.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.384 1.073 . . . . 74.409999999999997 111.278 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.72 -172.75 14.48 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.618 -0.193 . . . . 74.230000000000004 112.618 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -85.67 136.29 33.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.255 0.622 . . . . 74.239999999999995 110.756 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -173.38 -177.77 42.86 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.99 -0.55 . . . . 72.219999999999999 112.49 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -107.2 125.21 50.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.837 0.455 . . . . 71.420000000000002 111.58 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.561 HG21 HD13 ' A' ' 135' ' ' ILE . 26.8 m -138.6 148.9 60.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 125.129 1.372 . . . . 75.030000000000001 109.461 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 90.3 Cg_endo -95.0 151.91 1.71 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.956 2.437 . . . . 64.400000000000006 115.538 -170.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.1 m -41.54 -38.5 1.34 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.424 1.89 . . . . 74.219999999999999 115.133 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -71.78 -13.37 61.68 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 122.113 -0.367 . . . . 75.209999999999994 111.175 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.433 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 15.5 m-85 -104.08 -25.26 13.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.007 0.923 . . . . 74.140000000000001 112.363 170.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 130' ' ' VAL . 32.7 pt -128.21 144.95 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 118.669 0.668 . . . . 75.200000000000003 112.486 -173.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.429 ' HG1' ' HB2' ' A' ' 142' ' ' GLU . 15.3 t -137.5 148.57 62.11 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 108.866 -0.79 . . . . 70.319999999999993 108.866 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.25 141.2 88.55 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.532 2.155 . . . . 72.439999999999998 110.948 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.05 -3.26 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.425 0 CA-C-O 121.056 0.455 . . . . 73.329999999999998 111.355 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.402 ' N ' HD21 ' A' ' 139' ' ' ASN . 0.9 OUTLIER -90.77 -8.54 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.379 0.672 . . . . 72.140000000000001 112.11 174.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.7 p -75.97 -177.27 3.8 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.155 0.582 . . . . 72.510000000000005 111.901 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.7 mt -86.85 -30.93 21.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.828 0.451 . . . . 72.340000000000003 110.082 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.429 ' HB2' ' HG1' ' A' ' 136' ' ' THR . 2.1 mp0 -64.34 -23.83 67.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.403 1.081 . . . . 75.430000000000007 111.8 -174.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -6.17 9.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.911 0.884 . . . . 74.129999999999995 112.425 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 73' ' ' LEU . 85.1 m-70 -97.21 155.47 16.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.887 0.875 . . . . 74.319999999999993 110.585 171.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.5 p -66.99 -41.51 86.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.501 1.12 . . . . 74.010000000000005 111.745 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -66.04 -41.67 90.56 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.113 0.783 . . . . 74.140000000000001 113.113 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 26.4 t80 -78.06 112.55 15.11 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.955 -0.387 . . . . 73.430000000000007 109.955 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.411 ' HB2' HG23 ' A' ' 151' ' ' VAL . 30.6 m170 -104.41 -5.29 21.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.376 0.51 . . . . 52.340000000000003 112.376 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.34 -141.73 30.37 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 118.506 -1.163 . . . . 75.299999999999997 112.673 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.59 94.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.596 2.864 . . . . 73.230000000000004 112.919 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.662 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.8 t -138.53 137.09 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.916 1.286 . . . . 61.310000000000002 109.702 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.4 p -89.4 176.26 6.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.394 1.078 . . . . 65.530000000000001 110.882 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -60.1 -49.29 78.21 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.984 0.513 . . . . 73.430000000000007 110.122 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -59.56 -41.56 90.43 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.194 0.934 . . . . 75.230000000000004 111.192 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -65.84 -44.82 84.36 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.307 -0.86 . . . . 73.439999999999998 111.522 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.56 89.63 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.56 -0.745 . . . . 75.310000000000002 111.123 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -80.68 -21.6 41.16 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.47 -0.786 . . . . 63.450000000000003 111.977 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.431 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -78.23 -25.63 47.03 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.992 0.814 . . . . 74.430000000000007 110.388 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 239' ' ' ARG . 62.2 mt -70.74 -42.48 70.45 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.518 0.675 . . . . 72.549999999999997 110.484 169.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.443 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 66.9 mt -94.37 22.44 6.05 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.757 -1.11 . . . . 75.430000000000007 111.388 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 99.1 p -74.06 -43.8 56.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.148 0.499 . . . . 73.430000000000007 110.164 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.7 p -112.05 19.56 17.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.633 0.773 . . . . 64.430000000000007 110.464 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.96 149.8 48.2 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.98 -0.555 . . . . 74.230000000000004 111.724 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.7 pt -87.35 169.82 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-O 121.166 0.508 . . . . 74.519999999999996 110.527 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -70.96 109.25 4.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.077 -0.511 . . . . 75.219999999999999 109.632 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.87 10.07 19.42 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.087 0.851 . . . . 72.349999999999994 112.863 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.0 m -86.22 131.99 34.11 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.089 0.944 . . . . 62.409999999999997 110.583 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 183' ' ' SER . 8.6 p90 -139.29 166.95 23.18 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.385 0.539 . . . . 74.439999999999998 111.569 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -162.62 147.63 12.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.916 -1.038 . . . . 73.040000000000006 108.483 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.691 HG22 HG12 ' A' ' 182' ' ' ILE . 99.2 t -105.32 124.53 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.56 -1.274 . . . . 74.530000000000001 107.56 169.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.662 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 44.7 ptt85 -114.68 159.99 19.86 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.456 1.102 . . . . 71.239999999999995 108.663 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.65 141.79 47.73 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.757 -1.201 . . . . 62.149999999999999 107.757 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.0 t -83.51 130.73 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.26 0.624 . . . . 71.230000000000004 110.003 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.05 -33.01 33.79 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.718 0.636 . . . . 75.329999999999998 109.973 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.8 p -72.45 -31.81 65.76 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.494 -0.775 . . . . 75.549999999999997 110.955 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.6 m -121.8 95.1 48.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.476 0.71 . . . . 72.030000000000001 109.293 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.57 114.44 2.54 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.39 2.727 . . . . 64.400000000000006 113.31 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.16 -15.15 61.83 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.755 -0.657 . . . . 75.219999999999999 112.964 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -79.16 116.6 19.53 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.505 0.653 . . . . 72.439999999999998 109.975 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -110.22 144.65 38.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.477 0.656 . . . . 72.140000000000001 110.46 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.6 m -138.43 150.67 46.71 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.834 0.854 . . . . 74.409999999999997 109.043 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.691 HG12 HG22 ' A' ' 170' ' ' VAL . 22.3 mt -101.87 150.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.54 -1.282 . . . . 74.340000000000003 107.54 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -124.87 108.24 11.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.778 -1.193 . . . . 75.319999999999993 107.778 168.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.455 HD22 ' OH ' ' A' ' 193' ' ' TYR . 56.7 tp -107.49 111.12 23.26 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.325 -0.62 . . . . 74.340000000000003 109.325 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -79.55 122.37 26.4 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.521 -0.548 . . . . 73.25 109.521 168.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -149.92 145.25 26.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.848 1.659 . . . . 74.319999999999993 107.458 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 59.45 21.79 10.23 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 124.255 1.022 . . . . 64.409999999999997 111.557 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.47 -7.15 62.11 Favored Glycine 0 C--N 1.358 1.765 0 CA-C-N 116.176 -0.465 . . . . 75.030000000000001 113.956 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -104.49 138.64 40.56 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.196 0.999 . . . . 75.340000000000003 108.581 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.33 103.81 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.397 0.544 . . . . 73.310000000000002 110.395 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.26 115.47 27.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.885 0.874 . . . . 75.040000000000006 109.65 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.63 118.25 30.84 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.194 0.598 . . . . 75.510000000000005 110.371 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.494 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 11.1 m-85 -94.33 148.49 22.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.447 1.099 . . . . 72.409999999999997 109.532 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -107.02 112.93 26.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 74.310000000000002 108.727 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.18 101.49 8.82 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 N-CA-C 108.8 -0.815 . . . . 75.219999999999999 108.8 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -80.79 121.81 26.39 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.662 -1.154 . . . . 73.420000000000002 108.931 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.2 m -93.39 113.88 26.15 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.917 0.887 . . . . 71.439999999999998 108.78 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.25 167.32 14.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.7 0.8 . . . . 74.019999999999996 110.799 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.9 p -62.45 -24.69 67.57 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.881 0.872 . . . . 74.049999999999997 112.195 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -96.87 -16.66 20.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.62 0.768 . . . . 74.230000000000004 111.516 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.87 9.94 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.217 -0.768 . . . . 70.409999999999997 114.81 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.72 124.71 26.54 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.32 1.06 . . . . 73.319999999999993 110.551 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -88.26 140.88 29.03 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.846 -0.798 . . . . 74.340000000000003 108.846 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.579 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 44.8 p90 -162.63 135.59 5.8 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.769 0.668 . . . . 75.400000000000006 110.516 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 217' ' ' LEU . 53.9 t -70.81 -53.28 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.902 -0.777 . . . . 74.129999999999995 108.902 165.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.3 m -107.06 136.15 47.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.629 -1.168 . . . . 74.439999999999998 109.744 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.8 t -60.4 -26.59 66.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.45 1.1 . . . . 71.230000000000004 112.942 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.39 -23.3 61.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.747 0.819 . . . . 73.409999999999997 111.479 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.2 m -134.4 101.17 4.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.182 0.593 . . . . 71.319999999999993 110.364 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.579 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.1 mtm180 -110.07 138.07 46.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.162 0.985 . . . . 75.230000000000004 110.197 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.87 149.22 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.623 -0.88 . . . . 72.239999999999995 108.623 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -68.66 -31.96 71.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 75.400000000000006 110.76 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -132.1 157.36 44.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 112.074 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -27.55 69.03 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.731 -1.122 . . . . 75.109999999999999 109.506 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.99 -45.44 86.79 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.553 0.741 . . . . 72.219999999999999 110.898 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.6 -34.83 72.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.527 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 205' ' ' VAL . 16.0 tp -56.98 -58.64 7.27 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.752 0.421 . . . . 64.239999999999995 110.873 174.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.22 -40.65 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.246 0.618 . . . . 74.239999999999995 111.165 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -57.13 -61.47 2.44 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.822 0.701 . . . . 74.340000000000003 111.566 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -71.9 -29.16 64.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.849 -0.614 . . . . 73.340000000000003 111.262 -171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.504 ' HB3' HD12 ' A' ' 228' ' ' LEU . 12.7 m170 -87.55 -9.88 53.17 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.675 0.39 . . . . 73.319999999999993 112.049 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.0 p -88.43 -35.33 17.14 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.98 0.355 . . . . 74.010000000000005 110.114 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 65.8 p -70.28 -46.65 63.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.631 0.372 . . . . 71.129999999999995 111.048 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.733 HG22 ' HB2' ' A' ' 226' ' ' ASP . 22.8 m -132.01 165.14 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.353 0.661 . . . . 71.450000000000003 111.973 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.62 15.41 0.37 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 126.714 2.005 . . . . 64.129999999999995 114.208 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.733 ' HB2' HG22 ' A' ' 224' ' ' VAL . 23.8 t70 -44.65 36.23 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.723 1 C-N-CA 132.429 4.292 . . . . 75.109999999999999 119.561 -157.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 124.1 -7.08 8.73 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.537 -0.727 . . . . 74.430000000000007 112.493 -170.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 221' ' ' HIS . 14.4 mt -94.65 162.45 13.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.116 1.366 . . . . 74.209999999999994 110.059 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.76 -35.26 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.604 0.24 . . . . 74.150000000000006 110.786 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.5 t -159.06 -179.22 7.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.996 0.519 . . . . 74.219999999999999 110.677 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.2 p -66.13 137.24 56.9 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.622 1.169 . . . . 73.219999999999999 112.311 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.44 96.69 1.19 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.75 0.82 . . . . 73.349999999999994 109.051 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -97.53 -82.61 0.41 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.818 -0.551 . . . . 64.25 111.99 -170.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -75.22 120.72 82.99 Favored Pre-proline 0 C--N 1.351 0.647 0 N-CA-C 108.857 -0.794 . . . . 74.400000000000006 108.857 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.88 127.7 7.97 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.038 1.825 . . . . 73.120000000000005 111.275 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.95 140.94 88.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 108.851 -0.796 . . . . 74.409999999999997 108.851 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.76 176.58 9.34 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.488 2.125 . . . . 74.140000000000001 113.051 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -63.53 140.7 58.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.897 0.879 . . . . 75.109999999999999 109.654 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.597 ' HE ' HG22 ' A' ' 151' ' ' VAL . 20.8 ptt85 -90.49 -61.31 1.71 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.524 0.935 . . . . 75.310000000000002 113.524 -165.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.405 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.8 t30 -109.08 128.84 55.32 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.595 0.758 . . . . 74.140000000000001 109.614 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 90.8 mttt -76.94 113.26 28.6 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.092 -1.447 . . . . 74.349999999999994 107.092 164.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 39.0 Cg_exo -63.15 132.65 37.31 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.534 2.156 . . . . 74.239999999999995 112.46 -172.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 89.5 m -69.25 123.84 22.22 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.404 0.682 . . . . 72.319999999999993 110.284 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.65 111.74 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.405 -0.961 . . . . 74.519999999999996 108.405 172.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.638 ' HA ' ' HB3' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -106.56 112.37 25.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.303 0.641 . . . . 72.319999999999993 111.917 -169.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 69.34 -38.18 0.34 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 117.366 1.706 . . . . 71.040000000000006 117.366 165.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.33 129.33 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 117.833 0.817 . . . . 73.219999999999999 112.771 -158.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.9 t -83.35 135.82 43.7 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 107.339 -1.356 . . . . 75.409999999999997 107.339 168.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.92 -60.46 0.39 Allowed 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 122.126 1.884 . . . . 75.129999999999995 115.265 -156.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.572 HD21 HG12 ' A' ' 41' ' ' VAL . 25.8 p-10 -128.98 -31.58 2.13 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-O 121.734 0.778 . . . . 70.340000000000003 109.841 153.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.454 ' CG ' ' HB2' ' A' ' 254' ' ' TRP . 0.2 OUTLIER -104.33 150.19 24.69 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.071 -0.968 . . . . 75.519999999999996 111.905 -162.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -103.02 -44.99 5.08 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.029 0.531 . . . . 65.409999999999997 110.251 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -110.78 13.45 22.33 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.604 0.965 . . . . 72.400000000000006 113.604 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.497 ' HH2' ' HA2' ' A' ' 128' ' ' GLY . 25.9 t90 -71.25 145.92 49.29 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.119 0.418 . . . . 74.25 111.255 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 32.0 tt0 . . . . . 0 C--O 1.259 1.591 0 C-N-CA 125.683 1.593 . . . . 73.530000000000001 106.998 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.256 -0.646 . . . . 75.120000000000005 109.256 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.61 -119.86 15.27 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 124.1 0.875 . . . . 74.329999999999998 112.191 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -76.81 117.9 18.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.387 0.675 . . . . 61.530000000000001 109.251 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.01 144.41 47.49 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.466 0.706 . . . . 73.540000000000006 110.537 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -53.76 98.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 123.939 3.093 . . . . 71.219999999999999 114.498 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.87 -152.01 13.26 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.32 -0.4 . . . . 71.140000000000001 112.621 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.01 82.58 4.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.476 0.655 . . . . 72.400000000000006 109.346 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.07 -35.69 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.048 0.939 . . . . 60.439999999999998 110.425 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.7 mt 58.94 -165.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.78 1.232 . . . . 75.519999999999996 111.197 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.18 -178.62 11.01 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 112.274 -0.33 . . . . 72.329999999999998 112.274 170.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -134.35 -67.27 0.58 Allowed 'General case' 0 CA--C 1.55 0.967 0 O-C-N 122.043 -0.68 . . . . 54.450000000000003 112.009 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -126.1 168.99 13.24 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.584 0.629 . . . . 75.129999999999995 111.362 -170.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -73.95 93.3 2.19 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.023 -0.99 . . . . 72.450000000000003 111.401 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -141.04 -55.5 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 CA-C-O 118.057 -0.973 . . . . 71.040000000000006 112.509 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HB2' HD22 ' A' ' 250' ' ' ASN . 24.2 Cg_exo -62.11 127.88 22.46 Favored 'Trans proline' 0 C--N 1.401 3.309 0 C-N-CA 122.054 1.836 . . . . 74.340000000000003 113.18 -169.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.2 t -135.53 -78.95 0.43 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.59 -1.263 . . . . 61.310000000000002 107.59 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.4 mt 51.25 71.71 1.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 C-N-CA 124.416 1.087 . . . . 74.099999999999994 112.219 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.23 141.19 60.21 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.765 2.976 . . . . 72.230000000000004 114.526 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.67 -163.24 1.73 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.324 1.05 . . . . 65.420000000000002 109.105 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -136.9 125.06 23.01 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.697 0.799 . . . . 72.540000000000006 108.934 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -126.88 127.67 45.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.822 -0.807 . . . . 75.439999999999998 108.822 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -80.56 149.03 30.1 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.284 0.633 . . . . 74.400000000000006 111.453 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.94 -179.83 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.44 1.496 . . . . 73.310000000000002 109.524 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -139.08 155.89 47.58 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.266 0.626 . . . . 75.219999999999999 109.958 171.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.99 110.12 0.24 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.854 -0.612 . . . . 63.32 112.589 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.57 139.71 14.38 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.309 1.044 . . . . 74.5 109.176 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.94 -27.86 0.46 Allowed Glycine 0 C--N 1.352 1.443 0 C-N-CA 121.903 -0.189 . . . . 73.319999999999993 113.083 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -117.24 167.25 11.38 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.928 0.891 . . . . 74.150000000000006 110.092 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 120.28 18.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.53 0.732 . . . . 74.299999999999997 109.601 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HB3' ' HZ1' ' A' ' 103' ' ' LYS . 49.7 mm-40 -99.29 134.15 42.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.127 0.571 . . . . 73.439999999999998 111.634 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.6 m -67.46 130.23 42.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.042 0.937 . . . . 74.299999999999997 110.082 176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -134.78 99.11 4.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.695 0.398 . . . . 62.140000000000001 111.101 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -161.64 148.62 14.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.115 0.566 . . . . 72.200000000000003 111.328 169.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -178.57 89.49 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.534 1.534 . . . . 74.129999999999995 108.361 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.86 -126.91 7.57 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.785 -0.453 . . . . 43.439999999999998 112.874 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.87 137.98 8.42 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.179 -0.789 . . . . 65.519999999999996 112.545 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -79.38 -120.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.244 2.629 . . . . 74.109999999999999 111.609 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.536 ' HB2' HD21 ' A' ' 61' ' ' LEU . 56.2 p-80 -162.55 130.07 3.79 Favored 'General case' 0 C--N 1.366 1.305 0 CA-C-N 118.917 0.78 . . . . 65.340000000000003 112.049 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.1 m -152.58 157.14 40.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.153 0.981 . . . . 63.539999999999999 109.644 170.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -79.27 94.76 5.51 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.669 0.788 . . . . 65.140000000000001 109.62 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.33 96.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 N-CA-C 107.199 -1.408 . . . . 73.120000000000005 107.199 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -102.39 133.78 46.76 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 114.84 1.422 . . . . 75.319999999999993 114.84 -157.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 m -150.8 -38.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 126.244 1.818 . . . . 74.140000000000001 108.28 161.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -149.25 173.07 13.87 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.434 0.693 . . . . 73.310000000000002 110.703 -167.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 46.9 t60 85.21 133.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.509 1.924 . . . . 72.109999999999999 111.511 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -110.81 148.27 32.74 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.846 1.259 . . . . 74.329999999999998 111.025 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.85 -72.32 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.657 1.583 . . . . 74.109999999999999 108.786 166.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 tt -171.19 94.46 0.18 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.712 0.405 . . . . 74.409999999999997 110.032 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -163.57 176.7 9.44 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 126.094 1.757 . . . . 74.329999999999998 108.326 165.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -121.67 89.3 47.53 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 123.43 0.692 . . . . 73.209999999999994 110.364 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 76.1 Cg_endo -79.32 163.98 24.47 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.786 2.324 . . . . 74.150000000000006 112.033 169.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.66 90.45 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.688 -0.856 . . . . 74.129999999999995 108.688 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.62 -171.95 1.97 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.089 0.956 . . . . 74.109999999999999 110.149 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.1 p -74.97 -62.57 1.5 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.036 0.534 . . . . 71.549999999999997 111.876 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.63 -77.26 0.58 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.713 -0.847 . . . . 64.430000000000007 108.713 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -94.12 128.69 40.66 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.743 0.817 . . . . 74.430000000000007 108.915 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -110.38 129.43 23.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.009 0.524 . . . . 74.120000000000005 110.012 -175.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.78 -137.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.968 2.445 . . . . 74.140000000000001 111.618 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -90.57 -52.98 4.62 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.076 0.551 . . . . 72.219999999999999 109.856 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.76 30.37 9.69 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.187 -0.46 . . . . 74.040000000000006 112.754 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -95.37 74.42 3.32 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.695 -1.595 . . . . 75.319999999999993 106.695 174.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m -88.95 -19.62 25.53 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 114.497 1.295 . . . . 74.420000000000002 114.497 -158.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 1.4 pm0 -76.76 -37.36 56.04 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 118.656 0.662 . . . . 64.150000000000006 109.94 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.55 -18.03 64.48 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 120.765 0.317 . . . . 72.439999999999998 111.094 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.34 -24.35 39.93 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.059 0.944 . . . . 64.349999999999994 112.325 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HA ' ' HB3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -152.45 -44.01 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.096 0.776 . . . . 75.010000000000005 113.096 -176.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 63' ' ' GLU . 8.1 t90 -83.89 67.23 9.51 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 74.299999999999997 109.625 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 26.2 p-10 -66.97 -33.95 76.7 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.419 -0.81 . . . . 73.409999999999997 110.826 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 p -72.0 6.21 2.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.698 1.199 . . . . 74.510000000000005 112.72 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HD3' ' HG3' ' A' ' 63' ' ' GLU . 83.5 tttt -70.28 -21.24 62.98 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.75 0.42 . . . . 75.430000000000007 111.13 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.568 ' HG3' HD21 ' A' ' 72' ' ' ASN . 13.3 pt-20 -73.0 -38.11 66.72 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.474 -0.565 . . . . 73.450000000000003 109.474 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.568 HD21 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -77.43 -13.59 59.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.23 0.612 . . . . 75.230000000000004 111.075 176.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 60.3 tp -59.14 -50.32 74.5 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.684 0.794 . . . . 73.129999999999995 110.692 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 mt -108.06 23.8 13.94 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.78 -0.645 . . . . 72.099999999999994 110.922 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . -75.62 -28.92 59.02 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.073 0.549 . . . . 70.319999999999993 111.533 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.91 -137.71 30.43 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-O 119.141 -0.81 . . . . 74.349999999999994 111.712 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 86.6 Cg_exo -50.81 -177.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.892 0 C-N-CA 123.483 2.789 . . . . 65.400000000000006 114.817 166.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 2.8 m -67.98 167.74 13.2 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.934 -0.575 . . . . 71.530000000000001 109.854 171.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -63.75 -43.65 95.82 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.961 0.504 . . . . 74.519999999999996 111.587 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -127.1 -33.44 2.42 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.348 0.659 . . . . 74.340000000000003 111.035 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 78' ' ' SER . 25.6 m-20 -90.04 149.4 41.56 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 113.653 0.983 . . . . 74.140000000000001 113.653 -174.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -89.42 -9.77 4.09 Favored 'Trans proline' 0 CA--C 1.561 1.85 0 C-N-CA 122.717 2.278 . . . . 75.319999999999993 111.956 149.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.441 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 60.1 t30 -109.85 16.78 21.77 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.229 1.011 . . . . 73.010000000000005 111.681 -169.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.5 tp -100.11 139.52 35.66 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.65 -0.656 . . . . 72.239999999999995 110.315 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -116.5 172.3 7.29 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.362 1.065 . . . . 73.319999999999993 109.101 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.08 139.99 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.732 1.213 . . . . 74.430000000000007 109.538 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.32 117.26 20.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.207 1.003 . . . . 73.230000000000004 110.249 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.444 HD13 ' HZ3' ' A' ' 238' ' ' LYS . 69.9 mt -81.07 -31.7 34.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.09 0.956 . . . . 75.209999999999994 111.564 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.43 141.61 51.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.036 0.934 . . . . 74.540000000000006 108.921 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.99 120.2 24.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.158 -0.682 . . . . 71.409999999999997 109.158 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.2 t80 -115.43 142.87 46.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.786 0.834 . . . . 64.109999999999999 109.469 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.72 135.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.737 -0.838 . . . . 63.109999999999999 108.737 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.42 119.22 10.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.701 0.8 . . . . 75.510000000000005 111.035 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.3 p -94.4 10.94 32.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.428 1.091 . . . . 74.409999999999997 111.324 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.78 179.45 43.47 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.108 -0.496 . . . . 73.310000000000002 112.034 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.14 -34.81 63.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.892 0.877 . . . . 74.430000000000007 110.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' ND2' ' HD2' ' A' ' 249' ' ' PRO . 32.4 p-10 -90.37 -4.05 57.33 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.043 -0.981 . . . . 75.400000000000006 112.262 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.9 p -96.76 168.51 10.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.457 0.703 . . . . 72.299999999999997 109.936 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.58 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 66.1 tp -135.93 136.29 40.33 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.084 0.553 . . . . 73.049999999999997 111.38 -172.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -83.9 120.14 25.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.573 0.749 . . . . 70.239999999999995 110.073 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.751 HG22 HG23 ' A' ' 123' ' ' THR . 20.2 pt -117.43 152.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 123.171 0.588 . . . . 75.450000000000003 111.614 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -98.53 146.44 25.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.362 1.065 . . . . 72.310000000000002 109.601 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' HZ1' ' HB3' ' A' ' 30' ' ' GLU . 40.2 ttmt -70.17 118.59 13.19 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.907 0.483 . . . . 74.439999999999998 109.701 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.78 -11.5 56.21 Favored Glycine 0 N--CA 1.472 1.052 0 C-N-CA 123.197 0.427 . . . . 74.420000000000002 112.845 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.11 135.65 44.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.65 0.78 . . . . 73.319999999999993 110.97 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -85.92 142.46 28.83 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.572 -0.899 . . . . 74.040000000000006 108.572 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.628 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.15 150.4 34.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.25 0.62 . . . . 62.210000000000001 111.119 -176.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -95.4 106.41 18.46 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.687 -0.688 . . . . 73.409999999999997 109.287 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.583 HG11 ' HB2' ' A' ' 119' ' ' ALA . 42.1 t -86.75 107.88 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.621 -0.511 . . . . 74.439999999999998 109.621 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.605 HD23 ' HG3' ' A' ' 122' ' ' GLN . 2.1 mm? -69.52 -23.22 63.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.349 1.059 . . . . 75.409999999999997 110.935 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.7 166.42 13.61 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.276 -0.42 . . . . 75.140000000000001 112.46 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.566 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 61.1 m-85 -86.6 173.12 9.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.841 0.829 . . . . 74.140000000000001 111.794 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.434 ' HB2' ' HB2' ' A' ' 250' ' ' ASN . 31.2 p-10 -90.05 -178.66 5.49 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.208 -1.36 . . . . 64.25 110.97 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -53.26 -34.3 56.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.611 1.165 . . . . 71.030000000000001 113.11 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -105.35 -19.67 13.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 119.183 -0.436 . . . . 74.25 111.368 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.21 34.68 22.9 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.548 0.579 . . . . 71.109999999999999 114.548 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.55 -29.82 14.7 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.023 0.412 . . . . 73.310000000000002 111.057 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 60.6 m95 -128.75 156.02 44.2 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.16 0.984 . . . . 74.25 111.15 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.583 ' HB2' HG11 ' A' ' 109' ' ' VAL . . . -137.22 141.31 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.305 1.042 . . . . 73.319999999999993 110.263 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.483 ' HG2' HD21 ' A' ' 110' ' ' LEU . 40.7 tt0 -74.82 118.43 17.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.859 -1.163 . . . . 63.350000000000001 107.859 170.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.52 151.33 48.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.25 0.62 . . . . 75.430000000000007 111.307 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.605 ' HG3' HD23 ' A' ' 110' ' ' LEU . 56.4 mt-30 -115.05 116.43 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.148 0.979 . . . . 74.400000000000006 108.95 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.751 HG23 HG22 ' A' ' 101' ' ' ILE . 67.0 p -114.6 -178.51 3.39 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.349 1.059 . . . . 72.409999999999997 110.885 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.498 ' HB3' ' HZ2' ' A' ' 124' ' ' LYS . 1.1 mmmp? -68.66 -16.53 63.86 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.553 -0.748 . . . . 74.430000000000007 110.29 172.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -84.33 -20.46 32.01 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.202 1.001 . . . . 73.120000000000005 111.074 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.31 -168.43 14.84 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.096 -0.402 . . . . 55.240000000000002 112.096 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.27 145.45 28.83 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.35 0.575 . . . . 71.349999999999994 111.593 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.39 -161.91 27.65 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.713 -0.955 . . . . 31.43 110.713 177.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -110.94 136.24 50.25 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.797 0.798 . . . . 74.129999999999995 111.463 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.442 HG11 ' CG2' ' A' ' 101' ' ' ILE . 34.2 m -137.8 140.28 29.13 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.063 1.345 . . . . 73.109999999999999 109.252 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 8.8 Cg_exo -72.85 146.4 42.33 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.44 2.093 . . . . 74.120000000000005 114.38 -172.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 m -38.09 -50.96 1.4 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.469 1.907 . . . . 61.119999999999997 114.194 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 131' ' ' PRO . 12.7 p-10 -73.3 -3.65 28.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.375 1.07 . . . . 74.519999999999996 113.103 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -106.73 -9.39 16.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.858 0.863 . . . . 75.120000000000005 111.313 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.482 HD12 HG23 ' A' ' 109' ' ' VAL . 18.0 pt -130.8 168.59 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.137 0.975 . . . . 73.329999999999998 111.832 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 t -163.06 155.9 16.29 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 124.08 0.952 . . . . 62.340000000000003 108.672 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.74 142.71 91.65 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 121.795 1.663 . . . . 72.040000000000006 111.442 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.4 t -69.72 -11.37 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.796 0.807 . . . . 75.409999999999997 109.848 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.635 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 11.6 m120 -73.8 -18.36 60.97 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.523 1.129 . . . . 53.439999999999998 112.568 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.6 p -92.69 -178.25 4.8 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.318 0.858 . . . . 73.230000000000004 113.318 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.8 mt -83.5 -21.19 32.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.257 1.023 . . . . 74.409999999999997 111.689 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.54 -20.95 63.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.684 0.394 . . . . 73.200000000000003 111.792 -172.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -65.33 -15.99 63.12 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 112.266 0.469 . . . . 74.420000000000002 112.266 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -83.22 138.47 33.6 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.401 0.68 . . . . 75.319999999999993 109.28 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 p -65.11 -39.88 93.76 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.611 0.765 . . . . 72.329999999999998 112.203 -177.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.42 ' HE1' HD11 ' A' ' 73' ' ' LEU . 32.2 p-90 -67.78 -30.16 69.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.848 0.859 . . . . 72.219999999999999 112.87 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -80.58 102.99 10.13 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.742 -0.466 . . . . 75.230000000000004 109.742 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -99.72 -4.1 31.47 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.992 0.517 . . . . 75.439999999999998 111.788 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.8 -139.79 26.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 118.708 -1.051 . . . . 62.25 112.793 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.92 101.51 0.39 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.813 2.342 . . . . 74.010000000000005 112.399 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 76.7 t -132.3 141.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.77 0.828 . . . . 74.319999999999993 109.801 -175.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.6 p -87.72 172.65 9.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.924 0.89 . . . . 73.25 110.369 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 68.8 ttt180 -61.71 -45.51 93.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.243 -0.28 . . . . 63.539999999999999 110.243 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.5 -45.56 80.94 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.042 0.838 . . . . 64.299999999999997 111.019 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.593 ' HB1' HH12 ' A' ' 239' ' ' ARG . . . -71.65 -26.45 62.55 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.289 -0.869 . . . . 71.239999999999995 111.699 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.27 -43.27 52.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.27 0.628 . . . . 74.310000000000002 111.243 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 26.7 mm-40 -60.79 -36.19 78.38 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.722 0.809 . . . . 74.129999999999995 110.059 174.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -67.75 -47.29 69.67 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.704 -1.134 . . . . 73.209999999999994 111.205 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.33 -38.44 68.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.284 0.634 . . . . 73.010000000000005 111.307 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.9 mt -100.93 6.79 43.75 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.952 0.723 . . . . 73.109999999999999 112.952 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 90.6 p -59.17 -35.31 73.32 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 119.075 0.852 . . . . 70.5 111.166 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -102.86 18.92 20.37 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.495 1.118 . . . . 73.25 110.89 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.11 133.29 11.68 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 123.644 0.64 . . . . 74.109999999999999 113.057 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -79.54 -177.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.946 0.898 . . . . 51.100000000000001 111.837 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.96 116.43 3.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.601 0.761 . . . . 71.129999999999995 110.656 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.16 11.8 55.7 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.629 -0.714 . . . . 73.019999999999996 113.094 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.1 m -76.38 135.24 39.48 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 118.082 0.941 . . . . 74.510000000000005 110.622 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 183' ' ' SER . 33.6 p90 -142.22 168.13 20.47 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 118.782 0.719 . . . . 71.010000000000005 111.34 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 pp -159.29 152.67 22.52 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.337 -0.986 . . . . 73.140000000000001 108.337 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.679 HG21 HG12 ' A' ' 182' ' ' ILE . 89.4 t -110.91 142.05 24.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 N-CA-C 109.092 -0.707 . . . . 70.409999999999997 109.092 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.453 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.3 ptt85 -135.37 159.21 42.3 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.288 -1.323 . . . . 74.439999999999998 108.95 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.655 ' HG2' ' HG2' ' A' ' 180' ' ' ARG . 10.7 mt-10 -113.93 162.14 16.76 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.523 -0.918 . . . . 73.219999999999999 108.523 164.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -84.02 133.79 34.65 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.99 -0.744 . . . . 74.409999999999997 108.99 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -71.17 -43.73 66.89 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.722 -0.473 . . . . 74.450000000000003 109.722 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.5 p -76.25 -15.76 59.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.112 0.565 . . . . 71.420000000000002 112.145 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.5 m -139.54 82.99 17.57 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.141 0.577 . . . . 74.519999999999996 109.865 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.64 125.94 18.57 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.958 2.439 . . . . 72.109999999999999 111.531 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.42 -29.58 8.98 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.752 -0.539 . . . . 53.0 111.752 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -75.77 116.89 16.94 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.02 -0.733 . . . . 72.049999999999997 109.02 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.655 ' HG2' ' HG2' ' A' ' 172' ' ' GLU . 98.3 mtt180 -124.01 145.89 48.9 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 123.954 0.902 . . . . 75.010000000000005 110.121 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 64.3 m -142.27 146.46 35.14 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.221 -0.9 . . . . 71.319999999999993 109.668 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.679 HG12 HG21 ' A' ' 170' ' ' VAL . 34.6 mt -103.32 150.17 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.084 -1.45 . . . . 72.010000000000005 107.084 169.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.1 m -125.45 108.09 11.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.661 -1.237 . . . . 71.430000000000007 107.661 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 25.5 tp -107.72 110.16 21.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.658 0.663 . . . . 75.430000000000007 110.216 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.524 ' HB2' HG22 ' A' ' 190' ' ' VAL . 20.5 ttt180 -79.95 120.89 24.77 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.673 0.749 . . . . 75.299999999999997 110.773 168.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -140.59 135.51 31.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 113.816 -1.538 . . . . 73.5 107.446 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 60.14 22.4 11.67 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.799 0.84 . . . . 63.539999999999999 112.087 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.15 -10.77 73.05 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.142 0.417 . . . . 45.210000000000001 114.142 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -103.5 139.04 39.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.314 0.646 . . . . 73.209999999999994 109.908 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' A' ' 185' ' ' ARG . 48.1 t -99.3 110.33 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.897 0.479 . . . . 73.329999999999998 110.433 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -95.05 117.03 29.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.979 1.311 . . . . 73.030000000000001 109.133 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -96.54 122.94 39.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.947 0.499 . . . . 75.120000000000005 110.723 -172.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.468 ' HE1' HD21 ' A' ' 232' ' ' LEU . 8.2 m-30 -94.82 147.36 23.43 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.097 0.959 . . . . 75.040000000000006 109.795 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -99.24 117.65 34.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.132 -1.062 . . . . 74.540000000000006 108.132 173.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 180' ' ' ARG . 56.8 mt -82.4 100.59 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 107.649 -1.241 . . . . 73.439999999999998 107.649 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.28 119.81 15.96 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.051 -0.977 . . . . 72.209999999999994 109.206 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 m -87.71 110.47 20.46 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.677 -0.692 . . . . 73.200000000000003 109.16 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.25 157.3 10.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.167 0.987 . . . . 61.0 111.383 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.6 p -64.43 -31.79 73.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.641 0.776 . . . . 73.200000000000003 112.101 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -82.58 -13.92 55.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.319 0.648 . . . . 72.329999999999998 111.316 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.32 9.77 19.04 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.401 0.52 . . . . 65.5 114.401 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -79.66 164.09 24.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.686 0.743 . . . . 73.409999999999997 110.735 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -115.73 147.36 41.0 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.601 0.761 . . . . 75.420000000000002 109.172 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.594 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.6 p90 -170.3 140.06 1.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.027 0.829 . . . . 72.510000000000005 111.728 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.35 -44.38 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.733 -0.84 . . . . 63.130000000000003 108.733 165.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 43.1 m -92.7 130.83 38.2 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.941 -1.027 . . . . 71.140000000000001 109.992 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -72.27 -17.11 61.91 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.416 0.686 . . . . 74.099999999999994 111.884 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.47 -1.51 57.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.038 0.535 . . . . 64.450000000000003 111.399 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.36 101.86 3.53 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.769 0.428 . . . . 73.519999999999996 111.426 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.594 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 74.2 mtt180 -101.36 153.68 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.219 0.608 . . . . 72.530000000000001 110.32 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.4 154.72 47.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.411 0.684 . . . . 75.329999999999998 109.952 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -72.21 -44.74 62.48 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.233 -0.655 . . . . 63.240000000000002 109.233 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 156.41 31.39 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-O 121.938 0.875 . . . . 75.450000000000003 111.564 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.438 HD23 HD23 ' A' ' 217' ' ' LEU . 0.8 OUTLIER -64.55 -26.6 68.49 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-N 114.012 -1.449 . . . . 73.099999999999994 110.065 175.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.26 96.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.576 0.75 . . . . 70.140000000000001 111.331 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.84 -33.19 70.4 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.375 0.67 . . . . 72.5 111.154 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.438 HD23 HD23 ' A' ' 214' ' ' LEU . 15.3 tp -53.36 -57.23 11.31 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.729 0.643 . . . . 74.209999999999994 110.034 171.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 53.4 t -63.88 -37.83 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 O-C-N 123.802 0.689 . . . . 74.219999999999999 112.035 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -65.14 -51.89 58.46 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.853 0.358 . . . . 74.319999999999993 111.189 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -64.23 -35.11 79.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 75.150000000000006 110.776 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.623 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.5 m170 -85.72 -9.33 57.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.284 0.476 . . . . 72.430000000000007 112.284 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.4 p -90.93 -29.73 17.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.727 0.411 . . . . 73.549999999999997 110.761 170.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.7 p -75.48 -49.51 18.57 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.852 0.358 . . . . 75.140000000000001 110.735 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.3 m -125.7 154.23 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.979 0.895 . . . . 73.420000000000002 111.694 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.62 13.88 7.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.627 1.971 . . . . 71.150000000000006 113.694 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -46.77 34.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 131.182 3.793 . . . . 55.25 119.855 -159.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.58 -0.67 6.37 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 119.28 0.945 . . . . 74.430000000000007 112.941 -167.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.2 mt -92.33 161.92 14.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.434 1.094 . . . . 75.540000000000006 110.52 163.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.83 -42.19 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 122.564 0.345 . . . . 74.25 110.432 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -161.69 170.9 18.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.665 0.786 . . . . 71.120000000000005 110.102 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.3 p -61.29 139.36 58.17 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.456 1.102 . . . . 63.530000000000001 112.687 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.468 HD21 ' HE1' ' A' ' 193' ' ' TYR . 79.5 mt -68.17 99.55 0.91 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.033 0.933 . . . . 74.510000000000005 109.161 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -94.44 -50.24 5.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.329 0.492 . . . . 73.439999999999998 112.329 -163.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 167' ' ' SER . 15.5 t80 -130.77 124.16 20.62 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.936 1.294 . . . . 72.030000000000001 108.127 -171.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -84.95 146.91 10.4 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.256 1.97 . . . . 72.420000000000002 112.17 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -74.63 130.15 82.25 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.437 -1.32 . . . . 75.420000000000002 107.437 172.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.35 173.8 12.77 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.076 1.85 . . . . 73.310000000000002 112.5 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HZ3' HD13 ' A' ' 88' ' ' LEU . 34.0 mmtp -68.19 109.12 3.42 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.882 -0.784 . . . . 74.349999999999994 108.882 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.603 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 8.7 ptt180 -75.51 -68.3 0.58 Allowed 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.559 0.948 . . . . 73.319999999999993 113.559 -158.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.603 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 66.8 t30 -111.29 137.75 48.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.788 -0.57 . . . . 70.219999999999999 110.128 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -74.49 112.69 18.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 106.3 -1.741 . . . . 71.420000000000002 106.3 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.23 127.28 16.4 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.346 2.031 . . . . 64.329999999999998 111.568 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 84.8 m -61.53 110.76 1.56 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.969 0.907 . . . . 74.230000000000004 111.182 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.22 106.96 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 107.685 -1.228 . . . . 64.109999999999999 107.685 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.73 120.77 43.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.128 0.971 . . . . 73.209999999999994 112.777 -163.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.07 63.74 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 116.352 1.301 . . . . 64.409999999999997 116.352 161.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.63 122.42 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 123.187 0.595 . . . . 72.239999999999995 110.874 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.9 t -81.3 116.73 64.65 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 104.834 -2.284 . . . . 72.439999999999998 104.834 161.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.501 ' HD2' ' ND2' ' A' ' 97' ' ' ASN . 99.3 Cg_exo -47.51 -62.95 0.36 Allowed 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.677 2.252 . . . . 74.349999999999994 116.226 -148.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' A' ' 15' ' ' PRO . 2.9 t30 -129.4 -32.73 1.95 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 122.213 1.006 . . . . 72.219999999999999 109.783 162.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.504 ' HD2' ' HB3' ' A' ' 250' ' ' ASN . 6.6 m-85 -100.24 150.08 22.91 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 113.512 -1.676 . . . . 75.400000000000006 110.175 -169.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -113.24 -42.4 3.52 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.072 0.858 . . . . 73.109999999999999 109.973 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -94.33 11.78 29.25 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.611 0.765 . . . . 74.150000000000006 112.366 -174.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -92.14 141.83 28.16 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.828 0.451 . . . . 72.430000000000007 111.235 -172.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 106.993 -1.484 . . . . 75.400000000000006 106.993 178.155 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.21 -0.292 . . . . 73.310000000000002 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.12 122.15 23.06 Favored Glycine 0 C--N 1.357 1.709 0 O-C-N 123.81 0.694 . . . . 71.299999999999997 111.985 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -120.73 -60.54 1.65 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.181 0.992 . . . . 74.420000000000002 109.264 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 174.74 131.94 0.13 Allowed Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.194 1.397 . . . . 71.319999999999993 108.275 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.87 109.39 1.67 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.222 1.948 . . . . 75.430000000000007 111.717 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.89 -28.22 73.7 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.573 -0.739 . . . . 72.099999999999994 112.023 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 65.21 14.41 9.38 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.193 1.397 . . . . 75.450000000000003 112.667 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.03 118.99 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.987 0.915 . . . . 73.219999999999999 109.639 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.7 155.68 29.31 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.551 0.34 . . . . 74.420000000000002 110.197 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.4 84.74 0.06 OUTLIER Glycine 0 C--N 1.338 0.642 0 N-CA-C 112.024 -0.43 . . . . 72.150000000000006 112.024 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -158.07 153.54 26.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.031 0.532 . . . . 73.019999999999996 109.855 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -141.0 113.7 8.25 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.869 0.868 . . . . 74.430000000000007 109.191 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -77.06 90.26 3.6 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.188 0.595 . . . . 75.329999999999998 110.257 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 91.83 4.21 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.45 1.1 . . . . 73.120000000000005 108.644 170.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -87.74 126.82 2.2 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.11 1.873 . . . . 75.439999999999998 112.42 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.0 m -107.92 156.8 18.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.717 0.807 . . . . 72.310000000000002 108.978 172.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.73 82.48 13.87 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.48 0.712 . . . . 73.439999999999998 111.142 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.89 114.51 3.18 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.356 2.037 . . . . 73.099999999999994 111.02 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.41 132.04 40.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.393 0.677 . . . . 72.239999999999995 110.386 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.8 mt -142.32 -172.26 3.57 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.041 1.337 . . . . 74.099999999999994 109.35 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -156.2 110.81 2.84 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.792 -0.818 . . . . 65.329999999999998 108.792 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -134.62 -168.76 2.21 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.554 -0.906 . . . . 72.5 108.554 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.0 mm 73.55 100.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.055 1.342 . . . . 75.310000000000002 110.122 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -82.93 -51.37 7.66 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.285 -0.871 . . . . 74.219999999999999 109.176 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.83 7.66 83.91 Favored Glycine 0 C--N 1.355 1.637 0 CA-C-N 115.397 -0.819 . . . . 72.019999999999996 113.366 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.92 100.31 2.9 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.662 0.785 . . . . 71.5 110.118 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 48' ' ' LEU . . . -166.09 156.56 28.56 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.089 -0.804 . . . . 74.010000000000005 111.089 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.89 152.94 37.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.505 0.722 . . . . 73.129999999999995 110.369 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -95.59 95.52 8.43 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.373 -0.973 . . . . 73.340000000000003 108.373 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -79.15 133.11 36.74 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.695 -0.684 . . . . 75.519999999999996 111.407 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.494 ' HA ' ' HB2' ' A' ' 93' ' ' ALA . 58.9 m -99.47 23.55 9.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.82 0.848 . . . . 75.530000000000001 110.424 172.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.0 m -67.59 133.07 48.75 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 124.084 0.954 . . . . 72.530000000000001 110.224 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -116.5 100.32 7.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.027 0.931 . . . . 73.230000000000004 109.607 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -120.34 134.15 55.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.433 0.693 . . . . 72.340000000000003 109.649 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.19 161.06 29.49 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.844 -0.616 . . . . 63.229999999999997 112.332 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.63 96.46 0.13 Allowed Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.326 -1.11 . . . . 71.019999999999996 110.326 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HA ' ' CZ2' ' A' ' 254' ' ' TRP . 2.8 Cg_exo -70.05 87.92 0.58 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.033 2.489 . . . . 74.019999999999996 111.788 -173.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 255' ' ' GLU . 61.7 t-80 -145.93 149.0 33.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.47 0.708 . . . . 75.129999999999995 110.228 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.2 p 55.45 102.47 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.51 1.924 . . . . 62.43 112.599 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -75.14 -3.63 33.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.258 1.023 . . . . 74.5 112.54 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.3 m -85.11 120.87 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.307 0.643 . . . . 75.519999999999996 110.745 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -163.92 140.31 6.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 73.430000000000007 110.772 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -160.69 96.23 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.946 0.898 . . . . 75.120000000000005 109.959 174.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 252' ' ' ASP . 9.8 tp10 -163.2 147.28 10.95 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.928 -0.578 . . . . 73.219999999999999 110.224 172.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -155.28 92.47 1.42 Allowed 'General case' 0 CA--C 1.547 0.851 0 O-C-N 123.808 0.693 . . . . 74.439999999999998 109.388 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -74.04 166.27 23.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.423 0.689 . . . . 72.420000000000002 110.982 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.17 65.64 1.29 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 75.049999999999997 110.012 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.604 ' HB3' ' HA3' ' A' ' 27' ' ' GLY . 63.7 mt -122.99 117.29 25.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.617 0.767 . . . . 73.239999999999995 109.629 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -141.89 176.51 8.87 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.331 0.653 . . . . 75.25 110.067 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -130.1 156.91 78.51 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.68 0.792 . . . . 74.200000000000003 110.009 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.69 -176.63 2.1 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.31 2.007 . . . . 74.230000000000004 111.469 168.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.43 131.11 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-N 116.406 -0.361 . . . . 72.239999999999995 110.244 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.76 -173.67 4.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.813 0.845 . . . . 63.119999999999997 111.032 -177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.9 p -78.17 -0.66 29.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.256 1.023 . . . . 75.329999999999998 111.833 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.57 126.37 55.28 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.173 0.989 . . . . 74.129999999999995 108.858 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -129.56 178.18 6.67 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.231 1.013 . . . . 73.319999999999993 109.946 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.68 93.0 5.55 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.042 -1.096 . . . . 74.400000000000006 108.042 168.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.42 -45.03 5.64 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.985 2.456 . . . . 74.209999999999994 113.858 -167.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 pm0 -73.14 -39.78 65.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.714 0.406 . . . . 74.010000000000005 111.368 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.81 47.34 65.5 Favored Glycine 0 C--N 1.359 1.807 0 O-C-N 123.705 0.628 . . . . 51.409999999999997 113.486 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.29 140.26 58.01 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.475 0.71 . . . . 75.510000000000005 112.127 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.0 m -77.28 -167.6 0.94 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.077 0.951 . . . . 75.430000000000007 110.935 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -72.76 90.16 1.4 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.363 1.065 . . . . 74.430000000000007 109.424 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 68.56 -76.65 0.06 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.132 1.773 . . . . 64.430000000000007 110.878 -173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.56 -42.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.035 0.534 . . . . 75.319999999999993 111.485 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -142.09 -44.21 0.34 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.994 0.518 . . . . 74.340000000000003 110.823 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -174.47 104.38 0.1 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.158 0.983 . . . . 74.409999999999997 108.51 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 30.1 p-10 -94.38 -34.01 12.94 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.888 0.475 . . . . 74.430000000000007 110.68 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.3 p -71.25 2.94 4.05 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.959 0.903 . . . . 75.099999999999994 113.3 -171.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.08 -22.07 64.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.658 . . . . 72.209999999999994 110.636 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 10.9 pt-20 -65.76 -30.79 71.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.688 0.795 . . . . 74.540000000000006 110.673 172.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -84.17 -10.34 57.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.128 0.971 . . . . 74.549999999999997 110.928 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.5 tp -65.12 -48.91 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.807 0.843 . . . . 73.420000000000002 111.686 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.51 12.39 29.6 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 73.540000000000006 110.971 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.3 -19.78 65.52 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.179 0.591 . . . . 63.0 111.471 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.62 -136.03 21.46 Favored Glycine 0 C--N 1.358 1.789 0 CA-C-O 118.879 -0.956 . . . . 74.400000000000006 111.73 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.26 -176.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.432 2.754 . . . . 74.439999999999998 113.638 170.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -66.36 172.36 4.06 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.607 -0.724 . . . . 64.329999999999998 110.953 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.04 -48.85 19.33 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.932 0.345 . . . . 73.549999999999997 111.932 -169.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -133.45 -40.0 0.9 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.118 0.567 . . . . 75.109999999999999 110.639 171.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 8.6 m-20 -91.21 112.7 55.29 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 114.992 -1.004 . . . . 71.040000000000006 110.802 -169.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.24 -24.26 72.36 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.436 2.091 . . . . 73.310000000000002 112.228 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -96.64 19.54 12.2 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.451 1.101 . . . . 70.329999999999998 111.754 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 35.0 tp -84.23 127.29 33.86 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 121.258 0.552 . . . . 64.120000000000005 110.035 176.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -110.49 174.95 5.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.625 1.57 . . . . 74.239999999999995 108.652 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.66 141.56 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.744 1.218 . . . . 74.329999999999998 109.46 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.4 137.03 38.47 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.609 0.763 . . . . 72.310000000000002 110.079 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.518 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 73.1 mt -103.97 -20.85 13.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.942 0.897 . . . . 72.219999999999999 111.475 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.98 149.19 49.99 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.021 0.928 . . . . 73.430000000000007 109.552 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.4 119.58 19.69 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.515 -0.92 . . . . 74.349999999999994 108.515 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -129.8 133.6 47.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.222 -0.659 . . . . 73.549999999999997 109.222 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.9 136.23 37.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.534 -1.284 . . . . 74.450000000000003 107.534 169.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 31' ' ' SER . . . -55.65 136.07 50.81 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.349 1.06 . . . . 62.219999999999999 111.218 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -131.33 26.88 4.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.014 0.925 . . . . 70.310000000000002 112.254 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.46 -165.74 26.36 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.071 -0.513 . . . . 73.230000000000004 112.014 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.73 -42.51 19.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.143 0.577 . . . . 75.430000000000007 112.304 -172.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.671 ' HB3' ' HD2' ' A' ' 251' ' ' TYR . 25.5 p-10 -101.05 5.07 42.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.632 0.373 . . . . 72.239999999999995 111.767 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -76.27 172.31 13.09 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.698 0.799 . . . . 73.519999999999996 112.044 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.531 HD23 ' HG1' ' A' ' 123' ' ' THR . 39.5 tp -147.02 130.54 16.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 73.299999999999997 110.138 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -80.77 127.79 32.91 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.336 0.654 . . . . 62.219999999999999 109.86 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.627 HG21 HG21 ' A' ' 123' ' ' THR . 19.5 pt -126.72 154.22 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.549 0.74 . . . . 75.239999999999995 111.684 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -100.68 147.33 26.13 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.616 -1.175 . . . . 73.310000000000002 108.743 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.67 114.16 4.78 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.551 -0.537 . . . . 75.230000000000004 109.551 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.84 -1.34 44.99 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 115.924 -0.58 . . . . 74.109999999999999 113.124 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -79.65 127.18 31.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.951 0.501 . . . . 74.209999999999994 110.493 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -79.3 135.35 36.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.484 0.714 . . . . 74.140000000000001 109.435 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.652 ' HB3' HG23 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.64 147.87 30.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.651 0.78 . . . . 71.430000000000007 111.26 -174.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -104.93 109.51 21.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.854 0.461 . . . . 75.420000000000002 110.731 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.521 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.4 t -73.05 125.23 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.608 0.363 . . . . 72.239999999999995 110.162 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.9 mt -96.28 -36.76 10.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.877 1.271 . . . . 75.530000000000001 110.237 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.1 144.68 6.89 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.76 -0.655 . . . . 73.200000000000003 111.982 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 119' ' ' ALA . 29.5 m-85 -89.62 171.11 9.91 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.853 0.835 . . . . 63.340000000000003 111.616 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -68.98 161.02 29.81 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 113.784 -1.553 . . . . 74.099999999999994 108.021 169.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -54.29 -28.52 42.62 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.998 0.919 . . . . 74.329999999999998 113.141 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -106.11 -3.62 21.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.078 0.951 . . . . 73.299999999999997 111.847 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.72 33.38 58.05 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-O 119.818 -0.434 . . . . 72.319999999999993 113.981 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.611 ' HB3' ' HD1' ' A' ' 118' ' ' TRP . 37.6 mt-10 -70.23 -65.69 0.69 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.261 0.531 . . . . 71.219999999999999 110.544 171.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.773 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 23.5 m95 -119.65 167.09 12.37 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.277 1.031 . . . . 74.430000000000007 110.176 -171.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.554 ' HB3' ' CE2' ' A' ' 112' ' ' TYR . . . -141.7 131.56 24.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.462 1.105 . . . . 73.040000000000006 109.95 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.76 101.8 4.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . . . -104.64 144.69 31.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.35 0.66 . . . . 73.329999999999998 110.586 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -95.6 105.17 17.13 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.109 -1.071 . . . . 75.040000000000006 108.109 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.652 HG23 ' HB3' ' A' ' 107' ' ' LEU . 62.3 p -97.94 173.53 7.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.618 1.167 . . . . 74.0 110.152 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -68.69 -21.79 64.4 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.503 -0.772 . . . . 73.219999999999999 109.777 174.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.979 1.312 . . . . 75.299999999999997 111.474 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.11 -170.48 24.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.139 -0.384 . . . . 71.150000000000006 112.139 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -102.33 135.05 44.62 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.415 0.686 . . . . 74.129999999999995 110.554 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 172.34 -175.38 45.54 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 111.261 -0.735 . . . . 34.340000000000003 111.261 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -94.84 132.67 39.4 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.268 0.627 . . . . 74.299999999999997 112.023 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.525 HG21 HD11 ' A' ' 135' ' ' ILE . 36.0 m -137.72 139.98 28.41 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.75 1.62 . . . . 71.340000000000003 108.816 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 7.7 Cg_exo -71.21 145.35 48.73 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.598 2.198 . . . . 75.540000000000006 113.953 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -38.2 -50.75 1.44 Allowed 'General case' 0 C--N 1.369 1.444 0 C-N-CA 125.405 1.482 . . . . 72.230000000000004 112.763 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -80.66 12.38 3.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.442 1.097 . . . . 74.299999999999997 112.882 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -115.58 -16.13 11.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.36 1.064 . . . . 74.430000000000007 111.481 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 130' ' ' VAL . 21.3 pt -128.91 171.69 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.766 0.826 . . . . 73.109999999999999 111.511 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.8 t -161.71 153.24 15.75 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.649 -0.871 . . . . 71.430000000000007 108.649 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 36.8 Cg_endo -64.08 154.53 69.99 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.685 1.59 . . . . 73.430000000000007 112.067 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.4 t -72.59 -6.96 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-O 121.937 0.875 . . . . 74.450000000000003 110.382 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.54 -19.78 35.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.826 0.85 . . . . 60.350000000000001 111.401 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.6 p -88.42 171.84 9.81 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.338 0.655 . . . . 73.030000000000001 111.738 -172.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.41 -21.55 30.75 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.001 0.92 . . . . 74.109999999999999 110.668 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.86 -17.12 63.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.471 1.108 . . . . 74.109999999999999 111.761 -172.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.417 ' HA ' HD22 ' A' ' 88' ' ' LEU . 23.4 pttm -62.46 -12.53 22.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.66 0.784 . . . . 74.420000000000002 112.371 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -96.68 150.89 20.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.112 0.965 . . . . 74.310000000000002 110.303 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 p -67.33 -43.86 80.52 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.097 0.959 . . . . 73.129999999999995 111.5 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -57.85 -39.77 78.52 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 124.281 0.988 . . . . 74.5 111.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -77.83 112.67 14.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.062 -0.718 . . . . 73.099999999999994 109.062 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -108.53 -2.71 18.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.024 0.53 . . . . 75.430000000000007 111.695 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.41 -145.69 25.51 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 118.88 -0.955 . . . . 75.219999999999999 113.22 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.74 91.75 0.3 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.357 2.705 . . . . 71.140000000000001 111.85 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.21 144.14 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.724 1.21 . . . . 74.120000000000005 109.005 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.4 p -88.2 167.25 13.75 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.575 0.75 . . . . 74.450000000000003 109.835 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -60.05 -46.79 88.38 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.901 0.48 . . . . 73.340000000000003 111.702 -173.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -65.53 -35.31 80.49 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 123.754 0.659 . . . . 71.430000000000007 111.115 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.33 67.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.091 0.556 . . . . 64.319999999999993 110.87 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.617 ' HA ' HD12 ' A' ' 159' ' ' LEU . . . -68.35 -43.86 76.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.604 0.716 . . . . 33.43 110.885 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.24 -21.31 60.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.2 -0.909 . . . . 73.010000000000005 110.647 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -72.48 -42.35 65.01 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.594 0.757 . . . . 75.219999999999999 110.353 170.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 156' ' ' ALA . 21.5 mt -56.66 -37.33 70.66 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.276 0.631 . . . . 75.540000000000006 110.674 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 19.6 17.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.415 -0.811 . . . . 75.200000000000003 112.602 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 -35.86 51.22 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.759 -0.83 . . . . 72.239999999999995 108.759 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.5 p -94.54 -15.16 24.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.67 1.188 . . . . 74.219999999999999 111.586 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.18 148.65 50.28 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 123.267 0.355 . . . . 54.100000000000001 113.455 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.4 -178.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.767 . . . . 72.230000000000004 111.398 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.26 123.2 19.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.146 -0.479 . . . . 65.25 109.88 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.31 7.89 61.73 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.311 -0.716 . . . . 62.310000000000002 113.052 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.5 m -83.71 133.46 34.8 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 118.26 1.03 . . . . 75.239999999999995 110.479 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -139.37 166.34 24.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.095 0.474 . . . . 74.120000000000005 111.146 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -158.5 150.62 21.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.906 -1.043 . . . . 75.409999999999997 109.17 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.635 HG23 HG12 ' A' ' 182' ' ' ILE . 99.6 t -110.33 140.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 108.596 -0.89 . . . . 72.030000000000001 108.596 167.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.499 ' HD3' ' HB3' ' A' ' 156' ' ' ALA . 52.2 ptt85 -142.6 161.43 38.08 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.045 -0.979 . . . . 75.340000000000003 109.621 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.48 154.67 27.79 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.196 -1.409 . . . . 74.400000000000006 107.196 165.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -79.63 119.2 22.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 72.299999999999997 109.649 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.46 -37.02 85.69 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.609 -0.723 . . . . 73.510000000000005 109.886 168.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 -40.52 97.9 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.273 1.029 . . . . 75.120000000000005 111.659 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.4 m -143.47 94.84 6.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.648 0.779 . . . . 63.130000000000003 109.598 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -59.19 146.91 92.98 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.217 2.611 . . . . 73.129999999999995 112.812 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.06 -30.62 8.3 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.49 -0.777 . . . . 64.409999999999997 112.268 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.82 115.16 15.22 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 109.451 -0.574 . . . . 65.019999999999996 109.451 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -119.68 140.93 49.88 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.292 0.637 . . . . 74.430000000000007 109.441 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 71.1 m -145.24 147.39 32.36 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.065 0.946 . . . . 74.099999999999994 109.864 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.635 HG12 HG23 ' A' ' 170' ' ' VAL . 38.0 mt -102.74 147.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.221 -1.4 . . . . 74.299999999999997 107.221 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.6 m -124.3 113.0 17.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.519 -1.289 . . . . 65.349999999999994 107.519 172.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.0 112.34 24.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.048 0.539 . . . . 75.310000000000002 109.871 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.438 ' HB2' HG22 ' A' ' 190' ' ' VAL . 54.3 ttt180 -79.73 116.5 19.94 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 109.43 -0.581 . . . . 72.140000000000001 109.43 166.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -142.11 141.44 32.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.144 1.377 . . . . 75.329999999999998 107.938 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 54.55 31.05 14.19 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.403 1.081 . . . . 65.420000000000002 111.603 -173.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.24 -11.25 50.74 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-N 115.466 -0.788 . . . . 72.109999999999999 114.228 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -104.72 139.5 39.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.585 0.754 . . . . 74.150000000000006 110.129 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 185' ' ' ARG . 51.7 t -95.68 107.26 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.848 0.459 . . . . 73.319999999999993 110.511 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -93.1 132.38 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.471 1.108 . . . . 73.109999999999999 109.211 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -107.52 119.8 40.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.14 0.576 . . . . 71.219999999999999 110.636 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.501 ' HE1' HD22 ' A' ' 232' ' ' LEU . 7.8 m-85 -94.55 146.65 23.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.411 1.084 . . . . 73.120000000000005 109.192 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -100.38 114.72 28.47 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.217 -0.66 . . . . 72.430000000000007 109.217 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mt -85.15 101.06 9.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.198 -1.038 . . . . 73.519999999999996 108.198 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.93 121.27 23.94 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.948 -1.024 . . . . 65.219999999999999 108.641 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.7 m -94.23 118.7 31.95 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.343 -0.984 . . . . 75.450000000000003 108.343 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.9 169.54 14.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.867 0.867 . . . . 72.530000000000001 110.621 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.7 p -66.3 -28.51 68.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.839 0.456 . . . . 72.209999999999994 110.918 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.79 -11.3 42.54 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.542 0.737 . . . . 63.25 110.946 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.27 -0.31 25.21 Favored Glycine 0 C--N 1.356 1.683 0 CA-C-O 119.104 -0.831 . . . . 64.409999999999997 115.166 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.408 ' HE2' ' OD1' ' A' ' 212' ' ' ASN . 98.3 mttt -69.36 131.94 45.6 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.398 1.099 . . . . 72.129999999999995 112.155 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -89.22 142.94 27.21 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.037 -1.097 . . . . 70.019999999999996 108.037 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.503 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.1 p90 -167.48 138.0 2.92 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.57 0.543 . . . . 74.340000000000003 111.993 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.0 t -89.17 -30.8 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.583 -0.895 . . . . 72.230000000000004 108.583 163.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 14.7 m -93.2 115.58 28.2 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.26 -1.015 . . . . 74.430000000000007 108.26 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.3 t -56.98 -38.14 72.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.481 0.712 . . . . 74.310000000000002 111.863 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.34 -29.6 30.91 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.751 0.82 . . . . 64.430000000000007 111.15 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 58.9 m -102.2 91.28 4.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.062 0.545 . . . . 74.540000000000006 110.289 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.503 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 87.1 mtt180 -91.1 140.62 29.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.511 0.724 . . . . 73.5 109.688 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.2 m-85 -125.75 141.87 51.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.878 -0.786 . . . . 74.219999999999999 108.878 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.408 ' OD1' ' HE2' ' A' ' 202' ' ' LYS . 71.4 m-20 -64.75 -38.83 92.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.533 0.521 . . . . 72.319999999999993 110.132 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 63.7 p -123.88 155.33 38.26 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.072 0.939 . . . . 74.299999999999997 111.757 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.02 -24.29 66.72 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 113.869 -1.514 . . . . 74.510000000000005 109.496 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.65 94.83 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.857 0.863 . . . . 73.150000000000006 110.964 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 47.4 mt-10 -72.52 -36.8 68.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.489 0.716 . . . . 75.129999999999995 111.263 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.2 tp -53.91 -57.1 12.22 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.584 0.553 . . . . 73.409999999999997 110.492 173.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.64 -37.48 80.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 O-C-N 123.736 0.648 . . . . 74.209999999999994 111.413 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.981 0.355 . . . . 75.340000000000003 111.163 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -57.34 -36.83 71.66 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.142 0.901 . . . . 73.129999999999995 109.988 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.649 ' HB3' HD13 ' A' ' 228' ' ' LEU . 12.9 m170 -87.29 -12.28 47.04 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 112.513 0.56 . . . . 73.129999999999995 112.513 -175.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.6 p -98.16 -11.12 23.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.89 0.476 . . . . 74.329999999999998 110.575 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.8 p -87.66 -43.16 12.15 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 110.1 -0.334 . . . . 72.409999999999997 110.1 171.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 226' ' ' ASP . 29.1 m -137.46 172.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.461 0.648 . . . . 73.120000000000005 112.71 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.97 14.51 1.37 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.866 2.066 . . . . 71.510000000000005 114.106 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.576 ' HB2' HG21 ' A' ' 224' ' ' VAL . 28.0 t70 -42.66 29.8 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 1 C-N-CA 131.799 4.039 . . . . 73.340000000000003 120.073 -152.249 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.49 1.1 10.13 Favored Glycine 0 N--CA 1.483 1.825 0 O-C-N 120.071 -1.643 . . . . 72.129999999999995 112.192 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.649 HD13 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -92.83 161.96 14.3 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.082 1.353 . . . . 75.319999999999993 109.525 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.52 -37.4 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 N-CA-C 110.177 -0.305 . . . . 74.349999999999994 110.177 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -161.28 169.2 22.58 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.79 0.836 . . . . 70.439999999999998 110.388 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 27.8 m -61.31 135.9 57.87 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.372 1.069 . . . . 75.420000000000002 111.266 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.501 HD22 ' HE1' ' A' ' 193' ' ' TYR . 74.9 mt -69.5 128.11 35.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 74.0 109.701 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -113.39 -78.71 0.58 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.921 0.489 . . . . 73.310000000000002 111.765 -171.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 167' ' ' SER . 33.2 t80 -94.03 124.92 54.74 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.387 1.075 . . . . 75.430000000000007 109.444 -173.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.99 127.56 4.76 Favored 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 122.272 1.981 . . . . 74.430000000000007 111.477 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.59 124.52 87.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.273 0.629 . . . . 75.120000000000005 109.499 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.33 175.47 9.3 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.975 2.45 . . . . 74.230000000000004 113.11 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.518 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 72.1 mmtt -69.1 130.33 42.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.371 -0.831 . . . . 72.349999999999994 109.106 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -83.47 -59.13 2.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.518 0.562 . . . . 73.230000000000004 112.518 -168.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -108.6 132.75 53.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.784 1.234 . . . . 74.420000000000002 110.136 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -81.32 114.92 53.02 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 106.77 -1.567 . . . . 74.030000000000001 106.77 163.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.33 123.64 14.09 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.782 2.322 . . . . 65.239999999999995 111.897 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 20.8 m -74.73 100.21 3.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.818 0.447 . . . . 73.329999999999998 110.071 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.32 106.54 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 107.245 -1.391 . . . . 65.150000000000006 107.245 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.3 107.54 19.12 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.395 -0.224 . . . . 72.420000000000002 110.395 -161.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.27 11.74 7.18 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.76 1.464 . . . . 72.219999999999999 116.76 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -75.32 130.06 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 118.465 1.133 . . . . 75.510000000000005 112.722 -164.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 m -87.65 115.55 63.29 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.378 -2.082 . . . . 52.240000000000002 105.378 144.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.13 -51.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 121.006 1.138 . . . . 72.400000000000006 114.952 -169.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -123.01 -20.11 5.87 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.561 0.578 . . . . 72.430000000000007 112.561 -171.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.671 ' HD2' ' HB3' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -85.05 102.77 13.49 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.095 0.474 . . . . 72.310000000000002 109.979 -169.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 17.7 t70 -120.22 -51.55 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.492 1.139 . . . . 73.439999999999998 108.734 156.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -112.63 8.87 19.25 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.212 -1.813 . . . . 74.319999999999993 110.262 -174.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.482 ' CZ2' ' HA ' ' A' ' 37' ' ' PRO . 44.6 t-105 -58.51 121.89 12.03 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.03 0.532 . . . . 71.349999999999994 110.144 -172.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 38' ' ' HIS . 32.7 tt0 . . . . . 0 C--O 1.254 1.32 0 O-C-N 125.207 1.567 . . . . 71.230000000000004 109.373 -161.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 108.189 -1.041 . . . . 74.439999999999998 108.189 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.26 106.18 3.37 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.306 -0.719 . . . . 64.150000000000006 111.581 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -63.0 103.61 0.47 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.096 -1.076 . . . . 74.340000000000003 108.096 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -95.2 -47.48 0.26 Allowed Pre-proline 0 CA--C 1.569 1.691 0 C-N-CA 124.022 0.929 . . . . 75.129999999999995 111.881 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -82.52 -177.97 3.72 Favored 'Trans proline' 0 C--N 1.389 2.67 0 C-N-CA 122.1 1.867 . . . . 64.450000000000003 112.736 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 173.83 -86.89 0.08 OUTLIER Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.754 -0.657 . . . . 63.299999999999997 112.017 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mptt 65.24 146.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.417 1.487 . . . . 73.030000000000001 112.737 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m -107.98 165.51 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.692 0.797 . . . . 74.099999999999994 109.152 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.43 117.13 33.97 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.589 -0.893 . . . . 74.200000000000003 108.589 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.42 114.28 4.03 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 111.554 -0.619 . . . . 73.120000000000005 111.554 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.72 123.43 31.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.963 0.905 . . . . 73.530000000000001 110.223 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -91.54 -163.62 1.06 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 108.422 -0.955 . . . . 73.319999999999993 108.422 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.519 ' HG2' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -143.46 161.14 39.18 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.126 0.488 . . . . 74.099999999999994 111.664 -173.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -124.35 96.23 41.98 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.28 1.032 . . . . 70.430000000000007 108.937 173.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HD3' ' HG2' ' A' ' 13' ' ' ARG . 50.4 Cg_exo -60.8 -175.6 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.11 2.54 . . . . 75.540000000000006 113.116 163.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.5 p -146.74 91.99 2.09 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.808 0.443 . . . . 73.349999999999994 111.215 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -149.14 114.61 3.64 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 107.006 -1.479 . . . . 71.519999999999996 107.006 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.2 93.48 0.19 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.985 2.457 . . . . 72.420000000000002 112.187 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.16 -58.26 3.41 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.684 0.394 . . . . 70.310000000000002 110.029 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 47.68 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.426 1.49 . . . . 75.349999999999994 113.351 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -142.75 123.3 14.06 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.624 -1.25 . . . . 74.400000000000006 107.624 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -88.42 -131.28 0.08 Allowed 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.667 0.787 . . . . 74.25 111.165 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.3 mt 75.79 151.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 124.976 1.31 . . . . 73.209999999999994 109.015 -163.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.12 145.32 48.68 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.781 0.832 . . . . 72.109999999999999 109.849 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.36 141.34 7.46 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.899 0.761 . . . . 74.25 111.367 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 133' ' ' ASN . . . -147.39 154.28 40.67 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.386 0.593 . . . . 71.0 112.165 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.71 153.17 16.75 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 110.93 -0.868 . . . . 75.109999999999999 110.93 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.7 -0.63 0.15 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 118.008 0.904 . . . . 74.25 113.352 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -86.19 107.11 17.74 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.528 0.331 . . . . 75.200000000000003 111.587 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.518 ' HB3' ' ND2' ' A' ' 240' ' ' ASN . 2.1 tm-20 -171.7 -69.49 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.325 1.05 . . . . 74.420000000000002 108.305 167.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.4 m 75.82 128.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.607 1.563 . . . . 71.540000000000006 113.366 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.1 p -153.01 165.85 34.28 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.294 1.038 . . . . 71.430000000000007 109.313 173.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -85.33 124.01 31.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.175 0.59 . . . . 73.540000000000006 110.626 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -143.73 139.65 29.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.85 0.86 . . . . 72.430000000000007 110.072 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.4 173.25 41.13 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.139 -0.784 . . . . 62.340000000000003 111.139 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.94 122.71 0.99 Allowed Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.711 -1.05 . . . . 45.32 111.418 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.9 157.93 50.72 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.392 2.061 . . . . 70.25 111.915 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -146.57 -72.29 0.23 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.38 0.672 . . . . 75.439999999999998 109.492 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.6 t -163.67 169.04 19.07 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.37 0.605 . . . . 73.340000000000003 110.477 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -126.05 -170.07 2.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.599 1.159 . . . . 72.430000000000007 109.557 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.455 HG21 ' H ' ' A' ' 42' ' ' PHE . 4.2 p -145.05 172.0 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.981 -0.748 . . . . 74.219999999999999 108.981 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.455 ' H ' HG21 ' A' ' 41' ' ' VAL . 97.0 m-85 -67.27 -139.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.888 1.275 . . . . 75.239999999999995 113.143 -171.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HB ' HD23 ' A' ' 61' ' ' LEU . 73.1 t 76.44 -76.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.068 0 C-N-CA 125.11 1.364 . . . . 74.319999999999993 111.007 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -171.81 158.67 4.96 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 111.875 0.324 . . . . 73.129999999999995 111.875 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -150.1 112.35 4.65 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.819 1.248 . . . . 70.140000000000001 108.302 167.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -104.92 -172.73 2.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.424 0.69 . . . . 74.109999999999999 109.739 176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.33 133.69 49.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.24 0.616 . . . . 73.25 110.309 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.11 -60.43 2.36 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.899 -0.778 . . . . 74.209999999999994 108.899 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -175.89 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.797 1.239 . . . . 73.239999999999995 108.063 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -156.16 61.71 2.77 Favored Pre-proline 0 CA--C 1.562 1.438 0 C-N-CA 123.787 0.835 . . . . 74.530000000000001 110.405 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -90.93 -154.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.161 2.574 . . . . 73.140000000000001 111.615 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.25 169.19 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.435 0 C-N-CA 124.15 0.98 . . . . 55.210000000000001 110.041 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.46 109.08 0.31 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.099 0.96 . . . . 74.209999999999994 110.96 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.7 m -94.85 17.97 12.7 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.588 1.155 . . . . 72.340000000000003 112.433 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -58.51 -43.02 88.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.443 1.097 . . . . 63.409999999999997 112.587 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -128.7 120.11 25.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.734 0.814 . . . . 73.230000000000004 110.325 -174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.79 101.27 3.95 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 106.63 -1.618 . . . . 74.329999999999998 106.63 175.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.49 -52.44 8.47 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 124.126 3.217 . . . . 72.400000000000006 114.044 -164.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -112.45 -43.68 3.47 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.886 -0.783 . . . . 75.129999999999995 108.886 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.74 -50.1 1.06 Allowed Glycine 0 CA--C 1.537 1.442 0 N-CA-C 116.34 1.296 . . . . 64.019999999999996 116.34 166.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.434 HD23 ' HB ' ' A' ' 43' ' ' VAL . 18.2 tp -68.53 90.59 0.39 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.989 0.894 . . . . 74.209999999999994 110.665 -173.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.1 p -72.33 83.24 1.05 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.746 1.218 . . . . 72.420000000000002 112.998 -171.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.58 -53.36 3.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.294 0.638 . . . . 65.120000000000005 109.658 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.07 -10.93 16.3 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.454 0.909 . . . . 74.120000000000005 113.454 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.37 96.48 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.615 0.766 . . . . 75.230000000000004 111.697 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -125.95 -40.43 2.03 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.247 0.619 . . . . 62.509999999999998 110.919 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -84.78 66.67 9.76 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.967 0.889 . . . . 74.519999999999996 110.931 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -69.78 -31.75 69.85 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.218 -1.355 . . . . 72.219999999999999 109.428 166.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.9 p -80.21 6.28 12.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.921 1.288 . . . . 74.140000000000001 113.048 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.3 -48.16 82.66 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.871 0.468 . . . . 74.150000000000006 110.983 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -71.78 -24.97 61.84 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.217 0.607 . . . . 73.540000000000006 111.172 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.452 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 15.6 m120 -88.38 -2.46 58.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.706 0.802 . . . . 71.109999999999999 111.671 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.1 tp -61.84 -47.98 82.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.012 0.925 . . . . 65.329999999999998 111.304 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.02 36.1 2.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.142 0.977 . . . . 74.439999999999998 109.87 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 72' ' ' ASN . . . -76.58 -20.69 56.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.529 0.731 . . . . 72.049999999999997 110.938 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.11 -150.45 23.87 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.435 -0.647 . . . . 74.420000000000002 112.951 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.73 -173.09 1.65 Allowed 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.869 3.046 . . . . 75.420000000000002 112.796 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.2 m -55.48 136.99 49.36 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.531 -0.759 . . . . 63.210000000000001 110.914 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.03 -47.17 75.28 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.503 0.927 . . . . 75.310000000000002 113.503 -165.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -132.49 -40.75 0.98 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.476 0.655 . . . . 73.409999999999997 111.013 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.703 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 6.3 m-20 -93.67 122.61 62.08 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 114.63 -1.168 . . . . 74.319999999999993 110.243 -171.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.59 -21.36 59.6 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.3 2.0 . . . . 74.230000000000004 111.608 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -98.01 16.58 20.62 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.528 1.131 . . . . 72.510000000000005 112.073 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.703 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 30.1 tp -83.54 120.07 25.48 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.827 -0.805 . . . . 71.239999999999995 108.827 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -109.06 175.2 5.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.33 1.452 . . . . 72.329999999999998 108.717 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.34 135.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.756 1.222 . . . . 61.32 109.213 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.72 112.98 9.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.98 0.912 . . . . 75.340000000000003 110.404 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.19 -31.55 38.76 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.249 0.62 . . . . 75.049999999999997 111.32 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.511 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 55.3 m-85 -126.34 141.71 51.8 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.33 1.052 . . . . 74.030000000000001 108.758 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.96 122.98 27.38 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.83 -0.804 . . . . 72.140000000000001 108.83 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.45 ' HB3' HG12 ' A' ' 101' ' ' ILE . 78.5 t80 -111.66 135.47 52.2 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.524 -0.917 . . . . 72.109999999999999 108.524 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.95 130.17 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.278 -1.379 . . . . 74.319999999999993 107.278 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.96 132.62 53.29 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.119 0.887 . . . . 72.420000000000002 111.669 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -95.34 13.29 26.19 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.34 1.056 . . . . 62.539999999999999 111.189 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.21 -171.65 44.05 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.1 -0.5 . . . . 70.219999999999999 112.014 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -69.93 -41.85 74.06 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.736 0.814 . . . . 74.430000000000007 112.759 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -82.99 -25.92 31.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.951 0.9 . . . . 75.150000000000006 111.522 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -75.72 158.37 32.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.297 0.639 . . . . 74.319999999999993 109.733 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.575 HD22 ' HG1' ' A' ' 123' ' ' THR . 53.2 tp -127.82 137.37 52.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.807 0.443 . . . . 73.349999999999994 111.49 -169.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -86.61 118.02 25.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.881 0.872 . . . . 74.420000000000002 110.168 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 123' ' ' THR . 31.7 pt -122.12 162.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.812 0.845 . . . . 71.439999999999998 110.349 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -129.16 152.52 48.66 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 72.140000000000001 109.358 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -57.67 136.87 56.89 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.858 0.863 . . . . 74.409999999999997 112.143 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.5 67.77 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 123.586 0.612 . . . . 22.030000000000001 113.993 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.09 130.24 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.284 0.542 . . . . 73.099999999999994 111.237 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.13 123.21 28.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.141 0.977 . . . . 71.420000000000002 109.107 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.73 ' HB3' HG21 ' A' ' 123' ' ' THR . 0.4 OUTLIER -133.69 146.34 50.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.519 0.728 . . . . 74.219999999999999 110.857 -175.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -96.96 112.62 24.29 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.199 0.6 . . . . 71.25 110.447 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 119' ' ' ALA . 55.5 t -79.9 117.33 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.447 0.641 . . . . 74.310000000000002 109.671 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.453 HD13 ' HG3' ' A' ' 120' ' ' GLU . 29.6 mt -89.64 -19.35 24.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.069 1.348 . . . . 75.019999999999996 110.88 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.51 147.42 5.05 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.146 -0.934 . . . . 73.540000000000006 111.375 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.614 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 23.3 m-85 -87.42 178.58 6.78 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.561 0.745 . . . . 75.439999999999998 111.033 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.62 HD22 ' HB2' ' A' ' 117' ' ' GLU . 9.9 p30 -90.54 -174.0 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 71.510000000000005 110.918 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -44.75 -45.31 9.87 Favored 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 126.318 1.847 . . . . 73.340000000000003 114.389 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -115.86 7.81 14.6 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.15 0.58 . . . . 70.510000000000005 111.92 174.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.614 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 71.74 30.77 65.7 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 116.939 1.536 . . . . 53.149999999999999 116.939 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.62 ' HB2' HD22 ' A' ' 113' ' ' ASN . 22.4 mt-10 -68.48 -42.96 77.92 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 119.028 1.414 . . . . 72.549999999999997 109.972 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 51.4 m95 -123.05 159.57 28.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 75.099999999999994 110.204 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.491 ' HB2' HG13 ' A' ' 109' ' ' VAL . . . -135.37 138.52 43.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.185 0.994 . . . . 74.109999999999999 110.022 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HG3' HD13 ' A' ' 110' ' ' LEU . 9.1 tp10 -69.36 98.06 1.03 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 106.786 -1.561 . . . . 75.120000000000005 106.786 168.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.91 140.65 38.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.486 0.714 . . . . 75.439999999999998 110.854 -173.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -114.5 107.66 15.81 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.178 -0.919 . . . . 74.519999999999996 108.748 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.73 HG21 ' HB3' ' A' ' 107' ' ' LEU . 72.4 p -116.15 175.52 5.51 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.101 1.361 . . . . 74.409999999999997 110.491 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -75.6 -10.4 59.41 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.6 -0.727 . . . . 74.329999999999998 110.466 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -76.93 -22.74 52.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.819 0.848 . . . . 74.530000000000001 110.355 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.78 -160.48 23.24 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 112.233 -0.347 . . . . 43.149999999999999 112.233 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -104.09 137.82 41.49 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.983 0.913 . . . . 72.140000000000001 109.625 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.416 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 164.46 178.08 37.62 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 121.083 -0.579 . . . . 54.350000000000001 112.971 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -90.24 128.54 36.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.862 0.865 . . . . 71.140000000000001 112.19 -170.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 10.9 m -132.17 143.62 49.69 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.137 0.975 . . . . 74.5 108.936 171.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 6.2 Cg_exo -76.14 146.4 28.68 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 C-N-CA 122.685 2.257 . . . . 71.540000000000006 113.977 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -41.52 -46.92 3.66 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.882 1.673 . . . . 60.210000000000001 113.173 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 9.2 p-10 -75.35 2.52 11.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.661 0.784 . . . . 74.349999999999994 112.871 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.42 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -109.21 -9.63 15.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.681 0.792 . . . . 73.329999999999998 111.507 171.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.2 pt -132.26 175.86 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.904 0.882 . . . . 65.349999999999994 110.782 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -162.54 151.7 12.88 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.562 -0.903 . . . . 74.310000000000002 108.562 170.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.7 Cg_endo -60.11 149.56 84.07 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 121.636 1.557 . . . . 74.140000000000001 111.414 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.5 t -73.41 -7.05 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.465 0 CA-C-O 121.617 0.722 . . . . 72.409999999999997 110.119 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -79.49 -8.32 59.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.274 1.03 . . . . 74.450000000000003 112.173 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.2 p -95.6 171.45 8.67 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.499 0.666 . . . . 63.119999999999997 112.612 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.2 mt -85.28 -20.11 30.55 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.806 -1.088 . . . . 74.329999999999998 111.365 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.82 -21.44 66.48 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.684 0.794 . . . . 73.519999999999996 112.008 -172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.58 -13.59 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.241 0.616 . . . . 72.319999999999993 112.5 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -90.71 141.75 28.47 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.403 0.681 . . . . 73.219999999999999 109.969 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.6 m -58.5 -39.96 81.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.722 1.209 . . . . 73.109999999999999 112.39 -175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -70.11 -30.51 67.73 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 74.430000000000007 112.811 -175.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -82.55 117.65 22.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.558 -0.534 . . . . 74.209999999999994 109.558 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -112.12 -6.48 14.14 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.272 0.629 . . . . 74.530000000000001 111.681 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.83 -141.22 34.36 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 118.345 -1.253 . . . . 73.530000000000001 112.89 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -59.65 94.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.561 2.841 . . . . 72.319999999999993 113.144 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.634 HG23 HH12 ' A' ' 239' ' ' ARG . 85.6 t -133.93 132.02 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 70.120000000000005 108.905 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.4 p -78.57 173.01 12.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.446 0.699 . . . . 63.210000000000001 110.408 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -60.41 -43.6 96.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.299 0.639 . . . . 75.129999999999995 109.964 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.9 -46.59 88.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.925 0.89 . . . . 61.219999999999999 111.091 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.39 -26.4 63.69 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.028 0.531 . . . . 70.510000000000005 111.441 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.32 62.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.911 0.484 . . . . 64.329999999999998 110.671 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.08 -21.61 61.48 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.764 -0.653 . . . . 65.129999999999995 110.597 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.64 -49.06 72.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.499 0.719 . . . . 74.450000000000003 109.728 170.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.85 -39.22 80.65 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.595 -0.73 . . . . 74.349999999999994 110.947 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.8 -3.71 55.8 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.823 1.046 . . . . 64.540000000000006 113.823 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 61.3 p -69.47 -34.21 74.03 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.767 1.167 . . . . 65.420000000000002 110.239 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 p -90.02 9.1 29.3 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.234 1.014 . . . . 72.129999999999995 110.867 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -105.45 156.61 16.61 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 123.996 0.808 . . . . 55.229999999999997 111.723 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 26.8 pt -103.83 -176.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 124.955 1.302 . . . . 74.099999999999994 112.006 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.53 121.25 11.07 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.65 -0.705 . . . . 74.439999999999998 110.02 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.31 10.36 58.36 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 119.394 -0.67 . . . . 71.340000000000003 113.343 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.7 m -86.09 128.71 34.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.713 1.256 . . . . 74.340000000000003 111.148 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 183' ' ' SER . 13.3 p90 -135.52 167.24 21.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.077 0.551 . . . . 71.530000000000001 111.458 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.4 pp -164.22 143.54 7.62 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.008 -0.996 . . . . 75.129999999999995 108.926 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.647 HG21 HG12 ' A' ' 182' ' ' ILE . 90.8 t -98.13 137.86 24.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.439 -0.948 . . . . 74.239999999999995 108.439 167.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.487 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.8 ptt85 -134.3 160.67 37.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.962 1.305 . . . . 74.200000000000003 109.108 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.33 151.42 33.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.977 -1.49 . . . . 74.329999999999998 106.977 165.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 t -84.98 123.21 30.27 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.703 -0.851 . . . . 72.049999999999997 108.703 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.59 -35.6 73.11 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.565 -0.531 . . . . 61.5 109.565 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 p -71.64 -34.86 70.14 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.402 -0.817 . . . . 75.129999999999995 111.111 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.3 m -124.25 90.66 50.54 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 123.405 0.682 . . . . 64.540000000000006 109.943 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.28 127.56 24.43 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.499 2.8 . . . . 75.140000000000001 112.947 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.51 -28.32 15.45 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.915 -0.584 . . . . 75.340000000000003 112.969 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.431 ' HB3' ' NH1' ' A' ' 194' ' ' ARG . 79.2 mm-40 -69.03 115.03 7.86 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.293 -0.632 . . . . 75.299999999999997 109.293 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -119.82 149.22 42.42 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 109.882 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.2 m -148.0 152.12 36.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.806 -1.088 . . . . 74.219999999999999 109.704 -172.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.647 HG12 HG21 ' A' ' 170' ' ' VAL . 23.6 mt -102.47 150.05 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 106.511 -1.663 . . . . 72.239999999999995 106.511 166.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -125.93 107.1 10.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.708 -1.219 . . . . 71.200000000000003 107.708 171.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 168' ' ' PHE . 56.9 tp -107.5 110.91 22.95 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.538 0.608 . . . . 73.430000000000007 109.785 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 190' ' ' VAL . 59.1 ttt180 -80.66 121.36 25.76 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.054 0.542 . . . . 74.120000000000005 109.799 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.1 145.73 31.53 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.506 1.522 . . . . 74.549999999999997 107.688 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 57.97 22.39 8.75 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.931 0.892 . . . . 62.43 112.333 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.94 -9.4 72.33 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.333 -0.704 . . . . 74.019999999999996 114.538 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -113.35 150.37 32.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.291 1.045 . . . . 74.129999999999995 109.99 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . 41.8 t -99.08 111.24 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.851 0.46 . . . . 73.430000000000007 110.672 -177.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -93.73 112.22 24.05 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.278 -1.008 . . . . 55.420000000000002 108.278 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -89.64 124.49 34.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.714 -0.676 . . . . 75.209999999999994 109.209 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.439 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.0 m-85 -93.65 146.37 23.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.371 -0.974 . . . . 75.239999999999995 108.371 172.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 179' ' ' GLN . 6.8 tpp180 -106.41 120.64 42.42 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.994 -1.113 . . . . 72.099999999999994 107.994 175.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mt -79.03 100.3 3.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.05 -1.092 . . . . 70.099999999999994 108.05 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 196' ' ' ASN . 0.8 OUTLIER -80.37 145.34 32.08 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.476 -0.935 . . . . 74.540000000000006 108.476 177.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.6 m -105.87 136.78 44.9 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.122 0.969 . . . . 75.420000000000002 109.355 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.96 178.23 8.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.073 0.949 . . . . 75.200000000000003 110.15 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 p -65.68 -33.48 75.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.128 0.571 . . . . 75.209999999999994 111.706 -174.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.24 -13.53 28.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.643 0.377 . . . . 71.5 111.086 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 115.57 15.12 7.7 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 115.886 1.115 . . . . 63.340000000000003 115.886 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -68.99 141.51 54.89 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.291 1.045 . . . . 74.439999999999998 111.654 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.47 141.58 28.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.66 0.784 . . . . 74.310000000000002 109.153 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.574 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.1 p90 -164.98 148.01 8.39 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.54 0.525 . . . . 73.420000000000002 111.72 175.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.43 -40.36 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.174 -1.047 . . . . 75.340000000000003 108.174 164.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.0 m -99.9 125.13 45.84 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.011 -0.995 . . . . 71.430000000000007 108.831 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -62.81 -28.23 69.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.481 0.712 . . . . 61.32 111.41 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.87 -25.17 62.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.633 1.173 . . . . 74.129999999999995 110.55 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.5 m -129.45 89.94 2.92 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.58 0.752 . . . . 75.519999999999996 110.328 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 94.3 mtt180 -103.3 134.31 46.91 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.328 -0.619 . . . . 74.239999999999995 109.328 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -119.38 151.15 38.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.97 0.908 . . . . 74.5 108.602 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -74.04 -28.09 61.25 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.573 0.546 . . . . 74.349999999999994 110.468 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.8 p -132.74 156.01 47.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.876 0.87 . . . . 74.409999999999997 112.144 -177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.14 -25.88 64.6 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 114.272 -1.331 . . . . 73.349999999999994 109.427 172.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.14 96.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.4 0.68 . . . . 72.140000000000001 110.675 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.71 -41.88 87.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.47 0.708 . . . . 71.409999999999997 111.336 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.7 tp -52.49 -57.13 10.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 123.52 0.512 . . . . 74.109999999999999 111.157 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.84 -46.39 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.641 0.588 . . . . 74.519999999999996 111.415 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -55.72 -55.68 29.34 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.56 0.744 . . . . 75.310000000000002 111.447 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -67.82 -37.84 82.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.991 -1.004 . . . . 75.409999999999997 110.622 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.611 ' HB3' HD13 ' A' ' 228' ' ' LEU . 15.9 m170 -86.63 -4.41 59.17 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.544 0.572 . . . . 74.400000000000006 112.544 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.7 p -93.95 -35.11 12.8 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.595 0.358 . . . . 73.400000000000006 110.706 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 47.5 p -74.81 -42.13 58.64 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 116.061 -0.518 . . . . 74.040000000000006 111.855 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.703 HG23 ' HB2' ' A' ' 226' ' ' ASP . 31.6 m -128.35 158.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.334 0.654 . . . . 64.150000000000006 111.131 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.14 15.34 0.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.46 1.904 . . . . 74.439999999999998 114.027 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.703 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.9 t70 -44.47 33.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 1 C-N-CA 132.556 4.343 . . . . 64.329999999999998 119.386 -153.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.34 -0.82 9.61 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 120.07 -1.644 . . . . 64.150000000000006 112.049 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.611 HD13 ' HB3' ' A' ' 221' ' ' HIS . 15.4 mt -92.19 161.65 14.64 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.725 1.21 . . . . 75.040000000000006 109.768 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.9 tt -57.61 -37.01 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 O-C-N 123.419 0.449 . . . . 74.010000000000005 110.673 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -161.5 176.23 11.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.162 0.985 . . . . 71.349999999999994 109.682 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -64.29 145.47 55.96 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.853 0.861 . . . . 74.439999999999998 111.931 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.439 HD21 ' HE1' ' A' ' 193' ' ' TYR . 66.8 mt -75.54 119.48 19.65 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 108.606 -0.887 . . . . 70.109999999999999 108.606 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -113.19 -80.05 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.514 0.597 . . . . 73.540000000000006 112.206 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.7 t80 -87.14 120.0 71.22 Favored Pre-proline 0 C--O 1.208 -1.124 0 C-N-CA 124.266 1.027 . . . . 74.349999999999994 108.438 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.33 136.03 9.79 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 121.632 1.555 . . . . 74.140000000000001 110.947 171.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.87 136.6 96.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 108.9 -0.778 . . . . 74.430000000000007 108.9 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.49 171.94 16.03 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.01 1.807 . . . . 73.439999999999998 112.987 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.511 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 73.7 mmtt -70.33 108.54 4.26 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.053 -1.091 . . . . 73.200000000000003 108.053 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.634 HH12 HG23 ' A' ' 151' ' ' VAL . 15.6 ptt-85 -68.83 -62.92 1.18 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.838 1.051 . . . . 72.209999999999994 113.838 -160.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 30' ' ' GLU . 63.1 t30 -110.29 154.58 23.26 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.923 0.889 . . . . 75.450000000000003 109.814 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.21 112.66 27.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 106.188 -1.782 . . . . 74.340000000000003 106.188 158.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.468 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 39.3 Cg_exo -60.52 124.54 15.3 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.752 2.301 . . . . 63.539999999999999 112.965 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 16.6 m -65.46 123.56 19.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.502 0.721 . . . . 72.010000000000005 111.179 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.37 124.5 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 108.356 -0.979 . . . . 74.400000000000006 108.356 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -102.46 114.89 29.48 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.462 0.542 . . . . 75.140000000000001 112.462 -164.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.74 44.08 91.7 Favored Glycine 0 N--CA 1.482 1.712 0 O-C-N 124.046 0.841 . . . . 61.509999999999998 115.124 163.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -103.45 124.36 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 114.228 1.196 . . . . 62.140000000000001 114.228 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.3 t -86.09 119.09 71.48 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 104.057 -2.572 . . . . 63.240000000000002 104.057 143.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.02 -62.11 0.23 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 120.965 1.38 . . . . 74.219999999999999 113.0 -158.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -129.26 -13.34 4.44 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.506 -0.924 . . . . 74.439999999999998 108.506 148.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.51 103.2 13.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.419 -1.264 . . . . 74.310000000000002 111.109 -149.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -119.59 -44.96 2.53 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.235 -1.024 . . . . 74.040000000000006 108.235 158.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -109.25 -17.2 13.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.329 1.052 . . . . 73.319999999999993 112.073 -175.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -50.34 155.14 1.08 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.978 1.311 . . . . 72.340000000000003 113.772 -161.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.036 0.935 . . . . 75.400000000000006 108.7 178.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.819 -0.067 . . . . 71.510000000000005 110.819 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.35 78.83 0.55 Allowed Glycine 0 C--N 1.356 1.692 0 O-C-N 123.166 0.291 . . . . 63.240000000000002 113.356 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -176.05 100.04 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.597 1.559 . . . . 65.409999999999997 107.632 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.419 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -82.71 -53.33 0.63 Allowed Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.62 0.768 . . . . 74.049999999999997 110.636 173.159 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' A' ' 4' ' ' GLN . 51.5 Cg_endo -90.42 70.89 1.44 Allowed 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.205 1.937 . . . . 52.240000000000002 112.364 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.55 -59.25 6.85 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.419 -0.81 . . . . 74.420000000000002 112.169 171.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.31 -27.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.5 1.12 . . . . 74.409999999999997 110.473 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.5 t 61.84 -84.87 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 125.407 1.483 . . . . 74.450000000000003 110.588 -169.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.2 mt 56.86 -163.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.549 1.14 . . . . 74.019999999999996 111.718 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.12 -176.34 37.94 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 112.305 -0.318 . . . . 74.450000000000003 112.305 176.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.25 16.01 26.41 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.526 0.73 . . . . 72.230000000000004 111.073 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -64.04 168.98 4.72 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.421 0.688 . . . . 74.109999999999999 110.759 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -154.85 88.31 1.18 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.781 -0.822 . . . . 75.530000000000001 108.781 -168.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -96.88 101.5 9.56 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.65 0.78 . . . . 72.329999999999998 110.496 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HB3' HD13 ' A' ' 110' ' ' LEU . 62.1 Cg_endo -69.22 80.43 0.73 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.061 2.507 . . . . 73.230000000000004 113.162 -178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -74.79 156.57 36.38 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.662 -0.699 . . . . 65.299999999999997 109.883 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.5 mt -123.68 80.57 55.27 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 123.149 0.58 . . . . 74.319999999999993 110.939 -174.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -79.99 -46.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.01 2.473 . . . . 74.120000000000005 112.849 169.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 64.51 162.19 0.12 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.225 1.41 . . . . 71.239999999999995 112.625 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.658 HD13 ' HA3' ' A' ' 116' ' ' GLY . 66.1 mt -143.21 154.45 43.86 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.527 0.731 . . . . 74.219999999999999 110.773 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -160.88 114.09 2.0 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.539 1.135 . . . . 71.299999999999997 108.594 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -165.41 160.95 18.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.719 0.808 . . . . 75.219999999999999 110.021 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.03 -33.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.858 0.863 . . . . 74.409999999999997 109.955 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 66.0 -170.41 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.875 1.27 . . . . 74.219999999999999 111.333 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.01 144.49 6.82 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.658 -0.247 . . . . 71.519999999999996 112.738 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 176' ' ' SER . . . -160.26 177.97 10.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.398 1.079 . . . . 71.120000000000005 109.966 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.54 61.41 0.37 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 112.161 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -103.82 95.2 5.86 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.48 -1.304 . . . . 73.200000000000003 107.48 171.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.72 130.74 39.57 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.485 -0.561 . . . . 74.450000000000003 109.485 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.93 135.65 31.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.848 -1.167 . . . . 74.219999999999999 107.848 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.0 t -70.58 163.68 26.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.649 0.779 . . . . 71.519999999999996 111.53 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.525 ' OG ' ' HD2' ' A' ' 153' ' ' ARG . 9.5 t -155.76 130.13 8.91 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.517 -0.549 . . . . 72.209999999999994 109.517 -170.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -137.49 124.85 21.88 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.337 0.655 . . . . 74.430000000000007 110.844 -174.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.451 ' HB3' ' HE ' ' A' ' 153' ' ' ARG . 39.0 t-80 176.82 179.32 0.21 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.025 1.33 . . . . 74.219999999999999 108.171 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.87 89.74 0.95 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 121.882 -0.512 . . . . 73.340000000000003 113.04 169.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.76 51.84 0.39 Allowed Glycine 0 CA--C 1.541 1.704 0 CA-C-O 118.668 -1.073 . . . . 73.140000000000001 113.781 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.45 -178.37 4.41 Favored 'Trans proline' 0 C--N 1.387 2.563 0 CA-C-N 120.53 2.165 . . . . 71.319999999999993 112.495 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -149.57 129.2 13.16 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.435 0.694 . . . . 73.319999999999993 110.094 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.446 ' N ' HH22 ' A' ' 185' ' ' ARG . 35.7 t 173.18 171.33 0.14 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.239 1.416 . . . . 73.450000000000003 109.338 177.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -158.23 148.03 19.83 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.701 -0.481 . . . . 75.200000000000003 109.701 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.409 HG13 HG21 ' A' ' 164' ' ' ILE . 14.9 p -144.68 150.87 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.058 0.943 . . . . 71.129999999999995 109.392 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -102.34 156.28 17.69 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.198 0.599 . . . . 75.540000000000006 109.923 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 21.3 t -131.89 176.24 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.027 -1.101 . . . . 71.120000000000005 108.027 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.92 158.58 22.57 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.512 1.125 . . . . 74.019999999999996 109.579 172.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' A' ' 59' ' ' GLN . 71.7 m80 78.99 132.39 0.05 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 126.084 1.754 . . . . 74.030000000000001 111.29 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 10.4 pt-20 -131.66 146.83 52.39 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.512 0.725 . . . . 75.310000000000002 112.449 -168.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.66 -71.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.638 1.175 . . . . 71.230000000000004 108.278 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.1 tp -172.68 104.26 0.15 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 108.562 -0.903 . . . . 74.129999999999995 108.562 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -141.17 -163.19 1.5 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.249 1.019 . . . . 74.040000000000006 109.613 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -99.57 101.1 12.29 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.716 0.806 . . . . 71.129999999999995 109.557 170.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.733 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 38.4 Cg_endo -98.36 -161.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.874 2.383 . . . . 74.230000000000004 110.267 163.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.8 -159.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 C-N-CA 122.786 0.434 . . . . 71.219999999999999 111.212 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.09 119.48 2.94 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.695 0.798 . . . . 74.409999999999997 110.903 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 t -65.49 -9.96 30.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.889 1.275 . . . . 74.430000000000007 112.913 -171.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -51.35 -49.19 61.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.486 1.115 . . . . 75.129999999999995 111.017 171.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -125.95 69.01 1.19 Allowed 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.915 -1.513 . . . . 74.209999999999994 106.915 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.8 118.66 63.04 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 115.438 -0.801 . . . . 74.439999999999998 110.703 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.733 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 6.0 Cg_exo -81.33 -164.66 0.29 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.752 2.301 . . . . 74.109999999999999 111.039 167.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.473 ' HB3' ' O ' ' A' ' 45' ' ' HIS . 23.1 mp0 -72.49 -75.1 0.14 Allowed 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.26 1.024 . . . . 72.200000000000003 111.399 -172.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.47 -7.13 81.91 Favored Glycine 0 N--CA 1.479 1.521 0 N-CA-C 115.971 1.149 . . . . 61.350000000000001 115.971 167.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.7 tt -92.48 88.25 6.29 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.232 1.016 . . . . 75.299999999999997 110.155 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.428 ' HB2' HG22 ' A' ' 43' ' ' VAL . 35.1 t -68.41 114.8 7.16 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.937 0.895 . . . . 54.0 111.629 174.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.03 -117.15 0.1 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.164 1.386 . . . . 73.439999999999998 108.484 173.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.98 -12.74 61.84 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.451 1.023 . . . . 71.299999999999997 113.314 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.02 -39.69 95.5 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.628 0.371 . . . . 74.340000000000003 111.557 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -112.19 -52.02 2.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.606 0.762 . . . . 74.400000000000006 109.548 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.401 ' HB2' ' HG3' ' A' ' 235' ' ' PRO . 8.9 t90 -90.86 64.32 5.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.894 0.855 . . . . 71.540000000000006 109.463 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.446 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.9 p30 -72.51 -14.84 61.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.158 -0.928 . . . . 73.340000000000003 110.848 174.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.6 p -84.0 4.92 27.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.959 0.904 . . . . 75.340000000000003 112.073 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -67.21 -22.71 65.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.764 0.425 . . . . 73.120000000000005 111.021 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.7 pt-20 -68.49 -39.65 81.22 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.161 0.505 . . . . 63.539999999999999 109.837 168.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.523 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 8.8 m120 -75.2 -10.24 59.29 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.198 -0.91 . . . . 71.5 110.972 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.28 -50.93 69.75 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.045 0.938 . . . . 74.510000000000005 110.572 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.62 23.79 13.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.369 0.668 . . . . 75.530000000000001 110.639 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 72' ' ' ASN . . . -71.56 -38.12 71.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.842 0.457 . . . . 75.239999999999995 111.355 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.57 -134.91 21.39 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.193 -0.782 . . . . 74.420000000000002 111.27 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -53.73 154.16 17.2 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 123.07 2.514 . . . . 64.230000000000004 113.447 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -75.03 169.47 17.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.356 0.662 . . . . 74.099999999999994 109.965 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -58.38 -45.47 88.24 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.674 0.79 . . . . 73.230000000000004 112.925 -169.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.44 -34.23 1.83 Allowed 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.335 0.588 . . . . 52.109999999999999 111.056 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.415 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 4.6 m-20 -90.84 123.62 64.4 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 115.237 -0.892 . . . . 74.439999999999998 112.755 -163.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.2 -19.89 5.34 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.483 2.122 . . . . 75.439999999999998 112.379 167.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -110.21 19.36 18.99 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.067 0.947 . . . . 75.140000000000001 112.055 -172.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 30.5 tp -81.85 128.13 33.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.22 -0.659 . . . . 75.319999999999993 109.22 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -111.66 172.96 6.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.819 1.247 . . . . 74.129999999999995 108.684 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.75 138.21 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.279 1.032 . . . . 72.530000000000001 109.434 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.87 131.28 41.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 63.109999999999999 110.336 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.479 HD11 ' NZ ' ' A' ' 238' ' ' LYS . 77.5 mt -98.7 -26.56 14.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 74.439999999999998 111.329 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.428 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 48.6 m-85 -125.53 148.66 48.82 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.966 0.906 . . . . 74.340000000000003 108.739 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.482 ' HB2' ' HZ2' ' A' ' 241' ' ' LYS . 5.6 m-20 -72.2 136.33 46.37 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.61 -0.885 . . . . 74.230000000000004 108.61 170.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.596 ' HB3' HG12 ' A' ' 101' ' ' ILE . 82.3 t80 -129.79 133.36 46.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.534 -1.284 . . . . 74.25 107.534 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -103.65 137.14 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 107.248 -1.39 . . . . 65.030000000000001 107.248 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.28 114.23 3.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.242 0.617 . . . . 74.040000000000006 110.942 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -86.91 -51.44 6.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.852 0.861 . . . . 63.43 109.64 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.92 -177.14 38.04 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 115.279 -0.873 . . . . 71.019999999999996 112.261 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.62 -32.88 60.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.772 0.829 . . . . 74.209999999999994 111.645 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.433 HD22 ' HG2' ' A' ' 249' ' ' PRO . 29.3 p-10 -92.32 -20.43 21.1 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.034 0.534 . . . . 71.129999999999995 111.689 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 78.0 p -71.1 154.16 41.97 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.549 0.53 . . . . 75.319999999999993 109.834 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.566 HD23 ' HG1' ' A' ' 123' ' ' THR . 49.5 tp -128.28 124.36 36.4 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.731 0.412 . . . . 71.340000000000003 111.417 -164.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 m -68.36 117.71 10.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.566 0.746 . . . . 74.349999999999994 110.848 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.596 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -119.24 154.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.475 0.71 . . . . 75.120000000000005 111.739 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 21.6 m -99.18 147.87 24.67 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.333 -1.303 . . . . 74.200000000000003 109.108 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.93 125.77 26.45 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.74 -0.467 . . . . 74.340000000000003 109.74 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.0 1.66 79.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 116.1 -0.5 . . . . 54.229999999999997 113.278 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 80.9 tt0 -84.9 121.24 27.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.381 0.59 . . . . 74.329999999999998 110.071 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.412 ' HD3' HD21 ' A' ' 84' ' ' LEU . 56.8 mttp -73.87 142.82 46.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.379 0.672 . . . . 74.120000000000005 110.155 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB3' HG23 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.33 150.01 32.85 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.452 1.101 . . . . 75.430000000000007 110.142 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -100.15 108.36 20.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.039 -0.726 . . . . 65.209999999999994 109.039 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 119' ' ' ALA . 69.7 t -74.84 119.99 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.174 -0.676 . . . . 63.340000000000003 109.174 174.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.67 HD12 ' HG3' ' A' ' 122' ' ' GLN . 14.2 mt -82.07 -54.08 5.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.267 -1.333 . . . . 64.239999999999995 108.019 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.38 152.92 22.68 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.886 -1.052 . . . . 74.510000000000005 112.978 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.761 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 44.9 m-85 -89.29 174.72 7.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.903 0.881 . . . . 75.439999999999998 111.609 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.35 -173.59 4.8 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.13 0.972 . . . . 75.030000000000001 110.389 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -50.7 -39.47 51.43 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 113.741 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -111.16 2.08 17.62 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.453 0.701 . . . . 64.340000000000003 111.563 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.761 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.18 30.35 73.71 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.421 0.928 . . . . 74.209999999999994 115.421 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.48 -27.49 14.86 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.81 0.805 . . . . 75.319999999999993 110.889 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 28.2 m95 -114.38 152.18 31.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.317 1.047 . . . . 74.219999999999999 109.81 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -137.22 148.21 46.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.262 0.625 . . . . 60.020000000000003 111.26 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -96.64 118.86 34.03 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.434 -1.321 . . . . 73.209999999999994 107.434 166.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -132.8 151.12 52.07 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.141 0.976 . . . . 64.439999999999998 111.026 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.67 ' HG3' HD12 ' A' ' 110' ' ' LEU . 98.4 mt-30 -100.58 105.23 16.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.828 0.851 . . . . 75.099999999999994 109.243 175.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.583 HG23 ' HB3' ' A' ' 107' ' ' LEU . 40.9 p -98.4 176.5 5.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.743 1.217 . . . . 74.150000000000006 110.649 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -64.76 -20.32 66.29 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.588 -0.733 . . . . 74.530000000000001 110.728 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -80.49 -32.1 37.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.882 0.873 . . . . 63.240000000000002 111.185 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 144.73 -168.78 26.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.829 -0.428 . . . . 51.100000000000001 112.153 -171.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -104.32 132.25 50.77 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.268 0.627 . . . . 63.5 110.414 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.461 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 177.83 -165.49 35.12 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 111.775 -0.53 . . . . 72.129999999999995 111.775 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -100.12 121.75 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.598 0.962 . . . . 72.549999999999997 113.598 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.69 136.76 28.36 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.246 1.418 . . . . 71.25 108.487 170.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 81.8 Cg_endo -85.45 155.21 10.65 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 122.074 1.85 . . . . 72.120000000000005 114.887 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -38.77 -47.23 1.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 126.199 1.8 . . . . 74.430000000000007 114.443 173.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -77.58 0.02 24.65 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.794 0.838 . . . . 74.439999999999998 112.665 -172.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 12.1 m-85 -105.6 -18.54 14.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.16 0.984 . . . . 74.319999999999993 111.459 171.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 109' ' ' VAL . 12.7 pt -123.97 175.67 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.889 0.876 . . . . 72.420000000000002 111.672 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.0 t -161.41 150.82 13.69 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 123.797 0.839 . . . . 72.409999999999997 109.818 172.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.26 145.48 96.07 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.667 1.578 . . . . 73.349999999999994 111.853 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 41.7 t -73.78 -4.63 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 124.018 0.927 . . . . 73.420000000000002 110.797 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -91.26 -18.61 24.11 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 73.239999999999995 111.905 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 99.6 p -91.71 179.09 5.73 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.866 0.467 . . . . 64.329999999999998 111.607 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.0 mt -84.45 -22.75 30.22 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.812 0.845 . . . . 73.099999999999994 111.665 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -66.97 -17.98 65.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.508 0.723 . . . . 72.310000000000002 112.173 -171.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -64.09 -13.56 48.43 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.272 0.629 . . . . 72.329999999999998 112.104 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -97.53 148.58 23.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.163 0.985 . . . . 73.400000000000006 109.859 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.2 p -64.98 -41.41 95.45 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.094 0.871 . . . . 72.209999999999994 111.582 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -60.92 -38.44 85.78 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.023 0.749 . . . . 63.119999999999997 113.023 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.93 100.51 11.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.529 -0.915 . . . . 74.430000000000007 108.529 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.46 ' HB2' HG21 ' A' ' 151' ' ' VAL . 77.1 m80 -96.41 8.78 43.17 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.277 0.473 . . . . 74.549999999999997 112.277 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 151' ' ' VAL . . . 69.27 -145.54 42.83 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 118.631 -1.094 . . . . 74.299999999999997 112.498 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.92 106.17 0.91 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.801 2.334 . . . . 71.340000000000003 111.963 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 14.5 t -123.12 131.96 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.642 0.777 . . . . 75.109999999999999 110.236 -177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 151' ' ' VAL . 66.2 p -77.83 152.75 33.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.827 -0.805 . . . . 74.230000000000004 108.827 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.525 ' HD2' ' OG ' ' A' ' 32' ' ' SER . 34.6 ttt85 -55.81 -38.63 70.23 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.124 0.416 . . . . 75.450000000000003 112.124 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -58.08 -45.21 87.53 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.966 0.791 . . . . 74.129999999999995 111.138 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.82 75.75 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.677 -0.692 . . . . 55.030000000000001 111.179 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.15 68.95 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.463 0.649 . . . . 72.200000000000003 111.524 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -75.83 -19.72 58.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.306 0.642 . . . . 72.450000000000003 110.926 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -67.21 -44.3 79.92 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.653 0.781 . . . . 73.519999999999996 110.28 168.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 239' ' ' ARG . 53.5 mt -60.19 -38.08 82.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.34 0.656 . . . . 74.340000000000003 111.187 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.98 20.72 10.74 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.464 -0.789 . . . . 74.010000000000005 112.321 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.0 p -66.35 -40.96 90.15 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.926 0.393 . . . . 72.230000000000004 110.977 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.4 p -104.96 14.61 29.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.277 1.031 . . . . 73.209999999999994 111.399 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.63 163.91 50.25 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 114.404 0.522 . . . . 75.209999999999994 114.404 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.409 HG21 HG13 ' A' ' 41' ' ' VAL . 17.9 pt -109.18 -175.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.618 1.167 . . . . 74.150000000000006 111.223 174.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 4.5 m-20 -56.64 123.81 16.16 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.295 -0.866 . . . . 74.450000000000003 110.432 171.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.45 ' HA2' HD13 ' A' ' 184' ' ' LEU . . . 88.01 10.98 68.3 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.755 -0.657 . . . . 54.409999999999997 113.393 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.7 m -81.0 118.13 22.21 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.434 1.117 . . . . 72.340000000000003 110.296 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.509 ' HB3' HD11 ' A' ' 184' ' ' LEU . 13.7 p90 -129.6 171.45 12.6 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.391 0.615 . . . . 75.349999999999994 112.557 -168.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.74 146.7 6.93 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 113.884 -1.507 . . . . 73.109999999999999 109.336 171.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.681 HG22 HG12 ' A' ' 182' ' ' ILE . 93.7 t -100.39 131.87 47.09 Favored 'Isoleucine or valine' 0 C--O 1.261 1.659 0 N-CA-C 108.567 -0.901 . . . . 75.019999999999996 108.567 167.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.62 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt85 -116.5 133.83 55.56 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.645 -1.161 . . . . 73.109999999999999 109.115 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.473 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.6 tp10 -84.95 145.72 27.61 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.4 1.08 . . . . 71.340000000000003 108.2 166.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.5 t -83.02 126.69 32.82 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.339 -0.615 . . . . 74.120000000000005 109.339 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.47 -40.99 93.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.028 0.531 . . . . 71.239999999999995 109.929 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.8 p -70.09 -25.76 63.66 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 73.519999999999996 111.307 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.652 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 66.5 m -145.43 91.88 5.69 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 122.678 0.391 . . . . 73.230000000000004 111.68 -176.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.79 136.18 68.59 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.44 2.093 . . . . 73.200000000000003 111.625 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.23 -24.7 31.2 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 112.127 -173.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -95.78 114.76 26.52 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.743 -0.836 . . . . 71.129999999999995 108.743 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.608 HH11 HD12 ' A' ' 214' ' ' LEU . 94.4 mtt180 -131.29 157.15 44.07 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.221 0.608 . . . . 72.329999999999998 110.947 -171.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.5 m -145.36 147.85 32.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.636 0.774 . . . . 74.299999999999997 109.227 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.681 HG12 HG22 ' A' ' 170' ' ' VAL . 24.6 mt -103.96 125.84 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.923 -0.769 . . . . 75.200000000000003 108.923 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 14.5 m -96.72 110.21 22.7 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.691 -1.226 . . . . 73.340000000000003 107.691 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 168' ' ' PHE . 54.8 tp -116.54 111.79 20.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.22 1.008 . . . . 74.329999999999998 109.739 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.446 HH22 ' N ' ' A' ' 39' ' ' CYS . 41.5 ttt180 -81.59 127.69 33.14 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.178 0.991 . . . . 75.329999999999998 111.087 172.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 88.5 t80 -143.03 136.76 28.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.258 1.423 . . . . 74.510000000000005 107.947 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 53.78 29.18 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.208 1.003 . . . . 75.25 112.499 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.34 -12.6 64.28 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.035 -0.869 . . . . 73.099999999999994 114.669 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -97.81 146.43 25.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.212 1.006 . . . . 72.319999999999993 109.608 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.99 112.69 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 122.572 0.349 . . . . 75.409999999999997 110.1 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -97.94 143.87 28.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.716 1.207 . . . . 74.450000000000003 109.11 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -130.13 118.29 21.24 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.354 0.524 . . . . 75.120000000000005 110.227 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.667 ' HH ' HD11 ' A' ' 228' ' ' LEU . 0.6 OUTLIER -121.24 131.72 54.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.497 0.719 . . . . 75.109999999999999 111.045 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 21.4 tpp85 -70.72 131.27 43.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.428 1.091 . . . . 75.030000000000001 111.519 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.58 104.95 11.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.184 -1.043 . . . . 72.409999999999997 108.184 166.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -78.35 138.05 38.35 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.908 -0.775 . . . . 72.329999999999998 108.908 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -111.05 117.25 32.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.66 -0.867 . . . . 73.230000000000004 108.66 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.66 171.49 11.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.537 0.735 . . . . 74.049999999999997 111.258 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 12.8 p -64.52 -26.62 68.5 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.928 0.891 . . . . 74.230000000000004 112.639 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -81.75 -14.47 56.41 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.567 0.747 . . . . 74.140000000000001 111.828 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.44 11.19 39.33 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 119.802 -0.443 . . . . 72.310000000000002 113.432 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -79.39 132.61 36.45 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 116.901 0.35 . . . . 75.209999999999994 110.922 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.24 146.92 26.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.537 -0.912 . . . . 73.340000000000003 108.537 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.2 p90 -170.27 142.77 2.26 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.379 0.425 . . . . 75.209999999999994 111.128 176.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -89.49 -35.85 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.469 -0.937 . . . . 72.549999999999997 108.469 163.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.468 ' HG ' ' HA3' ' A' ' 227' ' ' GLY . 15.6 m -105.5 124.34 49.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.062 0.945 . . . . 74.310000000000002 109.474 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.4 t -65.03 -21.9 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.367 0.667 . . . . 74.510000000000005 111.435 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -66.18 -26.6 67.48 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.275 1.43 . . . . 71.109999999999999 111.459 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.3 m -144.22 106.67 4.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.192 0.597 . . . . 61.25 110.248 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.514 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 84.5 mtt180 -104.23 143.37 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.347 1.059 . . . . 74.420000000000002 109.206 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.62 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 6.3 m-85 -125.84 136.34 52.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.05 0.54 . . . . 71.040000000000006 110.073 -167.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -57.51 -34.34 68.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.956 0.902 . . . . 74.340000000000003 111.031 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.3 p -131.2 154.4 48.45 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 122.016 0.912 . . . . 75.310000000000002 111.582 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.608 HD12 HH11 ' A' ' 180' ' ' ARG . 0.8 OUTLIER -62.65 -23.98 67.38 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.008 -1.451 . . . . 73.140000000000001 109.309 170.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.92 94.21 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.753 0.821 . . . . 75.340000000000003 111.005 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 53.9 mt-10 -72.92 -35.01 66.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.999 0.519 . . . . 60.329999999999998 111.021 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.35 -57.31 11.75 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.414 0.446 . . . . 74.319999999999993 110.053 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.88 -37.72 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 123.839 0.712 . . . . 64.239999999999995 111.54 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -63.32 -59.22 5.0 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.081 0.238 . . . . 74.239999999999995 111.572 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -63.47 -33.02 74.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.352 0.408 . . . . 73.129999999999995 110.942 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.621 ' HB3' HD13 ' A' ' 228' ' ' LEU . 16.5 m170 -88.96 -7.19 56.5 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.433 0.531 . . . . 65.450000000000003 112.433 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -88.23 -35.77 17.13 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.199 0.454 . . . . 70.400000000000006 110.273 168.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 54.0 p -68.98 -47.45 65.57 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.503 -0.771 . . . . 75.150000000000006 110.765 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -131.67 164.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.835 0.826 . . . . 63.299999999999997 112.445 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.33 13.87 1.08 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.864 2.066 . . . . 70.120000000000005 114.69 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.519 ' HB2' HG21 ' A' ' 224' ' ' VAL . 28.5 t70 -42.18 30.57 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 131.56 3.944 . . . . 64.439999999999998 119.409 -152.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.468 ' HA3' ' HG ' ' A' ' 206' ' ' SER . . . 123.37 1.49 9.26 Favored Glycine 0 N--CA 1.486 2.031 0 O-C-N 120.065 -1.647 . . . . 75.329999999999998 112.354 -170.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.667 HD11 ' HH ' ' A' ' 193' ' ' TYR . 9.6 mt -91.87 163.97 13.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.174 1.389 . . . . 73.340000000000003 108.839 169.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 11.4 tt -61.57 -35.98 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-O 120.67 0.271 . . . . 70.200000000000003 110.808 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -157.48 -179.07 7.82 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.513 0.725 . . . . 75.299999999999997 110.322 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.8 p -67.32 146.94 53.59 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.748 0.819 . . . . 72.0 111.68 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 80.8 mt -79.03 92.44 4.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 108.874 -0.788 . . . . 74.439999999999998 108.874 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -88.93 -65.1 1.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.686 0.795 . . . . 75.140000000000001 112.231 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -108.75 120.9 44.79 Favored Pre-proline 0 C--O 1.216 -0.68 0 C-N-CA 124.749 1.22 . . . . 74.439999999999998 109.451 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.401 ' HG3' ' HB2' ' A' ' 67' ' ' TRP . 66.3 Cg_endo -84.51 129.96 4.39 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.009 1.806 . . . . 74.230000000000004 111.965 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -69.22 135.71 89.09 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.058 0.543 . . . . 64.450000000000003 110.664 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.407 ' O ' HD22 ' A' ' 159' ' ' LEU . 10.6 Cg_exo -72.27 172.74 14.26 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.825 2.35 . . . . 75.109999999999999 111.999 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.479 ' NZ ' HD11 ' A' ' 88' ' ' LEU . 33.7 mmtp -71.27 145.59 49.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.02 0.528 . . . . 72.430000000000007 111.478 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.58 ' HB3' HD23 ' A' ' 159' ' ' LEU . 20.8 ptt-85 -82.68 -63.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.248 0.833 . . . . 72.420000000000002 113.248 -163.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.491 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.0 t30 -113.39 130.51 56.28 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.015 0.926 . . . . 74.200000000000003 110.707 -174.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.482 ' HZ2' ' HB2' ' A' ' 90' ' ' ASP . 97.4 mttt -77.73 113.41 32.12 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 107.484 -1.302 . . . . 74.209999999999994 107.484 164.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.65 124.44 13.68 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.892 2.394 . . . . 71.329999999999998 113.556 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 88.2 m -76.9 123.4 26.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.983 -0.747 . . . . 75.439999999999998 108.983 173.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 47.9 t -92.58 114.54 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.384 -0.969 . . . . 74.310000000000002 108.384 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -95.2 112.33 24.05 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.565 -0.255 . . . . 75.209999999999994 111.306 -167.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.68 5.92 2.23 Favored Glycine 0 CA--C 1.542 1.773 0 N-CA-C 118.28 2.072 . . . . 54.039999999999999 118.28 161.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.43 143.81 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.63 1.715 . . . . 73.040000000000006 111.615 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.6 t -77.54 128.91 78.7 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.592 -1.262 . . . . 72.430000000000007 107.592 167.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.433 ' HG2' HD22 ' A' ' 97' ' ' ASN . 78.5 Cg_exo -51.37 -52.21 9.54 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.703 2.269 . . . . 75.319999999999993 113.737 -167.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.646 HD21 ' HB2' ' A' ' 254' ' ' TRP . 65.7 t30 -128.38 -20.19 3.72 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.375 0.534 . . . . 70.140000000000001 111.13 154.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -69.17 98.01 0.97 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.731 0.777 . . . . 72.430000000000007 113.038 -145.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.516 ' HB2' ' HD2' ' A' ' 253' ' ' LYS . 4.3 m-20 -120.91 -46.24 2.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.503 -1.665 . . . . 73.129999999999995 106.503 152.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.516 ' HD2' ' HB2' ' A' ' 252' ' ' ASP . 2.1 mptp? -106.56 -39.21 5.92 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.543 -1.208 . . . . 72.430000000000007 110.499 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.646 ' HB2' HD21 ' A' ' 250' ' ' ASN . 3.1 t-105 -60.67 125.16 22.66 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.057 0.943 . . . . 75.310000000000002 110.605 -174.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.258 1.547 0 N-CA-C 107.715 -1.217 . . . . 71.200000000000003 107.715 175.446 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.253 -0.277 . . . . 74.430000000000007 110.253 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.24 -174.23 43.06 Favored Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.7 -0.56 . . . . 71.340000000000003 111.7 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 63.33 12.11 5.98 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.512 0.725 . . . . 74.0 112.228 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -135.86 100.26 11.03 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 123.831 0.852 . . . . 75.129999999999995 111.153 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -85.79 -165.2 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.284 2.656 . . . . 74.439999999999998 111.776 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.57 82.59 1.58 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.352 -0.299 . . . . 74.010000000000005 112.352 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.3 -38.63 11.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.915 0.886 . . . . 74.319999999999993 109.721 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 m 53.83 175.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 C-N-CA 126.525 1.93 . . . . 75.109999999999999 113.818 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.37 164.87 11.83 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.892 0.877 . . . . 74.439999999999998 109.219 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.58 123.24 0.89 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.44 -1.064 . . . . 71.120000000000005 110.44 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.53 142.26 20.97 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.477 0.639 . . . . 74.299999999999997 110.58 -174.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -169.13 124.74 0.88 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.123 0.969 . . . . 73.010000000000005 110.487 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -81.13 115.6 20.64 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.261 0.624 . . . . 75.430000000000007 109.332 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 53.7 mmt-85 -126.54 107.65 23.42 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.007 0.923 . . . . 75.340000000000003 110.109 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -60.44 117.15 3.87 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.346 2.698 . . . . 63.119999999999997 112.309 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -77.71 156.09 30.86 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.503 0.721 . . . . 72.239999999999995 110.855 175.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 mp -85.59 150.56 54.07 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.282 0.633 . . . . 72.209999999999994 109.749 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HG3' ' HB3' ' A' ' 252' ' ' ASP . 73.3 Cg_endo -71.65 156.71 57.12 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.978 2.452 . . . . 70.310000000000002 112.449 176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.25 154.26 39.06 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.77 -0.65 . . . . 73.340000000000003 111.167 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -97.94 -179.85 4.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.292 1.037 . . . . 75.120000000000005 112.233 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -71.2 172.88 8.47 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.575 1.15 . . . . 74.209999999999994 111.8 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 59.2 t80 54.41 78.98 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.756 1.622 . . . . 75.150000000000006 112.464 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 10.8 tt -179.28 149.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.233 1.413 . . . . 61.109999999999999 108.759 174.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -104.46 167.19 9.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.225 0.61 . . . . 75.219999999999999 110.469 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.18 164.94 33.97 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 116.176 -0.465 . . . . 60.420000000000002 113.034 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.47 138.58 34.75 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.669 0.788 . . . . 74.510000000000005 109.936 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.06 -162.44 24.72 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 116.572 -0.285 . . . . 73.239999999999995 112.635 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -138.01 164.37 29.22 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.359 1.064 . . . . 74.209999999999994 109.756 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HG2' ' NE ' ' A' ' 239' ' ' ARG . 89.0 mtm180 -124.95 -175.39 3.28 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.774 1.23 . . . . 75.319999999999993 109.4 173.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 69.41 131.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.179 1.392 . . . . 74.049999999999997 111.996 -173.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.8 t -173.54 175.23 3.05 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 125.443 1.497 . . . . 74.120000000000005 108.169 174.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.1 m -95.07 145.52 24.92 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.319 0.648 . . . . 72.430000000000007 109.487 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -85.04 152.46 23.41 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.607 0.763 . . . . 52.140000000000001 109.585 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -160.85 105.2 1.37 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.868 0.467 . . . . 73.430000000000007 110.394 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.87 -140.83 5.74 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 123.788 0.68 . . . . 55.149999999999999 111.577 168.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.95 -167.08 27.11 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 117.127 0.464 . . . . 72.120000000000005 113.391 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.56 153.91 74.79 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 123.543 2.828 . . . . 75.140000000000001 112.198 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -83.43 132.33 34.98 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.778 0.323 . . . . 71.109999999999999 110.197 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.4 p -164.51 99.18 0.81 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.441 0.697 . . . . 73.200000000000003 109.659 -173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 172.14 147.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.46 1.504 . . . . 72.140000000000001 109.207 170.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -56.29 160.26 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.989 1.315 . . . . 73.219999999999999 112.873 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -77.98 149.61 34.07 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.424 1.089 . . . . 72.319999999999993 112.193 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.9 p -173.01 -38.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 125.161 1.384 . . . . 71.299999999999997 109.845 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.609 ' H ' HD23 ' A' ' 61' ' ' LEU . 10.4 tp10 -133.7 140.3 46.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.1 0.96 . . . . 53.240000000000002 109.441 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -75.79 124.06 26.65 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.606 0.362 . . . . 74.439999999999998 110.935 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 165' ' ' ASN . 4.8 mm-40 -87.67 142.3 27.94 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.88 0.872 . . . . 75.200000000000003 109.502 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.71 99.33 0.79 Allowed 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.236 -1.024 . . . . 41.350000000000001 108.236 172.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.85 90.52 0.13 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.554 0.742 . . . . 74.510000000000005 110.236 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.421 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 7.9 tt0 -167.21 124.95 1.26 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 125.915 1.686 . . . . 72.230000000000004 107.053 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 98.19 -55.95 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 C-N-CA 128.013 2.525 . . . . 71.530000000000001 110.944 -171.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 49' ' ' GLN . 23.9 Cg_endo -63.85 94.63 0.19 Allowed 'Trans proline' 0 C--N 1.397 3.079 0 CA-C-N 122.26 1.843 . . . . 72.120000000000005 110.145 157.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -69.55 95.81 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 CA-C-O 121.797 0.808 . . . . 74.349999999999994 111.332 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.52 93.82 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.468 1.507 . . . . 74.439999999999998 111.464 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 m -87.22 41.8 1.0 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.546 0.738 . . . . 74.450000000000003 110.25 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.93 -53.93 38.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.543 1.137 . . . . 72.219999999999999 111.623 -172.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -78.46 -6.72 56.13 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.655 0.782 . . . . 75.349999999999994 112.399 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -65.43 122.0 77.91 Favored Pre-proline 0 N--CA 1.475 0.803 0 N-CA-C 112.988 0.736 . . . . 72.219999999999999 112.988 -171.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -86.73 0.93 7.7 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.938 2.425 . . . . 74.400000000000006 110.893 162.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -113.27 -79.35 0.58 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.606 1.162 . . . . 75.409999999999997 109.354 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.53 -48.72 4.03 Favored Glycine 0 C--N 1.361 1.949 0 CA-C-N 116.16 -0.473 . . . . 75.5 113.863 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 44' ' ' GLU . 8.5 mp -85.99 -177.67 6.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.643 1.177 . . . . 73.400000000000006 112.824 -167.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 m -148.0 41.98 1.02 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.518 1.127 . . . . 70.430000000000007 110.625 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.499 ' HB2' ' CE1' ' A' ' 233' ' ' HIS . 31.7 tt0 -86.62 -90.86 0.11 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 119.207 -0.425 . . . . 64.420000000000002 111.179 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.38 -24.74 64.81 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.374 1.069 . . . . 75.519999999999996 113.818 -164.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.44 -26.42 60.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.68 0.276 . . . . 73.049999999999997 110.974 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -89.5 -42.64 11.35 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.552 0.692 . . . . 73.319999999999993 109.5 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -94.11 69.89 3.83 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.096 -0.956 . . . . 73.329999999999998 108.932 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -65.93 -25.13 67.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.853 -1.067 . . . . 74.219999999999999 110.419 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.5 m -75.3 4.45 7.11 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.967 1.307 . . . . 74.5 113.155 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -69.99 -33.82 72.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.332 0.515 . . . . 73.439999999999998 110.902 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.75 -36.12 43.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.947 0.499 . . . . 63.43 110.126 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -74.03 -7.28 51.89 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.626 0.77 . . . . 60.009999999999998 111.523 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.75 -23.95 67.57 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.63 1.172 . . . . 74.129999999999995 111.322 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.55 14.3 20.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.927 0.891 . . . . 74.239999999999995 110.968 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.6 -27.04 67.39 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.156 0.582 . . . . 73.019999999999996 111.307 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.17 -137.79 22.53 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.281 -0.733 . . . . 75.310000000000002 111.908 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.705 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 25.5 Cg_endo -59.96 -176.94 0.13 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.342 2.694 . . . . 74.319999999999993 114.109 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 m -58.2 155.76 10.87 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.729 -1.123 . . . . 73.019999999999996 111.913 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -65.16 -50.32 66.43 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.475 0.546 . . . . 74.200000000000003 112.475 -163.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -133.54 -36.58 0.96 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.84 0.456 . . . . 74.010000000000005 111.324 171.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.756 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 7.2 m-20 -89.45 111.84 48.0 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-O 117.822 -1.085 . . . . 64.209999999999994 110.793 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.93 -27.83 46.38 Favored 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.791 2.327 . . . . 73.0 113.715 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -98.45 18.5 16.42 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 124.878 1.271 . . . . 72.340000000000003 111.156 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 36.4 tp -85.07 131.41 34.46 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.368 -0.833 . . . . 74.299999999999997 110.339 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.0 m-85 -111.24 172.64 6.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.507 1.123 . . . . 74.310000000000002 108.443 173.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.41 137.22 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.215 1.006 . . . . 75.329999999999998 109.376 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.75 122.17 21.97 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.515 0.726 . . . . 74.349999999999994 110.8 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.4 mt -76.69 -35.87 57.6 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.708 0.803 . . . . 72.519999999999996 110.811 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 20.1 m-85 -124.31 168.21 13.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.2 -0.909 . . . . 73.510000000000005 109.888 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.65 117.71 24.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.207 -1.035 . . . . 75.150000000000006 108.207 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.644 ' HB3' HG12 ' A' ' 101' ' ' ILE . 61.3 t80 -106.46 131.55 53.51 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.374 -1.343 . . . . 74.129999999999995 107.374 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.14 133.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.871 -0.788 . . . . 70.239999999999995 108.871 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.33 123.2 20.56 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.279 0.631 . . . . 44.450000000000003 109.871 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 p -86.23 -16.31 38.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.601 0.76 . . . . 65.099999999999994 110.997 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -158.83 -173.7 27.58 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.621 -0.718 . . . . 75.400000000000006 111.483 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -69.46 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.964 0.905 . . . . 75.140000000000001 111.669 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -73.68 -27.5 61.26 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.58 1.152 . . . . 75.109999999999999 112.131 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.2 p -93.36 169.11 10.62 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.723 0.809 . . . . 65.409999999999997 109.744 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.535 HD22 ' HG1' ' A' ' 123' ' ' THR . 65.6 tp -136.06 128.8 30.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.696 0.398 . . . . 74.319999999999993 111.424 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 m -72.79 116.61 13.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.678 HG21 HG22 ' A' ' 123' ' ' THR . 27.1 pt -120.72 149.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.356 0.662 . . . . 72.209999999999994 110.04 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.4 m -102.12 142.2 33.75 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.306 -0.861 . . . . 71.219999999999999 110.256 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -59.2 114.45 2.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.735 0.814 . . . . 73.439999999999998 110.291 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.83 0.12 39.2 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.688 -0.687 . . . . 72.430000000000007 112.78 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.17 121.16 27.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.287 0.544 . . . . 63.229999999999997 111.294 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.545 ' HD3' HD22 ' A' ' 84' ' ' LEU . 62.7 mttp -70.83 130.39 41.56 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.797 0.839 . . . . 74.219999999999999 109.009 169.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.698 ' HB3' HG21 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.14 138.38 31.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.392 0.677 . . . . 74.409999999999997 110.464 -176.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.5 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 40.9 ttm180 -89.49 108.56 19.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.928 0.491 . . . . 75.450000000000003 110.068 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.547 HG13 ' HB1' ' A' ' 119' ' ' ALA . 4.6 t -78.61 117.88 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.347 0.659 . . . . 73.25 110.099 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.3 mt -90.3 -49.12 6.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.101 0.96 . . . . 75.129999999999995 110.229 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.67 144.56 9.47 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 115.38 -0.827 . . . . 71.450000000000003 111.606 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.511 ' CD2' ' HB3' ' A' ' 119' ' ' ALA . 25.0 m-85 -87.86 168.77 12.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.655 0.782 . . . . 74.540000000000006 111.252 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -88.71 -172.19 3.62 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.681 -1.145 . . . . 73.420000000000002 110.982 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -41.95 -44.72 3.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.838 1.655 . . . . 74.219999999999999 114.506 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 31.4 p-10 -114.34 6.42 16.07 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.174 0.805 . . . . 73.310000000000002 113.174 -174.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.56 16.14 80.59 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.252 -0.749 . . . . 61.219999999999999 114.711 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.77 -66.85 0.81 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.92 0.86 . . . . 74.299999999999997 109.668 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 70.1 m95 -90.68 131.91 36.1 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.926 0.49 . . . . 73.329999999999998 111.187 -168.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.547 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -124.5 139.14 54.16 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.208 1.003 . . . . 74.409999999999997 109.7 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.62 ' HG2' HE21 ' A' ' 127' ' ' GLN . 25.4 tt0 -73.44 110.41 7.7 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.115 -1.069 . . . . 74.209999999999994 108.115 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -101.61 143.78 31.15 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.591 0.756 . . . . 75.239999999999995 109.513 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 35.4 tt0 -102.66 104.5 14.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.138 -1.392 . . . . 74.430000000000007 107.504 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.698 HG21 ' HB3' ' A' ' 107' ' ' LEU . 58.7 p -112.17 166.83 10.91 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.282 1.033 . . . . 75.329999999999998 110.391 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -72.51 -17.49 61.73 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.796 -1.093 . . . . 74.25 109.536 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -75.23 -27.44 59.51 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.632 1.173 . . . . 75.510000000000005 111.088 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.16 -155.06 25.37 Favored Glycine 0 C--N 1.358 1.799 0 CA-C-O 120.246 -0.197 . . . . 75.540000000000006 112.969 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.62 HE21 ' HG2' ' A' ' 120' ' ' GLU . 56.8 tp60 -116.29 137.66 51.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.425 0.613 . . . . 75.319999999999993 110.516 -174.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 161.98 170.87 27.33 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 120.249 -0.976 . . . . 74.319999999999993 114.215 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -87.49 129.87 34.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.418 0.687 . . . . 74.230000000000004 111.783 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -137.68 145.2 47.75 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 74.310000000000002 109.106 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 18.3 Cg_endo -87.47 151.81 7.75 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 122.402 2.068 . . . . 63.200000000000003 114.917 -170.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.0 m -40.47 -30.79 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.133 2.173 . . . . 74.400000000000006 114.69 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.473 HD22 HG21 ' A' ' 244' ' ' VAL . 29.6 p30 -78.97 -27.02 43.42 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.111 0.565 . . . . 74.120000000000005 112.191 -175.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.455 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -91.4 -16.23 27.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.542 0.737 . . . . 75.010000000000005 112.05 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.6 pt -122.8 176.32 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.724 0.81 . . . . 73.049999999999997 111.122 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.0 m -160.03 136.67 6.54 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.649 1.18 . . . . 72.319999999999993 109.083 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 29.1 Cg_endo -59.98 134.9 59.42 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 121.942 1.762 . . . . 73.340000000000003 111.488 173.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.04 -7.33 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.557 0.743 . . . . 72.129999999999995 110.637 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 7.2 t30 -75.93 -23.44 55.45 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.292 0.637 . . . . 73.409999999999997 111.811 175.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.3 p -94.59 173.92 7.37 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.173 0.511 . . . . 74.239999999999995 111.91 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 mt -82.79 -19.51 37.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.341 1.056 . . . . 74.340000000000003 111.37 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.66 -18.89 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.207 1.003 . . . . 65.310000000000002 112.19 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -62.58 -25.55 68.13 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.174 0.589 . . . . 73.030000000000001 111.772 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -78.04 136.97 38.02 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.504 -0.771 . . . . 73.510000000000005 110.226 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 m -57.36 -36.58 71.38 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.212 1.005 . . . . 75.239999999999995 112.311 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.411 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 42.7 p-90 -67.72 -28.8 67.97 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.917 0.761 . . . . 71.349999999999994 112.621 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.416 ' O ' ' HE2' ' A' ' 238' ' ' LYS . 20.9 t80 -89.14 98.59 11.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.774 -0.824 . . . . 74.209999999999994 108.774 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.537 ' HB2' HG22 ' A' ' 151' ' ' VAL . 65.8 m80 -91.69 -9.04 45.3 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.752 0.421 . . . . 74.439999999999998 111.788 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.04 -126.91 9.02 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 118.317 -1.269 . . . . 62.530000000000001 113.175 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -69.24 88.31 0.48 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 123.25 2.633 . . . . 73.0 112.185 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 43.4 t -126.95 133.46 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.946 0.898 . . . . 74.439999999999998 109.494 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 p -86.46 171.1 11.36 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.025 0.93 . . . . 72.099999999999994 109.808 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -62.16 -42.31 99.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 110.002 -0.37 . . . . 74.329999999999998 110.002 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.27 -48.26 76.94 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.235 0.959 . . . . 73.409999999999997 110.867 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.3 69.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.236 0.614 . . . . 73.310000000000002 111.735 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.39 75.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 63.450000000000003 111.311 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.97 -20.98 47.81 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.544 -0.753 . . . . 71.230000000000004 110.677 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -37.12 81.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.111 0.964 . . . . 71.0 110.084 170.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.551 HD22 ' HB3' ' A' ' 239' ' ' ARG . 67.4 mt -68.97 -51.69 36.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.99 0.516 . . . . 75.530000000000001 110.673 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.455 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 80.7 mt -83.75 11.95 6.69 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.563 0.579 . . . . 70.439999999999998 112.563 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.7 p -62.05 -37.47 85.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.904 0.482 . . . . 75.519999999999996 111.663 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.5 m -111.28 18.62 19.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.678 0.791 . . . . 74.420000000000002 110.739 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 152.06 41.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 112.818 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.8 pt -87.74 -177.67 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.313 0.645 . . . . 64.349999999999994 110.533 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.508 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 5.1 m-20 -62.48 125.68 24.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.899 -0.591 . . . . 61.329999999999998 110.472 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.53 ' HA3' ' HB3' ' A' ' 233' ' ' HIS . . . 84.22 10.92 79.45 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.05 -0.977 . . . . 52.340000000000003 113.29 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.6 m -67.67 139.16 56.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.272 1.036 . . . . 63.229999999999997 109.703 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.458 ' HB3' HD13 ' A' ' 184' ' ' LEU . 18.1 p90 -149.17 166.49 28.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.804 0.729 . . . . 73.549999999999997 111.76 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.1 pp -161.84 135.6 6.53 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.841 -1.072 . . . . 75.530000000000001 109.724 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.654 HG22 HG12 ' A' ' 182' ' ' ILE . 74.5 t -91.66 141.55 14.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 N-CA-C 108.3 -1.0 . . . . 75.129999999999995 108.3 167.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.568 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 46.0 ptt85 -144.95 153.38 41.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.242 -0.89 . . . . 72.329999999999998 109.983 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -115.2 148.45 39.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.224 1.009 . . . . 70.319999999999993 108.393 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.8 t -78.67 125.4 29.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.07 0.548 . . . . 74.25 110.103 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.12 -41.77 88.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.172 0.989 . . . . 71.5 110.489 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 57.8 p -80.53 -25.17 38.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.496 0.718 . . . . 74.140000000000001 111.806 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.7 m -124.6 95.63 42.47 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.511 0.724 . . . . 72.519999999999996 110.668 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.81 139.61 81.09 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.211 2.608 . . . . 74.25 112.215 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.64 -28.38 4.9 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.279 -0.419 . . . . 71.450000000000003 113.06 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -75.67 116.18 16.11 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 117.062 0.431 . . . . 65.439999999999998 110.345 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.64 HH11 HD13 ' A' ' 214' ' ' LEU . 89.5 mtt180 -126.12 150.75 48.01 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.087 0.955 . . . . 75.349999999999994 109.281 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.4 m -149.41 153.75 37.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.098 0.959 . . . . 75.409999999999997 109.494 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.654 HG12 HG22 ' A' ' 170' ' ' VAL . 26.7 mt -110.9 149.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.107 -1.071 . . . . 71.510000000000005 108.107 172.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 55.0 m -121.75 115.4 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.34 -1.355 . . . . 41.100000000000001 107.34 169.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 168' ' ' PHE . 14.7 tp -108.45 112.76 25.33 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.569 0.622 . . . . 73.140000000000001 109.956 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 23.3 ttt180 -81.68 112.02 18.48 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 109.752 -0.462 . . . . 74.310000000000002 109.752 165.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -136.36 143.96 44.35 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 106.85 -1.537 . . . . 74.230000000000004 106.85 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 61.38 21.21 11.8 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.178 0.991 . . . . 75.319999999999993 111.815 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.07 1.35 68.22 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.976 -0.347 . . . . 75.109999999999999 113.759 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 71.6 mtp180 -105.66 139.31 40.45 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.683 1.193 . . . . 74.109999999999999 109.251 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.9 t -100.13 105.61 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.051 0.453 . . . . 74.239999999999995 110.147 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -90.98 120.15 31.74 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.862 1.265 . . . . 74.219999999999999 109.229 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -95.32 120.69 36.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.62 0.368 . . . . 72.450000000000003 110.462 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -96.95 147.28 24.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.739 1.215 . . . . 74.510000000000005 109.854 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 19.7 tpp180 -101.84 113.17 26.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.323 0.649 . . . . 72.310000000000002 109.277 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.1 mt -82.63 102.12 8.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.828 -1.175 . . . . 74.340000000000003 107.828 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -78.34 107.86 11.27 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.799 -1.091 . . . . 74.409999999999997 108.513 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.8 m -79.44 109.11 13.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.301 -1.0 . . . . 74.239999999999995 108.301 170.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.64 167.7 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.383 0.673 . . . . 64.209999999999994 110.731 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 21.7 p -60.83 -26.3 67.25 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.27 1.028 . . . . 75.200000000000003 113.186 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -94.29 -18.08 22.0 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.482 0.713 . . . . 71.219999999999999 111.502 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.5 10.78 16.39 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-O 119.535 -0.591 . . . . 72.150000000000006 113.662 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 96.3 mttt -76.68 127.26 32.45 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.643 0.721 . . . . 74.019999999999996 110.239 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.24 145.53 24.93 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.679 -0.86 . . . . 75.349999999999994 108.679 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.605 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 43.8 p90 -163.36 129.81 3.3 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.421 0.45 . . . . 75.310000000000002 111.162 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 60.1 t -72.87 -41.79 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.807 -0.812 . . . . 74.200000000000003 108.807 164.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.4 m -107.48 129.24 54.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.73 -1.123 . . . . 52.100000000000001 110.049 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.1 t -61.58 -26.88 68.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.54 0.736 . . . . 72.219999999999999 111.654 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -70.39 -27.91 64.68 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.764 1.225 . . . . 75.420000000000002 110.873 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.8 m -134.13 100.35 4.68 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.38 0.672 . . . . 74.319999999999993 109.766 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.605 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 58.2 mtt180 -105.93 128.72 53.98 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.97 0.908 . . . . 75.040000000000006 108.801 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.504 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 7.2 m-85 -115.13 139.68 49.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.698 0.799 . . . . 74.239999999999995 109.921 -167.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.633 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 6.7 m-80 -67.03 -31.28 71.71 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.167 0.917 . . . . 73.129999999999995 110.267 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.7 p -132.29 156.66 46.16 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.155 0.982 . . . . 74.140000000000001 111.497 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.64 HD13 HH11 ' A' ' 180' ' ' ARG . 0.7 OUTLIER -66.77 -24.37 66.19 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 114.916 -1.038 . . . . 74.140000000000001 109.772 173.023 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.39 79.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.621 0.768 . . . . 72.420000000000002 110.496 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 35.5 mt-10 -70.25 -36.93 74.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.059 0.943 . . . . 74.329999999999998 111.536 177.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 12.6 tp -54.91 -61.3 2.4 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.508 0.505 . . . . 75.099999999999994 110.956 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.2 -38.93 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.827 0.451 . . . . 73.519999999999996 111.093 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -61.51 -57.08 13.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.811 0.445 . . . . 75.010000000000005 111.146 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -67.88 -29.74 68.93 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.243 -0.435 . . . . 72.099999999999994 111.016 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.611 ' HB3' HD13 ' A' ' 228' ' ' LEU . 11.9 m170 -87.6 -11.51 48.39 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.26 0.467 . . . . 71.420000000000002 112.26 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.4 p -93.78 -27.14 16.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.742 0.417 . . . . 53.109999999999999 110.967 173.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.6 p -77.81 -48.25 16.98 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.831 -0.622 . . . . 75.209999999999994 110.535 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.636 HG21 ' HB2' ' A' ' 226' ' ' ASP . 15.8 m -129.77 163.89 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.566 0.698 . . . . 75.140000000000001 111.797 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.21 16.65 0.23 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 127.373 2.269 . . . . 45.439999999999998 114.236 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.636 ' HB2' HG21 ' A' ' 224' ' ' VAL . 36.1 t70 -43.84 33.81 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.606 1 C-N-CA 132.645 4.378 . . . . 73.109999999999999 119.231 -159.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.41 -0.9 10.43 Favored Glycine 0 N--CA 1.474 1.199 0 O-C-N 120.741 -1.224 . . . . 74.230000000000004 112.335 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.611 HD13 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -94.71 164.75 12.82 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.759 1.624 . . . . 74.310000000000002 109.878 169.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 9.6 tt -66.5 -39.35 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.036 0.446 . . . . 72.310000000000002 109.921 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.4 m -151.7 154.73 36.9 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 74.019999999999996 110.377 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.1 p -57.38 139.58 52.63 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.79 1.236 . . . . 63.240000000000002 112.475 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.44 HD22 HD12 ' A' ' 184' ' ' LEU . 86.8 mt -68.14 100.1 0.97 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.557 0.743 . . . . 73.439999999999998 109.007 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.53 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 24.3 t60 -96.45 -78.39 0.47 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.898 0.879 . . . . 74.150000000000006 111.643 -165.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -94.0 123.64 58.67 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.385 0.674 . . . . 74.310000000000002 110.11 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.4 130.88 8.24 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.539 2.159 . . . . 75.150000000000006 111.765 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.59 82.48 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 109.063 -0.717 . . . . 71.219999999999999 109.063 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.21 167.01 16.07 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.409 2.073 . . . . 73.239999999999995 112.261 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 32.4 mmtp -63.45 138.12 58.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.494 0.718 . . . . 74.319999999999993 110.252 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.551 ' HB3' HD22 ' A' ' 159' ' ' LEU . 14.7 ptt-85 -72.73 -63.28 1.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.341 1.237 . . . . 73.209999999999994 114.341 -160.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.512 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 53.6 t30 -112.87 146.48 38.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.992 0.917 . . . . 72.230000000000004 110.314 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 94.8 mttt -77.82 114.45 41.61 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 107.638 -1.245 . . . . 74.450000000000003 107.638 161.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.444 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 26.2 Cg_exo -64.44 127.41 18.94 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.16 2.573 . . . . 63.130000000000003 113.181 -171.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.4 m -76.87 117.2 18.24 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.102 0.561 . . . . 72.439999999999998 109.537 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.473 HG21 HD22 ' A' ' 133' ' ' ASN . 4.0 t -96.91 112.85 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.268 -1.012 . . . . 75.030000000000001 108.268 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -88.07 114.2 24.45 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.743 0.646 . . . . 73.040000000000006 112.743 -160.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.74 42.41 94.39 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 124.577 1.173 . . . . 74.319999999999993 114.438 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m -104.23 132.72 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 113.29 0.848 . . . . 62.299999999999997 113.29 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.8 t -83.98 120.11 74.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 105.083 -2.192 . . . . 70.439999999999998 105.083 148.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -54.94 -53.65 5.67 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.525 2.15 . . . . 64.310000000000002 113.996 -162.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -125.75 -21.53 4.4 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.156 0.503 . . . . 75.120000000000005 111.449 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -82.63 101.86 11.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.883 1.068 . . . . 74.150000000000006 113.883 -149.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.553 ' HB3' ' HG3' ' A' ' 18' ' ' PRO . 8.2 p-10 -122.22 -45.69 2.22 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.14 -0.936 . . . . 63.020000000000003 109.573 152.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.34 -28.31 11.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.476 -0.783 . . . . 73.230000000000004 110.523 -171.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -72.4 109.89 6.42 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.416 -0.811 . . . . 74.340000000000003 112.042 -156.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 C--O 1.254 1.303 0 C-N-CA 125.616 1.566 . . . . 74.109999999999999 111.361 176.271 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.404 -0.591 . . . . 75.25 109.404 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.0 -44.94 3.0 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 123.825 0.703 . . . . 72.219999999999999 112.324 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 58.28 75.78 0.37 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 124.857 1.263 . . . . 74.409999999999997 109.631 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -81.14 114.2 47.11 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 115.425 -0.807 . . . . 72.549999999999997 110.817 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.84 149.67 60.39 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.381 2.054 . . . . 74.239999999999995 111.147 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.29 93.51 0.14 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.445 -0.662 . . . . 73.230000000000004 111.445 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.26 165.04 21.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.353 0.661 . . . . 63.409999999999997 109.536 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -160.91 146.34 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.375 0.67 . . . . 71.230000000000004 109.894 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.77 147.83 33.38 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.56 0.744 . . . . 73.129999999999995 109.523 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.29 158.16 14.87 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.474 -0.651 . . . . 64.540000000000006 111.474 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -115.63 169.6 9.07 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.383 0.592 . . . . 54.310000000000002 110.712 -173.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -81.97 150.9 27.43 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.144 0.978 . . . . 72.329999999999998 110.71 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -104.26 178.98 4.4 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.095 0.958 . . . . 75.209999999999994 109.586 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -76.41 151.41 83.16 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.432 0.693 . . . . 74.439999999999998 110.899 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.04 171.39 5.06 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.03 2.487 . . . . 72.420000000000002 113.079 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.475 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 33.9 p -72.44 98.3 2.24 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.08 0.952 . . . . 75.239999999999995 111.644 -176.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.33 150.37 49.33 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 108.848 -0.797 . . . . 72.239999999999995 108.848 169.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.33 175.83 9.28 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.894 2.396 . . . . 75.519999999999996 112.101 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.02 96.83 3.28 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.714 0.806 . . . . 62.539999999999999 110.031 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -89.81 101.3 14.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.612 0.765 . . . . 72.450000000000003 108.974 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -130.8 -143.87 0.25 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.286 -1.375 . . . . 75.319999999999993 107.286 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -172.67 110.24 0.22 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.995 0.816 . . . . 75.219999999999999 109.979 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 11.1 pt -120.5 175.09 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.747 0.819 . . . . 72.439999999999998 109.22 172.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -145.15 139.08 27.02 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.578 0.751 . . . . 74.209999999999994 110.059 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.65 -164.85 32.73 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.501 -0.772 . . . . 65.209999999999994 111.454 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.14 175.45 14.04 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.703 0.801 . . . . 75.109999999999999 110.537 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.77 132.16 2.52 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.3 -0.32 . . . . 62.32 112.3 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -131.66 144.59 51.14 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.471 1.108 . . . . 73.349999999999994 109.405 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -133.76 131.97 39.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.59 0.756 . . . . 75.019999999999996 110.722 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -152.58 119.36 5.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.845 -1.169 . . . . 62.049999999999997 107.845 170.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -125.22 44.24 2.85 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.736 1.215 . . . . 72.310000000000002 108.611 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.697 ' HA ' ' HA3' ' A' ' 178' ' ' GLY . 22.8 t -59.06 94.91 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.341 1.056 . . . . 71.049999999999997 112.522 -174.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.2 mmt-85 -111.69 -170.03 1.57 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.914 1.285 . . . . 73.310000000000002 109.168 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -128.86 156.83 43.04 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.256 1.022 . . . . 64.409999999999997 110.048 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.35 -123.72 1.88 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 110.837 -0.905 . . . . 72.109999999999999 110.837 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.75 -137.56 4.71 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 117.689 0.745 . . . . 74.319999999999993 113.562 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.73 -152.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 124.263 3.309 . . . . 71.019999999999996 113.476 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -148.48 -68.8 0.23 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 123.535 0.734 . . . . 75.310000000000002 110.041 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.9 t -152.59 -167.53 2.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.1 0.56 . . . . 75.329999999999998 110.094 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -135.62 140.6 44.69 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.508 0.723 . . . . 72.340000000000003 110.488 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 158' ' ' TYR . 35.8 m -136.45 142.38 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.992 0.917 . . . . 65.439999999999998 108.84 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -129.19 137.63 51.26 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.826 0.851 . . . . 72.030000000000001 110.279 -173.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 158' ' ' TYR . 47.7 t -117.93 -41.77 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.176 0.591 . . . . 75.219999999999999 110.335 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 161' ' ' SER . 0.4 OUTLIER 73.67 119.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.405 1.482 . . . . 72.030000000000001 110.989 -178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -152.25 151.01 30.41 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.3 1.04 . . . . 73.519999999999996 109.212 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -115.51 82.56 1.78 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.823 -1.177 . . . . 71.329999999999998 107.823 173.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.81 119.86 27.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.763 0.825 . . . . 70.150000000000006 108.873 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tt -156.26 108.08 2.52 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 107.027 -1.472 . . . . 72.329999999999998 107.027 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 66.55 160.74 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.8 1.24 . . . . 75.040000000000006 112.044 -176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -143.76 -53.75 0.02 OUTLIER Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.828 1.251 . . . . 63.43 110.488 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -72.0 97.1 0.81 Allowed 'Trans proline' 0 C--N 1.397 3.096 0 CA-C-N 121.092 1.426 . . . . 63.549999999999997 110.837 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -88.13 177.21 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.766 0.826 . . . . 70.299999999999997 108.772 174.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.83 164.89 23.26 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.554 0.342 . . . . 61.32 111.521 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.6 t -76.49 -20.94 56.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.821 0.849 . . . . 63.299999999999997 111.611 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -152.62 -81.95 0.09 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.958 0.503 . . . . 71.239999999999995 109.828 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -98.61 137.56 37.07 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.673 -0.862 . . . . 71.030000000000001 108.673 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -87.31 111.8 43.73 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.195 -0.669 . . . . 72.439999999999998 109.195 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.03 -28.54 80.48 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.329 2.019 . . . . 72.510000000000005 111.586 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -145.59 -58.66 0.33 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.131 -0.941 . . . . 74.239999999999995 110.803 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.23 -26.01 4.63 Favored Glycine 0 C--N 1.35 1.344 0 C-N-CA 122.888 0.28 . . . . 74.129999999999995 113.528 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.7 mt -110.49 161.44 15.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.738 1.215 . . . . 72.200000000000003 108.936 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.8 p -102.92 87.88 3.04 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.337 -0.616 . . . . 75.109999999999999 109.337 175.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 55.4 -83.78 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.496 1.918 . . . . 73.109999999999999 113.655 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.36 -51.19 64.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.293 0.637 . . . . 74.129999999999995 110.261 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 176.88 -55.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.326 1.45 . . . . 75.129999999999995 107.989 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -140.61 43.62 1.85 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.01 -1.45 . . . . 73.409999999999997 107.958 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.408 ' HH2' HD23 ' A' ' 73' ' ' LEU . 20.6 t90 -158.88 92.23 1.09 Allowed 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.939 -1.028 . . . . 75.329999999999998 110.315 -171.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -77.8 -31.11 51.63 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.455 -1.248 . . . . 70.450000000000003 111.135 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.7 p -76.14 9.42 2.53 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.555 1.142 . . . . 75.230000000000004 111.98 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -41.61 -43.32 2.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.429 1.492 . . . . 74.310000000000002 113.302 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.64 -27.77 68.63 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.746 0.818 . . . . 72.120000000000005 112.703 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.487 ' HB2' ' HE1' ' A' ' 144' ' ' HIS . 12.8 m120 -86.11 -0.92 56.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.98 0.912 . . . . 72.019999999999996 111.373 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.408 HD23 ' HH2' ' A' ' 67' ' ' TRP . 59.3 tp -57.51 -52.91 63.49 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 122.604 0.362 . . . . 74.140000000000001 110.396 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.55 45.14 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.019 0.927 . . . . 72.129999999999995 110.18 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.38 -48.97 73.43 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.249 0.619 . . . . 73.239999999999995 110.779 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 65.56 -137.33 37.05 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 118.794 -1.003 . . . . 61.350000000000001 111.37 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.49 121.51 7.5 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.013 1.809 . . . . 72.219999999999999 109.64 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.3 t -120.34 164.81 15.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.506 0.323 . . . . 74.409999999999997 111.403 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.17 -21.9 66.84 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.06 0.944 . . . . 73.430000000000007 108.612 166.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.494 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.7 OUTLIER -79.05 33.18 0.22 Allowed 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 126.01 1.724 . . . . 74.129999999999995 111.445 175.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -44.61 140.72 3.09 Favored Pre-proline 0 CA--C 1.567 1.606 0 C-N-CA 127.439 2.295 . . . . 74.329999999999998 111.9 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -15.88 -43.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.399 3.228 1 C-N-CA 127.795 5.663 . . . . 73.030000000000001 120.492 -165.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -67.53 -13.85 62.42 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.683 0.793 . . . . 74.150000000000006 112.975 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 tp -100.37 123.65 44.86 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.805 0.812 . . . . 73.219999999999999 109.751 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -113.19 173.1 6.56 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.516 1.526 . . . . 73.430000000000007 109.491 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 p -136.72 132.44 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.069 1.347 . . . . 75.040000000000006 108.805 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.06 116.69 9.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.291 1.036 . . . . 74.420000000000002 110.025 173.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.6 mt -81.48 -36.07 29.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.76 0.824 . . . . 72.209999999999994 110.638 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.427 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 36.8 m-85 -122.85 143.91 49.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.967 -1.015 . . . . 75.510000000000005 108.819 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -74.23 134.3 42.68 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.843 -0.799 . . . . 63.439999999999998 108.843 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.614 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.0 t80 -134.87 138.33 44.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.093 0.957 . . . . 74.209999999999994 109.015 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.8 134.16 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.006 -1.479 . . . . 72.340000000000003 107.006 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 16' ' ' SER . . . -57.1 128.27 36.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.865 0.866 . . . . 74.340000000000003 110.996 -178.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 p -110.1 8.96 24.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.799 0.84 . . . . 72.540000000000006 111.725 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.9 -179.46 32.81 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.8 -0.52 . . . . 74.540000000000006 111.8 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.34 -21.49 39.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.575 0.75 . . . . 74.140000000000001 112.767 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -107.12 -7.92 16.68 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 111.852 0.315 . . . . 63.229999999999997 111.852 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.6 p -75.97 177.96 6.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.873 0.469 . . . . 74.219999999999999 111.217 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.535 HD22 ' HG1' ' A' ' 123' ' ' THR . 57.0 tp -142.65 145.53 33.55 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.825 -0.547 . . . . 74.439999999999998 110.985 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 m -94.11 120.49 34.43 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.936 0.895 . . . . 73.420000000000002 109.304 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.629 HG23 HG21 ' A' ' 123' ' ' THR . 15.8 pt -113.82 148.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.629 0.771 . . . . 74.040000000000006 111.079 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.9 m -94.92 143.96 26.05 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.714 0.806 . . . . 73.230000000000004 109.312 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.01 120.75 11.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.54 0.736 . . . . 74.010000000000005 109.923 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.95 -9.23 68.1 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.643 -0.532 . . . . 63.399999999999999 113.607 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.7 143.44 51.33 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.591 0.757 . . . . 65.420000000000002 111.461 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.33 134.88 35.09 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.87 0.868 . . . . 74.420000000000002 109.192 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.475 ' HB3' HG23 ' A' ' 123' ' ' THR . 0.4 OUTLIER -145.33 142.79 29.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 75.319999999999993 109.847 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -97.08 109.66 22.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.188 -0.671 . . . . 73.430000000000007 109.188 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.504 HG11 ' HB1' ' A' ' 119' ' ' ALA . 19.1 t -72.67 126.4 33.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-O 121.699 0.761 . . . . 71.450000000000003 109.363 171.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 23' ' ' ILE . 79.5 mt -88.63 -59.13 2.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.456 -1.702 . . . . 72.400000000000006 109.203 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.63 142.93 8.79 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.359 -0.382 . . . . 54.399999999999999 112.531 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.594 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 30.8 m-85 -86.4 168.12 14.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.513 1.125 . . . . 74.200000000000003 111.25 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -94.09 -171.58 2.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.088 1.355 . . . . 74.109999999999999 111.002 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -47.22 -36.35 8.75 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.924 1.689 . . . . 74.209999999999994 115.025 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -109.57 -6.18 15.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.543 0.337 . . . . 71.129999999999995 111.357 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.72 25.2 75.81 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.392 0.433 . . . . 74.099999999999994 113.451 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.47 -7.15 21.14 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.44 0.696 . . . . 74.239999999999995 112.296 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 33.4 m95 -140.48 134.33 30.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.67 0.788 . . . . 75.140000000000001 109.57 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.531 ' HB3' ' CD2' ' A' ' 112' ' ' TYR . . . -134.0 148.24 51.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 74.310000000000002 110.639 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.86 113.63 19.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.857 -1.164 . . . . 73.519999999999996 107.857 167.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.59 145.36 45.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.262 0.625 . . . . 62.119999999999997 110.95 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.44 103.53 15.49 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 109.03 -0.73 . . . . 73.25 109.03 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.629 HG21 HG23 ' A' ' 101' ' ' ILE . 75.7 p -86.36 168.44 13.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.356 0.662 . . . . 74.439999999999998 109.248 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -74.1 -11.2 60.24 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.671 -0.695 . . . . 75.239999999999995 110.57 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -79.99 -33.08 39.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.731 0.812 . . . . 72.219999999999999 110.19 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.58 -161.52 31.83 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 111.415 -0.674 . . . . 73.109999999999999 111.415 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -128.91 149.28 50.84 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.786 0.793 . . . . 74.5 110.597 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.06 178.35 35.87 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.706 0.629 . . . . 55.43 111.576 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -84.3 122.93 29.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.614 0.766 . . . . 75.140000000000001 111.989 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.415 HG23 HD11 ' A' ' 135' ' ' ILE . 19.8 m -128.61 145.21 55.16 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 124.992 1.317 . . . . 75.019999999999996 109.361 173.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.2 Cg_endo -84.3 146.61 11.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.287 1.991 . . . . 73.409999999999997 114.705 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 m -40.03 -41.85 1.29 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.191 1.796 . . . . 63.240000000000002 113.968 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -76.39 -17.91 59.13 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.175 -0.921 . . . . 74.219999999999999 112.657 -170.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.462 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 24.7 m-85 -92.28 -18.4 23.44 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.19 0.596 . . . . 73.329999999999998 111.713 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 130' ' ' VAL . 19.4 pt -120.24 -179.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.553 1.141 . . . . 72.099999999999994 110.408 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.9 t -162.5 151.08 12.35 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 118.428 -0.796 . . . . 71.450000000000003 108.872 166.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.72 145.71 97.21 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 121.49 1.46 . . . . 74.209999999999994 109.831 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.55 -4.38 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 121.778 0.799 . . . . 71.430000000000007 111.462 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.88 -22.74 49.31 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.777 0.831 . . . . 73.010000000000005 111.186 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.5 p -81.32 176.43 9.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.832 0.825 . . . . 75.019999999999996 111.705 -167.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.438 HD13 HD12 ' A' ' 214' ' ' LEU . 38.8 mt -85.78 -26.32 25.86 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.847 -1.07 . . . . 74.209999999999994 110.605 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.521 ' HG3' ' HD2' ' A' ' 147' ' ' TYR . 1.6 mp0 -64.47 -20.41 66.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.79 1.236 . . . . 75.319999999999993 111.966 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -63.75 -4.69 3.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.732 0.813 . . . . 75.019999999999996 113.095 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.487 ' HE1' ' HB2' ' A' ' 72' ' ' ASN . 42.4 m-70 -117.73 159.29 23.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.998 0.919 . . . . 73.120000000000005 110.728 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -42.94 89.29 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.447 1.099 . . . . 71.219999999999999 112.14 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 56.3 p-90 -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.364 0.875 . . . . 74.140000000000001 113.364 -172.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.521 ' HD2' ' HG3' ' A' ' 142' ' ' GLU . 21.0 t80 -85.34 106.76 16.97 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.705 0.684 . . . . 75.140000000000001 110.356 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.506 ' HB3' HG21 ' A' ' 151' ' ' VAL . 3.2 m80 -89.27 -14.04 36.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.982 0.913 . . . . 74.400000000000006 112.0 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.48 -140.62 23.79 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.035 -1.425 . . . . 71.329999999999998 112.197 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.62 88.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.535 2.823 . . . . 72.439999999999998 112.891 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 155' ' ' ALA . 37.6 t -140.14 128.05 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.849 1.659 . . . . 73.549999999999997 108.807 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.1 p -84.27 175.13 9.62 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 124.061 0.945 . . . . 70.409999999999997 109.997 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -60.08 -40.95 91.32 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.984 -0.531 . . . . 73.420000000000002 111.158 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -53.26 -51.33 62.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.199 0.937 . . . . 75.120000000000005 110.317 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.516 ' HB2' HG11 ' A' ' 151' ' ' VAL . . . -62.57 -46.35 88.72 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.057 -1.429 . . . . 54.100000000000001 111.168 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.464 ' HB3' ' HD3' ' A' ' 171' ' ' ARG . . . -56.86 -37.13 70.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.453 0.701 . . . . 43.310000000000002 112.184 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -68.83 -43.8 74.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.176 0.99 . . . . 74.219999999999999 111.155 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.455 ' HB3' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -71.74 -22.83 61.56 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.328 0.585 . . . . 73.219999999999999 112.214 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 239' ' ' ARG . 55.8 mt -75.67 -43.59 46.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.872 -1.058 . . . . 74.209999999999994 112.579 174.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.527 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 96.4 mt -83.21 -20.65 34.22 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.045 -0.525 . . . . 74.319999999999993 111.466 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.44 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 86.6 p -64.3 -27.77 69.26 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 108.599 -0.889 . . . . 73.140000000000001 108.599 167.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.5 m -90.41 16.63 8.46 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.516 1.127 . . . . 73.430000000000007 111.468 175.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.29 178.52 17.3 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.381 0.515 . . . . 72.439999999999998 112.688 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.3 pt -100.17 175.77 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.479 1.111 . . . . 74.439999999999998 112.241 -176.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -72.22 116.1 12.25 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.663 -0.698 . . . . 73.450000000000003 109.549 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.07 6.18 34.47 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.508 -0.769 . . . . 73.329999999999998 112.534 -167.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 66.1 m -85.26 135.36 33.96 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 117.979 0.889 . . . . 65.129999999999995 111.124 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.8 p90 -139.46 158.31 44.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.747 0.419 . . . . 74.129999999999995 110.661 -176.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.69 137.11 15.83 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.871 -0.788 . . . . 73.540000000000006 108.871 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.696 HG22 HG12 ' A' ' 182' ' ' ILE . 59.9 t -92.28 136.5 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.791 -1.189 . . . . 74.329999999999998 107.791 168.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.464 ' HD3' ' HB3' ' A' ' 156' ' ' ALA . 41.2 ptt85 -136.36 143.21 43.93 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.012 0.925 . . . . 63.399999999999999 108.643 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.89 117.11 30.4 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.764 -1.569 . . . . 74.340000000000003 106.764 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -53.44 120.58 6.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.197 0.999 . . . . 72.310000000000002 111.409 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.6 -29.3 69.88 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.684 0.754 . . . . 75.310000000000002 109.665 168.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -67.55 -32.61 73.5 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.678 -1.146 . . . . 73.329999999999998 111.446 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -148.09 94.77 4.24 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 123.929 0.892 . . . . 74.519999999999996 109.829 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.27 146.6 88.45 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.845 2.363 . . . . 75.439999999999998 111.899 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 32' ' ' SER . . . 83.15 -28.72 3.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.491 -0.616 . . . . 72.450000000000003 114.104 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -76.24 115.85 16.37 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 117.665 0.733 . . . . 73.010000000000005 110.078 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -113.93 140.5 48.34 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.006 0.922 . . . . 75.510000000000005 109.29 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.1 m -145.92 148.61 32.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.344 1.057 . . . . 71.420000000000002 108.977 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.696 HG12 HG22 ' A' ' 170' ' ' VAL . 14.2 mt -101.03 144.3 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.745 -1.576 . . . . 75.310000000000002 106.745 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -124.68 109.24 12.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.968 -1.493 . . . . 75.219999999999999 106.968 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.7 tp -106.59 113.96 27.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.038 0.535 . . . . 74.340000000000003 110.361 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.527 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 18.0 ttt180 -76.4 117.85 18.48 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.442 -0.947 . . . . 74.299999999999997 108.442 162.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -140.77 139.8 34.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 107.448 -1.315 . . . . 71.519999999999996 107.448 168.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 62.01 22.12 12.85 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.356 1.062 . . . . 74.129999999999995 112.472 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 1.91 89.66 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.331 -0.395 . . . . 75.129999999999995 113.369 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -111.96 140.12 46.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.152 0.981 . . . . 74.310000000000002 108.463 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.33 106.77 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-O 121.371 0.605 . . . . 70.219999999999999 110.657 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -90.86 145.69 24.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 73.510000000000005 108.805 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -125.02 117.92 25.07 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.083 0.468 . . . . 75.420000000000002 110.265 -173.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.574 ' HE1' HD23 ' A' ' 232' ' ' LEU . 3.0 m-85 -95.31 137.0 34.97 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.974 -1.121 . . . . 72.329999999999998 107.974 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -94.77 122.17 37.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.03 -1.1 . . . . 75.519999999999996 108.03 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 59.4 mt -84.65 101.99 9.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.583 -0.895 . . . . 75.340000000000003 108.583 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -76.18 139.52 41.27 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.856 -1.065 . . . . 71.010000000000005 109.094 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -118.39 117.3 28.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.639 0.776 . . . . 73.329999999999998 109.514 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.97 161.05 16.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.748 1.219 . . . . 75.530000000000001 110.464 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 70.0 p -64.41 -27.16 68.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.726 0.81 . . . . 71.420000000000002 112.258 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -83.84 -19.1 35.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.001 0.52 . . . . 73.340000000000003 111.032 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.48 14.3 10.72 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-O 119.014 -0.881 . . . . 64.319999999999993 115.004 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 34.7 mtmm -71.82 129.87 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.218 1.009 . . . . 71.430000000000007 111.09 173.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.93 142.85 26.91 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 71.230000000000004 108.294 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.532 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.9 p90 -169.76 137.73 1.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.097 0.873 . . . . 74.319999999999993 110.756 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -78.66 -46.02 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.435 -0.95 . . . . 75.549999999999997 108.435 164.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.1 m -98.56 124.58 43.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.437 -1.256 . . . . 74.030000000000001 108.764 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 31.4 t -65.97 -21.58 66.42 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.766 0.826 . . . . 65.340000000000003 112.051 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.13 -26.63 53.38 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.97 0.908 . . . . 74.409999999999997 110.163 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -125.42 98.41 5.6 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.798 0.839 . . . . 74.5 109.272 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.532 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 70.5 mtt180 -111.47 118.91 37.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.843 0.857 . . . . 74.219999999999999 110.179 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.87 147.84 34.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.703 0.801 . . . . 72.530000000000001 109.166 -169.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 7.9 m-80 -66.41 -38.88 88.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.265 0.626 . . . . 74.239999999999995 110.341 -175.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.8 p -124.32 154.57 40.1 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.652 0.781 . . . . 61.450000000000003 111.28 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.438 HD12 HD13 ' A' ' 141' ' ' LEU . 1.8 tt -65.21 -23.84 67.19 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.129 0.972 . . . . 63.530000000000001 109.377 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.57 80.36 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.789 0.836 . . . . 74.450000000000003 111.242 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.52 -30.74 64.75 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.378 -0.828 . . . . 72.329999999999998 111.551 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.21 -53.54 56.96 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 123.507 0.505 . . . . 75.120000000000005 110.744 171.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.77 -43.3 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.111 0.565 . . . . 75.239999999999995 110.475 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -55.15 -56.75 16.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.957 0.903 . . . . 75.430000000000007 111.248 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -65.58 -33.16 75.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.688 -1.142 . . . . 72.129999999999995 111.047 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.639 ' HB3' HD13 ' A' ' 228' ' ' LEU . 12.1 m170 -92.21 -10.58 38.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.015 0.526 . . . . 74.409999999999997 112.024 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 77.2 p -97.75 -11.68 23.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.279 0.632 . . . . 63.310000000000002 110.747 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 35.8 p -87.31 -52.07 5.6 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 122.399 0.28 . . . . 74.219999999999999 110.636 167.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.9 162.95 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 122.135 0.969 . . . . 65.319999999999993 113.204 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.84 11.76 17.01 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.616 1.966 . . . . 73.439999999999998 114.42 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -47.73 32.07 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 130.729 3.611 . . . . 75.430000000000007 120.065 -157.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.07 6.38 4.91 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.649 -1.282 . . . . 63.329999999999998 112.911 -167.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.639 HD13 ' HB3' ' A' ' 221' ' ' HIS . 14.9 mt -94.11 161.9 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.722 1.209 . . . . 74.010000000000005 109.067 161.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.4 tt -59.46 -40.09 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-O 120.736 0.303 . . . . 74.230000000000004 110.239 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -159.37 171.96 18.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.851 0.861 . . . . 72.200000000000003 109.904 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 34.0 m -68.73 138.38 54.84 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.144 0.978 . . . . 75.400000000000006 111.606 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.574 HD23 ' HE1' ' A' ' 193' ' ' TYR . 63.8 mt -71.9 131.41 42.94 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.199 0.999 . . . . 63.439999999999998 109.412 177.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -121.4 -77.98 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 118.65 0.659 . . . . 73.420000000000002 111.223 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.556 ' HH ' ' HD3' ' A' ' 237' ' ' PRO . 33.4 t80 -85.92 121.48 72.99 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 123.531 0.733 . . . . 73.329999999999998 109.366 -175.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.61 126.95 4.82 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.181 1.921 . . . . 72.329999999999998 111.519 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.73 145.7 98.97 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.813 0.845 . . . . 72.239999999999995 110.159 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.556 ' HD3' ' HH ' ' A' ' 234' ' ' TYR . 83.5 Cg_endo -81.44 167.17 17.48 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.524 2.15 . . . . 72.540000000000006 112.015 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 32.8 mmtp -69.45 150.12 47.56 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.442 0.697 . . . . 74.219999999999999 110.118 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.68 ' HB3' HD22 ' A' ' 159' ' ' LEU . 13.7 ptt180 -91.38 -64.18 1.16 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.249 0.833 . . . . 73.299999999999997 113.249 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.448 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 61.7 t30 -111.31 134.27 53.02 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.713 0.805 . . . . 73.040000000000006 109.743 -175.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -75.58 110.97 12.03 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 105.457 -2.053 . . . . 74.150000000000006 105.457 160.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.2 146.66 38.42 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.429 2.752 . . . . 74.430000000000007 115.732 -166.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.8 m -80.55 120.69 24.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.22 0.608 . . . . 75.299999999999997 110.78 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.41 108.01 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 108.023 -1.102 . . . . 73.549999999999997 108.023 170.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -108.33 111.75 23.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.192 0.597 . . . . 71.120000000000005 109.879 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 61.46 24.07 63.37 Favored Glycine 0 C--N 1.355 1.639 0 O-C-N 124.187 0.93 . . . . 70.420000000000002 114.871 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.4 116.99 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.328 0.651 . . . . 75.310000000000002 110.676 -174.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.9 t -87.99 120.44 70.74 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 105.829 -1.915 . . . . 72.439999999999998 105.829 151.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.28 -58.39 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.771 1.647 . . . . 75.329999999999998 114.793 -159.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -126.83 -12.58 5.93 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.458 0.703 . . . . 75.349999999999994 110.437 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -85.81 104.21 15.28 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.764 -0.653 . . . . 75.209999999999994 110.637 -156.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -120.88 -47.33 2.3 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.194 0.598 . . . . 73.010000000000005 110.262 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.71 -40.11 4.4 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.354 -0.61 . . . . 74.25 109.354 167.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -55.98 119.75 6.35 Favored 'General case' 0 C--N 1.361 1.074 0 O-C-N 124.691 1.244 . . . . 75.340000000000003 112.083 -164.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--O 1.251 1.138 0 N-CA-C 106.355 -1.72 . . . . 75.219999999999999 106.355 168.293 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.587 0.232 . . . . 73.120000000000005 110.762 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.48 -179.57 41.93 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.162 -0.375 . . . . 74.239999999999995 112.162 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -100.44 110.85 23.06 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.554 -0.536 . . . . 75.010000000000005 109.554 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -118.47 128.37 26.02 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.828 0.851 . . . . 73.019999999999996 109.117 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.97 104.38 1.84 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.404 2.069 . . . . 71.409999999999997 112.288 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.32 125.13 11.63 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 110.744 -0.942 . . . . 71.510000000000005 110.744 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -65.77 117.01 7.58 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.687 0.395 . . . . 75.200000000000003 110.913 -174.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 m -76.72 -173.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.003 0.921 . . . . 73.129999999999995 111.059 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.4 mt 73.55 161.73 0.25 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.806 1.242 . . . . 73.310000000000002 111.207 -176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.78 179.45 35.6 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.633 -0.712 . . . . 73.530000000000001 113.864 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -145.81 124.72 12.71 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.628 -1.249 . . . . 73.200000000000003 107.628 171.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -76.41 -53.33 8.3 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.94 0.896 . . . . 74.120000000000005 111.272 -172.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.63 86.21 6.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.967 -0.56 . . . . 73.140000000000001 110.744 -170.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -97.14 106.7 33.32 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.158 -0.928 . . . . 74.340000000000003 109.997 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.56 114.58 3.72 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.491 2.127 . . . . 72.439999999999998 110.817 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -71.05 88.97 0.79 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 107.827 -1.175 . . . . 74.430000000000007 107.827 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.07 147.78 93.89 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.17 0.988 . . . . 74.120000000000005 111.278 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.9 173.86 12.29 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.792 2.328 . . . . 73.140000000000001 111.62 175.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 64.65 19.0 11.68 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.38 1.072 . . . . 73.439999999999998 112.479 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.5 mt -86.48 96.57 10.09 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.962 -0.755 . . . . 74.510000000000005 108.962 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -140.75 108.62 5.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.396 -0.82 . . . . 73.010000000000005 108.87 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -133.06 101.0 5.05 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.621 -0.881 . . . . 74.030000000000001 108.621 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -66.24 97.72 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 109.139 -0.689 . . . . 74.319999999999993 109.139 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -143.98 -86.66 0.13 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.097 -0.501 . . . . 73.25 109.98 -173.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.47 98.43 0.04 OUTLIER Glycine 0 C--N 1.351 1.375 0 O-C-N 123.026 0.203 . . . . 72.340000000000003 113.467 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.02 -78.43 0.58 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.402 0.681 . . . . 64.200000000000003 109.34 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.97 -72.64 0.89 Allowed Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.368 -0.378 . . . . 73.109999999999999 112.696 -175.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.2 mttm 64.87 29.22 12.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.157 1.383 . . . . 74.239999999999995 112.819 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -109.82 178.08 4.52 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.068 0.947 . . . . 72.299999999999997 109.908 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -162.67 150.16 13.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.961 0.505 . . . . 75.219999999999999 110.491 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.2 t -119.06 146.88 44.7 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.618 0.767 . . . . 73.040000000000006 110.299 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 p -80.1 170.35 16.56 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.243 0.617 . . . . 63.32 110.227 170.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -114.68 -179.5 3.65 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.125 0.57 . . . . 75.239999999999995 109.815 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -133.12 137.18 46.21 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.319 0.648 . . . . 71.519999999999996 109.444 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.46 89.84 0.13 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 112.08 -0.408 . . . . 75.319999999999993 112.08 -174.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.16 123.42 6.32 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 119.403 -0.665 . . . . 70.129999999999995 112.689 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -72.05 -178.82 3.42 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.955 2.437 . . . . 72.209999999999994 113.076 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.0 t60 66.8 12.79 9.09 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.782 1.233 . . . . 75.25 112.371 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.6 m -146.82 15.33 1.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.439 0.695 . . . . 75.319999999999993 111.061 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -68.24 148.87 50.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.89 0.476 . . . . 62.340000000000003 110.196 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.05 138.43 53.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.402 0.681 . . . . 75.430000000000007 109.328 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -75.18 113.87 13.03 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.025 -0.731 . . . . 74.310000000000002 109.025 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.5 m -82.04 167.55 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.019 0.528 . . . . 73.540000000000006 109.812 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.14 151.91 38.4 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.77 0.828 . . . . 75.340000000000003 109.648 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -106.41 -40.17 5.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.788 0.835 . . . . 74.209999999999994 109.623 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 64.21 179.32 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.894 1.278 . . . . 74.400000000000006 112.157 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.02 115.41 8.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.368 0.667 . . . . 74.510000000000005 109.607 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.36 155.82 16.6 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.734 -0.839 . . . . 75.340000000000003 108.734 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -79.59 109.86 14.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.675 -0.491 . . . . 73.409999999999997 109.675 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.6 140.04 7.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 123.701 0.8 . . . . 75.129999999999995 109.227 170.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 117.61 5.2 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.383 2.055 . . . . 65.209999999999994 111.115 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.435 HG23 ' H ' ' A' ' 53' ' ' ALA . 9.6 p -73.13 176.91 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.298 0 C-N-CA 123.808 0.843 . . . . 71.340000000000003 109.262 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' H ' HG23 ' A' ' 52' ' ' VAL . . . -64.17 165.37 9.38 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 118.185 0.448 . . . . 74.120000000000005 111.265 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 p -52.76 -30.2 31.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.667 1.187 . . . . 74.109999999999999 113.876 -168.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.98 -50.68 0.26 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.448 0.699 . . . . 71.140000000000001 109.716 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -82.83 -176.84 6.51 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.973 -1.012 . . . . 72.349999999999994 111.122 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 146.1 57.6 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.683 0.793 . . . . 73.430000000000007 109.452 174.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.59 -75.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.715 2.276 . . . . 71.319999999999993 112.573 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -145.86 3.8 0.96 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.79 0.836 . . . . 73.019999999999996 111.135 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.42 -48.85 3.15 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.446 -0.662 . . . . 71.150000000000006 111.446 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.6 120.19 14.23 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.385 0.674 . . . . 75.439999999999998 109.911 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.2 p -164.88 40.11 0.07 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.171 0.988 . . . . 64.439999999999998 109.464 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -66.57 -34.72 78.53 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 114.617 -1.174 . . . . 74.120000000000005 111.025 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.22 -76.28 0.58 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.553 0.741 . . . . 73.010000000000005 109.649 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.62 -82.15 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.047 0.939 . . . . 61.049999999999997 108.543 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -88.84 -30.16 19.15 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.052 -0.722 . . . . 74.150000000000006 109.052 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -75.73 84.58 2.72 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.375 -0.83 . . . . 73.310000000000002 109.995 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -83.32 -31.52 26.78 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.627 -1.169 . . . . 74.340000000000003 109.805 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.6 p -69.58 3.48 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.153 0.981 . . . . 73.150000000000006 112.712 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.76 -25.04 67.09 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.419 0.688 . . . . 73.239999999999995 110.329 169.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.575 ' HG3' HD21 ' A' ' 72' ' ' ASN . 17.0 pt-20 -58.82 -36.81 75.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.588 0.755 . . . . 74.409999999999997 110.248 171.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.575 HD21 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -86.15 -7.04 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.945 1.298 . . . . 45.530000000000001 111.569 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.81 -49.42 70.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.246 0.618 . . . . 70.430000000000007 110.157 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.2 mt -112.84 18.45 18.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.384 0.674 . . . . 75.150000000000006 110.906 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.49 -46.68 21.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.906 0.482 . . . . 52.130000000000003 110.842 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.69 -135.35 12.8 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.19 -0.783 . . . . 52.020000000000003 111.746 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.56 -172.72 0.83 Allowed 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 123.799 2.999 . . . . 73.319999999999993 113.396 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 14.4 m -60.06 170.35 1.26 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.417 1.087 . . . . 73.219999999999999 112.466 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.75 -52.11 65.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.079 0.551 . . . . 54.340000000000003 112.39 -168.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -135.93 -38.4 0.71 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.198 0.523 . . . . 74.049999999999997 111.412 171.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 78' ' ' SER . 7.7 m-20 -90.02 143.65 30.2 Favored Pre-proline 0 N--CA 1.48 1.07 0 CA-C-N 115.607 -0.724 . . . . 75.140000000000001 112.105 -170.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.62 -35.79 27.78 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.977 2.451 . . . . 54.350000000000001 112.244 171.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -95.62 18.31 13.13 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.579 0.752 . . . . 75.239999999999995 112.205 -173.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 51.0 tp -82.34 120.15 25.04 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.93 -0.767 . . . . 75.299999999999997 108.93 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.91 174.22 5.98 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.758 1.223 . . . . 74.239999999999995 109.066 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.32 138.41 40.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.97 1.308 . . . . 74.400000000000006 108.66 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.49 116.84 18.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 75.239999999999995 109.968 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.41 HD13 ' HZ2' ' A' ' 238' ' ' LYS . 69.6 mt -79.4 -29.98 42.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.283 0.633 . . . . 74.519999999999996 110.864 175.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 87.4 m-85 -126.64 140.82 52.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.867 -1.06 . . . . 75.439999999999998 108.529 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -72.84 134.19 44.77 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.176 -1.046 . . . . 65.019999999999996 108.176 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.551 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.9 t80 -131.22 111.23 11.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.316 -0.994 . . . . 73.430000000000007 108.316 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.99 137.15 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.542 -1.281 . . . . 74.430000000000007 107.542 172.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.01 117.12 2.96 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.129 0.972 . . . . 75.340000000000003 112.497 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.8 p -88.5 4.99 44.67 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.918 0.887 . . . . 72.329999999999998 111.646 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.85 -175.39 33.84 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.245 -0.742 . . . . 72.209999999999994 111.245 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -79.39 -38.21 35.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.22 0.608 . . . . 72.099999999999994 110.508 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -83.25 -15.46 50.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.24 1.016 . . . . 71.439999999999998 111.458 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.7 p -77.24 177.24 8.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.967 0.507 . . . . 75.030000000000001 111.183 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 56.3 tp -134.31 132.22 39.3 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.814 0.446 . . . . 74.019999999999996 111.154 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 58.0 m -77.9 116.9 18.76 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.864 -0.607 . . . . 61.100000000000001 109.771 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 91' ' ' PHE . 15.2 pt -119.9 153.89 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.951 0.901 . . . . 75.219999999999999 110.137 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -106.9 145.87 31.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.106 0.562 . . . . 72.450000000000003 109.506 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -67.34 109.68 3.24 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 122.857 0.463 . . . . 75.019999999999996 110.156 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.18 -11.93 33.94 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 116.371 -0.377 . . . . 71.230000000000004 112.358 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -77.52 137.73 38.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.331 0.652 . . . . 73.319999999999993 110.443 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -84.55 145.23 28.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.816 0.847 . . . . 75.099999999999994 109.371 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.33 146.74 32.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.337 0.655 . . . . 71.439999999999998 110.301 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -92.49 109.65 21.05 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.112 -1.069 . . . . 73.239999999999995 108.112 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.56 HG13 ' HB3' ' A' ' 119' ' ' ALA . 74.8 t -85.21 122.92 38.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.979 -0.748 . . . . 74.120000000000005 108.979 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.403 HD12 HE21 ' A' ' 122' ' ' GLN . 17.3 mt -90.87 -21.91 21.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.814 1.246 . . . . 74.099999999999994 109.959 -174.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.92 152.69 6.39 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.639 -0.534 . . . . 62.030000000000001 112.668 174.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 47.1 m-85 -86.56 165.22 16.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.372 0.606 . . . . 74.549999999999997 110.81 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -86.91 -172.3 3.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.609 1.164 . . . . 73.409999999999997 111.077 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -58.61 -34.12 70.77 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.886 0.875 . . . . 72.409999999999997 112.53 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -102.5 -4.09 25.89 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.239 0.616 . . . . 74.450000000000003 111.741 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 63.49 26.84 70.02 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.59 -0.561 . . . . 71.540000000000006 114.44 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.19 -12.98 19.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.34 0.57 . . . . 72.329999999999998 111.49 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.429 ' CZ2' HG11 ' A' ' 244' ' ' VAL . 79.6 m95 -137.65 151.43 48.27 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.984 0.914 . . . . 74.430000000000007 109.967 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' A' ' 112' ' ' TYR . . . -135.35 140.22 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.581 0.752 . . . . 63.329999999999998 110.312 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.415 ' HG2' ' NE2' ' A' ' 127' ' ' GLN . 40.7 tt0 -77.19 99.87 5.59 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.684 -1.598 . . . . 72.319999999999993 106.684 169.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.98 161.7 24.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.275 0.63 . . . . 74.120000000000005 110.668 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.403 HE21 HD12 ' A' ' 110' ' ' LEU . 8.5 pt20 -132.11 123.64 27.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.25 0.548 . . . . 74.400000000000006 111.929 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.2 p -98.05 -176.95 3.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.958 1.303 . . . . 64.5 109.853 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 11.0 mptt -66.91 -22.27 65.96 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.762 -1.108 . . . . 71.420000000000002 109.514 172.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -75.96 -19.69 58.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.931 1.293 . . . . 74.310000000000002 110.9 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.62 -160.85 24.16 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.076 0.235 . . . . 64.120000000000005 112.873 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 128' ' ' GLY . 64.7 tp60 -98.59 158.34 15.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.917 0.887 . . . . 72.230000000000004 110.378 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 166.29 -163.42 36.86 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.234 -0.439 . . . . 63.149999999999999 112.416 169.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -102.76 131.64 49.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.906 0.882 . . . . 70.109999999999999 110.618 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 m -130.66 139.37 35.41 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.196 0.998 . . . . 73.340000000000003 108.947 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.94 141.32 16.67 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.522 2.148 . . . . 63.200000000000003 113.577 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.5 m -42.6 -44.74 4.34 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.614 1.566 . . . . 72.340000000000003 113.981 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.564 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 26.5 p-10 -78.25 6.09 8.95 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.895 0.878 . . . . 74.019999999999996 112.329 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.4 -14.29 12.2 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.3 1.04 . . . . 75.200000000000003 111.274 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.46 173.2 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.507 0.723 . . . . 75.310000000000002 112.034 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.8 t -161.56 153.33 16.1 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.602 1.161 . . . . 74.150000000000006 107.889 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.71 148.4 91.81 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.507 1.472 . . . . 74.510000000000005 111.634 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.2 t -73.46 -4.01 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 CA-C-O 121.711 0.767 . . . . 73.430000000000007 110.179 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -80.02 -19.99 46.41 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.697 0.799 . . . . 74.239999999999995 111.49 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.0 p -86.41 174.52 8.95 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.172 0.589 . . . . 64.129999999999995 112.129 -171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.59 -22.38 30.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.738 0.815 . . . . 64.299999999999997 111.516 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.47 -18.1 64.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.74 0.816 . . . . 75.349999999999994 111.611 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -60.74 -12.94 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.412 0.685 . . . . 73.010000000000005 112.744 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -95.44 158.18 15.57 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.029 0.931 . . . . 71.25 110.535 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.5 p -70.11 -42.79 72.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.588 0.755 . . . . 73.140000000000001 111.254 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.497 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 48.9 p-90 -61.98 -39.61 92.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.051 0.76 . . . . 75.409999999999997 113.051 -176.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -82.83 105.78 14.12 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.956 -0.387 . . . . 62.32 109.956 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -99.32 -3.55 33.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.292 0.637 . . . . 53.130000000000003 111.952 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.13 -148.86 33.45 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.754 -1.025 . . . . 73.409999999999997 113.102 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.34 106.76 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.792 2.328 . . . . 52.439999999999998 112.042 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.7 t -135.79 139.63 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.533 1.533 . . . . 72.439999999999998 109.152 -174.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.6 p -90.23 170.33 10.38 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 65.430000000000007 109.873 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.19 -29.81 70.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.795 0.27 . . . . 74.299999999999997 110.583 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -55.94 -53.84 51.98 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.275 0.63 . . . . 73.030000000000001 110.125 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' A' ' 151' ' ' VAL . . . -72.5 -27.88 62.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.844 -1.071 . . . . 75.510000000000005 111.725 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.41 61.97 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.111 0.564 . . . . 74.25 111.586 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -63.71 -38.17 90.09 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.731 . . . . 72.349999999999994 110.433 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.46 -45.81 92.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.903 -1.044 . . . . 74.340000000000003 110.753 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.67 -48.82 79.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.597 0.759 . . . . 75.400000000000006 111.772 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.17 11.18 24.15 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.709 1.003 . . . . 74.099999999999994 113.709 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.8 p -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.725 0.693 . . . . 54.409999999999997 109.991 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.1 p -94.0 10.1 34.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.57 0.748 . . . . 71.420000000000002 111.145 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -76.52 157.92 48.3 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.21 -0.45 . . . . 74.319999999999993 113.274 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.2 pt -100.74 176.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.878 0.871 . . . . 73.430000000000007 111.074 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.99 110.08 5.48 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.089 -0.708 . . . . 75.319999999999993 109.089 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.62 7.96 23.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.505 -0.608 . . . . 64.209999999999994 112.723 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.3 m -83.86 122.43 28.7 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.463 0.632 . . . . 73.340000000000003 111.014 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -129.53 164.82 22.95 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.475 0.579 . . . . 74.239999999999995 111.16 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.94 138.65 14.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.478 -0.934 . . . . 74.030000000000001 108.478 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 182' ' ' ILE . 72.5 t -98.27 138.8 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.136 -1.061 . . . . 72.239999999999995 108.136 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.565 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 2.1 ppt_? -146.7 162.38 38.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.881 0.873 . . . . 74.239999999999995 108.83 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -107.57 150.0 27.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.427 -1.323 . . . . 62.020000000000003 107.427 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t -68.33 125.1 25.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.454 -0.573 . . . . 63.310000000000002 109.454 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.25 -38.93 71.78 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.479 1.112 . . . . 73.219999999999999 111.154 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.3 m -102.88 5.92 38.81 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.605 0.762 . . . . 73.219999999999999 112.254 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.7 m -148.1 88.77 5.39 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 122.888 0.475 . . . . 61.509999999999998 110.532 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.55 134.47 35.67 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.69 2.26 . . . . 75.409999999999997 111.961 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.27 -28.54 13.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.934 -0.575 . . . . 72.109999999999999 112.378 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -88.91 116.98 27.58 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.844 -0.798 . . . . 75.400000000000006 108.844 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 77.5 mtt180 -119.16 159.35 24.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.284 0.564 . . . . 73.120000000000005 110.525 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.542 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 40.2 m -148.4 152.43 36.97 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.266 -0.879 . . . . 72.310000000000002 110.278 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.656 HG12 HG21 ' A' ' 170' ' ' VAL . 33.9 mt -104.18 150.48 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.373 -1.343 . . . . 72.450000000000003 107.373 170.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.0 m -122.94 108.18 12.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.186 -1.412 . . . . 64.549999999999997 107.186 170.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.95 110.49 22.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.319 -0.623 . . . . 73.25 109.319 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.503 ' HB2' HG23 ' A' ' 190' ' ' VAL . 35.6 ttt180 -78.3 115.68 18.19 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.982 -0.747 . . . . 75.319999999999993 108.982 166.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -140.34 138.25 34.74 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.552 1.158 . . . . 63.130000000000003 108.446 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 56.08 30.89 17.12 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.297 1.039 . . . . 72.409999999999997 112.033 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 75.96 12.95 83.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.87 -0.605 . . . . 74.510000000000005 114.264 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -122.0 136.56 54.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 73.530000000000001 109.391 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 185' ' ' ARG . 60.3 t -96.54 106.47 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 122.921 0.488 . . . . 75.120000000000005 110.252 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.02 136.48 33.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.593 1.157 . . . . 73.319999999999993 109.381 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -112.51 119.0 36.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.132 0.491 . . . . 64.420000000000002 110.231 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.524 ' HE1' HD22 ' A' ' 232' ' ' LEU . 10.6 m-30 -95.63 142.2 28.23 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.994 -1.003 . . . . 74.420000000000002 109.053 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 7.1 tpp180 -93.88 109.79 21.48 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.121 -0.696 . . . . 74.310000000000002 109.121 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 54.9 mt -85.7 101.95 10.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.079 -1.082 . . . . 71.439999999999998 108.079 170.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.06 116.46 19.37 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.051 -0.722 . . . . 75.400000000000006 109.051 170.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 m -87.66 112.92 22.85 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.786 -0.82 . . . . 73.439999999999998 108.786 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.487 ' HB1' ' HB2' ' A' ' 202' ' ' LYS . . . -67.13 157.65 33.13 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.232 0.613 . . . . 70.109999999999999 110.401 174.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.8 p -65.61 -20.93 66.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.005 0.922 . . . . 72.209999999999994 113.122 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.37 -14.96 39.25 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.1 0.56 . . . . 73.409999999999997 110.891 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.23 11.99 14.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.508 -0.607 . . . . 41.200000000000003 113.868 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.487 ' HB2' ' HB1' ' A' ' 198' ' ' ALA . 67.9 mttm -71.56 155.36 40.64 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.873 0.837 . . . . 74.439999999999998 110.563 171.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.43 143.41 49.25 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.011 -1.107 . . . . 64.420000000000002 108.011 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.589 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 52.9 p90 -162.83 133.79 4.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.403 0.44 . . . . 73.450000000000003 111.994 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 52.9 t -82.14 -36.32 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.466 -0.788 . . . . 72.010000000000005 109.432 168.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.481 ' HG ' ' HA3' ' A' ' 227' ' ' GLY . 16.0 m -105.47 124.64 49.89 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.006 -1.109 . . . . 75.040000000000006 108.006 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.2 m -62.25 -25.62 67.93 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 74.439999999999998 112.771 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -80.69 -31.32 36.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.876 . . . . 73.510000000000005 110.775 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 50.6 m -109.47 88.47 2.75 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.484 0.713 . . . . 71.310000000000002 109.933 -173.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.589 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 64.8 mtt180 -100.67 127.11 47.18 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.873 -0.788 . . . . 73.340000000000003 108.873 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.95 148.55 38.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.476 -0.935 . . . . 70.219999999999999 108.476 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -68.06 -37.45 81.32 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.555 0.534 . . . . 64.409999999999997 110.146 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 67.0 p -127.98 158.68 37.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.829 0.852 . . . . 74.109999999999999 112.031 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.9 -22.23 62.29 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.879 -1.055 . . . . 75.140000000000001 109.917 175.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.39 97.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.392 0.677 . . . . 74.150000000000006 110.348 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.28 -37.06 71.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.103 -0.953 . . . . 73.519999999999996 111.403 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.2 tp -55.04 -57.87 9.96 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.366 0.416 . . . . 64.099999999999994 110.963 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.46 -48.76 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.226 0.61 . . . . 71.239999999999995 110.976 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -57.84 -55.04 39.99 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.012 0.82 . . . . 74.329999999999998 111.071 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -65.13 -33.43 75.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.093 0.557 . . . . 63.229999999999997 111.576 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.691 ' HB3' HD13 ' A' ' 228' ' ' LEU . 14.0 m170 -89.76 -8.54 51.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.095 0.406 . . . . 73.140000000000001 112.095 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 84.5 p -93.59 -24.81 17.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.764 0.426 . . . . 43.420000000000002 110.209 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.9 p -81.31 -47.11 13.75 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.769 0.428 . . . . 73.400000000000006 110.856 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.582 HG23 ' HB2' ' A' ' 226' ' ' ASP . 23.5 m -128.17 164.37 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.043 0.925 . . . . 74.150000000000006 112.356 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.95 14.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 127.184 2.194 . . . . 72.319999999999993 114.125 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.582 ' HB2' HG23 ' A' ' 224' ' ' VAL . 35.4 t70 -45.41 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.356 1 C-N-CA 131.816 4.046 . . . . 74.040000000000006 119.614 -158.219 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.481 ' HA3' ' HG ' ' A' ' 206' ' ' SER . . . 124.52 -1.79 8.77 Favored Glycine 0 N--CA 1.486 1.977 0 O-C-N 120.808 -1.183 . . . . 71.340000000000003 112.48 -169.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 221' ' ' HIS . 11.7 mt -93.9 163.15 13.62 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.753 1.221 . . . . 74.109999999999999 110.016 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.7 tt -56.96 -40.45 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 120.824 0.345 . . . . 71.439999999999998 110.369 166.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -162.76 177.33 9.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.595 0.758 . . . . 72.409999999999997 110.69 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -66.15 136.24 55.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 73.310000000000002 111.686 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.524 HD22 ' HE1' ' A' ' 193' ' ' TYR . 49.2 mt -69.36 138.73 53.94 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 108.332 -0.988 . . . . 72.510000000000005 108.332 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -132.25 -77.63 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.962 1.255 . . . . 73.420000000000002 111.675 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 167' ' ' SER . 17.9 t80 -80.7 123.0 82.82 Favored Pre-proline 0 C--O 1.209 -1.049 0 CA-C-O 118.307 -0.854 . . . . 72.019999999999996 108.753 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 146' ' ' TRP . 8.3 Cg_endo -88.36 132.89 2.68 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.288 1.992 . . . . 72.430000000000007 111.609 171.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.77 131.94 93.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.484 0.714 . . . . 75.140000000000001 109.782 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.92 177.76 7.99 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.674 2.249 . . . . 71.439999999999998 113.116 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 32.7 mmtp -79.0 126.6 30.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.463 0.705 . . . . 73.430000000000007 109.349 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.487 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 15.3 ptt180 -93.14 -62.45 1.38 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.545 0.943 . . . . 75.120000000000005 113.545 -160.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.487 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 57.4 t30 -109.26 132.31 54.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.235 0.614 . . . . 73.340000000000003 111.09 -167.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -68.84 112.4 11.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 107.179 -1.415 . . . . 74.549999999999997 107.179 163.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.564 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 8.0 Cg_exo -74.61 124.59 8.93 Favored 'Trans proline' 0 C--N 1.364 1.395 0 C-N-CA 122.218 1.946 . . . . 74.030000000000001 112.098 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 87.7 m -64.96 123.27 19.0 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.318 0.647 . . . . 74.439999999999998 110.744 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.429 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 64.1 t -79.69 125.95 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 108.658 -0.868 . . . . 72.530000000000001 108.658 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -98.17 113.0 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 117.711 0.232 . . . . 64.230000000000004 111.096 -168.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 58.1 6.37 2.92 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 118.675 2.23 . . . . 75.340000000000003 118.675 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.419 HG23 ' HE1' ' A' ' 118' ' ' TRP . 17.1 m -106.53 123.07 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.943 1.371 . . . . 72.329999999999998 113.781 -170.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 t -82.89 122.94 78.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 106.326 -1.731 . . . . 73.409999999999997 106.326 157.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.7 -57.64 0.28 Allowed 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.423 1.415 . . . . 74.140000000000001 115.212 -157.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -126.78 -26.04 3.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.794 0.438 . . . . 72.219999999999999 110.803 164.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -69.03 99.43 1.09 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.767 0.794 . . . . 74.439999999999998 112.804 -142.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -123.81 -46.27 1.99 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 113.999 -1.455 . . . . 72.319999999999993 108.297 156.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -111.37 -43.14 3.74 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.786 -1.097 . . . . 73.409999999999997 113.372 -169.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -71.95 114.49 10.1 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.848 0.684 . . . . 65.230000000000004 112.848 -153.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.26 1.636 0 C-N-CA 125.359 1.464 . . . . 74.340000000000003 108.123 172.316 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.031 -0.359 . . . . 75.219999999999999 110.031 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.04 149.38 49.09 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 115.825 -0.625 . . . . 54.200000000000003 112.043 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -143.44 148.11 35.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.474 0.71 . . . . 63.409999999999997 110.081 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -100.19 110.11 58.69 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.772 -0.825 . . . . 73.219999999999999 108.772 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.37 111.59 2.97 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.801 2.334 . . . . 74.530000000000001 112.987 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.47 123.94 6.29 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 116.072 -0.513 . . . . 73.530000000000001 111.846 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.5 79.65 8.88 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.746 -0.835 . . . . 64.319999999999993 108.746 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m -83.32 177.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.772 0.829 . . . . 64.209999999999994 111.053 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.5 115.65 31.02 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.687 0.795 . . . . 72.409999999999997 109.024 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.44 84.77 0.95 Allowed Glycine 0 C--N 1.344 1.009 0 N-CA-C 110.273 -1.131 . . . . 75.099999999999994 110.273 170.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.85 152.91 25.99 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.519 0.728 . . . . 71.319999999999993 111.098 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -60.96 105.28 0.45 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.858 0.837 . . . . 73.5 110.574 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -108.29 162.55 13.98 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.553 1.141 . . . . 74.299999999999997 109.235 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -60.47 139.49 92.37 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.096 0.958 . . . . 75.439999999999998 111.068 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.59 -171.04 0.84 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.987 2.458 . . . . 74.530000000000001 112.886 -176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 t -146.43 -176.9 5.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.555 0.742 . . . . 74.140000000000001 109.723 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -69.59 116.67 45.47 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.548 0.739 . . . . 70.109999999999999 109.78 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.95 106.55 2.29 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.298 1.999 . . . . 74.010000000000005 110.7 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.04 136.81 32.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.133 0.573 . . . . 73.140000000000001 110.947 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -79.61 156.24 27.75 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.173 0.589 . . . . 73.140000000000001 110.342 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.48 171.14 14.87 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.444 0.698 . . . . 61.299999999999997 110.504 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -77.49 107.94 10.29 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.368 0.667 . . . . 75.120000000000005 109.485 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.493 ' HB ' ' ND2' ' A' ' 240' ' ' ASN . 7.0 pt -140.38 127.1 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.833 0.853 . . . . 72.299999999999997 109.501 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.09 153.09 19.6 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.804 0.842 . . . . 75.319999999999993 111.468 -171.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 178.68 -156.58 19.25 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 123.485 0.49 . . . . 54.240000000000002 112.184 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.1 176.86 8.79 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.147 0.979 . . . . 72.310000000000002 110.391 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.62 97.29 0.26 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.247 0.451 . . . . 71.150000000000006 112.297 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -62.49 -73.24 0.11 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.64 0.776 . . . . 73.239999999999995 110.523 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' HB3' HD22 ' A' ' 68' ' ' ASN . 60.8 mtm180 71.92 149.44 0.09 Allowed 'General case' 0 C--N 1.37 1.472 0 C-N-CA 125.348 1.459 . . . . 74.230000000000004 110.729 -174.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -82.56 18.34 1.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.868 1.433 . . . . 74.400000000000006 114.868 -165.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.7 t 69.39 145.23 0.05 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.582 1.153 . . . . 63.409999999999997 112.914 172.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 68' ' ' ASN . 28.6 t 178.61 175.88 0.55 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.531 1.533 . . . . 52.25 108.748 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.08 175.45 13.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.777 0.831 . . . . 72.239999999999995 109.719 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -155.19 -72.09 0.12 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 120.995 0.426 . . . . 74.439999999999998 110.695 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.37 135.67 2.35 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.003 -1.239 . . . . 61.240000000000002 110.003 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.11 137.33 5.22 Favored Glycine 0 C--N 1.358 1.753 0 CA-C-N 118.113 0.957 . . . . 70.109999999999999 113.158 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.04 -47.56 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.226 2.617 . . . . 73.129999999999995 114.028 -173.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -76.79 113.16 14.15 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 109.806 -0.442 . . . . 73.109999999999999 109.806 -176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.568 ' SG ' ' HG3' ' A' ' 51' ' ' PRO . 5.9 p -89.05 -178.37 5.67 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.049 0.939 . . . . 73.239999999999995 111.438 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.436 HD21 HG23 ' A' ' 41' ' ' VAL . 9.4 p-10 -153.69 -75.12 0.12 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.883 0.873 . . . . 75.030000000000001 109.911 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.436 HG23 HD21 ' A' ' 40' ' ' ASN . 8.5 m -149.12 159.19 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 124.98 1.312 . . . . 75.310000000000002 109.537 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 t80 80.53 157.62 0.15 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.316 1.447 . . . . 72.450000000000003 112.267 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.1 t 68.0 94.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.334 1.453 . . . . 70.439999999999998 110.344 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -66.34 119.41 11.52 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.584 1.153 . . . . 75.120000000000005 111.922 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.567 ' HB2' ' NE2' ' A' ' 59' ' ' GLN . 3.2 m170 -170.92 -165.37 0.42 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.887 1.675 . . . . 64.329999999999998 107.636 170.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -114.14 117.7 31.96 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.906 0.482 . . . . 70.200000000000003 109.874 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.78 133.06 0.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.362 1.465 . . . . 74.120000000000005 108.28 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -147.6 163.27 37.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.187 0.518 . . . . 65.340000000000003 110.571 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.62 -93.53 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.255 -1.758 . . . . 71.150000000000006 106.255 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -133.76 73.1 72.4 Favored Pre-proline 0 N--CA 1.477 0.912 0 N-CA-C 107.068 -1.456 . . . . 73.439999999999998 107.068 162.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.568 ' HG3' ' SG ' ' A' ' 39' ' ' CYS . 15.1 Cg_exo -70.24 -81.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.339 2.693 . . . . 74.420000000000002 112.457 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.7 m -143.6 -58.22 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.789 0.436 . . . . 72.349999999999994 112.057 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.38 91.79 2.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.692 0.797 . . . . 73.340000000000003 109.356 -170.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.0 m -62.56 -9.3 8.32 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.135 1.161 . . . . 73.239999999999995 114.135 -168.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -62.55 -52.45 63.38 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.974 0.51 . . . . 75.099999999999994 110.649 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -144.87 114.43 7.19 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.672 -0.862 . . . . 73.349999999999994 108.672 -176.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -118.11 120.59 32.25 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 109.254 -0.647 . . . . 74.129999999999995 109.254 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.59 59.44 7.25 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.836 2.357 . . . . 73.430000000000007 110.781 173.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.567 ' NE2' ' HB2' ' A' ' 45' ' ' HIS . 3.8 tt0 60.89 -83.1 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.8 1.64 . . . . 75.420000000000002 110.187 -167.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.27 23.94 3.99 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 115.103 0.801 . . . . 74.209999999999994 115.103 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.413 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . 1.0 OUTLIER -74.52 85.16 2.04 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.255 -1.017 . . . . 75.239999999999995 108.255 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -123.06 89.8 3.17 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.65 -0.87 . . . . 71.340000000000003 108.65 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.645 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 6.4 pt-20 -143.15 -22.4 0.62 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.923 -1.035 . . . . 74.540000000000006 110.841 174.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.8 66.75 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.04 0.448 . . . . 73.450000000000003 111.409 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.35 11.01 17.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.404 1.081 . . . . 73.209999999999994 111.211 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.645 ' HB2' ' HA ' ' A' ' 63' ' ' GLU . 58.3 mmt-85 -126.08 -60.25 1.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.88 0.872 . . . . 75.239999999999995 110.702 -174.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 6.7 t90 -119.97 81.38 1.73 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.969 0.908 . . . . 73.420000000000002 109.274 176.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 19.7 p-10 -76.84 -29.48 55.93 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 116.229 -0.441 . . . . 73.030000000000001 110.519 177.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -73.21 5.03 3.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.019 1.328 . . . . 74.129999999999995 113.095 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.53 -17.71 64.96 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.676 1.19 . . . . 73.140000000000001 112.922 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -26.84 19.51 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.255 0.622 . . . . 74.129999999999995 110.957 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.92 -5.63 55.94 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.62 0.768 . . . . 75.310000000000002 110.4 169.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.408 HD11 ' HE1' ' A' ' 146' ' ' TRP . 62.4 tp -60.72 -54.09 49.48 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.961 0.505 . . . . 73.019999999999996 109.869 174.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.02 84.3 1.9 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.98 -1.119 . . . . 71.109999999999999 107.98 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.53 -36.86 21.88 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.378 -0.828 . . . . 72.319999999999993 111.774 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.49 -153.13 43.9 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-O 118.874 -0.959 . . . . 71.519999999999996 112.599 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -83.92 112.79 1.8 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 CA-C-N 119.937 1.869 . . . . 74.439999999999998 110.154 165.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.433 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 33.5 t -127.55 177.18 6.94 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.034 0.933 . . . . 73.040000000000006 110.988 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -75.4 3.39 9.24 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 124.527 1.131 . . . . 70.349999999999994 110.87 173.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' A' ' 78' ' ' SER . 32.4 p-10 -82.67 31.34 0.42 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.058 1.343 . . . . 73.430000000000007 112.111 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.28 148.44 0.84 Allowed Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 126.298 1.839 . . . . 75.329999999999998 112.673 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.58 0.12 4.53 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.444 2.762 . . . . 73.319999999999993 115.813 -162.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.58 -24.24 45.63 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.447 0.642 . . . . 74.010000000000005 110.073 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 106' ' ' LYS . 38.5 tp -88.46 121.37 30.77 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 114.636 -1.165 . . . . 72.409999999999997 108.084 171.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.56 173.19 6.42 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.5 1.12 . . . . 72.230000000000004 108.704 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -131.18 135.81 58.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 124.424 1.089 . . . . 65.510000000000005 108.109 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.69 107.06 6.55 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.062 0.945 . . . . 73.25 109.405 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 143' ' ' LYS . 79.0 mt -69.29 -23.92 63.89 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.475 0.71 . . . . 74.209999999999994 111.528 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 77.0 m-85 -135.77 155.67 50.0 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 75.140000000000001 109.954 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.434 ' HB2' ' HE2' ' A' ' 241' ' ' LYS . 10.9 m-20 -70.87 156.09 40.0 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.908 -0.775 . . . . 73.420000000000002 108.908 167.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.578 ' HB3' HG12 ' A' ' 101' ' ' ILE . 71.1 t80 -149.3 124.32 10.03 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.133 -1.432 . . . . 72.319999999999993 107.133 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.4 135.34 27.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.789 -1.56 . . . . 62.409999999999997 106.789 169.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.48 117.46 3.11 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.964 0.79 . . . . 71.219999999999999 111.475 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.2 p -88.03 15.14 7.72 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.159 0.984 . . . . 64.239999999999995 110.991 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.47 179.54 46.06 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.912 -0.875 . . . . 74.319999999999993 110.912 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.09 -24.97 58.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.215 0.606 . . . . 72.319999999999993 111.444 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.609 HD21 ' HB3' ' A' ' 251' ' ' TYR . 43.6 p-10 -89.06 -17.56 29.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.724 0.809 . . . . 74.150000000000006 111.561 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.7 p -88.97 158.96 17.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.187 0.595 . . . . 75.040000000000006 110.508 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -121.63 134.15 54.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.215 0.606 . . . . 72.030000000000001 110.98 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.8 m -79.94 132.6 36.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.628 0.771 . . . . 71.450000000000003 110.512 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.679 HG23 HG23 ' A' ' 123' ' ' THR . 6.7 pt -129.22 154.49 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.617 0.767 . . . . 74.450000000000003 111.098 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.5 m -102.93 145.87 29.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.726 1.21 . . . . 51.420000000000002 109.922 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HE3' ' O ' ' A' ' 88' ' ' LEU . 42.3 tttt -70.63 108.15 4.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.252 0.621 . . . . 73.329999999999998 109.75 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.95 29.24 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-N 115.832 -0.622 . . . . 64.219999999999999 112.559 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 54.0 tt0 -74.2 144.99 44.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.787 0.835 . . . . 74.219999999999999 111.314 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HB3' HD13 ' A' ' 84' ' ' LEU . 43.0 mmtm -92.74 129.61 38.61 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.36 0.664 . . . . 64.430000000000007 109.843 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.578 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.3 OUTLIER -132.18 136.13 46.84 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.835 0.854 . . . . 75.129999999999995 109.505 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -95.15 109.66 21.72 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.902 -0.777 . . . . 74.120000000000005 108.902 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.512 HG12 ' HB1' ' A' ' 119' ' ' ALA . 42.5 t -77.22 134.35 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 123.644 0.59 . . . . 72.439999999999998 110.278 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.4 mt -102.75 -31.21 10.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.943 1.297 . . . . 74.530000000000001 109.906 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.32 142.94 3.93 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.5 -0.611 . . . . 75.409999999999997 113.331 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.545 ' CD2' ' HB3' ' A' ' 119' ' ' ALA . 33.6 m-85 -86.92 167.34 14.38 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.944 0.898 . . . . 63.420000000000002 110.857 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -88.49 -178.79 5.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.839 . . . . 71.530000000000001 110.565 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -55.42 -34.58 64.54 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.949 1.3 . . . . 75.239999999999995 113.625 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -111.38 9.29 21.5 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.071 0.548 . . . . 74.120000000000005 112.051 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.62 33.11 86.37 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 115.134 0.813 . . . . 63.200000000000003 115.134 172.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.65 -38.68 12.3 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.088 0.444 . . . . 73.549999999999997 111.924 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 66.9 m95 -129.9 147.37 51.65 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.44 0.696 . . . . 75.200000000000003 111.174 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.545 ' HB3' ' CD2' ' A' ' 112' ' ' TYR . . . -128.58 150.82 50.04 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.027 1.331 . . . . 73.299999999999997 109.3 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -87.21 115.76 24.83 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.952 -1.129 . . . . 64.299999999999997 107.952 166.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.51 168.68 10.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.432 0.693 . . . . 72.129999999999995 110.918 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -120.95 110.84 16.77 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.647 0.779 . . . . 74.239999999999995 110.364 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.679 HG23 HG23 ' A' ' 101' ' ' ILE . 82.7 p -100.63 177.58 4.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.347 1.059 . . . . 75.219999999999999 109.933 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.01 -18.3 64.02 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 110.753 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.79 -24.69 55.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.163 0.985 . . . . 73.430000000000007 111.035 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.34 -146.9 17.63 Favored Glycine 0 C--N 1.363 2.055 0 CA-C-N 117.706 0.23 . . . . 72.409999999999997 112.906 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -130.59 139.82 50.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.498 0.719 . . . . 71.109999999999999 109.946 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.21 -174.03 41.05 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.257 -0.737 . . . . 74.540000000000006 111.257 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -87.83 121.81 30.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.344 0.658 . . . . 71.340000000000003 112.41 -170.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.509 HG22 HD11 ' A' ' 135' ' ' ILE . 5.2 m -122.7 142.72 38.33 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.13 1.372 . . . . 75.239999999999995 108.726 173.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 10.6 Cg_endo -88.48 146.91 6.15 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 C-N-CA 122.241 1.961 . . . . 75.230000000000004 114.767 -172.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.4 m -41.35 -44.3 2.73 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.512 1.925 . . . . 75.200000000000003 114.551 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.573 HD21 ' HB2' ' A' ' 242' ' ' PRO . 22.4 p-10 -73.28 -4.16 31.41 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.012 0.525 . . . . 72.340000000000003 112.192 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.46 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 9.7 m-85 -106.44 -22.57 12.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.787 0.835 . . . . 74.349999999999994 111.475 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 130' ' ' VAL . 27.6 pt -123.28 164.65 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.325 0.65 . . . . 75.450000000000003 112.442 -172.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.2 t -160.41 149.55 13.91 Favored Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.126 -0.94 . . . . 74.150000000000006 109.166 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.12 145.98 40.5 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.517 2.145 . . . . 73.310000000000002 112.377 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 t -75.68 -3.73 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.576 0.703 . . . . 63.200000000000003 111.149 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.84 -2.78 43.34 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.601 -0.687 . . . . 63.43 112.297 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.8 p -78.25 171.58 14.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.2 0.524 . . . . 75.340000000000003 111.828 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.38 -27.71 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.882 -0.599 . . . . 74.239999999999995 109.66 165.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.6 -16.21 64.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.311 1.044 . . . . 73.129999999999995 112.139 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.507 ' HA ' HD21 ' A' ' 88' ' ' LEU . 16.7 pttm -69.49 -31.71 70.15 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.815 0.446 . . . . 75.120000000000005 111.742 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.01 133.8 51.57 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.721 0.809 . . . . 74.430000000000007 110.23 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.0 p -55.59 -32.55 63.16 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 74.420000000000002 112.702 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.408 ' HE1' HD11 ' A' ' 73' ' ' LEU . 25.7 p-90 -81.13 -32.42 33.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.222 0.609 . . . . 73.310000000000002 112.59 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -84.24 107.6 16.64 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.3 -0.63 . . . . 73.310000000000002 109.3 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.77 -5.57 24.73 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.494 0.717 . . . . 71.239999999999995 111.51 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.24 -130.62 21.72 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 118.065 -1.408 . . . . 75.430000000000007 112.941 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.623 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 32.2 Cg_exo -58.63 86.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.821 3.014 . . . . 74.230000000000004 113.603 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.97 132.48 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.285 1.034 . . . . 74.349999999999994 109.681 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.0 p -87.68 175.07 8.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.755 1.222 . . . . 72.420000000000002 110.193 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -61.85 -44.94 95.83 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.483 0.313 . . . . 74.5 110.508 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.23 -48.46 80.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.978 0.911 . . . . 74.140000000000001 110.295 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.3 77.95 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.853 -1.067 . . . . 72.340000000000003 111.419 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.95 -52.47 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.278 0.631 . . . . 73.420000000000002 111.935 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.512 ' HG2' HG13 ' A' ' 190' ' ' VAL . 43.2 mt-10 -68.8 -25.89 64.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.646 0.779 . . . . 75.310000000000002 110.677 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.23 -43.68 90.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.884 0.874 . . . . 70.120000000000005 111.373 170.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.3 mt -65.0 -34.6 78.83 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.285 0.564 . . . . 75.400000000000006 110.532 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 90.0 mt -89.72 2.23 55.08 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.324 -0.853 . . . . 74.540000000000006 112.807 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -61.98 -34.42 76.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.841 0.746 . . . . 71.349999999999994 111.471 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.6 p -101.73 11.08 39.4 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.631 0.772 . . . . 72.420000000000002 111.065 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.04 153.98 40.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.183 -0.462 . . . . 73.510000000000005 113.094 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.59 -176.89 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 124.259 1.024 . . . . 75.209999999999994 111.599 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 108.14 1.66 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.574 -0.739 . . . . 65.430000000000007 110.403 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 105.54 12.32 26.91 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.475 -0.625 . . . . 75.209999999999994 112.429 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' A' ' 185' ' ' ARG . 74.2 m -71.21 144.85 49.98 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 117.519 0.659 . . . . 72.140000000000001 111.209 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.2 p90 -157.52 164.35 37.45 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 122.799 0.44 . . . . 74.439999999999998 110.423 -174.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.07 146.4 12.44 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.647 -0.871 . . . . 72.230000000000004 108.647 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.631 HG22 HG12 ' A' ' 182' ' ' ILE . 91.4 t -96.62 126.67 49.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 108.889 -0.782 . . . . 62.420000000000002 108.889 167.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -116.08 143.4 45.52 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.959 1.303 . . . . 73.120000000000005 107.883 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.76 149.29 38.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.755 0.822 . . . . 75.5 108.922 171.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 t -83.76 125.47 31.95 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.242 -0.651 . . . . 74.140000000000001 109.242 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 150' ' ' PRO . 18.4 tp10 -77.71 -34.31 52.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.195 0.598 . . . . 73.010000000000005 109.392 172.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.0 p -75.22 -16.36 60.48 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.549 0.74 . . . . 74.450000000000003 111.186 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -147.37 79.16 9.84 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 123.768 0.827 . . . . 74.409999999999997 109.185 172.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.65 133.57 55.11 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.169 2.579 . . . . 72.209999999999994 112.406 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.73 -29.59 10.66 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.885 -0.598 . . . . 73.349999999999994 111.92 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -73.64 115.02 12.56 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 108.632 -0.877 . . . . 71.140000000000001 108.632 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.423 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.7 mtt85 -128.47 146.17 50.89 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.725 0.81 . . . . 73.340000000000003 109.098 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.9 m -140.51 148.84 41.69 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.385 1.074 . . . . 72.439999999999998 109.009 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.631 HG12 HG22 ' A' ' 170' ' ' VAL . 34.4 mt -101.51 148.44 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 106.734 -1.58 . . . . 75.5 106.734 168.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 24.6 m -123.46 109.35 13.73 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.203 -1.406 . . . . 74.510000000000005 107.203 171.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.445 HD11 HD21 ' A' ' 232' ' ' LEU . 20.5 tp -103.59 112.39 25.29 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.808 0.731 . . . . 74.040000000000006 109.614 177.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 23.8 ttt180 -80.47 111.17 16.62 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.471 0.653 . . . . 74.209999999999994 109.482 165.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -137.25 134.71 36.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.214 -1.357 . . . . 74.430000000000007 107.433 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 61.91 22.48 13.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.538 1.135 . . . . 74.329999999999998 111.547 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.34 85.94 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.938 -0.573 . . . . 65.129999999999995 113.006 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -105.01 130.77 53.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.132 0.973 . . . . 74.25 108.798 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.512 HG13 ' HG2' ' A' ' 157' ' ' GLU . 58.7 t -96.46 115.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.897 -0.409 . . . . 74.310000000000002 109.897 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -100.08 148.82 24.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.953 1.301 . . . . 72.219999999999999 107.747 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -119.63 116.41 25.95 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.377 0.535 . . . . 73.519999999999996 110.608 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.412 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 8.6 m-30 -93.89 149.48 21.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.434 1.094 . . . . 75.129999999999995 108.216 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -106.29 114.05 27.94 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.896 -0.409 . . . . 72.200000000000003 109.896 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 48.2 mt -87.42 102.75 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.315 -0.994 . . . . 75.510000000000005 108.315 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -87.17 132.52 33.84 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.101 -0.954 . . . . 63.299999999999997 108.72 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.6 m -100.76 106.77 18.21 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.979 -1.119 . . . . 75.299999999999997 107.979 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.07 159.56 3.29 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.686 0.794 . . . . 64.409999999999997 110.525 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.5 p -63.3 -22.31 66.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.063 0.945 . . . . 64.109999999999999 113.236 -172.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -93.79 -0.62 55.78 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.692 0.797 . . . . 75.349999999999994 111.44 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 100.17 14.05 34.55 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.601 -0.555 . . . . 74.219999999999999 114.068 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -88.15 127.03 35.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 117.852 0.826 . . . . 73.340000000000003 111.426 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -87.03 146.18 26.2 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.339 1.056 . . . . 74.109999999999999 108.545 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 39.7 p90 -165.43 140.41 5.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.374 0.421 . . . . 74.400000000000006 110.648 173.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.449 HG22 HD12 ' A' ' 217' ' ' LEU . 76.1 t -85.18 -43.04 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.229 -1.026 . . . . 74.299999999999997 108.229 163.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.2 m -104.79 129.95 52.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.526 -1.216 . . . . 73.329999999999998 109.099 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.5 t -67.66 -14.65 63.12 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.07 0.948 . . . . 64.129999999999995 112.693 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.44 -17.0 59.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.695 1.198 . . . . 55.030000000000001 111.729 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.2 m -149.57 112.17 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.902 0.481 . . . . 70.319999999999993 110.638 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 98.4 mtt180 -102.97 124.17 47.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.06 0.944 . . . . 75.510000000000005 109.021 175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -106.87 145.95 31.56 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.071 0.948 . . . . 75.25 109.284 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.49 -39.77 88.9 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.733 0.645 . . . . 75.540000000000006 110.159 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 69.2 p -126.49 151.62 47.57 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.985 -1.007 . . . . 74.040000000000006 111.482 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 195' ' ' ILE . 0.7 OUTLIER -62.94 -24.63 67.96 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.333 -1.303 . . . . 75.25 109.842 172.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.34 86.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.215 1.006 . . . . 61.520000000000003 111.602 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.37 -35.86 71.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.363 0.665 . . . . 74.120000000000005 111.274 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.449 HD12 HG22 ' A' ' 205' ' ' VAL . 12.4 tp -55.15 -56.18 22.8 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.635 0.584 . . . . 73.25 110.762 174.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.6 -39.44 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.81 -0.632 . . . . 72.310000000000002 111.041 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -61.26 -53.12 60.89 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.287 0.367 . . . . 71.299999999999997 110.661 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -62.03 -38.6 89.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.413 -0.812 . . . . 75.430000000000007 110.643 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.671 ' HB3' HD13 ' A' ' 228' ' ' LEU . 12.0 m170 -88.17 -5.18 58.56 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.112 -0.494 . . . . 74.099999999999994 112.258 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.7 p -95.31 -24.28 16.82 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.819 0.448 . . . . 72.010000000000005 110.837 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.7 p -81.74 -38.86 25.04 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 122.749 0.42 . . . . 72.219999999999999 111.274 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.589 HG21 ' HB2' ' A' ' 226' ' ' ASP . 27.4 m -135.52 162.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.984 0.897 . . . . 72.510000000000005 112.142 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.69 15.07 1.11 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.71 2.004 . . . . 72.120000000000005 114.231 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.589 ' HB2' HG21 ' A' ' 224' ' ' VAL . 33.7 t70 -43.36 33.65 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 131.634 3.974 . . . . 64.010000000000005 119.145 -156.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.55 -5.35 9.28 Favored Glycine 0 N--CA 1.478 1.459 0 O-C-N 120.738 -1.226 . . . . 70.010000000000005 112.846 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 221' ' ' HIS . 10.6 mt -91.3 162.23 14.7 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.121 1.368 . . . . 75.400000000000006 109.785 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -61.25 -36.07 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-O 120.843 0.354 . . . . 75.519999999999996 110.075 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -162.33 175.42 11.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.953 0.901 . . . . 62.409999999999997 109.427 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.6 p -61.88 148.42 43.49 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.454 1.102 . . . . 75.230000000000004 112.202 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.445 HD21 HD11 ' A' ' 184' ' ' LEU . 52.7 mt -75.13 145.93 41.78 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.873 0.869 . . . . 73.430000000000007 108.689 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -137.35 -72.29 0.43 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.799 0.727 . . . . 75.010000000000005 111.949 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 62.2 t80 -95.26 122.85 58.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.401 0.68 . . . . 73.340000000000003 109.775 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 71.1 Cg_endo -82.1 139.33 10.63 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.538 2.159 . . . . 62.439999999999998 111.058 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.19 141.79 95.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.061 0.545 . . . . 65.109999999999999 110.426 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.456 ' HD3' ' HH ' ' A' ' 234' ' ' TYR . 90.4 Cg_endo -79.49 136.37 12.38 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.339 2.026 . . . . 75.239999999999995 111.852 -177.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.24 102.73 2.18 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.563 -1.273 . . . . 73.340000000000003 107.563 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.604 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 17.7 ptt180 -73.38 -66.93 0.63 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 115.182 1.549 . . . . 71.049999999999997 115.182 -154.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.604 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 25.2 t-20 -113.75 150.14 33.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.039 0.536 . . . . 74.140000000000001 110.495 -172.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 90' ' ' ASP . 85.5 mttt -70.12 115.71 36.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.098 -1.075 . . . . 71.430000000000007 108.098 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 133' ' ' ASN . 23.6 Cg_exo -63.78 137.58 59.19 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.643 2.228 . . . . 73.319999999999993 111.933 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 25.5 m -68.81 122.29 18.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.151 0.58 . . . . 62.5 111.547 -172.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.417 HG13 ' CZ2' ' A' ' 118' ' ' TRP . 58.0 t -92.34 128.27 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.594 -1.261 . . . . 74.200000000000003 107.594 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -104.01 112.48 25.48 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.214 0.461 . . . . 74.430000000000007 111.159 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.71 8.28 3.99 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 118.366 2.106 . . . . 74.0 118.366 159.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.66 129.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 119.256 1.528 . . . . 65.530000000000001 111.865 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 t -73.5 121.67 85.72 Favored Pre-proline 0 C--N 1.355 0.818 0 N-CA-C 106.431 -1.692 . . . . 74.25 106.431 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HD2' HD22 ' A' ' 97' ' ' ASN . 82.0 Cg_exo -46.09 -63.07 0.36 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.791 2.327 . . . . 73.310000000000002 116.452 -153.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -130.92 -22.06 2.64 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.904 1.282 . . . . 73.400000000000006 108.122 139.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.609 ' HB3' HD21 ' A' ' 97' ' ' ASN . 17.5 t80 -81.87 101.8 10.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.08 -1.418 . . . . 74.310000000000002 109.69 -153.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -119.84 -45.87 2.47 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.174 0.989 . . . . 72.319999999999993 109.382 169.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -114.69 -26.4 7.87 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.389 1.475 . . . . 73.349999999999994 112.088 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -60.6 150.15 32.68 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.715 0.634 . . . . 73.019999999999996 111.269 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.005 0.922 . . . . 74.540000000000006 108.676 -177.1 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 tpt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 108.855 -0.794 . . . . 72.319999999999993 108.855 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.51 -32.36 3.22 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.356 -0.384 . . . . 63.409999999999997 112.742 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -82.06 74.28 9.05 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.643 0.735 . . . . 71.420000000000002 110.883 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -86.79 141.35 33.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 115.045 -0.98 . . . . 70.120000000000005 109.817 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.58 157.42 56.04 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.272 1.981 . . . . 64.239999999999995 111.879 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.54 126.42 27.54 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 112.526 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -91.05 -70.24 0.69 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.294 0.638 . . . . 72.209999999999994 110.907 -176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 m -143.5 147.47 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.196 0.598 . . . . 74.230000000000004 111.444 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.79 162.25 14.36 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.723 1.209 . . . . 74.150000000000006 108.131 171.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.64 -77.33 0.02 OUTLIER Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.12 -0.792 . . . . 45.009999999999998 111.12 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -174.84 132.27 0.33 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.562 1.145 . . . . 63.420000000000002 108.975 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.554 HE21 ' HG3' ' A' ' 255' ' ' GLU . 71.5 mm-40 -135.71 166.66 22.75 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.575 0.75 . . . . 72.420000000000002 111.81 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -68.47 141.83 55.5 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 114.577 -1.192 . . . . 74.340000000000003 110.034 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -104.82 129.84 24.2 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.483 0.713 . . . . 74.510000000000005 110.177 -166.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.91 162.97 36.41 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.682 2.255 . . . . 72.239999999999995 112.214 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.2 t -71.89 160.82 31.9 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.741 -0.663 . . . . 73.409999999999997 109.773 175.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.7 mt -93.21 142.9 25.9 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.956 -0.757 . . . . 73.219999999999999 108.956 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -72.36 156.84 54.26 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.512 2.141 . . . . 71.519999999999996 112.064 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.8 160.52 32.04 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.267 0.627 . . . . 73.129999999999995 111.2 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.55 -174.55 4.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.703 0.801 . . . . 75.200000000000003 109.449 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -125.44 158.23 34.92 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.101 0.56 . . . . 75.120000000000005 110.283 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -79.46 179.88 7.2 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.581 -0.736 . . . . 74.010000000000005 110.931 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.467 HD13 HD13 ' A' ' 203' ' ' LEU . 4.1 pt -124.18 152.43 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.511 1.124 . . . . 73.439999999999998 109.401 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -153.08 138.76 17.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.615 0.766 . . . . 75.209999999999994 109.497 -178.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 196' ' ' ASN . . . -128.39 167.41 20.6 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 123.452 0.47 . . . . 74.120000000000005 114.201 -174.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.71 -179.29 8.02 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.369 1.068 . . . . 65.099999999999994 110.073 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.92 157.84 53.48 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.284 0.365 . . . . 73.540000000000006 113.454 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -131.95 146.29 52.01 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.314 0.646 . . . . 74.129999999999995 111.343 -176.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.64 121.11 0.14 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.149 1.38 . . . . 75.310000000000002 108.509 168.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -172.1 132.55 0.67 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.689 0.796 . . . . 71.519999999999996 109.717 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.4 t -128.77 68.83 1.38 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.019 0.928 . . . . 72.200000000000003 109.026 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.513 ' HB2' HH22 ' A' ' 153' ' ' ARG . 23.2 t -76.71 173.08 12.05 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.053 -0.976 . . . . 74.439999999999998 109.613 175.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.703 ' HA ' ' HA ' ' A' ' 189' ' ' ARG . 0.0 OUTLIER -156.99 134.81 10.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.146 0.578 . . . . 75.030000000000001 110.137 -177.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -152.54 -170.3 3.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.246 1.418 . . . . 74.200000000000003 109.012 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.1 -168.19 25.76 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 121.68 -0.295 . . . . 71.349999999999994 113.122 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 127.73 -173.12 18.82 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.198 -0.779 . . . . 72.209999999999994 111.78 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -83.53 -161.17 0.14 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.4 2.734 . . . . 75.030000000000001 113.321 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -160.66 179.83 8.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.478 1.111 . . . . 75.310000000000002 110.899 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.6 m -153.47 130.55 11.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.281 1.032 . . . . 74.129999999999995 109.011 172.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -148.61 100.57 3.13 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.118 0.567 . . . . 74.120000000000005 110.221 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.0 t -142.73 136.61 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.663 1.185 . . . . 73.340000000000003 108.041 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -161.29 -128.9 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 108.436 -0.95 . . . . 74.099999999999994 108.436 171.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.633 HG11 ' HG3' ' A' ' 44' ' ' GLU . 48.2 t -145.03 134.48 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.289 1.036 . . . . 74.439999999999998 108.987 -169.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.654 ' H ' ' HB3' ' A' ' 59' ' ' GLN . 45.0 mt-10 79.01 92.39 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.309 1.843 . . . . 72.109999999999999 112.118 174.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.401 ' ND1' ' HG2' ' A' ' 46' ' ' GLU . 18.7 t-80 -158.07 -82.26 0.06 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.368 0.667 . . . . 72.349999999999994 109.235 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.678 ' HG3' ' HB2' ' A' ' 48' ' ' LEU . 14.5 pt-20 -176.21 18.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.437 1.095 . . . . 74.340000000000003 110.375 -177.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.686 ' HA ' ' HA3' ' A' ' 60' ' ' GLY . . . 59.08 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.577 1.151 . . . . 72.109999999999999 110.703 -164.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.678 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 48.0 tp 74.5 -71.99 0.12 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.271 1.428 . . . . 70.209999999999994 112.568 170.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 50' ' ' ARG . 9.7 tt0 -146.26 158.81 43.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.759 0.823 . . . . 75.200000000000003 109.754 -169.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 50' ' ' ARG . 4.7 mmp_? 81.63 147.47 0.1 Allowed Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 125.806 1.643 . . . . 75.400000000000006 112.979 171.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -48.16 102.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.398 3.17 0 C-N-CA 124.589 3.526 . . . . 74.530000000000001 114.203 -170.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.564 ' HB ' ' HB2' ' A' ' 57' ' ' GLU . 34.0 m -81.55 177.38 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.716 -1.129 . . . . 72.049999999999997 109.307 167.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -79.45 177.56 8.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.519 0.328 . . . . 72.409999999999997 111.44 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.5 p -62.15 -62.87 1.47 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.13 0.972 . . . . 64.030000000000001 112.211 -170.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.98 -72.05 0.71 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.25 -0.648 . . . . 72.450000000000003 109.25 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -76.85 86.02 3.42 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 108.809 -0.811 . . . . 75.530000000000001 108.809 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.624 ' HA ' ' HB3' ' A' ' 53' ' ' ALA . 12.5 pt-20 -66.38 148.89 98.39 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 114.988 -1.006 . . . . 75.099999999999994 110.174 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.14 -64.9 0.13 Allowed 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 122.319 2.012 . . . . 73.430000000000007 111.198 -173.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.654 ' HB3' ' H ' ' A' ' 44' ' ' GLU . 5.0 tp-100 176.13 -22.94 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.887 1.275 . . . . 75.349999999999994 108.713 176.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . 130.02 -101.29 0.51 Allowed Glycine 0 C--N 1.362 1.986 0 CA-C-N 116.222 -0.445 . . . . 54.140000000000001 112.75 165.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.8 mt -103.13 176.07 5.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.012 0.925 . . . . 72.319999999999993 109.131 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.1 p -76.99 -175.15 3.42 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.84 -0.43 . . . . 70.430000000000007 109.84 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.32 -30.67 62.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.174 0.59 . . . . 71.209999999999994 110.959 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.1 -63.94 1.08 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.274 1.03 . . . . 73.140000000000001 109.936 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.53 -54.39 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.38 1.072 . . . . 71.540000000000006 109.565 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -145.38 -8.3 0.59 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 114.412 -1.267 . . . . 74.340000000000003 109.158 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.614 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 12.0 t90 -86.17 65.55 9.14 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.162 0.585 . . . . 72.430000000000007 110.464 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -64.97 -17.06 64.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.568 0.747 . . . . 73.349999999999994 110.823 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.425 ' HA ' ' HB2' ' A' ' 72' ' ' ASN . 20.0 m -77.49 4.0 12.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.524 1.129 . . . . 74.219999999999999 112.169 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -75.52 -47.78 25.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.708 0.803 . . . . 74.019999999999996 110.358 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.9 -24.55 64.32 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 120.836 0.351 . . . . 64.239999999999995 110.424 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 69' ' ' SER . 10.7 m120 -89.43 -6.43 56.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.007 0.923 . . . . 75.209999999999994 111.634 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.22 -52.15 64.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.346 1.058 . . . . 65.409999999999997 112.219 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.91 16.14 26.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.605 0.762 . . . . 71.239999999999995 110.36 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.88 -20.17 64.88 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.35 0.66 . . . . 61.350000000000001 112.035 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.32 -138.67 25.58 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.178 -0.79 . . . . 54.329999999999998 112.224 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.775 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 93.4 Cg_endo -79.0 -174.81 2.44 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.753 2.302 . . . . 75.319999999999993 112.586 175.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.487 ' OG ' ' HB ' ' A' ' 138' ' ' VAL . 1.9 m -68.01 173.99 4.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.426 0.69 . . . . 71.430000000000007 110.489 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -72.64 -44.97 61.19 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 116.72 -0.218 . . . . 72.5 111.533 -174.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.55 -37.51 1.2 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 122.208 -0.308 . . . . 62.329999999999998 111.493 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 10.6 m-20 -90.64 113.52 58.05 Favored Pre-proline 0 N--CA 1.485 1.286 0 N-CA-C 113.415 0.894 . . . . 73.129999999999995 113.415 -170.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.0 -17.47 46.17 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.868 1.712 . . . . 75.420000000000002 111.175 163.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -89.6 9.67 25.96 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.65 1.18 . . . . 74.540000000000006 111.099 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 26.2 tp -96.16 126.83 41.65 Favored 'General case' 0 C--N 1.357 0.917 0 CA-C-O 121.65 0.738 . . . . 71.430000000000007 110.085 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -113.95 173.71 6.3 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.417 1.487 . . . . 75.230000000000004 108.257 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.47 139.19 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.088 0.955 . . . . 73.049999999999997 109.04 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HA ' HG23 ' A' ' 135' ' ' ILE . . . -74.4 120.4 19.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.213 0.605 . . . . 70.430000000000007 110.137 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 143' ' ' LYS . 83.8 mt -86.03 -34.97 20.6 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.462 0.705 . . . . 73.040000000000006 110.704 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.409 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 68.9 m-85 -123.78 146.19 48.5 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.131 -0.941 . . . . 74.219999999999999 108.879 -175.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB2' ' HZ1' ' A' ' 241' ' ' LYS . 6.8 m-20 -74.1 144.76 44.83 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.734 0.646 . . . . 74.5 109.409 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.582 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.6 t80 -142.18 140.5 32.4 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.437 -0.949 . . . . 73.230000000000004 108.437 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 68.0 t -110.99 134.82 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 108.209 -1.034 . . . . 74.310000000000002 108.209 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.68 116.27 2.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.167 0.987 . . . . 72.109999999999999 111.239 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.8 p -107.91 26.03 10.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.227 1.011 . . . . 64.400000000000006 110.209 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.27 177.52 43.49 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.086 -0.961 . . . . 64.230000000000004 110.929 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.71 -38.18 54.78 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.007 0.523 . . . . 72.239999999999995 111.254 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -84.32 -23.33 30.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.966 0.506 . . . . 74.530000000000001 111.152 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.6 p -72.92 153.99 40.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.151 0.58 . . . . 73.439999999999998 111.521 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.507 HD21 ' HG1' ' A' ' 123' ' ' THR . 61.8 tp -127.06 129.05 47.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.388 0.675 . . . . 72.230000000000004 110.968 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -69.66 130.56 42.71 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.692 0.797 . . . . 74.519999999999996 109.997 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.635 HG21 HG23 ' A' ' 123' ' ' THR . 22.0 pt -129.25 147.5 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 74.540000000000006 110.67 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -106.93 140.58 39.52 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.84 -1.17 . . . . 65.439999999999998 107.84 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -62.45 147.43 48.71 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 123.5 0.5 . . . . 75.310000000000002 110.271 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.74 -28.74 10.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.984 -0.342 . . . . 71.140000000000001 112.794 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.3 146.01 33.19 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.229 0.515 . . . . 74.299999999999997 111.04 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.433 ' HB3' HD12 ' A' ' 84' ' ' LEU . 39.9 mmtm -90.02 142.68 27.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.129 0.971 . . . . 74.200000000000003 109.696 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -145.57 146.1 31.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.861 0.865 . . . . 73.040000000000006 110.115 -178.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -99.65 107.06 19.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.811 0.444 . . . . 75.540000000000006 110.063 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 119' ' ' ALA . 53.5 t -79.02 119.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.873 -0.788 . . . . 70.430000000000007 108.873 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.8 -8.68 11.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.94 -0.573 . . . . 75.420000000000002 111.055 -175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.83 140.74 6.48 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 121.263 -0.494 . . . . 52.219999999999999 112.885 171.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -97.03 174.92 6.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.918 0.887 . . . . 75.109999999999999 110.439 172.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -96.09 -173.16 2.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.987 -1.006 . . . . 72.140000000000001 110.445 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -52.44 -39.38 60.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.657 1.183 . . . . 72.340000000000003 114.115 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -108.14 6.62 27.0 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.814 0.446 . . . . 72.209999999999994 112.092 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.66 12.15 45.73 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 115.361 0.904 . . . . 53.219999999999999 115.361 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.76 -7.71 33.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.6 0.76 . . . . 75.310000000000002 111.636 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.458 ' HZ2' HG12 ' A' ' 244' ' ' VAL . 39.2 m95 -127.52 145.38 50.87 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.97 -1.122 . . . . 72.230000000000004 107.97 167.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -148.02 125.78 11.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.274 -0.876 . . . . 73.030000000000001 109.219 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 37.9 tt0 -67.34 123.29 19.95 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 108.268 -1.012 . . . . 71.409999999999997 108.268 171.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . . . -126.98 145.71 50.6 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.76 0.824 . . . . 75.409999999999997 110.215 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -101.92 100.31 10.59 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.12 -1.067 . . . . 75.010000000000005 108.12 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.635 HG23 HG21 ' A' ' 101' ' ' ILE . 67.0 p -82.27 165.85 20.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.309 0.644 . . . . 74.530000000000001 109.831 173.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.46 ' HB3' ' HZ2' ' A' ' 124' ' ' LYS . 0.3 OUTLIER -66.34 -20.45 66.09 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 121.462 0.649 . . . . 75.510000000000005 109.445 175.139 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -79.38 -29.94 42.3 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.087 1.355 . . . . 74.099999999999994 112.297 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.33 -165.3 36.59 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 119.872 -0.405 . . . . 62.109999999999999 112.588 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -128.03 144.75 51.11 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.033 0.916 . . . . 74.209999999999994 110.367 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.13 178.42 36.0 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 112.589 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 75.1 m95 -75.07 118.4 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.324 1.05 . . . . 73.209999999999994 112.49 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.2 m -118.14 152.47 50.53 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 124.23 1.012 . . . . 54.299999999999997 108.428 174.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.12 129.07 17.59 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 121.772 1.648 . . . . 73.010000000000005 111.206 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 m -64.4 -25.84 68.19 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.099 0.96 . . . . 75.129999999999995 112.295 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -80.41 -5.48 56.57 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.236 1.015 . . . . 74.549999999999997 111.875 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.409 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 4.1 m-85 -96.87 -13.98 22.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.072 0.949 . . . . 75.299999999999997 110.944 173.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.5 HG23 ' HA ' ' A' ' 87' ' ' ALA . 16.1 pt -125.83 172.34 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.752 0.821 . . . . 73.510000000000005 110.585 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.401 HG23 ' HB2' ' A' ' 142' ' ' GLU . 2.5 m -159.63 142.35 10.15 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.403 1.081 . . . . 71.120000000000005 108.959 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.72 139.64 58.1 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.161 1.908 . . . . 75.239999999999995 112.237 170.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.487 ' HB ' ' OG ' ' A' ' 78' ' ' SER . 13.8 t -70.19 -6.05 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 121.603 0.716 . . . . 73.200000000000003 109.966 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.775 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 5.2 m120 -85.85 -21.16 28.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.831 0.852 . . . . 71.319999999999993 112.756 -176.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.3 p -102.11 179.01 4.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.383 0.673 . . . . 62.310000000000002 112.576 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.74 -22.24 37.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.429 1.092 . . . . 73.140000000000001 112.177 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.401 ' HB2' HG23 ' A' ' 136' ' ' THR . 3.1 mp0 -69.5 -13.87 62.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.075 0.95 . . . . 74.450000000000003 112.223 -172.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.529 ' HA ' HD22 ' A' ' 88' ' ' LEU . 22.2 pttm -69.88 -11.38 60.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.49 0.716 . . . . 72.120000000000005 112.175 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -87.05 143.37 27.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.293 0.637 . . . . 73.200000000000003 110.582 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 p -68.13 -33.29 74.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.29 1.036 . . . . 75.530000000000001 112.765 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -71.17 -33.28 69.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 75.109999999999999 111.46 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -78.43 112.79 15.82 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.52 -0.918 . . . . 74.400000000000006 108.52 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.46 -20.13 13.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.5 0.72 . . . . 75.510000000000005 111.345 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.95 -150.27 42.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 118.545 -1.142 . . . . 72.209999999999994 111.974 -174.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.03 100.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.66 2.907 . . . . 73.319999999999993 113.437 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.9 t -131.93 150.13 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.954 1.302 . . . . 75.200000000000003 108.94 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.3 p -90.95 175.19 7.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.368 0.667 . . . . 71.319999999999993 111.434 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.513 HH22 ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -62.92 -60.69 3.13 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.494 1.117 . . . . 70.430000000000007 110.886 -177.261 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.1 -29.03 70.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.936 0.895 . . . . 75.120000000000005 111.255 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.59 83.35 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 123.786 0.679 . . . . 65.329999999999998 110.944 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.78 -44.41 93.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.807 0.692 . . . . 73.329999999999998 110.84 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.99 -44.58 82.84 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.538 -0.755 . . . . 75.140000000000001 111.337 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.11 -44.46 88.68 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.592 -1.186 . . . . 74.030000000000001 111.888 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 237' ' ' PRO . 87.0 mt -59.8 -39.5 85.2 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.19 0.996 . . . . 73.129999999999995 111.571 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 90.8 mt -81.05 -27.53 35.71 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.283 -0.871 . . . . 74.530000000000001 112.074 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.9 p -68.39 -10.02 52.22 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 118.379 0.536 . . . . 51.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.9 p -103.55 21.16 16.57 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.62 1.168 . . . . 71.310000000000002 111.122 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.71 -178.15 15.19 Favored Glycine 0 C--N 1.353 1.499 0 C-N-CA 123.347 0.499 . . . . 51.149999999999999 113.79 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.4 pt -96.79 178.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.381 1.072 . . . . 74.439999999999998 112.06 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.47 112.46 5.31 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.158 -1.052 . . . . 71.319999999999993 108.158 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.59 24.89 Favored Glycine 0 CA--C 1.528 0.89 0 O-C-N 123.742 0.651 . . . . 74.329999999999998 112.746 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.436 ' O ' HD11 ' A' ' 184' ' ' LEU . 73.3 m -76.56 139.96 40.9 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.567 0.684 . . . . 75.430000000000007 110.868 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.2 p90 -148.78 163.53 37.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.068 0.461 . . . . 75.109999999999999 110.538 -175.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 4.1 pp -157.73 149.71 22.16 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.359 -0.837 . . . . 72.310000000000002 108.961 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.712 HG21 HG12 ' A' ' 182' ' ' ILE . 93.9 t -109.0 120.78 61.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.114 -1.069 . . . . 75.230000000000004 108.114 168.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.501 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 24.2 ptt85 -114.54 164.51 13.9 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.651 1.18 . . . . 71.25 108.452 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.16 160.84 20.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.98 0.912 . . . . 72.219999999999999 108.697 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.7 t -79.68 124.18 28.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.498 -0.556 . . . . 62.43 109.498 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.52 -36.24 83.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.85 0.86 . . . . 71.400000000000006 110.54 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.1 p -69.75 -31.27 69.14 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.897 0.879 . . . . 60.43 112.071 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 m -150.91 119.43 3.5 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.034 0.534 . . . . 75.239999999999995 110.305 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.8 154.4 74.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.832 2.355 . . . . 75.129999999999995 112.198 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.16 -31.22 8.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.004 -0.543 . . . . 65.230000000000004 112.316 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.59 112.19 17.72 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.93 -1.137 . . . . 72.129999999999995 107.93 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.52 ' H ' ' NH2' ' A' ' 194' ' ' ARG . 98.4 mtt180 -124.28 127.32 47.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.553 0.741 . . . . 74.430000000000007 110.068 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.1 m -125.28 145.51 49.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.74 0.816 . . . . 52.229999999999997 110.206 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.712 HG12 HG21 ' A' ' 170' ' ' VAL . 20.9 mt -100.12 143.93 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 107.696 -1.224 . . . . 75.329999999999998 107.696 173.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.2 m -125.61 109.84 13.12 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 176.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 167' ' ' SER . 32.0 tp -105.35 112.91 26.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.956 0.503 . . . . 74.25 110.994 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 76.1 ttt180 -78.25 110.97 13.73 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.54 -0.911 . . . . 71.140000000000001 108.54 163.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -133.1 125.88 30.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.009 1.324 . . . . 75.329999999999998 108.718 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 58.54 30.84 20.33 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.339 1.055 . . . . 71.040000000000006 110.433 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.431 ' HA2' ' HE ' ' A' ' 185' ' ' ARG . . . 79.84 -13.23 25.47 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-N 114.678 -1.146 . . . . 74.400000000000006 113.824 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.703 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 58.0 mtp85 -93.63 125.53 38.3 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.289 0.636 . . . . 75.409999999999997 109.406 -171.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.93 106.56 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.104 0.562 . . . . 73.430000000000007 110.847 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -96.51 131.99 42.56 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.586 1.154 . . . . 74.519999999999996 108.796 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -110.39 117.82 34.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.213 0.53 . . . . 75.109999999999999 111.439 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.461 ' HE1' HD22 ' A' ' 232' ' ' LEU . 2.8 m-30 -95.33 138.71 32.64 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 124.767 1.227 . . . . 70.140000000000001 108.768 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.52 ' NH2' ' H ' ' A' ' 180' ' ' ARG . 1.8 tpm_? -112.0 109.04 18.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 106.873 -1.528 . . . . 73.439999999999998 106.873 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -68.8 103.56 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 123.55 0.531 . . . . 74.049999999999997 110.759 -171.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.516 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 2.2 m-80 -68.85 143.44 54.55 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.671 0.788 . . . . 75.340000000000003 110.414 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.6 m -119.99 118.78 31.57 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.506 0.722 . . . . 75.450000000000003 109.702 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.35 159.83 33.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.668 0.787 . . . . 74.400000000000006 109.907 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.5 m -62.24 -22.83 66.28 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.632 0.975 . . . . 75.230000000000004 113.632 -170.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -90.24 -13.98 34.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.96 0.904 . . . . 51.109999999999999 112.03 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.42 12.9 12.48 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 114.501 0.561 . . . . 63.329999999999998 114.501 176.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -74.16 146.45 43.46 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.941 0.87 . . . . 74.109999999999999 111.254 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.467 HD13 HD13 ' A' ' 23' ' ' ILE . 2.9 mm? -104.4 150.3 24.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.931 0.892 . . . . 73.109999999999999 109.269 175.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 28.7 p90 -173.14 130.16 0.47 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.993 0.808 . . . . 74.420000000000002 109.492 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 217' ' ' LEU . 79.2 t -70.8 -53.78 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.092 -1.077 . . . . 73.319999999999993 108.092 163.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.6 m -103.08 138.99 39.19 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.674 -1.603 . . . . 74.010000000000005 110.147 -170.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.0 t -68.55 -10.46 55.86 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.041 0.936 . . . . 73.340000000000003 112.45 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.0 -29.36 61.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.306 1.042 . . . . 71.340000000000003 112.423 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.31 116.56 7.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.611 0.364 . . . . 75.340000000000003 110.219 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.51 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 95.7 mtt180 -97.98 132.2 43.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.696 0.798 . . . . 73.349999999999994 109.305 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -113.11 156.67 22.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.196 0.998 . . . . 72.329999999999998 109.371 -173.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -78.43 -29.83 47.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.726 -0.67 . . . . 74.209999999999994 109.844 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 35.2 p -137.34 159.15 42.76 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.852 0.834 . . . . 71.409999999999997 112.153 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.46 HD12 HG12 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -64.14 -31.64 72.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.809 1.243 . . . . 75.420000000000002 110.099 177.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.88 -37.83 80.47 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.09 0.556 . . . . 64.25 111.299 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -77.79 -32.17 52.3 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.706 -0.679 . . . . 70.430000000000007 111.335 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 205' ' ' VAL . 18.3 tp -54.69 -55.52 28.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.894 -0.41 . . . . 73.230000000000004 109.894 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.72 -44.38 98.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 O-C-N 124.251 0.969 . . . . 65.409999999999997 110.453 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -61.09 -57.7 11.46 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 123.451 0.469 . . . . 73.409999999999997 111.982 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -62.32 -38.75 90.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.052 -0.522 . . . . 75.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.632 ' HB3' HD13 ' A' ' 228' ' ' LEU . 16.2 m170 -84.84 -6.59 59.35 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.518 0.562 . . . . 74.010000000000005 112.518 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 86.7 p -95.75 -29.25 14.36 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.742 0.417 . . . . 75.310000000000002 111.16 172.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 38.0 p -81.55 -43.19 19.06 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.323 -0.398 . . . . 72.319999999999993 110.72 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 226' ' ' ASP . 28.9 m -126.65 160.84 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.405 0.682 . . . . 75.430000000000007 111.644 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.78 13.83 1.55 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.372 1.869 . . . . 70.319999999999993 114.624 -170.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.5 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.2 t70 -41.95 29.63 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 131.207 3.803 . . . . 74.239999999999995 120.148 -151.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.14 9.97 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 120.573 -1.329 . . . . 75.329999999999998 112.579 -169.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.632 HD13 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -90.56 162.56 14.95 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.762 1.225 . . . . 73.109999999999999 108.79 166.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.83 -36.57 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.474 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.2 t -159.84 -178.71 7.25 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.562 0.745 . . . . 74.420000000000002 110.483 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.5 p -66.99 143.34 56.85 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.114 0.965 . . . . 74.099999999999994 111.844 175.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.461 HD22 ' HE1' ' A' ' 193' ' ' TYR . 41.8 mt -74.89 146.44 41.88 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 107.802 -1.184 . . . . 73.510000000000005 107.802 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -147.72 -45.68 0.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 120.134 1.334 . . . . 72.209999999999994 113.833 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -112.55 133.31 21.87 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.323 0.649 . . . . 74.25 109.445 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 67.5 Cg_endo -87.39 124.45 2.01 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.388 2.059 . . . . 74.549999999999997 110.259 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.413 ' HB2' HD21 ' A' ' 160' ' ' LEU . . . -62.39 144.36 95.29 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.002 -0.74 . . . . 75.530000000000001 109.002 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.457 ' O ' HD23 ' A' ' 159' ' ' LEU . 86.8 Cg_endo -75.81 -178.82 4.61 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.242 1.961 . . . . 74.230000000000004 112.718 -177.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -85.48 138.12 32.44 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.637 -1.245 . . . . 74.329999999999998 107.637 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.405 ' HB3' HD21 ' A' ' 159' ' ' LEU . 15.0 ptt180 -90.42 -57.33 2.87 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.351 0.978 . . . . 74.299999999999997 111.257 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -106.78 136.68 46.18 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.156 0.583 . . . . 73.150000000000006 110.443 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.407 ' HZ1' ' HB2' ' A' ' 90' ' ' ASP . 95.8 mttt -82.85 116.96 66.92 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.076 -1.453 . . . . 74.340000000000003 107.076 162.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.03 127.63 15.21 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.896 3.064 . . . . 75.409999999999997 113.901 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.5 m -75.1 122.01 22.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.939 0.495 . . . . 74.010000000000005 111.13 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.458 HG12 ' HZ2' ' A' ' 118' ' ' TRP . 95.2 t -94.2 120.99 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.281 -1.007 . . . . 73.239999999999995 108.281 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -105.17 112.53 25.69 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.608 -0.516 . . . . 71.230000000000004 109.608 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.54 -28.44 0.22 Allowed Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.514 2.166 . . . . 73.230000000000004 118.514 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.1 m -72.03 132.0 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 118.856 1.328 . . . . 75.510000000000005 114.359 -160.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.8 t -73.45 122.99 88.99 Favored Pre-proline 0 C--N 1.355 0.83 0 N-CA-C 106.288 -1.745 . . . . 70.040000000000006 106.288 160.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.8 -57.42 1.74 Allowed 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 121.833 1.688 . . . . 72.200000000000003 113.838 -158.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -124.1 -21.82 4.95 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.38 0.672 . . . . 72.230000000000004 110.288 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -78.34 98.47 5.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.031 0.92 . . . . 71.540000000000006 111.702 -147.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.534 ' HB2' ' HD2' ' A' ' 253' ' ' LYS . 14.8 m-20 -121.76 -46.08 2.25 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 113.828 -1.533 . . . . 71.439999999999998 107.118 151.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.534 ' HD2' ' HB2' ' A' ' 252' ' ' ASP . 2.1 mptp? -109.15 -6.64 15.51 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 114.566 -1.197 . . . . 74.310000000000002 111.766 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -64.01 135.38 56.41 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 122.422 0.289 . . . . 73.420000000000002 110.863 -172.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.554 ' HG3' HE21 ' A' ' 12' ' ' GLN . 11.0 pt-20 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.643 1.177 . . . . 75.420000000000002 108.654 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.784 0.326 . . . . 73.519999999999996 110.334 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.21 -167.08 40.2 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.719 -0.553 . . . . 71.219999999999999 111.719 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -22.92 64.12 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.051 0.425 . . . . 65.129999999999995 111.568 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -117.65 109.65 41.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.793 0.837 . . . . 74.510000000000005 109.087 172.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.8 100.2 0.29 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.765 2.31 . . . . 75.049999999999997 112.294 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.03 -169.51 41.73 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.081 -0.509 . . . . 72.150000000000006 112.62 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -128.14 -63.13 1.02 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.306 0.643 . . . . 74.040000000000006 109.439 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -156.94 133.51 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.656 0.782 . . . . 64.319999999999993 109.765 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -128.44 137.07 51.66 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 106.48 -1.674 . . . . 73.340000000000003 106.48 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.77 132.29 46.67 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 123.382 0.426 . . . . 74.109999999999999 113.344 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.8 160.63 20.19 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.031 0.932 . . . . 75.349999999999994 111.432 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -78.19 152.54 32.63 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.049 0.939 . . . . 74.010000000000005 111.658 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.12 -57.05 2.64 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.3 1.04 . . . . 74.439999999999998 110.197 175.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 59.24 82.02 0.24 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.487 1.115 . . . . 73.310000000000002 110.926 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.68 -54.69 4.15 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.181 2.587 . . . . 72.030000000000001 112.89 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.4 p -179.15 -178.3 0.51 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.788 1.235 . . . . 63.43 109.956 176.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -146.13 123.48 6.06 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.976 0.91 . . . . 72.140000000000001 109.018 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.03 140.9 11.51 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.555 2.17 . . . . 75.349999999999994 112.293 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.92 116.68 29.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.514 0.726 . . . . 73.310000000000002 109.286 176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.49 -170.66 3.52 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.768 0.827 . . . . 73.040000000000006 110.073 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -69.34 170.46 10.3 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.444 0.64 . . . . 75.109999999999999 111.999 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.495 ' HA ' ' HB3' ' A' ' 33' ' ' ARG . 35.3 t80 -147.58 165.04 31.58 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.951 -1.022 . . . . 74.349999999999994 109.153 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 tp -85.94 11.54 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 C-N-CA 123.485 0.714 . . . . 74.409999999999997 111.488 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm 64.26 -178.12 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.663 1.185 . . . . 71.219999999999999 111.286 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.03 120.38 1.8 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 116.143 -0.481 . . . . 74.420000000000002 113.196 176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.73 102.08 2.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.243 1.017 . . . . 74.439999999999998 110.045 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.1 -8.37 27.14 Favored Glycine 0 N--CA 1.471 1.017 0 CA-C-O 119.632 -0.538 . . . . 73.549999999999997 113.186 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -62.92 137.49 58.28 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.279 0.632 . . . . 73.239999999999995 111.014 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.2 164.09 14.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.936 0.494 . . . . 75.430000000000007 110.785 172.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.2 -55.51 0.01 OUTLIER 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.027 -1.472 . . . . 55.020000000000003 107.027 169.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.9 m 78.04 -44.97 0.41 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.734 1.613 . . . . 72.25 112.793 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -68.23 -46.39 70.66 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.991 0.517 . . . . 74.0 109.651 173.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.495 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -69.65 147.09 51.09 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.935 -1.135 . . . . 63.240000000000002 107.935 161.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -60.74 98.19 0.07 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.925 0.49 . . . . 73.200000000000003 110.567 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.53 76.88 0.37 Allowed Glycine 0 C--N 1.344 0.994 0 O-C-N 124.214 0.947 . . . . 71.510000000000005 113.351 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.84 159.24 27.32 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.081 -0.808 . . . . 74.120000000000005 111.081 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.29 -52.86 6.23 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 123.526 2.817 . . . . 64.540000000000006 113.523 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.7 m80 67.11 -68.11 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.334 1.454 . . . . 55.039999999999999 111.136 -172.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 245' ' ' TYR . 9.2 p -149.14 139.38 22.27 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.913 0.885 . . . . 65.319999999999993 109.331 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -118.79 141.25 48.8 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.214 0.606 . . . . 64.329999999999998 110.695 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.553 HG23 HG13 ' A' ' 43' ' ' VAL . 26.4 m -73.12 179.18 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.397 0.679 . . . . 72.409999999999997 112.821 -173.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -55.61 -65.74 0.54 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 123.963 0.905 . . . . 73.230000000000004 112.286 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.553 HG13 HG23 ' A' ' 41' ' ' VAL . 29.9 m 38.72 -157.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 125.681 1.592 . . . . 75.439999999999998 114.353 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.17 124.0 43.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.472 1.109 . . . . 74.430000000000007 108.126 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -167.69 85.16 0.22 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.746 0.784 . . . . 75.310000000000002 109.578 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -94.5 92.74 7.25 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.745 -0.661 . . . . 74.400000000000006 109.396 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.24 6.65 38.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.678 0.791 . . . . 73.430000000000007 111.365 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.41 173.36 12.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.533 0.733 . . . . 72.430000000000007 111.488 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -115.83 128.64 55.97 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.63 -0.878 . . . . 74.230000000000004 108.63 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -99.01 -44.11 0.23 Allowed Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 117.951 -1.023 . . . . 74.239999999999995 113.565 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -69.4 83.24 0.64 Allowed 'Trans proline' 0 C--N 1.4 3.268 0 C-N-CA 122.002 1.801 . . . . 63.229999999999997 112.071 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.89 143.69 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.141 0.576 . . . . 75.230000000000004 110.097 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.47 90.17 0.07 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.333 0.653 . . . . 75.230000000000004 110.496 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.4 p -69.09 -12.57 61.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.785 1.234 . . . . 75.5 111.957 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -49.64 -54.36 18.92 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.435 1.094 . . . . 70.150000000000006 110.979 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -100.82 79.84 2.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.049 -0.978 . . . . 75.329999999999998 108.865 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -81.91 113.54 43.76 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 108.91 -0.774 . . . . 75.519999999999996 108.91 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.33 -61.27 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.009 2.472 . . . . 74.400000000000006 114.318 -167.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.46 -19.45 11.68 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.109 0.563 . . . . 75.010000000000005 112.08 -171.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.07 -86.92 0.67 Allowed Glycine 0 C--N 1.344 0.972 0 N-CA-C 112.189 -0.364 . . . . 71.349999999999994 112.189 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -105.97 110.88 23.3 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.835 -0.802 . . . . 74.239999999999995 108.835 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.3 m -114.83 81.4 1.56 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.202 1.001 . . . . 74.040000000000006 108.468 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.47 -50.34 73.98 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.27 1.028 . . . . 73.200000000000003 113.142 -166.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.79 -36.22 59.84 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.759 0.424 . . . . 74.319999999999993 110.754 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.05 -27.55 66.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.179 0.592 . . . . 65.540000000000006 111.957 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.518 ' HB2' ' HD2' ' A' ' 234' ' ' TYR . 7.6 ppt_? -83.45 -37.3 23.36 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-O 119.589 -0.244 . . . . 72.420000000000002 110.967 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -161.57 85.44 0.64 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.167 0.508 . . . . 74.430000000000007 111.376 178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 29.7 p-10 -88.09 -22.66 24.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.684 -0.689 . . . . 72.040000000000006 109.264 165.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.4 m -67.64 2.85 1.63 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.776 1.23 . . . . 74.329999999999998 113.381 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -70.01 -26.96 64.3 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.995 0.518 . . . . 72.310000000000002 110.997 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 13.2 pt-20 -77.54 -21.64 52.27 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.095 0.474 . . . . 74.040000000000006 110.327 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -91.66 -2.34 57.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.818 1.247 . . . . 62.509999999999998 110.827 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.31 -47.76 80.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.241 1.017 . . . . 75.530000000000001 111.733 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.1 mt -99.15 26.6 5.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.421 0.688 . . . . 72.340000000000003 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.22 64.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.19 0.596 . . . . 74.209999999999994 111.724 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.99 -141.28 44.81 Favored Glycine 0 C--N 1.356 1.642 0 CA-C-O 119.061 -0.855 . . . . 71.530000000000001 113.337 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 11.2 Cg_exo -71.15 -176.38 1.85 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.083 2.522 . . . . 74.540000000000006 112.361 171.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.458 ' H ' ' ND2' ' A' ' 139' ' ' ASN . 6.4 m -73.89 175.29 7.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.283 0.633 . . . . 73.129999999999995 109.542 172.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -69.6 -46.37 66.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 120.705 0.288 . . . . 75.040000000000006 111.091 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.62 -33.19 2.55 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.5 0.72 . . . . 70.219999999999999 110.961 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -89.51 115.61 64.22 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 114.866 1.432 . . . . 62.539999999999999 114.866 -163.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 74.7 Cg_endo -79.43 -20.44 9.57 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.556 2.171 . . . . 71.019999999999996 113.192 162.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -98.19 8.26 45.06 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.834 0.854 . . . . 75.049999999999997 111.47 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 tp -89.55 122.12 32.41 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.734 -0.839 . . . . 74.340000000000003 108.734 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -108.87 174.52 5.83 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.811 1.244 . . . . 71.439999999999998 109.099 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.96 138.88 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.109 1.364 . . . . 72.439999999999998 108.957 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.02 114.18 14.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 75.25 110.517 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.24 -35.62 66.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.288 0.635 . . . . 72.129999999999995 111.071 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 32.5 m-85 -122.96 143.96 49.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.512 -0.921 . . . . 75.510000000000005 108.512 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 6.3 p-10 -70.42 148.05 48.79 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 109.178 -0.675 . . . . 74.549999999999997 109.178 167.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.6 t80 -147.17 141.57 26.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.127 -1.064 . . . . 72.219999999999999 108.127 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.7 139.97 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.236 -1.024 . . . . 72.019999999999996 108.236 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.22 115.72 3.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.536 0.734 . . . . 75.209999999999994 111.009 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -93.24 -55.93 3.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.328 1.051 . . . . 75.430000000000007 109.704 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.54 -173.44 38.32 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.398 -0.819 . . . . 65.030000000000001 113.452 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.68 -38.94 80.73 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.278 1.031 . . . . 75.239999999999995 111.759 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -98.95 -12.85 20.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.906 0.882 . . . . 74.319999999999993 112.036 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.4 p -72.33 135.04 45.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.784 -0.451 . . . . 64.319999999999993 109.784 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.602 ' HB3' HG13 ' A' ' 130' ' ' VAL . 66.4 tp -103.42 130.91 50.85 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.411 0.684 . . . . 73.319999999999993 110.394 -174.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -70.94 125.74 27.67 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.722 -0.844 . . . . 74.430000000000007 108.722 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.591 HG21 HG21 ' A' ' 123' ' ' THR . 22.8 pt -125.47 144.86 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.604 0.762 . . . . 74.209999999999994 110.08 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 10.1 m -88.72 144.94 25.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.676 -0.861 . . . . 74.150000000000006 108.676 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 62.5 tttp -65.69 110.97 2.97 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.796 0.438 . . . . 63.509999999999998 110.616 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.13 -10.88 55.28 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.013 -0.54 . . . . 61.409999999999997 112.931 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.5 tt0 -71.27 130.84 42.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.784 0.834 . . . . 75.420000000000002 110.533 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -77.27 147.63 36.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.953 -0.758 . . . . 74.219999999999999 108.953 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -147.98 142.2 26.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.798 0.439 . . . . 65.329999999999998 111.222 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 19.6 tpp180 -89.12 107.26 18.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.526 -0.761 . . . . 72.510000000000005 109.214 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.504 HG11 ' HB1' ' A' ' 119' ' ' ALA . 77.7 t -88.81 102.59 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.443 -0.577 . . . . 64.319999999999993 109.443 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.528 HD22 ' HG3' ' A' ' 122' ' ' GLN . 2.2 mm? -67.53 -41.06 84.96 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.17 -0.923 . . . . 74.25 110.153 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.45 151.15 11.6 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.321 -0.854 . . . . 64.319999999999993 112.201 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.567 ' CE2' ' HB3' ' A' ' 119' ' ' ALA . 56.7 m-85 -88.35 174.45 8.15 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.791 0.836 . . . . 71.239999999999995 110.633 174.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -80.22 -176.34 5.54 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.614 -0.721 . . . . 71.0 109.217 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -54.63 -36.59 64.68 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.043 0.937 . . . . 75.420000000000002 113.296 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -112.48 10.46 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.077 0.769 . . . . 74.340000000000003 113.077 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.52 26.14 74.52 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.978 0.751 . . . . 70.310000000000002 114.978 171.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -80.81 -65.74 0.97 Allowed 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 109.027 -0.731 . . . . 71.329999999999998 109.027 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 73.8 m95 -90.59 150.94 21.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.015 0.926 . . . . 71.200000000000003 111.082 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.567 ' HB3' ' CE2' ' A' ' 112' ' ' TYR . . . -137.64 132.2 32.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.959 0.903 . . . . 71.120000000000005 110.641 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -76.85 107.48 9.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.889 -0.782 . . . . 70.219999999999999 108.889 167.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . . . -112.52 149.71 32.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.989 0.916 . . . . 62.030000000000001 110.89 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.528 ' HG3' HD22 ' A' ' 110' ' ' LEU . 56.1 mt-30 -112.39 123.15 49.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.899 0.879 . . . . 74.5 109.498 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.591 HG21 HG21 ' A' ' 101' ' ' ILE . 44.1 p -124.01 174.78 7.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.716 1.207 . . . . 74.230000000000004 110.824 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -58.05 -27.31 63.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.68 1.192 . . . . 73.400000000000006 110.696 167.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.79 -30.87 59.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.525 1.13 . . . . 72.120000000000005 111.299 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 138.03 -177.23 20.16 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.188 -0.229 . . . . 51.229999999999997 112.921 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -86.79 138.9 31.21 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.921 0.488 . . . . 70.430000000000007 109.948 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -178.33 -173.48 43.75 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.243 -0.743 . . . . 71.439999999999998 111.243 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.405 ' HE3' ' HB3' ' A' ' 118' ' ' TRP . 32.7 m95 -110.76 120.79 43.57 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.513 0.725 . . . . 74.329999999999998 111.426 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 99' ' ' LEU . 31.0 m -127.99 143.33 47.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 125.207 1.403 . . . . 73.209999999999994 108.969 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 4.6 Cg_endo -86.07 156.25 9.84 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.385 2.057 . . . . 72.319999999999993 114.39 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.3 m -36.5 -40.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 127.038 2.135 . . . . 64.319999999999993 114.691 170.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -65.98 -22.21 66.45 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.326 0.65 . . . . 71.400000000000006 111.977 -172.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.433 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 38.1 m-85 -98.6 -20.04 17.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.806 0.842 . . . . 73.150000000000006 112.387 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -122.8 171.11 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.332 0.653 . . . . 73.540000000000006 112.249 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.4 t -161.3 153.9 17.19 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.353 -0.98 . . . . 72.010000000000005 108.353 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.23 149.36 45.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 121.743 1.629 . . . . 74.209999999999994 112.351 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.88 -12.63 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.94 0.876 . . . . 75.409999999999997 109.852 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 1.6 m120 -87.22 -6.15 58.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.082 0.953 . . . . 73.25 111.516 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.3 p -89.11 174.26 7.98 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.924 0.489 . . . . 70.239999999999995 111.553 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.17 -23.63 30.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.507 -0.77 . . . . 72.030000000000001 110.849 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.64 -22.19 64.42 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.828 0.851 . . . . 74.409999999999997 111.929 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -59.55 -22.14 61.27 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.054 0.541 . . . . 75.439999999999998 111.91 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -82.55 139.59 33.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.522 0.729 . . . . 74.340000000000003 110.399 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.6 p -60.02 -42.17 93.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.695 1.198 . . . . 64.439999999999998 112.353 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -65.99 -38.42 88.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.734 0.813 . . . . 75.439999999999998 112.568 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.12 109.96 15.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.386 -0.598 . . . . 71.140000000000001 109.386 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.401 ' HB2' HG23 ' A' ' 151' ' ' VAL . 28.5 m170 -104.71 -9.78 17.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.009 0.524 . . . . 74.409999999999997 111.832 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.54 -132.26 27.14 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 118.208 -1.329 . . . . 72.540000000000006 112.294 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.88 95.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.254 2.636 . . . . 73.230000000000004 112.764 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.593 HG22 ' HE ' ' A' ' 239' ' ' ARG . 46.9 t -136.95 126.94 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.431 1.093 . . . . 62.030000000000001 108.956 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.6 p -76.29 172.51 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.307 0.643 . . . . 71.530000000000001 110.762 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -62.8 -48.46 79.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.739 0.416 . . . . 73.299999999999997 109.903 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -59.17 -35.88 74.32 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.113 0.883 . . . . 72.230000000000004 111.089 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -67.64 -47.84 68.41 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.602 -0.726 . . . . 72.450000000000003 111.182 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.36 86.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.409 -0.814 . . . . 73.319999999999993 110.798 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -81.94 -20.27 39.01 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.154 -0.93 . . . . 74.340000000000003 111.914 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.426 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -81.03 -24.7 37.7 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.156 0.889 . . . . 74.510000000000005 111.063 174.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 239' ' ' ARG . 65.4 mt -71.35 -46.24 60.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 74.519999999999996 110.12 168.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 40.4 mt -92.47 20.33 6.33 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.128 -0.942 . . . . 74.239999999999995 111.935 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.6 p -90.4 -37.66 13.83 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.392 -0.596 . . . . 64.430000000000007 109.392 166.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.0 p -96.38 -11.64 25.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.458 0.703 . . . . 63.509999999999998 111.179 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.67 166.21 35.66 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 123.439 0.462 . . . . 64.340000000000003 113.89 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 pt -98.35 -178.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.83 0.852 . . . . 73.349999999999994 111.703 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -68.03 125.66 27.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.97 -0.559 . . . . 72.319999999999993 109.98 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.93 9.65 65.66 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-O 119.084 -0.842 . . . . 73.219999999999999 112.794 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.8 m -75.56 135.76 40.56 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 118.093 0.947 . . . . 75.349999999999994 110.396 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 183' ' ' SER . 17.1 p90 -147.28 162.96 37.88 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.708 0.403 . . . . 72.5 110.63 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -160.51 148.33 16.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.537 -0.756 . . . . 71.400000000000006 109.324 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.634 HG23 HG12 ' A' ' 182' ' ' ILE . 70.8 t -101.55 125.17 55.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.168 -1.049 . . . . 72.340000000000003 108.168 169.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.549 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt180 -115.67 151.11 35.66 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.255 1.022 . . . . 71.329999999999998 108.418 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.96 149.96 36.51 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.573 -1.269 . . . . 73.549999999999997 107.573 165.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.6 t -81.04 120.85 25.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.111 0.564 . . . . 73.150000000000006 110.37 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.72 -36.03 77.82 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.152 0.981 . . . . 73.329999999999998 109.862 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.3 m -68.47 -34.04 75.24 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.631 0.773 . . . . 64.530000000000001 111.642 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.5 m -140.98 91.6 8.93 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.381 0.673 . . . . 72.420000000000002 110.969 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.1 124.93 17.46 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.158 2.572 . . . . 72.219999999999999 112.545 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.58 -28.92 11.84 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.815 -0.436 . . . . 63.310000000000002 112.76 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -74.38 116.69 15.34 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.844 -0.799 . . . . 75.129999999999995 108.844 173.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.49 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 72.3 mtt85 -123.84 144.35 49.79 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.462 0.705 . . . . 74.519999999999996 109.252 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.1 m -138.26 146.28 42.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.063 -0.971 . . . . 74.099999999999994 108.561 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.634 HG12 HG23 ' A' ' 170' ' ' VAL . 28.5 mt -100.41 149.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 106.589 -1.634 . . . . 74.510000000000005 106.589 168.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.1 m -124.52 120.07 30.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.474 -1.306 . . . . 73.219999999999999 107.474 170.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.6 tp -114.07 112.01 22.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.828 0.74 . . . . 74.420000000000002 110.399 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 32.9 ttt85 -78.07 114.44 16.96 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 109.258 -0.645 . . . . 72.340000000000003 109.258 165.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -136.9 132.3 34.31 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.08 -1.082 . . . . 75.530000000000001 108.08 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 59.36 28.59 17.98 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.7 1.2 . . . . 64.540000000000006 111.488 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.19 -9.81 56.14 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.889 -0.596 . . . . 72.120000000000005 114.034 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -96.49 124.1 40.37 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.085 0.954 . . . . 74.150000000000006 108.781 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.82 108.08 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 120.913 0.387 . . . . 74.120000000000005 110.104 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.99 151.07 21.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.56 1.144 . . . . 74.319999999999993 108.706 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -128.15 116.75 20.42 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.593 -0.521 . . . . 72.319999999999993 109.593 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.496 ' HE1' HD22 ' A' ' 232' ' ' LEU . 4.5 m-85 -95.74 149.59 21.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.412 1.085 . . . . 74.040000000000006 108.74 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -107.26 116.12 31.38 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.039 0.536 . . . . 74.409999999999997 109.577 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 45.3 mt -81.92 105.28 11.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.564 -0.902 . . . . 73.319999999999993 108.564 172.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -90.57 144.62 25.59 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.918 0.887 . . . . 71.049999999999997 109.288 173.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.8 m -98.39 128.97 45.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.903 0.881 . . . . 53.229999999999997 109.163 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 160.56 31.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.619 0.768 . . . . 71.420000000000002 109.951 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 40.9 p -62.64 -24.44 67.6 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.864 0.69 . . . . 73.010000000000005 112.864 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.07 -17.31 27.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.416 0.686 . . . . 75.349999999999994 111.372 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.55 14.02 9.17 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.451 0.94 . . . . 75.319999999999993 115.451 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -68.87 156.05 39.14 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.244 1.022 . . . . 74.439999999999998 110.492 170.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 146.8 34.2 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.413 -0.958 . . . . 63.340000000000003 108.413 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 30.7 p90 -167.97 141.52 3.32 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.681 0.613 . . . . 73.230000000000004 112.069 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.402 ' HB ' ' CE1' ' A' ' 221' ' ' HIS . 75.4 t -88.89 -31.87 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.186 -0.915 . . . . 72.540000000000006 108.87 162.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.7 m -105.54 123.04 47.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.301 1.04 . . . . 73.420000000000002 109.383 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -66.54 -24.7 66.41 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.163 0.585 . . . . 74.349999999999994 111.735 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.72 -15.18 57.15 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.41 1.084 . . . . 75.439999999999998 110.577 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.5 m -133.67 89.42 2.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.772 0.829 . . . . 74.549999999999997 109.338 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.47 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 52.9 mtt180 -97.11 120.04 36.71 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.725 0.81 . . . . 75.239999999999995 109.288 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.22 146.86 32.19 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.642 -0.873 . . . . 75.329999999999998 108.642 -174.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.21 -30.2 70.61 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 123.764 0.665 . . . . 72.209999999999994 111.622 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 75.2 p -132.08 158.79 40.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.32 0.648 . . . . 75.439999999999998 111.902 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.77 -28.56 67.71 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.471 1.108 . . . . 75.120000000000005 109.688 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.47 83.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.312 0.645 . . . . 73.310000000000002 110.668 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -77.33 -28.3 53.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.677 0.791 . . . . 72.209999999999994 111.666 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 12.4 tp -58.33 -57.64 12.02 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.541 0.336 . . . . 75.409999999999997 110.254 170.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.54 -38.28 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.892 0.745 . . . . 63.32 110.739 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.15 -56.33 23.49 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.789 0.681 . . . . 73.019999999999996 111.301 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -65.21 -33.54 76.25 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.406 0.682 . . . . 73.310000000000002 110.844 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.684 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.6 m170 -89.29 -8.39 53.46 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.138 -0.483 . . . . 71.209999999999994 112.115 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.6 p -97.52 -22.89 16.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.041 0.537 . . . . 72.310000000000002 110.775 170.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 44.6 p -82.25 -43.2 17.9 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.796 0.439 . . . . 54.340000000000003 111.051 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.526 HG23 ' HB2' ' A' ' 226' ' ' ASP . 32.0 m -130.32 167.71 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.844 0.83 . . . . 73.420000000000002 111.57 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -80.48 13.93 2.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.839 2.056 . . . . 52.439999999999998 114.549 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.526 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.6 t70 -40.98 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 131.18 3.792 . . . . 73.530000000000001 119.82 -150.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.48 -3.94 10.22 Favored Glycine 0 N--CA 1.481 1.639 0 O-C-N 119.438 -2.039 . . . . 72.349999999999994 112.133 -166.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.684 HD11 ' HB3' ' A' ' 221' ' ' HIS . 9.8 mt -89.59 162.49 15.62 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 125.139 1.375 . . . . 75.099999999999994 109.285 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.8 tt -57.5 -39.17 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-O 120.588 0.232 . . . . 75.219999999999999 110.499 168.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -162.64 175.62 11.2 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.492 0.717 . . . . 73.349999999999994 110.906 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.8 p -60.42 144.55 50.76 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.613 1.165 . . . . 73.409999999999997 112.209 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.496 HD22 ' HE1' ' A' ' 193' ' ' TYR . 78.4 mt -77.65 116.4 18.17 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.692 0.797 . . . . 64.209999999999994 109.353 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -104.94 -79.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.787 0.435 . . . . 74.450000000000003 111.308 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.518 ' HD2' ' HB2' ' A' ' 66' ' ' ARG . 46.3 t80 -90.39 121.52 68.38 Favored Pre-proline 0 C--O 1.213 -0.844 0 C-N-CA 123.7 0.8 . . . . 70.319999999999993 109.486 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.21 134.32 10.26 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.001 1.8 . . . . 71.219999999999999 111.228 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.17 151.35 92.42 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.492 0.717 . . . . 64.120000000000005 109.573 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -85.45 169.15 9.74 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.446 2.097 . . . . 73.120000000000005 113.873 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -59.05 119.19 6.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.006 0.922 . . . . 72.340000000000003 109.041 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.593 ' HE ' HG22 ' A' ' 151' ' ' VAL . 22.9 ptt85 -78.94 -59.67 2.69 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.794 1.035 . . . . 74.140000000000001 113.794 -161.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -106.98 122.0 45.58 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.84 0.856 . . . . 65.209999999999994 109.0 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.69 113.75 22.57 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 106.953 -1.499 . . . . 74.209999999999994 106.953 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.58 129.32 17.58 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.812 2.341 . . . . 74.519999999999996 112.521 -166.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.8 m -68.81 113.5 6.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.312 -0.858 . . . . 71.329999999999998 110.667 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.56 117.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.601 -1.259 . . . . 74.200000000000003 107.601 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.524 ' CE1' ' HA ' ' A' ' 41' ' ' VAL . 8.5 m-85 -96.03 110.39 22.64 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 118.927 -0.558 . . . . 75.430000000000007 110.707 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 63.42 -38.19 0.08 OUTLIER Glycine 0 CA--C 1.55 2.26 0 N-CA-C 118.639 2.216 . . . . 60.200000000000003 118.639 166.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.96 125.51 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.809 0.844 . . . . 75.25 113.226 -154.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.4 t -86.83 142.66 34.51 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 107.389 -1.338 . . . . 72.049999999999997 107.389 150.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.53 -54.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.375 1.968 0 CA-C-N 120.834 1.334 . . . . 75.299999999999997 114.019 -167.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -126.2 -25.59 3.51 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.966 0.728 . . . . 74.219999999999999 112.966 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -98.78 117.76 33.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.989 0.737 . . . . 73.019999999999996 112.989 -166.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -114.71 -37.19 4.3 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.596 0.759 . . . . 74.420000000000002 110.81 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -110.48 17.48 20.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.4 1.08 . . . . 73.450000000000003 111.44 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -86.48 141.96 28.71 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.636 -0.665 . . . . 73.329999999999998 112.665 -167.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.253 1.269 0 O-C-N 124.979 1.424 . . . . 72.340000000000003 107.669 165.775 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.061 -0.718 . . . . 74.239999999999995 109.061 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 147.68 80.59 0.03 OUTLIER Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.519 -0.632 . . . . 61.240000000000002 111.519 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -78.5 149.05 33.23 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 109.788 -0.449 . . . . 74.420000000000002 109.788 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -158.62 96.1 1.81 Allowed Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 108.757 -0.831 . . . . 74.120000000000005 108.757 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.86 -172.72 1.47 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.957 2.438 . . . . 60.310000000000002 112.971 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.55 146.12 8.43 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.909 -0.587 . . . . 74.530000000000001 111.843 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -67.52 162.99 22.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.074 0.95 . . . . 74.140000000000001 111.868 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.62 150.91 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.051 0.94 . . . . 73.140000000000001 109.283 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD22 ' H ' ' A' ' 9' ' ' LEU . 2.5 pt? -115.11 171.37 7.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.576 0.75 . . . . 75.230000000000004 109.152 176.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.04 83.3 0.32 Allowed Glycine 0 C--N 1.346 1.098 0 O-C-N 123.484 0.49 . . . . 74.439999999999998 112.08 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.17 147.5 43.96 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.311 1.044 . . . . 73.310000000000002 110.924 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -61.88 128.91 38.46 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.419 0.688 . . . . 73.439999999999998 111.296 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -70.15 83.88 0.53 Allowed 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 122.366 1.079 . . . . 75.409999999999997 110.628 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -132.31 134.78 25.37 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 115.306 -0.861 . . . . 71.120000000000005 109.195 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.78 111.85 2.28 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.41 2.074 . . . . 60.32 111.282 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 t -61.89 148.37 43.71 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.615 0.766 . . . . 64.140000000000001 110.506 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 mp -65.78 118.63 53.49 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.518 0.727 . . . . 72.030000000000001 109.732 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.94 119.61 6.72 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.461 2.107 . . . . 74.299999999999997 111.184 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -150.43 99.41 2.77 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.379 0.672 . . . . 72.420000000000002 110.363 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.52 155.25 21.6 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.134 0.974 . . . . 75.129999999999995 109.591 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -151.96 129.85 11.72 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.253 0.346 . . . . 75.400000000000006 110.697 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -159.6 87.49 0.82 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.49 0.716 . . . . 75.200000000000003 109.24 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 tt -162.86 139.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.86 0.864 . . . . 73.109999999999999 109.654 177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.593 ' HB2' ' HZ2' ' A' ' 24' ' ' LYS . 5.0 ttmp? -153.75 124.62 7.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.674 0.79 . . . . 74.540000000000006 109.372 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.94 158.45 10.43 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 111.482 -0.647 . . . . 65.120000000000005 111.482 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.2 85.12 4.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.138 -0.69 . . . . 64.219999999999999 109.138 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.79 -143.85 6.22 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.281 -0.872 . . . . 52.210000000000001 111.938 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.93 105.9 3.31 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.4 -1.333 . . . . 72.230000000000004 107.4 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.491 ' HG2' ' H ' ' A' ' 30' ' ' GLU . 55.4 ttt180 -85.46 -179.83 7.0 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.515 0.726 . . . . 74.010000000000005 110.137 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.491 ' H ' ' HG2' ' A' ' 29' ' ' ARG . 12.7 mt-10 -41.97 98.25 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.487 1.515 . . . . 73.299999999999997 111.182 170.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.5 p -106.52 168.01 9.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.271 0.628 . . . . 63.229999999999997 110.878 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 54.1 p -74.24 170.36 15.72 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.625 0.77 . . . . 63.299999999999997 109.996 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -61.91 92.26 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.096 0.559 . . . . 75.439999999999998 110.747 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -81.41 153.08 27.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.135 0.574 . . . . 75.140000000000001 110.536 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -132.86 39.1 1.78 Allowed Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.971 -0.852 . . . . 72.430000000000007 110.971 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.39 71.78 0.04 OUTLIER Glycine 0 C--O 1.241 0.581 0 N-CA-C 111.133 -0.787 . . . . 62.039999999999999 111.133 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -91.05 -131.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.217 2.612 . . . . 74.219999999999999 110.12 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.6 m170 65.15 -177.83 0.18 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.728 0.811 . . . . 74.409999999999997 110.674 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 40' ' ' ASN . 53.7 t 67.09 167.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.283 1.033 . . . . 72.349999999999994 112.643 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.417 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 21.8 t-20 -157.47 116.99 3.34 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.251 -1.388 . . . . 70.099999999999994 107.251 171.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.3 p -79.69 132.83 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 122.807 0.443 . . . . 71.310000000000002 110.277 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -75.59 134.41 40.68 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.221 -0.659 . . . . 74.439999999999998 109.221 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.92 138.37 49.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.968 0.907 . . . . 72.239999999999995 108.634 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.22 113.81 10.7 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.004 -0.739 . . . . 75.200000000000003 109.004 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -71.35 162.37 29.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.002 0.921 . . . . 74.430000000000007 111.956 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.28 154.09 42.71 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.6 1.16 . . . . 72.329999999999998 108.702 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.94 34.06 0.1 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.081 0.4 . . . . 73.409999999999997 112.081 -173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.92 133.0 40.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.111 -0.7 . . . . 72.230000000000004 109.111 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -137.9 -88.61 0.25 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.783 -0.821 . . . . 72.409999999999997 108.783 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.41 134.85 0.48 Allowed Pre-proline 0 C--N 1.35 0.625 0 N-CA-C 108.664 -0.865 . . . . 73.439999999999998 108.664 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.8 -173.04 1.7 Allowed 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.427 2.084 . . . . 71.510000000000005 112.187 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -75.06 -165.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.335 0.654 . . . . 74.239999999999995 110.867 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.57 97.04 0.05 OUTLIER 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.457 0.646 . . . . 55.340000000000003 110.153 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 p -86.92 22.59 1.96 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.345 1.058 . . . . 73.310000000000002 111.408 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -89.04 11.46 18.32 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.534 1.133 . . . . 71.530000000000001 110.929 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -128.78 133.91 48.22 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.842 0.857 . . . . 74.219999999999999 110.194 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.26 160.75 77.53 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.926 0.891 . . . . 71.420000000000002 110.641 174.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -40.77 -52.11 3.36 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.963 3.109 . . . . 74.010000000000005 114.816 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.482 ' HG3' HD12 ' A' ' 61' ' ' LEU . 24.1 tp60 -169.05 -42.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.365 0.666 . . . . 73.519999999999996 110.438 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.53 -23.51 35.89 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 116.152 -0.476 . . . . 73.409999999999997 112.625 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.482 HD12 ' HG3' ' A' ' 59' ' ' GLN . 9.4 mp -77.46 165.58 24.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.172 0.511 . . . . 73.340000000000003 111.049 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.0 m -89.59 -161.52 0.78 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.169 -0.923 . . . . 75.0 111.497 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -47.79 -36.52 11.81 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.685 1.594 . . . . 71.040000000000006 113.384 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -150.08 -70.61 0.19 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.376 -0.972 . . . . 75.209999999999994 108.376 172.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.73 -76.47 0.61 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.1 -0.704 . . . . 62.5 109.1 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -137.98 -83.74 0.31 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.64 0.776 . . . . 74.340000000000003 109.016 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -120.01 81.04 1.68 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.585 0.707 . . . . 73.439999999999998 109.611 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -85.65 -17.79 35.08 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.966 -1.015 . . . . 74.540000000000006 110.249 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.0 p -87.42 5.42 38.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.952 0.901 . . . . 74.239999999999995 111.684 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -64.34 -30.32 71.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.745 0.418 . . . . 73.319999999999993 111.553 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.555 ' HG3' HD21 ' A' ' 72' ' ' ASN . 11.6 pt-20 -65.24 -33.16 75.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.166 -0.47 . . . . 75.310000000000002 110.482 172.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.555 HD21 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -75.97 -17.95 59.51 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.575 0.75 . . . . 74.319999999999993 111.369 177.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.4 tp -55.48 -51.66 66.22 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.093 0.557 . . . . 74.109999999999999 110.73 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.11 14.84 23.71 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.448 0.699 . . . . 74.409999999999997 111.213 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.48 -34.79 72.77 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.477 0.311 . . . . 72.519999999999996 111.261 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.55 -135.61 33.52 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 118.617 -1.102 . . . . 64.25 111.034 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.25 -177.24 3.13 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 122.981 2.454 . . . . 75.400000000000006 112.17 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 m -77.84 172.27 13.71 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.964 -0.562 . . . . 75.349999999999994 109.67 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -70.23 -42.8 71.79 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.73 0.412 . . . . 73.030000000000001 111.412 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -125.65 -34.39 2.65 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.057 0.543 . . . . 74.129999999999995 111.484 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.0 109.35 29.96 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.049 0.54 . . . . 71.129999999999995 111.508 -170.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.11 -12.87 6.75 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.412 2.074 . . . . 61.439999999999998 112.008 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -109.73 16.41 22.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.61 1.164 . . . . 73.109999999999999 110.945 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -86.6 130.85 34.33 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 109.202 -0.666 . . . . 74.549999999999997 109.202 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -108.82 174.12 6.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.568 1.147 . . . . 75.230000000000004 108.975 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.44 139.36 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.666 1.186 . . . . 63.43 108.616 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.5 127.51 32.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.515 0.726 . . . . 71.340000000000003 110.739 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 143' ' ' LYS . 91.2 mt -83.55 -32.82 25.64 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.773 0.829 . . . . 74.140000000000001 111.916 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.426 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 25.8 m-85 -125.05 157.18 36.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.253 0.621 . . . . 74.219999999999999 109.485 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.62 119.16 23.93 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.384 -0.969 . . . . 71.530000000000001 108.384 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.597 ' HB3' HG12 ' A' ' 101' ' ' ILE . 79.7 t80 -119.03 138.62 52.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.532 -0.914 . . . . 72.040000000000006 108.532 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -104.95 131.08 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.437 -0.949 . . . . 73.010000000000005 108.437 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.26 56.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.23 0.612 . . . . 62.43 111.092 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -86.83 -42.94 12.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.414 0.686 . . . . 52.109999999999999 109.689 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.76 -167.77 11.17 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.584 -0.734 . . . . 71.099999999999994 112.561 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.449 ' HB3' ' HA ' ' A' ' 255' ' ' GLU . 5.7 m-20 -66.92 -37.87 85.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.129 0.972 . . . . 71.239999999999995 110.835 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 254' ' ' TRP . 26.5 p-10 -66.91 -21.01 66.01 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.259 -1.337 . . . . 74.340000000000003 112.222 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.0 p -100.39 -179.15 4.03 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.842 0.857 . . . . 73.129999999999995 110.484 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.638 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 62.9 tp -144.31 139.69 28.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.917 0.487 . . . . 75.239999999999995 111.073 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 m -85.35 132.9 34.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.442 0.697 . . . . 74.430000000000007 109.7 174.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.597 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -133.01 148.8 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 120.953 0.406 . . . . 75.099999999999994 111.621 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.8 m -99.3 150.23 22.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.076 0.95 . . . . 75.040000000000006 108.73 174.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -64.84 126.92 29.47 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.739 -0.467 . . . . 73.129999999999995 109.739 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.02 -14.13 64.19 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.127 -0.488 . . . . 75.120000000000005 112.575 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 39.2 tt0 -74.76 128.0 34.5 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.794 0.838 . . . . 73.349999999999994 110.774 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.88 134.68 35.08 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.412 0.685 . . . . 71.120000000000005 110.325 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 0.4 OUTLIER -146.21 136.86 24.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.817 0.847 . . . . 74.319999999999993 110.631 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -96.65 115.12 26.9 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.506 0.323 . . . . 72.420000000000002 110.602 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.508 HG11 ' HB2' ' A' ' 119' ' ' ALA . 52.7 t -74.58 110.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.424 0.63 . . . . 75.5 109.707 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.67 -32.13 60.04 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.246 -1.343 . . . . 74.099999999999994 110.044 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.54 155.34 11.17 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.231 -0.895 . . . . 72.129999999999995 111.878 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.594 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 43.0 m-85 -87.47 175.5 7.93 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.472 0.654 . . . . 72.219999999999999 111.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -85.38 -173.05 4.47 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.935 -1.029 . . . . 74.420000000000002 110.928 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -44.38 -44.17 8.12 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.472 1.509 . . . . 74.310000000000002 114.296 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -112.61 0.28 15.37 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.911 0.708 . . . . 75.409999999999997 112.911 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 81.83 22.69 59.24 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 115.313 0.885 . . . . 74.25 115.313 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.48 -65.44 1.0 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.98 0.89 . . . . 72.329999999999998 110.012 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 49.2 m95 -92.3 150.4 20.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.194 0.598 . . . . 74.510000000000005 111.369 -174.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.534 ' HB1' ' CE2' ' A' ' 112' ' ' TYR . . . -133.3 137.34 45.94 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.438 1.095 . . . . 71.439999999999998 110.193 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -78.37 98.8 6.11 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.292 -1.003 . . . . 73.409999999999997 108.292 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . . . -105.42 139.98 39.23 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.414 0.685 . . . . 64.129999999999995 110.339 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -102.27 105.7 16.39 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.216 -0.661 . . . . 71.310000000000002 109.216 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.456 HG21 HG23 ' A' ' 101' ' ' ILE . 69.4 p -80.4 168.42 19.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.952 0.783 . . . . 75.450000000000003 109.731 171.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -67.33 -8.19 30.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.607 -0.724 . . . . 75.420000000000002 111.537 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -91.4 -30.78 16.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.937 0.895 . . . . 74.019999999999996 110.958 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.28 174.68 24.64 Favored Glycine 0 C--N 1.36 1.886 0 N-CA-C 114.204 0.442 . . . . 73.450000000000003 114.204 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -86.62 142.49 28.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.809 0.843 . . . . 73.239999999999995 110.99 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -176.81 -170.01 38.8 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-N 114.945 -1.025 . . . . 75.230000000000004 110.646 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -109.77 129.34 55.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.817 0.808 . . . . 74.030000000000001 111.41 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 99' ' ' LEU . 27.6 m -136.07 145.21 51.43 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 124.698 1.199 . . . . 75.230000000000004 109.188 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 47.4 Cg_endo -88.44 156.35 6.57 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 122.541 2.161 . . . . 65.319999999999993 114.312 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 m -38.33 -43.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.611 1.964 . . . . 74.319999999999993 114.137 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.481 HD21 ' HB2' ' A' ' 242' ' ' PRO . 36.4 p-10 -72.23 -11.33 60.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.097 0.559 . . . . 75.120000000000005 112.057 -174.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 28.7 m-85 -105.9 -13.5 15.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.983 0.913 . . . . 74.310000000000002 112.581 176.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 130' ' ' VAL . 16.8 pt -130.98 172.83 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.373 0.669 . . . . 71.439999999999998 111.696 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -162.01 152.02 14.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 108.428 -0.953 . . . . 75.329999999999998 108.428 172.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.23 149.52 44.73 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.04 1.826 . . . . 71.420000000000002 112.065 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.17 -23.36 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.093 0.473 . . . . 73.340000000000003 110.531 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -69.69 -18.61 63.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.941 0.896 . . . . 64.409999999999997 112.291 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.2 p -77.93 166.16 23.21 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.157 0.799 . . . . 74.340000000000003 113.157 -167.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -84.52 -19.73 32.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.815 -1.084 . . . . 73.540000000000006 110.663 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -71.13 -24.15 62.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.294 1.037 . . . . 75.349999999999994 111.35 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.508 ' HA ' HD22 ' A' ' 88' ' ' LEU . 21.3 pttm -62.08 -18.64 61.37 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.44 0.696 . . . . 75.400000000000006 112.868 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -76.7 149.28 36.42 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.472 0.709 . . . . 72.310000000000002 110.418 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.4 p -61.72 -43.24 99.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.95 0.9 . . . . 73.230000000000004 111.456 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -68.89 -34.56 75.61 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.062 0.851 . . . . 74.299999999999997 113.103 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.92 113.92 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.148 -0.686 . . . . 75.140000000000001 109.148 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.412 ' HD2' ' HD3' ' A' ' 238' ' ' LYS . 29.8 m170 -110.94 3.59 18.93 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.633 0.605 . . . . 75.209999999999994 112.633 -175.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.58 -148.04 38.03 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-O 118.861 -0.966 . . . . 64.150000000000006 112.771 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.81 97.54 0.23 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.02 2.48 . . . . 74.319999999999993 111.952 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 61.0 t -131.89 129.28 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.666 0.787 . . . . 73.340000000000003 110.003 -175.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -79.36 172.34 13.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.55 0.74 . . . . 60.420000000000002 110.392 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -60.35 -47.62 85.27 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.645 0.378 . . . . 71.219999999999999 110.803 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -57.09 -41.59 79.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.652 0.781 . . . . 65.5 111.89 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.418 ' HB2' HG11 ' A' ' 151' ' ' VAL . . . -72.14 -34.25 68.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.763 0.425 . . . . 71.439999999999998 111.325 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.25 91.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.484 0.659 . . . . 75.540000000000006 110.915 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -79.6 -21.23 45.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.418 -0.81 . . . . 71.430000000000007 110.88 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -64.61 -42.06 95.78 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.221 0.608 . . . . 71.420000000000002 109.623 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.56 HD21 ' HA ' ' A' ' 239' ' ' ARG . 85.8 mt -64.76 -44.51 89.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.521 0.728 . . . . 70.219999999999999 111.692 174.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.5 13.72 13.15 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.959 -0.564 . . . . 74.239999999999995 112.17 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -65.39 -42.11 92.99 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.476 0.655 . . . . 72.209999999999994 110.002 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.3 p -102.58 19.61 18.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.59 1.156 . . . . 74.549999999999997 110.494 176.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.35 152.95 36.65 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.883 -0.599 . . . . 72.409999999999997 112.269 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 pt -102.31 -177.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.147 0.979 . . . . 74.200000000000003 110.709 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.41 120.95 10.29 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.176 0.59 . . . . 72.420000000000002 110.247 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.17 10.52 62.34 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.795 -0.639 . . . . 61.219999999999999 113.168 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 73.9 m -77.73 128.4 33.99 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.782 0.791 . . . . 72.319999999999993 110.044 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -139.69 164.34 30.2 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.381 0.61 . . . . 74.219999999999999 111.454 -170.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 236' ' ' ALA . 4.5 pp -160.2 154.92 24.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.464 -1.244 . . . . 75.549999999999997 108.968 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.602 HG21 HG12 ' A' ' 182' ' ' ILE . 87.5 t -110.14 127.93 66.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.533 -0.914 . . . . 75.140000000000001 108.533 168.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.542 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 20.4 ptt85 -115.66 155.36 27.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.41 -1.268 . . . . 75.230000000000004 108.514 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.52 147.46 40.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.257 -1.016 . . . . 74.439999999999998 108.257 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -87.33 129.08 35.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.687 -0.486 . . . . 70.239999999999995 109.687 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -80.7 -40.06 26.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.485 -0.779 . . . . 75.439999999999998 109.518 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.7 m -66.54 -33.07 74.85 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.999 0.92 . . . . 62.310000000000002 111.097 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -118.51 95.53 48.9 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 123.764 0.826 . . . . 74.349999999999994 109.529 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -58.14 126.55 21.89 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.322 2.681 . . . . 74.430000000000007 113.278 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.62 -27.52 8.66 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 116.242 -0.435 . . . . 62.530000000000001 113.152 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -66.65 136.3 55.35 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.353 0.661 . . . . 74.129999999999995 110.548 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -135.17 158.29 44.75 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.717 0.807 . . . . 72.230000000000004 109.793 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.4 m -147.37 150.1 34.05 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.432 1.093 . . . . 72.019999999999996 108.93 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.602 HG12 HG21 ' A' ' 170' ' ' VAL . 35.8 mt -103.93 149.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.954 -1.128 . . . . 73.420000000000002 107.954 173.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.2 m -125.09 110.85 14.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.286 -1.005 . . . . 74.209999999999994 108.286 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.1 tp -110.0 112.85 25.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.152 0.581 . . . . 74.120000000000005 110.104 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.502 ' HB2' HG21 ' A' ' 190' ' ' VAL . 39.1 ttt180 -78.47 114.79 17.69 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.268 0.556 . . . . 75.420000000000002 110.048 165.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.44 141.62 37.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.153 -1.385 . . . . 72.329999999999998 107.763 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 57.07 28.67 15.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.922 0.889 . . . . 75.099999999999994 111.575 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.42 -9.46 54.78 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-N 115.797 -0.638 . . . . 72.420000000000002 114.043 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -104.5 140.05 38.53 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.834 0.854 . . . . 74.340000000000003 109.839 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.502 HG21 ' HB2' ' A' ' 185' ' ' ARG . 48.9 t -98.77 106.51 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.852 0.461 . . . . 73.439999999999998 110.457 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -91.16 141.62 28.62 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.016 0.926 . . . . 75.140000000000001 109.115 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -114.88 118.58 33.9 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.713 0.405 . . . . 75.010000000000005 110.019 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.444 ' HE1' HD23 ' A' ' 232' ' ' LEU . 6.4 m-30 -94.02 149.78 20.93 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.05 0.94 . . . . 74.5 108.738 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -101.07 127.45 47.6 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.792 -0.818 . . . . 74.430000000000007 108.792 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 101.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.826 -1.176 . . . . 75.099999999999994 107.826 171.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -79.02 132.92 36.81 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.501 -0.772 . . . . 72.200000000000003 109.045 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.8 m -93.76 113.74 25.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.293 -1.003 . . . . 72.430000000000007 108.293 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.11 159.17 33.43 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.559 0.537 . . . . 71.120000000000005 111.257 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.5 p -66.8 -27.91 67.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.578 -0.737 . . . . 74.209999999999994 110.94 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.3 -1.05 48.33 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.985 0.914 . . . . 73.129999999999995 111.343 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 98.26 -7.92 62.36 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.822 -0.432 . . . . 75.310000000000002 114.116 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.33 133.49 34.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.652 0.726 . . . . 73.420000000000002 111.745 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.6 147.87 27.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.855 0.862 . . . . 75.019999999999996 108.913 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.3 p90 -166.53 151.46 7.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.967 0.413 . . . . 73.129999999999995 111.876 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 221' ' ' HIS . 59.8 t -99.19 -35.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.577 -0.897 . . . . 75.420000000000002 108.577 165.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -103.78 125.76 50.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.095 0.958 . . . . 73.510000000000005 109.252 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.9 t -63.01 -30.15 71.38 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 72.409999999999997 112.207 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.58 -26.9 61.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.624 0.769 . . . . 72.230000000000004 111.099 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.1 m -121.85 96.68 5.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 74.340000000000003 110.063 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.548 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.0 mtt180 -100.02 140.66 33.93 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.789 0.836 . . . . 75.150000000000006 109.195 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.572 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 3.1 m-85 -127.0 140.55 52.23 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.374 0.67 . . . . 72.230000000000004 109.818 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.19 -27.03 63.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.241 0.616 . . . . 74.329999999999998 110.289 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -133.29 153.72 51.32 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.813 0.845 . . . . 72.099999999999994 110.745 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.472 HD13 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -67.54 -21.52 65.46 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.128 -0.942 . . . . 75.310000000000002 109.708 172.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.01 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.9 0.88 . . . . 72.409999999999997 110.398 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.3 mt-10 -69.42 -37.04 77.25 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.289 -0.868 . . . . 74.420000000000002 111.338 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.17 -57.86 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.374 0.421 . . . . 71.310000000000002 111.152 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.9 -40.3 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.892 0.477 . . . . 73.0 111.355 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -59.15 -54.44 46.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.381 0.672 . . . . 74.340000000000003 111.004 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -63.76 -38.21 90.25 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.797 0.839 . . . . 72.450000000000003 110.925 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.676 ' HB3' HD13 ' A' ' 228' ' ' LEU . 11.0 m-70 -85.8 -8.24 58.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.922 0.489 . . . . 72.420000000000002 112.002 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.8 p -93.66 -28.9 15.72 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.627 0.371 . . . . 54.450000000000003 110.308 169.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.6 p -77.65 -40.71 40.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.322 0.249 . . . . 75.120000000000005 111.113 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.58 157.56 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.72 . . . . 74.340000000000003 111.487 -176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.59 10.24 18.57 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.08 1.752 . . . . 74.310000000000002 113.874 -173.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -45.96 32.78 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 130.799 3.64 . . . . 75.430000000000007 120.428 -155.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 127.84 -1.11 6.8 Favored Glycine 0 N--CA 1.464 0.564 0 O-C-N 120.925 -1.109 . . . . 50.100000000000001 112.788 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 221' ' ' HIS . 12.5 mt -91.58 161.38 14.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.51 1.124 . . . . 75.129999999999995 109.753 165.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -60.77 -36.37 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 120.816 0.341 . . . . 75.299999999999997 110.485 171.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.2 t -162.77 178.77 8.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.885 0.874 . . . . 75.530000000000001 109.471 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.5 p -63.78 143.77 57.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.24 0.616 . . . . 73.219999999999999 112.039 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.444 HD23 ' HE1' ' A' ' 193' ' ' TYR . 54.4 mt -69.5 138.15 53.12 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 108.159 -1.052 . . . . 75.150000000000006 108.159 169.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -135.95 -76.7 0.43 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.85 0.75 . . . . 75.120000000000005 112.238 -170.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -84.21 122.43 75.62 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.912 -0.773 . . . . 72.109999999999999 108.912 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.05 126.4 6.37 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 122.251 1.968 . . . . 64.420000000000002 111.918 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 169' ' ' LEU . . . -74.11 135.8 76.47 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.891 -0.781 . . . . 74.340000000000003 108.891 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.5 177.76 8.36 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.632 2.222 . . . . 52.5 112.322 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.412 ' HD3' ' HD2' ' A' ' 148' ' ' HIS . 72.5 mmtt -63.52 157.12 24.41 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.752 0.821 . . . . 74.209999999999994 109.971 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.56 ' HA ' HD21 ' A' ' 159' ' ' LEU . 29.3 ptt180 -91.13 -62.56 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.06 0.763 . . . . 74.109999999999999 113.06 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.546 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 24.8 t-20 -110.68 158.56 18.47 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.821 0.848 . . . . 74.109999999999999 108.794 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 114.55 57.37 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 106.131 -1.803 . . . . 74.400000000000006 106.131 156.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.481 ' HB2' HD21 ' A' ' 133' ' ' ASN . 36.6 Cg_endo -62.79 124.9 14.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.41 2.074 . . . . 72.420000000000002 112.19 -169.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 33.8 m -71.29 117.8 13.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.819 0.847 . . . . 75.420000000000002 110.646 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.43 HG12 ' CZ2' ' A' ' 118' ' ' TRP . 24.6 t -98.62 125.17 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.077 -1.083 . . . . 74.329999999999998 108.077 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.18 115.55 30.45 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.573 -0.251 . . . . 74.230000000000004 110.563 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.63 -3.36 0.25 Allowed Glycine 0 CA--C 1.54 1.626 0 N-CA-C 118.409 2.123 . . . . 63.409999999999997 118.409 161.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 11.9 m -91.53 122.99 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.372 1.586 . . . . 75.239999999999995 112.222 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 25.3 t -72.97 123.88 90.09 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 106.874 -1.528 . . . . 75.209999999999994 106.874 165.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.96 -63.79 0.25 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.321 2.014 . . . . 65.150000000000006 115.104 -153.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -131.76 -29.73 1.68 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.597 1.189 . . . . 74.140000000000001 108.321 147.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.454 ' HD1' ' HB2' ' A' ' 254' ' ' TRP . 9.9 m-85 -101.48 139.43 37.15 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 113.191 -1.822 . . . . 73.239999999999995 110.636 -174.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.08 -40.3 3.5 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.353 1.061 . . . . 54.240000000000002 109.397 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -76.74 -20.6 56.34 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.868 0.867 . . . . 74.010000000000005 111.731 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.494 ' HE3' ' HA ' ' A' ' 97' ' ' ASN . 35.3 t90 -67.44 138.32 56.56 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.61 0.596 . . . . 74.239999999999995 112.61 -171.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 6.7 pt-20 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 124.973 1.309 . . . . 75.120000000000005 109.295 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.526 0.203 . . . . 74.310000000000002 110.565 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.06 56.42 0.74 Allowed Glycine 0 C--N 1.347 1.179 0 N-CA-C 110.275 -1.13 . . . . 73.340000000000003 110.275 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -76.51 107.25 8.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.439 0.695 . . . . 74.219999999999999 110.301 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -111.89 102.12 52.98 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.476 0.71 . . . . 71.540000000000006 110.507 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.98 96.43 0.35 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.804 2.336 . . . . 74.400000000000006 110.82 165.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.57 -179.02 51.9 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.824 -0.625 . . . . 53.119999999999997 113.642 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' HZ1' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -86.74 158.16 19.47 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.468 0.707 . . . . 74.150000000000006 112.327 -175.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.0 t -81.81 136.42 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.938 0.895 . . . . 72.209999999999994 110.145 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.61 174.81 14.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.635 1.174 . . . . 74.200000000000003 109.898 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.62 -158.12 4.05 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-O 119.854 -0.414 . . . . 72.299999999999997 112.635 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -75.35 -72.12 0.32 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.367 0.583 . . . . 75.129999999999995 110.374 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 50.38 33.31 7.42 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.222 1.009 . . . . 74.099999999999994 110.989 -171.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 138.39 58.47 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.3 -0.864 . . . . 75.340000000000003 111.26 -169.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.447 ' H ' ' NE ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -135.03 146.79 59.98 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 123.664 0.786 . . . . 75.129999999999995 109.666 -176.217 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.23 135.88 68.7 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.499 2.132 . . . . 74.319999999999993 111.29 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.7 t -83.78 -46.08 12.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.835 0.854 . . . . 50.310000000000002 110.272 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.1 mt 56.54 85.87 0.18 Allowed Pre-proline 0 CA--C 1.562 1.409 0 C-N-CA 124.824 1.249 . . . . 75.340000000000003 112.735 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.42 156.39 36.75 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.01 2.473 . . . . 74.030000000000001 112.808 177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.78 134.28 48.34 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.798 0.839 . . . . 62.210000000000001 109.055 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.3 78.19 9.67 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.3 0.572 . . . . 72.129999999999995 110.382 -175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -92.07 89.93 7.15 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.618 -0.882 . . . . 74.450000000000003 108.618 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -95.03 141.46 28.65 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.062 0.545 . . . . 75.340000000000003 110.244 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.0 tt -102.24 127.7 55.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.023 -0.732 . . . . 74.230000000000004 109.023 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.431 ' HE2' ' HD2' ' A' ' 28' ' ' LYS . 41.5 tttp -127.44 -92.62 0.48 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.52 -0.918 . . . . 72.510000000000005 108.52 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.63 -51.57 2.65 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 118.141 0.428 . . . . 54.539999999999999 113.683 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.14 100.05 2.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.157 0.583 . . . . 72.310000000000002 110.826 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.99 -176.55 53.24 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 116.463 -0.335 . . . . 74.519999999999996 113.229 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HD2' ' HE2' ' A' ' 24' ' ' LYS . 63.3 tttp 72.49 137.52 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.194 1.398 . . . . 74.409999999999997 111.594 -176.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -73.19 77.9 1.28 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 122.451 1.119 . . . . 74.439999999999998 109.37 170.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.529 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 33.1 tt0 -127.83 133.34 49.39 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.86 -1.064 . . . . 53.229999999999997 109.304 -171.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -64.82 124.54 22.24 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 124.252 0.97 . . . . 74.329999999999998 110.501 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 m 73.93 127.32 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.415 1.486 . . . . 74.329999999999998 112.01 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.529 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -92.57 163.21 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.238 -1.023 . . . . 75.010000000000005 108.238 167.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -79.1 77.03 5.6 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.116 0.484 . . . . 74.120000000000005 111.784 -172.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.1 -171.01 8.02 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 114.753 -1.112 . . . . 72.010000000000005 114.909 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.536 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.47 -38.5 95.85 Favored Glycine 0 CA--C 1.549 2.207 0 CA-C-O 117.703 -1.61 . . . . 64.299999999999997 115.647 171.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 8.6 Cg_endo -47.73 -23.95 4.34 Favored 'Trans proline' 0 C--N 1.401 3.325 0 C-N-CA 123.881 3.054 . . . . 65.329999999999998 115.575 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 79.2 t60 70.63 9.87 6.98 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.176 0.99 . . . . 73.340000000000003 112.576 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.5 t 61.9 41.75 11.1 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.253 1.021 . . . . 64.310000000000002 109.833 -170.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 71.08 -177.76 0.21 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.921 1.688 . . . . 71.109999999999999 110.534 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.9 m -56.51 159.28 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 113.284 0.846 . . . . 64.439999999999998 113.284 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -76.49 164.59 25.81 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.193 -0.912 . . . . 75.040000000000006 109.968 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.59 153.04 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 123.073 0.549 . . . . 65.430000000000007 110.779 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.17 -152.51 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.729 1.211 . . . . 71.140000000000001 113.787 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -34.94 97.65 0.01 OUTLIER 'General case' 0 C--N 1.368 1.394 0 C-N-CA 126.599 1.96 . . . . 74.299999999999997 113.002 174.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.4 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.852 1.261 . . . . 71.219999999999999 111.979 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.04 163.28 13.19 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.359 0.664 . . . . 75.099999999999994 109.837 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.99 166.15 14.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.022 0.529 . . . . 63.140000000000001 110.556 172.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -54.89 123.14 12.48 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.583 -0.525 . . . . 75.030000000000001 109.583 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -63.5 116.36 25.32 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 124.269 0.98 . . . . 71.5 109.617 -168.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.69 98.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.857 2.371 . . . . 73.530000000000001 111.741 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.05 135.07 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.236 1.015 . . . . 74.109999999999999 111.134 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.6 -85.74 0.36 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.3 -0.409 . . . . 72.25 111.658 -169.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.1 p -115.94 -11.86 11.44 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.895 0.878 . . . . 75.519999999999996 110.048 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -88.61 8.13 29.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.85 1.26 . . . . 75.430000000000007 112.088 -171.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -58.61 147.58 31.94 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.603 0.761 . . . . 71.040000000000006 111.413 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -57.08 116.87 14.77 Favored Pre-proline 0 CA--C 1.555 1.158 0 O-C-N 123.763 0.664 . . . . 73.010000000000005 110.405 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.59 9.39 3.49 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.615 2.21 . . . . 74.0 112.955 -174.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -79.68 -74.12 0.31 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.336 0.654 . . . . 75.319999999999993 110.345 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.81 -37.56 3.07 Favored Glycine 0 N--CA 1.479 1.565 0 C-N-CA 122.762 0.22 . . . . 62.140000000000001 112.777 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.03 -178.88 7.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.353 1.061 . . . . 70.439999999999998 110.361 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 m -75.03 163.21 27.83 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.143 0.497 . . . . 53.240000000000002 111.039 174.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -30.4 64.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.306 1.042 . . . . 74.340000000000003 113.658 -176.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.47 -64.74 1.05 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.249 -0.648 . . . . 54.32 109.249 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.89 -77.99 0.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.053 -0.976 . . . . 71.120000000000005 109.871 175.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -125.23 -53.86 1.6 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.461 0.704 . . . . 75.430000000000007 109.289 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -136.24 102.44 4.99 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.947 0.499 . . . . 75.239999999999995 109.962 -173.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -84.2 -36.08 23.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.314 0.646 . . . . 74.349999999999994 111.355 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.9 p -77.53 7.26 5.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.954 0.902 . . . . 72.120000000000005 112.702 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -62.04 -39.49 92.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.766 1.226 . . . . 73.409999999999997 111.21 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.0 -34.13 71.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 110.274 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -73.28 -12.86 61.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.398 0.679 . . . . 65.209999999999994 110.989 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.1 tp -67.29 -51.68 49.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.801 0.84 . . . . 72.030000000000001 111.868 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.4 mt -112.46 22.04 15.06 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.741 0.416 . . . . 72.219999999999999 110.133 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.98 -21.19 65.95 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 62.409999999999997 112.036 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.47 -139.62 20.41 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.103 -0.831 . . . . 64.439999999999998 111.672 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.21 -178.22 3.93 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.561 2.174 . . . . 74.510000000000005 112.72 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 m -67.17 126.9 30.68 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.548 -0.908 . . . . 73.230000000000004 108.548 170.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -64.4 -46.18 84.42 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.057 1.132 . . . . 74.129999999999995 114.057 -161.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.95 -39.73 1.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 118.058 0.39 . . . . 75.010000000000005 110.852 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.629 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 20.3 m-20 -93.6 104.45 12.75 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.906 -1.045 . . . . 72.299999999999997 110.35 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.95 -33.47 92.35 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.317 2.012 . . . . 63.450000000000003 113.009 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -94.38 22.03 6.48 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.709 0.804 . . . . 73.319999999999993 110.744 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 23.9 tp -77.34 131.56 38.16 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.634 -0.666 . . . . 75.310000000000002 109.527 174.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -115.54 173.12 6.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.446 1.099 . . . . 74.329999999999998 109.84 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.73 138.96 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.003 1.321 . . . . 45.310000000000002 108.84 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HB1' HD23 ' A' ' 107' ' ' LEU . . . -79.72 138.23 37.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.511 0.724 . . . . 73.439999999999998 110.349 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 143' ' ' LYS . 82.7 mt -104.01 -35.48 8.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.728 0.811 . . . . 75.299999999999997 110.987 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.458 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 44.0 m-85 -122.48 140.93 52.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.194 -0.912 . . . . 74.5 108.874 -173.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HB2' ' HZ2' ' A' ' 241' ' ' LYS . 3.5 m-20 -68.5 124.87 24.75 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.984 -0.747 . . . . 75.310000000000002 108.984 171.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.624 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.2 t80 -114.24 139.45 49.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.261 -1.015 . . . . 74.310000000000002 108.261 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.97 131.82 59.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.523 -1.288 . . . . 74.340000000000003 107.523 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.71 119.13 4.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.839 0.855 . . . . 72.450000000000003 111.709 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.5 p -84.28 -27.31 27.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.498 0.719 . . . . 74.129999999999995 111.158 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -141.38 -169.62 11.96 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.805 -0.918 . . . . 71.540000000000006 110.805 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.68 -44.63 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.005 0.431 . . . . 74.439999999999998 111.257 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.473 HD22 ' HD2' ' A' ' 249' ' ' PRO . 26.5 p-10 -71.47 -24.68 62.04 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.151 -0.931 . . . . 63.439999999999998 111.657 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.0 p -79.99 160.28 25.96 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.332 0.653 . . . . 64.400000000000006 110.775 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.7 tp -133.44 136.4 45.16 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.968 0.507 . . . . 73.319999999999993 111.371 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 m -75.48 134.0 40.93 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.544 0.738 . . . . 63.420000000000002 111.312 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.624 HG12 ' HB3' ' A' ' 91' ' ' PHE . 21.8 pt -127.22 166.77 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.167 0.587 . . . . 74.329999999999998 111.818 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.0 m -126.42 157.19 39.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.727 -1.124 . . . . 62.240000000000002 110.479 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -47.29 119.57 2.71 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.227 1.011 . . . . 74.010000000000005 111.808 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.91 8.61 78.29 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 115.129 0.811 . . . . 71.239999999999995 115.129 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -68.53 122.24 18.06 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.268 0.627 . . . . 71.140000000000001 110.764 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -75.92 128.76 35.75 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.128 -0.693 . . . . 74.439999999999998 109.128 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.46 HD23 ' HB1' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -147.91 166.94 26.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.71 0.804 . . . . 75.329999999999998 110.783 -173.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -122.72 117.44 25.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.927 0.491 . . . . 75.230000000000004 110.151 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.531 HG11 ' HB1' ' A' ' 119' ' ' ALA . 41.6 t -81.05 112.38 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.196 0.598 . . . . 74.120000000000005 110.139 175.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.5 -35.17 40.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.442 -0.799 . . . . 71.420000000000002 109.965 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.98 147.56 6.09 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.437 0.461 . . . . 44.140000000000001 112.87 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.522 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 47.2 m-85 -86.95 162.78 17.49 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.381 0.672 . . . . 74.450000000000003 111.458 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -81.69 -173.73 4.6 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.302 -0.863 . . . . 71.200000000000003 110.361 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -52.5 -36.95 56.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.28 1.432 . . . . 74.040000000000006 113.838 -170.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -112.17 -3.76 14.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.471 0.708 . . . . 62.350000000000001 111.853 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 72.61 33.97 60.34 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.54 -0.589 . . . . 71.329999999999998 114.566 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -84.91 -38.39 19.44 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.402 0.601 . . . . 74.400000000000006 110.717 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 70.3 m95 -123.0 154.13 38.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.57 0.748 . . . . 74.439999999999998 110.561 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.531 ' HB1' HG11 ' A' ' 109' ' ' VAL . . . -134.35 132.4 39.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.027 0.931 . . . . 74.219999999999999 109.991 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.4 114.22 7.44 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 106.172 -1.788 . . . . 73.310000000000002 106.172 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.31 150.85 49.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 64.030000000000001 111.028 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -106.38 116.38 31.83 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.522 -1.288 . . . . 74.040000000000006 107.522 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.502 HG21 HG23 ' A' ' 101' ' ' ILE . 22.9 p -116.96 174.43 6.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.434 0.694 . . . . 74.120000000000005 110.167 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -62.85 -24.24 67.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.311 0.645 . . . . 74.129999999999995 110.22 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.06 -27.57 60.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.497 0.719 . . . . 74.519999999999996 111.608 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.75 -125.1 2.21 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 121.408 -0.425 . . . . 75.049999999999997 113.538 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -134.94 140.42 45.71 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.757 0.823 . . . . 70.450000000000003 110.499 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.478 ' HA2' ' HZ3' ' A' ' 254' ' ' TRP . . . 149.51 176.87 23.09 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 113.709 0.243 . . . . 75.219999999999999 113.709 176.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -80.87 120.6 24.91 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.127 0.971 . . . . 74.030000000000001 112.28 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.434 HG23 HD12 ' A' ' 135' ' ' ILE . 4.2 m -121.79 139.63 30.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.312 1.045 . . . . 65.430000000000007 108.638 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 3.1 Cg_exo -76.05 143.45 25.86 Favored 'Trans proline' 0 CA--C 1.561 1.863 0 C-N-CA 122.631 2.221 . . . . 74.310000000000002 114.46 -172.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -39.54 -49.61 2.14 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.85 1.66 . . . . 64.430000000000007 113.469 168.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 18.6 p-10 -76.3 7.18 4.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.777 0.831 . . . . 73.019999999999996 112.581 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.501 ' HB3' HD13 ' A' ' 101' ' ' ILE . 16.5 m-85 -115.87 -9.12 11.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.349 1.06 . . . . 74.349999999999994 111.568 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 130' ' ' VAL . 10.8 pt -132.37 171.43 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.96 0.904 . . . . 75.109999999999999 111.215 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -164.17 152.18 10.91 Favored Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.479 -0.772 . . . . 74.150000000000006 109.151 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -58.15 157.85 24.02 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.441 2.094 . . . . 74.530000000000001 113.791 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.55 -8.28 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 123.271 0.628 . . . . 65.209999999999994 111.783 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -102.11 0.82 35.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 72.040000000000006 111.866 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.9 p -77.1 168.11 20.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.13 0.572 . . . . 63.109999999999999 112.197 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.22 -24.65 27.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.149 -0.478 . . . . 72.049999999999997 110.352 167.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.4 -23.59 66.34 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.366 0.666 . . . . 73.019999999999996 111.599 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.65 ' HA ' HD22 ' A' ' 88' ' ' LEU . 20.9 pttm -62.49 -18.21 61.38 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.761 0.663 . . . . 73.430000000000007 112.522 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.99 141.98 30.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.648 -0.705 . . . . 75.430000000000007 110.512 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 p -62.67 -40.14 96.14 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.379 1.049 . . . . 73.319999999999993 111.13 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -66.14 -37.58 86.05 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.163 0.801 . . . . 75.409999999999997 113.163 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 38.9 t80 -76.41 113.6 14.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.854 -0.424 . . . . 75.239999999999995 109.854 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -109.23 -5.24 15.98 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.086 0.554 . . . . 74.049999999999997 112.473 -177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.67 -145.68 42.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 118.652 -1.082 . . . . 71.239999999999995 112.843 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.35 94.88 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.06 2.507 . . . . 75.219999999999999 112.996 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 49.0 t -135.74 126.98 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.994 1.318 . . . . 74.319999999999993 109.257 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.9 p -83.92 175.44 9.58 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.912 0.885 . . . . 72.540000000000006 110.323 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -60.75 -40.4 92.29 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 119.467 -0.301 . . . . 75.239999999999995 110.934 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -53.54 -49.88 66.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.183 0.593 . . . . 71.099999999999994 110.923 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.477 ' HB2' HG13 ' A' ' 151' ' ' VAL . . . -71.0 -26.18 63.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.224 -0.898 . . . . 62.32 111.634 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.4 -46.45 60.22 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.067 0.547 . . . . 64.209999999999994 111.821 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.6 mm-40 -68.72 -32.91 73.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.559 -0.534 . . . . 73.450000000000003 109.559 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.08 -47.82 82.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.115 0.966 . . . . 72.209999999999994 110.664 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.425 HD11 HD22 ' A' ' 169' ' ' LEU . 12.9 mt -58.54 -45.43 88.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.875 0.87 . . . . 72.409999999999997 111.487 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.42 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 97.9 mt -92.99 8.0 41.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.749 0.648 . . . . 74.219999999999999 112.749 -176.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.4 p -64.05 -37.26 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 118.713 0.688 . . . . 70.409999999999997 110.377 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.4 p -101.93 18.44 20.6 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.138 0.975 . . . . 73.549999999999997 111.504 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.21 165.26 32.68 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.285 -0.416 . . . . 74.519999999999996 112.409 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.34 -179.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.58 0.752 . . . . 75.010000000000005 111.213 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.57 125.81 24.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.316 -0.856 . . . . 74.549999999999997 110.026 169.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.435 ' HA2' HD13 ' A' ' 184' ' ' LEU . . . 90.02 9.67 65.46 Favored Glycine 0 C--O 1.242 0.651 0 CA-C-O 119.192 -0.782 . . . . 64.319999999999993 113.022 -177.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.8 m -87.68 116.87 26.11 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 117.669 0.734 . . . . 75.120000000000005 110.526 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.419 ' HB3' HD11 ' A' ' 184' ' ' LEU . 21.0 p90 -128.24 167.92 16.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.936 0.495 . . . . 75.420000000000002 111.118 -172.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.425 HD22 HD11 ' A' ' 159' ' ' LEU . 4.3 pp -159.56 142.35 13.95 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.579 -0.737 . . . . 73.099999999999994 109.622 174.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.657 HG21 HG12 ' A' ' 182' ' ' ILE . 74.2 t -100.27 115.3 41.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.988 -1.116 . . . . 75.040000000000006 107.988 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.583 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 41.9 ptt85 -115.91 143.1 45.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.566 0.746 . . . . 74.25 109.074 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -94.1 149.15 21.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.534 -0.913 . . . . 72.400000000000006 108.534 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 t -76.28 127.5 33.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.176 0.59 . . . . 72.129999999999995 109.585 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.0 -31.46 70.3 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.685 -0.689 . . . . 75.25 109.419 171.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 34.0 m -66.17 -34.81 78.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.924 0.89 . . . . 73.510000000000005 111.132 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.9 p -148.21 93.41 4.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.084 0.553 . . . . 71.120000000000005 110.841 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.14 138.23 85.35 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.895 2.396 . . . . 73.400000000000006 112.379 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.84 -29.93 10.74 Favored Glycine 0 C--N 1.345 1.029 0 C-N-CA 123.324 0.488 . . . . 74.439999999999998 111.959 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -82.72 117.72 22.85 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.822 -0.807 . . . . 74.439999999999998 108.822 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.505 0.669 . . . . 75.099999999999994 110.446 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 61.4 m -140.52 149.28 42.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.775 1.23 . . . . 71.310000000000002 108.588 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.657 HG12 HG21 ' A' ' 170' ' ' VAL . 25.9 mt -102.42 146.3 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.684 -1.228 . . . . 72.299999999999997 107.684 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 46.3 m -124.29 107.98 11.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.881 -1.155 . . . . 71.219999999999999 107.881 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.435 HD13 ' HA2' ' A' ' 166' ' ' GLY . 45.5 tp -105.45 114.25 28.31 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.087 0.555 . . . . 75.439999999999998 110.507 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.42 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -76.92 116.72 17.84 Favored 'General case' 0 C--O 1.254 1.321 0 CA-C-O 121.43 0.633 . . . . 73.019999999999996 109.946 166.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -139.59 138.52 36.27 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.498 1.519 . . . . 73.549999999999997 107.462 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 59.67 22.02 10.74 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.927 0.891 . . . . 62.530000000000001 111.887 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.61 -12.63 55.69 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.345 -0.389 . . . . 72.420000000000002 113.869 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -98.99 144.93 27.59 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.547 0.739 . . . . 74.209999999999994 109.463 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.8 t -103.31 110.19 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.066 0.46 . . . . 74.209999999999994 110.532 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -96.94 124.51 40.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.849 1.259 . . . . 74.109999999999999 109.513 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -98.66 119.09 36.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.31 0.644 . . . . 73.450000000000003 111.286 -172.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.548 ' HE1' HD21 ' A' ' 232' ' ' LEU . 4.9 m-85 -95.42 150.72 19.98 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.574 -0.899 . . . . 75.5 108.574 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -106.81 125.3 50.83 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.276 -0.639 . . . . 73.450000000000003 109.276 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.4 mt -85.39 102.41 11.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.428 -0.953 . . . . 74.430000000000007 108.428 172.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -85.38 147.14 26.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.823 -1.08 . . . . 74.530000000000001 109.666 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -108.68 135.69 49.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.475 0.71 . . . . 75.450000000000003 109.648 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.9 176.88 7.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.578 0.751 . . . . 72.150000000000006 110.227 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.0 p -65.7 -28.91 69.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.208 0.603 . . . . 72.129999999999995 112.379 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -91.85 -17.34 25.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 75.319999999999993 110.243 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.11 9.21 16.1 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.914 -0.937 . . . . 72.219999999999999 114.847 175.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.72 130.21 45.36 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.3 1.05 . . . . 73.140000000000001 111.58 176.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -86.54 141.12 29.28 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.876 -1.157 . . . . 71.030000000000001 107.876 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.611 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.1 p90 -167.44 132.11 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.579 0.55 . . . . 73.239999999999995 110.961 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 217' ' ' LEU . 70.6 t -77.62 -38.0 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.688 -0.856 . . . . 74.329999999999998 108.688 164.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.7 m -105.54 123.38 47.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.625 -1.17 . . . . 64.129999999999995 109.513 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -64.24 -25.16 67.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.488 0.715 . . . . 74.310000000000002 112.489 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -77.3 -24.38 50.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.625 0.77 . . . . 75.409999999999997 110.946 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.8 m -129.68 100.43 5.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.186 0.594 . . . . 75.340000000000003 109.679 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.611 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 77.7 mtt180 -107.22 138.8 42.73 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 74.530000000000001 109.209 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -124.34 146.65 48.7 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.85 -37.56 87.84 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.933 0.771 . . . . 73.5 110.381 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -127.81 157.43 40.45 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.738 0.815 . . . . 74.430000000000007 111.609 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.81 -25.32 67.18 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.689 -1.141 . . . . 75.219999999999999 109.741 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.85 97.35 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.447 0.699 . . . . 72.349999999999994 111.019 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.38 -34.42 67.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.438 0.695 . . . . 75.010000000000005 111.48 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.488 HD13 ' HD1' ' A' ' 221' ' ' HIS . 14.9 tp -56.48 -54.57 44.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.815 0.446 . . . . 75.310000000000002 111.141 174.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.68 -38.41 82.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 O-C-N 123.776 0.673 . . . . 64.430000000000007 110.677 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -58.29 -57.31 13.46 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 75.329999999999998 111.253 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -63.14 -39.61 95.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.722 -0.672 . . . . 73.230000000000004 111.1 -176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.699 ' HB3' HD13 ' A' ' 228' ' ' LEU . 41.8 m80 -85.45 -6.09 59.24 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.323 0.49 . . . . 65.230000000000004 112.323 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 91.6 p -98.07 -14.42 20.49 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.027 0.376 . . . . 64.200000000000003 111.12 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 50.7 p -83.63 -40.05 19.49 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 110.23 -0.285 . . . . 73.150000000000006 110.23 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 226' ' ' ASP . 16.1 m -138.6 167.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 113.36 0.874 . . . . 73.219999999999999 113.36 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -81.53 13.24 3.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.983 2.113 . . . . 74.340000000000003 113.659 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.565 ' HB2' HG21 ' A' ' 224' ' ' VAL . 35.8 t70 -41.95 33.67 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 1 C-N-CA 132.091 4.156 . . . . 71.319999999999993 118.744 -158.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 126.35 -5.52 7.67 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 120.068 -1.645 . . . . 63.009999999999998 112.986 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.699 HD13 ' HB3' ' A' ' 221' ' ' HIS . 14.1 mt -90.45 161.09 15.7 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.447 1.099 . . . . 71.109999999999999 109.484 174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.7 tt -56.74 -36.36 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-O 120.958 0.409 . . . . 72.140000000000001 110.418 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.3 t -161.03 170.9 19.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.292 0.637 . . . . 65.349999999999994 110.189 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 29.5 m -63.1 138.33 58.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.513 1.125 . . . . 70.430000000000007 111.889 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.548 HD21 ' HE1' ' A' ' 193' ' ' TYR . 65.1 mt -73.43 135.06 44.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.263 -0.643 . . . . 73.209999999999994 109.263 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.82 -76.16 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.524 0.602 . . . . 73.430000000000007 110.809 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 167' ' ' SER . 19.9 t80 -85.4 121.39 73.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 108.393 -0.966 . . . . 75.129999999999995 108.393 -177.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.05 125.06 3.98 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.364 2.043 . . . . 75.519999999999996 111.396 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.1 134.53 94.5 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.773 -0.649 . . . . 60.149999999999999 110.076 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.67 -179.15 4.85 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.603 2.202 . . . . 74.439999999999998 111.988 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.34 152.07 45.96 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.151 0.58 . . . . 74.430000000000007 109.587 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -88.92 -62.21 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.532 0.567 . . . . 74.409999999999997 112.532 -172.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -111.24 149.05 31.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.283 0.633 . . . . 74.349999999999994 110.74 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.537 ' HZ2' ' HB2' ' A' ' 90' ' ' ASP . 99.9 mttt -83.57 114.88 56.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 106.807 -1.553 . . . . 75.010000000000005 106.807 160.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.519 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 19.5 Cg_exo -65.27 122.52 10.26 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.085 1.857 . . . . 62.229999999999997 111.817 -168.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.0 m -72.24 112.43 8.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.948 0.499 . . . . 75.109999999999999 110.233 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.29 106.69 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.571 -1.27 . . . . 75.439999999999998 107.571 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -85.5 114.82 22.82 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.702 0.401 . . . . 64.129999999999995 111.776 -161.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.12 0.42 0.71 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.645 1.818 . . . . 73.420000000000002 117.645 164.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.48 HG22 ' HE1' ' A' ' 118' ' ' TRP . 24.1 m -96.99 122.82 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.174 1.487 . . . . 65.340000000000003 112.801 -169.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.4 t -78.66 135.33 60.23 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 113.793 -1.549 . . . . 73.25 107.377 160.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.473 ' HD2' HD22 ' A' ' 97' ' ' ASN . 33.1 Cg_exo -61.42 -59.91 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 121.137 1.225 . . . . 73.019999999999996 112.645 -169.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -132.66 -25.93 1.85 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.133 0.973 . . . . 71.510000000000005 109.168 149.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.16 121.31 41.61 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.635 -1.166 . . . . 74.439999999999998 113.427 -156.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -100.93 -27.0 13.54 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.018 -0.734 . . . . 74.109999999999999 109.018 162.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -79.4 -40.92 28.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.696 0.798 . . . . 73.230000000000004 112.444 -175.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.478 ' HZ3' ' HA2' ' A' ' 128' ' ' GLY . 25.8 t90 -59.51 135.69 57.75 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.512 0.507 . . . . 73.140000000000001 112.354 -163.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 CA--C 1.556 1.206 0 CA-C-N 114.159 -1.382 . . . . 74.400000000000006 111.665 179.81 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.451 -0.944 . . . . 74.230000000000004 108.451 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.47 74.07 0.1 OUTLIER Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.424 -0.671 . . . . 71.150000000000006 111.424 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -129.09 -86.83 0.54 Allowed 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.123 -1.066 . . . . 75.209999999999994 108.123 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 173.16 84.79 0.05 OUTLIER Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 125.008 1.323 . . . . 71.349999999999994 108.014 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.85 101.77 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.402 2.068 . . . . 72.450000000000003 111.557 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 -124.79 1.66 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.944 -0.462 . . . . 72.219999999999999 111.944 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -92.37 35.54 1.01 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.205 0.602 . . . . 74.519999999999996 110.466 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.8 m -73.9 80.5 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-O 122.01 0.909 . . . . 71.230000000000004 110.678 175.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -83.22 130.94 35.12 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.552 -1.277 . . . . 75.439999999999998 107.552 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.23 73.35 1.26 Allowed Glycine 0 C--N 1.339 0.749 0 O-C-N 123.604 0.565 . . . . 71.439999999999998 113.017 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -145.04 136.39 25.13 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.004 0.922 . . . . 61.049999999999997 109.598 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -163.06 88.71 0.61 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.586 1.154 . . . . 73.209999999999994 109.199 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -140.3 129.22 23.34 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.033 0.933 . . . . 72.310000000000002 109.718 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -113.22 90.35 16.38 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 124.322 1.049 . . . . 73.120000000000005 109.319 175.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.79 85.0 0.63 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.121 2.547 . . . . 74.010000000000005 111.708 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.2 m -86.0 96.97 10.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.613 0.765 . . . . 73.420000000000002 110.232 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.4 mt -119.8 110.16 37.1 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.933 0.893 . . . . 74.25 109.63 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.36 94.17 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.66 2.24 . . . . 64.209999999999994 111.101 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.38 121.62 26.46 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 122.95 0.5 . . . . 60.439999999999998 110.388 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.72 152.07 37.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.671 0.788 . . . . 73.430000000000007 109.172 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -160.87 173.74 14.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.88 0.872 . . . . 75.430000000000007 109.953 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -84.97 141.8 30.08 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.464 0.706 . . . . 62.509999999999998 110.13 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.2 pt -74.33 157.59 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.445 0.64 . . . . 54.530000000000001 111.51 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -111.56 88.58 2.83 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.379 -1.341 . . . . 74.230000000000004 107.379 171.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.54 47.21 3.79 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.621 -0.544 . . . . 63.210000000000001 113.821 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 63.87 -78.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.349 1.46 . . . . 75.409999999999997 111.448 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.97 -0.29 3.17 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.215 0.436 . . . . 70.430000000000007 112.887 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -73.51 88.58 1.64 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.561 0.745 . . . . 74.310000000000002 109.453 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.9 mmm-85 -141.76 86.94 2.02 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.997 0.919 . . . . 75.530000000000001 110.262 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -86.89 -75.11 0.41 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.544 -0.91 . . . . 74.230000000000004 108.544 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.1 m 58.53 -175.28 0.09 Allowed 'General case' 0 C--N 1.36 1.044 0 C-N-CA 124.248 1.019 . . . . 74.140000000000001 112.054 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.8 t -128.92 -21.0 3.4 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 122.017 -0.427 . . . . 71.310000000000002 110.166 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -78.14 -82.28 0.09 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.152 0.581 . . . . 75.239999999999995 109.475 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -155.69 -171.89 3.93 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.753 1.221 . . . . 74.230000000000004 108.543 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.02 -109.44 0.4 Allowed Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.555 -0.618 . . . . 74.120000000000005 111.555 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.39 -82.08 0.15 Allowed Glycine 0 C--N 1.339 0.73 0 CA-C-O 119.368 -0.684 . . . . 73.200000000000003 112.308 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.53 -179.92 5.9 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.792 2.328 . . . . 72.420000000000002 112.461 175.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -115.78 -163.56 0.9 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.788 0.835 . . . . 74.219999999999999 109.745 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.12 115.26 5.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.223 0.609 . . . . 72.209999999999994 111.791 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -76.13 -22.94 54.91 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.071 0.948 . . . . 63.200000000000003 110.985 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.4 t 58.68 -96.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 124.57 1.148 . . . . 64.409999999999997 109.815 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -177.2 -179.21 0.86 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.899 1.28 . . . . 72.099999999999994 109.116 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.85 157.41 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 N-CA-C 108.782 -0.822 . . . . 72.0 108.782 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 68.41 -169.08 0.19 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.772 1.229 . . . . 71.219999999999999 113.025 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -143.12 169.16 18.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.632 1.173 . . . . 71.530000000000001 109.429 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -75.63 146.47 40.29 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.152 0.581 . . . . 74.319999999999993 111.388 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.8 165.94 18.39 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.513 0.725 . . . . 73.299999999999997 110.005 173.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.409 HD13 ' HB2' ' A' ' 161' ' ' SER . 78.1 mt -83.89 170.6 13.88 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.306 0.642 . . . . 75.129999999999995 111.12 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -116.59 159.68 21.8 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.712 0.805 . . . . 74.109999999999999 109.908 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.84 135.72 55.41 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.523 0.729 . . . . 72.510000000000005 110.076 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.96 145.93 96.58 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.347 2.031 . . . . 73.129999999999995 112.386 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.3 m -79.61 172.94 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.49 0.716 . . . . 74.329999999999998 110.277 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.03 92.79 0.54 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.265 0.626 . . . . 74.310000000000002 109.318 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.8 p -100.73 78.48 1.98 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.762 0.825 . . . . 72.450000000000003 109.985 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.59 -67.46 0.47 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.852 -0.613 . . . . 74.209999999999994 109.971 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -94.07 114.56 26.74 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.543 0.737 . . . . 75.319999999999993 109.616 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.13 108.04 10.4 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.158 0.983 . . . . 71.430000000000007 108.448 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.23 -52.85 1.35 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.85 2.367 . . . . 74.299999999999997 114.004 -168.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -119.95 -27.32 5.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.284 0.476 . . . . 74.439999999999998 112.284 -171.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.33 -82.09 0.68 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.513 -0.635 . . . . 74.239999999999995 111.513 -171.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.9 tp -112.76 145.47 40.49 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.956 0.903 . . . . 72.209999999999994 109.18 175.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.0 p -136.53 168.58 19.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.894 1.278 . . . . 74.439999999999998 108.906 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -113.12 -49.51 2.92 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.127 0.571 . . . . 74.319999999999993 111.706 -172.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 68' ' ' ASN . . . -59.61 -71.96 0.11 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 112.994 0.739 . . . . 74.439999999999998 112.994 -168.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.26 16.01 4.77 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.015 0.526 . . . . 71.519999999999996 111.752 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -106.87 -61.08 1.59 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.029 -0.73 . . . . 65.540000000000006 109.029 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -165.76 73.25 0.18 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.348 0.594 . . . . 73.219999999999999 110.516 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 64' ' ' ALA . 33.6 p-10 -82.76 -20.73 35.34 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.755 -0.657 . . . . 72.209999999999994 110.074 169.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 m -70.79 3.15 3.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.306 1.443 . . . . 75.120000000000005 112.886 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.89 -24.4 66.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.794 0.838 . . . . 74.430000000000007 111.612 175.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -81.85 -36.58 28.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.034 0.534 . . . . 71.209999999999994 110.126 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.81 -5.81 49.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.949 0.9 . . . . 62.409999999999997 110.528 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.3 tp -58.96 -51.01 71.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.685 1.194 . . . . 75.329999999999998 111.522 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.75 -53.2 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.014 0.526 . . . . 72.209999999999994 110.37 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.66 -55.57 22.51 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.625 0.77 . . . . 75.25 111.897 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.08 140.1 4.37 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.987 -1.006 . . . . 73.450000000000003 111.254 -170.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.59 114.08 2.93 Favored 'Trans proline' 0 C--N 1.371 1.722 0 CA-C-N 119.745 1.772 . . . . 72.140000000000001 111.545 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.5 t -123.18 127.79 49.14 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.746 1.218 . . . . 74.349999999999994 108.444 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.76 -52.42 6.42 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.507 -0.553 . . . . 62.130000000000003 109.507 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -135.98 -37.18 0.73 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.828 0.851 . . . . 71.420000000000002 110.512 164.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -89.48 131.26 40.73 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 115.151 -0.931 . . . . 70.140000000000001 112.85 -166.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.29 -5.5 16.26 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.072 2.515 . . . . 72.040000000000006 111.874 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -106.24 7.81 31.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.45 1.1 . . . . 74.329999999999998 110.612 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -57.53 148.38 24.05 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 73.25 111.295 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -111.88 163.87 13.73 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.52 0.728 . . . . 74.129999999999995 109.653 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 138.58 46.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 124.423 1.089 . . . . 73.030000000000001 108.619 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.452 ' HB1' HD22 ' A' ' 107' ' ' LEU . . . -76.33 115.27 15.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.776 0.83 . . . . 74.409999999999997 109.481 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.525 HD13 ' HZ1' ' A' ' 238' ' ' LYS . 68.8 mt -71.98 -38.52 69.69 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.272 0.558 . . . . 74.450000000000003 110.698 175.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.55 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 6.0 m-85 -125.18 151.81 45.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.981 -1.008 . . . . 74.030000000000001 108.769 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.46 125.49 29.43 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.973 -0.751 . . . . 73.230000000000004 108.973 166.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.606 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.5 t80 -106.35 135.01 48.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.797 -1.186 . . . . 71.450000000000003 107.797 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -102.04 134.96 41.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.23 -1.026 . . . . 74.439999999999998 108.23 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.8 134.88 57.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.02 0.928 . . . . 70.329999999999998 111.822 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.5 p -98.82 -53.22 3.35 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.022 0.929 . . . . 74.430000000000007 109.071 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.73 176.28 33.45 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.116 -0.947 . . . . 61.119999999999997 111.747 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.59 -21.41 57.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.839 0.855 . . . . 72.439999999999998 111.521 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -93.55 -26.09 17.28 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.763 0.825 . . . . 72.420000000000002 111.656 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.3 p -73.03 134.83 44.78 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.111 -0.7 . . . . 74.409999999999997 109.111 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.638 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 63.6 tp -104.55 125.72 50.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.453 0.701 . . . . 72.450000000000003 110.561 -167.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -70.35 132.25 45.36 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.952 0.783 . . . . 74.329999999999998 109.842 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.712 HG22 HG23 ' A' ' 123' ' ' THR . 9.8 pt -119.13 148.82 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.728 -0.471 . . . . 71.239999999999995 109.728 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -86.3 149.48 25.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.625 0.77 . . . . 74.430000000000007 109.354 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.73 113.35 6.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.71 0.404 . . . . 74.120000000000005 110.318 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.79 61.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.379 -0.373 . . . . 73.310000000000002 112.927 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 36.6 tt0 -73.09 135.48 44.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.708 0.803 . . . . 75.120000000000005 111.801 -175.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -80.03 126.54 31.18 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.554 -0.906 . . . . 72.540000000000006 108.554 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.452 HD22 ' HB1' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -148.16 153.59 39.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.244 0.545 . . . . 72.420000000000002 110.8 -174.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -108.56 130.23 55.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.833 0.853 . . . . 73.439999999999998 108.965 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 119' ' ' ALA . 53.3 t -88.03 130.52 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.213 -1.032 . . . . 72.420000000000002 108.213 168.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' A' ' 120' ' ' GLU . 36.0 mt -92.67 -29.19 16.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.221 1.009 . . . . 74.209999999999994 109.623 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.54 145.36 4.44 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.207 -0.906 . . . . 74.109999999999999 111.547 175.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.678 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 62.3 m-85 -86.23 160.34 19.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.212 0.506 . . . . 74.219999999999999 110.033 173.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -83.34 -172.43 4.14 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 73.230000000000004 110.539 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -52.34 -41.46 63.04 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.268 1.027 . . . . 73.109999999999999 113.504 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -95.46 -2.41 48.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.407 0.683 . . . . 74.519999999999996 111.341 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 60.51 22.5 59.17 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.029 0.772 . . . . 61.100000000000001 115.029 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.02 -16.54 18.66 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.396 0.679 . . . . 74.010000000000005 110.82 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 56.2 m95 -131.53 143.4 50.35 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.068 0.947 . . . . 73.530000000000001 110.026 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.49 ' HB1' ' CD2' ' A' ' 112' ' ' TYR . . . -123.28 149.04 45.29 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.462 1.105 . . . . 74.519999999999996 110.042 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HG2' HD11 ' A' ' 110' ' ' LEU . 38.6 tt0 -82.85 107.73 15.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.469 -1.678 . . . . 72.329999999999998 106.469 164.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.45 152.53 40.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.419 0.628 . . . . 74.040000000000006 112.141 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -112.57 103.98 12.05 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.346 -1.297 . . . . 73.349999999999994 108.171 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.712 HG23 HG22 ' A' ' 101' ' ' ILE . 39.5 p -101.62 176.25 5.29 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.111 0.964 . . . . 75.430000000000007 110.206 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -71.56 -14.29 62.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.943 0.497 . . . . 70.439999999999998 110.265 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -85.28 -18.05 35.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.321 1.049 . . . . 73.340000000000003 111.187 172.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.25 -165.23 23.2 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-O 120.3 -0.167 . . . . 73.409999999999997 113.347 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -92.22 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.203 0.601 . . . . 72.340000000000003 111.393 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 176.01 -161.12 29.51 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.52 0.512 . . . . 54.350000000000001 112.443 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -112.11 120.46 41.9 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.34 0.656 . . . . 73.430000000000007 111.635 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.76 143.5 47.84 Favored Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 124.015 0.926 . . . . 73.340000000000003 109.923 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 83.1 Cg_endo -84.69 145.44 10.31 Favored 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 121.943 1.762 . . . . 75.109999999999999 114.827 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -38.68 -46.48 1.23 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.281 1.832 . . . . 74.540000000000006 114.526 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.482 HD21 ' HB2' ' A' ' 242' ' ' PRO . 30.0 p-10 -75.03 -7.66 54.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.857 0.863 . . . . 74.200000000000003 113.014 -169.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.55 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 29.4 m-85 -103.64 -10.61 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.388 0.675 . . . . 75.219999999999999 111.904 174.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.0 pt -123.78 170.84 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.92 0.888 . . . . 75.120000000000005 110.636 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 3.4 m -158.45 137.98 8.46 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.721 0.808 . . . . 71.129999999999995 109.941 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.53 136.71 47.55 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 121.686 1.591 . . . . 72.219999999999999 110.897 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.29 -11.79 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.167 0.987 . . . . 75.140000000000001 110.378 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -21.19 63.29 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.166 0.987 . . . . 74.219999999999999 112.177 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.413 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 91.7 p -109.61 -179.63 3.87 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.867 0.867 . . . . 64.129999999999995 111.852 -173.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.94 -22.84 36.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.535 1.134 . . . . 75.120000000000005 112.32 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.78 -12.4 61.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.943 0.897 . . . . 70.340000000000003 112.245 -173.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 140' ' ' SER . 20.8 pttm -63.82 -11.68 29.31 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.818 0.847 . . . . 74.219999999999999 111.911 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -99.63 146.64 26.24 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.867 0.867 . . . . 71.209999999999994 110.895 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -64.64 -33.94 77.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.156 -0.929 . . . . 70.040000000000006 112.517 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -72.93 -35.13 66.95 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.569 0.747 . . . . 75.430000000000007 112.471 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -80.29 103.02 9.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.825 -0.806 . . . . 73.310000000000002 108.825 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.455 ' HB2' HG22 ' A' ' 151' ' ' VAL . 52.8 m170 -95.59 -9.18 32.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.06 0.544 . . . . 72.230000000000004 112.056 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 -135.06 17.88 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-O 118.273 -1.293 . . . . 65.219999999999999 112.727 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.33 93.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.697 2.931 . . . . 74.329999999999998 113.127 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 75.4 t -139.64 132.39 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.915 1.286 . . . . 75.230000000000004 109.252 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.1 p -89.86 175.8 7.07 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.263 1.025 . . . . 74.340000000000003 109.896 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -58.2 -50.14 74.59 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.289 0.236 . . . . 74.329999999999998 111.111 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -55.49 -44.96 77.02 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.845 0.858 . . . . 60.439999999999998 111.145 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.58 84.33 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.397 -0.82 . . . . 55.32 110.751 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.0 80.41 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.946 0.898 . . . . 62.509999999999998 112.052 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -83.83 -21.16 32.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.757 -0.656 . . . . 75.209999999999994 111.759 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.402 ' OH ' ' HD2' ' A' ' 239' ' ' ARG . 0.1 OUTLIER -82.8 -19.36 37.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.27 0.557 . . . . 74.230000000000004 111.311 172.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 239' ' ' ARG . 51.6 mt -74.96 -42.97 56.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.344 -0.843 . . . . 64.129999999999995 110.669 168.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.538 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 89.0 mt -92.67 20.69 6.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.281 -0.872 . . . . 75.209999999999994 111.451 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.409 ' HB2' HD13 ' A' ' 48' ' ' LEU . 92.5 p -72.55 -40.19 66.9 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.679 -0.489 . . . . 65.030000000000001 109.679 171.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.4 p -100.63 3.65 42.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.201 1.0 . . . . 75.530000000000001 112.271 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.11 159.05 53.04 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.124 0.265 . . . . 72.040000000000006 113.469 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.77 -178.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 74.430000000000007 110.799 174.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -61.92 118.49 7.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.367 0.667 . . . . 72.340000000000003 109.814 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.78 12.03 59.75 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.292 -0.726 . . . . 73.430000000000007 113.444 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.0 m -76.06 133.04 40.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.182 0.991 . . . . 74.430000000000007 110.184 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.476 ' HB3' HD11 ' A' ' 184' ' ' LEU . 27.0 p90 -141.81 166.44 24.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.237 0.541 . . . . 73.030000000000001 111.187 -171.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -162.6 151.29 14.75 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.617 -1.174 . . . . 72.340000000000003 108.135 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.648 HG23 HG12 ' A' ' 182' ' ' ILE . 85.9 t -103.51 128.9 56.24 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 N-CA-C 108.101 -1.074 . . . . 63.340000000000003 108.101 169.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.616 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.0 ptt85 -114.97 143.26 45.44 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.731 -1.122 . . . . 75.25 108.313 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -114.95 130.21 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.329 -1.36 . . . . 74.409999999999997 107.329 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -62.67 127.56 31.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.66 0.384 . . . . 71.099999999999994 110.409 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.86 -43.5 98.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.173 0.589 . . . . 73.120000000000005 110.004 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.0 p -68.71 -27.09 65.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.838 0.855 . . . . 74.140000000000001 111.409 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.3 m -137.19 79.5 37.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.043 0.537 . . . . 74.109999999999999 110.582 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.42 137.32 73.53 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.629 2.219 . . . . 75.129999999999995 111.529 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.14 -29.57 12.23 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.809 -0.632 . . . . 64.099999999999994 111.668 -174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -81.38 114.93 20.48 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.95 -0.759 . . . . 75.510000000000005 108.95 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -129.29 147.77 51.16 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.847 0.859 . . . . 74.5 109.465 -173.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -148.54 150.97 34.3 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.142 0.977 . . . . 63.439999999999998 108.542 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.648 HG12 HG23 ' A' ' 170' ' ' VAL . 16.8 mt -103.23 121.87 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.224 -1.028 . . . . 74.519999999999996 108.224 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -93.82 127.25 39.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.646 -1.242 . . . . 74.109999999999999 107.646 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.525 ' HB2' ' HH ' ' A' ' 193' ' ' TYR . 61.9 tp -131.96 110.36 10.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.173 0.589 . . . . 71.019999999999996 109.511 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.538 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 21.7 ttt180 -79.7 113.81 18.14 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.076 0.55 . . . . 75.219999999999999 109.829 168.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -139.72 137.0 34.77 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.219 -1.4 . . . . 75.040000000000006 107.219 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 62.14 21.44 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.17 0.988 . . . . 74.239999999999995 111.624 -174.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 9.98 86.58 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.91 -0.586 . . . . 71.409999999999997 113.677 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -117.66 134.45 54.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.415 1.086 . . . . 75.319999999999993 109.487 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.58 115.56 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.735 0.414 . . . . 74.319999999999993 110.592 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -102.94 128.79 49.6 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.624 1.17 . . . . 75.109999999999999 108.696 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -110.37 110.13 20.8 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.316 0.646 . . . . 75.530000000000001 109.393 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.525 ' HH ' ' HB2' ' A' ' 184' ' ' LEU . 0.2 OUTLIER -115.23 122.89 47.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.553 0.741 . . . . 73.120000000000005 110.545 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.76 135.04 53.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.55 1.14 . . . . 72.239999999999995 111.301 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.49 103.44 12.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.303 -0.999 . . . . 74.310000000000002 108.303 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -66.16 112.73 4.07 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.59 0.756 . . . . 72.540000000000006 109.172 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.8 m -97.45 105.46 17.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.436 0.695 . . . . 73.209999999999994 109.133 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.1 155.75 26.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.033 0.933 . . . . 72.519999999999996 110.771 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.8 p -69.19 -13.73 62.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.489 0.922 . . . . 74.120000000000005 113.489 -170.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.11 -16.42 31.52 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.391 0.676 . . . . 73.439999999999998 111.141 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 111.72 14.45 11.33 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.72 -0.489 . . . . 73.510000000000005 113.763 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -78.52 138.71 38.54 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.167 0.484 . . . . 71.439999999999998 110.89 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.29 143.76 32.24 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.977 -1.12 . . . . 63.520000000000003 107.977 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.6 p90 -170.81 136.45 1.17 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.546 0.529 . . . . 75.239999999999995 111.525 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.441 HG23 ' HD1' ' A' ' 193' ' ' TYR . 63.7 t -79.89 -42.06 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.639 -0.875 . . . . 74.450000000000003 108.639 166.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.469 ' HG ' ' HA3' ' A' ' 227' ' ' GLY . 15.2 m -100.17 126.98 46.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.24 1.016 . . . . 74.310000000000002 109.605 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -63.16 -24.73 68.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.559 0.743 . . . . 74.439999999999998 112.12 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -77.09 -30.68 55.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.674 1.19 . . . . 62.149999999999999 111.233 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -120.87 100.62 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.575 0.75 . . . . 74.219999999999999 109.157 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.3 mtt180 -110.13 126.01 53.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.011 0.924 . . . . 75.129999999999995 109.514 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.529 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.5 m-85 -116.03 149.33 39.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.537 0.735 . . . . 75.129999999999995 110.043 -168.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.03 -44.33 72.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.403 -0.591 . . . . 75.239999999999995 109.403 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.1 p -117.93 154.95 31.05 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.955 0.883 . . . . 73.239999999999995 111.722 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.465 HD12 HG13 ' A' ' 170' ' ' VAL . 1.1 tt -65.47 -23.23 66.86 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.723 -1.126 . . . . 74.099999999999994 109.899 174.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.07 93.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.383 0.673 . . . . 61.299999999999997 110.662 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.2 mt-10 -68.04 -36.8 80.5 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 110.82 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 tp -54.04 -57.88 9.4 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.767 0.667 . . . . 74.120000000000005 110.407 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.01 -38.4 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 123.755 0.659 . . . . 72.349999999999994 110.716 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -62.94 -59.05 5.37 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.921 0.488 . . . . 75.400000000000006 111.55 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.26 -32.94 74.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.028 0.531 . . . . 75.319999999999993 111.063 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.657 ' HB3' HD12 ' A' ' 228' ' ' LEU . 17.4 m170 -89.44 -4.72 57.87 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.629 0.603 . . . . 73.150000000000006 112.629 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.2 p -96.24 -28.07 14.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.868 0.467 . . . . 74.329999999999998 110.807 168.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 52.7 p -77.29 -40.36 44.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.356 -0.384 . . . . 74.239999999999995 110.504 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 226' ' ' ASP . 16.5 m -134.5 161.44 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.304 1.049 . . . . 73.319999999999993 112.437 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.23 16.62 0.74 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.26 2.224 . . . . 73.219999999999999 114.442 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.541 ' HB2' HG22 ' A' ' 224' ' ' VAL . 28.1 t70 -44.37 25.31 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.617 1 C-N-CA 132.266 4.227 . . . . 54.229999999999997 119.821 -155.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.469 ' HA3' ' HG ' ' A' ' 206' ' ' SER . . . 123.95 6.22 7.16 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 120.114 -1.616 . . . . 64.310000000000002 111.823 -165.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.657 HD12 ' HB3' ' A' ' 221' ' ' HIS . 6.7 mt -95.23 163.67 13.17 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.749 1.22 . . . . 75.430000000000007 109.363 167.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 8.4 tt -65.89 -34.0 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-O 121.229 0.537 . . . . 74.140000000000001 109.834 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.405 HG21 HD21 ' A' ' 184' ' ' LEU . 6.4 t -159.67 170.67 21.08 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.592 0.757 . . . . 75.200000000000003 109.664 177.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.2 p -63.96 142.09 58.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.363 0.665 . . . . 62.140000000000001 111.385 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.42 112.21 4.5 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 108.686 -0.857 . . . . 74.299999999999997 108.686 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -104.75 -57.88 1.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.299999999999997 112.007 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -119.27 122.77 29.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.789 0.836 . . . . 74.420000000000002 109.54 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.2 123.33 4.99 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.449 2.099 . . . . 72.510000000000005 111.132 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -68.32 142.06 94.25 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 109.072 -0.714 . . . . 74.099999999999994 109.072 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.66 176.35 7.12 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.605 2.203 . . . . 74.319999999999993 112.943 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.525 ' HZ1' HD13 ' A' ' 88' ' ' LEU . 33.1 mmtp -71.41 155.7 40.33 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.394 -0.821 . . . . 64.409999999999997 109.974 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.829 ' HB3' HD21 ' A' ' 159' ' ' LEU . 16.7 ptt-85 -91.89 -60.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.578 0.584 . . . . 62.149999999999999 112.578 -167.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -110.89 155.06 23.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.348 1.059 . . . . 65.140000000000001 109.872 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.67 114.77 59.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.663 -1.606 . . . . 62.25 106.663 156.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.482 ' HB2' HD21 ' A' ' 133' ' ' ASN . 27.9 Cg_endo -61.59 124.88 15.49 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.595 2.197 . . . . 74.420000000000002 112.352 -171.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.4 m -72.4 112.83 8.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.543 -0.753 . . . . 72.400000000000006 110.833 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.07 111.77 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 107.416 -1.327 . . . . 73.310000000000002 107.416 171.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.74 111.05 22.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.157 -0.312 . . . . 74.230000000000004 110.157 -166.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 60.22 -14.13 0.04 OUTLIER Glycine 0 CA--C 1.542 1.764 0 N-CA-C 118.185 2.034 . . . . 53.210000000000001 118.185 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.3 m -89.52 122.96 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.376 1.588 . . . . 75.040000000000006 112.882 -164.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 36.4 t -82.61 140.02 44.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 106.928 -1.508 . . . . 74.400000000000006 106.928 159.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -63.67 -58.61 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 CA-C-N 120.723 1.294 . . . . 74.340000000000003 112.793 -163.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -132.85 -21.54 2.15 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.19 0.996 . . . . 62.109999999999999 109.285 152.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.643 ' HB3' ' HB2' ' A' ' 254' ' ' TRP . 59.5 m-85 -97.64 117.93 33.03 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.322 -1.308 . . . . 75.340000000000003 114.3 -152.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -104.36 -41.94 5.62 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.962 0.505 . . . . 71.040000000000006 109.731 170.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -104.31 25.14 10.49 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.626 1.171 . . . . 73.239999999999995 110.508 -172.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 251' ' ' TYR . 54.7 t90 -52.54 119.4 4.46 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.123 0.569 . . . . 75.430000000000007 112.179 -176.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 107.806 -1.183 . . . . 72.150000000000006 107.806 177.663 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.6 t90 . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 121.205 0.526 . . . . 75.120000000000005 109.804 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.51 -22.69 34.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.889 0.876 . . . . 71.030000000000001 111.104 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 m -78.95 7.32 7.42 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.241 1.416 . . . . 54.420000000000002 113.021 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.39 -18.18 65.02 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.464 1.106 . . . . 72.310000000000002 112.315 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -20.35 26.2 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.319 0.648 . . . . 72.310000000000002 110.916 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.453 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 12.7 m120 -78.45 -12.31 60.0 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.322 0.649 . . . . 55.119999999999997 110.377 170.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.05 -50.45 70.59 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.679 0.792 . . . . 74.140000000000001 110.623 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.438 HD11 ' CG ' ' A' ' 219' ' ' HIS . 84.8 mt -112.12 30.15 7.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.486 0.714 . . . . 75.450000000000003 110.063 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.473 0.722 0 C-N-CA 122.663 0.385 . . . . 75.140000000000001 110.562 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.105 0.479 . . . . 70.299999999999997 110.848 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.7 tp -76.78 138.42 39.88 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.75 -0.594 . . . . 52.539999999999999 109.455 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.7 m-85 -108.11 173.45 6.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.588 1.155 . . . . 72.109999999999999 110.06 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.6 147.55 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 125.221 1.409 . . . . 60.409999999999997 109.64 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.21 120.15 25.45 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.219 1.008 . . . . 51.219999999999999 110.205 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.3 -42.26 68.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.329 0.651 . . . . 63.32 111.161 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.511 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.8 m-85 -124.54 158.4 33.05 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.41 -0.813 . . . . 75.129999999999995 109.223 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 120.71 24.27 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.502 -1.296 . . . . 72.25 107.502 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.8 t80 -123.01 138.28 54.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.903 0.881 . . . . 72.340000000000003 108.712 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.48 134.18 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.76 -0.83 . . . . 75.120000000000005 108.76 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.6 117.18 4.62 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.078 0.862 . . . . 74.319999999999993 110.631 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 p -67.82 -38.33 83.12 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.654 0.782 . . . . 64.129999999999995 110.887 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.72 -175.95 14.28 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-N 115.717 -0.674 . . . . 65.040000000000006 111.826 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.79 -31.85 67.02 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.546 0.739 . . . . 71.129999999999995 110.661 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -75.52 -18.06 59.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.803 1.241 . . . . 52.32 112.115 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 57.2 p -95.63 171.25 8.79 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.48 -0.563 . . . . 74.140000000000001 109.48 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.9 tp -126.94 136.7 52.64 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.275 0.56 . . . . 63.32 111.735 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -82.25 117.03 22.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.726 -1.125 . . . . 62.130000000000003 109.042 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.594 HG12 ' HB3' ' A' ' 91' ' ' PHE . 20.7 pt -110.08 144.26 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.388 0.675 . . . . 72.219999999999999 110.104 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.3 m -95.76 140.23 30.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.424 -0.807 . . . . 65.040000000000006 108.845 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.29 125.99 25.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.318 0.647 . . . . 60.020000000000003 111.356 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.45 76.67 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 123.88 0.738 . . . . 60.049999999999997 113.605 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -82.11 138.34 34.79 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.46 0.63 . . . . 74.109999999999999 111.434 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -79.95 112.81 17.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.837 -0.801 . . . . 71.019999999999996 108.837 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -122.83 167.78 13.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.951 0.9 . . . . 74.230000000000004 110.024 -177.029 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -121.74 119.43 31.72 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.935 -0.478 . . . . 63.439999999999998 111.035 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.65 HG13 ' HB1' ' A' ' 119' ' ' ALA . 43.5 t -86.54 134.55 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.246 1.018 . . . . 75.230000000000004 109.881 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.556 HD12 ' HG3' ' A' ' 120' ' ' GLU . 46.1 mt -105.89 -31.49 8.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.467 1.107 . . . . 75.140000000000001 110.126 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.01 145.48 4.71 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 115.835 -0.62 . . . . 61.119999999999997 112.375 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 45.5 m-85 -85.68 169.74 13.17 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.436 0.694 . . . . 63.25 110.886 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -85.66 -176.26 5.97 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.213 -0.903 . . . . 70.230000000000004 110.694 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -52.83 -35.18 56.79 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.754 1.221 . . . . 74.430000000000007 114.17 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -112.12 2.63 16.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.855 0.462 . . . . 70.310000000000002 112.171 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.79 30.56 72.59 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.398 0.919 . . . . 54.5 115.398 173.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.03 -35.96 18.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.285 0.543 . . . . 74.510000000000005 110.716 173.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 35.3 m95 -131.0 151.66 51.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.743 0.817 . . . . 73.519999999999996 111.72 -171.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -133.54 137.09 45.39 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.534 1.134 . . . . 72.040000000000006 111.026 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.556 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.8 tp10 -66.81 114.45 5.68 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 106.854 -1.536 . . . . 75.030000000000001 106.854 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.15 162.13 33.8 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.184 0.516 . . . . 53.420000000000002 111.299 -170.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.468 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . 15.4 pt20 -132.8 128.96 37.9 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.414 -0.812 . . . . 64.129999999999995 111.122 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 107' ' ' LEU . 45.8 p -116.61 179.1 4.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 74.319999999999993 109.757 173.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -70.68 -16.35 62.79 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 109.513 -0.551 . . . . 72.340000000000003 109.513 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -78.78 -20.16 50.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.918 1.287 . . . . 71.530000000000001 110.984 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.68 -140.4 10.15 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 122.051 -0.118 . . . . 74.439999999999998 112.941 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' A' ' 122' ' ' GLN . 61.6 tp60 -128.67 155.83 44.4 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.348 1.059 . . . . 74.329999999999998 109.667 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.56 169.4 15.36 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.025 -0.43 . . . . 73.120000000000005 112.025 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -77.75 134.53 38.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.241 0.616 . . . . 75.310000000000002 111.668 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.487 HG23 HD13 ' A' ' 135' ' ' ILE . 5.9 m -132.0 143.26 48.26 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 124.308 1.043 . . . . 74.010000000000005 108.807 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 92.9 Cg_endo -80.4 143.04 15.19 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 C-N-CA 122.018 1.812 . . . . 41.350000000000001 114.075 -173.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -39.61 -44.73 1.52 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.583 1.953 . . . . 52.049999999999997 114.229 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 38.1 p-10 -79.04 -1.91 37.89 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.198 0.999 . . . . 74.25 113.132 -171.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.511 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 28.8 m-85 -113.14 -0.63 14.61 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.026 0.93 . . . . 73.129999999999995 111.308 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.487 HD13 HG23 ' A' ' 130' ' ' VAL . 21.0 pt -135.37 170.48 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.182 0.993 . . . . 63.030000000000001 110.667 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -163.4 155.39 15.14 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.812 -1.181 . . . . 64.430000000000007 107.812 170.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.8 Cg_endo -60.44 153.53 59.88 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.679 1.586 . . . . 73.310000000000002 111.632 171.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 143' ' ' LYS . 38.2 t -73.1 -8.44 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.107 0.956 . . . . 53.340000000000003 110.356 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.94 -18.61 55.86 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.336 1.054 . . . . 73.129999999999995 111.248 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.2 p -87.01 170.43 11.57 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.853 0.835 . . . . 65.530000000000001 113.024 -170.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.36 -23.79 26.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.512 -1.222 . . . . 55.119999999999997 110.931 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.64 -29.81 70.3 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.322 1.049 . . . . 75.140000000000001 111.447 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 138' ' ' VAL . 24.2 pttm -60.08 -19.28 52.34 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.614 0.765 . . . . 71.209999999999994 112.904 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -86.66 141.86 28.64 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.544 0.737 . . . . 72.329999999999998 109.749 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.1 m -58.9 -40.64 85.1 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.07 0.856 . . . . 64.430000000000007 112.182 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -62.53 -38.5 90.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.122 0.889 . . . . 73.140000000000001 112.336 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -76.6 112.37 13.07 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.728 -0.841 . . . . 73.219999999999999 108.728 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -109.07 -14.83 14.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.073 0.549 . . . . 70.400000000000006 111.517 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.78 -127.25 15.49 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 118.18 -1.344 . . . . 43.119999999999997 112.3 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.55 95.2 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.984 2.456 . . . . 62.030000000000001 112.591 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 77.3 t -137.78 119.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.605 0.762 . . . . 63.509999999999998 109.575 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.8 m -71.78 159.35 34.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.289 0.635 . . . . 71.329999999999998 109.32 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 78.0 ttt180 -59.04 -38.07 78.46 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 119.435 -0.317 . . . . 73.549999999999997 111.415 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -63.49 -36.88 85.21 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.362 0.665 . . . . 71.409999999999997 111.209 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.36 -30.27 67.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.16 0.584 . . . . 70.120000000000005 110.408 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.26 63.18 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 51.509999999999998 111.647 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 22.5 mm-40 -65.66 -43.11 90.38 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.119 -0.697 . . . . 74.310000000000002 109.119 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.489 ' HE1' ' HB2' ' A' ' 239' ' ' ARG . 17.0 t80 -62.73 -41.47 99.19 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.315 -1.311 . . . . 73.239999999999995 111.201 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.442 HD21 ' HB3' ' A' ' 239' ' ' ARG . 28.7 mt -61.48 -44.13 97.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.59 0.756 . . . . 52.340000000000003 111.478 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.0 mt -98.3 17.96 17.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.199 0.6 . . . . 62.5 112.59 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.0 p -69.35 -36.24 76.68 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.444 0.64 . . . . 74.219999999999999 110.694 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 p -106.42 15.81 25.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.342 1.057 . . . . 71.200000000000003 110.8 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.86 140.48 23.3 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.37 -0.377 . . . . 63.119999999999997 112.379 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.7 pt -86.81 -179.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.405 0.682 . . . . 74.0 111.431 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.6 112.33 3.13 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.679 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.6 10.88 39.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.392 -0.822 . . . . 72.209999999999994 112.94 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.4 m -75.54 143.31 42.52 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.634 0.717 . . . . 62.140000000000001 110.619 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -149.72 163.78 37.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.063 0.459 . . . . 71.409999999999997 111.937 -171.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 183' ' ' SER . 4.0 pp -161.72 152.69 18.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.873 -1.058 . . . . 73.540000000000006 109.482 175.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.612 HG22 HG12 ' A' ' 182' ' ' ILE . 59.5 t -107.64 126.73 63.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.424 -0.954 . . . . 55.210000000000001 108.424 168.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.543 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 13.1 ptt180 -114.97 147.29 40.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.182 -1.044 . . . . 71.340000000000003 108.182 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.89 145.99 40.68 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 107.741 -1.207 . . . . 72.340000000000003 107.741 166.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.4 t -78.55 121.64 24.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.169 -0.678 . . . . 74.109999999999999 109.169 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.25 -34.3 77.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.306 1.042 . . . . 73.109999999999999 110.485 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 p -83.18 -15.87 48.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.72 0.808 . . . . 72.340000000000003 111.788 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.8 m -142.2 86.03 10.43 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.423 0.689 . . . . 60.119999999999997 110.079 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.09 135.54 69.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.33 2.687 . . . . 73.239999999999995 112.529 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.15 -28.86 12.07 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.472 -0.331 . . . . 61.509999999999998 112.594 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -81.41 117.11 21.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.182 0.491 . . . . 74.329999999999998 110.193 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.628 HH11 HD12 ' A' ' 214' ' ' LEU . 99.4 mtt180 -130.03 157.6 41.9 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.908 0.883 . . . . 75.400000000000006 110.974 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.4 m -143.61 146.24 33.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.944 -1.026 . . . . 61.310000000000002 109.454 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.612 HG12 HG22 ' A' ' 170' ' ' VAL . 42.8 mt -100.81 108.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 107.394 -1.335 . . . . 72.219999999999999 107.394 169.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.428 ' HB2' ' HG ' ' A' ' 169' ' ' LEU . 14.9 m -87.38 106.81 18.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.243 -1.391 . . . . 65.310000000000002 107.243 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 193' ' ' TYR . 62.4 tp -115.47 110.95 20.03 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.78 -0.822 . . . . 74.5 108.78 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.444 ' HB2' HG22 ' A' ' 190' ' ' VAL . 75.9 ttt180 -89.61 122.77 33.07 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.316 0.646 . . . . 75.209999999999994 110.486 173.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -143.7 144.13 31.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.655 1.182 . . . . 70.109999999999999 108.352 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 61.11 21.93 12.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.422 1.089 . . . . 62.520000000000003 112.358 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.29 11.45 82.17 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 114.358 0.503 . . . . 60.219999999999999 114.358 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -120.14 134.5 55.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.49 0.716 . . . . 74.040000000000006 109.744 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 185' ' ' ARG . 91.0 t -88.65 118.24 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.304 -0.628 . . . . 74.439999999999998 109.304 174.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.37 157.42 16.92 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.147 0.979 . . . . 55.350000000000001 108.564 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -132.76 124.15 27.55 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.976 -0.75 . . . . 74.140000000000001 108.976 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' A' ' 184' ' ' LEU . 89.8 m-85 -113.83 141.24 47.56 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.415 1.086 . . . . 72.310000000000002 108.714 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 9.1 tpp180 -85.21 124.36 31.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.398 0.279 . . . . 73.129999999999995 110.391 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.2 mt -84.71 99.6 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.132 -1.433 . . . . 73.040000000000006 107.132 166.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -78.46 119.71 22.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.963 -1.017 . . . . 72.450000000000003 108.37 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -94.15 108.5 20.35 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.908 -0.775 . . . . 75.0 108.908 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.48 157.57 16.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.952 0.901 . . . . 52.240000000000002 110.886 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -61.85 -30.94 71.19 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.293 1.037 . . . . 75.129999999999995 113.395 -170.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -85.0 -11.5 55.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.803 0.841 . . . . 73.299999999999997 111.925 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.0 11.15 14.38 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.451 -0.638 . . . . 74.310000000000002 114.352 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -75.5 152.16 37.88 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 118.082 0.941 . . . . 62.0 110.983 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -113.56 142.6 45.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.327 -0.99 . . . . 71.120000000000005 108.327 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.613 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.8 p90 -165.0 137.0 4.31 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.52 0.512 . . . . 73.349999999999994 110.872 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 54.3 t -79.12 -45.73 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.832 -0.803 . . . . 72.099999999999994 108.832 166.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -101.29 135.93 41.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.763 -1.108 . . . . 71.219999999999999 110.696 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.5 t -64.14 -22.46 66.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.287 1.035 . . . . 74.219999999999999 112.267 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -81.47 -29.98 33.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.941 0.896 . . . . 73.109999999999999 111.176 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 17.1 m -123.17 99.01 6.14 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.026 0.53 . . . . 65.200000000000003 110.176 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.613 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 47.3 mtt180 -112.35 120.29 41.19 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.818 0.847 . . . . 65.420000000000002 109.632 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.62 156.0 20.75 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.083 0.953 . . . . 65.25 109.085 -171.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -69.32 -42.74 74.98 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 70.5 p -120.95 155.04 35.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.92 0.867 . . . . 75.420000000000002 111.904 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.628 HD12 HH11 ' A' ' 180' ' ' ARG . 1.3 tt -65.38 -24.61 67.28 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 114.352 -1.295 . . . . 75.230000000000004 109.559 172.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.33 93.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.41 0.684 . . . . 75.439999999999998 110.766 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.19 -34.81 75.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.83 0.852 . . . . 71.319999999999993 111.15 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.04 -54.92 39.08 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.09 0.556 . . . . 73.140000000000001 111.025 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.61 -41.09 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 123.655 0.597 . . . . 52.200000000000003 111.011 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.438 ' CG ' HD11 ' A' ' 74' ' ' LEU . 17.0 t-80 -55.63 -58.0 9.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.441 0.696 . . . . 61.340000000000003 111.362 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -64.17 -33.7 76.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.125 -0.943 . . . . 74.239999999999995 110.813 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.543 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.1 m-70 -88.28 -10.78 48.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.797 -0.638 . . . . 73.5 112.081 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 232' ' ' LEU . 89.1 p -93.92 -20.28 20.16 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.756 0.423 . . . . 61.420000000000002 111.255 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 37.7 p -81.98 -48.12 11.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.873 -0.417 . . . . 51.420000000000002 109.873 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 226' ' ' ASP . 33.2 m -128.72 158.92 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.636 0.732 . . . . 74.209999999999994 112.303 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.97 16.0 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.759 2.024 . . . . 61.119999999999997 115.217 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.9 t70 -42.64 31.69 0.0 OUTLIER 'General case' 0 CA--C 1.601 2.925 1 C-N-CA 131.88 4.072 . . . . 71.5 119.351 -157.043 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.86 -1.94 9.25 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 119.486 -2.009 . . . . 74.120000000000005 112.604 -168.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' A' ' 221' ' ' HIS . 45.1 mt -95.59 160.3 14.57 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.584 1.153 . . . . 70.420000000000002 110.216 168.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.11 -35.55 72.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 120.895 0.379 . . . . 72.120000000000005 110.322 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -149.18 173.52 13.35 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.506 0.722 . . . . 44.340000000000003 110.094 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -67.42 143.17 56.41 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.172 0.589 . . . . 72.319999999999993 110.675 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 222' ' ' SER . 90.2 mt -63.58 96.56 0.12 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.74 0.816 . . . . 64.329999999999998 109.275 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -89.45 -66.14 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.184 -0.916 . . . . 63.310000000000002 110.681 -169.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 167' ' ' SER . 43.0 t80 -114.81 121.77 34.92 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 123.852 0.861 . . . . 73.519999999999996 109.725 -170.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.36 123.71 5.61 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.09 1.86 . . . . 75.219999999999999 111.722 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.02 130.95 95.06 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.971 -0.751 . . . . 75.150000000000006 108.971 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.03 179.78 6.18 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.833 2.355 . . . . 75.400000000000006 112.413 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.78 150.92 48.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 52.329999999999998 109.575 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.489 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . 13.7 ptt180 -92.51 -60.49 1.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 111.838 0.31 . . . . 72.120000000000005 111.838 -174.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.42 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 55.5 t30 -109.47 138.45 45.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 73.530000000000001 110.482 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.1 113.64 47.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.256 -1.757 . . . . 71.549999999999997 106.256 159.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.506 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 35.8 Cg_exo -61.01 123.87 13.76 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.51 2.14 . . . . 62.439999999999998 112.709 -173.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 61.2 m -73.47 119.1 17.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.827 0.451 . . . . 71.519999999999996 110.558 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.3 t -98.62 127.04 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.281 1.032 . . . . 62.399999999999999 108.38 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.08 114.52 28.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.095 0.407 . . . . 74.310000000000002 111.51 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.8 21.89 38.57 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 116.426 1.331 . . . . 71.030000000000001 116.426 160.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.489 HG21 ' NE1' ' A' ' 118' ' ' TRP . 27.2 m -82.3 127.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 117.732 0.766 . . . . 74.420000000000002 111.913 -173.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 t -85.18 117.83 69.59 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 104.85 -2.278 . . . . 72.540000000000006 104.85 152.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo . . . . . 0 C--N 1.371 1.749 0 C-N-CA 120.92 1.08 . . . . 70.420000000000002 113.917 -159.081 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 6.2 t90 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 122.151 0.977 . . . . 75.409999999999997 109.272 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -79.14 -23.92 43.68 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.24 -1.345 . . . . 71.400000000000006 109.426 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.6 p -78.03 4.54 12.0 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.967 0.907 . . . . 74.430000000000007 112.337 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.96 -37.62 78.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.949 0.5 . . . . 75.340000000000003 110.987 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.49 -31.16 62.1 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.072 0.463 . . . . 63.109999999999999 109.943 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.51 -5.81 57.24 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.042 0.937 . . . . 72.5 111.06 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.418 HD13 ' HE1' ' A' ' 146' ' ' TRP . 21.0 tp -66.19 -49.71 66.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.296 1.038 . . . . 74.230000000000004 111.36 -173.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -103.61 20.97 16.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.999 0.52 . . . . 54.119999999999997 110.661 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 C-N-CA 122.65 0.38 . . . . 64.239999999999995 110.854 174.546 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.867 0.365 . . . . 71.340000000000003 111.524 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.6 tp -86.59 133.37 33.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.467 -0.938 . . . . 72.140000000000001 108.467 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -110.42 171.51 7.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.777 0.831 . . . . 75.239999999999995 109.14 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.19 138.71 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.473 1.109 . . . . 54.420000000000002 109.273 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 135' ' ' ILE . . . -82.68 111.14 18.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.966 0.906 . . . . 64.040000000000006 109.594 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.46 -38.06 68.34 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.699 0.799 . . . . 52.420000000000002 110.937 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 37.1 m-85 -122.54 140.91 52.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.341 -1.3 . . . . 72.209999999999994 107.574 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -84.34 150.07 25.63 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.734 -0.469 . . . . 72.239999999999995 109.734 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.626 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.9 t80 -139.84 143.52 36.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.051 0.94 . . . . 64.329999999999998 108.642 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.97 133.2 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.564 -1.273 . . . . 52.140000000000001 107.564 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 129.8 41.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.319 0.648 . . . . 52.520000000000003 111.345 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 p -88.35 -38.96 14.7 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.776 0.83 . . . . 71.439999999999998 109.678 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.76 -170.32 12.66 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.344 -0.844 . . . . 45.200000000000003 112.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.74 -35.1 60.3 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.682 0.793 . . . . 65.510000000000005 110.581 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -63.07 -29.32 70.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.054 0.942 . . . . 64.439999999999998 111.871 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.5 p -90.38 154.43 19.68 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.845 0.858 . . . . 61.43 109.491 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.661 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 58.6 tp -125.12 136.9 54.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.003 0.521 . . . . 64.140000000000001 110.467 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -75.23 131.39 40.35 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.958 0.503 . . . . 74.540000000000006 110.063 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.734 HG22 HG21 ' A' ' 123' ' ' THR . 19.3 pt -128.47 167.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.77 0.828 . . . . 53.219999999999999 111.215 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -123.11 152.36 41.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.363 1.065 . . . . 71.540000000000006 109.568 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.72 122.37 16.22 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.429 -0.582 . . . . 75.329999999999998 109.429 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.4 72.03 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-O 119.537 -0.591 . . . . 73.329999999999998 113.894 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -83.76 125.4 31.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.678 0.739 . . . . 53.009999999999998 110.745 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -78.3 133.86 37.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.277 -0.638 . . . . 71.540000000000006 109.277 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.673 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.77 147.03 34.86 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.574 0.75 . . . . 72.150000000000006 110.715 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -94.81 105.58 17.52 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.961 -0.755 . . . . 73.319999999999993 108.961 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.635 HG13 ' HB1' ' A' ' 119' ' ' ALA . 60.6 t -82.67 105.18 12.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.517 -0.92 . . . . 44.240000000000002 108.517 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.528 HD23 ' HG2' ' A' ' 120' ' ' GLU . 2.6 mm? -65.68 -52.88 48.06 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.162 0.914 . . . . 52.450000000000003 108.594 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.7 155.69 22.53 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.605 -0.725 . . . . 65.239999999999995 114.104 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 96.9 m-85 -88.15 163.54 16.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.801 0.84 . . . . 74.510000000000005 109.786 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -71.43 -172.57 0.77 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 120.803 0.335 . . . . 70.319999999999993 111.338 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -47.71 -41.1 22.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.858 1.263 . . . . 74.099999999999994 114.144 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -114.52 3.62 14.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.306 0.854 . . . . 74.439999999999998 113.306 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.14 32.86 47.02 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.921 0.728 . . . . 44.539999999999999 114.921 174.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.85 -65.65 0.71 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.437 0.695 . . . . 61.399999999999999 110.736 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 34.4 m95 -114.4 165.86 12.28 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 75.109999999999999 109.33 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.08 131.08 36.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.764 1.226 . . . . 74.049999999999997 111.384 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HG2' HD23 ' A' ' 110' ' ' LEU . 24.0 tt0 -68.6 103.05 1.61 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.198 -1.038 . . . . 71.400000000000006 108.198 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.4 140.52 48.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.979 0.912 . . . . 73.099999999999994 109.85 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.491 ' HG3' HD21 ' A' ' 110' ' ' LEU . 55.8 mt-30 -105.51 105.39 15.41 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.575 -0.898 . . . . 71.109999999999999 108.575 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.734 HG21 HG22 ' A' ' 101' ' ' ILE . 68.5 p -99.88 -176.37 3.23 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.816 1.246 . . . . 74.310000000000002 110.357 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.88 -18.37 64.12 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.529 -0.76 . . . . 62.329999999999998 110.231 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.64 -3.46 59.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.664 1.186 . . . . 72.109999999999999 111.714 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.53 -138.39 13.27 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-O 119.513 -0.604 . . . . 74.450000000000003 111.815 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -129.73 143.51 50.85 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.724 0.762 . . . . 75.329999999999998 110.096 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.661 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.5 -172.28 43.46 Favored Glycine 0 C--O 1.225 -0.428 0 N-CA-C 110.972 -0.851 . . . . 64.420000000000002 110.972 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 40.9 m95 -107.34 125.19 50.88 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.323 0.561 . . . . 74.239999999999995 110.505 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.52 140.42 38.6 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.433 1.493 . . . . 64.310000000000002 109.091 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 9.3 Cg_exo -72.15 147.96 49.25 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 122.731 2.287 . . . . 44.5 114.414 -171.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 m -37.2 -51.59 1.02 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.415 1.886 . . . . 64.239999999999995 114.189 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -75.11 -3.18 31.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.546 0.738 . . . . 73.209999999999994 112.809 -171.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -94.47 -23.21 17.82 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.493 0.717 . . . . 74.450000000000003 111.577 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 109' ' ' VAL . 11.4 pt -123.32 173.77 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.794 0.838 . . . . 71.420000000000002 111.346 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.3 t -160.97 153.63 17.43 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.039 -1.097 . . . . 73.319999999999993 108.039 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.24 147.76 93.61 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 121.59 1.527 . . . . 62.119999999999997 110.981 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.82 -6.9 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 CA-C-O 121.499 0.666 . . . . 64.409999999999997 110.885 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -79.29 -13.15 59.84 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.346 0.658 . . . . 73.329999999999998 112.076 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.0 p -88.53 174.82 7.87 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.336 0.588 . . . . 63.32 112.418 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -84.03 -22.68 31.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.047 -0.979 . . . . 72.019999999999996 110.475 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.23 -22.09 66.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.964 0.905 . . . . 75.099999999999994 112.121 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -63.28 -13.74 41.76 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.529 0.566 . . . . 53.450000000000003 112.529 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -94.25 150.65 20.1 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.76 0.824 . . . . 72.319999999999993 110.425 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.8 p -67.66 -38.82 84.3 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 124.272 0.983 . . . . 74.319999999999993 111.635 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.475 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 41.9 p-90 -60.38 -48.96 79.48 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.82 0.7 . . . . 72.239999999999995 111.958 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.48 96.88 2.99 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.125 -0.694 . . . . 73.420000000000002 109.125 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -91.57 -2.38 57.15 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.616 -0.72 . . . . 74.010000000000005 111.078 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.54 -161.82 42.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.158 -0.801 . . . . 51.049999999999997 112.588 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.33 98.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.4 2.733 . . . . 70.420000000000002 112.564 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 53.5 t -122.94 135.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 114.674 -1.148 . . . . 75.420000000000002 109.9 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.7 p -75.37 156.72 35.17 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.366 0.666 . . . . 62.130000000000003 109.489 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 71.1 ttt180 -62.71 -36.92 84.52 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 118.78 -0.629 . . . . 63.100000000000001 111.361 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -55.42 -43.94 75.8 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.559 0.695 . . . . 73.140000000000001 110.484 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.43 70.22 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.406 -1.27 . . . . 70.439999999999998 111.321 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.5 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.084 0.554 . . . . 74.510000000000005 111.402 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.2 mm-40 -68.98 -30.17 68.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.146 0.578 . . . . 71.209999999999994 110.009 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.73 -47.32 84.09 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.202 0.601 . . . . 73.439999999999998 110.329 171.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.6 mt -60.48 -35.33 75.65 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.987 0.515 . . . . 62.119999999999997 110.679 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 73.9 mt -105.74 21.32 17.45 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.539 -0.755 . . . . 71.140000000000001 113.036 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.8 p -88.61 -35.13 17.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.453 -0.943 . . . . 72.230000000000004 108.453 165.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.7 p -95.97 12.89 28.82 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.94 -1.027 . . . . 64.019999999999996 111.702 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.0 -175.59 40.97 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 112.493 -0.243 . . . . 73.140000000000001 112.493 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.439 HD11 ' HE2' ' A' ' 234' ' ' TYR . 32.3 pt -131.18 -174.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.363 1.065 . . . . 61.140000000000001 110.036 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -58.72 122.32 13.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 74.030000000000001 110.799 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.78 9.57 68.25 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.84 -0.618 . . . . 51.420000000000002 113.66 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 48.8 m -88.9 127.85 35.66 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.975 0.887 . . . . 61.149999999999999 110.035 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -132.41 -178.33 4.87 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.772 0.714 . . . . 62.100000000000001 112.793 -172.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.418 HD23 ' HG ' ' A' ' 160' ' ' LEU . 4.0 pp -164.69 155.97 15.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.048 0.939 . . . . 73.010000000000005 109.633 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.679 HG22 HG12 ' A' ' 182' ' ' ILE . 88.1 t -116.37 134.36 60.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.356 -0.979 . . . . 72.420000000000002 108.356 167.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.437 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 15.4 ptt180 -130.26 149.39 51.98 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.522 -0.763 . . . . 62.32 110.077 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -93.11 150.44 20.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.076 1.35 . . . . 74.439999999999998 108.036 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.8 t -79.5 123.51 27.63 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.819 -0.437 . . . . 64.310000000000002 109.819 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.98 -36.14 72.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.284 1.033 . . . . 74.409999999999997 111.2 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.0 p -78.39 -31.09 48.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.409 0.683 . . . . 71.420000000000002 111.566 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.4 m -140.04 89.43 11.19 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.192 0.597 . . . . 75.120000000000005 109.764 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.38 132.7 53.44 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.068 2.512 . . . . 71.420000000000002 112.819 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.52 -27.82 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.842 0.734 . . . . 62.210000000000001 112.388 -175.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -86.87 114.56 23.62 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.817 -0.808 . . . . 73.519999999999996 108.817 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -125.96 148.45 49.25 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.235 0.54 . . . . 63.109999999999999 110.914 -172.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.6 p -144.42 148.88 35.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.782 -1.099 . . . . 54.32 109.923 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.679 HG12 HG22 ' A' ' 170' ' ' VAL . 41.6 mt -102.25 149.71 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.264 -1.384 . . . . 71.129999999999995 107.264 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -125.29 120.85 32.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.105 -1.443 . . . . 54.420000000000002 107.105 170.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 67.7 tp -114.04 114.11 25.69 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.921 0.782 . . . . 73.420000000000002 110.52 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 29.3 ttt85 -77.48 113.85 15.71 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 109.761 -0.459 . . . . 74.209999999999994 109.761 166.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -142.06 138.68 31.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.206 1.402 . . . . 71.150000000000006 107.477 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 58.74 22.14 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.426 1.09 . . . . 72.310000000000002 111.984 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.93 86.7 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 114.226 0.45 . . . . 72.030000000000001 114.226 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -108.17 147.62 31.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.925 0.89 . . . . 73.019999999999996 108.685 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.32 105.58 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.384 0.674 . . . . 72.109999999999999 109.827 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.35 116.46 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.486 1.115 . . . . 74.040000000000006 109.333 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -91.59 118.95 31.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.826 0.451 . . . . 52.109999999999999 110.751 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.56 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.4 m-85 -94.77 151.17 19.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.185 0.994 . . . . 52.409999999999997 108.782 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -104.71 122.72 46.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.415 -0.587 . . . . 74.420000000000002 109.415 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.2 mt -90.98 105.87 16.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.084 -0.71 . . . . 63.219999999999999 109.084 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.91 140.3 29.63 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.412 0.685 . . . . 52.140000000000001 110.033 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 42.6 m -98.36 119.05 36.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.655 1.182 . . . . 70.019999999999996 107.854 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 174.45 6.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.978 0.911 . . . . 71.120000000000005 110.569 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 61.0 p -66.01 -25.63 67.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.373 0.669 . . . . 53.119999999999997 111.937 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.36 -17.21 29.29 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.143 0.577 . . . . 74.040000000000006 111.0 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.55 6.0 23.81 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-O 119.352 -0.693 . . . . 74.209999999999994 114.493 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -70.96 128.6 36.54 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.915 0.857 . . . . 74.540000000000006 112.097 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.21 143.12 34.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.783 0.833 . . . . 70.510000000000005 108.924 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.518 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.2 p90 -165.9 146.84 6.79 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.506 0.504 . . . . 71.329999999999998 111.624 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.528 HG23 HD11 ' A' ' 217' ' ' LEU . 78.0 t -89.39 -42.44 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.561 -0.903 . . . . 73.030000000000001 108.561 165.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.2 m -104.87 129.32 53.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.95 -1.023 . . . . 73.310000000000002 109.155 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -67.14 -18.54 65.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.305 0.642 . . . . 60.229999999999997 111.739 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -70.29 -26.56 63.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.608 1.163 . . . . 63.32 110.942 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 51.1 p -137.46 107.66 6.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.535 0.734 . . . . 72.400000000000006 109.93 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.2 mtt180 -116.56 133.82 55.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.303 1.041 . . . . 74.329999999999998 108.881 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.409 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.2 OUTLIER -128.78 143.67 50.97 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.365 0.666 . . . . 75.040000000000006 109.945 -170.059 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -67.91 -22.29 65.09 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.974 0.51 . . . . 73.329999999999998 112.066 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.2 p -130.89 155.14 47.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.121 0.962 . . . . 45.310000000000002 112.05 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -28.19 69.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 113.631 -1.622 . . . . 73.439999999999998 109.327 173.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.79 94.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.733 0.813 . . . . 72.439999999999998 110.945 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.407 0.683 . . . . 73.219999999999999 111.15 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.528 HD11 HG23 ' A' ' 205' ' ' VAL . 17.8 tp -55.2 -54.37 44.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 123.552 0.533 . . . . 50.200000000000003 111.158 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.88 -46.79 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 124.038 0.836 . . . . 74.140000000000001 110.703 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -61.74 -48.05 82.45 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.544 0.527 . . . . 61.329999999999998 111.968 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.02 -47.04 78.86 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.939 -0.573 . . . . 75.150000000000006 109.609 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.671 ' HB3' HD11 ' A' ' 228' ' ' LEU . 15.9 m-70 -82.76 -1.45 51.59 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 112.296 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.8 p -94.14 -40.83 9.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.919 0.488 . . . . 74.349999999999994 110.913 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.7 p -69.63 -38.3 77.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.321 -0.399 . . . . 71.450000000000003 111.019 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.651 HG23 ' HB2' ' A' ' 226' ' ' ASP . 17.6 m -132.97 162.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.669 0.747 . . . . 54.350000000000001 112.237 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.34 15.71 0.92 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 127.219 2.208 . . . . 54.549999999999997 113.988 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.651 ' HB2' HG23 ' A' ' 224' ' ' VAL . 23.4 t70 -44.2 33.44 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.464 1 C-N-CA 132.357 4.263 . . . . 74.329999999999998 119.519 -156.124 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.28 2.14 9.16 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.243 -1.536 . . . . 72.349999999999994 112.63 -171.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.5 mt -94.5 165.58 12.47 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 125.701 1.6 . . . . 74.109999999999999 109.972 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.1 tt -56.38 -42.05 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 109.982 -0.377 . . . . 63.43 109.982 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.9 t -160.91 177.39 10.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.995 0.918 . . . . 70.540000000000006 109.693 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 68.3 p -61.85 150.12 38.26 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.451 1.1 . . . . 75.530000000000001 113.106 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.56 HD21 ' HE1' ' A' ' 193' ' ' TYR . 86.5 mt -83.65 92.44 7.68 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.384 -0.969 . . . . 62.140000000000001 108.384 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -78.76 -51.32 9.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.504 0.557 . . . . 72.329999999999998 112.504 -161.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.4 OUTLIER -148.16 150.22 34.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.843 -1.169 . . . . 71.230000000000004 107.843 169.109 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.413 ' HB3' ' HB3' ' A' ' 146' ' ' TRP . 11.6 Cg_endo -96.0 153.29 1.41 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.384 2.722 . . . . 73.109999999999999 114.149 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -60.51 128.38 88.1 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 114.653 -1.158 . . . . 71.439999999999998 109.53 168.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 11.2 Cg_exo -73.58 -173.79 1.45 Allowed 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 123.006 2.47 . . . . 74.319999999999993 113.31 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 74.1 mmtt -67.3 133.27 49.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.867 0.867 . . . . 73.099999999999994 109.523 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.482 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 13.5 ptt180 -86.49 -66.72 0.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.538 0.94 . . . . 62.43 113.538 -167.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.482 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 8.4 t-20 -114.98 158.03 22.61 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.984 0.514 . . . . 64.549999999999997 111.323 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.91 114.62 41.09 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 108.115 -1.068 . . . . 71.25 108.115 166.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.56 123.12 12.87 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.018 2.478 . . . . 74.409999999999997 112.167 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 5.1 m -72.95 103.64 3.82 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.651 -0.704 . . . . 72.420000000000002 111.268 -167.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.488 HG21 ' HG2' ' A' ' 131' ' ' PRO . 25.0 t -93.39 127.92 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.261 -1.014 . . . . 75.209999999999994 108.261 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -104.44 111.18 23.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.426 -0.321 . . . . 71.099999999999994 110.331 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.84 -39.39 0.24 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 118.245 2.058 . . . . 43.310000000000002 118.245 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.3 123.55 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.818 1.044 . . . . 74.439999999999998 113.818 -157.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.1 t -82.04 129.31 64.84 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 106.01 -1.848 . . . . 70.299999999999997 106.01 157.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.371 1.74 0 C-N-CA 121.484 1.456 . . . . 73.129999999999995 113.957 -154.217 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 2.1 t90 . . . . . 0 CA--C 1.55 0.958 0 CA-C-O 121.506 0.669 . . . . 65.349999999999994 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.6 p-10 -63.98 -24.18 67.62 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.355 1.062 . . . . 71.010000000000005 110.236 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.5 m -67.34 3.04 1.37 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.871 1.269 . . . . 75.299999999999997 112.796 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.8 -40.28 83.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.401 1.08 . . . . 63.539999999999999 111.508 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 7.9 pt-20 -68.53 -39.14 81.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.829 0.452 . . . . 75.109999999999999 110.146 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -81.12 -10.29 59.68 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.254 -0.884 . . . . 61.539999999999999 111.025 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.3 tp -62.78 -52.75 61.98 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.313 0.645 . . . . 73.140000000000001 110.122 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.9 mt -104.34 20.92 17.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.04 0.536 . . . . 72.010000000000005 110.624 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 122.94 0.496 . . . . 44.119999999999997 111.278 179.169 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 CA--C 1.554 1.13 0 CA-C-O 120.502 0.191 . . . . 73.420000000000002 110.767 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.2 tp -84.14 135.28 34.45 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.699 -0.625 . . . . 53.409999999999997 109.462 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -119.22 174.23 6.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.238 1.415 . . . . 75.349999999999994 109.734 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.62 139.41 35.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.959 1.303 . . . . 53.32 108.338 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.416 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -76.09 130.8 38.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.619 0.768 . . . . 23.420000000000002 109.344 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 136' ' ' THR . 72.0 mt -91.26 -26.91 18.77 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.395 0.678 . . . . 63.43 110.728 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.14 165.64 21.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.504 0.721 . . . . 75.019999999999996 110.362 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 3.4 m-20 -89.18 120.21 30.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.191 -0.913 . . . . 70.549999999999997 108.915 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.542 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.5 t80 -114.96 148.14 39.13 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.282 -1.007 . . . . 61.32 108.282 173.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.6 t -122.92 134.54 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.19 -1.041 . . . . 70.230000000000004 108.19 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.3 124.54 22.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.804 . . . . 74.450000000000003 111.573 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 p -141.32 18.56 2.24 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.076 0.95 . . . . 72.409999999999997 111.213 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.25 -179.28 24.08 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.944 -0.863 . . . . 44.439999999999998 110.944 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.93 -38.84 76.33 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.985 0.514 . . . . 64.200000000000003 111.516 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.511 HD21 ' HG2' ' A' ' 249' ' ' PRO . 27.0 p-10 -105.47 -3.19 22.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.977 0.511 . . . . 75.310000000000002 112.305 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.416 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 73.6 p -72.47 164.57 26.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.728 0.64 . . . . 72.340000000000003 112.728 -170.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.445 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 67.3 tp -147.18 136.31 22.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.022 0.529 . . . . 70.120000000000005 110.744 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.4 m -80.0 117.6 20.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.307 0.643 . . . . 42.020000000000003 110.615 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.658 HG22 HG21 ' A' ' 123' ' ' THR . 22.6 pt -117.72 157.04 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.167 0.587 . . . . 74.109999999999999 111.009 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.8 m -111.31 151.54 28.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.566 1.146 . . . . 75.200000000000003 109.064 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -60.05 125.62 24.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.231 0.612 . . . . 71.310000000000002 110.414 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.62 -7.23 82.41 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.611 . . . . 51.409999999999997 113.751 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -69.57 124.39 23.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.366 0.583 . . . . 71.129999999999995 111.058 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -73.86 134.94 43.35 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.348 -0.612 . . . . 54.039999999999999 109.348 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.662 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.0 159.05 44.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.8 0.84 . . . . 52.140000000000001 110.457 -175.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.509 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 56.7 ttm-85 -115.43 109.97 18.64 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.881 0.472 . . . . 72.439999999999998 110.578 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.695 HG13 ' HB1' ' A' ' 119' ' ' ALA . 25.5 t -70.61 112.18 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.56 0.695 . . . . 73.150000000000006 109.127 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.08 -41.83 58.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.042 -0.981 . . . . 70.140000000000001 108.364 175.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.77 158.33 16.79 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.843 0.714 . . . . 50.119999999999997 113.639 171.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.783 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 59.9 m-85 -88.16 164.89 15.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 70.209999999999994 111.666 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.7 -172.56 3.37 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.972 0.909 . . . . 70.25 111.162 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.24 -35.43 11.97 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 115.158 1.54 . . . . 73.540000000000006 115.158 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -110.5 -15.43 13.9 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.136 0.574 . . . . 74.299999999999997 111.791 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.783 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 87.97 30.19 18.26 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 114.631 0.613 . . . . 60.219999999999999 114.631 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.45 -38.05 17.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.516 0.658 . . . . 65.129999999999995 111.79 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 18.1 m95 -125.52 146.25 49.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.163 0.585 . . . . 74.129999999999995 110.559 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.695 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -129.72 136.5 49.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 74.129999999999995 110.927 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.41 103.79 2.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.11 -1.07 . . . . 74.409999999999997 108.11 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.7 138.42 39.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.108 0.563 . . . . 54.219999999999999 111.135 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 61.3 tt0 -97.75 104.89 16.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.903 -1.147 . . . . 74.310000000000002 107.903 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 107' ' ' LEU . 68.5 p -111.09 172.07 7.1 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.753 0.821 . . . . 71.439999999999998 110.86 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -14.53 62.97 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 114.718 -1.128 . . . . 73.319999999999993 110.031 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.1 -26.66 30.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.18 0.992 . . . . 64.439999999999998 111.539 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 136.22 -158.68 24.07 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 120.158 -0.245 . . . . 75.019999999999996 112.533 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.429 HE22 ' HB2' ' A' ' 122' ' ' GLN . 11.8 tp-100 -101.82 137.39 40.18 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.208 0.504 . . . . 74.010000000000005 111.377 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 165.9 162.67 17.76 Favored Glycine 0 C--N 1.347 1.143 0 C-N-CA 121.403 -0.427 . . . . 63.520000000000003 113.399 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 43.1 m95 -77.15 133.69 38.9 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.319 1.047 . . . . 70.510000000000005 112.19 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.3 m -136.28 146.32 55.64 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 125.108 1.363 . . . . 70.530000000000001 108.552 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 73.4 Cg_endo -76.06 150.05 33.25 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.1 1.867 . . . . 64.519999999999996 114.888 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -39.23 -49.06 1.87 Allowed 'General case' 0 C--N 1.366 1.308 0 C-N-CA 126.243 1.817 . . . . 61.299999999999997 113.516 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -79.22 -0.85 33.78 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.082 0.771 . . . . 73.219999999999999 113.082 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -98.76 -13.38 20.22 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.85 0.86 . . . . 74.519999999999996 111.487 170.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.73 177.25 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.26 1.024 . . . . 71.129999999999995 110.451 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.426 HG22 HD21 ' A' ' 88' ' ' LEU . 6.4 t -161.75 151.91 14.3 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 108.463 -0.939 . . . . 73.450000000000003 108.463 170.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.03 148.15 86.69 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.705 1.603 . . . . 61.310000000000002 111.679 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 36.9 t -71.27 -7.76 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-O 121.688 0.756 . . . . 62.210000000000001 109.893 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -75.45 -20.26 58.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.078 0.951 . . . . 71.209999999999994 111.746 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.5 p -91.83 174.41 7.35 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.448 0.699 . . . . 75.25 111.607 -172.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.28 -20.04 32.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 61.420000000000002 110.569 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.5 -19.13 65.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.086 0.955 . . . . 75.299999999999997 111.992 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -62.68 -21.43 65.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.499 0.72 . . . . 74.340000000000003 112.658 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -78.47 139.75 38.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.285 0.634 . . . . 75.420000000000002 110.143 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.9 p -59.65 -41.94 91.66 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.187 0.995 . . . . 61.399999999999999 111.906 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -67.01 -38.66 86.35 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.834 0.709 . . . . 72.439999999999998 112.229 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.5 118.51 20.71 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.179 -0.674 . . . . 74.140000000000001 109.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -112.63 -1.46 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.122 0.569 . . . . 73.530000000000001 112.273 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.55 -162.23 49.0 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 118.807 -0.996 . . . . 75.099999999999994 112.794 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.38 95.9 0.15 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.988 2.459 . . . . 71.329999999999998 112.721 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 82.3 t -119.93 149.72 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.996 1.318 . . . . 53.0 109.002 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 45.6 m -85.66 166.8 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.525 0.73 . . . . 54.240000000000002 110.598 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -60.04 -50.92 71.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.988 0.515 . . . . 73.150000000000006 110.975 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -58.24 -39.75 79.95 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.0 0.92 . . . . 74.430000000000007 111.7 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.4 75.48 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.907 -0.588 . . . . 73.319999999999993 110.801 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 159' ' ' LEU . . . -57.34 -39.21 75.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.585 0.707 . . . . 65.530000000000001 111.505 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -83.7 -19.04 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.254 -0.884 . . . . 73.5 111.971 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -24.69 43.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.839 0.745 . . . . 73.200000000000003 110.936 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.843 HD21 ' HA ' ' A' ' 239' ' ' ARG . 42.7 mt -69.77 -43.66 71.76 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.013 -0.994 . . . . 74.310000000000002 110.007 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.433 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 75.4 mt -94.8 22.77 6.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.844 -1.071 . . . . 70.209999999999994 112.285 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.7 p -74.23 -41.68 60.96 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.099 0.476 . . . . 75.239999999999995 110.152 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 p -111.99 15.06 20.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.183 0.993 . . . . 55.5 112.247 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.29 168.73 52.2 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 121.908 -0.187 . . . . 61.240000000000002 113.235 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 pt -101.8 -176.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.641 0.776 . . . . 65.299999999999997 111.056 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -63.31 125.35 23.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.459 -0.791 . . . . 74.319999999999993 109.853 172.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.438 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 90.56 10.79 63.08 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 119.313 -0.715 . . . . 30.140000000000001 113.181 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 68.4 m -82.17 116.01 21.53 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.364 1.082 . . . . 64.040000000000006 111.627 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 183' ' ' SER . 12.9 p90 -132.25 168.47 17.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.448 0.642 . . . . 73.530000000000001 111.494 -171.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.32 155.88 25.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.355 -1.293 . . . . 52.450000000000003 108.584 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.658 HG22 HG12 ' A' ' 182' ' ' ILE . 77.5 t -112.33 125.04 69.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.028 -1.101 . . . . 74.530000000000001 108.028 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.565 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 36.3 ptt85 -114.81 161.65 17.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.039 -1.097 . . . . 75.340000000000003 108.039 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 155.24 23.11 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.9 t -79.79 126.41 30.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.049 0.54 . . . . 75.209999999999994 109.794 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -63.42 -34.87 78.69 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 123.948 0.78 . . . . 41.329999999999998 110.265 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 p -82.01 -19.38 40.57 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.626 0.77 . . . . 63.119999999999997 111.989 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -143.86 98.78 5.21 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.901 0.48 . . . . 71.209999999999994 111.176 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.53 136.35 75.33 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.089 2.526 . . . . 74.219999999999999 112.638 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.33 -29.53 6.07 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.135 -0.484 . . . . 50.439999999999998 113.546 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -75.83 117.3 17.42 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.384 -0.599 . . . . 74.140000000000001 109.384 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -122.29 145.79 47.9 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.658 0.742 . . . . 73.310000000000002 110.288 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.1 m -132.49 144.52 50.51 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.523 -1.217 . . . . 71.450000000000003 108.291 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 170' ' ' VAL . 31.9 mt -99.68 148.56 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.787 -1.56 . . . . 72.109999999999999 106.787 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -123.9 108.71 12.73 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.336 -1.357 . . . . 62.039999999999999 107.336 172.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.438 HD11 ' HA2' ' A' ' 166' ' ' GLY . 67.3 tp -105.93 142.75 35.11 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.367 -0.605 . . . . 73.319999999999993 109.367 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.5 ttt85 -117.53 119.38 34.85 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.525 1.13 . . . . 73.329999999999998 109.486 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -140.97 136.27 32.01 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.061 1.344 . . . . 63.149999999999999 107.84 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 58.18 21.23 7.83 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.637 1.175 . . . . 74.329999999999998 111.62 -170.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.17 -9.5 74.73 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.185 0.434 . . . . 52.409999999999997 114.185 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 57.4 mtp85 -96.18 140.12 31.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.522 0.661 . . . . 75.219999999999999 110.177 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.15 108.42 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.691 0.796 . . . . 72.109999999999999 110.81 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.82 150.6 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.278 1.431 . . . . 74.549999999999997 108.51 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 86.0 m-70 -125.45 127.13 46.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.469 0.307 . . . . 72.120000000000005 110.174 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.41 ' HE1' HD21 ' A' ' 232' ' ' LEU . 5.9 m-85 -101.06 149.29 24.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.899 0.88 . . . . 74.439999999999998 109.287 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -97.99 117.25 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.708 -0.849 . . . . 72.349999999999994 108.708 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.7 mt -82.2 99.83 5.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.299 -1.371 . . . . 74.049999999999997 107.299 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -75.04 110.6 9.47 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.555 -1.276 . . . . 73.099999999999994 107.555 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.7 m -89.28 106.4 18.42 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.956 -0.757 . . . . 63.420000000000002 108.956 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.437 ' HB2' ' HE1' ' A' ' 204' ' ' TYR . . . -63.06 148.68 47.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.909 0.884 . . . . 75.049999999999997 110.743 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.3 p -65.5 -23.81 66.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.255 0.622 . . . . 73.319999999999993 112.13 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -78.24 -18.6 55.16 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.862 0.465 . . . . 72.439999999999998 110.986 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.61 14.77 12.06 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.869 -0.406 . . . . 62.310000000000002 114.012 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -92.15 139.0 31.07 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.779 0.789 . . . . 74.25 110.949 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.13 143.03 29.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.956 -1.128 . . . . 62.200000000000003 107.956 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.509 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.5 p90 -163.39 135.45 5.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.221 0.326 . . . . 74.019999999999996 111.675 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.423 HG23 HD11 ' A' ' 217' ' ' LEU . 87.4 t -82.94 -34.02 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.315 -0.995 . . . . 64.299999999999997 108.315 161.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 35.9 m -99.48 119.91 38.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.446 1.099 . . . . 71.549999999999997 110.344 -175.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.6 t -59.12 -34.15 71.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.805 1.242 . . . . 75.340000000000003 112.634 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.22 -2.86 58.85 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.968 0.907 . . . . 52.310000000000002 111.836 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 15.5 m -135.05 85.63 2.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.068 0.547 . . . . 73.319999999999993 109.527 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.509 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 43.5 mtt180 -93.59 120.49 33.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.929 0.891 . . . . 72.010000000000005 109.286 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -107.44 149.68 27.64 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.533 0.733 . . . . 74.450000000000003 109.351 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -62.36 -44.13 97.18 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.523 0.514 . . . . 70.420000000000002 110.161 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.4 p -125.68 160.5 29.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.637 0.732 . . . . 60.439999999999998 111.785 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.24 -25.92 68.27 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.728 -1.124 . . . . 71.200000000000003 109.317 171.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.13 86.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.039 0.936 . . . . 34.210000000000001 111.395 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -72.02 -30.71 65.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.131 -0.94 . . . . 74.049999999999997 111.346 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.423 HD11 HG23 ' A' ' 205' ' ' VAL . 14.8 tp -57.12 -55.49 34.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.306 0.379 . . . . 75.299999999999997 110.351 171.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.2 -41.96 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.752 0.658 . . . . 53.340000000000003 111.254 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -61.87 -55.1 33.24 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.452 0.47 . . . . 75.420000000000002 111.445 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -61.52 -38.08 86.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.443 0.697 . . . . 73.230000000000004 110.866 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.76 ' HB3' HD11 ' A' ' 228' ' ' LEU . 18.6 m170 -88.65 -6.41 57.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.793 -0.639 . . . . 73.510000000000005 112.386 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.0 p -91.07 -31.89 16.09 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 110.22 -0.289 . . . . 62.240000000000002 110.22 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 40.4 p -76.71 -40.63 48.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.206 -0.452 . . . . 72.439999999999998 111.351 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.644 HG23 ' HB2' ' A' ' 226' ' ' ASP . 18.3 m -134.84 158.45 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.331 0.652 . . . . 71.540000000000006 111.623 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.45 14.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 126.932 2.093 . . . . 71.219999999999999 114.424 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.644 ' HB2' HG23 ' A' ' 224' ' ' VAL . 36.4 t70 -42.92 32.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.78 1 C-N-CA 132.07 4.148 . . . . 73.319999999999993 119.761 -155.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.22 -1.8 9.71 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.22 -1.55 . . . . 71.299999999999997 112.112 -168.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.76 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.2 mt -92.07 162.8 14.21 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.691 1.196 . . . . 74.040000000000006 109.434 168.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.49 -42.57 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 121.046 0.45 . . . . 74.340000000000003 110.42 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -161.36 -179.23 7.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.106 0.962 . . . . 63.329999999999998 109.127 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 49.0 p -70.08 143.99 52.27 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.471 0.708 . . . . 65.140000000000001 112.346 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.41 HD21 ' HE1' ' A' ' 193' ' ' TYR . 49.3 mt -72.21 145.66 47.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.649 -1.241 . . . . 72.340000000000003 107.649 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -147.26 -78.66 0.16 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.323 0.965 . . . . 73.129999999999995 111.534 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 167' ' ' SER . 11.5 t80 -83.41 124.06 76.17 Favored Pre-proline 0 C--O 1.208 -1.09 0 C-N-CA 124.284 1.034 . . . . 73.129999999999995 108.445 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -86.6 139.3 5.69 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.291 1.994 . . . . 71.400000000000006 112.122 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.25 151.9 90.14 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.408 0.683 . . . . 74.219999999999999 109.778 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.06 176.83 9.52 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.508 2.139 . . . . 72.209999999999994 112.118 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.62 154.57 40.2 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.129 0.572 . . . . 72.329999999999998 110.285 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.843 ' HA ' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -69.9 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.723 1.008 . . . . 74.109999999999999 113.723 -158.249 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.447 ' H ' ' HG2' ' A' ' 239' ' ' ARG . 65.3 t30 -120.45 159.33 25.34 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.012 -1.055 . . . . 75.200000000000003 108.561 159.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.458 ' NZ ' ' HB2' ' A' ' 90' ' ' ASP . 98.6 mttt -73.43 115.64 43.33 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 107.686 -1.227 . . . . 65.219999999999999 107.686 160.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.49 127.44 21.83 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.042 2.495 . . . . 53.43 112.587 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 26.0 m -80.49 116.43 20.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.84 -0.43 . . . . 52.409999999999997 109.84 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.37 111.89 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.643 0.777 . . . . 72.409999999999997 108.964 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.9 112.8 20.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.541 -0.299 . . . . 75.140000000000001 110.692 -166.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 70.47 -41.51 0.51 Allowed Glycine 0 CA--C 1.542 1.737 0 N-CA-C 117.436 1.735 . . . . 71.239999999999995 117.436 163.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.61 135.4 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 117.687 0.743 . . . . 64.150000000000006 112.667 -157.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -82.8 130.08 59.47 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 105.757 -1.942 . . . . 73.010000000000005 105.757 157.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.511 ' HG2' HD21 ' A' ' 97' ' ' ASN . 12.2 Cg_exo . . . . . 0 C--N 1.365 1.419 0 C-N-CA 121.575 1.516 . . . . 54.130000000000003 113.829 -153.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.799 ' HB2' ' HG3' ' A' ' 235' ' ' PRO . 11.6 t90 . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 121.949 0.881 . . . . 73.319999999999993 109.021 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.7 p-10 -64.53 -24.18 67.52 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.367 -0.833 . . . . 64.439999999999998 110.012 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.7 p -69.69 3.67 2.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.863 1.265 . . . . 45.450000000000003 112.775 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.6 -20.96 66.13 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.816 0.446 . . . . 62.32 110.664 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 14.4 pt-20 -63.33 -42.46 98.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.056 0.542 . . . . 75.239999999999995 109.816 168.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -72.39 -16.5 61.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.469 1.108 . . . . 71.109999999999999 110.924 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 tp -63.53 -51.4 65.61 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.675 0.79 . . . . 62.109999999999999 110.632 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.6 mt -103.13 4.17 36.68 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 111.41 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 122.667 0.387 . . . . 60.43 110.93 175.183 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 t30 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 121.242 0.544 . . . . 71.409999999999997 110.069 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.6 tp -79.4 139.12 37.81 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.327 -0.397 . . . . 71.219999999999999 110.033 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.2 m-85 -118.62 171.54 8.12 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.729 1.212 . . . . 73.200000000000003 109.723 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.35 131.48 22.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.502 1.121 . . . . 53.109999999999999 109.406 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.74 114.11 6.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.542 1.137 . . . . 65.5 109.889 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 78.0 mt -73.92 -32.63 63.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.516 0.726 . . . . 62.310000000000002 110.496 173.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.53 163.78 21.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.606 -1.179 . . . . 61.140000000000001 108.69 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.15 149.69 23.75 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.803 -0.814 . . . . 75.200000000000003 108.803 166.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.624 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.2 t80 -132.96 141.52 48.38 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.809 -1.182 . . . . 63.32 107.809 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.24 133.47 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.321 -0.992 . . . . 72.329999999999998 108.321 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.25 132.51 53.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.51 0.724 . . . . 52.229999999999997 111.108 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 p -129.39 -41.12 1.4 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.186 0.995 . . . . 65.409999999999997 111.065 -172.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.88 23.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.307 -0.406 . . . . 55.439999999999998 112.524 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.26 -43.57 10.88 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.638 0.719 . . . . 65.230000000000004 111.067 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.472 HD21 ' HD2' ' A' ' 249' ' ' PRO . 6.6 p30 -108.24 10.84 27.73 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.613 0.765 . . . . 70.230000000000004 112.123 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.0 p -73.14 150.35 42.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.347 0.659 . . . . 74.200000000000003 110.122 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 128' ' ' GLY . 58.1 tp -130.32 127.73 40.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.089 0.556 . . . . 64.420000000000002 110.824 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -74.27 133.14 42.62 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.221 0.609 . . . . 71.230000000000004 111.619 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.624 HG12 ' HB3' ' A' ' 91' ' ' PHE . 11.4 pt -130.28 166.84 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.208 1.003 . . . . 74.140000000000001 111.1 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 26.9 m -109.84 155.89 21.08 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.577 1.151 . . . . 74.430000000000007 110.329 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -58.95 127.84 34.24 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.162 0.585 . . . . 64.519999999999996 110.196 171.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.83 3.88 84.68 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.388 0.515 . . . . 45.43 114.388 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' HB ' ' A' ' 123' ' ' THR . 38.1 tt0 -73.45 142.48 46.86 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.053 0.541 . . . . 64.420000000000002 110.516 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -93.1 132.28 37.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.454 -0.573 . . . . 72.439999999999998 109.454 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -143.46 163.44 33.11 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.012 0.925 . . . . 72.450000000000003 110.511 -177.088 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -123.79 108.05 12.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.771 0.428 . . . . 72.409999999999997 110.345 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.658 HG13 ' HB1' ' A' ' 119' ' ' ALA . 41.3 t -73.65 117.86 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.197 0.522 . . . . 72.430000000000007 110.47 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.8 mt -84.08 -60.3 2.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.822 -1.081 . . . . 73.549999999999997 109.079 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.4 141.1 9.01 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 120.853 -0.689 . . . . 42.219999999999999 112.942 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.64 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 20.5 m-85 -88.41 154.54 20.29 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.413 0.685 . . . . 65.140000000000001 109.781 171.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -78.54 -174.9 4.06 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.527 -1.215 . . . . 71.420000000000002 111.857 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -50.01 -31.65 13.36 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.185 1.394 . . . . 71.25 114.253 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -112.8 3.08 16.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.836 0.68 . . . . 60.149999999999999 112.836 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.49 19.65 74.74 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.974 0.75 . . . . 73.549999999999997 114.974 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.46 -12.13 18.79 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.453 0.701 . . . . 65.049999999999997 112.806 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 44.7 m95 -134.34 144.87 48.52 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.535 0.734 . . . . 72.010000000000005 110.248 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -132.98 129.7 38.55 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.716 0.807 . . . . 63.439999999999998 110.962 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.83 97.43 2.24 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 106.814 -1.55 . . . . 74.239999999999995 106.814 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.08 144.49 33.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.393 0.677 . . . . 43.119999999999997 111.434 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -93.76 103.37 15.51 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.78 -1.192 . . . . 62.439999999999998 107.78 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 107' ' ' LEU . 38.5 p -97.36 174.56 6.63 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.003 0.921 . . . . 74.129999999999995 109.979 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -63.83 -23.21 67.26 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.189 0.518 . . . . 74.5 110.187 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -79.19 -29.35 42.87 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.598 1.159 . . . . 74.209999999999994 111.036 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 139.86 -170.03 24.43 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 112.282 -0.327 . . . . 50.32 112.282 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -97.33 135.93 38.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.463 0.632 . . . . 63.200000000000003 111.224 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.463 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 170.6 172.28 36.79 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.328 -0.709 . . . . 63.149999999999999 111.328 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -85.19 124.02 31.35 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.344 0.572 . . . . 70.5 112.076 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.52 HG23 HD13 ' A' ' 135' ' ' ILE . 17.2 m -126.99 143.39 46.71 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.09 1.356 . . . . 72.510000000000005 108.445 170.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 66.2 Cg_endo -88.13 149.61 6.82 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.257 1.971 . . . . 73.219999999999999 115.33 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 m -46.67 -28.09 1.37 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.607 1.963 . . . . 70.129999999999995 115.592 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.572 HD21 HG22 ' A' ' 244' ' ' VAL . 32.0 p-10 -81.95 -16.32 50.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.478 0.311 . . . . 73.349999999999994 111.769 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 30.1 m-85 -94.48 -23.53 17.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 72.109999999999999 111.688 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.52 HD13 HG23 ' A' ' 130' ' ' VAL . 20.4 pt -123.56 168.01 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.071 0.549 . . . . 72.099999999999994 112.282 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.3 t -159.75 151.3 16.54 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.964 0.906 . . . . 72.349999999999994 108.643 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.3 Cg_endo -60.7 147.24 95.53 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 121.745 1.63 . . . . 73.230000000000004 111.724 174.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.29 -11.56 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.738 0.78 . . . . 52.25 110.767 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -80.26 -13.53 59.13 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.146 0.578 . . . . 73.099999999999994 111.648 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.2 p -89.16 165.16 14.65 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.253 0.621 . . . . 44.43 110.973 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.9 mt -80.35 -21.35 42.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.804 0.842 . . . . 60.140000000000001 110.817 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.83 -17.16 62.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.843 1.257 . . . . 74.409999999999997 111.68 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.417 ' HA ' HD21 ' A' ' 88' ' ' LEU . 22.0 pttm -61.54 -20.22 63.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.957 0.903 . . . . 51.439999999999998 112.976 176.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.47 144.55 25.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.167 0.587 . . . . 70.430000000000007 111.276 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -60.95 -41.5 96.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.596 1.158 . . . . 72.040000000000006 111.869 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -67.26 -33.07 74.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.649 0.779 . . . . 72.209999999999994 112.556 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -77.59 116.31 18.05 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.69 -0.856 . . . . 73.209999999999994 108.69 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.405 ' ND1' HD13 ' A' ' 159' ' ' LEU . 33.0 m170 -113.33 -2.71 13.94 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.36 0.504 . . . . 50.140000000000001 112.36 -175.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.9 -136.25 25.43 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 118.543 -1.143 . . . . 72.519999999999996 113.091 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.79 90.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.53 2.82 . . . . 54.229999999999997 112.71 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.646 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.6 t -132.31 133.73 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 74.209999999999994 108.963 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -89.79 175.53 7.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.862 0.865 . . . . 73.409999999999997 109.87 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 2.6 tmt_? -58.75 -45.92 88.6 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.76 0.424 . . . . 64.150000000000006 110.261 175.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -63.44 -35.12 79.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.714 0.805 . . . . 72.209999999999994 111.547 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.83 -30.34 62.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.058 -0.519 . . . . 65.310000000000002 110.95 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.7 71.23 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.009 0.524 . . . . 73.140000000000001 111.063 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 12.0 mm-40 -62.86 -48.28 79.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.251 0.62 . . . . 70.340000000000003 109.503 170.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.54 -41.21 69.45 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.077 1.751 . . . . 63.119999999999997 111.669 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 239' ' ' ARG . 59.0 mt -68.1 -55.43 12.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.036 0.934 . . . . 65.319999999999993 111.684 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -84.89 16.02 3.62 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.576 0.584 . . . . 71.530000000000001 112.576 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.6 p -65.0 -40.34 94.8 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.405 0.621 . . . . 74.150000000000006 110.397 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.9 p -98.29 18.89 15.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.34 1.056 . . . . 54.409999999999997 111.0 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.46 162.97 32.31 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.243 -0.435 . . . . 73.299999999999997 112.56 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.1 -176.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.39 1.076 . . . . 54.420000000000002 110.039 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -67.47 123.2 19.75 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.422 -0.585 . . . . 74.340000000000003 109.422 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.78 5.98 57.36 Favored Glycine 0 C--O 1.25 1.155 0 CA-C-O 119.555 -0.581 . . . . 75.299999999999997 113.187 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 52.6 m -83.88 131.69 34.85 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 119.188 -0.434 . . . . 71.329999999999998 110.5 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.58 168.07 20.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.409 0.623 . . . . 65.340000000000003 111.557 -172.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.16 158.72 27.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 114.326 -1.306 . . . . 74.140000000000001 108.979 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.594 HG22 HG12 ' A' ' 182' ' ' ILE . 98.9 t -119.31 137.69 52.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 N-CA-C 108.338 -0.986 . . . . 72.519999999999996 108.338 168.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.646 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 0.4 OUTLIER -122.26 146.86 46.89 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.009 -0.996 . . . . 63.329999999999998 109.634 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.1 tp10 -97.15 139.64 32.84 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.005 1.322 . . . . 71.310000000000002 108.207 164.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.4 t -83.82 123.14 29.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 72.519999999999996 109.093 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -81.88 -26.55 34.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.28 0.562 . . . . 65.239999999999995 109.799 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.8 m -64.49 -39.12 93.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.281 1.033 . . . . 71.409999999999997 110.213 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 47.5 m -137.51 91.3 14.19 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.035 -1.098 . . . . 54.549999999999997 108.035 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.68 134.38 60.31 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.98 2.453 . . . . 63.140000000000001 112.679 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.06 -27.23 21.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.483 -0.78 . . . . 24.309999999999999 112.549 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -85.22 116.9 23.84 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.538 -0.912 . . . . 64.319999999999993 108.538 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 99.4 mtt180 -123.38 159.5 28.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.477 0.656 . . . . 63.009999999999998 111.668 -170.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.444 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 18.8 m -149.0 152.51 36.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.914 -1.039 . . . . 71.120000000000005 109.516 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.594 HG12 HG22 ' A' ' 170' ' ' VAL . 25.3 mt -102.72 149.08 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.389 -1.337 . . . . 72.400000000000006 107.389 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.2 m -126.43 114.6 18.39 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.311 -0.996 . . . . 52.200000000000003 108.311 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.7 tp -113.03 113.5 25.54 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.088 0.404 . . . . 73.040000000000006 109.911 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.435 ' HE ' ' HA2' ' A' ' 188' ' ' GLY . 44.4 ttt180 -77.82 115.3 17.46 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.324 0.583 . . . . 72.25 110.013 166.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -139.03 144.65 38.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.613 1.565 . . . . 61.219999999999999 107.361 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 58.3 21.07 7.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.04 0.936 . . . . 75.209999999999994 111.919 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.435 ' HA2' ' HE ' ' A' ' 185' ' ' ARG . . . 82.82 -0.37 89.62 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 119.418 -0.657 . . . . 43.149999999999999 114.535 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 55.8 mtp180 -115.36 150.42 36.35 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 117.893 0.846 . . . . 75.010000000000005 109.672 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 62.0 t -100.82 118.94 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.146 0.578 . . . . 73.519999999999996 110.541 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -108.21 117.47 34.23 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.184 0.993 . . . . 71.109999999999999 108.634 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -91.42 122.32 33.91 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.022 0.529 . . . . 75.510000000000005 110.503 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.488 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.6 m-85 -94.36 149.08 21.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.43 1.092 . . . . 74.209999999999994 108.291 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -101.21 127.5 47.75 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.087 -0.708 . . . . 73.120000000000005 109.087 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.51 101.05 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.83 -1.174 . . . . 71.209999999999994 107.83 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -88.11 144.51 26.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.934 1.294 . . . . 73.230000000000004 109.062 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -111.46 116.86 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.55 -0.537 . . . . 75.010000000000005 109.55 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.34 168.15 13.09 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.715 0.806 . . . . 71.129999999999995 110.652 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.6 m -62.81 -28.02 69.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.931 0.892 . . . . 70.530000000000001 112.368 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -90.19 -0.04 57.42 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.063 0.945 . . . . 75.209999999999994 111.969 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 92.09 12.74 58.53 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 114.081 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -83.23 128.09 34.2 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.453 0.627 . . . . 73.450000000000003 111.016 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -81.45 148.14 29.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.648 0.779 . . . . 75.439999999999998 109.288 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 47.3 p90 -168.21 147.11 4.51 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.361 0.413 . . . . 64.319999999999993 111.115 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.522 HG23 HD11 ' A' ' 217' ' ' LEU . 66.0 t -89.65 -41.05 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.38 -0.97 . . . . 74.400000000000006 108.38 164.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 46.6 m -104.94 130.17 53.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.091 0.956 . . . . 65.400000000000006 110.029 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.5 t -66.03 -20.59 66.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 73.510000000000005 112.959 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -76.87 -28.64 55.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.615 0.766 . . . . 73.019999999999996 110.666 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.4 m -124.6 98.09 5.58 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.233 0.613 . . . . 60.32 110.137 -172.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.4 mtt180 -112.08 144.36 41.58 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.973 0.909 . . . . 71.420000000000002 109.284 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.95 151.7 52.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.773 0.829 . . . . 65.430000000000007 108.985 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.33 -40.6 77.49 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.988 -0.375 . . . . 72.140000000000001 109.988 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -121.42 160.69 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.042 0.925 . . . . 64.230000000000004 112.353 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.469 HD11 HG11 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -66.8 -27.74 67.81 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.714 -1.584 . . . . 72.549999999999997 109.431 171.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.76 96.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.492 0.717 . . . . 44.43 110.782 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -68.78 -38.78 80.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.068 0.947 . . . . 65.129999999999995 111.165 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.522 HD11 HG23 ' A' ' 205' ' ' VAL . 16.6 tp -55.12 -56.9 14.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.037 0.535 . . . . 65.439999999999998 110.712 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.62 -38.22 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.545 0.738 . . . . 73.040000000000006 111.774 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -61.37 -57.96 10.17 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.784 0.326 . . . . 75.129999999999995 111.177 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -64.14 -28.15 69.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.805 -0.634 . . . . 75.099999999999994 111.028 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.673 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.6 m170 -91.13 -10.85 40.41 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.88 0.472 . . . . 62.149999999999999 112.186 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 98.3 p -87.62 -29.19 21.4 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 110.181 -0.303 . . . . 70.25 110.181 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 59.0 p -77.27 -50.38 12.99 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.021 0.528 . . . . 74.329999999999998 110.74 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.614 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.7 m -126.4 157.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 121.667 0.746 . . . . 62.030000000000001 111.942 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.63 17.74 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 127.552 2.341 . . . . 74.310000000000002 114.538 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.614 ' HB2' HG23 ' A' ' 224' ' ' VAL . 32.0 t70 -42.47 28.66 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.581 1 C-N-CA 132.619 4.368 . . . . 63.049999999999997 119.497 -152.074 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.11 -5.4 9.55 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 119.835 -1.79 . . . . 42.450000000000003 112.169 -165.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -89.62 160.87 16.43 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.831 1.252 . . . . 41.32 109.792 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.07 -34.35 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 116.272 -0.422 . . . . 73.200000000000003 110.855 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.8 t -162.3 178.49 8.65 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.865 0.866 . . . . 73.209999999999994 109.796 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 50.1 p -73.07 142.39 47.59 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.873 0.469 . . . . 71.109999999999999 111.184 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.488 HD21 ' HE1' ' A' ' 193' ' ' TYR . 46.8 mt -73.36 134.74 44.19 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.474 -0.935 . . . . 70.239999999999995 108.474 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -140.26 -68.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 119.982 1.264 . . . . 73.430000000000007 112.508 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 167' ' ' SER . 16.6 t80 -80.1 120.82 80.89 Favored Pre-proline 0 C--O 1.212 -0.915 0 N-CA-C 107.861 -1.162 . . . . 74.340000000000003 107.861 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.799 ' HG3' ' HB2' ' A' ' 67' ' ' TRP . 58.5 Cg_endo -86.69 144.02 7.42 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.012 1.808 . . . . 62.140000000000001 112.736 173.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.54 149.09 80.85 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 108.878 -0.786 . . . . 72.530000000000001 108.878 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -88.26 174.59 4.34 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.359 2.039 . . . . 71.239999999999995 111.661 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 75.6 mmtt -59.57 138.1 57.82 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.127 -0.694 . . . . 74.329999999999998 109.127 175.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.605 ' HB3' HD21 ' A' ' 159' ' ' LEU . 15.9 ptt180 -62.69 -67.4 0.42 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.758 1.021 . . . . 71.340000000000003 113.758 -157.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.595 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 7.9 t30 -119.03 165.19 14.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.844 0.747 . . . . 62.43 110.004 164.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 82.4 mttt -65.27 136.19 96.36 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 110.16 -0.311 . . . . 63.109999999999999 110.16 163.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 7.4 Cg_exo -72.58 126.96 11.96 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.945 2.43 . . . . 62.229999999999997 112.901 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 99.1 m -84.6 124.28 31.26 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.833 -0.802 . . . . 74.319999999999993 108.833 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.572 HG22 HD21 ' A' ' 133' ' ' ASN . 4.3 t -99.84 139.21 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.392 -0.966 . . . . 72.409999999999997 108.392 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.3 114.82 28.98 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.712 0.405 . . . . 74.230000000000004 111.822 -161.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.62 62.19 Favored Glycine 0 C--N 1.362 1.997 0 N-CA-C 115.827 1.091 . . . . 64.200000000000003 115.827 163.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.456 HG21 ' NE1' ' A' ' 118' ' ' TRP . 9.3 p -105.6 130.06 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 114.605 1.335 . . . . 63.229999999999997 114.605 -161.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.0 m -86.42 118.89 71.03 Favored Pre-proline 0 N--CA 1.48 1.066 0 N-CA-C 105.236 -2.135 . . . . 73.120000000000005 105.236 148.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.472 ' HD2' HD21 ' A' ' 97' ' ' ASN . 82.9 Cg_exo . . . . . 0 C--N 1.385 2.476 0 C-N-CA 122.115 1.877 . . . . 61.229999999999997 113.97 -162.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 9.3 t90 . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 121.403 0.62 . . . . 71.010000000000005 111.344 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -81.45 -20.94 39.24 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.664 -0.698 . . . . 72.209999999999994 110.538 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.8 p -73.21 1.03 10.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.243 0.617 . . . . 75.219999999999999 112.1 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -71.55 -18.9 62.23 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.37 0.668 . . . . 70.230000000000004 111.431 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.87 -32.92 71.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.614 0.721 . . . . 64.450000000000003 110.678 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -85.9 -9.09 57.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.701 -1.136 . . . . 73.019999999999996 110.978 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 215' ' ' ALA . 37.7 tp -70.57 -46.4 63.57 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.467 0.707 . . . . 60.329999999999998 109.457 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.91 52.22 1.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.439 0.638 . . . . 74.010000000000005 110.076 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.546 0 CA-C-N 115.245 -0.889 . . . . 72.400000000000006 109.972 175.336 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 p30 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.528 0.204 . . . . 73.0 111.109 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.53 139.17 44.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 74.140000000000001 108.676 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 11.3 m-85 -118.97 172.95 7.18 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.008 1.323 . . . . 63.119999999999997 109.928 -176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.94 141.54 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 125.246 1.418 . . . . 72.019999999999996 108.985 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -78.33 129.57 35.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.35 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.487 HD21 ' HA ' ' A' ' 143' ' ' LYS . 82.4 mt -87.25 -26.54 23.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.14 0.976 . . . . 63.409999999999997 112.483 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.2 m-85 -134.24 153.19 52.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.011 0.524 . . . . 62.310000000000002 110.227 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.33 119.11 21.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.091 -0.707 . . . . 71.200000000000003 109.091 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.559 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.5 t80 -117.62 126.14 52.0 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.388 -0.967 . . . . 74.400000000000006 108.388 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.45 133.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.857 -1.164 . . . . 54.310000000000002 107.857 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.66 116.46 14.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.719 0.408 . . . . 71.310000000000002 111.304 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.9 p -115.77 77.22 1.07 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.637 0.775 . . . . 73.549999999999997 108.941 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 140.58 -175.89 21.77 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.41 -0.814 . . . . 72.040000000000006 111.535 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -89.31 -42.03 11.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.407 0.683 . . . . 70.040000000000006 112.031 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.6 -26.73 60.94 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.705 0.802 . . . . 72.140000000000001 110.571 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 77.8 p -72.7 143.19 48.15 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.229 0.611 . . . . 64.340000000000003 110.241 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 128' ' ' GLY . 56.1 tp -132.55 132.05 42.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.195 0.598 . . . . 44.030000000000001 109.932 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.3 m -70.81 130.03 40.63 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.468 0.707 . . . . 70.109999999999999 110.914 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 91' ' ' PHE . 23.3 pt -133.6 150.26 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.773 0.829 . . . . 74.439999999999998 110.313 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -102.45 146.82 27.54 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.942 0.897 . . . . 70.239999999999995 109.319 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -67.94 114.37 6.44 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.542 -0.54 . . . . 74.430000000000007 109.542 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.58 -9.62 32.65 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 123.327 0.489 . . . . 15.43 112.382 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 37.5 tt0 -77.9 137.89 38.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.972 0.909 . . . . 71.329999999999998 111.334 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.43 133.39 35.94 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.432 0.693 . . . . 74.239999999999995 110.2 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.6 OUTLIER -149.08 161.59 41.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.667 1.187 . . . . 61.43 110.117 -174.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -120.34 118.74 31.17 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.88 -0.513 . . . . 72.099999999999994 110.256 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.635 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.5 t -73.35 121.34 23.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.56 0.695 . . . . 71.109999999999999 110.02 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 122' ' ' GLN . 23.6 mt -84.58 -51.95 6.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.967 -1.469 . . . . 64.319999999999993 108.874 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.95 149.39 12.35 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.883 -0.599 . . . . 75.209999999999994 112.784 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.55 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 51.6 m-85 -85.3 168.26 14.85 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.399 0.68 . . . . 73.329999999999998 110.605 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -82.21 -172.87 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.379 -0.828 . . . . 41.450000000000003 109.842 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -53.84 -42.32 68.38 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.836 0.854 . . . . 74.430000000000007 112.945 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -112.43 13.6 20.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.933 0.716 . . . . 44.210000000000001 112.933 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.8 21.07 76.45 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 115.685 1.034 . . . . 62.100000000000001 115.685 170.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -77.28 -54.5 6.4 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.611 0.706 . . . . 75.219999999999999 110.571 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.796 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 20.4 m95 -110.95 152.9 26.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.809 0.844 . . . . 70.340000000000003 111.55 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -129.53 140.46 51.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.688 1.195 . . . . 75.209999999999994 109.981 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 38.4 tt0 -75.82 130.04 37.96 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.956 -1.127 . . . . 72.219999999999999 107.956 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.34 144.55 44.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.526 0.731 . . . . 70.230000000000004 110.003 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.428 ' HG3' HD21 ' A' ' 110' ' ' LEU . 47.8 mt-30 -96.51 107.8 20.27 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.763 -1.199 . . . . 72.349999999999994 107.763 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 107' ' ' LEU . 34.6 p -106.42 -177.04 3.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.111 0.964 . . . . 73.430000000000007 111.395 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -71.83 -10.42 59.75 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.504 -0.771 . . . . 71.040000000000006 110.828 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -101.44 16.42 25.7 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.52 1.128 . . . . 63.439999999999998 110.585 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.79 -122.68 7.06 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.218 -0.768 . . . . 74.120000000000005 112.044 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.83 152.45 47.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 118.032 0.916 . . . . 72.209999999999994 110.849 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.496 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 153.8 172.55 21.99 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 111.575 -0.61 . . . . 55.399999999999999 111.575 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 66.0 m95 -80.15 131.81 35.8 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.225 0.61 . . . . 70.400000000000006 112.561 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.426 HG23 HD13 ' A' ' 135' ' ' ILE . 34.3 m -136.8 141.89 36.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 125.645 1.578 . . . . 74.129999999999995 109.215 168.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.796 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.1 Cg_endo -77.92 151.26 27.5 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.438 2.092 . . . . 73.230000000000004 115.284 -172.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -36.63 -50.54 0.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.628 1.971 . . . . 60.32 113.856 170.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -74.22 -7.96 54.53 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.417 0.687 . . . . 52.530000000000001 112.352 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.416 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 13.6 m-85 -104.03 -4.92 22.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.88 0.872 . . . . 63.210000000000001 112.118 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 130' ' ' VAL . 6.3 pt -135.24 168.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 124.003 0.921 . . . . 52.210000000000001 111.826 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.9 t -163.54 155.98 15.46 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 108.334 -0.987 . . . . 52.210000000000001 108.334 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 51.1 Cg_exo -56.55 151.77 44.37 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.108 1.872 . . . . 63.340000000000003 113.029 171.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.51 -5.66 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.166 0.507 . . . . 73.150000000000006 110.209 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.4 -20.21 23.07 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.625 -0.672 . . . . 74.319999999999993 110.881 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.1 p -80.9 172.49 13.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.328 0.585 . . . . 63.200000000000003 111.742 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 214' ' ' LEU . 61.5 mt -84.67 -25.02 28.73 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.785 0.834 . . . . 75.120000000000005 111.291 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.5 -24.01 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.474 1.11 . . . . 75.200000000000003 112.092 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.487 ' HA ' HD21 ' A' ' 88' ' ' LEU . 23.1 pttm -64.2 -26.16 68.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.39 0.676 . . . . 71.430000000000007 112.476 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -75.15 148.35 39.7 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.61 -0.723 . . . . 72.310000000000002 110.159 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 235' ' ' PRO . 16.9 m -60.52 -41.09 93.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.115 0.885 . . . . 63.439999999999998 111.552 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -67.18 -48.32 68.28 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.324 0.65 . . . . 74.400000000000006 112.549 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -75.66 112.53 12.12 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.538 -0.541 . . . . 75.109999999999999 109.538 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.448 ' HB2' HG21 ' A' ' 151' ' ' VAL . 32.6 m170 -102.39 -1.98 29.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.379 0.672 . . . . 71.400000000000006 111.612 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.34 -151.26 36.27 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 118.887 -0.952 . . . . 74.310000000000002 112.232 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.62 114.29 1.93 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.053 2.502 . . . . 62.439999999999998 111.407 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 54.0 t -142.72 137.85 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 125.398 1.479 . . . . 34.32 108.863 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.2 p -82.58 170.22 15.42 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.627 0.771 . . . . 52.299999999999997 110.95 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -59.7 -48.47 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.932 0.893 . . . . 73.349999999999994 110.389 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.35 -44.37 84.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.466 1.107 . . . . 71.129999999999995 111.465 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.78 76.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.973 -1.012 . . . . 51.439999999999998 111.518 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.77 82.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.447 0.699 . . . . 51.420000000000002 111.636 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -78.64 -25.49 45.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.565 -0.743 . . . . 74.409999999999997 112.709 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -24.88 59.71 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.943 0.792 . . . . 74.230000000000004 110.678 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.811 HD21 ' HA ' ' A' ' 239' ' ' ARG . 69.0 mt -71.92 -48.97 41.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.963 -1.017 . . . . 75.109999999999999 110.056 170.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.694 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 63.8 mt -89.23 19.49 4.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.044 -0.98 . . . . 75.120000000000005 112.642 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.3 p -90.42 -34.11 15.76 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.091 -1.077 . . . . 41.32 108.091 157.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.5 m -92.05 2.49 56.53 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.949 1.299 . . . . 70.150000000000006 111.892 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.1 -178.07 40.43 Favored Glycine 0 C--N 1.351 1.386 0 C-N-CA 122.771 0.224 . . . . 74.310000000000002 112.839 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -107.62 177.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.241 1.016 . . . . 63.329999999999998 110.31 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.05 131.26 46.09 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.84 6.42 72.5 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.079 -0.845 . . . . 73.310000000000002 113.695 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.5 m -81.39 136.18 35.7 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.217 1.008 . . . . 73.409999999999997 110.524 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -142.8 163.12 33.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.303 0.573 . . . . 72.420000000000002 111.218 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.64 145.32 22.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.83 -1.077 . . . . 75.5 108.666 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.645 HG22 HG12 ' A' ' 182' ' ' ILE . 83.2 t -103.48 126.73 57.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.947 -1.131 . . . . 54.32 107.947 169.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.63 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.5 ptt85 -115.71 160.98 19.35 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.177 0.991 . . . . 74.409999999999997 109.06 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -114.35 150.29 34.8 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.259 -1.756 . . . . 70.239999999999995 106.259 167.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -67.96 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.299 -0.63 . . . . 73.239999999999995 109.299 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.07 -31.33 71.74 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.822 0.849 . . . . 65.030000000000001 111.176 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.8 p -97.17 -5.31 37.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.135 0.974 . . . . 52.329999999999998 112.008 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -149.88 102.84 3.21 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 122.719 0.408 . . . . 63.409999999999997 111.189 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.23 146.81 70.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.551 2.167 . . . . 55.32 111.833 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.69 -28.36 3.55 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 123.069 0.366 . . . . 73.219999999999999 113.403 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.91 114.45 18.83 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -130.8 156.54 44.83 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.52 0.676 . . . . 75.5 111.12 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.8 m -147.2 150.86 35.73 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.833 -1.076 . . . . 71.239999999999995 109.241 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.645 HG12 HG22 ' A' ' 170' ' ' VAL . 22.6 mt -103.81 151.57 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.54 -1.281 . . . . 75.319999999999993 107.54 170.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -124.73 121.98 36.18 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.678 -1.23 . . . . 62.109999999999999 107.678 168.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.2 tp -115.65 114.36 24.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.36 0.664 . . . . 75.25 110.377 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.694 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 56.1 ttt85 -76.3 111.53 11.84 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.551 0.74 . . . . 51.149999999999999 109.033 164.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -139.44 139.58 37.11 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.991 1.316 . . . . 72.530000000000001 107.791 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 59.7 21.76 10.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.47 1.108 . . . . 51.109999999999999 111.782 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.75 -12.31 59.75 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.628 -0.714 . . . . 42.229999999999997 113.85 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -98.96 146.73 25.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.237 0.615 . . . . 73.150000000000006 110.211 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 115.24 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.08 0.552 . . . . 64.450000000000003 110.405 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -101.47 137.96 39.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.487 1.115 . . . . 63.100000000000001 108.807 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.54 120.04 41.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.889 0.376 . . . . 73.209999999999994 110.74 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.471 ' HE1' HD21 ' A' ' 232' ' ' LEU . 5.8 m-85 -95.59 152.31 18.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.224 1.009 . . . . 74.25 108.738 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -104.7 115.81 30.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.401 -0.592 . . . . 63.039999999999999 109.401 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -85.73 101.96 10.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.849 -1.167 . . . . 64.219999999999999 107.849 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -84.04 107.21 16.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.403 -1.271 . . . . 65.099999999999994 108.382 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -74.52 112.65 10.91 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.862 -1.162 . . . . 75.340000000000003 107.862 164.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.94 160.97 19.45 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.682 0.393 . . . . 54.130000000000003 110.704 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.0 p -62.43 -28.36 69.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.59 0.756 . . . . 74.340000000000003 111.07 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -89.76 -5.2 57.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.245 1.018 . . . . 72.319999999999993 111.128 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 106.58 -6.82 38.79 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 114.787 0.675 . . . . 63.240000000000002 114.787 168.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.13 127.47 32.68 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.887 0.843 . . . . 75.420000000000002 111.646 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.71 142.68 30.55 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.099 0.96 . . . . 73.209999999999994 109.051 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.617 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 39.9 p90 -164.71 139.74 5.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.214 0.321 . . . . 62.149999999999999 111.686 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.431 HG23 HD11 ' A' ' 217' ' ' LEU . 72.0 t -84.64 -37.84 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.559 -0.904 . . . . 73.329999999999998 108.559 163.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 24.2 m -101.23 126.91 48.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 109.771 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.9 t -69.7 -16.72 63.39 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.421 0.689 . . . . 65.430000000000007 112.129 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -92.66 -15.3 26.94 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.776 1.23 . . . . 73.219999999999999 110.99 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.2 m -133.93 95.46 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.746 0.818 . . . . 71.439999999999998 109.116 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.617 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -111.59 134.77 52.94 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.87 0.868 . . . . 73.200000000000003 109.527 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.471 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.2 OUTLIER -124.0 151.97 43.1 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.104 0.961 . . . . 72.109999999999999 108.538 -170.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -69.47 -34.2 74.01 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.601 0.563 . . . . 74.439999999999998 110.692 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.3 p -126.76 152.58 46.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.73 0.812 . . . . 73.420000000000002 111.718 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 141' ' ' LEU . 1.3 tt -63.84 -24.44 67.75 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 114.674 -1.148 . . . . 75.329999999999998 109.215 172.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 73' ' ' LEU . . . -59.16 -49.12 79.06 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.976 0.91 . . . . 52.340000000000003 111.275 173.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -65.33 -36.8 85.14 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.526 0.73 . . . . 75.299999999999997 111.325 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.431 HD11 HG23 ' A' ' 205' ' ' VAL . 15.9 tp -56.43 -56.76 17.22 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.495 0.497 . . . . 74.010000000000005 111.102 176.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.44 -41.5 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.317 0.647 . . . . 74.519999999999996 110.897 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.11 -52.25 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.741 0.416 . . . . 75.409999999999997 111.524 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -65.44 -40.61 93.46 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.203 0.601 . . . . 65.420000000000002 109.85 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.659 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.3 m-70 -86.6 -4.54 59.19 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.446 -0.797 . . . . 74.400000000000006 111.917 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 89.9 p -91.98 -35.31 14.05 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 110.181 -0.303 . . . . 64.519999999999996 110.181 167.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.2 m -68.4 -49.63 58.7 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.306 0.574 . . . . 71.409999999999997 110.216 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -128.18 161.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.006 -0.997 . . . . 72.329999999999998 110.161 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.47 19.61 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.377 1.871 . . . . 72.299999999999997 114.637 -174.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 224' ' ' VAL . 10.9 t70 -43.02 31.64 0.0 OUTLIER 'General case' 0 CA--C 1.598 2.8 1 C-N-CA 132.319 4.247 . . . . 75.25 120.203 -153.279 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 125.22 0.82 8.04 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 121.259 -0.9 . . . . 75.540000000000006 112.583 -167.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.0 mt -95.06 165.61 12.34 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 126.169 1.788 . . . . 51.420000000000002 110.025 168.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.99 -41.92 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-N 116.604 -0.271 . . . . 61.229999999999997 110.314 168.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -157.41 -179.78 8.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.104 0.561 . . . . 71.239999999999995 110.969 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.0 p -63.55 137.1 57.99 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.837 1.255 . . . . 71.219999999999999 112.243 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.471 HD21 ' HE1' ' A' ' 193' ' ' TYR . 75.7 mt -72.62 111.03 7.42 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.949 -0.76 . . . . 72.010000000000005 108.949 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -106.87 -44.54 4.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.948 0.722 . . . . 73.439999999999998 112.948 -163.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -130.84 125.24 21.22 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.15 0.98 . . . . 72.450000000000003 109.138 -169.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 145' ' ' SER . 76.1 Cg_endo -81.56 129.17 6.39 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 122.234 1.956 . . . . 71.409999999999997 112.121 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.36 151.94 85.62 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.852 0.861 . . . . 63.119999999999997 110.113 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.71 170.3 17.12 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.966 2.444 . . . . 74.25 112.593 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.9 154.02 35.08 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.044 0.937 . . . . 62.229999999999997 110.917 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.811 ' HA ' HD21 ' A' ' 159' ' ' LEU . 18.8 ptt180 -81.66 -60.34 2.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.541 0.941 . . . . 74.439999999999998 113.541 -168.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.562 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 64.9 t30 -108.69 153.92 22.75 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.701 0.8 . . . . 72.239999999999995 109.122 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 84.2 tttt -87.4 114.77 60.25 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.204 -1.776 . . . . 75.340000000000003 106.204 159.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 31.7 Cg_exo -62.21 144.39 95.52 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.373 2.715 . . . . 63.130000000000003 113.151 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.4 m -94.66 134.72 36.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.283 0.633 . . . . 74.040000000000006 110.86 -172.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -90.43 125.82 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 64.310000000000002 108.664 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -109.81 115.9 30.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.689 0.395 . . . . 75.129999999999995 110.988 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 75.94 -48.27 2.34 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 119.277 2.471 . . . . 50.119999999999997 119.277 155.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 31.2 m -99.48 144.1 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 114.366 1.247 . . . . 61.420000000000002 114.366 -157.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.0 t -82.34 115.83 60.16 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 104.405 -2.443 . . . . 72.340000000000003 104.405 149.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 11.3 Cg_endo . . . . . 0 N--CA 1.496 1.655 0 C-N-CA 122.94 2.427 . . . . 71.049999999999997 116.858 -152.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 3.3 t90 . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.917 0.865 . . . . 74.329999999999998 109.213 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 23.8 p-10 -65.43 -21.82 66.7 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.982 -1.008 . . . . 74.010000000000005 109.46 165.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.4 p -77.47 5.41 8.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.573 1.549 . . . . 73.120000000000005 112.782 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.55 -25.4 68.03 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.202 0.456 . . . . 75.030000000000001 111.167 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.5 pt-20 -62.63 -43.45 98.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.26 0.624 . . . . 71.420000000000002 110.502 168.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -82.47 -2.97 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.48 1.112 . . . . 73.0 111.331 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.0 tp -52.33 -49.18 64.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.005 0.922 . . . . 75.150000000000006 110.274 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.5 mt -95.58 83.26 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.779 -1.193 . . . . 71.010000000000005 107.779 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-N 115.098 -0.956 . . . . 74.430000000000007 113.054 -168.538 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.55 0.977 0 N-CA-C 110.862 -0.051 . . . . 75.409999999999997 110.862 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.609 HD21 ' HD3' ' A' ' 106' ' ' LYS . 35.7 tp -80.65 125.52 30.12 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.22 172.49 6.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.727 1.211 . . . . 73.329999999999998 108.178 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.57 137.22 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.276 1.031 . . . . 72.150000000000006 108.836 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.2 123.66 26.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.62 0.768 . . . . 65.040000000000006 109.968 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.405 HD22 ' HE3' ' A' ' 238' ' ' LYS . 95.1 mt -79.03 -32.86 45.13 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 53.210000000000001 110.982 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.576 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 55.9 m-85 -126.54 160.14 31.47 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.068 0.547 . . . . 71.230000000000004 110.792 -174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.7 120.38 23.93 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.477 -0.934 . . . . 70.530000000000001 108.477 166.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.729 ' HB3' HG12 ' A' ' 101' ' ' ILE . 93.8 t80 -113.14 132.53 55.42 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.71 -0.848 . . . . 65.329999999999998 108.71 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -93.92 128.59 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.328 -0.99 . . . . 71.150000000000006 108.328 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.3 114.56 6.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.408 -0.59 . . . . 50.219999999999999 109.408 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.9 p -98.69 -0.83 42.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.735 0.814 . . . . 73.310000000000002 111.431 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.9 166.26 24.92 Favored Glycine 0 C--O 1.244 0.742 0 N-CA-C 110.703 -0.959 . . . . 60.509999999999998 110.703 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -70.87 -39.16 73.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.103 0.478 . . . . 65.209999999999994 110.45 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -79.95 -24.53 40.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 62.219999999999999 111.809 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 p -76.25 166.7 23.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.678 0.391 . . . . 71.439999999999998 110.829 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -134.96 133.47 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.042 0.537 . . . . 74.409999999999997 110.629 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.6 m -74.61 141.75 44.66 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.793 0.837 . . . . 74.25 110.177 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.729 HG12 ' HB3' ' A' ' 91' ' ' PHE . 14.1 pt -128.5 156.51 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.174 0.59 . . . . 51.130000000000003 110.412 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 7.2 m -108.03 152.45 24.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.159 0.984 . . . . 74.340000000000003 109.938 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -60.04 110.69 1.26 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.636 0.774 . . . . 71.239999999999995 109.13 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.85 8.33 63.64 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.688 -0.507 . . . . 51.25 113.646 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.2 tt0 -76.23 120.89 22.13 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.478 0.639 . . . . 64.540000000000006 110.355 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.609 ' HD3' HD21 ' A' ' 84' ' ' LEU . 64.6 mttp -78.69 127.7 32.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.274 0.629 . . . . 52.32 109.474 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.422 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.45 150.68 40.89 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.364 1.066 . . . . 64.099999999999994 110.351 -171.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -100.99 118.86 37.83 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.056 0.543 . . . . 75.420000000000002 109.939 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.54 HG13 ' HB1' ' A' ' 119' ' ' ALA . 56.5 t -84.97 118.22 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.617 0.722 . . . . 71.209999999999994 109.862 172.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.63 HD12 ' HG3' ' A' ' 120' ' ' GLU . 18.9 mt -85.37 -13.99 47.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.142 1.377 . . . . 72.409999999999997 110.889 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.25 4.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.491 -1.043 . . . . 64.450000000000003 110.491 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 62.3 m-85 -88.71 173.28 8.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.543 0.687 . . . . 73.540000000000006 110.625 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -78.36 -179.53 6.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.663 -1.153 . . . . 74.310000000000002 110.844 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -45.72 -41.47 10.66 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.167 1.387 . . . . 71.25 113.766 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -114.24 12.07 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.612 0.968 . . . . 73.420000000000002 113.612 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.56 10.63 85.71 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 116.249 1.26 . . . . 74.109999999999999 116.249 168.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.85 -42.21 28.08 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.987 0.894 . . . . 71.329999999999998 111.655 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 21.1 m95 -119.66 157.38 28.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.707 0.803 . . . . 74.219999999999999 110.36 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.54 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.24 145.69 47.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.662 0.785 . . . . 72.329999999999998 110.361 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.63 ' HG3' HD12 ' A' ' 110' ' ' LEU . 13.2 tp10 -79.22 113.55 17.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.578 -1.638 . . . . 64.049999999999997 106.578 164.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -134.08 140.35 46.57 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.08 0.466 . . . . 63.030000000000001 111.233 -171.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -104.11 106.57 17.12 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.363 1.065 . . . . 63.240000000000002 108.705 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.667 HG21 HG22 ' A' ' 101' ' ' ILE . 50.8 p -97.98 175.1 6.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.2 1.0 . . . . 64.010000000000005 109.482 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -65.15 -22.72 66.96 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.84 -0.429 . . . . 74.040000000000006 109.84 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.32 -21.16 56.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.514 1.126 . . . . 74.409999999999997 111.802 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.07 -139.89 9.3 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.311 0.505 . . . . 52.43 113.589 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -130.37 127.86 40.24 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.982 0.913 . . . . 72.439999999999998 109.898 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 169.37 -173.18 43.71 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 123.256 0.347 . . . . 64.109999999999999 112.723 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -85.56 126.86 34.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.321 0.648 . . . . 74.319999999999993 112.339 -172.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -133.84 144.07 50.2 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.097 0.959 . . . . 73.310000000000002 108.618 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 2.2 Cg_endo -83.04 142.64 11.09 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.532 2.154 . . . . 72.420000000000002 114.385 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.471 ' HB3' ' CE2' ' A' ' 112' ' ' TYR . 69.2 p -40.92 -44.57 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.867 1.667 . . . . 75.329999999999998 113.707 167.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.627 ' HB2' ' HG2' ' A' ' 242' ' ' PRO . 27.8 p30 -77.94 -6.59 54.87 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.243 -0.89 . . . . 63.439999999999998 112.558 -172.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.576 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 30.2 m-85 -103.58 -10.0 18.8 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.371 0.668 . . . . 70.329999999999998 111.719 170.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.9 pt -126.32 178.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 124.099 0.959 . . . . 64.319999999999993 110.812 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.2 t -160.96 149.99 13.57 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.125 0.97 . . . . 65.420000000000002 108.71 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.557 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 24.3 Cg_endo -61.51 150.07 86.88 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.801 1.667 . . . . 64.129999999999995 111.548 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.1 t -71.32 -15.95 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 CA-C-O 120.955 0.407 . . . . 73.219999999999999 110.598 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -76.28 -17.94 59.22 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.449 0.699 . . . . 74.439999999999998 112.326 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.557 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 59.9 p -71.53 163.75 27.15 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.632 0.729 . . . . 61.5 112.648 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.41 -23.43 40.37 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.241 -0.891 . . . . 74.230000000000004 109.261 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.88 -15.48 63.09 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.607 1.163 . . . . 73.519999999999996 112.678 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -66.72 -24.08 66.19 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.919 0.39 . . . . 71.010000000000005 111.187 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -79.09 134.8 36.73 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.375 0.67 . . . . 72.129999999999995 109.788 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.7 p -59.12 -43.8 91.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.514 1.134 . . . . 52.020000000000003 111.745 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -62.88 -39.05 93.27 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.059 0.85 . . . . 44.43 112.467 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -77.76 110.83 12.97 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.128 -0.693 . . . . 75.409999999999997 109.128 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -107.03 -6.68 17.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.196 0.598 . . . . 73.140000000000001 111.155 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.57 -133.08 25.26 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.639 -1.09 . . . . 61.109999999999999 113.041 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.34 100.65 0.22 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.941 2.427 . . . . 74.010000000000005 112.006 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 55.9 t -138.71 131.74 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.747 1.219 . . . . 71.209999999999994 108.912 -175.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.3 p -84.7 171.57 12.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 62.329999999999998 109.987 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -62.07 -43.81 98.04 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.95 -0.548 . . . . 60.030000000000001 111.069 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -54.22 -43.44 70.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.731 0.645 . . . . 75.340000000000003 110.938 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.403 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -67.93 -38.45 82.88 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.282 -0.872 . . . . 74.340000000000003 111.155 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.3 -42.45 88.32 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.588 0.755 . . . . 63.329999999999998 111.732 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 67.5 mm-40 -59.85 -46.57 88.86 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.669 0.787 . . . . 74.439999999999998 109.421 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.536 ' HE1' ' HD2' ' A' ' 239' ' ' ARG . 42.3 t80 -62.01 -46.26 89.98 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.308 -1.314 . . . . 73.409999999999997 111.932 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.03 -40.33 84.71 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.912 0.885 . . . . 61.140000000000001 111.142 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.73 18.01 13.89 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.747 -0.661 . . . . 73.549999999999997 112.367 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 96.8 p -63.84 -41.23 97.87 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.083 0.856 . . . . 75.239999999999995 111.167 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 p -100.7 13.32 35.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.439 0.696 . . . . 62.340000000000003 111.299 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 151.87 41.69 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 123.117 0.26 . . . . 75.230000000000004 113.223 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.6 pt -101.96 -175.39 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.968 0.907 . . . . 75.530000000000001 110.898 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -52.7 122.2 8.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.63 0.772 . . . . 72.239999999999995 110.414 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.441 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 88.4 10.25 68.38 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.019 -0.879 . . . . 62.219999999999999 113.528 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 61.7 m -83.76 115.68 22.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.221 1.011 . . . . 54.030000000000001 111.282 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.459 ' HB3' HD13 ' A' ' 184' ' ' LEU . 11.1 p90 -130.22 167.08 19.0 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.202 0.525 . . . . 75.230000000000004 112.083 -170.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.27 146.79 24.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.717 -1.129 . . . . 74.340000000000003 108.609 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 182' ' ' ILE . 78.3 t -107.65 135.56 45.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.152 -1.055 . . . . 73.230000000000004 108.152 171.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.523 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 19.8 ptt85 -134.62 160.22 38.79 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.273 1.029 . . . . 75.430000000000007 109.811 -175.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -117.56 155.35 29.95 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.163 -1.051 . . . . 74.400000000000006 108.163 164.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -80.11 125.75 30.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.14 -0.689 . . . . 40.439999999999998 109.14 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.12 -39.77 65.48 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.339 0.656 . . . . 74.120000000000005 109.619 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.9 p -75.07 -13.29 60.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.41 0.684 . . . . 73.540000000000006 111.74 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 35.3 m -141.72 80.55 15.77 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.511 0.724 . . . . 71.5 109.502 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -59.42 131.26 39.69 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.867 2.378 . . . . 72.319999999999993 112.292 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.45 -29.24 10.77 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.855 -0.611 . . . . 72.430000000000007 112.24 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -80.93 115.89 20.63 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.076 -0.713 . . . . 64.439999999999998 109.076 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -116.26 150.09 38.15 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.55 0.691 . . . . 71.400000000000006 111.077 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.9 m -150.08 153.66 36.8 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.583 -1.19 . . . . 72.010000000000005 109.886 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.605 HG12 HG22 ' A' ' 170' ' ' VAL . 30.0 mt -110.78 149.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.486 -0.931 . . . . 54.32 108.486 172.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 36.3 m -123.11 108.28 12.69 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.666 -1.235 . . . . 73.420000000000002 107.666 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.475 HD23 ' OH ' ' A' ' 193' ' ' TYR . 70.0 tp -106.78 128.04 53.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.915 0.486 . . . . 54.210000000000001 110.069 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -102.36 129.17 48.75 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.098 0.959 . . . . 65.010000000000005 109.085 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -150.17 131.32 14.45 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.602 1.561 . . . . 71.209999999999994 107.174 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 63.72 23.99 13.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.087 0.955 . . . . 70.120000000000005 111.736 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.04 81.04 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.012 0.365 . . . . 51.119999999999997 114.012 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -105.77 128.27 53.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.929 0.892 . . . . 62.009999999999998 109.432 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.2 t -93.63 111.99 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.195 0.598 . . . . 64.310000000000002 110.465 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -96.53 147.81 23.47 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.725 1.21 . . . . 73.540000000000006 109.589 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -121.86 117.48 26.61 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.305 0.574 . . . . 74.209999999999994 110.445 -171.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 9.1 m-30 -96.07 148.21 22.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.76 1.224 . . . . 54.409999999999997 109.42 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.98 117.58 34.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.696 -0.854 . . . . 73.439999999999998 108.696 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 mt -84.08 100.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 N-CA-C 107.304 -1.369 . . . . 63.450000000000003 107.304 172.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -82.95 131.44 35.19 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.077 0.951 . . . . 71.5 108.769 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.7 m -97.33 121.76 39.59 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.767 -0.827 . . . . 62.240000000000002 108.767 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.71 174.31 8.56 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.277 0.631 . . . . 61.32 110.705 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.2 p -62.83 -32.68 73.94 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.655 0.782 . . . . 75.010000000000005 111.737 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.85 -14.9 27.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.742 0.817 . . . . 74.519999999999996 110.891 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.93 13.69 13.42 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 118.983 -0.898 . . . . 72.409999999999997 114.252 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.16 125.69 27.5 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.039 0.92 . . . . 71.420000000000002 110.798 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -84.87 141.16 30.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.51 -0.922 . . . . 60.119999999999997 108.51 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.55 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 31.4 p90 -165.55 137.5 4.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.325 0.391 . . . . 63.109999999999999 111.506 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.475 HG23 HD11 ' A' ' 217' ' ' LEU . 73.1 t -84.19 -36.72 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.573 -0.899 . . . . 51.210000000000001 108.573 163.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.5 m -100.99 127.44 47.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.859 -1.064 . . . . 62.32 109.962 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.2 t -63.67 -22.59 66.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.235 1.014 . . . . 74.140000000000001 111.909 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -82.87 -29.15 29.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.723 1.209 . . . . 73.340000000000003 110.859 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.6 m -126.33 99.02 5.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.33 0.652 . . . . 71.209999999999994 110.531 -175.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -97.34 133.46 41.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.871 0.868 . . . . 61.520000000000003 109.592 174.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.69 151.49 38.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.684 0.793 . . . . 65.219999999999999 109.327 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -73.09 -42.76 62.65 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.917 -0.401 . . . . 72.409999999999997 109.917 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 44.0 p -118.7 159.05 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.741 0.781 . . . . 75.239999999999995 112.248 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.06 -27.71 68.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.462 -1.245 . . . . 62.329999999999998 109.847 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.88 95.83 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.51 0.724 . . . . 71.219999999999999 110.629 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.11 -39.92 75.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.879 0.871 . . . . 72.109999999999999 110.865 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.475 HD11 HG23 ' A' ' 205' ' ' VAL . 15.3 tp -55.38 -56.07 24.29 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.848 0.718 . . . . 73.430000000000007 111.23 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.1 -42.35 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 123.797 0.686 . . . . 73.209999999999994 111.001 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.84 -55.57 30.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.016 0.823 . . . . 63.25 111.339 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -68.29 -34.77 76.77 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.41 -0.814 . . . . 62.25 111.214 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.61 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.8 m170 -87.64 -9.56 53.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.812 0.445 . . . . 64.409999999999997 112.083 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 90.7 p -90.51 -33.72 15.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.947 0.499 . . . . 71.120000000000005 110.231 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.1 p -72.98 -49.51 28.59 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.717 -0.674 . . . . 71.120000000000005 111.169 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.557 HG23 ' HB2' ' A' ' 226' ' ' ASP . 35.5 m -123.77 159.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.833 0.825 . . . . 61.32 112.459 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.15 16.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 128.205 2.602 . . . . 64.230000000000004 115.246 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.557 ' HB2' HG23 ' A' ' 224' ' ' VAL . 32.6 t70 -40.02 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 131.676 3.99 . . . . 61.539999999999999 119.852 -150.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.06 -3.22 10.68 Favored Glycine 0 N--CA 1.469 0.898 0 O-C-N 118.985 -2.322 . . . . 63.5 112.042 -165.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.1 mt -90.13 163.64 14.77 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.93 1.692 . . . . 74.310000000000002 109.231 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.76 -38.91 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 120.756 0.313 . . . . 71.540000000000006 110.881 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -158.02 -178.0 6.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.099 0.959 . . . . 71.310000000000002 109.938 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.5 p -67.41 144.01 55.99 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.588 0.755 . . . . 71.430000000000007 112.183 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 184' ' ' LEU . 76.8 mt -75.4 90.21 2.67 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 107.565 -1.272 . . . . 63.049999999999997 107.565 169.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -121.71 9.35 10.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.054 -1.029 . . . . 65.310000000000002 113.673 -158.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 167' ' ' SER . 20.2 t80 -159.17 122.95 2.07 Favored Pre-proline 0 C--O 1.22 -0.493 0 N-CA-C 106.957 -1.497 . . . . 74.140000000000001 106.957 174.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.2 139.3 6.06 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 122.214 1.942 . . . . 75.340000000000003 112.592 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.46 124.8 89.16 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.181 -1.044 . . . . 13.1 108.181 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.13 -176.98 3.34 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.321 2.014 . . . . 72.439999999999998 113.218 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.405 ' HE3' HD22 ' A' ' 88' ' ' LEU . 73.1 mmtt -76.85 118.74 19.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.034 -0.985 . . . . 73.430000000000007 109.318 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.551 ' HG3' ' N ' ' A' ' 240' ' ' ASN . 6.3 ptt180 -76.53 -53.65 7.79 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.591 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.551 ' N ' ' HG3' ' A' ' 239' ' ' ARG . 10.5 t30 -108.72 122.54 47.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.778 1.029 . . . . 62.340000000000003 113.778 -158.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 89' ' ' TYR . 97.2 mttt -79.8 113.46 37.88 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.183 -1.414 . . . . 54.329999999999998 107.183 159.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.627 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 25.5 Cg_exo -68.84 153.36 73.01 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.789 2.326 . . . . 62.399999999999999 113.601 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 24.5 m -73.44 139.94 46.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.725 -0.671 . . . . 74.319999999999993 110.993 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 52.0 t -95.65 113.51 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.99 -1.115 . . . . 62.049999999999997 107.99 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 247' ' ' VAL . 7.9 m-85 -102.94 110.85 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 119.256 -0.402 . . . . 34.439999999999998 110.414 -173.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.47 25.11 48.82 Favored Glycine 0 N--CA 1.477 1.373 0 N-CA-C 118.078 1.991 . . . . 73.319999999999993 118.078 160.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 245' ' ' TYR . 33.7 m -101.1 134.04 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 119.065 1.433 . . . . 43.020000000000003 113.421 -172.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -83.38 118.35 71.31 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 103.508 -2.775 . . . . 65.540000000000006 103.508 142.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo . . . . . 0 C--N 1.375 1.94 0 C-N-CA 121.501 1.467 . . . . 63.109999999999999 113.753 -152.419 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.405 ' NE1' ' HB2' ' A' ' 69' ' ' SER . 11.7 t90 . . . . . 0 C--O 1.238 0.462 0 N-CA-C 109.007 -0.738 . . . . 74.540000000000006 109.007 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.434 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 24.1 p-10 -84.2 -8.97 58.9 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.718 -0.674 . . . . 53.399999999999999 110.868 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.445 ' HB3' ' HD1' ' A' ' 144' ' ' HIS . 23.8 m -61.17 -4.3 1.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.778 1.399 . . . . 72.430000000000007 114.778 -165.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.51 -34.36 69.0 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.45 0.7 . . . . 62.350000000000001 111.145 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 12.7 pt-20 -65.32 -46.59 79.72 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.444 0.698 . . . . 73.25 110.589 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.04 -5.34 59.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.147 0.979 . . . . 71.219999999999999 111.014 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 tp -76.22 -49.68 16.5 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.429 1.091 . . . . 63.130000000000003 109.111 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.5 mt -104.45 36.7 2.31 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.229 -0.896 . . . . 71.230000000000004 109.529 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.955 0 C-N-CA 124.412 1.085 . . . . 51.210000000000001 112.677 -175.578 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.158 0.504 . . . . 71.400000000000006 110.607 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.402 ' HB2' ' NH2' ' A' ' 108' ' ' ARG . 26.1 tp -79.67 127.54 32.3 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.714 -0.847 . . . . 61.210000000000001 108.714 165.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.4 174.9 5.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.028 1.331 . . . . 71.5 109.165 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.12 135.12 32.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.726 0.81 . . . . 63.350000000000001 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.07 5.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.967 0.907 . . . . 22.199999999999999 110.373 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.9 -30.71 64.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.688 0.795 . . . . 73.310000000000002 110.735 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.0 m-85 -123.91 141.23 52.22 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.922 -1.036 . . . . 73.409999999999997 109.019 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -73.53 146.89 44.49 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.14 0.576 . . . . 64.340000000000003 109.524 168.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.421 ' HE2' ' HB ' ' A' ' 98' ' ' THR . 86.1 t80 -154.14 107.66 2.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.278 0.631 . . . . 74.530000000000001 109.361 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.49 137.03 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.111 -1.07 . . . . 62.219999999999999 108.111 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 115.53 10.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.035 0.534 . . . . 75.420000000000002 110.528 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.1 p -88.63 -25.5 22.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.288 0.635 . . . . 71.420000000000002 109.654 171.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.19 157.84 15.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-N 115.227 -0.897 . . . . 72.5 111.242 173.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.1 -34.69 75.49 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.722 0.809 . . . . 51.039999999999999 109.735 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -76.51 -26.91 55.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.356 -1.293 . . . . 74.0 112.3 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.421 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 67.0 p -82.77 155.36 24.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.425 -0.583 . . . . 55.329999999999998 109.425 173.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.548 ' HB3' HG13 ' A' ' 130' ' ' VAL . 67.2 tp -113.65 136.21 53.08 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.9 0.48 . . . . 71.239999999999995 111.741 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.7 m -74.55 117.09 15.97 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.794 0.837 . . . . 53.039999999999999 110.482 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.653 HG22 HG21 ' A' ' 123' ' ' THR . 22.0 pt -124.53 147.22 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.714 0.805 . . . . 74.439999999999998 111.343 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 57.5 m -89.88 145.65 24.99 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.262 1.025 . . . . 74.420000000000002 109.474 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -62.08 114.34 3.35 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.985 0.514 . . . . 72.030000000000001 109.749 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 7.05 61.68 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 119.648 -0.529 . . . . 61.539999999999999 113.457 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 88.4 tt0 -83.85 135.09 34.64 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.437 0.618 . . . . 55.240000000000002 110.371 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -85.02 138.59 32.35 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.225 0.61 . . . . 74.420000000000002 109.617 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.61 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.3 OUTLIER -147.6 135.11 20.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.238 1.015 . . . . 62.310000000000002 109.935 -174.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.402 ' NH2' ' HB2' ' A' ' 84' ' ' LEU . 53.0 ttm-85 -99.15 115.9 30.12 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 122.306 -0.246 . . . . 73.450000000000003 110.624 -172.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.628 HG13 ' HB1' ' A' ' 119' ' ' ALA . 74.0 t -76.36 122.97 31.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.8 0.687 . . . . 64.209999999999994 110.39 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 122' ' ' GLN . 20.9 mt -90.81 -36.96 13.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.927 1.291 . . . . 75.140000000000001 109.448 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.46 148.77 9.66 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.421 -0.809 . . . . 72.450000000000003 112.373 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 22.0 m-85 -95.37 156.92 16.12 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 73.120000000000005 110.839 176.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -70.83 -178.39 1.87 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.434 -0.803 . . . . 72.420000000000002 110.791 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -55.29 -27.72 48.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.959 1.096 . . . . 64.299999999999997 113.959 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.02 -2.69 15.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.144 0.578 . . . . 74.319999999999993 112.436 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.63 20.98 75.85 Favored Glycine 0 C--N 1.349 1.305 0 N-CA-C 114.478 0.551 . . . . 51.100000000000001 114.478 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.49 -61.42 1.72 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 117.381 0.591 . . . . 72.310000000000002 110.152 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -92.3 145.48 24.45 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.735 0.414 . . . . 63.100000000000001 110.896 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -130.66 139.19 50.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.667 1.187 . . . . 62.109999999999999 110.679 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.2 98.75 5.97 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 107.779 -1.193 . . . . 72.230000000000004 107.779 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -105.46 134.8 47.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.678 0.791 . . . . 40.149999999999999 109.694 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.448 ' HG3' HD11 ' A' ' 110' ' ' LEU . 90.2 mt-30 -93.59 113.14 25.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.945 -0.761 . . . . 71.129999999999995 108.945 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.653 HG21 HG22 ' A' ' 101' ' ' ILE . 57.4 p -98.22 179.5 4.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.144 0.978 . . . . 75.329999999999998 110.589 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -72.51 -18.76 61.63 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.908 -1.042 . . . . 72.340000000000003 110.005 170.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -80.38 -12.5 59.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.384 1.073 . . . . 73.030000000000001 111.278 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.72 -172.75 14.48 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.618 -0.193 . . . . 63.109999999999999 112.618 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -85.67 136.29 33.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.255 0.622 . . . . 74.239999999999995 110.756 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -173.38 -177.77 42.86 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.99 -0.55 . . . . 72.219999999999999 112.49 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -107.2 125.21 50.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.837 0.455 . . . . 71.420000000000002 111.58 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.595 HG23 HD13 ' A' ' 135' ' ' ILE . 26.8 m -138.6 148.9 60.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 125.129 1.372 . . . . 75.030000000000001 109.461 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -95.0 151.91 1.71 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.956 2.437 . . . . 63.32 115.538 -170.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.1 m -41.54 -38.5 1.34 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.424 1.89 . . . . 74.219999999999999 115.133 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -71.78 -13.37 61.68 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 122.113 -0.367 . . . . 52.450000000000003 111.175 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.433 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 15.5 m-85 -104.08 -25.26 13.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.007 0.923 . . . . 70.400000000000006 112.363 170.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.595 HD13 HG23 ' A' ' 130' ' ' VAL . 32.7 pt -128.21 144.95 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 118.669 0.668 . . . . 74.329999999999998 112.486 -173.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -137.5 148.57 62.11 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 108.866 -0.79 . . . . 54.399999999999999 108.866 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.25 141.2 88.55 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.532 2.155 . . . . 72.439999999999998 110.948 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.05 -3.26 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.425 0 CA-C-O 121.056 0.455 . . . . 73.329999999999998 111.355 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.77 -8.54 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.379 0.672 . . . . 72.140000000000001 112.11 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.7 p -75.97 -177.27 3.8 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.155 0.582 . . . . 72.430000000000007 111.901 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.7 mt -86.85 -30.93 21.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.828 0.451 . . . . 64.519999999999996 110.082 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -64.34 -23.83 67.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.403 1.081 . . . . 75.430000000000007 111.8 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -6.17 9.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.911 0.884 . . . . 64.140000000000001 112.425 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.445 ' HD1' ' HB3' ' A' ' 69' ' ' SER . 85.1 m-70 -97.21 155.47 16.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.887 0.875 . . . . 74.140000000000001 110.585 171.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.5 p -66.99 -41.51 86.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.501 1.12 . . . . 73.239999999999995 111.745 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -66.04 -41.67 90.56 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.113 0.783 . . . . 74.140000000000001 113.113 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 26.4 t80 -78.06 112.55 15.11 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.955 -0.387 . . . . 73.430000000000007 109.955 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.456 ' HB2' HG21 ' A' ' 151' ' ' VAL . 30.6 m170 -104.41 -5.29 21.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.376 0.51 . . . . 34.340000000000003 112.376 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.34 -141.73 30.37 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 118.506 -1.163 . . . . 73.310000000000002 112.673 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.59 94.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.596 2.864 . . . . 64.310000000000002 112.919 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.8 t -138.53 137.09 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.916 1.286 . . . . 61.310000000000002 109.702 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.4 p -89.4 176.26 6.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.394 1.078 . . . . 65.530000000000001 110.882 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -60.1 -49.29 78.21 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.984 0.513 . . . . 73.430000000000007 110.122 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -59.56 -41.56 90.43 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.194 0.934 . . . . 73.120000000000005 111.192 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -65.84 -44.82 84.36 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.307 -0.86 . . . . 63.25 111.522 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.56 89.63 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.56 -0.745 . . . . 75.310000000000002 111.123 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -80.68 -21.6 41.16 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.47 -0.786 . . . . 63.450000000000003 111.977 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -78.23 -25.63 47.03 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.992 0.814 . . . . 70.230000000000004 110.388 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 239' ' ' ARG . 62.2 mt -70.74 -42.48 70.45 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.518 0.675 . . . . 72.549999999999997 110.484 169.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 66.9 mt -94.37 22.44 6.05 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.757 -1.11 . . . . 75.430000000000007 111.388 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 99.1 p -74.06 -43.8 56.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.148 0.499 . . . . 71.540000000000006 110.164 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.7 p -112.05 19.56 17.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.633 0.773 . . . . 64.430000000000007 110.464 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.96 149.8 48.2 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.98 -0.555 . . . . 74.230000000000004 111.724 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.7 pt -87.35 169.82 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-O 121.166 0.508 . . . . 74.519999999999996 110.527 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -70.96 109.25 4.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.077 -0.511 . . . . 75.219999999999999 109.632 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.87 10.07 19.42 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.087 0.851 . . . . 72.349999999999994 112.863 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.0 m -86.22 131.99 34.11 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.089 0.944 . . . . 62.409999999999997 110.583 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 183' ' ' SER . 8.6 p90 -139.29 166.95 23.18 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.385 0.539 . . . . 74.439999999999998 111.569 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -162.62 147.63 12.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.916 -1.038 . . . . 72.310000000000002 108.483 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 182' ' ' ILE . 99.2 t -105.32 124.53 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.56 -1.274 . . . . 62.240000000000002 107.56 169.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.685 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 44.7 ptt85 -114.68 159.99 19.86 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.456 1.102 . . . . 65.319999999999993 108.663 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.65 141.79 47.73 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.757 -1.201 . . . . 62.149999999999999 107.757 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.0 t -83.51 130.73 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.26 0.624 . . . . 71.230000000000004 110.003 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.05 -33.01 33.79 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.718 0.636 . . . . 74.430000000000007 109.973 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.8 p -72.45 -31.81 65.76 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.494 -0.775 . . . . 55.119999999999997 110.955 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.6 m -121.8 95.1 48.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.476 0.71 . . . . 64.010000000000005 109.293 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.57 114.44 2.54 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.39 2.727 . . . . 55.509999999999998 113.31 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.16 -15.15 61.83 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.755 -0.657 . . . . 75.219999999999999 112.964 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -79.16 116.6 19.53 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.505 0.653 . . . . 72.439999999999998 109.975 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -110.22 144.65 38.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.477 0.656 . . . . 72.140000000000001 110.46 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.6 m -138.43 150.67 46.71 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.834 0.854 . . . . 74.409999999999997 109.043 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.707 HG12 HG22 ' A' ' 170' ' ' VAL . 22.3 mt -101.87 150.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.54 -1.282 . . . . 74.340000000000003 107.54 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -124.87 108.24 11.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.778 -1.193 . . . . 73.400000000000006 107.778 168.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.425 HD23 ' OH ' ' A' ' 193' ' ' TYR . 56.7 tp -107.49 111.12 23.26 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.325 -0.62 . . . . 73.430000000000007 109.325 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.454 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -79.55 122.37 26.4 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.521 -0.548 . . . . 72.010000000000005 109.521 168.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -149.92 145.25 26.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.848 1.659 . . . . 73.040000000000006 107.458 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 59.45 21.79 10.23 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 124.255 1.022 . . . . 62.420000000000002 111.557 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.47 -7.15 62.11 Favored Glycine 0 C--N 1.358 1.765 0 CA-C-N 116.176 -0.465 . . . . 75.030000000000001 113.956 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -104.49 138.64 40.56 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.196 0.999 . . . . 71.299999999999997 108.581 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.33 103.81 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.397 0.544 . . . . 73.310000000000002 110.395 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.26 115.47 27.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.885 0.874 . . . . 74.530000000000001 109.65 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.63 118.25 30.84 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.194 0.598 . . . . 73.439999999999998 110.371 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 11.1 m-85 -94.33 148.49 22.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.447 1.099 . . . . 72.239999999999995 109.532 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -107.02 112.93 26.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 74.310000000000002 108.727 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.18 101.49 8.82 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 N-CA-C 108.8 -0.815 . . . . 40.229999999999997 108.8 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -80.79 121.81 26.39 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.662 -1.154 . . . . 52.450000000000003 108.931 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.2 m -93.39 113.88 26.15 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.917 0.887 . . . . 32.149999999999999 108.78 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.25 167.32 14.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.7 0.8 . . . . 74.019999999999996 110.799 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.9 p -62.45 -24.69 67.57 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.881 0.872 . . . . 74.049999999999997 112.195 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -96.87 -16.66 20.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.62 0.768 . . . . 74.230000000000004 111.516 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.87 9.94 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.217 -0.768 . . . . 70.409999999999997 114.81 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.72 124.71 26.54 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.32 1.06 . . . . 70.040000000000006 110.551 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -88.26 140.88 29.03 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.846 -0.798 . . . . 74.340000000000003 108.846 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.585 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 44.8 p90 -162.63 135.59 5.8 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.769 0.668 . . . . 75.400000000000006 110.516 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.504 HG23 HD11 ' A' ' 217' ' ' LEU . 53.9 t -70.81 -53.28 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.902 -0.777 . . . . 73.409999999999997 108.902 165.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.3 m -107.06 136.15 47.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.629 -1.168 . . . . 74.439999999999998 109.744 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.8 t -60.4 -26.59 66.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.45 1.1 . . . . 71.230000000000004 112.942 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.39 -23.3 61.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.747 0.819 . . . . 73.409999999999997 111.479 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.2 m -134.4 101.17 4.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.182 0.593 . . . . 71.310000000000002 110.364 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.585 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.1 mtm180 -110.07 138.07 46.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.162 0.985 . . . . 72.430000000000007 110.197 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.87 149.22 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.623 -0.88 . . . . 71.120000000000005 108.623 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -68.66 -31.96 71.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 72.319999999999993 110.76 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -132.1 157.36 44.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 112.074 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -27.55 69.03 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.731 -1.122 . . . . 74.019999999999996 109.506 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.99 -45.44 86.79 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.553 0.741 . . . . 71.040000000000006 110.898 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.6 -34.83 72.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.527 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 205' ' ' VAL . 16.0 tp -56.98 -58.64 7.27 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.752 0.421 . . . . 64.239999999999995 110.873 174.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.22 -40.65 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.246 0.618 . . . . 74.239999999999995 111.165 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -57.13 -61.47 2.44 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.822 0.701 . . . . 74.340000000000003 111.566 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -71.9 -29.16 64.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.849 -0.614 . . . . 73.340000000000003 111.262 -171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.518 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.7 m170 -87.55 -9.88 53.17 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.675 0.39 . . . . 73.319999999999993 112.049 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.0 p -88.43 -35.33 17.14 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.98 0.355 . . . . 71.409999999999997 110.114 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 65.8 p -70.28 -46.65 63.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.631 0.372 . . . . 71.129999999999995 111.048 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.745 HG23 ' HB2' ' A' ' 226' ' ' ASP . 22.8 m -132.01 165.14 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.353 0.661 . . . . 52.130000000000003 111.973 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.62 15.41 0.37 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 126.714 2.005 . . . . 64.129999999999995 114.208 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.745 ' HB2' HG23 ' A' ' 224' ' ' VAL . 23.8 t70 -44.65 36.23 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.723 1 C-N-CA 132.429 4.292 . . . . 75.109999999999999 119.561 -157.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 124.1 -7.08 8.73 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.537 -0.727 . . . . 51.439999999999998 112.493 -170.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.4 mt -94.65 162.45 13.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.116 1.366 . . . . 74.209999999999994 110.059 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.76 -35.26 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.604 0.24 . . . . 72.109999999999999 110.786 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.5 t -159.06 -179.22 7.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.996 0.519 . . . . 72.310000000000002 110.677 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.2 p -66.13 137.24 56.9 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.622 1.169 . . . . 73.219999999999999 112.311 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.44 96.69 1.19 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.75 0.82 . . . . 42.229999999999997 109.051 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -97.53 -82.61 0.41 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.818 -0.551 . . . . 53.200000000000003 111.99 -170.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -75.22 120.72 82.99 Favored Pre-proline 0 C--N 1.351 0.647 0 N-CA-C 108.857 -0.794 . . . . 74.219999999999999 108.857 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.88 127.7 7.97 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.038 1.825 . . . . 73.120000000000005 111.275 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.95 140.94 88.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 108.851 -0.796 . . . . 74.409999999999997 108.851 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.76 176.58 9.34 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.488 2.125 . . . . 74.140000000000001 113.051 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -63.53 140.7 58.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.897 0.879 . . . . 75.109999999999999 109.654 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.6 ' HE ' HG22 ' A' ' 151' ' ' VAL . 20.8 ptt85 -90.49 -61.31 1.71 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.524 0.935 . . . . 75.310000000000002 113.524 -165.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.453 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.8 t30 -109.08 128.84 55.32 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.595 0.758 . . . . 64.150000000000006 109.614 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -76.94 113.26 28.6 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.092 -1.447 . . . . 74.340000000000003 107.092 164.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -63.15 132.65 37.31 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.534 2.156 . . . . 74.239999999999995 112.46 -172.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 89.5 m -69.25 123.84 22.22 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.404 0.682 . . . . 63.329999999999998 110.284 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.65 111.74 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.405 -0.961 . . . . 73.239999999999995 108.405 172.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.56 112.37 25.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.303 0.641 . . . . 72.319999999999993 111.917 -169.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 69.34 -38.18 0.34 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 117.366 1.706 . . . . 61.049999999999997 117.366 165.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.33 129.33 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 117.833 0.817 . . . . 73.219999999999999 112.771 -158.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.9 t -83.35 135.82 43.7 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 107.339 -1.356 . . . . 75.409999999999997 107.339 168.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 C--N 1.387 2.562 0 C-N-CA 122.126 1.884 . . . . 75.129999999999995 115.265 -156.246 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.1 t90 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 74.299999999999997 109.625 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 26.2 p-10 -66.97 -33.95 76.7 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.419 -0.81 . . . . 72.340000000000003 110.826 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 p -72.0 6.21 2.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.698 1.199 . . . . 64.450000000000003 112.72 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 83.5 tttt -70.28 -21.24 62.98 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.75 0.42 . . . . 64.439999999999998 111.13 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 13.3 pt-20 -73.0 -38.11 66.72 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.474 -0.565 . . . . 72.340000000000003 109.474 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 4.9 m-20 -77.43 -13.59 59.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.23 0.612 . . . . 74.329999999999998 111.075 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.461 HD13 ' HE1' ' A' ' 146' ' ' TRP . 60.3 tp -59.14 -50.32 74.5 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.684 0.794 . . . . 71.0 110.692 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 mt -108.06 23.8 13.94 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.78 -0.645 . . . . 42.100000000000001 110.922 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 123.073 0.549 . . . . 70.319999999999993 111.533 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.933 0.397 . . . . 73.010000000000005 111.681 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.5 tp -100.11 139.52 35.66 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.65 -0.656 . . . . 72.239999999999995 110.315 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -116.5 172.3 7.29 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.362 1.065 . . . . 73.319999999999993 109.101 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.08 139.99 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.732 1.213 . . . . 74.430000000000007 109.538 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.32 117.26 20.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.207 1.003 . . . . 41.32 110.249 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.07 -31.7 34.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.09 0.956 . . . . 50.219999999999999 111.564 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.43 141.61 51.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.036 0.934 . . . . 74.540000000000006 108.921 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.99 120.2 24.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.158 -0.682 . . . . 71.409999999999997 109.158 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.525 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.2 t80 -115.43 142.87 46.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.786 0.834 . . . . 64.109999999999999 109.469 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.72 135.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.737 -0.838 . . . . 63.109999999999999 108.737 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.42 119.22 10.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.701 0.8 . . . . 64.040000000000006 111.035 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.3 p -94.4 10.94 32.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.428 1.091 . . . . 74.409999999999997 111.324 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.78 179.45 43.47 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.108 -0.496 . . . . 73.310000000000002 112.034 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.14 -34.81 63.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.892 0.877 . . . . 74.430000000000007 110.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.519 ' ND2' ' HD2' ' A' ' 249' ' ' PRO . 32.4 p-10 -90.37 -4.05 57.33 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.043 -0.981 . . . . 75.400000000000006 112.262 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.9 p -96.76 168.51 10.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.457 0.703 . . . . 72.150000000000006 109.936 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.576 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 66.1 tp -135.93 136.29 40.33 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.084 0.553 . . . . 60.240000000000002 111.38 -172.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -83.9 120.14 25.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.573 0.749 . . . . 70.239999999999995 110.073 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.784 HG22 HG21 ' A' ' 123' ' ' THR . 20.2 pt -117.43 152.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 123.171 0.588 . . . . 75.450000000000003 111.614 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -98.53 146.44 25.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.362 1.065 . . . . 72.310000000000002 109.601 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -70.17 118.59 13.19 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.907 0.483 . . . . 71.450000000000003 109.701 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.78 -11.5 56.21 Favored Glycine 0 N--CA 1.472 1.052 0 C-N-CA 123.197 0.427 . . . . 71.319999999999993 112.845 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.11 135.65 44.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.65 0.78 . . . . 73.150000000000006 110.97 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -85.92 142.46 28.83 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.572 -0.899 . . . . 71.319999999999993 108.572 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.677 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.15 150.4 34.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.25 0.62 . . . . 51.310000000000002 111.119 -176.238 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -95.4 106.41 18.46 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.687 -0.688 . . . . 73.150000000000006 109.287 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.652 HG13 ' HB1' ' A' ' 119' ' ' ALA . 42.1 t -86.75 107.88 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.621 -0.511 . . . . 74.040000000000006 109.621 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.613 HD21 ' HG3' ' A' ' 122' ' ' GLN . 2.1 mm? -69.52 -23.22 63.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.349 1.059 . . . . 32.329999999999998 110.935 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.7 166.42 13.61 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.276 -0.42 . . . . 75.140000000000001 112.46 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.593 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 61.1 m-85 -86.6 173.12 9.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.841 0.829 . . . . 74.140000000000001 111.794 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -90.05 -178.66 5.49 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.208 -1.36 . . . . 64.25 110.97 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -53.26 -34.3 56.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.611 1.165 . . . . 71.030000000000001 113.11 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -105.35 -19.67 13.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 119.183 -0.436 . . . . 74.25 111.368 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.21 34.68 22.9 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.548 0.579 . . . . 71.109999999999999 114.548 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.55 -29.82 14.7 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.023 0.412 . . . . 62.350000000000001 111.057 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 60.6 m95 -128.75 156.02 44.2 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.16 0.984 . . . . 74.25 111.15 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.652 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.22 141.31 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.305 1.042 . . . . 25.440000000000001 110.263 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 110' ' ' LEU . 40.7 tt0 -74.82 118.43 17.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.859 -1.163 . . . . 63.350000000000001 107.859 170.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.52 151.33 48.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.25 0.62 . . . . 75.430000000000007 111.307 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.613 ' HG3' HD21 ' A' ' 110' ' ' LEU . 56.4 mt-30 -115.05 116.43 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.148 0.979 . . . . 74.400000000000006 108.95 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.784 HG21 HG22 ' A' ' 101' ' ' ILE . 67.0 p -114.6 -178.51 3.39 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.349 1.059 . . . . 71.150000000000006 110.885 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -68.66 -16.53 63.86 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.553 -0.748 . . . . 74.129999999999995 110.29 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -84.33 -20.46 32.01 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.202 1.001 . . . . 73.120000000000005 111.074 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.31 -168.43 14.84 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.096 -0.402 . . . . 55.240000000000002 112.096 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.27 145.45 28.83 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.35 0.575 . . . . 71.349999999999994 111.593 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.39 -161.91 27.65 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.713 -0.955 . . . . 21.25 110.713 177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -110.94 136.24 50.25 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.797 0.798 . . . . 72.510000000000005 111.463 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.484 HG11 ' CG2' ' A' ' 101' ' ' ILE . 34.2 m -137.8 140.28 29.13 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.063 1.345 . . . . 73.109999999999999 109.252 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 8.8 Cg_exo -72.85 146.4 42.33 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.44 2.093 . . . . 74.120000000000005 114.38 -172.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 m -38.09 -50.96 1.4 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.469 1.907 . . . . 44.539999999999999 114.194 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 131' ' ' PRO . 12.7 p-10 -73.3 -3.65 28.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.375 1.07 . . . . 74.519999999999996 113.103 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -106.73 -9.39 16.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.858 0.863 . . . . 75.120000000000005 111.313 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 109' ' ' VAL . 18.0 pt -130.8 168.59 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.137 0.975 . . . . 73.329999999999998 111.832 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 t -163.06 155.9 16.29 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 124.08 0.952 . . . . 62.340000000000003 108.672 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.74 142.71 91.65 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 121.795 1.663 . . . . 72.040000000000006 111.442 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.4 t -69.72 -11.37 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.796 0.807 . . . . 75.409999999999997 109.848 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -73.8 -18.36 60.97 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.523 1.129 . . . . 51.130000000000003 112.568 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.6 p -92.69 -178.25 4.8 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.318 0.858 . . . . 51.340000000000003 113.318 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.8 mt -83.5 -21.19 32.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.257 1.023 . . . . 61.009999999999998 111.689 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.54 -20.95 63.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.684 0.394 . . . . 73.200000000000003 111.792 -172.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 72' ' ' ASN . 21.8 pttm -65.33 -15.99 63.12 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 112.266 0.469 . . . . 74.420000000000002 112.266 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -83.22 138.47 33.6 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.401 0.68 . . . . 75.319999999999993 109.28 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 p -65.11 -39.88 93.76 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.611 0.765 . . . . 63.219999999999999 112.203 -177.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.461 ' HE1' HD13 ' A' ' 73' ' ' LEU . 32.2 p-90 -67.78 -30.16 69.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.848 0.859 . . . . 61.520000000000003 112.87 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -80.58 102.99 10.13 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.742 -0.466 . . . . 71.219999999999999 109.742 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -99.72 -4.1 31.47 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.992 0.517 . . . . 75.439999999999998 111.788 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.8 -139.79 26.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 118.708 -1.051 . . . . 60.130000000000003 112.793 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.92 101.51 0.39 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.813 2.342 . . . . 74.010000000000005 112.399 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 76.7 t -132.3 141.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.77 0.828 . . . . 74.319999999999993 109.801 -175.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.6 p -87.72 172.65 9.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.924 0.89 . . . . 73.25 110.369 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 68.8 ttt180 -61.71 -45.51 93.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.243 -0.28 . . . . 54.409999999999997 110.243 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.5 -45.56 80.94 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.042 0.838 . . . . 64.299999999999997 111.019 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.624 ' HB1' HH12 ' A' ' 239' ' ' ARG . . . -71.65 -26.45 62.55 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.289 -0.869 . . . . 71.230000000000004 111.699 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.27 -43.27 52.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.27 0.628 . . . . 74.310000000000002 111.243 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 26.7 mm-40 -60.79 -36.19 78.38 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.722 0.809 . . . . 74.129999999999995 110.059 174.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -67.75 -47.29 69.67 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.704 -1.134 . . . . 73.209999999999994 111.205 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.33 -38.44 68.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.284 0.634 . . . . 55.200000000000003 111.307 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.9 mt -100.93 6.79 43.75 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.952 0.723 . . . . 73.109999999999999 112.952 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 90.6 p -59.17 -35.31 73.32 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 119.075 0.852 . . . . 70.5 111.166 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -102.86 18.92 20.37 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.495 1.118 . . . . 54.299999999999997 110.89 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.11 133.29 11.68 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 123.644 0.64 . . . . 74.109999999999999 113.057 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -79.54 -177.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.946 0.898 . . . . 41.210000000000001 111.837 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.96 116.43 3.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.601 0.761 . . . . 63.32 110.656 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.16 11.8 55.7 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.629 -0.714 . . . . 73.019999999999996 113.094 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.1 m -76.38 135.24 39.48 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 118.082 0.941 . . . . 73.209999999999994 110.622 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 183' ' ' SER . 33.6 p90 -142.22 168.13 20.47 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 118.782 0.719 . . . . 55.549999999999997 111.34 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 pp -159.29 152.67 22.52 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.337 -0.986 . . . . 50.009999999999998 108.337 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.689 HG22 HG12 ' A' ' 182' ' ' ILE . 89.4 t -110.91 142.05 24.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 N-CA-C 109.092 -0.707 . . . . 70.409999999999997 109.092 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.467 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.3 ptt85 -135.37 159.21 42.3 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.288 -1.323 . . . . 74.439999999999998 108.95 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.658 ' HG2' ' HG2' ' A' ' 180' ' ' ARG . 10.7 mt-10 -113.93 162.14 16.76 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.523 -0.918 . . . . 64.319999999999993 108.523 164.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -84.02 133.79 34.65 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.99 -0.744 . . . . 74.409999999999997 108.99 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -71.17 -43.73 66.89 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.722 -0.473 . . . . 74.450000000000003 109.722 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.5 p -76.25 -15.76 59.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.112 0.565 . . . . 71.420000000000002 112.145 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.5 m -139.54 82.99 17.57 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.141 0.577 . . . . 64.230000000000004 109.865 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.64 125.94 18.57 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.958 2.439 . . . . 62.340000000000003 111.531 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.42 -29.58 8.98 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.752 -0.539 . . . . 53.0 111.752 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -75.77 116.89 16.94 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.02 -0.733 . . . . 72.049999999999997 109.02 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.658 ' HG2' ' HG2' ' A' ' 172' ' ' GLU . 98.3 mtt180 -124.01 145.89 48.9 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 123.954 0.902 . . . . 71.329999999999998 110.121 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 64.3 m -142.27 146.46 35.14 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.221 -0.9 . . . . 71.319999999999993 109.668 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.689 HG12 HG22 ' A' ' 170' ' ' VAL . 34.6 mt -103.32 150.17 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.084 -1.45 . . . . 34.240000000000002 107.084 169.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.1 m -125.45 108.09 11.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.661 -1.237 . . . . 55.530000000000001 107.661 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 25.5 tp -107.72 110.16 21.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.658 0.663 . . . . 55.219999999999999 110.216 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.514 ' HB2' HG22 ' A' ' 190' ' ' VAL . 20.5 ttt180 -79.95 120.89 24.77 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.673 0.749 . . . . 75.299999999999997 110.773 168.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -140.59 135.51 31.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 113.816 -1.538 . . . . 70.319999999999993 107.446 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 60.14 22.4 11.67 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.799 0.84 . . . . 50.32 112.087 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.15 -10.77 73.05 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.142 0.417 . . . . 42.329999999999998 114.142 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -103.5 139.04 39.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.314 0.646 . . . . 70.430000000000007 109.908 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 185' ' ' ARG . 48.1 t -99.3 110.33 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.897 0.479 . . . . 73.329999999999998 110.433 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -95.05 117.03 29.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.979 1.311 . . . . 73.030000000000001 109.133 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -96.54 122.94 39.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.947 0.499 . . . . 74.400000000000006 110.723 -172.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.46 ' HE1' HD21 ' A' ' 232' ' ' LEU . 8.2 m-30 -94.82 147.36 23.43 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.097 0.959 . . . . 75.040000000000006 109.795 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -99.24 117.65 34.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.132 -1.062 . . . . 74.239999999999995 108.132 173.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.531 HD12 ' HB3' ' A' ' 180' ' ' ARG . 56.8 mt -82.4 100.59 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 107.649 -1.241 . . . . 73.439999999999998 107.649 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -71.28 119.81 15.96 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.051 -0.977 . . . . 52.219999999999999 109.206 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 m -87.71 110.47 20.46 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.677 -0.692 . . . . 73.200000000000003 109.16 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.25 157.3 10.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.167 0.987 . . . . 53.43 111.383 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.6 p -64.43 -31.79 73.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.641 0.776 . . . . 73.200000000000003 112.101 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -82.58 -13.92 55.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.319 0.648 . . . . 71.109999999999999 111.316 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.32 9.77 19.04 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.401 0.52 . . . . 64.030000000000001 114.401 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -79.66 164.09 24.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.686 0.743 . . . . 72.530000000000001 110.735 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -115.73 147.36 41.0 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.601 0.761 . . . . 73.209999999999994 109.172 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.608 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.6 p90 -170.3 140.06 1.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.027 0.829 . . . . 62.240000000000002 111.728 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 217' ' ' LEU . 98.9 t -85.35 -44.38 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.733 -0.84 . . . . 43.450000000000003 108.733 165.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 43.1 m -92.7 130.83 38.2 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.941 -1.027 . . . . 71.140000000000001 109.992 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -72.27 -17.11 61.91 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.416 0.686 . . . . 74.099999999999994 111.884 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.47 -1.51 57.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.038 0.535 . . . . 61.030000000000001 111.399 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.36 101.86 3.53 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.769 0.428 . . . . 73.519999999999996 111.426 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.608 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 74.2 mtt180 -101.36 153.68 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.219 0.608 . . . . 72.530000000000001 110.32 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.4 154.72 47.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.411 0.684 . . . . 75.329999999999998 109.952 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -72.21 -44.74 62.48 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.233 -0.655 . . . . 63.240000000000002 109.233 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 156.41 31.39 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-O 121.938 0.875 . . . . 75.450000000000003 111.564 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.426 HD23 HD23 ' A' ' 217' ' ' LEU . 0.8 OUTLIER -64.55 -26.6 68.49 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-N 114.012 -1.449 . . . . 52.140000000000001 110.065 175.027 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.26 96.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.576 0.75 . . . . 61.450000000000003 111.331 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.84 -33.19 70.4 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.375 0.67 . . . . 72.5 111.154 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.451 HD11 HG23 ' A' ' 205' ' ' VAL . 15.3 tp -53.36 -57.23 11.31 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.729 0.643 . . . . 64.099999999999994 110.034 171.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 53.4 t -63.88 -37.83 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 O-C-N 123.802 0.689 . . . . 74.219999999999999 112.035 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -65.14 -51.89 58.46 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.853 0.358 . . . . 61.299999999999997 111.189 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -64.23 -35.11 79.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 75.150000000000006 110.776 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.652 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.5 m170 -85.72 -9.33 57.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.284 0.476 . . . . 72.430000000000007 112.284 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.4 p -90.93 -29.73 17.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.727 0.411 . . . . 71.430000000000007 110.761 170.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.7 p -75.48 -49.51 18.57 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.852 0.358 . . . . 75.140000000000001 110.735 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.3 m -125.7 154.23 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.979 0.895 . . . . 73.420000000000002 111.694 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.62 13.88 7.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.627 1.971 . . . . 71.150000000000006 113.694 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -46.77 34.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 131.182 3.793 . . . . 55.25 119.855 -159.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.58 -0.67 6.37 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 119.28 0.945 . . . . 52.32 112.941 -167.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.2 mt -92.33 161.92 14.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.434 1.094 . . . . 75.230000000000004 110.52 163.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.83 -42.19 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 122.564 0.345 . . . . 71.030000000000001 110.432 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -161.69 170.9 18.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.665 0.786 . . . . 55.039999999999999 110.102 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.3 p -61.29 139.36 58.17 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.456 1.102 . . . . 63.530000000000001 112.687 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.46 HD21 ' HE1' ' A' ' 193' ' ' TYR . 79.5 mt -68.17 99.55 0.91 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.033 0.933 . . . . 74.510000000000005 109.161 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -94.44 -50.24 5.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.329 0.492 . . . . 61.329999999999998 112.329 -163.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 167' ' ' SER . 15.5 t80 -130.77 124.16 20.62 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.936 1.294 . . . . 62.530000000000001 108.127 -171.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -84.95 146.91 10.4 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.256 1.97 . . . . 72.420000000000002 112.17 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -74.63 130.15 82.25 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.437 -1.32 . . . . 54.219999999999999 107.437 172.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.35 173.8 12.77 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.076 1.85 . . . . 73.310000000000002 112.5 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -68.19 109.12 3.42 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.882 -0.784 . . . . 74.340000000000003 108.882 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.637 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 8.7 ptt180 -75.51 -68.3 0.58 Allowed 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.559 0.948 . . . . 64.109999999999999 113.559 -158.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.637 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 66.8 t30 -111.29 137.75 48.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.788 -0.57 . . . . 70.219999999999999 110.128 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -74.49 112.69 18.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 106.3 -1.741 . . . . 71.420000000000002 106.3 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.23 127.28 16.4 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.346 2.031 . . . . 63.130000000000003 111.568 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 84.8 m -61.53 110.76 1.56 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.969 0.907 . . . . 74.230000000000004 111.182 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.22 106.96 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 107.685 -1.228 . . . . 53.520000000000003 107.685 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.73 120.77 43.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.128 0.971 . . . . 43.509999999999998 112.777 -163.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.07 63.74 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 116.352 1.301 . . . . 64.409999999999997 116.352 161.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.63 122.42 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 123.187 0.595 . . . . 72.239999999999995 110.874 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.9 t -81.3 116.73 64.65 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 104.834 -2.284 . . . . 72.439999999999998 104.834 161.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.519 ' HD2' ' ND2' ' A' ' 97' ' ' ASN . 99.3 Cg_exo . . . . . 0 C--N 1.378 2.11 0 C-N-CA 122.677 2.252 . . . . 74.349999999999994 116.226 -148.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.8 t90 . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 108.51 -0.922 . . . . 74.409999999999997 108.51 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.41 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 30.1 p-10 -94.38 -34.01 12.94 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.888 0.475 . . . . 74.409999999999997 110.68 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.3 p -71.25 2.94 4.05 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.959 0.903 . . . . 60.210000000000001 113.3 -171.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.08 -22.07 64.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.658 . . . . 72.209999999999994 110.636 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 10.9 pt-20 -65.76 -30.79 71.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.688 0.795 . . . . 73.519999999999996 110.673 172.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -84.17 -10.34 57.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.128 0.971 . . . . 54.020000000000003 110.928 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.5 tp -65.12 -48.91 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.807 0.843 . . . . 73.420000000000002 111.686 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.51 12.39 29.6 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 73.540000000000006 110.971 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 123.179 0.591 . . . . 63.0 111.471 179.792 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 111.754 0.279 . . . . 63.119999999999997 111.754 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.0 tp -84.23 127.29 33.86 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 121.258 0.552 . . . . 64.120000000000005 110.035 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -110.49 174.95 5.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.625 1.57 . . . . 74.049999999999997 108.652 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.66 141.56 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.744 1.218 . . . . 71.420000000000002 109.46 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.4 137.03 38.47 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.609 0.763 . . . . 50.350000000000001 110.079 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.526 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 73.1 mt -103.97 -20.85 13.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.942 0.897 . . . . 72.219999999999999 111.475 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.98 149.19 49.99 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.021 0.928 . . . . 73.430000000000007 109.552 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.4 119.58 19.69 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.515 -0.92 . . . . 74.349999999999994 108.515 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -129.8 133.6 47.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.222 -0.659 . . . . 73.549999999999997 109.222 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.9 136.23 37.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.534 -1.284 . . . . 74.200000000000003 107.534 169.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.65 136.07 50.81 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.349 1.06 . . . . 62.219999999999999 111.218 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -131.33 26.88 4.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.014 0.925 . . . . 65.430000000000007 112.254 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.46 -165.74 26.36 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.071 -0.513 . . . . 73.230000000000004 112.014 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.73 -42.51 19.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.143 0.577 . . . . 75.430000000000007 112.304 -172.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -101.05 5.07 42.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.632 0.373 . . . . 72.239999999999995 111.767 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -76.27 172.31 13.09 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.698 0.799 . . . . 73.519999999999996 112.044 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.433 ' HB3' HG13 ' A' ' 130' ' ' VAL . 39.5 tp -147.02 130.54 16.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 73.299999999999997 110.138 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -80.77 127.79 32.91 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.336 0.654 . . . . 62.219999999999999 109.86 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.665 HG22 HG21 ' A' ' 123' ' ' THR . 19.5 pt -126.72 154.22 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.549 0.74 . . . . 74.219999999999999 111.684 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -100.68 147.33 26.13 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.616 -1.175 . . . . 73.310000000000002 108.743 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.67 114.16 4.78 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.551 -0.537 . . . . 75.230000000000004 109.551 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.84 -1.34 44.99 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 115.924 -0.58 . . . . 74.109999999999999 113.124 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -79.65 127.18 31.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.951 0.501 . . . . 74.120000000000005 110.493 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -79.3 135.35 36.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.484 0.714 . . . . 61.539999999999999 109.435 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.705 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.64 147.87 30.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.651 0.78 . . . . 52.43 111.26 -174.445 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -104.93 109.51 21.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.854 0.461 . . . . 72.140000000000001 110.731 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.645 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.4 t -73.05 125.23 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.608 0.363 . . . . 72.239999999999995 110.162 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.9 mt -96.28 -36.76 10.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.877 1.271 . . . . 75.109999999999999 110.237 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.1 144.68 6.89 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.76 -0.655 . . . . 73.200000000000003 111.982 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 29.5 m-85 -89.62 171.11 9.91 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.853 0.835 . . . . 63.100000000000001 111.616 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -68.98 161.02 29.81 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 113.784 -1.553 . . . . 74.099999999999994 108.021 169.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -54.29 -28.52 42.62 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.998 0.919 . . . . 64.420000000000002 113.141 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -106.11 -3.62 21.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.078 0.951 . . . . 73.299999999999997 111.847 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.72 33.38 58.05 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-O 119.818 -0.434 . . . . 72.319999999999993 113.981 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.651 ' HB3' ' HD1' ' A' ' 118' ' ' TRP . 37.6 mt-10 -70.23 -65.69 0.69 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.261 0.531 . . . . 71.219999999999999 110.544 171.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 23.5 m95 -119.65 167.09 12.37 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.277 1.031 . . . . 74.430000000000007 110.176 -171.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.645 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -141.7 131.56 24.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.462 1.105 . . . . 73.040000000000006 109.95 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.76 101.8 4.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -104.64 144.69 31.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.35 0.66 . . . . 73.329999999999998 110.586 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -95.6 105.17 17.13 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.109 -1.071 . . . . 75.040000000000006 108.109 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.705 HG22 ' HB3' ' A' ' 107' ' ' LEU . 62.3 p -97.94 173.53 7.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.618 1.167 . . . . 62.240000000000002 110.152 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -68.69 -21.79 64.4 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.503 -0.772 . . . . 62.439999999999998 109.777 174.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.979 1.312 . . . . 75.299999999999997 111.474 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.11 -170.48 24.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.139 -0.384 . . . . 71.150000000000006 112.139 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -102.33 135.05 44.62 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.415 0.686 . . . . 74.129999999999995 110.554 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 172.34 -175.38 45.54 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 111.261 -0.735 . . . . 34.340000000000003 111.261 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -94.84 132.67 39.4 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.268 0.627 . . . . 74.299999999999997 112.023 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 135' ' ' ILE . 36.0 m -137.72 139.98 28.41 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.75 1.62 . . . . 52.350000000000001 108.816 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 7.7 Cg_exo -71.21 145.35 48.73 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.598 2.198 . . . . 75.540000000000006 113.953 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -38.2 -50.75 1.44 Allowed 'General case' 0 C--N 1.369 1.444 0 C-N-CA 125.405 1.482 . . . . 72.230000000000004 112.763 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -80.66 12.38 3.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.442 1.097 . . . . 74.299999999999997 112.882 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -115.58 -16.13 11.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.36 1.064 . . . . 74.430000000000007 111.481 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 130' ' ' VAL . 21.3 pt -128.91 171.69 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.766 0.826 . . . . 73.109999999999999 111.511 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.8 t -161.71 153.24 15.75 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.649 -0.871 . . . . 71.430000000000007 108.649 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 36.8 Cg_endo -64.08 154.53 69.99 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.685 1.59 . . . . 73.430000000000007 112.067 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.4 t -72.59 -6.96 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-O 121.937 0.875 . . . . 74.450000000000003 110.382 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.54 -19.78 35.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.826 0.85 . . . . 60.350000000000001 111.401 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.6 p -88.42 171.84 9.81 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.338 0.655 . . . . 54.340000000000003 111.738 -172.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.41 -21.55 30.75 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.001 0.92 . . . . 73.049999999999997 110.668 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.86 -17.12 63.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.471 1.108 . . . . 74.109999999999999 111.761 -172.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.418 ' HA ' HD21 ' A' ' 88' ' ' LEU . 23.4 pttm -62.46 -12.53 22.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.66 0.784 . . . . 74.420000000000002 112.371 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -96.68 150.89 20.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.112 0.965 . . . . 74.310000000000002 110.303 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 p -67.33 -43.86 80.52 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.097 0.959 . . . . 72.129999999999995 111.5 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -57.85 -39.77 78.52 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 124.281 0.988 . . . . 74.319999999999993 111.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -77.83 112.67 14.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.062 -0.718 . . . . 73.099999999999994 109.062 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.401 ' HB2' HG21 ' A' ' 151' ' ' VAL . 70.8 m80 -108.53 -2.71 18.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.024 0.53 . . . . 64.010000000000005 111.695 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.41 -145.69 25.51 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 118.88 -0.955 . . . . 53.420000000000002 113.22 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.74 91.75 0.3 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.357 2.705 . . . . 71.140000000000001 111.85 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 148' ' ' HIS . 61.2 t -121.21 144.14 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.724 1.21 . . . . 74.120000000000005 109.005 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.4 p -88.2 167.25 13.75 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.575 0.75 . . . . 74.450000000000003 109.835 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -60.05 -46.79 88.38 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.901 0.48 . . . . 64.109999999999999 111.702 -173.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -65.53 -35.31 80.49 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 123.754 0.659 . . . . 44.210000000000001 111.115 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.33 67.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.091 0.556 . . . . 64.319999999999993 110.87 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 159' ' ' LEU . . . -68.35 -43.86 76.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.604 0.716 . . . . 33.350000000000001 110.885 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.24 -21.31 60.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.2 -0.909 . . . . 60.109999999999999 110.647 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -72.48 -42.35 65.01 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.594 0.757 . . . . 75.219999999999999 110.353 170.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.612 HD12 ' HA ' ' A' ' 156' ' ' ALA . 21.5 mt -56.66 -37.33 70.66 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.276 0.631 . . . . 75.540000000000006 110.674 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 19.6 17.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.415 -0.811 . . . . 75.200000000000003 112.602 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 -35.86 51.22 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.759 -0.83 . . . . 72.239999999999995 108.759 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.5 p -94.54 -15.16 24.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.67 1.188 . . . . 74.219999999999999 111.586 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.18 148.65 50.28 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 123.267 0.355 . . . . 42.350000000000001 113.455 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.4 -178.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.767 . . . . 72.230000000000004 111.398 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.26 123.2 19.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.146 -0.479 . . . . 62.399999999999999 109.88 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.31 7.89 61.73 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.311 -0.716 . . . . 62.310000000000002 113.052 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.5 m -83.71 133.46 34.8 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 118.26 1.03 . . . . 75.239999999999995 110.479 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -139.37 166.34 24.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.095 0.474 . . . . 74.120000000000005 111.146 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -158.5 150.62 21.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.906 -1.043 . . . . 75.409999999999997 109.17 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 182' ' ' ILE . 99.6 t -110.33 140.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 108.596 -0.89 . . . . 64.239999999999995 108.596 167.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 156' ' ' ALA . 52.2 ptt85 -142.6 161.43 38.08 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.045 -0.979 . . . . 74.109999999999999 109.621 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.48 154.67 27.79 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.196 -1.409 . . . . 74.400000000000006 107.196 165.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -79.63 119.2 22.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 62.109999999999999 109.649 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.46 -37.02 85.69 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.609 -0.723 . . . . 73.510000000000005 109.886 168.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 -40.52 97.9 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.273 1.029 . . . . 75.120000000000005 111.659 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.4 m -143.47 94.84 6.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.648 0.779 . . . . 63.130000000000003 109.598 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -59.19 146.91 92.98 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.217 2.611 . . . . 73.129999999999995 112.812 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.06 -30.62 8.3 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.49 -0.777 . . . . 64.409999999999997 112.268 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.82 115.16 15.22 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 109.451 -0.574 . . . . 65.019999999999996 109.451 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -119.68 140.93 49.88 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.292 0.637 . . . . 74.430000000000007 109.441 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 71.1 m -145.24 147.39 32.36 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.065 0.946 . . . . 73.430000000000007 109.864 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.642 HG12 HG22 ' A' ' 170' ' ' VAL . 38.0 mt -102.74 147.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.221 -1.4 . . . . 63.229999999999997 107.221 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.6 m -124.3 113.0 17.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.519 -1.289 . . . . 52.329999999999998 107.519 172.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.0 112.34 24.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.048 0.539 . . . . 74.109999999999999 109.871 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.441 ' HB2' HG22 ' A' ' 190' ' ' VAL . 54.3 ttt180 -79.73 116.5 19.94 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 109.43 -0.581 . . . . 72.140000000000001 109.43 166.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -142.11 141.44 32.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.144 1.377 . . . . 65.420000000000002 107.938 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 54.55 31.05 14.19 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.403 1.081 . . . . 55.32 111.603 -173.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.24 -11.25 50.74 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-N 115.466 -0.788 . . . . 45.399999999999999 114.228 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -104.72 139.5 39.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.585 0.754 . . . . 74.040000000000006 110.129 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 185' ' ' ARG . 51.7 t -95.68 107.26 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.848 0.459 . . . . 71.219999999999999 110.511 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -93.1 132.38 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.471 1.108 . . . . 73.109999999999999 109.211 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -107.52 119.8 40.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.14 0.576 . . . . 71.219999999999999 110.636 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.495 ' HE1' HD21 ' A' ' 232' ' ' LEU . 7.8 m-85 -94.55 146.65 23.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.411 1.084 . . . . 73.120000000000005 109.192 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -100.38 114.72 28.47 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.217 -0.66 . . . . 71.049999999999997 109.217 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mt -85.15 101.06 9.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.198 -1.038 . . . . 53.43 108.198 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.93 121.27 23.94 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.948 -1.024 . . . . 55.340000000000003 108.641 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.7 m -94.23 118.7 31.95 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.343 -0.984 . . . . 70.430000000000007 108.343 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.9 169.54 14.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.867 0.867 . . . . 72.530000000000001 110.621 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.7 p -66.3 -28.51 68.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.839 0.456 . . . . 64.150000000000006 110.918 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.79 -11.3 42.54 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.542 0.737 . . . . 63.25 110.946 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.27 -0.31 25.21 Favored Glycine 0 C--N 1.356 1.683 0 CA-C-O 119.104 -0.831 . . . . 64.409999999999997 115.166 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.412 ' HE2' ' OD1' ' A' ' 212' ' ' ASN . 98.3 mttt -69.36 131.94 45.6 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.398 1.099 . . . . 60.119999999999997 112.155 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -89.22 142.94 27.21 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.037 -1.097 . . . . 62.5 108.037 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.505 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.1 p90 -167.48 138.0 2.92 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.57 0.543 . . . . 73.409999999999997 111.993 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.46 HG23 HD11 ' A' ' 217' ' ' LEU . 68.0 t -89.17 -30.8 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.583 -0.895 . . . . 72.230000000000004 108.583 163.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 14.7 m -93.2 115.58 28.2 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.26 -1.015 . . . . 74.430000000000007 108.26 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.3 t -56.98 -38.14 72.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.481 0.712 . . . . 74.099999999999994 111.863 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.34 -29.6 30.91 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.751 0.82 . . . . 64.430000000000007 111.15 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 58.9 m -102.2 91.28 4.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.062 0.545 . . . . 74.540000000000006 110.289 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.505 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 87.1 mtt180 -91.1 140.62 29.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.511 0.724 . . . . 62.25 109.688 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.2 m-85 -125.75 141.87 51.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.878 -0.786 . . . . 64.129999999999995 108.878 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' A' ' 202' ' ' LYS . 71.4 m-20 -64.75 -38.83 92.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.533 0.521 . . . . 72.319999999999993 110.132 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 63.7 p -123.88 155.33 38.26 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.072 0.939 . . . . 73.209999999999994 111.757 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.02 -24.29 66.72 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 113.869 -1.514 . . . . 74.510000000000005 109.496 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.65 94.83 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.857 0.863 . . . . 65.200000000000003 110.964 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 47.4 mt-10 -72.52 -36.8 68.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.489 0.716 . . . . 75.129999999999995 111.263 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.46 HD11 HG23 ' A' ' 205' ' ' VAL . 14.2 tp -53.91 -57.1 12.22 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.584 0.553 . . . . 72.439999999999998 110.492 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.64 -37.48 80.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 O-C-N 123.736 0.648 . . . . 74.209999999999994 111.413 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.981 0.355 . . . . 75.340000000000003 111.163 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -57.34 -36.83 71.66 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.142 0.901 . . . . 73.129999999999995 109.988 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.693 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.9 m170 -87.29 -12.28 47.04 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 112.513 0.56 . . . . 73.129999999999995 112.513 -175.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.6 p -98.16 -11.12 23.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.89 0.476 . . . . 74.329999999999998 110.575 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.8 p -87.66 -43.16 12.15 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 110.1 -0.334 . . . . 72.319999999999993 110.1 171.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 226' ' ' ASP . 29.1 m -137.46 172.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.461 0.648 . . . . 72.540000000000006 112.71 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.97 14.51 1.37 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.866 2.066 . . . . 63.009999999999998 114.106 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.594 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.0 t70 -42.66 29.8 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 1 C-N-CA 131.799 4.039 . . . . 73.340000000000003 120.073 -152.249 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.49 1.1 10.13 Favored Glycine 0 N--CA 1.483 1.825 0 O-C-N 120.071 -1.643 . . . . 72.129999999999995 112.192 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -92.83 161.96 14.3 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.082 1.353 . . . . 65.120000000000005 109.525 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.52 -37.4 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 N-CA-C 110.177 -0.305 . . . . 72.340000000000003 110.177 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -161.28 169.2 22.58 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.79 0.836 . . . . 70.439999999999998 110.388 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 27.8 m -61.31 135.9 57.87 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.372 1.069 . . . . 74.510000000000005 111.266 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.495 HD21 ' HE1' ' A' ' 193' ' ' TYR . 74.9 mt -69.5 128.11 35.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 74.0 109.701 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -113.39 -78.71 0.58 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.921 0.489 . . . . 53.020000000000003 111.765 -171.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 167' ' ' SER . 33.2 t80 -94.03 124.92 54.74 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.387 1.075 . . . . 63.329999999999998 109.444 -173.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.99 127.56 4.76 Favored 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 122.272 1.981 . . . . 73.129999999999995 111.477 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -65.59 124.52 87.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.273 0.629 . . . . 50.340000000000003 109.499 178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 14.9 Cg_exo -71.33 175.47 9.3 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.975 2.45 . . . . 74.230000000000004 113.11 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.526 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 72.1 mmtt -69.1 130.33 42.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.371 -0.831 . . . . 64.540000000000006 109.106 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -83.47 -59.13 2.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.518 0.562 . . . . 72.25 112.518 -168.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -108.6 132.75 53.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.784 1.234 . . . . 74.420000000000002 110.136 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -81.32 114.92 53.02 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 106.77 -1.567 . . . . 55.229999999999997 106.77 163.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.33 123.64 14.09 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.782 2.322 . . . . 65.239999999999995 111.897 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 20.8 m -74.73 100.21 3.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.818 0.447 . . . . 73.329999999999998 110.071 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.32 106.54 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 107.245 -1.391 . . . . 64.120000000000005 107.245 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.3 107.54 19.12 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.395 -0.224 . . . . 64.329999999999998 110.395 -161.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.27 11.74 7.18 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.76 1.464 . . . . 72.219999999999999 116.76 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -75.32 130.06 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 118.465 1.133 . . . . 72.099999999999994 112.722 -164.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 m -87.65 115.55 63.29 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.378 -2.082 . . . . 31.420000000000002 105.378 144.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 C--N 1.367 1.509 0 C-N-CA 121.006 1.138 . . . . 72.400000000000006 114.952 -169.503 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 1.2 t90 . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 121.967 0.889 . . . . 74.519999999999996 110.931 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -69.78 -31.75 69.85 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.218 -1.355 . . . . 65.230000000000004 109.428 166.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.9 p -80.21 6.28 12.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.921 1.288 . . . . 74.140000000000001 113.048 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.3 -48.16 82.66 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.871 0.468 . . . . 71.400000000000006 110.983 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -71.78 -24.97 61.84 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.217 0.607 . . . . 70.329999999999998 111.172 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 15.6 m120 -88.38 -2.46 58.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.706 0.802 . . . . 54.420000000000002 111.671 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.402 HD13 ' HE1' ' A' ' 146' ' ' TRP . 29.1 tp -61.84 -47.98 82.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.012 0.925 . . . . 65.329999999999998 111.304 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.02 36.1 2.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.142 0.977 . . . . 63.520000000000003 109.87 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 123.529 0.731 . . . . 72.049999999999997 110.938 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.3 p30 . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 112.073 0.397 . . . . 64.230000000000004 112.073 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.1 tp -83.54 120.07 25.48 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.827 -0.805 . . . . 71.239999999999995 108.827 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -109.06 175.2 5.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.33 1.452 . . . . 65.420000000000002 108.717 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.34 135.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.756 1.222 . . . . 44.149999999999999 109.213 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.72 112.98 9.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.98 0.912 . . . . 73.239999999999995 110.404 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.19 -31.55 38.76 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.249 0.62 . . . . 75.049999999999997 111.32 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 55.3 m-85 -126.34 141.71 51.8 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.33 1.052 . . . . 74.030000000000001 108.758 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.96 122.98 27.38 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.83 -0.804 . . . . 72.140000000000001 108.83 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.461 ' HB3' HG12 ' A' ' 101' ' ' ILE . 78.5 t80 -111.66 135.47 52.2 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.524 -0.917 . . . . 71.120000000000005 108.524 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.95 130.17 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.278 -1.379 . . . . 62.100000000000001 107.278 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.96 132.62 53.29 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.119 0.887 . . . . 72.420000000000002 111.669 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -95.34 13.29 26.19 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.34 1.056 . . . . 62.539999999999999 111.189 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.21 -171.65 44.05 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.1 -0.5 . . . . 70.219999999999999 112.014 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -69.93 -41.85 74.06 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.736 0.814 . . . . 74.430000000000007 112.759 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -82.99 -25.92 31.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.951 0.9 . . . . 73.430000000000007 111.522 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -75.72 158.37 32.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.297 0.639 . . . . 74.319999999999993 109.733 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.414 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 53.2 tp -127.82 137.37 52.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.807 0.443 . . . . 70.200000000000003 111.49 -169.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -86.61 118.02 25.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.881 0.872 . . . . 74.420000000000002 110.168 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.629 HG22 HG21 ' A' ' 123' ' ' THR . 31.7 pt -122.12 162.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.812 0.845 . . . . 71.439999999999998 110.349 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -129.16 152.52 48.66 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 72.140000000000001 109.358 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -57.67 136.87 56.89 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.858 0.863 . . . . 72.010000000000005 112.143 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.5 67.77 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 123.586 0.612 . . . . 22.030000000000001 113.993 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.09 130.24 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.284 0.542 . . . . 73.099999999999994 111.237 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.13 123.21 28.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.141 0.977 . . . . 71.420000000000002 109.107 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.791 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -133.69 146.34 50.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.519 0.728 . . . . 72.409999999999997 110.857 -175.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -96.96 112.62 24.29 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.199 0.6 . . . . 71.25 110.447 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.615 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.5 t -79.9 117.33 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.447 0.641 . . . . 65.049999999999997 109.671 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.462 HD12 ' HG3' ' A' ' 120' ' ' GLU . 29.6 mt -89.64 -19.35 24.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.069 1.348 . . . . 71.430000000000007 110.88 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.51 147.42 5.05 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.146 -0.934 . . . . 63.109999999999999 111.375 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.635 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 23.3 m-85 -87.42 178.58 6.78 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.561 0.745 . . . . 74.140000000000001 111.033 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.66 HD21 ' HB2' ' A' ' 117' ' ' GLU . 9.9 p30 -90.54 -174.0 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 70.099999999999994 110.918 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -44.75 -45.31 9.87 Favored 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 126.318 1.847 . . . . 73.340000000000003 114.389 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -115.86 7.81 14.6 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.15 0.58 . . . . 61.5 111.92 174.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.635 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 71.74 30.77 65.7 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 116.939 1.536 . . . . 50.039999999999999 116.939 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.66 ' HB2' HD21 ' A' ' 113' ' ' ASN . 22.4 mt-10 -68.48 -42.96 77.92 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 119.028 1.414 . . . . 61.43 109.972 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.58 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 51.4 m95 -123.05 159.57 28.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 75.099999999999994 110.204 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.615 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.37 138.52 43.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.185 0.994 . . . . 74.109999999999999 110.022 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.1 tp10 -69.36 98.06 1.03 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 106.786 -1.561 . . . . 75.120000000000005 106.786 168.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.91 140.65 38.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.486 0.714 . . . . 73.239999999999995 110.854 -173.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -114.5 107.66 15.81 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.178 -0.919 . . . . 74.329999999999998 108.748 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.791 HG22 ' HB3' ' A' ' 107' ' ' LEU . 72.4 p -116.15 175.52 5.51 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.101 1.361 . . . . 74.0 110.491 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -75.6 -10.4 59.41 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.6 -0.727 . . . . 72.549999999999997 110.466 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -76.93 -22.74 52.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.819 0.848 . . . . 74.530000000000001 110.355 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.78 -160.48 23.24 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 112.233 -0.347 . . . . 31.52 112.233 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -104.09 137.82 41.49 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.983 0.913 . . . . 63.539999999999999 109.625 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 164.46 178.08 37.62 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 121.083 -0.579 . . . . 54.109999999999999 112.971 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -90.24 128.54 36.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.862 0.865 . . . . 71.140000000000001 112.19 -170.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 m -132.17 143.62 49.69 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.137 0.975 . . . . 74.5 108.936 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 6.2 Cg_exo -76.14 146.4 28.68 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 C-N-CA 122.685 2.257 . . . . 65.400000000000006 113.977 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -41.52 -46.92 3.66 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.882 1.673 . . . . 60.210000000000001 113.173 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 9.2 p-10 -75.35 2.52 11.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.661 0.784 . . . . 52.439999999999998 112.871 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.418 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -109.21 -9.63 15.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.681 0.792 . . . . 64.340000000000003 111.507 171.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.2 pt -132.26 175.86 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.904 0.882 . . . . 65.310000000000002 110.782 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 142' ' ' GLU . 9.0 t -162.54 151.7 12.88 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.562 -0.903 . . . . 54.310000000000002 108.562 170.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.7 Cg_endo -60.11 149.56 84.07 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 121.636 1.557 . . . . 72.150000000000006 111.414 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.5 t -73.41 -7.05 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.465 0 CA-C-O 121.617 0.722 . . . . 60.140000000000001 110.119 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -79.49 -8.32 59.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.274 1.03 . . . . 74.450000000000003 112.173 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.2 p -95.6 171.45 8.67 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.499 0.666 . . . . 63.020000000000003 112.612 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.2 mt -85.28 -20.11 30.55 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.806 -1.088 . . . . 74.329999999999998 111.365 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.403 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.6 mp0 -65.82 -21.44 66.48 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.684 0.794 . . . . 73.519999999999996 112.008 -172.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.58 -13.59 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.241 0.616 . . . . 72.319999999999993 112.5 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -90.71 141.75 28.47 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.403 0.681 . . . . 65.549999999999997 109.969 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.6 m -58.5 -39.96 81.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.722 1.209 . . . . 73.109999999999999 112.39 -175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.402 ' HE1' HD13 ' A' ' 73' ' ' LEU . 39.8 p-90 -70.11 -30.51 67.73 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 74.430000000000007 112.811 -175.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -82.55 117.65 22.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.558 -0.534 . . . . 74.209999999999994 109.558 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -112.12 -6.48 14.14 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.272 0.629 . . . . 74.530000000000001 111.681 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.83 -141.22 34.36 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 118.345 -1.253 . . . . 73.239999999999995 112.89 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -59.65 94.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.561 2.841 . . . . 72.319999999999993 113.144 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.652 HG22 HH12 ' A' ' 239' ' ' ARG . 85.6 t -133.93 132.02 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 44.520000000000003 108.905 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.4 p -78.57 173.01 12.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.446 0.699 . . . . 63.210000000000001 110.408 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -60.41 -43.6 96.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.299 0.639 . . . . 75.129999999999995 109.964 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.9 -46.59 88.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.925 0.89 . . . . 61.219999999999999 111.091 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.39 -26.4 63.69 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.028 0.531 . . . . 70.510000000000005 111.441 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.32 62.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.911 0.484 . . . . 51.229999999999997 110.671 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.08 -21.61 61.48 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.764 -0.653 . . . . 61.140000000000001 110.597 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.64 -49.06 72.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.499 0.719 . . . . 72.420000000000002 109.728 170.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.401 HD21 ' HD3' ' A' ' 239' ' ' ARG . 73.9 mt -58.85 -39.22 80.65 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.595 -0.73 . . . . 74.010000000000005 110.947 175.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.8 -3.71 55.8 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.823 1.046 . . . . 63.539999999999999 113.823 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 61.3 p -69.47 -34.21 74.03 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.767 1.167 . . . . 65.420000000000002 110.239 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 p -90.02 9.1 29.3 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.234 1.014 . . . . 70.519999999999996 110.867 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -105.45 156.61 16.61 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 123.996 0.808 . . . . 55.229999999999997 111.723 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 26.8 pt -103.83 -176.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 124.955 1.302 . . . . 62.310000000000002 112.006 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.53 121.25 11.07 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.65 -0.705 . . . . 74.439999999999998 110.02 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.31 10.36 58.36 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 119.394 -0.67 . . . . 63.119999999999997 113.343 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.7 m -86.09 128.71 34.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.713 1.256 . . . . 73.200000000000003 111.148 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 183' ' ' SER . 13.3 p90 -135.52 167.24 21.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.077 0.551 . . . . 71.530000000000001 111.458 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.4 pp -164.22 143.54 7.62 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.008 -0.996 . . . . 73.329999999999998 108.926 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.666 HG22 HG12 ' A' ' 182' ' ' ILE . 90.8 t -98.13 137.86 24.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.439 -0.948 . . . . 72.319999999999993 108.439 167.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.501 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.8 ptt85 -134.3 160.67 37.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.962 1.305 . . . . 70.510000000000005 109.108 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.33 151.42 33.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.977 -1.49 . . . . 62.25 106.977 165.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 t -84.98 123.21 30.27 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.703 -0.851 . . . . 53.439999999999998 108.703 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.59 -35.6 73.11 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.565 -0.531 . . . . 61.5 109.565 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 p -71.64 -34.86 70.14 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.402 -0.817 . . . . 52.43 111.111 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.3 m -124.25 90.66 50.54 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 123.405 0.682 . . . . 62.43 109.943 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.28 127.56 24.43 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.499 2.8 . . . . 75.140000000000001 112.947 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.51 -28.32 15.45 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.915 -0.584 . . . . 75.340000000000003 112.969 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.426 ' HB3' ' NH1' ' A' ' 194' ' ' ARG . 79.2 mm-40 -69.03 115.03 7.86 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.293 -0.632 . . . . 75.299999999999997 109.293 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -119.82 149.22 42.42 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 109.882 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.2 m -148.0 152.12 36.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.806 -1.088 . . . . 64.219999999999999 109.704 -172.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.666 HG12 HG22 ' A' ' 170' ' ' VAL . 23.6 mt -102.47 150.05 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 106.511 -1.663 . . . . 52.530000000000001 106.511 166.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -125.93 107.1 10.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.708 -1.219 . . . . 63.329999999999998 107.708 171.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 168' ' ' PHE . 56.9 tp -107.5 110.91 22.95 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.538 0.608 . . . . 63.5 109.785 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 190' ' ' VAL . 59.1 ttt180 -80.66 121.36 25.76 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.054 0.542 . . . . 71.430000000000007 109.799 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.1 145.73 31.53 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.506 1.522 . . . . 74.549999999999997 107.688 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 57.97 22.39 8.75 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.931 0.892 . . . . 62.43 112.333 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.94 -9.4 72.33 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.333 -0.704 . . . . 72.200000000000003 114.538 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -113.35 150.37 32.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.291 1.045 . . . . 74.129999999999995 109.99 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . 41.8 t -99.08 111.24 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.851 0.46 . . . . 63.509999999999998 110.672 -177.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -93.73 112.22 24.05 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.278 -1.008 . . . . 54.32 108.278 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -89.64 124.49 34.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.714 -0.676 . . . . 75.209999999999994 109.209 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.417 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.0 m-85 -93.65 146.37 23.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.371 -0.974 . . . . 75.239999999999995 108.371 172.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 179' ' ' GLN . 6.8 tpp180 -106.41 120.64 42.42 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.994 -1.113 . . . . 72.099999999999994 107.994 175.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mt -79.03 100.3 3.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.05 -1.092 . . . . 53.25 108.05 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.37 145.34 32.08 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.476 -0.935 . . . . 74.519999999999996 108.476 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.6 m -105.87 136.78 44.9 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.122 0.969 . . . . 75.420000000000002 109.355 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.96 178.23 8.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.073 0.949 . . . . 75.200000000000003 110.15 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 p -65.68 -33.48 75.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.128 0.571 . . . . 75.209999999999994 111.706 -174.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.24 -13.53 28.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.643 0.377 . . . . 71.5 111.086 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 115.57 15.12 7.7 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 115.886 1.115 . . . . 42.0 115.886 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -68.99 141.51 54.89 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.291 1.045 . . . . 74.439999999999998 111.654 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.47 141.58 28.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.66 0.784 . . . . 74.030000000000001 109.153 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.572 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.1 p90 -164.98 148.01 8.39 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.54 0.525 . . . . 64.099999999999994 111.72 175.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.423 HG23 HD11 ' A' ' 217' ' ' LEU . 91.4 t -93.43 -40.36 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.174 -1.047 . . . . 75.340000000000003 108.174 164.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.0 m -99.9 125.13 45.84 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.011 -0.995 . . . . 71.430000000000007 108.831 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -62.81 -28.23 69.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.481 0.712 . . . . 54.140000000000001 111.41 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.87 -25.17 62.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.633 1.173 . . . . 74.129999999999995 110.55 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.5 m -129.45 89.94 2.92 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.58 0.752 . . . . 75.519999999999996 110.328 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.572 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 94.3 mtt180 -103.3 134.31 46.91 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.328 -0.619 . . . . 63.409999999999997 109.328 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -119.38 151.15 38.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.97 0.908 . . . . 74.5 108.602 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -74.04 -28.09 61.25 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.573 0.546 . . . . 74.349999999999994 110.468 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.8 p -132.74 156.01 47.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.876 0.87 . . . . 73.549999999999997 112.144 -177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -69.14 -25.88 64.6 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 114.272 -1.331 . . . . 73.349999999999994 109.427 172.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.14 96.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.4 0.68 . . . . 63.310000000000002 110.675 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.71 -41.88 87.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.47 0.708 . . . . 34.030000000000001 111.336 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.423 HD11 HG23 ' A' ' 205' ' ' VAL . 16.7 tp -52.49 -57.13 10.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 123.52 0.512 . . . . 71.209999999999994 111.157 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.84 -46.39 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.641 0.588 . . . . 72.340000000000003 111.415 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -55.72 -55.68 29.34 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.56 0.744 . . . . 75.310000000000002 111.447 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -67.82 -37.84 82.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.991 -1.004 . . . . 75.409999999999997 110.622 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.631 ' HB3' HD11 ' A' ' 228' ' ' LEU . 15.9 m170 -86.63 -4.41 59.17 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.544 0.572 . . . . 74.400000000000006 112.544 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.7 p -93.95 -35.11 12.8 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.595 0.358 . . . . 73.400000000000006 110.706 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 47.5 p -74.81 -42.13 58.64 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 116.061 -0.518 . . . . 74.040000000000006 111.855 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.76 HG23 ' HB2' ' A' ' 226' ' ' ASP . 31.6 m -128.35 158.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.334 0.654 . . . . 60.43 111.131 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.14 15.34 0.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.46 1.904 . . . . 74.439999999999998 114.027 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.76 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.9 t70 -44.47 33.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 1 C-N-CA 132.556 4.343 . . . . 64.329999999999998 119.386 -153.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.34 -0.82 9.61 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 120.07 -1.644 . . . . 51.009999999999998 112.049 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 221' ' ' HIS . 15.4 mt -92.19 161.65 14.64 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.725 1.21 . . . . 74.349999999999994 109.768 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.9 tt -57.61 -37.01 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 O-C-N 123.419 0.449 . . . . 63.039999999999999 110.673 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -161.5 176.23 11.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.162 0.985 . . . . 65.310000000000002 109.682 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -64.29 145.47 55.96 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.853 0.861 . . . . 72.329999999999998 111.931 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.417 HD21 ' HE1' ' A' ' 193' ' ' TYR . 66.8 mt -75.54 119.48 19.65 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 108.606 -0.887 . . . . 70.109999999999999 108.606 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -113.19 -80.05 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.514 0.597 . . . . 72.430000000000007 112.206 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.7 t80 -87.14 120.0 71.22 Favored Pre-proline 0 C--O 1.208 -1.124 0 C-N-CA 124.266 1.027 . . . . 73.140000000000001 108.438 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.33 136.03 9.79 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 121.632 1.555 . . . . 74.140000000000001 110.947 171.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.87 136.6 96.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 108.9 -0.778 . . . . 70.439999999999998 108.9 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.49 171.94 16.03 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.01 1.807 . . . . 73.439999999999998 112.987 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.521 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 73.7 mmtt -70.33 108.54 4.26 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.053 -1.091 . . . . 72.040000000000006 108.053 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.652 HH12 HG22 ' A' ' 151' ' ' VAL . 15.6 ptt-85 -68.83 -62.92 1.18 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.838 1.051 . . . . 72.209999999999994 113.838 -160.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.434 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 63.1 t30 -110.29 154.58 23.26 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.923 0.889 . . . . 75.450000000000003 109.814 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.21 112.66 27.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 106.188 -1.782 . . . . 64.140000000000001 106.188 158.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.482 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 39.3 Cg_exo -60.52 124.54 15.3 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.752 2.301 . . . . 63.539999999999999 112.965 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 16.6 m -65.46 123.56 19.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.502 0.721 . . . . 34.119999999999997 111.179 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.37 124.5 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 108.356 -0.979 . . . . 74.400000000000006 108.356 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -102.46 114.89 29.48 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.462 0.542 . . . . 75.140000000000001 112.462 -164.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.74 44.08 91.7 Favored Glycine 0 N--CA 1.482 1.712 0 O-C-N 124.046 0.841 . . . . 61.509999999999998 115.124 163.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -103.45 124.36 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 114.228 1.196 . . . . 55.109999999999999 114.228 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.3 t -86.09 119.09 71.48 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 104.057 -2.572 . . . . 63.240000000000002 104.057 143.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--N 1.389 2.692 0 CA-C-N 120.965 1.38 . . . . 74.219999999999999 113.0 -158.707 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.9 t90 . . . . . 0 CA--C 1.543 0.704 0 CA-C-O 121.894 0.855 . . . . 71.540000000000006 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.9 p30 -72.51 -14.84 61.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.158 -0.928 . . . . 73.340000000000003 110.848 174.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.6 p -84.0 4.92 27.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.959 0.904 . . . . 72.200000000000003 112.073 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -67.21 -22.71 65.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.764 0.425 . . . . 73.120000000000005 111.021 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.7 pt-20 -68.49 -39.65 81.22 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.161 0.505 . . . . 53.210000000000001 109.837 168.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 8.8 m120 -75.2 -10.24 59.29 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.198 -0.91 . . . . 63.240000000000002 110.972 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.28 -50.93 69.75 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.045 0.938 . . . . 72.319999999999993 110.572 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.62 23.79 13.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.369 0.668 . . . . 74.140000000000001 110.639 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 122.842 0.457 . . . . 73.340000000000003 111.355 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 112.055 0.391 . . . . 75.140000000000001 112.055 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.414 HD21 ' HD3' ' A' ' 106' ' ' LYS . 30.5 tp -81.85 128.13 33.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.22 -0.659 . . . . 75.0 109.22 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -111.66 172.96 6.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.819 1.247 . . . . 73.530000000000001 108.684 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.75 138.21 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.279 1.032 . . . . 62.030000000000001 109.434 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.87 131.28 41.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 63.109999999999999 110.336 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.497 HD13 ' NZ ' ' A' ' 238' ' ' LYS . 77.5 mt -98.7 -26.56 14.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 65.109999999999999 111.329 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.424 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 48.6 m-85 -125.53 148.66 48.82 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.966 0.906 . . . . 74.340000000000003 108.739 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.2 136.33 46.37 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.61 -0.885 . . . . 74.230000000000004 108.61 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HB3' HG12 ' A' ' 101' ' ' ILE . 82.3 t80 -129.79 133.36 46.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.534 -1.284 . . . . 63.43 107.534 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -103.65 137.14 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 107.248 -1.39 . . . . 34.420000000000002 107.248 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.28 114.23 3.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.242 0.617 . . . . 74.040000000000006 110.942 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -86.91 -51.44 6.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.852 0.861 . . . . 63.43 109.64 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.92 -177.14 38.04 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 115.279 -0.873 . . . . 71.019999999999996 112.261 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.62 -32.88 60.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.772 0.829 . . . . 71.099999999999994 111.645 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.462 HD21 ' HG2' ' A' ' 249' ' ' PRO . 29.3 p-10 -92.32 -20.43 21.1 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.034 0.534 . . . . 71.129999999999995 111.689 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 78.0 p -71.1 154.16 41.97 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.549 0.53 . . . . 75.319999999999993 109.834 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 128' ' ' GLY . 49.5 tp -128.28 124.36 36.4 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.731 0.412 . . . . 55.240000000000002 111.417 -164.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 m -68.36 117.71 10.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.566 0.746 . . . . 74.349999999999994 110.848 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -119.24 154.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.475 0.71 . . . . 65.25 111.739 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 21.6 m -99.18 147.87 24.67 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.333 -1.303 . . . . 74.200000000000003 109.108 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.93 125.77 26.45 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.74 -0.467 . . . . 74.340000000000003 109.74 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.0 1.66 79.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 116.1 -0.5 . . . . 54.229999999999997 113.278 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 80.9 tt0 -84.9 121.24 27.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.381 0.59 . . . . 74.329999999999998 110.071 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.414 ' HD3' HD21 ' A' ' 84' ' ' LEU . 56.8 mttp -73.87 142.82 46.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.379 0.672 . . . . 74.120000000000005 110.155 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.33 150.01 32.85 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.452 1.101 . . . . 73.319999999999993 110.142 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -100.15 108.36 20.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.039 -0.726 . . . . 65.209999999999994 109.039 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.489 HG13 ' HB1' ' A' ' 119' ' ' ALA . 69.7 t -74.84 119.99 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.174 -0.676 . . . . 63.340000000000003 109.174 174.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.712 HD11 ' HG3' ' A' ' 122' ' ' GLN . 14.2 mt -82.07 -54.08 5.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.267 -1.333 . . . . 63.539999999999999 108.019 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.38 152.92 22.68 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.886 -1.052 . . . . 74.510000000000005 112.978 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.781 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 44.9 m-85 -89.29 174.72 7.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.903 0.881 . . . . 62.340000000000003 111.609 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.35 -173.59 4.8 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.13 0.972 . . . . 75.030000000000001 110.389 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -50.7 -39.47 51.43 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 113.741 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -111.16 2.08 17.62 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.453 0.701 . . . . 51.409999999999997 111.563 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.781 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.18 30.35 73.71 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.421 0.928 . . . . 65.340000000000003 115.421 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.48 -27.49 14.86 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.81 0.805 . . . . 75.319999999999993 110.889 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 28.2 m95 -114.38 152.18 31.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.317 1.047 . . . . 63.43 109.81 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.489 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.22 148.21 46.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.262 0.625 . . . . 55.140000000000001 111.26 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -96.64 118.86 34.03 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.434 -1.321 . . . . 73.209999999999994 107.434 166.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -132.8 151.12 52.07 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.141 0.976 . . . . 64.439999999999998 111.026 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.712 ' HG3' HD11 ' A' ' 110' ' ' LEU . 98.4 mt-30 -100.58 105.23 16.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.828 0.851 . . . . 75.099999999999994 109.243 175.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 107' ' ' LEU . 40.9 p -98.4 176.5 5.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.743 1.217 . . . . 73.340000000000003 110.649 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -64.76 -20.32 66.29 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.588 -0.733 . . . . 70.010000000000005 110.728 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -80.49 -32.1 37.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.882 0.873 . . . . 63.240000000000002 111.185 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 144.73 -168.78 26.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.829 -0.428 . . . . 51.100000000000001 112.153 -171.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -104.32 132.25 50.77 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.268 0.627 . . . . 63.5 110.414 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.47 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 177.83 -165.49 35.12 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 111.775 -0.53 . . . . 72.129999999999995 111.775 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -100.12 121.75 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.598 0.962 . . . . 72.549999999999997 113.598 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 101' ' ' ILE . 18.1 m -132.69 136.76 28.36 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.246 1.418 . . . . 53.530000000000001 108.487 170.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 81.8 Cg_endo -85.45 155.21 10.65 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 122.074 1.85 . . . . 72.120000000000005 114.887 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -38.77 -47.23 1.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 126.199 1.8 . . . . 74.430000000000007 114.443 173.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -77.58 0.02 24.65 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.794 0.838 . . . . 72.129999999999995 112.665 -172.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 12.1 m-85 -105.6 -18.54 14.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.16 0.984 . . . . 74.25 111.459 171.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 109' ' ' VAL . 12.7 pt -123.97 175.67 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.889 0.876 . . . . 61.329999999999998 111.672 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 142' ' ' GLU . 12.0 t -161.41 150.82 13.69 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 123.797 0.839 . . . . 72.409999999999997 109.818 172.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.26 145.48 96.07 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.667 1.578 . . . . 73.349999999999994 111.853 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 41.7 t -73.78 -4.63 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 124.018 0.927 . . . . 73.420000000000002 110.797 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -91.26 -18.61 24.11 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 62.43 111.905 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 99.6 p -91.71 179.09 5.73 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.866 0.467 . . . . 61.210000000000001 111.607 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.0 mt -84.45 -22.75 30.22 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.812 0.845 . . . . 71.109999999999999 111.665 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.402 ' HB2' ' OG1' ' A' ' 136' ' ' THR . 2.0 mp0 -66.97 -17.98 65.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.508 0.723 . . . . 72.310000000000002 112.173 -171.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -64.09 -13.56 48.43 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.272 0.629 . . . . 72.329999999999998 112.104 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -97.53 148.58 23.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.163 0.985 . . . . 73.400000000000006 109.859 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.2 p -64.98 -41.41 95.45 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.094 0.871 . . . . 72.209999999999994 111.582 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -60.92 -38.44 85.78 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.023 0.749 . . . . 54.420000000000002 113.023 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.93 100.51 11.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.529 -0.915 . . . . 74.430000000000007 108.529 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.479 ' HB2' HG21 ' A' ' 151' ' ' VAL . 77.1 m80 -96.41 8.78 43.17 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.277 0.473 . . . . 74.549999999999997 112.277 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.459 ' O ' HG23 ' A' ' 151' ' ' VAL . . . 69.27 -145.54 42.83 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 118.631 -1.094 . . . . 74.299999999999997 112.498 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.92 106.17 0.91 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.801 2.334 . . . . 51.420000000000002 111.963 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.634 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 14.5 t -123.12 131.96 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.642 0.777 . . . . 75.109999999999999 110.236 -177.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 151' ' ' VAL . 66.2 p -77.83 152.75 33.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.827 -0.805 . . . . 74.219999999999999 108.827 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -55.81 -38.63 70.23 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.124 0.416 . . . . 73.219999999999999 112.124 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -58.08 -45.21 87.53 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.966 0.791 . . . . 74.129999999999995 111.138 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.82 75.75 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.677 -0.692 . . . . 55.030000000000001 111.179 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.15 68.95 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.463 0.649 . . . . 72.200000000000003 111.524 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -75.83 -19.72 58.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.306 0.642 . . . . 52.539999999999999 110.926 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -67.21 -44.3 79.92 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.653 0.781 . . . . 73.519999999999996 110.28 168.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.648 HD21 ' HB3' ' A' ' 239' ' ' ARG . 53.5 mt -60.19 -38.08 82.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.34 0.656 . . . . 74.310000000000002 111.187 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.98 20.72 10.74 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.464 -0.789 . . . . 74.010000000000005 112.321 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.0 p -66.35 -40.96 90.15 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.926 0.393 . . . . 65.439999999999998 110.977 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.4 p -104.96 14.61 29.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.277 1.031 . . . . 73.209999999999994 111.399 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.63 163.91 50.25 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 114.404 0.522 . . . . 53.210000000000001 114.404 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 17.9 pt -109.18 -175.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.618 1.167 . . . . 74.150000000000006 111.223 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 4.5 m-20 -56.64 123.81 16.16 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.295 -0.866 . . . . 72.519999999999996 110.432 171.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.454 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 88.01 10.98 68.3 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.755 -0.657 . . . . 54.409999999999997 113.393 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.7 m -81.0 118.13 22.21 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.434 1.117 . . . . 72.340000000000003 110.296 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.512 ' HB3' HD13 ' A' ' 184' ' ' LEU . 13.7 p90 -129.6 171.45 12.6 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.391 0.615 . . . . 74.230000000000004 112.557 -168.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.74 146.7 6.93 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 113.884 -1.507 . . . . 73.109999999999999 109.336 171.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.697 HG22 HG12 ' A' ' 182' ' ' ILE . 93.7 t -100.39 131.87 47.09 Favored 'Isoleucine or valine' 0 C--O 1.261 1.659 0 N-CA-C 108.567 -0.901 . . . . 64.239999999999995 108.567 167.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.634 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt85 -116.5 133.83 55.56 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.645 -1.161 . . . . 72.200000000000003 109.115 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.6 tp10 -84.95 145.72 27.61 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.4 1.08 . . . . 71.340000000000003 108.2 166.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.5 t -83.02 126.69 32.82 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.339 -0.615 . . . . 61.119999999999997 109.339 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.47 -40.99 93.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.028 0.531 . . . . 71.239999999999995 109.929 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.8 p -70.09 -25.76 63.66 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 50.130000000000003 111.307 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 66.5 m -145.43 91.88 5.69 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 122.678 0.391 . . . . 73.230000000000004 111.68 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.79 136.18 68.59 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.44 2.093 . . . . 45.210000000000001 111.625 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.23 -24.7 31.2 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 112.127 -173.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -95.78 114.76 26.52 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.743 -0.836 . . . . 71.129999999999995 108.743 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.635 HH11 HD12 ' A' ' 214' ' ' LEU . 94.4 mtt180 -131.29 157.15 44.07 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.221 0.608 . . . . 64.439999999999998 110.947 -171.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.5 m -145.36 147.85 32.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.636 0.774 . . . . 74.299999999999997 109.227 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.697 HG12 HG22 ' A' ' 170' ' ' VAL . 24.6 mt -103.96 125.84 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.923 -0.769 . . . . 75.200000000000003 108.923 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 14.5 m -96.72 110.21 22.7 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.691 -1.226 . . . . 63.439999999999998 107.691 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 168' ' ' PHE . 54.8 tp -116.54 111.79 20.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.22 1.008 . . . . 71.5 109.739 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -81.59 127.69 33.14 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.178 0.991 . . . . 73.329999999999998 111.087 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 88.5 t80 -143.03 136.76 28.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.258 1.423 . . . . 72.109999999999999 107.947 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 53.78 29.18 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.208 1.003 . . . . 75.25 112.499 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.34 -12.6 64.28 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.035 -0.869 . . . . 73.099999999999994 114.669 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -97.81 146.43 25.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.212 1.006 . . . . 65.329999999999998 109.608 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.99 112.69 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 122.572 0.349 . . . . 71.319999999999993 110.1 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -97.94 143.87 28.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.716 1.207 . . . . 74.450000000000003 109.11 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -130.13 118.29 21.24 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.354 0.524 . . . . 72.430000000000007 110.227 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.584 ' CE1' HD22 ' A' ' 228' ' ' LEU . 0.6 OUTLIER -121.24 131.72 54.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.497 0.719 . . . . 75.109999999999999 111.045 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 21.4 tpp85 -70.72 131.27 43.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.428 1.091 . . . . 70.25 111.519 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.58 104.95 11.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.184 -1.043 . . . . 61.299999999999997 108.184 166.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -78.35 138.05 38.35 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.908 -0.775 . . . . 43.109999999999999 108.908 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -111.05 117.25 32.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.66 -0.867 . . . . 71.400000000000006 108.66 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.66 171.49 11.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.537 0.735 . . . . 74.049999999999997 111.258 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 12.8 p -64.52 -26.62 68.5 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.928 0.891 . . . . 74.230000000000004 112.639 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -81.75 -14.47 56.41 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.567 0.747 . . . . 74.140000000000001 111.828 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.44 11.19 39.33 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 119.802 -0.443 . . . . 72.310000000000002 113.432 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.403 ' HE2' ' OD1' ' A' ' 212' ' ' ASN . 98.2 mttt -79.39 132.61 36.45 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 116.901 0.35 . . . . 75.209999999999994 110.922 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.24 146.92 26.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.537 -0.912 . . . . 73.340000000000003 108.537 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.2 p90 -170.27 142.77 2.26 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.379 0.425 . . . . 75.209999999999994 111.128 176.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -89.49 -35.85 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.469 -0.937 . . . . 72.549999999999997 108.469 163.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.6 m -105.5 124.34 49.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.062 0.945 . . . . 73.409999999999997 109.474 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.4 t -65.03 -21.9 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.367 0.667 . . . . 64.209999999999994 111.435 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -66.18 -26.6 67.48 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.275 1.43 . . . . 64.310000000000002 111.459 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.3 m -144.22 106.67 4.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.192 0.597 . . . . 51.43 110.248 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 84.5 mtt180 -104.23 143.37 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.347 1.059 . . . . 55.229999999999997 109.206 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.641 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 6.3 m-85 -125.84 136.34 52.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.05 0.54 . . . . 71.040000000000006 110.073 -167.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.403 ' OD1' ' HE2' ' A' ' 202' ' ' LYS . 78.8 m-20 -57.51 -34.34 68.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.956 0.902 . . . . 71.430000000000007 111.031 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.3 p -131.2 154.4 48.45 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 122.016 0.912 . . . . 71.150000000000006 111.582 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.635 HD12 HH11 ' A' ' 180' ' ' ARG . 0.8 OUTLIER -62.65 -23.98 67.38 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.008 -1.451 . . . . 64.340000000000003 109.309 170.059 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.92 94.21 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.753 0.821 . . . . 55.210000000000001 111.005 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 53.9 mt-10 -72.92 -35.01 66.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.999 0.519 . . . . 60.329999999999998 111.021 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.35 -57.31 11.75 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.414 0.446 . . . . 74.319999999999993 110.053 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.88 -37.72 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 123.839 0.712 . . . . 64.239999999999995 111.54 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -63.32 -59.22 5.0 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.081 0.238 . . . . 74.239999999999995 111.572 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -63.47 -33.02 74.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.352 0.408 . . . . 73.129999999999995 110.942 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.645 ' HB3' HD11 ' A' ' 228' ' ' LEU . 16.5 m170 -88.96 -7.19 56.5 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.433 0.531 . . . . 63.329999999999998 112.433 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -88.23 -35.77 17.13 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.199 0.454 . . . . 70.400000000000006 110.273 168.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 54.0 p -68.98 -47.45 65.57 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.503 -0.771 . . . . 25.41 110.765 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -131.67 164.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.835 0.826 . . . . 63.299999999999997 112.445 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.33 13.87 1.08 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.864 2.066 . . . . 54.43 114.69 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.549 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.5 t70 -42.18 30.57 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 131.56 3.944 . . . . 64.439999999999998 119.409 -152.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.37 1.49 9.26 Favored Glycine 0 N--CA 1.486 2.031 0 O-C-N 120.065 -1.647 . . . . 61.210000000000001 112.354 -170.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 221' ' ' HIS . 9.6 mt -91.87 163.97 13.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.174 1.389 . . . . 73.340000000000003 108.839 169.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 11.4 tt -61.57 -35.98 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-O 120.67 0.271 . . . . 61.140000000000001 110.808 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -157.48 -179.07 7.82 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.513 0.725 . . . . 71.420000000000002 110.322 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.8 p -67.32 146.94 53.59 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.748 0.819 . . . . 72.0 111.68 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 80.8 mt -79.03 92.44 4.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 108.874 -0.788 . . . . 74.420000000000002 108.874 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -88.93 -65.1 1.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.686 0.795 . . . . 74.420000000000002 112.231 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -108.75 120.9 44.79 Favored Pre-proline 0 C--O 1.216 -0.68 0 C-N-CA 124.749 1.22 . . . . 74.439999999999998 109.451 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.51 129.96 4.39 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.009 1.806 . . . . 73.439999999999998 111.965 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -69.22 135.71 89.09 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.058 0.543 . . . . 64.450000000000003 110.664 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 10.6 Cg_exo -72.27 172.74 14.26 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.825 2.35 . . . . 75.109999999999999 111.999 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.497 ' NZ ' HD13 ' A' ' 88' ' ' LEU . 33.7 mmtp -71.27 145.59 49.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.02 0.528 . . . . 72.430000000000007 111.478 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.648 ' HB3' HD21 ' A' ' 159' ' ' LEU . 20.8 ptt-85 -82.68 -63.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.248 0.833 . . . . 71.140000000000001 113.248 -163.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.533 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.0 t30 -113.39 130.51 56.28 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.015 0.926 . . . . 73.230000000000004 110.707 -174.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.73 113.41 32.12 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 107.484 -1.302 . . . . 73.439999999999998 107.484 164.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.65 124.44 13.68 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.892 2.394 . . . . 65.400000000000006 113.556 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 88.2 m -76.9 123.4 26.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.983 -0.747 . . . . 75.439999999999998 108.983 173.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.411 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 47.9 t -92.58 114.54 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.384 -0.969 . . . . 71.420000000000002 108.384 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -95.2 112.33 24.05 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.565 -0.255 . . . . 75.209999999999994 111.306 -167.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.68 5.92 2.23 Favored Glycine 0 CA--C 1.542 1.773 0 N-CA-C 118.28 2.072 . . . . 53.310000000000002 118.28 161.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.43 143.81 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.63 1.715 . . . . 65.030000000000001 111.615 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.6 t -77.54 128.91 78.7 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.592 -1.262 . . . . 62.119999999999997 107.592 167.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.462 ' HG2' HD21 ' A' ' 97' ' ' ASN . 78.5 Cg_exo . . . . . 0 C--N 1.385 2.483 0 C-N-CA 122.703 2.269 . . . . 74.340000000000003 113.737 -167.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.9 t90 . . . . . 0 C--O 1.242 0.678 0 N-CA-C 108.932 -0.766 . . . . 73.329999999999998 108.932 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -65.93 -25.13 67.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.853 -1.067 . . . . 63.009999999999998 110.419 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.5 m -75.3 4.45 7.11 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.967 1.307 . . . . 74.5 113.155 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -69.99 -33.82 72.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.332 0.515 . . . . 73.439999999999998 110.902 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.75 -36.12 43.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.947 0.499 . . . . 63.420000000000002 110.126 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -74.03 -7.28 51.89 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.626 0.77 . . . . 52.439999999999998 111.523 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.75 -23.95 67.57 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.63 1.172 . . . . 74.129999999999995 111.322 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.55 14.3 20.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.927 0.891 . . . . 61.020000000000003 110.968 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.156 0.582 . . . . 73.019999999999996 111.307 177.691 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 CA--C 1.565 1.528 0 CA-C-O 121.59 0.709 . . . . 72.340000000000003 111.156 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.547 HD21 ' HD3' ' A' ' 106' ' ' LYS . 36.4 tp -85.07 131.41 34.46 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.368 -0.833 . . . . 74.299999999999997 110.339 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.0 m-85 -111.24 172.64 6.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.507 1.123 . . . . 71.420000000000002 108.443 173.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.41 137.22 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.215 1.006 . . . . 73.519999999999996 109.376 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.75 122.17 21.97 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.515 0.726 . . . . 74.349999999999994 110.8 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.4 mt -76.69 -35.87 57.6 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.708 0.803 . . . . 72.519999999999996 110.811 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.452 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 20.1 m-85 -124.31 168.21 13.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.2 -0.909 . . . . 72.030000000000001 109.888 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.65 117.71 24.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.207 -1.035 . . . . 75.150000000000006 108.207 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.662 ' HB3' HG12 ' A' ' 101' ' ' ILE . 61.3 t80 -106.46 131.55 53.51 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.374 -1.343 . . . . 64.420000000000002 107.374 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.14 133.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.871 -0.788 . . . . 65.109999999999999 108.871 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.33 123.2 20.56 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.279 0.631 . . . . 44.409999999999997 109.871 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 p -86.23 -16.31 38.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.601 0.76 . . . . 65.099999999999994 110.997 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -158.83 -173.7 27.58 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.621 -0.718 . . . . 75.400000000000006 111.483 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -69.46 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.964 0.905 . . . . 63.030000000000001 111.669 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -73.68 -27.5 61.26 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.58 1.152 . . . . 71.129999999999995 112.131 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.2 p -93.36 169.11 10.62 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.723 0.809 . . . . 65.409999999999997 109.744 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 65.6 tp -136.06 128.8 30.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.696 0.398 . . . . 72.209999999999994 111.424 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 m -72.79 116.61 13.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.708 HG22 HG21 ' A' ' 123' ' ' THR . 27.1 pt -120.72 149.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.356 0.662 . . . . 71.349999999999994 110.04 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.4 m -102.12 142.2 33.75 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.306 -0.861 . . . . 63.130000000000003 110.256 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -59.2 114.45 2.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.735 0.814 . . . . 50.310000000000002 110.291 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.83 0.12 39.2 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.688 -0.687 . . . . 72.430000000000007 112.78 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.17 121.16 27.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.287 0.544 . . . . 44.450000000000003 111.294 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HD3' HD21 ' A' ' 84' ' ' LEU . 62.7 mttp -70.83 130.39 41.56 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.797 0.839 . . . . 74.219999999999999 109.009 169.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.739 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.14 138.38 31.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.392 0.677 . . . . 74.409999999999997 110.464 -176.293 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 40.9 ttm180 -89.49 108.56 19.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.928 0.491 . . . . 64.140000000000001 110.068 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.663 HG13 ' HB1' ' A' ' 119' ' ' ALA . 4.6 t -78.61 117.88 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.347 0.659 . . . . 63.119999999999997 110.099 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.3 mt -90.3 -49.12 6.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.101 0.96 . . . . 73.230000000000004 110.229 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.67 144.56 9.47 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 115.38 -0.827 . . . . 71.450000000000003 111.606 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 25.0 m-85 -87.86 168.77 12.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.655 0.782 . . . . 74.540000000000006 111.252 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -88.71 -172.19 3.62 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.681 -1.145 . . . . 73.150000000000006 110.982 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -41.95 -44.72 3.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.838 1.655 . . . . 73.109999999999999 114.506 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -114.34 6.42 16.07 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.174 0.805 . . . . 73.310000000000002 113.174 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.56 16.14 80.59 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.252 -0.749 . . . . 54.530000000000001 114.711 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.77 -66.85 0.81 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.92 0.86 . . . . 74.299999999999997 109.668 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -90.68 131.91 36.1 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.926 0.49 . . . . 70.319999999999993 111.187 -168.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.663 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -124.5 139.14 54.16 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.208 1.003 . . . . 62.520000000000003 109.7 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.44 110.41 7.7 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.115 -1.069 . . . . 74.209999999999994 108.115 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -101.61 143.78 31.15 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.591 0.756 . . . . 74.450000000000003 109.513 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 35.4 tt0 -102.66 104.5 14.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.138 -1.392 . . . . 74.430000000000007 107.504 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.739 HG22 ' HB3' ' A' ' 107' ' ' LEU . 58.7 p -112.17 166.83 10.91 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.282 1.033 . . . . 75.329999999999998 110.391 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -72.51 -17.49 61.73 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.796 -1.093 . . . . 72.409999999999997 109.536 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -75.23 -27.44 59.51 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.632 1.173 . . . . 75.510000000000005 111.088 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.16 -155.06 25.37 Favored Glycine 0 C--N 1.358 1.799 0 CA-C-O 120.246 -0.197 . . . . 75.540000000000006 112.969 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -116.29 137.66 51.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.425 0.613 . . . . 72.319999999999993 110.516 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 161.98 170.87 27.33 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 120.249 -0.976 . . . . 74.319999999999993 114.215 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -87.49 129.87 34.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.418 0.687 . . . . 64.040000000000006 111.783 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -137.68 145.2 47.75 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 74.310000000000002 109.106 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.47 151.81 7.75 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 122.402 2.068 . . . . 52.32 114.917 -170.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.0 m -40.47 -30.79 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.133 2.173 . . . . 74.400000000000006 114.69 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.523 HD21 HG22 ' A' ' 244' ' ' VAL . 29.6 p30 -78.97 -27.02 43.42 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.111 0.565 . . . . 74.120000000000005 112.191 -175.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.452 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -91.4 -16.23 27.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.542 0.737 . . . . 75.010000000000005 112.05 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.6 pt -122.8 176.32 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.724 0.81 . . . . 72.510000000000005 111.122 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.0 m -160.03 136.67 6.54 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.649 1.18 . . . . 63.119999999999997 109.083 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 29.1 Cg_endo -59.98 134.9 59.42 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 121.942 1.762 . . . . 72.450000000000003 111.488 173.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.04 -7.33 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.557 0.743 . . . . 35.329999999999998 110.637 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -75.93 -23.44 55.45 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.292 0.637 . . . . 72.150000000000006 111.811 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.3 p -94.59 173.92 7.37 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.173 0.511 . . . . 74.239999999999995 111.91 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 mt -82.79 -19.51 37.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.341 1.056 . . . . 73.209999999999994 111.37 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.66 -18.89 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.207 1.003 . . . . 65.310000000000002 112.19 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -62.58 -25.55 68.13 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.174 0.589 . . . . 72.030000000000001 111.772 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -78.04 136.97 38.02 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.504 -0.771 . . . . 73.510000000000005 110.226 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 m -57.36 -36.58 71.38 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.212 1.005 . . . . 75.239999999999995 112.311 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -67.72 -28.8 67.97 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.917 0.761 . . . . 70.439999999999998 112.621 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.411 ' O ' ' HE2' ' A' ' 238' ' ' LYS . 20.9 t80 -89.14 98.59 11.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.774 -0.824 . . . . 65.140000000000001 108.774 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.541 ' HB2' HG21 ' A' ' 151' ' ' VAL . 65.8 m80 -91.69 -9.04 45.3 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.752 0.421 . . . . 74.439999999999998 111.788 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 150' ' ' PRO . . . 75.04 -126.91 9.02 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 118.317 -1.269 . . . . 44.329999999999998 113.175 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 149' ' ' GLY . 10.1 Cg_exo -69.24 88.31 0.48 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 123.25 2.633 . . . . 60.32 112.185 -175.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 43.4 t -126.95 133.46 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.946 0.898 . . . . 74.430000000000007 109.494 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 p -86.46 171.1 11.36 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.025 0.93 . . . . 72.099999999999994 109.808 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -62.16 -42.31 99.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 110.002 -0.37 . . . . 72.439999999999998 110.002 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.27 -48.26 76.94 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.235 0.959 . . . . 73.409999999999997 110.867 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.3 69.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.236 0.614 . . . . 71.340000000000003 111.735 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.39 75.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 63.450000000000003 111.311 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.97 -20.98 47.81 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.544 -0.753 . . . . 71.230000000000004 110.677 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -37.12 81.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.111 0.964 . . . . 71.0 110.084 170.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 239' ' ' ARG . 67.4 mt -68.97 -51.69 36.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.99 0.516 . . . . 75.530000000000001 110.673 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.464 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 80.7 mt -83.75 11.95 6.69 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.563 0.579 . . . . 64.409999999999997 112.563 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.7 p -62.05 -37.47 85.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.904 0.482 . . . . 75.519999999999996 111.663 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.5 m -111.28 18.62 19.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.678 0.791 . . . . 74.420000000000002 110.739 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 152.06 41.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 112.818 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.8 pt -87.74 -177.67 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.313 0.645 . . . . 53.340000000000003 110.533 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -62.48 125.68 24.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.899 -0.591 . . . . 61.329999999999998 110.472 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 233' ' ' HIS . . . 84.22 10.92 79.45 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.05 -0.977 . . . . 44.530000000000001 113.29 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.6 m -67.67 139.16 56.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.272 1.036 . . . . 63.229999999999997 109.703 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.474 ' HB3' HD12 ' A' ' 184' ' ' LEU . 18.1 p90 -149.17 166.49 28.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.804 0.729 . . . . 73.549999999999997 111.76 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.1 pp -161.84 135.6 6.53 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.841 -1.072 . . . . 75.099999999999994 109.724 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.668 HG22 HG12 ' A' ' 182' ' ' ILE . 74.5 t -91.66 141.55 14.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 N-CA-C 108.3 -1.0 . . . . 75.129999999999995 108.3 167.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.568 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 46.0 ptt85 -144.95 153.38 41.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.242 -0.89 . . . . 71.200000000000003 109.983 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -115.2 148.45 39.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.224 1.009 . . . . 70.319999999999993 108.393 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.8 t -78.67 125.4 29.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.07 0.548 . . . . 74.25 110.103 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.12 -41.77 88.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.172 0.989 . . . . 71.5 110.489 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 57.8 p -80.53 -25.17 38.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.496 0.718 . . . . 71.549999999999997 111.806 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.7 m -124.6 95.63 42.47 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.511 0.724 . . . . 72.519999999999996 110.668 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.81 139.61 81.09 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.211 2.608 . . . . 74.25 112.215 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.64 -28.38 4.9 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.279 -0.419 . . . . 71.450000000000003 113.06 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -75.67 116.18 16.11 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 117.062 0.431 . . . . 50.409999999999997 110.345 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.667 HH11 HD12 ' A' ' 214' ' ' LEU . 89.5 mtt180 -126.12 150.75 48.01 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.087 0.955 . . . . 72.299999999999997 109.281 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.4 m -149.41 153.75 37.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.098 0.959 . . . . 63.420000000000002 109.494 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.668 HG12 HG22 ' A' ' 170' ' ' VAL . 26.7 mt -110.9 149.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.107 -1.071 . . . . 71.510000000000005 108.107 172.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 55.0 m -121.75 115.4 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.34 -1.355 . . . . 41.030000000000001 107.34 169.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 168' ' ' PHE . 14.7 tp -108.45 112.76 25.33 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.569 0.622 . . . . 73.140000000000001 109.956 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 23.3 ttt180 -81.68 112.02 18.48 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 109.752 -0.462 . . . . 65.439999999999998 109.752 165.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -136.36 143.96 44.35 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 106.85 -1.537 . . . . 74.230000000000004 106.85 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 61.38 21.21 11.8 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.178 0.991 . . . . 74.439999999999998 111.815 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.07 1.35 68.22 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.976 -0.347 . . . . 71.019999999999996 113.759 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 71.6 mtp180 -105.66 139.31 40.45 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.683 1.193 . . . . 62.439999999999998 109.251 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.9 t -100.13 105.61 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.051 0.453 . . . . 62.210000000000001 110.147 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -90.98 120.15 31.74 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.862 1.265 . . . . 74.219999999999999 109.229 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -95.32 120.69 36.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.62 0.368 . . . . 70.120000000000005 110.462 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -96.95 147.28 24.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.739 1.215 . . . . 65.239999999999995 109.854 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 19.7 tpp180 -101.84 113.17 26.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.323 0.649 . . . . 72.310000000000002 109.277 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.1 mt -82.63 102.12 8.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.828 -1.175 . . . . 41.32 107.828 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -78.34 107.86 11.27 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.799 -1.091 . . . . 60.450000000000003 108.513 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.8 m -79.44 109.11 13.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.301 -1.0 . . . . 74.239999999999995 108.301 170.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.64 167.7 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.383 0.673 . . . . 64.209999999999994 110.731 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 21.7 p -60.83 -26.3 67.25 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.27 1.028 . . . . 62.109999999999999 113.186 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -94.29 -18.08 22.0 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.482 0.713 . . . . 63.420000000000002 111.502 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.5 10.78 16.39 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-O 119.535 -0.591 . . . . 61.539999999999999 113.662 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.631 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 96.3 mttt -76.68 127.26 32.45 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.643 0.721 . . . . 72.349999999999994 110.239 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.24 145.53 24.93 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.679 -0.86 . . . . 74.230000000000004 108.679 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.596 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 43.8 p90 -163.36 129.81 3.3 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.421 0.45 . . . . 62.149999999999999 111.162 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 60.1 t -72.87 -41.79 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.807 -0.812 . . . . 74.200000000000003 108.807 164.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.403 ' OG ' ' HA3' ' A' ' 227' ' ' GLY . 13.4 m -107.48 129.24 54.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.73 -1.123 . . . . 52.100000000000001 110.049 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.1 t -61.58 -26.88 68.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.54 0.736 . . . . 72.219999999999999 111.654 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -70.39 -27.91 64.68 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.764 1.225 . . . . 75.420000000000002 110.873 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.8 m -134.13 100.35 4.68 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.38 0.672 . . . . 51.049999999999997 109.766 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.596 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 58.2 mtt180 -105.93 128.72 53.98 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.97 0.908 . . . . 75.040000000000006 108.801 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.524 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 7.2 m-85 -115.13 139.68 49.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.698 0.799 . . . . 74.049999999999997 109.921 -167.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.631 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 6.7 m-80 -67.03 -31.28 71.71 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.167 0.917 . . . . 73.129999999999995 110.267 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.7 p -132.29 156.66 46.16 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.155 0.982 . . . . 74.140000000000001 111.497 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.667 HD12 HH11 ' A' ' 180' ' ' ARG . 0.7 OUTLIER -66.77 -24.37 66.19 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 114.916 -1.038 . . . . 73.430000000000007 109.772 173.023 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.39 79.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.621 0.768 . . . . 54.310000000000002 110.496 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 35.5 mt-10 -70.25 -36.93 74.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.059 0.943 . . . . 73.099999999999994 111.536 177.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.411 HD11 HG23 ' A' ' 205' ' ' VAL . 12.6 tp -54.91 -61.3 2.4 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.508 0.505 . . . . 75.099999999999994 110.956 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.2 -38.93 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.827 0.451 . . . . 73.519999999999996 111.093 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -61.51 -57.08 13.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.811 0.445 . . . . 70.409999999999997 111.146 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -67.88 -29.74 68.93 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.243 -0.435 . . . . 65.439999999999998 111.016 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.654 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.9 m170 -87.6 -11.51 48.39 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.26 0.467 . . . . 71.420000000000002 112.26 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.4 p -93.78 -27.14 16.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.742 0.417 . . . . 52.240000000000002 110.967 173.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.6 p -77.81 -48.25 16.98 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.831 -0.622 . . . . 75.209999999999994 110.535 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 226' ' ' ASP . 15.8 m -129.77 163.89 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.566 0.698 . . . . 70.150000000000006 111.797 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.21 16.65 0.23 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 127.373 2.269 . . . . 45.439999999999998 114.236 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.656 ' HB2' HG23 ' A' ' 224' ' ' VAL . 36.1 t70 -43.84 33.81 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.606 1 C-N-CA 132.645 4.378 . . . . 54.350000000000001 119.231 -159.011 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.403 ' HA3' ' OG ' ' A' ' 206' ' ' SER . . . 122.41 -0.9 10.43 Favored Glycine 0 N--CA 1.474 1.199 0 O-C-N 120.741 -1.224 . . . . 52.5 112.335 -171.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.654 HD11 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -94.71 164.75 12.82 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.759 1.624 . . . . 74.310000000000002 109.878 169.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 9.6 tt -66.5 -39.35 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.036 0.446 . . . . 72.310000000000002 109.921 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.4 m -151.7 154.73 36.9 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 74.019999999999996 110.377 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.1 p -57.38 139.58 52.63 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.79 1.236 . . . . 63.240000000000002 112.475 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.444 HD23 HD13 ' A' ' 184' ' ' LEU . 86.8 mt -68.14 100.1 0.97 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.557 0.743 . . . . 73.439999999999998 109.007 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.532 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 24.3 t60 -96.45 -78.39 0.47 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.898 0.879 . . . . 61.439999999999998 111.643 -165.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -94.0 123.64 58.67 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.385 0.674 . . . . 74.310000000000002 110.11 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.4 130.88 8.24 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.539 2.159 . . . . 75.150000000000006 111.765 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.59 82.48 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 109.063 -0.717 . . . . 71.219999999999999 109.063 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.21 167.01 16.07 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.409 2.073 . . . . 64.349999999999994 112.261 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 32.4 mmtp -63.45 138.12 58.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.494 0.718 . . . . 74.319999999999993 110.252 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.581 ' HB3' HD21 ' A' ' 159' ' ' LEU . 14.7 ptt-85 -72.73 -63.28 1.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.341 1.237 . . . . 73.040000000000006 114.341 -160.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.556 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 53.6 t30 -112.87 146.48 38.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.992 0.917 . . . . 64.319999999999993 110.314 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 94.8 mttt -77.82 114.45 41.61 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 107.638 -1.245 . . . . 74.430000000000007 107.638 161.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 26.2 Cg_exo -64.44 127.41 18.94 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.16 2.573 . . . . 63.130000000000003 113.181 -171.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.4 m -76.87 117.2 18.24 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.102 0.561 . . . . 72.439999999999998 109.537 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.523 HG22 HD21 ' A' ' 133' ' ' ASN . 4.0 t -96.91 112.85 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.268 -1.012 . . . . 75.030000000000001 108.268 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -88.07 114.2 24.45 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.743 0.646 . . . . 73.019999999999996 112.743 -160.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.74 42.41 94.39 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 124.577 1.173 . . . . 74.319999999999993 114.438 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m -104.23 132.72 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 113.29 0.848 . . . . 60.210000000000001 113.29 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.8 t -83.98 120.11 74.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 105.083 -2.192 . . . . 70.439999999999998 105.083 148.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--N 1.373 1.851 0 C-N-CA 122.525 2.15 . . . . 64.310000000000002 113.996 -162.667 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.43 ' HH2' HD22 ' A' ' 73' ' ' LEU . 20.6 t90 . . . . . 0 C--O 1.244 0.801 0 CA-C-O 121.518 0.675 . . . . 73.5 110.315 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -77.8 -31.11 51.63 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.455 -1.248 . . . . 64.230000000000004 111.135 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.7 p -76.14 9.42 2.53 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.555 1.142 . . . . 75.230000000000004 111.98 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -41.61 -43.32 2.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.429 1.492 . . . . 73.129999999999995 113.302 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.64 -27.77 68.63 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.746 0.818 . . . . 72.120000000000005 112.703 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.509 ' HB2' ' HE1' ' A' ' 144' ' ' HIS . 12.8 m120 -86.11 -0.92 56.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.98 0.912 . . . . 53.32 111.373 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.43 HD22 ' HH2' ' A' ' 67' ' ' TRP . 59.3 tp -57.51 -52.91 63.49 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 122.604 0.362 . . . . 74.140000000000001 110.396 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.55 45.14 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.019 0.927 . . . . 72.129999999999995 110.18 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.889 0 C-N-CA 123.249 0.619 . . . . 52.439999999999998 110.779 -177.938 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 112.975 0.732 . . . . 74.150000000000006 112.975 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 tp -100.37 123.65 44.86 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.805 0.812 . . . . 70.420000000000002 109.751 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -113.19 173.1 6.56 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.516 1.526 . . . . 53.100000000000001 109.491 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 p -136.72 132.44 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.069 1.347 . . . . 75.040000000000006 108.805 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.06 116.69 9.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.291 1.036 . . . . 74.420000000000002 110.025 173.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.6 mt -81.48 -36.07 29.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.76 0.824 . . . . 72.209999999999994 110.638 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 36.8 m-85 -122.85 143.91 49.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.967 -1.015 . . . . 65.329999999999998 108.819 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -74.23 134.3 42.68 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.843 -0.799 . . . . 63.439999999999998 108.843 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.619 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.0 t80 -134.87 138.33 44.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.093 0.957 . . . . 63.43 109.015 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.8 134.16 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.006 -1.479 . . . . 64.209999999999994 107.006 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.1 128.27 36.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.865 0.866 . . . . 74.340000000000003 110.996 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 p -110.1 8.96 24.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.799 0.84 . . . . 42.210000000000001 111.725 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.9 -179.46 32.81 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.8 -0.52 . . . . 64.409999999999997 111.8 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.34 -21.49 39.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.575 0.75 . . . . 55.210000000000001 112.767 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -107.12 -7.92 16.68 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 111.852 0.315 . . . . 63.229999999999997 111.852 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.6 p -75.97 177.96 6.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.873 0.469 . . . . 62.43 111.217 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.0 tp -142.65 145.53 33.55 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.825 -0.547 . . . . 64.420000000000002 110.985 -176.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 m -94.11 120.49 34.43 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.936 0.895 . . . . 73.420000000000002 109.304 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.628 HG22 HG21 ' A' ' 123' ' ' THR . 15.8 pt -113.82 148.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.629 0.771 . . . . 53.140000000000001 111.079 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.9 m -94.92 143.96 26.05 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.714 0.806 . . . . 73.230000000000004 109.312 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.01 120.75 11.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.54 0.736 . . . . 70.200000000000003 109.923 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.95 -9.23 68.1 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.643 -0.532 . . . . 52.210000000000001 113.607 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.7 143.44 51.33 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.591 0.757 . . . . 60.039999999999999 111.461 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.33 134.88 35.09 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.87 0.868 . . . . 72.340000000000003 109.192 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.499 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -145.33 142.79 29.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 75.319999999999993 109.847 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -97.08 109.66 22.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.188 -0.671 . . . . 73.430000000000007 109.188 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.591 HG13 ' HB1' ' A' ' 119' ' ' ALA . 19.1 t -72.67 126.4 33.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-O 121.699 0.761 . . . . 63.229999999999997 109.363 171.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.5 mt -88.63 -59.13 2.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.456 -1.702 . . . . 72.400000000000006 109.203 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.63 142.93 8.79 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.359 -0.382 . . . . 35.109999999999999 112.531 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.606 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 30.8 m-85 -86.4 168.12 14.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.513 1.125 . . . . 74.200000000000003 111.25 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -94.09 -171.58 2.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.088 1.355 . . . . 74.109999999999999 111.002 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -47.22 -36.35 8.75 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.924 1.689 . . . . 65.230000000000004 115.025 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -109.57 -6.18 15.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.543 0.337 . . . . 43.439999999999998 111.357 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.72 25.2 75.81 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.392 0.433 . . . . 53.009999999999998 113.451 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.47 -7.15 21.14 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.44 0.696 . . . . 72.150000000000006 112.296 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 33.4 m95 -140.48 134.33 30.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.67 0.788 . . . . 75.140000000000001 109.57 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.591 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -134.0 148.24 51.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 74.310000000000002 110.639 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.86 113.63 19.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.857 -1.164 . . . . 64.129999999999995 107.857 167.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.59 145.36 45.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.262 0.625 . . . . 62.119999999999997 110.95 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.44 103.53 15.49 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 109.03 -0.73 . . . . 73.25 109.03 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.628 HG21 HG22 ' A' ' 101' ' ' ILE . 75.7 p -86.36 168.44 13.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.356 0.662 . . . . 65.430000000000007 109.248 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -74.1 -11.2 60.24 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.671 -0.695 . . . . 35.530000000000001 110.57 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -79.99 -33.08 39.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.731 0.812 . . . . 72.019999999999996 110.19 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.58 -161.52 31.83 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 111.415 -0.674 . . . . 13.550000000000001 111.415 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -128.91 149.28 50.84 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.786 0.793 . . . . 73.120000000000005 110.597 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.06 178.35 35.87 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.706 0.629 . . . . 32.149999999999999 111.576 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -84.3 122.93 29.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.614 0.766 . . . . 73.099999999999994 111.989 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.411 HG11 ' CG2' ' A' ' 101' ' ' ILE . 19.8 m -128.61 145.21 55.16 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 124.992 1.317 . . . . 61.140000000000001 109.361 173.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.2 Cg_endo -84.3 146.61 11.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.287 1.991 . . . . 72.530000000000001 114.705 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 m -40.03 -41.85 1.29 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.191 1.796 . . . . 63.240000000000002 113.968 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -76.39 -17.91 59.13 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.175 -0.921 . . . . 74.219999999999999 112.657 -170.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.476 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 24.7 m-85 -92.28 -18.4 23.44 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.19 0.596 . . . . 61.030000000000001 111.713 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 130' ' ' VAL . 19.4 pt -120.24 -179.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.553 1.141 . . . . 63.530000000000001 110.408 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.9 t -162.5 151.08 12.35 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 118.428 -0.796 . . . . 70.549999999999997 108.872 166.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.72 145.71 97.21 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 121.49 1.46 . . . . 74.209999999999994 109.831 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.55 -4.38 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 121.778 0.799 . . . . 44.549999999999997 111.462 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.88 -22.74 49.31 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.777 0.831 . . . . 60.409999999999997 111.186 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.5 p -81.32 176.43 9.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.832 0.825 . . . . 72.120000000000005 111.705 -167.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 214' ' ' LEU . 38.8 mt -85.78 -26.32 25.86 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.847 -1.07 . . . . 70.140000000000001 110.605 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.525 ' HG3' ' HD2' ' A' ' 147' ' ' TYR . 1.6 mp0 -64.47 -20.41 66.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.79 1.236 . . . . 75.319999999999993 111.966 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -63.75 -4.69 3.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.732 0.813 . . . . 73.239999999999995 113.095 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.509 ' HE1' ' HB2' ' A' ' 72' ' ' ASN . 42.4 m-70 -117.73 159.29 23.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.998 0.919 . . . . 73.120000000000005 110.728 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -42.94 89.29 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.447 1.099 . . . . 71.219999999999999 112.14 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.402 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 56.3 p-90 -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.364 0.875 . . . . 72.329999999999998 113.364 -172.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.525 ' HD2' ' HG3' ' A' ' 142' ' ' GLU . 21.0 t80 -85.34 106.76 16.97 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.705 0.684 . . . . 75.140000000000001 110.356 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.513 ' HB3' HG21 ' A' ' 151' ' ' VAL . 3.2 m80 -89.27 -14.04 36.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.982 0.913 . . . . 62.299999999999997 112.0 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.48 -140.62 23.79 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.035 -1.425 . . . . 71.329999999999998 112.197 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.62 88.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.535 2.823 . . . . 71.109999999999999 112.891 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 155' ' ' ALA . 37.6 t -140.14 128.05 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.849 1.659 . . . . 73.549999999999997 108.807 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.1 p -84.27 175.13 9.62 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 124.061 0.945 . . . . 70.409999999999997 109.997 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -60.08 -40.95 91.32 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.984 -0.531 . . . . 73.420000000000002 111.158 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -53.26 -51.33 62.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.199 0.937 . . . . 75.120000000000005 110.317 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -62.57 -46.35 88.72 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.057 -1.429 . . . . 52.130000000000003 111.168 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 171' ' ' ARG . . . -56.86 -37.13 70.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.453 0.701 . . . . 31.440000000000001 112.184 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -68.83 -43.8 74.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.176 0.99 . . . . 74.219999999999999 111.155 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.42 ' OH ' ' HD2' ' A' ' 239' ' ' ARG . 0.1 OUTLIER -71.74 -22.83 61.56 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.328 0.585 . . . . 72.540000000000006 112.214 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 239' ' ' ARG . 55.8 mt -75.67 -43.59 46.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.872 -1.058 . . . . 73.329999999999998 112.579 174.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.539 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 96.4 mt -83.21 -20.65 34.22 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.045 -0.525 . . . . 62.240000000000002 111.466 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.425 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 86.6 p -64.3 -27.77 69.26 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 108.599 -0.889 . . . . 73.109999999999999 108.599 167.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.5 m -90.41 16.63 8.46 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.516 1.127 . . . . 44.100000000000001 111.468 175.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.29 178.52 17.3 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.381 0.515 . . . . 72.439999999999998 112.688 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.3 pt -100.17 175.77 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.479 1.111 . . . . 73.340000000000003 112.241 -176.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -72.22 116.1 12.25 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.663 -0.698 . . . . 73.450000000000003 109.549 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.07 6.18 34.47 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.508 -0.769 . . . . 73.329999999999998 112.534 -167.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 66.1 m -85.26 135.36 33.96 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 117.979 0.889 . . . . 65.129999999999995 111.124 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.8 p90 -139.46 158.31 44.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.747 0.419 . . . . 73.230000000000004 110.661 -176.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.2 pp -153.69 137.11 15.83 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.871 -0.788 . . . . 72.340000000000003 108.871 170.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 182' ' ' ILE . 59.9 t -92.28 136.5 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.791 -1.189 . . . . 71.019999999999996 107.791 168.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 156' ' ' ALA . 41.2 ptt85 -136.36 143.21 43.93 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.012 0.925 . . . . 63.399999999999999 108.643 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.89 117.11 30.4 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.764 -1.569 . . . . 51.439999999999998 106.764 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -53.44 120.58 6.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.197 0.999 . . . . 70.329999999999998 111.409 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.6 -29.3 69.88 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.684 0.754 . . . . 75.310000000000002 109.665 168.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -67.55 -32.61 73.5 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.678 -1.146 . . . . 73.329999999999998 111.446 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -148.09 94.77 4.24 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 123.929 0.892 . . . . 72.310000000000002 109.829 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.27 146.6 88.45 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.845 2.363 . . . . 75.439999999999998 111.899 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.15 -28.72 3.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.491 -0.616 . . . . 72.450000000000003 114.104 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -76.24 115.85 16.37 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 117.665 0.733 . . . . 73.010000000000005 110.078 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -113.93 140.5 48.34 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.006 0.922 . . . . 65.349999999999994 109.29 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.1 m -145.92 148.61 32.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.344 1.057 . . . . 71.420000000000002 108.977 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.711 HG12 HG22 ' A' ' 170' ' ' VAL . 14.2 mt -101.03 144.3 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.745 -1.576 . . . . 75.310000000000002 106.745 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -124.68 109.24 12.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.968 -1.493 . . . . 75.219999999999999 106.968 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.7 tp -106.59 113.96 27.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.038 0.535 . . . . 74.340000000000003 110.361 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 18.0 ttt180 -76.4 117.85 18.48 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.442 -0.947 . . . . 74.299999999999997 108.442 162.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -140.77 139.8 34.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 107.448 -1.315 . . . . 54.25 107.448 168.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 62.01 22.12 12.85 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.356 1.062 . . . . 74.129999999999995 112.472 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 1.91 89.66 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.331 -0.395 . . . . 65.140000000000001 113.369 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -111.96 140.12 46.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.152 0.981 . . . . 74.219999999999999 108.463 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.33 106.77 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-O 121.371 0.605 . . . . 64.329999999999998 110.657 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -90.86 145.69 24.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 72.239999999999995 108.805 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -125.02 117.92 25.07 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.083 0.468 . . . . 71.219999999999999 110.265 -173.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.572 ' HE1' HD21 ' A' ' 232' ' ' LEU . 3.0 m-85 -95.31 137.0 34.97 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.974 -1.121 . . . . 64.099999999999994 107.974 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -94.77 122.17 37.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.03 -1.1 . . . . 71.329999999999998 108.03 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 59.4 mt -84.65 101.99 9.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.583 -0.895 . . . . 75.340000000000003 108.583 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -76.18 139.52 41.27 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.856 -1.065 . . . . 71.010000000000005 109.094 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -118.39 117.3 28.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.639 0.776 . . . . 73.329999999999998 109.514 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.97 161.05 16.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.748 1.219 . . . . 63.009999999999998 110.464 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 70.0 p -64.41 -27.16 68.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.726 0.81 . . . . 52.340000000000003 112.258 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -83.84 -19.1 35.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.001 0.52 . . . . 45.509999999999998 111.032 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.48 14.3 10.72 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-O 119.014 -0.881 . . . . 64.319999999999993 115.004 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 34.7 mtmm -71.82 129.87 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.218 1.009 . . . . 71.430000000000007 111.09 173.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.93 142.85 26.91 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 71.230000000000004 108.294 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.9 p90 -169.76 137.73 1.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.097 0.873 . . . . 74.319999999999993 110.756 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -78.66 -46.02 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.435 -0.95 . . . . 75.549999999999997 108.435 164.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.1 m -98.56 124.58 43.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.437 -1.256 . . . . 74.030000000000001 108.764 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 31.4 t -65.97 -21.58 66.42 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.766 0.826 . . . . 65.340000000000003 112.051 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.13 -26.63 53.38 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.97 0.908 . . . . 71.340000000000003 110.163 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -125.42 98.41 5.6 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.798 0.839 . . . . 74.5 109.272 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 70.5 mtt180 -111.47 118.91 37.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.843 0.857 . . . . 74.219999999999999 110.179 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.421 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.5 OUTLIER -111.87 147.84 34.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.703 0.801 . . . . 72.530000000000001 109.166 -169.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.536 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 7.1 m120 -66.41 -38.88 88.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.265 0.626 . . . . 74.239999999999995 110.341 -175.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.8 p -124.32 154.57 40.1 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.652 0.781 . . . . 61.450000000000003 111.28 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 141' ' ' LEU . 1.8 tt -65.21 -23.84 67.19 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.129 0.972 . . . . 63.530000000000001 109.377 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.57 80.36 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.789 0.836 . . . . 74.450000000000003 111.242 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.52 -30.74 64.75 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.378 -0.828 . . . . 72.329999999999998 111.551 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.21 -53.54 56.96 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 123.507 0.505 . . . . 73.409999999999997 110.744 171.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.77 -43.3 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.111 0.565 . . . . 63.210000000000001 110.475 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -55.15 -56.75 16.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.957 0.903 . . . . 73.030000000000001 111.248 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -65.58 -33.16 75.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.688 -1.142 . . . . 62.25 111.047 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.666 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.1 m170 -92.21 -10.58 38.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.015 0.526 . . . . 72.439999999999998 112.024 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 77.2 p -97.75 -11.68 23.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.279 0.632 . . . . 63.310000000000002 110.747 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 35.8 p -87.31 -52.07 5.6 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 122.399 0.28 . . . . 74.219999999999999 110.636 167.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.9 162.95 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 122.135 0.969 . . . . 65.319999999999993 113.204 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.84 11.76 17.01 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.616 1.966 . . . . 73.439999999999998 114.42 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -47.73 32.07 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 130.729 3.611 . . . . 75.430000000000007 120.065 -157.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.07 6.38 4.91 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.649 -1.282 . . . . 60.409999999999997 112.911 -167.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.9 mt -94.11 161.9 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.722 1.209 . . . . 74.010000000000005 109.067 161.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.4 tt -59.46 -40.09 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-O 120.736 0.303 . . . . 52.130000000000003 110.239 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -159.37 171.96 18.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.851 0.861 . . . . 64.430000000000007 109.904 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 34.0 m -68.73 138.38 54.84 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.144 0.978 . . . . 73.340000000000003 111.606 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.572 HD21 ' HE1' ' A' ' 193' ' ' TYR . 63.8 mt -71.9 131.41 42.94 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.199 0.999 . . . . 61.539999999999999 109.412 177.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -121.4 -77.98 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 118.65 0.659 . . . . 53.420000000000002 111.223 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -85.92 121.48 72.99 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 123.531 0.733 . . . . 73.329999999999998 109.366 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.61 126.95 4.82 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.181 1.921 . . . . 72.329999999999998 111.519 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . . . -66.73 145.7 98.97 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.813 0.845 . . . . 72.239999999999995 110.159 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.44 167.17 17.48 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.524 2.15 . . . . 72.540000000000006 112.015 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -69.45 150.12 47.56 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.442 0.697 . . . . 74.140000000000001 110.118 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.719 ' HB3' HD21 ' A' ' 159' ' ' LEU . 13.7 ptt180 -91.38 -64.18 1.16 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.249 0.833 . . . . 73.120000000000005 113.249 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.512 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 61.7 t30 -111.31 134.27 53.02 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.713 0.805 . . . . 73.040000000000006 109.743 -175.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -75.58 110.97 12.03 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 105.457 -2.053 . . . . 74.150000000000006 105.457 160.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.2 146.66 38.42 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.429 2.752 . . . . 74.430000000000007 115.732 -166.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.8 m -80.55 120.69 24.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.22 0.608 . . . . 75.299999999999997 110.78 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.41 108.01 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 108.023 -1.102 . . . . 73.549999999999997 108.023 170.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -108.33 111.75 23.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.192 0.597 . . . . 61.32 109.879 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 61.46 24.07 63.37 Favored Glycine 0 C--N 1.355 1.639 0 O-C-N 124.187 0.93 . . . . 70.420000000000002 114.871 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.4 116.99 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.328 0.651 . . . . 75.310000000000002 110.676 -174.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.9 t -87.99 120.44 70.74 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 105.829 -1.915 . . . . 71.109999999999999 105.829 151.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 N--CA 1.497 1.686 0 C-N-CA 121.771 1.647 . . . . 75.329999999999998 114.793 -159.919 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.2 t90 . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.411 0.624 . . . . 65.129999999999995 109.995 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -83.32 -31.52 26.78 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.627 -1.169 . . . . 52.210000000000001 109.805 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.6 p -69.58 3.48 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.153 0.981 . . . . 61.439999999999998 112.712 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.76 -25.04 67.09 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.419 0.688 . . . . 50.140000000000001 110.329 169.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.603 ' HG3' HD22 ' A' ' 72' ' ' ASN . 17.0 pt-20 -58.82 -36.81 75.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.588 0.755 . . . . 74.409999999999997 110.248 171.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.603 HD22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -86.15 -7.04 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.945 1.298 . . . . 45.530000000000001 111.569 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.81 -49.42 70.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.246 0.618 . . . . 64.340000000000003 110.157 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.2 mt -112.84 18.45 18.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.384 0.674 . . . . 72.319999999999993 110.906 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.119 0 C-N-CA 122.906 0.482 . . . . 30.34 110.842 177.819 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 112.205 0.446 . . . . 60.439999999999998 112.205 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 106' ' ' LYS . 51.0 tp -82.34 120.15 25.04 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.93 -0.767 . . . . 75.299999999999997 108.93 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.1 m-85 -106.91 174.22 5.98 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.758 1.223 . . . . 74.239999999999995 109.066 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.32 138.41 40.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.97 1.308 . . . . 54.549999999999997 108.66 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.49 116.84 18.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 74.319999999999993 109.968 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 69.6 mt -79.4 -29.98 42.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.283 0.633 . . . . 71.430000000000007 110.864 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 87.4 m-85 -126.64 140.82 52.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.867 -1.06 . . . . 75.030000000000001 108.529 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -72.84 134.19 44.77 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.176 -1.046 . . . . 65.019999999999996 108.176 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.9 t80 -131.22 111.23 11.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.316 -0.994 . . . . 73.430000000000007 108.316 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.99 137.15 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.542 -1.281 . . . . 74.430000000000007 107.542 172.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.01 117.12 2.96 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.129 0.972 . . . . 75.340000000000003 112.497 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.8 p -88.5 4.99 44.67 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.918 0.887 . . . . 72.329999999999998 111.646 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.85 -175.39 33.84 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.245 -0.742 . . . . 72.209999999999994 111.245 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -79.39 -38.21 35.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.22 0.608 . . . . 72.099999999999994 110.508 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -83.25 -15.46 50.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.24 1.016 . . . . 70.439999999999998 111.458 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.455 ' HA ' ' H ' ' A' ' 129' ' ' TRP . 71.7 p -77.24 177.24 8.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.967 0.507 . . . . 53.130000000000003 111.183 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.497 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 56.3 tp -134.31 132.22 39.3 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.814 0.446 . . . . 54.409999999999997 111.154 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 58.0 m -77.9 116.9 18.76 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.864 -0.607 . . . . 61.100000000000001 109.771 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 91' ' ' PHE . 15.2 pt -119.9 153.89 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.951 0.901 . . . . 75.219999999999999 110.137 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -106.9 145.87 31.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.106 0.562 . . . . 72.450000000000003 109.506 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -67.34 109.68 3.24 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 122.857 0.463 . . . . 63.140000000000001 110.156 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.18 -11.93 33.94 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 116.371 -0.377 . . . . 71.230000000000004 112.358 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -77.52 137.73 38.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.331 0.652 . . . . 71.409999999999997 110.443 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.41 ' HB3' HD11 ' A' ' 84' ' ' LEU . 42.0 mmtm -84.55 145.23 28.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.816 0.847 . . . . 71.420000000000002 109.371 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.33 146.74 32.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.337 0.655 . . . . 71.439999999999998 110.301 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -92.49 109.65 21.05 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.112 -1.069 . . . . 73.239999999999995 108.112 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.582 HG13 ' HB1' ' A' ' 119' ' ' ALA . 74.8 t -85.21 122.92 38.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.979 -0.748 . . . . 74.120000000000005 108.979 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.87 -21.91 21.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.814 1.246 . . . . 74.099999999999994 109.959 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.92 152.69 6.39 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.639 -0.534 . . . . 62.030000000000001 112.668 174.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 47.1 m-85 -86.56 165.22 16.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.372 0.606 . . . . 63.140000000000001 110.81 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -86.91 -172.3 3.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.609 1.164 . . . . 64.400000000000006 111.077 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -58.61 -34.12 70.77 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.886 0.875 . . . . 72.409999999999997 112.53 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -102.5 -4.09 25.89 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.239 0.616 . . . . 74.450000000000003 111.741 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 63.49 26.84 70.02 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.59 -0.561 . . . . 71.540000000000006 114.44 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.19 -12.98 19.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.34 0.57 . . . . 72.329999999999998 111.49 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.464 ' HE1' HG23 ' A' ' 247' ' ' VAL . 79.6 m95 -137.65 151.43 48.27 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.984 0.914 . . . . 71.209999999999994 109.967 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 112' ' ' TYR . . . -135.35 140.22 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.581 0.752 . . . . 61.420000000000002 110.312 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.432 ' HG2' ' NE2' ' A' ' 127' ' ' GLN . 40.7 tt0 -77.19 99.87 5.59 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.684 -1.598 . . . . 72.319999999999993 106.684 169.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.98 161.7 24.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.275 0.63 . . . . 74.120000000000005 110.668 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -132.11 123.64 27.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.25 0.548 . . . . 73.109999999999999 111.929 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.2 p -98.05 -176.95 3.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.958 1.303 . . . . 64.5 109.853 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 11.0 mptt -66.91 -22.27 65.96 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.762 -1.108 . . . . 61.450000000000003 109.514 172.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -75.96 -19.69 58.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.931 1.293 . . . . 74.310000000000002 110.9 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.62 -160.85 24.16 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.076 0.235 . . . . 23.43 112.873 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.432 ' NE2' ' HG2' ' A' ' 120' ' ' GLU . 64.7 tp60 -98.59 158.34 15.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.917 0.887 . . . . 71.209999999999994 110.378 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 166.29 -163.42 36.86 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.234 -0.439 . . . . 35.140000000000001 112.416 169.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.455 ' H ' ' HA ' ' A' ' 98' ' ' THR . 87.0 m95 -102.76 131.64 49.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.906 0.882 . . . . 70.109999999999999 110.618 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 8.8 m -130.66 139.37 35.41 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.196 0.998 . . . . 64.219999999999999 108.947 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 130' ' ' VAL . 3.8 Cg_exo -78.94 141.32 16.67 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.522 2.148 . . . . 50.329999999999998 113.577 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.5 m -42.6 -44.74 4.34 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.614 1.566 . . . . 72.120000000000005 113.981 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.57 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 26.5 p-10 -78.25 6.09 8.95 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.895 0.878 . . . . 64.239999999999995 112.329 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.4 -14.29 12.2 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.3 1.04 . . . . 65.230000000000004 111.274 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.46 173.2 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.507 0.723 . . . . 72.129999999999995 112.034 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.415 HG21 ' HB2' ' A' ' 142' ' ' GLU . 5.8 t -161.56 153.33 16.1 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.602 1.161 . . . . 74.150000000000006 107.889 170.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 28.3 Cg_endo -60.71 148.4 91.81 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.507 1.472 . . . . 74.510000000000005 111.634 172.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.2 t -73.46 -4.01 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 CA-C-O 121.711 0.767 . . . . 73.430000000000007 110.179 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -80.02 -19.99 46.41 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.697 0.799 . . . . 74.239999999999995 111.49 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.0 p -86.41 174.52 8.95 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.172 0.589 . . . . 64.129999999999995 112.129 -171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.59 -22.38 30.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.738 0.815 . . . . 60.329999999999998 111.516 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.415 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.9 mp0 -68.47 -18.1 64.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.74 0.816 . . . . 75.349999999999994 111.611 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -60.74 -12.94 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.412 0.685 . . . . 73.010000000000005 112.744 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -95.44 158.18 15.57 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.029 0.931 . . . . 71.25 110.535 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.5 p -70.11 -42.79 72.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.588 0.755 . . . . 62.32 111.254 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.487 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 48.9 p-90 -61.98 -39.61 92.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.051 0.76 . . . . 74.530000000000001 113.051 -176.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -82.83 105.78 14.12 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.956 -0.387 . . . . 61.329999999999998 109.956 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -99.32 -3.55 33.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.292 0.637 . . . . 53.130000000000003 111.952 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.13 -148.86 33.45 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.754 -1.025 . . . . 73.409999999999997 113.102 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.34 106.76 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.792 2.328 . . . . 52.439999999999998 112.042 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.7 t -135.79 139.63 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.533 1.533 . . . . 72.439999999999998 109.152 -174.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.6 p -90.23 170.33 10.38 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 65.430000000000007 109.873 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.19 -29.81 70.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.795 0.27 . . . . 74.040000000000006 110.583 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -55.94 -53.84 51.98 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.275 0.63 . . . . 71.25 110.125 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.536 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -72.5 -27.88 62.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.844 -1.071 . . . . 71.540000000000006 111.725 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.41 61.97 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.111 0.564 . . . . 74.25 111.586 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -63.71 -38.17 90.09 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.731 . . . . 72.349999999999994 110.433 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.46 -45.81 92.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.903 -1.044 . . . . 70.340000000000003 110.753 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.67 -48.82 79.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.597 0.759 . . . . 75.400000000000006 111.772 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.17 11.18 24.15 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.709 1.003 . . . . 70.030000000000001 113.709 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.8 p -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.725 0.693 . . . . 54.409999999999997 109.991 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.1 p -94.0 10.1 34.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.57 0.748 . . . . 70.140000000000001 111.145 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -76.52 157.92 48.3 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.21 -0.45 . . . . 72.140000000000001 113.274 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.2 pt -100.74 176.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.878 0.871 . . . . 60.310000000000002 111.074 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.99 110.08 5.48 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.089 -0.708 . . . . 75.319999999999993 109.089 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.62 7.96 23.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.505 -0.608 . . . . 63.539999999999999 112.723 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.3 m -83.86 122.43 28.7 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.463 0.632 . . . . 54.020000000000003 111.014 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -129.53 164.82 22.95 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.475 0.579 . . . . 74.239999999999995 111.16 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.94 138.65 14.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.478 -0.934 . . . . 74.030000000000001 108.478 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.663 HG22 HG12 ' A' ' 182' ' ' ILE . 72.5 t -98.27 138.8 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.136 -1.061 . . . . 72.239999999999995 108.136 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.595 ' HE ' ' HB2' ' A' ' 181' ' ' SER . 2.1 ppt_? -146.7 162.38 38.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.881 0.873 . . . . 72.340000000000003 108.83 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -107.57 150.0 27.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.427 -1.323 . . . . 54.439999999999998 107.427 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t -68.33 125.1 25.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.454 -0.573 . . . . 60.130000000000003 109.454 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.25 -38.93 71.78 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.479 1.112 . . . . 73.219999999999999 111.154 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.3 m -102.88 5.92 38.81 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.605 0.762 . . . . 31.129999999999999 112.254 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.7 m -148.1 88.77 5.39 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 122.888 0.475 . . . . 61.32 110.532 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.55 134.47 35.67 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.69 2.26 . . . . 73.340000000000003 111.961 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.27 -28.54 13.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.934 -0.575 . . . . 31.34 112.378 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -88.91 116.98 27.58 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.844 -0.798 . . . . 75.400000000000006 108.844 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 77.5 mtt180 -119.16 159.35 24.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.284 0.564 . . . . 73.120000000000005 110.525 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.595 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 40.2 m -148.4 152.43 36.97 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.266 -0.879 . . . . 72.310000000000002 110.278 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.663 HG12 HG22 ' A' ' 170' ' ' VAL . 33.9 mt -104.18 150.48 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.373 -1.343 . . . . 72.450000000000003 107.373 170.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.0 m -122.94 108.18 12.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.186 -1.412 . . . . 64.549999999999997 107.186 170.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.95 110.49 22.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.319 -0.623 . . . . 72.129999999999995 109.319 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.505 ' HB2' HG22 ' A' ' 190' ' ' VAL . 35.6 ttt180 -78.3 115.68 18.19 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.982 -0.747 . . . . 75.319999999999993 108.982 166.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -140.34 138.25 34.74 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.552 1.158 . . . . 52.009999999999998 108.446 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 56.08 30.89 17.12 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.297 1.039 . . . . 72.409999999999997 112.033 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 75.96 12.95 83.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.87 -0.605 . . . . 74.140000000000001 114.264 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -122.0 136.56 54.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 73.530000000000001 109.391 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 185' ' ' ARG . 60.3 t -96.54 106.47 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 122.921 0.488 . . . . 75.120000000000005 110.252 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.02 136.48 33.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.593 1.157 . . . . 71.409999999999997 109.381 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -112.51 119.0 36.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.132 0.491 . . . . 64.319999999999993 110.231 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.505 ' HE1' HD21 ' A' ' 232' ' ' LEU . 10.6 m-30 -95.63 142.2 28.23 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.994 -1.003 . . . . 65.530000000000001 109.053 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 7.1 tpp180 -93.88 109.79 21.48 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.121 -0.696 . . . . 71.439999999999998 109.121 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 54.9 mt -85.7 101.95 10.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.079 -1.082 . . . . 62.539999999999999 108.079 170.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.06 116.46 19.37 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.051 -0.722 . . . . 75.400000000000006 109.051 170.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 m -87.66 112.92 22.85 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.786 -0.82 . . . . 73.439999999999998 108.786 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -67.13 157.65 33.13 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.232 0.613 . . . . 51.439999999999998 110.401 174.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.8 p -65.61 -20.93 66.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.005 0.922 . . . . 72.209999999999994 113.122 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.37 -14.96 39.25 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.1 0.56 . . . . 54.100000000000001 110.891 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.23 11.99 14.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.508 -0.607 . . . . 33.229999999999997 113.868 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 67.9 mttm -71.56 155.36 40.64 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.873 0.837 . . . . 74.439999999999998 110.563 171.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.43 143.41 49.25 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.011 -1.107 . . . . 64.230000000000004 108.011 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 52.9 p90 -162.83 133.79 4.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.403 0.44 . . . . 73.450000000000003 111.994 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 52.9 t -82.14 -36.32 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.466 -0.788 . . . . 61.219999999999999 109.432 168.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 16.0 m -105.47 124.64 49.89 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.006 -1.109 . . . . 75.040000000000006 108.006 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.2 m -62.25 -25.62 67.93 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 60.32 112.771 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -80.69 -31.32 36.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.876 . . . . 73.510000000000005 110.775 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 50.6 m -109.47 88.47 2.75 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.484 0.713 . . . . 63.549999999999997 109.933 -173.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.592 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 64.8 mtt180 -100.67 127.11 47.18 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.873 -0.788 . . . . 73.340000000000003 108.873 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.95 148.55 38.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.476 -0.935 . . . . 70.219999999999999 108.476 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -68.06 -37.45 81.32 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.555 0.534 . . . . 64.409999999999997 110.146 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 67.0 p -127.98 158.68 37.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.829 0.852 . . . . 74.109999999999999 112.031 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.9 -22.23 62.29 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.879 -1.055 . . . . 75.140000000000001 109.917 175.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.39 97.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.392 0.677 . . . . 74.150000000000006 110.348 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.28 -37.06 71.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.103 -0.953 . . . . 73.519999999999996 111.403 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.422 HD11 HG23 ' A' ' 205' ' ' VAL . 15.2 tp -55.04 -57.87 9.96 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.366 0.416 . . . . 45.420000000000002 110.963 173.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.46 -48.76 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.226 0.61 . . . . 71.239999999999995 110.976 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -57.84 -55.04 39.99 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.012 0.82 . . . . 74.329999999999998 111.071 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -65.13 -33.43 75.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.093 0.557 . . . . 54.420000000000002 111.576 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.737 ' HB3' HD11 ' A' ' 228' ' ' LEU . 14.0 m170 -89.76 -8.54 51.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.095 0.406 . . . . 73.140000000000001 112.095 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 84.5 p -93.59 -24.81 17.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.764 0.426 . . . . 43.399999999999999 110.209 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.9 p -81.31 -47.11 13.75 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.769 0.428 . . . . 51.039999999999999 110.856 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.613 HG23 ' HB2' ' A' ' 226' ' ' ASP . 23.5 m -128.17 164.37 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.043 0.925 . . . . 74.150000000000006 112.356 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.95 14.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 127.184 2.194 . . . . 71.099999999999994 114.125 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.613 ' HB2' HG23 ' A' ' 224' ' ' VAL . 35.4 t70 -45.41 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.356 1 C-N-CA 131.816 4.046 . . . . 74.040000000000006 119.614 -158.219 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 124.52 -1.79 8.77 Favored Glycine 0 N--CA 1.486 1.977 0 O-C-N 120.808 -1.183 . . . . 71.340000000000003 112.48 -169.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.737 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.7 mt -93.9 163.15 13.62 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.753 1.221 . . . . 64.450000000000003 110.016 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.7 tt -56.96 -40.45 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 120.824 0.345 . . . . 64.129999999999995 110.369 166.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -162.76 177.33 9.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.595 0.758 . . . . 70.409999999999997 110.69 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -66.15 136.24 55.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 54.32 111.686 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.505 HD21 ' HE1' ' A' ' 193' ' ' TYR . 49.2 mt -69.36 138.73 53.94 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 108.332 -0.988 . . . . 72.510000000000005 108.332 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -132.25 -77.63 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.962 1.255 . . . . 73.420000000000002 111.675 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 167' ' ' SER . 17.9 t80 -80.7 123.0 82.82 Favored Pre-proline 0 C--O 1.209 -1.049 0 CA-C-O 118.307 -0.854 . . . . 72.019999999999996 108.753 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 146' ' ' TRP . 8.3 Cg_endo -88.36 132.89 2.68 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.288 1.992 . . . . 51.210000000000001 111.609 171.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.77 131.94 93.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.484 0.714 . . . . 74.340000000000003 109.782 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.92 177.76 7.99 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.674 2.249 . . . . 71.439999999999998 113.116 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 32.7 mmtp -79.0 126.6 30.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.463 0.705 . . . . 73.430000000000007 109.349 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.522 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 15.3 ptt180 -93.14 -62.45 1.38 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.545 0.943 . . . . 74.540000000000006 113.545 -160.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.522 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 57.4 t30 -109.26 132.31 54.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.235 0.614 . . . . 73.340000000000003 111.09 -167.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -68.84 112.4 11.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 107.179 -1.415 . . . . 61.229999999999997 107.179 163.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.57 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 8.0 Cg_exo -74.61 124.59 8.93 Favored 'Trans proline' 0 C--N 1.364 1.395 0 C-N-CA 122.218 1.946 . . . . 74.030000000000001 112.098 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 87.7 m -64.96 123.27 19.0 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.318 0.647 . . . . 74.439999999999998 110.744 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.438 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 64.1 t -79.69 125.95 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 108.658 -0.868 . . . . 72.530000000000001 108.658 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -98.17 113.0 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 117.711 0.232 . . . . 64.230000000000004 111.096 -168.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 58.1 6.37 2.92 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 118.675 2.23 . . . . 75.340000000000003 118.675 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.464 HG23 ' HE1' ' A' ' 118' ' ' TRP . 17.1 m -106.53 123.07 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.943 1.371 . . . . 72.329999999999998 113.781 -170.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 t -82.89 122.94 78.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 106.326 -1.731 . . . . 50.130000000000003 106.326 157.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 118' ' ' TRP . 41.0 Cg_endo . . . . . 0 C--N 1.367 1.534 0 C-N-CA 121.423 1.415 . . . . 74.140000000000001 115.212 -157.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.422 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 6.7 t90 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.274 -0.639 . . . . 73.420000000000002 109.274 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -76.84 -29.48 55.93 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 116.229 -0.441 . . . . 71.420000000000002 110.519 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -73.21 5.03 3.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.019 1.328 . . . . 74.129999999999995 113.095 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.53 -17.71 64.96 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.676 1.19 . . . . 73.140000000000001 112.922 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -26.84 19.51 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.255 0.622 . . . . 74.129999999999995 110.957 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.92 -5.63 55.94 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.62 0.768 . . . . 73.430000000000007 110.4 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.447 HD13 ' HE1' ' A' ' 146' ' ' TRP . 62.4 tp -60.72 -54.09 49.48 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.961 0.505 . . . . 71.349999999999994 109.869 174.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.02 84.3 1.9 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.98 -1.119 . . . . 71.109999999999999 107.98 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.725 0 CA-C-N 115.378 -0.828 . . . . 72.319999999999993 111.774 -173.41 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.447 0.642 . . . . 73.099999999999994 110.073 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 106' ' ' LYS . 38.5 tp -88.46 121.37 30.77 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 114.636 -1.165 . . . . 63.539999999999999 108.084 171.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.56 173.19 6.42 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.5 1.12 . . . . 71.120000000000005 108.704 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -131.18 135.81 58.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 124.424 1.089 . . . . 63.539999999999999 108.109 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.69 107.06 6.55 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.062 0.945 . . . . 70.239999999999995 109.405 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.521 HD22 ' HZ2' ' A' ' 238' ' ' LYS . 79.0 mt -69.29 -23.92 63.89 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.475 0.71 . . . . 74.209999999999994 111.528 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 77.0 m-85 -135.77 155.67 50.0 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 75.140000000000001 109.954 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 241' ' ' LYS . 10.9 m-20 -70.87 156.09 40.0 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.908 -0.775 . . . . 71.25 108.908 167.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.586 ' HB3' HG12 ' A' ' 101' ' ' ILE . 71.1 t80 -149.3 124.32 10.03 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.133 -1.432 . . . . 72.319999999999993 107.133 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.4 135.34 27.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.789 -1.56 . . . . 62.409999999999997 106.789 169.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.48 117.46 3.11 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.964 0.79 . . . . 41.509999999999998 111.475 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.2 p -88.03 15.14 7.72 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.159 0.984 . . . . 60.350000000000001 110.991 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.47 179.54 46.06 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.912 -0.875 . . . . 74.319999999999993 110.912 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.09 -24.97 58.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.215 0.606 . . . . 72.319999999999993 111.444 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.484 HD21 ' HD2' ' A' ' 249' ' ' PRO . 43.6 p-10 -89.06 -17.56 29.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.724 0.809 . . . . 74.150000000000006 111.561 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.7 p -88.97 158.96 17.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.187 0.595 . . . . 65.549999999999997 110.508 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -121.63 134.15 54.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.215 0.606 . . . . 61.509999999999998 110.98 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.8 m -79.94 132.6 36.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.628 0.771 . . . . 71.450000000000003 110.512 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.696 HG22 HG21 ' A' ' 123' ' ' THR . 6.7 pt -129.22 154.49 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.617 0.767 . . . . 45.140000000000001 111.098 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.5 m -102.93 145.87 29.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.726 1.21 . . . . 34.299999999999997 109.922 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 88' ' ' LEU . 42.3 tttt -70.63 108.15 4.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.252 0.621 . . . . 71.0 109.75 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.95 29.24 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-N 115.832 -0.622 . . . . 64.219999999999999 112.559 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 54.0 tt0 -74.2 144.99 44.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.787 0.835 . . . . 61.140000000000001 111.314 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.449 ' HB3' HD11 ' A' ' 84' ' ' LEU . 43.0 mmtm -92.74 129.61 38.61 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.36 0.664 . . . . 64.430000000000007 109.843 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.606 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.3 OUTLIER -132.18 136.13 46.84 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.835 0.854 . . . . 75.129999999999995 109.505 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -95.15 109.66 21.72 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.902 -0.777 . . . . 44.299999999999997 108.902 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.608 HG13 ' HB1' ' A' ' 119' ' ' ALA . 42.5 t -77.22 134.35 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 123.644 0.59 . . . . 63.149999999999999 110.278 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.4 mt -102.75 -31.21 10.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.943 1.297 . . . . 74.530000000000001 109.906 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.32 142.94 3.93 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.5 -0.611 . . . . 63.439999999999998 113.331 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 33.6 m-85 -86.92 167.34 14.38 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.944 0.898 . . . . 45.329999999999998 110.857 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -88.49 -178.79 5.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.839 . . . . 71.530000000000001 110.565 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -55.42 -34.58 64.54 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.949 1.3 . . . . 63.130000000000003 113.625 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -111.38 9.29 21.5 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.071 0.548 . . . . 74.120000000000005 112.051 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.62 33.11 86.37 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 115.134 0.813 . . . . 62.130000000000003 115.134 172.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.65 -38.68 12.3 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.088 0.444 . . . . 73.549999999999997 111.924 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 66.9 m95 -129.9 147.37 51.65 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.44 0.696 . . . . 72.219999999999999 111.174 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.608 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -128.58 150.82 50.04 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.027 1.331 . . . . 73.299999999999997 109.3 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -87.21 115.76 24.83 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.952 -1.129 . . . . 64.299999999999997 107.952 166.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.51 168.68 10.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.432 0.693 . . . . 72.129999999999995 110.918 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -120.95 110.84 16.77 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.647 0.779 . . . . 73.430000000000007 110.364 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.696 HG21 HG22 ' A' ' 101' ' ' ILE . 82.7 p -100.63 177.58 4.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.347 1.059 . . . . 72.420000000000002 109.933 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.01 -18.3 64.02 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 110.753 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.79 -24.69 55.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.163 0.985 . . . . 73.219999999999999 111.035 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.34 -146.9 17.63 Favored Glycine 0 C--N 1.363 2.055 0 CA-C-N 117.706 0.23 . . . . 72.409999999999997 112.906 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -130.59 139.82 50.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.498 0.719 . . . . 71.109999999999999 109.946 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.21 -174.03 41.05 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.257 -0.737 . . . . 74.540000000000006 111.257 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -87.83 121.81 30.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.344 0.658 . . . . 61.229999999999997 112.41 -170.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.511 HG23 HD13 ' A' ' 135' ' ' ILE . 5.2 m -122.7 142.72 38.33 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.13 1.372 . . . . 63.340000000000003 108.726 173.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 10.6 Cg_endo -88.48 146.91 6.15 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 C-N-CA 122.241 1.961 . . . . 74.430000000000007 114.767 -172.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.4 m -41.35 -44.3 2.73 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.512 1.925 . . . . 74.420000000000002 114.551 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.635 HD22 ' HB2' ' A' ' 242' ' ' PRO . 22.4 p-10 -73.28 -4.16 31.41 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.012 0.525 . . . . 63.340000000000003 112.192 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.455 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 9.7 m-85 -106.44 -22.57 12.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.787 0.835 . . . . 73.120000000000005 111.475 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.511 HD13 HG23 ' A' ' 130' ' ' VAL . 27.6 pt -123.28 164.65 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.325 0.65 . . . . 74.030000000000001 112.442 -172.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.2 t -160.41 149.55 13.91 Favored Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.126 -0.94 . . . . 73.420000000000002 109.166 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.12 145.98 40.5 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.517 2.145 . . . . 62.350000000000001 112.377 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 t -75.68 -3.73 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.576 0.703 . . . . 63.200000000000003 111.149 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -96.84 -2.78 43.34 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.601 -0.687 . . . . 63.43 112.297 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.8 p -78.25 171.58 14.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.2 0.524 . . . . 64.019999999999996 111.828 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.38 -27.71 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.882 -0.599 . . . . 74.239999999999995 109.66 165.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.6 -16.21 64.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.311 1.044 . . . . 73.129999999999995 112.139 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.512 ' HA ' HD21 ' A' ' 88' ' ' LEU . 16.7 pttm -69.49 -31.71 70.15 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.815 0.446 . . . . 52.409999999999997 111.742 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.01 133.8 51.57 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.721 0.809 . . . . 74.430000000000007 110.23 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.0 p -55.59 -32.55 63.16 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 74.420000000000002 112.702 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.447 ' HE1' HD13 ' A' ' 73' ' ' LEU . 25.7 p-90 -81.13 -32.42 33.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.222 0.609 . . . . 73.310000000000002 112.59 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -84.24 107.6 16.64 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.3 -0.63 . . . . 73.310000000000002 109.3 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.77 -5.57 24.73 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.494 0.717 . . . . 71.239999999999995 111.51 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.24 -130.62 21.72 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 118.065 -1.408 . . . . 75.430000000000007 112.941 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.617 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 32.2 Cg_exo -58.63 86.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.821 3.014 . . . . 74.230000000000004 113.603 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.97 132.48 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.285 1.034 . . . . 74.349999999999994 109.681 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.0 p -87.68 175.07 8.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.755 1.222 . . . . 70.129999999999995 110.193 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -61.85 -44.94 95.83 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.483 0.313 . . . . 74.5 110.508 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.23 -48.46 80.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.978 0.911 . . . . 74.140000000000001 110.295 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.3 77.95 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.853 -1.067 . . . . 72.340000000000003 111.419 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.95 -52.47 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.278 0.631 . . . . 72.310000000000002 111.935 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.524 ' HG2' HG11 ' A' ' 190' ' ' VAL . 43.2 mt-10 -68.8 -25.89 64.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.646 0.779 . . . . 75.310000000000002 110.677 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.23 -43.68 90.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.884 0.874 . . . . 70.120000000000005 111.373 170.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.3 mt -65.0 -34.6 78.83 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.285 0.564 . . . . 75.400000000000006 110.532 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 90.0 mt -89.72 2.23 55.08 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.324 -0.853 . . . . 74.310000000000002 112.807 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -61.98 -34.42 76.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.841 0.746 . . . . 71.349999999999994 111.471 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.6 p -101.73 11.08 39.4 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.631 0.772 . . . . 72.420000000000002 111.065 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.04 153.98 40.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.183 -0.462 . . . . 63.0 113.094 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.59 -176.89 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 124.259 1.024 . . . . 75.209999999999994 111.599 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 108.14 1.66 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.574 -0.739 . . . . 54.420000000000002 110.403 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 105.54 12.32 26.91 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.475 -0.625 . . . . 75.209999999999994 112.429 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.483 ' HG ' ' HD1' ' A' ' 234' ' ' TYR . 74.2 m -71.21 144.85 49.98 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 117.519 0.659 . . . . 72.140000000000001 111.209 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.2 p90 -157.52 164.35 37.45 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 122.799 0.44 . . . . 73.439999999999998 110.423 -174.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.07 146.4 12.44 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.647 -0.871 . . . . 61.219999999999999 108.647 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.658 HG22 HG12 ' A' ' 182' ' ' ILE . 91.4 t -96.62 126.67 49.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 108.889 -0.782 . . . . 61.450000000000003 108.889 167.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -116.08 143.4 45.52 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.959 1.303 . . . . 70.030000000000001 107.883 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.76 149.29 38.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.755 0.822 . . . . 75.5 108.922 171.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 t -83.76 125.47 31.95 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.242 -0.651 . . . . 63.100000000000001 109.242 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 150' ' ' PRO . 18.4 tp10 -77.71 -34.31 52.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.195 0.598 . . . . 64.049999999999997 109.392 172.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.0 p -75.22 -16.36 60.48 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.549 0.74 . . . . 52.509999999999998 111.186 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -147.37 79.16 9.84 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 123.768 0.827 . . . . 74.409999999999997 109.185 172.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.65 133.57 55.11 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.169 2.579 . . . . 72.209999999999994 112.406 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.73 -29.59 10.66 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.885 -0.598 . . . . 73.349999999999994 111.92 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -73.64 115.02 12.56 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 108.632 -0.877 . . . . 71.140000000000001 108.632 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.7 mtt85 -128.47 146.17 50.89 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.725 0.81 . . . . 72.120000000000005 109.098 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.9 m -140.51 148.84 41.69 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.385 1.074 . . . . 70.439999999999998 109.009 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 170' ' ' VAL . 34.4 mt -101.51 148.44 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 106.734 -1.58 . . . . 75.5 106.734 168.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 24.6 m -123.46 109.35 13.73 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.203 -1.406 . . . . 71.319999999999993 107.203 171.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 167' ' ' SER . 20.5 tp -103.59 112.39 25.29 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.808 0.731 . . . . 65.219999999999999 109.614 177.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 23.8 ttt180 -80.47 111.17 16.62 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.471 0.653 . . . . 72.25 109.482 165.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -137.25 134.71 36.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.214 -1.357 . . . . 74.430000000000007 107.433 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 61.91 22.48 13.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.538 1.135 . . . . 73.530000000000001 111.547 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.34 85.94 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.938 -0.573 . . . . 64.310000000000002 113.006 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -105.01 130.77 53.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.132 0.973 . . . . 73.549999999999997 108.798 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.524 HG11 ' HG2' ' A' ' 157' ' ' GLU . 58.7 t -96.46 115.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.897 -0.409 . . . . 74.310000000000002 109.897 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -100.08 148.82 24.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.953 1.301 . . . . 65.439999999999998 107.747 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -119.63 116.41 25.95 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.377 0.535 . . . . 73.519999999999996 110.608 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 8.6 m-30 -93.89 149.48 21.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.434 1.094 . . . . 75.129999999999995 108.216 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 15.3 tpp180 -106.29 114.05 27.94 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.896 -0.409 . . . . 64.319999999999993 109.896 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.446 HD13 HD21 ' A' ' 214' ' ' LEU . 48.2 mt -87.42 102.75 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.315 -0.994 . . . . 70.209999999999994 108.315 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -87.17 132.52 33.84 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.101 -0.954 . . . . 63.299999999999997 108.72 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.6 m -100.76 106.77 18.21 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.979 -1.119 . . . . 75.299999999999997 107.979 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.07 159.56 3.29 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.686 0.794 . . . . 64.409999999999997 110.525 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.5 p -63.3 -22.31 66.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.063 0.945 . . . . 64.109999999999999 113.236 -172.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -93.79 -0.62 55.78 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.692 0.797 . . . . 61.039999999999999 111.44 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 100.17 14.05 34.55 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.601 -0.555 . . . . 74.219999999999999 114.068 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -88.15 127.03 35.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 117.852 0.826 . . . . 54.229999999999997 111.426 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -87.03 146.18 26.2 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.339 1.056 . . . . 52.329999999999998 108.545 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -165.43 140.41 5.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.374 0.421 . . . . 61.439999999999998 110.648 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.506 HG23 HD11 ' A' ' 217' ' ' LEU . 76.1 t -85.18 -43.04 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.229 -1.026 . . . . 74.299999999999997 108.229 163.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.2 m -104.79 129.95 52.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.526 -1.216 . . . . 73.329999999999998 109.099 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.5 t -67.66 -14.65 63.12 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.07 0.948 . . . . 64.129999999999995 112.693 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.44 -17.0 59.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.695 1.198 . . . . 43.420000000000002 111.729 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.2 m -149.57 112.17 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.902 0.481 . . . . 44.350000000000001 110.638 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -102.97 124.17 47.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.06 0.944 . . . . 75.510000000000005 109.021 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -106.87 145.95 31.56 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.071 0.948 . . . . 65.319999999999993 109.284 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.49 -39.77 88.9 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.733 0.645 . . . . 75.540000000000006 110.159 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 69.2 p -126.49 151.62 47.57 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.985 -1.007 . . . . 71.030000000000001 111.482 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 195' ' ' ILE . 0.7 OUTLIER -62.94 -24.63 67.96 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.333 -1.303 . . . . 75.25 109.842 172.681 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.34 86.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.215 1.006 . . . . 51.409999999999997 111.602 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.37 -35.86 71.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.363 0.665 . . . . 74.120000000000005 111.274 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.506 HD11 HG23 ' A' ' 205' ' ' VAL . 12.4 tp -55.15 -56.18 22.8 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.635 0.584 . . . . 62.140000000000001 110.762 174.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.6 -39.44 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.81 -0.632 . . . . 64.439999999999998 111.041 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -61.26 -53.12 60.89 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.287 0.367 . . . . 71.120000000000005 110.661 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -62.03 -38.6 89.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.413 -0.812 . . . . 75.430000000000007 110.643 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.708 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.0 m170 -88.17 -5.18 58.56 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.112 -0.494 . . . . 74.099999999999994 112.258 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.7 p -95.31 -24.28 16.82 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.819 0.448 . . . . 72.010000000000005 110.837 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.7 p -81.74 -38.86 25.04 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 122.749 0.42 . . . . 72.219999999999999 111.274 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.4 m -135.52 162.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.984 0.897 . . . . 62.100000000000001 112.142 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.69 15.07 1.11 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.71 2.004 . . . . 54.149999999999999 114.231 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.623 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.7 t70 -43.36 33.65 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 131.634 3.974 . . . . 63.399999999999999 119.145 -156.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.55 -5.35 9.28 Favored Glycine 0 N--CA 1.478 1.459 0 O-C-N 120.738 -1.226 . . . . 65.340000000000003 112.846 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 221' ' ' HIS . 10.6 mt -91.3 162.23 14.7 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.121 1.368 . . . . 75.400000000000006 109.785 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -61.25 -36.07 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-O 120.843 0.354 . . . . 75.519999999999996 110.075 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -162.33 175.42 11.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.953 0.901 . . . . 62.409999999999997 109.427 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.6 p -61.88 148.42 43.49 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.454 1.102 . . . . 75.230000000000004 112.202 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.433 HD23 HD13 ' A' ' 184' ' ' LEU . 52.7 mt -75.13 145.93 41.78 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.873 0.869 . . . . 65.109999999999999 108.689 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -137.35 -72.29 0.43 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.799 0.727 . . . . 75.010000000000005 111.949 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.483 ' HD1' ' HG ' ' A' ' 167' ' ' SER . 62.2 t80 -95.26 122.85 58.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.401 0.68 . . . . 73.340000000000003 109.775 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 71.1 Cg_endo -82.1 139.33 10.63 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.538 2.159 . . . . 53.539999999999999 111.058 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.19 141.79 95.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.061 0.545 . . . . 52.310000000000002 110.426 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.49 136.37 12.38 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.339 2.026 . . . . 75.239999999999995 111.852 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.521 ' HZ2' HD22 ' A' ' 88' ' ' LEU . 97.4 mttt -70.24 102.73 2.18 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.563 -1.273 . . . . 73.340000000000003 107.563 172.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.643 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 17.7 ptt180 -73.38 -66.93 0.63 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 115.182 1.549 . . . . 52.240000000000002 115.182 -154.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.643 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 25.2 t-20 -113.75 150.14 33.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.039 0.536 . . . . 74.140000000000001 110.495 -172.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 90' ' ' ASP . 85.5 mttt -70.12 115.71 36.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.098 -1.075 . . . . 63.100000000000001 108.098 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.635 ' HB2' HD22 ' A' ' 133' ' ' ASN . 23.6 Cg_exo -63.78 137.58 59.19 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.643 2.228 . . . . 54.049999999999997 111.933 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 25.5 m -68.81 122.29 18.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.151 0.58 . . . . 45.299999999999997 111.547 -172.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.427 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 58.0 t -92.34 128.27 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.594 -1.261 . . . . 74.200000000000003 107.594 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -104.01 112.48 25.48 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.214 0.461 . . . . 74.430000000000007 111.159 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.71 8.28 3.99 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 118.366 2.106 . . . . 74.0 118.366 159.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.66 129.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 119.256 1.528 . . . . 65.140000000000001 111.865 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 t -73.5 121.67 85.72 Favored Pre-proline 0 C--N 1.355 0.818 0 N-CA-C 106.431 -1.692 . . . . 65.430000000000007 106.431 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.484 ' HD2' HD21 ' A' ' 97' ' ' ASN . 82.0 Cg_exo . . . . . 0 C--N 1.374 1.872 0 C-N-CA 122.791 2.327 . . . . 73.310000000000002 116.452 -153.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.609 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 12.0 t90 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 120.799 0.333 . . . . 72.0 110.464 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -64.97 -17.06 64.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.568 0.747 . . . . 73.349999999999994 110.823 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 72' ' ' ASN . 20.0 m -77.49 4.0 12.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.524 1.129 . . . . 74.219999999999999 112.169 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -75.52 -47.78 25.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.708 0.803 . . . . 70.510000000000005 110.358 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.9 -24.55 64.32 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 120.836 0.351 . . . . 64.099999999999994 110.424 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 69' ' ' SER . 10.7 m120 -89.43 -6.43 56.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.007 0.923 . . . . 75.209999999999994 111.634 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.22 -52.15 64.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.346 1.058 . . . . 60.549999999999997 112.219 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.91 16.14 26.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.605 0.762 . . . . 71.239999999999995 110.36 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 C-N-CA 123.35 0.66 . . . . 61.350000000000001 112.035 -177.248 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 CA--C 1.553 1.066 0 CA-C-O 120.658 0.266 . . . . 74.540000000000006 111.099 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 106' ' ' LYS . 26.2 tp -96.16 126.83 41.65 Favored 'General case' 0 C--N 1.357 0.917 0 CA-C-O 121.65 0.738 . . . . 62.420000000000002 110.085 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -113.95 173.71 6.3 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.417 1.487 . . . . 75.230000000000004 108.257 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.47 139.19 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.088 0.955 . . . . 60.310000000000002 109.04 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.478 ' HA ' HG22 ' A' ' 135' ' ' ILE . . . -74.4 120.4 19.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.213 0.605 . . . . 70.430000000000007 110.137 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 143' ' ' LYS . 83.8 mt -86.03 -34.97 20.6 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.462 0.705 . . . . 73.040000000000006 110.704 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -123.78 146.19 48.5 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.131 -0.941 . . . . 74.219999999999999 108.879 -175.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.1 144.76 44.83 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.734 0.646 . . . . 71.150000000000006 109.409 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.592 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.6 t80 -142.18 140.5 32.4 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.437 -0.949 . . . . 61.43 108.437 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 68.0 t -110.99 134.82 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 108.209 -1.034 . . . . 62.119999999999997 108.209 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.68 116.27 2.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.167 0.987 . . . . 72.109999999999999 111.239 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.8 p -107.91 26.03 10.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.227 1.011 . . . . 55.100000000000001 110.209 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.27 177.52 43.49 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.086 -0.961 . . . . 51.329999999999998 110.929 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.71 -38.18 54.78 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.007 0.523 . . . . 72.239999999999995 111.254 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -84.32 -23.33 30.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.966 0.506 . . . . 71.319999999999993 111.152 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.6 p -72.92 153.99 40.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.151 0.58 . . . . 71.140000000000001 111.521 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.8 tp -127.06 129.05 47.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.388 0.675 . . . . 65.200000000000003 110.968 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -69.66 130.56 42.71 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.692 0.797 . . . . 73.310000000000002 109.997 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.657 HG22 HG21 ' A' ' 123' ' ' THR . 22.0 pt -129.25 147.5 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 72.019999999999996 110.67 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -106.93 140.58 39.52 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.84 -1.17 . . . . 65.439999999999998 107.84 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -62.45 147.43 48.71 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 123.5 0.5 . . . . 73.310000000000002 110.271 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.74 -28.74 10.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.984 -0.342 . . . . 61.130000000000003 112.794 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.3 146.01 33.19 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.229 0.515 . . . . 74.299999999999997 111.04 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HB3' HD11 ' A' ' 84' ' ' LEU . 39.9 mmtm -90.02 142.68 27.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.129 0.971 . . . . 71.530000000000001 109.696 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.586 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -145.57 146.1 31.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.861 0.865 . . . . 73.040000000000006 110.115 -178.698 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -99.65 107.06 19.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.811 0.444 . . . . 65.200000000000003 110.063 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.538 HG13 ' HB1' ' A' ' 119' ' ' ALA . 53.5 t -79.02 119.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.873 -0.788 . . . . 62.439999999999998 108.873 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -116.8 -8.68 11.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.055 -175.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.83 140.74 6.48 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 121.263 -0.494 . . . . 43.119999999999997 112.885 171.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.404 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 74.4 m-85 -97.03 174.92 6.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.918 0.887 . . . . 74.439999999999998 110.439 172.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -96.09 -173.16 2.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.987 -1.006 . . . . 54.140000000000001 110.445 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -52.44 -39.38 60.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.657 1.183 . . . . 51.420000000000002 114.115 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -108.14 6.62 27.0 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.814 0.446 . . . . 72.209999999999994 112.092 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 63.66 12.15 45.73 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 115.361 0.904 . . . . 53.219999999999999 115.361 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.76 -7.71 33.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.6 0.76 . . . . 75.310000000000002 111.636 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.5 ' HZ2' HG11 ' A' ' 244' ' ' VAL . 39.2 m95 -127.52 145.38 50.87 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.97 -1.122 . . . . 65.239999999999995 107.97 167.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.538 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -148.02 125.78 11.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.274 -0.876 . . . . 51.109999999999999 109.219 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 37.9 tt0 -67.34 123.29 19.95 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 108.268 -1.012 . . . . 71.409999999999997 108.268 171.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -126.98 145.71 50.6 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.76 0.824 . . . . 65.549999999999997 110.215 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -101.92 100.31 10.59 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.12 -1.067 . . . . 60.219999999999999 108.12 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.657 HG21 HG22 ' A' ' 101' ' ' ILE . 67.0 p -82.27 165.85 20.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.309 0.644 . . . . 73.109999999999999 109.831 173.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -20.45 66.09 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 121.462 0.649 . . . . 65.519999999999996 109.445 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -79.38 -29.94 42.3 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.087 1.355 . . . . 74.099999999999994 112.297 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.33 -165.3 36.59 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 119.872 -0.405 . . . . 62.109999999999999 112.588 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -128.03 144.75 51.11 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.033 0.916 . . . . 72.549999999999997 110.367 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.13 178.42 36.0 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 112.589 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 75.1 m95 -75.07 118.4 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.324 1.05 . . . . 73.209999999999994 112.49 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.2 m -118.14 152.47 50.53 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 124.23 1.012 . . . . 35.32 108.428 174.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.12 129.07 17.59 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 121.772 1.648 . . . . 53.020000000000003 111.206 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 m -64.4 -25.84 68.19 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.099 0.96 . . . . 64.420000000000002 112.295 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -80.41 -5.48 56.57 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.236 1.015 . . . . 74.209999999999994 111.875 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -96.87 -13.98 22.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.072 0.949 . . . . 74.420000000000002 110.944 173.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 87' ' ' ALA . 16.1 pt -125.83 172.34 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.752 0.821 . . . . 73.040000000000006 110.585 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.417 HG21 ' HB2' ' A' ' 142' ' ' GLU . 2.5 m -159.63 142.35 10.15 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.403 1.081 . . . . 64.409999999999997 108.959 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.72 139.64 58.1 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.161 1.908 . . . . 70.219999999999999 112.237 170.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.8 t -70.19 -6.05 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 121.603 0.716 . . . . 73.200000000000003 109.966 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -85.85 -21.16 28.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.831 0.852 . . . . 71.319999999999993 112.756 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.3 p -102.11 179.01 4.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.383 0.673 . . . . 53.299999999999997 112.576 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.74 -22.24 37.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.429 1.092 . . . . 73.140000000000001 112.177 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.417 ' HB2' HG21 ' A' ' 136' ' ' THR . 3.1 mp0 -69.5 -13.87 62.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.075 0.95 . . . . 71.0 112.223 -172.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.534 ' HA ' HD21 ' A' ' 88' ' ' LEU . 22.2 pttm -69.88 -11.38 60.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.49 0.716 . . . . 70.140000000000001 112.175 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -87.05 143.37 27.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.293 0.637 . . . . 62.340000000000003 110.582 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 p -68.13 -33.29 74.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.29 1.036 . . . . 75.530000000000001 112.765 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -71.17 -33.28 69.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 74.25 111.46 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -78.43 112.79 15.82 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.52 -0.918 . . . . 74.400000000000006 108.52 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.46 -20.13 13.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.5 0.72 . . . . 71.409999999999997 111.345 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.95 -150.27 42.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 118.545 -1.142 . . . . 72.209999999999994 111.974 -174.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.03 100.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.66 2.907 . . . . 73.319999999999993 113.437 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.9 t -131.93 150.13 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.954 1.302 . . . . 72.140000000000001 108.94 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.3 p -90.95 175.19 7.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.368 0.667 . . . . 53.210000000000001 111.434 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -60.69 3.13 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.494 1.117 . . . . 63.140000000000001 110.886 -177.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.1 -29.03 70.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.936 0.895 . . . . 75.120000000000005 111.255 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.59 83.35 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 123.786 0.679 . . . . 64.099999999999994 110.944 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.78 -44.41 93.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.807 0.692 . . . . 64.510000000000005 110.84 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.99 -44.58 82.84 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.538 -0.755 . . . . 74.340000000000003 111.337 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.11 -44.46 88.68 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.592 -1.186 . . . . 74.030000000000001 111.888 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 237' ' ' PRO . 87.0 mt -59.8 -39.5 85.2 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.19 0.996 . . . . 73.129999999999995 111.571 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 90.8 mt -81.05 -27.53 35.71 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.283 -0.871 . . . . 70.329999999999998 112.074 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.9 p -68.39 -10.02 52.22 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 118.379 0.536 . . . . 51.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.9 p -103.55 21.16 16.57 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.62 1.168 . . . . 71.310000000000002 111.122 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.71 -178.15 15.19 Favored Glycine 0 C--N 1.353 1.499 0 C-N-CA 123.347 0.499 . . . . 51.149999999999999 113.79 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.4 pt -96.79 178.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.381 1.072 . . . . 74.439999999999998 112.06 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.47 112.46 5.31 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.158 -1.052 . . . . 71.319999999999993 108.158 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.59 24.89 Favored Glycine 0 CA--C 1.528 0.89 0 O-C-N 123.742 0.651 . . . . 61.399999999999999 112.746 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 184' ' ' LEU . 73.3 m -76.56 139.96 40.9 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.567 0.684 . . . . 75.430000000000007 110.868 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.2 p90 -148.78 163.53 37.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.068 0.461 . . . . 75.109999999999999 110.538 -175.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.1 pp -157.73 149.71 22.16 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.359 -0.837 . . . . 64.510000000000005 108.961 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.734 HG22 HG12 ' A' ' 182' ' ' ILE . 93.9 t -109.0 120.78 61.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.114 -1.069 . . . . 44.009999999999998 108.114 168.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.504 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 24.2 ptt85 -114.54 164.51 13.9 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.651 1.18 . . . . 71.25 108.452 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.16 160.84 20.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.98 0.912 . . . . 72.219999999999999 108.697 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.7 t -79.68 124.18 28.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.498 -0.556 . . . . 62.43 109.498 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.52 -36.24 83.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.85 0.86 . . . . 71.400000000000006 110.54 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.1 p -69.75 -31.27 69.14 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.897 0.879 . . . . 53.119999999999997 112.071 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 m -150.91 119.43 3.5 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.034 0.534 . . . . 64.519999999999996 110.305 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.8 154.4 74.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.832 2.355 . . . . 61.100000000000001 112.198 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.16 -31.22 8.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.004 -0.543 . . . . 65.230000000000004 112.316 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.59 112.19 17.72 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.93 -1.137 . . . . 72.129999999999995 107.93 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.572 ' H ' ' NH2' ' A' ' 194' ' ' ARG . 98.4 mtt180 -124.28 127.32 47.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.553 0.741 . . . . 73.310000000000002 110.068 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.1 m -125.28 145.51 49.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.74 0.816 . . . . 52.229999999999997 110.206 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.734 HG12 HG22 ' A' ' 170' ' ' VAL . 20.9 mt -100.12 143.93 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 107.696 -1.224 . . . . 65.340000000000003 107.696 173.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.2 m -125.61 109.84 13.12 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 176.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 167' ' ' SER . 32.0 tp -105.35 112.91 26.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.956 0.503 . . . . 51.149999999999999 110.994 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 76.1 ttt180 -78.25 110.97 13.73 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.54 -0.911 . . . . 71.030000000000001 108.54 163.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -133.1 125.88 30.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.009 1.324 . . . . 75.329999999999998 108.718 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 58.54 30.84 20.33 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.339 1.055 . . . . 60.350000000000001 110.433 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.482 ' HA2' ' HE ' ' A' ' 185' ' ' ARG . . . 79.84 -13.23 25.47 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-N 114.678 -1.146 . . . . 43.210000000000001 113.824 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 58.0 mtp85 -93.63 125.53 38.3 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.289 0.636 . . . . 62.420000000000002 109.406 -171.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.93 106.56 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.104 0.562 . . . . 64.030000000000001 110.847 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -96.51 131.99 42.56 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.586 1.154 . . . . 71.400000000000006 108.796 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -110.39 117.82 34.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.213 0.53 . . . . 62.32 111.439 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.453 ' HE1' HD21 ' A' ' 232' ' ' LEU . 2.8 m-30 -95.33 138.71 32.64 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 124.767 1.227 . . . . 70.140000000000001 108.768 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.572 ' NH2' ' H ' ' A' ' 180' ' ' ARG . 1.8 tpm_? -112.0 109.04 18.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 106.873 -1.528 . . . . 52.409999999999997 106.873 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -68.8 103.56 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 123.55 0.531 . . . . 73.409999999999997 110.759 -171.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -68.85 143.44 54.55 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.671 0.788 . . . . 75.340000000000003 110.414 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.6 m -119.99 118.78 31.57 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.506 0.722 . . . . 71.430000000000007 109.702 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.35 159.83 33.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.668 0.787 . . . . 55.399999999999999 109.907 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.5 m -62.24 -22.83 66.28 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.632 0.975 . . . . 75.230000000000004 113.632 -170.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -90.24 -13.98 34.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.96 0.904 . . . . 51.109999999999999 112.03 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.42 12.9 12.48 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 114.501 0.561 . . . . 63.329999999999998 114.501 176.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -74.16 146.45 43.46 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.941 0.87 . . . . 62.32 111.254 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.4 150.3 24.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.931 0.892 . . . . 73.109999999999999 109.269 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.521 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 28.7 p90 -173.14 130.16 0.47 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.993 0.808 . . . . 74.420000000000002 109.492 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.482 HG23 HD11 ' A' ' 217' ' ' LEU . 79.2 t -70.8 -53.78 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.092 -1.077 . . . . 72.299999999999997 108.092 163.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.6 m -103.08 138.99 39.19 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.674 -1.603 . . . . 65.439999999999998 110.147 -170.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.0 t -68.55 -10.46 55.86 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.041 0.936 . . . . 73.340000000000003 112.45 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.0 -29.36 61.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.306 1.042 . . . . 71.040000000000006 112.423 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.31 116.56 7.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.611 0.364 . . . . 73.030000000000001 110.219 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.521 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 95.7 mtt180 -97.98 132.2 43.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.696 0.798 . . . . 73.310000000000002 109.305 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -113.11 156.67 22.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.196 0.998 . . . . 72.329999999999998 109.371 -173.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -78.43 -29.83 47.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.726 -0.67 . . . . 71.439999999999998 109.844 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 35.2 p -137.34 159.15 42.76 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.852 0.834 . . . . 61.109999999999999 112.153 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.465 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -64.14 -31.64 72.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.809 1.243 . . . . 75.420000000000002 110.099 177.013 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.88 -37.83 80.47 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.09 0.556 . . . . 53.409999999999997 111.299 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -77.79 -32.17 52.3 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.706 -0.679 . . . . 70.430000000000007 111.335 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.482 HD11 HG23 ' A' ' 205' ' ' VAL . 18.3 tp -54.69 -55.52 28.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.894 -0.41 . . . . 71.329999999999998 109.894 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.72 -44.38 98.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 O-C-N 124.251 0.969 . . . . 65.0 110.453 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -61.09 -57.7 11.46 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 123.451 0.469 . . . . 73.409999999999997 111.982 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -62.32 -38.75 90.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.052 -0.522 . . . . 55.100000000000001 110.967 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.655 ' HB3' HD11 ' A' ' 228' ' ' LEU . 16.2 m170 -84.84 -6.59 59.35 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.518 0.562 . . . . 63.039999999999999 112.518 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 86.7 p -95.75 -29.25 14.36 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.742 0.417 . . . . 75.310000000000002 111.16 172.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 38.0 p -81.55 -43.19 19.06 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.323 -0.398 . . . . 62.229999999999997 110.72 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 226' ' ' ASP . 28.9 m -126.65 160.84 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.405 0.682 . . . . 73.400000000000006 111.644 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.78 13.83 1.55 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.372 1.869 . . . . 64.239999999999995 114.624 -170.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.528 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.2 t70 -41.95 29.63 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 131.207 3.803 . . . . 74.109999999999999 120.148 -151.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.14 9.97 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 120.573 -1.329 . . . . 75.329999999999998 112.579 -169.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -90.56 162.56 14.95 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.762 1.225 . . . . 72.530000000000001 108.79 166.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.83 -36.57 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.474 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.2 t -159.84 -178.71 7.25 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.562 0.745 . . . . 64.310000000000002 110.483 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.5 p -66.99 143.34 56.85 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.114 0.965 . . . . 65.219999999999999 111.844 175.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.453 HD21 ' HE1' ' A' ' 193' ' ' TYR . 41.8 mt -74.89 146.44 41.88 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 107.802 -1.184 . . . . 73.209999999999994 107.802 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -147.72 -45.68 0.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 120.134 1.334 . . . . 72.209999999999994 113.833 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -112.55 133.31 21.87 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.323 0.649 . . . . 74.25 109.445 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 67.5 Cg_endo -87.39 124.45 2.01 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.388 2.059 . . . . 71.219999999999999 110.259 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.447 ' HB2' HD23 ' A' ' 160' ' ' LEU . . . -62.39 144.36 95.29 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.002 -0.74 . . . . 71.099999999999994 109.002 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.486 ' O ' HD22 ' A' ' 159' ' ' LEU . 86.8 Cg_endo -75.81 -178.82 4.61 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.242 1.961 . . . . 73.239999999999995 112.718 -177.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -85.48 138.12 32.44 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.637 -1.245 . . . . 73.400000000000006 107.637 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.463 ' HB3' HD21 ' A' ' 159' ' ' LEU . 15.0 ptt180 -90.42 -57.33 2.87 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.351 0.978 . . . . 74.299999999999997 111.257 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -106.78 136.68 46.18 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.156 0.583 . . . . 72.439999999999998 110.443 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -82.85 116.96 66.92 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.076 -1.453 . . . . 71.329999999999998 107.076 162.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.03 127.63 15.21 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.896 3.064 . . . . 71.450000000000003 113.901 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.5 m -75.1 122.01 22.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.939 0.495 . . . . 74.010000000000005 111.13 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.5 HG11 ' HZ2' ' A' ' 118' ' ' TRP . 95.2 t -94.2 120.99 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.281 -1.007 . . . . 73.120000000000005 108.281 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -105.17 112.53 25.69 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.608 -0.516 . . . . 71.150000000000006 109.608 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.54 -28.44 0.22 Allowed Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.514 2.166 . . . . 54.140000000000001 118.514 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.1 m -72.03 132.0 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 118.856 1.328 . . . . 72.349999999999994 114.359 -160.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.8 t -73.45 122.99 88.99 Favored Pre-proline 0 C--N 1.355 0.83 0 N-CA-C 106.288 -1.745 . . . . 70.040000000000006 106.288 160.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 C--N 1.375 1.944 0 C-N-CA 121.833 1.688 . . . . 62.020000000000003 113.838 -158.98 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.2 t90 . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.167 0.508 . . . . 64.510000000000005 111.376 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 29.7 p-10 -88.09 -22.66 24.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.684 -0.689 . . . . 71.540000000000006 109.264 165.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.4 m -67.64 2.85 1.63 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.776 1.23 . . . . 74.329999999999998 113.381 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -70.01 -26.96 64.3 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.995 0.518 . . . . 72.310000000000002 110.997 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 13.2 pt-20 -77.54 -21.64 52.27 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.095 0.474 . . . . 74.040000000000006 110.327 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -91.66 -2.34 57.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.818 1.247 . . . . 41.310000000000002 110.827 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.31 -47.76 80.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.241 1.017 . . . . 63.530000000000001 111.733 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.1 mt -99.15 26.6 5.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.421 0.688 . . . . 72.340000000000003 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.19 0.596 . . . . 74.209999999999994 111.724 178.408 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.036 0.446 . . . . 65.409999999999997 111.47 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 tp -89.55 122.12 32.41 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.734 -0.839 . . . . 73.239999999999995 108.734 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.7 m-85 -108.87 174.52 5.83 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.811 1.244 . . . . 71.439999999999998 109.099 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.96 138.88 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.109 1.364 . . . . 45.210000000000001 108.957 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.02 114.18 14.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 50.109999999999999 110.517 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.24 -35.62 66.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.288 0.635 . . . . 71.420000000000002 111.071 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.446 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 32.5 m-85 -122.96 143.96 49.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.512 -0.921 . . . . 75.510000000000005 108.512 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 6.3 p-10 -70.42 148.05 48.79 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 109.178 -0.675 . . . . 74.549999999999997 109.178 167.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.563 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.6 t80 -147.17 141.57 26.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.127 -1.064 . . . . 72.219999999999999 108.127 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.7 139.97 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.236 -1.024 . . . . 72.019999999999996 108.236 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.22 115.72 3.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.536 0.734 . . . . 75.209999999999994 111.009 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -93.24 -55.93 3.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.328 1.051 . . . . 75.430000000000007 109.704 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.54 -173.44 38.32 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.398 -0.819 . . . . 65.030000000000001 113.452 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.68 -38.94 80.73 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.278 1.031 . . . . 75.239999999999995 111.759 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -98.95 -12.85 20.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.906 0.882 . . . . 74.319999999999993 112.036 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.4 p -72.33 135.04 45.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.784 -0.451 . . . . 54.140000000000001 109.784 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.6 ' HB3' HG13 ' A' ' 130' ' ' VAL . 66.4 tp -103.42 130.91 50.85 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.411 0.684 . . . . 73.319999999999993 110.394 -174.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -70.94 125.74 27.67 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.722 -0.844 . . . . 62.340000000000003 108.722 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.612 HG22 HG21 ' A' ' 123' ' ' THR . 22.8 pt -125.47 144.86 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.604 0.762 . . . . 65.25 110.08 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 10.1 m -88.72 144.94 25.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.676 -0.861 . . . . 64.239999999999995 108.676 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 62.5 tttp -65.69 110.97 2.97 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.796 0.438 . . . . 61.119999999999997 110.616 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.13 -10.88 55.28 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.013 -0.54 . . . . 61.409999999999997 112.931 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.645 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.5 tt0 -71.27 130.84 42.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.784 0.834 . . . . 74.349999999999994 110.533 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -77.27 147.63 36.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.953 -0.758 . . . . 65.409999999999997 108.953 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.614 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -147.98 142.2 26.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.798 0.439 . . . . 51.229999999999997 111.222 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 19.6 tpp180 -89.12 107.26 18.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.526 -0.761 . . . . 54.219999999999999 109.214 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.6 HG13 ' HB1' ' A' ' 119' ' ' ALA . 77.7 t -88.81 102.59 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.443 -0.577 . . . . 64.319999999999993 109.443 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 122' ' ' GLN . 2.2 mm? -67.53 -41.06 84.96 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.17 -0.923 . . . . 71.450000000000003 110.153 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.45 151.15 11.6 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.321 -0.854 . . . . 64.319999999999993 112.201 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 56.7 m-85 -88.35 174.45 8.15 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.791 0.836 . . . . 71.239999999999995 110.633 174.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -80.22 -176.34 5.54 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.614 -0.721 . . . . 71.0 109.217 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -54.63 -36.59 64.68 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.043 0.937 . . . . 71.25 113.296 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -112.48 10.46 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.077 0.769 . . . . 63.030000000000001 113.077 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.52 26.14 74.52 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.978 0.751 . . . . 70.310000000000002 114.978 171.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -80.81 -65.74 0.97 Allowed 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 109.027 -0.731 . . . . 71.329999999999998 109.027 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.416 ' HB3' ' HE3' ' A' ' 129' ' ' TRP . 73.8 m95 -90.59 150.94 21.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.015 0.926 . . . . 53.399999999999999 111.082 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.6 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.64 132.2 32.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.959 0.903 . . . . 71.120000000000005 110.641 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -76.85 107.48 9.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.889 -0.782 . . . . 70.219999999999999 108.889 167.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -112.52 149.71 32.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.989 0.916 . . . . 61.229999999999997 110.89 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.536 ' HG3' HD21 ' A' ' 110' ' ' LEU . 56.1 mt-30 -112.39 123.15 49.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.899 0.879 . . . . 74.120000000000005 109.498 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.612 HG21 HG22 ' A' ' 101' ' ' ILE . 44.1 p -124.01 174.78 7.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.716 1.207 . . . . 60.439999999999998 110.824 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -58.05 -27.31 63.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.68 1.192 . . . . 73.400000000000006 110.696 167.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.79 -30.87 59.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.525 1.13 . . . . 72.120000000000005 111.299 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 138.03 -177.23 20.16 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.188 -0.229 . . . . 51.229999999999997 112.921 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -86.79 138.9 31.21 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.921 0.488 . . . . 63.409999999999997 109.948 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -178.33 -173.48 43.75 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.243 -0.743 . . . . 63.210000000000001 111.243 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.416 ' HE3' ' HB3' ' A' ' 118' ' ' TRP . 32.7 m95 -110.76 120.79 43.57 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.513 0.725 . . . . 74.0 111.426 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.6 HG13 ' HB3' ' A' ' 99' ' ' LEU . 31.0 m -127.99 143.33 47.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 125.207 1.403 . . . . 73.209999999999994 108.969 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 4.6 Cg_endo -86.07 156.25 9.84 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.385 2.057 . . . . 72.319999999999993 114.39 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.3 m -36.5 -40.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 127.038 2.135 . . . . 54.130000000000003 114.691 170.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.407 HD22 ' HB2' ' A' ' 242' ' ' PRO . 35.6 p-10 -65.98 -22.21 66.45 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.326 0.65 . . . . 71.400000000000006 111.977 -172.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 38.1 m-85 -98.6 -20.04 17.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.806 0.842 . . . . 64.099999999999994 112.387 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -122.8 171.11 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.332 0.653 . . . . 63.119999999999997 112.249 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.4 t -161.3 153.9 17.19 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.353 -0.98 . . . . 72.010000000000005 108.353 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 54.3 Cg_exo -55.23 149.36 45.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 121.743 1.629 . . . . 72.140000000000001 112.351 172.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.88 -12.63 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.94 0.876 . . . . 72.400000000000006 109.852 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -87.22 -6.15 58.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.082 0.953 . . . . 73.25 111.516 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.3 p -89.11 174.26 7.98 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.924 0.489 . . . . 70.239999999999995 111.553 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.17 -23.63 30.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.507 -0.77 . . . . 62.030000000000001 110.849 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.64 -22.19 64.42 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.828 0.851 . . . . 65.340000000000003 111.929 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -59.55 -22.14 61.27 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.054 0.541 . . . . 72.049999999999997 111.91 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -82.55 139.59 33.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.522 0.729 . . . . 74.340000000000003 110.399 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.6 p -60.02 -42.17 93.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.695 1.198 . . . . 64.439999999999998 112.353 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -65.99 -38.42 88.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.734 0.813 . . . . 75.439999999999998 112.568 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.12 109.96 15.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.386 -0.598 . . . . 64.040000000000006 109.386 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.413 ' HB2' HG21 ' A' ' 151' ' ' VAL . 28.5 m170 -104.71 -9.78 17.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.009 0.524 . . . . 73.439999999999998 111.832 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.54 -132.26 27.14 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 118.208 -1.329 . . . . 52.240000000000002 112.294 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.88 95.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.254 2.636 . . . . 73.230000000000004 112.764 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.619 HG22 ' HE ' ' A' ' 239' ' ' ARG . 46.9 t -136.95 126.94 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.431 1.093 . . . . 61.520000000000003 108.956 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.6 p -76.29 172.51 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.307 0.643 . . . . 71.530000000000001 110.762 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -62.8 -48.46 79.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.739 0.416 . . . . 73.299999999999997 109.903 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -59.17 -35.88 74.32 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.113 0.883 . . . . 72.230000000000004 111.089 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -67.64 -47.84 68.41 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.602 -0.726 . . . . 72.450000000000003 111.182 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.36 86.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.409 -0.814 . . . . 73.319999999999993 110.798 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -81.94 -20.27 39.01 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.154 -0.93 . . . . 51.350000000000001 111.914 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -81.03 -24.7 37.7 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.156 0.889 . . . . 74.340000000000003 111.063 174.598 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.59 HD21 ' HB3' ' A' ' 239' ' ' ARG . 65.4 mt -71.35 -46.24 60.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 51.329999999999998 110.12 168.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 40.4 mt -92.47 20.33 6.33 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.128 -0.942 . . . . 74.129999999999995 111.935 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.6 p -90.4 -37.66 13.83 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.392 -0.596 . . . . 43.399999999999999 109.392 166.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.0 p -96.38 -11.64 25.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.458 0.703 . . . . 54.25 111.179 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.67 166.21 35.66 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 123.439 0.462 . . . . 64.340000000000003 113.89 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 pt -98.35 -178.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.83 0.852 . . . . 73.349999999999994 111.703 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -68.03 125.66 27.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.97 -0.559 . . . . 61.439999999999998 109.98 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.93 9.65 65.66 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-O 119.084 -0.842 . . . . 73.219999999999999 112.794 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.8 m -75.56 135.76 40.56 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 118.093 0.947 . . . . 73.120000000000005 110.396 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 183' ' ' SER . 17.1 p90 -147.28 162.96 37.88 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.708 0.403 . . . . 72.5 110.63 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -160.51 148.33 16.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.537 -0.756 . . . . 71.400000000000006 109.324 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.652 HG22 HG12 ' A' ' 182' ' ' ILE . 70.8 t -101.55 125.17 55.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.168 -1.049 . . . . 72.340000000000003 108.168 169.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.59 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt180 -115.67 151.11 35.66 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.255 1.022 . . . . 71.329999999999998 108.418 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.96 149.96 36.51 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.573 -1.269 . . . . 72.340000000000003 107.573 165.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.6 t -81.04 120.85 25.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.111 0.564 . . . . 63.149999999999999 110.37 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.72 -36.03 77.82 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.152 0.981 . . . . 72.340000000000003 109.862 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.3 m -68.47 -34.04 75.24 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.631 0.773 . . . . 64.530000000000001 111.642 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.5 m -140.98 91.6 8.93 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.381 0.673 . . . . 72.420000000000002 110.969 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.1 124.93 17.46 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.158 2.572 . . . . 72.219999999999999 112.545 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.58 -28.92 11.84 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.815 -0.436 . . . . 63.310000000000002 112.76 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -74.38 116.69 15.34 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.844 -0.799 . . . . 75.129999999999995 108.844 173.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.515 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 72.3 mtt85 -123.84 144.35 49.79 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.462 0.705 . . . . 71.5 109.252 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.1 m -138.26 146.28 42.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.063 -0.971 . . . . 72.349999999999994 108.561 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.652 HG12 HG22 ' A' ' 170' ' ' VAL . 28.5 mt -100.41 149.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 106.589 -1.634 . . . . 72.310000000000002 106.589 168.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.1 m -124.52 120.07 30.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.474 -1.306 . . . . 73.219999999999999 107.474 170.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.6 tp -114.07 112.01 22.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.828 0.74 . . . . 71.510000000000005 110.399 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.546 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 32.9 ttt85 -78.07 114.44 16.96 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 109.258 -0.645 . . . . 71.319999999999993 109.258 165.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -136.9 132.3 34.31 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.08 -1.082 . . . . 71.049999999999997 108.08 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 59.36 28.59 17.98 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.7 1.2 . . . . 64.540000000000006 111.488 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.19 -9.81 56.14 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.889 -0.596 . . . . 72.120000000000005 114.034 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -96.49 124.1 40.37 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.085 0.954 . . . . 74.150000000000006 108.781 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.82 108.08 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 120.913 0.387 . . . . 74.120000000000005 110.104 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.99 151.07 21.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.56 1.144 . . . . 70.239999999999995 108.706 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -128.15 116.75 20.42 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.593 -0.521 . . . . 72.319999999999993 109.593 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.487 ' HE1' HD21 ' A' ' 232' ' ' LEU . 4.5 m-85 -95.74 149.59 21.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.412 1.085 . . . . 62.329999999999998 108.74 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -107.26 116.12 31.38 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.039 0.536 . . . . 74.409999999999997 109.577 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 45.3 mt -81.92 105.28 11.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.564 -0.902 . . . . 61.119999999999997 108.564 172.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -90.57 144.62 25.59 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.918 0.887 . . . . 64.209999999999994 109.288 173.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.8 m -98.39 128.97 45.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.903 0.881 . . . . 51.520000000000003 109.163 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 160.56 31.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.619 0.768 . . . . 71.420000000000002 109.951 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 40.9 p -62.64 -24.44 67.6 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.864 0.69 . . . . 64.140000000000001 112.864 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.07 -17.31 27.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.416 0.686 . . . . 65.439999999999998 111.372 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.55 14.02 9.17 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.451 0.94 . . . . 75.319999999999993 115.451 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -68.87 156.05 39.14 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.244 1.022 . . . . 74.439999999999998 110.492 170.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 146.8 34.2 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.413 -0.958 . . . . 63.109999999999999 108.413 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 30.7 p90 -167.97 141.52 3.32 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.681 0.613 . . . . 73.230000000000004 112.069 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.448 HG23 HD11 ' A' ' 217' ' ' LEU . 75.4 t -88.89 -31.87 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.186 -0.915 . . . . 71.219999999999999 108.87 162.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.7 m -105.54 123.04 47.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.301 1.04 . . . . 73.420000000000002 109.383 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -66.54 -24.7 66.41 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.163 0.585 . . . . 72.530000000000001 111.735 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.72 -15.18 57.15 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.41 1.084 . . . . 75.439999999999998 110.577 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.5 m -133.67 89.42 2.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.772 0.829 . . . . 70.409999999999997 109.338 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.469 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 52.9 mtt180 -97.11 120.04 36.71 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.725 0.81 . . . . 73.230000000000004 109.288 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.22 146.86 32.19 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.642 -0.873 . . . . 75.329999999999998 108.642 -174.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.21 -30.2 70.61 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 123.764 0.665 . . . . 72.209999999999994 111.622 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 75.2 p -132.08 158.79 40.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.32 0.648 . . . . 74.319999999999993 111.902 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.77 -28.56 67.71 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.471 1.108 . . . . 54.439999999999998 109.688 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.47 83.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.312 0.645 . . . . 73.310000000000002 110.668 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -77.33 -28.3 53.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.677 0.791 . . . . 72.209999999999994 111.666 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 205' ' ' VAL . 12.4 tp -58.33 -57.64 12.02 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.541 0.336 . . . . 72.519999999999996 110.254 170.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.54 -38.28 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.892 0.745 . . . . 63.32 110.739 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.15 -56.33 23.49 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.789 0.681 . . . . 73.019999999999996 111.301 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -65.21 -33.54 76.25 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.406 0.682 . . . . 73.140000000000001 110.844 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.697 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.6 m170 -89.29 -8.39 53.46 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.138 -0.483 . . . . 64.319999999999993 112.115 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.6 p -97.52 -22.89 16.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.041 0.537 . . . . 55.340000000000003 110.775 170.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 44.6 p -82.25 -43.2 17.9 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.796 0.439 . . . . 54.340000000000003 111.051 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' A' ' 226' ' ' ASP . 32.0 m -130.32 167.71 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.844 0.83 . . . . 64.340000000000003 111.57 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -80.48 13.93 2.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.839 2.056 . . . . 52.420000000000002 114.549 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.552 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.6 t70 -40.98 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 131.18 3.792 . . . . 73.530000000000001 119.82 -150.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.48 -3.94 10.22 Favored Glycine 0 N--CA 1.481 1.639 0 O-C-N 119.438 -2.039 . . . . 44.020000000000003 112.133 -166.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 221' ' ' HIS . 9.8 mt -89.59 162.49 15.62 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 125.139 1.375 . . . . 75.099999999999994 109.285 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.8 tt -57.5 -39.17 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-O 120.588 0.232 . . . . 75.219999999999999 110.499 168.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -162.64 175.62 11.2 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.492 0.717 . . . . 64.200000000000003 110.906 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.8 p -60.42 144.55 50.76 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.613 1.165 . . . . 65.129999999999995 112.209 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.487 HD21 ' HE1' ' A' ' 193' ' ' TYR . 78.4 mt -77.65 116.4 18.17 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.692 0.797 . . . . 61.210000000000001 109.353 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -104.94 -79.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.787 0.435 . . . . 74.450000000000003 111.308 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 167' ' ' SER . 46.3 t80 -90.39 121.52 68.38 Favored Pre-proline 0 C--O 1.213 -0.844 0 C-N-CA 123.7 0.8 . . . . 41.32 109.486 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.21 134.32 10.26 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.001 1.8 . . . . 71.219999999999999 111.228 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.17 151.35 92.42 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.492 0.717 . . . . 64.120000000000005 109.573 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -85.45 169.15 9.74 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.446 2.097 . . . . 60.340000000000003 113.873 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -59.05 119.19 6.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.006 0.922 . . . . 71.420000000000002 109.041 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.619 ' HE ' HG22 ' A' ' 151' ' ' VAL . 22.9 ptt85 -78.94 -59.67 2.69 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.794 1.035 . . . . 74.140000000000001 113.794 -161.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.415 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 49.2 t30 -106.98 122.0 45.58 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.84 0.856 . . . . 65.209999999999994 109.0 -176.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.69 113.75 22.57 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 106.953 -1.499 . . . . 74.209999999999994 106.953 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.407 ' HB2' HD22 ' A' ' 133' ' ' ASN . 60.0 Cg_endo -69.58 129.32 17.58 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.812 2.341 . . . . 44.409999999999997 112.521 -166.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.8 m -68.81 113.5 6.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.312 -0.858 . . . . 61.109999999999999 110.667 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.56 117.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.601 -1.259 . . . . 71.120000000000005 107.601 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -96.03 110.39 22.64 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 118.927 -0.558 . . . . 71.120000000000005 110.707 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 63.42 -38.19 0.08 OUTLIER Glycine 0 CA--C 1.55 2.26 0 N-CA-C 118.639 2.216 . . . . 60.200000000000003 118.639 166.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.96 125.51 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.809 0.844 . . . . 75.25 113.226 -154.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.4 t -86.83 142.66 34.51 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 107.389 -1.338 . . . . 72.049999999999997 107.389 150.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 C--N 1.375 1.968 0 CA-C-N 120.834 1.334 . . . . 75.299999999999997 114.019 -167.561 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 5.4 t90 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 121.585 0.707 . . . . 73.439999999999998 109.611 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -85.65 -17.79 35.08 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.966 -1.015 . . . . 74.540000000000006 110.249 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.0 p -87.42 5.42 38.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.952 0.901 . . . . 74.239999999999995 111.684 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -64.34 -30.32 71.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.745 0.418 . . . . 64.0 111.553 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.24 -33.16 75.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.166 -0.47 . . . . 75.310000000000002 110.482 172.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -75.97 -17.95 59.51 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.575 0.75 . . . . 74.319999999999993 111.369 177.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.4 tp -55.48 -51.66 66.22 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.093 0.557 . . . . 74.109999999999999 110.73 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.11 14.84 23.71 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.448 0.699 . . . . 74.409999999999997 111.213 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 C-N-CA 122.477 0.311 . . . . 71.430000000000007 111.261 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.429 0.157 . . . . 71.450000000000003 110.945 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -86.6 130.85 34.33 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 109.202 -0.666 . . . . 74.310000000000002 109.202 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -108.82 174.12 6.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.568 1.147 . . . . 72.439999999999998 108.975 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.44 139.36 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.666 1.186 . . . . 61.43 108.616 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.5 127.51 32.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.515 0.726 . . . . 71.340000000000003 110.739 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 143' ' ' LYS . 91.2 mt -83.55 -32.82 25.64 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.773 0.829 . . . . 62.539999999999999 111.916 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.43 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 25.8 m-85 -125.05 157.18 36.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.253 0.621 . . . . 65.200000000000003 109.485 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.62 119.16 23.93 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.384 -0.969 . . . . 61.329999999999998 108.384 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.606 ' HB3' HG12 ' A' ' 101' ' ' ILE . 79.7 t80 -119.03 138.62 52.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.532 -0.914 . . . . 72.040000000000006 108.532 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -104.95 131.08 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.437 -0.949 . . . . 63.020000000000003 108.437 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.26 56.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.23 0.612 . . . . 62.43 111.092 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -86.83 -42.94 12.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.414 0.686 . . . . 52.109999999999999 109.689 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.76 -167.77 11.17 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.584 -0.734 . . . . 71.099999999999994 112.561 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.92 -37.87 85.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.129 0.972 . . . . 71.239999999999995 110.835 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -66.91 -21.01 66.01 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.259 -1.337 . . . . 74.340000000000003 112.222 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.0 p -100.39 -179.15 4.03 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.842 0.857 . . . . 64.150000000000006 110.484 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.637 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 62.9 tp -144.31 139.69 28.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.917 0.487 . . . . 44.130000000000003 111.073 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 m -85.35 132.9 34.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.442 0.697 . . . . 74.430000000000007 109.7 174.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -133.01 148.8 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 120.953 0.406 . . . . 72.109999999999999 111.621 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.8 m -99.3 150.23 22.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.076 0.95 . . . . 51.509999999999998 108.73 174.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -64.84 126.92 29.47 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.739 -0.467 . . . . 73.129999999999995 109.739 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.02 -14.13 64.19 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.127 -0.488 . . . . 75.120000000000005 112.575 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 39.2 tt0 -74.76 128.0 34.5 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.794 0.838 . . . . 62.530000000000001 110.774 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.88 134.68 35.08 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.412 0.685 . . . . 71.120000000000005 110.325 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.4 OUTLIER -146.21 136.86 24.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.817 0.847 . . . . 74.319999999999993 110.631 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -96.65 115.12 26.9 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.506 0.323 . . . . 72.420000000000002 110.602 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.644 HG13 ' HB1' ' A' ' 119' ' ' ALA . 52.7 t -74.58 110.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.424 0.63 . . . . 75.5 109.707 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.67 -32.13 60.04 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.246 -1.343 . . . . 74.099999999999994 110.044 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.54 155.34 11.17 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.231 -0.895 . . . . 63.100000000000001 111.878 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.61 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 43.0 m-85 -87.47 175.5 7.93 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.472 0.654 . . . . 72.219999999999999 111.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -85.38 -173.05 4.47 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.935 -1.029 . . . . 74.219999999999999 110.928 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -44.38 -44.17 8.12 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.472 1.509 . . . . 74.200000000000003 114.296 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -112.61 0.28 15.37 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.911 0.708 . . . . 74.230000000000004 112.911 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.61 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 81.83 22.69 59.24 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 115.313 0.885 . . . . 71.299999999999997 115.313 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.48 -65.44 1.0 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.98 0.89 . . . . 71.030000000000001 110.012 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 49.2 m95 -92.3 150.4 20.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.194 0.598 . . . . 74.510000000000005 111.369 -174.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.644 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -133.3 137.34 45.94 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.438 1.095 . . . . 30.43 110.193 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -78.37 98.8 6.11 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.292 -1.003 . . . . 73.409999999999997 108.292 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -105.42 139.98 39.23 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.414 0.685 . . . . 64.129999999999995 110.339 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -102.27 105.7 16.39 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.216 -0.661 . . . . 71.310000000000002 109.216 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.462 HG21 HG22 ' A' ' 101' ' ' ILE . 69.4 p -80.4 168.42 19.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.952 0.783 . . . . 75.450000000000003 109.731 171.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -67.33 -8.19 30.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.607 -0.724 . . . . 75.420000000000002 111.537 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -91.4 -30.78 16.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.937 0.895 . . . . 74.019999999999996 110.958 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.28 174.68 24.64 Favored Glycine 0 C--N 1.36 1.886 0 N-CA-C 114.204 0.442 . . . . 44.130000000000003 114.204 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -86.62 142.49 28.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.809 0.843 . . . . 71.219999999999999 110.99 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.637 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -176.81 -170.01 38.8 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-N 114.945 -1.025 . . . . 53.310000000000002 110.646 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -109.77 129.34 55.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.817 0.808 . . . . 74.030000000000001 111.41 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' A' ' 99' ' ' LEU . 27.6 m -136.07 145.21 51.43 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 124.698 1.199 . . . . 65.349999999999994 109.188 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 47.4 Cg_endo -88.44 156.35 6.57 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 122.541 2.161 . . . . 65.319999999999993 114.312 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 m -38.33 -43.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.611 1.964 . . . . 64.540000000000006 114.137 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.54 HD22 ' HB2' ' A' ' 242' ' ' PRO . 36.4 p-10 -72.23 -11.33 60.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.097 0.559 . . . . 70.409999999999997 112.057 -174.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 28.7 m-85 -105.9 -13.5 15.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.983 0.913 . . . . 74.310000000000002 112.581 176.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 130' ' ' VAL . 16.8 pt -130.98 172.83 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.373 0.669 . . . . 71.439999999999998 111.696 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -162.01 152.02 14.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 108.428 -0.953 . . . . 71.540000000000006 108.428 172.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.23 149.52 44.73 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.04 1.826 . . . . 71.420000000000002 112.065 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.17 -23.36 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.093 0.473 . . . . 64.150000000000006 110.531 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -69.69 -18.61 63.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.941 0.896 . . . . 64.409999999999997 112.291 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.2 p -77.93 166.16 23.21 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.157 0.799 . . . . 74.340000000000003 113.157 -167.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -84.52 -19.73 32.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.815 -1.084 . . . . 72.25 110.663 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -71.13 -24.15 62.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.294 1.037 . . . . 72.409999999999997 111.35 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.529 ' HA ' HD21 ' A' ' 88' ' ' LEU . 21.3 pttm -62.08 -18.64 61.37 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.44 0.696 . . . . 74.340000000000003 112.868 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -76.7 149.28 36.42 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.472 0.709 . . . . 72.310000000000002 110.418 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.4 p -61.72 -43.24 99.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.95 0.9 . . . . 73.230000000000004 111.456 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -68.89 -34.56 75.61 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.062 0.851 . . . . 74.299999999999997 113.103 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.92 113.92 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.148 -0.686 . . . . 74.019999999999996 109.148 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.425 ' HD2' ' HD3' ' A' ' 238' ' ' LYS . 29.8 m170 -110.94 3.59 18.93 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.633 0.605 . . . . 75.209999999999994 112.633 -175.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.58 -148.04 38.03 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-O 118.861 -0.966 . . . . 64.150000000000006 112.771 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.81 97.54 0.23 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.02 2.48 . . . . 74.319999999999993 111.952 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 61.0 t -131.89 129.28 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.666 0.787 . . . . 61.049999999999997 110.003 -175.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -79.36 172.34 13.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.55 0.74 . . . . 35.340000000000003 110.392 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -60.35 -47.62 85.27 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.645 0.378 . . . . 71.219999999999999 110.803 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -57.09 -41.59 79.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.652 0.781 . . . . 64.519999999999996 111.89 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -72.14 -34.25 68.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.763 0.425 . . . . 71.439999999999998 111.325 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.25 91.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.484 0.659 . . . . 75.540000000000006 110.915 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -79.6 -21.23 45.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.418 -0.81 . . . . 54.009999999999998 110.88 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -64.61 -42.06 95.78 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.221 0.608 . . . . 71.420000000000002 109.623 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 239' ' ' ARG . 85.8 mt -64.76 -44.51 89.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.521 0.728 . . . . 70.219999999999999 111.692 174.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.5 13.72 13.15 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.959 -0.564 . . . . 63.409999999999997 112.17 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -65.39 -42.11 92.99 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.476 0.655 . . . . 72.209999999999994 110.002 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.3 p -102.58 19.61 18.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.59 1.156 . . . . 65.109999999999999 110.494 176.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.35 152.95 36.65 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.883 -0.599 . . . . 51.539999999999999 112.269 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 pt -102.31 -177.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.147 0.979 . . . . 74.200000000000003 110.709 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.41 120.95 10.29 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.176 0.59 . . . . 61.130000000000003 110.247 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.17 10.52 62.34 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.795 -0.639 . . . . 34.310000000000002 113.168 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 73.9 m -77.73 128.4 33.99 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.782 0.791 . . . . 72.319999999999993 110.044 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -139.69 164.34 30.2 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.381 0.61 . . . . 64.420000000000002 111.454 -170.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.5 pp -160.2 154.92 24.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.464 -1.244 . . . . 75.549999999999997 108.968 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 182' ' ' ILE . 87.5 t -110.14 127.93 66.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.533 -0.914 . . . . 63.32 108.533 168.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.574 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 20.4 ptt85 -115.66 155.36 27.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.41 -1.268 . . . . 65.120000000000005 108.514 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.52 147.46 40.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.257 -1.016 . . . . 74.439999999999998 108.257 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -87.33 129.08 35.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.687 -0.486 . . . . 70.239999999999995 109.687 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -80.7 -40.06 26.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.485 -0.779 . . . . 71.310000000000002 109.518 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.7 m -66.54 -33.07 74.85 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.999 0.92 . . . . 62.310000000000002 111.097 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -118.51 95.53 48.9 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 123.764 0.826 . . . . 41.310000000000002 109.529 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -58.14 126.55 21.89 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.322 2.681 . . . . 74.430000000000007 113.278 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.62 -27.52 8.66 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 116.242 -0.435 . . . . 54.130000000000003 113.152 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -66.65 136.3 55.35 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.353 0.661 . . . . 74.019999999999996 110.548 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -135.17 158.29 44.75 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.717 0.807 . . . . 72.230000000000004 109.793 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.4 m -147.37 150.1 34.05 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.432 1.093 . . . . 72.019999999999996 108.93 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.611 HG12 HG22 ' A' ' 170' ' ' VAL . 35.8 mt -103.93 149.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.954 -1.128 . . . . 73.420000000000002 107.954 173.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.2 m -125.09 110.85 14.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.286 -1.005 . . . . 72.25 108.286 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.1 tp -110.0 112.85 25.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.152 0.581 . . . . 52.109999999999999 110.104 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.503 ' HB2' HG22 ' A' ' 190' ' ' VAL . 39.1 ttt180 -78.47 114.79 17.69 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.268 0.556 . . . . 75.420000000000002 110.048 165.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.44 141.62 37.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.153 -1.385 . . . . 54.119999999999997 107.763 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 57.07 28.67 15.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.922 0.889 . . . . 75.099999999999994 111.575 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.42 -9.46 54.78 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-N 115.797 -0.638 . . . . 72.420000000000002 114.043 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -104.5 140.05 38.53 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.834 0.854 . . . . 73.230000000000004 109.839 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 185' ' ' ARG . 48.9 t -98.77 106.51 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.852 0.461 . . . . 63.409999999999997 110.457 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -91.16 141.62 28.62 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.016 0.926 . . . . 74.219999999999999 109.115 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -114.88 118.58 33.9 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.713 0.405 . . . . 74.310000000000002 110.019 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.425 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.4 m-30 -94.02 149.78 20.93 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.05 0.94 . . . . 74.5 108.738 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -101.07 127.45 47.6 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.792 -0.818 . . . . 74.430000000000007 108.792 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 101.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.826 -1.176 . . . . 63.43 107.826 171.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -79.02 132.92 36.81 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.501 -0.772 . . . . 61.119999999999997 109.045 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.8 m -93.76 113.74 25.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.293 -1.003 . . . . 72.430000000000007 108.293 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.11 159.17 33.43 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.559 0.537 . . . . 71.120000000000005 111.257 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.5 p -66.8 -27.91 67.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.578 -0.737 . . . . 71.329999999999998 110.94 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.3 -1.05 48.33 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.985 0.914 . . . . 72.329999999999998 111.343 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 98.26 -7.92 62.36 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.822 -0.432 . . . . 75.310000000000002 114.116 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.33 133.49 34.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.652 0.726 . . . . 55.240000000000002 111.745 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.416 ' H ' HD22 ' A' ' 203' ' ' LEU . 1.3 mm? -83.6 147.87 27.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.855 0.862 . . . . 75.019999999999996 108.913 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.554 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.3 p90 -166.53 151.46 7.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.967 0.413 . . . . 64.340000000000003 111.876 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.438 ' HB ' ' HE1' ' A' ' 221' ' ' HIS . 59.8 t -99.19 -35.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.577 -0.897 . . . . 63.100000000000001 108.577 165.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -103.78 125.76 50.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.095 0.958 . . . . 72.209999999999994 109.252 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.9 t -63.01 -30.15 71.38 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 71.299999999999997 112.207 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.58 -26.9 61.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.624 0.769 . . . . 72.030000000000001 111.099 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.1 m -121.85 96.68 5.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 74.340000000000003 110.063 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.554 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.0 mtt180 -100.02 140.66 33.93 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.789 0.836 . . . . 75.150000000000006 109.195 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 3.1 m-85 -127.0 140.55 52.23 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.374 0.67 . . . . 72.230000000000004 109.818 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.19 -27.03 63.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.241 0.616 . . . . 74.329999999999998 110.289 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -133.29 153.72 51.32 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.813 0.845 . . . . 64.209999999999994 110.745 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.498 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -67.54 -21.52 65.46 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.128 -0.942 . . . . 74.439999999999998 109.708 172.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.01 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.9 0.88 . . . . 71.219999999999999 110.398 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.3 mt-10 -69.42 -37.04 77.25 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.289 -0.868 . . . . 74.420000000000002 111.338 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 205' ' ' VAL . 13.8 tp -55.17 -57.86 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.374 0.421 . . . . 71.310000000000002 111.152 176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.9 -40.3 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.892 0.477 . . . . 51.43 111.355 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -59.15 -54.44 46.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.381 0.672 . . . . 74.340000000000003 111.004 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.423 ' O ' HG22 ' A' ' 224' ' ' VAL . 45.4 t60 -63.76 -38.21 90.25 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.797 0.839 . . . . 72.450000000000003 110.925 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.71 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.0 m-70 -85.8 -8.24 58.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.922 0.489 . . . . 64.040000000000006 112.002 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.8 p -93.66 -28.9 15.72 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.627 0.371 . . . . 54.450000000000003 110.308 169.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.6 p -77.65 -40.71 40.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.322 0.249 . . . . 73.209999999999994 111.113 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 220' ' ' HIS . 32.6 m -131.58 157.56 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.72 . . . . 74.340000000000003 111.487 -176.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.59 10.24 18.57 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.08 1.752 . . . . 62.43 113.874 -173.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -45.96 32.78 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 130.799 3.64 . . . . 75.430000000000007 120.428 -155.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 127.84 -1.11 6.8 Favored Glycine 0 N--CA 1.464 0.564 0 O-C-N 120.925 -1.109 . . . . 50.100000000000001 112.788 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.5 mt -91.58 161.38 14.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.51 1.124 . . . . 64.099999999999994 109.753 165.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -60.77 -36.37 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 120.816 0.341 . . . . 61.229999999999997 110.485 171.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.2 t -162.77 178.77 8.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.885 0.874 . . . . 75.530000000000001 109.471 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.5 p -63.78 143.77 57.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.24 0.616 . . . . 72.219999999999999 112.039 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.425 HD21 ' HE1' ' A' ' 193' ' ' TYR . 54.4 mt -69.5 138.15 53.12 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 108.159 -1.052 . . . . 70.25 108.159 169.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -135.95 -76.7 0.43 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.85 0.75 . . . . 75.120000000000005 112.238 -170.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -84.21 122.43 75.62 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.912 -0.773 . . . . 64.120000000000005 108.912 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.05 126.4 6.37 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 122.251 1.968 . . . . 64.420000000000002 111.918 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . . . -74.11 135.8 76.47 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.891 -0.781 . . . . 74.340000000000003 108.891 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.5 177.76 8.36 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.632 2.222 . . . . 52.5 112.322 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HD3' ' HD2' ' A' ' 148' ' ' HIS . 72.5 mmtt -63.52 157.12 24.41 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.752 0.821 . . . . 63.219999999999999 109.971 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 29.3 ptt180 -91.13 -62.56 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.06 0.763 . . . . 54.200000000000003 113.06 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.564 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 24.8 t-20 -110.68 158.56 18.47 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.821 0.848 . . . . 64.319999999999993 108.794 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 114.55 57.37 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 106.131 -1.803 . . . . 71.530000000000001 106.131 156.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.54 ' HB2' HD22 ' A' ' 133' ' ' ASN . 36.6 Cg_endo -62.79 124.9 14.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.41 2.074 . . . . 54.420000000000002 112.19 -169.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 33.8 m -71.29 117.8 13.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.819 0.847 . . . . 75.420000000000002 110.646 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.44 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 24.6 t -98.62 125.17 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.077 -1.083 . . . . 70.430000000000007 108.077 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.18 115.55 30.45 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.573 -0.251 . . . . 74.230000000000004 110.563 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.63 -3.36 0.25 Allowed Glycine 0 CA--C 1.54 1.626 0 N-CA-C 118.409 2.123 . . . . 63.409999999999997 118.409 161.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 11.9 m -91.53 122.99 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.372 1.586 . . . . 75.239999999999995 112.222 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 25.3 t -72.97 123.88 90.09 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 106.874 -1.528 . . . . 75.209999999999994 106.874 165.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo . . . . . 0 C--N 1.378 2.092 0 C-N-CA 122.321 2.014 . . . . 52.5 115.104 -153.795 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.3 t90 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 109.962 -0.385 . . . . 75.239999999999995 109.962 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -84.2 -36.08 23.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.314 0.646 . . . . 74.349999999999994 111.355 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.9 p -77.53 7.26 5.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.954 0.902 . . . . 52.219999999999999 112.702 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -62.04 -39.49 92.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.766 1.226 . . . . 64.420000000000002 111.21 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.0 -34.13 71.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 110.274 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -73.28 -12.86 61.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.398 0.679 . . . . 65.209999999999994 110.989 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.1 tp -67.29 -51.68 49.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.801 0.84 . . . . 52.210000000000001 111.868 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.4 mt -112.46 22.04 15.06 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.741 0.416 . . . . 72.219999999999999 110.133 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 62.409999999999997 112.036 177.071 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.057 0.456 . . . . 73.319999999999993 110.744 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.9 tp -77.34 131.56 38.16 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.634 -0.666 . . . . 71.439999999999998 109.527 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -115.54 173.12 6.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.446 1.099 . . . . 74.329999999999998 109.84 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.73 138.96 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.003 1.321 . . . . 43.240000000000002 108.84 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -79.72 138.23 37.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.511 0.724 . . . . 64.040000000000006 110.349 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 143' ' ' LYS . 82.7 mt -104.01 -35.48 8.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.728 0.811 . . . . 75.299999999999997 110.987 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.462 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 44.0 m-85 -122.48 140.93 52.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.194 -0.912 . . . . 74.5 108.874 -173.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 3.5 m-20 -68.5 124.87 24.75 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.984 -0.747 . . . . 73.400000000000006 108.984 171.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.637 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.2 t80 -114.24 139.45 49.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.261 -1.015 . . . . 74.310000000000002 108.261 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.97 131.82 59.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.523 -1.288 . . . . 74.340000000000003 107.523 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.71 119.13 4.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.839 0.855 . . . . 70.310000000000002 111.709 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.5 p -84.28 -27.31 27.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.498 0.719 . . . . 74.129999999999995 111.158 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -141.38 -169.62 11.96 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.805 -0.918 . . . . 61.130000000000003 110.805 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.68 -44.63 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.005 0.431 . . . . 65.329999999999998 111.257 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.549 HD21 ' HD2' ' A' ' 249' ' ' PRO . 26.5 p-10 -71.47 -24.68 62.04 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.151 -0.931 . . . . 63.439999999999998 111.657 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.0 p -79.99 160.28 25.96 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.332 0.653 . . . . 64.400000000000006 110.775 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.7 tp -133.44 136.4 45.16 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.968 0.507 . . . . 61.439999999999998 111.371 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 m -75.48 134.0 40.93 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.544 0.738 . . . . 63.340000000000003 111.312 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.637 HG12 ' HB3' ' A' ' 91' ' ' PHE . 21.8 pt -127.22 166.77 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.167 0.587 . . . . 72.409999999999997 111.818 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.0 m -126.42 157.19 39.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.727 -1.124 . . . . 62.240000000000002 110.479 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -47.29 119.57 2.71 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.227 1.011 . . . . 73.219999999999999 111.808 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.91 8.61 78.29 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 115.129 0.811 . . . . 71.239999999999995 115.129 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -68.53 122.24 18.06 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.268 0.627 . . . . 44.539999999999999 110.764 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -75.92 128.76 35.75 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.128 -0.693 . . . . 65.400000000000006 109.128 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -147.91 166.94 26.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.71 0.804 . . . . 75.329999999999998 110.783 -173.064 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -122.72 117.44 25.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.927 0.491 . . . . 75.230000000000004 110.151 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.606 HG13 ' HB1' ' A' ' 119' ' ' ALA . 41.6 t -81.05 112.38 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.196 0.598 . . . . 74.120000000000005 110.139 175.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.5 -35.17 40.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.442 -0.799 . . . . 62.329999999999998 109.965 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.98 147.56 6.09 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.437 0.461 . . . . 44.140000000000001 112.87 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.531 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 47.2 m-85 -86.95 162.78 17.49 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.381 0.672 . . . . 74.450000000000003 111.458 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -81.69 -173.73 4.6 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.302 -0.863 . . . . 64.510000000000005 110.361 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -52.5 -36.95 56.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.28 1.432 . . . . 72.340000000000003 113.838 -170.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -112.17 -3.76 14.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.471 0.708 . . . . 62.350000000000001 111.853 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 72.61 33.97 60.34 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.54 -0.589 . . . . 71.329999999999998 114.566 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -84.91 -38.39 19.44 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.402 0.601 . . . . 74.400000000000006 110.717 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 70.3 m95 -123.0 154.13 38.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.57 0.748 . . . . 73.519999999999996 110.561 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.606 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -134.35 132.4 39.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.027 0.931 . . . . 74.219999999999999 109.991 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.4 114.22 7.44 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 106.172 -1.788 . . . . 73.310000000000002 106.172 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.31 150.85 49.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 63.229999999999997 111.028 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -106.38 116.38 31.83 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.522 -1.288 . . . . 74.040000000000006 107.522 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.536 HG21 HG22 ' A' ' 101' ' ' ILE . 22.9 p -116.96 174.43 6.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.434 0.694 . . . . 73.040000000000006 110.167 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -62.85 -24.24 67.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.311 0.645 . . . . 54.210000000000001 110.22 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.06 -27.57 60.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.497 0.719 . . . . 74.519999999999996 111.608 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.75 -125.1 2.21 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 121.408 -0.425 . . . . 75.049999999999997 113.538 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -134.94 140.42 45.71 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.757 0.823 . . . . 34.210000000000001 110.499 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.51 176.87 23.09 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 113.709 0.243 . . . . 75.219999999999999 113.709 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -80.87 120.6 24.91 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.127 0.971 . . . . 74.030000000000001 112.28 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.431 HG23 HD13 ' A' ' 135' ' ' ILE . 4.2 m -121.79 139.63 30.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.312 1.045 . . . . 54.350000000000001 108.638 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 3.1 Cg_exo -76.05 143.45 25.86 Favored 'Trans proline' 0 CA--C 1.561 1.863 0 C-N-CA 122.631 2.221 . . . . 74.310000000000002 114.46 -172.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -39.54 -49.61 2.14 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.85 1.66 . . . . 42.439999999999998 113.469 168.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 18.6 p-10 -76.3 7.18 4.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.777 0.831 . . . . 63.32 112.581 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.514 ' HB3' HD11 ' A' ' 101' ' ' ILE . 16.5 m-85 -115.87 -9.12 11.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.349 1.06 . . . . 74.349999999999994 111.568 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.431 HD13 HG23 ' A' ' 130' ' ' VAL . 10.8 pt -132.37 171.43 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.96 0.904 . . . . 72.450000000000003 111.215 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -164.17 152.18 10.91 Favored Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.479 -0.772 . . . . 74.150000000000006 109.151 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -58.15 157.85 24.02 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.441 2.094 . . . . 73.209999999999994 113.791 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.55 -8.28 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 123.271 0.628 . . . . 53.439999999999998 111.783 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -102.11 0.82 35.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 72.040000000000006 111.866 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.9 p -77.1 168.11 20.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.13 0.572 . . . . 63.109999999999999 112.197 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.22 -24.65 27.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.149 -0.478 . . . . 71.319999999999993 110.352 167.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.4 -23.59 66.34 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.366 0.666 . . . . 73.019999999999996 111.599 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.66 ' HA ' HD21 ' A' ' 88' ' ' LEU . 20.9 pttm -62.49 -18.21 61.38 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.761 0.663 . . . . 50.039999999999999 112.522 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -83.99 141.98 30.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.648 -0.705 . . . . 75.430000000000007 110.512 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 p -62.67 -40.14 96.14 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.379 1.049 . . . . 73.319999999999993 111.13 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -66.14 -37.58 86.05 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.163 0.801 . . . . 75.409999999999997 113.163 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 38.9 t80 -76.41 113.6 14.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.854 -0.424 . . . . 75.239999999999995 109.854 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -109.23 -5.24 15.98 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.086 0.554 . . . . 74.049999999999997 112.473 -177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.67 -145.68 42.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 118.652 -1.082 . . . . 65.329999999999998 112.843 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.35 94.88 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.06 2.507 . . . . 71.129999999999995 112.996 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 49.0 t -135.74 126.98 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.994 1.318 . . . . 74.319999999999993 109.257 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.9 p -83.92 175.44 9.58 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.912 0.885 . . . . 71.209999999999994 110.323 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -60.75 -40.4 92.29 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 119.467 -0.301 . . . . 75.239999999999995 110.934 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -53.54 -49.88 66.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.183 0.593 . . . . 64.230000000000004 110.923 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.504 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -71.0 -26.18 63.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.224 -0.898 . . . . 53.0 111.634 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.4 -46.45 60.22 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.067 0.547 . . . . 34.32 111.821 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.6 mm-40 -68.72 -32.91 73.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.559 -0.534 . . . . 73.420000000000002 109.559 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.08 -47.82 82.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.115 0.966 . . . . 72.209999999999994 110.664 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.43 HD13 HD22 ' A' ' 169' ' ' LEU . 12.9 mt -58.54 -45.43 88.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.875 0.87 . . . . 72.329999999999998 111.487 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 97.9 mt -92.99 8.0 41.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.749 0.648 . . . . 72.140000000000001 112.749 -176.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.4 p -64.05 -37.26 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 118.713 0.688 . . . . 70.409999999999997 110.377 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.4 p -101.93 18.44 20.6 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.138 0.975 . . . . 60.009999999999998 111.504 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.21 165.26 32.68 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.285 -0.416 . . . . 53.25 112.409 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.34 -179.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.58 0.752 . . . . 73.329999999999998 111.213 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.57 125.81 24.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.316 -0.856 . . . . 74.549999999999997 110.026 169.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 90.02 9.67 65.46 Favored Glycine 0 C--O 1.242 0.651 0 CA-C-O 119.192 -0.782 . . . . 50.240000000000002 113.022 -177.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.8 m -87.68 116.87 26.11 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 117.669 0.734 . . . . 75.120000000000005 110.526 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.426 ' HB3' HD13 ' A' ' 184' ' ' LEU . 21.0 p90 -128.24 167.92 16.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.936 0.495 . . . . 75.019999999999996 111.118 -172.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.43 HD22 HD13 ' A' ' 159' ' ' LEU . 4.3 pp -159.56 142.35 13.95 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.579 -0.737 . . . . 72.420000000000002 109.622 174.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 182' ' ' ILE . 74.2 t -100.27 115.3 41.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.988 -1.116 . . . . 75.040000000000006 107.988 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.609 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 41.9 ptt85 -115.91 143.1 45.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.566 0.746 . . . . 74.25 109.074 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -94.1 149.15 21.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.534 -0.913 . . . . 72.400000000000006 108.534 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 t -76.28 127.5 33.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.176 0.59 . . . . 71.230000000000004 109.585 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.0 -31.46 70.3 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.685 -0.689 . . . . 75.25 109.419 171.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 34.0 m -66.17 -34.81 78.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.924 0.89 . . . . 73.510000000000005 111.132 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.9 p -148.21 93.41 4.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.084 0.553 . . . . 71.120000000000005 110.841 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.14 138.23 85.35 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.895 2.396 . . . . 73.400000000000006 112.379 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.84 -29.93 10.74 Favored Glycine 0 C--N 1.345 1.029 0 C-N-CA 123.324 0.488 . . . . 72.450000000000003 111.959 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -82.72 117.72 22.85 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.822 -0.807 . . . . 74.340000000000003 108.822 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.505 0.669 . . . . 74.299999999999997 110.446 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 61.4 m -140.52 149.28 42.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.775 1.23 . . . . 71.120000000000005 108.588 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 170' ' ' VAL . 25.9 mt -102.42 146.3 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.684 -1.228 . . . . 65.019999999999996 107.684 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 46.3 m -124.29 107.98 11.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.881 -1.155 . . . . 71.219999999999999 107.881 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.426 HD13 ' HB3' ' A' ' 168' ' ' PHE . 45.5 tp -105.45 114.25 28.31 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.087 0.555 . . . . 53.409999999999997 110.507 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -76.92 116.72 17.84 Favored 'General case' 0 C--O 1.254 1.321 0 CA-C-O 121.43 0.633 . . . . 62.219999999999999 109.946 166.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -139.59 138.52 36.27 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.498 1.519 . . . . 73.549999999999997 107.462 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 59.67 22.02 10.74 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.927 0.891 . . . . 62.329999999999998 111.887 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.61 -12.63 55.69 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.345 -0.389 . . . . 72.420000000000002 113.869 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -98.99 144.93 27.59 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.547 0.739 . . . . 74.209999999999994 109.463 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.8 t -103.31 110.19 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.066 0.46 . . . . 71.430000000000007 110.532 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -96.94 124.51 40.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.849 1.259 . . . . 74.109999999999999 109.513 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -98.66 119.09 36.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.31 0.644 . . . . 73.450000000000003 111.286 -172.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.539 ' HE1' HD21 ' A' ' 232' ' ' LEU . 4.9 m-85 -95.42 150.72 19.98 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.574 -0.899 . . . . 64.349999999999994 108.574 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -106.81 125.3 50.83 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.276 -0.639 . . . . 72.230000000000004 109.276 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.4 mt -85.39 102.41 11.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.428 -0.953 . . . . 61.119999999999997 108.428 172.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -85.38 147.14 26.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.823 -1.08 . . . . 64.319999999999993 109.666 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -108.68 135.69 49.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.475 0.71 . . . . 75.450000000000003 109.648 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.9 176.88 7.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.578 0.751 . . . . 72.150000000000006 110.227 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.0 p -65.7 -28.91 69.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.208 0.603 . . . . 72.129999999999995 112.379 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -91.85 -17.34 25.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 75.319999999999993 110.243 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.11 9.21 16.1 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.914 -0.937 . . . . 72.219999999999999 114.847 175.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.72 130.21 45.36 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.3 1.05 . . . . 73.140000000000001 111.58 176.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -86.54 141.12 29.28 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.876 -1.157 . . . . 41.509999999999998 107.876 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.615 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.1 p90 -167.44 132.11 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.579 0.55 . . . . 73.209999999999994 110.961 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.525 HG23 HD11 ' A' ' 217' ' ' LEU . 70.6 t -77.62 -38.0 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.688 -0.856 . . . . 74.329999999999998 108.688 164.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.7 m -105.54 123.38 47.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.625 -1.17 . . . . 61.240000000000002 109.513 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -64.24 -25.16 67.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.488 0.715 . . . . 73.439999999999998 112.489 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -77.3 -24.38 50.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.625 0.77 . . . . 75.409999999999997 110.946 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.8 m -129.68 100.43 5.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.186 0.594 . . . . 75.340000000000003 109.679 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.615 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 77.7 mtt180 -107.22 138.8 42.73 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 64.150000000000006 109.209 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -124.34 146.65 48.7 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.303 -0.629 . . . . 63.240000000000002 109.303 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.85 -37.56 87.84 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.933 0.771 . . . . 73.5 110.381 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -127.81 157.43 40.45 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.738 0.815 . . . . 65.230000000000004 111.609 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.81 -25.32 67.18 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.689 -1.141 . . . . 63.240000000000002 109.741 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.85 97.35 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.447 0.699 . . . . 71.340000000000003 111.019 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.38 -34.42 67.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.438 0.695 . . . . 75.010000000000005 111.48 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.525 HD11 HG23 ' A' ' 205' ' ' VAL . 14.9 tp -56.48 -54.57 44.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.815 0.446 . . . . 62.299999999999997 111.141 174.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.68 -38.41 82.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 O-C-N 123.776 0.673 . . . . 53.32 110.677 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -58.29 -57.31 13.46 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 62.32 111.253 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -63.14 -39.61 95.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.722 -0.672 . . . . 70.340000000000003 111.1 -176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.719 ' HB3' HD11 ' A' ' 228' ' ' LEU . 41.8 m80 -85.45 -6.09 59.24 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.323 0.49 . . . . 65.230000000000004 112.323 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 91.6 p -98.07 -14.42 20.49 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.027 0.376 . . . . 64.200000000000003 111.12 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 50.7 p -83.63 -40.05 19.49 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 110.23 -0.285 . . . . 72.439999999999998 110.23 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.1 m -138.6 167.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 113.36 0.874 . . . . 63.100000000000001 113.36 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -81.53 13.24 3.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.983 2.113 . . . . 74.329999999999998 113.659 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 224' ' ' VAL . 35.8 t70 -41.95 33.67 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 1 C-N-CA 132.091 4.156 . . . . 63.439999999999998 118.744 -158.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 126.35 -5.52 7.67 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 120.068 -1.645 . . . . 63.009999999999998 112.986 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.1 mt -90.45 161.09 15.7 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.447 1.099 . . . . 62.450000000000003 109.484 174.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.7 tt -56.74 -36.36 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-O 120.958 0.409 . . . . 72.140000000000001 110.418 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.3 t -161.03 170.9 19.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.292 0.637 . . . . 65.349999999999994 110.189 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 29.5 m -63.1 138.33 58.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.513 1.125 . . . . 51.450000000000003 111.889 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.539 HD21 ' HE1' ' A' ' 193' ' ' TYR . 65.1 mt -73.43 135.06 44.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.263 -0.643 . . . . 73.209999999999994 109.263 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.82 -76.16 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.524 0.602 . . . . 41.32 110.809 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 167' ' ' SER . 19.9 t80 -85.4 121.39 73.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 108.393 -0.966 . . . . 75.129999999999995 108.393 -177.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.05 125.06 3.98 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.364 2.043 . . . . 75.519999999999996 111.396 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.1 134.53 94.5 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.773 -0.649 . . . . 54.149999999999999 110.076 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.67 -179.15 4.85 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.603 2.202 . . . . 74.439999999999998 111.988 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.34 152.07 45.96 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.151 0.58 . . . . 54.340000000000003 109.587 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.401 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 10.9 ptt180 -88.92 -62.21 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.532 0.567 . . . . 74.409999999999997 112.532 -172.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.401 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 66.1 t30 -111.24 149.05 31.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.283 0.633 . . . . 74.349999999999994 110.74 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.452 ' NZ ' ' HB2' ' A' ' 90' ' ' ASP . 99.9 mttt -83.57 114.88 56.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 106.807 -1.553 . . . . 75.010000000000005 106.807 160.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.525 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 19.5 Cg_exo -65.27 122.52 10.26 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.085 1.857 . . . . 61.509999999999998 111.817 -168.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.0 m -72.24 112.43 8.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.948 0.499 . . . . 74.140000000000001 110.233 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.29 106.69 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.571 -1.27 . . . . 51.109999999999999 107.571 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -85.5 114.82 22.82 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.702 0.401 . . . . 64.129999999999995 111.776 -161.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.12 0.42 0.71 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.645 1.818 . . . . 73.420000000000002 117.645 164.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.52 HG23 ' HE1' ' A' ' 118' ' ' TRP . 24.1 m -96.99 122.82 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.174 1.487 . . . . 61.039999999999999 112.801 -169.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.4 t -78.66 135.33 60.23 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 113.793 -1.549 . . . . 73.25 107.377 160.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.549 ' HD2' HD21 ' A' ' 97' ' ' ASN . 33.1 Cg_exo . . . . . 0 C--N 1.379 2.177 0 C-N-CA 121.137 1.225 . . . . 73.019999999999996 112.645 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 t90 . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 121.348 0.594 . . . . 73.219999999999999 110.516 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -82.76 -20.73 35.34 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.755 -0.657 . . . . 71.230000000000004 110.074 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 m -70.79 3.15 3.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.306 1.443 . . . . 75.120000000000005 112.886 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.89 -24.4 66.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.794 0.838 . . . . 74.430000000000007 111.612 175.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -81.85 -36.58 28.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.034 0.534 . . . . 71.209999999999994 110.126 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.81 -5.81 49.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.949 0.9 . . . . 62.409999999999997 110.528 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.418 HD13 ' HE1' ' A' ' 146' ' ' TRP . 27.3 tp -58.96 -51.01 71.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.685 1.194 . . . . 75.329999999999998 111.522 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.75 -53.2 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.014 0.526 . . . . 50.350000000000001 110.37 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.625 0.77 . . . . 75.25 111.897 -173.962 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.612 -0.144 . . . . 74.329999999999998 110.612 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -57.53 148.38 24.05 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 73.140000000000001 111.295 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -111.88 163.87 13.73 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.52 0.728 . . . . 72.430000000000007 109.653 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 138.58 46.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 124.423 1.089 . . . . 73.030000000000001 108.619 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -76.33 115.27 15.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.776 0.83 . . . . 60.100000000000001 109.481 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.8 mt -71.98 -38.52 69.69 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.272 0.558 . . . . 64.209999999999994 110.698 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.554 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 6.0 m-85 -125.18 151.81 45.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.981 -1.008 . . . . 74.030000000000001 108.769 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.46 125.49 29.43 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.973 -0.751 . . . . 61.43 108.973 166.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.614 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.5 t80 -106.35 135.01 48.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.797 -1.186 . . . . 64.230000000000004 107.797 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -102.04 134.96 41.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.23 -1.026 . . . . 73.040000000000006 108.23 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.8 134.88 57.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.02 0.928 . . . . 62.229999999999997 111.822 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.5 p -98.82 -53.22 3.35 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.022 0.929 . . . . 72.120000000000005 109.071 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.73 176.28 33.45 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.116 -0.947 . . . . 61.119999999999997 111.747 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.59 -21.41 57.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.839 0.855 . . . . 72.439999999999998 111.521 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -93.55 -26.09 17.28 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.763 0.825 . . . . 72.420000000000002 111.656 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.3 p -73.03 134.83 44.78 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.111 -0.7 . . . . 74.409999999999997 109.111 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.636 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 63.6 tp -104.55 125.72 50.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.453 0.701 . . . . 63.229999999999997 110.561 -167.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -70.35 132.25 45.36 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.952 0.783 . . . . 74.329999999999998 109.842 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.77 HG22 HG21 ' A' ' 123' ' ' THR . 9.8 pt -119.13 148.82 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.728 -0.471 . . . . 71.239999999999995 109.728 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.615 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -86.3 149.48 25.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.625 0.77 . . . . 74.430000000000007 109.354 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.73 113.35 6.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.71 0.404 . . . . 72.030000000000001 110.318 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.79 61.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.379 -0.373 . . . . 33.039999999999999 112.927 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 36.6 tt0 -73.09 135.48 44.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.708 0.803 . . . . 62.43 111.801 -175.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -80.03 126.54 31.18 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.554 -0.906 . . . . 70.129999999999995 108.554 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -148.16 153.59 39.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.244 0.545 . . . . 64.129999999999995 110.8 -174.702 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -108.56 130.23 55.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.833 0.853 . . . . 72.140000000000001 108.965 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.525 HG13 ' HB1' ' A' ' 119' ' ' ALA . 53.3 t -88.03 130.52 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.213 -1.032 . . . . 71.540000000000006 108.213 168.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.462 HD12 ' HG2' ' A' ' 120' ' ' GLU . 36.0 mt -92.67 -29.19 16.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.221 1.009 . . . . 74.209999999999994 109.623 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.54 145.36 4.44 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.207 -0.906 . . . . 74.109999999999999 111.547 175.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.694 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 62.3 m-85 -86.23 160.34 19.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.212 0.506 . . . . 64.450000000000003 110.033 173.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -83.34 -172.43 4.14 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 73.230000000000004 110.539 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -52.34 -41.46 63.04 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.268 1.027 . . . . 73.109999999999999 113.504 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -95.46 -2.41 48.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.407 0.683 . . . . 70.209999999999994 111.341 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 60.51 22.5 59.17 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.029 0.772 . . . . 61.100000000000001 115.029 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.02 -16.54 18.66 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.396 0.679 . . . . 61.530000000000001 110.82 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 56.2 m95 -131.53 143.4 50.35 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.068 0.947 . . . . 73.530000000000001 110.026 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.525 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -123.28 149.04 45.29 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.462 1.105 . . . . 72.200000000000003 110.042 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HG2' HD12 ' A' ' 110' ' ' LEU . 38.6 tt0 -82.85 107.73 15.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.469 -1.678 . . . . 72.329999999999998 106.469 164.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.45 152.53 40.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.419 0.628 . . . . 71.299999999999997 112.141 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -112.57 103.98 12.05 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.346 -1.297 . . . . 71.310000000000002 108.171 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.77 HG21 HG22 ' A' ' 101' ' ' ILE . 39.5 p -101.62 176.25 5.29 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.111 0.964 . . . . 43.240000000000002 110.206 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -71.56 -14.29 62.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.943 0.497 . . . . 64.019999999999996 110.265 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -85.28 -18.05 35.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.321 1.049 . . . . 73.340000000000003 111.187 172.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.25 -165.23 23.2 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-O 120.3 -0.167 . . . . 44.140000000000001 113.347 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.416 ' NE2' ' HG2' ' A' ' 120' ' ' GLU . 68.3 tp60 -92.22 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.203 0.601 . . . . 70.140000000000001 111.393 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 176.01 -161.12 29.51 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.52 0.512 . . . . 54.350000000000001 112.443 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -112.11 120.46 41.9 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.34 0.656 . . . . 73.140000000000001 111.635 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.76 143.5 47.84 Favored Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 124.015 0.926 . . . . 71.0 109.923 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 83.1 Cg_endo -84.69 145.44 10.31 Favored 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 121.943 1.762 . . . . 70.430000000000007 114.827 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -38.68 -46.48 1.23 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.281 1.832 . . . . 71.230000000000004 114.526 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.554 HD22 ' HB2' ' A' ' 242' ' ' PRO . 30.0 p-10 -75.03 -7.66 54.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.857 0.863 . . . . 74.200000000000003 113.014 -169.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 29.4 m-85 -103.64 -10.61 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.388 0.675 . . . . 61.340000000000003 111.904 174.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.0 pt -123.78 170.84 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.92 0.888 . . . . 74.420000000000002 110.636 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 3.4 m -158.45 137.98 8.46 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.721 0.808 . . . . 61.409999999999997 109.941 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.53 136.71 47.55 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 121.686 1.591 . . . . 72.219999999999999 110.897 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.29 -11.79 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.167 0.987 . . . . 75.140000000000001 110.378 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -21.19 63.29 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.166 0.987 . . . . 71.299999999999997 112.177 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 91.7 p -109.61 -179.63 3.87 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.867 0.867 . . . . 64.129999999999995 111.852 -173.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.94 -22.84 36.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.535 1.134 . . . . 63.399999999999999 112.32 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.78 -12.4 61.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.943 0.897 . . . . 70.340000000000003 112.245 -173.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.504 ' HE2' ' CE1' ' A' ' 144' ' ' HIS . 20.8 pttm -63.82 -11.68 29.31 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.818 0.847 . . . . 72.209999999999994 111.911 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.504 ' CE1' ' HE2' ' A' ' 143' ' ' LYS . 33.3 m170 -99.63 146.64 26.24 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.867 0.867 . . . . 71.209999999999994 110.895 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -64.64 -33.94 77.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.156 -0.929 . . . . 53.340000000000003 112.517 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.418 ' HE1' HD13 ' A' ' 73' ' ' LEU . 41.9 p-90 -72.93 -35.13 66.95 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.569 0.747 . . . . 75.400000000000006 112.471 -176.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HE2' ' A' ' 238' ' ' LYS . 23.1 t80 -80.29 103.02 9.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.825 -0.806 . . . . 73.200000000000003 108.825 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.455 ' HB2' HG21 ' A' ' 151' ' ' VAL . 52.8 m170 -95.59 -9.18 32.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.06 0.544 . . . . 72.230000000000004 112.056 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 -135.06 17.88 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-O 118.273 -1.293 . . . . 65.219999999999999 112.727 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.33 93.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.697 2.931 . . . . 63.25 113.127 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 75.4 t -139.64 132.39 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.915 1.286 . . . . 64.099999999999994 109.252 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.1 p -89.86 175.8 7.07 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.263 1.025 . . . . 74.340000000000003 109.896 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -58.2 -50.14 74.59 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.289 0.236 . . . . 74.329999999999998 111.111 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -55.49 -44.96 77.02 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.845 0.858 . . . . 50.219999999999999 111.145 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.58 84.33 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.397 -0.82 . . . . 55.32 110.751 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.0 80.41 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.946 0.898 . . . . 43.340000000000003 112.052 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -83.83 -21.16 32.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.757 -0.656 . . . . 75.209999999999994 111.759 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.409 ' OH ' ' HD2' ' A' ' 239' ' ' ARG . 0.1 OUTLIER -82.8 -19.36 37.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.27 0.557 . . . . 73.420000000000002 111.311 172.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' A' ' 239' ' ' ARG . 51.6 mt -74.96 -42.97 56.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.344 -0.843 . . . . 34.130000000000003 110.669 168.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.548 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 89.0 mt -92.67 20.69 6.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.281 -0.872 . . . . 75.209999999999994 111.451 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 92.5 p -72.55 -40.19 66.9 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.679 -0.489 . . . . 65.030000000000001 109.679 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.4 p -100.63 3.65 42.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.201 1.0 . . . . 75.530000000000001 112.271 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.11 159.05 53.04 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.124 0.265 . . . . 72.040000000000006 113.469 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.77 -178.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 63.25 110.799 174.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -61.92 118.49 7.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.367 0.667 . . . . 72.340000000000003 109.814 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.78 12.03 59.75 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.292 -0.726 . . . . 73.430000000000007 113.444 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.0 m -76.06 133.04 40.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.182 0.991 . . . . 71.140000000000001 110.184 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.489 ' HB3' HD13 ' A' ' 184' ' ' LEU . 27.0 p90 -141.81 166.44 24.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.237 0.541 . . . . 73.030000000000001 111.187 -171.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -162.6 151.29 14.75 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.617 -1.174 . . . . 63.130000000000003 108.135 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.662 HG22 HG12 ' A' ' 182' ' ' ILE . 85.9 t -103.51 128.9 56.24 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 N-CA-C 108.101 -1.074 . . . . 61.200000000000003 108.101 169.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.651 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.0 ptt85 -114.97 143.26 45.44 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.731 -1.122 . . . . 71.040000000000006 108.313 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -114.95 130.21 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.329 -1.36 . . . . 62.420000000000002 107.329 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -62.67 127.56 31.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.66 0.384 . . . . 71.099999999999994 110.409 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.86 -43.5 98.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.173 0.589 . . . . 73.120000000000005 110.004 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.0 p -68.71 -27.09 65.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.838 0.855 . . . . 74.129999999999995 111.409 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.3 m -137.19 79.5 37.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.043 0.537 . . . . 64.400000000000006 110.582 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.42 137.32 73.53 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.629 2.219 . . . . 53.549999999999997 111.529 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.14 -29.57 12.23 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.809 -0.632 . . . . 64.099999999999994 111.668 -174.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -81.38 114.93 20.48 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.95 -0.759 . . . . 60.299999999999997 108.95 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -129.29 147.77 51.16 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.847 0.859 . . . . 73.200000000000003 109.465 -173.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -148.54 150.97 34.3 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.142 0.977 . . . . 63.439999999999998 108.542 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 170' ' ' VAL . 16.8 mt -103.23 121.87 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.224 -1.028 . . . . 72.129999999999995 108.224 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -93.82 127.25 39.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.646 -1.242 . . . . 74.109999999999999 107.646 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 168' ' ' PHE . 61.9 tp -131.96 110.36 10.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.173 0.589 . . . . 71.019999999999996 109.511 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 21.7 ttt180 -79.7 113.81 18.14 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.076 0.55 . . . . 72.129999999999995 109.829 168.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -139.72 137.0 34.77 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.219 -1.4 . . . . 64.420000000000002 107.219 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 62.14 21.44 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.17 0.988 . . . . 74.239999999999995 111.624 -174.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 9.98 86.58 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.91 -0.586 . . . . 71.409999999999997 113.677 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -117.66 134.45 54.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.415 1.086 . . . . 73.019999999999996 109.487 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.58 115.56 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.735 0.414 . . . . 72.120000000000005 110.592 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -102.94 128.79 49.6 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.624 1.17 . . . . 75.109999999999999 108.696 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -110.37 110.13 20.8 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.316 0.646 . . . . 70.140000000000001 109.393 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.601 ' CE1' HD22 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -115.23 122.89 47.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.553 0.741 . . . . 73.120000000000005 110.545 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.76 135.04 53.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.55 1.14 . . . . 72.239999999999995 111.301 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.49 103.44 12.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.303 -0.999 . . . . 71.25 108.303 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -66.16 112.73 4.07 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.59 0.756 . . . . 64.439999999999998 109.172 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.8 m -97.45 105.46 17.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.436 0.695 . . . . 54.329999999999998 109.133 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.1 155.75 26.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.033 0.933 . . . . 72.519999999999996 110.771 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.8 p -69.19 -13.73 62.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.489 0.922 . . . . 74.120000000000005 113.489 -170.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.11 -16.42 31.52 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.391 0.676 . . . . 71.409999999999997 111.141 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 111.72 14.45 11.33 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.72 -0.489 . . . . 73.510000000000005 113.763 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -78.52 138.71 38.54 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.167 0.484 . . . . 61.340000000000003 110.89 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.29 143.76 32.24 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.977 -1.12 . . . . 63.310000000000002 107.977 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.6 p90 -170.81 136.45 1.17 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.546 0.529 . . . . 75.239999999999995 111.525 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.436 HG21 ' HD1' ' A' ' 193' ' ' TYR . 63.7 t -79.89 -42.06 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.639 -0.875 . . . . 74.450000000000003 108.639 166.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.2 m -100.17 126.98 46.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.24 1.016 . . . . 74.310000000000002 109.605 -174.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -63.16 -24.73 68.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.559 0.743 . . . . 64.140000000000001 112.12 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -77.09 -30.68 55.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.674 1.19 . . . . 62.149999999999999 111.233 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -120.87 100.62 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.575 0.75 . . . . 54.119999999999997 109.157 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.523 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.3 mtt180 -110.13 126.01 53.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.011 0.924 . . . . 74.010000000000005 109.514 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.557 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.5 m-85 -116.03 149.33 39.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.537 0.735 . . . . 75.129999999999995 110.043 -168.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.03 -44.33 72.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.403 -0.591 . . . . 75.239999999999995 109.403 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.1 p -117.93 154.95 31.05 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.955 0.883 . . . . 73.239999999999995 111.722 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.493 HD11 HG11 ' A' ' 170' ' ' VAL . 1.1 tt -65.47 -23.23 66.86 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.723 -1.126 . . . . 74.099999999999994 109.899 174.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.07 93.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.383 0.673 . . . . 61.299999999999997 110.662 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.2 mt-10 -68.04 -36.8 80.5 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 110.82 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 tp -54.04 -57.88 9.4 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.767 0.667 . . . . 74.120000000000005 110.407 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.01 -38.4 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 123.755 0.659 . . . . 72.329999999999998 110.716 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -62.94 -59.05 5.37 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.921 0.488 . . . . 72.019999999999996 111.55 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.26 -32.94 74.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.028 0.531 . . . . 73.450000000000003 111.063 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.671 ' HB3' HD11 ' A' ' 228' ' ' LEU . 17.4 m170 -89.44 -4.72 57.87 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.629 0.603 . . . . 70.120000000000005 112.629 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.2 p -96.24 -28.07 14.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.868 0.467 . . . . 63.229999999999997 110.807 168.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 52.7 p -77.29 -40.36 44.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.356 -0.384 . . . . 74.239999999999995 110.504 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.561 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.5 m -134.5 161.44 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.304 1.049 . . . . 73.319999999999993 112.437 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.23 16.62 0.74 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.26 2.224 . . . . 55.439999999999998 114.442 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.1 t70 -44.37 25.31 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.617 1 C-N-CA 132.266 4.227 . . . . 32.119999999999997 119.821 -155.183 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.95 6.22 7.16 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 120.114 -1.616 . . . . 64.310000000000002 111.823 -165.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 221' ' ' HIS . 6.7 mt -95.23 163.67 13.17 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.749 1.22 . . . . 63.039999999999999 109.363 167.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 8.4 tt -65.89 -34.0 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-O 121.229 0.537 . . . . 72.109999999999999 109.834 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.4 t -159.67 170.67 21.08 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.592 0.757 . . . . 74.129999999999995 109.664 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.2 p -63.96 142.09 58.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.363 0.665 . . . . 62.140000000000001 111.385 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.42 112.21 4.5 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 108.686 -0.857 . . . . 72.439999999999998 108.686 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -104.75 -57.88 1.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.140000000000001 112.007 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -119.27 122.77 29.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.789 0.836 . . . . 74.420000000000002 109.54 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.2 123.33 4.99 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.449 2.099 . . . . 72.510000000000005 111.132 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -68.32 142.06 94.25 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 109.072 -0.714 . . . . 74.099999999999994 109.072 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.66 176.35 7.12 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.605 2.203 . . . . 65.329999999999998 112.943 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 33.1 mmtp -71.41 155.7 40.33 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.394 -0.821 . . . . 64.409999999999997 109.974 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.855 ' HB3' HD21 ' A' ' 159' ' ' LEU . 16.7 ptt-85 -91.89 -60.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.578 0.584 . . . . 62.149999999999999 112.578 -167.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -110.89 155.06 23.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.348 1.059 . . . . 65.140000000000001 109.872 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.67 114.77 59.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.663 -1.606 . . . . 50.32 106.663 156.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.554 ' HB2' HD22 ' A' ' 133' ' ' ASN . 27.9 Cg_endo -61.59 124.88 15.49 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.595 2.197 . . . . 74.420000000000002 112.352 -171.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.4 m -72.4 112.83 8.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.543 -0.753 . . . . 72.400000000000006 110.833 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.07 111.77 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 107.416 -1.327 . . . . 72.040000000000006 107.416 171.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.74 111.05 22.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.157 -0.312 . . . . 73.150000000000006 110.157 -166.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 60.22 -14.13 0.04 OUTLIER Glycine 0 CA--C 1.542 1.764 0 N-CA-C 118.185 2.034 . . . . 32.200000000000003 118.185 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.3 m -89.52 122.96 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.376 1.588 . . . . 74.25 112.882 -164.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 36.4 t -82.61 140.02 44.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 106.928 -1.508 . . . . 63.549999999999997 106.928 159.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo . . . . . 0 C--N 1.382 2.325 0 CA-C-N 120.723 1.294 . . . . 74.340000000000003 112.793 -163.193 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.1 ttm . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 108.976 -0.75 . . . . 74.150000000000006 108.976 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.7 66.05 3.67 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.337 0.398 . . . . 54.229999999999997 112.787 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -113.74 140.5 48.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.882 0.873 . . . . 73.010000000000005 109.617 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -95.8 106.01 24.82 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.607 0.763 . . . . 62.229999999999997 109.163 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.01 155.32 22.95 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.952 2.435 . . . . 73.549999999999997 112.73 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.54 73.73 2.56 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.148 -0.781 . . . . 65.430000000000007 111.148 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -65.95 -58.2 6.09 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.91 0.884 . . . . 65.450000000000003 113.072 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -159.7 129.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.32 0.648 . . . . 53.229999999999997 109.758 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.8 tt -75.99 -67.93 0.63 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.916 0.886 . . . . 73.340000000000003 109.493 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.35 -141.57 7.32 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 121.573 -0.346 . . . . 72.299999999999997 112.622 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.429 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 10.9 t70 -83.98 129.22 34.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.6 0.76 . . . . 74.109999999999999 108.978 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -127.88 -175.55 3.51 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.736 0.815 . . . . 72.530000000000001 110.964 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.57 177.82 6.45 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.942 0.897 . . . . 72.219999999999999 109.76 173.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 1.8 mpt_? -106.27 113.02 63.8 Favored Pre-proline 0 N--CA 1.477 0.875 0 C-N-CA 124.043 0.937 . . . . 61.439999999999998 109.488 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -82.22 174.68 9.77 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.924 2.416 . . . . 64.409999999999997 111.913 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.0 p -122.18 75.35 1.22 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.025 0.53 . . . . 62.32 111.001 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.54 105.83 55.78 Favored Pre-proline 0 N--CA 1.483 1.196 0 N-CA-C 108.981 -0.748 . . . . 71.439999999999998 108.981 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -80.43 92.81 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.614 2.209 . . . . 64.200000000000003 111.774 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.09 124.4 24.9 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.354 0.662 . . . . 72.450000000000003 109.914 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.4 tp -141.75 134.12 28.03 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.627 0.771 . . . . 64.329999999999998 109.713 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -160.14 136.83 9.05 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.903 0.881 . . . . 75.319999999999993 110.231 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.06 149.92 47.72 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.902 0.881 . . . . 64.340000000000003 109.681 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.416 ' H ' HG21 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -169.57 148.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 107.506 -1.294 . . . . 73.099999999999994 107.506 176.192 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.406 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -78.31 94.11 4.78 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.433 -0.58 . . . . 73.019999999999996 109.433 -178.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.52 79.24 0.34 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.685 -0.689 . . . . 62.100000000000001 112.201 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.65 166.18 25.91 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.941 0.896 . . . . 64.129999999999995 110.048 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.96 90.95 0.46 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.875 -0.49 . . . . 72.319999999999993 111.875 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -144.53 138.24 27.4 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.483 0.713 . . . . 74.5 110.247 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -115.06 92.07 3.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.233 1.013 . . . . 72.25 109.747 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.74 88.08 3.31 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 105.976 -1.861 . . . . 61.399999999999999 105.976 159.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.1 m -133.75 143.09 48.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.716 0.807 . . . . 72.030000000000001 111.161 -164.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.6 t -156.96 -172.43 4.04 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.336 1.054 . . . . 75.329999999999998 108.959 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -125.21 148.01 48.82 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.306 1.042 . . . . 72.109999999999999 110.349 -173.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -128.87 -41.87 1.44 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.54 0.336 . . . . 75.329999999999998 110.729 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.84 -167.37 34.79 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.532 -0.758 . . . . 74.450000000000003 113.441 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.44 67.6 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.729 -1.348 . . . . 60.109999999999999 109.729 -175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -63.27 128.51 22.86 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 123.589 2.859 . . . . 61.409999999999997 114.604 -165.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -176.66 -159.55 0.06 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.547 1.139 . . . . 73.140000000000001 109.872 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.3 m -45.41 156.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.698 1.599 . . . . 64.519999999999996 114.156 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -97.1 170.18 9.3 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.658 0.783 . . . . 60.409999999999997 111.049 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.0 t -123.74 -97.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 108.153 -1.055 . . . . 74.019999999999996 108.153 165.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.1 t80 179.38 69.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.569 -0.9 . . . . 64.349999999999994 108.569 -172.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 p -161.42 161.4 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 124.401 1.08 . . . . 61.450000000000003 108.855 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.485 ' HA ' HG23 ' A' ' 52' ' ' VAL . 10.8 pt-20 -128.03 134.69 49.24 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.9 1.074 . . . . 75.019999999999996 113.9 -171.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.01 -157.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.769 1.627 . . . . 74.400000000000006 109.093 168.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -91.22 -175.55 4.31 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.365 0.666 . . . . 65.310000000000002 110.431 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . 74.79 118.88 0.05 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.364 1.466 . . . . 70.230000000000004 112.618 170.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.09 82.59 6.99 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.64 0.776 . . . . 72.129999999999995 110.434 -169.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.516 ' HG2' ' HD3' ' A' ' 50' ' ' ARG . 7.5 tt0 -115.63 -66.18 1.11 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.435 -0.95 . . . . 73.129999999999995 108.435 169.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.516 ' HD3' ' HG2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -114.06 120.67 38.21 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 106.709 -1.589 . . . . 64.219999999999999 106.709 174.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -49.01 156.53 2.12 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.996 2.464 . . . . 73.219999999999999 113.553 165.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 44' ' ' GLU . 9.6 p -70.8 159.5 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 123.935 0.894 . . . . 73.310000000000002 111.625 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.63 115.17 5.53 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.814 -1.18 . . . . 55.539999999999999 107.814 165.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.2 t -61.1 -9.92 5.4 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.662 1.356 . . . . 71.129999999999995 114.662 -165.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.43 -48.57 74.83 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.472 0.654 . . . . 74.329999999999998 110.489 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.13 137.47 51.99 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.897 0.879 . . . . 72.439999999999998 109.017 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.8 78.31 30.75 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.886 -1.153 . . . . 71.409999999999997 107.886 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -84.58 -24.07 2.49 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.519 2.146 . . . . 73.239999999999995 112.424 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -142.48 -36.54 0.4 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.809 1.244 . . . . 72.420000000000002 109.728 -174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.53 -14.66 29.98 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 114.381 0.513 . . . . 65.549999999999997 114.381 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -125.96 -161.1 1.02 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.327 0.651 . . . . 72.129999999999995 110.284 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 p -169.6 119.3 0.65 Allowed 'General case' 0 C--O 1.246 0.899 0 C-N-CA 124.016 0.927 . . . . 73.150000000000006 110.537 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 27.6 tt0 -161.6 -48.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.255 1.022 . . . . 65.420000000000002 110.061 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.01 -15.58 56.91 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.781 1.03 . . . . 73.109999999999999 113.781 -172.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.51 -15.82 55.77 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.32 0.648 . . . . 45.299999999999997 112.327 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' NH2' ' HA ' ' A' ' 63' ' ' GLU . 33.8 mtm105 -118.64 -35.34 3.74 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.085 0.954 . . . . 74.329999999999998 110.274 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -159.69 89.67 0.9 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.9 0.88 . . . . 75.120000000000005 109.804 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.51 -22.69 34.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.889 0.876 . . . . 71.030000000000001 111.104 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 m -78.95 7.32 7.42 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.241 1.416 . . . . 54.420000000000002 113.021 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.39 -18.18 65.02 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.464 1.106 . . . . 72.310000000000002 112.315 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -20.35 26.2 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.319 0.648 . . . . 72.310000000000002 110.916 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.453 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 12.7 m120 -78.45 -12.31 60.0 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.322 0.649 . . . . 55.119999999999997 110.377 170.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.05 -50.45 70.59 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.679 0.792 . . . . 74.140000000000001 110.623 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.438 HD11 ' CG ' ' A' ' 219' ' ' HIS . 84.8 mt -112.12 30.15 7.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.486 0.714 . . . . 75.450000000000003 110.063 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . -72.05 -25.78 61.93 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.663 0.385 . . . . 75.140000000000001 110.562 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.31 -136.24 16.96 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 118.96 -0.911 . . . . 54.229999999999997 110.869 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.13 175.6 0.32 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.551 2.167 . . . . 63.32 112.406 166.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 1.7 m -71.46 175.64 5.34 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 116.267 -0.424 . . . . 64.409999999999997 111.227 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.77 -48.95 66.44 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.089 0.956 . . . . 63.450000000000003 112.981 -164.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -132.76 -41.08 0.94 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.91 0.484 . . . . 60.539999999999999 110.598 169.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 78' ' ' SER . 18.1 t70 -92.19 118.69 68.26 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 115.345 -0.843 . . . . 72.239999999999995 110.922 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.24 -13.3 39.05 Favored 'Trans proline' 0 CA--C 1.559 1.736 0 C-N-CA 122.937 2.425 . . . . 72.239999999999995 114.832 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -110.69 20.42 17.64 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.435 0.694 . . . . 70.299999999999997 110.848 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.7 tp -76.78 138.42 39.88 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.75 -0.594 . . . . 52.539999999999999 109.455 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.7 m-85 -108.11 173.45 6.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.588 1.155 . . . . 72.109999999999999 110.06 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.6 147.55 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 125.221 1.409 . . . . 60.409999999999997 109.64 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.21 120.15 25.45 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.219 1.008 . . . . 51.219999999999999 110.205 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.3 -42.26 68.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.329 0.651 . . . . 63.32 111.161 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.511 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.8 m-85 -124.54 158.4 33.05 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.41 -0.813 . . . . 75.129999999999995 109.223 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 120.71 24.27 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.502 -1.296 . . . . 72.25 107.502 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.8 t80 -123.01 138.28 54.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.903 0.881 . . . . 72.340000000000003 108.712 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.416 HG21 ' H ' ' A' ' 23' ' ' ILE . 40.8 t -97.48 134.18 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.76 -0.83 . . . . 75.120000000000005 108.76 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.6 117.18 4.62 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.078 0.862 . . . . 74.319999999999993 110.631 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 p -67.82 -38.33 83.12 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.654 0.782 . . . . 64.129999999999995 110.887 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.72 -175.95 14.28 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-N 115.717 -0.674 . . . . 65.040000000000006 111.826 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.79 -31.85 67.02 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.546 0.739 . . . . 71.129999999999995 110.661 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.445 HD22 ' HB3' ' A' ' 251' ' ' TYR . 35.5 p-10 -75.52 -18.06 59.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.803 1.241 . . . . 52.32 112.115 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 57.2 p -95.63 171.25 8.79 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.48 -0.563 . . . . 74.140000000000001 109.48 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.9 tp -126.94 136.7 52.64 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.275 0.56 . . . . 63.32 111.735 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -82.25 117.03 22.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.726 -1.125 . . . . 62.130000000000003 109.042 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.594 HG12 ' HB3' ' A' ' 91' ' ' PHE . 20.7 pt -110.08 144.26 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.388 0.675 . . . . 72.219999999999999 110.104 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.3 m -95.76 140.23 30.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.424 -0.807 . . . . 65.040000000000006 108.845 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.29 125.99 25.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.318 0.647 . . . . 60.020000000000003 111.356 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.45 76.67 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 123.88 0.738 . . . . 60.049999999999997 113.605 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -82.11 138.34 34.79 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.46 0.63 . . . . 74.109999999999999 111.434 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -79.95 112.81 17.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.837 -0.801 . . . . 71.019999999999996 108.837 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -122.83 167.78 13.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.951 0.9 . . . . 74.230000000000004 110.024 -177.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -121.74 119.43 31.72 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.935 -0.478 . . . . 63.439999999999998 111.035 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.65 HG13 ' HB1' ' A' ' 119' ' ' ALA . 43.5 t -86.54 134.55 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.246 1.018 . . . . 75.230000000000004 109.881 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.556 HD12 ' HG3' ' A' ' 120' ' ' GLU . 46.1 mt -105.89 -31.49 8.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.467 1.107 . . . . 75.140000000000001 110.126 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.01 145.48 4.71 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 115.835 -0.62 . . . . 61.119999999999997 112.375 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 45.5 m-85 -85.68 169.74 13.17 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.436 0.694 . . . . 63.25 110.886 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -85.66 -176.26 5.97 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.213 -0.903 . . . . 70.230000000000004 110.694 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -52.83 -35.18 56.79 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.754 1.221 . . . . 74.430000000000007 114.17 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -112.12 2.63 16.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.855 0.462 . . . . 70.310000000000002 112.171 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.79 30.56 72.59 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.398 0.919 . . . . 54.5 115.398 173.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.03 -35.96 18.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.285 0.543 . . . . 74.510000000000005 110.716 173.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 35.3 m95 -131.0 151.66 51.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.743 0.817 . . . . 73.519999999999996 111.72 -171.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -133.54 137.09 45.39 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.534 1.134 . . . . 72.040000000000006 111.026 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.556 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.8 tp10 -66.81 114.45 5.68 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 106.854 -1.536 . . . . 75.030000000000001 106.854 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.15 162.13 33.8 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.184 0.516 . . . . 53.420000000000002 111.299 -170.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.468 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . 15.4 pt20 -132.8 128.96 37.9 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.414 -0.812 . . . . 64.129999999999995 111.122 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 107' ' ' LEU . 45.8 p -116.61 179.1 4.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 74.319999999999993 109.757 173.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -70.68 -16.35 62.79 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 109.513 -0.551 . . . . 72.340000000000003 109.513 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -78.78 -20.16 50.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.918 1.287 . . . . 71.530000000000001 110.984 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.68 -140.4 10.15 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 122.051 -0.118 . . . . 74.439999999999998 112.941 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' A' ' 122' ' ' GLN . 61.6 tp60 -128.67 155.83 44.4 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.348 1.059 . . . . 74.329999999999998 109.667 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.56 169.4 15.36 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.025 -0.43 . . . . 73.120000000000005 112.025 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -77.75 134.53 38.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.241 0.616 . . . . 75.310000000000002 111.668 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG23 HD13 ' A' ' 135' ' ' ILE . 5.9 m -132.0 143.26 48.26 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 124.308 1.043 . . . . 74.010000000000005 108.807 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 92.9 Cg_endo -80.4 143.04 15.19 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 C-N-CA 122.018 1.812 . . . . 41.350000000000001 114.075 -173.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -39.61 -44.73 1.52 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.583 1.953 . . . . 52.049999999999997 114.229 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 38.1 p-10 -79.04 -1.91 37.89 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.198 0.999 . . . . 74.25 113.132 -171.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.511 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 28.8 m-85 -113.14 -0.63 14.61 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.026 0.93 . . . . 73.129999999999995 111.308 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.487 HD13 HG23 ' A' ' 130' ' ' VAL . 21.0 pt -135.37 170.48 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.182 0.993 . . . . 63.030000000000001 110.667 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -163.4 155.39 15.14 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.812 -1.181 . . . . 64.430000000000007 107.812 170.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.8 Cg_endo -60.44 153.53 59.88 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.679 1.586 . . . . 73.310000000000002 111.632 171.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 143' ' ' LYS . 38.2 t -73.1 -8.44 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.107 0.956 . . . . 53.340000000000003 110.356 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.94 -18.61 55.86 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.336 1.054 . . . . 73.129999999999995 111.248 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.2 p -87.01 170.43 11.57 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.853 0.835 . . . . 65.530000000000001 113.024 -170.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.36 -23.79 26.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.512 -1.222 . . . . 55.119999999999997 110.931 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.64 -29.81 70.3 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.322 1.049 . . . . 75.140000000000001 111.447 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 138' ' ' VAL . 24.2 pttm -60.08 -19.28 52.34 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.614 0.765 . . . . 71.209999999999994 112.904 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -86.66 141.86 28.64 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.544 0.737 . . . . 72.329999999999998 109.749 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.1 m -58.9 -40.64 85.1 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.07 0.856 . . . . 64.430000000000007 112.182 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -62.53 -38.5 90.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.122 0.889 . . . . 73.140000000000001 112.336 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -76.6 112.37 13.07 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.728 -0.841 . . . . 73.219999999999999 108.728 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -109.07 -14.83 14.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.073 0.549 . . . . 70.400000000000006 111.517 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.78 -127.25 15.49 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 118.18 -1.344 . . . . 43.119999999999997 112.3 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.55 95.2 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.984 2.456 . . . . 62.030000000000001 112.591 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 77.3 t -137.78 119.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.605 0.762 . . . . 63.509999999999998 109.575 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.8 m -71.78 159.35 34.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.289 0.635 . . . . 71.329999999999998 109.32 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 78.0 ttt180 -59.04 -38.07 78.46 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 119.435 -0.317 . . . . 73.549999999999997 111.415 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -63.49 -36.88 85.21 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.362 0.665 . . . . 71.409999999999997 111.209 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.36 -30.27 67.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.16 0.584 . . . . 70.120000000000005 110.408 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.26 63.18 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 51.509999999999998 111.647 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 22.5 mm-40 -65.66 -43.11 90.38 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.119 -0.697 . . . . 74.310000000000002 109.119 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.489 ' HE1' ' HB2' ' A' ' 239' ' ' ARG . 17.0 t80 -62.73 -41.47 99.19 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.315 -1.311 . . . . 73.239999999999995 111.201 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.442 HD21 ' HB3' ' A' ' 239' ' ' ARG . 28.7 mt -61.48 -44.13 97.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.59 0.756 . . . . 52.340000000000003 111.478 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.0 mt -98.3 17.96 17.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.199 0.6 . . . . 62.5 112.59 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.0 p -69.35 -36.24 76.68 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.444 0.64 . . . . 74.219999999999999 110.694 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 p -106.42 15.81 25.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.342 1.057 . . . . 71.200000000000003 110.8 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.86 140.48 23.3 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.37 -0.377 . . . . 63.119999999999997 112.379 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.7 pt -86.81 -179.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.405 0.682 . . . . 74.0 111.431 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.6 112.33 3.13 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.679 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.6 10.88 39.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.392 -0.822 . . . . 72.209999999999994 112.94 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.4 m -75.54 143.31 42.52 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.634 0.717 . . . . 62.140000000000001 110.619 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -149.72 163.78 37.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.063 0.459 . . . . 71.409999999999997 111.937 -171.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 183' ' ' SER . 4.0 pp -161.72 152.69 18.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.873 -1.058 . . . . 73.540000000000006 109.482 175.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.612 HG22 HG12 ' A' ' 182' ' ' ILE . 59.5 t -107.64 126.73 63.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.424 -0.954 . . . . 55.210000000000001 108.424 168.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.543 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 13.1 ptt180 -114.97 147.29 40.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.182 -1.044 . . . . 71.340000000000003 108.182 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.89 145.99 40.68 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 107.741 -1.207 . . . . 72.340000000000003 107.741 166.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.4 t -78.55 121.64 24.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.169 -0.678 . . . . 74.109999999999999 109.169 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.25 -34.3 77.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.306 1.042 . . . . 73.109999999999999 110.485 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 p -83.18 -15.87 48.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.72 0.808 . . . . 72.340000000000003 111.788 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.8 m -142.2 86.03 10.43 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.423 0.689 . . . . 60.119999999999997 110.079 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.09 135.54 69.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.33 2.687 . . . . 73.239999999999995 112.529 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.15 -28.86 12.07 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.472 -0.331 . . . . 61.509999999999998 112.594 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -81.41 117.11 21.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.182 0.491 . . . . 74.329999999999998 110.193 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.628 HH11 HD12 ' A' ' 214' ' ' LEU . 99.4 mtt180 -130.03 157.6 41.9 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.908 0.883 . . . . 75.400000000000006 110.974 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.4 m -143.61 146.24 33.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.944 -1.026 . . . . 61.310000000000002 109.454 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.612 HG12 HG22 ' A' ' 170' ' ' VAL . 42.8 mt -100.81 108.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 107.394 -1.335 . . . . 72.219999999999999 107.394 169.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.428 ' HB2' ' HG ' ' A' ' 169' ' ' LEU . 14.9 m -87.38 106.81 18.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.243 -1.391 . . . . 65.310000000000002 107.243 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 193' ' ' TYR . 62.4 tp -115.47 110.95 20.03 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.78 -0.822 . . . . 74.5 108.78 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.444 ' HB2' HG22 ' A' ' 190' ' ' VAL . 75.9 ttt180 -89.61 122.77 33.07 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.316 0.646 . . . . 75.209999999999994 110.486 173.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -143.7 144.13 31.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.655 1.182 . . . . 70.109999999999999 108.352 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 61.11 21.93 12.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.422 1.089 . . . . 62.520000000000003 112.358 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.29 11.45 82.17 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 114.358 0.503 . . . . 60.219999999999999 114.358 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -120.14 134.5 55.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.49 0.716 . . . . 74.040000000000006 109.744 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 185' ' ' ARG . 91.0 t -88.65 118.24 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.304 -0.628 . . . . 74.439999999999998 109.304 174.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.37 157.42 16.92 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.147 0.979 . . . . 55.350000000000001 108.564 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -132.76 124.15 27.55 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.976 -0.75 . . . . 74.140000000000001 108.976 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' A' ' 184' ' ' LEU . 89.8 m-85 -113.83 141.24 47.56 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.415 1.086 . . . . 72.310000000000002 108.714 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 9.1 tpp180 -85.21 124.36 31.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.398 0.279 . . . . 73.129999999999995 110.391 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.2 mt -84.71 99.6 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.132 -1.433 . . . . 73.040000000000006 107.132 166.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -78.46 119.71 22.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.963 -1.017 . . . . 72.450000000000003 108.37 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -94.15 108.5 20.35 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.908 -0.775 . . . . 75.0 108.908 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.48 157.57 16.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.952 0.901 . . . . 52.240000000000002 110.886 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -61.85 -30.94 71.19 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.293 1.037 . . . . 75.129999999999995 113.395 -170.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -85.0 -11.5 55.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.803 0.841 . . . . 73.299999999999997 111.925 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.0 11.15 14.38 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.451 -0.638 . . . . 74.310000000000002 114.352 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -75.5 152.16 37.88 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 118.082 0.941 . . . . 62.0 110.983 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -113.56 142.6 45.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.327 -0.99 . . . . 71.120000000000005 108.327 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.613 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.8 p90 -165.0 137.0 4.31 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.52 0.512 . . . . 73.349999999999994 110.872 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 54.3 t -79.12 -45.73 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.832 -0.803 . . . . 72.099999999999994 108.832 166.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -101.29 135.93 41.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.763 -1.108 . . . . 71.219999999999999 110.696 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.5 t -64.14 -22.46 66.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.287 1.035 . . . . 74.219999999999999 112.267 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -81.47 -29.98 33.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.941 0.896 . . . . 73.109999999999999 111.176 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 17.1 m -123.17 99.01 6.14 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.026 0.53 . . . . 65.200000000000003 110.176 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.613 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 47.3 mtt180 -112.35 120.29 41.19 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.818 0.847 . . . . 65.420000000000002 109.632 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.62 156.0 20.75 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.083 0.953 . . . . 65.25 109.085 -171.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -69.32 -42.74 74.98 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 70.5 p -120.95 155.04 35.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.92 0.867 . . . . 75.420000000000002 111.904 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.628 HD12 HH11 ' A' ' 180' ' ' ARG . 1.3 tt -65.38 -24.61 67.28 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 114.352 -1.295 . . . . 75.230000000000004 109.559 172.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.33 93.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.41 0.684 . . . . 75.439999999999998 110.766 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.19 -34.81 75.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.83 0.852 . . . . 71.319999999999993 111.15 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.04 -54.92 39.08 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.09 0.556 . . . . 73.140000000000001 111.025 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.61 -41.09 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 123.655 0.597 . . . . 52.200000000000003 111.011 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.438 ' CG ' HD11 ' A' ' 74' ' ' LEU . 17.0 t-80 -55.63 -58.0 9.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.441 0.696 . . . . 61.340000000000003 111.362 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -64.17 -33.7 76.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.125 -0.943 . . . . 74.239999999999995 110.813 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.543 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.1 m-70 -88.28 -10.78 48.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.797 -0.638 . . . . 73.5 112.081 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 232' ' ' LEU . 89.1 p -93.92 -20.28 20.16 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.756 0.423 . . . . 61.420000000000002 111.255 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 37.7 p -81.98 -48.12 11.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.873 -0.417 . . . . 51.420000000000002 109.873 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 226' ' ' ASP . 33.2 m -128.72 158.92 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.636 0.732 . . . . 74.209999999999994 112.303 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.97 16.0 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.759 2.024 . . . . 61.119999999999997 115.217 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.9 t70 -42.64 31.69 0.0 OUTLIER 'General case' 0 CA--C 1.601 2.925 1 C-N-CA 131.88 4.072 . . . . 71.5 119.351 -157.043 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.86 -1.94 9.25 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 119.486 -2.009 . . . . 74.120000000000005 112.604 -168.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' A' ' 221' ' ' HIS . 45.1 mt -95.59 160.3 14.57 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.584 1.153 . . . . 70.420000000000002 110.216 168.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.11 -35.55 72.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 120.895 0.379 . . . . 72.120000000000005 110.322 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -149.18 173.52 13.35 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.506 0.722 . . . . 44.340000000000003 110.094 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -67.42 143.17 56.41 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.172 0.589 . . . . 72.319999999999993 110.675 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 222' ' ' SER . 90.2 mt -63.58 96.56 0.12 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.74 0.816 . . . . 64.329999999999998 109.275 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -89.45 -66.14 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.184 -0.916 . . . . 63.310000000000002 110.681 -169.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 167' ' ' SER . 43.0 t80 -114.81 121.77 34.92 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 123.852 0.861 . . . . 73.519999999999996 109.725 -170.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.36 123.71 5.61 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.09 1.86 . . . . 75.219999999999999 111.722 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.02 130.95 95.06 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.971 -0.751 . . . . 75.150000000000006 108.971 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.03 179.78 6.18 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.833 2.355 . . . . 75.400000000000006 112.413 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.78 150.92 48.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 52.329999999999998 109.575 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.489 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . 13.7 ptt180 -92.51 -60.49 1.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 111.838 0.31 . . . . 72.120000000000005 111.838 -174.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.42 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 55.5 t30 -109.47 138.45 45.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 73.530000000000001 110.482 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.1 113.64 47.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.256 -1.757 . . . . 71.549999999999997 106.256 159.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.506 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 35.8 Cg_exo -61.01 123.87 13.76 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.51 2.14 . . . . 62.439999999999998 112.709 -173.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 61.2 m -73.47 119.1 17.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.827 0.451 . . . . 71.519999999999996 110.558 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.3 t -98.62 127.04 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.281 1.032 . . . . 62.399999999999999 108.38 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.08 114.52 28.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.095 0.407 . . . . 74.310000000000002 111.51 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.8 21.89 38.57 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 116.426 1.331 . . . . 71.030000000000001 116.426 160.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.489 HG21 ' NE1' ' A' ' 118' ' ' TRP . 27.2 m -82.3 127.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 117.732 0.766 . . . . 74.420000000000002 111.913 -173.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 t -85.18 117.83 69.59 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 104.85 -2.278 . . . . 72.540000000000006 104.85 152.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.99 -59.23 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 120.92 1.08 . . . . 70.420000000000002 113.917 -159.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -128.86 -18.53 3.79 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.368 0.667 . . . . 74.439999999999998 109.576 159.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.445 ' HB3' HD22 ' A' ' 97' ' ' ASN . 0.9 OUTLIER -77.62 105.99 9.13 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 115.192 -0.913 . . . . 72.049999999999997 111.164 -158.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -117.71 -43.59 2.78 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.549 -1.278 . . . . 74.319999999999993 107.549 157.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 11' ' ' ASP . 29.3 ttmt -112.65 -15.98 12.9 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.767 1.227 . . . . 72.310000000000002 111.295 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -50.42 135.45 22.17 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.632 1.173 . . . . 64.329999999999998 113.555 -163.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.251 1.164 0 N-CA-C 108.457 -0.942 . . . . 74.25 108.457 -179.905 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.494 -0.558 . . . . 74.129999999999995 109.494 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.55 106.41 0.2 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.102 -0.799 . . . . 73.329999999999998 111.102 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -69.58 110.77 4.99 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.251 0.621 . . . . 74.329999999999998 110.246 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -113.12 154.29 45.16 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 124.183 0.993 . . . . 74.040000000000006 109.602 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -68.38 -164.12 0.1 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.107 2.538 . . . . 74.040000000000006 112.483 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.06 90.25 0.02 OUTLIER Glycine 0 C--N 1.354 1.569 0 C-N-CA 123.137 0.399 . . . . 73.310000000000002 112.838 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 1.3 tpmt? -75.29 116.26 15.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.61 0.764 . . . . 73.310000000000002 110.474 -171.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.31 124.89 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.041 0.536 . . . . 74.219999999999999 109.74 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.4 119.46 27.69 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.076 -1.083 . . . . 75.319999999999993 108.076 173.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.38 111.22 3.93 Favored Glycine 0 C--N 1.345 1.03 0 O-C-N 123.56 0.537 . . . . 72.319999999999993 113.303 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.69 156.71 22.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.569 1.147 . . . . 71.219999999999999 109.773 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -54.19 118.25 3.91 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.198 0.599 . . . . 74.319999999999993 111.934 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -145.15 -169.57 3.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.386 0.674 . . . . 62.119999999999997 111.52 -166.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -55.42 139.0 67.54 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.824 1.25 . . . . 75.450000000000003 112.903 -173.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 49.7 Cg_exo -59.73 127.3 23.07 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.69 2.927 . . . . 64.0 114.084 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.0 t -101.22 -8.84 21.82 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.008 0.923 . . . . 73.109999999999999 110.254 173.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 mp 47.72 65.9 6.39 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.098 1.359 . . . . 74.329999999999998 110.762 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.63 -23.98 2.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.619 2.213 . . . . 62.399999999999999 114.072 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 62.56 175.07 0.14 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.947 1.299 . . . . 64.030000000000001 112.316 -170.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -156.99 -54.06 0.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.887 -1.153 . . . . 75.349999999999994 107.887 176.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 71.66 -68.97 0.2 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.008 1.323 . . . . 72.430000000000007 111.2 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.525 ' HB2' HD22 ' A' ' 20' ' ' LEU . 9.1 t80 57.74 -71.5 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 126.404 1.882 . . . . 70.450000000000003 114.732 166.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.411 HG12 ' HA2' ' A' ' 111' ' ' GLY . 36.5 mt 76.13 112.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.705 2.002 . . . . 74.109999999999999 111.214 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.598 ' H ' ' HB2' ' A' ' 112' ' ' TYR . 24.1 mmtm -140.3 160.83 39.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.909 0.883 . . . . 71.030000000000001 110.02 168.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.2 104.23 1.41 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.688 -0.687 . . . . 65.400000000000006 111.604 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -141.36 -176.92 4.9 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.725 0.81 . . . . 74.25 109.633 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.86 -169.96 42.97 Favored Glycine 0 C--O 1.241 0.549 0 N-CA-C 111.082 -0.807 . . . . 61.219999999999999 111.082 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -143.32 137.23 28.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.439 -0.578 . . . . 72.239999999999995 109.439 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HD2' ' HG2' ' A' ' 150' ' ' PRO . 19.5 mmt85 -86.69 168.34 13.66 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.1 0.96 . . . . 75.109999999999999 110.045 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 52.99 87.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.072 0.949 . . . . 72.340000000000003 113.217 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 p -72.35 164.47 26.27 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.128 -0.693 . . . . 43.100000000000001 109.128 167.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.553 ' HA ' HH21 ' A' ' 33' ' ' ARG . 15.1 m -68.68 166.88 16.39 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 121.092 0.472 . . . . 73.430000000000007 111.656 -176.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.553 HH21 ' HA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -108.79 78.98 1.18 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.909 0.385 . . . . 75.209999999999994 111.34 -177.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -163.68 131.54 3.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.043 0.937 . . . . 53.439999999999998 108.833 165.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.07 -143.7 5.89 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.524 -0.63 . . . . 61.539999999999999 111.524 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.58 132.48 1.52 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-O 118.863 -0.965 . . . . 75.299999999999997 112.292 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.63 178.55 6.9 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.611 2.207 . . . . 61.350000000000001 112.392 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -132.57 147.03 52.34 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.809 -0.811 . . . . 73.340000000000003 108.809 174.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.409 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 71.7 m -127.38 95.72 4.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.341 0.656 . . . . 73.310000000000002 111.007 -177.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.614 ' H ' ' HA ' ' A' ' 65' ' ' ALA . 15.5 m120 -81.55 -179.08 7.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.277 1.031 . . . . 63.5 111.042 169.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.6 m -97.23 -169.43 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.985 0.914 . . . . 75.230000000000004 111.077 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 83.24 118.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 126.334 1.854 . . . . 73.5 112.741 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.594 HG23 ' HG3' ' A' ' 63' ' ' GLU . 8.6 p -156.73 143.27 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.944 1.298 . . . . 72.25 109.452 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -165.69 153.08 10.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.869 0.467 . . . . 74.25 110.451 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 83.1 t60 77.57 -50.14 0.52 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.558 1.943 . . . . 73.409999999999997 111.961 177.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.39 136.61 58.03 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.113 -1.069 . . . . 74.219999999999999 108.113 172.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.89 110.39 10.77 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.445 0.906 . . . . 71.219999999999999 113.445 -164.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.9 tt -138.78 120.79 15.59 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.375 -1.343 . . . . 63.140000000000001 107.375 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -67.73 103.99 1.54 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.428 1.091 . . . . 52.530000000000001 112.144 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.5 ' HB3' ' HD2' ' A' ' 51' ' ' PRO . 80.6 mtt85 -126.1 177.75 1.81 Allowed Pre-proline 0 CA--C 1.565 1.526 0 C-N-CA 125.065 1.346 . . . . 65.540000000000006 109.297 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 50' ' ' ARG . 21.1 Cg_exo -37.61 132.94 0.65 Allowed 'Trans proline' 0 C--N 1.398 3.177 0 C-N-CA 123.944 3.096 . . . . 71.349999999999994 114.621 171.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -67.15 148.67 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 113.635 0.976 . . . . 73.230000000000004 113.635 -169.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.5 -161.16 0.81 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.271 1.028 . . . . 74.530000000000001 110.093 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -72.22 -52.36 16.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.032 0.533 . . . . 71.510000000000005 111.4 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -110.46 -83.21 0.57 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.525 -0.546 . . . . 50.520000000000003 109.525 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -95.19 146.77 24.09 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.931 0.492 . . . . 75.209999999999994 109.856 172.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.03 103.85 10.3 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 106.564 -1.643 . . . . 73.209999999999994 106.564 173.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.58 -52.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 121.962 1.774 . . . . 33.549999999999997 112.735 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.41 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 25.6 mm-40 -159.28 -43.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.883 0.873 . . . . 63.439999999999998 110.166 -168.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.91 18.03 79.22 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.525 0.515 . . . . 71.019999999999996 112.5 -170.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -161.37 131.81 5.08 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 106.94 -1.504 . . . . 52.399999999999999 106.94 -176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.577 ' HA ' ' HB ' ' A' ' 43' ' ' VAL . 20.2 m -90.52 147.03 23.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.757 0.823 . . . . 71.439999999999998 113.218 -166.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.594 ' HG3' HG23 ' A' ' 43' ' ' VAL . 32.5 mt-10 -101.94 -28.58 12.31 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.797 0.839 . . . . 75.310000000000002 111.212 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.67 21.23 0.4 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.255 0.622 . . . . 62.039999999999999 112.023 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.614 ' HA ' ' H ' ' A' ' 40' ' ' ASN . . . -48.98 -52.89 22.36 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.736 1.614 . . . . 75.400000000000006 111.589 174.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -166.84 19.94 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 O-C-N 124.549 1.156 . . . . 64.310000000000002 109.229 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -93.45 70.94 4.33 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 122.151 0.977 . . . . 75.409999999999997 109.272 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -79.14 -23.92 43.68 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.24 -1.345 . . . . 71.400000000000006 109.426 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.6 p -78.03 4.54 12.0 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.967 0.907 . . . . 74.430000000000007 112.337 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.96 -37.62 78.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.949 0.5 . . . . 75.340000000000003 110.987 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.49 -31.16 62.1 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.072 0.463 . . . . 63.109999999999999 109.943 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.51 -5.81 57.24 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.042 0.937 . . . . 72.5 111.06 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.418 HD13 ' HE1' ' A' ' 146' ' ' TRP . 21.0 tp -66.19 -49.71 66.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.296 1.038 . . . . 74.230000000000004 111.36 -173.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -103.61 20.97 16.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.999 0.52 . . . . 54.119999999999997 110.661 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.46 -22.27 25.04 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.65 0.38 . . . . 64.239999999999995 110.854 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.03 -134.27 21.48 Favored Glycine 0 C--N 1.356 1.684 0 CA-C-O 119.014 -0.881 . . . . 61.219999999999999 112.349 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.52 -174.67 0.1 Allowed 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.831 3.02 . . . . 74.200000000000003 113.558 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 m -64.11 169.72 4.2 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.93 -0.577 . . . . 71.099999999999994 109.725 166.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.91 -41.84 88.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 122.978 0.511 . . . . 60.43 111.557 -173.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -127.81 -35.18 2.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.049 0.54 . . . . 71.430000000000007 111.928 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -88.92 122.38 69.03 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.124 0.787 . . . . 75.209999999999994 113.124 -167.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.42 -8.54 12.67 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.567 2.178 . . . . 74.230000000000004 111.653 164.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -109.52 6.81 24.38 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.081 0.953 . . . . 71.340000000000003 111.524 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.6 tp -86.59 133.37 33.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.467 -0.938 . . . . 72.140000000000001 108.467 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -110.42 171.51 7.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.777 0.831 . . . . 75.239999999999995 109.14 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.19 138.71 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.473 1.109 . . . . 54.420000000000002 109.273 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 135' ' ' ILE . . . -82.68 111.14 18.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.966 0.906 . . . . 64.040000000000006 109.594 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.46 -38.06 68.34 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.699 0.799 . . . . 52.420000000000002 110.937 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 37.1 m-85 -122.54 140.91 52.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.341 -1.3 . . . . 72.209999999999994 107.574 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -84.34 150.07 25.63 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.734 -0.469 . . . . 72.239999999999995 109.734 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.626 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.9 t80 -139.84 143.52 36.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.051 0.94 . . . . 64.329999999999998 108.642 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.97 133.2 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.564 -1.273 . . . . 52.140000000000001 107.564 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 129.8 41.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.319 0.648 . . . . 52.520000000000003 111.345 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 p -88.35 -38.96 14.7 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.776 0.83 . . . . 71.439999999999998 109.678 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.76 -170.32 12.66 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.344 -0.844 . . . . 45.200000000000003 112.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.74 -35.1 60.3 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.682 0.793 . . . . 65.510000000000005 110.581 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.457 ' HA ' ' HE3' ' A' ' 254' ' ' TRP . 24.2 p-10 -63.07 -29.32 70.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.054 0.942 . . . . 64.439999999999998 111.871 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.5 p -90.38 154.43 19.68 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.845 0.858 . . . . 61.43 109.491 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.661 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 58.6 tp -125.12 136.9 54.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.003 0.521 . . . . 64.140000000000001 110.467 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -75.23 131.39 40.35 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.958 0.503 . . . . 74.540000000000006 110.063 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.734 HG22 HG21 ' A' ' 123' ' ' THR . 19.3 pt -128.47 167.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.77 0.828 . . . . 53.219999999999999 111.215 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -123.11 152.36 41.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.363 1.065 . . . . 71.540000000000006 109.568 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.72 122.37 16.22 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.429 -0.582 . . . . 75.329999999999998 109.429 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.4 72.03 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-O 119.537 -0.591 . . . . 73.329999999999998 113.894 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -83.76 125.4 31.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.678 0.739 . . . . 53.009999999999998 110.745 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -78.3 133.86 37.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.277 -0.638 . . . . 71.540000000000006 109.277 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.673 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.77 147.03 34.86 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.574 0.75 . . . . 72.150000000000006 110.715 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -94.81 105.58 17.52 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.961 -0.755 . . . . 73.319999999999993 108.961 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.635 HG13 ' HB1' ' A' ' 119' ' ' ALA . 60.6 t -82.67 105.18 12.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.517 -0.92 . . . . 44.240000000000002 108.517 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.528 HD23 ' HG2' ' A' ' 120' ' ' GLU . 2.6 mm? -65.68 -52.88 48.06 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.162 0.914 . . . . 52.450000000000003 108.594 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.411 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . -173.7 155.69 22.53 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.605 -0.725 . . . . 65.239999999999995 114.104 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 96.9 m-85 -88.15 163.54 16.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.801 0.84 . . . . 74.510000000000005 109.786 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -71.43 -172.57 0.77 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 120.803 0.335 . . . . 70.319999999999993 111.338 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -47.71 -41.1 22.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.858 1.263 . . . . 74.099999999999994 114.144 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -114.52 3.62 14.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.306 0.854 . . . . 74.439999999999998 113.306 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.14 32.86 47.02 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.921 0.728 . . . . 44.539999999999999 114.921 174.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.85 -65.65 0.71 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.437 0.695 . . . . 61.399999999999999 110.736 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 34.4 m95 -114.4 165.86 12.28 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 75.109999999999999 109.33 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.08 131.08 36.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.764 1.226 . . . . 74.049999999999997 111.384 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HG2' HD23 ' A' ' 110' ' ' LEU . 24.0 tt0 -68.6 103.05 1.61 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.198 -1.038 . . . . 71.400000000000006 108.198 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.4 140.52 48.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.979 0.912 . . . . 73.099999999999994 109.85 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.491 ' HG3' HD21 ' A' ' 110' ' ' LEU . 55.8 mt-30 -105.51 105.39 15.41 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.575 -0.898 . . . . 71.109999999999999 108.575 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.734 HG21 HG22 ' A' ' 101' ' ' ILE . 68.5 p -99.88 -176.37 3.23 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.816 1.246 . . . . 74.310000000000002 110.357 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.88 -18.37 64.12 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.529 -0.76 . . . . 62.329999999999998 110.231 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.64 -3.46 59.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.664 1.186 . . . . 72.109999999999999 111.714 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.53 -138.39 13.27 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-O 119.513 -0.604 . . . . 74.450000000000003 111.815 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -129.73 143.51 50.85 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.724 0.762 . . . . 75.329999999999998 110.096 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.661 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.5 -172.28 43.46 Favored Glycine 0 C--O 1.225 -0.428 0 N-CA-C 110.972 -0.851 . . . . 64.420000000000002 110.972 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 40.9 m95 -107.34 125.19 50.88 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.323 0.561 . . . . 74.239999999999995 110.505 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.52 140.42 38.6 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.433 1.493 . . . . 64.310000000000002 109.091 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 9.3 Cg_exo -72.15 147.96 49.25 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 122.731 2.287 . . . . 44.5 114.414 -171.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 m -37.2 -51.59 1.02 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.415 1.886 . . . . 64.239999999999995 114.189 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -75.11 -3.18 31.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.546 0.738 . . . . 73.209999999999994 112.809 -171.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -94.47 -23.21 17.82 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.493 0.717 . . . . 74.450000000000003 111.577 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 109' ' ' VAL . 11.4 pt -123.32 173.77 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.794 0.838 . . . . 71.420000000000002 111.346 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.3 t -160.97 153.63 17.43 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.039 -1.097 . . . . 73.319999999999993 108.039 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.24 147.76 93.61 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 121.59 1.527 . . . . 62.119999999999997 110.981 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.82 -6.9 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 CA-C-O 121.499 0.666 . . . . 64.409999999999997 110.885 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -79.29 -13.15 59.84 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.346 0.658 . . . . 73.329999999999998 112.076 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.0 p -88.53 174.82 7.87 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.336 0.588 . . . . 63.32 112.418 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -84.03 -22.68 31.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.047 -0.979 . . . . 72.019999999999996 110.475 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.23 -22.09 66.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.964 0.905 . . . . 75.099999999999994 112.121 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -63.28 -13.74 41.76 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.529 0.566 . . . . 53.450000000000003 112.529 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -94.25 150.65 20.1 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.76 0.824 . . . . 72.319999999999993 110.425 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.8 p -67.66 -38.82 84.3 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 124.272 0.983 . . . . 74.319999999999993 111.635 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.475 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 41.9 p-90 -60.38 -48.96 79.48 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.82 0.7 . . . . 72.239999999999995 111.958 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.48 96.88 2.99 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.125 -0.694 . . . . 73.420000000000002 109.125 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -91.57 -2.38 57.15 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.616 -0.72 . . . . 74.010000000000005 111.078 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.54 -161.82 42.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.158 -0.801 . . . . 51.049999999999997 112.588 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.449 ' HG2' ' HD2' ' A' ' 29' ' ' ARG . 52.2 Cg_exo -58.33 98.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.4 2.733 . . . . 70.420000000000002 112.564 174.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 53.5 t -122.94 135.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 114.674 -1.148 . . . . 75.420000000000002 109.9 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.7 p -75.37 156.72 35.17 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.366 0.666 . . . . 62.130000000000003 109.489 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 71.1 ttt180 -62.71 -36.92 84.52 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 118.78 -0.629 . . . . 63.100000000000001 111.361 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -55.42 -43.94 75.8 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.559 0.695 . . . . 73.140000000000001 110.484 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.43 70.22 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.406 -1.27 . . . . 70.439999999999998 111.321 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.5 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.084 0.554 . . . . 74.510000000000005 111.402 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.2 mm-40 -68.98 -30.17 68.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.146 0.578 . . . . 71.209999999999994 110.009 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.73 -47.32 84.09 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.202 0.601 . . . . 73.439999999999998 110.329 171.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.6 mt -60.48 -35.33 75.65 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.987 0.515 . . . . 62.119999999999997 110.679 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 73.9 mt -105.74 21.32 17.45 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.539 -0.755 . . . . 71.140000000000001 113.036 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.8 p -88.61 -35.13 17.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.453 -0.943 . . . . 72.230000000000004 108.453 165.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.7 p -95.97 12.89 28.82 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.94 -1.027 . . . . 64.019999999999996 111.702 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.0 -175.59 40.97 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 112.493 -0.243 . . . . 73.140000000000001 112.493 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.439 HD11 ' HE2' ' A' ' 234' ' ' TYR . 32.3 pt -131.18 -174.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.363 1.065 . . . . 61.140000000000001 110.036 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -58.72 122.32 13.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 74.030000000000001 110.799 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.78 9.57 68.25 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.84 -0.618 . . . . 51.420000000000002 113.66 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 48.8 m -88.9 127.85 35.66 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.975 0.887 . . . . 61.149999999999999 110.035 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -132.41 -178.33 4.87 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.772 0.714 . . . . 62.100000000000001 112.793 -172.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.418 HD23 ' HG ' ' A' ' 160' ' ' LEU . 4.0 pp -164.69 155.97 15.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.048 0.939 . . . . 73.010000000000005 109.633 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.679 HG22 HG12 ' A' ' 182' ' ' ILE . 88.1 t -116.37 134.36 60.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.356 -0.979 . . . . 72.420000000000002 108.356 167.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.437 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 15.4 ptt180 -130.26 149.39 51.98 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.522 -0.763 . . . . 62.32 110.077 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -93.11 150.44 20.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.076 1.35 . . . . 74.439999999999998 108.036 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.8 t -79.5 123.51 27.63 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.819 -0.437 . . . . 64.310000000000002 109.819 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.98 -36.14 72.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.284 1.033 . . . . 74.409999999999997 111.2 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.0 p -78.39 -31.09 48.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.409 0.683 . . . . 71.420000000000002 111.566 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.4 m -140.04 89.43 11.19 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.192 0.597 . . . . 75.120000000000005 109.764 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.38 132.7 53.44 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.068 2.512 . . . . 71.420000000000002 112.819 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.52 -27.82 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.842 0.734 . . . . 62.210000000000001 112.388 -175.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -86.87 114.56 23.62 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.817 -0.808 . . . . 73.519999999999996 108.817 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -125.96 148.45 49.25 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.235 0.54 . . . . 63.109999999999999 110.914 -172.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.6 p -144.42 148.88 35.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.782 -1.099 . . . . 54.32 109.923 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.679 HG12 HG22 ' A' ' 170' ' ' VAL . 41.6 mt -102.25 149.71 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.264 -1.384 . . . . 71.129999999999995 107.264 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -125.29 120.85 32.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.105 -1.443 . . . . 54.420000000000002 107.105 170.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 67.7 tp -114.04 114.11 25.69 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.921 0.782 . . . . 73.420000000000002 110.52 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 29.3 ttt85 -77.48 113.85 15.71 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 109.761 -0.459 . . . . 74.209999999999994 109.761 166.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -142.06 138.68 31.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.206 1.402 . . . . 71.150000000000006 107.477 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 58.74 22.14 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.426 1.09 . . . . 72.310000000000002 111.984 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.93 86.7 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 114.226 0.45 . . . . 72.030000000000001 114.226 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -108.17 147.62 31.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.925 0.89 . . . . 73.019999999999996 108.685 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.32 105.58 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.384 0.674 . . . . 72.109999999999999 109.827 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.35 116.46 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.486 1.115 . . . . 74.040000000000006 109.333 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -91.59 118.95 31.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.826 0.451 . . . . 52.109999999999999 110.751 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.56 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.4 m-85 -94.77 151.17 19.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.185 0.994 . . . . 52.409999999999997 108.782 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -104.71 122.72 46.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.415 -0.587 . . . . 74.420000000000002 109.415 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.2 mt -90.98 105.87 16.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.084 -0.71 . . . . 63.219999999999999 109.084 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.91 140.3 29.63 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.412 0.685 . . . . 52.140000000000001 110.033 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 42.6 m -98.36 119.05 36.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.655 1.182 . . . . 70.019999999999996 107.854 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 174.45 6.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.978 0.911 . . . . 71.120000000000005 110.569 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 61.0 p -66.01 -25.63 67.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.373 0.669 . . . . 53.119999999999997 111.937 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.36 -17.21 29.29 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.143 0.577 . . . . 74.040000000000006 111.0 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.55 6.0 23.81 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-O 119.352 -0.693 . . . . 74.209999999999994 114.493 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -70.96 128.6 36.54 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.915 0.857 . . . . 74.540000000000006 112.097 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.21 143.12 34.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.783 0.833 . . . . 70.510000000000005 108.924 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.518 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.2 p90 -165.9 146.84 6.79 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.506 0.504 . . . . 71.329999999999998 111.624 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.528 HG23 HD11 ' A' ' 217' ' ' LEU . 78.0 t -89.39 -42.44 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.561 -0.903 . . . . 73.030000000000001 108.561 165.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.2 m -104.87 129.32 53.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.95 -1.023 . . . . 73.310000000000002 109.155 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -67.14 -18.54 65.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.305 0.642 . . . . 60.229999999999997 111.739 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -70.29 -26.56 63.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.608 1.163 . . . . 63.32 110.942 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 51.1 p -137.46 107.66 6.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.535 0.734 . . . . 72.400000000000006 109.93 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.2 mtt180 -116.56 133.82 55.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.303 1.041 . . . . 74.329999999999998 108.881 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.409 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.2 OUTLIER -128.78 143.67 50.97 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.365 0.666 . . . . 75.040000000000006 109.945 -170.059 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -67.91 -22.29 65.09 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.974 0.51 . . . . 73.329999999999998 112.066 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.2 p -130.89 155.14 47.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.121 0.962 . . . . 45.310000000000002 112.05 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -28.19 69.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 113.631 -1.622 . . . . 73.439999999999998 109.327 173.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.79 94.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.733 0.813 . . . . 72.439999999999998 110.945 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.407 0.683 . . . . 73.219999999999999 111.15 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.528 HD11 HG23 ' A' ' 205' ' ' VAL . 17.8 tp -55.2 -54.37 44.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 123.552 0.533 . . . . 50.200000000000003 111.158 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.88 -46.79 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 124.038 0.836 . . . . 74.140000000000001 110.703 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -61.74 -48.05 82.45 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.544 0.527 . . . . 61.329999999999998 111.968 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.02 -47.04 78.86 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.939 -0.573 . . . . 75.150000000000006 109.609 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.671 ' HB3' HD11 ' A' ' 228' ' ' LEU . 15.9 m-70 -82.76 -1.45 51.59 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 112.296 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.8 p -94.14 -40.83 9.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.919 0.488 . . . . 74.349999999999994 110.913 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.7 p -69.63 -38.3 77.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.321 -0.399 . . . . 71.450000000000003 111.019 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.651 HG23 ' HB2' ' A' ' 226' ' ' ASP . 17.6 m -132.97 162.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.669 0.747 . . . . 54.350000000000001 112.237 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.34 15.71 0.92 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 127.219 2.208 . . . . 54.549999999999997 113.988 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.651 ' HB2' HG23 ' A' ' 224' ' ' VAL . 23.4 t70 -44.2 33.44 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.464 1 C-N-CA 132.357 4.263 . . . . 74.329999999999998 119.519 -156.124 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.28 2.14 9.16 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.243 -1.536 . . . . 72.349999999999994 112.63 -171.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.5 mt -94.5 165.58 12.47 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 125.701 1.6 . . . . 74.109999999999999 109.972 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.1 tt -56.38 -42.05 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 109.982 -0.377 . . . . 63.43 109.982 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.9 t -160.91 177.39 10.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.995 0.918 . . . . 70.540000000000006 109.693 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 68.3 p -61.85 150.12 38.26 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.451 1.1 . . . . 75.530000000000001 113.106 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.56 HD21 ' HE1' ' A' ' 193' ' ' TYR . 86.5 mt -83.65 92.44 7.68 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.384 -0.969 . . . . 62.140000000000001 108.384 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -78.76 -51.32 9.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.504 0.557 . . . . 72.329999999999998 112.504 -161.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.4 OUTLIER -148.16 150.22 34.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.843 -1.169 . . . . 71.230000000000004 107.843 169.109 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.413 ' HB3' ' HB3' ' A' ' 146' ' ' TRP . 11.6 Cg_endo -96.0 153.29 1.41 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.384 2.722 . . . . 73.109999999999999 114.149 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -60.51 128.38 88.1 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 114.653 -1.158 . . . . 71.439999999999998 109.53 168.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 11.2 Cg_exo -73.58 -173.79 1.45 Allowed 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 123.006 2.47 . . . . 74.319999999999993 113.31 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 74.1 mmtt -67.3 133.27 49.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.867 0.867 . . . . 73.099999999999994 109.523 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.482 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 13.5 ptt180 -86.49 -66.72 0.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.538 0.94 . . . . 62.43 113.538 -167.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.482 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 9.1 t30 -114.98 158.03 22.61 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.984 0.514 . . . . 64.549999999999997 111.323 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.91 114.62 41.09 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 108.115 -1.068 . . . . 71.25 108.115 166.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.56 123.12 12.87 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.018 2.478 . . . . 74.409999999999997 112.167 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 5.1 m -72.95 103.64 3.82 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.651 -0.704 . . . . 72.420000000000002 111.268 -167.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.488 HG21 ' HG2' ' A' ' 131' ' ' PRO . 25.0 t -93.39 127.92 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.261 -1.014 . . . . 75.209999999999994 108.261 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -104.44 111.18 23.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.426 -0.321 . . . . 71.099999999999994 110.331 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.84 -39.39 0.24 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 118.245 2.058 . . . . 43.310000000000002 118.245 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.3 123.55 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.818 1.044 . . . . 74.439999999999998 113.818 -157.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.1 t -82.04 129.31 64.84 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 106.01 -1.848 . . . . 70.299999999999997 106.01 157.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.08 -55.61 0.98 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.484 1.456 . . . . 73.129999999999995 113.957 -154.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -129.46 -17.3 3.75 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.943 0.897 . . . . 74.340000000000003 111.243 161.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.42 ' CD1' ' HB2' ' A' ' 254' ' ' TRP . 73.7 m-85 -86.39 108.97 18.71 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.0 1.111 . . . . 75.209999999999994 114.0 -158.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -104.41 -23.53 13.17 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.225 -0.898 . . . . 63.329999999999998 108.764 159.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -94.04 9.38 37.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.05 0.94 . . . . 65.439999999999998 112.247 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.457 ' HE3' ' HA ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -94.38 157.88 15.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.493 0.588 . . . . 75.430000000000007 110.008 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 C--O 1.25 1.117 0 N-CA-C 107.49 -1.3 . . . . 63.009999999999998 107.49 173.693 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.139 -0.689 . . . . 72.519999999999996 109.139 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.8 78.06 0.51 Allowed Glycine 0 C--N 1.353 1.526 0 O-C-N 123.645 0.59 . . . . 54.299999999999997 112.732 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -132.86 175.74 9.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.837 1.255 . . . . 73.329999999999998 109.319 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -71.32 136.3 84.15 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 109.162 -0.681 . . . . 73.439999999999998 109.162 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -52.69 108.28 0.25 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.029 2.486 . . . . 71.010000000000005 112.615 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.61 134.92 35.64 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.303 -0.862 . . . . 65.340000000000003 112.036 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -82.48 67.71 8.64 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.825 0.85 . . . . 72.439999999999998 108.903 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.6 m -87.64 130.77 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.761 -1.108 . . . . 51.43 109.514 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.79 150.71 23.21 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.336 -0.986 . . . . 62.100000000000001 108.336 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.79 114.53 0.62 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.064 -0.814 . . . . 72.25 111.064 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -151.94 111.24 3.92 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.636 -0.875 . . . . 74.409999999999997 108.636 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -136.32 -179.23 5.55 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.047 0.939 . . . . 51.409999999999997 108.931 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 164.0 39.07 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.993 -0.743 . . . . 75.019999999999996 108.993 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.43 142.84 25.13 Favored Pre-proline 0 N--CA 1.487 1.375 0 CA-C-N 118.088 0.404 . . . . 74.5 110.802 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.49 93.11 0.58 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.951 2.434 . . . . 54.43 111.714 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.2 p -81.49 116.53 21.32 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.225 0.61 . . . . 74.549999999999997 110.19 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -155.48 113.35 2.24 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.638 -1.245 . . . . 71.099999999999994 107.638 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.12 155.77 59.13 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 123.377 2.718 . . . . 74.549999999999997 112.977 -172.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -127.14 153.69 45.7 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.354 0.662 . . . . 64.239999999999995 111.621 -170.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.3 mt -101.83 131.36 48.2 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.893 0.877 . . . . 50.100000000000001 110.011 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.496 ' HA ' ' OH ' ' A' ' 251' ' ' TYR . 0.6 OUTLIER -80.4 147.64 30.91 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 117.575 0.17 . . . . 73.439999999999998 110.845 177.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -112.92 149.26 33.44 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.4 0.68 . . . . 75.230000000000004 109.685 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.55 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 37.7 pt -112.96 177.29 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.43 0.692 . . . . 74.25 110.879 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt 78.31 142.35 0.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 126.243 1.817 . . . . 72.120000000000005 112.29 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.48 ' HA3' ' HD1' ' A' ' 112' ' ' TYR . . . 137.66 150.63 5.74 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.097 -0.956 . . . . 52.130000000000003 111.97 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.727 ' HA ' ' HZ ' ' A' ' 85' ' ' PHE . . . -147.44 98.43 2.99 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.197 0.599 . . . . 71.109999999999999 111.414 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.35 -179.3 3.56 Favored Glycine 0 C--N 1.364 2.104 0 O-C-N 123.662 0.601 . . . . 74.450000000000003 113.33 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -162.08 -104.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.762 1.225 . . . . 73.310000000000002 109.102 169.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.72 90.94 3.46 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.462 -0.94 . . . . 72.239999999999995 108.462 -175.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -81.42 63.77 5.87 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.306 1.051 . . . . 63.109999999999999 108.264 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.2 p -84.86 156.71 21.17 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 114.052 -1.431 . . . . 53.43 111.291 -170.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.7 m -76.27 179.44 5.76 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.028 -0.987 . . . . 54.25 111.551 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 240' ' ' ASN . 0.2 OUTLIER -161.41 142.25 11.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.526 -1.657 . . . . 51.039999999999999 106.526 178.246 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -86.98 119.74 27.51 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.416 0.553 . . . . 61.420000000000002 109.776 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.38 -152.15 6.84 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.241 -0.436 . . . . 74.5 113.079 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.4 96.03 0.21 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.363 -0.687 . . . . 62.329999999999998 111.865 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -83.9 156.84 13.55 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.062 2.508 . . . . 74.140000000000001 112.029 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -147.28 145.33 29.35 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.702 0.401 . . . . 75.120000000000005 110.37 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 237' ' ' PRO . 94.7 m -131.21 155.74 46.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.105 0.962 . . . . 72.049999999999997 111.014 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -150.48 -176.9 5.67 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 107.479 -1.304 . . . . 73.019999999999996 107.479 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.5 t 79.66 118.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 125.09 1.356 . . . . 63.409999999999997 110.243 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -77.42 172.52 13.2 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.372 0.669 . . . . 74.439999999999998 110.389 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.603 HG22 ' HB3' ' A' ' 65' ' ' ALA . 43.6 t -121.52 -174.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.816 1.246 . . . . 44.030000000000001 107.957 -175.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' H ' HG12 ' A' ' 43' ' ' VAL . 9.6 tp10 -133.9 138.4 45.53 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.331 0.652 . . . . 75.109999999999999 110.292 168.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -164.15 -93.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.654 0.782 . . . . 72.209999999999994 110.434 166.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 162.48 153.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.473 1.509 . . . . 71.019999999999996 108.07 -166.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.14 158.8 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.178 1.391 . . . . 73.319999999999993 113.027 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -157.34 173.03 17.55 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.375 0.67 . . . . 75.25 110.225 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.08 -55.46 0.45 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.946 -1.131 . . . . 44.420000000000002 107.946 174.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.9 86.69 36.82 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 106.989 -1.486 . . . . 64.049999999999997 106.989 170.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.56 141.89 51.92 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.88 2.387 . . . . 64.510000000000005 112.99 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 m -82.36 -14.7 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-O 121.149 0.5 . . . . 64.219999999999999 110.583 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.53 101.28 3.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.52 1.128 . . . . 75.549999999999997 108.209 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.0 m -85.71 71.81 10.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.919 0.888 . . . . 72.430000000000007 109.918 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -173.81 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.264 1.425 . . . . 71.209999999999994 108.676 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -167.98 124.94 1.11 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 124.441 1.096 . . . . 64.439999999999998 108.458 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.69 105.92 56.33 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.607 0.763 . . . . 75.409999999999997 109.333 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.99 -36.64 58.58 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.489 2.126 . . . . 64.150000000000006 111.501 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.485 ' HB3' ' H ' ' A' ' 43' ' ' VAL . 5.0 pm0 -91.77 -45.87 8.19 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.863 -1.062 . . . . 74.340000000000003 111.091 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.56 -107.58 1.45 Allowed Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.695 -0.962 . . . . 73.319999999999993 110.695 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.431 ' HB3' ' CE1' ' A' ' 233' ' ' HIS . 96.3 mt -77.41 90.22 3.82 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 109.303 -0.629 . . . . 74.120000000000005 109.303 168.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.5 t -67.51 105.35 1.81 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.945 1.298 . . . . 74.450000000000003 111.606 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.542 ' H ' HG11 ' A' ' 43' ' ' VAL . 11.1 pt-20 -144.19 -48.01 0.27 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.103 1.149 . . . . 73.129999999999995 114.103 -171.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.7 -48.61 80.97 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.399 0.888 . . . . 73.420000000000002 113.399 -168.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.603 ' HB3' HG22 ' A' ' 43' ' ' VAL . . . -86.52 -9.79 55.43 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.16 0.584 . . . . 62.420000000000002 112.219 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HG2' HG21 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -102.08 -63.74 1.13 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.358 0.663 . . . . 74.409999999999997 109.62 -176.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.42 46.12 1.19 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.372 1.069 . . . . 65.349999999999994 109.615 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.6 p-10 -63.98 -24.18 67.62 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.355 1.062 . . . . 71.010000000000005 110.236 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.5 m -67.34 3.04 1.37 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.871 1.269 . . . . 75.299999999999997 112.796 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.8 -40.28 83.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.401 1.08 . . . . 63.539999999999999 111.508 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 7.9 pt-20 -68.53 -39.14 81.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.829 0.452 . . . . 75.109999999999999 110.146 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -81.12 -10.29 59.68 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.254 -0.884 . . . . 61.539999999999999 111.025 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.3 tp -62.78 -52.75 61.98 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.313 0.645 . . . . 73.140000000000001 110.122 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.9 mt -104.34 20.92 17.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.04 0.536 . . . . 72.010000000000005 110.624 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.72 -32.75 70.06 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.94 0.496 . . . . 44.119999999999997 111.278 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.6 -134.44 22.4 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-O 118.785 -1.008 . . . . 43.450000000000003 110.856 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 31.3 Cg_exo -58.63 -175.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.85 2.367 . . . . 74.310000000000002 113.096 167.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.44 ' OG ' ' HB ' ' A' ' 138' ' ' VAL . 7.0 m -72.94 170.74 14.15 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 122.808 0.443 . . . . 74.019999999999996 110.406 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.65 -50.57 29.4 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 111.92 0.341 . . . . 63.310000000000002 111.92 -170.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -131.2 -38.46 1.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.278 0.631 . . . . 75.230000000000004 110.883 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 24.0 m-20 -91.35 111.03 46.76 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 117.972 -1.013 . . . . 63.140000000000001 112.003 -174.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -58.31 -26.69 78.17 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.439 2.093 . . . . 62.329999999999998 112.217 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -96.41 20.45 10.53 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.386 0.674 . . . . 73.420000000000002 110.767 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.2 tp -84.14 135.28 34.45 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.699 -0.625 . . . . 53.409999999999997 109.462 175.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.727 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 5.3 m-85 -119.22 174.23 6.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.238 1.415 . . . . 75.349999999999994 109.734 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.62 139.41 35.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.959 1.303 . . . . 53.32 108.338 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.416 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -76.09 130.8 38.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.619 0.768 . . . . 23.420000000000002 109.344 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 136' ' ' THR . 72.0 mt -91.26 -26.91 18.77 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.395 0.678 . . . . 63.43 110.728 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.14 165.64 21.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.504 0.721 . . . . 75.019999999999996 110.362 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 3.4 m-20 -89.18 120.21 30.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.191 -0.913 . . . . 70.549999999999997 108.915 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.542 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.5 t80 -114.96 148.14 39.13 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.282 -1.007 . . . . 61.32 108.282 173.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.6 t -122.92 134.54 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.19 -1.041 . . . . 70.230000000000004 108.19 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.3 124.54 22.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.804 . . . . 74.450000000000003 111.573 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 p -141.32 18.56 2.24 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.076 0.95 . . . . 72.409999999999997 111.213 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.25 -179.28 24.08 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.944 -0.863 . . . . 44.439999999999998 110.944 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.93 -38.84 76.33 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.985 0.514 . . . . 64.200000000000003 111.516 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.511 HD21 ' HG2' ' A' ' 249' ' ' PRO . 27.0 p-10 -105.47 -3.19 22.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.977 0.511 . . . . 75.310000000000002 112.305 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.416 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 73.6 p -72.47 164.57 26.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.728 0.64 . . . . 72.340000000000003 112.728 -170.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.445 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 67.3 tp -147.18 136.31 22.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.022 0.529 . . . . 70.120000000000005 110.744 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.4 m -80.0 117.6 20.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.307 0.643 . . . . 42.020000000000003 110.615 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.658 HG22 HG21 ' A' ' 123' ' ' THR . 22.6 pt -117.72 157.04 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.167 0.587 . . . . 74.109999999999999 111.009 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.8 m -111.31 151.54 28.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.566 1.146 . . . . 75.200000000000003 109.064 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -60.05 125.62 24.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.231 0.612 . . . . 71.310000000000002 110.414 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.62 -7.23 82.41 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.611 . . . . 51.409999999999997 113.751 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -69.57 124.39 23.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.366 0.583 . . . . 71.129999999999995 111.058 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -73.86 134.94 43.35 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.348 -0.612 . . . . 54.039999999999999 109.348 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.662 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.0 159.05 44.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.8 0.84 . . . . 52.140000000000001 110.457 -175.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.509 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 56.7 ttm-85 -115.43 109.97 18.64 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.881 0.472 . . . . 72.439999999999998 110.578 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.695 HG13 ' HB1' ' A' ' 119' ' ' ALA . 25.5 t -70.61 112.18 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.56 0.695 . . . . 73.150000000000006 109.127 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.08 -41.83 58.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.042 -0.981 . . . . 70.140000000000001 108.364 175.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 23' ' ' ILE . . . 172.77 158.33 16.79 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.843 0.714 . . . . 50.119999999999997 113.639 171.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.783 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 59.9 m-85 -88.16 164.89 15.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 70.209999999999994 111.666 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.7 -172.56 3.37 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.972 0.909 . . . . 70.25 111.162 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.24 -35.43 11.97 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 115.158 1.54 . . . . 73.540000000000006 115.158 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -110.5 -15.43 13.9 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.136 0.574 . . . . 74.299999999999997 111.791 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.783 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 87.97 30.19 18.26 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 114.631 0.613 . . . . 60.219999999999999 114.631 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.45 -38.05 17.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.516 0.658 . . . . 65.129999999999995 111.79 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 18.1 m95 -125.52 146.25 49.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.163 0.585 . . . . 74.129999999999995 110.559 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.695 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -129.72 136.5 49.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 74.129999999999995 110.927 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.41 103.79 2.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.11 -1.07 . . . . 74.409999999999997 108.11 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.7 138.42 39.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.108 0.563 . . . . 54.219999999999999 111.135 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 61.3 tt0 -97.75 104.89 16.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.903 -1.147 . . . . 74.310000000000002 107.903 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 107' ' ' LEU . 68.5 p -111.09 172.07 7.1 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.753 0.821 . . . . 71.439999999999998 110.86 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -14.53 62.97 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 114.718 -1.128 . . . . 73.319999999999993 110.031 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.1 -26.66 30.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.18 0.992 . . . . 64.439999999999998 111.539 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 136.22 -158.68 24.07 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 120.158 -0.245 . . . . 75.019999999999996 112.533 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.429 HE22 ' HB2' ' A' ' 122' ' ' GLN . 11.8 tp-100 -101.82 137.39 40.18 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.208 0.504 . . . . 74.010000000000005 111.377 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 165.9 162.67 17.76 Favored Glycine 0 C--N 1.347 1.143 0 C-N-CA 121.403 -0.427 . . . . 63.520000000000003 113.399 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 43.1 m95 -77.15 133.69 38.9 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.319 1.047 . . . . 70.510000000000005 112.19 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.3 m -136.28 146.32 55.64 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 125.108 1.363 . . . . 70.530000000000001 108.552 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 73.4 Cg_endo -76.06 150.05 33.25 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.1 1.867 . . . . 64.519999999999996 114.888 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -39.23 -49.06 1.87 Allowed 'General case' 0 C--N 1.366 1.308 0 C-N-CA 126.243 1.817 . . . . 61.299999999999997 113.516 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -79.22 -0.85 33.78 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.082 0.771 . . . . 73.219999999999999 113.082 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -98.76 -13.38 20.22 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.85 0.86 . . . . 74.519999999999996 111.487 170.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.73 177.25 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.26 1.024 . . . . 71.129999999999995 110.451 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.426 HG22 HD21 ' A' ' 88' ' ' LEU . 6.4 t -161.75 151.91 14.3 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 108.463 -0.939 . . . . 73.450000000000003 108.463 170.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.03 148.15 86.69 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.705 1.603 . . . . 61.310000000000002 111.679 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.44 ' HB ' ' OG ' ' A' ' 78' ' ' SER . 36.9 t -71.27 -7.76 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-O 121.688 0.756 . . . . 62.210000000000001 109.893 173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.639 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 19.2 m-20 -75.45 -20.26 58.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.078 0.951 . . . . 71.209999999999994 111.746 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.5 p -91.83 174.41 7.35 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.448 0.699 . . . . 75.25 111.607 -172.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.28 -20.04 32.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 61.420000000000002 110.569 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.5 -19.13 65.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.086 0.955 . . . . 75.299999999999997 111.992 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -62.68 -21.43 65.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.499 0.72 . . . . 74.340000000000003 112.658 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -78.47 139.75 38.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.285 0.634 . . . . 75.420000000000002 110.143 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.9 p -59.65 -41.94 91.66 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.187 0.995 . . . . 61.399999999999999 111.906 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -67.01 -38.66 86.35 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.834 0.709 . . . . 72.439999999999998 112.229 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.5 118.51 20.71 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.179 -0.674 . . . . 74.140000000000001 109.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -112.63 -1.46 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.122 0.569 . . . . 73.530000000000001 112.273 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.55 -162.23 49.0 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 118.807 -0.996 . . . . 75.099999999999994 112.794 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.38 95.9 0.15 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.988 2.459 . . . . 71.329999999999998 112.721 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 82.3 t -119.93 149.72 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.996 1.318 . . . . 53.0 109.002 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 45.6 m -85.66 166.8 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.525 0.73 . . . . 54.240000000000002 110.598 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -60.04 -50.92 71.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.988 0.515 . . . . 73.150000000000006 110.975 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -58.24 -39.75 79.95 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.0 0.92 . . . . 74.430000000000007 111.7 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.4 75.48 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.907 -0.588 . . . . 73.319999999999993 110.801 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 159' ' ' LEU . . . -57.34 -39.21 75.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.585 0.707 . . . . 65.530000000000001 111.505 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -83.7 -19.04 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.254 -0.884 . . . . 73.5 111.971 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -24.69 43.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.839 0.745 . . . . 73.200000000000003 110.936 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.843 HD21 ' HA ' ' A' ' 239' ' ' ARG . 42.7 mt -69.77 -43.66 71.76 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.013 -0.994 . . . . 74.310000000000002 110.007 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.433 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 75.4 mt -94.8 22.77 6.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.844 -1.071 . . . . 70.209999999999994 112.285 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.7 p -74.23 -41.68 60.96 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.099 0.476 . . . . 75.239999999999995 110.152 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 p -111.99 15.06 20.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.183 0.993 . . . . 55.5 112.247 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.29 168.73 52.2 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 121.908 -0.187 . . . . 61.240000000000002 113.235 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 pt -101.8 -176.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.641 0.776 . . . . 65.299999999999997 111.056 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.31 125.35 23.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.459 -0.791 . . . . 74.319999999999993 109.853 172.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.438 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 90.56 10.79 63.08 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 119.313 -0.715 . . . . 30.140000000000001 113.181 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 68.4 m -82.17 116.01 21.53 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.364 1.082 . . . . 64.040000000000006 111.627 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 183' ' ' SER . 12.9 p90 -132.25 168.47 17.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.448 0.642 . . . . 73.530000000000001 111.494 -171.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.32 155.88 25.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.355 -1.293 . . . . 52.450000000000003 108.584 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.658 HG22 HG12 ' A' ' 182' ' ' ILE . 77.5 t -112.33 125.04 69.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.028 -1.101 . . . . 74.530000000000001 108.028 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.565 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 36.3 ptt85 -114.81 161.65 17.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.039 -1.097 . . . . 75.340000000000003 108.039 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 155.24 23.11 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.9 t -79.79 126.41 30.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.049 0.54 . . . . 75.209999999999994 109.794 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -63.42 -34.87 78.69 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 123.948 0.78 . . . . 41.329999999999998 110.265 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 p -82.01 -19.38 40.57 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.626 0.77 . . . . 63.119999999999997 111.989 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -143.86 98.78 5.21 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.901 0.48 . . . . 71.209999999999994 111.176 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.53 136.35 75.33 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.089 2.526 . . . . 74.219999999999999 112.638 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.33 -29.53 6.07 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.135 -0.484 . . . . 50.439999999999998 113.546 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -75.83 117.3 17.42 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.384 -0.599 . . . . 74.140000000000001 109.384 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -122.29 145.79 47.9 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.658 0.742 . . . . 73.310000000000002 110.288 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.1 m -132.49 144.52 50.51 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.523 -1.217 . . . . 71.450000000000003 108.291 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 170' ' ' VAL . 31.9 mt -99.68 148.56 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.787 -1.56 . . . . 72.109999999999999 106.787 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -123.9 108.71 12.73 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.336 -1.357 . . . . 62.039999999999999 107.336 172.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.438 HD11 ' HA2' ' A' ' 166' ' ' GLY . 67.3 tp -105.93 142.75 35.11 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.367 -0.605 . . . . 73.319999999999993 109.367 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.5 ttt85 -117.53 119.38 34.85 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.525 1.13 . . . . 73.329999999999998 109.486 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -140.97 136.27 32.01 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.061 1.344 . . . . 63.149999999999999 107.84 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 58.18 21.23 7.83 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.637 1.175 . . . . 74.329999999999998 111.62 -170.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.17 -9.5 74.73 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.185 0.434 . . . . 52.409999999999997 114.185 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 57.4 mtp85 -96.18 140.12 31.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.522 0.661 . . . . 75.219999999999999 110.177 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.15 108.42 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.691 0.796 . . . . 72.109999999999999 110.81 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.82 150.6 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.278 1.431 . . . . 74.549999999999997 108.51 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 86.0 m-70 -125.45 127.13 46.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.469 0.307 . . . . 72.120000000000005 110.174 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.41 ' HE1' HD21 ' A' ' 232' ' ' LEU . 5.9 m-85 -101.06 149.29 24.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.899 0.88 . . . . 74.439999999999998 109.287 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -97.99 117.25 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.708 -0.849 . . . . 72.349999999999994 108.708 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.7 mt -82.2 99.83 5.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.299 -1.371 . . . . 74.049999999999997 107.299 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -75.04 110.6 9.47 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.555 -1.276 . . . . 73.099999999999994 107.555 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.7 m -89.28 106.4 18.42 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.956 -0.757 . . . . 63.420000000000002 108.956 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.437 ' HB2' ' HE1' ' A' ' 204' ' ' TYR . . . -63.06 148.68 47.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.909 0.884 . . . . 75.049999999999997 110.743 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.3 p -65.5 -23.81 66.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.255 0.622 . . . . 73.319999999999993 112.13 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -78.24 -18.6 55.16 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.862 0.465 . . . . 72.439999999999998 110.986 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.61 14.77 12.06 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.869 -0.406 . . . . 62.310000000000002 114.012 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -92.15 139.0 31.07 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.779 0.789 . . . . 74.25 110.949 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.13 143.03 29.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.956 -1.128 . . . . 62.200000000000003 107.956 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.509 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.5 p90 -163.39 135.45 5.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.221 0.326 . . . . 74.019999999999996 111.675 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.423 HG23 HD11 ' A' ' 217' ' ' LEU . 87.4 t -82.94 -34.02 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.315 -0.995 . . . . 64.299999999999997 108.315 161.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 35.9 m -99.48 119.91 38.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.446 1.099 . . . . 71.549999999999997 110.344 -175.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.6 t -59.12 -34.15 71.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.805 1.242 . . . . 75.340000000000003 112.634 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.22 -2.86 58.85 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.968 0.907 . . . . 52.310000000000002 111.836 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 15.5 m -135.05 85.63 2.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.068 0.547 . . . . 73.319999999999993 109.527 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.509 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 43.5 mtt180 -93.59 120.49 33.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.929 0.891 . . . . 72.010000000000005 109.286 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -107.44 149.68 27.64 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.533 0.733 . . . . 74.450000000000003 109.351 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -62.36 -44.13 97.18 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.523 0.514 . . . . 70.420000000000002 110.161 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.4 p -125.68 160.5 29.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.637 0.732 . . . . 60.439999999999998 111.785 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.24 -25.92 68.27 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.728 -1.124 . . . . 71.200000000000003 109.317 171.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.13 86.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.039 0.936 . . . . 34.210000000000001 111.395 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -72.02 -30.71 65.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.131 -0.94 . . . . 74.049999999999997 111.346 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.423 HD11 HG23 ' A' ' 205' ' ' VAL . 14.8 tp -57.12 -55.49 34.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.306 0.379 . . . . 75.299999999999997 110.351 171.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.2 -41.96 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.752 0.658 . . . . 53.340000000000003 111.254 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -61.87 -55.1 33.24 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.452 0.47 . . . . 75.420000000000002 111.445 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -61.52 -38.08 86.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.443 0.697 . . . . 73.230000000000004 110.866 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.76 ' HB3' HD11 ' A' ' 228' ' ' LEU . 18.6 m170 -88.65 -6.41 57.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.793 -0.639 . . . . 73.510000000000005 112.386 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.0 p -91.07 -31.89 16.09 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 110.22 -0.289 . . . . 62.240000000000002 110.22 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 40.4 p -76.71 -40.63 48.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.206 -0.452 . . . . 72.439999999999998 111.351 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.644 HG23 ' HB2' ' A' ' 226' ' ' ASP . 18.3 m -134.84 158.45 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.331 0.652 . . . . 71.540000000000006 111.623 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.45 14.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 126.932 2.093 . . . . 71.219999999999999 114.424 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.644 ' HB2' HG23 ' A' ' 224' ' ' VAL . 36.4 t70 -42.92 32.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.78 1 C-N-CA 132.07 4.148 . . . . 73.319999999999993 119.761 -155.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.22 -1.8 9.71 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.22 -1.55 . . . . 71.299999999999997 112.112 -168.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.76 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.2 mt -92.07 162.8 14.21 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.691 1.196 . . . . 74.040000000000006 109.434 168.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.49 -42.57 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 121.046 0.45 . . . . 74.340000000000003 110.42 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -161.36 -179.23 7.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.106 0.962 . . . . 63.329999999999998 109.127 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 49.0 p -70.08 143.99 52.27 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.471 0.708 . . . . 65.140000000000001 112.346 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.41 HD21 ' HE1' ' A' ' 193' ' ' TYR . 49.3 mt -72.21 145.66 47.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.649 -1.241 . . . . 72.340000000000003 107.649 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.431 ' CE1' ' HB3' ' A' ' 61' ' ' LEU . 15.8 t60 -147.26 -78.66 0.16 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.323 0.965 . . . . 73.129999999999995 111.534 -175.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 167' ' ' SER . 11.5 t80 -83.41 124.06 76.17 Favored Pre-proline 0 C--O 1.208 -1.09 0 C-N-CA 124.284 1.034 . . . . 73.129999999999995 108.445 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -86.6 139.3 5.69 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.291 1.994 . . . . 71.400000000000006 112.122 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.25 151.9 90.14 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.408 0.683 . . . . 74.219999999999999 109.778 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.463 ' HG3' ' SG ' ' A' ' 39' ' ' CYS . 92.6 Cg_endo -76.06 176.83 9.52 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.508 2.139 . . . . 72.209999999999994 112.118 177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.62 154.57 40.2 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.129 0.572 . . . . 72.329999999999998 110.285 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.843 ' HA ' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -69.9 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.723 1.008 . . . . 74.109999999999999 113.723 -158.249 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 33' ' ' ARG . 65.3 t30 -120.45 159.33 25.34 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.012 -1.055 . . . . 75.200000000000003 108.561 159.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.458 ' NZ ' ' HB2' ' A' ' 90' ' ' ASP . 98.6 mttt -73.43 115.64 43.33 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 107.686 -1.227 . . . . 65.219999999999999 107.686 160.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.49 127.44 21.83 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.042 2.495 . . . . 53.43 112.587 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 26.0 m -80.49 116.43 20.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.84 -0.43 . . . . 52.409999999999997 109.84 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.37 111.89 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.643 0.777 . . . . 72.409999999999997 108.964 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.9 112.8 20.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.541 -0.299 . . . . 75.140000000000001 110.692 -166.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 70.47 -41.51 0.51 Allowed Glycine 0 CA--C 1.542 1.737 0 N-CA-C 117.436 1.735 . . . . 71.239999999999995 117.436 163.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.61 135.4 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 117.687 0.743 . . . . 64.150000000000006 112.667 -157.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -82.8 130.08 59.47 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 105.757 -1.942 . . . . 73.010000000000005 105.757 157.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.511 ' HG2' HD21 ' A' ' 97' ' ' ASN . 12.2 Cg_exo -68.55 -57.21 0.15 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 121.575 1.516 . . . . 54.130000000000003 113.829 -153.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -129.76 -24.41 2.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.054 0.454 . . . . 71.400000000000006 110.437 164.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 21' ' ' HIS . 82.2 m-85 -99.79 139.81 34.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.807 1.039 . . . . 70.340000000000003 113.807 -159.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 253' ' ' LYS . 19.1 t70 -119.45 -31.99 4.46 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.922 1.289 . . . . 74.120000000000005 110.614 166.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.446 ' HD2' ' HB3' ' A' ' 252' ' ' ASP . 1.2 mptp? -110.73 13.81 22.35 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.169 0.803 . . . . 74.340000000000003 113.169 -168.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.447 ' CE3' ' HA ' ' A' ' 97' ' ' ASN . 68.3 t90 -70.91 111.74 6.55 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.208 0.913 . . . . 73.299999999999997 110.766 -171.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 CA--C 1.558 1.284 0 C-N-CA 125.803 1.641 . . . . 53.420000000000002 112.468 179.747 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.542 0.21 . . . . 61.229999999999997 110.565 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.88 153.77 5.96 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.349 -0.387 . . . . 64.540000000000006 112.207 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -80.71 68.75 7.05 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.995 0.902 . . . . 72.010000000000005 109.677 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -141.14 140.68 21.52 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.582 1.553 . . . . 64.450000000000003 107.34 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.61 136.65 77.21 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.453 2.102 . . . . 64.450000000000003 112.175 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.13 110.14 3.37 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.219 -0.352 . . . . 71.519999999999996 112.219 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.22 112.18 23.15 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.86 -0.793 . . . . 74.010000000000005 108.86 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -64.94 -27.32 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 122.875 0.47 . . . . 61.409999999999997 111.404 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.4 mt 62.0 -176.23 0.13 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.752 1.221 . . . . 71.430000000000007 112.157 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.74 -142.96 10.13 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.768 -0.933 . . . . 70.129999999999995 110.768 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.94 141.49 40.46 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.352 -0.61 . . . . 63.509999999999998 109.352 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -78.18 149.34 33.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.172 0.589 . . . . 73.099999999999994 110.292 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -76.64 179.28 6.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.757 0.823 . . . . 74.319999999999993 111.94 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -56.94 168.04 0.94 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 124.821 1.248 . . . . 74.310000000000002 113.367 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 253' ' ' LYS . 1.2 Cg_exo -32.01 119.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 124.565 3.51 . . . . 63.439999999999998 116.477 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.0 m -108.45 20.73 18.23 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.834 -1.075 . . . . 71.340000000000003 109.817 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 255' ' ' GLU . 0.6 OUTLIER 37.26 85.67 0.15 Allowed Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 127.027 2.131 . . . . 74.049999999999997 115.918 173.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HD2' ' HA ' ' A' ' 254' ' ' TRP . 75.6 Cg_exo -56.42 152.49 39.5 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.846 2.364 . . . . 62.130000000000003 112.4 159.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.76 85.62 7.29 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.217 0.607 . . . . 53.43 111.326 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HA ' ' HZ2' ' A' ' 254' ' ' TRP . 10.5 mp 53.17 -87.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.695 1.598 . . . . 73.340000000000003 114.128 169.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 86.37 145.92 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 126.707 2.003 . . . . 72.049999999999997 111.364 -168.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -140.67 126.32 19.1 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.627 0.771 . . . . 71.409999999999997 109.923 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.4 pt -147.8 -171.45 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 124.99 1.316 . . . . 71.430000000000007 108.268 172.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -130.0 128.23 41.6 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 123.226 0.61 . . . . 74.530000000000001 109.848 171.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.3 166.07 26.51 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.63 -0.588 . . . . 52.310000000000002 111.63 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.492 ' HA ' ' HZ ' ' A' ' 85' ' ' PHE . . . -144.92 156.25 43.88 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.802 0.441 . . . . 73.129999999999995 111.831 -176.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.26 -177.55 36.67 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-N 116.151 -0.477 . . . . 43.350000000000001 112.401 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' HE3' ' HD2' ' A' ' 137' ' ' PRO . 9.2 ptpp? -171.6 169.28 6.09 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.965 0.906 . . . . 75.329999999999998 110.358 176.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.625 ' HG2' ' HB2' ' A' ' 132' ' ' SER . 9.4 ptm180 -165.76 -171.17 1.99 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.106 0.963 . . . . 71.530000000000001 109.646 165.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.77 -171.74 2.64 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.825 0.85 . . . . 73.530000000000001 111.505 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.9 t -163.28 159.44 22.67 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.514 1.126 . . . . 63.240000000000002 108.6 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.5 p -140.41 110.65 6.62 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.074 0.55 . . . . 72.319999999999993 111.122 -168.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -133.11 -149.46 0.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.584 1.154 . . . . 74.019999999999996 108.602 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -151.94 130.94 12.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.209 0.604 . . . . 72.209999999999994 110.077 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.26 -115.28 0.33 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.171 -1.171 . . . . 45.439999999999998 110.171 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.7 81.47 0.04 OUTLIER Glycine 0 C--N 1.346 1.134 0 CA-C-O 119.411 -0.661 . . . . 45.25 112.114 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.56 159.87 35.36 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.679 2.252 . . . . 73.400000000000006 112.599 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -133.76 150.81 51.47 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.696 1.198 . . . . 75.109999999999999 109.828 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.0 t -152.85 141.83 21.23 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.423 0.689 . . . . 64.540000000000006 109.887 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -160.62 126.5 3.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.787 0.835 . . . . 52.109999999999999 110.005 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.76 -159.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.331 1.052 . . . . 51.130000000000003 108.915 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -60.52 143.31 53.91 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.326 0.651 . . . . 73.140000000000001 111.49 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.2 m -85.08 -177.63 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.756 0.822 . . . . 73.340000000000003 109.777 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.3 -74.05 0.24 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.568 0.622 . . . . 73.519999999999996 111.867 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -158.88 -160.6 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 122.162 -0.336 . . . . 75.510000000000005 111.368 -166.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 70.84 -177.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.241 1.016 . . . . 75.340000000000003 112.94 172.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.71 167.46 13.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.28 1.032 . . . . 72.219999999999999 110.185 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.92 -174.32 2.52 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.739 0.816 . . . . 73.349999999999994 109.921 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.598 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -117.09 6.97 12.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.815 0.846 . . . . 45.210000000000001 110.22 169.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 165' ' ' ASN . 48.9 ttt85 -173.29 106.51 0.31 Allowed Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.938 1.295 . . . . 71.319999999999993 107.935 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.54 153.66 30.7 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.809 2.339 . . . . 54.140000000000001 110.784 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.17 -175.88 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.892 0 C-N-CA 122.785 0.434 . . . . 73.0 110.527 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.1 116.91 3.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.276 0.63 . . . . 63.509999999999998 109.803 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 m -63.57 -23.47 67.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.261 1.025 . . . . 71.439999999999998 112.134 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.08 -30.38 70.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.613 1.165 . . . . 71.120000000000005 111.429 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.473 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 59.8 m-85 -128.65 39.18 3.85 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.887 0.875 . . . . 74.420000000000002 110.164 -174.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.84 97.51 17.76 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 123.504 0.722 . . . . 62.219999999999999 110.071 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 56' ' ' PHE . 4.6 Cg_exo -88.95 -50.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.317 2.678 . . . . 74.340000000000003 112.866 169.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -84.42 -58.32 2.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.595 0.758 . . . . 74.540000000000006 110.496 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.27 -79.6 0.9 Allowed Glycine 0 C--N 1.35 1.331 0 N-CA-C 111.002 -0.839 . . . . 63.43 111.002 -173.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.52 127.25 32.03 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.859 -0.793 . . . . 63.210000000000001 108.859 171.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.4 m -143.98 31.77 1.26 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.465 0.706 . . . . 71.450000000000003 109.756 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -48.5 74.4 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.356 -0.838 . . . . 73.019999999999996 110.488 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.72 -24.16 53.09 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.035 0.534 . . . . 42.509999999999998 111.213 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.9 -26.87 67.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.225 0.536 . . . . 34.149999999999999 111.129 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.549 HH22 ' HD3' ' A' ' 237' ' ' PRO . 15.7 mmm180 -114.46 -15.46 12.06 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.535 1.134 . . . . 54.030000000000001 111.768 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.799 ' HB2' ' HG3' ' A' ' 235' ' ' PRO . 11.6 t90 -150.6 53.04 0.88 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.949 0.881 . . . . 73.319999999999993 109.021 -169.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.7 p-10 -64.53 -24.18 67.52 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.367 -0.833 . . . . 64.439999999999998 110.012 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.7 p -69.69 3.67 2.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.863 1.265 . . . . 45.450000000000003 112.775 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.6 -20.96 66.13 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.816 0.446 . . . . 62.32 110.664 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 14.4 pt-20 -63.33 -42.46 98.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.056 0.542 . . . . 75.239999999999995 109.816 168.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -72.39 -16.5 61.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.469 1.108 . . . . 71.109999999999999 110.924 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 tp -63.53 -51.4 65.61 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.675 0.79 . . . . 62.109999999999999 110.632 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.6 mt -103.13 4.17 36.68 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 111.41 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.61 -30.27 62.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.667 0.387 . . . . 60.43 110.93 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.75 -136.51 27.65 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.118 -0.823 . . . . 70.120000000000005 111.59 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.02 151.36 82.11 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.57 2.18 . . . . 74.510000000000005 111.636 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 20.2 m -66.96 141.01 57.76 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.716 -0.475 . . . . 73.439999999999998 109.716 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -57.61 -44.5 85.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.483 1.113 . . . . 73.230000000000004 113.357 -168.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -113.11 -38.87 4.34 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.548 0.214 . . . . 62.25 111.424 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 78' ' ' SER . 57.4 m-20 -94.07 107.04 25.64 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 123.451 0.7 . . . . 74.150000000000006 111.607 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.28 -11.64 7.22 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.689 2.259 . . . . 60.420000000000002 112.477 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -110.73 19.58 18.48 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.822 0.849 . . . . 71.409999999999997 110.069 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.6 tp -79.4 139.12 37.81 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.327 -0.397 . . . . 71.219999999999999 110.033 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.492 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 7.2 m-85 -118.62 171.54 8.12 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.729 1.212 . . . . 73.200000000000003 109.723 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.35 131.48 22.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.502 1.121 . . . . 53.109999999999999 109.406 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.74 114.11 6.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.542 1.137 . . . . 65.5 109.889 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 78.0 mt -73.92 -32.63 63.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.516 0.726 . . . . 62.310000000000002 110.496 173.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.53 163.78 21.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.606 -1.179 . . . . 61.140000000000001 108.69 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.15 149.69 23.75 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.803 -0.814 . . . . 75.200000000000003 108.803 166.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.624 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.2 t80 -132.96 141.52 48.38 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.809 -1.182 . . . . 63.32 107.809 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.24 133.47 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.321 -0.992 . . . . 72.329999999999998 108.321 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.25 132.51 53.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.51 0.724 . . . . 52.229999999999997 111.108 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 p -129.39 -41.12 1.4 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.186 0.995 . . . . 65.409999999999997 111.065 -172.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.88 23.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.307 -0.406 . . . . 55.439999999999998 112.524 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.26 -43.57 10.88 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.638 0.719 . . . . 65.230000000000004 111.067 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.484 ' HB2' ' HE3' ' A' ' 254' ' ' TRP . 6.6 p30 -108.24 10.84 27.73 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.613 0.765 . . . . 70.230000000000004 112.123 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.0 p -73.14 150.35 42.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.347 0.659 . . . . 74.200000000000003 110.122 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 128' ' ' GLY . 58.1 tp -130.32 127.73 40.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.089 0.556 . . . . 64.420000000000002 110.824 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -74.27 133.14 42.62 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.221 0.609 . . . . 71.230000000000004 111.619 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.624 HG12 ' HB3' ' A' ' 91' ' ' PHE . 11.4 pt -130.28 166.84 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.208 1.003 . . . . 74.140000000000001 111.1 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 26.9 m -109.84 155.89 21.08 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.577 1.151 . . . . 74.430000000000007 110.329 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -58.95 127.84 34.24 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.162 0.585 . . . . 64.519999999999996 110.196 171.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.83 3.88 84.68 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.388 0.515 . . . . 45.43 114.388 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' HB ' ' A' ' 123' ' ' THR . 38.1 tt0 -73.45 142.48 46.86 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.053 0.541 . . . . 64.420000000000002 110.516 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -93.1 132.28 37.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.454 -0.573 . . . . 72.439999999999998 109.454 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -143.46 163.44 33.11 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.012 0.925 . . . . 72.450000000000003 110.511 -177.088 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -123.79 108.05 12.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.771 0.428 . . . . 72.409999999999997 110.345 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.658 HG13 ' HB1' ' A' ' 119' ' ' ALA . 41.3 t -73.65 117.86 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.197 0.522 . . . . 72.430000000000007 110.47 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.8 mt -84.08 -60.3 2.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.822 -1.081 . . . . 73.549999999999997 109.079 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.4 141.1 9.01 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 120.853 -0.689 . . . . 42.219999999999999 112.942 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.64 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 20.5 m-85 -88.41 154.54 20.29 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.413 0.685 . . . . 65.140000000000001 109.781 171.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -78.54 -174.9 4.06 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.527 -1.215 . . . . 71.420000000000002 111.857 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -50.01 -31.65 13.36 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.185 1.394 . . . . 71.25 114.253 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -112.8 3.08 16.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.836 0.68 . . . . 60.149999999999999 112.836 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.49 19.65 74.74 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.974 0.75 . . . . 73.549999999999997 114.974 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.46 -12.13 18.79 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.453 0.701 . . . . 65.049999999999997 112.806 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 44.7 m95 -134.34 144.87 48.52 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.535 0.734 . . . . 72.010000000000005 110.248 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -132.98 129.7 38.55 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.716 0.807 . . . . 63.439999999999998 110.962 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.83 97.43 2.24 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 106.814 -1.55 . . . . 74.239999999999995 106.814 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.08 144.49 33.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.393 0.677 . . . . 43.119999999999997 111.434 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -93.76 103.37 15.51 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.78 -1.192 . . . . 62.439999999999998 107.78 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 107' ' ' LEU . 38.5 p -97.36 174.56 6.63 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.003 0.921 . . . . 74.129999999999995 109.979 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -63.83 -23.21 67.26 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.189 0.518 . . . . 74.5 110.187 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -79.19 -29.35 42.87 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.598 1.159 . . . . 74.209999999999994 111.036 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 139.86 -170.03 24.43 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 112.282 -0.327 . . . . 50.32 112.282 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -97.33 135.93 38.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.463 0.632 . . . . 63.200000000000003 111.224 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.463 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 170.6 172.28 36.79 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.328 -0.709 . . . . 63.149999999999999 111.328 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -85.19 124.02 31.35 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.344 0.572 . . . . 70.5 112.076 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.52 HG23 HD13 ' A' ' 135' ' ' ILE . 17.2 m -126.99 143.39 46.71 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.09 1.356 . . . . 72.510000000000005 108.445 170.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 66.2 Cg_endo -88.13 149.61 6.82 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.257 1.971 . . . . 73.219999999999999 115.33 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.625 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 2.4 m -46.67 -28.09 1.37 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.607 1.963 . . . . 70.129999999999995 115.592 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.572 HD21 HG22 ' A' ' 244' ' ' VAL . 32.0 p-10 -81.95 -16.32 50.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.478 0.311 . . . . 73.349999999999994 111.769 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 30.1 m-85 -94.48 -23.53 17.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 72.109999999999999 111.688 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.52 HD13 HG23 ' A' ' 130' ' ' VAL . 20.4 pt -123.56 168.01 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.071 0.549 . . . . 72.099999999999994 112.282 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.3 t -159.75 151.3 16.54 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.964 0.906 . . . . 72.349999999999994 108.643 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.434 ' HD2' ' HE3' ' A' ' 28' ' ' LYS . 24.3 Cg_endo -60.7 147.24 95.53 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 121.745 1.63 . . . . 73.230000000000004 111.724 174.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.29 -11.56 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.738 0.78 . . . . 52.25 110.767 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -80.26 -13.53 59.13 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.146 0.578 . . . . 73.099999999999994 111.648 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.2 p -89.16 165.16 14.65 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.253 0.621 . . . . 44.43 110.973 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.9 mt -80.35 -21.35 42.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.804 0.842 . . . . 60.140000000000001 110.817 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.83 -17.16 62.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.843 1.257 . . . . 74.409999999999997 111.68 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.417 ' HA ' HD21 ' A' ' 88' ' ' LEU . 22.0 pttm -61.54 -20.22 63.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.957 0.903 . . . . 51.439999999999998 112.976 176.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.47 144.55 25.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.167 0.587 . . . . 70.430000000000007 111.276 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -60.95 -41.5 96.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.596 1.158 . . . . 72.040000000000006 111.869 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -67.26 -33.07 74.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.649 0.779 . . . . 72.209999999999994 112.556 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -77.59 116.31 18.05 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.69 -0.856 . . . . 73.209999999999994 108.69 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.405 ' ND1' HD13 ' A' ' 159' ' ' LEU . 33.0 m170 -113.33 -2.71 13.94 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.36 0.504 . . . . 50.140000000000001 112.36 -175.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.9 -136.25 25.43 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 118.543 -1.143 . . . . 72.519999999999996 113.091 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.79 90.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.53 2.82 . . . . 54.229999999999997 112.71 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.646 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.6 t -132.31 133.73 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 74.209999999999994 108.963 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -89.79 175.53 7.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.862 0.865 . . . . 73.409999999999997 109.87 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 2.6 tmt_? -58.75 -45.92 88.6 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.76 0.424 . . . . 64.150000000000006 110.261 175.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -63.44 -35.12 79.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.714 0.805 . . . . 72.209999999999994 111.547 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.83 -30.34 62.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.058 -0.519 . . . . 65.310000000000002 110.95 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.7 71.23 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.009 0.524 . . . . 73.140000000000001 111.063 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 12.0 mm-40 -62.86 -48.28 79.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.251 0.62 . . . . 70.340000000000003 109.503 170.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.54 -41.21 69.45 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.077 1.751 . . . . 63.119999999999997 111.669 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 239' ' ' ARG . 59.0 mt -68.1 -55.43 12.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.036 0.934 . . . . 65.319999999999993 111.684 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -84.89 16.02 3.62 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.576 0.584 . . . . 71.530000000000001 112.576 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.6 p -65.0 -40.34 94.8 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.405 0.621 . . . . 74.150000000000006 110.397 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.9 p -98.29 18.89 15.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.34 1.056 . . . . 54.409999999999997 111.0 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.46 162.97 32.31 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.243 -0.435 . . . . 73.299999999999997 112.56 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.1 -176.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.39 1.076 . . . . 54.420000000000002 110.039 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 50' ' ' ARG . 40.2 m-20 -67.47 123.2 19.75 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.422 -0.585 . . . . 74.340000000000003 109.422 175.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.78 5.98 57.36 Favored Glycine 0 C--O 1.25 1.155 0 CA-C-O 119.555 -0.581 . . . . 75.299999999999997 113.187 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 52.6 m -83.88 131.69 34.85 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 119.188 -0.434 . . . . 71.329999999999998 110.5 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.58 168.07 20.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.409 0.623 . . . . 65.340000000000003 111.557 -172.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.16 158.72 27.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 114.326 -1.306 . . . . 74.140000000000001 108.979 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.594 HG22 HG12 ' A' ' 182' ' ' ILE . 98.9 t -119.31 137.69 52.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 N-CA-C 108.338 -0.986 . . . . 72.519999999999996 108.338 168.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.646 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 0.4 OUTLIER -122.26 146.86 46.89 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.009 -0.996 . . . . 63.329999999999998 109.634 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.1 tp10 -97.15 139.64 32.84 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.005 1.322 . . . . 71.310000000000002 108.207 164.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.4 t -83.82 123.14 29.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 72.519999999999996 109.093 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -81.88 -26.55 34.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.28 0.562 . . . . 65.239999999999995 109.799 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.8 m -64.49 -39.12 93.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.281 1.033 . . . . 71.409999999999997 110.213 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 47.5 m -137.51 91.3 14.19 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.035 -1.098 . . . . 54.549999999999997 108.035 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.68 134.38 60.31 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.98 2.453 . . . . 63.140000000000001 112.679 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.06 -27.23 21.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.483 -0.78 . . . . 24.309999999999999 112.549 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -85.22 116.9 23.84 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.538 -0.912 . . . . 64.319999999999993 108.538 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 99.4 mtt180 -123.38 159.5 28.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.477 0.656 . . . . 63.009999999999998 111.668 -170.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.444 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 18.8 m -149.0 152.51 36.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.914 -1.039 . . . . 71.120000000000005 109.516 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.594 HG12 HG22 ' A' ' 170' ' ' VAL . 25.3 mt -102.72 149.08 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.389 -1.337 . . . . 72.400000000000006 107.389 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.2 m -126.43 114.6 18.39 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.311 -0.996 . . . . 52.200000000000003 108.311 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.7 tp -113.03 113.5 25.54 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.088 0.404 . . . . 73.040000000000006 109.911 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.435 ' HE ' ' HA2' ' A' ' 188' ' ' GLY . 44.4 ttt180 -77.82 115.3 17.46 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.324 0.583 . . . . 72.25 110.013 166.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -139.03 144.65 38.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.613 1.565 . . . . 61.219999999999999 107.361 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 58.3 21.07 7.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.04 0.936 . . . . 75.209999999999994 111.919 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.435 ' HA2' ' HE ' ' A' ' 185' ' ' ARG . . . 82.82 -0.37 89.62 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 119.418 -0.657 . . . . 43.149999999999999 114.535 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 55.8 mtp180 -115.36 150.42 36.35 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 117.893 0.846 . . . . 75.010000000000005 109.672 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 62.0 t -100.82 118.94 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.146 0.578 . . . . 73.519999999999996 110.541 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -108.21 117.47 34.23 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.184 0.993 . . . . 71.109999999999999 108.634 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -91.42 122.32 33.91 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.022 0.529 . . . . 75.510000000000005 110.503 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.488 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.6 m-85 -94.36 149.08 21.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.43 1.092 . . . . 74.209999999999994 108.291 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -101.21 127.5 47.75 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.087 -0.708 . . . . 73.120000000000005 109.087 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.51 101.05 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.83 -1.174 . . . . 71.209999999999994 107.83 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -88.11 144.51 26.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.934 1.294 . . . . 73.230000000000004 109.062 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -111.46 116.86 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.55 -0.537 . . . . 75.010000000000005 109.55 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.34 168.15 13.09 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.715 0.806 . . . . 71.129999999999995 110.652 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.6 m -62.81 -28.02 69.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.931 0.892 . . . . 70.530000000000001 112.368 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -90.19 -0.04 57.42 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.063 0.945 . . . . 75.209999999999994 111.969 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 92.09 12.74 58.53 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 114.081 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -83.23 128.09 34.2 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.453 0.627 . . . . 73.450000000000003 111.016 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -81.45 148.14 29.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.648 0.779 . . . . 75.439999999999998 109.288 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 47.3 p90 -168.21 147.11 4.51 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.361 0.413 . . . . 64.319999999999993 111.115 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.522 HG23 HD11 ' A' ' 217' ' ' LEU . 66.0 t -89.65 -41.05 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.38 -0.97 . . . . 74.400000000000006 108.38 164.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 46.6 m -104.94 130.17 53.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.091 0.956 . . . . 65.400000000000006 110.029 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.5 t -66.03 -20.59 66.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 73.510000000000005 112.959 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -76.87 -28.64 55.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.615 0.766 . . . . 73.019999999999996 110.666 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.4 m -124.6 98.09 5.58 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.233 0.613 . . . . 60.32 110.137 -172.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.4 mtt180 -112.08 144.36 41.58 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.973 0.909 . . . . 71.420000000000002 109.284 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.95 151.7 52.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.773 0.829 . . . . 65.430000000000007 108.985 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.33 -40.6 77.49 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.988 -0.375 . . . . 72.140000000000001 109.988 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -121.42 160.69 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.042 0.925 . . . . 64.230000000000004 112.353 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.469 HD11 HG11 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -66.8 -27.74 67.81 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.714 -1.584 . . . . 72.549999999999997 109.431 171.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.76 96.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.492 0.717 . . . . 44.43 110.782 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -68.78 -38.78 80.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.068 0.947 . . . . 65.129999999999995 111.165 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.522 HD11 HG23 ' A' ' 205' ' ' VAL . 16.6 tp -55.12 -56.9 14.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.037 0.535 . . . . 65.439999999999998 110.712 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.62 -38.22 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.545 0.738 . . . . 73.040000000000006 111.774 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -61.37 -57.96 10.17 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.784 0.326 . . . . 75.129999999999995 111.177 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -64.14 -28.15 69.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.805 -0.634 . . . . 75.099999999999994 111.028 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.673 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.6 m170 -91.13 -10.85 40.41 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.88 0.472 . . . . 62.149999999999999 112.186 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 98.3 p -87.62 -29.19 21.4 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 110.181 -0.303 . . . . 70.25 110.181 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 59.0 p -77.27 -50.38 12.99 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.021 0.528 . . . . 74.329999999999998 110.74 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.614 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.7 m -126.4 157.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 121.667 0.746 . . . . 62.030000000000001 111.942 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.63 17.74 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 127.552 2.341 . . . . 74.310000000000002 114.538 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.614 ' HB2' HG23 ' A' ' 224' ' ' VAL . 32.0 t70 -42.47 28.66 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.581 1 C-N-CA 132.619 4.368 . . . . 63.049999999999997 119.497 -152.074 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.11 -5.4 9.55 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 119.835 -1.79 . . . . 42.450000000000003 112.169 -165.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -89.62 160.87 16.43 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.831 1.252 . . . . 41.32 109.792 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.07 -34.35 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 116.272 -0.422 . . . . 73.200000000000003 110.855 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.8 t -162.3 178.49 8.65 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.865 0.866 . . . . 73.209999999999994 109.796 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 50.1 p -73.07 142.39 47.59 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.873 0.469 . . . . 71.109999999999999 111.184 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.488 HD21 ' HE1' ' A' ' 193' ' ' TYR . 46.8 mt -73.36 134.74 44.19 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.474 -0.935 . . . . 70.239999999999995 108.474 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -140.26 -68.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 119.982 1.264 . . . . 73.430000000000007 112.508 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 167' ' ' SER . 16.6 t80 -80.1 120.82 80.89 Favored Pre-proline 0 C--O 1.212 -0.915 0 N-CA-C 107.861 -1.162 . . . . 74.340000000000003 107.861 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.799 ' HG3' ' HB2' ' A' ' 67' ' ' TRP . 58.5 Cg_endo -86.69 144.02 7.42 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.012 1.808 . . . . 62.140000000000001 112.736 173.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.54 149.09 80.85 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 108.878 -0.786 . . . . 72.530000000000001 108.878 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.549 ' HD3' HH22 ' A' ' 66' ' ' ARG . 44.3 Cg_endo -88.26 174.59 4.34 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.359 2.039 . . . . 71.239999999999995 111.661 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 75.6 mmtt -59.57 138.1 57.82 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.127 -0.694 . . . . 74.329999999999998 109.127 175.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.605 ' HB3' HD21 ' A' ' 159' ' ' LEU . 15.9 ptt180 -62.69 -67.4 0.42 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.758 1.021 . . . . 71.340000000000003 113.758 -157.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.595 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 7.9 t30 -119.03 165.19 14.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.844 0.747 . . . . 62.43 110.004 164.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 82.4 mttt -65.27 136.19 96.36 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 110.16 -0.311 . . . . 63.109999999999999 110.16 163.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 7.4 Cg_exo -72.58 126.96 11.96 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.945 2.43 . . . . 62.229999999999997 112.901 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 99.1 m -84.6 124.28 31.26 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.833 -0.802 . . . . 74.319999999999993 108.833 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.572 HG22 HD21 ' A' ' 133' ' ' ASN . 4.3 t -99.84 139.21 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.392 -0.966 . . . . 72.409999999999997 108.392 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.3 114.82 28.98 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.712 0.405 . . . . 74.230000000000004 111.822 -161.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.62 62.19 Favored Glycine 0 C--N 1.362 1.997 0 N-CA-C 115.827 1.091 . . . . 64.200000000000003 115.827 163.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.456 HG21 ' NE1' ' A' ' 118' ' ' TRP . 9.3 p -105.6 130.06 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 114.605 1.335 . . . . 63.229999999999997 114.605 -161.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.0 m -86.42 118.89 71.03 Favored Pre-proline 0 N--CA 1.48 1.066 0 N-CA-C 105.236 -2.135 . . . . 73.120000000000005 105.236 148.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.472 ' HD2' HD21 ' A' ' 97' ' ' ASN . 82.9 Cg_exo -50.61 -58.01 1.93 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.115 1.877 . . . . 61.229999999999997 113.97 -162.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -129.37 -27.5 2.42 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.18 -1.044 . . . . 64.200000000000003 108.18 140.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -100.06 149.38 23.55 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 113.518 -1.674 . . . . 75.530000000000001 112.722 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.49 -17.07 12.75 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.611 -1.631 . . . . 63.210000000000001 108.556 161.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.475 ' HB3' ' HZ3' ' A' ' 253' ' ' LYS . 0.1 OUTLIER -111.6 3.51 17.99 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.724 1.379 . . . . 71.219999999999999 114.724 -165.346 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.553 ' HA ' ' HD2' ' A' ' 18' ' ' PRO . 7.4 t90 -93.65 154.77 17.64 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.41 1.005 . . . . 73.329999999999998 111.269 -176.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 10.1 tp10 . . . . . 0 C--O 1.251 1.157 0 CA-C-N 115.315 -0.857 . . . . 73.129999999999995 109.438 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.818 0.342 . . . . 71.549999999999997 110.825 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.31 117.14 0.7 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.928 -0.578 . . . . 53.399999999999999 111.716 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.47 112.89 15.97 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.468 0.707 . . . . 74.099999999999994 110.092 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.79 120.32 62.0 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.211 0.605 . . . . 62.039999999999999 109.564 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.08 144.02 91.74 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.517 2.145 . . . . 72.439999999999998 111.784 168.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.71 141.49 12.98 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.989 -0.551 . . . . 64.5 112.619 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.558 ' HD2' HG12 ' A' ' 247' ' ' VAL . 15.7 ptpt -80.97 137.28 36.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.531 0.732 . . . . 63.329999999999998 110.156 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.407 HG23 ' HG ' ' A' ' 9' ' ' LEU . 27.4 m -100.73 -42.73 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.237 0.615 . . . . 74.310000000000002 111.099 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' HG ' HG23 ' A' ' 8' ' ' VAL . 2.5 pp -176.68 -178.9 0.93 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.613 1.165 . . . . 71.040000000000006 110.242 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.47 62.85 0.18 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.957 -0.565 . . . . 52.240000000000002 111.921 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.43 106.58 2.57 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.108 -0.701 . . . . 54.329999999999998 109.108 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.477 ' HG2' ' HG3' ' A' ' 13' ' ' ARG . 58.0 tt0 -159.53 145.68 16.19 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.539 1.136 . . . . 74.209999999999994 108.037 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HB2' ' HB3' ' A' ' 96' ' ' ASP . 59.6 mtt180 68.1 159.67 0.16 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.435 1.094 . . . . 71.120000000000005 110.566 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -100.95 156.44 35.14 Favored Pre-proline 0 CA--C 1.556 1.18 0 CA-C-O 118.771 -0.633 . . . . 73.319999999999993 110.452 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -39.65 106.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 124.854 3.702 . . . . 51.509999999999998 114.959 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.7 m -95.2 91.19 6.17 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.831 -0.803 . . . . 51.0 108.831 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.74 112.82 8.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.36 1.064 . . . . 61.109999999999999 110.579 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -83.41 -171.8 1.19 Allowed 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.758 2.305 . . . . 62.109999999999999 112.536 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.02 112.18 9.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.198 0.599 . . . . 61.340000000000003 109.393 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.2 tp -166.09 150.45 7.99 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.083 0.953 . . . . 65.340000000000003 108.964 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.427 ' HA ' HD22 ' A' ' 110' ' ' LEU . 61.6 t60 -143.41 134.1 25.13 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.898 0.479 . . . . 72.239999999999995 110.511 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -147.39 -166.32 2.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.788 1.235 . . . . 73.409999999999997 109.523 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 tt -143.1 152.27 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.56 1.144 . . . . 73.409999999999997 109.474 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HE2' ' HA2' ' A' ' 111' ' ' GLY . 35.3 mmtm -136.18 173.74 11.38 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.206 1.003 . . . . 71.310000000000002 110.196 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 82' ' ' PRO . . . 166.36 108.85 0.21 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.96 -0.856 . . . . 61.530000000000001 110.96 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.93 155.45 48.9 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.799 0.84 . . . . 72.230000000000004 110.658 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.98 136.04 2.63 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-O 119.747 -0.474 . . . . 51.420000000000002 112.279 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -157.85 158.01 34.31 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.638 0.775 . . . . 63.030000000000001 110.825 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.64 171.21 12.38 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.621 1.169 . . . . 40.030000000000001 109.072 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.65 124.3 9.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.01 -1.107 . . . . 73.109999999999999 108.01 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 t -68.54 114.48 6.98 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.754 0.821 . . . . 62.149999999999999 111.837 -171.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 196' ' ' ASN . 14.6 m -82.98 -168.96 2.28 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.457 1.103 . . . . 64.120000000000005 110.658 171.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -86.76 -152.46 0.18 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.897 0.879 . . . . 75.430000000000007 111.035 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -137.81 112.77 9.07 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.168 -1.049 . . . . 74.150000000000006 108.168 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.79 125.78 1.12 Allowed Glycine 0 C--N 1.346 1.097 0 C-N-CA 121.336 -0.459 . . . . 61.409999999999997 113.292 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 205' ' ' VAL . . . 163.88 155.44 8.27 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.303 -0.72 . . . . 73.510000000000005 111.534 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -90.55 -165.42 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.534 2.822 . . . . 61.140000000000001 113.416 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -149.94 110.0 4.13 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.323 1.049 . . . . 65.319999999999993 109.369 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.0 m -145.97 160.79 41.35 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.98 1.312 . . . . 61.009999999999998 108.729 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.624 ' HA ' ' HB3' ' A' ' 225' ' ' ALA . 24.7 t-20 -156.58 133.65 10.46 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.621 0.646 . . . . 74.219999999999999 111.327 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.534 ' H ' ' HB3' ' A' ' 225' ' ' ALA . 13.8 p -148.89 142.81 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.267 1.427 . . . . 73.420000000000002 107.518 176.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.92 159.11 36.87 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.515 1.126 . . . . 71.540000000000006 109.36 -171.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 44' ' ' GLU . 15.2 t -87.46 173.39 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 C-N-CA 124.892 1.277 . . . . 60.039999999999999 109.65 -176.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 12.9 pt-20 -150.01 148.25 28.82 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.487 0.715 . . . . 55.109999999999999 111.621 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 178.97 -76.76 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.506 1.522 . . . . 72.049999999999997 109.391 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -131.46 159.44 38.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.202 1.001 . . . . 72.349999999999994 109.661 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.73 113.43 20.89 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.154 0.582 . . . . 55.149999999999999 110.908 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.81 97.93 2.41 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.605 -1.628 . . . . 73.310000000000002 106.605 171.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' HG3' ' H ' ' A' ' 50' ' ' ARG . 4.4 tp-100 61.95 -153.96 0.35 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.916 1.287 . . . . 72.209999999999994 109.441 -174.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.638 ' HG2' ' HB3' ' A' ' 57' ' ' GLU . 10.4 mpt_? 69.31 158.89 0.15 Allowed Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 124.88 1.272 . . . . 62.219999999999999 112.526 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.11 -173.36 0.89 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.53 2.153 . . . . 71.25 111.667 163.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -65.55 99.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.718 0.77 . . . . 71.230000000000004 109.098 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.18 -164.98 0.6 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.452 -0.795 . . . . 62.229999999999997 110.825 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -51.34 -44.09 61.94 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.165 0.983 . . . . 64.239999999999995 109.508 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . 16.2 t70 -126.79 -85.89 0.6 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 106.608 -1.627 . . . . 54.130000000000003 106.608 162.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -151.52 120.89 6.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.045 1.338 . . . . 71.409999999999997 107.393 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.638 ' HB3' ' HG2' ' A' ' 50' ' ' ARG . 36.8 tt0 -88.95 125.72 61.56 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 122.463 0.305 . . . . 65.310000000000002 110.373 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -86.36 -34.09 0.16 Allowed 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.726 2.284 . . . . 73.329999999999998 114.23 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -155.5 -38.77 0.09 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.979 0.912 . . . . 74.219999999999999 109.648 -172.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.51 -70.5 2.83 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.646 -0.706 . . . . 72.140000000000001 112.454 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' ' 233' ' ' HIS . 51.3 mt -83.17 153.0 25.0 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.104 0.962 . . . . 72.140000000000001 111.712 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -98.01 42.41 1.09 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.254 1.022 . . . . 75.219999999999999 109.015 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.04 -35.4 81.06 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.367 -1.288 . . . . 54.030000000000001 111.363 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.13 -24.63 67.98 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.646 0.778 . . . . 65.209999999999994 112.042 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.69 -46.14 22.78 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.545 0.738 . . . . 71.450000000000003 111.85 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -125.51 -53.56 1.58 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.831 0.452 . . . . 73.099999999999994 111.782 -173.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -79.2 71.91 5.74 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.405 0.682 . . . . 71.010000000000005 111.344 -169.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -81.45 -20.94 39.24 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.664 -0.698 . . . . 72.209999999999994 110.538 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.8 p -73.21 1.03 10.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.243 0.617 . . . . 75.219999999999999 112.1 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -71.55 -18.9 62.23 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.37 0.668 . . . . 70.230000000000004 111.431 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.87 -32.92 71.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.614 0.721 . . . . 64.450000000000003 110.678 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -85.9 -9.09 57.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.701 -1.136 . . . . 73.019999999999996 110.978 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 215' ' ' ALA . 37.7 tp -70.57 -46.4 63.57 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.467 0.707 . . . . 60.329999999999998 109.457 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.91 52.22 1.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.439 0.638 . . . . 74.010000000000005 110.076 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 78' ' ' SER . . . -95.02 -49.03 5.72 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.245 -0.889 . . . . 72.400000000000006 109.972 175.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.83 -138.33 44.43 Favored Glycine 0 C--N 1.356 1.682 0 N-CA-C 110.418 -1.073 . . . . 71.319999999999993 110.418 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -65.91 116.78 4.17 Favored 'Trans proline' 0 C--N 1.367 1.531 0 CA-C-N 119.628 1.714 . . . . 63.130000000000003 108.459 159.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.545 ' HB2' ' HB1' ' A' ' 75' ' ' ALA . 46.6 t -121.63 176.04 5.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.611 0.764 . . . . 64.019999999999996 110.913 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -72.12 -13.02 61.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.121 0.968 . . . . 71.439999999999998 108.763 167.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -78.7 29.72 0.2 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.441 1.496 . . . . 71.349999999999994 112.18 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' HB2' ' ND2' ' A' ' 83' ' ' ASN . 6.4 m-20 -45.39 149.48 0.99 Allowed Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 126.002 1.721 . . . . 65.019999999999996 112.989 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 57.3 Cg_endo -63.52 -0.26 2.31 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.42 2.746 . . . . 75.310000000000002 115.518 -171.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 81' ' ' ASP . 10.1 p30 -69.89 -23.8 63.3 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.578 0.351 . . . . 73.0 111.109 172.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.53 139.17 44.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 74.140000000000001 108.676 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 11.3 m-85 -118.97 172.95 7.18 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.008 1.323 . . . . 63.119999999999997 109.928 -176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.94 141.54 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 125.246 1.418 . . . . 72.019999999999996 108.985 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -78.33 129.57 35.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.35 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.487 HD21 ' HA ' ' A' ' 143' ' ' LYS . 82.4 mt -87.25 -26.54 23.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.14 0.976 . . . . 63.409999999999997 112.483 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.2 m-85 -134.24 153.19 52.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.011 0.524 . . . . 62.310000000000002 110.227 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.33 119.11 21.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.091 -0.707 . . . . 71.200000000000003 109.091 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.559 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.5 t80 -117.62 126.14 52.0 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.388 -0.967 . . . . 74.400000000000006 108.388 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.45 133.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.857 -1.164 . . . . 54.310000000000002 107.857 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.66 116.46 14.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.719 0.408 . . . . 71.310000000000002 111.304 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.9 p -115.77 77.22 1.07 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.637 0.775 . . . . 73.549999999999997 108.941 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 140.58 -175.89 21.77 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.41 -0.814 . . . . 72.040000000000006 111.535 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 30.9 p-10 -89.31 -42.03 11.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.407 0.683 . . . . 70.040000000000006 112.031 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.6 -26.73 60.94 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.705 0.802 . . . . 72.140000000000001 110.571 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 77.8 p -72.7 143.19 48.15 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.229 0.611 . . . . 64.340000000000003 110.241 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 128' ' ' GLY . 56.1 tp -132.55 132.05 42.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.195 0.598 . . . . 44.030000000000001 109.932 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.3 m -70.81 130.03 40.63 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.468 0.707 . . . . 70.109999999999999 110.914 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 91' ' ' PHE . 23.3 pt -133.6 150.26 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.773 0.829 . . . . 74.439999999999998 110.313 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -102.45 146.82 27.54 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.942 0.897 . . . . 70.239999999999995 109.319 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -67.94 114.37 6.44 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.542 -0.54 . . . . 74.430000000000007 109.542 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.58 -9.62 32.65 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 123.327 0.489 . . . . 15.43 112.382 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 37.5 tt0 -77.9 137.89 38.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.972 0.909 . . . . 71.329999999999998 111.334 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.43 133.39 35.94 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.432 0.693 . . . . 74.239999999999995 110.2 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.6 OUTLIER -149.08 161.59 41.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.667 1.187 . . . . 61.43 110.117 -174.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -120.34 118.74 31.17 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.88 -0.513 . . . . 72.099999999999994 110.256 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.635 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.5 t -73.35 121.34 23.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.56 0.695 . . . . 71.109999999999999 110.02 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 122' ' ' GLN . 23.6 mt -84.58 -51.95 6.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.967 -1.469 . . . . 64.319999999999993 108.874 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.435 ' HA2' ' HE2' ' A' ' 24' ' ' LYS . . . -170.95 149.39 12.35 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.883 -0.599 . . . . 75.209999999999994 112.784 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.55 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 51.6 m-85 -85.3 168.26 14.85 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.399 0.68 . . . . 73.329999999999998 110.605 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -82.21 -172.87 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.379 -0.828 . . . . 41.450000000000003 109.842 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -53.84 -42.32 68.38 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.836 0.854 . . . . 74.430000000000007 112.945 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -112.43 13.6 20.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.933 0.716 . . . . 44.210000000000001 112.933 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.8 21.07 76.45 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 115.685 1.034 . . . . 62.100000000000001 115.685 170.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -77.28 -54.5 6.4 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.611 0.706 . . . . 75.219999999999999 110.571 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.796 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 20.4 m95 -110.95 152.9 26.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.809 0.844 . . . . 70.340000000000003 111.55 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -129.53 140.46 51.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.688 1.195 . . . . 75.209999999999994 109.981 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 38.4 tt0 -75.82 130.04 37.96 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.956 -1.127 . . . . 72.219999999999999 107.956 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.34 144.55 44.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.526 0.731 . . . . 70.230000000000004 110.003 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.428 ' HG3' HD21 ' A' ' 110' ' ' LEU . 47.8 mt-30 -96.51 107.8 20.27 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.763 -1.199 . . . . 72.349999999999994 107.763 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 107' ' ' LEU . 34.6 p -106.42 -177.04 3.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.111 0.964 . . . . 73.430000000000007 111.395 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -71.83 -10.42 59.75 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.504 -0.771 . . . . 71.040000000000006 110.828 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -101.44 16.42 25.7 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.52 1.128 . . . . 63.439999999999998 110.585 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.79 -122.68 7.06 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.218 -0.768 . . . . 74.120000000000005 112.044 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.83 152.45 47.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 118.032 0.916 . . . . 72.209999999999994 110.849 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.496 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 153.8 172.55 21.99 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 111.575 -0.61 . . . . 55.399999999999999 111.575 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 66.0 m95 -80.15 131.81 35.8 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.225 0.61 . . . . 70.400000000000006 112.561 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.426 HG23 HD13 ' A' ' 135' ' ' ILE . 34.3 m -136.8 141.89 36.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 125.645 1.578 . . . . 74.129999999999995 109.215 168.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.796 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.1 Cg_endo -77.92 151.26 27.5 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.438 2.092 . . . . 73.230000000000004 115.284 -172.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -36.63 -50.54 0.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.628 1.971 . . . . 60.32 113.856 170.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -74.22 -7.96 54.53 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.417 0.687 . . . . 52.530000000000001 112.352 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.416 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 13.6 m-85 -104.03 -4.92 22.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.88 0.872 . . . . 63.210000000000001 112.118 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 130' ' ' VAL . 6.3 pt -135.24 168.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 124.003 0.921 . . . . 52.210000000000001 111.826 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.9 t -163.54 155.98 15.46 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 108.334 -0.987 . . . . 52.210000000000001 108.334 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 51.1 Cg_exo -56.55 151.77 44.37 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.108 1.872 . . . . 63.340000000000003 113.029 171.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.51 -5.66 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.166 0.507 . . . . 73.150000000000006 110.209 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.4 -20.21 23.07 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.625 -0.672 . . . . 74.319999999999993 110.881 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.1 p -80.9 172.49 13.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.328 0.585 . . . . 63.200000000000003 111.742 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 214' ' ' LEU . 61.5 mt -84.67 -25.02 28.73 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.785 0.834 . . . . 75.120000000000005 111.291 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.5 -24.01 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.474 1.11 . . . . 75.200000000000003 112.092 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.487 ' HA ' HD21 ' A' ' 88' ' ' LEU . 23.1 pttm -64.2 -26.16 68.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.39 0.676 . . . . 71.430000000000007 112.476 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -75.15 148.35 39.7 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.61 -0.723 . . . . 72.310000000000002 110.159 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 235' ' ' PRO . 16.9 m -60.52 -41.09 93.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.115 0.885 . . . . 63.439999999999998 111.552 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -67.18 -48.32 68.28 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.324 0.65 . . . . 74.400000000000006 112.549 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -75.66 112.53 12.12 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.538 -0.541 . . . . 75.109999999999999 109.538 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.448 ' HB2' HG21 ' A' ' 151' ' ' VAL . 32.6 m170 -102.39 -1.98 29.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.379 0.672 . . . . 71.400000000000006 111.612 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.34 -151.26 36.27 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 118.887 -0.952 . . . . 74.310000000000002 112.232 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.62 114.29 1.93 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.053 2.502 . . . . 62.439999999999998 111.407 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 54.0 t -142.72 137.85 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 125.398 1.479 . . . . 34.32 108.863 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.2 p -82.58 170.22 15.42 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.627 0.771 . . . . 52.299999999999997 110.95 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -59.7 -48.47 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.932 0.893 . . . . 73.349999999999994 110.389 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.35 -44.37 84.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.466 1.107 . . . . 71.129999999999995 111.465 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.78 76.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.973 -1.012 . . . . 51.439999999999998 111.518 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.77 82.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.447 0.699 . . . . 51.420000000000002 111.636 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -78.64 -25.49 45.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.565 -0.743 . . . . 74.409999999999997 112.709 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -24.88 59.71 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.943 0.792 . . . . 74.230000000000004 110.678 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.811 HD21 ' HA ' ' A' ' 239' ' ' ARG . 69.0 mt -71.92 -48.97 41.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.963 -1.017 . . . . 75.109999999999999 110.056 170.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.694 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 63.8 mt -89.23 19.49 4.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.044 -0.98 . . . . 75.120000000000005 112.642 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.3 p -90.42 -34.11 15.76 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.091 -1.077 . . . . 41.32 108.091 157.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.5 m -92.05 2.49 56.53 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.949 1.299 . . . . 70.150000000000006 111.892 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.1 -178.07 40.43 Favored Glycine 0 C--N 1.351 1.386 0 C-N-CA 122.771 0.224 . . . . 74.310000000000002 112.839 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -107.62 177.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.241 1.016 . . . . 63.329999999999998 110.31 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.05 131.26 46.09 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.84 6.42 72.5 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.079 -0.845 . . . . 73.310000000000002 113.695 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.5 m -81.39 136.18 35.7 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.217 1.008 . . . . 73.409999999999997 110.524 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -142.8 163.12 33.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.303 0.573 . . . . 72.420000000000002 111.218 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.64 145.32 22.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.83 -1.077 . . . . 75.5 108.666 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.645 HG22 HG12 ' A' ' 182' ' ' ILE . 83.2 t -103.48 126.73 57.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.947 -1.131 . . . . 54.32 107.947 169.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.63 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.5 ptt85 -115.71 160.98 19.35 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.177 0.991 . . . . 74.409999999999997 109.06 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -114.35 150.29 34.8 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.259 -1.756 . . . . 70.239999999999995 106.259 167.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -67.96 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.299 -0.63 . . . . 73.239999999999995 109.299 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.07 -31.33 71.74 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.822 0.849 . . . . 65.030000000000001 111.176 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.8 p -97.17 -5.31 37.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.135 0.974 . . . . 52.329999999999998 112.008 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -149.88 102.84 3.21 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 122.719 0.408 . . . . 63.409999999999997 111.189 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.23 146.81 70.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.551 2.167 . . . . 55.32 111.833 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.69 -28.36 3.55 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 123.069 0.366 . . . . 73.219999999999999 113.403 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.91 114.45 18.83 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -130.8 156.54 44.83 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.52 0.676 . . . . 75.5 111.12 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.8 m -147.2 150.86 35.73 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.833 -1.076 . . . . 71.239999999999995 109.241 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.645 HG12 HG22 ' A' ' 170' ' ' VAL . 22.6 mt -103.81 151.57 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.54 -1.281 . . . . 75.319999999999993 107.54 170.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -124.73 121.98 36.18 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.678 -1.23 . . . . 62.109999999999999 107.678 168.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.2 tp -115.65 114.36 24.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.36 0.664 . . . . 75.25 110.377 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.694 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 56.1 ttt85 -76.3 111.53 11.84 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.551 0.74 . . . . 51.149999999999999 109.033 164.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -139.44 139.58 37.11 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.991 1.316 . . . . 72.530000000000001 107.791 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 59.7 21.76 10.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.47 1.108 . . . . 51.109999999999999 111.782 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.75 -12.31 59.75 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.628 -0.714 . . . . 42.229999999999997 113.85 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -98.96 146.73 25.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.237 0.615 . . . . 73.150000000000006 110.211 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 115.24 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.08 0.552 . . . . 64.450000000000003 110.405 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -101.47 137.96 39.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.487 1.115 . . . . 63.100000000000001 108.807 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.54 120.04 41.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.889 0.376 . . . . 73.209999999999994 110.74 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.471 ' HE1' HD21 ' A' ' 232' ' ' LEU . 5.8 m-85 -95.59 152.31 18.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.224 1.009 . . . . 74.25 108.738 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -104.7 115.81 30.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.401 -0.592 . . . . 63.039999999999999 109.401 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -85.73 101.96 10.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.849 -1.167 . . . . 64.219999999999999 107.849 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 32' ' ' SER . 22.2 m-80 -84.04 107.21 16.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.403 -1.271 . . . . 65.099999999999994 108.382 176.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -74.52 112.65 10.91 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.862 -1.162 . . . . 75.340000000000003 107.862 164.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.94 160.97 19.45 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.682 0.393 . . . . 54.130000000000003 110.704 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.0 p -62.43 -28.36 69.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.59 0.756 . . . . 74.340000000000003 111.07 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -89.76 -5.2 57.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.245 1.018 . . . . 72.319999999999993 111.128 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 106.58 -6.82 38.79 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 114.787 0.675 . . . . 63.240000000000002 114.787 168.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.13 127.47 32.68 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.887 0.843 . . . . 75.420000000000002 111.646 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.71 142.68 30.55 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.099 0.96 . . . . 73.209999999999994 109.051 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.617 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 39.9 p90 -164.71 139.74 5.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.214 0.321 . . . . 62.149999999999999 111.686 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.467 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 72.0 t -84.64 -37.84 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.559 -0.904 . . . . 73.329999999999998 108.559 163.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 24.2 m -101.23 126.91 48.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 109.771 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.9 t -69.7 -16.72 63.39 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.421 0.689 . . . . 65.430000000000007 112.129 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -92.66 -15.3 26.94 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.776 1.23 . . . . 73.219999999999999 110.99 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.2 m -133.93 95.46 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.746 0.818 . . . . 71.439999999999998 109.116 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.617 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -111.59 134.77 52.94 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.87 0.868 . . . . 73.200000000000003 109.527 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.471 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.2 OUTLIER -124.0 151.97 43.1 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.104 0.961 . . . . 72.109999999999999 108.538 -170.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -69.47 -34.2 74.01 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.601 0.563 . . . . 74.439999999999998 110.692 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.3 p -126.76 152.58 46.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.73 0.812 . . . . 73.420000000000002 111.718 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 141' ' ' LEU . 1.3 tt -63.84 -24.44 67.75 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 114.674 -1.148 . . . . 75.329999999999998 109.215 172.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 73' ' ' LEU . . . -59.16 -49.12 79.06 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.976 0.91 . . . . 52.340000000000003 111.275 173.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -65.33 -36.8 85.14 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.526 0.73 . . . . 75.299999999999997 111.325 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.431 HD11 HG23 ' A' ' 205' ' ' VAL . 15.9 tp -56.43 -56.76 17.22 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.495 0.497 . . . . 74.010000000000005 111.102 176.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.44 -41.5 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.317 0.647 . . . . 74.519999999999996 110.897 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.11 -52.25 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.741 0.416 . . . . 75.409999999999997 111.524 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -65.44 -40.61 93.46 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.203 0.601 . . . . 65.420000000000002 109.85 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.659 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.3 m-70 -86.6 -4.54 59.19 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.446 -0.797 . . . . 74.400000000000006 111.917 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 89.9 p -91.98 -35.31 14.05 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 110.181 -0.303 . . . . 64.519999999999996 110.181 167.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.2 m -68.4 -49.63 58.7 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.306 0.574 . . . . 71.409999999999997 110.216 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -128.18 161.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.006 -0.997 . . . . 72.329999999999998 110.161 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' A' ' 40' ' ' ASN . . . -74.47 19.61 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.377 1.871 . . . . 72.299999999999997 114.637 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 224' ' ' VAL . 10.9 t70 -43.02 31.64 0.0 OUTLIER 'General case' 0 CA--C 1.598 2.8 1 C-N-CA 132.319 4.247 . . . . 75.25 120.203 -153.279 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 125.22 0.82 8.04 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 121.259 -0.9 . . . . 75.540000000000006 112.583 -167.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.0 mt -95.06 165.61 12.34 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 126.169 1.788 . . . . 51.420000000000002 110.025 168.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.99 -41.92 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-N 116.604 -0.271 . . . . 61.229999999999997 110.314 168.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -157.41 -179.78 8.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.104 0.561 . . . . 71.239999999999995 110.969 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.0 p -63.55 137.1 57.99 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.837 1.255 . . . . 71.219999999999999 112.243 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.471 HD21 ' HE1' ' A' ' 193' ' ' TYR . 75.7 mt -72.62 111.03 7.42 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.949 -0.76 . . . . 72.010000000000005 108.949 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.636 ' HA ' HD22 ' A' ' 61' ' ' LEU . 13.4 t60 -106.87 -44.54 4.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.948 0.722 . . . . 73.439999999999998 112.948 -163.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -130.84 125.24 21.22 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.15 0.98 . . . . 72.450000000000003 109.138 -169.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 145' ' ' SER . 76.1 Cg_endo -81.56 129.17 6.39 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 122.234 1.956 . . . . 71.409999999999997 112.121 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.36 151.94 85.62 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.852 0.861 . . . . 63.119999999999997 110.113 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.71 170.3 17.12 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.966 2.444 . . . . 74.25 112.593 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.9 154.02 35.08 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.044 0.937 . . . . 62.229999999999997 110.917 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.811 ' HA ' HD21 ' A' ' 159' ' ' LEU . 18.8 ptt180 -81.66 -60.34 2.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.541 0.941 . . . . 74.439999999999998 113.541 -168.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.562 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 64.9 t30 -108.69 153.92 22.75 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.701 0.8 . . . . 72.239999999999995 109.122 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 84.2 tttt -87.4 114.77 60.25 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.204 -1.776 . . . . 75.340000000000003 106.204 159.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 31.7 Cg_exo -62.21 144.39 95.52 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.373 2.715 . . . . 63.130000000000003 113.151 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.4 m -94.66 134.72 36.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.283 0.633 . . . . 74.040000000000006 110.86 -172.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -90.43 125.82 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 64.310000000000002 108.664 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -109.81 115.9 30.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.689 0.395 . . . . 75.129999999999995 110.988 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 75.94 -48.27 2.34 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 119.277 2.471 . . . . 50.119999999999997 119.277 155.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.558 HG12 ' HD2' ' A' ' 7' ' ' LYS . 31.2 m -99.48 144.1 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 114.366 1.247 . . . . 61.420000000000002 114.366 -157.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.0 t -82.34 115.83 60.16 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 104.405 -2.443 . . . . 72.340000000000003 104.405 149.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 11.3 Cg_endo -53.78 -53.2 6.85 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.94 2.427 . . . . 71.049999999999997 116.858 -152.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -123.23 -11.46 7.97 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.989 0.916 . . . . 64.450000000000003 110.226 165.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.506 ' HA ' ' HB3' ' A' ' 254' ' ' TRP . 32.1 t80 -85.1 93.11 8.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.681 0.753 . . . . 74.549999999999997 111.444 -154.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -128.85 -45.48 1.29 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.936 1.294 . . . . 74.409999999999997 108.414 146.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -81.17 -34.55 32.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.191 0.597 . . . . 53.240000000000002 109.528 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.506 ' HB3' ' HA ' ' A' ' 251' ' ' TYR . 38.8 t-105 -60.0 147.82 37.64 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 114.692 -1.14 . . . . 64.219999999999999 110.597 -175.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 C--O 1.246 0.902 0 N-CA-C 106.837 -1.542 . . . . 74.150000000000006 106.837 176.956 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 mtm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.037 -0.727 . . . . 74.099999999999994 109.037 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.93 43.64 0.02 OUTLIER Glycine 0 C--N 1.349 1.28 0 O-C-N 123.343 0.402 . . . . 64.120000000000005 112.234 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -68.05 112.44 5.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.302 0.641 . . . . 70.239999999999995 110.233 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -122.73 90.9 49.83 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 123.307 0.643 . . . . 62.329999999999998 109.889 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.9 177.14 9.24 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.73 2.286 . . . . 71.319999999999993 111.949 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.77 117.88 0.62 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.325 -0.71 . . . . 72.129999999999995 111.325 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.96 135.49 37.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.785 0.834 . . . . 71.129999999999995 109.9 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.02 96.95 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 124.097 0.959 . . . . 73.230000000000004 109.552 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.59 175.22 10.75 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.908 0.883 . . . . 52.409999999999997 110.395 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.0 155.31 17.89 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.314 -0.715 . . . . 63.329999999999998 111.314 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.03 160.02 44.18 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.853 -1.166 . . . . 74.019999999999996 107.853 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -158.43 105.89 1.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.76 0.79 . . . . 73.340000000000003 111.422 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -110.6 138.59 46.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.696 -1.224 . . . . 74.239999999999995 107.696 164.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.576 ' HD2' HD11 ' A' ' 17' ' ' LEU . 33.2 mmt180 -119.21 81.66 21.69 Favored Pre-proline 0 N--CA 1.484 1.273 0 C-N-CA 123.397 0.679 . . . . 73.239999999999995 109.939 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 255' ' ' GLU . 6.4 Cg_exo -75.57 -66.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.797 2.332 . . . . 63.130000000000003 110.706 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.9 m -154.75 116.97 4.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.215 1.006 . . . . 72.209999999999994 108.511 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.576 HD11 ' HD2' ' A' ' 14' ' ' ARG . 5.9 mp -75.2 129.99 81.38 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.955 0.902 . . . . 74.439999999999998 109.653 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.54 160.59 6.85 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.477 2.785 . . . . 72.209999999999994 114.685 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.21 178.11 2.47 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.353 1.061 . . . . 52.329999999999998 112.683 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.409 HD21 ' OD1' ' A' ' 83' ' ' ASN . 7.8 mp -63.3 120.82 12.31 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.603 -0.726 . . . . 75.140000000000001 110.999 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -150.19 121.36 7.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.814 -1.55 . . . . 72.439999999999998 106.814 169.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.702 ' HB3' ' H ' ' A' ' 112' ' ' TYR . 47.2 p90 -161.5 149.56 15.29 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.709 0.633 . . . . 72.5 112.709 -169.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.478 HD11 ' HA ' ' A' ' 115' ' ' ASN . 34.6 pt -131.21 176.74 8.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 115.066 -0.97 . . . . 73.120000000000005 108.816 168.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -94.84 105.8 17.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.608 0.763 . . . . 72.209999999999994 110.1 -174.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.0 168.7 20.64 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.573 -1.011 . . . . 70.150000000000006 110.573 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.95 -177.62 3.45 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 117.495 0.647 . . . . 55.210000000000001 111.338 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' N ' HD22 ' A' ' 133' ' ' ASN . . . -131.67 -178.03 15.25 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 110.799 -0.92 . . . . 61.340000000000003 110.799 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.86 167.45 28.08 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 117.251 0.525 . . . . 71.129999999999995 111.923 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.63 167.97 7.71 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.36 1.464 . . . . 75.329999999999998 108.68 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.99 -92.53 0.13 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.61 0.764 . . . . 70.230000000000004 111.928 -172.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.7 p -89.86 128.63 36.22 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.271 0.628 . . . . 52.0 110.844 -165.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 10.7 p 178.75 148.51 0.2 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.006 1.722 . . . . 73.209999999999994 107.495 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.36 144.58 22.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.09 0.471 . . . . 75.239999999999995 110.122 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -131.32 155.83 46.53 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.413 -0.958 . . . . 75.400000000000006 108.413 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.95 -115.15 1.66 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.347 -1.101 . . . . 73.040000000000006 110.347 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.93 -173.13 31.22 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.895 0.409 . . . . 74.109999999999999 112.095 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -87.1 -165.84 0.27 Allowed 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.208 2.605 . . . . 71.099999999999994 111.283 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -125.87 173.94 8.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.287 0.635 . . . . 73.140000000000001 110.897 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.7 t -155.52 -144.68 0.14 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 108.395 -0.965 . . . . 65.540000000000006 108.395 -171.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -102.22 168.5 9.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.477 0.711 . . . . 70.219999999999999 110.304 173.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.621 HG23 ' HG3' ' A' ' 63' ' ' GLU . 7.5 p -122.74 149.04 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.13 0.972 . . . . 51.240000000000002 109.525 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -68.7 153.33 43.97 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.34 0.656 . . . . 74.319999999999993 110.29 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.4 m -56.42 110.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 123.882 0.873 . . . . 60.0 112.068 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.18 -171.97 2.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.086 0.954 . . . . 65.439999999999998 109.54 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -139.26 139.23 37.34 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.048 0.539 . . . . 75.319999999999993 111.287 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.24 -29.48 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.536 0.734 . . . . 72.230000000000004 109.503 175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 60.24 -152.84 0.39 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.995 0.918 . . . . 75.409999999999997 112.454 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 71.54 171.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.115 1.366 . . . . 73.140000000000001 112.068 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.85 114.9 4.35 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.48 0.712 . . . . 72.140000000000001 111.505 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.459 ' HG3' ' HA3' ' A' ' 60' ' ' GLY . 2.6 ptp180 179.25 146.33 0.38 Allowed Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 125.57 1.548 . . . . 75.450000000000003 108.937 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.55 90.25 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.763 2.308 . . . . 73.209999999999994 112.373 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.53 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 27.1 m -81.39 172.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.932 0.893 . . . . 73.299999999999997 111.169 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.81 164.69 16.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.416 0.686 . . . . 74.219999999999999 110.983 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.5 t -67.42 135.64 53.46 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.26 0.624 . . . . 75.430000000000007 110.253 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t70 69.1 -78.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.593 1.183 . . . . 71.409999999999997 111.083 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -79.16 137.3 37.4 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.778 0.431 . . . . 54.409999999999997 110.497 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -104.6 102.55 34.92 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.435 0.694 . . . . 72.209999999999994 109.744 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.62 -68.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 121.833 1.689 . . . . 74.140000000000001 109.653 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -173.58 21.0 0.01 OUTLIER 'General case' 0 C--N 1.36 1.035 0 O-C-N 123.91 0.756 . . . . 74.140000000000001 112.868 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 52' ' ' VAL . . . 72.08 -76.28 0.74 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.888 -0.396 . . . . 51.109999999999999 114.048 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 pp -49.18 129.26 17.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.152 1.381 . . . . 51.329999999999998 111.127 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.487 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 33.2 p -99.81 126.94 45.99 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.378 0.671 . . . . 72.420000000000002 111.177 -170.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.621 ' HG3' HG23 ' A' ' 41' ' ' VAL . 45.4 mt-10 -74.38 -54.17 8.15 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.761 0.663 . . . . 72.329999999999998 109.812 173.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.21 -20.29 6.65 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.326 1.051 . . . . 64.430000000000007 113.544 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.9 -62.99 1.32 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.288 1.035 . . . . 70.299999999999997 111.84 174.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -113.04 7.09 17.95 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.95 0.9 . . . . 64.5 110.945 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -144.45 45.36 1.41 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.917 0.865 . . . . 74.329999999999998 109.213 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 23.8 p-10 -65.43 -21.82 66.7 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.982 -1.008 . . . . 74.010000000000005 109.46 165.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.4 p -77.47 5.41 8.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.573 1.549 . . . . 73.120000000000005 112.782 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.55 -25.4 68.03 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.202 0.456 . . . . 75.030000000000001 111.167 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.5 pt-20 -62.63 -43.45 98.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.26 0.624 . . . . 71.420000000000002 110.502 168.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -82.47 -2.97 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.48 1.112 . . . . 73.0 111.331 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.0 tp -52.33 -49.18 64.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.005 0.922 . . . . 75.150000000000006 110.274 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.5 mt -95.58 83.26 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.779 -1.193 . . . . 71.010000000000005 107.779 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.77 -57.04 3.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.098 -0.956 . . . . 74.430000000000007 113.054 -168.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.11 -137.92 20.56 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.07 -0.85 . . . . 62.409999999999997 111.031 -169.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.76 176.83 5.5 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.636 2.224 . . . . 74.310000000000002 112.349 171.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 m -80.38 178.24 8.44 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.713 0.805 . . . . 63.340000000000003 110.632 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -60.39 -52.12 66.59 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.895 0.702 . . . . 72.329999999999998 112.895 -167.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -136.91 -40.12 0.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.289 0.636 . . . . 71.200000000000003 110.527 163.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 13.7 m-20 -92.05 124.11 60.92 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 115.326 -0.852 . . . . 75.230000000000004 111.785 -176.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.19 -17.15 50.13 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.102 1.868 . . . . 74.439999999999998 111.345 164.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.409 ' OD1' HD21 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -86.44 2.51 47.49 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.109 0.964 . . . . 75.409999999999997 110.862 177.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.609 HD21 ' HD3' ' A' ' 106' ' ' LYS . 35.7 tp -80.65 125.52 30.12 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.22 172.49 6.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.727 1.211 . . . . 73.329999999999998 108.178 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.57 137.22 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.276 1.031 . . . . 72.150000000000006 108.836 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.2 123.66 26.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.62 0.768 . . . . 65.040000000000006 109.968 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.405 HD22 ' HE3' ' A' ' 238' ' ' LYS . 95.1 mt -79.03 -32.86 45.13 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 53.210000000000001 110.982 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.576 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 55.9 m-85 -126.54 160.14 31.47 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.068 0.547 . . . . 71.230000000000004 110.792 -174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.7 120.38 23.93 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.477 -0.934 . . . . 70.530000000000001 108.477 166.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.729 ' HB3' HG12 ' A' ' 101' ' ' ILE . 93.8 t80 -113.14 132.53 55.42 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.71 -0.848 . . . . 65.329999999999998 108.71 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -93.92 128.59 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.328 -0.99 . . . . 71.150000000000006 108.328 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.3 114.56 6.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.408 -0.59 . . . . 50.219999999999999 109.408 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.9 p -98.69 -0.83 42.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.735 0.814 . . . . 73.310000000000002 111.431 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.9 166.26 24.92 Favored Glycine 0 C--O 1.244 0.742 0 N-CA-C 110.703 -0.959 . . . . 60.509999999999998 110.703 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -70.87 -39.16 73.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.103 0.478 . . . . 65.209999999999994 110.45 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -79.95 -24.53 40.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 62.219999999999999 111.809 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 p -76.25 166.7 23.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.678 0.391 . . . . 71.439999999999998 110.829 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -134.96 133.47 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.042 0.537 . . . . 74.409999999999997 110.629 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.6 m -74.61 141.75 44.66 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.793 0.837 . . . . 74.25 110.177 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.729 HG12 ' HB3' ' A' ' 91' ' ' PHE . 14.1 pt -128.5 156.51 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.174 0.59 . . . . 51.130000000000003 110.412 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 7.2 m -108.03 152.45 24.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.159 0.984 . . . . 74.340000000000003 109.938 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -60.04 110.69 1.26 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.636 0.774 . . . . 71.239999999999995 109.13 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.85 8.33 63.64 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.688 -0.507 . . . . 51.25 113.646 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.2 tt0 -76.23 120.89 22.13 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.478 0.639 . . . . 64.540000000000006 110.355 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.609 ' HD3' HD21 ' A' ' 84' ' ' LEU . 64.6 mttp -78.69 127.7 32.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.274 0.629 . . . . 52.32 109.474 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.422 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.45 150.68 40.89 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.364 1.066 . . . . 64.099999999999994 110.351 -171.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -100.99 118.86 37.83 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.056 0.543 . . . . 75.420000000000002 109.939 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.54 HG13 ' HB1' ' A' ' 119' ' ' ALA . 56.5 t -84.97 118.22 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.617 0.722 . . . . 71.209999999999994 109.862 172.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.63 HD12 ' HG3' ' A' ' 120' ' ' GLU . 18.9 mt -85.37 -13.99 47.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.142 1.377 . . . . 72.409999999999997 110.889 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.25 4.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.491 -1.043 . . . . 64.450000000000003 110.491 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.702 ' H ' ' HB3' ' A' ' 22' ' ' PHE . 62.3 m-85 -88.71 173.28 8.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.543 0.687 . . . . 73.540000000000006 110.625 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -78.36 -179.53 6.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.663 -1.153 . . . . 74.310000000000002 110.844 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -45.72 -41.47 10.66 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.167 1.387 . . . . 71.25 113.766 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.478 ' HA ' HD11 ' A' ' 23' ' ' ILE . 31.4 p-10 -114.24 12.07 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.612 0.968 . . . . 73.420000000000002 113.612 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.56 10.63 85.71 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 116.249 1.26 . . . . 74.109999999999999 116.249 168.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.85 -42.21 28.08 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.987 0.894 . . . . 71.329999999999998 111.655 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 21.1 m95 -119.66 157.38 28.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.707 0.803 . . . . 74.219999999999999 110.36 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.54 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.24 145.69 47.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.662 0.785 . . . . 72.329999999999998 110.361 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.63 ' HG3' HD12 ' A' ' 110' ' ' LEU . 13.2 tp10 -79.22 113.55 17.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.578 -1.638 . . . . 64.049999999999997 106.578 164.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -134.08 140.35 46.57 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.08 0.466 . . . . 63.030000000000001 111.233 -171.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -104.11 106.57 17.12 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.363 1.065 . . . . 63.240000000000002 108.705 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.667 HG21 HG22 ' A' ' 101' ' ' ILE . 50.8 p -97.98 175.1 6.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.2 1.0 . . . . 64.010000000000005 109.482 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -65.15 -22.72 66.96 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.84 -0.429 . . . . 74.040000000000006 109.84 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.32 -21.16 56.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.514 1.126 . . . . 74.409999999999997 111.802 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.07 -139.89 9.3 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.311 0.505 . . . . 52.43 113.589 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -130.37 127.86 40.24 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.982 0.913 . . . . 72.439999999999998 109.898 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 169.37 -173.18 43.71 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 123.256 0.347 . . . . 64.109999999999999 112.723 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.519 ' CH2' ' HB3' ' A' ' 250' ' ' ASN . 91.3 m95 -85.56 126.86 34.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.321 0.648 . . . . 74.319999999999993 112.339 -172.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -133.84 144.07 50.2 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.097 0.959 . . . . 73.310000000000002 108.618 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 2.2 Cg_endo -83.04 142.64 11.09 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.532 2.154 . . . . 72.420000000000002 114.385 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.471 ' HB3' ' CE2' ' A' ' 112' ' ' TYR . 69.2 p -40.92 -44.57 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.867 1.667 . . . . 75.329999999999998 113.707 167.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.627 ' HB2' ' HG2' ' A' ' 242' ' ' PRO . 27.8 p30 -77.94 -6.59 54.87 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.243 -0.89 . . . . 63.439999999999998 112.558 -172.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.576 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 30.2 m-85 -103.58 -10.0 18.8 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.371 0.668 . . . . 70.329999999999998 111.719 170.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.9 pt -126.32 178.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 124.099 0.959 . . . . 64.319999999999993 110.812 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.2 t -160.96 149.99 13.57 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.125 0.97 . . . . 65.420000000000002 108.71 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.557 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 24.3 Cg_endo -61.51 150.07 86.88 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.801 1.667 . . . . 64.129999999999995 111.548 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.1 t -71.32 -15.95 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 CA-C-O 120.955 0.407 . . . . 73.219999999999999 110.598 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -76.28 -17.94 59.22 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.449 0.699 . . . . 74.439999999999998 112.326 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.557 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 59.9 p -71.53 163.75 27.15 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.632 0.729 . . . . 61.5 112.648 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.41 -23.43 40.37 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.241 -0.891 . . . . 74.230000000000004 109.261 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.88 -15.48 63.09 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.607 1.163 . . . . 73.519999999999996 112.678 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -66.72 -24.08 66.19 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.919 0.39 . . . . 71.010000000000005 111.187 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -79.09 134.8 36.73 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.375 0.67 . . . . 72.129999999999995 109.788 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.7 p -59.12 -43.8 91.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.514 1.134 . . . . 52.020000000000003 111.745 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -62.88 -39.05 93.27 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.059 0.85 . . . . 44.43 112.467 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -77.76 110.83 12.97 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.128 -0.693 . . . . 75.409999999999997 109.128 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -107.03 -6.68 17.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.196 0.598 . . . . 73.140000000000001 111.155 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.57 -133.08 25.26 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.639 -1.09 . . . . 61.109999999999999 113.041 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.34 100.65 0.22 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.941 2.427 . . . . 74.010000000000005 112.006 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 55.9 t -138.71 131.74 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.747 1.219 . . . . 71.209999999999994 108.912 -175.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.3 p -84.7 171.57 12.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 62.329999999999998 109.987 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -62.07 -43.81 98.04 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.95 -0.548 . . . . 60.030000000000001 111.069 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -54.22 -43.44 70.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.731 0.645 . . . . 75.340000000000003 110.938 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.403 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -67.93 -38.45 82.88 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.282 -0.872 . . . . 74.340000000000003 111.155 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.3 -42.45 88.32 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.588 0.755 . . . . 63.329999999999998 111.732 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 67.5 mm-40 -59.85 -46.57 88.86 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.669 0.787 . . . . 74.439999999999998 109.421 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.536 ' HE1' ' HD2' ' A' ' 239' ' ' ARG . 42.3 t80 -62.01 -46.26 89.98 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.308 -1.314 . . . . 73.409999999999997 111.932 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.03 -40.33 84.71 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.912 0.885 . . . . 61.140000000000001 111.142 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.73 18.01 13.89 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.747 -0.661 . . . . 73.549999999999997 112.367 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 96.8 p -63.84 -41.23 97.87 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.083 0.856 . . . . 75.239999999999995 111.167 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 p -100.7 13.32 35.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.439 0.696 . . . . 62.340000000000003 111.299 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 151.87 41.69 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 123.117 0.26 . . . . 75.230000000000004 113.223 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.6 pt -101.96 -175.39 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.968 0.907 . . . . 75.530000000000001 110.898 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -52.7 122.2 8.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.63 0.772 . . . . 72.239999999999995 110.414 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.441 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 88.4 10.25 68.38 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.019 -0.879 . . . . 62.219999999999999 113.528 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 61.7 m -83.76 115.68 22.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.221 1.011 . . . . 54.030000000000001 111.282 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.459 ' HB3' HD13 ' A' ' 184' ' ' LEU . 11.1 p90 -130.22 167.08 19.0 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.202 0.525 . . . . 75.230000000000004 112.083 -170.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.27 146.79 24.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.717 -1.129 . . . . 74.340000000000003 108.609 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 182' ' ' ILE . 78.3 t -107.65 135.56 45.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.152 -1.055 . . . . 73.230000000000004 108.152 171.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.523 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 19.8 ptt85 -134.62 160.22 38.79 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.273 1.029 . . . . 75.430000000000007 109.811 -175.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -117.56 155.35 29.95 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.163 -1.051 . . . . 74.400000000000006 108.163 164.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -80.11 125.75 30.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.14 -0.689 . . . . 40.439999999999998 109.14 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.12 -39.77 65.48 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.339 0.656 . . . . 74.120000000000005 109.619 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.9 p -75.07 -13.29 60.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.41 0.684 . . . . 73.540000000000006 111.74 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 35.3 m -141.72 80.55 15.77 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.511 0.724 . . . . 71.5 109.502 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -59.42 131.26 39.69 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.867 2.378 . . . . 72.319999999999993 112.292 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.45 -29.24 10.77 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.855 -0.611 . . . . 72.430000000000007 112.24 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -80.93 115.89 20.63 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.076 -0.713 . . . . 64.439999999999998 109.076 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -116.26 150.09 38.15 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.55 0.691 . . . . 71.400000000000006 111.077 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.9 m -150.08 153.66 36.8 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.583 -1.19 . . . . 72.010000000000005 109.886 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.605 HG12 HG22 ' A' ' 170' ' ' VAL . 30.0 mt -110.78 149.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.486 -0.931 . . . . 54.32 108.486 172.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 36.3 m -123.11 108.28 12.69 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.666 -1.235 . . . . 73.420000000000002 107.666 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.475 HD23 ' OH ' ' A' ' 193' ' ' TYR . 70.0 tp -106.78 128.04 53.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.915 0.486 . . . . 54.210000000000001 110.069 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -102.36 129.17 48.75 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.098 0.959 . . . . 65.010000000000005 109.085 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -150.17 131.32 14.45 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.602 1.561 . . . . 71.209999999999994 107.174 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 63.72 23.99 13.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.087 0.955 . . . . 70.120000000000005 111.736 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.04 81.04 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.012 0.365 . . . . 51.119999999999997 114.012 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -105.77 128.27 53.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.929 0.892 . . . . 62.009999999999998 109.432 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.2 t -93.63 111.99 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.195 0.598 . . . . 64.310000000000002 110.465 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -96.53 147.81 23.47 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.725 1.21 . . . . 73.540000000000006 109.589 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -121.86 117.48 26.61 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.305 0.574 . . . . 74.209999999999994 110.445 -171.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 9.1 m-30 -96.07 148.21 22.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.76 1.224 . . . . 54.409999999999997 109.42 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.98 117.58 34.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.696 -0.854 . . . . 73.439999999999998 108.696 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 mt -84.08 100.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 N-CA-C 107.304 -1.369 . . . . 63.450000000000003 107.304 172.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -82.95 131.44 35.19 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.077 0.951 . . . . 71.5 108.769 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.7 m -97.33 121.76 39.59 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.767 -0.827 . . . . 62.240000000000002 108.767 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.71 174.31 8.56 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.277 0.631 . . . . 61.32 110.705 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.2 p -62.83 -32.68 73.94 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.655 0.782 . . . . 75.010000000000005 111.737 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.85 -14.9 27.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.742 0.817 . . . . 74.519999999999996 110.891 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.93 13.69 13.42 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 118.983 -0.898 . . . . 72.409999999999997 114.252 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.16 125.69 27.5 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.039 0.92 . . . . 71.420000000000002 110.798 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -84.87 141.16 30.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.51 -0.922 . . . . 60.119999999999997 108.51 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.55 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 31.4 p90 -165.55 137.5 4.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.325 0.391 . . . . 63.109999999999999 111.506 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.475 HG23 HD11 ' A' ' 217' ' ' LEU . 73.1 t -84.19 -36.72 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.573 -0.899 . . . . 51.210000000000001 108.573 163.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.5 m -100.99 127.44 47.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.859 -1.064 . . . . 62.32 109.962 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.2 t -63.67 -22.59 66.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.235 1.014 . . . . 74.140000000000001 111.909 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -82.87 -29.15 29.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.723 1.209 . . . . 73.340000000000003 110.859 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.6 m -126.33 99.02 5.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.33 0.652 . . . . 71.209999999999994 110.531 -175.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -97.34 133.46 41.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.871 0.868 . . . . 61.520000000000003 109.592 174.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.69 151.49 38.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.684 0.793 . . . . 65.219999999999999 109.327 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -73.09 -42.76 62.65 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.917 -0.401 . . . . 72.409999999999997 109.917 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 44.0 p -118.7 159.05 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.741 0.781 . . . . 75.239999999999995 112.248 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.06 -27.71 68.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.462 -1.245 . . . . 62.329999999999998 109.847 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.88 95.83 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.51 0.724 . . . . 71.219999999999999 110.629 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.11 -39.92 75.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.879 0.871 . . . . 72.109999999999999 110.865 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.475 HD11 HG23 ' A' ' 205' ' ' VAL . 15.3 tp -55.38 -56.07 24.29 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.848 0.718 . . . . 73.430000000000007 111.23 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.1 -42.35 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 123.797 0.686 . . . . 73.209999999999994 111.001 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.84 -55.57 30.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.016 0.823 . . . . 63.25 111.339 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -68.29 -34.77 76.77 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.41 -0.814 . . . . 62.25 111.214 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.61 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.8 m170 -87.64 -9.56 53.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.812 0.445 . . . . 64.409999999999997 112.083 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 90.7 p -90.51 -33.72 15.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.947 0.499 . . . . 71.120000000000005 110.231 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.1 p -72.98 -49.51 28.59 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.717 -0.674 . . . . 71.120000000000005 111.169 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.557 HG23 ' HB2' ' A' ' 226' ' ' ASP . 35.5 m -123.77 159.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.833 0.825 . . . . 61.32 112.459 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.15 16.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 128.205 2.602 . . . . 64.230000000000004 115.246 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.557 ' HB2' HG23 ' A' ' 224' ' ' VAL . 32.6 t70 -40.02 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 131.676 3.99 . . . . 61.539999999999999 119.852 -150.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.06 -3.22 10.68 Favored Glycine 0 N--CA 1.469 0.898 0 O-C-N 118.985 -2.322 . . . . 63.5 112.042 -165.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.1 mt -90.13 163.64 14.77 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.93 1.692 . . . . 74.310000000000002 109.231 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.76 -38.91 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 120.756 0.313 . . . . 71.540000000000006 110.881 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -158.02 -178.0 6.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.099 0.959 . . . . 71.310000000000002 109.938 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.5 p -67.41 144.01 55.99 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.588 0.755 . . . . 71.430000000000007 112.183 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 184' ' ' LEU . 76.8 mt -75.4 90.21 2.67 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 107.565 -1.272 . . . . 63.049999999999997 107.565 169.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -121.71 9.35 10.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.054 -1.029 . . . . 65.310000000000002 113.673 -158.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 167' ' ' SER . 20.2 t80 -159.17 122.95 2.07 Favored Pre-proline 0 C--O 1.22 -0.493 0 N-CA-C 106.957 -1.497 . . . . 74.140000000000001 106.957 174.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.2 139.3 6.06 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 122.214 1.942 . . . . 75.340000000000003 112.592 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.46 124.8 89.16 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.181 -1.044 . . . . 13.1 108.181 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.13 -176.98 3.34 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.321 2.014 . . . . 72.439999999999998 113.218 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.405 ' HE3' HD22 ' A' ' 88' ' ' LEU . 73.1 mmtt -76.85 118.74 19.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.034 -0.985 . . . . 73.430000000000007 109.318 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.551 ' HG3' ' N ' ' A' ' 240' ' ' ASN . 6.3 ptt180 -76.53 -53.65 7.79 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.591 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.551 ' N ' ' HG3' ' A' ' 239' ' ' ARG . 10.5 t30 -108.72 122.54 47.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.778 1.029 . . . . 62.340000000000003 113.778 -158.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 89' ' ' TYR . 97.2 mttt -79.8 113.46 37.88 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.183 -1.414 . . . . 54.329999999999998 107.183 159.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.627 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 25.5 Cg_exo -68.84 153.36 73.01 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.789 2.326 . . . . 62.399999999999999 113.601 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 24.5 m -73.44 139.94 46.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.725 -0.671 . . . . 74.319999999999993 110.993 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 52.0 t -95.65 113.51 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.99 -1.115 . . . . 62.049999999999997 107.99 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 247' ' ' VAL . 7.9 m-85 -102.94 110.85 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 119.256 -0.402 . . . . 34.439999999999998 110.414 -173.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.47 25.11 48.82 Favored Glycine 0 N--CA 1.477 1.373 0 N-CA-C 118.078 1.991 . . . . 73.319999999999993 118.078 160.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 245' ' ' TYR . 33.7 m -101.1 134.04 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 119.065 1.433 . . . . 43.020000000000003 113.421 -172.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -83.38 118.35 71.31 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 103.508 -2.775 . . . . 65.540000000000006 103.508 142.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.64 -59.5 0.83 Allowed 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 121.501 1.467 . . . . 63.109999999999999 113.753 -152.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.519 ' HB3' ' CH2' ' A' ' 129' ' ' TRP . 10.2 t30 -129.89 -19.99 3.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.016 0.526 . . . . 60.299999999999997 109.8 151.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -72.9 98.83 2.54 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.977 -0.556 . . . . 74.430000000000007 110.984 -154.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -123.01 -48.95 1.98 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.361 1.064 . . . . 73.400000000000006 108.933 162.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -111.8 -14.99 13.48 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 114.262 -1.336 . . . . 63.240000000000002 110.735 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -56.89 153.35 11.15 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.685 0.794 . . . . 72.510000000000005 110.342 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 7.7 pt-20 . . . . . 0 CA--C 1.56 1.338 0 CA-C-O 117.638 -1.173 . . . . 72.329999999999998 110.288 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 110.107 -0.331 . . . . 74.209999999999994 110.107 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.54 33.94 0.02 OUTLIER Glycine 0 C--N 1.345 1.076 0 CA-C-N 116.409 -0.36 . . . . 44.439999999999998 112.529 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -159.03 132.88 7.52 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.317 0.647 . . . . 73.019999999999996 109.883 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -107.92 106.63 58.97 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.026 0.931 . . . . 72.230000000000004 109.506 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.2 77.93 1.95 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.573 2.182 . . . . 74.129999999999995 111.45 169.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.67 -21.69 79.47 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.508 -0.769 . . . . 61.100000000000001 113.459 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -79.44 3.44 18.5 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.617 0.767 . . . . 75.120000000000005 111.092 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.41 96.78 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 N-CA-C 109.495 -0.557 . . . . 74.310000000000002 109.495 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.59 82.07 7.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.387 0.675 . . . . 71.319999999999993 110.199 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.87 -175.5 35.67 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.976 -0.556 . . . . 64.019999999999996 112.056 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -103.06 142.91 33.3 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.587 0.355 . . . . 72.230000000000004 110.315 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -135.97 21.64 3.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.108 0.963 . . . . 61.350000000000001 110.63 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -70.9 166.5 21.02 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.858 0.463 . . . . 72.310000000000002 109.937 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 59.84 74.86 0.53 Allowed Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.045 0.938 . . . . 75.239999999999995 109.203 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.13 160.07 48.3 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.35 2.033 . . . . 70.329999999999998 112.152 -172.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.1 m -76.08 138.83 41.06 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.371 0.669 . . . . 71.150000000000006 109.901 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 pp -81.54 153.91 71.06 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.038 0.535 . . . . 75.010000000000005 110.251 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.16 162.6 28.56 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.032 1.821 . . . . 64.129999999999995 112.582 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.05 160.26 14.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.793 0.837 . . . . 62.149999999999999 109.665 172.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.57 124.0 48.84 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 109.045 -0.724 . . . . 65.049999999999997 109.045 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -95.26 143.13 26.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.106 0.562 . . . . 63.340000000000003 110.342 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -91.23 154.44 19.28 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.82 0.848 . . . . 74.519999999999996 109.845 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 tt -63.98 146.35 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 124.447 1.099 . . . . 72.340000000000003 112.201 -175.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -125.96 91.97 3.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.918 1.287 . . . . 72.209999999999994 109.262 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.64 -0.09 73.08 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.831 -0.622 . . . . 43.530000000000001 113.781 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.0 102.57 11.04 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 117.727 0.764 . . . . 64.319999999999993 110.37 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.73 149.86 19.75 Favored Glycine 0 C--N 1.348 1.25 0 O-C-N 123.624 0.577 . . . . 44.240000000000002 112.59 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 11.5 mmpt? -91.55 169.93 10.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.471 1.108 . . . . 65.019999999999996 111.244 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -107.74 -76.92 0.6 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.977 0.511 . . . . 62.130000000000003 110.429 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.79 85.96 1.24 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.724 0.81 . . . . 75.310000000000002 109.78 -175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.3 p -169.68 32.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.055 1.742 . . . . 74.120000000000005 106.995 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.6 m -101.96 169.86 8.5 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 113.865 -1.516 . . . . 64.099999999999994 112.343 -164.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.501 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -163.38 160.63 23.8 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.347 -0.842 . . . . 74.310000000000002 109.41 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -96.46 132.85 41.6 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.147 -0.686 . . . . 70.409999999999997 109.147 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.19 -36.64 1.77 Allowed Glycine 0 C--N 1.344 0.987 0 O-C-N 123.886 0.741 . . . . 33.530000000000001 112.091 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.69 135.16 2.53 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 118.461 -1.188 . . . . 74.319999999999993 111.468 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.56 124.5 12.92 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.145 2.563 . . . . 73.430000000000007 112.806 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -117.56 140.98 48.9 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.973 0.909 . . . . 72.329999999999998 110.028 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.9 m -84.28 -178.52 6.96 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.083 0.953 . . . . 72.319999999999993 111.158 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 85.65 156.98 0.09 Allowed 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 126.527 1.931 . . . . 73.420000000000002 111.09 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.584 HG12 HD22 ' A' ' 250' ' ' ASN . 23.4 m -130.93 141.95 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.13 0.972 . . . . 71.239999999999995 110.177 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -127.69 -166.77 1.66 Allowed 'General case' 0 C--O 1.246 0.876 0 C-N-CA 124.688 1.195 . . . . 62.43 108.443 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -167.13 139.93 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.164 0.585 . . . . 62.210000000000001 110.578 172.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -164.25 167.78 19.57 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.611 1.164 . . . . 74.010000000000005 109.745 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -128.35 131.54 48.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.79 0.836 . . . . 73.099999999999994 108.79 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.67 -77.73 0.59 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.128 -1.064 . . . . 63.009999999999998 108.128 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.73 -175.78 0.95 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.602 0.761 . . . . 55.520000000000003 110.661 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.65 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 1.1 pt? -146.26 -175.9 4.95 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.476 1.11 . . . . 62.200000000000003 110.236 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 71.99 142.49 0.06 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.273 1.429 . . . . 73.010000000000005 112.342 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.1 mmt-85 -130.96 143.12 48.12 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.161 0.985 . . . . 75.420000000000002 108.777 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.73 110.46 1.28 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.701 2.267 . . . . 74.209999999999994 111.477 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.3 p -88.33 125.37 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 109.261 -0.644 . . . . 43.210000000000001 109.261 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.25 155.44 28.56 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.197 0.599 . . . . 70.040000000000006 110.303 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.3 p -64.54 -30.18 71.21 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.008 0.818 . . . . 72.140000000000001 109.473 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.83 81.17 4.26 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.178 -0.919 . . . . 73.150000000000006 109.537 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -151.48 159.2 44.28 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.251 1.02 . . . . 74.209999999999994 108.614 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.7 109.87 3.38 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.859 0.864 . . . . 73.310000000000002 108.904 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.2 -32.7 97.53 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.181 2.587 . . . . 73.420000000000002 113.918 -171.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -90.31 -38.52 13.32 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.4 0.68 . . . . 65.420000000000002 110.949 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.56 45.47 22.93 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.02 -1.232 . . . . 61.25 110.02 -163.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.96 136.82 58.2 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.332 1.053 . . . . 62.020000000000003 111.337 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -127.61 175.38 8.31 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.72 0.808 . . . . 73.120000000000005 110.508 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 30.62 0.71 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.86 1.264 . . . . 54.039999999999999 111.82 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.85 10.69 0.65 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.283 1.033 . . . . 73.519999999999996 113.366 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.56 -18.55 64.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.249 1.02 . . . . 65.319999999999993 111.904 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -95.71 125.73 40.49 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.339 0.656 . . . . 70.019999999999996 109.684 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.405 ' NE1' ' HB2' ' A' ' 69' ' ' SER . 11.7 t90 -142.4 86.41 1.96 Allowed 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.007 -0.738 . . . . 74.540000000000006 109.007 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.434 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 24.1 p-10 -84.2 -8.97 58.9 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.718 -0.674 . . . . 53.399999999999999 110.868 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.445 ' HB3' ' HD1' ' A' ' 144' ' ' HIS . 23.8 m -61.17 -4.3 1.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.778 1.399 . . . . 72.430000000000007 114.778 -165.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.51 -34.36 69.0 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.45 0.7 . . . . 62.350000000000001 111.145 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 12.7 pt-20 -65.32 -46.59 79.72 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.444 0.698 . . . . 73.25 110.589 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.04 -5.34 59.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.147 0.979 . . . . 71.219999999999999 111.014 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 tp -76.22 -49.68 16.5 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.429 1.091 . . . . 63.130000000000003 109.111 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.5 mt -104.45 36.7 2.31 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.229 -0.896 . . . . 71.230000000000004 109.529 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.63 92.02 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.412 1.085 . . . . 51.210000000000001 112.677 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.3 -140.37 35.49 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 119.123 -0.821 . . . . 63.409999999999997 111.989 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -67.95 120.09 7.09 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.095 1.863 . . . . 65.140000000000001 109.843 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 m -120.54 157.23 29.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.426 0.69 . . . . 71.030000000000001 111.404 -172.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -65.74 -25.43 67.28 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.421 1.088 . . . . 63.130000000000003 108.687 167.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.32 39.49 0.15 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.03 2.132 . . . . 75.510000000000005 113.018 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -42.59 151.99 0.36 Allowed Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 126.592 1.957 . . . . 64.0 113.523 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -51.96 -25.71 22.79 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.953 3.102 . . . . 63.509999999999998 115.753 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -75.54 -21.63 57.77 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.158 0.504 . . . . 71.400000000000006 110.607 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.402 ' HB2' ' NH2' ' A' ' 108' ' ' ARG . 26.1 tp -79.67 127.54 32.3 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.714 -0.847 . . . . 61.210000000000001 108.714 165.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.4 174.9 5.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.028 1.331 . . . . 71.5 109.165 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.12 135.12 32.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.726 0.81 . . . . 63.350000000000001 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.07 5.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.967 0.907 . . . . 22.199999999999999 110.373 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.9 -30.71 64.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.688 0.795 . . . . 73.310000000000002 110.735 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.0 m-85 -123.91 141.23 52.22 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.922 -1.036 . . . . 73.409999999999997 109.019 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -73.53 146.89 44.49 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.14 0.576 . . . . 64.340000000000003 109.524 168.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.421 ' HE2' ' HB ' ' A' ' 98' ' ' THR . 86.1 t80 -154.14 107.66 2.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.278 0.631 . . . . 74.530000000000001 109.361 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.49 137.03 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.111 -1.07 . . . . 62.219999999999999 108.111 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 115.53 10.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.035 0.534 . . . . 75.420000000000002 110.528 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.1 p -88.63 -25.5 22.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.288 0.635 . . . . 71.420000000000002 109.654 171.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.19 157.84 15.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-N 115.227 -0.897 . . . . 72.5 111.242 173.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 255' ' ' GLU . 4.2 m-20 -69.1 -34.69 75.49 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.722 0.809 . . . . 51.039999999999999 109.735 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -76.51 -26.91 55.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.356 -1.293 . . . . 74.0 112.3 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.421 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 67.0 p -82.77 155.36 24.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.425 -0.583 . . . . 55.329999999999998 109.425 173.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.548 ' HB3' HG13 ' A' ' 130' ' ' VAL . 67.2 tp -113.65 136.21 53.08 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.9 0.48 . . . . 71.239999999999995 111.741 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.7 m -74.55 117.09 15.97 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.794 0.837 . . . . 53.039999999999999 110.482 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.653 HG22 HG21 ' A' ' 123' ' ' THR . 22.0 pt -124.53 147.22 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.714 0.805 . . . . 74.439999999999998 111.343 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 57.5 m -89.88 145.65 24.99 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.262 1.025 . . . . 74.420000000000002 109.474 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -62.08 114.34 3.35 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.985 0.514 . . . . 72.030000000000001 109.749 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 7.05 61.68 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 119.648 -0.529 . . . . 61.539999999999999 113.457 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 88.4 tt0 -83.85 135.09 34.64 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.437 0.618 . . . . 55.240000000000002 110.371 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -85.02 138.59 32.35 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.225 0.61 . . . . 74.420000000000002 109.617 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.61 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.3 OUTLIER -147.6 135.11 20.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.238 1.015 . . . . 62.310000000000002 109.935 -174.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.402 ' NH2' ' HB2' ' A' ' 84' ' ' LEU . 53.0 ttm-85 -99.15 115.9 30.12 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 122.306 -0.246 . . . . 73.450000000000003 110.624 -172.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.628 HG13 ' HB1' ' A' ' 119' ' ' ALA . 74.0 t -76.36 122.97 31.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.8 0.687 . . . . 64.209999999999994 110.39 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 122' ' ' GLN . 20.9 mt -90.81 -36.96 13.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.927 1.291 . . . . 75.140000000000001 109.448 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.46 148.77 9.66 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.421 -0.809 . . . . 72.450000000000003 112.373 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 22.0 m-85 -95.37 156.92 16.12 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 73.120000000000005 110.839 176.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -70.83 -178.39 1.87 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.434 -0.803 . . . . 72.420000000000002 110.791 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -55.29 -27.72 48.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.959 1.096 . . . . 64.299999999999997 113.959 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.02 -2.69 15.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.144 0.578 . . . . 74.319999999999993 112.436 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.63 20.98 75.85 Favored Glycine 0 C--N 1.349 1.305 0 N-CA-C 114.478 0.551 . . . . 51.100000000000001 114.478 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.49 -61.42 1.72 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 117.381 0.591 . . . . 72.310000000000002 110.152 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -92.3 145.48 24.45 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.735 0.414 . . . . 63.100000000000001 110.896 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -130.66 139.19 50.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.667 1.187 . . . . 62.109999999999999 110.679 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.2 98.75 5.97 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 107.779 -1.193 . . . . 72.230000000000004 107.779 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -105.46 134.8 47.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.678 0.791 . . . . 40.149999999999999 109.694 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.448 ' HG3' HD11 ' A' ' 110' ' ' LEU . 90.2 mt-30 -93.59 113.14 25.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.945 -0.761 . . . . 71.129999999999995 108.945 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.653 HG21 HG22 ' A' ' 101' ' ' ILE . 57.4 p -98.22 179.5 4.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.144 0.978 . . . . 75.329999999999998 110.589 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -72.51 -18.76 61.63 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.908 -1.042 . . . . 72.340000000000003 110.005 170.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -80.38 -12.5 59.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.384 1.073 . . . . 73.030000000000001 111.278 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.72 -172.75 14.48 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.618 -0.193 . . . . 63.109999999999999 112.618 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -85.67 136.29 33.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.255 0.622 . . . . 74.239999999999995 110.756 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -173.38 -177.77 42.86 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.99 -0.55 . . . . 72.219999999999999 112.49 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -107.2 125.21 50.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.837 0.455 . . . . 71.420000000000002 111.58 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.595 HG23 HD13 ' A' ' 135' ' ' ILE . 26.8 m -138.6 148.9 60.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 125.129 1.372 . . . . 75.030000000000001 109.461 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -95.0 151.91 1.71 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.956 2.437 . . . . 63.32 115.538 -170.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.1 m -41.54 -38.5 1.34 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.424 1.89 . . . . 74.219999999999999 115.133 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -71.78 -13.37 61.68 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 122.113 -0.367 . . . . 52.450000000000003 111.175 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.433 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 15.5 m-85 -104.08 -25.26 13.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.007 0.923 . . . . 70.400000000000006 112.363 170.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.595 HD13 HG23 ' A' ' 130' ' ' VAL . 32.7 pt -128.21 144.95 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 118.669 0.668 . . . . 74.329999999999998 112.486 -173.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -137.5 148.57 62.11 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 108.866 -0.79 . . . . 54.399999999999999 108.866 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.25 141.2 88.55 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.532 2.155 . . . . 72.439999999999998 110.948 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.05 -3.26 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.425 0 CA-C-O 121.056 0.455 . . . . 73.329999999999998 111.355 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.77 -8.54 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.379 0.672 . . . . 72.140000000000001 112.11 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.7 p -75.97 -177.27 3.8 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.155 0.582 . . . . 72.430000000000007 111.901 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.7 mt -86.85 -30.93 21.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.828 0.451 . . . . 64.519999999999996 110.082 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -64.34 -23.83 67.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.403 1.081 . . . . 75.430000000000007 111.8 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -6.17 9.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.911 0.884 . . . . 64.140000000000001 112.425 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.445 ' HD1' ' HB3' ' A' ' 69' ' ' SER . 85.1 m-70 -97.21 155.47 16.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.887 0.875 . . . . 74.140000000000001 110.585 171.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.5 p -66.99 -41.51 86.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.501 1.12 . . . . 73.239999999999995 111.745 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -66.04 -41.67 90.56 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.113 0.783 . . . . 74.140000000000001 113.113 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 26.4 t80 -78.06 112.55 15.11 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.955 -0.387 . . . . 73.430000000000007 109.955 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.456 ' HB2' HG21 ' A' ' 151' ' ' VAL . 30.6 m170 -104.41 -5.29 21.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.376 0.51 . . . . 34.340000000000003 112.376 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.34 -141.73 30.37 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 118.506 -1.163 . . . . 73.310000000000002 112.673 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.59 94.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.596 2.864 . . . . 64.310000000000002 112.919 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.8 t -138.53 137.09 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.916 1.286 . . . . 61.310000000000002 109.702 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.4 p -89.4 176.26 6.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.394 1.078 . . . . 65.530000000000001 110.882 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -60.1 -49.29 78.21 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.984 0.513 . . . . 73.430000000000007 110.122 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -59.56 -41.56 90.43 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.194 0.934 . . . . 73.120000000000005 111.192 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -65.84 -44.82 84.36 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.307 -0.86 . . . . 63.25 111.522 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.56 89.63 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.56 -0.745 . . . . 75.310000000000002 111.123 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -80.68 -21.6 41.16 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.47 -0.786 . . . . 63.450000000000003 111.977 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -78.23 -25.63 47.03 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.992 0.814 . . . . 70.230000000000004 110.388 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 239' ' ' ARG . 62.2 mt -70.74 -42.48 70.45 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.518 0.675 . . . . 72.549999999999997 110.484 169.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 66.9 mt -94.37 22.44 6.05 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.757 -1.11 . . . . 75.430000000000007 111.388 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 99.1 p -74.06 -43.8 56.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.148 0.499 . . . . 71.540000000000006 110.164 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.7 p -112.05 19.56 17.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.633 0.773 . . . . 64.430000000000007 110.464 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.96 149.8 48.2 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.98 -0.555 . . . . 74.230000000000004 111.724 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.7 pt -87.35 169.82 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-O 121.166 0.508 . . . . 74.519999999999996 110.527 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -70.96 109.25 4.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.077 -0.511 . . . . 75.219999999999999 109.632 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.87 10.07 19.42 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.087 0.851 . . . . 72.349999999999994 112.863 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.0 m -86.22 131.99 34.11 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.089 0.944 . . . . 62.409999999999997 110.583 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 183' ' ' SER . 8.6 p90 -139.29 166.95 23.18 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.385 0.539 . . . . 74.439999999999998 111.569 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -162.62 147.63 12.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.916 -1.038 . . . . 72.310000000000002 108.483 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 182' ' ' ILE . 99.2 t -105.32 124.53 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.56 -1.274 . . . . 62.240000000000002 107.56 169.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.685 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 44.7 ptt85 -114.68 159.99 19.86 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.456 1.102 . . . . 65.319999999999993 108.663 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.65 141.79 47.73 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.757 -1.201 . . . . 62.149999999999999 107.757 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.0 t -83.51 130.73 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.26 0.624 . . . . 71.230000000000004 110.003 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.05 -33.01 33.79 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.718 0.636 . . . . 74.430000000000007 109.973 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.8 p -72.45 -31.81 65.76 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.494 -0.775 . . . . 55.119999999999997 110.955 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.6 m -121.8 95.1 48.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.476 0.71 . . . . 64.010000000000005 109.293 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.57 114.44 2.54 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.39 2.727 . . . . 55.509999999999998 113.31 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.16 -15.15 61.83 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.755 -0.657 . . . . 75.219999999999999 112.964 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -79.16 116.6 19.53 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.505 0.653 . . . . 72.439999999999998 109.975 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -110.22 144.65 38.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.477 0.656 . . . . 72.140000000000001 110.46 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.6 m -138.43 150.67 46.71 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.834 0.854 . . . . 74.409999999999997 109.043 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.707 HG12 HG22 ' A' ' 170' ' ' VAL . 22.3 mt -101.87 150.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.54 -1.282 . . . . 74.340000000000003 107.54 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -124.87 108.24 11.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.778 -1.193 . . . . 73.400000000000006 107.778 168.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.425 HD23 ' OH ' ' A' ' 193' ' ' TYR . 56.7 tp -107.49 111.12 23.26 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.325 -0.62 . . . . 73.430000000000007 109.325 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.454 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -79.55 122.37 26.4 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.521 -0.548 . . . . 72.010000000000005 109.521 168.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -149.92 145.25 26.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.848 1.659 . . . . 73.040000000000006 107.458 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 59.45 21.79 10.23 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 124.255 1.022 . . . . 62.420000000000002 111.557 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.47 -7.15 62.11 Favored Glycine 0 C--N 1.358 1.765 0 CA-C-N 116.176 -0.465 . . . . 75.030000000000001 113.956 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -104.49 138.64 40.56 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.196 0.999 . . . . 71.299999999999997 108.581 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.33 103.81 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.397 0.544 . . . . 73.310000000000002 110.395 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.26 115.47 27.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.885 0.874 . . . . 74.530000000000001 109.65 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.63 118.25 30.84 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.194 0.598 . . . . 73.439999999999998 110.371 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 11.1 m-85 -94.33 148.49 22.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.447 1.099 . . . . 72.239999999999995 109.532 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -107.02 112.93 26.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 74.310000000000002 108.727 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.18 101.49 8.82 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 N-CA-C 108.8 -0.815 . . . . 40.229999999999997 108.8 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -80.79 121.81 26.39 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.662 -1.154 . . . . 52.450000000000003 108.931 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.2 m -93.39 113.88 26.15 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.917 0.887 . . . . 32.149999999999999 108.78 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.25 167.32 14.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.7 0.8 . . . . 74.019999999999996 110.799 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.9 p -62.45 -24.69 67.57 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.881 0.872 . . . . 74.049999999999997 112.195 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -96.87 -16.66 20.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.62 0.768 . . . . 74.230000000000004 111.516 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.87 9.94 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.217 -0.768 . . . . 70.409999999999997 114.81 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.72 124.71 26.54 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.32 1.06 . . . . 70.040000000000006 110.551 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -88.26 140.88 29.03 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.846 -0.798 . . . . 74.340000000000003 108.846 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.585 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 44.8 p90 -162.63 135.59 5.8 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.769 0.668 . . . . 75.400000000000006 110.516 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.504 HG23 HD11 ' A' ' 217' ' ' LEU . 53.9 t -70.81 -53.28 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.902 -0.777 . . . . 73.409999999999997 108.902 165.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.3 m -107.06 136.15 47.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.629 -1.168 . . . . 74.439999999999998 109.744 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.8 t -60.4 -26.59 66.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.45 1.1 . . . . 71.230000000000004 112.942 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.39 -23.3 61.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.747 0.819 . . . . 73.409999999999997 111.479 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.2 m -134.4 101.17 4.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.182 0.593 . . . . 71.310000000000002 110.364 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.585 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.1 mtm180 -110.07 138.07 46.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.162 0.985 . . . . 72.430000000000007 110.197 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.87 149.22 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.623 -0.88 . . . . 71.120000000000005 108.623 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -68.66 -31.96 71.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 72.319999999999993 110.76 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -132.1 157.36 44.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 112.074 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -27.55 69.03 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.731 -1.122 . . . . 74.019999999999996 109.506 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.99 -45.44 86.79 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.553 0.741 . . . . 71.040000000000006 110.898 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.6 -34.83 72.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.527 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 205' ' ' VAL . 16.0 tp -56.98 -58.64 7.27 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.752 0.421 . . . . 64.239999999999995 110.873 174.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.22 -40.65 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.246 0.618 . . . . 74.239999999999995 111.165 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -57.13 -61.47 2.44 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.822 0.701 . . . . 74.340000000000003 111.566 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -71.9 -29.16 64.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.849 -0.614 . . . . 73.340000000000003 111.262 -171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.518 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.7 m170 -87.55 -9.88 53.17 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.675 0.39 . . . . 73.319999999999993 112.049 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.0 p -88.43 -35.33 17.14 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.98 0.355 . . . . 71.409999999999997 110.114 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 65.8 p -70.28 -46.65 63.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.631 0.372 . . . . 71.129999999999995 111.048 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.745 HG23 ' HB2' ' A' ' 226' ' ' ASP . 22.8 m -132.01 165.14 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.353 0.661 . . . . 52.130000000000003 111.973 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.62 15.41 0.37 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 126.714 2.005 . . . . 64.129999999999995 114.208 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.745 ' HB2' HG23 ' A' ' 224' ' ' VAL . 23.8 t70 -44.65 36.23 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.723 1 C-N-CA 132.429 4.292 . . . . 75.109999999999999 119.561 -157.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 124.1 -7.08 8.73 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.537 -0.727 . . . . 51.439999999999998 112.493 -170.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.4 mt -94.65 162.45 13.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.116 1.366 . . . . 74.209999999999994 110.059 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.76 -35.26 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.604 0.24 . . . . 72.109999999999999 110.786 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.5 t -159.06 -179.22 7.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.996 0.519 . . . . 72.310000000000002 110.677 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.2 p -66.13 137.24 56.9 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.622 1.169 . . . . 73.219999999999999 112.311 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.44 96.69 1.19 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.75 0.82 . . . . 42.229999999999997 109.051 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -97.53 -82.61 0.41 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.818 -0.551 . . . . 53.200000000000003 111.99 -170.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -75.22 120.72 82.99 Favored Pre-proline 0 C--N 1.351 0.647 0 N-CA-C 108.857 -0.794 . . . . 74.219999999999999 108.857 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.88 127.7 7.97 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.038 1.825 . . . . 73.120000000000005 111.275 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.95 140.94 88.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 108.851 -0.796 . . . . 74.409999999999997 108.851 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.76 176.58 9.34 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.488 2.125 . . . . 74.140000000000001 113.051 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -63.53 140.7 58.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.897 0.879 . . . . 75.109999999999999 109.654 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.6 ' HE ' HG22 ' A' ' 151' ' ' VAL . 20.8 ptt85 -90.49 -61.31 1.71 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.524 0.935 . . . . 75.310000000000002 113.524 -165.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.453 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.8 t30 -109.08 128.84 55.32 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.595 0.758 . . . . 64.150000000000006 109.614 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -76.94 113.26 28.6 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.092 -1.447 . . . . 74.340000000000003 107.092 164.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -63.15 132.65 37.31 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.534 2.156 . . . . 74.239999999999995 112.46 -172.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 89.5 m -69.25 123.84 22.22 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.404 0.682 . . . . 63.329999999999998 110.284 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.65 111.74 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.405 -0.961 . . . . 73.239999999999995 108.405 172.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.65 ' HA ' ' HB3' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -106.56 112.37 25.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.303 0.641 . . . . 72.319999999999993 111.917 -169.052 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 69.34 -38.18 0.34 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 117.366 1.706 . . . . 61.049999999999997 117.366 165.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.33 129.33 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 117.833 0.817 . . . . 73.219999999999999 112.771 -158.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.9 t -83.35 135.82 43.7 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 107.339 -1.356 . . . . 75.409999999999997 107.339 168.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.92 -60.46 0.39 Allowed 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 122.126 1.884 . . . . 75.129999999999995 115.265 -156.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.584 HD22 HG12 ' A' ' 41' ' ' VAL . 25.8 p-10 -128.98 -31.58 2.13 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-O 121.734 0.778 . . . . 70.340000000000003 109.841 153.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.482 ' CG ' ' HB2' ' A' ' 254' ' ' TRP . 0.2 OUTLIER -104.33 150.19 24.69 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.071 -0.968 . . . . 75.519999999999996 111.905 -162.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -103.02 -44.99 5.08 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.029 0.531 . . . . 65.409999999999997 110.251 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -110.78 13.45 22.33 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.604 0.965 . . . . 62.219999999999999 113.604 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.498 ' HH2' ' HA2' ' A' ' 128' ' ' GLY . 25.9 t90 -71.25 145.92 49.29 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.119 0.418 . . . . 74.25 111.255 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 32.0 tt0 . . . . . 0 C--O 1.259 1.591 0 C-N-CA 125.683 1.593 . . . . 73.530000000000001 106.998 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.256 -0.646 . . . . 74.209999999999994 109.256 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.61 -119.86 15.27 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 124.1 0.875 . . . . 74.329999999999998 112.191 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -76.81 117.9 18.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.387 0.675 . . . . 43.420000000000002 109.251 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.01 144.41 47.49 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.466 0.706 . . . . 55.240000000000002 110.537 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -53.76 98.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 123.939 3.093 . . . . 64.25 114.498 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.87 -152.01 13.26 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.32 -0.4 . . . . 71.140000000000001 112.621 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.01 82.58 4.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.476 0.655 . . . . 72.400000000000006 109.346 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.07 -35.69 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.048 0.939 . . . . 54.109999999999999 110.425 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.7 mt 58.94 -165.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.78 1.232 . . . . 73.299999999999997 111.197 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.18 -178.62 11.01 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 112.274 -0.33 . . . . 71.329999999999998 112.274 170.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -134.35 -67.27 0.58 Allowed 'General case' 0 CA--C 1.55 0.967 0 O-C-N 122.043 -0.68 . . . . 54.450000000000003 112.009 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -126.1 168.99 13.24 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.584 0.629 . . . . 72.510000000000005 111.362 -170.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -73.95 93.3 2.19 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.023 -0.99 . . . . 61.25 111.401 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -141.04 -55.5 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 CA-C-O 118.057 -0.973 . . . . 71.040000000000006 112.509 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HB2' HD21 ' A' ' 250' ' ' ASN . 24.2 Cg_exo -62.11 127.88 22.46 Favored 'Trans proline' 0 C--N 1.401 3.309 0 C-N-CA 122.054 1.836 . . . . 63.109999999999999 113.18 -169.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.2 t -135.53 -78.95 0.43 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.59 -1.263 . . . . 61.310000000000002 107.59 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.4 mt 51.25 71.71 1.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 C-N-CA 124.416 1.087 . . . . 74.099999999999994 112.219 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.23 141.19 60.21 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.765 2.976 . . . . 72.230000000000004 114.526 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.67 -163.24 1.73 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.324 1.05 . . . . 33.340000000000003 109.105 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -136.9 125.06 23.01 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.697 0.799 . . . . 72.530000000000001 108.934 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -126.88 127.67 45.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.822 -0.807 . . . . 75.439999999999998 108.822 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -80.56 149.03 30.1 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.284 0.633 . . . . 73.129999999999995 111.453 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.94 -179.83 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.44 1.496 . . . . 65.209999999999994 109.524 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -139.08 155.89 47.58 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.266 0.626 . . . . 73.150000000000006 109.958 171.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.99 110.12 0.24 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.854 -0.612 . . . . 63.32 112.589 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.57 139.71 14.38 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.309 1.044 . . . . 63.329999999999998 109.176 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.94 -27.86 0.46 Allowed Glycine 0 C--N 1.352 1.443 0 C-N-CA 121.903 -0.189 . . . . 73.319999999999993 113.083 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -117.24 167.25 11.38 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.928 0.891 . . . . 74.099999999999994 110.092 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 120.28 18.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.53 0.732 . . . . 74.299999999999997 109.601 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -99.29 134.15 42.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.127 0.571 . . . . 73.209999999999994 111.634 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.6 m -67.46 130.23 42.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.042 0.937 . . . . 74.299999999999997 110.082 176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -134.78 99.11 4.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.695 0.398 . . . . 61.240000000000002 111.101 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.445 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -161.64 148.62 14.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.115 0.566 . . . . 72.200000000000003 111.328 169.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -178.57 89.49 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.534 1.534 . . . . 45.100000000000001 108.361 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.86 -126.91 7.57 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.785 -0.453 . . . . 35.530000000000001 112.874 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . 92.87 137.98 8.42 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.179 -0.789 . . . . 65.519999999999996 112.545 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HB2' ' H ' ' A' ' 38' ' ' HIS . 3.3 Cg_exo -79.38 -120.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.244 2.629 . . . . 51.509999999999998 111.609 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.554 ' HB2' HD21 ' A' ' 61' ' ' LEU . 56.2 p-80 -162.55 130.07 3.79 Favored 'General case' 0 C--N 1.366 1.305 0 CA-C-N 118.917 0.78 . . . . 65.340000000000003 112.049 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.1 m -152.58 157.14 40.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.153 0.981 . . . . 61.140000000000001 109.644 170.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -79.27 94.76 5.51 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.669 0.788 . . . . 65.140000000000001 109.62 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.33 96.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 N-CA-C 107.199 -1.408 . . . . 73.120000000000005 107.199 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -102.39 133.78 46.76 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 114.84 1.422 . . . . 65.219999999999999 114.84 -157.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 m -150.8 -38.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 126.244 1.818 . . . . 74.140000000000001 108.28 161.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -149.25 173.07 13.87 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.434 0.693 . . . . 73.310000000000002 110.703 -167.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 85.21 133.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.509 1.924 . . . . 72.109999999999999 111.511 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -110.81 148.27 32.74 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.846 1.259 . . . . 74.329999999999998 111.025 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.85 -72.32 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.657 1.583 . . . . 74.109999999999999 108.786 166.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 tt -171.19 94.46 0.18 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.712 0.405 . . . . 64.230000000000004 110.032 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -163.57 176.7 9.44 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 126.094 1.757 . . . . 63.039999999999999 108.326 165.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -121.67 89.3 47.53 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 123.43 0.692 . . . . 70.310000000000002 110.364 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 76.1 Cg_endo -79.32 163.98 24.47 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.786 2.324 . . . . 74.150000000000006 112.033 169.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.66 90.45 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.688 -0.856 . . . . 74.129999999999995 108.688 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.62 -171.95 1.97 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.089 0.956 . . . . 53.119999999999997 110.149 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.1 p -74.97 -62.57 1.5 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.036 0.534 . . . . 71.549999999999997 111.876 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.63 -77.26 0.58 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.713 -0.847 . . . . 64.430000000000007 108.713 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -94.12 128.69 40.66 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.743 0.817 . . . . 74.430000000000007 108.915 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -110.38 129.43 23.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.009 0.524 . . . . 74.120000000000005 110.012 -175.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.78 -137.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.968 2.445 . . . . 74.140000000000001 111.618 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -90.57 -52.98 4.62 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.076 0.551 . . . . 62.109999999999999 109.856 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.76 30.37 9.69 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.187 -0.46 . . . . 74.040000000000006 112.754 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -95.37 74.42 3.32 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.695 -1.595 . . . . 75.319999999999993 106.695 174.488 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m -88.95 -19.62 25.53 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 114.497 1.295 . . . . 73.310000000000002 114.497 -158.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 1.4 pm0 -76.76 -37.36 56.04 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 118.656 0.662 . . . . 64.150000000000006 109.94 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.55 -18.03 64.48 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 120.765 0.317 . . . . 54.229999999999997 111.094 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.34 -24.35 39.93 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.059 0.944 . . . . 64.349999999999994 112.325 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.445 ' HA ' ' HB3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -152.45 -44.01 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.096 0.776 . . . . 75.010000000000005 113.096 -176.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 63' ' ' GLU . 8.1 t90 -83.89 67.23 9.51 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 74.299999999999997 109.625 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 26.2 p-10 -66.97 -33.95 76.7 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.419 -0.81 . . . . 72.340000000000003 110.826 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 p -72.0 6.21 2.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.698 1.199 . . . . 64.450000000000003 112.72 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HD3' ' HG3' ' A' ' 63' ' ' GLU . 83.5 tttt -70.28 -21.24 62.98 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.75 0.42 . . . . 64.439999999999998 111.13 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 13.3 pt-20 -73.0 -38.11 66.72 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.474 -0.565 . . . . 72.340000000000003 109.474 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 4.9 m-20 -77.43 -13.59 59.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.23 0.612 . . . . 74.329999999999998 111.075 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.461 HD13 ' HE1' ' A' ' 146' ' ' TRP . 60.3 tp -59.14 -50.32 74.5 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.684 0.794 . . . . 71.0 110.692 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 mt -108.06 23.8 13.94 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.78 -0.645 . . . . 42.100000000000001 110.922 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . -75.62 -28.92 59.02 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.073 0.549 . . . . 70.319999999999993 111.533 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.91 -137.71 30.43 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-O 119.141 -0.81 . . . . 74.349999999999994 111.712 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 86.6 Cg_exo -50.81 -177.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.892 0 C-N-CA 123.483 2.789 . . . . 55.009999999999998 114.817 166.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 2.8 m -67.98 167.74 13.2 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.934 -0.575 . . . . 64.129999999999995 109.854 171.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -63.75 -43.65 95.82 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.961 0.504 . . . . 74.519999999999996 111.587 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -127.1 -33.44 2.42 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.348 0.659 . . . . 72.349999999999994 111.035 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.505 ' HB3' ' H ' ' A' ' 83' ' ' ASN . 25.6 m-20 -90.04 149.4 41.56 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 113.653 0.983 . . . . 74.140000000000001 113.653 -174.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -89.42 -9.77 4.09 Favored 'Trans proline' 0 CA--C 1.561 1.85 0 C-N-CA 122.717 2.278 . . . . 75.319999999999993 111.956 149.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.505 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 60.1 t30 -109.85 16.78 21.77 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.229 1.011 . . . . 73.010000000000005 111.681 -169.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.5 tp -100.11 139.52 35.66 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.65 -0.656 . . . . 72.239999999999995 110.315 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -116.5 172.3 7.29 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.362 1.065 . . . . 73.319999999999993 109.101 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.08 139.99 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.732 1.213 . . . . 74.430000000000007 109.538 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.32 117.26 20.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.207 1.003 . . . . 41.32 110.249 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.07 -31.7 34.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.09 0.956 . . . . 50.219999999999999 111.564 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.43 141.61 51.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.036 0.934 . . . . 74.540000000000006 108.921 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.99 120.2 24.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.158 -0.682 . . . . 71.409999999999997 109.158 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.525 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.2 t80 -115.43 142.87 46.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.786 0.834 . . . . 64.109999999999999 109.469 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.72 135.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.737 -0.838 . . . . 63.109999999999999 108.737 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.42 119.22 10.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.701 0.8 . . . . 64.040000000000006 111.035 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.3 p -94.4 10.94 32.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.428 1.091 . . . . 74.409999999999997 111.324 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.78 179.45 43.47 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.108 -0.496 . . . . 73.310000000000002 112.034 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.14 -34.81 63.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.892 0.877 . . . . 74.430000000000007 110.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.519 ' ND2' ' HD2' ' A' ' 249' ' ' PRO . 32.4 p-10 -90.37 -4.05 57.33 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.043 -0.981 . . . . 75.400000000000006 112.262 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.9 p -96.76 168.51 10.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.457 0.703 . . . . 72.150000000000006 109.936 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.576 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 66.1 tp -135.93 136.29 40.33 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.084 0.553 . . . . 60.240000000000002 111.38 -172.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -83.9 120.14 25.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.573 0.749 . . . . 70.239999999999995 110.073 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.784 HG22 HG21 ' A' ' 123' ' ' THR . 20.2 pt -117.43 152.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 123.171 0.588 . . . . 75.450000000000003 111.614 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -98.53 146.44 25.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.362 1.065 . . . . 72.310000000000002 109.601 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -70.17 118.59 13.19 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.907 0.483 . . . . 71.450000000000003 109.701 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.78 -11.5 56.21 Favored Glycine 0 N--CA 1.472 1.052 0 C-N-CA 123.197 0.427 . . . . 71.319999999999993 112.845 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.11 135.65 44.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.65 0.78 . . . . 73.150000000000006 110.97 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -85.92 142.46 28.83 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.572 -0.899 . . . . 71.319999999999993 108.572 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.677 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.15 150.4 34.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.25 0.62 . . . . 51.310000000000002 111.119 -176.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -95.4 106.41 18.46 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.687 -0.688 . . . . 73.150000000000006 109.287 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.652 HG13 ' HB1' ' A' ' 119' ' ' ALA . 42.1 t -86.75 107.88 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.621 -0.511 . . . . 74.040000000000006 109.621 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.613 HD21 ' HG3' ' A' ' 122' ' ' GLN . 2.1 mm? -69.52 -23.22 63.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.349 1.059 . . . . 32.329999999999998 110.935 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.7 166.42 13.61 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.276 -0.42 . . . . 75.140000000000001 112.46 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.593 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 61.1 m-85 -86.6 173.12 9.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.841 0.829 . . . . 74.140000000000001 111.794 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 250' ' ' ASN . 31.2 p-10 -90.05 -178.66 5.49 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.208 -1.36 . . . . 64.25 110.97 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -53.26 -34.3 56.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.611 1.165 . . . . 71.030000000000001 113.11 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -105.35 -19.67 13.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 119.183 -0.436 . . . . 74.25 111.368 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.21 34.68 22.9 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.548 0.579 . . . . 71.109999999999999 114.548 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.55 -29.82 14.7 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.023 0.412 . . . . 62.350000000000001 111.057 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 60.6 m95 -128.75 156.02 44.2 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.16 0.984 . . . . 74.25 111.15 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.652 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.22 141.31 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.305 1.042 . . . . 25.440000000000001 110.263 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 110' ' ' LEU . 40.7 tt0 -74.82 118.43 17.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.859 -1.163 . . . . 63.350000000000001 107.859 170.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.52 151.33 48.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.25 0.62 . . . . 75.430000000000007 111.307 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.613 ' HG3' HD21 ' A' ' 110' ' ' LEU . 56.4 mt-30 -115.05 116.43 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.148 0.979 . . . . 74.400000000000006 108.95 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.784 HG21 HG22 ' A' ' 101' ' ' ILE . 67.0 p -114.6 -178.51 3.39 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.349 1.059 . . . . 71.150000000000006 110.885 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -68.66 -16.53 63.86 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.553 -0.748 . . . . 74.129999999999995 110.29 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -84.33 -20.46 32.01 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.202 1.001 . . . . 73.120000000000005 111.074 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.31 -168.43 14.84 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.096 -0.402 . . . . 55.240000000000002 112.096 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.27 145.45 28.83 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.35 0.575 . . . . 71.349999999999994 111.593 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.39 -161.91 27.65 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.713 -0.955 . . . . 21.25 110.713 177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -110.94 136.24 50.25 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.797 0.798 . . . . 72.510000000000005 111.463 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.484 HG11 ' CG2' ' A' ' 101' ' ' ILE . 34.2 m -137.8 140.28 29.13 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.063 1.345 . . . . 73.109999999999999 109.252 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 8.8 Cg_exo -72.85 146.4 42.33 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.44 2.093 . . . . 74.120000000000005 114.38 -172.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 m -38.09 -50.96 1.4 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.469 1.907 . . . . 44.539999999999999 114.194 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 131' ' ' PRO . 12.7 p-10 -73.3 -3.65 28.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.375 1.07 . . . . 74.519999999999996 113.103 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -106.73 -9.39 16.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.858 0.863 . . . . 75.120000000000005 111.313 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 109' ' ' VAL . 18.0 pt -130.8 168.59 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.137 0.975 . . . . 73.329999999999998 111.832 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 t -163.06 155.9 16.29 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 124.08 0.952 . . . . 62.340000000000003 108.672 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.74 142.71 91.65 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 121.795 1.663 . . . . 72.040000000000006 111.442 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.4 t -69.72 -11.37 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.796 0.807 . . . . 75.409999999999997 109.848 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 9.5 m-80 -73.8 -18.36 60.97 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.523 1.129 . . . . 51.130000000000003 112.568 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.6 p -92.69 -178.25 4.8 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.318 0.858 . . . . 51.340000000000003 113.318 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.8 mt -83.5 -21.19 32.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.257 1.023 . . . . 61.009999999999998 111.689 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.54 -20.95 63.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.684 0.394 . . . . 73.200000000000003 111.792 -172.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 72' ' ' ASN . 21.8 pttm -65.33 -15.99 63.12 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 112.266 0.469 . . . . 74.420000000000002 112.266 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -83.22 138.47 33.6 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.401 0.68 . . . . 75.319999999999993 109.28 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 p -65.11 -39.88 93.76 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.611 0.765 . . . . 63.219999999999999 112.203 -177.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.461 ' HE1' HD13 ' A' ' 73' ' ' LEU . 32.2 p-90 -67.78 -30.16 69.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.848 0.859 . . . . 61.520000000000003 112.87 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -80.58 102.99 10.13 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.742 -0.466 . . . . 71.219999999999999 109.742 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -99.72 -4.1 31.47 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.992 0.517 . . . . 75.439999999999998 111.788 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.8 -139.79 26.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 118.708 -1.051 . . . . 60.130000000000003 112.793 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.92 101.51 0.39 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.813 2.342 . . . . 74.010000000000005 112.399 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 76.7 t -132.3 141.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.77 0.828 . . . . 74.319999999999993 109.801 -175.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.6 p -87.72 172.65 9.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.924 0.89 . . . . 73.25 110.369 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 68.8 ttt180 -61.71 -45.51 93.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.243 -0.28 . . . . 54.409999999999997 110.243 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.5 -45.56 80.94 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.042 0.838 . . . . 64.299999999999997 111.019 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.624 ' HB1' HH12 ' A' ' 239' ' ' ARG . . . -71.65 -26.45 62.55 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.289 -0.869 . . . . 71.230000000000004 111.699 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.27 -43.27 52.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.27 0.628 . . . . 74.310000000000002 111.243 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 26.7 mm-40 -60.79 -36.19 78.38 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.722 0.809 . . . . 74.129999999999995 110.059 174.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -67.75 -47.29 69.67 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.704 -1.134 . . . . 73.209999999999994 111.205 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.33 -38.44 68.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.284 0.634 . . . . 55.200000000000003 111.307 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.9 mt -100.93 6.79 43.75 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.952 0.723 . . . . 73.109999999999999 112.952 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 90.6 p -59.17 -35.31 73.32 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 119.075 0.852 . . . . 70.5 111.166 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -102.86 18.92 20.37 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.495 1.118 . . . . 54.299999999999997 110.89 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.11 133.29 11.68 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 123.644 0.64 . . . . 74.109999999999999 113.057 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -79.54 -177.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.946 0.898 . . . . 41.210000000000001 111.837 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.96 116.43 3.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.601 0.761 . . . . 63.32 110.656 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.16 11.8 55.7 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.629 -0.714 . . . . 73.019999999999996 113.094 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.1 m -76.38 135.24 39.48 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 118.082 0.941 . . . . 73.209999999999994 110.622 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 183' ' ' SER . 33.6 p90 -142.22 168.13 20.47 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 118.782 0.719 . . . . 55.549999999999997 111.34 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 pp -159.29 152.67 22.52 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.337 -0.986 . . . . 50.009999999999998 108.337 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.689 HG22 HG12 ' A' ' 182' ' ' ILE . 89.4 t -110.91 142.05 24.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 N-CA-C 109.092 -0.707 . . . . 70.409999999999997 109.092 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.467 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.3 ptt85 -135.37 159.21 42.3 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.288 -1.323 . . . . 74.439999999999998 108.95 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.658 ' HG2' ' HG2' ' A' ' 180' ' ' ARG . 10.7 mt-10 -113.93 162.14 16.76 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.523 -0.918 . . . . 64.319999999999993 108.523 164.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -84.02 133.79 34.65 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.99 -0.744 . . . . 74.409999999999997 108.99 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -71.17 -43.73 66.89 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.722 -0.473 . . . . 74.450000000000003 109.722 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.5 p -76.25 -15.76 59.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.112 0.565 . . . . 71.420000000000002 112.145 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.5 m -139.54 82.99 17.57 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.141 0.577 . . . . 64.230000000000004 109.865 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.64 125.94 18.57 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.958 2.439 . . . . 62.340000000000003 111.531 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.42 -29.58 8.98 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.752 -0.539 . . . . 53.0 111.752 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -75.77 116.89 16.94 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.02 -0.733 . . . . 72.049999999999997 109.02 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.658 ' HG2' ' HG2' ' A' ' 172' ' ' GLU . 98.3 mtt180 -124.01 145.89 48.9 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 123.954 0.902 . . . . 71.329999999999998 110.121 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 64.3 m -142.27 146.46 35.14 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.221 -0.9 . . . . 71.319999999999993 109.668 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.689 HG12 HG22 ' A' ' 170' ' ' VAL . 34.6 mt -103.32 150.17 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.084 -1.45 . . . . 34.240000000000002 107.084 169.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.1 m -125.45 108.09 11.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.661 -1.237 . . . . 55.530000000000001 107.661 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 25.5 tp -107.72 110.16 21.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.658 0.663 . . . . 55.219999999999999 110.216 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.514 ' HB2' HG22 ' A' ' 190' ' ' VAL . 20.5 ttt180 -79.95 120.89 24.77 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.673 0.749 . . . . 75.299999999999997 110.773 168.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -140.59 135.51 31.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 113.816 -1.538 . . . . 70.319999999999993 107.446 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 60.14 22.4 11.67 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.799 0.84 . . . . 50.32 112.087 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.15 -10.77 73.05 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.142 0.417 . . . . 42.329999999999998 114.142 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -103.5 139.04 39.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.314 0.646 . . . . 70.430000000000007 109.908 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 185' ' ' ARG . 48.1 t -99.3 110.33 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.897 0.479 . . . . 73.329999999999998 110.433 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -95.05 117.03 29.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.979 1.311 . . . . 73.030000000000001 109.133 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -96.54 122.94 39.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.947 0.499 . . . . 74.400000000000006 110.723 -172.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.46 ' HE1' HD21 ' A' ' 232' ' ' LEU . 8.2 m-30 -94.82 147.36 23.43 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.097 0.959 . . . . 75.040000000000006 109.795 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -99.24 117.65 34.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.132 -1.062 . . . . 74.239999999999995 108.132 173.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.531 HD12 ' HB3' ' A' ' 180' ' ' ARG . 56.8 mt -82.4 100.59 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 107.649 -1.241 . . . . 73.439999999999998 107.649 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -71.28 119.81 15.96 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.051 -0.977 . . . . 52.219999999999999 109.206 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 m -87.71 110.47 20.46 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.677 -0.692 . . . . 73.200000000000003 109.16 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.25 157.3 10.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.167 0.987 . . . . 53.43 111.383 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.6 p -64.43 -31.79 73.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.641 0.776 . . . . 73.200000000000003 112.101 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -82.58 -13.92 55.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.319 0.648 . . . . 71.109999999999999 111.316 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.32 9.77 19.04 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.401 0.52 . . . . 64.030000000000001 114.401 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -79.66 164.09 24.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.686 0.743 . . . . 72.530000000000001 110.735 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -115.73 147.36 41.0 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.601 0.761 . . . . 73.209999999999994 109.172 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.608 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.6 p90 -170.3 140.06 1.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.027 0.829 . . . . 62.240000000000002 111.728 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 217' ' ' LEU . 98.9 t -85.35 -44.38 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.733 -0.84 . . . . 43.450000000000003 108.733 165.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 43.1 m -92.7 130.83 38.2 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.941 -1.027 . . . . 71.140000000000001 109.992 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -72.27 -17.11 61.91 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.416 0.686 . . . . 74.099999999999994 111.884 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.47 -1.51 57.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.038 0.535 . . . . 61.030000000000001 111.399 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.36 101.86 3.53 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.769 0.428 . . . . 73.519999999999996 111.426 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.608 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 74.2 mtt180 -101.36 153.68 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.219 0.608 . . . . 72.530000000000001 110.32 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.4 154.72 47.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.411 0.684 . . . . 75.329999999999998 109.952 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -72.21 -44.74 62.48 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.233 -0.655 . . . . 63.240000000000002 109.233 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 156.41 31.39 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-O 121.938 0.875 . . . . 75.450000000000003 111.564 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.426 HD23 HD23 ' A' ' 217' ' ' LEU . 0.8 OUTLIER -64.55 -26.6 68.49 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-N 114.012 -1.449 . . . . 52.140000000000001 110.065 175.027 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.26 96.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.576 0.75 . . . . 61.450000000000003 111.331 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.84 -33.19 70.4 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.375 0.67 . . . . 72.5 111.154 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.451 HD11 HG23 ' A' ' 205' ' ' VAL . 15.3 tp -53.36 -57.23 11.31 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.729 0.643 . . . . 64.099999999999994 110.034 171.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 53.4 t -63.88 -37.83 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 O-C-N 123.802 0.689 . . . . 74.219999999999999 112.035 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -65.14 -51.89 58.46 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.853 0.358 . . . . 61.299999999999997 111.189 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -64.23 -35.11 79.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 75.150000000000006 110.776 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.652 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.5 m170 -85.72 -9.33 57.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.284 0.476 . . . . 72.430000000000007 112.284 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.4 p -90.93 -29.73 17.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.727 0.411 . . . . 71.430000000000007 110.761 170.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.7 p -75.48 -49.51 18.57 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.852 0.358 . . . . 75.140000000000001 110.735 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.3 m -125.7 154.23 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.979 0.895 . . . . 73.420000000000002 111.694 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.62 13.88 7.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.627 1.971 . . . . 71.150000000000006 113.694 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -46.77 34.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 131.182 3.793 . . . . 55.25 119.855 -159.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.58 -0.67 6.37 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 119.28 0.945 . . . . 52.32 112.941 -167.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.2 mt -92.33 161.92 14.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.434 1.094 . . . . 75.230000000000004 110.52 163.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.83 -42.19 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 122.564 0.345 . . . . 71.030000000000001 110.432 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -161.69 170.9 18.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.665 0.786 . . . . 55.039999999999999 110.102 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.3 p -61.29 139.36 58.17 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.456 1.102 . . . . 63.530000000000001 112.687 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.46 HD21 ' HE1' ' A' ' 193' ' ' TYR . 79.5 mt -68.17 99.55 0.91 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.033 0.933 . . . . 74.510000000000005 109.161 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -94.44 -50.24 5.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.329 0.492 . . . . 61.329999999999998 112.329 -163.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 167' ' ' SER . 15.5 t80 -130.77 124.16 20.62 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.936 1.294 . . . . 62.530000000000001 108.127 -171.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -84.95 146.91 10.4 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.256 1.97 . . . . 72.420000000000002 112.17 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -74.63 130.15 82.25 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.437 -1.32 . . . . 54.219999999999999 107.437 172.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.35 173.8 12.77 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.076 1.85 . . . . 73.310000000000002 112.5 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -68.19 109.12 3.42 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.882 -0.784 . . . . 74.340000000000003 108.882 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.637 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 8.7 ptt180 -75.51 -68.3 0.58 Allowed 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.559 0.948 . . . . 64.109999999999999 113.559 -158.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.637 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 66.8 t30 -111.29 137.75 48.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.788 -0.57 . . . . 70.219999999999999 110.128 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -74.49 112.69 18.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 106.3 -1.741 . . . . 71.420000000000002 106.3 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.23 127.28 16.4 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.346 2.031 . . . . 63.130000000000003 111.568 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 84.8 m -61.53 110.76 1.56 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.969 0.907 . . . . 74.230000000000004 111.182 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.22 106.96 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 107.685 -1.228 . . . . 53.520000000000003 107.685 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.73 120.77 43.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.128 0.971 . . . . 43.509999999999998 112.777 -163.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.07 63.74 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 116.352 1.301 . . . . 64.409999999999997 116.352 161.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.63 122.42 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 123.187 0.595 . . . . 72.239999999999995 110.874 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.9 t -81.3 116.73 64.65 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 104.834 -2.284 . . . . 72.439999999999998 104.834 161.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.519 ' HD2' ' ND2' ' A' ' 97' ' ' ASN . 99.3 Cg_exo -47.51 -62.95 0.36 Allowed 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.677 2.252 . . . . 74.349999999999994 116.226 -148.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.619 HD21 ' HB2' ' A' ' 15' ' ' PRO . 2.9 t30 -129.4 -32.73 1.95 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 122.213 1.006 . . . . 72.219999999999999 109.783 162.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.517 ' HD2' ' HB3' ' A' ' 250' ' ' ASN . 6.6 m-85 -100.24 150.08 22.91 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 113.512 -1.676 . . . . 72.150000000000006 110.175 -169.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -113.24 -42.4 3.52 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.072 0.858 . . . . 73.109999999999999 109.973 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -94.33 11.78 29.25 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.611 0.765 . . . . 74.150000000000006 112.366 -174.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -92.14 141.83 28.16 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.828 0.451 . . . . 72.430000000000007 111.235 -172.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 106.993 -1.484 . . . . 75.400000000000006 106.993 178.155 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.21 -0.292 . . . . 73.310000000000002 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.12 122.15 23.06 Favored Glycine 0 C--N 1.357 1.709 0 O-C-N 123.81 0.694 . . . . 71.299999999999997 111.985 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -120.73 -60.54 1.65 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.181 0.992 . . . . 74.420000000000002 109.264 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 174.74 131.94 0.13 Allowed Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.194 1.397 . . . . 71.319999999999993 108.275 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.87 109.39 1.67 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.222 1.948 . . . . 74.439999999999998 111.717 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.89 -28.22 73.7 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.573 -0.739 . . . . 72.099999999999994 112.023 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 65.21 14.41 9.38 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.193 1.397 . . . . 70.109999999999999 112.667 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.03 118.99 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.987 0.915 . . . . 64.420000000000002 109.639 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.7 155.68 29.31 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.551 0.34 . . . . 74.420000000000002 110.197 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.4 84.74 0.06 OUTLIER Glycine 0 C--N 1.338 0.642 0 N-CA-C 112.024 -0.43 . . . . 72.150000000000006 112.024 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -158.07 153.54 26.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.031 0.532 . . . . 73.019999999999996 109.855 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -141.0 113.7 8.25 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.869 0.868 . . . . 74.430000000000007 109.191 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -77.06 90.26 3.6 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.188 0.595 . . . . 75.329999999999998 110.257 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 91.83 4.21 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.45 1.1 . . . . 70.209999999999994 108.644 170.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -87.74 126.82 2.2 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.11 1.873 . . . . 75.439999999999998 112.42 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.0 m -107.92 156.8 18.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.717 0.807 . . . . 72.310000000000002 108.978 172.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.73 82.48 13.87 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.48 0.712 . . . . 73.230000000000004 111.142 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.89 114.51 3.18 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.356 2.037 . . . . 72.239999999999995 111.02 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.41 132.04 40.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.393 0.677 . . . . 70.329999999999998 110.386 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.8 mt -142.32 -172.26 3.57 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.041 1.337 . . . . 74.099999999999994 109.35 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -156.2 110.81 2.84 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.792 -0.818 . . . . 64.099999999999994 108.792 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -134.62 -168.76 2.21 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.554 -0.906 . . . . 71.430000000000007 108.554 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.0 mm 73.55 100.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.055 1.342 . . . . 64.450000000000003 110.122 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -82.93 -51.37 7.66 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.285 -0.871 . . . . 74.219999999999999 109.176 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.83 7.66 83.91 Favored Glycine 0 C--N 1.355 1.637 0 CA-C-N 115.397 -0.819 . . . . 72.019999999999996 113.366 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.92 100.31 2.9 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.662 0.785 . . . . 71.5 110.118 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' ' 48' ' ' LEU . . . -166.09 156.56 28.56 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.089 -0.804 . . . . 74.010000000000005 111.089 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.89 152.94 37.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.505 0.722 . . . . 52.329999999999998 110.369 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -95.59 95.52 8.43 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.373 -0.973 . . . . 73.340000000000003 108.373 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -79.15 133.11 36.74 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.695 -0.684 . . . . 54.5 111.407 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.508 ' HA ' ' HB3' ' A' ' 93' ' ' ALA . 58.9 m -99.47 23.55 9.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.82 0.848 . . . . 75.530000000000001 110.424 172.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.0 m -67.59 133.07 48.75 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 124.084 0.954 . . . . 63.420000000000002 110.224 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -116.5 100.32 7.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.027 0.931 . . . . 73.120000000000005 109.607 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -120.34 134.15 55.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.433 0.693 . . . . 63.219999999999999 109.649 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.19 161.06 29.49 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.844 -0.616 . . . . 53.229999999999997 112.332 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.63 96.46 0.13 Allowed Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.326 -1.11 . . . . 71.019999999999996 110.326 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 254' ' ' TRP . 2.8 Cg_exo -70.05 87.92 0.58 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.033 2.489 . . . . 74.019999999999996 111.788 -173.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -145.93 149.0 33.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.47 0.708 . . . . 75.129999999999995 110.228 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.2 p 55.45 102.47 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.51 1.924 . . . . 62.43 112.599 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -75.14 -3.63 33.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.258 1.023 . . . . 74.439999999999998 112.54 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.3 m -85.11 120.87 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.307 0.643 . . . . 74.129999999999995 110.745 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -163.92 140.31 6.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 71.329999999999998 110.772 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -160.69 96.23 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.946 0.898 . . . . 71.439999999999998 109.959 174.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 252' ' ' ASP . 9.8 tp10 -163.2 147.28 10.95 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.928 -0.578 . . . . 73.040000000000006 110.224 172.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -155.28 92.47 1.42 Allowed 'General case' 0 CA--C 1.547 0.851 0 O-C-N 123.808 0.693 . . . . 74.439999999999998 109.388 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -74.04 166.27 23.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.423 0.689 . . . . 72.129999999999995 110.982 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.17 65.64 1.29 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 75.049999999999997 110.012 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.597 ' HB3' ' HA3' ' A' ' 27' ' ' GLY . 63.7 mt -122.99 117.29 25.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.617 0.767 . . . . 72.030000000000001 109.629 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.89 176.51 8.87 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.331 0.653 . . . . 73.510000000000005 110.067 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -130.1 156.91 78.51 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.68 0.792 . . . . 73.519999999999996 110.009 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.69 -176.63 2.1 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.31 2.007 . . . . 63.240000000000002 111.469 168.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.43 131.11 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-N 116.406 -0.361 . . . . 33.340000000000003 110.244 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.76 -173.67 4.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.813 0.845 . . . . 63.119999999999997 111.032 -177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.9 p -78.17 -0.66 29.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.256 1.023 . . . . 75.329999999999998 111.833 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.57 126.37 55.28 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.173 0.989 . . . . 54.329999999999998 108.858 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -129.56 178.18 6.67 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.231 1.013 . . . . 73.319999999999993 109.946 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.68 93.0 5.55 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.042 -1.096 . . . . 72.409999999999997 108.042 168.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.42 -45.03 5.64 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.985 2.456 . . . . 74.209999999999994 113.858 -167.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 pm0 -73.14 -39.78 65.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.714 0.406 . . . . 72.319999999999993 111.368 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.81 47.34 65.5 Favored Glycine 0 C--N 1.359 1.807 0 O-C-N 123.705 0.628 . . . . 51.409999999999997 113.486 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.29 140.26 58.01 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.475 0.71 . . . . 75.510000000000005 112.127 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.0 m -77.28 -167.6 0.94 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.077 0.951 . . . . 74.230000000000004 110.935 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -72.76 90.16 1.4 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.363 1.065 . . . . 73.519999999999996 109.424 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 68.56 -76.65 0.06 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.132 1.773 . . . . 63.43 110.878 -173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.56 -42.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.035 0.534 . . . . 60.229999999999997 111.485 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -142.09 -44.21 0.34 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.994 0.518 . . . . 62.140000000000001 110.823 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -174.47 104.38 0.1 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.158 0.983 . . . . 74.409999999999997 108.51 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.41 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 30.1 p-10 -94.38 -34.01 12.94 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.888 0.475 . . . . 74.409999999999997 110.68 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.3 p -71.25 2.94 4.05 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.959 0.903 . . . . 60.210000000000001 113.3 -171.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.08 -22.07 64.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.658 . . . . 72.209999999999994 110.636 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 10.9 pt-20 -65.76 -30.79 71.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.688 0.795 . . . . 73.519999999999996 110.673 172.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -84.17 -10.34 57.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.128 0.971 . . . . 54.020000000000003 110.928 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.5 tp -65.12 -48.91 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.807 0.843 . . . . 73.420000000000002 111.686 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.51 12.39 29.6 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 73.540000000000006 110.971 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.3 -19.78 65.52 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.179 0.591 . . . . 63.0 111.471 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.62 -136.03 21.46 Favored Glycine 0 C--N 1.358 1.789 0 CA-C-O 118.879 -0.956 . . . . 74.400000000000006 111.73 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.26 -176.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.432 2.754 . . . . 74.439999999999998 113.638 170.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -66.36 172.36 4.06 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.607 -0.724 . . . . 64.329999999999998 110.953 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.04 -48.85 19.33 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.932 0.345 . . . . 73.549999999999997 111.932 -169.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -133.45 -40.0 0.9 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.118 0.567 . . . . 63.119999999999997 110.639 171.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 8.6 m-20 -91.21 112.7 55.29 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 114.992 -1.004 . . . . 70.129999999999995 110.802 -169.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.24 -24.26 72.36 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.436 2.091 . . . . 73.219999999999999 112.228 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -96.64 19.54 12.2 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.451 1.101 . . . . 63.119999999999997 111.754 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 35.0 tp -84.23 127.29 33.86 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 121.258 0.552 . . . . 64.120000000000005 110.035 176.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -110.49 174.95 5.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.625 1.57 . . . . 74.049999999999997 108.652 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.66 141.56 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.744 1.218 . . . . 71.420000000000002 109.46 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.4 137.03 38.47 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.609 0.763 . . . . 50.350000000000001 110.079 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.526 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 73.1 mt -103.97 -20.85 13.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.942 0.897 . . . . 72.219999999999999 111.475 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.98 149.19 49.99 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.021 0.928 . . . . 73.430000000000007 109.552 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.4 119.58 19.69 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.515 -0.92 . . . . 74.349999999999994 108.515 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -129.8 133.6 47.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.222 -0.659 . . . . 73.549999999999997 109.222 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.9 136.23 37.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.534 -1.284 . . . . 74.200000000000003 107.534 169.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.508 ' HB3' ' HA ' ' A' ' 31' ' ' SER . . . -55.65 136.07 50.81 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.349 1.06 . . . . 62.219999999999999 111.218 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -131.33 26.88 4.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.014 0.925 . . . . 65.430000000000007 112.254 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.46 -165.74 26.36 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.071 -0.513 . . . . 73.230000000000004 112.014 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.73 -42.51 19.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.143 0.577 . . . . 75.430000000000007 112.304 -172.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.68 ' HB3' ' HD2' ' A' ' 251' ' ' TYR . 25.5 p-10 -101.05 5.07 42.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.632 0.373 . . . . 72.239999999999995 111.767 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -76.27 172.31 13.09 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.698 0.799 . . . . 73.519999999999996 112.044 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.433 ' HB3' HG13 ' A' ' 130' ' ' VAL . 39.5 tp -147.02 130.54 16.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 73.299999999999997 110.138 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -80.77 127.79 32.91 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.336 0.654 . . . . 62.219999999999999 109.86 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.665 HG22 HG21 ' A' ' 123' ' ' THR . 19.5 pt -126.72 154.22 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.549 0.74 . . . . 74.219999999999999 111.684 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -100.68 147.33 26.13 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.616 -1.175 . . . . 73.310000000000002 108.743 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.67 114.16 4.78 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.551 -0.537 . . . . 75.230000000000004 109.551 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.84 -1.34 44.99 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 115.924 -0.58 . . . . 74.109999999999999 113.124 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -79.65 127.18 31.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.951 0.501 . . . . 74.120000000000005 110.493 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -79.3 135.35 36.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.484 0.714 . . . . 61.539999999999999 109.435 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.705 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.64 147.87 30.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.651 0.78 . . . . 52.43 111.26 -174.445 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -104.93 109.51 21.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.854 0.461 . . . . 72.140000000000001 110.731 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.645 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.4 t -73.05 125.23 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.608 0.363 . . . . 72.239999999999995 110.162 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.9 mt -96.28 -36.76 10.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.877 1.271 . . . . 75.109999999999999 110.237 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.1 144.68 6.89 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.76 -0.655 . . . . 73.200000000000003 111.982 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 29.5 m-85 -89.62 171.11 9.91 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.853 0.835 . . . . 63.100000000000001 111.616 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -68.98 161.02 29.81 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 113.784 -1.553 . . . . 74.099999999999994 108.021 169.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -54.29 -28.52 42.62 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.998 0.919 . . . . 64.420000000000002 113.141 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -106.11 -3.62 21.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.078 0.951 . . . . 73.299999999999997 111.847 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.72 33.38 58.05 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-O 119.818 -0.434 . . . . 72.319999999999993 113.981 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.651 ' HB3' ' HD1' ' A' ' 118' ' ' TRP . 37.6 mt-10 -70.23 -65.69 0.69 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.261 0.531 . . . . 71.219999999999999 110.544 171.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 23.5 m95 -119.65 167.09 12.37 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.277 1.031 . . . . 74.430000000000007 110.176 -171.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.645 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -141.7 131.56 24.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.462 1.105 . . . . 73.040000000000006 109.95 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.76 101.8 4.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -104.64 144.69 31.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.35 0.66 . . . . 73.329999999999998 110.586 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -95.6 105.17 17.13 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.109 -1.071 . . . . 75.040000000000006 108.109 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.705 HG22 ' HB3' ' A' ' 107' ' ' LEU . 62.3 p -97.94 173.53 7.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.618 1.167 . . . . 62.240000000000002 110.152 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -68.69 -21.79 64.4 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.503 -0.772 . . . . 62.439999999999998 109.777 174.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.979 1.312 . . . . 75.299999999999997 111.474 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.11 -170.48 24.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.139 -0.384 . . . . 71.150000000000006 112.139 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -102.33 135.05 44.62 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.415 0.686 . . . . 74.129999999999995 110.554 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 172.34 -175.38 45.54 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 111.261 -0.735 . . . . 34.340000000000003 111.261 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -94.84 132.67 39.4 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.268 0.627 . . . . 74.299999999999997 112.023 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 135' ' ' ILE . 36.0 m -137.72 139.98 28.41 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.75 1.62 . . . . 52.350000000000001 108.816 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 7.7 Cg_exo -71.21 145.35 48.73 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.598 2.198 . . . . 75.540000000000006 113.953 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -38.2 -50.75 1.44 Allowed 'General case' 0 C--N 1.369 1.444 0 C-N-CA 125.405 1.482 . . . . 72.230000000000004 112.763 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -80.66 12.38 3.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.442 1.097 . . . . 74.299999999999997 112.882 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -115.58 -16.13 11.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.36 1.064 . . . . 74.430000000000007 111.481 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 130' ' ' VAL . 21.3 pt -128.91 171.69 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.766 0.826 . . . . 73.109999999999999 111.511 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.8 t -161.71 153.24 15.75 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.649 -0.871 . . . . 71.430000000000007 108.649 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 36.8 Cg_endo -64.08 154.53 69.99 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.685 1.59 . . . . 73.430000000000007 112.067 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.4 t -72.59 -6.96 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-O 121.937 0.875 . . . . 74.450000000000003 110.382 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -83.54 -19.78 35.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.826 0.85 . . . . 60.350000000000001 111.401 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.6 p -88.42 171.84 9.81 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.338 0.655 . . . . 54.340000000000003 111.738 -172.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.41 -21.55 30.75 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.001 0.92 . . . . 73.049999999999997 110.668 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.86 -17.12 63.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.471 1.108 . . . . 74.109999999999999 111.761 -172.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.418 ' HA ' HD21 ' A' ' 88' ' ' LEU . 23.4 pttm -62.46 -12.53 22.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.66 0.784 . . . . 74.420000000000002 112.371 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -96.68 150.89 20.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.112 0.965 . . . . 74.310000000000002 110.303 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 p -67.33 -43.86 80.52 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.097 0.959 . . . . 72.129999999999995 111.5 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -57.85 -39.77 78.52 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 124.281 0.988 . . . . 74.319999999999993 111.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -77.83 112.67 14.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.062 -0.718 . . . . 73.099999999999994 109.062 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.401 ' HB2' HG21 ' A' ' 151' ' ' VAL . 70.8 m80 -108.53 -2.71 18.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.024 0.53 . . . . 64.010000000000005 111.695 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.41 -145.69 25.51 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 118.88 -0.955 . . . . 53.420000000000002 113.22 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.74 91.75 0.3 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.357 2.705 . . . . 71.140000000000001 111.85 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 148' ' ' HIS . 61.2 t -121.21 144.14 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.724 1.21 . . . . 74.120000000000005 109.005 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.4 p -88.2 167.25 13.75 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.575 0.75 . . . . 74.450000000000003 109.835 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -60.05 -46.79 88.38 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.901 0.48 . . . . 64.109999999999999 111.702 -173.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -65.53 -35.31 80.49 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 123.754 0.659 . . . . 44.210000000000001 111.115 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.33 67.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.091 0.556 . . . . 64.319999999999993 110.87 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 159' ' ' LEU . . . -68.35 -43.86 76.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.604 0.716 . . . . 33.350000000000001 110.885 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.24 -21.31 60.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.2 -0.909 . . . . 60.109999999999999 110.647 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -72.48 -42.35 65.01 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.594 0.757 . . . . 75.219999999999999 110.353 170.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.612 HD12 ' HA ' ' A' ' 156' ' ' ALA . 21.5 mt -56.66 -37.33 70.66 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.276 0.631 . . . . 75.540000000000006 110.674 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 19.6 17.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.415 -0.811 . . . . 75.200000000000003 112.602 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 -35.86 51.22 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.759 -0.83 . . . . 72.239999999999995 108.759 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.5 p -94.54 -15.16 24.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.67 1.188 . . . . 74.219999999999999 111.586 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.18 148.65 50.28 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 123.267 0.355 . . . . 42.350000000000001 113.455 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.4 -178.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.767 . . . . 72.230000000000004 111.398 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.26 123.2 19.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.146 -0.479 . . . . 62.399999999999999 109.88 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.31 7.89 61.73 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.311 -0.716 . . . . 62.310000000000002 113.052 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.5 m -83.71 133.46 34.8 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 118.26 1.03 . . . . 75.239999999999995 110.479 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -139.37 166.34 24.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.095 0.474 . . . . 74.120000000000005 111.146 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -158.5 150.62 21.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.906 -1.043 . . . . 75.409999999999997 109.17 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 182' ' ' ILE . 99.6 t -110.33 140.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 108.596 -0.89 . . . . 64.239999999999995 108.596 167.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 156' ' ' ALA . 52.2 ptt85 -142.6 161.43 38.08 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.045 -0.979 . . . . 74.109999999999999 109.621 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.48 154.67 27.79 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.196 -1.409 . . . . 74.400000000000006 107.196 165.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -79.63 119.2 22.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 62.109999999999999 109.649 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.46 -37.02 85.69 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.609 -0.723 . . . . 73.510000000000005 109.886 168.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 -40.52 97.9 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.273 1.029 . . . . 75.120000000000005 111.659 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.4 m -143.47 94.84 6.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.648 0.779 . . . . 63.130000000000003 109.598 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -59.19 146.91 92.98 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.217 2.611 . . . . 73.129999999999995 112.812 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.06 -30.62 8.3 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.49 -0.777 . . . . 64.409999999999997 112.268 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.82 115.16 15.22 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 109.451 -0.574 . . . . 65.019999999999996 109.451 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -119.68 140.93 49.88 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.292 0.637 . . . . 74.430000000000007 109.441 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 71.1 m -145.24 147.39 32.36 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.065 0.946 . . . . 73.430000000000007 109.864 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.642 HG12 HG22 ' A' ' 170' ' ' VAL . 38.0 mt -102.74 147.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.221 -1.4 . . . . 63.229999999999997 107.221 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.6 m -124.3 113.0 17.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.519 -1.289 . . . . 52.329999999999998 107.519 172.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.0 112.34 24.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.048 0.539 . . . . 74.109999999999999 109.871 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.441 ' HB2' HG22 ' A' ' 190' ' ' VAL . 54.3 ttt180 -79.73 116.5 19.94 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 109.43 -0.581 . . . . 72.140000000000001 109.43 166.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -142.11 141.44 32.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.144 1.377 . . . . 65.420000000000002 107.938 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 54.55 31.05 14.19 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.403 1.081 . . . . 55.32 111.603 -173.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.24 -11.25 50.74 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-N 115.466 -0.788 . . . . 45.399999999999999 114.228 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -104.72 139.5 39.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.585 0.754 . . . . 74.040000000000006 110.129 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 185' ' ' ARG . 51.7 t -95.68 107.26 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.848 0.459 . . . . 71.219999999999999 110.511 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -93.1 132.38 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.471 1.108 . . . . 73.109999999999999 109.211 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -107.52 119.8 40.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.14 0.576 . . . . 71.219999999999999 110.636 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.495 ' HE1' HD21 ' A' ' 232' ' ' LEU . 7.8 m-85 -94.55 146.65 23.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.411 1.084 . . . . 73.120000000000005 109.192 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -100.38 114.72 28.47 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.217 -0.66 . . . . 71.049999999999997 109.217 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mt -85.15 101.06 9.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.198 -1.038 . . . . 53.43 108.198 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.93 121.27 23.94 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.948 -1.024 . . . . 55.340000000000003 108.641 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.7 m -94.23 118.7 31.95 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.343 -0.984 . . . . 70.430000000000007 108.343 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.9 169.54 14.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.867 0.867 . . . . 72.530000000000001 110.621 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.7 p -66.3 -28.51 68.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.839 0.456 . . . . 64.150000000000006 110.918 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.79 -11.3 42.54 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.542 0.737 . . . . 63.25 110.946 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.27 -0.31 25.21 Favored Glycine 0 C--N 1.356 1.683 0 CA-C-O 119.104 -0.831 . . . . 64.409999999999997 115.166 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.412 ' HE2' ' OD1' ' A' ' 212' ' ' ASN . 98.3 mttt -69.36 131.94 45.6 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.398 1.099 . . . . 60.119999999999997 112.155 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -89.22 142.94 27.21 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.037 -1.097 . . . . 62.5 108.037 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.505 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.1 p90 -167.48 138.0 2.92 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.57 0.543 . . . . 73.409999999999997 111.993 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.46 HG23 HD11 ' A' ' 217' ' ' LEU . 68.0 t -89.17 -30.8 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.583 -0.895 . . . . 72.230000000000004 108.583 163.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 14.7 m -93.2 115.58 28.2 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.26 -1.015 . . . . 74.430000000000007 108.26 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.3 t -56.98 -38.14 72.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.481 0.712 . . . . 74.099999999999994 111.863 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.34 -29.6 30.91 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.751 0.82 . . . . 64.430000000000007 111.15 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 58.9 m -102.2 91.28 4.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.062 0.545 . . . . 74.540000000000006 110.289 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.505 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 87.1 mtt180 -91.1 140.62 29.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.511 0.724 . . . . 62.25 109.688 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.2 m-85 -125.75 141.87 51.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.878 -0.786 . . . . 64.129999999999995 108.878 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' A' ' 202' ' ' LYS . 71.4 m-20 -64.75 -38.83 92.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.533 0.521 . . . . 72.319999999999993 110.132 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 63.7 p -123.88 155.33 38.26 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.072 0.939 . . . . 73.209999999999994 111.757 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.02 -24.29 66.72 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 113.869 -1.514 . . . . 74.510000000000005 109.496 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.65 94.83 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.857 0.863 . . . . 65.200000000000003 110.964 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 47.4 mt-10 -72.52 -36.8 68.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.489 0.716 . . . . 75.129999999999995 111.263 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.46 HD11 HG23 ' A' ' 205' ' ' VAL . 14.2 tp -53.91 -57.1 12.22 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.584 0.553 . . . . 72.439999999999998 110.492 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.64 -37.48 80.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 O-C-N 123.736 0.648 . . . . 74.209999999999994 111.413 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.981 0.355 . . . . 75.340000000000003 111.163 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -57.34 -36.83 71.66 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.142 0.901 . . . . 73.129999999999995 109.988 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.693 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.9 m170 -87.29 -12.28 47.04 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 112.513 0.56 . . . . 73.129999999999995 112.513 -175.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.6 p -98.16 -11.12 23.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.89 0.476 . . . . 74.329999999999998 110.575 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.8 p -87.66 -43.16 12.15 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 110.1 -0.334 . . . . 72.319999999999993 110.1 171.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 226' ' ' ASP . 29.1 m -137.46 172.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.461 0.648 . . . . 72.540000000000006 112.71 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.97 14.51 1.37 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.866 2.066 . . . . 63.009999999999998 114.106 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.594 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.0 t70 -42.66 29.8 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 1 C-N-CA 131.799 4.039 . . . . 73.340000000000003 120.073 -152.249 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.49 1.1 10.13 Favored Glycine 0 N--CA 1.483 1.825 0 O-C-N 120.071 -1.643 . . . . 72.129999999999995 112.192 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -92.83 161.96 14.3 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.082 1.353 . . . . 65.120000000000005 109.525 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.52 -37.4 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 N-CA-C 110.177 -0.305 . . . . 72.340000000000003 110.177 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -161.28 169.2 22.58 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.79 0.836 . . . . 70.439999999999998 110.388 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 27.8 m -61.31 135.9 57.87 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.372 1.069 . . . . 74.510000000000005 111.266 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.495 HD21 ' HE1' ' A' ' 193' ' ' TYR . 74.9 mt -69.5 128.11 35.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 74.0 109.701 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -113.39 -78.71 0.58 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.921 0.489 . . . . 53.020000000000003 111.765 -171.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 167' ' ' SER . 33.2 t80 -94.03 124.92 54.74 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.387 1.075 . . . . 63.329999999999998 109.444 -173.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.99 127.56 4.76 Favored 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 122.272 1.981 . . . . 73.129999999999995 111.477 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -65.59 124.52 87.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.273 0.629 . . . . 50.340000000000003 109.499 178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 14.9 Cg_exo -71.33 175.47 9.3 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.975 2.45 . . . . 74.230000000000004 113.11 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.526 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 72.1 mmtt -69.1 130.33 42.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.371 -0.831 . . . . 64.540000000000006 109.106 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -83.47 -59.13 2.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.518 0.562 . . . . 72.25 112.518 -168.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -108.6 132.75 53.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.784 1.234 . . . . 74.420000000000002 110.136 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -81.32 114.92 53.02 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 106.77 -1.567 . . . . 55.229999999999997 106.77 163.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.33 123.64 14.09 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.782 2.322 . . . . 65.239999999999995 111.897 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 20.8 m -74.73 100.21 3.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.818 0.447 . . . . 73.329999999999998 110.071 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.32 106.54 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 107.245 -1.391 . . . . 64.120000000000005 107.245 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.3 107.54 19.12 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.395 -0.224 . . . . 64.329999999999998 110.395 -161.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.27 11.74 7.18 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.76 1.464 . . . . 72.219999999999999 116.76 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -75.32 130.06 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 118.465 1.133 . . . . 72.099999999999994 112.722 -164.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 m -87.65 115.55 63.29 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.378 -2.082 . . . . 31.420000000000002 105.378 144.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.13 -51.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 121.006 1.138 . . . . 72.400000000000006 114.952 -169.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -123.01 -20.11 5.87 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.561 0.578 . . . . 71.0 112.561 -171.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.68 ' HD2' ' HB3' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -85.05 102.77 13.49 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.095 0.474 . . . . 72.310000000000002 109.979 -169.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.556 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 17.7 t70 -120.22 -51.55 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.492 1.139 . . . . 53.340000000000003 108.734 156.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -112.63 8.87 19.25 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.212 -1.813 . . . . 72.420000000000002 110.262 -174.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.469 ' CZ2' ' HA ' ' A' ' 37' ' ' PRO . 44.6 t-105 -58.51 121.89 12.03 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.03 0.532 . . . . 71.349999999999994 110.144 -172.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--O 1.254 1.32 0 O-C-N 125.207 1.567 . . . . 71.230000000000004 109.373 -161.373 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 108.189 -1.041 . . . . 74.439999999999998 108.189 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.26 106.18 3.37 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.306 -0.719 . . . . 43.039999999999999 111.581 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -63.0 103.61 0.47 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.096 -1.076 . . . . 74.340000000000003 108.096 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -95.2 -47.48 0.26 Allowed Pre-proline 0 CA--C 1.569 1.691 0 C-N-CA 124.022 0.929 . . . . 71.120000000000005 111.881 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -82.52 -177.97 3.72 Favored 'Trans proline' 0 C--N 1.389 2.67 0 C-N-CA 122.1 1.867 . . . . 64.329999999999998 112.736 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 173.83 -86.89 0.08 OUTLIER Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.754 -0.657 . . . . 61.450000000000003 112.017 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mptt 65.24 146.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.417 1.487 . . . . 73.010000000000005 112.737 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m -107.98 165.51 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.692 0.797 . . . . 74.099999999999994 109.152 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.43 117.13 33.97 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.589 -0.893 . . . . 74.200000000000003 108.589 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.42 114.28 4.03 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 111.554 -0.619 . . . . 73.120000000000005 111.554 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.72 123.43 31.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.963 0.905 . . . . 70.109999999999999 110.223 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -91.54 -163.62 1.06 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 108.422 -0.955 . . . . 73.319999999999993 108.422 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.518 ' HG2' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -143.46 161.14 39.18 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.126 0.488 . . . . 70.329999999999998 111.664 -173.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -124.35 96.23 41.98 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.28 1.032 . . . . 62.25 108.937 173.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HD3' ' HG2' ' A' ' 13' ' ' ARG . 50.4 Cg_exo -60.8 -175.6 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.11 2.54 . . . . 75.540000000000006 113.116 163.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.5 p -146.74 91.99 2.09 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.808 0.443 . . . . 73.349999999999994 111.215 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -149.14 114.61 3.64 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 107.006 -1.479 . . . . 71.519999999999996 107.006 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.2 93.48 0.19 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.985 2.457 . . . . 72.420000000000002 112.187 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.16 -58.26 3.41 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.684 0.394 . . . . 64.209999999999994 110.029 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 47.68 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.426 1.49 . . . . 75.349999999999994 113.351 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -142.75 123.3 14.06 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.624 -1.25 . . . . 74.400000000000006 107.624 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -88.42 -131.28 0.08 Allowed 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.667 0.787 . . . . 74.25 111.165 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.3 mt 75.79 151.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 124.976 1.31 . . . . 71.439999999999998 109.015 -163.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.12 145.32 48.68 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.781 0.832 . . . . 72.109999999999999 109.849 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.36 141.34 7.46 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.899 0.761 . . . . 61.340000000000003 111.367 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 133' ' ' ASN . . . -147.39 154.28 40.67 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.386 0.593 . . . . 71.0 112.165 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.71 153.17 16.75 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 110.93 -0.868 . . . . 75.109999999999999 110.93 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.7 -0.63 0.15 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 118.008 0.904 . . . . 60.43 113.352 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -86.19 107.11 17.74 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.528 0.331 . . . . 75.200000000000003 111.587 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.521 ' HB3' ' ND2' ' A' ' 240' ' ' ASN . 2.1 tm-20 -171.7 -69.49 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.325 1.05 . . . . 74.420000000000002 108.305 167.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.4 m 75.82 128.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.607 1.563 . . . . 71.540000000000006 113.366 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.1 p -153.01 165.85 34.28 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.294 1.038 . . . . 64.510000000000005 109.313 173.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -85.33 124.01 31.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.175 0.59 . . . . 72.450000000000003 110.626 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -143.73 139.65 29.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.85 0.86 . . . . 52.530000000000001 110.072 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.4 173.25 41.13 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.139 -0.784 . . . . 62.340000000000003 111.139 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.94 122.71 0.99 Allowed Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.711 -1.05 . . . . 43.030000000000001 111.418 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.9 157.93 50.72 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.392 2.061 . . . . 70.25 111.915 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -146.57 -72.29 0.23 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.38 0.672 . . . . 75.439999999999998 109.492 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.6 t -163.67 169.04 19.07 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.37 0.605 . . . . 52.520000000000003 110.477 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -126.05 -170.07 2.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.599 1.159 . . . . 72.430000000000007 109.557 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 42' ' ' PHE . 4.2 p -145.05 172.0 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.981 -0.748 . . . . 73.409999999999997 108.981 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.488 ' H ' HG22 ' A' ' 41' ' ' VAL . 97.0 m-85 -67.27 -139.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.888 1.275 . . . . 73.019999999999996 113.143 -171.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.445 ' HB ' HD22 ' A' ' 61' ' ' LEU . 73.1 t 76.44 -76.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.068 0 C-N-CA 125.11 1.364 . . . . 74.319999999999993 111.007 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -171.81 158.67 4.96 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 111.875 0.324 . . . . 73.129999999999995 111.875 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -150.1 112.35 4.65 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.819 1.248 . . . . 64.409999999999997 108.302 167.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -104.92 -172.73 2.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.424 0.69 . . . . 74.109999999999999 109.739 176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.33 133.69 49.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.24 0.616 . . . . 73.25 110.309 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.11 -60.43 2.36 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.899 -0.778 . . . . 64.099999999999994 108.899 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -175.89 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.797 1.239 . . . . 71.099999999999994 108.063 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -156.16 61.71 2.77 Favored Pre-proline 0 CA--C 1.562 1.438 0 C-N-CA 123.787 0.835 . . . . 72.409999999999997 110.405 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -90.93 -154.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.161 2.574 . . . . 64.150000000000006 111.615 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.25 169.19 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.435 0 C-N-CA 124.15 0.98 . . . . 52.100000000000001 110.041 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.46 109.08 0.31 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.099 0.96 . . . . 72.209999999999994 110.96 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.7 m -94.85 17.97 12.7 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.588 1.155 . . . . 72.340000000000003 112.433 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -58.51 -43.02 88.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.443 1.097 . . . . 63.409999999999997 112.587 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -128.7 120.11 25.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.734 0.814 . . . . 73.230000000000004 110.325 -174.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.79 101.27 3.95 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 106.63 -1.618 . . . . 74.120000000000005 106.63 175.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.49 -52.44 8.47 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 124.126 3.217 . . . . 54.140000000000001 114.044 -164.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -112.45 -43.68 3.47 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.886 -0.783 . . . . 75.129999999999995 108.886 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.74 -50.1 1.06 Allowed Glycine 0 CA--C 1.537 1.442 0 N-CA-C 116.34 1.296 . . . . 42.130000000000003 116.34 166.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.445 HD22 ' HB ' ' A' ' 43' ' ' VAL . 18.2 tp -68.53 90.59 0.39 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.989 0.894 . . . . 73.099999999999994 110.665 -173.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.1 p -72.33 83.24 1.05 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.746 1.218 . . . . 72.340000000000003 112.998 -171.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.58 -53.36 3.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.294 0.638 . . . . 65.120000000000005 109.658 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.07 -10.93 16.3 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.454 0.909 . . . . 74.120000000000005 113.454 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.37 96.48 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.615 0.766 . . . . 71.420000000000002 111.697 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -125.95 -40.43 2.03 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.247 0.619 . . . . 55.450000000000003 110.919 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -84.78 66.67 9.76 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.967 0.889 . . . . 74.519999999999996 110.931 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -69.78 -31.75 69.85 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.218 -1.355 . . . . 65.230000000000004 109.428 166.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.9 p -80.21 6.28 12.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.921 1.288 . . . . 74.140000000000001 113.048 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.3 -48.16 82.66 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.871 0.468 . . . . 71.400000000000006 110.983 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -71.78 -24.97 61.84 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.217 0.607 . . . . 70.329999999999998 111.172 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 15.6 m120 -88.38 -2.46 58.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.706 0.802 . . . . 54.420000000000002 111.671 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.402 HD13 ' HE1' ' A' ' 146' ' ' TRP . 29.1 tp -61.84 -47.98 82.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.012 0.925 . . . . 65.329999999999998 111.304 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.02 36.1 2.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.142 0.977 . . . . 63.520000000000003 109.87 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . -76.58 -20.69 56.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.529 0.731 . . . . 72.049999999999997 110.938 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.11 -150.45 23.87 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.435 -0.647 . . . . 74.420000000000002 112.951 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.73 -173.09 1.65 Allowed 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.869 3.046 . . . . 75.420000000000002 112.796 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.2 m -55.48 136.99 49.36 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.531 -0.759 . . . . 63.210000000000001 110.914 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.03 -47.17 75.28 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.503 0.927 . . . . 75.310000000000002 113.503 -165.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -132.49 -40.75 0.98 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.476 0.655 . . . . 73.409999999999997 111.013 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.712 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 6.3 m-20 -93.67 122.61 62.08 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 114.63 -1.168 . . . . 74.319999999999993 110.243 -171.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.59 -21.36 59.6 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.3 2.0 . . . . 70.430000000000007 111.608 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -98.01 16.58 20.62 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.528 1.131 . . . . 64.230000000000004 112.073 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.712 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 30.1 tp -83.54 120.07 25.48 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.827 -0.805 . . . . 71.239999999999995 108.827 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -109.06 175.2 5.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.33 1.452 . . . . 65.420000000000002 108.717 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.34 135.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.756 1.222 . . . . 44.149999999999999 109.213 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.72 112.98 9.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.98 0.912 . . . . 73.239999999999995 110.404 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.19 -31.55 38.76 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.249 0.62 . . . . 75.049999999999997 111.32 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 55.3 m-85 -126.34 141.71 51.8 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.33 1.052 . . . . 74.030000000000001 108.758 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.96 122.98 27.38 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.83 -0.804 . . . . 72.140000000000001 108.83 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.461 ' HB3' HG12 ' A' ' 101' ' ' ILE . 78.5 t80 -111.66 135.47 52.2 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.524 -0.917 . . . . 71.120000000000005 108.524 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.95 130.17 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.278 -1.379 . . . . 62.100000000000001 107.278 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.96 132.62 53.29 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.119 0.887 . . . . 72.420000000000002 111.669 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -95.34 13.29 26.19 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.34 1.056 . . . . 62.539999999999999 111.189 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.21 -171.65 44.05 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.1 -0.5 . . . . 70.219999999999999 112.014 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -69.93 -41.85 74.06 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.736 0.814 . . . . 74.430000000000007 112.759 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -82.99 -25.92 31.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.951 0.9 . . . . 73.430000000000007 111.522 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -75.72 158.37 32.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.297 0.639 . . . . 74.319999999999993 109.733 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.414 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 53.2 tp -127.82 137.37 52.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.807 0.443 . . . . 70.200000000000003 111.49 -169.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -86.61 118.02 25.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.881 0.872 . . . . 74.420000000000002 110.168 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.629 HG22 HG21 ' A' ' 123' ' ' THR . 31.7 pt -122.12 162.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.812 0.845 . . . . 71.439999999999998 110.349 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -129.16 152.52 48.66 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 72.140000000000001 109.358 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -57.67 136.87 56.89 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.858 0.863 . . . . 72.010000000000005 112.143 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.5 67.77 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 123.586 0.612 . . . . 22.030000000000001 113.993 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.09 130.24 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.284 0.542 . . . . 73.099999999999994 111.237 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.13 123.21 28.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.141 0.977 . . . . 71.420000000000002 109.107 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.791 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -133.69 146.34 50.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.519 0.728 . . . . 72.409999999999997 110.857 -175.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -96.96 112.62 24.29 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.199 0.6 . . . . 71.25 110.447 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.615 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.5 t -79.9 117.33 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.447 0.641 . . . . 65.049999999999997 109.671 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.462 HD12 ' HG3' ' A' ' 120' ' ' GLU . 29.6 mt -89.64 -19.35 24.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.069 1.348 . . . . 71.430000000000007 110.88 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.51 147.42 5.05 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.146 -0.934 . . . . 63.109999999999999 111.375 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.635 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 23.3 m-85 -87.42 178.58 6.78 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.561 0.745 . . . . 74.140000000000001 111.033 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.66 HD21 ' HB2' ' A' ' 117' ' ' GLU . 9.9 p30 -90.54 -174.0 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 70.099999999999994 110.918 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -44.75 -45.31 9.87 Favored 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 126.318 1.847 . . . . 73.340000000000003 114.389 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -115.86 7.81 14.6 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.15 0.58 . . . . 61.5 111.92 174.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.635 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 71.74 30.77 65.7 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 116.939 1.536 . . . . 50.039999999999999 116.939 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.66 ' HB2' HD21 ' A' ' 113' ' ' ASN . 22.4 mt-10 -68.48 -42.96 77.92 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 119.028 1.414 . . . . 61.43 109.972 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.58 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 51.4 m95 -123.05 159.57 28.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 75.099999999999994 110.204 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.615 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.37 138.52 43.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.185 0.994 . . . . 74.109999999999999 110.022 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.1 tp10 -69.36 98.06 1.03 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 106.786 -1.561 . . . . 75.120000000000005 106.786 168.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.91 140.65 38.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.486 0.714 . . . . 73.239999999999995 110.854 -173.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -114.5 107.66 15.81 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.178 -0.919 . . . . 74.329999999999998 108.748 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.791 HG22 ' HB3' ' A' ' 107' ' ' LEU . 72.4 p -116.15 175.52 5.51 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.101 1.361 . . . . 74.0 110.491 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -75.6 -10.4 59.41 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.6 -0.727 . . . . 72.549999999999997 110.466 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -76.93 -22.74 52.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.819 0.848 . . . . 74.530000000000001 110.355 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.78 -160.48 23.24 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 112.233 -0.347 . . . . 31.52 112.233 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -104.09 137.82 41.49 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.983 0.913 . . . . 63.539999999999999 109.625 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 164.46 178.08 37.62 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 121.083 -0.579 . . . . 54.109999999999999 112.971 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -90.24 128.54 36.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.862 0.865 . . . . 71.140000000000001 112.19 -170.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 m -132.17 143.62 49.69 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.137 0.975 . . . . 74.5 108.936 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 6.2 Cg_exo -76.14 146.4 28.68 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 C-N-CA 122.685 2.257 . . . . 65.400000000000006 113.977 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -41.52 -46.92 3.66 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.882 1.673 . . . . 60.210000000000001 113.173 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.498 ' HB3' ' HB1' ' A' ' 26' ' ' ALA . 9.2 p-10 -75.35 2.52 11.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.661 0.784 . . . . 52.439999999999998 112.871 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.418 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -109.21 -9.63 15.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.681 0.792 . . . . 64.340000000000003 111.507 171.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.2 pt -132.26 175.86 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.904 0.882 . . . . 65.310000000000002 110.782 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 142' ' ' GLU . 9.0 t -162.54 151.7 12.88 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.562 -0.903 . . . . 54.310000000000002 108.562 170.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.7 Cg_endo -60.11 149.56 84.07 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 121.636 1.557 . . . . 72.150000000000006 111.414 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.5 t -73.41 -7.05 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.465 0 CA-C-O 121.617 0.722 . . . . 60.140000000000001 110.119 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -79.49 -8.32 59.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.274 1.03 . . . . 74.450000000000003 112.173 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.2 p -95.6 171.45 8.67 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.499 0.666 . . . . 63.020000000000003 112.612 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.2 mt -85.28 -20.11 30.55 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.806 -1.088 . . . . 74.329999999999998 111.365 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.403 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.6 mp0 -65.82 -21.44 66.48 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.684 0.794 . . . . 73.519999999999996 112.008 -172.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.58 -13.59 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.241 0.616 . . . . 72.319999999999993 112.5 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -90.71 141.75 28.47 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.403 0.681 . . . . 65.549999999999997 109.969 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.6 m -58.5 -39.96 81.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.722 1.209 . . . . 73.109999999999999 112.39 -175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.402 ' HE1' HD13 ' A' ' 73' ' ' LEU . 39.8 p-90 -70.11 -30.51 67.73 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 74.430000000000007 112.811 -175.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -82.55 117.65 22.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.558 -0.534 . . . . 74.209999999999994 109.558 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -112.12 -6.48 14.14 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.272 0.629 . . . . 74.530000000000001 111.681 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.83 -141.22 34.36 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 118.345 -1.253 . . . . 73.239999999999995 112.89 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -59.65 94.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.561 2.841 . . . . 72.319999999999993 113.144 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.652 HG22 HH12 ' A' ' 239' ' ' ARG . 85.6 t -133.93 132.02 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 44.520000000000003 108.905 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.4 p -78.57 173.01 12.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.446 0.699 . . . . 63.210000000000001 110.408 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -60.41 -43.6 96.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.299 0.639 . . . . 75.129999999999995 109.964 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.9 -46.59 88.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.925 0.89 . . . . 61.219999999999999 111.091 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.39 -26.4 63.69 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.028 0.531 . . . . 70.510000000000005 111.441 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.32 62.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.911 0.484 . . . . 51.229999999999997 110.671 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.08 -21.61 61.48 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.764 -0.653 . . . . 61.140000000000001 110.597 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.64 -49.06 72.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.499 0.719 . . . . 72.420000000000002 109.728 170.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.401 HD21 ' HD3' ' A' ' 239' ' ' ARG . 73.9 mt -58.85 -39.22 80.65 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.595 -0.73 . . . . 74.010000000000005 110.947 175.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.8 -3.71 55.8 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.823 1.046 . . . . 63.539999999999999 113.823 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 61.3 p -69.47 -34.21 74.03 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.767 1.167 . . . . 65.420000000000002 110.239 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 p -90.02 9.1 29.3 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.234 1.014 . . . . 70.519999999999996 110.867 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -105.45 156.61 16.61 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 123.996 0.808 . . . . 55.229999999999997 111.723 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 26.8 pt -103.83 -176.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 124.955 1.302 . . . . 62.310000000000002 112.006 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.53 121.25 11.07 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.65 -0.705 . . . . 74.439999999999998 110.02 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.31 10.36 58.36 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 119.394 -0.67 . . . . 63.119999999999997 113.343 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.7 m -86.09 128.71 34.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.713 1.256 . . . . 73.200000000000003 111.148 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 183' ' ' SER . 13.3 p90 -135.52 167.24 21.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.077 0.551 . . . . 71.530000000000001 111.458 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.4 pp -164.22 143.54 7.62 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.008 -0.996 . . . . 73.329999999999998 108.926 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.666 HG22 HG12 ' A' ' 182' ' ' ILE . 90.8 t -98.13 137.86 24.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.439 -0.948 . . . . 72.319999999999993 108.439 167.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.501 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.8 ptt85 -134.3 160.67 37.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.962 1.305 . . . . 70.510000000000005 109.108 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.33 151.42 33.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.977 -1.49 . . . . 62.25 106.977 165.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 t -84.98 123.21 30.27 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.703 -0.851 . . . . 53.439999999999998 108.703 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.59 -35.6 73.11 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.565 -0.531 . . . . 61.5 109.565 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 p -71.64 -34.86 70.14 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.402 -0.817 . . . . 52.43 111.111 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.3 m -124.25 90.66 50.54 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 123.405 0.682 . . . . 62.43 109.943 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.28 127.56 24.43 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.499 2.8 . . . . 75.140000000000001 112.947 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.51 -28.32 15.45 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.915 -0.584 . . . . 75.340000000000003 112.969 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.426 ' HB3' ' NH1' ' A' ' 194' ' ' ARG . 79.2 mm-40 -69.03 115.03 7.86 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.293 -0.632 . . . . 75.299999999999997 109.293 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -119.82 149.22 42.42 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 109.882 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.2 m -148.0 152.12 36.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.806 -1.088 . . . . 64.219999999999999 109.704 -172.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.666 HG12 HG22 ' A' ' 170' ' ' VAL . 23.6 mt -102.47 150.05 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 106.511 -1.663 . . . . 52.530000000000001 106.511 166.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -125.93 107.1 10.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.708 -1.219 . . . . 63.329999999999998 107.708 171.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 168' ' ' PHE . 56.9 tp -107.5 110.91 22.95 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.538 0.608 . . . . 63.5 109.785 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 190' ' ' VAL . 59.1 ttt180 -80.66 121.36 25.76 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.054 0.542 . . . . 71.430000000000007 109.799 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.1 145.73 31.53 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.506 1.522 . . . . 74.549999999999997 107.688 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 57.97 22.39 8.75 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.931 0.892 . . . . 62.43 112.333 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.94 -9.4 72.33 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.333 -0.704 . . . . 72.200000000000003 114.538 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -113.35 150.37 32.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.291 1.045 . . . . 74.129999999999995 109.99 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . 41.8 t -99.08 111.24 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.851 0.46 . . . . 63.509999999999998 110.672 -177.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -93.73 112.22 24.05 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.278 -1.008 . . . . 54.32 108.278 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -89.64 124.49 34.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.714 -0.676 . . . . 75.209999999999994 109.209 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.417 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.0 m-85 -93.65 146.37 23.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.371 -0.974 . . . . 75.239999999999995 108.371 172.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 179' ' ' GLN . 6.8 tpp180 -106.41 120.64 42.42 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.994 -1.113 . . . . 72.099999999999994 107.994 175.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mt -79.03 100.3 3.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.05 -1.092 . . . . 53.25 108.05 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.37 145.34 32.08 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.476 -0.935 . . . . 74.519999999999996 108.476 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.6 m -105.87 136.78 44.9 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.122 0.969 . . . . 75.420000000000002 109.355 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.96 178.23 8.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.073 0.949 . . . . 75.200000000000003 110.15 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 p -65.68 -33.48 75.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.128 0.571 . . . . 75.209999999999994 111.706 -174.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.24 -13.53 28.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.643 0.377 . . . . 71.5 111.086 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 115.57 15.12 7.7 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 115.886 1.115 . . . . 42.0 115.886 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -68.99 141.51 54.89 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.291 1.045 . . . . 74.439999999999998 111.654 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.47 141.58 28.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.66 0.784 . . . . 74.030000000000001 109.153 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.572 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.1 p90 -164.98 148.01 8.39 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.54 0.525 . . . . 64.099999999999994 111.72 175.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.423 HG23 HD11 ' A' ' 217' ' ' LEU . 91.4 t -93.43 -40.36 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.174 -1.047 . . . . 75.340000000000003 108.174 164.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.0 m -99.9 125.13 45.84 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.011 -0.995 . . . . 71.430000000000007 108.831 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -62.81 -28.23 69.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.481 0.712 . . . . 54.140000000000001 111.41 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.87 -25.17 62.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.633 1.173 . . . . 74.129999999999995 110.55 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.5 m -129.45 89.94 2.92 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.58 0.752 . . . . 75.519999999999996 110.328 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.572 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 94.3 mtt180 -103.3 134.31 46.91 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.328 -0.619 . . . . 63.409999999999997 109.328 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -119.38 151.15 38.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.97 0.908 . . . . 74.5 108.602 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -74.04 -28.09 61.25 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.573 0.546 . . . . 74.349999999999994 110.468 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.8 p -132.74 156.01 47.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.876 0.87 . . . . 73.549999999999997 112.144 -177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -69.14 -25.88 64.6 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 114.272 -1.331 . . . . 73.349999999999994 109.427 172.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.14 96.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.4 0.68 . . . . 63.310000000000002 110.675 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.71 -41.88 87.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.47 0.708 . . . . 34.030000000000001 111.336 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.423 HD11 HG23 ' A' ' 205' ' ' VAL . 16.7 tp -52.49 -57.13 10.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 123.52 0.512 . . . . 71.209999999999994 111.157 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.84 -46.39 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.641 0.588 . . . . 72.340000000000003 111.415 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -55.72 -55.68 29.34 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.56 0.744 . . . . 75.310000000000002 111.447 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -67.82 -37.84 82.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.991 -1.004 . . . . 75.409999999999997 110.622 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.631 ' HB3' HD11 ' A' ' 228' ' ' LEU . 15.9 m170 -86.63 -4.41 59.17 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.544 0.572 . . . . 74.400000000000006 112.544 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.7 p -93.95 -35.11 12.8 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.595 0.358 . . . . 73.400000000000006 110.706 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 47.5 p -74.81 -42.13 58.64 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 116.061 -0.518 . . . . 74.040000000000006 111.855 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.76 HG23 ' HB2' ' A' ' 226' ' ' ASP . 31.6 m -128.35 158.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.334 0.654 . . . . 60.43 111.131 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.14 15.34 0.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.46 1.904 . . . . 74.439999999999998 114.027 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.76 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.9 t70 -44.47 33.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 1 C-N-CA 132.556 4.343 . . . . 64.329999999999998 119.386 -153.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.34 -0.82 9.61 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 120.07 -1.644 . . . . 51.009999999999998 112.049 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 221' ' ' HIS . 15.4 mt -92.19 161.65 14.64 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.725 1.21 . . . . 74.349999999999994 109.768 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.9 tt -57.61 -37.01 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 O-C-N 123.419 0.449 . . . . 63.039999999999999 110.673 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -161.5 176.23 11.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.162 0.985 . . . . 65.310000000000002 109.682 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -64.29 145.47 55.96 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.853 0.861 . . . . 72.329999999999998 111.931 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.417 HD21 ' HE1' ' A' ' 193' ' ' TYR . 66.8 mt -75.54 119.48 19.65 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 108.606 -0.887 . . . . 70.109999999999999 108.606 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -113.19 -80.05 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.514 0.597 . . . . 72.430000000000007 112.206 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.7 t80 -87.14 120.0 71.22 Favored Pre-proline 0 C--O 1.208 -1.124 0 C-N-CA 124.266 1.027 . . . . 73.140000000000001 108.438 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.33 136.03 9.79 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 121.632 1.555 . . . . 74.140000000000001 110.947 171.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.87 136.6 96.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 108.9 -0.778 . . . . 70.439999999999998 108.9 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.49 171.94 16.03 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.01 1.807 . . . . 73.439999999999998 112.987 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.521 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 73.7 mmtt -70.33 108.54 4.26 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.053 -1.091 . . . . 72.040000000000006 108.053 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.652 HH12 HG22 ' A' ' 151' ' ' VAL . 15.6 ptt-85 -68.83 -62.92 1.18 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.838 1.051 . . . . 72.209999999999994 113.838 -160.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.521 ' ND2' ' HB3' ' A' ' 30' ' ' GLU . 63.1 t30 -110.29 154.58 23.26 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.923 0.889 . . . . 75.450000000000003 109.814 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.21 112.66 27.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 106.188 -1.782 . . . . 64.140000000000001 106.188 158.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.482 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 39.3 Cg_exo -60.52 124.54 15.3 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.752 2.301 . . . . 63.539999999999999 112.965 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 16.6 m -65.46 123.56 19.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.502 0.721 . . . . 34.119999999999997 111.179 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.37 124.5 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 108.356 -0.979 . . . . 74.400000000000006 108.356 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -102.46 114.89 29.48 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.462 0.542 . . . . 75.140000000000001 112.462 -164.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.74 44.08 91.7 Favored Glycine 0 N--CA 1.482 1.712 0 O-C-N 124.046 0.841 . . . . 61.509999999999998 115.124 163.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -103.45 124.36 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 114.228 1.196 . . . . 55.109999999999999 114.228 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.3 t -86.09 119.09 71.48 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 104.057 -2.572 . . . . 63.240000000000002 104.057 143.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.02 -62.11 0.23 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 120.965 1.38 . . . . 74.219999999999999 113.0 -158.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -129.26 -13.34 4.44 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.506 -0.924 . . . . 74.439999999999998 108.506 148.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.51 103.2 13.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.419 -1.264 . . . . 74.310000000000002 111.109 -149.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -119.59 -44.96 2.53 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.235 -1.024 . . . . 74.040000000000006 108.235 158.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -109.25 -17.2 13.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.329 1.052 . . . . 73.319999999999993 112.073 -175.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -50.34 155.14 1.08 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.978 1.311 . . . . 72.030000000000001 113.772 -161.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.036 0.935 . . . . 75.400000000000006 108.7 178.991 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.819 -0.067 . . . . 71.430000000000007 110.819 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.35 78.83 0.55 Allowed Glycine 0 C--N 1.356 1.692 0 O-C-N 123.166 0.291 . . . . 63.240000000000002 113.356 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -176.05 100.04 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.597 1.559 . . . . 65.409999999999997 107.632 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.428 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 18.3 mm-40 -82.71 -53.33 0.63 Allowed Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.62 0.768 . . . . 71.450000000000003 110.636 173.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 4' ' ' GLN . 51.5 Cg_endo -90.42 70.89 1.44 Allowed 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.205 1.937 . . . . 51.32 112.364 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.55 -59.25 6.85 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.419 -0.81 . . . . 74.420000000000002 112.169 171.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.31 -27.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.5 1.12 . . . . 74.409999999999997 110.473 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.5 t 61.84 -84.87 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 125.407 1.483 . . . . 74.450000000000003 110.588 -169.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.2 mt 56.86 -163.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.549 1.14 . . . . 71.109999999999999 111.718 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.12 -176.34 37.94 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 112.305 -0.318 . . . . 53.039999999999999 112.305 176.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.25 16.01 26.41 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.526 0.73 . . . . 72.230000000000004 111.073 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -64.04 168.98 4.72 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.421 0.688 . . . . 74.109999999999999 110.759 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -154.85 88.31 1.18 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.781 -0.822 . . . . 72.519999999999996 108.781 -168.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -96.88 101.5 9.56 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.65 0.78 . . . . 70.510000000000005 110.496 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.541 ' HB3' HD13 ' A' ' 110' ' ' LEU . 62.1 Cg_endo -69.22 80.43 0.73 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.061 2.507 . . . . 73.230000000000004 113.162 -178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -74.79 156.57 36.38 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.662 -0.699 . . . . 65.299999999999997 109.883 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.5 mt -123.68 80.57 55.27 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 123.149 0.58 . . . . 74.319999999999993 110.939 -174.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -79.99 -46.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.01 2.473 . . . . 74.120000000000005 112.849 169.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 64.51 162.19 0.12 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.225 1.41 . . . . 65.140000000000001 112.625 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.68 HD11 ' HA3' ' A' ' 116' ' ' GLY . 66.1 mt -143.21 154.45 43.86 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.527 0.731 . . . . 55.350000000000001 110.773 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -160.88 114.09 2.0 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.539 1.135 . . . . 71.299999999999997 108.594 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HE2' HD13 ' A' ' 20' ' ' LEU . 45.4 p90 -165.41 160.95 18.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.719 0.808 . . . . 75.219999999999999 110.021 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.03 -33.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.858 0.863 . . . . 53.210000000000001 109.955 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 66.0 -170.41 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.875 1.27 . . . . 73.219999999999999 111.333 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.01 144.49 6.82 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.658 -0.247 . . . . 62.140000000000001 112.738 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB3' ' HA ' ' A' ' 176' ' ' SER . . . -160.26 177.97 10.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.398 1.079 . . . . 62.030000000000001 109.966 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.54 61.41 0.37 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.128 -0.487 . . . . 72.549999999999997 112.161 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -103.82 95.2 5.86 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.48 -1.304 . . . . 72.319999999999993 107.48 171.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.72 130.74 39.57 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.485 -0.561 . . . . 73.120000000000005 109.485 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.93 135.65 31.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.848 -1.167 . . . . 74.120000000000005 107.848 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.0 t -70.58 163.68 26.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.649 0.779 . . . . 71.519999999999996 111.53 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.535 ' OG ' ' HD2' ' A' ' 153' ' ' ARG . 9.5 t -155.76 130.13 8.91 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.517 -0.549 . . . . 72.209999999999994 109.517 -170.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -137.49 124.85 21.88 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.337 0.655 . . . . 72.129999999999995 110.844 -174.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.483 ' HB3' ' HE ' ' A' ' 153' ' ' ARG . 39.0 t-80 176.82 179.32 0.21 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.025 1.33 . . . . 74.219999999999999 108.171 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.87 89.74 0.95 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 121.882 -0.512 . . . . 53.530000000000001 113.04 169.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.76 51.84 0.39 Allowed Glycine 0 CA--C 1.541 1.704 0 CA-C-O 118.668 -1.073 . . . . 73.140000000000001 113.781 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.45 -178.37 4.41 Favored 'Trans proline' 0 C--N 1.387 2.563 0 CA-C-N 120.53 2.165 . . . . 71.319999999999993 112.495 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -149.57 129.2 13.16 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.435 0.694 . . . . 73.319999999999993 110.094 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' N ' HH22 ' A' ' 185' ' ' ARG . 35.7 t 173.18 171.33 0.14 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.239 1.416 . . . . 73.450000000000003 109.338 177.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -158.23 148.03 19.83 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.701 -0.481 . . . . 75.200000000000003 109.701 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -144.68 150.87 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.058 0.943 . . . . 63.240000000000002 109.392 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -102.34 156.28 17.69 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.198 0.599 . . . . 75.540000000000006 109.923 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 21.3 t -131.89 176.24 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.027 -1.101 . . . . 71.120000000000005 108.027 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.8 OUTLIER -82.92 158.58 22.57 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.512 1.125 . . . . 74.019999999999996 109.579 172.597 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.482 ' O ' ' HB3' ' A' ' 59' ' ' GLN . 71.7 m80 78.99 132.39 0.05 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 126.084 1.754 . . . . 64.219999999999999 111.29 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.411 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 10.4 pt-20 -131.66 146.83 52.39 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.512 0.725 . . . . 73.310000000000002 112.449 -168.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.66 -71.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.638 1.175 . . . . 70.209999999999994 108.278 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.1 tp -172.68 104.26 0.15 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 108.562 -0.903 . . . . 74.129999999999995 108.562 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -141.17 -163.19 1.5 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.249 1.019 . . . . 64.540000000000006 109.613 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -99.57 101.1 12.29 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.716 0.806 . . . . 71.129999999999995 109.557 170.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.758 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 38.4 Cg_endo -98.36 -161.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.874 2.383 . . . . 54.439999999999998 110.267 163.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.8 -159.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 C-N-CA 122.786 0.434 . . . . 71.219999999999999 111.212 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.09 119.48 2.94 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.695 0.798 . . . . 74.409999999999997 110.903 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 t -65.49 -9.96 30.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.889 1.275 . . . . 74.430000000000007 112.913 -171.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -51.35 -49.19 61.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.486 1.115 . . . . 52.149999999999999 111.017 171.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -125.95 69.01 1.19 Allowed 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.915 -1.513 . . . . 74.209999999999994 106.915 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.8 118.66 63.04 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 115.438 -0.801 . . . . 73.099999999999994 110.703 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 6.0 Cg_exo -81.33 -164.66 0.29 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.752 2.301 . . . . 71.420000000000002 111.039 167.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' A' ' 45' ' ' HIS . 23.1 mp0 -72.49 -75.1 0.14 Allowed 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.26 1.024 . . . . 72.200000000000003 111.399 -172.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.47 -7.13 81.91 Favored Glycine 0 N--CA 1.479 1.521 0 N-CA-C 115.971 1.149 . . . . 43.039999999999999 115.971 167.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.7 tt -92.48 88.25 6.29 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.232 1.016 . . . . 71.120000000000005 110.155 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.444 ' HB2' HG21 ' A' ' 43' ' ' VAL . 35.1 t -68.41 114.8 7.16 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.937 0.895 . . . . 54.0 111.629 174.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.03 -117.15 0.1 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.164 1.386 . . . . 73.439999999999998 108.484 173.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.98 -12.74 61.84 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.451 1.023 . . . . 71.299999999999997 113.314 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.02 -39.69 95.5 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.628 0.371 . . . . 74.340000000000003 111.557 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -112.19 -52.02 2.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.606 0.762 . . . . 74.400000000000006 109.548 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -90.86 64.32 5.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.894 0.855 . . . . 71.540000000000006 109.463 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.9 p30 -72.51 -14.84 61.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.158 -0.928 . . . . 73.340000000000003 110.848 174.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.6 p -84.0 4.92 27.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.959 0.904 . . . . 72.200000000000003 112.073 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -67.21 -22.71 65.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.764 0.425 . . . . 73.120000000000005 111.021 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.7 pt-20 -68.49 -39.65 81.22 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.161 0.505 . . . . 53.210000000000001 109.837 168.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 8.8 m120 -75.2 -10.24 59.29 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.198 -0.91 . . . . 63.240000000000002 110.972 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.28 -50.93 69.75 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.045 0.938 . . . . 72.319999999999993 110.572 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.62 23.79 13.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.369 0.668 . . . . 74.140000000000001 110.639 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . -71.56 -38.12 71.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.842 0.457 . . . . 73.340000000000003 111.355 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.57 -134.91 21.39 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.193 -0.782 . . . . 74.420000000000002 111.27 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -53.73 154.16 17.2 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 123.07 2.514 . . . . 64.230000000000004 113.447 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -75.03 169.47 17.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.356 0.662 . . . . 74.049999999999997 109.965 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -58.38 -45.47 88.24 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.674 0.79 . . . . 52.119999999999997 112.925 -169.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.44 -34.23 1.83 Allowed 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.335 0.588 . . . . 50.299999999999997 111.056 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 4.6 m-20 -90.84 123.62 64.4 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 115.237 -0.892 . . . . 74.439999999999998 112.755 -163.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.2 -19.89 5.34 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.483 2.122 . . . . 71.120000000000005 112.379 167.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -110.21 19.36 18.99 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.067 0.947 . . . . 75.140000000000001 112.055 -172.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 30.5 tp -81.85 128.13 33.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.22 -0.659 . . . . 75.0 109.22 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -111.66 172.96 6.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.819 1.247 . . . . 73.530000000000001 108.684 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.75 138.21 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.279 1.032 . . . . 62.030000000000001 109.434 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.87 131.28 41.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 63.109999999999999 110.336 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.497 HD13 ' NZ ' ' A' ' 238' ' ' LYS . 77.5 mt -98.7 -26.56 14.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 65.109999999999999 111.329 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.424 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 48.6 m-85 -125.53 148.66 48.82 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.966 0.906 . . . . 74.340000000000003 108.739 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.2 136.33 46.37 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.61 -0.885 . . . . 74.230000000000004 108.61 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HB3' HG12 ' A' ' 101' ' ' ILE . 82.3 t80 -129.79 133.36 46.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.534 -1.284 . . . . 63.43 107.534 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -103.65 137.14 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 107.248 -1.39 . . . . 34.420000000000002 107.248 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.28 114.23 3.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.242 0.617 . . . . 74.040000000000006 110.942 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -86.91 -51.44 6.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.852 0.861 . . . . 63.43 109.64 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.92 -177.14 38.04 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 115.279 -0.873 . . . . 71.019999999999996 112.261 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.62 -32.88 60.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.772 0.829 . . . . 71.099999999999994 111.645 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.462 HD21 ' HG2' ' A' ' 249' ' ' PRO . 29.3 p-10 -92.32 -20.43 21.1 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.034 0.534 . . . . 71.129999999999995 111.689 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 78.0 p -71.1 154.16 41.97 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.549 0.53 . . . . 75.319999999999993 109.834 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 128' ' ' GLY . 49.5 tp -128.28 124.36 36.4 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.731 0.412 . . . . 55.240000000000002 111.417 -164.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 m -68.36 117.71 10.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.566 0.746 . . . . 74.349999999999994 110.848 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -119.24 154.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.475 0.71 . . . . 65.25 111.739 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 21.6 m -99.18 147.87 24.67 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.333 -1.303 . . . . 74.200000000000003 109.108 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.93 125.77 26.45 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.74 -0.467 . . . . 74.340000000000003 109.74 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.0 1.66 79.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 116.1 -0.5 . . . . 54.229999999999997 113.278 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 80.9 tt0 -84.9 121.24 27.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.381 0.59 . . . . 74.329999999999998 110.071 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.414 ' HD3' HD21 ' A' ' 84' ' ' LEU . 56.8 mttp -73.87 142.82 46.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.379 0.672 . . . . 74.120000000000005 110.155 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.33 150.01 32.85 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.452 1.101 . . . . 73.319999999999993 110.142 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -100.15 108.36 20.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.039 -0.726 . . . . 65.209999999999994 109.039 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.489 HG13 ' HB1' ' A' ' 119' ' ' ALA . 69.7 t -74.84 119.99 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.174 -0.676 . . . . 63.340000000000003 109.174 174.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.712 HD11 ' HG3' ' A' ' 122' ' ' GLN . 14.2 mt -82.07 -54.08 5.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.267 -1.333 . . . . 63.539999999999999 108.019 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.38 152.92 22.68 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.886 -1.052 . . . . 74.510000000000005 112.978 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.781 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 44.9 m-85 -89.29 174.72 7.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.903 0.881 . . . . 62.340000000000003 111.609 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.35 -173.59 4.8 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.13 0.972 . . . . 75.030000000000001 110.389 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -50.7 -39.47 51.43 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 113.741 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -111.16 2.08 17.62 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.453 0.701 . . . . 51.409999999999997 111.563 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.781 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.18 30.35 73.71 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.421 0.928 . . . . 65.340000000000003 115.421 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.48 -27.49 14.86 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.81 0.805 . . . . 75.319999999999993 110.889 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 28.2 m95 -114.38 152.18 31.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.317 1.047 . . . . 63.43 109.81 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.489 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.22 148.21 46.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.262 0.625 . . . . 55.140000000000001 111.26 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -96.64 118.86 34.03 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.434 -1.321 . . . . 73.209999999999994 107.434 166.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -132.8 151.12 52.07 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.141 0.976 . . . . 64.439999999999998 111.026 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.712 ' HG3' HD11 ' A' ' 110' ' ' LEU . 98.4 mt-30 -100.58 105.23 16.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.828 0.851 . . . . 75.099999999999994 109.243 175.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 107' ' ' LEU . 40.9 p -98.4 176.5 5.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.743 1.217 . . . . 73.340000000000003 110.649 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -64.76 -20.32 66.29 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.588 -0.733 . . . . 70.010000000000005 110.728 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -80.49 -32.1 37.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.882 0.873 . . . . 63.240000000000002 111.185 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 144.73 -168.78 26.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.829 -0.428 . . . . 51.100000000000001 112.153 -171.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -104.32 132.25 50.77 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.268 0.627 . . . . 63.5 110.414 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.47 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 177.83 -165.49 35.12 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 111.775 -0.53 . . . . 72.129999999999995 111.775 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -100.12 121.75 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.598 0.962 . . . . 72.549999999999997 113.598 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 101' ' ' ILE . 18.1 m -132.69 136.76 28.36 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.246 1.418 . . . . 53.530000000000001 108.487 170.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 81.8 Cg_endo -85.45 155.21 10.65 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 122.074 1.85 . . . . 72.120000000000005 114.887 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -38.77 -47.23 1.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 126.199 1.8 . . . . 74.430000000000007 114.443 173.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -77.58 0.02 24.65 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.794 0.838 . . . . 72.129999999999995 112.665 -172.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 12.1 m-85 -105.6 -18.54 14.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.16 0.984 . . . . 74.25 111.459 171.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 109' ' ' VAL . 12.7 pt -123.97 175.67 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.889 0.876 . . . . 61.329999999999998 111.672 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 142' ' ' GLU . 12.0 t -161.41 150.82 13.69 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 123.797 0.839 . . . . 72.409999999999997 109.818 172.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.26 145.48 96.07 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.667 1.578 . . . . 73.349999999999994 111.853 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 41.7 t -73.78 -4.63 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 124.018 0.927 . . . . 73.420000000000002 110.797 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -91.26 -18.61 24.11 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 62.43 111.905 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 99.6 p -91.71 179.09 5.73 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.866 0.467 . . . . 61.210000000000001 111.607 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.0 mt -84.45 -22.75 30.22 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.812 0.845 . . . . 71.109999999999999 111.665 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.402 ' HB2' ' OG1' ' A' ' 136' ' ' THR . 2.0 mp0 -66.97 -17.98 65.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.508 0.723 . . . . 72.310000000000002 112.173 -171.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -64.09 -13.56 48.43 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.272 0.629 . . . . 72.329999999999998 112.104 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -97.53 148.58 23.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.163 0.985 . . . . 73.400000000000006 109.859 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.2 p -64.98 -41.41 95.45 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.094 0.871 . . . . 72.209999999999994 111.582 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -60.92 -38.44 85.78 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.023 0.749 . . . . 54.420000000000002 113.023 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.93 100.51 11.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.529 -0.915 . . . . 74.430000000000007 108.529 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.479 ' HB2' HG21 ' A' ' 151' ' ' VAL . 77.1 m80 -96.41 8.78 43.17 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.277 0.473 . . . . 74.549999999999997 112.277 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.459 ' O ' HG23 ' A' ' 151' ' ' VAL . . . 69.27 -145.54 42.83 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 118.631 -1.094 . . . . 74.299999999999997 112.498 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.92 106.17 0.91 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.801 2.334 . . . . 51.420000000000002 111.963 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.634 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 14.5 t -123.12 131.96 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.642 0.777 . . . . 75.109999999999999 110.236 -177.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 151' ' ' VAL . 66.2 p -77.83 152.75 33.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.827 -0.805 . . . . 74.219999999999999 108.827 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.535 ' HD2' ' OG ' ' A' ' 32' ' ' SER . 34.6 ttt85 -55.81 -38.63 70.23 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.124 0.416 . . . . 73.219999999999999 112.124 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -58.08 -45.21 87.53 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.966 0.791 . . . . 74.129999999999995 111.138 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.82 75.75 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.677 -0.692 . . . . 55.030000000000001 111.179 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.15 68.95 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.463 0.649 . . . . 72.200000000000003 111.524 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -75.83 -19.72 58.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.306 0.642 . . . . 52.539999999999999 110.926 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -67.21 -44.3 79.92 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.653 0.781 . . . . 73.519999999999996 110.28 168.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.648 HD21 ' HB3' ' A' ' 239' ' ' ARG . 53.5 mt -60.19 -38.08 82.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.34 0.656 . . . . 74.310000000000002 111.187 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.98 20.72 10.74 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.464 -0.789 . . . . 74.010000000000005 112.321 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.0 p -66.35 -40.96 90.15 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.926 0.393 . . . . 65.439999999999998 110.977 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.4 p -104.96 14.61 29.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.277 1.031 . . . . 73.209999999999994 111.399 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.63 163.91 50.25 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 114.404 0.522 . . . . 53.210000000000001 114.404 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 17.9 pt -109.18 -175.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.618 1.167 . . . . 74.150000000000006 111.223 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 4.5 m-20 -56.64 123.81 16.16 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.295 -0.866 . . . . 72.519999999999996 110.432 171.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.454 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 88.01 10.98 68.3 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.755 -0.657 . . . . 54.409999999999997 113.393 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.7 m -81.0 118.13 22.21 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.434 1.117 . . . . 72.340000000000003 110.296 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.512 ' HB3' HD13 ' A' ' 184' ' ' LEU . 13.7 p90 -129.6 171.45 12.6 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.391 0.615 . . . . 74.230000000000004 112.557 -168.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.74 146.7 6.93 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 113.884 -1.507 . . . . 73.109999999999999 109.336 171.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.697 HG22 HG12 ' A' ' 182' ' ' ILE . 93.7 t -100.39 131.87 47.09 Favored 'Isoleucine or valine' 0 C--O 1.261 1.659 0 N-CA-C 108.567 -0.901 . . . . 64.239999999999995 108.567 167.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.634 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt85 -116.5 133.83 55.56 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.645 -1.161 . . . . 72.200000000000003 109.115 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.6 tp10 -84.95 145.72 27.61 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.4 1.08 . . . . 71.340000000000003 108.2 166.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.5 t -83.02 126.69 32.82 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.339 -0.615 . . . . 61.119999999999997 109.339 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.47 -40.99 93.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.028 0.531 . . . . 71.239999999999995 109.929 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.8 p -70.09 -25.76 63.66 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 50.130000000000003 111.307 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.664 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 66.5 m -145.43 91.88 5.69 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 122.678 0.391 . . . . 73.230000000000004 111.68 -176.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.79 136.18 68.59 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.44 2.093 . . . . 45.210000000000001 111.625 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.23 -24.7 31.2 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 112.127 -173.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -95.78 114.76 26.52 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.743 -0.836 . . . . 71.129999999999995 108.743 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.635 HH11 HD12 ' A' ' 214' ' ' LEU . 94.4 mtt180 -131.29 157.15 44.07 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.221 0.608 . . . . 64.439999999999998 110.947 -171.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.5 m -145.36 147.85 32.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.636 0.774 . . . . 74.299999999999997 109.227 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.697 HG12 HG22 ' A' ' 170' ' ' VAL . 24.6 mt -103.96 125.84 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.923 -0.769 . . . . 75.200000000000003 108.923 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 14.5 m -96.72 110.21 22.7 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.691 -1.226 . . . . 63.439999999999998 107.691 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 168' ' ' PHE . 54.8 tp -116.54 111.79 20.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.22 1.008 . . . . 71.5 109.739 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.46 HH22 ' N ' ' A' ' 39' ' ' CYS . 41.5 ttt180 -81.59 127.69 33.14 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.178 0.991 . . . . 73.329999999999998 111.087 172.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 88.5 t80 -143.03 136.76 28.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.258 1.423 . . . . 72.109999999999999 107.947 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 53.78 29.18 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.208 1.003 . . . . 75.25 112.499 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.34 -12.6 64.28 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.035 -0.869 . . . . 73.099999999999994 114.669 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -97.81 146.43 25.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.212 1.006 . . . . 65.329999999999998 109.608 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.99 112.69 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 122.572 0.349 . . . . 71.319999999999993 110.1 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -97.94 143.87 28.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.716 1.207 . . . . 74.450000000000003 109.11 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -130.13 118.29 21.24 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.354 0.524 . . . . 72.430000000000007 110.227 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.584 ' CE1' HD22 ' A' ' 228' ' ' LEU . 0.6 OUTLIER -121.24 131.72 54.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.497 0.719 . . . . 75.109999999999999 111.045 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 21.4 tpp85 -70.72 131.27 43.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.428 1.091 . . . . 70.25 111.519 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.58 104.95 11.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.184 -1.043 . . . . 61.299999999999997 108.184 166.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -78.35 138.05 38.35 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.908 -0.775 . . . . 43.109999999999999 108.908 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -111.05 117.25 32.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.66 -0.867 . . . . 71.400000000000006 108.66 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.66 171.49 11.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.537 0.735 . . . . 74.049999999999997 111.258 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 12.8 p -64.52 -26.62 68.5 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.928 0.891 . . . . 74.230000000000004 112.639 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -81.75 -14.47 56.41 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.567 0.747 . . . . 74.140000000000001 111.828 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.44 11.19 39.33 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 119.802 -0.443 . . . . 72.310000000000002 113.432 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.403 ' HE2' ' OD1' ' A' ' 212' ' ' ASN . 98.2 mttt -79.39 132.61 36.45 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 116.901 0.35 . . . . 75.209999999999994 110.922 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.24 146.92 26.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.537 -0.912 . . . . 73.340000000000003 108.537 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.2 p90 -170.27 142.77 2.26 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.379 0.425 . . . . 75.209999999999994 111.128 176.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -89.49 -35.85 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.469 -0.937 . . . . 72.549999999999997 108.469 163.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.6 m -105.5 124.34 49.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.062 0.945 . . . . 73.409999999999997 109.474 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.4 t -65.03 -21.9 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.367 0.667 . . . . 64.209999999999994 111.435 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -66.18 -26.6 67.48 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.275 1.43 . . . . 64.310000000000002 111.459 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.3 m -144.22 106.67 4.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.192 0.597 . . . . 51.43 110.248 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 84.5 mtt180 -104.23 143.37 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.347 1.059 . . . . 55.229999999999997 109.206 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.641 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 6.3 m-85 -125.84 136.34 52.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.05 0.54 . . . . 71.040000000000006 110.073 -167.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.403 ' OD1' ' HE2' ' A' ' 202' ' ' LYS . 78.8 m-20 -57.51 -34.34 68.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.956 0.902 . . . . 71.430000000000007 111.031 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.3 p -131.2 154.4 48.45 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 122.016 0.912 . . . . 71.150000000000006 111.582 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.635 HD12 HH11 ' A' ' 180' ' ' ARG . 0.8 OUTLIER -62.65 -23.98 67.38 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.008 -1.451 . . . . 64.340000000000003 109.309 170.059 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.92 94.21 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.753 0.821 . . . . 55.210000000000001 111.005 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 53.9 mt-10 -72.92 -35.01 66.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.999 0.519 . . . . 60.329999999999998 111.021 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.35 -57.31 11.75 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.414 0.446 . . . . 74.319999999999993 110.053 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.88 -37.72 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 123.839 0.712 . . . . 64.239999999999995 111.54 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -63.32 -59.22 5.0 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.081 0.238 . . . . 74.239999999999995 111.572 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -63.47 -33.02 74.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.352 0.408 . . . . 73.129999999999995 110.942 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.645 ' HB3' HD11 ' A' ' 228' ' ' LEU . 16.5 m170 -88.96 -7.19 56.5 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.433 0.531 . . . . 63.329999999999998 112.433 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -88.23 -35.77 17.13 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.199 0.454 . . . . 70.400000000000006 110.273 168.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 54.0 p -68.98 -47.45 65.57 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.503 -0.771 . . . . 25.41 110.765 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -131.67 164.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.835 0.826 . . . . 63.299999999999997 112.445 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.33 13.87 1.08 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.864 2.066 . . . . 54.43 114.69 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.549 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.5 t70 -42.18 30.57 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 131.56 3.944 . . . . 64.439999999999998 119.409 -152.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.37 1.49 9.26 Favored Glycine 0 N--CA 1.486 2.031 0 O-C-N 120.065 -1.647 . . . . 61.210000000000001 112.354 -170.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 221' ' ' HIS . 9.6 mt -91.87 163.97 13.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.174 1.389 . . . . 73.340000000000003 108.839 169.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 11.4 tt -61.57 -35.98 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-O 120.67 0.271 . . . . 61.140000000000001 110.808 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -157.48 -179.07 7.82 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.513 0.725 . . . . 71.420000000000002 110.322 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.8 p -67.32 146.94 53.59 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.748 0.819 . . . . 72.0 111.68 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 80.8 mt -79.03 92.44 4.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 108.874 -0.788 . . . . 74.420000000000002 108.874 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -88.93 -65.1 1.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.686 0.795 . . . . 74.420000000000002 112.231 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -108.75 120.9 44.79 Favored Pre-proline 0 C--O 1.216 -0.68 0 C-N-CA 124.749 1.22 . . . . 74.439999999999998 109.451 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.51 129.96 4.39 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.009 1.806 . . . . 73.439999999999998 111.965 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -69.22 135.71 89.09 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.058 0.543 . . . . 64.450000000000003 110.664 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 10.6 Cg_exo -72.27 172.74 14.26 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.825 2.35 . . . . 75.109999999999999 111.999 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.497 ' NZ ' HD13 ' A' ' 88' ' ' LEU . 33.7 mmtp -71.27 145.59 49.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.02 0.528 . . . . 72.430000000000007 111.478 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.648 ' HB3' HD21 ' A' ' 159' ' ' LEU . 20.8 ptt-85 -82.68 -63.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.248 0.833 . . . . 71.140000000000001 113.248 -163.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.533 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.0 t30 -113.39 130.51 56.28 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.015 0.926 . . . . 73.230000000000004 110.707 -174.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.73 113.41 32.12 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 107.484 -1.302 . . . . 73.439999999999998 107.484 164.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.65 124.44 13.68 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.892 2.394 . . . . 65.400000000000006 113.556 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 88.2 m -76.9 123.4 26.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.983 -0.747 . . . . 75.439999999999998 108.983 173.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.411 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 47.9 t -92.58 114.54 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.384 -0.969 . . . . 71.420000000000002 108.384 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -95.2 112.33 24.05 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.565 -0.255 . . . . 75.209999999999994 111.306 -167.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.68 5.92 2.23 Favored Glycine 0 CA--C 1.542 1.773 0 N-CA-C 118.28 2.072 . . . . 53.310000000000002 118.28 161.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.43 143.81 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.63 1.715 . . . . 65.030000000000001 111.615 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.6 t -77.54 128.91 78.7 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.592 -1.262 . . . . 62.119999999999997 107.592 167.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.462 ' HG2' HD21 ' A' ' 97' ' ' ASN . 78.5 Cg_exo -51.37 -52.21 9.54 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.703 2.269 . . . . 74.340000000000003 113.737 -167.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.687 HD22 ' HB2' ' A' ' 254' ' ' TRP . 65.7 t30 -128.38 -20.19 3.72 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.375 0.534 . . . . 70.140000000000001 111.13 154.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -69.17 98.01 0.97 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.731 0.777 . . . . 72.430000000000007 113.038 -145.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.532 ' HB2' ' HD2' ' A' ' 253' ' ' LYS . 4.3 m-20 -120.91 -46.24 2.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.503 -1.665 . . . . 60.340000000000003 106.503 152.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.532 ' HD2' ' HB2' ' A' ' 252' ' ' ASP . 2.1 mptp? -106.56 -39.21 5.92 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.543 -1.208 . . . . 72.430000000000007 110.499 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.687 ' HB2' HD22 ' A' ' 250' ' ' ASN . 3.1 t-105 -60.67 125.16 22.66 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.057 0.943 . . . . 75.310000000000002 110.605 -174.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.258 1.547 0 N-CA-C 107.715 -1.217 . . . . 71.200000000000003 107.715 175.446 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.253 -0.277 . . . . 74.430000000000007 110.253 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.24 -174.23 43.06 Favored Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.7 -0.56 . . . . 71.340000000000003 111.7 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 63.33 12.11 5.98 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.512 0.725 . . . . 73.109999999999999 112.228 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -135.86 100.26 11.03 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 123.831 0.852 . . . . 75.129999999999995 111.153 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -85.79 -165.2 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.284 2.656 . . . . 74.439999999999998 111.776 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.57 82.59 1.58 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.352 -0.299 . . . . 71.129999999999995 112.352 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.3 -38.63 11.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.915 0.886 . . . . 63.43 109.721 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 m 53.83 175.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 C-N-CA 126.525 1.93 . . . . 50.509999999999998 113.818 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.37 164.87 11.83 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.892 0.877 . . . . 74.439999999999998 109.219 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.58 123.24 0.89 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.44 -1.064 . . . . 71.120000000000005 110.44 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.53 142.26 20.97 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.477 0.639 . . . . 74.299999999999997 110.58 -174.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -169.13 124.74 0.88 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.123 0.969 . . . . 73.010000000000005 110.487 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -81.13 115.6 20.64 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.261 0.624 . . . . 75.430000000000007 109.332 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 53.7 mmt-85 -126.54 107.65 23.42 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.007 0.923 . . . . 75.340000000000003 110.109 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 14' ' ' ARG . 25.4 Cg_endo -60.44 117.15 3.87 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.346 2.698 . . . . 63.119999999999997 112.309 175.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -77.71 156.09 30.86 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.503 0.721 . . . . 62.43 110.855 175.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 mp -85.59 150.56 54.07 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.282 0.633 . . . . 72.209999999999994 109.749 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.599 ' HG3' ' HB3' ' A' ' 252' ' ' ASP . 73.3 Cg_endo -71.65 156.71 57.12 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.978 2.452 . . . . 70.310000000000002 112.449 176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.25 154.26 39.06 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.77 -0.65 . . . . 43.119999999999997 111.167 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -97.94 -179.85 4.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.292 1.037 . . . . 75.120000000000005 112.233 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -71.2 172.88 8.47 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.575 1.15 . . . . 63.420000000000002 111.8 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 59.2 t80 54.41 78.98 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.756 1.622 . . . . 75.150000000000006 112.464 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 10.8 tt -179.28 149.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.233 1.413 . . . . 54.310000000000002 108.759 174.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -104.46 167.19 9.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.225 0.61 . . . . 53.210000000000001 110.469 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.18 164.94 33.97 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 116.176 -0.465 . . . . 53.140000000000001 113.034 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.47 138.58 34.75 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.669 0.788 . . . . 54.409999999999997 109.936 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.06 -162.44 24.72 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 116.572 -0.285 . . . . 73.239999999999995 112.635 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -138.01 164.37 29.22 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.359 1.064 . . . . 74.209999999999994 109.756 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HG2' ' NE ' ' A' ' 239' ' ' ARG . 89.0 mtm180 -124.95 -175.39 3.28 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.774 1.23 . . . . 64.530000000000001 109.4 173.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 69.41 131.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.179 1.392 . . . . 74.049999999999997 111.996 -173.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.8 t -173.54 175.23 3.05 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 125.443 1.497 . . . . 62.149999999999999 108.169 174.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.1 m -95.07 145.52 24.92 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.319 0.648 . . . . 51.229999999999997 109.487 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -85.04 152.46 23.41 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.607 0.763 . . . . 52.140000000000001 109.585 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -160.85 105.2 1.37 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.868 0.467 . . . . 51.030000000000001 110.394 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.87 -140.83 5.74 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 123.788 0.68 . . . . 43.149999999999999 111.577 168.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.95 -167.08 27.11 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 117.127 0.464 . . . . 44.450000000000003 113.391 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.56 153.91 74.79 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 123.543 2.828 . . . . 75.140000000000001 112.198 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -83.43 132.33 34.98 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.778 0.323 . . . . 71.109999999999999 110.197 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.4 p -164.51 99.18 0.81 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.441 0.697 . . . . 43.329999999999998 109.659 -173.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 172.14 147.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.46 1.504 . . . . 61.039999999999999 109.207 170.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -56.29 160.26 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.989 1.315 . . . . 62.32 112.873 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -77.98 149.61 34.07 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.424 1.089 . . . . 72.319999999999993 112.193 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.9 p -173.01 -38.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 125.161 1.384 . . . . 71.299999999999997 109.845 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.649 ' H ' HD21 ' A' ' 61' ' ' LEU . 10.4 tp10 -133.7 140.3 46.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.1 0.96 . . . . 53.240000000000002 109.441 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -75.79 124.06 26.65 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.606 0.362 . . . . 74.439999999999998 110.935 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 165' ' ' ASN . 4.8 mm-40 -87.67 142.3 27.94 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.88 0.872 . . . . 75.200000000000003 109.502 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.71 99.33 0.79 Allowed 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.236 -1.024 . . . . 41.350000000000001 108.236 172.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.85 90.52 0.13 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.554 0.742 . . . . 72.319999999999993 110.236 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 57.3 tt0 -167.21 124.95 1.26 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 125.915 1.686 . . . . 72.230000000000004 107.053 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 98.19 -55.95 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 C-N-CA 128.013 2.525 . . . . 53.439999999999998 110.944 -171.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 49' ' ' GLN . 23.9 Cg_endo -63.85 94.63 0.19 Allowed 'Trans proline' 0 C--N 1.397 3.079 0 CA-C-N 122.26 1.843 . . . . 72.120000000000005 110.145 157.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -69.55 95.81 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 CA-C-O 121.797 0.808 . . . . 40.420000000000002 111.332 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.52 93.82 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.468 1.507 . . . . 74.439999999999998 111.464 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 m -87.22 41.8 1.0 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.546 0.738 . . . . 74.450000000000003 110.25 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.93 -53.93 38.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.543 1.137 . . . . 62.009999999999998 111.623 -172.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -78.46 -6.72 56.13 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.655 0.782 . . . . 75.349999999999994 112.399 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -65.43 122.0 77.91 Favored Pre-proline 0 N--CA 1.475 0.803 0 N-CA-C 112.988 0.736 . . . . 72.219999999999999 112.988 -171.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -86.73 0.93 7.7 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.938 2.425 . . . . 71.150000000000006 110.893 162.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -113.27 -79.35 0.58 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.606 1.162 . . . . 72.430000000000007 109.354 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.53 -48.72 4.03 Favored Glycine 0 C--N 1.361 1.949 0 CA-C-N 116.16 -0.473 . . . . 75.5 113.863 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.649 HD21 ' H ' ' A' ' 44' ' ' GLU . 8.5 mp -85.99 -177.67 6.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.643 1.177 . . . . 72.409999999999997 112.824 -167.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 m -148.0 41.98 1.02 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.518 1.127 . . . . 53.450000000000003 110.625 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -86.62 -90.86 0.11 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 119.207 -0.425 . . . . 62.549999999999997 111.179 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.38 -24.74 64.81 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.374 1.069 . . . . 75.519999999999996 113.818 -164.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.44 -26.42 60.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.68 0.276 . . . . 73.049999999999997 110.974 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -89.5 -42.64 11.35 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.552 0.692 . . . . 72.329999999999998 109.5 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -94.11 69.89 3.83 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.096 -0.956 . . . . 73.329999999999998 108.932 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -65.93 -25.13 67.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.853 -1.067 . . . . 63.009999999999998 110.419 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.5 m -75.3 4.45 7.11 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.967 1.307 . . . . 74.5 113.155 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -69.99 -33.82 72.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.332 0.515 . . . . 73.439999999999998 110.902 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.75 -36.12 43.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.947 0.499 . . . . 63.420000000000002 110.126 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -74.03 -7.28 51.89 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.626 0.77 . . . . 52.439999999999998 111.523 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.75 -23.95 67.57 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.63 1.172 . . . . 74.129999999999995 111.322 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.55 14.3 20.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.927 0.891 . . . . 61.020000000000003 110.968 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.6 -27.04 67.39 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.156 0.582 . . . . 73.019999999999996 111.307 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.17 -137.79 22.53 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.281 -0.733 . . . . 75.310000000000002 111.908 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.766 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 25.5 Cg_endo -59.96 -176.94 0.13 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.342 2.694 . . . . 71.450000000000003 114.109 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 m -58.2 155.76 10.87 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.729 -1.123 . . . . 73.019999999999996 111.913 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -65.16 -50.32 66.43 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.475 0.546 . . . . 74.200000000000003 112.475 -163.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -133.54 -36.58 0.96 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.84 0.456 . . . . 72.230000000000004 111.324 171.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.772 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 7.2 m-20 -89.45 111.84 48.0 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-O 117.822 -1.085 . . . . 54.310000000000002 110.793 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.93 -27.83 46.38 Favored 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.791 2.327 . . . . 63.130000000000003 113.715 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -98.45 18.5 16.42 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 124.878 1.271 . . . . 72.340000000000003 111.156 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.772 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 36.4 tp -85.07 131.41 34.46 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.368 -0.833 . . . . 74.299999999999997 110.339 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.0 m-85 -111.24 172.64 6.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.507 1.123 . . . . 71.420000000000002 108.443 173.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.41 137.22 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.215 1.006 . . . . 73.519999999999996 109.376 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.75 122.17 21.97 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.515 0.726 . . . . 74.349999999999994 110.8 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.4 mt -76.69 -35.87 57.6 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.708 0.803 . . . . 72.519999999999996 110.811 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.452 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 20.1 m-85 -124.31 168.21 13.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.2 -0.909 . . . . 72.030000000000001 109.888 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.65 117.71 24.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.207 -1.035 . . . . 75.150000000000006 108.207 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.662 ' HB3' HG12 ' A' ' 101' ' ' ILE . 61.3 t80 -106.46 131.55 53.51 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.374 -1.343 . . . . 64.420000000000002 107.374 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.14 133.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.871 -0.788 . . . . 65.109999999999999 108.871 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.33 123.2 20.56 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.279 0.631 . . . . 44.409999999999997 109.871 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 p -86.23 -16.31 38.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.601 0.76 . . . . 65.099999999999994 110.997 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -158.83 -173.7 27.58 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.621 -0.718 . . . . 75.400000000000006 111.483 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -69.46 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.964 0.905 . . . . 63.030000000000001 111.669 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -73.68 -27.5 61.26 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.58 1.152 . . . . 71.129999999999995 112.131 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.2 p -93.36 169.11 10.62 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.723 0.809 . . . . 65.409999999999997 109.744 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 65.6 tp -136.06 128.8 30.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.696 0.398 . . . . 72.209999999999994 111.424 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 m -72.79 116.61 13.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.708 HG22 HG21 ' A' ' 123' ' ' THR . 27.1 pt -120.72 149.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.356 0.662 . . . . 71.349999999999994 110.04 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.4 m -102.12 142.2 33.75 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.306 -0.861 . . . . 63.130000000000003 110.256 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -59.2 114.45 2.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.735 0.814 . . . . 50.310000000000002 110.291 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.83 0.12 39.2 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.688 -0.687 . . . . 72.430000000000007 112.78 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.17 121.16 27.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.287 0.544 . . . . 44.450000000000003 111.294 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HD3' HD21 ' A' ' 84' ' ' LEU . 62.7 mttp -70.83 130.39 41.56 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.797 0.839 . . . . 74.219999999999999 109.009 169.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.739 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.14 138.38 31.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.392 0.677 . . . . 74.409999999999997 110.464 -176.293 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 40.9 ttm180 -89.49 108.56 19.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.928 0.491 . . . . 64.140000000000001 110.068 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.663 HG13 ' HB1' ' A' ' 119' ' ' ALA . 4.6 t -78.61 117.88 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.347 0.659 . . . . 63.119999999999997 110.099 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.3 mt -90.3 -49.12 6.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.101 0.96 . . . . 73.230000000000004 110.229 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.67 144.56 9.47 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 115.38 -0.827 . . . . 71.450000000000003 111.606 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 25.0 m-85 -87.86 168.77 12.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.655 0.782 . . . . 74.540000000000006 111.252 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -88.71 -172.19 3.62 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.681 -1.145 . . . . 73.150000000000006 110.982 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -41.95 -44.72 3.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.838 1.655 . . . . 73.109999999999999 114.506 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 31.4 p-10 -114.34 6.42 16.07 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.174 0.805 . . . . 73.310000000000002 113.174 -174.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.56 16.14 80.59 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.252 -0.749 . . . . 54.530000000000001 114.711 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.77 -66.85 0.81 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.92 0.86 . . . . 74.299999999999997 109.668 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -90.68 131.91 36.1 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.926 0.49 . . . . 70.319999999999993 111.187 -168.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.663 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -124.5 139.14 54.16 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.208 1.003 . . . . 62.520000000000003 109.7 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.44 110.41 7.7 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.115 -1.069 . . . . 74.209999999999994 108.115 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -101.61 143.78 31.15 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.591 0.756 . . . . 74.450000000000003 109.513 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 35.4 tt0 -102.66 104.5 14.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.138 -1.392 . . . . 74.430000000000007 107.504 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.739 HG22 ' HB3' ' A' ' 107' ' ' LEU . 58.7 p -112.17 166.83 10.91 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.282 1.033 . . . . 75.329999999999998 110.391 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -72.51 -17.49 61.73 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.796 -1.093 . . . . 72.409999999999997 109.536 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -75.23 -27.44 59.51 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.632 1.173 . . . . 75.510000000000005 111.088 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.16 -155.06 25.37 Favored Glycine 0 C--N 1.358 1.799 0 CA-C-O 120.246 -0.197 . . . . 75.540000000000006 112.969 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -116.29 137.66 51.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.425 0.613 . . . . 72.319999999999993 110.516 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 161.98 170.87 27.33 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 120.249 -0.976 . . . . 74.319999999999993 114.215 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -87.49 129.87 34.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.418 0.687 . . . . 64.040000000000006 111.783 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -137.68 145.2 47.75 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 74.310000000000002 109.106 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.47 151.81 7.75 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 122.402 2.068 . . . . 52.32 114.917 -170.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.0 m -40.47 -30.79 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.133 2.173 . . . . 74.400000000000006 114.69 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.523 HD21 HG22 ' A' ' 244' ' ' VAL . 29.6 p30 -78.97 -27.02 43.42 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.111 0.565 . . . . 74.120000000000005 112.191 -175.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.452 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -91.4 -16.23 27.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.542 0.737 . . . . 75.010000000000005 112.05 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.6 pt -122.8 176.32 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.724 0.81 . . . . 72.510000000000005 111.122 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.0 m -160.03 136.67 6.54 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.649 1.18 . . . . 63.119999999999997 109.083 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 29.1 Cg_endo -59.98 134.9 59.42 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 121.942 1.762 . . . . 72.450000000000003 111.488 173.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.04 -7.33 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.557 0.743 . . . . 35.329999999999998 110.637 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.766 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 7.2 t30 -75.93 -23.44 55.45 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.292 0.637 . . . . 72.150000000000006 111.811 175.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.3 p -94.59 173.92 7.37 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.173 0.511 . . . . 74.239999999999995 111.91 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 mt -82.79 -19.51 37.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.341 1.056 . . . . 73.209999999999994 111.37 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.66 -18.89 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.207 1.003 . . . . 65.310000000000002 112.19 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -62.58 -25.55 68.13 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.174 0.589 . . . . 72.030000000000001 111.772 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -78.04 136.97 38.02 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.504 -0.771 . . . . 73.510000000000005 110.226 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 m -57.36 -36.58 71.38 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.212 1.005 . . . . 75.239999999999995 112.311 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -67.72 -28.8 67.97 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.917 0.761 . . . . 70.439999999999998 112.621 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.411 ' O ' ' HE2' ' A' ' 238' ' ' LYS . 20.9 t80 -89.14 98.59 11.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.774 -0.824 . . . . 65.140000000000001 108.774 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.541 ' HB2' HG21 ' A' ' 151' ' ' VAL . 65.8 m80 -91.69 -9.04 45.3 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.752 0.421 . . . . 74.439999999999998 111.788 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 150' ' ' PRO . . . 75.04 -126.91 9.02 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 118.317 -1.269 . . . . 44.329999999999998 113.175 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 149' ' ' GLY . 10.1 Cg_exo -69.24 88.31 0.48 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 123.25 2.633 . . . . 60.32 112.185 -175.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 43.4 t -126.95 133.46 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.946 0.898 . . . . 74.430000000000007 109.494 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 p -86.46 171.1 11.36 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.025 0.93 . . . . 72.099999999999994 109.808 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -62.16 -42.31 99.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 110.002 -0.37 . . . . 72.439999999999998 110.002 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.27 -48.26 76.94 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.235 0.959 . . . . 73.409999999999997 110.867 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.3 69.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.236 0.614 . . . . 71.340000000000003 111.735 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.39 75.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 63.450000000000003 111.311 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.97 -20.98 47.81 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.544 -0.753 . . . . 71.230000000000004 110.677 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -37.12 81.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.111 0.964 . . . . 71.0 110.084 170.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 239' ' ' ARG . 67.4 mt -68.97 -51.69 36.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.99 0.516 . . . . 75.530000000000001 110.673 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.464 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 80.7 mt -83.75 11.95 6.69 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.563 0.579 . . . . 64.409999999999997 112.563 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.7 p -62.05 -37.47 85.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.904 0.482 . . . . 75.519999999999996 111.663 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.5 m -111.28 18.62 19.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.678 0.791 . . . . 74.420000000000002 110.739 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 152.06 41.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 112.818 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.8 pt -87.74 -177.67 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.313 0.645 . . . . 53.340000000000003 110.533 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 5.1 m-20 -62.48 125.68 24.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.899 -0.591 . . . . 61.329999999999998 110.472 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 233' ' ' HIS . . . 84.22 10.92 79.45 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.05 -0.977 . . . . 44.530000000000001 113.29 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.6 m -67.67 139.16 56.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.272 1.036 . . . . 63.229999999999997 109.703 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.474 ' HB3' HD12 ' A' ' 184' ' ' LEU . 18.1 p90 -149.17 166.49 28.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.804 0.729 . . . . 73.549999999999997 111.76 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.1 pp -161.84 135.6 6.53 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.841 -1.072 . . . . 75.099999999999994 109.724 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.668 HG22 HG12 ' A' ' 182' ' ' ILE . 74.5 t -91.66 141.55 14.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 N-CA-C 108.3 -1.0 . . . . 75.129999999999995 108.3 167.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.568 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 46.0 ptt85 -144.95 153.38 41.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.242 -0.89 . . . . 71.200000000000003 109.983 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -115.2 148.45 39.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.224 1.009 . . . . 70.319999999999993 108.393 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.8 t -78.67 125.4 29.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.07 0.548 . . . . 74.25 110.103 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.12 -41.77 88.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.172 0.989 . . . . 71.5 110.489 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 57.8 p -80.53 -25.17 38.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.496 0.718 . . . . 71.549999999999997 111.806 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.7 m -124.6 95.63 42.47 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.511 0.724 . . . . 72.519999999999996 110.668 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.81 139.61 81.09 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.211 2.608 . . . . 74.25 112.215 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.64 -28.38 4.9 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.279 -0.419 . . . . 71.450000000000003 113.06 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -75.67 116.18 16.11 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 117.062 0.431 . . . . 50.409999999999997 110.345 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.667 HH11 HD12 ' A' ' 214' ' ' LEU . 89.5 mtt180 -126.12 150.75 48.01 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.087 0.955 . . . . 72.299999999999997 109.281 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.4 m -149.41 153.75 37.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.098 0.959 . . . . 63.420000000000002 109.494 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.668 HG12 HG22 ' A' ' 170' ' ' VAL . 26.7 mt -110.9 149.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.107 -1.071 . . . . 71.510000000000005 108.107 172.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 55.0 m -121.75 115.4 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.34 -1.355 . . . . 41.030000000000001 107.34 169.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 168' ' ' PHE . 14.7 tp -108.45 112.76 25.33 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.569 0.622 . . . . 73.140000000000001 109.956 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 23.3 ttt180 -81.68 112.02 18.48 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 109.752 -0.462 . . . . 65.439999999999998 109.752 165.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -136.36 143.96 44.35 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 106.85 -1.537 . . . . 74.230000000000004 106.85 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 61.38 21.21 11.8 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.178 0.991 . . . . 74.439999999999998 111.815 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.07 1.35 68.22 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.976 -0.347 . . . . 71.019999999999996 113.759 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 71.6 mtp180 -105.66 139.31 40.45 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.683 1.193 . . . . 62.439999999999998 109.251 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.9 t -100.13 105.61 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.051 0.453 . . . . 62.210000000000001 110.147 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -90.98 120.15 31.74 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.862 1.265 . . . . 74.219999999999999 109.229 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -95.32 120.69 36.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.62 0.368 . . . . 70.120000000000005 110.462 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -96.95 147.28 24.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.739 1.215 . . . . 65.239999999999995 109.854 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 19.7 tpp180 -101.84 113.17 26.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.323 0.649 . . . . 72.310000000000002 109.277 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.1 mt -82.63 102.12 8.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.828 -1.175 . . . . 41.32 107.828 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -78.34 107.86 11.27 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.799 -1.091 . . . . 60.450000000000003 108.513 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.8 m -79.44 109.11 13.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.301 -1.0 . . . . 74.239999999999995 108.301 170.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.64 167.7 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.383 0.673 . . . . 64.209999999999994 110.731 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 21.7 p -60.83 -26.3 67.25 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.27 1.028 . . . . 62.109999999999999 113.186 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -94.29 -18.08 22.0 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.482 0.713 . . . . 63.420000000000002 111.502 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.5 10.78 16.39 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-O 119.535 -0.591 . . . . 61.539999999999999 113.662 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.631 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 96.3 mttt -76.68 127.26 32.45 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.643 0.721 . . . . 72.349999999999994 110.239 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.24 145.53 24.93 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.679 -0.86 . . . . 74.230000000000004 108.679 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.596 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 43.8 p90 -163.36 129.81 3.3 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.421 0.45 . . . . 62.149999999999999 111.162 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 60.1 t -72.87 -41.79 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.807 -0.812 . . . . 74.200000000000003 108.807 164.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.403 ' OG ' ' HA3' ' A' ' 227' ' ' GLY . 13.4 m -107.48 129.24 54.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.73 -1.123 . . . . 52.100000000000001 110.049 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.1 t -61.58 -26.88 68.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.54 0.736 . . . . 72.219999999999999 111.654 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -70.39 -27.91 64.68 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.764 1.225 . . . . 75.420000000000002 110.873 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.8 m -134.13 100.35 4.68 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.38 0.672 . . . . 51.049999999999997 109.766 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.596 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 58.2 mtt180 -105.93 128.72 53.98 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.97 0.908 . . . . 75.040000000000006 108.801 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.524 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 7.2 m-85 -115.13 139.68 49.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.698 0.799 . . . . 74.049999999999997 109.921 -167.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.631 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 6.7 m-80 -67.03 -31.28 71.71 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.167 0.917 . . . . 73.129999999999995 110.267 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.7 p -132.29 156.66 46.16 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.155 0.982 . . . . 74.140000000000001 111.497 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.667 HD12 HH11 ' A' ' 180' ' ' ARG . 0.7 OUTLIER -66.77 -24.37 66.19 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 114.916 -1.038 . . . . 73.430000000000007 109.772 173.023 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.39 79.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.621 0.768 . . . . 54.310000000000002 110.496 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 35.5 mt-10 -70.25 -36.93 74.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.059 0.943 . . . . 73.099999999999994 111.536 177.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.411 HD11 HG23 ' A' ' 205' ' ' VAL . 12.6 tp -54.91 -61.3 2.4 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.508 0.505 . . . . 75.099999999999994 110.956 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.2 -38.93 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.827 0.451 . . . . 73.519999999999996 111.093 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -61.51 -57.08 13.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.811 0.445 . . . . 70.409999999999997 111.146 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -67.88 -29.74 68.93 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.243 -0.435 . . . . 65.439999999999998 111.016 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.654 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.9 m170 -87.6 -11.51 48.39 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.26 0.467 . . . . 71.420000000000002 112.26 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.4 p -93.78 -27.14 16.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.742 0.417 . . . . 52.240000000000002 110.967 173.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.6 p -77.81 -48.25 16.98 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.831 -0.622 . . . . 75.209999999999994 110.535 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 226' ' ' ASP . 15.8 m -129.77 163.89 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.566 0.698 . . . . 70.150000000000006 111.797 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.21 16.65 0.23 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 127.373 2.269 . . . . 45.439999999999998 114.236 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.656 ' HB2' HG23 ' A' ' 224' ' ' VAL . 36.1 t70 -43.84 33.81 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.606 1 C-N-CA 132.645 4.378 . . . . 54.350000000000001 119.231 -159.011 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.403 ' HA3' ' OG ' ' A' ' 206' ' ' SER . . . 122.41 -0.9 10.43 Favored Glycine 0 N--CA 1.474 1.199 0 O-C-N 120.741 -1.224 . . . . 52.5 112.335 -171.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.654 HD11 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -94.71 164.75 12.82 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.759 1.624 . . . . 74.310000000000002 109.878 169.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 9.6 tt -66.5 -39.35 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.036 0.446 . . . . 72.310000000000002 109.921 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.4 m -151.7 154.73 36.9 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 74.019999999999996 110.377 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.1 p -57.38 139.58 52.63 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.79 1.236 . . . . 63.240000000000002 112.475 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.444 HD23 HD13 ' A' ' 184' ' ' LEU . 86.8 mt -68.14 100.1 0.97 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.557 0.743 . . . . 73.439999999999998 109.007 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.532 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 26.1 t-80 -96.45 -78.39 0.47 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.898 0.879 . . . . 61.439999999999998 111.643 -165.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -94.0 123.64 58.67 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.385 0.674 . . . . 74.310000000000002 110.11 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.4 130.88 8.24 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.539 2.159 . . . . 75.150000000000006 111.765 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.59 82.48 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 109.063 -0.717 . . . . 71.219999999999999 109.063 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.21 167.01 16.07 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.409 2.073 . . . . 64.349999999999994 112.261 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 32.4 mmtp -63.45 138.12 58.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.494 0.718 . . . . 74.319999999999993 110.252 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.581 ' HB3' HD21 ' A' ' 159' ' ' LEU . 14.7 ptt-85 -72.73 -63.28 1.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.341 1.237 . . . . 73.040000000000006 114.341 -160.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.556 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 11.0 t-20 -112.87 146.48 38.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.992 0.917 . . . . 64.319999999999993 110.314 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 94.8 mttt -77.82 114.45 41.61 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 107.638 -1.245 . . . . 74.430000000000007 107.638 161.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 26.2 Cg_exo -64.44 127.41 18.94 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.16 2.573 . . . . 63.130000000000003 113.181 -171.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.4 m -76.87 117.2 18.24 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.102 0.561 . . . . 72.439999999999998 109.537 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.523 HG22 HD21 ' A' ' 133' ' ' ASN . 4.0 t -96.91 112.85 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.268 -1.012 . . . . 75.030000000000001 108.268 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -88.07 114.2 24.45 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.743 0.646 . . . . 73.019999999999996 112.743 -160.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.74 42.41 94.39 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 124.577 1.173 . . . . 74.319999999999993 114.438 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m -104.23 132.72 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 113.29 0.848 . . . . 60.210000000000001 113.29 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.8 t -83.98 120.11 74.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 105.083 -2.192 . . . . 70.439999999999998 105.083 148.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -54.94 -53.65 5.67 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.525 2.15 . . . . 64.310000000000002 113.996 -162.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -125.75 -21.53 4.4 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.156 0.503 . . . . 64.340000000000003 111.449 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -82.63 101.86 11.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.883 1.068 . . . . 74.150000000000006 113.883 -149.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' A' ' 18' ' ' PRO . 8.2 p-10 -122.22 -45.69 2.22 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.14 -0.936 . . . . 63.020000000000003 109.573 152.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER -103.34 -28.31 11.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.476 -0.783 . . . . 70.25 110.523 -171.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -72.4 109.89 6.42 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.416 -0.811 . . . . 74.340000000000003 112.042 -156.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 C--O 1.254 1.303 0 C-N-CA 125.616 1.566 . . . . 74.109999999999999 111.361 176.271 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.404 -0.591 . . . . 75.25 109.404 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.0 -44.94 3.0 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 123.825 0.703 . . . . 63.109999999999999 112.324 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 58.28 75.78 0.37 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 124.857 1.263 . . . . 73.109999999999999 109.631 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -81.14 114.2 47.11 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 115.425 -0.807 . . . . 72.549999999999997 110.817 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.84 149.67 60.39 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.381 2.054 . . . . 70.5 111.147 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.29 93.51 0.14 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.445 -0.662 . . . . 73.230000000000004 111.445 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.26 165.04 21.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.353 0.661 . . . . 51.520000000000003 109.536 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -160.91 146.34 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.375 0.67 . . . . 71.230000000000004 109.894 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.77 147.83 33.38 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.56 0.744 . . . . 54.399999999999999 109.523 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.29 158.16 14.87 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.474 -0.651 . . . . 30.52 111.474 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -115.63 169.6 9.07 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.383 0.592 . . . . 54.310000000000002 110.712 -173.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -81.97 150.9 27.43 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.144 0.978 . . . . 72.329999999999998 110.71 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -104.26 178.98 4.4 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.095 0.958 . . . . 75.209999999999994 109.586 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -76.41 151.41 83.16 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.432 0.693 . . . . 74.439999999999998 110.899 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.04 171.39 5.06 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.03 2.487 . . . . 72.420000000000002 113.079 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 33.9 p -72.44 98.3 2.24 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.08 0.952 . . . . 75.239999999999995 111.644 -176.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.33 150.37 49.33 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 108.848 -0.797 . . . . 72.129999999999995 108.848 169.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.33 175.83 9.28 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.894 2.396 . . . . 61.109999999999999 112.101 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.02 96.83 3.28 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.714 0.806 . . . . 62.539999999999999 110.031 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -89.81 101.3 14.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.612 0.765 . . . . 63.439999999999998 108.974 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -130.8 -143.87 0.25 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.286 -1.375 . . . . 75.319999999999993 107.286 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -172.67 110.24 0.22 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.995 0.816 . . . . 75.219999999999999 109.979 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 11.1 pt -120.5 175.09 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.747 0.819 . . . . 62.450000000000003 109.22 172.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -145.15 139.08 27.02 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.578 0.751 . . . . 54.240000000000002 110.059 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.65 -164.85 32.73 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.501 -0.772 . . . . 63.299999999999997 111.454 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.14 175.45 14.04 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.703 0.801 . . . . 55.310000000000002 110.537 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.77 132.16 2.52 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.3 -0.32 . . . . 62.32 112.3 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -131.66 144.59 51.14 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.471 1.108 . . . . 64.120000000000005 109.405 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -133.76 131.97 39.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.59 0.756 . . . . 74.329999999999998 110.722 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -152.58 119.36 5.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.845 -1.169 . . . . 61.43 107.845 170.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -125.22 44.24 2.85 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.736 1.215 . . . . 72.310000000000002 108.611 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.711 ' HA ' ' HA3' ' A' ' 178' ' ' GLY . 22.8 t -59.06 94.91 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.341 1.056 . . . . 62.32 112.522 -174.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.2 mmt-85 -111.69 -170.03 1.57 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.914 1.285 . . . . 70.319999999999993 109.168 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -128.86 156.83 43.04 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.256 1.022 . . . . 55.43 110.048 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.35 -123.72 1.88 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 110.837 -0.905 . . . . 72.109999999999999 110.837 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.75 -137.56 4.71 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 117.689 0.745 . . . . 74.319999999999993 113.562 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.73 -152.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 124.263 3.309 . . . . 71.019999999999996 113.476 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -148.48 -68.8 0.23 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 123.535 0.734 . . . . 75.310000000000002 110.041 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.9 t -152.59 -167.53 2.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.1 0.56 . . . . 75.329999999999998 110.094 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -135.62 140.6 44.69 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.508 0.723 . . . . 72.340000000000003 110.488 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 158' ' ' TYR . 35.8 m -136.45 142.38 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.992 0.917 . . . . 34.130000000000003 108.84 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -129.19 137.63 51.26 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.826 0.851 . . . . 72.030000000000001 110.279 -173.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 158' ' ' TYR . 47.7 t -117.93 -41.77 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.176 0.591 . . . . 43.439999999999998 110.335 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 161' ' ' SER . 0.4 OUTLIER 73.67 119.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.405 1.482 . . . . 71.340000000000003 110.989 -178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -152.25 151.01 30.41 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.3 1.04 . . . . 52.200000000000003 109.212 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -115.51 82.56 1.78 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.823 -1.177 . . . . 64.430000000000007 107.823 173.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.81 119.86 27.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.763 0.825 . . . . 51.329999999999998 108.873 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tt -156.26 108.08 2.52 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 107.027 -1.472 . . . . 61.329999999999998 107.027 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 66.55 160.74 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.8 1.24 . . . . 75.040000000000006 112.044 -176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -143.76 -53.75 0.02 OUTLIER Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.828 1.251 . . . . 63.43 110.488 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -72.0 97.1 0.81 Allowed 'Trans proline' 0 C--N 1.397 3.096 0 CA-C-N 121.092 1.426 . . . . 63.549999999999997 110.837 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -88.13 177.21 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.766 0.826 . . . . 70.299999999999997 108.772 174.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.83 164.89 23.26 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.554 0.342 . . . . 61.130000000000003 111.521 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.6 t -76.49 -20.94 56.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.821 0.849 . . . . 54.450000000000003 111.611 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -152.62 -81.95 0.09 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.958 0.503 . . . . 70.010000000000005 109.828 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -98.61 137.56 37.07 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.673 -0.862 . . . . 71.030000000000001 108.673 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -87.31 111.8 43.73 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.195 -0.669 . . . . 72.439999999999998 109.195 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.03 -28.54 80.48 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.329 2.019 . . . . 72.510000000000005 111.586 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -145.59 -58.66 0.33 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.131 -0.941 . . . . 53.310000000000002 110.803 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.23 -26.01 4.63 Favored Glycine 0 C--N 1.35 1.344 0 C-N-CA 122.888 0.28 . . . . 62.509999999999998 113.528 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.7 mt -110.49 161.44 15.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.738 1.215 . . . . 72.200000000000003 108.936 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.8 p -102.92 87.88 3.04 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.337 -0.616 . . . . 75.109999999999999 109.337 175.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 55.4 -83.78 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.496 1.918 . . . . 73.109999999999999 113.655 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.36 -51.19 64.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.293 0.637 . . . . 61.030000000000001 110.261 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 176.88 -55.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.326 1.45 . . . . 72.430000000000007 107.989 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -140.61 43.62 1.85 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.01 -1.45 . . . . 73.409999999999997 107.958 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.43 ' HH2' HD22 ' A' ' 73' ' ' LEU . 20.6 t90 -158.88 92.23 1.09 Allowed 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.939 -1.028 . . . . 73.5 110.315 -171.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -77.8 -31.11 51.63 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.455 -1.248 . . . . 64.230000000000004 111.135 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.7 p -76.14 9.42 2.53 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.555 1.142 . . . . 75.230000000000004 111.98 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -41.61 -43.32 2.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.429 1.492 . . . . 73.129999999999995 113.302 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.64 -27.77 68.63 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.746 0.818 . . . . 72.120000000000005 112.703 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.509 ' HB2' ' HE1' ' A' ' 144' ' ' HIS . 12.8 m120 -86.11 -0.92 56.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.98 0.912 . . . . 53.32 111.373 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.43 HD22 ' HH2' ' A' ' 67' ' ' TRP . 59.3 tp -57.51 -52.91 63.49 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 122.604 0.362 . . . . 74.140000000000001 110.396 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.55 45.14 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.019 0.927 . . . . 72.129999999999995 110.18 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.38 -48.97 73.43 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.249 0.619 . . . . 52.439999999999998 110.779 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 65.56 -137.33 37.05 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 118.794 -1.003 . . . . 61.350000000000001 111.37 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.49 121.51 7.5 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.013 1.809 . . . . 60.43 109.64 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.3 t -120.34 164.81 15.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.506 0.323 . . . . 74.349999999999994 111.403 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.17 -21.9 66.84 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.06 0.944 . . . . 73.430000000000007 108.612 166.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.516 ' N ' HD22 ' A' ' 80' ' ' ASN . 0.7 OUTLIER -79.05 33.18 0.22 Allowed 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 126.01 1.724 . . . . 72.040000000000006 111.445 175.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -44.61 140.72 3.09 Favored Pre-proline 0 CA--C 1.567 1.606 0 C-N-CA 127.439 2.295 . . . . 74.329999999999998 111.9 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -15.88 -43.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.399 3.228 1 C-N-CA 127.795 5.663 . . . . 73.030000000000001 120.492 -165.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -67.53 -13.85 62.42 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.683 0.793 . . . . 74.150000000000006 112.975 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 tp -100.37 123.65 44.86 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.805 0.812 . . . . 70.420000000000002 109.751 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -113.19 173.1 6.56 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.516 1.526 . . . . 53.100000000000001 109.491 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 p -136.72 132.44 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.069 1.347 . . . . 75.040000000000006 108.805 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.06 116.69 9.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.291 1.036 . . . . 74.420000000000002 110.025 173.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.6 mt -81.48 -36.07 29.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.76 0.824 . . . . 72.209999999999994 110.638 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 36.8 m-85 -122.85 143.91 49.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.967 -1.015 . . . . 65.329999999999998 108.819 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -74.23 134.3 42.68 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.843 -0.799 . . . . 63.439999999999998 108.843 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.619 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.0 t80 -134.87 138.33 44.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.093 0.957 . . . . 63.43 109.015 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.8 134.16 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.006 -1.479 . . . . 64.209999999999994 107.006 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 16' ' ' SER . . . -57.1 128.27 36.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.865 0.866 . . . . 74.340000000000003 110.996 -178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 p -110.1 8.96 24.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.799 0.84 . . . . 42.210000000000001 111.725 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.9 -179.46 32.81 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.8 -0.52 . . . . 64.409999999999997 111.8 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.34 -21.49 39.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.575 0.75 . . . . 55.210000000000001 112.767 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -107.12 -7.92 16.68 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 111.852 0.315 . . . . 63.229999999999997 111.852 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.6 p -75.97 177.96 6.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.873 0.469 . . . . 62.43 111.217 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.0 tp -142.65 145.53 33.55 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.825 -0.547 . . . . 64.420000000000002 110.985 -176.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 m -94.11 120.49 34.43 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.936 0.895 . . . . 73.420000000000002 109.304 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.628 HG22 HG21 ' A' ' 123' ' ' THR . 15.8 pt -113.82 148.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.629 0.771 . . . . 53.140000000000001 111.079 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.9 m -94.92 143.96 26.05 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.714 0.806 . . . . 73.230000000000004 109.312 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.01 120.75 11.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.54 0.736 . . . . 70.200000000000003 109.923 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.95 -9.23 68.1 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.643 -0.532 . . . . 52.210000000000001 113.607 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.7 143.44 51.33 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.591 0.757 . . . . 60.039999999999999 111.461 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.33 134.88 35.09 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.87 0.868 . . . . 72.340000000000003 109.192 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.499 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -145.33 142.79 29.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 75.319999999999993 109.847 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -97.08 109.66 22.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.188 -0.671 . . . . 73.430000000000007 109.188 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.591 HG13 ' HB1' ' A' ' 119' ' ' ALA . 19.1 t -72.67 126.4 33.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-O 121.699 0.761 . . . . 63.229999999999997 109.363 171.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 23' ' ' ILE . 79.5 mt -88.63 -59.13 2.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.456 -1.702 . . . . 72.400000000000006 109.203 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.63 142.93 8.79 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.359 -0.382 . . . . 35.109999999999999 112.531 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.606 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 30.8 m-85 -86.4 168.12 14.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.513 1.125 . . . . 74.200000000000003 111.25 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -94.09 -171.58 2.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.088 1.355 . . . . 74.109999999999999 111.002 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -47.22 -36.35 8.75 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.924 1.689 . . . . 65.230000000000004 115.025 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -109.57 -6.18 15.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.543 0.337 . . . . 43.439999999999998 111.357 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.72 25.2 75.81 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.392 0.433 . . . . 53.009999999999998 113.451 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.47 -7.15 21.14 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.44 0.696 . . . . 72.150000000000006 112.296 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 33.4 m95 -140.48 134.33 30.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.67 0.788 . . . . 75.140000000000001 109.57 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.591 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -134.0 148.24 51.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 74.310000000000002 110.639 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.86 113.63 19.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.857 -1.164 . . . . 64.129999999999995 107.857 167.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.59 145.36 45.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.262 0.625 . . . . 62.119999999999997 110.95 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.44 103.53 15.49 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 109.03 -0.73 . . . . 73.25 109.03 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.628 HG21 HG22 ' A' ' 101' ' ' ILE . 75.7 p -86.36 168.44 13.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.356 0.662 . . . . 65.430000000000007 109.248 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -74.1 -11.2 60.24 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.671 -0.695 . . . . 35.530000000000001 110.57 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -79.99 -33.08 39.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.731 0.812 . . . . 72.019999999999996 110.19 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.58 -161.52 31.83 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 111.415 -0.674 . . . . 13.550000000000001 111.415 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -128.91 149.28 50.84 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.786 0.793 . . . . 73.120000000000005 110.597 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.06 178.35 35.87 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.706 0.629 . . . . 32.149999999999999 111.576 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -84.3 122.93 29.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.614 0.766 . . . . 73.099999999999994 111.989 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.411 HG11 ' CG2' ' A' ' 101' ' ' ILE . 19.8 m -128.61 145.21 55.16 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 124.992 1.317 . . . . 61.140000000000001 109.361 173.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.2 Cg_endo -84.3 146.61 11.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.287 1.991 . . . . 72.530000000000001 114.705 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 m -40.03 -41.85 1.29 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.191 1.796 . . . . 63.240000000000002 113.968 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -76.39 -17.91 59.13 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.175 -0.921 . . . . 74.219999999999999 112.657 -170.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.476 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 24.7 m-85 -92.28 -18.4 23.44 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.19 0.596 . . . . 61.030000000000001 111.713 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 130' ' ' VAL . 19.4 pt -120.24 -179.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.553 1.141 . . . . 63.530000000000001 110.408 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.9 t -162.5 151.08 12.35 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 118.428 -0.796 . . . . 70.549999999999997 108.872 166.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.72 145.71 97.21 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 121.49 1.46 . . . . 74.209999999999994 109.831 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.55 -4.38 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 121.778 0.799 . . . . 44.549999999999997 111.462 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.88 -22.74 49.31 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.777 0.831 . . . . 60.409999999999997 111.186 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.5 p -81.32 176.43 9.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.832 0.825 . . . . 72.120000000000005 111.705 -167.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 214' ' ' LEU . 38.8 mt -85.78 -26.32 25.86 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.847 -1.07 . . . . 70.140000000000001 110.605 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.525 ' HG3' ' HD2' ' A' ' 147' ' ' TYR . 1.6 mp0 -64.47 -20.41 66.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.79 1.236 . . . . 75.319999999999993 111.966 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -63.75 -4.69 3.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.732 0.813 . . . . 73.239999999999995 113.095 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.509 ' HE1' ' HB2' ' A' ' 72' ' ' ASN . 42.4 m-70 -117.73 159.29 23.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.998 0.919 . . . . 73.120000000000005 110.728 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -42.94 89.29 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.447 1.099 . . . . 71.219999999999999 112.14 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.402 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 56.3 p-90 -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.364 0.875 . . . . 72.329999999999998 113.364 -172.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.525 ' HD2' ' HG3' ' A' ' 142' ' ' GLU . 21.0 t80 -85.34 106.76 16.97 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.705 0.684 . . . . 75.140000000000001 110.356 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.513 ' HB3' HG21 ' A' ' 151' ' ' VAL . 3.2 m80 -89.27 -14.04 36.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.982 0.913 . . . . 62.299999999999997 112.0 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.48 -140.62 23.79 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.035 -1.425 . . . . 71.329999999999998 112.197 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.62 88.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.535 2.823 . . . . 71.109999999999999 112.891 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 155' ' ' ALA . 37.6 t -140.14 128.05 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.849 1.659 . . . . 73.549999999999997 108.807 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.1 p -84.27 175.13 9.62 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 124.061 0.945 . . . . 70.409999999999997 109.997 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -60.08 -40.95 91.32 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.984 -0.531 . . . . 73.420000000000002 111.158 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -53.26 -51.33 62.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.199 0.937 . . . . 75.120000000000005 110.317 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -62.57 -46.35 88.72 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.057 -1.429 . . . . 52.130000000000003 111.168 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 171' ' ' ARG . . . -56.86 -37.13 70.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.453 0.701 . . . . 31.440000000000001 112.184 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -68.83 -43.8 74.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.176 0.99 . . . . 74.219999999999999 111.155 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -71.74 -22.83 61.56 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.328 0.585 . . . . 72.540000000000006 112.214 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 239' ' ' ARG . 55.8 mt -75.67 -43.59 46.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.872 -1.058 . . . . 73.329999999999998 112.579 174.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.539 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 96.4 mt -83.21 -20.65 34.22 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.045 -0.525 . . . . 62.240000000000002 111.466 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.425 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 86.6 p -64.3 -27.77 69.26 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 108.599 -0.889 . . . . 73.109999999999999 108.599 167.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.5 m -90.41 16.63 8.46 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.516 1.127 . . . . 44.100000000000001 111.468 175.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.29 178.52 17.3 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.381 0.515 . . . . 72.439999999999998 112.688 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.3 pt -100.17 175.77 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.479 1.111 . . . . 73.340000000000003 112.241 -176.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -72.22 116.1 12.25 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.663 -0.698 . . . . 73.450000000000003 109.549 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.07 6.18 34.47 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.508 -0.769 . . . . 73.329999999999998 112.534 -167.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 66.1 m -85.26 135.36 33.96 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 117.979 0.889 . . . . 65.129999999999995 111.124 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.8 p90 -139.46 158.31 44.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.747 0.419 . . . . 73.230000000000004 110.661 -176.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.2 pp -153.69 137.11 15.83 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.871 -0.788 . . . . 72.340000000000003 108.871 170.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 182' ' ' ILE . 59.9 t -92.28 136.5 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.791 -1.189 . . . . 71.019999999999996 107.791 168.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 156' ' ' ALA . 41.2 ptt85 -136.36 143.21 43.93 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.012 0.925 . . . . 63.399999999999999 108.643 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.89 117.11 30.4 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.764 -1.569 . . . . 51.439999999999998 106.764 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -53.44 120.58 6.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.197 0.999 . . . . 70.329999999999998 111.409 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.6 -29.3 69.88 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.684 0.754 . . . . 75.310000000000002 109.665 168.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -67.55 -32.61 73.5 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.678 -1.146 . . . . 73.329999999999998 111.446 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -148.09 94.77 4.24 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 123.929 0.892 . . . . 72.310000000000002 109.829 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.27 146.6 88.45 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.845 2.363 . . . . 75.439999999999998 111.899 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.711 ' HA3' ' HA ' ' A' ' 32' ' ' SER . . . 83.15 -28.72 3.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.491 -0.616 . . . . 72.450000000000003 114.104 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -76.24 115.85 16.37 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 117.665 0.733 . . . . 73.010000000000005 110.078 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -113.93 140.5 48.34 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.006 0.922 . . . . 65.349999999999994 109.29 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.1 m -145.92 148.61 32.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.344 1.057 . . . . 71.420000000000002 108.977 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.711 HG12 HG22 ' A' ' 170' ' ' VAL . 14.2 mt -101.03 144.3 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.745 -1.576 . . . . 75.310000000000002 106.745 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -124.68 109.24 12.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.968 -1.493 . . . . 75.219999999999999 106.968 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.7 tp -106.59 113.96 27.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.038 0.535 . . . . 74.340000000000003 110.361 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 18.0 ttt180 -76.4 117.85 18.48 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.442 -0.947 . . . . 74.299999999999997 108.442 162.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -140.77 139.8 34.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 107.448 -1.315 . . . . 54.25 107.448 168.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 62.01 22.12 12.85 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.356 1.062 . . . . 74.129999999999995 112.472 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 1.91 89.66 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.331 -0.395 . . . . 65.140000000000001 113.369 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -111.96 140.12 46.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.152 0.981 . . . . 74.219999999999999 108.463 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.33 106.77 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-O 121.371 0.605 . . . . 64.329999999999998 110.657 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -90.86 145.69 24.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 72.239999999999995 108.805 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -125.02 117.92 25.07 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.083 0.468 . . . . 71.219999999999999 110.265 -173.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.572 ' HE1' HD21 ' A' ' 232' ' ' LEU . 3.0 m-85 -95.31 137.0 34.97 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.974 -1.121 . . . . 64.099999999999994 107.974 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -94.77 122.17 37.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.03 -1.1 . . . . 71.329999999999998 108.03 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 59.4 mt -84.65 101.99 9.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.583 -0.895 . . . . 75.340000000000003 108.583 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -76.18 139.52 41.27 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.856 -1.065 . . . . 71.010000000000005 109.094 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -118.39 117.3 28.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.639 0.776 . . . . 73.329999999999998 109.514 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.97 161.05 16.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.748 1.219 . . . . 63.009999999999998 110.464 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 70.0 p -64.41 -27.16 68.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.726 0.81 . . . . 52.340000000000003 112.258 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -83.84 -19.1 35.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.001 0.52 . . . . 45.509999999999998 111.032 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.48 14.3 10.72 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-O 119.014 -0.881 . . . . 64.319999999999993 115.004 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 34.7 mtmm -71.82 129.87 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.218 1.009 . . . . 71.430000000000007 111.09 173.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.93 142.85 26.91 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 71.230000000000004 108.294 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.9 p90 -169.76 137.73 1.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.097 0.873 . . . . 74.319999999999993 110.756 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -78.66 -46.02 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.435 -0.95 . . . . 75.549999999999997 108.435 164.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.1 m -98.56 124.58 43.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.437 -1.256 . . . . 74.030000000000001 108.764 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 31.4 t -65.97 -21.58 66.42 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.766 0.826 . . . . 65.340000000000003 112.051 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.13 -26.63 53.38 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.97 0.908 . . . . 71.340000000000003 110.163 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -125.42 98.41 5.6 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.798 0.839 . . . . 74.5 109.272 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 70.5 mtt180 -111.47 118.91 37.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.843 0.857 . . . . 74.219999999999999 110.179 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.421 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.5 OUTLIER -111.87 147.84 34.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.703 0.801 . . . . 72.530000000000001 109.166 -169.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.536 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 7.1 m120 -66.41 -38.88 88.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.265 0.626 . . . . 74.239999999999995 110.341 -175.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.8 p -124.32 154.57 40.1 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.652 0.781 . . . . 61.450000000000003 111.28 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 141' ' ' LEU . 1.8 tt -65.21 -23.84 67.19 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.129 0.972 . . . . 63.530000000000001 109.377 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.57 80.36 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.789 0.836 . . . . 74.450000000000003 111.242 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.52 -30.74 64.75 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.378 -0.828 . . . . 72.329999999999998 111.551 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.21 -53.54 56.96 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 123.507 0.505 . . . . 73.409999999999997 110.744 171.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.77 -43.3 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.111 0.565 . . . . 63.210000000000001 110.475 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -55.15 -56.75 16.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.957 0.903 . . . . 73.030000000000001 111.248 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -65.58 -33.16 75.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.688 -1.142 . . . . 62.25 111.047 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.666 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.1 m170 -92.21 -10.58 38.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.015 0.526 . . . . 72.439999999999998 112.024 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 77.2 p -97.75 -11.68 23.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.279 0.632 . . . . 63.310000000000002 110.747 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 35.8 p -87.31 -52.07 5.6 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 122.399 0.28 . . . . 74.219999999999999 110.636 167.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.9 162.95 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 122.135 0.969 . . . . 65.319999999999993 113.204 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.84 11.76 17.01 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.616 1.966 . . . . 73.439999999999998 114.42 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -47.73 32.07 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 130.729 3.611 . . . . 75.430000000000007 120.065 -157.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.07 6.38 4.91 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.649 -1.282 . . . . 60.409999999999997 112.911 -167.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.9 mt -94.11 161.9 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.722 1.209 . . . . 74.010000000000005 109.067 161.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.4 tt -59.46 -40.09 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-O 120.736 0.303 . . . . 52.130000000000003 110.239 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -159.37 171.96 18.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.851 0.861 . . . . 64.430000000000007 109.904 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 34.0 m -68.73 138.38 54.84 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.144 0.978 . . . . 73.340000000000003 111.606 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.572 HD21 ' HE1' ' A' ' 193' ' ' TYR . 63.8 mt -71.9 131.41 42.94 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.199 0.999 . . . . 61.539999999999999 109.412 177.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -121.4 -77.98 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 118.65 0.659 . . . . 53.420000000000002 111.223 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -85.92 121.48 72.99 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 123.531 0.733 . . . . 73.329999999999998 109.366 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.61 126.95 4.82 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.181 1.921 . . . . 72.329999999999998 111.519 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . . . -66.73 145.7 98.97 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.813 0.845 . . . . 72.239999999999995 110.159 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.44 167.17 17.48 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.524 2.15 . . . . 72.540000000000006 112.015 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -69.45 150.12 47.56 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.442 0.697 . . . . 74.140000000000001 110.118 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.719 ' HB3' HD21 ' A' ' 159' ' ' LEU . 13.7 ptt180 -91.38 -64.18 1.16 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.249 0.833 . . . . 73.120000000000005 113.249 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.512 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 61.7 t30 -111.31 134.27 53.02 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.713 0.805 . . . . 73.040000000000006 109.743 -175.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -75.58 110.97 12.03 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 105.457 -2.053 . . . . 74.150000000000006 105.457 160.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.2 146.66 38.42 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.429 2.752 . . . . 74.430000000000007 115.732 -166.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.8 m -80.55 120.69 24.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.22 0.608 . . . . 75.299999999999997 110.78 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.41 108.01 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 108.023 -1.102 . . . . 73.549999999999997 108.023 170.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -108.33 111.75 23.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.192 0.597 . . . . 61.32 109.879 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 61.46 24.07 63.37 Favored Glycine 0 C--N 1.355 1.639 0 O-C-N 124.187 0.93 . . . . 70.420000000000002 114.871 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.4 116.99 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.328 0.651 . . . . 75.310000000000002 110.676 -174.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.9 t -87.99 120.44 70.74 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 105.829 -1.915 . . . . 71.109999999999999 105.829 151.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.28 -58.39 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.771 1.647 . . . . 75.329999999999998 114.793 -159.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -126.83 -12.58 5.93 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.458 0.703 . . . . 70.310000000000002 110.437 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -85.81 104.21 15.28 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.764 -0.653 . . . . 75.209999999999994 110.637 -156.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -120.88 -47.33 2.3 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.194 0.598 . . . . 73.010000000000005 110.262 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.71 -40.11 4.4 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.354 -0.61 . . . . 74.25 109.354 167.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -55.98 119.75 6.35 Favored 'General case' 0 C--N 1.361 1.074 0 O-C-N 124.691 1.244 . . . . 75.340000000000003 112.083 -164.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--O 1.251 1.138 0 N-CA-C 106.355 -1.72 . . . . 75.219999999999999 106.355 168.293 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.587 0.232 . . . . 72.25 110.762 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.48 -179.57 41.93 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.162 -0.375 . . . . 74.239999999999995 112.162 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -100.44 110.85 23.06 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.554 -0.536 . . . . 75.010000000000005 109.554 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -118.47 128.37 26.02 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.828 0.851 . . . . 73.019999999999996 109.117 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.97 104.38 1.84 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.404 2.069 . . . . 71.409999999999997 112.288 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.32 125.13 11.63 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 110.744 -0.942 . . . . 71.510000000000005 110.744 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -65.77 117.01 7.58 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.687 0.395 . . . . 75.200000000000003 110.913 -174.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 m -76.72 -173.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.003 0.921 . . . . 73.129999999999995 111.059 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.4 mt 73.55 161.73 0.25 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.806 1.242 . . . . 73.310000000000002 111.207 -176.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.78 179.45 35.6 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.633 -0.712 . . . . 42.210000000000001 113.864 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -145.81 124.72 12.71 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.628 -1.249 . . . . 73.200000000000003 107.628 171.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -76.41 -53.33 8.3 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.94 0.896 . . . . 72.129999999999995 111.272 -172.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.63 86.21 6.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.967 -0.56 . . . . 73.140000000000001 110.744 -170.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -97.14 106.7 33.32 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.158 -0.928 . . . . 74.340000000000003 109.997 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.56 114.58 3.72 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.491 2.127 . . . . 72.439999999999998 110.817 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -71.05 88.97 0.79 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 107.827 -1.175 . . . . 74.430000000000007 107.827 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.07 147.78 93.89 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.17 0.988 . . . . 71.140000000000001 111.278 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.9 173.86 12.29 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.792 2.328 . . . . 71.239999999999995 111.62 175.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 64.65 19.0 11.68 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.38 1.072 . . . . 73.400000000000006 112.479 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.5 mt -86.48 96.57 10.09 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.962 -0.755 . . . . 74.510000000000005 108.962 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -140.75 108.62 5.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.396 -0.82 . . . . 62.109999999999999 108.87 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -133.06 101.0 5.05 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.621 -0.881 . . . . 74.030000000000001 108.621 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -66.24 97.72 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 109.139 -0.689 . . . . 74.319999999999993 109.139 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -143.98 -86.66 0.13 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.097 -0.501 . . . . 72.120000000000005 109.98 -173.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.47 98.43 0.04 OUTLIER Glycine 0 C--N 1.351 1.375 0 O-C-N 123.026 0.203 . . . . 72.340000000000003 113.467 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.02 -78.43 0.58 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.402 0.681 . . . . 64.200000000000003 109.34 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.97 -72.64 0.89 Allowed Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.368 -0.378 . . . . 73.109999999999999 112.696 -175.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.2 mttm 64.87 29.22 12.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.157 1.383 . . . . 74.239999999999995 112.819 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -109.82 178.08 4.52 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.068 0.947 . . . . 63.399999999999999 109.908 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -162.67 150.16 13.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.961 0.505 . . . . 75.219999999999999 110.491 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.2 t -119.06 146.88 44.7 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.618 0.767 . . . . 51.350000000000001 110.299 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 p -80.1 170.35 16.56 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.243 0.617 . . . . 51.240000000000002 110.227 170.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -114.68 -179.5 3.65 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.125 0.57 . . . . 61.439999999999998 109.815 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -133.12 137.18 46.21 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.319 0.648 . . . . 71.409999999999997 109.444 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.46 89.84 0.13 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 112.08 -0.408 . . . . 35.520000000000003 112.08 -174.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.16 123.42 6.32 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 119.403 -0.665 . . . . 43.130000000000003 112.689 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -72.05 -178.82 3.42 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.955 2.437 . . . . 72.209999999999994 113.076 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.0 t60 66.8 12.79 9.09 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.782 1.233 . . . . 75.25 112.371 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.6 m -146.82 15.33 1.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.439 0.695 . . . . 75.319999999999993 111.061 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -68.24 148.87 50.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.89 0.476 . . . . 55.399999999999999 110.196 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.05 138.43 53.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.402 0.681 . . . . 65.310000000000002 109.328 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -75.18 113.87 13.03 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.025 -0.731 . . . . 72.150000000000006 109.025 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.5 m -82.04 167.55 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.019 0.528 . . . . 61.420000000000002 109.812 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.14 151.91 38.4 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.77 0.828 . . . . 75.340000000000003 109.648 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -106.41 -40.17 5.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.788 0.835 . . . . 74.129999999999995 109.623 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 64.21 179.32 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.894 1.278 . . . . 53.420000000000002 112.157 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.02 115.41 8.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.368 0.667 . . . . 74.510000000000005 109.607 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.36 155.82 16.6 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.734 -0.839 . . . . 63.450000000000003 108.734 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -79.59 109.86 14.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.675 -0.491 . . . . 53.219999999999999 109.675 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.6 140.04 7.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 123.701 0.8 . . . . 64.200000000000003 109.227 170.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 117.61 5.2 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.383 2.055 . . . . 64.5 111.115 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 53' ' ' ALA . 9.6 p -73.13 176.91 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.298 0 C-N-CA 123.808 0.843 . . . . 71.340000000000003 109.262 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.418 ' H ' HG22 ' A' ' 52' ' ' VAL . . . -64.17 165.37 9.38 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 118.185 0.448 . . . . 74.120000000000005 111.265 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 p -52.76 -30.2 31.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.667 1.187 . . . . 71.310000000000002 113.876 -168.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.98 -50.68 0.26 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.448 0.699 . . . . 54.039999999999999 109.716 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -82.83 -176.84 6.51 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.973 -1.012 . . . . 61.210000000000001 111.122 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 146.1 57.6 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.683 0.793 . . . . 64.25 109.452 174.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.59 -75.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.715 2.276 . . . . 71.109999999999999 112.573 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -145.86 3.8 0.96 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.79 0.836 . . . . 73.019999999999996 111.135 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.42 -48.85 3.15 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.446 -0.662 . . . . 71.010000000000005 111.446 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.6 120.19 14.23 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.385 0.674 . . . . 75.439999999999998 109.911 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.2 p -164.88 40.11 0.07 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.171 0.988 . . . . 64.439999999999998 109.464 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -66.57 -34.72 78.53 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 114.617 -1.174 . . . . 74.120000000000005 111.025 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.22 -76.28 0.58 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.553 0.741 . . . . 53.119999999999997 109.649 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.62 -82.15 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.047 0.939 . . . . 60.039999999999999 108.543 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -88.84 -30.16 19.15 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.052 -0.722 . . . . 54.200000000000003 109.052 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -75.73 84.58 2.72 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.375 -0.83 . . . . 65.129999999999995 109.995 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -83.32 -31.52 26.78 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.627 -1.169 . . . . 52.210000000000001 109.805 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.6 p -69.58 3.48 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.153 0.981 . . . . 61.439999999999998 112.712 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.76 -25.04 67.09 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.419 0.688 . . . . 50.140000000000001 110.329 169.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.603 ' HG3' HD22 ' A' ' 72' ' ' ASN . 17.0 pt-20 -58.82 -36.81 75.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.588 0.755 . . . . 74.409999999999997 110.248 171.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.603 HD22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -86.15 -7.04 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.945 1.298 . . . . 45.530000000000001 111.569 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.81 -49.42 70.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.246 0.618 . . . . 64.340000000000003 110.157 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.2 mt -112.84 18.45 18.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.384 0.674 . . . . 72.319999999999993 110.906 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.49 -46.68 21.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.906 0.482 . . . . 30.34 110.842 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.69 -135.35 12.8 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.19 -0.783 . . . . 52.020000000000003 111.746 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.56 -172.72 0.83 Allowed 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 123.799 2.999 . . . . 73.319999999999993 113.396 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 14.4 m -60.06 170.35 1.26 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.417 1.087 . . . . 44.140000000000001 112.466 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.75 -52.11 65.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.079 0.551 . . . . 54.340000000000003 112.39 -168.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -135.93 -38.4 0.71 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.198 0.523 . . . . 72.239999999999995 111.412 171.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 78' ' ' SER . 7.7 m-20 -90.02 143.65 30.2 Favored Pre-proline 0 N--CA 1.48 1.07 0 CA-C-N 115.607 -0.724 . . . . 73.510000000000005 112.105 -170.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.62 -35.79 27.78 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.977 2.451 . . . . 54.350000000000001 112.244 171.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -95.62 18.31 13.13 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.579 0.752 . . . . 60.439999999999998 112.205 -173.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 51.0 tp -82.34 120.15 25.04 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.93 -0.767 . . . . 75.299999999999997 108.93 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.1 m-85 -106.91 174.22 5.98 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.758 1.223 . . . . 74.239999999999995 109.066 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.32 138.41 40.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.97 1.308 . . . . 54.549999999999997 108.66 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.49 116.84 18.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 74.319999999999993 109.968 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 69.6 mt -79.4 -29.98 42.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.283 0.633 . . . . 71.430000000000007 110.864 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 87.4 m-85 -126.64 140.82 52.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.867 -1.06 . . . . 75.030000000000001 108.529 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -72.84 134.19 44.77 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.176 -1.046 . . . . 65.019999999999996 108.176 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.9 t80 -131.22 111.23 11.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.316 -0.994 . . . . 73.430000000000007 108.316 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.99 137.15 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.542 -1.281 . . . . 74.430000000000007 107.542 172.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.01 117.12 2.96 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.129 0.972 . . . . 75.340000000000003 112.497 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.8 p -88.5 4.99 44.67 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.918 0.887 . . . . 72.329999999999998 111.646 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.85 -175.39 33.84 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.245 -0.742 . . . . 72.209999999999994 111.245 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -79.39 -38.21 35.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.22 0.608 . . . . 72.099999999999994 110.508 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -83.25 -15.46 50.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.24 1.016 . . . . 70.439999999999998 111.458 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.455 ' HA ' ' H ' ' A' ' 129' ' ' TRP . 71.7 p -77.24 177.24 8.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.967 0.507 . . . . 53.130000000000003 111.183 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.497 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 56.3 tp -134.31 132.22 39.3 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.814 0.446 . . . . 54.409999999999997 111.154 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 58.0 m -77.9 116.9 18.76 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.864 -0.607 . . . . 61.100000000000001 109.771 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 91' ' ' PHE . 15.2 pt -119.9 153.89 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.951 0.901 . . . . 75.219999999999999 110.137 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -106.9 145.87 31.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.106 0.562 . . . . 72.450000000000003 109.506 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -67.34 109.68 3.24 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 122.857 0.463 . . . . 63.140000000000001 110.156 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.18 -11.93 33.94 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 116.371 -0.377 . . . . 71.230000000000004 112.358 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -77.52 137.73 38.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.331 0.652 . . . . 71.409999999999997 110.443 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.41 ' HB3' HD11 ' A' ' 84' ' ' LEU . 42.0 mmtm -84.55 145.23 28.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.816 0.847 . . . . 71.420000000000002 109.371 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.33 146.74 32.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.337 0.655 . . . . 71.439999999999998 110.301 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -92.49 109.65 21.05 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.112 -1.069 . . . . 73.239999999999995 108.112 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.582 HG13 ' HB1' ' A' ' 119' ' ' ALA . 74.8 t -85.21 122.92 38.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.979 -0.748 . . . . 74.120000000000005 108.979 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.473 HD11 HE21 ' A' ' 122' ' ' GLN . 17.3 mt -90.87 -21.91 21.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.814 1.246 . . . . 74.099999999999994 109.959 -174.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.92 152.69 6.39 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.639 -0.534 . . . . 62.030000000000001 112.668 174.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 47.1 m-85 -86.56 165.22 16.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.372 0.606 . . . . 63.140000000000001 110.81 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -86.91 -172.3 3.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.609 1.164 . . . . 64.400000000000006 111.077 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -58.61 -34.12 70.77 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.886 0.875 . . . . 72.409999999999997 112.53 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -102.5 -4.09 25.89 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.239 0.616 . . . . 74.450000000000003 111.741 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 63.49 26.84 70.02 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.59 -0.561 . . . . 71.540000000000006 114.44 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.19 -12.98 19.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.34 0.57 . . . . 72.329999999999998 111.49 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.464 ' HE1' HG23 ' A' ' 247' ' ' VAL . 79.6 m95 -137.65 151.43 48.27 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.984 0.914 . . . . 71.209999999999994 109.967 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 112' ' ' TYR . . . -135.35 140.22 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.581 0.752 . . . . 61.420000000000002 110.312 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.432 ' HG2' ' NE2' ' A' ' 127' ' ' GLN . 40.7 tt0 -77.19 99.87 5.59 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.684 -1.598 . . . . 72.319999999999993 106.684 169.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.98 161.7 24.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.275 0.63 . . . . 74.120000000000005 110.668 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.473 HE21 HD11 ' A' ' 110' ' ' LEU . 8.5 pt20 -132.11 123.64 27.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.25 0.548 . . . . 73.109999999999999 111.929 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.2 p -98.05 -176.95 3.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.958 1.303 . . . . 64.5 109.853 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 11.0 mptt -66.91 -22.27 65.96 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.762 -1.108 . . . . 61.450000000000003 109.514 172.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -75.96 -19.69 58.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.931 1.293 . . . . 74.310000000000002 110.9 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.62 -160.85 24.16 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.076 0.235 . . . . 23.43 112.873 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.432 ' NE2' ' HG2' ' A' ' 120' ' ' GLU . 64.7 tp60 -98.59 158.34 15.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.917 0.887 . . . . 71.209999999999994 110.378 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 166.29 -163.42 36.86 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.234 -0.439 . . . . 35.140000000000001 112.416 169.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.455 ' H ' ' HA ' ' A' ' 98' ' ' THR . 87.0 m95 -102.76 131.64 49.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.906 0.882 . . . . 70.109999999999999 110.618 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 8.8 m -130.66 139.37 35.41 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.196 0.998 . . . . 64.219999999999999 108.947 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 130' ' ' VAL . 3.8 Cg_exo -78.94 141.32 16.67 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.522 2.148 . . . . 50.329999999999998 113.577 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.5 m -42.6 -44.74 4.34 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.614 1.566 . . . . 72.120000000000005 113.981 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.57 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 26.5 p-10 -78.25 6.09 8.95 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.895 0.878 . . . . 64.239999999999995 112.329 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.4 -14.29 12.2 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.3 1.04 . . . . 65.230000000000004 111.274 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.46 173.2 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.507 0.723 . . . . 72.129999999999995 112.034 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.415 HG21 ' HB2' ' A' ' 142' ' ' GLU . 5.8 t -161.56 153.33 16.1 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.602 1.161 . . . . 74.150000000000006 107.889 170.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 28.3 Cg_endo -60.71 148.4 91.81 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.507 1.472 . . . . 74.510000000000005 111.634 172.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.2 t -73.46 -4.01 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 CA-C-O 121.711 0.767 . . . . 73.430000000000007 110.179 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -80.02 -19.99 46.41 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.697 0.799 . . . . 74.239999999999995 111.49 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.0 p -86.41 174.52 8.95 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.172 0.589 . . . . 64.129999999999995 112.129 -171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.59 -22.38 30.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.738 0.815 . . . . 60.329999999999998 111.516 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.415 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.9 mp0 -68.47 -18.1 64.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.74 0.816 . . . . 75.349999999999994 111.611 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -60.74 -12.94 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.412 0.685 . . . . 73.010000000000005 112.744 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -95.44 158.18 15.57 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.029 0.931 . . . . 71.25 110.535 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.5 p -70.11 -42.79 72.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.588 0.755 . . . . 62.32 111.254 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.487 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 48.9 p-90 -61.98 -39.61 92.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.051 0.76 . . . . 74.530000000000001 113.051 -176.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -82.83 105.78 14.12 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.956 -0.387 . . . . 61.329999999999998 109.956 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -99.32 -3.55 33.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.292 0.637 . . . . 53.130000000000003 111.952 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.13 -148.86 33.45 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.754 -1.025 . . . . 73.409999999999997 113.102 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.34 106.76 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.792 2.328 . . . . 52.439999999999998 112.042 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.7 t -135.79 139.63 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.533 1.533 . . . . 72.439999999999998 109.152 -174.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.6 p -90.23 170.33 10.38 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 65.430000000000007 109.873 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.19 -29.81 70.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.795 0.27 . . . . 74.040000000000006 110.583 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -55.94 -53.84 51.98 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.275 0.63 . . . . 71.25 110.125 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.536 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -72.5 -27.88 62.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.844 -1.071 . . . . 71.540000000000006 111.725 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.41 61.97 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.111 0.564 . . . . 74.25 111.586 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -63.71 -38.17 90.09 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.731 . . . . 72.349999999999994 110.433 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.46 -45.81 92.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.903 -1.044 . . . . 70.340000000000003 110.753 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.67 -48.82 79.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.597 0.759 . . . . 75.400000000000006 111.772 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.17 11.18 24.15 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.709 1.003 . . . . 70.030000000000001 113.709 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.8 p -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.725 0.693 . . . . 54.409999999999997 109.991 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.1 p -94.0 10.1 34.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.57 0.748 . . . . 70.140000000000001 111.145 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -76.52 157.92 48.3 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.21 -0.45 . . . . 72.140000000000001 113.274 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.2 pt -100.74 176.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.878 0.871 . . . . 60.310000000000002 111.074 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.99 110.08 5.48 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.089 -0.708 . . . . 75.319999999999993 109.089 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.62 7.96 23.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.505 -0.608 . . . . 63.539999999999999 112.723 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.3 m -83.86 122.43 28.7 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.463 0.632 . . . . 54.020000000000003 111.014 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -129.53 164.82 22.95 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.475 0.579 . . . . 74.239999999999995 111.16 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.94 138.65 14.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.478 -0.934 . . . . 74.030000000000001 108.478 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.663 HG22 HG12 ' A' ' 182' ' ' ILE . 72.5 t -98.27 138.8 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.136 -1.061 . . . . 72.239999999999995 108.136 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.595 ' HE ' ' HB2' ' A' ' 181' ' ' SER . 2.1 ppt_? -146.7 162.38 38.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.881 0.873 . . . . 72.340000000000003 108.83 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -107.57 150.0 27.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.427 -1.323 . . . . 54.439999999999998 107.427 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t -68.33 125.1 25.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.454 -0.573 . . . . 60.130000000000003 109.454 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.25 -38.93 71.78 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.479 1.112 . . . . 73.219999999999999 111.154 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.3 m -102.88 5.92 38.81 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.605 0.762 . . . . 31.129999999999999 112.254 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.7 m -148.1 88.77 5.39 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 122.888 0.475 . . . . 61.32 110.532 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.55 134.47 35.67 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.69 2.26 . . . . 73.340000000000003 111.961 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.27 -28.54 13.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.934 -0.575 . . . . 31.34 112.378 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -88.91 116.98 27.58 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.844 -0.798 . . . . 75.400000000000006 108.844 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 77.5 mtt180 -119.16 159.35 24.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.284 0.564 . . . . 73.120000000000005 110.525 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.595 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 40.2 m -148.4 152.43 36.97 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.266 -0.879 . . . . 72.310000000000002 110.278 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.663 HG12 HG22 ' A' ' 170' ' ' VAL . 33.9 mt -104.18 150.48 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.373 -1.343 . . . . 72.450000000000003 107.373 170.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.0 m -122.94 108.18 12.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.186 -1.412 . . . . 64.549999999999997 107.186 170.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.95 110.49 22.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.319 -0.623 . . . . 72.129999999999995 109.319 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.505 ' HB2' HG22 ' A' ' 190' ' ' VAL . 35.6 ttt180 -78.3 115.68 18.19 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.982 -0.747 . . . . 75.319999999999993 108.982 166.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -140.34 138.25 34.74 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.552 1.158 . . . . 52.009999999999998 108.446 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 56.08 30.89 17.12 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.297 1.039 . . . . 72.409999999999997 112.033 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 75.96 12.95 83.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.87 -0.605 . . . . 74.140000000000001 114.264 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -122.0 136.56 54.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 73.530000000000001 109.391 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 185' ' ' ARG . 60.3 t -96.54 106.47 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 122.921 0.488 . . . . 75.120000000000005 110.252 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.02 136.48 33.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.593 1.157 . . . . 71.409999999999997 109.381 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -112.51 119.0 36.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.132 0.491 . . . . 64.319999999999993 110.231 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.505 ' HE1' HD21 ' A' ' 232' ' ' LEU . 10.6 m-30 -95.63 142.2 28.23 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.994 -1.003 . . . . 65.530000000000001 109.053 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 7.1 tpp180 -93.88 109.79 21.48 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.121 -0.696 . . . . 71.439999999999998 109.121 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 54.9 mt -85.7 101.95 10.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.079 -1.082 . . . . 62.539999999999999 108.079 170.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.06 116.46 19.37 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.051 -0.722 . . . . 75.400000000000006 109.051 170.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 m -87.66 112.92 22.85 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.786 -0.82 . . . . 73.439999999999998 108.786 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -67.13 157.65 33.13 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.232 0.613 . . . . 51.439999999999998 110.401 174.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.8 p -65.61 -20.93 66.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.005 0.922 . . . . 72.209999999999994 113.122 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.37 -14.96 39.25 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.1 0.56 . . . . 54.100000000000001 110.891 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.23 11.99 14.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.508 -0.607 . . . . 33.229999999999997 113.868 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 67.9 mttm -71.56 155.36 40.64 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.873 0.837 . . . . 74.439999999999998 110.563 171.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.43 143.41 49.25 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.011 -1.107 . . . . 64.230000000000004 108.011 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 52.9 p90 -162.83 133.79 4.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.403 0.44 . . . . 73.450000000000003 111.994 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 52.9 t -82.14 -36.32 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.466 -0.788 . . . . 61.219999999999999 109.432 168.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 16.0 m -105.47 124.64 49.89 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.006 -1.109 . . . . 75.040000000000006 108.006 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.2 m -62.25 -25.62 67.93 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 60.32 112.771 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -80.69 -31.32 36.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.876 . . . . 73.510000000000005 110.775 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 50.6 m -109.47 88.47 2.75 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.484 0.713 . . . . 63.549999999999997 109.933 -173.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.592 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 64.8 mtt180 -100.67 127.11 47.18 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.873 -0.788 . . . . 73.340000000000003 108.873 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.95 148.55 38.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.476 -0.935 . . . . 70.219999999999999 108.476 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -68.06 -37.45 81.32 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.555 0.534 . . . . 64.409999999999997 110.146 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 67.0 p -127.98 158.68 37.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.829 0.852 . . . . 74.109999999999999 112.031 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.9 -22.23 62.29 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.879 -1.055 . . . . 75.140000000000001 109.917 175.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.39 97.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.392 0.677 . . . . 74.150000000000006 110.348 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.28 -37.06 71.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.103 -0.953 . . . . 73.519999999999996 111.403 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.422 HD11 HG23 ' A' ' 205' ' ' VAL . 15.2 tp -55.04 -57.87 9.96 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.366 0.416 . . . . 45.420000000000002 110.963 173.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.46 -48.76 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.226 0.61 . . . . 71.239999999999995 110.976 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -57.84 -55.04 39.99 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.012 0.82 . . . . 74.329999999999998 111.071 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -65.13 -33.43 75.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.093 0.557 . . . . 54.420000000000002 111.576 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.737 ' HB3' HD11 ' A' ' 228' ' ' LEU . 14.0 m170 -89.76 -8.54 51.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.095 0.406 . . . . 73.140000000000001 112.095 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 84.5 p -93.59 -24.81 17.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.764 0.426 . . . . 43.399999999999999 110.209 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.9 p -81.31 -47.11 13.75 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.769 0.428 . . . . 51.039999999999999 110.856 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.613 HG23 ' HB2' ' A' ' 226' ' ' ASP . 23.5 m -128.17 164.37 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.043 0.925 . . . . 74.150000000000006 112.356 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.95 14.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 127.184 2.194 . . . . 71.099999999999994 114.125 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.613 ' HB2' HG23 ' A' ' 224' ' ' VAL . 35.4 t70 -45.41 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.356 1 C-N-CA 131.816 4.046 . . . . 74.040000000000006 119.614 -158.219 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 124.52 -1.79 8.77 Favored Glycine 0 N--CA 1.486 1.977 0 O-C-N 120.808 -1.183 . . . . 71.340000000000003 112.48 -169.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.737 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.7 mt -93.9 163.15 13.62 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.753 1.221 . . . . 64.450000000000003 110.016 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.7 tt -56.96 -40.45 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 120.824 0.345 . . . . 64.129999999999995 110.369 166.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -162.76 177.33 9.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.595 0.758 . . . . 70.409999999999997 110.69 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -66.15 136.24 55.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 54.32 111.686 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.505 HD21 ' HE1' ' A' ' 193' ' ' TYR . 49.2 mt -69.36 138.73 53.94 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 108.332 -0.988 . . . . 72.510000000000005 108.332 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -132.25 -77.63 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.962 1.255 . . . . 73.420000000000002 111.675 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 167' ' ' SER . 17.9 t80 -80.7 123.0 82.82 Favored Pre-proline 0 C--O 1.209 -1.049 0 CA-C-O 118.307 -0.854 . . . . 72.019999999999996 108.753 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 146' ' ' TRP . 8.3 Cg_endo -88.36 132.89 2.68 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.288 1.992 . . . . 51.210000000000001 111.609 171.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.77 131.94 93.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.484 0.714 . . . . 74.340000000000003 109.782 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.92 177.76 7.99 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.674 2.249 . . . . 71.439999999999998 113.116 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 32.7 mmtp -79.0 126.6 30.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.463 0.705 . . . . 73.430000000000007 109.349 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.522 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 15.3 ptt180 -93.14 -62.45 1.38 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.545 0.943 . . . . 74.540000000000006 113.545 -160.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.522 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 57.4 t30 -109.26 132.31 54.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.235 0.614 . . . . 73.340000000000003 111.09 -167.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -68.84 112.4 11.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 107.179 -1.415 . . . . 61.229999999999997 107.179 163.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.57 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 8.0 Cg_exo -74.61 124.59 8.93 Favored 'Trans proline' 0 C--N 1.364 1.395 0 C-N-CA 122.218 1.946 . . . . 74.030000000000001 112.098 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 87.7 m -64.96 123.27 19.0 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.318 0.647 . . . . 74.439999999999998 110.744 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.438 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 64.1 t -79.69 125.95 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 108.658 -0.868 . . . . 72.530000000000001 108.658 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -98.17 113.0 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 117.711 0.232 . . . . 64.230000000000004 111.096 -168.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 58.1 6.37 2.92 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 118.675 2.23 . . . . 75.340000000000003 118.675 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.464 HG23 ' HE1' ' A' ' 118' ' ' TRP . 17.1 m -106.53 123.07 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.943 1.371 . . . . 72.329999999999998 113.781 -170.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 t -82.89 122.94 78.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 106.326 -1.731 . . . . 50.130000000000003 106.326 157.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 118' ' ' TRP . 41.0 Cg_endo -64.7 -57.64 0.28 Allowed 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.423 1.415 . . . . 74.140000000000001 115.212 -157.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -126.78 -26.04 3.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.794 0.438 . . . . 72.099999999999994 110.803 164.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -69.03 99.43 1.09 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.767 0.794 . . . . 74.439999999999998 112.804 -142.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -123.81 -46.27 1.99 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 113.999 -1.455 . . . . 62.140000000000001 108.297 156.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -111.37 -43.14 3.74 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.786 -1.097 . . . . 73.340000000000003 113.372 -169.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -71.95 114.49 10.1 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.848 0.684 . . . . 65.230000000000004 112.848 -153.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.26 1.636 0 C-N-CA 125.359 1.464 . . . . 73.329999999999998 108.123 172.316 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.031 -0.359 . . . . 75.219999999999999 110.031 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.04 149.38 49.09 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 115.825 -0.625 . . . . 44.100000000000001 112.043 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -143.44 148.11 35.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.474 0.71 . . . . 63.200000000000003 110.081 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -100.19 110.11 58.69 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.772 -0.825 . . . . 73.219999999999999 108.772 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.37 111.59 2.97 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.801 2.334 . . . . 72.120000000000005 112.987 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.47 123.94 6.29 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 116.072 -0.513 . . . . 73.530000000000001 111.846 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.5 79.65 8.88 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.746 -0.835 . . . . 64.319999999999993 108.746 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m -83.32 177.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.772 0.829 . . . . 60.140000000000001 111.053 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.5 115.65 31.02 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.687 0.795 . . . . 72.409999999999997 109.024 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.44 84.77 0.95 Allowed Glycine 0 C--N 1.344 1.009 0 N-CA-C 110.273 -1.131 . . . . 75.099999999999994 110.273 170.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.85 152.91 25.99 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.519 0.728 . . . . 63.219999999999999 111.098 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -60.96 105.28 0.45 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.858 0.837 . . . . 73.5 110.574 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -108.29 162.55 13.98 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.553 1.141 . . . . 62.32 109.235 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -60.47 139.49 92.37 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.096 0.958 . . . . 74.430000000000007 111.068 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.59 -171.04 0.84 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.987 2.458 . . . . 61.439999999999998 112.886 -176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 t -146.43 -176.9 5.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.555 0.742 . . . . 62.399999999999999 109.723 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -69.59 116.67 45.47 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.548 0.739 . . . . 70.109999999999999 109.78 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.95 106.55 2.29 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.298 1.999 . . . . 74.010000000000005 110.7 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.04 136.81 32.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.133 0.573 . . . . 70.109999999999999 110.947 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.7 pt? -79.61 156.24 27.75 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.173 0.589 . . . . 73.140000000000001 110.342 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.48 171.14 14.87 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.444 0.698 . . . . 61.299999999999997 110.504 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -77.49 107.94 10.29 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.368 0.667 . . . . 73.439999999999998 109.485 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.495 ' HB ' ' ND2' ' A' ' 240' ' ' ASN . 7.0 pt -140.38 127.1 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.833 0.853 . . . . 71.140000000000001 109.501 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.09 153.09 19.6 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.804 0.842 . . . . 75.319999999999993 111.468 -171.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 178.68 -156.58 19.25 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 123.485 0.49 . . . . 54.240000000000002 112.184 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.1 176.86 8.79 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.147 0.979 . . . . 64.400000000000006 110.391 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.62 97.29 0.26 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.247 0.451 . . . . 71.150000000000006 112.297 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -62.49 -73.24 0.11 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.64 0.776 . . . . 61.310000000000002 110.523 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HB3' HD21 ' A' ' 68' ' ' ASN . 60.8 mtm180 71.92 149.44 0.09 Allowed 'General case' 0 C--N 1.37 1.472 0 C-N-CA 125.348 1.459 . . . . 74.230000000000004 110.729 -174.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -82.56 18.34 1.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.868 1.433 . . . . 74.400000000000006 114.868 -165.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.7 t 69.39 145.23 0.05 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.582 1.153 . . . . 63.409999999999997 112.914 172.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 68' ' ' ASN . 28.6 t 178.61 175.88 0.55 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.531 1.533 . . . . 52.25 108.748 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.08 175.45 13.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.777 0.831 . . . . 62.039999999999999 109.719 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -155.19 -72.09 0.12 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 120.995 0.426 . . . . 74.439999999999998 110.695 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.37 135.67 2.35 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.003 -1.239 . . . . 61.240000000000002 110.003 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.11 137.33 5.22 Favored Glycine 0 C--N 1.358 1.753 0 CA-C-N 118.113 0.957 . . . . 70.109999999999999 113.158 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.04 -47.56 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.226 2.617 . . . . 73.129999999999995 114.028 -173.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -76.79 113.16 14.15 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 109.806 -0.442 . . . . 72.400000000000006 109.806 -176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.586 ' SG ' ' HG3' ' A' ' 51' ' ' PRO . 5.9 p -89.05 -178.37 5.67 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.049 0.939 . . . . 73.239999999999995 111.438 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.477 HD22 HG22 ' A' ' 41' ' ' VAL . 9.4 p-10 -153.69 -75.12 0.12 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.883 0.873 . . . . 75.030000000000001 109.911 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.477 HG22 HD22 ' A' ' 40' ' ' ASN . 8.5 m -149.12 159.19 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 124.98 1.312 . . . . 75.310000000000002 109.537 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 t80 80.53 157.62 0.15 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.316 1.447 . . . . 60.329999999999998 112.267 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.1 t 68.0 94.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.334 1.453 . . . . 54.0 110.344 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -66.34 119.41 11.52 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.584 1.153 . . . . 75.120000000000005 111.922 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.424 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . 3.2 m170 -170.92 -165.37 0.42 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.887 1.675 . . . . 64.219999999999999 107.636 170.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -114.14 117.7 31.96 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.906 0.482 . . . . 70.200000000000003 109.874 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.78 133.06 0.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.362 1.465 . . . . 74.120000000000005 108.28 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -147.6 163.27 37.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.187 0.518 . . . . 62.229999999999997 110.571 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.62 -93.53 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.255 -1.758 . . . . 71.150000000000006 106.255 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -133.76 73.1 72.4 Favored Pre-proline 0 N--CA 1.477 0.912 0 N-CA-C 107.068 -1.456 . . . . 71.129999999999995 107.068 162.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HG3' ' SG ' ' A' ' 39' ' ' CYS . 15.1 Cg_exo -70.24 -81.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.339 2.693 . . . . 62.299999999999997 112.457 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.7 m -143.6 -58.22 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.789 0.436 . . . . 63.140000000000001 112.057 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.38 91.79 2.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.692 0.797 . . . . 53.210000000000001 109.356 -170.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.0 m -62.56 -9.3 8.32 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.135 1.161 . . . . 70.409999999999997 114.135 -168.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -62.55 -52.45 63.38 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.974 0.51 . . . . 73.219999999999999 110.649 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -144.87 114.43 7.19 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.672 -0.862 . . . . 63.520000000000003 108.672 -176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -118.11 120.59 32.25 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 109.254 -0.647 . . . . 74.129999999999995 109.254 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.59 59.44 7.25 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.836 2.357 . . . . 73.430000000000007 110.781 173.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.561 ' NE2' ' HB2' ' A' ' 61' ' ' LEU . 19.3 tt0 60.89 -83.1 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.8 1.64 . . . . 75.319999999999993 110.187 -167.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.27 23.94 3.99 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 115.103 0.801 . . . . 74.209999999999994 115.103 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' HB2' ' NE2' ' A' ' 59' ' ' GLN . 1.0 OUTLIER -74.52 85.16 2.04 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.255 -1.017 . . . . 71.030000000000001 108.255 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -123.06 89.8 3.17 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.65 -0.87 . . . . 71.340000000000003 108.65 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.643 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 6.4 pt-20 -143.15 -22.4 0.62 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.923 -1.035 . . . . 74.540000000000006 110.841 174.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.8 66.75 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.04 0.448 . . . . 73.450000000000003 111.409 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.35 11.01 17.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.404 1.081 . . . . 73.209999999999994 111.211 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.643 ' HB2' ' HA ' ' A' ' 63' ' ' GLU . 58.3 mmt-85 -126.08 -60.25 1.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.88 0.872 . . . . 74.129999999999995 110.702 -174.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.422 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 6.7 t90 -119.97 81.38 1.73 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.969 0.908 . . . . 73.420000000000002 109.274 176.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 19.7 p-10 -76.84 -29.48 55.93 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 116.229 -0.441 . . . . 71.420000000000002 110.519 177.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -73.21 5.03 3.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.019 1.328 . . . . 74.129999999999995 113.095 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.53 -17.71 64.96 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.676 1.19 . . . . 73.140000000000001 112.922 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -26.84 19.51 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.255 0.622 . . . . 74.129999999999995 110.957 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.92 -5.63 55.94 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.62 0.768 . . . . 73.430000000000007 110.4 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.447 HD13 ' HE1' ' A' ' 146' ' ' TRP . 62.4 tp -60.72 -54.09 49.48 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.961 0.505 . . . . 71.349999999999994 109.869 174.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.02 84.3 1.9 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.98 -1.119 . . . . 71.109999999999999 107.98 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.53 -36.86 21.88 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.378 -0.828 . . . . 72.319999999999993 111.774 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.49 -153.13 43.9 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-O 118.874 -0.959 . . . . 71.519999999999996 112.599 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -83.92 112.79 1.8 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 CA-C-N 119.937 1.869 . . . . 74.439999999999998 110.154 165.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.44 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 33.5 t -127.55 177.18 6.94 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.034 0.933 . . . . 54.240000000000002 110.988 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -75.4 3.39 9.24 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 124.527 1.131 . . . . 70.349999999999994 110.87 173.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 78' ' ' SER . 32.4 p-10 -82.67 31.34 0.42 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.058 1.343 . . . . 73.430000000000007 112.111 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.28 148.44 0.84 Allowed Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 126.298 1.839 . . . . 75.329999999999998 112.673 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.58 0.12 4.53 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.444 2.762 . . . . 73.319999999999993 115.813 -162.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.58 -24.24 45.63 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.447 0.642 . . . . 73.099999999999994 110.073 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 106' ' ' LYS . 38.5 tp -88.46 121.37 30.77 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 114.636 -1.165 . . . . 63.539999999999999 108.084 171.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.56 173.19 6.42 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.5 1.12 . . . . 71.120000000000005 108.704 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -131.18 135.81 58.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 124.424 1.089 . . . . 63.539999999999999 108.109 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.69 107.06 6.55 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.062 0.945 . . . . 70.239999999999995 109.405 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.521 HD22 ' HZ2' ' A' ' 238' ' ' LYS . 79.0 mt -69.29 -23.92 63.89 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.475 0.71 . . . . 74.209999999999994 111.528 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 77.0 m-85 -135.77 155.67 50.0 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 75.140000000000001 109.954 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 241' ' ' LYS . 10.9 m-20 -70.87 156.09 40.0 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.908 -0.775 . . . . 71.25 108.908 167.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.586 ' HB3' HG12 ' A' ' 101' ' ' ILE . 71.1 t80 -149.3 124.32 10.03 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.133 -1.432 . . . . 72.319999999999993 107.133 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.4 135.34 27.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.789 -1.56 . . . . 62.409999999999997 106.789 169.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.48 117.46 3.11 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.964 0.79 . . . . 41.509999999999998 111.475 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.2 p -88.03 15.14 7.72 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.159 0.984 . . . . 60.350000000000001 110.991 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.47 179.54 46.06 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.912 -0.875 . . . . 74.319999999999993 110.912 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.09 -24.97 58.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.215 0.606 . . . . 72.319999999999993 111.444 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.445 ' H ' HD21 ' A' ' 97' ' ' ASN . 0.0 OUTLIER -89.06 -17.56 29.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.724 0.809 . . . . 74.150000000000006 111.561 -178.48 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.7 p -88.97 158.96 17.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.187 0.595 . . . . 65.549999999999997 110.508 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -121.63 134.15 54.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.215 0.606 . . . . 61.509999999999998 110.98 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.8 m -79.94 132.6 36.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.628 0.771 . . . . 71.450000000000003 110.512 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.696 HG22 HG21 ' A' ' 123' ' ' THR . 6.7 pt -129.22 154.49 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.617 0.767 . . . . 45.140000000000001 111.098 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.5 m -102.93 145.87 29.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.726 1.21 . . . . 34.299999999999997 109.922 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 88' ' ' LEU . 42.3 tttt -70.63 108.15 4.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.252 0.621 . . . . 71.0 109.75 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.95 29.24 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-N 115.832 -0.622 . . . . 64.219999999999999 112.559 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 54.0 tt0 -74.2 144.99 44.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.787 0.835 . . . . 61.140000000000001 111.314 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.449 ' HB3' HD11 ' A' ' 84' ' ' LEU . 43.0 mmtm -92.74 129.61 38.61 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.36 0.664 . . . . 64.430000000000007 109.843 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.606 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.3 OUTLIER -132.18 136.13 46.84 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.835 0.854 . . . . 75.129999999999995 109.505 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -95.15 109.66 21.72 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.902 -0.777 . . . . 44.299999999999997 108.902 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.608 HG13 ' HB1' ' A' ' 119' ' ' ALA . 42.5 t -77.22 134.35 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 123.644 0.59 . . . . 63.149999999999999 110.278 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.4 mt -102.75 -31.21 10.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.943 1.297 . . . . 74.530000000000001 109.906 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.32 142.94 3.93 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.5 -0.611 . . . . 63.439999999999998 113.331 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 33.6 m-85 -86.92 167.34 14.38 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.944 0.898 . . . . 45.329999999999998 110.857 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -88.49 -178.79 5.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.839 . . . . 71.530000000000001 110.565 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -55.42 -34.58 64.54 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.949 1.3 . . . . 63.130000000000003 113.625 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -111.38 9.29 21.5 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.071 0.548 . . . . 74.120000000000005 112.051 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.62 33.11 86.37 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 115.134 0.813 . . . . 62.130000000000003 115.134 172.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.65 -38.68 12.3 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.088 0.444 . . . . 73.549999999999997 111.924 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 66.9 m95 -129.9 147.37 51.65 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.44 0.696 . . . . 72.219999999999999 111.174 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.608 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -128.58 150.82 50.04 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.027 1.331 . . . . 73.299999999999997 109.3 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -87.21 115.76 24.83 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.952 -1.129 . . . . 64.299999999999997 107.952 166.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.51 168.68 10.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.432 0.693 . . . . 72.129999999999995 110.918 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -120.95 110.84 16.77 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.647 0.779 . . . . 73.430000000000007 110.364 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.696 HG21 HG22 ' A' ' 101' ' ' ILE . 82.7 p -100.63 177.58 4.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.347 1.059 . . . . 72.420000000000002 109.933 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.01 -18.3 64.02 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 110.753 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.79 -24.69 55.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.163 0.985 . . . . 73.219999999999999 111.035 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.34 -146.9 17.63 Favored Glycine 0 C--N 1.363 2.055 0 CA-C-N 117.706 0.23 . . . . 72.409999999999997 112.906 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -130.59 139.82 50.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.498 0.719 . . . . 71.109999999999999 109.946 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.21 -174.03 41.05 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.257 -0.737 . . . . 74.540000000000006 111.257 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -87.83 121.81 30.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.344 0.658 . . . . 61.229999999999997 112.41 -170.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.511 HG23 HD13 ' A' ' 135' ' ' ILE . 5.2 m -122.7 142.72 38.33 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.13 1.372 . . . . 63.340000000000003 108.726 173.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 10.6 Cg_endo -88.48 146.91 6.15 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 C-N-CA 122.241 1.961 . . . . 74.430000000000007 114.767 -172.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.4 m -41.35 -44.3 2.73 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.512 1.925 . . . . 74.420000000000002 114.551 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.635 HD22 ' HB2' ' A' ' 242' ' ' PRO . 22.4 p-10 -73.28 -4.16 31.41 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.012 0.525 . . . . 63.340000000000003 112.192 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.455 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 9.7 m-85 -106.44 -22.57 12.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.787 0.835 . . . . 73.120000000000005 111.475 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.511 HD13 HG23 ' A' ' 130' ' ' VAL . 27.6 pt -123.28 164.65 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.325 0.65 . . . . 74.030000000000001 112.442 -172.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.2 t -160.41 149.55 13.91 Favored Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.126 -0.94 . . . . 73.420000000000002 109.166 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.12 145.98 40.5 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.517 2.145 . . . . 62.350000000000001 112.377 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.431 HG12 HD22 ' A' ' 80' ' ' ASN . 3.9 t -75.68 -3.73 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.576 0.703 . . . . 63.200000000000003 111.149 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.84 -2.78 43.34 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.601 -0.687 . . . . 63.43 112.297 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.8 p -78.25 171.58 14.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.2 0.524 . . . . 64.019999999999996 111.828 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.38 -27.71 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.882 -0.599 . . . . 74.239999999999995 109.66 165.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.6 -16.21 64.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.311 1.044 . . . . 73.129999999999995 112.139 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.512 ' HA ' HD21 ' A' ' 88' ' ' LEU . 16.7 pttm -69.49 -31.71 70.15 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.815 0.446 . . . . 52.409999999999997 111.742 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.01 133.8 51.57 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.721 0.809 . . . . 74.430000000000007 110.23 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.0 p -55.59 -32.55 63.16 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 74.420000000000002 112.702 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.447 ' HE1' HD13 ' A' ' 73' ' ' LEU . 25.7 p-90 -81.13 -32.42 33.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.222 0.609 . . . . 73.310000000000002 112.59 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -84.24 107.6 16.64 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.3 -0.63 . . . . 73.310000000000002 109.3 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.77 -5.57 24.73 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.494 0.717 . . . . 71.239999999999995 111.51 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.24 -130.62 21.72 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 118.065 -1.408 . . . . 75.430000000000007 112.941 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.617 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 32.2 Cg_exo -58.63 86.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.821 3.014 . . . . 74.230000000000004 113.603 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.97 132.48 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.285 1.034 . . . . 74.349999999999994 109.681 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.0 p -87.68 175.07 8.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.755 1.222 . . . . 70.129999999999995 110.193 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -61.85 -44.94 95.83 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.483 0.313 . . . . 74.5 110.508 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.23 -48.46 80.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.978 0.911 . . . . 74.140000000000001 110.295 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.3 77.95 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.853 -1.067 . . . . 72.340000000000003 111.419 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.95 -52.47 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.278 0.631 . . . . 72.310000000000002 111.935 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.524 ' HG2' HG11 ' A' ' 190' ' ' VAL . 43.2 mt-10 -68.8 -25.89 64.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.646 0.779 . . . . 75.310000000000002 110.677 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.23 -43.68 90.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.884 0.874 . . . . 70.120000000000005 111.373 170.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.3 mt -65.0 -34.6 78.83 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.285 0.564 . . . . 75.400000000000006 110.532 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 90.0 mt -89.72 2.23 55.08 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.324 -0.853 . . . . 74.310000000000002 112.807 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -61.98 -34.42 76.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.841 0.746 . . . . 71.349999999999994 111.471 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.6 p -101.73 11.08 39.4 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.631 0.772 . . . . 72.420000000000002 111.065 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.04 153.98 40.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.183 -0.462 . . . . 63.0 113.094 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.59 -176.89 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 124.259 1.024 . . . . 75.209999999999994 111.599 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 108.14 1.66 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.574 -0.739 . . . . 54.420000000000002 110.403 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 105.54 12.32 26.91 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.475 -0.625 . . . . 75.209999999999994 112.429 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.483 ' HG ' ' HD1' ' A' ' 234' ' ' TYR . 74.2 m -71.21 144.85 49.98 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 117.519 0.659 . . . . 72.140000000000001 111.209 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.2 p90 -157.52 164.35 37.45 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 122.799 0.44 . . . . 73.439999999999998 110.423 -174.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.07 146.4 12.44 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.647 -0.871 . . . . 61.219999999999999 108.647 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.658 HG22 HG12 ' A' ' 182' ' ' ILE . 91.4 t -96.62 126.67 49.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 108.889 -0.782 . . . . 61.450000000000003 108.889 167.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -116.08 143.4 45.52 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.959 1.303 . . . . 70.030000000000001 107.883 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.76 149.29 38.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.755 0.822 . . . . 75.5 108.922 171.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 t -83.76 125.47 31.95 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.242 -0.651 . . . . 63.100000000000001 109.242 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 150' ' ' PRO . 18.4 tp10 -77.71 -34.31 52.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.195 0.598 . . . . 64.049999999999997 109.392 172.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.0 p -75.22 -16.36 60.48 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.549 0.74 . . . . 52.509999999999998 111.186 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -147.37 79.16 9.84 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 123.768 0.827 . . . . 74.409999999999997 109.185 172.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.65 133.57 55.11 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.169 2.579 . . . . 72.209999999999994 112.406 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.73 -29.59 10.66 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.885 -0.598 . . . . 73.349999999999994 111.92 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -73.64 115.02 12.56 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 108.632 -0.877 . . . . 71.140000000000001 108.632 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.7 mtt85 -128.47 146.17 50.89 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.725 0.81 . . . . 72.120000000000005 109.098 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.9 m -140.51 148.84 41.69 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.385 1.074 . . . . 70.439999999999998 109.009 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 170' ' ' VAL . 34.4 mt -101.51 148.44 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 106.734 -1.58 . . . . 75.5 106.734 168.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 24.6 m -123.46 109.35 13.73 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.203 -1.406 . . . . 71.319999999999993 107.203 171.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 167' ' ' SER . 20.5 tp -103.59 112.39 25.29 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.808 0.731 . . . . 65.219999999999999 109.614 177.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 23.8 ttt180 -80.47 111.17 16.62 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.471 0.653 . . . . 72.25 109.482 165.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -137.25 134.71 36.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.214 -1.357 . . . . 74.430000000000007 107.433 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 61.91 22.48 13.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.538 1.135 . . . . 73.530000000000001 111.547 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.34 85.94 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.938 -0.573 . . . . 64.310000000000002 113.006 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -105.01 130.77 53.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.132 0.973 . . . . 73.549999999999997 108.798 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.524 HG11 ' HG2' ' A' ' 157' ' ' GLU . 58.7 t -96.46 115.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.897 -0.409 . . . . 74.310000000000002 109.897 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -100.08 148.82 24.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.953 1.301 . . . . 65.439999999999998 107.747 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -119.63 116.41 25.95 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.377 0.535 . . . . 73.519999999999996 110.608 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 8.6 m-30 -93.89 149.48 21.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.434 1.094 . . . . 75.129999999999995 108.216 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 15.3 tpp180 -106.29 114.05 27.94 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.896 -0.409 . . . . 64.319999999999993 109.896 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.446 HD13 HD21 ' A' ' 214' ' ' LEU . 48.2 mt -87.42 102.75 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.315 -0.994 . . . . 70.209999999999994 108.315 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -87.17 132.52 33.84 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.101 -0.954 . . . . 63.299999999999997 108.72 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.6 m -100.76 106.77 18.21 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.979 -1.119 . . . . 75.299999999999997 107.979 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.07 159.56 3.29 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.686 0.794 . . . . 64.409999999999997 110.525 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.5 p -63.3 -22.31 66.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.063 0.945 . . . . 64.109999999999999 113.236 -172.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -93.79 -0.62 55.78 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.692 0.797 . . . . 61.039999999999999 111.44 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 100.17 14.05 34.55 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.601 -0.555 . . . . 74.219999999999999 114.068 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -88.15 127.03 35.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 117.852 0.826 . . . . 54.229999999999997 111.426 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -87.03 146.18 26.2 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.339 1.056 . . . . 52.329999999999998 108.545 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -165.43 140.41 5.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.374 0.421 . . . . 61.439999999999998 110.648 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.506 HG23 HD11 ' A' ' 217' ' ' LEU . 76.1 t -85.18 -43.04 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.229 -1.026 . . . . 74.299999999999997 108.229 163.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.2 m -104.79 129.95 52.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.526 -1.216 . . . . 73.329999999999998 109.099 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.5 t -67.66 -14.65 63.12 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.07 0.948 . . . . 64.129999999999995 112.693 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.44 -17.0 59.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.695 1.198 . . . . 43.420000000000002 111.729 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.2 m -149.57 112.17 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.902 0.481 . . . . 44.350000000000001 110.638 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -102.97 124.17 47.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.06 0.944 . . . . 75.510000000000005 109.021 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -106.87 145.95 31.56 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.071 0.948 . . . . 65.319999999999993 109.284 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.49 -39.77 88.9 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.733 0.645 . . . . 75.540000000000006 110.159 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 69.2 p -126.49 151.62 47.57 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.985 -1.007 . . . . 71.030000000000001 111.482 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 195' ' ' ILE . 0.7 OUTLIER -62.94 -24.63 67.96 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.333 -1.303 . . . . 75.25 109.842 172.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.34 86.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.215 1.006 . . . . 51.409999999999997 111.602 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.37 -35.86 71.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.363 0.665 . . . . 74.120000000000005 111.274 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.506 HD11 HG23 ' A' ' 205' ' ' VAL . 12.4 tp -55.15 -56.18 22.8 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.635 0.584 . . . . 62.140000000000001 110.762 174.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.6 -39.44 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.81 -0.632 . . . . 64.439999999999998 111.041 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -61.26 -53.12 60.89 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.287 0.367 . . . . 71.120000000000005 110.661 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -62.03 -38.6 89.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.413 -0.812 . . . . 75.430000000000007 110.643 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.708 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.0 m170 -88.17 -5.18 58.56 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.112 -0.494 . . . . 74.099999999999994 112.258 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.7 p -95.31 -24.28 16.82 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.819 0.448 . . . . 72.010000000000005 110.837 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.7 p -81.74 -38.86 25.04 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 122.749 0.42 . . . . 72.219999999999999 111.274 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.4 m -135.52 162.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.984 0.897 . . . . 62.100000000000001 112.142 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.69 15.07 1.11 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.71 2.004 . . . . 54.149999999999999 114.231 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.623 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.7 t70 -43.36 33.65 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 131.634 3.974 . . . . 63.399999999999999 119.145 -156.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.55 -5.35 9.28 Favored Glycine 0 N--CA 1.478 1.459 0 O-C-N 120.738 -1.226 . . . . 65.340000000000003 112.846 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 221' ' ' HIS . 10.6 mt -91.3 162.23 14.7 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.121 1.368 . . . . 75.400000000000006 109.785 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -61.25 -36.07 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-O 120.843 0.354 . . . . 75.519999999999996 110.075 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -162.33 175.42 11.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.953 0.901 . . . . 62.409999999999997 109.427 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.6 p -61.88 148.42 43.49 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.454 1.102 . . . . 75.230000000000004 112.202 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.433 HD23 HD13 ' A' ' 184' ' ' LEU . 52.7 mt -75.13 145.93 41.78 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.873 0.869 . . . . 65.109999999999999 108.689 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -137.35 -72.29 0.43 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.799 0.727 . . . . 75.010000000000005 111.949 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.532 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 62.2 t80 -95.26 122.85 58.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.401 0.68 . . . . 73.340000000000003 109.775 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 71.1 Cg_endo -82.1 139.33 10.63 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.538 2.159 . . . . 53.539999999999999 111.058 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.19 141.79 95.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.061 0.545 . . . . 52.310000000000002 110.426 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.49 136.37 12.38 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.339 2.026 . . . . 75.239999999999995 111.852 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.521 ' HZ2' HD22 ' A' ' 88' ' ' LEU . 97.4 mttt -70.24 102.73 2.18 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.563 -1.273 . . . . 73.340000000000003 107.563 172.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.643 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 17.7 ptt180 -73.38 -66.93 0.63 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 115.182 1.549 . . . . 52.240000000000002 115.182 -154.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.643 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 25.2 t-20 -113.75 150.14 33.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.039 0.536 . . . . 74.140000000000001 110.495 -172.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 90' ' ' ASP . 85.5 mttt -70.12 115.71 36.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.098 -1.075 . . . . 63.100000000000001 108.098 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.635 ' HB2' HD22 ' A' ' 133' ' ' ASN . 23.6 Cg_exo -63.78 137.58 59.19 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.643 2.228 . . . . 54.049999999999997 111.933 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 25.5 m -68.81 122.29 18.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.151 0.58 . . . . 45.299999999999997 111.547 -172.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.427 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 58.0 t -92.34 128.27 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.594 -1.261 . . . . 74.200000000000003 107.594 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -104.01 112.48 25.48 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.214 0.461 . . . . 74.430000000000007 111.159 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.71 8.28 3.99 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 118.366 2.106 . . . . 74.0 118.366 159.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.66 129.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 119.256 1.528 . . . . 65.140000000000001 111.865 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 t -73.5 121.67 85.72 Favored Pre-proline 0 C--N 1.355 0.818 0 N-CA-C 106.431 -1.692 . . . . 65.430000000000007 106.431 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.09 -63.07 0.36 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.791 2.327 . . . . 73.310000000000002 116.452 -153.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -130.92 -22.06 2.64 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.904 1.282 . . . . 72.400000000000006 108.122 139.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -81.87 101.8 10.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.08 -1.418 . . . . 73.230000000000004 109.69 -153.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -119.84 -45.87 2.47 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.174 0.989 . . . . 72.319999999999993 109.382 169.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -114.69 -26.4 7.87 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.389 1.475 . . . . 64.150000000000006 112.088 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -60.6 150.15 32.68 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.715 0.634 . . . . 73.019999999999996 111.269 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.005 0.922 . . . . 54.409999999999997 108.676 -177.1 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 tpt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 108.855 -0.794 . . . . 72.319999999999993 108.855 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.51 -32.36 3.22 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.356 -0.384 . . . . 63.409999999999997 112.742 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -82.06 74.28 9.05 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.643 0.735 . . . . 53.509999999999998 110.883 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -86.79 141.35 33.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 115.045 -0.98 . . . . 70.120000000000005 109.817 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.58 157.42 56.04 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.272 1.981 . . . . 64.239999999999995 111.879 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.54 126.42 27.54 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 112.526 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -91.05 -70.24 0.69 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.294 0.638 . . . . 65.200000000000003 110.907 -176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 m -143.5 147.47 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.196 0.598 . . . . 64.230000000000004 111.444 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.79 162.25 14.36 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.723 1.209 . . . . 72.019999999999996 108.131 171.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.64 -77.33 0.02 OUTLIER Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.12 -0.792 . . . . 41.329999999999998 111.12 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -174.84 132.27 0.33 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.562 1.145 . . . . 63.420000000000002 108.975 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -135.71 166.66 22.75 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.575 0.75 . . . . 72.239999999999995 111.81 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -68.47 141.83 55.5 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 114.577 -1.192 . . . . 74.340000000000003 110.034 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -104.82 129.84 24.2 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.483 0.713 . . . . 71.329999999999998 110.177 -166.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.91 162.97 36.41 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.682 2.255 . . . . 72.239999999999995 112.214 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.2 t -71.89 160.82 31.9 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.741 -0.663 . . . . 73.409999999999997 109.773 175.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.7 mt -93.21 142.9 25.9 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.956 -0.757 . . . . 73.219999999999999 108.956 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -72.36 156.84 54.26 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.512 2.141 . . . . 71.519999999999996 112.064 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.8 160.52 32.04 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.267 0.627 . . . . 72.519999999999996 111.2 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.55 -174.55 4.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.703 0.801 . . . . 64.299999999999997 109.449 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -125.44 158.23 34.92 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.101 0.56 . . . . 75.120000000000005 110.283 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -79.46 179.88 7.2 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.581 -0.736 . . . . 70.329999999999998 110.931 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 203' ' ' LEU . 4.1 pt -124.18 152.43 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.511 1.124 . . . . 73.230000000000004 109.401 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.571 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -153.08 138.76 17.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.615 0.766 . . . . 75.209999999999994 109.497 -178.366 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 196' ' ' ASN . . . -128.39 167.41 20.6 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 123.452 0.47 . . . . 74.120000000000005 114.201 -174.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.71 -179.29 8.02 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.369 1.068 . . . . 54.43 110.073 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.92 157.84 53.48 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.284 0.365 . . . . 73.540000000000006 113.454 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.49 ' HB3' ' H ' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -131.95 146.29 52.01 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.314 0.646 . . . . 74.129999999999995 111.343 -176.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.64 121.11 0.14 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.149 1.38 . . . . 74.109999999999999 108.509 168.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -172.1 132.55 0.67 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.689 0.796 . . . . 70.310000000000002 109.717 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.4 t -128.77 68.83 1.38 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.019 0.928 . . . . 61.240000000000002 109.026 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.531 ' HB2' HH22 ' A' ' 153' ' ' ARG . 23.2 t -76.71 173.08 12.05 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.053 -0.976 . . . . 74.439999999999998 109.613 175.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 189' ' ' ARG . 0.0 OUTLIER -156.99 134.81 10.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.146 0.578 . . . . 74.530000000000001 110.137 -177.114 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -152.54 -170.3 3.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.246 1.418 . . . . 73.450000000000003 109.012 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.1 -168.19 25.76 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 121.68 -0.295 . . . . 71.349999999999994 113.122 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 127.73 -173.12 18.82 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.198 -0.779 . . . . 63.0 111.78 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -83.53 -161.17 0.14 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.4 2.734 . . . . 75.030000000000001 113.321 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -160.66 179.83 8.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.478 1.111 . . . . 75.310000000000002 110.899 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.6 m -153.47 130.55 11.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.281 1.032 . . . . 74.129999999999995 109.011 172.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -148.61 100.57 3.13 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.118 0.567 . . . . 74.120000000000005 110.221 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.0 t -142.73 136.61 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.663 1.185 . . . . 73.340000000000003 108.041 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -161.29 -128.9 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 108.436 -0.95 . . . . 71.209999999999994 108.436 171.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.648 HG12 ' HG3' ' A' ' 44' ' ' GLU . 48.2 t -145.03 134.48 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.289 1.036 . . . . 74.439999999999998 108.987 -169.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.677 ' H ' ' HB3' ' A' ' 59' ' ' GLN . 45.0 mt-10 79.01 92.39 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.309 1.843 . . . . 54.009999999999998 112.118 174.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.41 ' ND1' ' HG2' ' A' ' 46' ' ' GLU . 18.7 t-80 -158.07 -82.26 0.06 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.368 0.667 . . . . 72.349999999999994 109.235 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 48' ' ' LEU . 14.5 pt-20 -176.21 18.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.437 1.095 . . . . 74.340000000000003 110.375 -177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.672 ' HA ' ' HA3' ' A' ' 60' ' ' GLY . . . 59.08 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.577 1.151 . . . . 70.329999999999998 110.703 -164.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.692 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 48.0 tp 74.5 -71.99 0.12 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.271 1.428 . . . . 70.209999999999994 112.568 170.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' HG2' ' HG2' ' A' ' 50' ' ' ARG . 9.7 tt0 -146.26 158.81 43.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.759 0.823 . . . . 75.200000000000003 109.754 -169.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.461 ' HA ' ' NE ' ' A' ' 50' ' ' ARG . 4.7 mmp_? 81.63 147.47 0.1 Allowed Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 125.806 1.643 . . . . 73.109999999999999 112.979 171.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -48.16 102.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.398 3.17 0 C-N-CA 124.589 3.526 . . . . 74.530000000000001 114.203 -170.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 57' ' ' GLU . 34.0 m -81.55 177.38 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.716 -1.129 . . . . 52.030000000000001 109.307 167.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.677 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -79.45 177.56 8.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.519 0.328 . . . . 72.409999999999997 111.44 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.5 p -62.15 -62.87 1.47 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.13 0.972 . . . . 53.350000000000001 112.211 -170.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.98 -72.05 0.71 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.25 -0.648 . . . . 72.450000000000003 109.25 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -76.85 86.02 3.42 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 108.809 -0.811 . . . . 75.120000000000005 108.809 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HA ' ' HB3' ' A' ' 53' ' ' ALA . 12.5 pt-20 -66.38 148.89 98.39 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 114.988 -1.006 . . . . 72.140000000000001 110.174 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.14 -64.9 0.13 Allowed 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 122.319 2.012 . . . . 73.209999999999994 111.198 -173.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.677 ' HB3' ' H ' ' A' ' 44' ' ' GLU . 5.0 tp-100 176.13 -22.94 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.887 1.275 . . . . 74.409999999999997 108.713 176.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . 130.02 -101.29 0.51 Allowed Glycine 0 C--N 1.362 1.986 0 CA-C-N 116.222 -0.445 . . . . 21.510000000000002 112.75 165.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.8 mt -103.13 176.07 5.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.012 0.925 . . . . 64.209999999999994 109.131 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.1 p -76.99 -175.15 3.42 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.84 -0.43 . . . . 63.229999999999997 109.84 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.32 -30.67 62.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.174 0.59 . . . . 71.209999999999994 110.959 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.1 -63.94 1.08 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.274 1.03 . . . . 73.140000000000001 109.936 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.53 -54.39 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.38 1.072 . . . . 63.229999999999997 109.565 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -145.38 -8.3 0.59 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 114.412 -1.267 . . . . 70.439999999999998 109.158 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.609 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 12.0 t90 -86.17 65.55 9.14 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.162 0.585 . . . . 72.0 110.464 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -64.97 -17.06 64.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.568 0.747 . . . . 73.349999999999994 110.823 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 72' ' ' ASN . 20.0 m -77.49 4.0 12.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.524 1.129 . . . . 74.219999999999999 112.169 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -75.52 -47.78 25.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.708 0.803 . . . . 70.510000000000005 110.358 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.9 -24.55 64.32 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 120.836 0.351 . . . . 64.099999999999994 110.424 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 69' ' ' SER . 10.7 m120 -89.43 -6.43 56.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.007 0.923 . . . . 75.209999999999994 111.634 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.22 -52.15 64.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.346 1.058 . . . . 60.549999999999997 112.219 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.91 16.14 26.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.605 0.762 . . . . 71.239999999999995 110.36 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.88 -20.17 64.88 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.35 0.66 . . . . 61.350000000000001 112.035 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.32 -138.67 25.58 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.178 -0.79 . . . . 54.329999999999998 112.224 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 93.4 Cg_endo -79.0 -174.81 2.44 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.753 2.302 . . . . 75.319999999999993 112.586 175.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.482 ' OG ' ' HB ' ' A' ' 138' ' ' VAL . 1.9 m -68.01 173.99 4.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.426 0.69 . . . . 62.219999999999999 110.489 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -72.64 -44.97 61.19 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 116.72 -0.218 . . . . 72.5 111.533 -174.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.55 -37.51 1.2 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 122.208 -0.308 . . . . 62.030000000000001 111.493 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 10.6 m-20 -90.64 113.52 58.05 Favored Pre-proline 0 N--CA 1.485 1.286 0 N-CA-C 113.415 0.894 . . . . 63.140000000000001 113.415 -170.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HA ' HD22 ' A' ' 139' ' ' ASN . 45.1 Cg_endo -68.0 -17.47 46.17 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.868 1.712 . . . . 75.420000000000002 111.175 163.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -89.6 9.67 25.96 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.65 1.18 . . . . 74.540000000000006 111.099 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 26.2 tp -96.16 126.83 41.65 Favored 'General case' 0 C--N 1.357 0.917 0 CA-C-O 121.65 0.738 . . . . 62.420000000000002 110.085 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -113.95 173.71 6.3 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.417 1.487 . . . . 75.230000000000004 108.257 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.47 139.19 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.088 0.955 . . . . 60.310000000000002 109.04 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.478 ' HA ' HG22 ' A' ' 135' ' ' ILE . . . -74.4 120.4 19.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.213 0.605 . . . . 70.430000000000007 110.137 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 143' ' ' LYS . 83.8 mt -86.03 -34.97 20.6 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.462 0.705 . . . . 73.040000000000006 110.704 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -123.78 146.19 48.5 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.131 -0.941 . . . . 74.219999999999999 108.879 -175.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.1 144.76 44.83 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.734 0.646 . . . . 71.150000000000006 109.409 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.592 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.6 t80 -142.18 140.5 32.4 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.437 -0.949 . . . . 61.43 108.437 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 68.0 t -110.99 134.82 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 108.209 -1.034 . . . . 62.119999999999997 108.209 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.68 116.27 2.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.167 0.987 . . . . 72.109999999999999 111.239 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.8 p -107.91 26.03 10.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.227 1.011 . . . . 55.100000000000001 110.209 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.27 177.52 43.49 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.086 -0.961 . . . . 51.329999999999998 110.929 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.71 -38.18 54.78 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.007 0.523 . . . . 72.239999999999995 111.254 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -84.32 -23.33 30.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.966 0.506 . . . . 71.319999999999993 111.152 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.6 p -72.92 153.99 40.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.151 0.58 . . . . 71.140000000000001 111.521 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.8 tp -127.06 129.05 47.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.388 0.675 . . . . 65.200000000000003 110.968 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -69.66 130.56 42.71 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.692 0.797 . . . . 73.310000000000002 109.997 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.657 HG22 HG21 ' A' ' 123' ' ' THR . 22.0 pt -129.25 147.5 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 72.019999999999996 110.67 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -106.93 140.58 39.52 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.84 -1.17 . . . . 65.439999999999998 107.84 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -62.45 147.43 48.71 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 123.5 0.5 . . . . 73.310000000000002 110.271 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.74 -28.74 10.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.984 -0.342 . . . . 61.130000000000003 112.794 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.3 146.01 33.19 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.229 0.515 . . . . 74.299999999999997 111.04 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HB3' HD11 ' A' ' 84' ' ' LEU . 39.9 mmtm -90.02 142.68 27.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.129 0.971 . . . . 71.530000000000001 109.696 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.586 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -145.57 146.1 31.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.861 0.865 . . . . 73.040000000000006 110.115 -178.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -99.65 107.06 19.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.811 0.444 . . . . 65.200000000000003 110.063 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.538 HG13 ' HB1' ' A' ' 119' ' ' ALA . 53.5 t -79.02 119.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.873 -0.788 . . . . 62.439999999999998 108.873 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -116.8 -8.68 11.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.055 -175.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.83 140.74 6.48 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 121.263 -0.494 . . . . 43.119999999999997 112.885 171.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.404 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 74.4 m-85 -97.03 174.92 6.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.918 0.887 . . . . 74.439999999999998 110.439 172.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -96.09 -173.16 2.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.987 -1.006 . . . . 54.140000000000001 110.445 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -52.44 -39.38 60.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.657 1.183 . . . . 51.420000000000002 114.115 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -108.14 6.62 27.0 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.814 0.446 . . . . 72.209999999999994 112.092 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 63.66 12.15 45.73 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 115.361 0.904 . . . . 53.219999999999999 115.361 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.76 -7.71 33.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.6 0.76 . . . . 75.310000000000002 111.636 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.5 ' HZ2' HG11 ' A' ' 244' ' ' VAL . 39.2 m95 -127.52 145.38 50.87 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.97 -1.122 . . . . 65.239999999999995 107.97 167.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.538 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -148.02 125.78 11.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.274 -0.876 . . . . 51.109999999999999 109.219 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 37.9 tt0 -67.34 123.29 19.95 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 108.268 -1.012 . . . . 71.409999999999997 108.268 171.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -126.98 145.71 50.6 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.76 0.824 . . . . 65.549999999999997 110.215 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -101.92 100.31 10.59 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.12 -1.067 . . . . 60.219999999999999 108.12 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.657 HG21 HG22 ' A' ' 101' ' ' ILE . 67.0 p -82.27 165.85 20.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.309 0.644 . . . . 73.109999999999999 109.831 173.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -20.45 66.09 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 121.462 0.649 . . . . 65.519999999999996 109.445 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -79.38 -29.94 42.3 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.087 1.355 . . . . 74.099999999999994 112.297 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.33 -165.3 36.59 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 119.872 -0.405 . . . . 62.109999999999999 112.588 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -128.03 144.75 51.11 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.033 0.916 . . . . 72.549999999999997 110.367 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.13 178.42 36.0 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 112.589 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 75.1 m95 -75.07 118.4 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.324 1.05 . . . . 73.209999999999994 112.49 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.2 m -118.14 152.47 50.53 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 124.23 1.012 . . . . 35.32 108.428 174.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.12 129.07 17.59 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 121.772 1.648 . . . . 53.020000000000003 111.206 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 m -64.4 -25.84 68.19 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.099 0.96 . . . . 64.420000000000002 112.295 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -80.41 -5.48 56.57 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.236 1.015 . . . . 74.209999999999994 111.875 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -96.87 -13.98 22.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.072 0.949 . . . . 74.420000000000002 110.944 173.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 87' ' ' ALA . 16.1 pt -125.83 172.34 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.752 0.821 . . . . 73.040000000000006 110.585 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.417 HG21 ' HB2' ' A' ' 142' ' ' GLU . 2.5 m -159.63 142.35 10.15 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.403 1.081 . . . . 64.409999999999997 108.959 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.72 139.64 58.1 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.161 1.908 . . . . 70.219999999999999 112.237 170.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.482 ' HB ' ' OG ' ' A' ' 78' ' ' SER . 13.8 t -70.19 -6.05 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 121.603 0.716 . . . . 73.200000000000003 109.966 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.769 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 16.9 m-20 -85.85 -21.16 28.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.831 0.852 . . . . 71.319999999999993 112.756 -176.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.3 p -102.11 179.01 4.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.383 0.673 . . . . 53.299999999999997 112.576 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.74 -22.24 37.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.429 1.092 . . . . 73.140000000000001 112.177 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.417 ' HB2' HG21 ' A' ' 136' ' ' THR . 3.1 mp0 -69.5 -13.87 62.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.075 0.95 . . . . 71.0 112.223 -172.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.534 ' HA ' HD21 ' A' ' 88' ' ' LEU . 22.2 pttm -69.88 -11.38 60.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.49 0.716 . . . . 70.140000000000001 112.175 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -87.05 143.37 27.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.293 0.637 . . . . 62.340000000000003 110.582 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 p -68.13 -33.29 74.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.29 1.036 . . . . 75.530000000000001 112.765 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -71.17 -33.28 69.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 74.25 111.46 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -78.43 112.79 15.82 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.52 -0.918 . . . . 74.400000000000006 108.52 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.46 -20.13 13.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.5 0.72 . . . . 71.409999999999997 111.345 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.95 -150.27 42.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 118.545 -1.142 . . . . 72.209999999999994 111.974 -174.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.03 100.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.66 2.907 . . . . 73.319999999999993 113.437 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.9 t -131.93 150.13 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.954 1.302 . . . . 72.140000000000001 108.94 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.3 p -90.95 175.19 7.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.368 0.667 . . . . 53.210000000000001 111.434 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.531 HH22 ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -62.92 -60.69 3.13 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.494 1.117 . . . . 63.140000000000001 110.886 -177.261 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.1 -29.03 70.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.936 0.895 . . . . 75.120000000000005 111.255 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.59 83.35 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 123.786 0.679 . . . . 64.099999999999994 110.944 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.78 -44.41 93.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.807 0.692 . . . . 64.510000000000005 110.84 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.99 -44.58 82.84 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.538 -0.755 . . . . 74.340000000000003 111.337 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.11 -44.46 88.68 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.592 -1.186 . . . . 74.030000000000001 111.888 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 237' ' ' PRO . 87.0 mt -59.8 -39.5 85.2 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.19 0.996 . . . . 73.129999999999995 111.571 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 90.8 mt -81.05 -27.53 35.71 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.283 -0.871 . . . . 70.329999999999998 112.074 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.9 p -68.39 -10.02 52.22 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 118.379 0.536 . . . . 51.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.9 p -103.55 21.16 16.57 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.62 1.168 . . . . 71.310000000000002 111.122 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.71 -178.15 15.19 Favored Glycine 0 C--N 1.353 1.499 0 C-N-CA 123.347 0.499 . . . . 51.149999999999999 113.79 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.4 pt -96.79 178.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.381 1.072 . . . . 74.439999999999998 112.06 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.47 112.46 5.31 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.158 -1.052 . . . . 71.319999999999993 108.158 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.59 24.89 Favored Glycine 0 CA--C 1.528 0.89 0 O-C-N 123.742 0.651 . . . . 61.399999999999999 112.746 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 184' ' ' LEU . 73.3 m -76.56 139.96 40.9 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.567 0.684 . . . . 75.430000000000007 110.868 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.2 p90 -148.78 163.53 37.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.068 0.461 . . . . 75.109999999999999 110.538 -175.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.1 pp -157.73 149.71 22.16 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.359 -0.837 . . . . 64.510000000000005 108.961 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.734 HG22 HG12 ' A' ' 182' ' ' ILE . 93.9 t -109.0 120.78 61.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.114 -1.069 . . . . 44.009999999999998 108.114 168.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.504 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 24.2 ptt85 -114.54 164.51 13.9 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.651 1.18 . . . . 71.25 108.452 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.16 160.84 20.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.98 0.912 . . . . 72.219999999999999 108.697 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.7 t -79.68 124.18 28.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.498 -0.556 . . . . 62.43 109.498 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.52 -36.24 83.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.85 0.86 . . . . 71.400000000000006 110.54 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.1 p -69.75 -31.27 69.14 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.897 0.879 . . . . 53.119999999999997 112.071 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 m -150.91 119.43 3.5 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.034 0.534 . . . . 64.519999999999996 110.305 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.8 154.4 74.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.832 2.355 . . . . 61.100000000000001 112.198 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.16 -31.22 8.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.004 -0.543 . . . . 65.230000000000004 112.316 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.59 112.19 17.72 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.93 -1.137 . . . . 72.129999999999995 107.93 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.572 ' H ' ' NH2' ' A' ' 194' ' ' ARG . 98.4 mtt180 -124.28 127.32 47.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.553 0.741 . . . . 73.310000000000002 110.068 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.1 m -125.28 145.51 49.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.74 0.816 . . . . 52.229999999999997 110.206 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.734 HG12 HG22 ' A' ' 170' ' ' VAL . 20.9 mt -100.12 143.93 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 107.696 -1.224 . . . . 65.340000000000003 107.696 173.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.2 m -125.61 109.84 13.12 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 176.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 167' ' ' SER . 32.0 tp -105.35 112.91 26.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.956 0.503 . . . . 51.149999999999999 110.994 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 76.1 ttt180 -78.25 110.97 13.73 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.54 -0.911 . . . . 71.030000000000001 108.54 163.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -133.1 125.88 30.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.009 1.324 . . . . 75.329999999999998 108.718 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 58.54 30.84 20.33 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.339 1.055 . . . . 60.350000000000001 110.433 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.482 ' HA2' ' HE ' ' A' ' 185' ' ' ARG . . . 79.84 -13.23 25.47 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-N 114.678 -1.146 . . . . 43.210000000000001 113.824 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 58.0 mtp85 -93.63 125.53 38.3 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.289 0.636 . . . . 62.420000000000002 109.406 -171.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.93 106.56 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.104 0.562 . . . . 64.030000000000001 110.847 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -96.51 131.99 42.56 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.586 1.154 . . . . 71.400000000000006 108.796 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -110.39 117.82 34.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.213 0.53 . . . . 62.32 111.439 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.453 ' HE1' HD21 ' A' ' 232' ' ' LEU . 2.8 m-30 -95.33 138.71 32.64 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 124.767 1.227 . . . . 70.140000000000001 108.768 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.572 ' NH2' ' H ' ' A' ' 180' ' ' ARG . 1.8 tpm_? -112.0 109.04 18.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 106.873 -1.528 . . . . 52.409999999999997 106.873 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -68.8 103.56 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 123.55 0.531 . . . . 73.409999999999997 110.759 -171.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.522 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 6.4 m120 -68.85 143.44 54.55 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.671 0.788 . . . . 75.340000000000003 110.414 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.6 m -119.99 118.78 31.57 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.506 0.722 . . . . 71.430000000000007 109.702 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.35 159.83 33.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.668 0.787 . . . . 55.399999999999999 109.907 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.5 m -62.24 -22.83 66.28 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.632 0.975 . . . . 75.230000000000004 113.632 -170.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -90.24 -13.98 34.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.96 0.904 . . . . 51.109999999999999 112.03 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.42 12.9 12.48 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 114.501 0.561 . . . . 63.329999999999998 114.501 176.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -74.16 146.45 43.46 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.941 0.87 . . . . 62.32 111.254 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.532 HD11 HD12 ' A' ' 23' ' ' ILE . 2.9 mm? -104.4 150.3 24.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.931 0.892 . . . . 73.109999999999999 109.269 175.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.521 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 28.7 p90 -173.14 130.16 0.47 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.993 0.808 . . . . 74.420000000000002 109.492 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.482 HG23 HD11 ' A' ' 217' ' ' LEU . 79.2 t -70.8 -53.78 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.092 -1.077 . . . . 72.299999999999997 108.092 163.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.6 m -103.08 138.99 39.19 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.674 -1.603 . . . . 65.439999999999998 110.147 -170.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.0 t -68.55 -10.46 55.86 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.041 0.936 . . . . 73.340000000000003 112.45 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.0 -29.36 61.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.306 1.042 . . . . 71.040000000000006 112.423 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.31 116.56 7.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.611 0.364 . . . . 73.030000000000001 110.219 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.521 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 95.7 mtt180 -97.98 132.2 43.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.696 0.798 . . . . 73.310000000000002 109.305 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -113.11 156.67 22.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.196 0.998 . . . . 72.329999999999998 109.371 -173.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -78.43 -29.83 47.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.726 -0.67 . . . . 71.439999999999998 109.844 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 35.2 p -137.34 159.15 42.76 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.852 0.834 . . . . 61.109999999999999 112.153 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.465 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -64.14 -31.64 72.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.809 1.243 . . . . 75.420000000000002 110.099 177.013 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.88 -37.83 80.47 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.09 0.556 . . . . 53.409999999999997 111.299 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -77.79 -32.17 52.3 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.706 -0.679 . . . . 70.430000000000007 111.335 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.482 HD11 HG23 ' A' ' 205' ' ' VAL . 18.3 tp -54.69 -55.52 28.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.894 -0.41 . . . . 71.329999999999998 109.894 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.72 -44.38 98.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 O-C-N 124.251 0.969 . . . . 65.0 110.453 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -61.09 -57.7 11.46 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 123.451 0.469 . . . . 73.409999999999997 111.982 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -62.32 -38.75 90.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.052 -0.522 . . . . 55.100000000000001 110.967 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.655 ' HB3' HD11 ' A' ' 228' ' ' LEU . 16.2 m170 -84.84 -6.59 59.35 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.518 0.562 . . . . 63.039999999999999 112.518 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 86.7 p -95.75 -29.25 14.36 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.742 0.417 . . . . 75.310000000000002 111.16 172.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 38.0 p -81.55 -43.19 19.06 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.323 -0.398 . . . . 62.229999999999997 110.72 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 226' ' ' ASP . 28.9 m -126.65 160.84 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.405 0.682 . . . . 73.400000000000006 111.644 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.78 13.83 1.55 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.372 1.869 . . . . 64.239999999999995 114.624 -170.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.528 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.2 t70 -41.95 29.63 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 131.207 3.803 . . . . 74.109999999999999 120.148 -151.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.14 9.97 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 120.573 -1.329 . . . . 75.329999999999998 112.579 -169.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -90.56 162.56 14.95 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.762 1.225 . . . . 72.530000000000001 108.79 166.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.83 -36.57 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.474 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.2 t -159.84 -178.71 7.25 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.562 0.745 . . . . 64.310000000000002 110.483 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.5 p -66.99 143.34 56.85 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.114 0.965 . . . . 65.219999999999999 111.844 175.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.453 HD21 ' HE1' ' A' ' 193' ' ' TYR . 41.8 mt -74.89 146.44 41.88 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 107.802 -1.184 . . . . 73.209999999999994 107.802 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -147.72 -45.68 0.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 120.134 1.334 . . . . 72.209999999999994 113.833 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -112.55 133.31 21.87 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.323 0.649 . . . . 74.25 109.445 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 67.5 Cg_endo -87.39 124.45 2.01 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.388 2.059 . . . . 71.219999999999999 110.259 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.447 ' HB2' HD23 ' A' ' 160' ' ' LEU . . . -62.39 144.36 95.29 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.002 -0.74 . . . . 71.099999999999994 109.002 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.486 ' O ' HD22 ' A' ' 159' ' ' LEU . 86.8 Cg_endo -75.81 -178.82 4.61 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.242 1.961 . . . . 73.239999999999995 112.718 -177.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -85.48 138.12 32.44 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.637 -1.245 . . . . 73.400000000000006 107.637 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.463 ' HB3' HD21 ' A' ' 159' ' ' LEU . 15.0 ptt180 -90.42 -57.33 2.87 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.351 0.978 . . . . 74.299999999999997 111.257 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -106.78 136.68 46.18 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.156 0.583 . . . . 72.439999999999998 110.443 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -82.85 116.96 66.92 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.076 -1.453 . . . . 71.329999999999998 107.076 162.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.03 127.63 15.21 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.896 3.064 . . . . 71.450000000000003 113.901 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.5 m -75.1 122.01 22.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.939 0.495 . . . . 74.010000000000005 111.13 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.5 HG11 ' HZ2' ' A' ' 118' ' ' TRP . 95.2 t -94.2 120.99 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.281 -1.007 . . . . 73.120000000000005 108.281 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -105.17 112.53 25.69 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.608 -0.516 . . . . 71.150000000000006 109.608 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.54 -28.44 0.22 Allowed Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.514 2.166 . . . . 54.140000000000001 118.514 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.1 m -72.03 132.0 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 118.856 1.328 . . . . 72.349999999999994 114.359 -160.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.8 t -73.45 122.99 88.99 Favored Pre-proline 0 C--N 1.355 0.83 0 N-CA-C 106.288 -1.745 . . . . 70.040000000000006 106.288 160.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.8 -57.42 1.74 Allowed 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 121.833 1.688 . . . . 62.020000000000003 113.838 -158.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -124.1 -21.82 4.95 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.38 0.672 . . . . 72.230000000000004 110.288 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -78.34 98.47 5.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.031 0.92 . . . . 71.450000000000003 111.702 -147.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.553 ' HB2' ' HD2' ' A' ' 253' ' ' LYS . 14.8 m-20 -121.76 -46.08 2.25 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 113.828 -1.533 . . . . 71.439999999999998 107.118 151.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.553 ' HD2' ' HB2' ' A' ' 252' ' ' ASP . 2.1 mptp? -109.15 -6.64 15.51 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 114.566 -1.197 . . . . 74.310000000000002 111.766 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -64.01 135.38 56.41 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 122.422 0.289 . . . . 73.420000000000002 110.863 -172.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.643 1.177 . . . . 64.5 108.654 -179.453 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.784 0.326 . . . . 41.119999999999997 110.334 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.21 -167.08 40.2 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.719 -0.553 . . . . 61.009999999999998 111.719 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -22.92 64.12 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.051 0.425 . . . . 65.129999999999995 111.568 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -117.65 109.65 41.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.793 0.837 . . . . 74.510000000000005 109.087 172.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.8 100.2 0.29 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.765 2.31 . . . . 72.209999999999994 112.294 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.03 -169.51 41.73 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.081 -0.509 . . . . 60.020000000000003 112.62 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -128.14 -63.13 1.02 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.306 0.643 . . . . 60.020000000000003 109.439 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -156.94 133.51 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.656 0.782 . . . . 64.319999999999993 109.765 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -128.44 137.07 51.66 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 106.48 -1.674 . . . . 73.340000000000003 106.48 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.77 132.29 46.67 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 123.382 0.426 . . . . 70.219999999999999 113.344 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.8 160.63 20.19 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.031 0.932 . . . . 75.349999999999994 111.432 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -78.19 152.54 32.63 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.049 0.939 . . . . 73.530000000000001 111.658 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.12 -57.05 2.64 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.3 1.04 . . . . 74.439999999999998 110.197 175.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 59.24 82.02 0.24 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.487 1.115 . . . . 64.209999999999994 110.926 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.68 -54.69 4.15 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.181 2.587 . . . . 72.030000000000001 112.89 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.4 p -179.15 -178.3 0.51 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.788 1.235 . . . . 61.310000000000002 109.956 176.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -146.13 123.48 6.06 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.976 0.91 . . . . 64.209999999999994 109.018 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.03 140.9 11.51 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.555 2.17 . . . . 75.349999999999994 112.293 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.92 116.68 29.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.514 0.726 . . . . 73.310000000000002 109.286 176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.49 -170.66 3.52 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.768 0.827 . . . . 70.0 110.073 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -69.34 170.46 10.3 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.444 0.64 . . . . 64.150000000000006 111.999 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 33' ' ' ARG . 35.3 t80 -147.58 165.04 31.58 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.951 -1.022 . . . . 64.540000000000006 109.153 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 tp -85.94 11.54 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 C-N-CA 123.485 0.714 . . . . 74.409999999999997 111.488 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm 64.26 -178.12 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.663 1.185 . . . . 53.509999999999998 111.286 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.03 120.38 1.8 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 116.143 -0.481 . . . . 74.420000000000002 113.196 176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.73 102.08 2.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.243 1.017 . . . . 74.439999999999998 110.045 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.1 -8.37 27.14 Favored Glycine 0 N--CA 1.471 1.017 0 CA-C-O 119.632 -0.538 . . . . 53.350000000000001 113.186 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -62.92 137.49 58.28 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.279 0.632 . . . . 71.030000000000001 111.014 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.2 164.09 14.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.936 0.494 . . . . 65.040000000000006 110.785 172.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.2 -55.51 0.01 OUTLIER 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.027 -1.472 . . . . 55.020000000000003 107.027 169.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.9 m 78.04 -44.97 0.41 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.734 1.613 . . . . 72.25 112.793 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -68.23 -46.39 70.66 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.991 0.517 . . . . 71.140000000000001 109.651 173.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -69.65 147.09 51.09 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.935 -1.135 . . . . 63.240000000000002 107.935 161.539 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -60.74 98.19 0.07 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.925 0.49 . . . . 53.43 110.567 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.53 76.88 0.37 Allowed Glycine 0 C--N 1.344 0.994 0 O-C-N 124.214 0.947 . . . . 63.409999999999997 113.351 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.84 159.24 27.32 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.081 -0.808 . . . . 53.219999999999999 111.081 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.29 -52.86 6.23 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 123.526 2.817 . . . . 41.020000000000003 113.523 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.7 m80 67.11 -68.11 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.334 1.454 . . . . 55.039999999999999 111.136 -172.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 245' ' ' TYR . 9.2 p -149.14 139.38 22.27 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.913 0.885 . . . . 65.319999999999993 109.331 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -118.79 141.25 48.8 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.214 0.606 . . . . 64.329999999999998 110.695 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.536 HG23 HG13 ' A' ' 43' ' ' VAL . 26.4 m -73.12 179.18 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.397 0.679 . . . . 65.510000000000005 112.821 -173.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -55.61 -65.74 0.54 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 123.963 0.905 . . . . 72.25 112.286 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.536 HG13 HG23 ' A' ' 41' ' ' VAL . 29.9 m 38.72 -157.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 125.681 1.592 . . . . 65.439999999999998 114.353 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.17 124.0 43.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.472 1.109 . . . . 74.430000000000007 108.126 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -167.69 85.16 0.22 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.746 0.784 . . . . 75.310000000000002 109.578 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -94.5 92.74 7.25 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.745 -0.661 . . . . 74.400000000000006 109.396 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.24 6.65 38.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.678 0.791 . . . . 52.130000000000003 111.365 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.41 173.36 12.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.533 0.733 . . . . 71.430000000000007 111.488 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -115.83 128.64 55.97 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.63 -0.878 . . . . 43.030000000000001 108.63 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.407 ' HD2' ' OG ' ' A' ' 161' ' ' SER . 70.4 mtm180 -99.01 -44.11 0.23 Allowed Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 117.951 -1.023 . . . . 74.120000000000005 113.565 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -69.4 83.24 0.64 Allowed 'Trans proline' 0 C--N 1.4 3.268 0 C-N-CA 122.002 1.801 . . . . 63.149999999999999 112.071 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.89 143.69 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.141 0.576 . . . . 74.219999999999999 110.097 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.47 90.17 0.07 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.333 0.653 . . . . 64.439999999999998 110.496 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.4 p -69.09 -12.57 61.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.785 1.234 . . . . 75.5 111.957 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -49.64 -54.36 18.92 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.435 1.094 . . . . 70.150000000000006 110.979 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -100.82 79.84 2.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.049 -0.978 . . . . 75.329999999999998 108.865 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -81.91 113.54 43.76 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 108.91 -0.774 . . . . 65.150000000000006 108.91 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.33 -61.27 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.009 2.472 . . . . 72.010000000000005 114.318 -167.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -113.46 -19.45 11.68 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.109 0.563 . . . . 64.219999999999999 112.08 -171.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.07 -86.92 0.67 Allowed Glycine 0 C--N 1.344 0.972 0 N-CA-C 112.189 -0.364 . . . . 62.140000000000001 112.189 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -105.97 110.88 23.3 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.835 -0.802 . . . . 74.239999999999995 108.835 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . 18.3 m -114.83 81.4 1.56 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.202 1.001 . . . . 74.040000000000006 108.468 176.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.47 -50.34 73.98 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.27 1.028 . . . . 52.240000000000002 113.142 -166.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.79 -36.22 59.84 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.759 0.424 . . . . 71.310000000000002 110.754 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 62' ' ' SER . . . -68.05 -27.55 66.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.179 0.592 . . . . 65.540000000000006 111.957 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HB2' ' HD2' ' A' ' 234' ' ' TYR . 7.6 ppt_? -83.45 -37.3 23.36 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-O 119.589 -0.244 . . . . 72.420000000000002 110.967 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -161.57 85.44 0.64 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.167 0.508 . . . . 64.510000000000005 111.376 178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 29.7 p-10 -88.09 -22.66 24.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.684 -0.689 . . . . 71.540000000000006 109.264 165.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.4 m -67.64 2.85 1.63 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.776 1.23 . . . . 74.329999999999998 113.381 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -70.01 -26.96 64.3 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.995 0.518 . . . . 72.310000000000002 110.997 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 13.2 pt-20 -77.54 -21.64 52.27 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.095 0.474 . . . . 74.040000000000006 110.327 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -91.66 -2.34 57.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.818 1.247 . . . . 41.310000000000002 110.827 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.31 -47.76 80.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.241 1.017 . . . . 63.530000000000001 111.733 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.1 mt -99.15 26.6 5.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.421 0.688 . . . . 72.340000000000003 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.22 64.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.19 0.596 . . . . 74.209999999999994 111.724 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.99 -141.28 44.81 Favored Glycine 0 C--N 1.356 1.642 0 CA-C-O 119.061 -0.855 . . . . 71.530000000000001 113.337 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 11.2 Cg_exo -71.15 -176.38 1.85 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.083 2.522 . . . . 74.540000000000006 112.361 171.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.485 ' H ' ' ND2' ' A' ' 139' ' ' ASN . 6.4 m -73.89 175.29 7.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.283 0.633 . . . . 73.129999999999995 109.542 172.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -69.6 -46.37 66.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 120.705 0.288 . . . . 75.040000000000006 111.091 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -126.62 -33.19 2.55 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.5 0.72 . . . . 63.100000000000001 110.961 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -89.51 115.61 64.22 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 114.866 1.432 . . . . 62.539999999999999 114.866 -163.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.441 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 74.7 Cg_endo -79.43 -20.44 9.57 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.556 2.171 . . . . 62.210000000000001 113.192 162.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -98.19 8.26 45.06 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.834 0.854 . . . . 65.409999999999997 111.47 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 tp -89.55 122.12 32.41 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.734 -0.839 . . . . 73.239999999999995 108.734 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.7 m-85 -108.87 174.52 5.83 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.811 1.244 . . . . 71.439999999999998 109.099 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.96 138.88 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.109 1.364 . . . . 45.210000000000001 108.957 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.02 114.18 14.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 50.109999999999999 110.517 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.24 -35.62 66.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.288 0.635 . . . . 71.420000000000002 111.071 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.446 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 32.5 m-85 -122.96 143.96 49.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.512 -0.921 . . . . 75.510000000000005 108.512 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 6.3 p-10 -70.42 148.05 48.79 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 109.178 -0.675 . . . . 74.549999999999997 109.178 167.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.563 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.6 t80 -147.17 141.57 26.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.127 -1.064 . . . . 72.219999999999999 108.127 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.7 139.97 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.236 -1.024 . . . . 72.019999999999996 108.236 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.22 115.72 3.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.536 0.734 . . . . 75.209999999999994 111.009 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -93.24 -55.93 3.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.328 1.051 . . . . 75.430000000000007 109.704 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.54 -173.44 38.32 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.398 -0.819 . . . . 65.030000000000001 113.452 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.68 -38.94 80.73 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.278 1.031 . . . . 75.239999999999995 111.759 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -98.95 -12.85 20.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.906 0.882 . . . . 74.319999999999993 112.036 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.4 p -72.33 135.04 45.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.784 -0.451 . . . . 54.140000000000001 109.784 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.6 ' HB3' HG13 ' A' ' 130' ' ' VAL . 66.4 tp -103.42 130.91 50.85 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.411 0.684 . . . . 73.319999999999993 110.394 -174.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -70.94 125.74 27.67 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.722 -0.844 . . . . 62.340000000000003 108.722 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.612 HG22 HG21 ' A' ' 123' ' ' THR . 22.8 pt -125.47 144.86 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.604 0.762 . . . . 65.25 110.08 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 10.1 m -88.72 144.94 25.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.676 -0.861 . . . . 64.239999999999995 108.676 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 62.5 tttp -65.69 110.97 2.97 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.796 0.438 . . . . 61.119999999999997 110.616 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.13 -10.88 55.28 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.013 -0.54 . . . . 61.409999999999997 112.931 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.645 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.5 tt0 -71.27 130.84 42.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.784 0.834 . . . . 74.349999999999994 110.533 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -77.27 147.63 36.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.953 -0.758 . . . . 65.409999999999997 108.953 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.614 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -147.98 142.2 26.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.798 0.439 . . . . 51.229999999999997 111.222 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 19.6 tpp180 -89.12 107.26 18.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.526 -0.761 . . . . 54.219999999999999 109.214 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.6 HG13 ' HB1' ' A' ' 119' ' ' ALA . 77.7 t -88.81 102.59 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.443 -0.577 . . . . 64.319999999999993 109.443 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 122' ' ' GLN . 2.2 mm? -67.53 -41.06 84.96 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.17 -0.923 . . . . 71.450000000000003 110.153 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.45 151.15 11.6 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.321 -0.854 . . . . 64.319999999999993 112.201 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 56.7 m-85 -88.35 174.45 8.15 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.791 0.836 . . . . 71.239999999999995 110.633 174.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -80.22 -176.34 5.54 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.614 -0.721 . . . . 71.0 109.217 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -54.63 -36.59 64.68 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.043 0.937 . . . . 71.25 113.296 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -112.48 10.46 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.077 0.769 . . . . 63.030000000000001 113.077 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.52 26.14 74.52 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.978 0.751 . . . . 70.310000000000002 114.978 171.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -80.81 -65.74 0.97 Allowed 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 109.027 -0.731 . . . . 71.329999999999998 109.027 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.416 ' HB3' ' HE3' ' A' ' 129' ' ' TRP . 73.8 m95 -90.59 150.94 21.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.015 0.926 . . . . 53.399999999999999 111.082 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.6 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.64 132.2 32.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.959 0.903 . . . . 71.120000000000005 110.641 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -76.85 107.48 9.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.889 -0.782 . . . . 70.219999999999999 108.889 167.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -112.52 149.71 32.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.989 0.916 . . . . 61.229999999999997 110.89 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.536 ' HG3' HD21 ' A' ' 110' ' ' LEU . 56.1 mt-30 -112.39 123.15 49.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.899 0.879 . . . . 74.120000000000005 109.498 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.612 HG21 HG22 ' A' ' 101' ' ' ILE . 44.1 p -124.01 174.78 7.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.716 1.207 . . . . 60.439999999999998 110.824 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -58.05 -27.31 63.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.68 1.192 . . . . 73.400000000000006 110.696 167.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.79 -30.87 59.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.525 1.13 . . . . 72.120000000000005 111.299 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 138.03 -177.23 20.16 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.188 -0.229 . . . . 51.229999999999997 112.921 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -86.79 138.9 31.21 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.921 0.488 . . . . 63.409999999999997 109.948 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -178.33 -173.48 43.75 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.243 -0.743 . . . . 63.210000000000001 111.243 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.416 ' HE3' ' HB3' ' A' ' 118' ' ' TRP . 32.7 m95 -110.76 120.79 43.57 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.513 0.725 . . . . 74.0 111.426 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.6 HG13 ' HB3' ' A' ' 99' ' ' LEU . 31.0 m -127.99 143.33 47.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 125.207 1.403 . . . . 73.209999999999994 108.969 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 4.6 Cg_endo -86.07 156.25 9.84 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.385 2.057 . . . . 72.319999999999993 114.39 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.3 m -36.5 -40.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 127.038 2.135 . . . . 54.130000000000003 114.691 170.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.407 HD22 ' HB2' ' A' ' 242' ' ' PRO . 35.6 p-10 -65.98 -22.21 66.45 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.326 0.65 . . . . 71.400000000000006 111.977 -172.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 38.1 m-85 -98.6 -20.04 17.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.806 0.842 . . . . 64.099999999999994 112.387 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -122.8 171.11 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.332 0.653 . . . . 63.119999999999997 112.249 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.4 t -161.3 153.9 17.19 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.353 -0.98 . . . . 72.010000000000005 108.353 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 54.3 Cg_exo -55.23 149.36 45.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 121.743 1.629 . . . . 72.140000000000001 112.351 172.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.88 -12.63 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.94 0.876 . . . . 72.400000000000006 109.852 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 1.6 m120 -87.22 -6.15 58.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.082 0.953 . . . . 73.25 111.516 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.3 p -89.11 174.26 7.98 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.924 0.489 . . . . 70.239999999999995 111.553 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.17 -23.63 30.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.507 -0.77 . . . . 62.030000000000001 110.849 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.64 -22.19 64.42 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.828 0.851 . . . . 65.340000000000003 111.929 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -59.55 -22.14 61.27 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.054 0.541 . . . . 72.049999999999997 111.91 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -82.55 139.59 33.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.522 0.729 . . . . 74.340000000000003 110.399 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.6 p -60.02 -42.17 93.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.695 1.198 . . . . 64.439999999999998 112.353 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -65.99 -38.42 88.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.734 0.813 . . . . 75.439999999999998 112.568 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.12 109.96 15.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.386 -0.598 . . . . 64.040000000000006 109.386 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.413 ' HB2' HG21 ' A' ' 151' ' ' VAL . 28.5 m170 -104.71 -9.78 17.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.009 0.524 . . . . 73.439999999999998 111.832 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.54 -132.26 27.14 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 118.208 -1.329 . . . . 52.240000000000002 112.294 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.88 95.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.254 2.636 . . . . 73.230000000000004 112.764 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.619 HG22 ' HE ' ' A' ' 239' ' ' ARG . 46.9 t -136.95 126.94 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.431 1.093 . . . . 61.520000000000003 108.956 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.6 p -76.29 172.51 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.307 0.643 . . . . 71.530000000000001 110.762 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -62.8 -48.46 79.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.739 0.416 . . . . 73.299999999999997 109.903 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -59.17 -35.88 74.32 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.113 0.883 . . . . 72.230000000000004 111.089 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -67.64 -47.84 68.41 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.602 -0.726 . . . . 72.450000000000003 111.182 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.36 86.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.409 -0.814 . . . . 73.319999999999993 110.798 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -81.94 -20.27 39.01 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.154 -0.93 . . . . 51.350000000000001 111.914 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -81.03 -24.7 37.7 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.156 0.889 . . . . 74.340000000000003 111.063 174.598 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.59 HD21 ' HB3' ' A' ' 239' ' ' ARG . 65.4 mt -71.35 -46.24 60.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 51.329999999999998 110.12 168.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 40.4 mt -92.47 20.33 6.33 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.128 -0.942 . . . . 74.129999999999995 111.935 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.407 ' OG ' ' HD2' ' A' ' 50' ' ' ARG . 83.6 p -90.4 -37.66 13.83 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.392 -0.596 . . . . 43.399999999999999 109.392 166.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.0 p -96.38 -11.64 25.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.458 0.703 . . . . 54.25 111.179 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.67 166.21 35.66 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 123.439 0.462 . . . . 64.340000000000003 113.89 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 pt -98.35 -178.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.83 0.852 . . . . 73.349999999999994 111.703 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -68.03 125.66 27.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.97 -0.559 . . . . 61.439999999999998 109.98 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.93 9.65 65.66 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-O 119.084 -0.842 . . . . 73.219999999999999 112.794 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.8 m -75.56 135.76 40.56 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 118.093 0.947 . . . . 73.120000000000005 110.396 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 183' ' ' SER . 17.1 p90 -147.28 162.96 37.88 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.708 0.403 . . . . 72.5 110.63 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -160.51 148.33 16.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.537 -0.756 . . . . 71.400000000000006 109.324 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.652 HG22 HG12 ' A' ' 182' ' ' ILE . 70.8 t -101.55 125.17 55.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.168 -1.049 . . . . 72.340000000000003 108.168 169.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.59 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt180 -115.67 151.11 35.66 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.255 1.022 . . . . 71.329999999999998 108.418 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.96 149.96 36.51 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.573 -1.269 . . . . 72.340000000000003 107.573 165.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.6 t -81.04 120.85 25.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.111 0.564 . . . . 63.149999999999999 110.37 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.72 -36.03 77.82 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.152 0.981 . . . . 72.340000000000003 109.862 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.3 m -68.47 -34.04 75.24 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.631 0.773 . . . . 64.530000000000001 111.642 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.5 m -140.98 91.6 8.93 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.381 0.673 . . . . 72.420000000000002 110.969 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.1 124.93 17.46 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.158 2.572 . . . . 72.219999999999999 112.545 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.58 -28.92 11.84 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.815 -0.436 . . . . 63.310000000000002 112.76 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -74.38 116.69 15.34 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.844 -0.799 . . . . 75.129999999999995 108.844 173.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.515 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 72.3 mtt85 -123.84 144.35 49.79 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.462 0.705 . . . . 71.5 109.252 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.1 m -138.26 146.28 42.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.063 -0.971 . . . . 72.349999999999994 108.561 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.652 HG12 HG22 ' A' ' 170' ' ' VAL . 28.5 mt -100.41 149.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 106.589 -1.634 . . . . 72.310000000000002 106.589 168.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.1 m -124.52 120.07 30.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.474 -1.306 . . . . 73.219999999999999 107.474 170.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.6 tp -114.07 112.01 22.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.828 0.74 . . . . 71.510000000000005 110.399 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.546 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 32.9 ttt85 -78.07 114.44 16.96 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 109.258 -0.645 . . . . 71.319999999999993 109.258 165.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -136.9 132.3 34.31 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.08 -1.082 . . . . 71.049999999999997 108.08 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 59.36 28.59 17.98 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.7 1.2 . . . . 64.540000000000006 111.488 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.19 -9.81 56.14 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.889 -0.596 . . . . 72.120000000000005 114.034 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -96.49 124.1 40.37 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.085 0.954 . . . . 74.150000000000006 108.781 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.82 108.08 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 120.913 0.387 . . . . 74.120000000000005 110.104 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.99 151.07 21.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.56 1.144 . . . . 70.239999999999995 108.706 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -128.15 116.75 20.42 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.593 -0.521 . . . . 72.319999999999993 109.593 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.487 ' HE1' HD21 ' A' ' 232' ' ' LEU . 4.5 m-85 -95.74 149.59 21.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.412 1.085 . . . . 62.329999999999998 108.74 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -107.26 116.12 31.38 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.039 0.536 . . . . 74.409999999999997 109.577 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 45.3 mt -81.92 105.28 11.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.564 -0.902 . . . . 61.119999999999997 108.564 172.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -90.57 144.62 25.59 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.918 0.887 . . . . 64.209999999999994 109.288 173.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.8 m -98.39 128.97 45.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.903 0.881 . . . . 51.520000000000003 109.163 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 160.56 31.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.619 0.768 . . . . 71.420000000000002 109.951 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 40.9 p -62.64 -24.44 67.6 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.864 0.69 . . . . 64.140000000000001 112.864 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.07 -17.31 27.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.416 0.686 . . . . 65.439999999999998 111.372 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.55 14.02 9.17 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.451 0.94 . . . . 75.319999999999993 115.451 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -68.87 156.05 39.14 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.244 1.022 . . . . 74.439999999999998 110.492 170.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 146.8 34.2 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.413 -0.958 . . . . 63.109999999999999 108.413 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 30.7 p90 -167.97 141.52 3.32 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.681 0.613 . . . . 73.230000000000004 112.069 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.448 HG23 HD11 ' A' ' 217' ' ' LEU . 75.4 t -88.89 -31.87 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.186 -0.915 . . . . 71.219999999999999 108.87 162.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.7 m -105.54 123.04 47.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.301 1.04 . . . . 73.420000000000002 109.383 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -66.54 -24.7 66.41 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.163 0.585 . . . . 72.530000000000001 111.735 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.72 -15.18 57.15 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.41 1.084 . . . . 75.439999999999998 110.577 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.5 m -133.67 89.42 2.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.772 0.829 . . . . 70.409999999999997 109.338 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.469 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 52.9 mtt180 -97.11 120.04 36.71 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.725 0.81 . . . . 73.230000000000004 109.288 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.22 146.86 32.19 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.642 -0.873 . . . . 75.329999999999998 108.642 -174.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.21 -30.2 70.61 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 123.764 0.665 . . . . 72.209999999999994 111.622 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 75.2 p -132.08 158.79 40.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.32 0.648 . . . . 74.319999999999993 111.902 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.77 -28.56 67.71 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.471 1.108 . . . . 54.439999999999998 109.688 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.47 83.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.312 0.645 . . . . 73.310000000000002 110.668 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -77.33 -28.3 53.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.677 0.791 . . . . 72.209999999999994 111.666 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 205' ' ' VAL . 12.4 tp -58.33 -57.64 12.02 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.541 0.336 . . . . 72.519999999999996 110.254 170.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.54 -38.28 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.892 0.745 . . . . 63.32 110.739 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.15 -56.33 23.49 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.789 0.681 . . . . 73.019999999999996 111.301 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -65.21 -33.54 76.25 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.406 0.682 . . . . 73.140000000000001 110.844 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.697 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.6 m170 -89.29 -8.39 53.46 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.138 -0.483 . . . . 64.319999999999993 112.115 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.6 p -97.52 -22.89 16.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.041 0.537 . . . . 55.340000000000003 110.775 170.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 44.6 p -82.25 -43.2 17.9 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.796 0.439 . . . . 54.340000000000003 111.051 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' A' ' 226' ' ' ASP . 32.0 m -130.32 167.71 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.844 0.83 . . . . 64.340000000000003 111.57 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -80.48 13.93 2.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.839 2.056 . . . . 52.420000000000002 114.549 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.552 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.6 t70 -40.98 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 131.18 3.792 . . . . 73.530000000000001 119.82 -150.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.48 -3.94 10.22 Favored Glycine 0 N--CA 1.481 1.639 0 O-C-N 119.438 -2.039 . . . . 44.020000000000003 112.133 -166.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 221' ' ' HIS . 9.8 mt -89.59 162.49 15.62 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 125.139 1.375 . . . . 75.099999999999994 109.285 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.8 tt -57.5 -39.17 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-O 120.588 0.232 . . . . 75.219999999999999 110.499 168.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -162.64 175.62 11.2 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.492 0.717 . . . . 64.200000000000003 110.906 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.8 p -60.42 144.55 50.76 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.613 1.165 . . . . 65.129999999999995 112.209 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.487 HD21 ' HE1' ' A' ' 193' ' ' TYR . 78.4 mt -77.65 116.4 18.17 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.692 0.797 . . . . 61.210000000000001 109.353 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -104.94 -79.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.787 0.435 . . . . 74.450000000000003 111.308 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.52 ' HD2' ' HB2' ' A' ' 66' ' ' ARG . 46.3 t80 -90.39 121.52 68.38 Favored Pre-proline 0 C--O 1.213 -0.844 0 C-N-CA 123.7 0.8 . . . . 41.32 109.486 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.21 134.32 10.26 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.001 1.8 . . . . 71.219999999999999 111.228 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.17 151.35 92.42 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.492 0.717 . . . . 64.120000000000005 109.573 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -85.45 169.15 9.74 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.446 2.097 . . . . 60.340000000000003 113.873 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -59.05 119.19 6.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.006 0.922 . . . . 71.420000000000002 109.041 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.619 ' HE ' HG22 ' A' ' 151' ' ' VAL . 22.9 ptt85 -78.94 -59.67 2.69 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.794 1.035 . . . . 74.140000000000001 113.794 -161.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.415 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 49.2 t30 -106.98 122.0 45.58 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.84 0.856 . . . . 65.209999999999994 109.0 -176.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.69 113.75 22.57 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 106.953 -1.499 . . . . 74.209999999999994 106.953 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.407 ' HB2' HD22 ' A' ' 133' ' ' ASN . 60.0 Cg_endo -69.58 129.32 17.58 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.812 2.341 . . . . 44.409999999999997 112.521 -166.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.8 m -68.81 113.5 6.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.312 -0.858 . . . . 61.109999999999999 110.667 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.56 117.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.601 -1.259 . . . . 71.120000000000005 107.601 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 41' ' ' VAL . 8.5 m-85 -96.03 110.39 22.64 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 118.927 -0.558 . . . . 71.120000000000005 110.707 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 63.42 -38.19 0.08 OUTLIER Glycine 0 CA--C 1.55 2.26 0 N-CA-C 118.639 2.216 . . . . 60.200000000000003 118.639 166.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.96 125.51 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.809 0.844 . . . . 75.25 113.226 -154.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.4 t -86.83 142.66 34.51 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 107.389 -1.338 . . . . 72.049999999999997 107.389 150.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.53 -54.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.375 1.968 0 CA-C-N 120.834 1.334 . . . . 75.299999999999997 114.019 -167.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -126.2 -25.59 3.51 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.966 0.728 . . . . 63.009999999999998 112.966 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -98.78 117.76 33.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.989 0.737 . . . . 73.019999999999996 112.989 -166.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -114.71 -37.19 4.3 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.596 0.759 . . . . 74.420000000000002 110.81 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -110.48 17.48 20.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.4 1.08 . . . . 73.450000000000003 111.44 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -86.48 141.96 28.71 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.636 -0.665 . . . . 73.329999999999998 112.665 -167.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.253 1.269 0 O-C-N 124.979 1.424 . . . . 70.450000000000003 107.669 165.775 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.061 -0.718 . . . . 74.239999999999995 109.061 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 147.68 80.59 0.03 OUTLIER Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.519 -0.632 . . . . 61.240000000000002 111.519 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -78.5 149.05 33.23 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 109.788 -0.449 . . . . 74.420000000000002 109.788 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -158.62 96.1 1.81 Allowed Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 108.757 -0.831 . . . . 74.120000000000005 108.757 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.86 -172.72 1.47 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.957 2.438 . . . . 53.020000000000003 112.971 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.55 146.12 8.43 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.909 -0.587 . . . . 74.530000000000001 111.843 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -67.52 162.99 22.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.074 0.95 . . . . 42.420000000000002 111.868 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.62 150.91 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.051 0.94 . . . . 72.040000000000006 109.283 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.5 pt? -115.11 171.37 7.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.576 0.75 . . . . 75.230000000000004 109.152 176.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.04 83.3 0.32 Allowed Glycine 0 C--N 1.346 1.098 0 O-C-N 123.484 0.49 . . . . 71.329999999999998 112.08 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.17 147.5 43.96 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.311 1.044 . . . . 72.010000000000005 110.924 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -61.88 128.91 38.46 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.419 0.688 . . . . 73.439999999999998 111.296 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -70.15 83.88 0.53 Allowed 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 122.366 1.079 . . . . 75.310000000000002 110.628 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -132.31 134.78 25.37 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 115.306 -0.861 . . . . 63.439999999999998 109.195 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.78 111.85 2.28 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.41 2.074 . . . . 60.32 111.282 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 t -61.89 148.37 43.71 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.615 0.766 . . . . 64.140000000000001 110.506 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 mp -65.78 118.63 53.49 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.518 0.727 . . . . 53.340000000000003 109.732 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.94 119.61 6.72 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.461 2.107 . . . . 73.340000000000003 111.184 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -150.43 99.41 2.77 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.379 0.672 . . . . 72.420000000000002 110.363 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.52 155.25 21.6 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.134 0.974 . . . . 73.329999999999998 109.591 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -151.96 129.85 11.72 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.253 0.346 . . . . 75.400000000000006 110.697 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -159.6 87.49 0.82 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.49 0.716 . . . . 75.200000000000003 109.24 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 tt -162.86 139.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.86 0.864 . . . . 51.119999999999997 109.654 177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -153.75 124.62 7.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.674 0.79 . . . . 74.540000000000006 109.372 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.94 158.45 10.43 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 111.482 -0.647 . . . . 22.32 111.482 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.2 85.12 4.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.138 -0.69 . . . . 50.140000000000001 109.138 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.79 -143.85 6.22 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.281 -0.872 . . . . 52.210000000000001 111.938 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.93 105.9 3.31 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.4 -1.333 . . . . 44.140000000000001 107.4 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HG2' ' H ' ' A' ' 30' ' ' GLU . 55.4 ttt180 -85.46 -179.83 7.0 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.515 0.726 . . . . 74.010000000000005 110.137 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.53 ' H ' ' HG2' ' A' ' 29' ' ' ARG . 12.7 mt-10 -41.97 98.25 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.487 1.515 . . . . 73.299999999999997 111.182 170.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.5 p -106.52 168.01 9.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.271 0.628 . . . . 61.439999999999998 110.878 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 54.1 p -74.24 170.36 15.72 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.625 0.77 . . . . 63.299999999999997 109.996 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -61.91 92.26 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.096 0.559 . . . . 74.230000000000004 110.747 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -81.41 153.08 27.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.135 0.574 . . . . 75.140000000000001 110.536 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -132.86 39.1 1.78 Allowed Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.971 -0.852 . . . . 72.430000000000007 110.971 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.39 71.78 0.04 OUTLIER Glycine 0 C--O 1.241 0.581 0 N-CA-C 111.133 -0.787 . . . . 62.039999999999999 111.133 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -91.05 -131.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.217 2.612 . . . . 74.219999999999999 110.12 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.15 -177.83 0.18 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.728 0.811 . . . . 74.409999999999997 110.674 177.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 40' ' ' ASN . 53.7 t 67.09 167.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.283 1.033 . . . . 72.349999999999994 112.643 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.417 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 21.8 t-20 -157.47 116.99 3.34 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.251 -1.388 . . . . 70.099999999999994 107.251 171.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.3 p -79.69 132.83 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 122.807 0.443 . . . . 70.040000000000006 110.277 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -75.59 134.41 40.68 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.221 -0.659 . . . . 74.439999999999998 109.221 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.92 138.37 49.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.968 0.907 . . . . 70.120000000000005 108.634 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.22 113.81 10.7 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.004 -0.739 . . . . 63.549999999999997 109.004 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -71.35 162.37 29.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.002 0.921 . . . . 74.430000000000007 111.956 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.28 154.09 42.71 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.6 1.16 . . . . 72.329999999999998 108.702 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.94 34.06 0.1 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.081 0.4 . . . . 73.409999999999997 112.081 -173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.92 133.0 40.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.111 -0.7 . . . . 72.230000000000004 109.111 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -137.9 -88.61 0.25 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.783 -0.821 . . . . 72.409999999999997 108.783 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.41 134.85 0.48 Allowed Pre-proline 0 C--N 1.35 0.625 0 N-CA-C 108.664 -0.865 . . . . 73.439999999999998 108.664 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.8 -173.04 1.7 Allowed 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.427 2.084 . . . . 71.510000000000005 112.187 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -75.06 -165.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.335 0.654 . . . . 64.510000000000005 110.867 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.57 97.04 0.05 OUTLIER 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.457 0.646 . . . . 55.340000000000003 110.153 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 p -86.92 22.59 1.96 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.345 1.058 . . . . 73.310000000000002 111.408 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -89.04 11.46 18.32 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.534 1.133 . . . . 64.340000000000003 110.929 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -128.78 133.91 48.22 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.842 0.857 . . . . 74.219999999999999 110.194 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.26 160.75 77.53 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.926 0.891 . . . . 71.420000000000002 110.641 174.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -40.77 -52.11 3.36 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.963 3.109 . . . . 53.409999999999997 114.816 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.522 ' HG3' HD13 ' A' ' 61' ' ' LEU . 24.1 tp60 -169.05 -42.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.365 0.666 . . . . 61.149999999999999 110.438 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.53 -23.51 35.89 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 116.152 -0.476 . . . . 73.409999999999997 112.625 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.522 HD13 ' HG3' ' A' ' 59' ' ' GLN . 9.4 mp -77.46 165.58 24.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.172 0.511 . . . . 65.120000000000005 111.049 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.0 m -89.59 -161.52 0.78 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.169 -0.923 . . . . 75.0 111.497 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -47.79 -36.52 11.81 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.685 1.594 . . . . 71.040000000000006 113.384 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -150.08 -70.61 0.19 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.376 -0.972 . . . . 63.420000000000002 108.376 172.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.73 -76.47 0.61 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.1 -0.704 . . . . 45.43 109.1 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -137.98 -83.74 0.31 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.64 0.776 . . . . 73.439999999999998 109.016 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -120.01 81.04 1.68 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.585 0.707 . . . . 73.439999999999998 109.611 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -85.65 -17.79 35.08 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.966 -1.015 . . . . 74.540000000000006 110.249 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.0 p -87.42 5.42 38.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.952 0.901 . . . . 74.239999999999995 111.684 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -64.34 -30.32 71.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.745 0.418 . . . . 64.0 111.553 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.24 -33.16 75.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.166 -0.47 . . . . 75.310000000000002 110.482 172.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -75.97 -17.95 59.51 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.575 0.75 . . . . 74.319999999999993 111.369 177.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.4 tp -55.48 -51.66 66.22 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.093 0.557 . . . . 74.109999999999999 110.73 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.11 14.84 23.71 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.448 0.699 . . . . 74.409999999999997 111.213 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.48 -34.79 72.77 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.477 0.311 . . . . 71.430000000000007 111.261 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.55 -135.61 33.52 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 118.617 -1.102 . . . . 64.25 111.034 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.25 -177.24 3.13 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 122.981 2.454 . . . . 75.400000000000006 112.17 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 m -77.84 172.27 13.71 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.964 -0.562 . . . . 75.349999999999994 109.67 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -70.23 -42.8 71.79 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.73 0.412 . . . . 51.409999999999997 111.412 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -125.65 -34.39 2.65 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.057 0.543 . . . . 72.329999999999998 111.484 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.0 109.35 29.96 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.049 0.54 . . . . 50.229999999999997 111.508 -170.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.11 -12.87 6.75 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.412 2.074 . . . . 61.439999999999998 112.008 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -109.73 16.41 22.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.61 1.164 . . . . 71.450000000000003 110.945 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -86.6 130.85 34.33 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 109.202 -0.666 . . . . 74.310000000000002 109.202 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -108.82 174.12 6.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.568 1.147 . . . . 72.439999999999998 108.975 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.44 139.36 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.666 1.186 . . . . 61.43 108.616 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.5 127.51 32.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.515 0.726 . . . . 71.340000000000003 110.739 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 143' ' ' LYS . 91.2 mt -83.55 -32.82 25.64 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.773 0.829 . . . . 62.539999999999999 111.916 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.43 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 25.8 m-85 -125.05 157.18 36.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.253 0.621 . . . . 65.200000000000003 109.485 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.62 119.16 23.93 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.384 -0.969 . . . . 61.329999999999998 108.384 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.606 ' HB3' HG12 ' A' ' 101' ' ' ILE . 79.7 t80 -119.03 138.62 52.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.532 -0.914 . . . . 72.040000000000006 108.532 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -104.95 131.08 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.437 -0.949 . . . . 63.020000000000003 108.437 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.26 56.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.23 0.612 . . . . 62.43 111.092 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -86.83 -42.94 12.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.414 0.686 . . . . 52.109999999999999 109.689 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.76 -167.77 11.17 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.584 -0.734 . . . . 71.099999999999994 112.561 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' A' ' 255' ' ' GLU . 5.7 m-20 -66.92 -37.87 85.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.129 0.972 . . . . 71.239999999999995 110.835 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.508 ' HA ' ' HE3' ' A' ' 254' ' ' TRP . 26.5 p-10 -66.91 -21.01 66.01 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.259 -1.337 . . . . 74.340000000000003 112.222 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.0 p -100.39 -179.15 4.03 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.842 0.857 . . . . 64.150000000000006 110.484 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.637 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 62.9 tp -144.31 139.69 28.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.917 0.487 . . . . 44.130000000000003 111.073 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 m -85.35 132.9 34.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.442 0.697 . . . . 74.430000000000007 109.7 174.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -133.01 148.8 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 120.953 0.406 . . . . 72.109999999999999 111.621 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.8 m -99.3 150.23 22.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.076 0.95 . . . . 51.509999999999998 108.73 174.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -64.84 126.92 29.47 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.739 -0.467 . . . . 73.129999999999995 109.739 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.02 -14.13 64.19 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.127 -0.488 . . . . 75.120000000000005 112.575 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 39.2 tt0 -74.76 128.0 34.5 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.794 0.838 . . . . 62.530000000000001 110.774 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.88 134.68 35.08 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.412 0.685 . . . . 71.120000000000005 110.325 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.4 OUTLIER -146.21 136.86 24.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.817 0.847 . . . . 74.319999999999993 110.631 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -96.65 115.12 26.9 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.506 0.323 . . . . 72.420000000000002 110.602 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.644 HG13 ' HB1' ' A' ' 119' ' ' ALA . 52.7 t -74.58 110.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.424 0.63 . . . . 75.5 109.707 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.67 -32.13 60.04 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.246 -1.343 . . . . 74.099999999999994 110.044 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.54 155.34 11.17 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.231 -0.895 . . . . 63.100000000000001 111.878 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.61 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 43.0 m-85 -87.47 175.5 7.93 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.472 0.654 . . . . 72.219999999999999 111.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -85.38 -173.05 4.47 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.935 -1.029 . . . . 74.219999999999999 110.928 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -44.38 -44.17 8.12 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.472 1.509 . . . . 74.200000000000003 114.296 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -112.61 0.28 15.37 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.911 0.708 . . . . 74.230000000000004 112.911 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.61 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 81.83 22.69 59.24 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 115.313 0.885 . . . . 71.299999999999997 115.313 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.48 -65.44 1.0 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.98 0.89 . . . . 71.030000000000001 110.012 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 49.2 m95 -92.3 150.4 20.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.194 0.598 . . . . 74.510000000000005 111.369 -174.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.644 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -133.3 137.34 45.94 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.438 1.095 . . . . 30.43 110.193 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -78.37 98.8 6.11 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.292 -1.003 . . . . 73.409999999999997 108.292 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -105.42 139.98 39.23 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.414 0.685 . . . . 64.129999999999995 110.339 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -102.27 105.7 16.39 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.216 -0.661 . . . . 71.310000000000002 109.216 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.462 HG21 HG22 ' A' ' 101' ' ' ILE . 69.4 p -80.4 168.42 19.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.952 0.783 . . . . 75.450000000000003 109.731 171.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -67.33 -8.19 30.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.607 -0.724 . . . . 75.420000000000002 111.537 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -91.4 -30.78 16.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.937 0.895 . . . . 74.019999999999996 110.958 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.28 174.68 24.64 Favored Glycine 0 C--N 1.36 1.886 0 N-CA-C 114.204 0.442 . . . . 44.130000000000003 114.204 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -86.62 142.49 28.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.809 0.843 . . . . 71.219999999999999 110.99 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.637 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -176.81 -170.01 38.8 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-N 114.945 -1.025 . . . . 53.310000000000002 110.646 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -109.77 129.34 55.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.817 0.808 . . . . 74.030000000000001 111.41 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' A' ' 99' ' ' LEU . 27.6 m -136.07 145.21 51.43 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 124.698 1.199 . . . . 65.349999999999994 109.188 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 47.4 Cg_endo -88.44 156.35 6.57 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 122.541 2.161 . . . . 65.319999999999993 114.312 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 m -38.33 -43.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.611 1.964 . . . . 64.540000000000006 114.137 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.54 HD22 ' HB2' ' A' ' 242' ' ' PRO . 36.4 p-10 -72.23 -11.33 60.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.097 0.559 . . . . 70.409999999999997 112.057 -174.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 28.7 m-85 -105.9 -13.5 15.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.983 0.913 . . . . 74.310000000000002 112.581 176.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 130' ' ' VAL . 16.8 pt -130.98 172.83 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.373 0.669 . . . . 71.439999999999998 111.696 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -162.01 152.02 14.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 108.428 -0.953 . . . . 71.540000000000006 108.428 172.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.23 149.52 44.73 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.04 1.826 . . . . 71.420000000000002 112.065 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.17 -23.36 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.093 0.473 . . . . 64.150000000000006 110.531 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -69.69 -18.61 63.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.941 0.896 . . . . 64.409999999999997 112.291 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.2 p -77.93 166.16 23.21 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.157 0.799 . . . . 74.340000000000003 113.157 -167.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -84.52 -19.73 32.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.815 -1.084 . . . . 72.25 110.663 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -71.13 -24.15 62.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.294 1.037 . . . . 72.409999999999997 111.35 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.529 ' HA ' HD21 ' A' ' 88' ' ' LEU . 21.3 pttm -62.08 -18.64 61.37 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.44 0.696 . . . . 74.340000000000003 112.868 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -76.7 149.28 36.42 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.472 0.709 . . . . 72.310000000000002 110.418 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.4 p -61.72 -43.24 99.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.95 0.9 . . . . 73.230000000000004 111.456 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -68.89 -34.56 75.61 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.062 0.851 . . . . 74.299999999999997 113.103 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.92 113.92 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.148 -0.686 . . . . 74.019999999999996 109.148 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.425 ' HD2' ' HD3' ' A' ' 238' ' ' LYS . 29.8 m170 -110.94 3.59 18.93 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.633 0.605 . . . . 75.209999999999994 112.633 -175.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.58 -148.04 38.03 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-O 118.861 -0.966 . . . . 64.150000000000006 112.771 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.81 97.54 0.23 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.02 2.48 . . . . 74.319999999999993 111.952 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 61.0 t -131.89 129.28 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.666 0.787 . . . . 61.049999999999997 110.003 -175.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -79.36 172.34 13.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.55 0.74 . . . . 35.340000000000003 110.392 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -60.35 -47.62 85.27 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.645 0.378 . . . . 71.219999999999999 110.803 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -57.09 -41.59 79.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.652 0.781 . . . . 64.519999999999996 111.89 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -72.14 -34.25 68.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.763 0.425 . . . . 71.439999999999998 111.325 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.25 91.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.484 0.659 . . . . 75.540000000000006 110.915 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -79.6 -21.23 45.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.418 -0.81 . . . . 54.009999999999998 110.88 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -64.61 -42.06 95.78 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.221 0.608 . . . . 71.420000000000002 109.623 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 239' ' ' ARG . 85.8 mt -64.76 -44.51 89.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.521 0.728 . . . . 70.219999999999999 111.692 174.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.5 13.72 13.15 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.959 -0.564 . . . . 63.409999999999997 112.17 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -65.39 -42.11 92.99 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.476 0.655 . . . . 72.209999999999994 110.002 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.3 p -102.58 19.61 18.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.59 1.156 . . . . 65.109999999999999 110.494 176.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.35 152.95 36.65 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.883 -0.599 . . . . 51.539999999999999 112.269 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 pt -102.31 -177.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.147 0.979 . . . . 74.200000000000003 110.709 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.41 120.95 10.29 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.176 0.59 . . . . 61.130000000000003 110.247 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.17 10.52 62.34 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.795 -0.639 . . . . 34.310000000000002 113.168 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 73.9 m -77.73 128.4 33.99 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.782 0.791 . . . . 72.319999999999993 110.044 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -139.69 164.34 30.2 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.381 0.61 . . . . 64.420000000000002 111.454 -170.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.5 pp -160.2 154.92 24.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.464 -1.244 . . . . 75.549999999999997 108.968 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 182' ' ' ILE . 87.5 t -110.14 127.93 66.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.533 -0.914 . . . . 63.32 108.533 168.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.574 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 20.4 ptt85 -115.66 155.36 27.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.41 -1.268 . . . . 65.120000000000005 108.514 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.52 147.46 40.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.257 -1.016 . . . . 74.439999999999998 108.257 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -87.33 129.08 35.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.687 -0.486 . . . . 70.239999999999995 109.687 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -80.7 -40.06 26.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.485 -0.779 . . . . 71.310000000000002 109.518 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.7 m -66.54 -33.07 74.85 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.999 0.92 . . . . 62.310000000000002 111.097 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -118.51 95.53 48.9 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 123.764 0.826 . . . . 41.310000000000002 109.529 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -58.14 126.55 21.89 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.322 2.681 . . . . 74.430000000000007 113.278 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.62 -27.52 8.66 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 116.242 -0.435 . . . . 54.130000000000003 113.152 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -66.65 136.3 55.35 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.353 0.661 . . . . 74.019999999999996 110.548 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -135.17 158.29 44.75 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.717 0.807 . . . . 72.230000000000004 109.793 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.4 m -147.37 150.1 34.05 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.432 1.093 . . . . 72.019999999999996 108.93 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.611 HG12 HG22 ' A' ' 170' ' ' VAL . 35.8 mt -103.93 149.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.954 -1.128 . . . . 73.420000000000002 107.954 173.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.2 m -125.09 110.85 14.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.286 -1.005 . . . . 72.25 108.286 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.1 tp -110.0 112.85 25.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.152 0.581 . . . . 52.109999999999999 110.104 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.503 ' HB2' HG22 ' A' ' 190' ' ' VAL . 39.1 ttt180 -78.47 114.79 17.69 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.268 0.556 . . . . 75.420000000000002 110.048 165.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.44 141.62 37.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.153 -1.385 . . . . 54.119999999999997 107.763 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 57.07 28.67 15.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.922 0.889 . . . . 75.099999999999994 111.575 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.42 -9.46 54.78 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-N 115.797 -0.638 . . . . 72.420000000000002 114.043 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -104.5 140.05 38.53 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.834 0.854 . . . . 73.230000000000004 109.839 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 185' ' ' ARG . 48.9 t -98.77 106.51 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.852 0.461 . . . . 63.409999999999997 110.457 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -91.16 141.62 28.62 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.016 0.926 . . . . 74.219999999999999 109.115 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -114.88 118.58 33.9 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.713 0.405 . . . . 74.310000000000002 110.019 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.425 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.4 m-30 -94.02 149.78 20.93 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.05 0.94 . . . . 74.5 108.738 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -101.07 127.45 47.6 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.792 -0.818 . . . . 74.430000000000007 108.792 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 101.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.826 -1.176 . . . . 63.43 107.826 171.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -79.02 132.92 36.81 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.501 -0.772 . . . . 61.119999999999997 109.045 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.8 m -93.76 113.74 25.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.293 -1.003 . . . . 72.430000000000007 108.293 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.11 159.17 33.43 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.559 0.537 . . . . 71.120000000000005 111.257 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.5 p -66.8 -27.91 67.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.578 -0.737 . . . . 71.329999999999998 110.94 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.3 -1.05 48.33 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.985 0.914 . . . . 72.329999999999998 111.343 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 98.26 -7.92 62.36 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.822 -0.432 . . . . 75.310000000000002 114.116 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.33 133.49 34.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.652 0.726 . . . . 55.240000000000002 111.745 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.416 ' H ' HD22 ' A' ' 203' ' ' LEU . 1.3 mm? -83.6 147.87 27.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.855 0.862 . . . . 75.019999999999996 108.913 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.554 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.3 p90 -166.53 151.46 7.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.967 0.413 . . . . 64.340000000000003 111.876 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.438 ' HB ' ' HE1' ' A' ' 221' ' ' HIS . 59.8 t -99.19 -35.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.577 -0.897 . . . . 63.100000000000001 108.577 165.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -103.78 125.76 50.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.095 0.958 . . . . 72.209999999999994 109.252 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.9 t -63.01 -30.15 71.38 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 71.299999999999997 112.207 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.58 -26.9 61.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.624 0.769 . . . . 72.030000000000001 111.099 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.1 m -121.85 96.68 5.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 74.340000000000003 110.063 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.554 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.0 mtt180 -100.02 140.66 33.93 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.789 0.836 . . . . 75.150000000000006 109.195 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 3.1 m-85 -127.0 140.55 52.23 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.374 0.67 . . . . 72.230000000000004 109.818 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.19 -27.03 63.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.241 0.616 . . . . 74.329999999999998 110.289 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -133.29 153.72 51.32 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.813 0.845 . . . . 64.209999999999994 110.745 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.498 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -67.54 -21.52 65.46 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.128 -0.942 . . . . 74.439999999999998 109.708 172.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.01 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.9 0.88 . . . . 71.219999999999999 110.398 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.3 mt-10 -69.42 -37.04 77.25 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.289 -0.868 . . . . 74.420000000000002 111.338 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 205' ' ' VAL . 13.8 tp -55.17 -57.86 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.374 0.421 . . . . 71.310000000000002 111.152 176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.9 -40.3 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.892 0.477 . . . . 51.43 111.355 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -59.15 -54.44 46.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.381 0.672 . . . . 74.340000000000003 111.004 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.423 ' O ' HG22 ' A' ' 224' ' ' VAL . 45.4 t60 -63.76 -38.21 90.25 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.797 0.839 . . . . 72.450000000000003 110.925 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.71 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.0 m-70 -85.8 -8.24 58.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.922 0.489 . . . . 64.040000000000006 112.002 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.8 p -93.66 -28.9 15.72 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.627 0.371 . . . . 54.450000000000003 110.308 169.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.6 p -77.65 -40.71 40.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.322 0.249 . . . . 73.209999999999994 111.113 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 220' ' ' HIS . 32.6 m -131.58 157.56 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.72 . . . . 74.340000000000003 111.487 -176.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.59 10.24 18.57 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.08 1.752 . . . . 62.43 113.874 -173.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -45.96 32.78 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 130.799 3.64 . . . . 75.430000000000007 120.428 -155.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 127.84 -1.11 6.8 Favored Glycine 0 N--CA 1.464 0.564 0 O-C-N 120.925 -1.109 . . . . 50.100000000000001 112.788 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.5 mt -91.58 161.38 14.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.51 1.124 . . . . 64.099999999999994 109.753 165.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -60.77 -36.37 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 120.816 0.341 . . . . 61.229999999999997 110.485 171.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.2 t -162.77 178.77 8.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.885 0.874 . . . . 75.530000000000001 109.471 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.5 p -63.78 143.77 57.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.24 0.616 . . . . 72.219999999999999 112.039 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.425 HD21 ' HE1' ' A' ' 193' ' ' TYR . 54.4 mt -69.5 138.15 53.12 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 108.159 -1.052 . . . . 70.25 108.159 169.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -135.95 -76.7 0.43 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.85 0.75 . . . . 75.120000000000005 112.238 -170.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -84.21 122.43 75.62 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.912 -0.773 . . . . 64.120000000000005 108.912 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.05 126.4 6.37 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 122.251 1.968 . . . . 64.420000000000002 111.918 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . . . -74.11 135.8 76.47 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.891 -0.781 . . . . 74.340000000000003 108.891 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.5 177.76 8.36 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.632 2.222 . . . . 52.5 112.322 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HD3' ' HD2' ' A' ' 148' ' ' HIS . 72.5 mmtt -63.52 157.12 24.41 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.752 0.821 . . . . 63.219999999999999 109.971 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 29.3 ptt180 -91.13 -62.56 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.06 0.763 . . . . 54.200000000000003 113.06 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.564 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 24.8 t-20 -110.68 158.56 18.47 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.821 0.848 . . . . 64.319999999999993 108.794 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 114.55 57.37 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 106.131 -1.803 . . . . 71.530000000000001 106.131 156.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.54 ' HB2' HD22 ' A' ' 133' ' ' ASN . 36.6 Cg_endo -62.79 124.9 14.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.41 2.074 . . . . 54.420000000000002 112.19 -169.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 33.8 m -71.29 117.8 13.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.819 0.847 . . . . 75.420000000000002 110.646 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.44 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 24.6 t -98.62 125.17 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.077 -1.083 . . . . 70.430000000000007 108.077 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.18 115.55 30.45 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.573 -0.251 . . . . 74.230000000000004 110.563 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.63 -3.36 0.25 Allowed Glycine 0 CA--C 1.54 1.626 0 N-CA-C 118.409 2.123 . . . . 63.409999999999997 118.409 161.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 11.9 m -91.53 122.99 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.372 1.586 . . . . 75.239999999999995 112.222 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 25.3 t -72.97 123.88 90.09 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 106.874 -1.528 . . . . 75.209999999999994 106.874 165.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.96 -63.79 0.25 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.321 2.014 . . . . 52.5 115.104 -153.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -131.76 -29.73 1.68 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.597 1.189 . . . . 62.149999999999999 108.321 147.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.455 ' HD1' ' HB2' ' A' ' 254' ' ' TRP . 9.9 m-85 -101.48 139.43 37.15 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 113.191 -1.822 . . . . 73.239999999999995 110.636 -174.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.08 -40.3 3.5 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.353 1.061 . . . . 54.240000000000002 109.397 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -76.74 -20.6 56.34 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.868 0.867 . . . . 73.230000000000004 111.731 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.508 ' HE3' ' HA ' ' A' ' 97' ' ' ASN . 35.3 t90 -67.44 138.32 56.56 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.61 0.596 . . . . 71.219999999999999 112.61 -171.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 6.7 pt-20 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 124.973 1.309 . . . . 70.310000000000002 109.295 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.526 0.203 . . . . 60.030000000000001 110.565 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.06 56.42 0.74 Allowed Glycine 0 C--N 1.347 1.179 0 N-CA-C 110.275 -1.13 . . . . 73.340000000000003 110.275 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -76.51 107.25 8.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.439 0.695 . . . . 74.219999999999999 110.301 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -111.89 102.12 52.98 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.476 0.71 . . . . 64.450000000000003 110.507 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.98 96.43 0.35 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.804 2.336 . . . . 74.400000000000006 110.82 165.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.57 -179.02 51.9 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.824 -0.625 . . . . 34.409999999999997 113.642 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 158.16 19.47 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.468 0.707 . . . . 74.150000000000006 112.327 -175.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.0 t -81.81 136.42 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.938 0.895 . . . . 72.209999999999994 110.145 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.61 174.81 14.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.635 1.174 . . . . 74.109999999999999 109.898 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.62 -158.12 4.05 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-O 119.854 -0.414 . . . . 72.299999999999997 112.635 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -75.35 -72.12 0.32 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.367 0.583 . . . . 75.129999999999995 110.374 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 50.38 33.31 7.42 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.222 1.009 . . . . 74.099999999999994 110.989 -171.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 138.39 58.47 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.3 -0.864 . . . . 75.340000000000003 111.26 -169.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.507 ' H ' ' NE ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -135.03 146.79 59.98 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 123.664 0.786 . . . . 75.129999999999995 109.666 -176.217 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.23 135.88 68.7 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.499 2.132 . . . . 74.319999999999993 111.29 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.7 t -83.78 -46.08 12.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.835 0.854 . . . . 50.310000000000002 110.272 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.1 mt 56.54 85.87 0.18 Allowed Pre-proline 0 CA--C 1.562 1.409 0 C-N-CA 124.824 1.249 . . . . 74.450000000000003 112.735 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.42 156.39 36.75 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.01 2.473 . . . . 74.030000000000001 112.808 177.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.78 134.28 48.34 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.798 0.839 . . . . 62.210000000000001 109.055 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.3 78.19 9.67 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.3 0.572 . . . . 71.040000000000006 110.382 -175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -92.07 89.93 7.15 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.618 -0.882 . . . . 74.450000000000003 108.618 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -95.03 141.46 28.65 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.062 0.545 . . . . 73.239999999999995 110.244 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.0 tt -102.24 127.7 55.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.023 -0.732 . . . . 71.549999999999997 109.023 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HE2' ' HD2' ' A' ' 28' ' ' LYS . 41.5 tttp -127.44 -92.62 0.48 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.52 -0.918 . . . . 64.140000000000001 108.52 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.63 -51.57 2.65 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 118.141 0.428 . . . . 54.539999999999999 113.683 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.14 100.05 2.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.157 0.583 . . . . 54.509999999999998 110.826 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.99 -176.55 53.24 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 116.463 -0.335 . . . . 65.409999999999997 113.229 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HD2' ' HE2' ' A' ' 24' ' ' LYS . 63.3 tttp 72.49 137.52 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.194 1.398 . . . . 73.219999999999999 111.594 -176.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -73.19 77.9 1.28 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 122.451 1.119 . . . . 74.439999999999998 109.37 170.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.528 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 33.1 tt0 -127.83 133.34 49.39 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.86 -1.064 . . . . 53.229999999999997 109.304 -171.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -64.82 124.54 22.24 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 124.252 0.97 . . . . 74.329999999999998 110.501 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 m 73.93 127.32 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.415 1.486 . . . . 74.329999999999998 112.01 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.528 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -92.57 163.21 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.238 -1.023 . . . . 72.400000000000006 108.238 167.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -79.1 77.03 5.6 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.116 0.484 . . . . 74.120000000000005 111.784 -172.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.1 -171.01 8.02 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 114.753 -1.112 . . . . 72.010000000000005 114.909 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.551 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.47 -38.5 95.85 Favored Glycine 0 CA--C 1.549 2.207 0 CA-C-O 117.703 -1.61 . . . . 55.43 115.647 171.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 8.6 Cg_endo -47.73 -23.95 4.34 Favored 'Trans proline' 0 C--N 1.401 3.325 0 C-N-CA 123.881 3.054 . . . . 45.329999999999998 115.575 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 79.2 t60 70.63 9.87 6.98 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.176 0.99 . . . . 62.450000000000003 112.576 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.5 t 61.9 41.75 11.1 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.253 1.021 . . . . 64.310000000000002 109.833 -170.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 71.08 -177.76 0.21 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.921 1.688 . . . . 64.120000000000005 110.534 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.9 m -56.51 159.28 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 113.284 0.846 . . . . 52.43 113.284 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -76.49 164.59 25.81 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.193 -0.912 . . . . 73.099999999999994 109.968 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.59 153.04 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 123.073 0.549 . . . . 65.430000000000007 110.779 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.17 -152.51 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.729 1.211 . . . . 65.109999999999999 113.787 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -34.94 97.65 0.01 OUTLIER 'General case' 0 C--N 1.368 1.394 0 C-N-CA 126.599 1.96 . . . . 73.140000000000001 113.002 174.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.4 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.852 1.261 . . . . 70.239999999999995 111.979 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.04 163.28 13.19 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.359 0.664 . . . . 75.099999999999994 109.837 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.99 166.15 14.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.022 0.529 . . . . 41.100000000000001 110.556 172.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -54.89 123.14 12.48 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.583 -0.525 . . . . 75.030000000000001 109.583 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -63.5 116.36 25.32 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 124.269 0.98 . . . . 70.439999999999998 109.617 -168.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.69 98.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.857 2.371 . . . . 73.530000000000001 111.741 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.05 135.07 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.236 1.015 . . . . 71.439999999999998 111.134 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.6 -85.74 0.36 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.3 -0.409 . . . . 72.25 111.658 -169.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.1 p -115.94 -11.86 11.44 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.895 0.878 . . . . 75.519999999999996 110.048 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -88.61 8.13 29.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.85 1.26 . . . . 74.239999999999995 112.088 -171.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -58.61 147.58 31.94 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.603 0.761 . . . . 71.040000000000006 111.413 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -57.08 116.87 14.77 Favored Pre-proline 0 CA--C 1.555 1.158 0 O-C-N 123.763 0.664 . . . . 73.010000000000005 110.405 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.59 9.39 3.49 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.615 2.21 . . . . 74.0 112.955 -174.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -79.68 -74.12 0.31 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.336 0.654 . . . . 75.319999999999993 110.345 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.81 -37.56 3.07 Favored Glycine 0 N--CA 1.479 1.565 0 C-N-CA 122.762 0.22 . . . . 52.299999999999997 112.777 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.03 -178.88 7.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.353 1.061 . . . . 70.439999999999998 110.361 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 m -75.03 163.21 27.83 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.143 0.497 . . . . 53.240000000000002 111.039 174.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -30.4 64.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.306 1.042 . . . . 74.340000000000003 113.658 -176.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.47 -64.74 1.05 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.249 -0.648 . . . . 52.509999999999998 109.249 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.89 -77.99 0.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.053 -0.976 . . . . 70.150000000000006 109.871 175.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -125.23 -53.86 1.6 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.461 0.704 . . . . 75.430000000000007 109.289 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -136.24 102.44 4.99 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.947 0.499 . . . . 75.239999999999995 109.962 -173.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -84.2 -36.08 23.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.314 0.646 . . . . 74.349999999999994 111.355 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.9 p -77.53 7.26 5.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.954 0.902 . . . . 52.219999999999999 112.702 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -62.04 -39.49 92.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.766 1.226 . . . . 64.420000000000002 111.21 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.0 -34.13 71.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 110.274 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -73.28 -12.86 61.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.398 0.679 . . . . 65.209999999999994 110.989 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.1 tp -67.29 -51.68 49.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.801 0.84 . . . . 52.210000000000001 111.868 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.4 mt -112.46 22.04 15.06 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.741 0.416 . . . . 72.219999999999999 110.133 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.98 -21.19 65.95 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 62.409999999999997 112.036 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.47 -139.62 20.41 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.103 -0.831 . . . . 64.439999999999998 111.672 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.21 -178.22 3.93 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.561 2.174 . . . . 63.009999999999998 112.72 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 m -67.17 126.9 30.68 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.548 -0.908 . . . . 63.420000000000002 108.548 170.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -64.4 -46.18 84.42 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.057 1.132 . . . . 74.129999999999995 114.057 -161.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.95 -39.73 1.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 118.058 0.39 . . . . 61.32 110.852 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.647 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 20.3 m-20 -93.6 104.45 12.75 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.906 -1.045 . . . . 72.299999999999997 110.35 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.95 -33.47 92.35 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.317 2.012 . . . . 63.450000000000003 113.009 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -94.38 22.03 6.48 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.709 0.804 . . . . 73.319999999999993 110.744 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 23.9 tp -77.34 131.56 38.16 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.634 -0.666 . . . . 71.439999999999998 109.527 174.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -115.54 173.12 6.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.446 1.099 . . . . 74.329999999999998 109.84 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.73 138.96 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.003 1.321 . . . . 43.240000000000002 108.84 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -79.72 138.23 37.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.511 0.724 . . . . 64.040000000000006 110.349 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 143' ' ' LYS . 82.7 mt -104.01 -35.48 8.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.728 0.811 . . . . 75.299999999999997 110.987 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.462 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 44.0 m-85 -122.48 140.93 52.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.194 -0.912 . . . . 74.5 108.874 -173.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 3.5 m-20 -68.5 124.87 24.75 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.984 -0.747 . . . . 73.400000000000006 108.984 171.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.637 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.2 t80 -114.24 139.45 49.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.261 -1.015 . . . . 74.310000000000002 108.261 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.97 131.82 59.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.523 -1.288 . . . . 74.340000000000003 107.523 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.71 119.13 4.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.839 0.855 . . . . 70.310000000000002 111.709 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.5 p -84.28 -27.31 27.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.498 0.719 . . . . 74.129999999999995 111.158 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -141.38 -169.62 11.96 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.805 -0.918 . . . . 61.130000000000003 110.805 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.68 -44.63 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.005 0.431 . . . . 65.329999999999998 111.257 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.549 HD21 ' HD2' ' A' ' 249' ' ' PRO . 26.5 p-10 -71.47 -24.68 62.04 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.151 -0.931 . . . . 63.439999999999998 111.657 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.0 p -79.99 160.28 25.96 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.332 0.653 . . . . 64.400000000000006 110.775 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.7 tp -133.44 136.4 45.16 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.968 0.507 . . . . 61.439999999999998 111.371 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 m -75.48 134.0 40.93 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.544 0.738 . . . . 63.340000000000003 111.312 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.637 HG12 ' HB3' ' A' ' 91' ' ' PHE . 21.8 pt -127.22 166.77 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.167 0.587 . . . . 72.409999999999997 111.818 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.0 m -126.42 157.19 39.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.727 -1.124 . . . . 62.240000000000002 110.479 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -47.29 119.57 2.71 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.227 1.011 . . . . 73.219999999999999 111.808 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.91 8.61 78.29 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 115.129 0.811 . . . . 71.239999999999995 115.129 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -68.53 122.24 18.06 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.268 0.627 . . . . 44.539999999999999 110.764 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -75.92 128.76 35.75 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.128 -0.693 . . . . 65.400000000000006 109.128 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -147.91 166.94 26.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.71 0.804 . . . . 75.329999999999998 110.783 -173.064 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -122.72 117.44 25.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.927 0.491 . . . . 75.230000000000004 110.151 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.606 HG13 ' HB1' ' A' ' 119' ' ' ALA . 41.6 t -81.05 112.38 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.196 0.598 . . . . 74.120000000000005 110.139 175.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.5 -35.17 40.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.442 -0.799 . . . . 62.329999999999998 109.965 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.98 147.56 6.09 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.437 0.461 . . . . 44.140000000000001 112.87 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.531 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 47.2 m-85 -86.95 162.78 17.49 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.381 0.672 . . . . 74.450000000000003 111.458 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -81.69 -173.73 4.6 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.302 -0.863 . . . . 64.510000000000005 110.361 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -52.5 -36.95 56.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.28 1.432 . . . . 72.340000000000003 113.838 -170.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -112.17 -3.76 14.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.471 0.708 . . . . 62.350000000000001 111.853 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 72.61 33.97 60.34 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.54 -0.589 . . . . 71.329999999999998 114.566 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -84.91 -38.39 19.44 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.402 0.601 . . . . 74.400000000000006 110.717 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 70.3 m95 -123.0 154.13 38.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.57 0.748 . . . . 73.519999999999996 110.561 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.606 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -134.35 132.4 39.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.027 0.931 . . . . 74.219999999999999 109.991 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.4 114.22 7.44 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 106.172 -1.788 . . . . 73.310000000000002 106.172 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.31 150.85 49.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 63.229999999999997 111.028 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -106.38 116.38 31.83 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.522 -1.288 . . . . 74.040000000000006 107.522 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.536 HG21 HG22 ' A' ' 101' ' ' ILE . 22.9 p -116.96 174.43 6.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.434 0.694 . . . . 73.040000000000006 110.167 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -62.85 -24.24 67.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.311 0.645 . . . . 54.210000000000001 110.22 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.06 -27.57 60.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.497 0.719 . . . . 74.519999999999996 111.608 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.75 -125.1 2.21 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 121.408 -0.425 . . . . 75.049999999999997 113.538 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -134.94 140.42 45.71 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.757 0.823 . . . . 34.210000000000001 110.499 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.486 ' HA2' ' HZ3' ' A' ' 254' ' ' TRP . . . 149.51 176.87 23.09 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 113.709 0.243 . . . . 75.219999999999999 113.709 176.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -80.87 120.6 24.91 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.127 0.971 . . . . 74.030000000000001 112.28 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.431 HG23 HD13 ' A' ' 135' ' ' ILE . 4.2 m -121.79 139.63 30.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.312 1.045 . . . . 54.350000000000001 108.638 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 3.1 Cg_exo -76.05 143.45 25.86 Favored 'Trans proline' 0 CA--C 1.561 1.863 0 C-N-CA 122.631 2.221 . . . . 74.310000000000002 114.46 -172.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -39.54 -49.61 2.14 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.85 1.66 . . . . 42.439999999999998 113.469 168.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 18.6 p-10 -76.3 7.18 4.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.777 0.831 . . . . 63.32 112.581 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.514 ' HB3' HD11 ' A' ' 101' ' ' ILE . 16.5 m-85 -115.87 -9.12 11.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.349 1.06 . . . . 74.349999999999994 111.568 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.431 HD13 HG23 ' A' ' 130' ' ' VAL . 10.8 pt -132.37 171.43 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.96 0.904 . . . . 72.450000000000003 111.215 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -164.17 152.18 10.91 Favored Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.479 -0.772 . . . . 74.150000000000006 109.151 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -58.15 157.85 24.02 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.441 2.094 . . . . 73.209999999999994 113.791 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.55 -8.28 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 123.271 0.628 . . . . 53.439999999999998 111.783 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -102.11 0.82 35.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 72.040000000000006 111.866 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.9 p -77.1 168.11 20.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.13 0.572 . . . . 63.109999999999999 112.197 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.22 -24.65 27.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.149 -0.478 . . . . 71.319999999999993 110.352 167.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.4 -23.59 66.34 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.366 0.666 . . . . 73.019999999999996 111.599 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.66 ' HA ' HD21 ' A' ' 88' ' ' LEU . 20.9 pttm -62.49 -18.21 61.38 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.761 0.663 . . . . 50.039999999999999 112.522 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -83.99 141.98 30.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.648 -0.705 . . . . 75.430000000000007 110.512 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 p -62.67 -40.14 96.14 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.379 1.049 . . . . 73.319999999999993 111.13 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -66.14 -37.58 86.05 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.163 0.801 . . . . 75.409999999999997 113.163 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 38.9 t80 -76.41 113.6 14.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.854 -0.424 . . . . 75.239999999999995 109.854 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -109.23 -5.24 15.98 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.086 0.554 . . . . 74.049999999999997 112.473 -177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.67 -145.68 42.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 118.652 -1.082 . . . . 65.329999999999998 112.843 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.35 94.88 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.06 2.507 . . . . 71.129999999999995 112.996 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 49.0 t -135.74 126.98 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.994 1.318 . . . . 74.319999999999993 109.257 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.9 p -83.92 175.44 9.58 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.912 0.885 . . . . 71.209999999999994 110.323 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -60.75 -40.4 92.29 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 119.467 -0.301 . . . . 75.239999999999995 110.934 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -53.54 -49.88 66.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.183 0.593 . . . . 64.230000000000004 110.923 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.504 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -71.0 -26.18 63.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.224 -0.898 . . . . 53.0 111.634 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.4 -46.45 60.22 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.067 0.547 . . . . 34.32 111.821 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.6 mm-40 -68.72 -32.91 73.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.559 -0.534 . . . . 73.420000000000002 109.559 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.08 -47.82 82.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.115 0.966 . . . . 72.209999999999994 110.664 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.43 HD13 HD22 ' A' ' 169' ' ' LEU . 12.9 mt -58.54 -45.43 88.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.875 0.87 . . . . 72.329999999999998 111.487 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 97.9 mt -92.99 8.0 41.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.749 0.648 . . . . 72.140000000000001 112.749 -176.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.4 p -64.05 -37.26 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 118.713 0.688 . . . . 70.409999999999997 110.377 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.4 p -101.93 18.44 20.6 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.138 0.975 . . . . 60.009999999999998 111.504 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.21 165.26 32.68 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.285 -0.416 . . . . 53.25 112.409 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.34 -179.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.58 0.752 . . . . 73.329999999999998 111.213 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.57 125.81 24.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.316 -0.856 . . . . 74.549999999999997 110.026 169.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 90.02 9.67 65.46 Favored Glycine 0 C--O 1.242 0.651 0 CA-C-O 119.192 -0.782 . . . . 50.240000000000002 113.022 -177.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.8 m -87.68 116.87 26.11 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 117.669 0.734 . . . . 75.120000000000005 110.526 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.426 ' HB3' HD13 ' A' ' 184' ' ' LEU . 21.0 p90 -128.24 167.92 16.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.936 0.495 . . . . 75.019999999999996 111.118 -172.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.43 HD22 HD13 ' A' ' 159' ' ' LEU . 4.3 pp -159.56 142.35 13.95 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.579 -0.737 . . . . 72.420000000000002 109.622 174.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 182' ' ' ILE . 74.2 t -100.27 115.3 41.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.988 -1.116 . . . . 75.040000000000006 107.988 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.609 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 41.9 ptt85 -115.91 143.1 45.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.566 0.746 . . . . 74.25 109.074 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -94.1 149.15 21.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.534 -0.913 . . . . 72.400000000000006 108.534 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 t -76.28 127.5 33.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.176 0.59 . . . . 71.230000000000004 109.585 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.0 -31.46 70.3 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.685 -0.689 . . . . 75.25 109.419 171.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 34.0 m -66.17 -34.81 78.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.924 0.89 . . . . 73.510000000000005 111.132 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.9 p -148.21 93.41 4.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.084 0.553 . . . . 71.120000000000005 110.841 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.14 138.23 85.35 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.895 2.396 . . . . 73.400000000000006 112.379 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.84 -29.93 10.74 Favored Glycine 0 C--N 1.345 1.029 0 C-N-CA 123.324 0.488 . . . . 72.450000000000003 111.959 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -82.72 117.72 22.85 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.822 -0.807 . . . . 74.340000000000003 108.822 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.505 0.669 . . . . 74.299999999999997 110.446 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 61.4 m -140.52 149.28 42.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.775 1.23 . . . . 71.120000000000005 108.588 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 170' ' ' VAL . 25.9 mt -102.42 146.3 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.684 -1.228 . . . . 65.019999999999996 107.684 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 46.3 m -124.29 107.98 11.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.881 -1.155 . . . . 71.219999999999999 107.881 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.426 HD13 ' HB3' ' A' ' 168' ' ' PHE . 45.5 tp -105.45 114.25 28.31 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.087 0.555 . . . . 53.409999999999997 110.507 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -76.92 116.72 17.84 Favored 'General case' 0 C--O 1.254 1.321 0 CA-C-O 121.43 0.633 . . . . 62.219999999999999 109.946 166.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -139.59 138.52 36.27 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.498 1.519 . . . . 73.549999999999997 107.462 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 59.67 22.02 10.74 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.927 0.891 . . . . 62.329999999999998 111.887 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.61 -12.63 55.69 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.345 -0.389 . . . . 72.420000000000002 113.869 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -98.99 144.93 27.59 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.547 0.739 . . . . 74.209999999999994 109.463 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.8 t -103.31 110.19 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.066 0.46 . . . . 71.430000000000007 110.532 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -96.94 124.51 40.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.849 1.259 . . . . 74.109999999999999 109.513 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -98.66 119.09 36.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.31 0.644 . . . . 73.450000000000003 111.286 -172.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.539 ' HE1' HD21 ' A' ' 232' ' ' LEU . 4.9 m-85 -95.42 150.72 19.98 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.574 -0.899 . . . . 64.349999999999994 108.574 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -106.81 125.3 50.83 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.276 -0.639 . . . . 72.230000000000004 109.276 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.4 mt -85.39 102.41 11.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.428 -0.953 . . . . 61.119999999999997 108.428 172.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -85.38 147.14 26.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.823 -1.08 . . . . 64.319999999999993 109.666 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -108.68 135.69 49.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.475 0.71 . . . . 75.450000000000003 109.648 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.9 176.88 7.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.578 0.751 . . . . 72.150000000000006 110.227 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.0 p -65.7 -28.91 69.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.208 0.603 . . . . 72.129999999999995 112.379 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -91.85 -17.34 25.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 75.319999999999993 110.243 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.11 9.21 16.1 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.914 -0.937 . . . . 72.219999999999999 114.847 175.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.72 130.21 45.36 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.3 1.05 . . . . 73.140000000000001 111.58 176.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -86.54 141.12 29.28 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.876 -1.157 . . . . 41.509999999999998 107.876 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.615 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.1 p90 -167.44 132.11 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.579 0.55 . . . . 73.209999999999994 110.961 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.525 HG23 HD11 ' A' ' 217' ' ' LEU . 70.6 t -77.62 -38.0 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.688 -0.856 . . . . 74.329999999999998 108.688 164.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.7 m -105.54 123.38 47.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.625 -1.17 . . . . 61.240000000000002 109.513 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -64.24 -25.16 67.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.488 0.715 . . . . 73.439999999999998 112.489 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -77.3 -24.38 50.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.625 0.77 . . . . 75.409999999999997 110.946 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.8 m -129.68 100.43 5.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.186 0.594 . . . . 75.340000000000003 109.679 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.615 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 77.7 mtt180 -107.22 138.8 42.73 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 64.150000000000006 109.209 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -124.34 146.65 48.7 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.303 -0.629 . . . . 63.240000000000002 109.303 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.85 -37.56 87.84 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.933 0.771 . . . . 73.5 110.381 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -127.81 157.43 40.45 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.738 0.815 . . . . 65.230000000000004 111.609 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.81 -25.32 67.18 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.689 -1.141 . . . . 63.240000000000002 109.741 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.85 97.35 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.447 0.699 . . . . 71.340000000000003 111.019 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.38 -34.42 67.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.438 0.695 . . . . 75.010000000000005 111.48 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.525 HD11 HG23 ' A' ' 205' ' ' VAL . 14.9 tp -56.48 -54.57 44.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.815 0.446 . . . . 62.299999999999997 111.141 174.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.68 -38.41 82.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 O-C-N 123.776 0.673 . . . . 53.32 110.677 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -58.29 -57.31 13.46 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 62.32 111.253 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -63.14 -39.61 95.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.722 -0.672 . . . . 70.340000000000003 111.1 -176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.719 ' HB3' HD11 ' A' ' 228' ' ' LEU . 41.8 m80 -85.45 -6.09 59.24 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.323 0.49 . . . . 65.230000000000004 112.323 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 91.6 p -98.07 -14.42 20.49 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.027 0.376 . . . . 64.200000000000003 111.12 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 50.7 p -83.63 -40.05 19.49 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 110.23 -0.285 . . . . 72.439999999999998 110.23 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.1 m -138.6 167.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 113.36 0.874 . . . . 63.100000000000001 113.36 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -81.53 13.24 3.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.983 2.113 . . . . 74.329999999999998 113.659 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 224' ' ' VAL . 35.8 t70 -41.95 33.67 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 1 C-N-CA 132.091 4.156 . . . . 63.439999999999998 118.744 -158.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 126.35 -5.52 7.67 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 120.068 -1.645 . . . . 63.009999999999998 112.986 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.1 mt -90.45 161.09 15.7 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.447 1.099 . . . . 62.450000000000003 109.484 174.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.7 tt -56.74 -36.36 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-O 120.958 0.409 . . . . 72.140000000000001 110.418 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.3 t -161.03 170.9 19.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.292 0.637 . . . . 65.349999999999994 110.189 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 29.5 m -63.1 138.33 58.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.513 1.125 . . . . 51.450000000000003 111.889 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.539 HD21 ' HE1' ' A' ' 193' ' ' TYR . 65.1 mt -73.43 135.06 44.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.263 -0.643 . . . . 73.209999999999994 109.263 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.82 -76.16 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.524 0.602 . . . . 41.32 110.809 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 167' ' ' SER . 19.9 t80 -85.4 121.39 73.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 108.393 -0.966 . . . . 75.129999999999995 108.393 -177.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.05 125.06 3.98 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.364 2.043 . . . . 75.519999999999996 111.396 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.1 134.53 94.5 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.773 -0.649 . . . . 54.149999999999999 110.076 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.67 -179.15 4.85 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.603 2.202 . . . . 74.439999999999998 111.988 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.34 152.07 45.96 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.151 0.58 . . . . 54.340000000000003 109.587 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.401 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 10.9 ptt180 -88.92 -62.21 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.532 0.567 . . . . 74.409999999999997 112.532 -172.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.401 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 66.1 t30 -111.24 149.05 31.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.283 0.633 . . . . 74.349999999999994 110.74 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.452 ' NZ ' ' HB2' ' A' ' 90' ' ' ASP . 99.9 mttt -83.57 114.88 56.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 106.807 -1.553 . . . . 75.010000000000005 106.807 160.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.525 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 19.5 Cg_exo -65.27 122.52 10.26 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.085 1.857 . . . . 61.509999999999998 111.817 -168.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.0 m -72.24 112.43 8.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.948 0.499 . . . . 74.140000000000001 110.233 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.29 106.69 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.571 -1.27 . . . . 51.109999999999999 107.571 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -85.5 114.82 22.82 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.702 0.401 . . . . 64.129999999999995 111.776 -161.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.12 0.42 0.71 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.645 1.818 . . . . 73.420000000000002 117.645 164.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.52 HG23 ' HE1' ' A' ' 118' ' ' TRP . 24.1 m -96.99 122.82 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.174 1.487 . . . . 61.039999999999999 112.801 -169.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.4 t -78.66 135.33 60.23 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 113.793 -1.549 . . . . 73.25 107.377 160.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.549 ' HD2' HD21 ' A' ' 97' ' ' ASN . 33.1 Cg_exo -61.42 -59.91 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 121.137 1.225 . . . . 73.019999999999996 112.645 -169.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -132.66 -25.93 1.85 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.133 0.973 . . . . 71.510000000000005 109.168 149.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.16 121.31 41.61 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.635 -1.166 . . . . 74.439999999999998 113.427 -156.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -100.93 -27.0 13.54 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.018 -0.734 . . . . 73.140000000000001 109.018 162.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -79.4 -40.92 28.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.696 0.798 . . . . 73.129999999999995 112.444 -175.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.486 ' HZ3' ' HA2' ' A' ' 128' ' ' GLY . 25.8 t90 -59.51 135.69 57.75 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.512 0.507 . . . . 60.020000000000003 112.354 -163.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 CA--C 1.556 1.206 0 CA-C-N 114.159 -1.382 . . . . 74.400000000000006 111.665 179.81 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.451 -0.944 . . . . 74.010000000000005 108.451 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.47 74.07 0.1 OUTLIER Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.424 -0.671 . . . . 71.150000000000006 111.424 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -129.09 -86.83 0.54 Allowed 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.123 -1.066 . . . . 75.209999999999994 108.123 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 173.16 84.79 0.05 OUTLIER Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 125.008 1.323 . . . . 71.349999999999994 108.014 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.85 101.77 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.402 2.068 . . . . 72.450000000000003 111.557 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 -124.79 1.66 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.944 -0.462 . . . . 72.219999999999999 111.944 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -92.37 35.54 1.01 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.205 0.602 . . . . 74.340000000000003 110.466 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.8 m -73.9 80.5 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-O 122.01 0.909 . . . . 54.350000000000001 110.678 175.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -83.22 130.94 35.12 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.552 -1.277 . . . . 75.150000000000006 107.552 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.23 73.35 1.26 Allowed Glycine 0 C--N 1.339 0.749 0 O-C-N 123.604 0.565 . . . . 53.399999999999999 113.017 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -145.04 136.39 25.13 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.004 0.922 . . . . 60.539999999999999 109.598 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -163.06 88.71 0.61 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.586 1.154 . . . . 63.439999999999998 109.199 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -140.3 129.22 23.34 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.033 0.933 . . . . 54.229999999999997 109.718 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -113.22 90.35 16.38 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 124.322 1.049 . . . . 71.120000000000005 109.319 175.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.79 85.0 0.63 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.121 2.547 . . . . 74.010000000000005 111.708 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.2 m -86.0 96.97 10.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.613 0.765 . . . . 73.420000000000002 110.232 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.4 mt -119.8 110.16 37.1 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.933 0.893 . . . . 74.25 109.63 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.36 94.17 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.66 2.24 . . . . 64.209999999999994 111.101 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.38 121.62 26.46 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 122.95 0.5 . . . . 60.439999999999998 110.388 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.72 152.07 37.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.671 0.788 . . . . 73.430000000000007 109.172 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -160.87 173.74 14.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.88 0.872 . . . . 75.430000000000007 109.953 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -84.97 141.8 30.08 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.464 0.706 . . . . 62.329999999999998 110.13 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.2 pt -74.33 157.59 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.445 0.64 . . . . 54.530000000000001 111.51 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -111.56 88.58 2.83 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.379 -1.341 . . . . 74.230000000000004 107.379 171.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.54 47.21 3.79 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.621 -0.544 . . . . 63.210000000000001 113.821 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 63.87 -78.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.349 1.46 . . . . 75.409999999999997 111.448 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.97 -0.29 3.17 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.215 0.436 . . . . 64.5 112.887 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -73.51 88.58 1.64 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.561 0.745 . . . . 74.310000000000002 109.453 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.9 mmm-85 -141.76 86.94 2.02 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.997 0.919 . . . . 75.530000000000001 110.262 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -86.89 -75.11 0.41 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.544 -0.91 . . . . 73.310000000000002 108.544 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.1 m 58.53 -175.28 0.09 Allowed 'General case' 0 C--N 1.36 1.044 0 C-N-CA 124.248 1.019 . . . . 73.450000000000003 112.054 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.8 t -128.92 -21.0 3.4 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 122.017 -0.427 . . . . 71.310000000000002 110.166 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -78.14 -82.28 0.09 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.152 0.581 . . . . 75.109999999999999 109.475 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -155.69 -171.89 3.93 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.753 1.221 . . . . 74.230000000000004 108.543 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.02 -109.44 0.4 Allowed Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.555 -0.618 . . . . 64.329999999999998 111.555 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.39 -82.08 0.15 Allowed Glycine 0 C--N 1.339 0.73 0 CA-C-O 119.368 -0.684 . . . . 43.340000000000003 112.308 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.53 -179.92 5.9 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.792 2.328 . . . . 64.230000000000004 112.461 175.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -115.78 -163.56 0.9 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.788 0.835 . . . . 74.219999999999999 109.745 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.12 115.26 5.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.223 0.609 . . . . 50.509999999999998 111.791 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -76.13 -22.94 54.91 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.071 0.948 . . . . 63.200000000000003 110.985 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.4 t 58.68 -96.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 124.57 1.148 . . . . 64.409999999999997 109.815 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -177.2 -179.21 0.86 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.899 1.28 . . . . 72.099999999999994 109.116 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.85 157.41 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 N-CA-C 108.782 -0.822 . . . . 63.520000000000003 108.782 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 68.41 -169.08 0.19 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.772 1.229 . . . . 30.239999999999998 113.025 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -143.12 169.16 18.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.632 1.173 . . . . 71.530000000000001 109.429 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -75.63 146.47 40.29 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.152 0.581 . . . . 74.319999999999993 111.388 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.8 165.94 18.39 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.513 0.725 . . . . 50.5 110.005 173.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.42 HD22 ' HB3' ' A' ' 162' ' ' SER . 78.1 mt -83.89 170.6 13.88 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.306 0.642 . . . . 75.129999999999995 111.12 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -116.59 159.68 21.8 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.712 0.805 . . . . 74.109999999999999 109.908 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.84 135.72 55.41 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.523 0.729 . . . . 72.510000000000005 110.076 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.96 145.93 96.58 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.347 2.031 . . . . 73.129999999999995 112.386 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.3 m -79.61 172.94 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.49 0.716 . . . . 74.329999999999998 110.277 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.03 92.79 0.54 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.265 0.626 . . . . 74.310000000000002 109.318 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.8 p -100.73 78.48 1.98 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.762 0.825 . . . . 72.450000000000003 109.985 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.59 -67.46 0.47 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.852 -0.613 . . . . 74.209999999999994 109.971 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -94.07 114.56 26.74 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.543 0.737 . . . . 75.319999999999993 109.616 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.13 108.04 10.4 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.158 0.983 . . . . 71.430000000000007 108.448 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.23 -52.85 1.35 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.85 2.367 . . . . 74.299999999999997 114.004 -168.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -119.95 -27.32 5.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.284 0.476 . . . . 62.140000000000001 112.284 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.33 -82.09 0.68 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.513 -0.635 . . . . 32.299999999999997 111.513 -171.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.9 tp -112.76 145.47 40.49 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.956 0.903 . . . . 72.209999999999994 109.18 175.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.0 p -136.53 168.58 19.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.894 1.278 . . . . 74.439999999999998 108.906 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -113.12 -49.51 2.92 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.127 0.571 . . . . 74.319999999999993 111.706 -172.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' A' ' 68' ' ' ASN . . . -59.61 -71.96 0.11 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 112.994 0.739 . . . . 63.450000000000003 112.994 -168.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.26 16.01 4.77 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.015 0.526 . . . . 71.340000000000003 111.752 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -106.87 -61.08 1.59 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.029 -0.73 . . . . 65.540000000000006 109.029 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -165.76 73.25 0.18 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.348 0.594 . . . . 73.219999999999999 110.516 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 64' ' ' ALA . 33.6 p-10 -82.76 -20.73 35.34 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.755 -0.657 . . . . 71.230000000000004 110.074 169.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 m -70.79 3.15 3.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.306 1.443 . . . . 75.120000000000005 112.886 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.89 -24.4 66.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.794 0.838 . . . . 74.430000000000007 111.612 175.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -81.85 -36.58 28.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.034 0.534 . . . . 71.209999999999994 110.126 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.81 -5.81 49.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.949 0.9 . . . . 62.409999999999997 110.528 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.418 HD13 ' HE1' ' A' ' 146' ' ' TRP . 27.3 tp -58.96 -51.01 71.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.685 1.194 . . . . 75.329999999999998 111.522 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.75 -53.2 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.014 0.526 . . . . 50.350000000000001 110.37 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.66 -55.57 22.51 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.625 0.77 . . . . 75.25 111.897 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.08 140.1 4.37 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.987 -1.006 . . . . 73.450000000000003 111.254 -170.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.59 114.08 2.93 Favored 'Trans proline' 0 C--N 1.371 1.722 0 CA-C-N 119.745 1.772 . . . . 65.129999999999995 111.545 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.5 t -123.18 127.79 49.14 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.746 1.218 . . . . 74.349999999999994 108.444 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.403 ' H ' HD22 ' A' ' 84' ' ' LEU . 9.5 mm-40 -83.76 -52.42 6.42 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.507 -0.553 . . . . 62.130000000000003 109.507 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -135.98 -37.18 0.73 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.828 0.851 . . . . 71.209999999999994 110.512 164.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -89.48 131.26 40.73 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 115.151 -0.931 . . . . 61.109999999999999 112.85 -166.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.29 -5.5 16.26 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.072 2.515 . . . . 63.109999999999999 111.874 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -106.24 7.81 31.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.45 1.1 . . . . 74.329999999999998 110.612 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 79' ' ' GLU . 42.8 tp -57.53 148.38 24.05 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 73.140000000000001 111.295 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -111.88 163.87 13.73 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.52 0.728 . . . . 72.430000000000007 109.653 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 138.58 46.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 124.423 1.089 . . . . 73.030000000000001 108.619 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -76.33 115.27 15.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.776 0.83 . . . . 60.100000000000001 109.481 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.8 mt -71.98 -38.52 69.69 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.272 0.558 . . . . 64.209999999999994 110.698 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.554 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 6.0 m-85 -125.18 151.81 45.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.981 -1.008 . . . . 74.030000000000001 108.769 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.46 125.49 29.43 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.973 -0.751 . . . . 61.43 108.973 166.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.614 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.5 t80 -106.35 135.01 48.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.797 -1.186 . . . . 64.230000000000004 107.797 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -102.04 134.96 41.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.23 -1.026 . . . . 73.040000000000006 108.23 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.8 134.88 57.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.02 0.928 . . . . 62.229999999999997 111.822 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.5 p -98.82 -53.22 3.35 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.022 0.929 . . . . 72.120000000000005 109.071 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.73 176.28 33.45 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.116 -0.947 . . . . 61.119999999999997 111.747 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.59 -21.41 57.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.839 0.855 . . . . 72.439999999999998 111.521 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -93.55 -26.09 17.28 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.763 0.825 . . . . 72.420000000000002 111.656 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.3 p -73.03 134.83 44.78 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.111 -0.7 . . . . 74.409999999999997 109.111 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.636 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 63.6 tp -104.55 125.72 50.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.453 0.701 . . . . 63.229999999999997 110.561 -167.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -70.35 132.25 45.36 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.952 0.783 . . . . 74.329999999999998 109.842 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.77 HG22 HG21 ' A' ' 123' ' ' THR . 9.8 pt -119.13 148.82 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.728 -0.471 . . . . 71.239999999999995 109.728 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.615 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -86.3 149.48 25.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.625 0.77 . . . . 74.430000000000007 109.354 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.73 113.35 6.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.71 0.404 . . . . 72.030000000000001 110.318 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.79 61.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.379 -0.373 . . . . 33.039999999999999 112.927 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 36.6 tt0 -73.09 135.48 44.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.708 0.803 . . . . 62.43 111.801 -175.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -80.03 126.54 31.18 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.554 -0.906 . . . . 70.129999999999995 108.554 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -148.16 153.59 39.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.244 0.545 . . . . 64.129999999999995 110.8 -174.702 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -108.56 130.23 55.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.833 0.853 . . . . 72.140000000000001 108.965 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.525 HG13 ' HB1' ' A' ' 119' ' ' ALA . 53.3 t -88.03 130.52 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.213 -1.032 . . . . 71.540000000000006 108.213 168.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.462 HD12 ' HG2' ' A' ' 120' ' ' GLU . 36.0 mt -92.67 -29.19 16.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.221 1.009 . . . . 74.209999999999994 109.623 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.54 145.36 4.44 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.207 -0.906 . . . . 74.109999999999999 111.547 175.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.694 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 62.3 m-85 -86.23 160.34 19.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.212 0.506 . . . . 64.450000000000003 110.033 173.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -83.34 -172.43 4.14 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 73.230000000000004 110.539 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -52.34 -41.46 63.04 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.268 1.027 . . . . 73.109999999999999 113.504 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -95.46 -2.41 48.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.407 0.683 . . . . 70.209999999999994 111.341 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 60.51 22.5 59.17 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.029 0.772 . . . . 61.100000000000001 115.029 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.02 -16.54 18.66 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.396 0.679 . . . . 61.530000000000001 110.82 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 56.2 m95 -131.53 143.4 50.35 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.068 0.947 . . . . 73.530000000000001 110.026 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.525 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -123.28 149.04 45.29 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.462 1.105 . . . . 72.200000000000003 110.042 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HG2' HD12 ' A' ' 110' ' ' LEU . 38.6 tt0 -82.85 107.73 15.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.469 -1.678 . . . . 72.329999999999998 106.469 164.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.45 152.53 40.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.419 0.628 . . . . 71.299999999999997 112.141 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -112.57 103.98 12.05 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.346 -1.297 . . . . 71.310000000000002 108.171 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.77 HG21 HG22 ' A' ' 101' ' ' ILE . 39.5 p -101.62 176.25 5.29 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.111 0.964 . . . . 43.240000000000002 110.206 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -71.56 -14.29 62.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.943 0.497 . . . . 64.019999999999996 110.265 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -85.28 -18.05 35.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.321 1.049 . . . . 73.340000000000003 111.187 172.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.25 -165.23 23.2 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-O 120.3 -0.167 . . . . 44.140000000000001 113.347 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.416 ' NE2' ' HG2' ' A' ' 120' ' ' GLU . 68.3 tp60 -92.22 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.203 0.601 . . . . 70.140000000000001 111.393 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 176.01 -161.12 29.51 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.52 0.512 . . . . 54.350000000000001 112.443 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -112.11 120.46 41.9 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.34 0.656 . . . . 73.140000000000001 111.635 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.76 143.5 47.84 Favored Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 124.015 0.926 . . . . 71.0 109.923 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 83.1 Cg_endo -84.69 145.44 10.31 Favored 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 121.943 1.762 . . . . 70.430000000000007 114.827 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -38.68 -46.48 1.23 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.281 1.832 . . . . 71.230000000000004 114.526 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.554 HD22 ' HB2' ' A' ' 242' ' ' PRO . 30.0 p-10 -75.03 -7.66 54.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.857 0.863 . . . . 74.200000000000003 113.014 -169.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 29.4 m-85 -103.64 -10.61 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.388 0.675 . . . . 61.340000000000003 111.904 174.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.0 pt -123.78 170.84 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.92 0.888 . . . . 74.420000000000002 110.636 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 3.4 m -158.45 137.98 8.46 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.721 0.808 . . . . 61.409999999999997 109.941 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.53 136.71 47.55 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 121.686 1.591 . . . . 72.219999999999999 110.897 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.29 -11.79 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.167 0.987 . . . . 75.140000000000001 110.378 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -21.19 63.29 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.166 0.987 . . . . 71.299999999999997 112.177 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 91.7 p -109.61 -179.63 3.87 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.867 0.867 . . . . 64.129999999999995 111.852 -173.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.94 -22.84 36.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.535 1.134 . . . . 63.399999999999999 112.32 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.78 -12.4 61.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.943 0.897 . . . . 70.340000000000003 112.245 -173.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.504 ' HE2' ' CE1' ' A' ' 144' ' ' HIS . 20.8 pttm -63.82 -11.68 29.31 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.818 0.847 . . . . 72.209999999999994 111.911 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.504 ' CE1' ' HE2' ' A' ' 143' ' ' LYS . 33.3 m170 -99.63 146.64 26.24 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.867 0.867 . . . . 71.209999999999994 110.895 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -64.64 -33.94 77.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.156 -0.929 . . . . 53.340000000000003 112.517 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.418 ' HE1' HD13 ' A' ' 73' ' ' LEU . 41.9 p-90 -72.93 -35.13 66.95 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.569 0.747 . . . . 75.400000000000006 112.471 -176.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HE2' ' A' ' 238' ' ' LYS . 23.1 t80 -80.29 103.02 9.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.825 -0.806 . . . . 73.200000000000003 108.825 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.455 ' HB2' HG21 ' A' ' 151' ' ' VAL . 52.8 m170 -95.59 -9.18 32.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.06 0.544 . . . . 72.230000000000004 112.056 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 -135.06 17.88 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-O 118.273 -1.293 . . . . 65.219999999999999 112.727 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.33 93.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.697 2.931 . . . . 63.25 113.127 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 75.4 t -139.64 132.39 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.915 1.286 . . . . 64.099999999999994 109.252 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.1 p -89.86 175.8 7.07 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.263 1.025 . . . . 74.340000000000003 109.896 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -58.2 -50.14 74.59 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.289 0.236 . . . . 74.329999999999998 111.111 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -55.49 -44.96 77.02 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.845 0.858 . . . . 50.219999999999999 111.145 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.58 84.33 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.397 -0.82 . . . . 55.32 110.751 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.0 80.41 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.946 0.898 . . . . 43.340000000000003 112.052 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -83.83 -21.16 32.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.757 -0.656 . . . . 75.209999999999994 111.759 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.409 ' OH ' ' HD2' ' A' ' 239' ' ' ARG . 0.1 OUTLIER -82.8 -19.36 37.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.27 0.557 . . . . 73.420000000000002 111.311 172.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' A' ' 239' ' ' ARG . 51.6 mt -74.96 -42.97 56.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.344 -0.843 . . . . 34.130000000000003 110.669 168.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.548 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 89.0 mt -92.67 20.69 6.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.281 -0.872 . . . . 75.209999999999994 111.451 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 92.5 p -72.55 -40.19 66.9 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.679 -0.489 . . . . 65.030000000000001 109.679 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.42 ' HB3' HD22 ' A' ' 48' ' ' LEU . 21.4 p -100.63 3.65 42.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.201 1.0 . . . . 75.530000000000001 112.271 -178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.11 159.05 53.04 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.124 0.265 . . . . 72.040000000000006 113.469 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.77 -178.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 63.25 110.799 174.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -61.92 118.49 7.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.367 0.667 . . . . 72.340000000000003 109.814 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.78 12.03 59.75 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.292 -0.726 . . . . 73.430000000000007 113.444 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.0 m -76.06 133.04 40.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.182 0.991 . . . . 71.140000000000001 110.184 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.489 ' HB3' HD13 ' A' ' 184' ' ' LEU . 27.0 p90 -141.81 166.44 24.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.237 0.541 . . . . 73.030000000000001 111.187 -171.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -162.6 151.29 14.75 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.617 -1.174 . . . . 63.130000000000003 108.135 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.662 HG22 HG12 ' A' ' 182' ' ' ILE . 85.9 t -103.51 128.9 56.24 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 N-CA-C 108.101 -1.074 . . . . 61.200000000000003 108.101 169.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.651 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.0 ptt85 -114.97 143.26 45.44 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.731 -1.122 . . . . 71.040000000000006 108.313 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -114.95 130.21 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.329 -1.36 . . . . 62.420000000000002 107.329 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -62.67 127.56 31.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.66 0.384 . . . . 71.099999999999994 110.409 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.86 -43.5 98.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.173 0.589 . . . . 73.120000000000005 110.004 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.0 p -68.71 -27.09 65.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.838 0.855 . . . . 74.129999999999995 111.409 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.3 m -137.19 79.5 37.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.043 0.537 . . . . 64.400000000000006 110.582 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.42 137.32 73.53 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.629 2.219 . . . . 53.549999999999997 111.529 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.14 -29.57 12.23 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.809 -0.632 . . . . 64.099999999999994 111.668 -174.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -81.38 114.93 20.48 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.95 -0.759 . . . . 60.299999999999997 108.95 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -129.29 147.77 51.16 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.847 0.859 . . . . 73.200000000000003 109.465 -173.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -148.54 150.97 34.3 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.142 0.977 . . . . 63.439999999999998 108.542 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 170' ' ' VAL . 16.8 mt -103.23 121.87 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.224 -1.028 . . . . 72.129999999999995 108.224 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -93.82 127.25 39.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.646 -1.242 . . . . 74.109999999999999 107.646 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 168' ' ' PHE . 61.9 tp -131.96 110.36 10.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.173 0.589 . . . . 71.019999999999996 109.511 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 21.7 ttt180 -79.7 113.81 18.14 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.076 0.55 . . . . 72.129999999999995 109.829 168.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -139.72 137.0 34.77 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.219 -1.4 . . . . 64.420000000000002 107.219 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 62.14 21.44 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.17 0.988 . . . . 74.239999999999995 111.624 -174.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 9.98 86.58 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.91 -0.586 . . . . 71.409999999999997 113.677 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -117.66 134.45 54.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.415 1.086 . . . . 73.019999999999996 109.487 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.58 115.56 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.735 0.414 . . . . 72.120000000000005 110.592 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -102.94 128.79 49.6 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.624 1.17 . . . . 75.109999999999999 108.696 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -110.37 110.13 20.8 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.316 0.646 . . . . 70.140000000000001 109.393 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.601 ' CE1' HD22 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -115.23 122.89 47.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.553 0.741 . . . . 73.120000000000005 110.545 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.76 135.04 53.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.55 1.14 . . . . 72.239999999999995 111.301 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.49 103.44 12.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.303 -0.999 . . . . 71.25 108.303 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -66.16 112.73 4.07 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.59 0.756 . . . . 64.439999999999998 109.172 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.8 m -97.45 105.46 17.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.436 0.695 . . . . 54.329999999999998 109.133 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.1 155.75 26.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.033 0.933 . . . . 72.519999999999996 110.771 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.8 p -69.19 -13.73 62.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.489 0.922 . . . . 74.120000000000005 113.489 -170.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.11 -16.42 31.52 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.391 0.676 . . . . 71.409999999999997 111.141 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 111.72 14.45 11.33 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.72 -0.489 . . . . 73.510000000000005 113.763 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -78.52 138.71 38.54 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.167 0.484 . . . . 61.340000000000003 110.89 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.29 143.76 32.24 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.977 -1.12 . . . . 63.310000000000002 107.977 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.6 p90 -170.81 136.45 1.17 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.546 0.529 . . . . 75.239999999999995 111.525 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.436 HG21 ' HD1' ' A' ' 193' ' ' TYR . 63.7 t -79.89 -42.06 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.639 -0.875 . . . . 74.450000000000003 108.639 166.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.2 m -100.17 126.98 46.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.24 1.016 . . . . 74.310000000000002 109.605 -174.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -63.16 -24.73 68.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.559 0.743 . . . . 64.140000000000001 112.12 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -77.09 -30.68 55.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.674 1.19 . . . . 62.149999999999999 111.233 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -120.87 100.62 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.575 0.75 . . . . 54.119999999999997 109.157 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.523 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.3 mtt180 -110.13 126.01 53.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.011 0.924 . . . . 74.010000000000005 109.514 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.557 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.5 m-85 -116.03 149.33 39.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.537 0.735 . . . . 75.129999999999995 110.043 -168.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.03 -44.33 72.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.403 -0.591 . . . . 75.239999999999995 109.403 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.1 p -117.93 154.95 31.05 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.955 0.883 . . . . 73.239999999999995 111.722 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.493 HD11 HG11 ' A' ' 170' ' ' VAL . 1.1 tt -65.47 -23.23 66.86 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.723 -1.126 . . . . 74.099999999999994 109.899 174.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.07 93.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.383 0.673 . . . . 61.299999999999997 110.662 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.2 mt-10 -68.04 -36.8 80.5 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 110.82 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 tp -54.04 -57.88 9.4 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.767 0.667 . . . . 74.120000000000005 110.407 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.01 -38.4 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 123.755 0.659 . . . . 72.329999999999998 110.716 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -62.94 -59.05 5.37 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.921 0.488 . . . . 72.019999999999996 111.55 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.26 -32.94 74.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.028 0.531 . . . . 73.450000000000003 111.063 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.671 ' HB3' HD11 ' A' ' 228' ' ' LEU . 17.4 m170 -89.44 -4.72 57.87 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.629 0.603 . . . . 70.120000000000005 112.629 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.2 p -96.24 -28.07 14.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.868 0.467 . . . . 63.229999999999997 110.807 168.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 52.7 p -77.29 -40.36 44.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.356 -0.384 . . . . 74.239999999999995 110.504 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.561 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.5 m -134.5 161.44 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.304 1.049 . . . . 73.319999999999993 112.437 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.23 16.62 0.74 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.26 2.224 . . . . 55.439999999999998 114.442 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.1 t70 -44.37 25.31 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.617 1 C-N-CA 132.266 4.227 . . . . 32.119999999999997 119.821 -155.183 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.95 6.22 7.16 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 120.114 -1.616 . . . . 64.310000000000002 111.823 -165.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 221' ' ' HIS . 6.7 mt -95.23 163.67 13.17 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.749 1.22 . . . . 63.039999999999999 109.363 167.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 8.4 tt -65.89 -34.0 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-O 121.229 0.537 . . . . 72.109999999999999 109.834 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.4 t -159.67 170.67 21.08 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.592 0.757 . . . . 74.129999999999995 109.664 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.2 p -63.96 142.09 58.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.363 0.665 . . . . 62.140000000000001 111.385 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.42 112.21 4.5 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 108.686 -0.857 . . . . 72.439999999999998 108.686 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -104.75 -57.88 1.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.140000000000001 112.007 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -119.27 122.77 29.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.789 0.836 . . . . 74.420000000000002 109.54 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.2 123.33 4.99 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.449 2.099 . . . . 72.510000000000005 111.132 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -68.32 142.06 94.25 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 109.072 -0.714 . . . . 74.099999999999994 109.072 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.66 176.35 7.12 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.605 2.203 . . . . 65.329999999999998 112.943 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 33.1 mmtp -71.41 155.7 40.33 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.394 -0.821 . . . . 64.409999999999997 109.974 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.855 ' HB3' HD21 ' A' ' 159' ' ' LEU . 16.7 ptt-85 -91.89 -60.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.578 0.584 . . . . 62.149999999999999 112.578 -167.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -110.89 155.06 23.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.348 1.059 . . . . 65.140000000000001 109.872 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.67 114.77 59.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.663 -1.606 . . . . 50.32 106.663 156.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.554 ' HB2' HD22 ' A' ' 133' ' ' ASN . 27.9 Cg_endo -61.59 124.88 15.49 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.595 2.197 . . . . 74.420000000000002 112.352 -171.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.4 m -72.4 112.83 8.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.543 -0.753 . . . . 72.400000000000006 110.833 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.07 111.77 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 107.416 -1.327 . . . . 72.040000000000006 107.416 171.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.74 111.05 22.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.157 -0.312 . . . . 73.150000000000006 110.157 -166.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 60.22 -14.13 0.04 OUTLIER Glycine 0 CA--C 1.542 1.764 0 N-CA-C 118.185 2.034 . . . . 32.200000000000003 118.185 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.3 m -89.52 122.96 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.376 1.588 . . . . 74.25 112.882 -164.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 36.4 t -82.61 140.02 44.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 106.928 -1.508 . . . . 63.549999999999997 106.928 159.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -63.67 -58.61 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 CA-C-N 120.723 1.294 . . . . 74.340000000000003 112.793 -163.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -132.85 -21.54 2.15 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.19 0.996 . . . . 62.109999999999999 109.285 152.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.658 ' HB3' ' HB2' ' A' ' 254' ' ' TRP . 59.5 m-85 -97.64 117.93 33.03 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.322 -1.308 . . . . 63.119999999999997 114.3 -152.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -104.36 -41.94 5.62 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.962 0.505 . . . . 61.539999999999999 109.731 170.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -104.31 25.14 10.49 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.626 1.171 . . . . 73.239999999999995 110.508 -172.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.658 ' HB2' ' HB3' ' A' ' 251' ' ' TYR . 54.7 t90 -52.54 119.4 4.46 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.123 0.569 . . . . 74.329999999999998 112.179 -176.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 107.806 -1.183 . . . . 63.0 107.806 177.663 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.6 t90 . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 121.205 0.526 . . . . 75.120000000000005 109.804 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.51 -22.69 34.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.889 0.876 . . . . 71.030000000000001 111.104 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 m -78.95 7.32 7.42 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.241 1.416 . . . . 54.420000000000002 113.021 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.39 -18.18 65.02 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.464 1.106 . . . . 72.310000000000002 112.315 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -20.35 26.2 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.319 0.648 . . . . 72.310000000000002 110.916 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.453 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 12.7 m120 -78.45 -12.31 60.0 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.322 0.649 . . . . 55.119999999999997 110.377 170.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.05 -50.45 70.59 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.679 0.792 . . . . 74.140000000000001 110.623 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.438 HD11 ' CG ' ' A' ' 219' ' ' HIS . 84.8 mt -112.12 30.15 7.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.486 0.714 . . . . 75.450000000000003 110.063 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.473 0.722 0 C-N-CA 122.663 0.385 . . . . 75.140000000000001 110.562 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.105 0.479 . . . . 70.299999999999997 110.848 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.7 tp -76.78 138.42 39.88 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.75 -0.594 . . . . 52.539999999999999 109.455 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.7 m-85 -108.11 173.45 6.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.588 1.155 . . . . 72.109999999999999 110.06 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.6 147.55 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 125.221 1.409 . . . . 60.409999999999997 109.64 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.21 120.15 25.45 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.219 1.008 . . . . 51.219999999999999 110.205 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.3 -42.26 68.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.329 0.651 . . . . 63.32 111.161 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.511 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.8 m-85 -124.54 158.4 33.05 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.41 -0.813 . . . . 75.129999999999995 109.223 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 120.71 24.27 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.502 -1.296 . . . . 72.25 107.502 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.8 t80 -123.01 138.28 54.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.903 0.881 . . . . 72.340000000000003 108.712 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.48 134.18 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.76 -0.83 . . . . 75.120000000000005 108.76 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.6 117.18 4.62 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.078 0.862 . . . . 74.319999999999993 110.631 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 p -67.82 -38.33 83.12 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.654 0.782 . . . . 64.129999999999995 110.887 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.72 -175.95 14.28 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-N 115.717 -0.674 . . . . 65.040000000000006 111.826 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.79 -31.85 67.02 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.546 0.739 . . . . 71.129999999999995 110.661 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -75.52 -18.06 59.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.803 1.241 . . . . 52.32 112.115 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 57.2 p -95.63 171.25 8.79 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.48 -0.563 . . . . 74.140000000000001 109.48 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.9 tp -126.94 136.7 52.64 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.275 0.56 . . . . 63.32 111.735 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -82.25 117.03 22.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.726 -1.125 . . . . 62.130000000000003 109.042 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.594 HG12 ' HB3' ' A' ' 91' ' ' PHE . 20.7 pt -110.08 144.26 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.388 0.675 . . . . 72.219999999999999 110.104 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.3 m -95.76 140.23 30.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.424 -0.807 . . . . 65.040000000000006 108.845 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.29 125.99 25.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.318 0.647 . . . . 60.020000000000003 111.356 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.45 76.67 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 123.88 0.738 . . . . 60.049999999999997 113.605 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -82.11 138.34 34.79 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.46 0.63 . . . . 74.109999999999999 111.434 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -79.95 112.81 17.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.837 -0.801 . . . . 71.019999999999996 108.837 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -122.83 167.78 13.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.951 0.9 . . . . 74.230000000000004 110.024 -177.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -121.74 119.43 31.72 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.935 -0.478 . . . . 63.439999999999998 111.035 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.65 HG13 ' HB1' ' A' ' 119' ' ' ALA . 43.5 t -86.54 134.55 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.246 1.018 . . . . 75.230000000000004 109.881 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.556 HD12 ' HG3' ' A' ' 120' ' ' GLU . 46.1 mt -105.89 -31.49 8.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.467 1.107 . . . . 75.140000000000001 110.126 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.01 145.48 4.71 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 115.835 -0.62 . . . . 61.119999999999997 112.375 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 45.5 m-85 -85.68 169.74 13.17 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.436 0.694 . . . . 63.25 110.886 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -85.66 -176.26 5.97 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.213 -0.903 . . . . 70.230000000000004 110.694 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -52.83 -35.18 56.79 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.754 1.221 . . . . 74.430000000000007 114.17 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -112.12 2.63 16.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.855 0.462 . . . . 70.310000000000002 112.171 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.79 30.56 72.59 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.398 0.919 . . . . 54.5 115.398 173.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.03 -35.96 18.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.285 0.543 . . . . 74.510000000000005 110.716 173.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 35.3 m95 -131.0 151.66 51.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.743 0.817 . . . . 73.519999999999996 111.72 -171.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -133.54 137.09 45.39 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.534 1.134 . . . . 72.040000000000006 111.026 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.556 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.8 tp10 -66.81 114.45 5.68 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 106.854 -1.536 . . . . 75.030000000000001 106.854 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.15 162.13 33.8 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.184 0.516 . . . . 53.420000000000002 111.299 -170.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.468 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . 9.8 pt20 -132.8 128.96 37.9 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.414 -0.812 . . . . 64.129999999999995 111.122 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 107' ' ' LEU . 45.8 p -116.61 179.1 4.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 74.319999999999993 109.757 173.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -70.68 -16.35 62.79 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 109.513 -0.551 . . . . 72.340000000000003 109.513 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -78.78 -20.16 50.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.918 1.287 . . . . 71.530000000000001 110.984 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.68 -140.4 10.15 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 122.051 -0.118 . . . . 74.439999999999998 112.941 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' A' ' 122' ' ' GLN . 61.6 tp60 -128.67 155.83 44.4 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.348 1.059 . . . . 74.329999999999998 109.667 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.56 169.4 15.36 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.025 -0.43 . . . . 73.120000000000005 112.025 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -77.75 134.53 38.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.241 0.616 . . . . 75.310000000000002 111.668 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.487 HG23 HD13 ' A' ' 135' ' ' ILE . 5.9 m -132.0 143.26 48.26 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 124.308 1.043 . . . . 74.010000000000005 108.807 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 92.9 Cg_endo -80.4 143.04 15.19 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 C-N-CA 122.018 1.812 . . . . 41.350000000000001 114.075 -173.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -39.61 -44.73 1.52 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.583 1.953 . . . . 52.049999999999997 114.229 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 38.1 p-10 -79.04 -1.91 37.89 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.198 0.999 . . . . 74.25 113.132 -171.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.511 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 28.8 m-85 -113.14 -0.63 14.61 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.026 0.93 . . . . 73.129999999999995 111.308 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.487 HD13 HG23 ' A' ' 130' ' ' VAL . 21.0 pt -135.37 170.48 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.182 0.993 . . . . 63.030000000000001 110.667 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -163.4 155.39 15.14 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.812 -1.181 . . . . 64.430000000000007 107.812 170.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.8 Cg_endo -60.44 153.53 59.88 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.679 1.586 . . . . 73.310000000000002 111.632 171.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 143' ' ' LYS . 38.2 t -73.1 -8.44 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.107 0.956 . . . . 53.340000000000003 110.356 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.94 -18.61 55.86 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.336 1.054 . . . . 73.129999999999995 111.248 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.2 p -87.01 170.43 11.57 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.853 0.835 . . . . 65.530000000000001 113.024 -170.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.36 -23.79 26.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.512 -1.222 . . . . 55.119999999999997 110.931 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.64 -29.81 70.3 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.322 1.049 . . . . 75.140000000000001 111.447 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 138' ' ' VAL . 24.2 pttm -60.08 -19.28 52.34 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.614 0.765 . . . . 71.209999999999994 112.904 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -86.66 141.86 28.64 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.544 0.737 . . . . 72.329999999999998 109.749 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.1 m -58.9 -40.64 85.1 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.07 0.856 . . . . 64.430000000000007 112.182 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -62.53 -38.5 90.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.122 0.889 . . . . 73.140000000000001 112.336 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -76.6 112.37 13.07 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.728 -0.841 . . . . 73.219999999999999 108.728 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -109.07 -14.83 14.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.073 0.549 . . . . 70.400000000000006 111.517 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.78 -127.25 15.49 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 118.18 -1.344 . . . . 43.119999999999997 112.3 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.55 95.2 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.984 2.456 . . . . 62.030000000000001 112.591 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 77.3 t -137.78 119.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.605 0.762 . . . . 63.509999999999998 109.575 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.8 m -71.78 159.35 34.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.289 0.635 . . . . 71.329999999999998 109.32 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 78.0 ttt180 -59.04 -38.07 78.46 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 119.435 -0.317 . . . . 73.549999999999997 111.415 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -63.49 -36.88 85.21 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.362 0.665 . . . . 71.409999999999997 111.209 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.36 -30.27 67.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.16 0.584 . . . . 70.120000000000005 110.408 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.26 63.18 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 51.509999999999998 111.647 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 22.5 mm-40 -65.66 -43.11 90.38 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.119 -0.697 . . . . 74.310000000000002 109.119 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.489 ' HE1' ' HB2' ' A' ' 239' ' ' ARG . 17.0 t80 -62.73 -41.47 99.19 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.315 -1.311 . . . . 73.239999999999995 111.201 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.442 HD21 ' HB3' ' A' ' 239' ' ' ARG . 28.7 mt -61.48 -44.13 97.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.59 0.756 . . . . 52.340000000000003 111.478 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.0 mt -98.3 17.96 17.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.199 0.6 . . . . 62.5 112.59 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.0 p -69.35 -36.24 76.68 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.444 0.64 . . . . 74.219999999999999 110.694 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 p -106.42 15.81 25.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.342 1.057 . . . . 71.200000000000003 110.8 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.86 140.48 23.3 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.37 -0.377 . . . . 63.119999999999997 112.379 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.7 pt -86.81 -179.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.405 0.682 . . . . 74.0 111.431 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.6 112.33 3.13 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.679 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.6 10.88 39.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.392 -0.822 . . . . 72.209999999999994 112.94 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.4 m -75.54 143.31 42.52 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.634 0.717 . . . . 62.140000000000001 110.619 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -149.72 163.78 37.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.063 0.459 . . . . 71.409999999999997 111.937 -171.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 183' ' ' SER . 4.0 pp -161.72 152.69 18.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.873 -1.058 . . . . 73.540000000000006 109.482 175.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.612 HG22 HG12 ' A' ' 182' ' ' ILE . 59.5 t -107.64 126.73 63.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.424 -0.954 . . . . 55.210000000000001 108.424 168.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.543 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 13.1 ptt180 -114.97 147.29 40.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.182 -1.044 . . . . 71.340000000000003 108.182 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.89 145.99 40.68 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 107.741 -1.207 . . . . 72.340000000000003 107.741 166.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.4 t -78.55 121.64 24.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.169 -0.678 . . . . 74.109999999999999 109.169 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.25 -34.3 77.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.306 1.042 . . . . 73.109999999999999 110.485 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 p -83.18 -15.87 48.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.72 0.808 . . . . 72.340000000000003 111.788 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.8 m -142.2 86.03 10.43 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.423 0.689 . . . . 60.119999999999997 110.079 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.09 135.54 69.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.33 2.687 . . . . 73.239999999999995 112.529 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.15 -28.86 12.07 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.472 -0.331 . . . . 61.509999999999998 112.594 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -81.41 117.11 21.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.182 0.491 . . . . 74.329999999999998 110.193 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.628 HH11 HD12 ' A' ' 214' ' ' LEU . 99.4 mtt180 -130.03 157.6 41.9 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.908 0.883 . . . . 75.400000000000006 110.974 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.4 m -143.61 146.24 33.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.944 -1.026 . . . . 61.310000000000002 109.454 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.612 HG12 HG22 ' A' ' 170' ' ' VAL . 42.8 mt -100.81 108.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 107.394 -1.335 . . . . 72.219999999999999 107.394 169.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.428 ' HB2' ' HG ' ' A' ' 169' ' ' LEU . 14.9 m -87.38 106.81 18.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.243 -1.391 . . . . 65.310000000000002 107.243 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 193' ' ' TYR . 62.4 tp -115.47 110.95 20.03 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.78 -0.822 . . . . 74.5 108.78 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.444 ' HB2' HG22 ' A' ' 190' ' ' VAL . 75.9 ttt180 -89.61 122.77 33.07 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.316 0.646 . . . . 75.209999999999994 110.486 173.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -143.7 144.13 31.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.655 1.182 . . . . 70.109999999999999 108.352 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 61.11 21.93 12.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.422 1.089 . . . . 62.520000000000003 112.358 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.29 11.45 82.17 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 114.358 0.503 . . . . 60.219999999999999 114.358 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -120.14 134.5 55.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.49 0.716 . . . . 74.040000000000006 109.744 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 185' ' ' ARG . 91.0 t -88.65 118.24 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.304 -0.628 . . . . 74.439999999999998 109.304 174.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.37 157.42 16.92 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.147 0.979 . . . . 55.350000000000001 108.564 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -132.76 124.15 27.55 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.976 -0.75 . . . . 74.140000000000001 108.976 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' A' ' 184' ' ' LEU . 89.8 m-85 -113.83 141.24 47.56 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.415 1.086 . . . . 72.310000000000002 108.714 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 9.1 tpp180 -85.21 124.36 31.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.398 0.279 . . . . 73.129999999999995 110.391 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.2 mt -84.71 99.6 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.132 -1.433 . . . . 73.040000000000006 107.132 166.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -78.46 119.71 22.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.963 -1.017 . . . . 72.450000000000003 108.37 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -94.15 108.5 20.35 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.908 -0.775 . . . . 75.0 108.908 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.48 157.57 16.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.952 0.901 . . . . 52.240000000000002 110.886 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -61.85 -30.94 71.19 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.293 1.037 . . . . 75.129999999999995 113.395 -170.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -85.0 -11.5 55.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.803 0.841 . . . . 73.299999999999997 111.925 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.0 11.15 14.38 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.451 -0.638 . . . . 74.310000000000002 114.352 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -75.5 152.16 37.88 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 118.082 0.941 . . . . 62.0 110.983 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -113.56 142.6 45.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.327 -0.99 . . . . 71.120000000000005 108.327 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.613 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.8 p90 -165.0 137.0 4.31 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.52 0.512 . . . . 73.349999999999994 110.872 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 54.3 t -79.12 -45.73 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.832 -0.803 . . . . 72.099999999999994 108.832 166.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -101.29 135.93 41.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.763 -1.108 . . . . 71.219999999999999 110.696 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.5 t -64.14 -22.46 66.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.287 1.035 . . . . 74.219999999999999 112.267 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -81.47 -29.98 33.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.941 0.896 . . . . 73.109999999999999 111.176 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 17.1 m -123.17 99.01 6.14 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.026 0.53 . . . . 65.200000000000003 110.176 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.613 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 47.3 mtt180 -112.35 120.29 41.19 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.818 0.847 . . . . 65.420000000000002 109.632 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.62 156.0 20.75 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.083 0.953 . . . . 65.25 109.085 -171.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -69.32 -42.74 74.98 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 70.5 p -120.95 155.04 35.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.92 0.867 . . . . 75.420000000000002 111.904 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.628 HD12 HH11 ' A' ' 180' ' ' ARG . 1.3 tt -65.38 -24.61 67.28 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 114.352 -1.295 . . . . 75.230000000000004 109.559 172.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.33 93.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.41 0.684 . . . . 75.439999999999998 110.766 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.19 -34.81 75.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.83 0.852 . . . . 71.319999999999993 111.15 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.04 -54.92 39.08 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.09 0.556 . . . . 73.140000000000001 111.025 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.61 -41.09 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 123.655 0.597 . . . . 52.200000000000003 111.011 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.438 ' CG ' HD11 ' A' ' 74' ' ' LEU . 17.0 t-80 -55.63 -58.0 9.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.441 0.696 . . . . 61.340000000000003 111.362 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -64.17 -33.7 76.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.125 -0.943 . . . . 74.239999999999995 110.813 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.543 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.1 m-70 -88.28 -10.78 48.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.797 -0.638 . . . . 73.5 112.081 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 232' ' ' LEU . 89.1 p -93.92 -20.28 20.16 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.756 0.423 . . . . 61.420000000000002 111.255 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 37.7 p -81.98 -48.12 11.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.873 -0.417 . . . . 51.420000000000002 109.873 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 226' ' ' ASP . 33.2 m -128.72 158.92 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.636 0.732 . . . . 74.209999999999994 112.303 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.97 16.0 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.759 2.024 . . . . 61.119999999999997 115.217 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.9 t70 -42.64 31.69 0.0 OUTLIER 'General case' 0 CA--C 1.601 2.925 1 C-N-CA 131.88 4.072 . . . . 71.5 119.351 -157.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.86 -1.94 9.25 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 119.486 -2.009 . . . . 74.120000000000005 112.604 -168.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' A' ' 221' ' ' HIS . 45.1 mt -95.59 160.3 14.57 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.584 1.153 . . . . 70.420000000000002 110.216 168.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.11 -35.55 72.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 120.895 0.379 . . . . 72.120000000000005 110.322 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -149.18 173.52 13.35 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.506 0.722 . . . . 44.340000000000003 110.094 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -67.42 143.17 56.41 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.172 0.589 . . . . 72.319999999999993 110.675 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 222' ' ' SER . 90.2 mt -63.58 96.56 0.12 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.74 0.816 . . . . 64.329999999999998 109.275 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -89.45 -66.14 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.184 -0.916 . . . . 63.310000000000002 110.681 -169.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 167' ' ' SER . 43.0 t80 -114.81 121.77 34.92 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 123.852 0.861 . . . . 73.519999999999996 109.725 -170.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.36 123.71 5.61 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.09 1.86 . . . . 75.219999999999999 111.722 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.02 130.95 95.06 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.971 -0.751 . . . . 75.150000000000006 108.971 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.03 179.78 6.18 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.833 2.355 . . . . 75.400000000000006 112.413 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.78 150.92 48.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 52.329999999999998 109.575 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.489 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . 13.7 ptt180 -92.51 -60.49 1.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 111.838 0.31 . . . . 72.120000000000005 111.838 -174.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.42 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 55.5 t30 -109.47 138.45 45.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 73.530000000000001 110.482 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.1 113.64 47.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.256 -1.757 . . . . 71.549999999999997 106.256 159.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.506 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 35.8 Cg_exo -61.01 123.87 13.76 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.51 2.14 . . . . 62.439999999999998 112.709 -173.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 61.2 m -73.47 119.1 17.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.827 0.451 . . . . 71.519999999999996 110.558 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.3 t -98.62 127.04 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.281 1.032 . . . . 62.399999999999999 108.38 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.08 114.52 28.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.095 0.407 . . . . 74.310000000000002 111.51 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.8 21.89 38.57 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 116.426 1.331 . . . . 71.030000000000001 116.426 160.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.489 HG21 ' NE1' ' A' ' 118' ' ' TRP . 27.2 m -82.3 127.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 117.732 0.766 . . . . 74.420000000000002 111.913 -173.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 t -85.18 117.83 69.59 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 104.85 -2.278 . . . . 72.540000000000006 104.85 152.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo . . . . . 0 C--N 1.371 1.749 0 C-N-CA 120.92 1.08 . . . . 70.420000000000002 113.917 -159.081 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 6.2 t90 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 122.151 0.977 . . . . 75.409999999999997 109.272 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -79.14 -23.92 43.68 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.24 -1.345 . . . . 71.400000000000006 109.426 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.6 p -78.03 4.54 12.0 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.967 0.907 . . . . 74.430000000000007 112.337 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.96 -37.62 78.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.949 0.5 . . . . 75.340000000000003 110.987 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.49 -31.16 62.1 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.072 0.463 . . . . 63.109999999999999 109.943 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.51 -5.81 57.24 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.042 0.937 . . . . 72.5 111.06 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.418 HD13 ' HE1' ' A' ' 146' ' ' TRP . 21.0 tp -66.19 -49.71 66.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.296 1.038 . . . . 74.230000000000004 111.36 -173.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -103.61 20.97 16.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.999 0.52 . . . . 54.119999999999997 110.661 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 C-N-CA 122.65 0.38 . . . . 64.239999999999995 110.854 174.546 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.867 0.365 . . . . 71.340000000000003 111.524 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.6 tp -86.59 133.37 33.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.467 -0.938 . . . . 72.140000000000001 108.467 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -110.42 171.51 7.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.777 0.831 . . . . 75.239999999999995 109.14 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.19 138.71 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.473 1.109 . . . . 54.420000000000002 109.273 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 135' ' ' ILE . . . -82.68 111.14 18.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.966 0.906 . . . . 64.040000000000006 109.594 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.46 -38.06 68.34 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.699 0.799 . . . . 52.420000000000002 110.937 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 37.1 m-85 -122.54 140.91 52.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.341 -1.3 . . . . 72.209999999999994 107.574 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -84.34 150.07 25.63 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.734 -0.469 . . . . 72.239999999999995 109.734 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.626 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.9 t80 -139.84 143.52 36.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.051 0.94 . . . . 64.329999999999998 108.642 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.97 133.2 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.564 -1.273 . . . . 52.140000000000001 107.564 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 129.8 41.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.319 0.648 . . . . 52.520000000000003 111.345 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 p -88.35 -38.96 14.7 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.776 0.83 . . . . 71.439999999999998 109.678 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.76 -170.32 12.66 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.344 -0.844 . . . . 45.200000000000003 112.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.74 -35.1 60.3 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.682 0.793 . . . . 65.510000000000005 110.581 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -63.07 -29.32 70.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.054 0.942 . . . . 64.439999999999998 111.871 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.5 p -90.38 154.43 19.68 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.845 0.858 . . . . 61.43 109.491 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.661 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 58.6 tp -125.12 136.9 54.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.003 0.521 . . . . 64.140000000000001 110.467 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -75.23 131.39 40.35 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.958 0.503 . . . . 74.540000000000006 110.063 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.734 HG22 HG21 ' A' ' 123' ' ' THR . 19.3 pt -128.47 167.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.77 0.828 . . . . 53.219999999999999 111.215 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -123.11 152.36 41.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.363 1.065 . . . . 71.540000000000006 109.568 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.72 122.37 16.22 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.429 -0.582 . . . . 75.329999999999998 109.429 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.4 72.03 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-O 119.537 -0.591 . . . . 73.329999999999998 113.894 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -83.76 125.4 31.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.678 0.739 . . . . 53.009999999999998 110.745 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -78.3 133.86 37.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.277 -0.638 . . . . 71.540000000000006 109.277 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.673 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.77 147.03 34.86 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.574 0.75 . . . . 72.150000000000006 110.715 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -94.81 105.58 17.52 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.961 -0.755 . . . . 73.319999999999993 108.961 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.635 HG13 ' HB1' ' A' ' 119' ' ' ALA . 60.6 t -82.67 105.18 12.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.517 -0.92 . . . . 44.240000000000002 108.517 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.528 HD23 ' HG2' ' A' ' 120' ' ' GLU . 2.6 mm? -65.68 -52.88 48.06 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.162 0.914 . . . . 52.450000000000003 108.594 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.7 155.69 22.53 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.605 -0.725 . . . . 65.239999999999995 114.104 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 96.9 m-85 -88.15 163.54 16.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.801 0.84 . . . . 74.510000000000005 109.786 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -71.43 -172.57 0.77 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 120.803 0.335 . . . . 70.319999999999993 111.338 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -47.71 -41.1 22.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.858 1.263 . . . . 74.099999999999994 114.144 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -114.52 3.62 14.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.306 0.854 . . . . 74.439999999999998 113.306 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.14 32.86 47.02 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.921 0.728 . . . . 44.539999999999999 114.921 174.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.85 -65.65 0.71 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.437 0.695 . . . . 61.399999999999999 110.736 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 34.4 m95 -114.4 165.86 12.28 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 75.109999999999999 109.33 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.08 131.08 36.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.764 1.226 . . . . 74.049999999999997 111.384 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HG2' HD23 ' A' ' 110' ' ' LEU . 24.0 tt0 -68.6 103.05 1.61 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.198 -1.038 . . . . 71.400000000000006 108.198 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.4 140.52 48.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.979 0.912 . . . . 73.099999999999994 109.85 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.491 ' HG3' HD21 ' A' ' 110' ' ' LEU . 55.8 mt-30 -105.51 105.39 15.41 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.575 -0.898 . . . . 71.109999999999999 108.575 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.734 HG21 HG22 ' A' ' 101' ' ' ILE . 68.5 p -99.88 -176.37 3.23 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.816 1.246 . . . . 74.310000000000002 110.357 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.88 -18.37 64.12 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.529 -0.76 . . . . 62.329999999999998 110.231 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.64 -3.46 59.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.664 1.186 . . . . 72.109999999999999 111.714 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.53 -138.39 13.27 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-O 119.513 -0.604 . . . . 74.450000000000003 111.815 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -129.73 143.51 50.85 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.724 0.762 . . . . 75.329999999999998 110.096 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.661 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.5 -172.28 43.46 Favored Glycine 0 C--O 1.225 -0.428 0 N-CA-C 110.972 -0.851 . . . . 64.420000000000002 110.972 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 40.9 m95 -107.34 125.19 50.88 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.323 0.561 . . . . 74.239999999999995 110.505 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.52 140.42 38.6 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.433 1.493 . . . . 64.310000000000002 109.091 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 9.3 Cg_exo -72.15 147.96 49.25 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 122.731 2.287 . . . . 44.5 114.414 -171.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 m -37.2 -51.59 1.02 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.415 1.886 . . . . 64.239999999999995 114.189 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -75.11 -3.18 31.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.546 0.738 . . . . 73.209999999999994 112.809 -171.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -94.47 -23.21 17.82 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.493 0.717 . . . . 74.450000000000003 111.577 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 109' ' ' VAL . 11.4 pt -123.32 173.77 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.794 0.838 . . . . 71.420000000000002 111.346 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.3 t -160.97 153.63 17.43 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.039 -1.097 . . . . 73.319999999999993 108.039 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.24 147.76 93.61 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 121.59 1.527 . . . . 62.119999999999997 110.981 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.82 -6.9 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 CA-C-O 121.499 0.666 . . . . 64.409999999999997 110.885 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -79.29 -13.15 59.84 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.346 0.658 . . . . 73.329999999999998 112.076 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.0 p -88.53 174.82 7.87 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.336 0.588 . . . . 63.32 112.418 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -84.03 -22.68 31.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.047 -0.979 . . . . 72.019999999999996 110.475 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.23 -22.09 66.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.964 0.905 . . . . 75.099999999999994 112.121 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -63.28 -13.74 41.76 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.529 0.566 . . . . 53.450000000000003 112.529 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -94.25 150.65 20.1 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.76 0.824 . . . . 72.319999999999993 110.425 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.8 p -67.66 -38.82 84.3 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 124.272 0.983 . . . . 74.319999999999993 111.635 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.475 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 41.9 p-90 -60.38 -48.96 79.48 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.82 0.7 . . . . 72.239999999999995 111.958 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.48 96.88 2.99 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.125 -0.694 . . . . 73.420000000000002 109.125 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -91.57 -2.38 57.15 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.616 -0.72 . . . . 74.010000000000005 111.078 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.54 -161.82 42.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.158 -0.801 . . . . 51.049999999999997 112.588 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.33 98.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.4 2.733 . . . . 70.420000000000002 112.564 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 53.5 t -122.94 135.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 114.674 -1.148 . . . . 75.420000000000002 109.9 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.7 p -75.37 156.72 35.17 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.366 0.666 . . . . 62.130000000000003 109.489 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 71.1 ttt180 -62.71 -36.92 84.52 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 118.78 -0.629 . . . . 63.100000000000001 111.361 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -55.42 -43.94 75.8 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.559 0.695 . . . . 73.140000000000001 110.484 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.43 70.22 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.406 -1.27 . . . . 70.439999999999998 111.321 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.5 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.084 0.554 . . . . 74.510000000000005 111.402 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.2 mm-40 -68.98 -30.17 68.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.146 0.578 . . . . 71.209999999999994 110.009 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.73 -47.32 84.09 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.202 0.601 . . . . 73.439999999999998 110.329 171.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.6 mt -60.48 -35.33 75.65 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.987 0.515 . . . . 62.119999999999997 110.679 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 73.9 mt -105.74 21.32 17.45 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.539 -0.755 . . . . 71.140000000000001 113.036 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.8 p -88.61 -35.13 17.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.453 -0.943 . . . . 72.230000000000004 108.453 165.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.7 p -95.97 12.89 28.82 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.94 -1.027 . . . . 64.019999999999996 111.702 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.0 -175.59 40.97 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 112.493 -0.243 . . . . 73.140000000000001 112.493 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.439 HD11 ' HE2' ' A' ' 234' ' ' TYR . 32.3 pt -131.18 -174.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.363 1.065 . . . . 61.140000000000001 110.036 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -58.72 122.32 13.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 74.030000000000001 110.799 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.78 9.57 68.25 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.84 -0.618 . . . . 51.420000000000002 113.66 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 48.8 m -88.9 127.85 35.66 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.975 0.887 . . . . 61.149999999999999 110.035 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -132.41 -178.33 4.87 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.772 0.714 . . . . 62.100000000000001 112.793 -172.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.418 HD23 ' HG ' ' A' ' 160' ' ' LEU . 4.0 pp -164.69 155.97 15.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.048 0.939 . . . . 73.010000000000005 109.633 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.679 HG22 HG12 ' A' ' 182' ' ' ILE . 88.1 t -116.37 134.36 60.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.356 -0.979 . . . . 72.420000000000002 108.356 167.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.437 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 15.4 ptt180 -130.26 149.39 51.98 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.522 -0.763 . . . . 62.32 110.077 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -93.11 150.44 20.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.076 1.35 . . . . 74.439999999999998 108.036 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.8 t -79.5 123.51 27.63 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.819 -0.437 . . . . 64.310000000000002 109.819 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.98 -36.14 72.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.284 1.033 . . . . 74.409999999999997 111.2 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.0 p -78.39 -31.09 48.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.409 0.683 . . . . 71.420000000000002 111.566 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.4 m -140.04 89.43 11.19 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.192 0.597 . . . . 75.120000000000005 109.764 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.38 132.7 53.44 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.068 2.512 . . . . 71.420000000000002 112.819 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.52 -27.82 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.842 0.734 . . . . 62.210000000000001 112.388 -175.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -86.87 114.56 23.62 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.817 -0.808 . . . . 73.519999999999996 108.817 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -125.96 148.45 49.25 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.235 0.54 . . . . 63.109999999999999 110.914 -172.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.6 p -144.42 148.88 35.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.782 -1.099 . . . . 54.32 109.923 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.679 HG12 HG22 ' A' ' 170' ' ' VAL . 41.6 mt -102.25 149.71 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.264 -1.384 . . . . 71.129999999999995 107.264 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -125.29 120.85 32.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.105 -1.443 . . . . 54.420000000000002 107.105 170.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 67.7 tp -114.04 114.11 25.69 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.921 0.782 . . . . 73.420000000000002 110.52 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 29.3 ttt85 -77.48 113.85 15.71 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 109.761 -0.459 . . . . 74.209999999999994 109.761 166.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -142.06 138.68 31.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.206 1.402 . . . . 71.150000000000006 107.477 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 58.74 22.14 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.426 1.09 . . . . 72.310000000000002 111.984 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.93 86.7 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 114.226 0.45 . . . . 72.030000000000001 114.226 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -108.17 147.62 31.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.925 0.89 . . . . 73.019999999999996 108.685 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.32 105.58 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.384 0.674 . . . . 72.109999999999999 109.827 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.35 116.46 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.486 1.115 . . . . 74.040000000000006 109.333 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -91.59 118.95 31.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.826 0.451 . . . . 52.109999999999999 110.751 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.56 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.4 m-85 -94.77 151.17 19.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.185 0.994 . . . . 52.409999999999997 108.782 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -104.71 122.72 46.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.415 -0.587 . . . . 74.420000000000002 109.415 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.2 mt -90.98 105.87 16.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.084 -0.71 . . . . 63.219999999999999 109.084 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.91 140.3 29.63 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.412 0.685 . . . . 52.140000000000001 110.033 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 42.6 m -98.36 119.05 36.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.655 1.182 . . . . 70.019999999999996 107.854 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 174.45 6.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.978 0.911 . . . . 71.120000000000005 110.569 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 61.0 p -66.01 -25.63 67.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.373 0.669 . . . . 53.119999999999997 111.937 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.36 -17.21 29.29 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.143 0.577 . . . . 74.040000000000006 111.0 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.55 6.0 23.81 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-O 119.352 -0.693 . . . . 74.209999999999994 114.493 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -70.96 128.6 36.54 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.915 0.857 . . . . 74.540000000000006 112.097 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.21 143.12 34.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.783 0.833 . . . . 70.510000000000005 108.924 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.518 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.2 p90 -165.9 146.84 6.79 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.506 0.504 . . . . 71.329999999999998 111.624 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.528 HG23 HD11 ' A' ' 217' ' ' LEU . 78.0 t -89.39 -42.44 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.561 -0.903 . . . . 73.030000000000001 108.561 165.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.2 m -104.87 129.32 53.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.95 -1.023 . . . . 73.310000000000002 109.155 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -67.14 -18.54 65.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.305 0.642 . . . . 60.229999999999997 111.739 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -70.29 -26.56 63.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.608 1.163 . . . . 63.32 110.942 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 51.1 p -137.46 107.66 6.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.535 0.734 . . . . 72.400000000000006 109.93 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.2 mtt180 -116.56 133.82 55.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.303 1.041 . . . . 74.329999999999998 108.881 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.409 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.2 OUTLIER -128.78 143.67 50.97 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.365 0.666 . . . . 75.040000000000006 109.945 -170.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -67.91 -22.29 65.09 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.974 0.51 . . . . 73.329999999999998 112.066 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.2 p -130.89 155.14 47.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.121 0.962 . . . . 45.310000000000002 112.05 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -28.19 69.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 113.631 -1.622 . . . . 73.439999999999998 109.327 173.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.79 94.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.733 0.813 . . . . 72.439999999999998 110.945 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.407 0.683 . . . . 73.219999999999999 111.15 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.528 HD11 HG23 ' A' ' 205' ' ' VAL . 17.8 tp -55.2 -54.37 44.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 123.552 0.533 . . . . 50.200000000000003 111.158 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.88 -46.79 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 124.038 0.836 . . . . 74.140000000000001 110.703 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -61.74 -48.05 82.45 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.544 0.527 . . . . 61.329999999999998 111.968 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.02 -47.04 78.86 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.939 -0.573 . . . . 75.150000000000006 109.609 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.671 ' HB3' HD11 ' A' ' 228' ' ' LEU . 15.9 m-70 -82.76 -1.45 51.59 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 112.296 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.8 p -94.14 -40.83 9.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.919 0.488 . . . . 74.349999999999994 110.913 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.7 p -69.63 -38.3 77.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.321 -0.399 . . . . 71.450000000000003 111.019 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.651 HG23 ' HB2' ' A' ' 226' ' ' ASP . 17.6 m -132.97 162.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.669 0.747 . . . . 54.350000000000001 112.237 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.34 15.71 0.92 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 127.219 2.208 . . . . 54.549999999999997 113.988 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.651 ' HB2' HG23 ' A' ' 224' ' ' VAL . 23.4 t70 -44.2 33.44 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.464 1 C-N-CA 132.357 4.263 . . . . 74.329999999999998 119.519 -156.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.28 2.14 9.16 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.243 -1.536 . . . . 72.349999999999994 112.63 -171.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.5 mt -94.5 165.58 12.47 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 125.701 1.6 . . . . 74.109999999999999 109.972 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.1 tt -56.38 -42.05 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 109.982 -0.377 . . . . 63.43 109.982 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.9 t -160.91 177.39 10.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.995 0.918 . . . . 70.540000000000006 109.693 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 68.3 p -61.85 150.12 38.26 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.451 1.1 . . . . 75.530000000000001 113.106 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.56 HD21 ' HE1' ' A' ' 193' ' ' TYR . 86.5 mt -83.65 92.44 7.68 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.384 -0.969 . . . . 62.140000000000001 108.384 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -78.76 -51.32 9.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.504 0.557 . . . . 72.329999999999998 112.504 -161.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.4 OUTLIER -148.16 150.22 34.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.843 -1.169 . . . . 71.230000000000004 107.843 169.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.413 ' HB3' ' HB3' ' A' ' 146' ' ' TRP . 11.6 Cg_endo -96.0 153.29 1.41 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.384 2.722 . . . . 73.109999999999999 114.149 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -60.51 128.38 88.1 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 114.653 -1.158 . . . . 71.439999999999998 109.53 168.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 11.2 Cg_exo -73.58 -173.79 1.45 Allowed 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 123.006 2.47 . . . . 74.319999999999993 113.31 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 74.1 mmtt -67.3 133.27 49.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.867 0.867 . . . . 73.099999999999994 109.523 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.482 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 13.5 ptt180 -86.49 -66.72 0.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.538 0.94 . . . . 62.43 113.538 -167.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.482 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 9.1 t30 -114.98 158.03 22.61 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.984 0.514 . . . . 64.549999999999997 111.323 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.91 114.62 41.09 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 108.115 -1.068 . . . . 71.25 108.115 166.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.56 123.12 12.87 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.018 2.478 . . . . 74.409999999999997 112.167 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 5.1 m -72.95 103.64 3.82 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.651 -0.704 . . . . 72.420000000000002 111.268 -167.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.488 HG21 ' HG2' ' A' ' 131' ' ' PRO . 25.0 t -93.39 127.92 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.261 -1.014 . . . . 75.209999999999994 108.261 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -104.44 111.18 23.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.426 -0.321 . . . . 71.099999999999994 110.331 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.84 -39.39 0.24 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 118.245 2.058 . . . . 43.310000000000002 118.245 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.3 123.55 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.818 1.044 . . . . 74.439999999999998 113.818 -157.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.1 t -82.04 129.31 64.84 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 106.01 -1.848 . . . . 70.299999999999997 106.01 157.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.371 1.74 0 C-N-CA 121.484 1.456 . . . . 73.129999999999995 113.957 -154.217 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 2.1 t90 . . . . . 0 CA--C 1.55 0.958 0 CA-C-O 121.506 0.669 . . . . 65.349999999999994 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.6 p-10 -63.98 -24.18 67.62 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.355 1.062 . . . . 71.010000000000005 110.236 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.5 m -67.34 3.04 1.37 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.871 1.269 . . . . 75.299999999999997 112.796 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.8 -40.28 83.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.401 1.08 . . . . 63.539999999999999 111.508 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 7.9 pt-20 -68.53 -39.14 81.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.829 0.452 . . . . 75.109999999999999 110.146 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.495 HD22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -81.12 -10.29 59.68 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.254 -0.884 . . . . 61.539999999999999 111.025 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.3 tp -62.78 -52.75 61.98 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.313 0.645 . . . . 73.140000000000001 110.122 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.9 mt -104.34 20.92 17.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.04 0.536 . . . . 72.010000000000005 110.624 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 122.94 0.496 . . . . 44.119999999999997 111.278 179.169 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 CA--C 1.554 1.13 0 CA-C-O 120.502 0.191 . . . . 73.420000000000002 110.767 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.2 tp -84.14 135.28 34.45 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.699 -0.625 . . . . 53.409999999999997 109.462 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -119.22 174.23 6.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.238 1.415 . . . . 75.349999999999994 109.734 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.62 139.41 35.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.959 1.303 . . . . 53.32 108.338 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.416 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -76.09 130.8 38.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.619 0.768 . . . . 23.420000000000002 109.344 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 136' ' ' THR . 72.0 mt -91.26 -26.91 18.77 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.395 0.678 . . . . 63.43 110.728 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.14 165.64 21.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.504 0.721 . . . . 75.019999999999996 110.362 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 3.4 m-20 -89.18 120.21 30.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.191 -0.913 . . . . 70.549999999999997 108.915 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.542 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.5 t80 -114.96 148.14 39.13 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.282 -1.007 . . . . 61.32 108.282 173.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.6 t -122.92 134.54 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.19 -1.041 . . . . 70.230000000000004 108.19 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.3 124.54 22.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.804 . . . . 74.450000000000003 111.573 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 p -141.32 18.56 2.24 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.076 0.95 . . . . 72.409999999999997 111.213 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.25 -179.28 24.08 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.944 -0.863 . . . . 44.439999999999998 110.944 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.93 -38.84 76.33 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.985 0.514 . . . . 64.200000000000003 111.516 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.511 HD21 ' HG2' ' A' ' 249' ' ' PRO . 27.0 p-10 -105.47 -3.19 22.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.977 0.511 . . . . 75.310000000000002 112.305 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.416 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 73.6 p -72.47 164.57 26.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.728 0.64 . . . . 72.340000000000003 112.728 -170.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.445 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 67.3 tp -147.18 136.31 22.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.022 0.529 . . . . 70.120000000000005 110.744 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.4 m -80.0 117.6 20.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.307 0.643 . . . . 42.020000000000003 110.615 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.658 HG22 HG21 ' A' ' 123' ' ' THR . 22.6 pt -117.72 157.04 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.167 0.587 . . . . 74.109999999999999 111.009 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.8 m -111.31 151.54 28.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.566 1.146 . . . . 75.200000000000003 109.064 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -60.05 125.62 24.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.231 0.612 . . . . 71.310000000000002 110.414 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.62 -7.23 82.41 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.611 . . . . 51.409999999999997 113.751 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -69.57 124.39 23.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.366 0.583 . . . . 71.129999999999995 111.058 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -73.86 134.94 43.35 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.348 -0.612 . . . . 54.039999999999999 109.348 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.662 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.0 159.05 44.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.8 0.84 . . . . 52.140000000000001 110.457 -175.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.509 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 56.7 ttm-85 -115.43 109.97 18.64 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.881 0.472 . . . . 72.439999999999998 110.578 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.695 HG13 ' HB1' ' A' ' 119' ' ' ALA . 25.5 t -70.61 112.18 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.56 0.695 . . . . 73.150000000000006 109.127 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.08 -41.83 58.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.042 -0.981 . . . . 70.140000000000001 108.364 175.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.77 158.33 16.79 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.843 0.714 . . . . 50.119999999999997 113.639 171.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.783 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 59.9 m-85 -88.16 164.89 15.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 70.209999999999994 111.666 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.7 -172.56 3.37 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.972 0.909 . . . . 70.25 111.162 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.24 -35.43 11.97 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 115.158 1.54 . . . . 73.540000000000006 115.158 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -110.5 -15.43 13.9 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.136 0.574 . . . . 74.299999999999997 111.791 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.783 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 87.97 30.19 18.26 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 114.631 0.613 . . . . 60.219999999999999 114.631 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.45 -38.05 17.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.516 0.658 . . . . 65.129999999999995 111.79 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 18.1 m95 -125.52 146.25 49.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.163 0.585 . . . . 74.129999999999995 110.559 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.695 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -129.72 136.5 49.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 74.129999999999995 110.927 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.728 ' HG2' HE21 ' A' ' 127' ' ' GLN . 27.1 tt0 -69.41 103.79 2.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.11 -1.07 . . . . 74.409999999999997 108.11 173.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.7 138.42 39.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.108 0.563 . . . . 54.219999999999999 111.135 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 61.3 tt0 -97.75 104.89 16.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.903 -1.147 . . . . 74.310000000000002 107.903 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 107' ' ' LEU . 68.5 p -111.09 172.07 7.1 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.753 0.821 . . . . 71.439999999999998 110.86 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -14.53 62.97 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 114.718 -1.128 . . . . 73.319999999999993 110.031 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.1 -26.66 30.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.18 0.992 . . . . 64.439999999999998 111.539 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 136.22 -158.68 24.07 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 120.158 -0.245 . . . . 75.019999999999996 112.533 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.728 HE21 ' HG2' ' A' ' 120' ' ' GLU . 66.5 tp60 -101.82 137.39 40.18 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.208 0.504 . . . . 74.010000000000005 111.377 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 165.9 162.67 17.76 Favored Glycine 0 C--N 1.347 1.143 0 C-N-CA 121.403 -0.427 . . . . 63.520000000000003 113.399 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 43.1 m95 -77.15 133.69 38.9 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.319 1.047 . . . . 70.510000000000005 112.19 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.3 m -136.28 146.32 55.64 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 125.108 1.363 . . . . 70.530000000000001 108.552 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 73.4 Cg_endo -76.06 150.05 33.25 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.1 1.867 . . . . 64.519999999999996 114.888 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -39.23 -49.06 1.87 Allowed 'General case' 0 C--N 1.366 1.308 0 C-N-CA 126.243 1.817 . . . . 61.299999999999997 113.516 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -79.22 -0.85 33.78 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.082 0.771 . . . . 73.219999999999999 113.082 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -98.76 -13.38 20.22 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.85 0.86 . . . . 74.519999999999996 111.487 170.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.73 177.25 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.26 1.024 . . . . 71.129999999999995 110.451 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.426 HG22 HD21 ' A' ' 88' ' ' LEU . 6.4 t -161.75 151.91 14.3 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 108.463 -0.939 . . . . 73.450000000000003 108.463 170.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.03 148.15 86.69 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.705 1.603 . . . . 61.310000000000002 111.679 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 36.9 t -71.27 -7.76 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-O 121.688 0.756 . . . . 62.210000000000001 109.893 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -75.45 -20.26 58.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.078 0.951 . . . . 71.209999999999994 111.746 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.5 p -91.83 174.41 7.35 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.448 0.699 . . . . 75.25 111.607 -172.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.28 -20.04 32.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 61.420000000000002 110.569 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.5 -19.13 65.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.086 0.955 . . . . 75.299999999999997 111.992 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -62.68 -21.43 65.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.499 0.72 . . . . 74.340000000000003 112.658 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -78.47 139.75 38.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.285 0.634 . . . . 75.420000000000002 110.143 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.9 p -59.65 -41.94 91.66 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.187 0.995 . . . . 61.399999999999999 111.906 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -67.01 -38.66 86.35 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.834 0.709 . . . . 72.439999999999998 112.229 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.5 118.51 20.71 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.179 -0.674 . . . . 74.140000000000001 109.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -112.63 -1.46 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.122 0.569 . . . . 73.530000000000001 112.273 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.55 -162.23 49.0 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 118.807 -0.996 . . . . 75.099999999999994 112.794 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.38 95.9 0.15 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.988 2.459 . . . . 71.329999999999998 112.721 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 82.3 t -119.93 149.72 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.996 1.318 . . . . 53.0 109.002 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 45.6 m -85.66 166.8 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.525 0.73 . . . . 54.240000000000002 110.598 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -60.04 -50.92 71.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.988 0.515 . . . . 73.150000000000006 110.975 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -58.24 -39.75 79.95 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.0 0.92 . . . . 74.430000000000007 111.7 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.4 75.48 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.907 -0.588 . . . . 73.319999999999993 110.801 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 159' ' ' LEU . . . -57.34 -39.21 75.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.585 0.707 . . . . 65.530000000000001 111.505 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -83.7 -19.04 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.254 -0.884 . . . . 73.5 111.971 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -24.69 43.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.839 0.745 . . . . 73.200000000000003 110.936 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.843 HD21 ' HA ' ' A' ' 239' ' ' ARG . 42.7 mt -69.77 -43.66 71.76 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.013 -0.994 . . . . 74.310000000000002 110.007 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.433 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 75.4 mt -94.8 22.77 6.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.844 -1.071 . . . . 70.209999999999994 112.285 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.7 p -74.23 -41.68 60.96 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.099 0.476 . . . . 75.239999999999995 110.152 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 p -111.99 15.06 20.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.183 0.993 . . . . 55.5 112.247 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.29 168.73 52.2 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 121.908 -0.187 . . . . 61.240000000000002 113.235 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 pt -101.8 -176.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.641 0.776 . . . . 65.299999999999997 111.056 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -63.31 125.35 23.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.459 -0.791 . . . . 74.319999999999993 109.853 172.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.438 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 90.56 10.79 63.08 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 119.313 -0.715 . . . . 30.140000000000001 113.181 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 68.4 m -82.17 116.01 21.53 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.364 1.082 . . . . 64.040000000000006 111.627 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 183' ' ' SER . 12.9 p90 -132.25 168.47 17.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.448 0.642 . . . . 73.530000000000001 111.494 -171.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.32 155.88 25.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.355 -1.293 . . . . 52.450000000000003 108.584 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.658 HG22 HG12 ' A' ' 182' ' ' ILE . 77.5 t -112.33 125.04 69.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.028 -1.101 . . . . 74.530000000000001 108.028 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.565 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 36.3 ptt85 -114.81 161.65 17.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.039 -1.097 . . . . 75.340000000000003 108.039 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 155.24 23.11 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.9 t -79.79 126.41 30.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.049 0.54 . . . . 75.209999999999994 109.794 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -63.42 -34.87 78.69 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 123.948 0.78 . . . . 41.329999999999998 110.265 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 p -82.01 -19.38 40.57 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.626 0.77 . . . . 63.119999999999997 111.989 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -143.86 98.78 5.21 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.901 0.48 . . . . 71.209999999999994 111.176 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.53 136.35 75.33 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.089 2.526 . . . . 74.219999999999999 112.638 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.33 -29.53 6.07 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.135 -0.484 . . . . 50.439999999999998 113.546 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -75.83 117.3 17.42 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.384 -0.599 . . . . 74.140000000000001 109.384 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -122.29 145.79 47.9 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.658 0.742 . . . . 73.310000000000002 110.288 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.1 m -132.49 144.52 50.51 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.523 -1.217 . . . . 71.450000000000003 108.291 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 170' ' ' VAL . 31.9 mt -99.68 148.56 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.787 -1.56 . . . . 72.109999999999999 106.787 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -123.9 108.71 12.73 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.336 -1.357 . . . . 62.039999999999999 107.336 172.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.438 HD11 ' HA2' ' A' ' 166' ' ' GLY . 67.3 tp -105.93 142.75 35.11 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.367 -0.605 . . . . 73.319999999999993 109.367 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.5 ttt85 -117.53 119.38 34.85 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.525 1.13 . . . . 73.329999999999998 109.486 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -140.97 136.27 32.01 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.061 1.344 . . . . 63.149999999999999 107.84 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 58.18 21.23 7.83 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.637 1.175 . . . . 74.329999999999998 111.62 -170.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.17 -9.5 74.73 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.185 0.434 . . . . 52.409999999999997 114.185 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 57.4 mtp85 -96.18 140.12 31.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.522 0.661 . . . . 75.219999999999999 110.177 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.15 108.42 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.691 0.796 . . . . 72.109999999999999 110.81 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.82 150.6 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.278 1.431 . . . . 74.549999999999997 108.51 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 86.0 m-70 -125.45 127.13 46.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.469 0.307 . . . . 72.120000000000005 110.174 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.41 ' HE1' HD21 ' A' ' 232' ' ' LEU . 5.9 m-85 -101.06 149.29 24.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.899 0.88 . . . . 74.439999999999998 109.287 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -97.99 117.25 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.708 -0.849 . . . . 72.349999999999994 108.708 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.7 mt -82.2 99.83 5.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.299 -1.371 . . . . 74.049999999999997 107.299 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -75.04 110.6 9.47 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.555 -1.276 . . . . 73.099999999999994 107.555 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.7 m -89.28 106.4 18.42 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.956 -0.757 . . . . 63.420000000000002 108.956 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.437 ' HB2' ' HE1' ' A' ' 204' ' ' TYR . . . -63.06 148.68 47.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.909 0.884 . . . . 75.049999999999997 110.743 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.3 p -65.5 -23.81 66.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.255 0.622 . . . . 73.319999999999993 112.13 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -78.24 -18.6 55.16 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.862 0.465 . . . . 72.439999999999998 110.986 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.61 14.77 12.06 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.869 -0.406 . . . . 62.310000000000002 114.012 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -92.15 139.0 31.07 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.779 0.789 . . . . 74.25 110.949 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.13 143.03 29.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.956 -1.128 . . . . 62.200000000000003 107.956 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.509 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.5 p90 -163.39 135.45 5.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.221 0.326 . . . . 74.019999999999996 111.675 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.423 HG23 HD11 ' A' ' 217' ' ' LEU . 87.4 t -82.94 -34.02 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.315 -0.995 . . . . 64.299999999999997 108.315 161.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 35.9 m -99.48 119.91 38.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.446 1.099 . . . . 71.549999999999997 110.344 -175.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.6 t -59.12 -34.15 71.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.805 1.242 . . . . 75.340000000000003 112.634 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.22 -2.86 58.85 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.968 0.907 . . . . 52.310000000000002 111.836 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 15.5 m -135.05 85.63 2.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.068 0.547 . . . . 73.319999999999993 109.527 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.509 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 43.5 mtt180 -93.59 120.49 33.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.929 0.891 . . . . 72.010000000000005 109.286 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -107.44 149.68 27.64 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.533 0.733 . . . . 74.450000000000003 109.351 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -62.36 -44.13 97.18 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.523 0.514 . . . . 70.420000000000002 110.161 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.4 p -125.68 160.5 29.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.637 0.732 . . . . 60.439999999999998 111.785 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.24 -25.92 68.27 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.728 -1.124 . . . . 71.200000000000003 109.317 171.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.13 86.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.039 0.936 . . . . 34.210000000000001 111.395 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -72.02 -30.71 65.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.131 -0.94 . . . . 74.049999999999997 111.346 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.423 HD11 HG23 ' A' ' 205' ' ' VAL . 14.8 tp -57.12 -55.49 34.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.306 0.379 . . . . 75.299999999999997 110.351 171.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.2 -41.96 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.752 0.658 . . . . 53.340000000000003 111.254 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -61.87 -55.1 33.24 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.452 0.47 . . . . 75.420000000000002 111.445 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -61.52 -38.08 86.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.443 0.697 . . . . 73.230000000000004 110.866 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.76 ' HB3' HD11 ' A' ' 228' ' ' LEU . 18.6 m170 -88.65 -6.41 57.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.793 -0.639 . . . . 73.510000000000005 112.386 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.0 p -91.07 -31.89 16.09 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 110.22 -0.289 . . . . 62.240000000000002 110.22 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 40.4 p -76.71 -40.63 48.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.206 -0.452 . . . . 72.439999999999998 111.351 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.644 HG23 ' HB2' ' A' ' 226' ' ' ASP . 18.3 m -134.84 158.45 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.331 0.652 . . . . 71.540000000000006 111.623 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.45 14.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 126.932 2.093 . . . . 71.219999999999999 114.424 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.644 ' HB2' HG23 ' A' ' 224' ' ' VAL . 36.4 t70 -42.92 32.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.78 1 C-N-CA 132.07 4.148 . . . . 73.319999999999993 119.761 -155.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.22 -1.8 9.71 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.22 -1.55 . . . . 71.299999999999997 112.112 -168.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.76 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.2 mt -92.07 162.8 14.21 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.691 1.196 . . . . 74.040000000000006 109.434 168.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.49 -42.57 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 121.046 0.45 . . . . 74.340000000000003 110.42 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -161.36 -179.23 7.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.106 0.962 . . . . 63.329999999999998 109.127 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 49.0 p -70.08 143.99 52.27 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.471 0.708 . . . . 65.140000000000001 112.346 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.41 HD21 ' HE1' ' A' ' 193' ' ' TYR . 49.3 mt -72.21 145.66 47.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.649 -1.241 . . . . 72.340000000000003 107.649 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -147.26 -78.66 0.16 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.323 0.965 . . . . 73.129999999999995 111.534 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 167' ' ' SER . 11.5 t80 -83.41 124.06 76.17 Favored Pre-proline 0 C--O 1.208 -1.09 0 C-N-CA 124.284 1.034 . . . . 73.129999999999995 108.445 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -86.6 139.3 5.69 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.291 1.994 . . . . 71.400000000000006 112.122 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.25 151.9 90.14 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.408 0.683 . . . . 74.219999999999999 109.778 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.06 176.83 9.52 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.508 2.139 . . . . 72.209999999999994 112.118 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.62 154.57 40.2 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.129 0.572 . . . . 72.329999999999998 110.285 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.843 ' HA ' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -69.9 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.723 1.008 . . . . 74.109999999999999 113.723 -158.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.447 ' H ' ' HG2' ' A' ' 239' ' ' ARG . 65.3 t30 -120.45 159.33 25.34 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.012 -1.055 . . . . 75.200000000000003 108.561 159.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.458 ' NZ ' ' HB2' ' A' ' 90' ' ' ASP . 98.6 mttt -73.43 115.64 43.33 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 107.686 -1.227 . . . . 65.219999999999999 107.686 160.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.49 127.44 21.83 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.042 2.495 . . . . 53.43 112.587 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 26.0 m -80.49 116.43 20.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.84 -0.43 . . . . 52.409999999999997 109.84 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.37 111.89 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.643 0.777 . . . . 72.409999999999997 108.964 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.9 112.8 20.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.541 -0.299 . . . . 75.140000000000001 110.692 -166.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 70.47 -41.51 0.51 Allowed Glycine 0 CA--C 1.542 1.737 0 N-CA-C 117.436 1.735 . . . . 71.239999999999995 117.436 163.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.61 135.4 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 117.687 0.743 . . . . 64.150000000000006 112.667 -157.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -82.8 130.08 59.47 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 105.757 -1.942 . . . . 73.010000000000005 105.757 157.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.511 ' HG2' HD21 ' A' ' 97' ' ' ASN . 12.2 Cg_exo . . . . . 0 C--N 1.365 1.419 0 C-N-CA 121.575 1.516 . . . . 54.130000000000003 113.829 -153.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.799 ' HB2' ' HG3' ' A' ' 235' ' ' PRO . 11.6 t90 . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 121.949 0.881 . . . . 73.319999999999993 109.021 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.7 p-10 -64.53 -24.18 67.52 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.367 -0.833 . . . . 64.439999999999998 110.012 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.7 p -69.69 3.67 2.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.863 1.265 . . . . 45.450000000000003 112.775 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.6 -20.96 66.13 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.816 0.446 . . . . 62.32 110.664 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 14.4 pt-20 -63.33 -42.46 98.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.056 0.542 . . . . 75.239999999999995 109.816 168.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -72.39 -16.5 61.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.469 1.108 . . . . 71.109999999999999 110.924 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 tp -63.53 -51.4 65.61 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.675 0.79 . . . . 62.109999999999999 110.632 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.6 mt -103.13 4.17 36.68 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 111.41 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 122.667 0.387 . . . . 60.43 110.93 175.183 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 t30 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 121.242 0.544 . . . . 71.409999999999997 110.069 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.6 tp -79.4 139.12 37.81 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.327 -0.397 . . . . 71.219999999999999 110.033 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.2 m-85 -118.62 171.54 8.12 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.729 1.212 . . . . 73.200000000000003 109.723 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.35 131.48 22.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.502 1.121 . . . . 53.109999999999999 109.406 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.74 114.11 6.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.542 1.137 . . . . 65.5 109.889 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 78.0 mt -73.92 -32.63 63.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.516 0.726 . . . . 62.310000000000002 110.496 173.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.53 163.78 21.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.606 -1.179 . . . . 61.140000000000001 108.69 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.15 149.69 23.75 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.803 -0.814 . . . . 75.200000000000003 108.803 166.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.624 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.2 t80 -132.96 141.52 48.38 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.809 -1.182 . . . . 63.32 107.809 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.24 133.47 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.321 -0.992 . . . . 72.329999999999998 108.321 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.25 132.51 53.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.51 0.724 . . . . 52.229999999999997 111.108 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 p -129.39 -41.12 1.4 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.186 0.995 . . . . 65.409999999999997 111.065 -172.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.88 23.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.307 -0.406 . . . . 55.439999999999998 112.524 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.26 -43.57 10.88 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.638 0.719 . . . . 65.230000000000004 111.067 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.472 HD21 ' HD2' ' A' ' 249' ' ' PRO . 6.6 p30 -108.24 10.84 27.73 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.613 0.765 . . . . 70.230000000000004 112.123 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.0 p -73.14 150.35 42.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.347 0.659 . . . . 74.200000000000003 110.122 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 128' ' ' GLY . 58.1 tp -130.32 127.73 40.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.089 0.556 . . . . 64.420000000000002 110.824 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -74.27 133.14 42.62 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.221 0.609 . . . . 71.230000000000004 111.619 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.624 HG12 ' HB3' ' A' ' 91' ' ' PHE . 11.4 pt -130.28 166.84 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.208 1.003 . . . . 74.140000000000001 111.1 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 26.9 m -109.84 155.89 21.08 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.577 1.151 . . . . 74.430000000000007 110.329 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -58.95 127.84 34.24 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.162 0.585 . . . . 64.519999999999996 110.196 171.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.83 3.88 84.68 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.388 0.515 . . . . 45.43 114.388 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' HB ' ' A' ' 123' ' ' THR . 38.1 tt0 -73.45 142.48 46.86 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.053 0.541 . . . . 64.420000000000002 110.516 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -93.1 132.28 37.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.454 -0.573 . . . . 72.439999999999998 109.454 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -143.46 163.44 33.11 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.012 0.925 . . . . 72.450000000000003 110.511 -177.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -123.79 108.05 12.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.771 0.428 . . . . 72.409999999999997 110.345 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.658 HG13 ' HB1' ' A' ' 119' ' ' ALA . 41.3 t -73.65 117.86 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.197 0.522 . . . . 72.430000000000007 110.47 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.8 mt -84.08 -60.3 2.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.822 -1.081 . . . . 73.549999999999997 109.079 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.4 141.1 9.01 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 120.853 -0.689 . . . . 42.219999999999999 112.942 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.64 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 20.5 m-85 -88.41 154.54 20.29 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.413 0.685 . . . . 65.140000000000001 109.781 171.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -78.54 -174.9 4.06 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.527 -1.215 . . . . 71.420000000000002 111.857 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -50.01 -31.65 13.36 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.185 1.394 . . . . 71.25 114.253 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -112.8 3.08 16.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.836 0.68 . . . . 60.149999999999999 112.836 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.49 19.65 74.74 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.974 0.75 . . . . 73.549999999999997 114.974 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.46 -12.13 18.79 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.453 0.701 . . . . 65.049999999999997 112.806 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 44.7 m95 -134.34 144.87 48.52 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.535 0.734 . . . . 72.010000000000005 110.248 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -132.98 129.7 38.55 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.716 0.807 . . . . 63.439999999999998 110.962 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.83 97.43 2.24 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 106.814 -1.55 . . . . 74.239999999999995 106.814 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.08 144.49 33.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.393 0.677 . . . . 43.119999999999997 111.434 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -93.76 103.37 15.51 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.78 -1.192 . . . . 62.439999999999998 107.78 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 107' ' ' LEU . 38.5 p -97.36 174.56 6.63 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.003 0.921 . . . . 74.129999999999995 109.979 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -63.83 -23.21 67.26 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.189 0.518 . . . . 74.5 110.187 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -79.19 -29.35 42.87 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.598 1.159 . . . . 74.209999999999994 111.036 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 139.86 -170.03 24.43 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 112.282 -0.327 . . . . 50.32 112.282 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -97.33 135.93 38.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.463 0.632 . . . . 63.200000000000003 111.224 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.463 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 170.6 172.28 36.79 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.328 -0.709 . . . . 63.149999999999999 111.328 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -85.19 124.02 31.35 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.344 0.572 . . . . 70.5 112.076 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.52 HG23 HD13 ' A' ' 135' ' ' ILE . 17.2 m -126.99 143.39 46.71 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.09 1.356 . . . . 72.510000000000005 108.445 170.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 66.2 Cg_endo -88.13 149.61 6.82 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.257 1.971 . . . . 73.219999999999999 115.33 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 m -46.67 -28.09 1.37 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.607 1.963 . . . . 70.129999999999995 115.592 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.572 HD21 HG22 ' A' ' 244' ' ' VAL . 32.0 p-10 -81.95 -16.32 50.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.478 0.311 . . . . 73.349999999999994 111.769 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 30.1 m-85 -94.48 -23.53 17.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 72.109999999999999 111.688 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.52 HD13 HG23 ' A' ' 130' ' ' VAL . 20.4 pt -123.56 168.01 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.071 0.549 . . . . 72.099999999999994 112.282 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.3 t -159.75 151.3 16.54 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.964 0.906 . . . . 72.349999999999994 108.643 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.3 Cg_endo -60.7 147.24 95.53 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 121.745 1.63 . . . . 73.230000000000004 111.724 174.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.29 -11.56 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.738 0.78 . . . . 52.25 110.767 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -80.26 -13.53 59.13 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.146 0.578 . . . . 73.099999999999994 111.648 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.2 p -89.16 165.16 14.65 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.253 0.621 . . . . 44.43 110.973 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.9 mt -80.35 -21.35 42.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.804 0.842 . . . . 60.140000000000001 110.817 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.83 -17.16 62.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.843 1.257 . . . . 74.409999999999997 111.68 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.417 ' HA ' HD21 ' A' ' 88' ' ' LEU . 22.0 pttm -61.54 -20.22 63.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.957 0.903 . . . . 51.439999999999998 112.976 176.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.47 144.55 25.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.167 0.587 . . . . 70.430000000000007 111.276 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -60.95 -41.5 96.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.596 1.158 . . . . 72.040000000000006 111.869 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -67.26 -33.07 74.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.649 0.779 . . . . 72.209999999999994 112.556 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -77.59 116.31 18.05 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.69 -0.856 . . . . 73.209999999999994 108.69 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.405 ' ND1' HD13 ' A' ' 159' ' ' LEU . 33.0 m170 -113.33 -2.71 13.94 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.36 0.504 . . . . 50.140000000000001 112.36 -175.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.9 -136.25 25.43 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 118.543 -1.143 . . . . 72.519999999999996 113.091 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.79 90.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.53 2.82 . . . . 54.229999999999997 112.71 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.646 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.6 t -132.31 133.73 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 74.209999999999994 108.963 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -89.79 175.53 7.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.862 0.865 . . . . 73.409999999999997 109.87 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 2.6 tmt_? -58.75 -45.92 88.6 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.76 0.424 . . . . 64.150000000000006 110.261 175.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -63.44 -35.12 79.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.714 0.805 . . . . 72.209999999999994 111.547 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.83 -30.34 62.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.058 -0.519 . . . . 65.310000000000002 110.95 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.7 71.23 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.009 0.524 . . . . 73.140000000000001 111.063 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 12.0 mm-40 -62.86 -48.28 79.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.251 0.62 . . . . 70.340000000000003 109.503 170.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.54 -41.21 69.45 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.077 1.751 . . . . 63.119999999999997 111.669 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 239' ' ' ARG . 59.0 mt -68.1 -55.43 12.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.036 0.934 . . . . 65.319999999999993 111.684 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -84.89 16.02 3.62 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.576 0.584 . . . . 71.530000000000001 112.576 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.6 p -65.0 -40.34 94.8 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.405 0.621 . . . . 74.150000000000006 110.397 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.9 p -98.29 18.89 15.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.34 1.056 . . . . 54.409999999999997 111.0 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.46 162.97 32.31 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.243 -0.435 . . . . 73.299999999999997 112.56 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.1 -176.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.39 1.076 . . . . 54.420000000000002 110.039 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -67.47 123.2 19.75 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.422 -0.585 . . . . 74.340000000000003 109.422 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.78 5.98 57.36 Favored Glycine 0 C--O 1.25 1.155 0 CA-C-O 119.555 -0.581 . . . . 75.299999999999997 113.187 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 52.6 m -83.88 131.69 34.85 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 119.188 -0.434 . . . . 71.329999999999998 110.5 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.58 168.07 20.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.409 0.623 . . . . 65.340000000000003 111.557 -172.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.16 158.72 27.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 114.326 -1.306 . . . . 74.140000000000001 108.979 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.594 HG22 HG12 ' A' ' 182' ' ' ILE . 98.9 t -119.31 137.69 52.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 N-CA-C 108.338 -0.986 . . . . 72.519999999999996 108.338 168.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.646 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 0.4 OUTLIER -122.26 146.86 46.89 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.009 -0.996 . . . . 63.329999999999998 109.634 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.1 tp10 -97.15 139.64 32.84 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.005 1.322 . . . . 71.310000000000002 108.207 164.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.4 t -83.82 123.14 29.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 72.519999999999996 109.093 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -81.88 -26.55 34.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.28 0.562 . . . . 65.239999999999995 109.799 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.8 m -64.49 -39.12 93.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.281 1.033 . . . . 71.409999999999997 110.213 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 47.5 m -137.51 91.3 14.19 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.035 -1.098 . . . . 54.549999999999997 108.035 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.68 134.38 60.31 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.98 2.453 . . . . 63.140000000000001 112.679 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.06 -27.23 21.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.483 -0.78 . . . . 24.309999999999999 112.549 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -85.22 116.9 23.84 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.538 -0.912 . . . . 64.319999999999993 108.538 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 99.4 mtt180 -123.38 159.5 28.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.477 0.656 . . . . 63.009999999999998 111.668 -170.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.444 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 18.8 m -149.0 152.51 36.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.914 -1.039 . . . . 71.120000000000005 109.516 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.594 HG12 HG22 ' A' ' 170' ' ' VAL . 25.3 mt -102.72 149.08 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.389 -1.337 . . . . 72.400000000000006 107.389 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.2 m -126.43 114.6 18.39 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.311 -0.996 . . . . 52.200000000000003 108.311 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.7 tp -113.03 113.5 25.54 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.088 0.404 . . . . 73.040000000000006 109.911 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.435 ' HE ' ' HA2' ' A' ' 188' ' ' GLY . 44.4 ttt180 -77.82 115.3 17.46 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.324 0.583 . . . . 72.25 110.013 166.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -139.03 144.65 38.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.613 1.565 . . . . 61.219999999999999 107.361 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 58.3 21.07 7.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.04 0.936 . . . . 75.209999999999994 111.919 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.435 ' HA2' ' HE ' ' A' ' 185' ' ' ARG . . . 82.82 -0.37 89.62 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 119.418 -0.657 . . . . 43.149999999999999 114.535 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 55.8 mtp180 -115.36 150.42 36.35 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 117.893 0.846 . . . . 75.010000000000005 109.672 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 62.0 t -100.82 118.94 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.146 0.578 . . . . 73.519999999999996 110.541 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -108.21 117.47 34.23 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.184 0.993 . . . . 71.109999999999999 108.634 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -91.42 122.32 33.91 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.022 0.529 . . . . 75.510000000000005 110.503 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.488 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.6 m-85 -94.36 149.08 21.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.43 1.092 . . . . 74.209999999999994 108.291 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -101.21 127.5 47.75 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.087 -0.708 . . . . 73.120000000000005 109.087 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.51 101.05 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.83 -1.174 . . . . 71.209999999999994 107.83 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -88.11 144.51 26.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.934 1.294 . . . . 73.230000000000004 109.062 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -111.46 116.86 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.55 -0.537 . . . . 75.010000000000005 109.55 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.34 168.15 13.09 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.715 0.806 . . . . 71.129999999999995 110.652 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.6 m -62.81 -28.02 69.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.931 0.892 . . . . 70.530000000000001 112.368 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -90.19 -0.04 57.42 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.063 0.945 . . . . 75.209999999999994 111.969 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 92.09 12.74 58.53 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 114.081 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -83.23 128.09 34.2 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.453 0.627 . . . . 73.450000000000003 111.016 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -81.45 148.14 29.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.648 0.779 . . . . 75.439999999999998 109.288 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 47.3 p90 -168.21 147.11 4.51 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.361 0.413 . . . . 64.319999999999993 111.115 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.522 HG23 HD11 ' A' ' 217' ' ' LEU . 66.0 t -89.65 -41.05 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.38 -0.97 . . . . 74.400000000000006 108.38 164.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 46.6 m -104.94 130.17 53.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.091 0.956 . . . . 65.400000000000006 110.029 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.5 t -66.03 -20.59 66.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 73.510000000000005 112.959 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -76.87 -28.64 55.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.615 0.766 . . . . 73.019999999999996 110.666 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.4 m -124.6 98.09 5.58 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.233 0.613 . . . . 60.32 110.137 -172.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.4 mtt180 -112.08 144.36 41.58 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.973 0.909 . . . . 71.420000000000002 109.284 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.95 151.7 52.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.773 0.829 . . . . 65.430000000000007 108.985 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.33 -40.6 77.49 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.988 -0.375 . . . . 72.140000000000001 109.988 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -121.42 160.69 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.042 0.925 . . . . 64.230000000000004 112.353 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.469 HD11 HG11 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -66.8 -27.74 67.81 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.714 -1.584 . . . . 72.549999999999997 109.431 171.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.76 96.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.492 0.717 . . . . 44.43 110.782 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -68.78 -38.78 80.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.068 0.947 . . . . 65.129999999999995 111.165 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.522 HD11 HG23 ' A' ' 205' ' ' VAL . 16.6 tp -55.12 -56.9 14.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.037 0.535 . . . . 65.439999999999998 110.712 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.62 -38.22 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.545 0.738 . . . . 73.040000000000006 111.774 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -61.37 -57.96 10.17 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.784 0.326 . . . . 75.129999999999995 111.177 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -64.14 -28.15 69.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.805 -0.634 . . . . 75.099999999999994 111.028 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.673 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.6 m170 -91.13 -10.85 40.41 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.88 0.472 . . . . 62.149999999999999 112.186 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 98.3 p -87.62 -29.19 21.4 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 110.181 -0.303 . . . . 70.25 110.181 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 59.0 p -77.27 -50.38 12.99 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.021 0.528 . . . . 74.329999999999998 110.74 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.614 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.7 m -126.4 157.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 121.667 0.746 . . . . 62.030000000000001 111.942 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.63 17.74 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 127.552 2.341 . . . . 74.310000000000002 114.538 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.614 ' HB2' HG23 ' A' ' 224' ' ' VAL . 32.0 t70 -42.47 28.66 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.581 1 C-N-CA 132.619 4.368 . . . . 63.049999999999997 119.497 -152.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.11 -5.4 9.55 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 119.835 -1.79 . . . . 42.450000000000003 112.169 -165.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -89.62 160.87 16.43 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.831 1.252 . . . . 41.32 109.792 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.07 -34.35 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 116.272 -0.422 . . . . 73.200000000000003 110.855 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.8 t -162.3 178.49 8.65 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.865 0.866 . . . . 73.209999999999994 109.796 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 50.1 p -73.07 142.39 47.59 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.873 0.469 . . . . 71.109999999999999 111.184 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.488 HD21 ' HE1' ' A' ' 193' ' ' TYR . 46.8 mt -73.36 134.74 44.19 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.474 -0.935 . . . . 70.239999999999995 108.474 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -140.26 -68.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 119.982 1.264 . . . . 73.430000000000007 112.508 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 167' ' ' SER . 16.6 t80 -80.1 120.82 80.89 Favored Pre-proline 0 C--O 1.212 -0.915 0 N-CA-C 107.861 -1.162 . . . . 74.340000000000003 107.861 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.799 ' HG3' ' HB2' ' A' ' 67' ' ' TRP . 58.5 Cg_endo -86.69 144.02 7.42 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.012 1.808 . . . . 62.140000000000001 112.736 173.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.54 149.09 80.85 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 108.878 -0.786 . . . . 72.530000000000001 108.878 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -88.26 174.59 4.34 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.359 2.039 . . . . 71.239999999999995 111.661 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 75.6 mmtt -59.57 138.1 57.82 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.127 -0.694 . . . . 74.329999999999998 109.127 175.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.605 ' HB3' HD21 ' A' ' 159' ' ' LEU . 15.9 ptt180 -62.69 -67.4 0.42 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.758 1.021 . . . . 71.340000000000003 113.758 -157.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.595 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 7.9 t30 -119.03 165.19 14.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.844 0.747 . . . . 62.43 110.004 164.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 82.4 mttt -65.27 136.19 96.36 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 110.16 -0.311 . . . . 63.109999999999999 110.16 163.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 7.4 Cg_exo -72.58 126.96 11.96 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.945 2.43 . . . . 62.229999999999997 112.901 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 99.1 m -84.6 124.28 31.26 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.833 -0.802 . . . . 74.319999999999993 108.833 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.572 HG22 HD21 ' A' ' 133' ' ' ASN . 4.3 t -99.84 139.21 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.392 -0.966 . . . . 72.409999999999997 108.392 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.3 114.82 28.98 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.712 0.405 . . . . 74.230000000000004 111.822 -161.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.62 62.19 Favored Glycine 0 C--N 1.362 1.997 0 N-CA-C 115.827 1.091 . . . . 64.200000000000003 115.827 163.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.456 HG21 ' NE1' ' A' ' 118' ' ' TRP . 9.3 p -105.6 130.06 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 114.605 1.335 . . . . 63.229999999999997 114.605 -161.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.0 m -86.42 118.89 71.03 Favored Pre-proline 0 N--CA 1.48 1.066 0 N-CA-C 105.236 -2.135 . . . . 73.120000000000005 105.236 148.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.472 ' HD2' HD21 ' A' ' 97' ' ' ASN . 82.9 Cg_exo . . . . . 0 C--N 1.385 2.476 0 C-N-CA 122.115 1.877 . . . . 61.229999999999997 113.97 -162.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 9.3 t90 . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 121.403 0.62 . . . . 71.010000000000005 111.344 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -81.45 -20.94 39.24 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.664 -0.698 . . . . 72.209999999999994 110.538 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.8 p -73.21 1.03 10.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.243 0.617 . . . . 75.219999999999999 112.1 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -71.55 -18.9 62.23 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.37 0.668 . . . . 70.230000000000004 111.431 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.87 -32.92 71.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.614 0.721 . . . . 64.450000000000003 110.678 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -85.9 -9.09 57.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.701 -1.136 . . . . 73.019999999999996 110.978 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 215' ' ' ALA . 37.7 tp -70.57 -46.4 63.57 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.467 0.707 . . . . 60.329999999999998 109.457 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.91 52.22 1.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.439 0.638 . . . . 74.010000000000005 110.076 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.546 0 CA-C-N 115.245 -0.889 . . . . 72.400000000000006 109.972 175.336 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 p30 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.528 0.204 . . . . 73.0 111.109 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.53 139.17 44.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 74.140000000000001 108.676 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 11.3 m-85 -118.97 172.95 7.18 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.008 1.323 . . . . 63.119999999999997 109.928 -176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.94 141.54 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 125.246 1.418 . . . . 72.019999999999996 108.985 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -78.33 129.57 35.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.35 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.487 HD21 ' HA ' ' A' ' 143' ' ' LYS . 82.4 mt -87.25 -26.54 23.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.14 0.976 . . . . 63.409999999999997 112.483 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.2 m-85 -134.24 153.19 52.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.011 0.524 . . . . 62.310000000000002 110.227 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.33 119.11 21.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.091 -0.707 . . . . 71.200000000000003 109.091 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.559 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.5 t80 -117.62 126.14 52.0 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.388 -0.967 . . . . 74.400000000000006 108.388 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.45 133.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.857 -1.164 . . . . 54.310000000000002 107.857 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.66 116.46 14.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.719 0.408 . . . . 71.310000000000002 111.304 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.9 p -115.77 77.22 1.07 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.637 0.775 . . . . 73.549999999999997 108.941 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 140.58 -175.89 21.77 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.41 -0.814 . . . . 72.040000000000006 111.535 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -89.31 -42.03 11.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.407 0.683 . . . . 70.040000000000006 112.031 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.6 -26.73 60.94 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.705 0.802 . . . . 72.140000000000001 110.571 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 77.8 p -72.7 143.19 48.15 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.229 0.611 . . . . 64.340000000000003 110.241 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 128' ' ' GLY . 56.1 tp -132.55 132.05 42.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.195 0.598 . . . . 44.030000000000001 109.932 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.3 m -70.81 130.03 40.63 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.468 0.707 . . . . 70.109999999999999 110.914 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 91' ' ' PHE . 23.3 pt -133.6 150.26 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.773 0.829 . . . . 74.439999999999998 110.313 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -102.45 146.82 27.54 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.942 0.897 . . . . 70.239999999999995 109.319 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -67.94 114.37 6.44 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.542 -0.54 . . . . 74.430000000000007 109.542 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.58 -9.62 32.65 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 123.327 0.489 . . . . 15.43 112.382 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 37.5 tt0 -77.9 137.89 38.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.972 0.909 . . . . 71.329999999999998 111.334 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.43 133.39 35.94 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.432 0.693 . . . . 74.239999999999995 110.2 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.6 OUTLIER -149.08 161.59 41.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.667 1.187 . . . . 61.43 110.117 -174.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -120.34 118.74 31.17 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.88 -0.513 . . . . 72.099999999999994 110.256 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.635 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.5 t -73.35 121.34 23.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.56 0.695 . . . . 71.109999999999999 110.02 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 122' ' ' GLN . 23.6 mt -84.58 -51.95 6.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.967 -1.469 . . . . 64.319999999999993 108.874 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.95 149.39 12.35 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.883 -0.599 . . . . 75.209999999999994 112.784 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.55 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 51.6 m-85 -85.3 168.26 14.85 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.399 0.68 . . . . 73.329999999999998 110.605 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -82.21 -172.87 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.379 -0.828 . . . . 41.450000000000003 109.842 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -53.84 -42.32 68.38 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.836 0.854 . . . . 74.430000000000007 112.945 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -112.43 13.6 20.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.933 0.716 . . . . 44.210000000000001 112.933 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.8 21.07 76.45 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 115.685 1.034 . . . . 62.100000000000001 115.685 170.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -77.28 -54.5 6.4 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.611 0.706 . . . . 75.219999999999999 110.571 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.796 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 20.4 m95 -110.95 152.9 26.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.809 0.844 . . . . 70.340000000000003 111.55 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -129.53 140.46 51.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.688 1.195 . . . . 75.209999999999994 109.981 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 38.4 tt0 -75.82 130.04 37.96 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.956 -1.127 . . . . 72.219999999999999 107.956 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.34 144.55 44.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.526 0.731 . . . . 70.230000000000004 110.003 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.428 ' HG3' HD21 ' A' ' 110' ' ' LEU . 47.8 mt-30 -96.51 107.8 20.27 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.763 -1.199 . . . . 72.349999999999994 107.763 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 107' ' ' LEU . 34.6 p -106.42 -177.04 3.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.111 0.964 . . . . 73.430000000000007 111.395 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -71.83 -10.42 59.75 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.504 -0.771 . . . . 71.040000000000006 110.828 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -101.44 16.42 25.7 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.52 1.128 . . . . 63.439999999999998 110.585 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.79 -122.68 7.06 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.218 -0.768 . . . . 74.120000000000005 112.044 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.83 152.45 47.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 118.032 0.916 . . . . 72.209999999999994 110.849 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.496 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 153.8 172.55 21.99 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 111.575 -0.61 . . . . 55.399999999999999 111.575 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 66.0 m95 -80.15 131.81 35.8 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.225 0.61 . . . . 70.400000000000006 112.561 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.426 HG23 HD13 ' A' ' 135' ' ' ILE . 34.3 m -136.8 141.89 36.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 125.645 1.578 . . . . 74.129999999999995 109.215 168.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.796 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.1 Cg_endo -77.92 151.26 27.5 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.438 2.092 . . . . 73.230000000000004 115.284 -172.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -36.63 -50.54 0.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.628 1.971 . . . . 60.32 113.856 170.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -74.22 -7.96 54.53 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.417 0.687 . . . . 52.530000000000001 112.352 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.416 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 13.6 m-85 -104.03 -4.92 22.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.88 0.872 . . . . 63.210000000000001 112.118 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 130' ' ' VAL . 6.3 pt -135.24 168.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 124.003 0.921 . . . . 52.210000000000001 111.826 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.9 t -163.54 155.98 15.46 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 108.334 -0.987 . . . . 52.210000000000001 108.334 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 51.1 Cg_exo -56.55 151.77 44.37 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.108 1.872 . . . . 63.340000000000003 113.029 171.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.51 -5.66 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.166 0.507 . . . . 73.150000000000006 110.209 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.4 -20.21 23.07 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.625 -0.672 . . . . 74.319999999999993 110.881 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.1 p -80.9 172.49 13.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.328 0.585 . . . . 63.200000000000003 111.742 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 214' ' ' LEU . 61.5 mt -84.67 -25.02 28.73 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.785 0.834 . . . . 75.120000000000005 111.291 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.5 -24.01 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.474 1.11 . . . . 75.200000000000003 112.092 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.487 ' HA ' HD21 ' A' ' 88' ' ' LEU . 23.1 pttm -64.2 -26.16 68.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.39 0.676 . . . . 71.430000000000007 112.476 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -75.15 148.35 39.7 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.61 -0.723 . . . . 72.310000000000002 110.159 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 235' ' ' PRO . 16.9 m -60.52 -41.09 93.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.115 0.885 . . . . 63.439999999999998 111.552 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -67.18 -48.32 68.28 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.324 0.65 . . . . 74.400000000000006 112.549 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -75.66 112.53 12.12 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.538 -0.541 . . . . 75.109999999999999 109.538 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.448 ' HB2' HG21 ' A' ' 151' ' ' VAL . 32.6 m170 -102.39 -1.98 29.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.379 0.672 . . . . 71.400000000000006 111.612 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.34 -151.26 36.27 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 118.887 -0.952 . . . . 74.310000000000002 112.232 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.62 114.29 1.93 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.053 2.502 . . . . 62.439999999999998 111.407 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 54.0 t -142.72 137.85 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 125.398 1.479 . . . . 34.32 108.863 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.2 p -82.58 170.22 15.42 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.627 0.771 . . . . 52.299999999999997 110.95 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -59.7 -48.47 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.932 0.893 . . . . 73.349999999999994 110.389 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.35 -44.37 84.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.466 1.107 . . . . 71.129999999999995 111.465 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.78 76.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.973 -1.012 . . . . 51.439999999999998 111.518 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.77 82.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.447 0.699 . . . . 51.420000000000002 111.636 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -78.64 -25.49 45.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.565 -0.743 . . . . 74.409999999999997 112.709 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -24.88 59.71 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.943 0.792 . . . . 74.230000000000004 110.678 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.811 HD21 ' HA ' ' A' ' 239' ' ' ARG . 69.0 mt -71.92 -48.97 41.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.963 -1.017 . . . . 75.109999999999999 110.056 170.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.694 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 63.8 mt -89.23 19.49 4.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.044 -0.98 . . . . 75.120000000000005 112.642 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.3 p -90.42 -34.11 15.76 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.091 -1.077 . . . . 41.32 108.091 157.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.5 m -92.05 2.49 56.53 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.949 1.299 . . . . 70.150000000000006 111.892 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.1 -178.07 40.43 Favored Glycine 0 C--N 1.351 1.386 0 C-N-CA 122.771 0.224 . . . . 74.310000000000002 112.839 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -107.62 177.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.241 1.016 . . . . 63.329999999999998 110.31 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.05 131.26 46.09 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.84 6.42 72.5 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.079 -0.845 . . . . 73.310000000000002 113.695 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.5 m -81.39 136.18 35.7 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.217 1.008 . . . . 73.409999999999997 110.524 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -142.8 163.12 33.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.303 0.573 . . . . 72.420000000000002 111.218 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.64 145.32 22.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.83 -1.077 . . . . 75.5 108.666 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.645 HG22 HG12 ' A' ' 182' ' ' ILE . 83.2 t -103.48 126.73 57.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.947 -1.131 . . . . 54.32 107.947 169.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.63 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.5 ptt85 -115.71 160.98 19.35 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.177 0.991 . . . . 74.409999999999997 109.06 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -114.35 150.29 34.8 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.259 -1.756 . . . . 70.239999999999995 106.259 167.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -67.96 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.299 -0.63 . . . . 73.239999999999995 109.299 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.07 -31.33 71.74 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.822 0.849 . . . . 65.030000000000001 111.176 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.8 p -97.17 -5.31 37.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.135 0.974 . . . . 52.329999999999998 112.008 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -149.88 102.84 3.21 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 122.719 0.408 . . . . 63.409999999999997 111.189 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.23 146.81 70.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.551 2.167 . . . . 55.32 111.833 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.69 -28.36 3.55 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 123.069 0.366 . . . . 73.219999999999999 113.403 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.91 114.45 18.83 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -130.8 156.54 44.83 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.52 0.676 . . . . 75.5 111.12 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.8 m -147.2 150.86 35.73 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.833 -1.076 . . . . 71.239999999999995 109.241 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.645 HG12 HG22 ' A' ' 170' ' ' VAL . 22.6 mt -103.81 151.57 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.54 -1.281 . . . . 75.319999999999993 107.54 170.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -124.73 121.98 36.18 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.678 -1.23 . . . . 62.109999999999999 107.678 168.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.2 tp -115.65 114.36 24.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.36 0.664 . . . . 75.25 110.377 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.694 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 56.1 ttt85 -76.3 111.53 11.84 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.551 0.74 . . . . 51.149999999999999 109.033 164.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -139.44 139.58 37.11 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.991 1.316 . . . . 72.530000000000001 107.791 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 59.7 21.76 10.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.47 1.108 . . . . 51.109999999999999 111.782 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.75 -12.31 59.75 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.628 -0.714 . . . . 42.229999999999997 113.85 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -98.96 146.73 25.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.237 0.615 . . . . 73.150000000000006 110.211 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 115.24 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.08 0.552 . . . . 64.450000000000003 110.405 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -101.47 137.96 39.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.487 1.115 . . . . 63.100000000000001 108.807 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.54 120.04 41.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.889 0.376 . . . . 73.209999999999994 110.74 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.471 ' HE1' HD21 ' A' ' 232' ' ' LEU . 5.8 m-85 -95.59 152.31 18.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.224 1.009 . . . . 74.25 108.738 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -104.7 115.81 30.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.401 -0.592 . . . . 63.039999999999999 109.401 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -85.73 101.96 10.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.849 -1.167 . . . . 64.219999999999999 107.849 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -84.04 107.21 16.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.403 -1.271 . . . . 65.099999999999994 108.382 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -74.52 112.65 10.91 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.862 -1.162 . . . . 75.340000000000003 107.862 164.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.94 160.97 19.45 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.682 0.393 . . . . 54.130000000000003 110.704 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.0 p -62.43 -28.36 69.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.59 0.756 . . . . 74.340000000000003 111.07 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -89.76 -5.2 57.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.245 1.018 . . . . 72.319999999999993 111.128 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 106.58 -6.82 38.79 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 114.787 0.675 . . . . 63.240000000000002 114.787 168.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.13 127.47 32.68 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.887 0.843 . . . . 75.420000000000002 111.646 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.71 142.68 30.55 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.099 0.96 . . . . 73.209999999999994 109.051 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.617 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 39.9 p90 -164.71 139.74 5.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.214 0.321 . . . . 62.149999999999999 111.686 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.431 HG23 HD11 ' A' ' 217' ' ' LEU . 72.0 t -84.64 -37.84 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.559 -0.904 . . . . 73.329999999999998 108.559 163.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 24.2 m -101.23 126.91 48.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 109.771 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.9 t -69.7 -16.72 63.39 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.421 0.689 . . . . 65.430000000000007 112.129 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -92.66 -15.3 26.94 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.776 1.23 . . . . 73.219999999999999 110.99 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.2 m -133.93 95.46 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.746 0.818 . . . . 71.439999999999998 109.116 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.617 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -111.59 134.77 52.94 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.87 0.868 . . . . 73.200000000000003 109.527 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.471 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.2 OUTLIER -124.0 151.97 43.1 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.104 0.961 . . . . 72.109999999999999 108.538 -170.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -69.47 -34.2 74.01 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.601 0.563 . . . . 74.439999999999998 110.692 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.3 p -126.76 152.58 46.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.73 0.812 . . . . 73.420000000000002 111.718 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 141' ' ' LEU . 1.3 tt -63.84 -24.44 67.75 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 114.674 -1.148 . . . . 75.329999999999998 109.215 172.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 73' ' ' LEU . . . -59.16 -49.12 79.06 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.976 0.91 . . . . 52.340000000000003 111.275 173.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -65.33 -36.8 85.14 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.526 0.73 . . . . 75.299999999999997 111.325 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.431 HD11 HG23 ' A' ' 205' ' ' VAL . 15.9 tp -56.43 -56.76 17.22 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.495 0.497 . . . . 74.010000000000005 111.102 176.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.44 -41.5 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.317 0.647 . . . . 74.519999999999996 110.897 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.11 -52.25 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.741 0.416 . . . . 75.409999999999997 111.524 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -65.44 -40.61 93.46 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.203 0.601 . . . . 65.420000000000002 109.85 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.659 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.3 m-70 -86.6 -4.54 59.19 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.446 -0.797 . . . . 74.400000000000006 111.917 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 89.9 p -91.98 -35.31 14.05 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 110.181 -0.303 . . . . 64.519999999999996 110.181 167.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.2 m -68.4 -49.63 58.7 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.306 0.574 . . . . 71.409999999999997 110.216 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -128.18 161.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.006 -0.997 . . . . 72.329999999999998 110.161 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.47 19.61 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.377 1.871 . . . . 72.299999999999997 114.637 -174.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 224' ' ' VAL . 10.9 t70 -43.02 31.64 0.0 OUTLIER 'General case' 0 CA--C 1.598 2.8 1 C-N-CA 132.319 4.247 . . . . 75.25 120.203 -153.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 125.22 0.82 8.04 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 121.259 -0.9 . . . . 75.540000000000006 112.583 -167.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.0 mt -95.06 165.61 12.34 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 126.169 1.788 . . . . 51.420000000000002 110.025 168.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.99 -41.92 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-N 116.604 -0.271 . . . . 61.229999999999997 110.314 168.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -157.41 -179.78 8.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.104 0.561 . . . . 71.239999999999995 110.969 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.0 p -63.55 137.1 57.99 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.837 1.255 . . . . 71.219999999999999 112.243 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.471 HD21 ' HE1' ' A' ' 193' ' ' TYR . 75.7 mt -72.62 111.03 7.42 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.949 -0.76 . . . . 72.010000000000005 108.949 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -106.87 -44.54 4.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.948 0.722 . . . . 73.439999999999998 112.948 -163.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -130.84 125.24 21.22 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.15 0.98 . . . . 72.450000000000003 109.138 -169.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 145' ' ' SER . 76.1 Cg_endo -81.56 129.17 6.39 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 122.234 1.956 . . . . 71.409999999999997 112.121 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.36 151.94 85.62 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.852 0.861 . . . . 63.119999999999997 110.113 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.71 170.3 17.12 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.966 2.444 . . . . 74.25 112.593 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.9 154.02 35.08 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.044 0.937 . . . . 62.229999999999997 110.917 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.811 ' HA ' HD21 ' A' ' 159' ' ' LEU . 18.8 ptt180 -81.66 -60.34 2.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.541 0.941 . . . . 74.439999999999998 113.541 -168.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.562 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 64.9 t30 -108.69 153.92 22.75 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.701 0.8 . . . . 72.239999999999995 109.122 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 84.2 tttt -87.4 114.77 60.25 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.204 -1.776 . . . . 75.340000000000003 106.204 159.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 31.7 Cg_exo -62.21 144.39 95.52 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.373 2.715 . . . . 63.130000000000003 113.151 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.4 m -94.66 134.72 36.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.283 0.633 . . . . 74.040000000000006 110.86 -172.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -90.43 125.82 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 64.310000000000002 108.664 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -109.81 115.9 30.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.689 0.395 . . . . 75.129999999999995 110.988 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 75.94 -48.27 2.34 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 119.277 2.471 . . . . 50.119999999999997 119.277 155.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 31.2 m -99.48 144.1 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 114.366 1.247 . . . . 61.420000000000002 114.366 -157.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.0 t -82.34 115.83 60.16 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 104.405 -2.443 . . . . 72.340000000000003 104.405 149.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 11.3 Cg_endo . . . . . 0 N--CA 1.496 1.655 0 C-N-CA 122.94 2.427 . . . . 71.049999999999997 116.858 -152.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 3.3 t90 . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.917 0.865 . . . . 74.329999999999998 109.213 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 23.8 p-10 -65.43 -21.82 66.7 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.982 -1.008 . . . . 74.010000000000005 109.46 165.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.4 p -77.47 5.41 8.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.573 1.549 . . . . 73.120000000000005 112.782 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.55 -25.4 68.03 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.202 0.456 . . . . 75.030000000000001 111.167 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.5 pt-20 -62.63 -43.45 98.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.26 0.624 . . . . 71.420000000000002 110.502 168.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -82.47 -2.97 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.48 1.112 . . . . 73.0 111.331 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.0 tp -52.33 -49.18 64.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.005 0.922 . . . . 75.150000000000006 110.274 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.5 mt -95.58 83.26 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.779 -1.193 . . . . 71.010000000000005 107.779 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-N 115.098 -0.956 . . . . 74.430000000000007 113.054 -168.538 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.55 0.977 0 N-CA-C 110.862 -0.051 . . . . 75.409999999999997 110.862 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.609 HD21 ' HD3' ' A' ' 106' ' ' LYS . 35.7 tp -80.65 125.52 30.12 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.22 172.49 6.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.727 1.211 . . . . 73.329999999999998 108.178 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.57 137.22 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.276 1.031 . . . . 72.150000000000006 108.836 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.2 123.66 26.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.62 0.768 . . . . 65.040000000000006 109.968 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.405 HD22 ' HE3' ' A' ' 238' ' ' LYS . 95.1 mt -79.03 -32.86 45.13 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 53.210000000000001 110.982 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.576 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 55.9 m-85 -126.54 160.14 31.47 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.068 0.547 . . . . 71.230000000000004 110.792 -174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.7 120.38 23.93 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.477 -0.934 . . . . 70.530000000000001 108.477 166.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.729 ' HB3' HG12 ' A' ' 101' ' ' ILE . 93.8 t80 -113.14 132.53 55.42 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.71 -0.848 . . . . 65.329999999999998 108.71 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -93.92 128.59 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.328 -0.99 . . . . 71.150000000000006 108.328 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.3 114.56 6.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.408 -0.59 . . . . 50.219999999999999 109.408 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.9 p -98.69 -0.83 42.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.735 0.814 . . . . 73.310000000000002 111.431 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.9 166.26 24.92 Favored Glycine 0 C--O 1.244 0.742 0 N-CA-C 110.703 -0.959 . . . . 60.509999999999998 110.703 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -70.87 -39.16 73.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.103 0.478 . . . . 65.209999999999994 110.45 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -79.95 -24.53 40.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 62.219999999999999 111.809 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 p -76.25 166.7 23.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.678 0.391 . . . . 71.439999999999998 110.829 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -134.96 133.47 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.042 0.537 . . . . 74.409999999999997 110.629 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.6 m -74.61 141.75 44.66 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.793 0.837 . . . . 74.25 110.177 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.729 HG12 ' HB3' ' A' ' 91' ' ' PHE . 14.1 pt -128.5 156.51 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.174 0.59 . . . . 51.130000000000003 110.412 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 7.2 m -108.03 152.45 24.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.159 0.984 . . . . 74.340000000000003 109.938 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -60.04 110.69 1.26 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.636 0.774 . . . . 71.239999999999995 109.13 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.85 8.33 63.64 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.688 -0.507 . . . . 51.25 113.646 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.2 tt0 -76.23 120.89 22.13 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.478 0.639 . . . . 64.540000000000006 110.355 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.609 ' HD3' HD21 ' A' ' 84' ' ' LEU . 64.6 mttp -78.69 127.7 32.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.274 0.629 . . . . 52.32 109.474 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.422 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.45 150.68 40.89 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.364 1.066 . . . . 64.099999999999994 110.351 -171.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -100.99 118.86 37.83 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.056 0.543 . . . . 75.420000000000002 109.939 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.54 HG13 ' HB1' ' A' ' 119' ' ' ALA . 56.5 t -84.97 118.22 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.617 0.722 . . . . 71.209999999999994 109.862 172.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.63 HD12 ' HG3' ' A' ' 120' ' ' GLU . 18.9 mt -85.37 -13.99 47.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.142 1.377 . . . . 72.409999999999997 110.889 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.25 4.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.491 -1.043 . . . . 64.450000000000003 110.491 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 62.3 m-85 -88.71 173.28 8.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.543 0.687 . . . . 73.540000000000006 110.625 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -78.36 -179.53 6.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.663 -1.153 . . . . 74.310000000000002 110.844 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -45.72 -41.47 10.66 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.167 1.387 . . . . 71.25 113.766 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -114.24 12.07 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.612 0.968 . . . . 73.420000000000002 113.612 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.56 10.63 85.71 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 116.249 1.26 . . . . 74.109999999999999 116.249 168.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.85 -42.21 28.08 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.987 0.894 . . . . 71.329999999999998 111.655 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 21.1 m95 -119.66 157.38 28.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.707 0.803 . . . . 74.219999999999999 110.36 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.54 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.24 145.69 47.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.662 0.785 . . . . 72.329999999999998 110.361 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.63 ' HG3' HD12 ' A' ' 110' ' ' LEU . 13.2 tp10 -79.22 113.55 17.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.578 -1.638 . . . . 64.049999999999997 106.578 164.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -134.08 140.35 46.57 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.08 0.466 . . . . 63.030000000000001 111.233 -171.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -104.11 106.57 17.12 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.363 1.065 . . . . 63.240000000000002 108.705 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.667 HG21 HG22 ' A' ' 101' ' ' ILE . 50.8 p -97.98 175.1 6.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.2 1.0 . . . . 64.010000000000005 109.482 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -65.15 -22.72 66.96 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.84 -0.429 . . . . 74.040000000000006 109.84 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.32 -21.16 56.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.514 1.126 . . . . 74.409999999999997 111.802 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.07 -139.89 9.3 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.311 0.505 . . . . 52.43 113.589 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -130.37 127.86 40.24 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.982 0.913 . . . . 72.439999999999998 109.898 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 169.37 -173.18 43.71 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 123.256 0.347 . . . . 64.109999999999999 112.723 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -85.56 126.86 34.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.321 0.648 . . . . 74.319999999999993 112.339 -172.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -133.84 144.07 50.2 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.097 0.959 . . . . 73.310000000000002 108.618 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 2.2 Cg_endo -83.04 142.64 11.09 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.532 2.154 . . . . 72.420000000000002 114.385 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.471 ' HB3' ' CE2' ' A' ' 112' ' ' TYR . 69.2 p -40.92 -44.57 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.867 1.667 . . . . 75.329999999999998 113.707 167.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.627 ' HB2' ' HG2' ' A' ' 242' ' ' PRO . 27.8 p30 -77.94 -6.59 54.87 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.243 -0.89 . . . . 63.439999999999998 112.558 -172.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.576 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 30.2 m-85 -103.58 -10.0 18.8 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.371 0.668 . . . . 70.329999999999998 111.719 170.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.9 pt -126.32 178.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 124.099 0.959 . . . . 64.319999999999993 110.812 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.2 t -160.96 149.99 13.57 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.125 0.97 . . . . 65.420000000000002 108.71 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.557 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 24.3 Cg_endo -61.51 150.07 86.88 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.801 1.667 . . . . 64.129999999999995 111.548 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.1 t -71.32 -15.95 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 CA-C-O 120.955 0.407 . . . . 73.219999999999999 110.598 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -76.28 -17.94 59.22 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.449 0.699 . . . . 74.439999999999998 112.326 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.557 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 59.9 p -71.53 163.75 27.15 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.632 0.729 . . . . 61.5 112.648 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.41 -23.43 40.37 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.241 -0.891 . . . . 74.230000000000004 109.261 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.88 -15.48 63.09 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.607 1.163 . . . . 73.519999999999996 112.678 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -66.72 -24.08 66.19 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.919 0.39 . . . . 71.010000000000005 111.187 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -79.09 134.8 36.73 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.375 0.67 . . . . 72.129999999999995 109.788 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.7 p -59.12 -43.8 91.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.514 1.134 . . . . 52.020000000000003 111.745 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -62.88 -39.05 93.27 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.059 0.85 . . . . 44.43 112.467 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -77.76 110.83 12.97 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.128 -0.693 . . . . 75.409999999999997 109.128 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -107.03 -6.68 17.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.196 0.598 . . . . 73.140000000000001 111.155 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.57 -133.08 25.26 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.639 -1.09 . . . . 61.109999999999999 113.041 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.34 100.65 0.22 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.941 2.427 . . . . 74.010000000000005 112.006 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 55.9 t -138.71 131.74 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.747 1.219 . . . . 71.209999999999994 108.912 -175.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.3 p -84.7 171.57 12.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 62.329999999999998 109.987 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -62.07 -43.81 98.04 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.95 -0.548 . . . . 60.030000000000001 111.069 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -54.22 -43.44 70.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.731 0.645 . . . . 75.340000000000003 110.938 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.403 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -67.93 -38.45 82.88 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.282 -0.872 . . . . 74.340000000000003 111.155 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.3 -42.45 88.32 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.588 0.755 . . . . 63.329999999999998 111.732 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 67.5 mm-40 -59.85 -46.57 88.86 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.669 0.787 . . . . 74.439999999999998 109.421 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.536 ' HE1' ' HD2' ' A' ' 239' ' ' ARG . 42.3 t80 -62.01 -46.26 89.98 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.308 -1.314 . . . . 73.409999999999997 111.932 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.03 -40.33 84.71 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.912 0.885 . . . . 61.140000000000001 111.142 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.73 18.01 13.89 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.747 -0.661 . . . . 73.549999999999997 112.367 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 96.8 p -63.84 -41.23 97.87 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.083 0.856 . . . . 75.239999999999995 111.167 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 p -100.7 13.32 35.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.439 0.696 . . . . 62.340000000000003 111.299 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 151.87 41.69 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 123.117 0.26 . . . . 75.230000000000004 113.223 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.6 pt -101.96 -175.39 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.968 0.907 . . . . 75.530000000000001 110.898 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -52.7 122.2 8.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.63 0.772 . . . . 72.239999999999995 110.414 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.441 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 88.4 10.25 68.38 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.019 -0.879 . . . . 62.219999999999999 113.528 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 61.7 m -83.76 115.68 22.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.221 1.011 . . . . 54.030000000000001 111.282 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.459 ' HB3' HD13 ' A' ' 184' ' ' LEU . 11.1 p90 -130.22 167.08 19.0 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.202 0.525 . . . . 75.230000000000004 112.083 -170.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.27 146.79 24.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.717 -1.129 . . . . 74.340000000000003 108.609 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 182' ' ' ILE . 78.3 t -107.65 135.56 45.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.152 -1.055 . . . . 73.230000000000004 108.152 171.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.523 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 19.8 ptt85 -134.62 160.22 38.79 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.273 1.029 . . . . 75.430000000000007 109.811 -175.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -117.56 155.35 29.95 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.163 -1.051 . . . . 74.400000000000006 108.163 164.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -80.11 125.75 30.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.14 -0.689 . . . . 40.439999999999998 109.14 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.12 -39.77 65.48 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.339 0.656 . . . . 74.120000000000005 109.619 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.9 p -75.07 -13.29 60.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.41 0.684 . . . . 73.540000000000006 111.74 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 35.3 m -141.72 80.55 15.77 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.511 0.724 . . . . 71.5 109.502 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -59.42 131.26 39.69 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.867 2.378 . . . . 72.319999999999993 112.292 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.45 -29.24 10.77 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.855 -0.611 . . . . 72.430000000000007 112.24 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -80.93 115.89 20.63 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.076 -0.713 . . . . 64.439999999999998 109.076 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -116.26 150.09 38.15 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.55 0.691 . . . . 71.400000000000006 111.077 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.9 m -150.08 153.66 36.8 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.583 -1.19 . . . . 72.010000000000005 109.886 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.605 HG12 HG22 ' A' ' 170' ' ' VAL . 30.0 mt -110.78 149.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.486 -0.931 . . . . 54.32 108.486 172.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 36.3 m -123.11 108.28 12.69 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.666 -1.235 . . . . 73.420000000000002 107.666 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.475 HD23 ' OH ' ' A' ' 193' ' ' TYR . 70.0 tp -106.78 128.04 53.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.915 0.486 . . . . 54.210000000000001 110.069 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -102.36 129.17 48.75 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.098 0.959 . . . . 65.010000000000005 109.085 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -150.17 131.32 14.45 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.602 1.561 . . . . 71.209999999999994 107.174 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 63.72 23.99 13.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.087 0.955 . . . . 70.120000000000005 111.736 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.04 81.04 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.012 0.365 . . . . 51.119999999999997 114.012 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -105.77 128.27 53.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.929 0.892 . . . . 62.009999999999998 109.432 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.2 t -93.63 111.99 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.195 0.598 . . . . 64.310000000000002 110.465 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -96.53 147.81 23.47 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.725 1.21 . . . . 73.540000000000006 109.589 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -121.86 117.48 26.61 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.305 0.574 . . . . 74.209999999999994 110.445 -171.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 9.1 m-30 -96.07 148.21 22.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.76 1.224 . . . . 54.409999999999997 109.42 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.98 117.58 34.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.696 -0.854 . . . . 73.439999999999998 108.696 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 mt -84.08 100.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 N-CA-C 107.304 -1.369 . . . . 63.450000000000003 107.304 172.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -82.95 131.44 35.19 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.077 0.951 . . . . 71.5 108.769 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.7 m -97.33 121.76 39.59 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.767 -0.827 . . . . 62.240000000000002 108.767 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.71 174.31 8.56 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.277 0.631 . . . . 61.32 110.705 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.2 p -62.83 -32.68 73.94 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.655 0.782 . . . . 75.010000000000005 111.737 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.85 -14.9 27.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.742 0.817 . . . . 74.519999999999996 110.891 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.93 13.69 13.42 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 118.983 -0.898 . . . . 72.409999999999997 114.252 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.16 125.69 27.5 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.039 0.92 . . . . 71.420000000000002 110.798 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -84.87 141.16 30.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.51 -0.922 . . . . 60.119999999999997 108.51 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.55 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 31.4 p90 -165.55 137.5 4.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.325 0.391 . . . . 63.109999999999999 111.506 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.475 HG23 HD11 ' A' ' 217' ' ' LEU . 73.1 t -84.19 -36.72 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.573 -0.899 . . . . 51.210000000000001 108.573 163.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.5 m -100.99 127.44 47.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.859 -1.064 . . . . 62.32 109.962 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.2 t -63.67 -22.59 66.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.235 1.014 . . . . 74.140000000000001 111.909 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -82.87 -29.15 29.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.723 1.209 . . . . 73.340000000000003 110.859 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.6 m -126.33 99.02 5.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.33 0.652 . . . . 71.209999999999994 110.531 -175.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -97.34 133.46 41.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.871 0.868 . . . . 61.520000000000003 109.592 174.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.69 151.49 38.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.684 0.793 . . . . 65.219999999999999 109.327 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -73.09 -42.76 62.65 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.917 -0.401 . . . . 72.409999999999997 109.917 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 44.0 p -118.7 159.05 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.741 0.781 . . . . 75.239999999999995 112.248 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.06 -27.71 68.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.462 -1.245 . . . . 62.329999999999998 109.847 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.88 95.83 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.51 0.724 . . . . 71.219999999999999 110.629 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.11 -39.92 75.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.879 0.871 . . . . 72.109999999999999 110.865 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.475 HD11 HG23 ' A' ' 205' ' ' VAL . 15.3 tp -55.38 -56.07 24.29 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.848 0.718 . . . . 73.430000000000007 111.23 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.1 -42.35 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 123.797 0.686 . . . . 73.209999999999994 111.001 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.84 -55.57 30.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.016 0.823 . . . . 63.25 111.339 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -68.29 -34.77 76.77 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.41 -0.814 . . . . 62.25 111.214 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.61 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.8 m170 -87.64 -9.56 53.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.812 0.445 . . . . 64.409999999999997 112.083 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 90.7 p -90.51 -33.72 15.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.947 0.499 . . . . 71.120000000000005 110.231 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.1 p -72.98 -49.51 28.59 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.717 -0.674 . . . . 71.120000000000005 111.169 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.557 HG23 ' HB2' ' A' ' 226' ' ' ASP . 35.5 m -123.77 159.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.833 0.825 . . . . 61.32 112.459 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.15 16.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 128.205 2.602 . . . . 64.230000000000004 115.246 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.557 ' HB2' HG23 ' A' ' 224' ' ' VAL . 32.6 t70 -40.02 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 131.676 3.99 . . . . 61.539999999999999 119.852 -150.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.06 -3.22 10.68 Favored Glycine 0 N--CA 1.469 0.898 0 O-C-N 118.985 -2.322 . . . . 63.5 112.042 -165.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.1 mt -90.13 163.64 14.77 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.93 1.692 . . . . 74.310000000000002 109.231 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.76 -38.91 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 120.756 0.313 . . . . 71.540000000000006 110.881 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -158.02 -178.0 6.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.099 0.959 . . . . 71.310000000000002 109.938 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.5 p -67.41 144.01 55.99 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.588 0.755 . . . . 71.430000000000007 112.183 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 184' ' ' LEU . 76.8 mt -75.4 90.21 2.67 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 107.565 -1.272 . . . . 63.049999999999997 107.565 169.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -121.71 9.35 10.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.054 -1.029 . . . . 65.310000000000002 113.673 -158.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 167' ' ' SER . 20.2 t80 -159.17 122.95 2.07 Favored Pre-proline 0 C--O 1.22 -0.493 0 N-CA-C 106.957 -1.497 . . . . 74.140000000000001 106.957 174.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.2 139.3 6.06 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 122.214 1.942 . . . . 75.340000000000003 112.592 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.46 124.8 89.16 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.181 -1.044 . . . . 13.1 108.181 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.13 -176.98 3.34 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.321 2.014 . . . . 72.439999999999998 113.218 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.405 ' HE3' HD22 ' A' ' 88' ' ' LEU . 73.1 mmtt -76.85 118.74 19.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.034 -0.985 . . . . 73.430000000000007 109.318 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.551 ' HG3' ' N ' ' A' ' 240' ' ' ASN . 6.3 ptt180 -76.53 -53.65 7.79 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.591 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.551 ' N ' ' HG3' ' A' ' 239' ' ' ARG . 10.5 t30 -108.72 122.54 47.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.778 1.029 . . . . 62.340000000000003 113.778 -158.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 89' ' ' TYR . 97.2 mttt -79.8 113.46 37.88 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.183 -1.414 . . . . 54.329999999999998 107.183 159.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.627 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 25.5 Cg_exo -68.84 153.36 73.01 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.789 2.326 . . . . 62.399999999999999 113.601 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 24.5 m -73.44 139.94 46.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.725 -0.671 . . . . 74.319999999999993 110.993 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 52.0 t -95.65 113.51 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.99 -1.115 . . . . 62.049999999999997 107.99 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 247' ' ' VAL . 7.9 m-85 -102.94 110.85 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 119.256 -0.402 . . . . 34.439999999999998 110.414 -173.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.47 25.11 48.82 Favored Glycine 0 N--CA 1.477 1.373 0 N-CA-C 118.078 1.991 . . . . 73.319999999999993 118.078 160.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 245' ' ' TYR . 33.7 m -101.1 134.04 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 119.065 1.433 . . . . 43.020000000000003 113.421 -172.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -83.38 118.35 71.31 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 103.508 -2.775 . . . . 65.540000000000006 103.508 142.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo . . . . . 0 C--N 1.375 1.94 0 C-N-CA 121.501 1.467 . . . . 63.109999999999999 113.753 -152.419 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.405 ' NE1' ' HB2' ' A' ' 69' ' ' SER . 11.7 t90 . . . . . 0 C--O 1.238 0.462 0 N-CA-C 109.007 -0.738 . . . . 74.540000000000006 109.007 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.434 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 24.1 p-10 -84.2 -8.97 58.9 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.718 -0.674 . . . . 53.399999999999999 110.868 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.445 ' HB3' ' HD1' ' A' ' 144' ' ' HIS . 23.8 m -61.17 -4.3 1.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.778 1.399 . . . . 72.430000000000007 114.778 -165.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.51 -34.36 69.0 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.45 0.7 . . . . 62.350000000000001 111.145 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 12.7 pt-20 -65.32 -46.59 79.72 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.444 0.698 . . . . 73.25 110.589 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.04 -5.34 59.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.147 0.979 . . . . 71.219999999999999 111.014 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 tp -76.22 -49.68 16.5 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.429 1.091 . . . . 63.130000000000003 109.111 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.5 mt -104.45 36.7 2.31 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.229 -0.896 . . . . 71.230000000000004 109.529 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.955 0 C-N-CA 124.412 1.085 . . . . 51.210000000000001 112.677 -175.578 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.158 0.504 . . . . 71.400000000000006 110.607 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.402 ' HB2' ' NH2' ' A' ' 108' ' ' ARG . 26.1 tp -79.67 127.54 32.3 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.714 -0.847 . . . . 61.210000000000001 108.714 165.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.4 174.9 5.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.028 1.331 . . . . 71.5 109.165 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.12 135.12 32.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.726 0.81 . . . . 63.350000000000001 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.07 5.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.967 0.907 . . . . 22.199999999999999 110.373 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.9 -30.71 64.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.688 0.795 . . . . 73.310000000000002 110.735 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.0 m-85 -123.91 141.23 52.22 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.922 -1.036 . . . . 73.409999999999997 109.019 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -73.53 146.89 44.49 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.14 0.576 . . . . 64.340000000000003 109.524 168.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.421 ' HE2' ' HB ' ' A' ' 98' ' ' THR . 86.1 t80 -154.14 107.66 2.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.278 0.631 . . . . 74.530000000000001 109.361 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.49 137.03 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.111 -1.07 . . . . 62.219999999999999 108.111 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 115.53 10.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.035 0.534 . . . . 75.420000000000002 110.528 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.1 p -88.63 -25.5 22.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.288 0.635 . . . . 71.420000000000002 109.654 171.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.19 157.84 15.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-N 115.227 -0.897 . . . . 72.5 111.242 173.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.1 -34.69 75.49 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.722 0.809 . . . . 51.039999999999999 109.735 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -76.51 -26.91 55.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.356 -1.293 . . . . 74.0 112.3 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.421 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 67.0 p -82.77 155.36 24.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.425 -0.583 . . . . 55.329999999999998 109.425 173.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.548 ' HB3' HG13 ' A' ' 130' ' ' VAL . 67.2 tp -113.65 136.21 53.08 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.9 0.48 . . . . 71.239999999999995 111.741 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.7 m -74.55 117.09 15.97 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.794 0.837 . . . . 53.039999999999999 110.482 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.653 HG22 HG21 ' A' ' 123' ' ' THR . 22.0 pt -124.53 147.22 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.714 0.805 . . . . 74.439999999999998 111.343 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 57.5 m -89.88 145.65 24.99 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.262 1.025 . . . . 74.420000000000002 109.474 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -62.08 114.34 3.35 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.985 0.514 . . . . 72.030000000000001 109.749 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 7.05 61.68 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 119.648 -0.529 . . . . 61.539999999999999 113.457 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 88.4 tt0 -83.85 135.09 34.64 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.437 0.618 . . . . 55.240000000000002 110.371 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -85.02 138.59 32.35 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.225 0.61 . . . . 74.420000000000002 109.617 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.61 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.3 OUTLIER -147.6 135.11 20.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.238 1.015 . . . . 62.310000000000002 109.935 -174.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.402 ' NH2' ' HB2' ' A' ' 84' ' ' LEU . 53.0 ttm-85 -99.15 115.9 30.12 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 122.306 -0.246 . . . . 73.450000000000003 110.624 -172.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.628 HG13 ' HB1' ' A' ' 119' ' ' ALA . 74.0 t -76.36 122.97 31.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.8 0.687 . . . . 64.209999999999994 110.39 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 122' ' ' GLN . 20.9 mt -90.81 -36.96 13.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.927 1.291 . . . . 75.140000000000001 109.448 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.46 148.77 9.66 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.421 -0.809 . . . . 72.450000000000003 112.373 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 22.0 m-85 -95.37 156.92 16.12 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 73.120000000000005 110.839 176.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -70.83 -178.39 1.87 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.434 -0.803 . . . . 72.420000000000002 110.791 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -55.29 -27.72 48.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.959 1.096 . . . . 64.299999999999997 113.959 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.02 -2.69 15.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.144 0.578 . . . . 74.319999999999993 112.436 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.63 20.98 75.85 Favored Glycine 0 C--N 1.349 1.305 0 N-CA-C 114.478 0.551 . . . . 51.100000000000001 114.478 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.49 -61.42 1.72 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 117.381 0.591 . . . . 72.310000000000002 110.152 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -92.3 145.48 24.45 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.735 0.414 . . . . 63.100000000000001 110.896 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -130.66 139.19 50.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.667 1.187 . . . . 62.109999999999999 110.679 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.2 98.75 5.97 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 107.779 -1.193 . . . . 72.230000000000004 107.779 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -105.46 134.8 47.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.678 0.791 . . . . 40.149999999999999 109.694 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.448 ' HG3' HD11 ' A' ' 110' ' ' LEU . 90.2 mt-30 -93.59 113.14 25.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.945 -0.761 . . . . 71.129999999999995 108.945 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.653 HG21 HG22 ' A' ' 101' ' ' ILE . 57.4 p -98.22 179.5 4.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.144 0.978 . . . . 75.329999999999998 110.589 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -72.51 -18.76 61.63 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.908 -1.042 . . . . 72.340000000000003 110.005 170.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -80.38 -12.5 59.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.384 1.073 . . . . 73.030000000000001 111.278 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.72 -172.75 14.48 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.618 -0.193 . . . . 63.109999999999999 112.618 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -85.67 136.29 33.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.255 0.622 . . . . 74.239999999999995 110.756 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -173.38 -177.77 42.86 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.99 -0.55 . . . . 72.219999999999999 112.49 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -107.2 125.21 50.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.837 0.455 . . . . 71.420000000000002 111.58 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.595 HG23 HD13 ' A' ' 135' ' ' ILE . 26.8 m -138.6 148.9 60.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 125.129 1.372 . . . . 75.030000000000001 109.461 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -95.0 151.91 1.71 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.956 2.437 . . . . 63.32 115.538 -170.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.1 m -41.54 -38.5 1.34 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.424 1.89 . . . . 74.219999999999999 115.133 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -71.78 -13.37 61.68 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 122.113 -0.367 . . . . 52.450000000000003 111.175 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.433 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 15.5 m-85 -104.08 -25.26 13.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.007 0.923 . . . . 70.400000000000006 112.363 170.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.595 HD13 HG23 ' A' ' 130' ' ' VAL . 32.7 pt -128.21 144.95 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 118.669 0.668 . . . . 74.329999999999998 112.486 -173.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -137.5 148.57 62.11 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 108.866 -0.79 . . . . 54.399999999999999 108.866 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.25 141.2 88.55 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.532 2.155 . . . . 72.439999999999998 110.948 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.05 -3.26 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.425 0 CA-C-O 121.056 0.455 . . . . 73.329999999999998 111.355 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.425 HD22 ' N ' ' A' ' 139' ' ' ASN . 0.9 OUTLIER -90.77 -8.54 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.379 0.672 . . . . 72.140000000000001 112.11 174.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.7 p -75.97 -177.27 3.8 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.155 0.582 . . . . 72.430000000000007 111.901 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.7 mt -86.85 -30.93 21.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.828 0.451 . . . . 64.519999999999996 110.082 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -64.34 -23.83 67.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.403 1.081 . . . . 75.430000000000007 111.8 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -6.17 9.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.911 0.884 . . . . 64.140000000000001 112.425 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.445 ' HD1' ' HB3' ' A' ' 69' ' ' SER . 85.1 m-70 -97.21 155.47 16.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.887 0.875 . . . . 74.140000000000001 110.585 171.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.5 p -66.99 -41.51 86.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.501 1.12 . . . . 73.239999999999995 111.745 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -66.04 -41.67 90.56 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.113 0.783 . . . . 74.140000000000001 113.113 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 26.4 t80 -78.06 112.55 15.11 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.955 -0.387 . . . . 73.430000000000007 109.955 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.456 ' HB2' HG21 ' A' ' 151' ' ' VAL . 30.6 m170 -104.41 -5.29 21.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.376 0.51 . . . . 34.340000000000003 112.376 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.34 -141.73 30.37 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 118.506 -1.163 . . . . 73.310000000000002 112.673 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.59 94.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.596 2.864 . . . . 64.310000000000002 112.919 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.8 t -138.53 137.09 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.916 1.286 . . . . 61.310000000000002 109.702 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.4 p -89.4 176.26 6.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.394 1.078 . . . . 65.530000000000001 110.882 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -60.1 -49.29 78.21 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.984 0.513 . . . . 73.430000000000007 110.122 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -59.56 -41.56 90.43 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.194 0.934 . . . . 73.120000000000005 111.192 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -65.84 -44.82 84.36 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.307 -0.86 . . . . 63.25 111.522 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.56 89.63 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.56 -0.745 . . . . 75.310000000000002 111.123 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -80.68 -21.6 41.16 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.47 -0.786 . . . . 63.450000000000003 111.977 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -78.23 -25.63 47.03 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.992 0.814 . . . . 70.230000000000004 110.388 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 239' ' ' ARG . 62.2 mt -70.74 -42.48 70.45 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.518 0.675 . . . . 72.549999999999997 110.484 169.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 66.9 mt -94.37 22.44 6.05 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.757 -1.11 . . . . 75.430000000000007 111.388 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 99.1 p -74.06 -43.8 56.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.148 0.499 . . . . 71.540000000000006 110.164 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.7 p -112.05 19.56 17.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.633 0.773 . . . . 64.430000000000007 110.464 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.96 149.8 48.2 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.98 -0.555 . . . . 74.230000000000004 111.724 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.7 pt -87.35 169.82 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-O 121.166 0.508 . . . . 74.519999999999996 110.527 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -70.96 109.25 4.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.077 -0.511 . . . . 75.219999999999999 109.632 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.87 10.07 19.42 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.087 0.851 . . . . 72.349999999999994 112.863 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.0 m -86.22 131.99 34.11 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.089 0.944 . . . . 62.409999999999997 110.583 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 183' ' ' SER . 8.6 p90 -139.29 166.95 23.18 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.385 0.539 . . . . 74.439999999999998 111.569 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -162.62 147.63 12.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.916 -1.038 . . . . 72.310000000000002 108.483 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 182' ' ' ILE . 99.2 t -105.32 124.53 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.56 -1.274 . . . . 62.240000000000002 107.56 169.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.685 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 44.7 ptt85 -114.68 159.99 19.86 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.456 1.102 . . . . 65.319999999999993 108.663 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.65 141.79 47.73 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.757 -1.201 . . . . 62.149999999999999 107.757 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.0 t -83.51 130.73 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.26 0.624 . . . . 71.230000000000004 110.003 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.05 -33.01 33.79 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.718 0.636 . . . . 74.430000000000007 109.973 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.8 p -72.45 -31.81 65.76 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.494 -0.775 . . . . 55.119999999999997 110.955 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.6 m -121.8 95.1 48.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.476 0.71 . . . . 64.010000000000005 109.293 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.57 114.44 2.54 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.39 2.727 . . . . 55.509999999999998 113.31 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.16 -15.15 61.83 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.755 -0.657 . . . . 75.219999999999999 112.964 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -79.16 116.6 19.53 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.505 0.653 . . . . 72.439999999999998 109.975 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -110.22 144.65 38.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.477 0.656 . . . . 72.140000000000001 110.46 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.6 m -138.43 150.67 46.71 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.834 0.854 . . . . 74.409999999999997 109.043 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.707 HG12 HG22 ' A' ' 170' ' ' VAL . 22.3 mt -101.87 150.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.54 -1.282 . . . . 74.340000000000003 107.54 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -124.87 108.24 11.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.778 -1.193 . . . . 73.400000000000006 107.778 168.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.425 HD23 ' OH ' ' A' ' 193' ' ' TYR . 56.7 tp -107.49 111.12 23.26 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.325 -0.62 . . . . 73.430000000000007 109.325 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.454 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -79.55 122.37 26.4 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.521 -0.548 . . . . 72.010000000000005 109.521 168.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -149.92 145.25 26.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.848 1.659 . . . . 73.040000000000006 107.458 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 59.45 21.79 10.23 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 124.255 1.022 . . . . 62.420000000000002 111.557 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.47 -7.15 62.11 Favored Glycine 0 C--N 1.358 1.765 0 CA-C-N 116.176 -0.465 . . . . 75.030000000000001 113.956 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -104.49 138.64 40.56 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.196 0.999 . . . . 71.299999999999997 108.581 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.33 103.81 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.397 0.544 . . . . 73.310000000000002 110.395 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.26 115.47 27.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.885 0.874 . . . . 74.530000000000001 109.65 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.63 118.25 30.84 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.194 0.598 . . . . 73.439999999999998 110.371 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 11.1 m-85 -94.33 148.49 22.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.447 1.099 . . . . 72.239999999999995 109.532 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -107.02 112.93 26.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 74.310000000000002 108.727 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.18 101.49 8.82 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 N-CA-C 108.8 -0.815 . . . . 40.229999999999997 108.8 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -80.79 121.81 26.39 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.662 -1.154 . . . . 52.450000000000003 108.931 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.2 m -93.39 113.88 26.15 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.917 0.887 . . . . 32.149999999999999 108.78 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.25 167.32 14.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.7 0.8 . . . . 74.019999999999996 110.799 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.9 p -62.45 -24.69 67.57 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.881 0.872 . . . . 74.049999999999997 112.195 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -96.87 -16.66 20.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.62 0.768 . . . . 74.230000000000004 111.516 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.87 9.94 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.217 -0.768 . . . . 70.409999999999997 114.81 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.72 124.71 26.54 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.32 1.06 . . . . 70.040000000000006 110.551 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -88.26 140.88 29.03 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.846 -0.798 . . . . 74.340000000000003 108.846 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.585 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 44.8 p90 -162.63 135.59 5.8 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.769 0.668 . . . . 75.400000000000006 110.516 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.504 HG23 HD11 ' A' ' 217' ' ' LEU . 53.9 t -70.81 -53.28 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.902 -0.777 . . . . 73.409999999999997 108.902 165.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.3 m -107.06 136.15 47.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.629 -1.168 . . . . 74.439999999999998 109.744 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.8 t -60.4 -26.59 66.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.45 1.1 . . . . 71.230000000000004 112.942 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.39 -23.3 61.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.747 0.819 . . . . 73.409999999999997 111.479 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.2 m -134.4 101.17 4.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.182 0.593 . . . . 71.310000000000002 110.364 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.585 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.1 mtm180 -110.07 138.07 46.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.162 0.985 . . . . 72.430000000000007 110.197 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.87 149.22 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.623 -0.88 . . . . 71.120000000000005 108.623 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -68.66 -31.96 71.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 72.319999999999993 110.76 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -132.1 157.36 44.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 112.074 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -27.55 69.03 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.731 -1.122 . . . . 74.019999999999996 109.506 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.99 -45.44 86.79 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.553 0.741 . . . . 71.040000000000006 110.898 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.6 -34.83 72.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.527 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 205' ' ' VAL . 16.0 tp -56.98 -58.64 7.27 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.752 0.421 . . . . 64.239999999999995 110.873 174.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.22 -40.65 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.246 0.618 . . . . 74.239999999999995 111.165 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -57.13 -61.47 2.44 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.822 0.701 . . . . 74.340000000000003 111.566 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -71.9 -29.16 64.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.849 -0.614 . . . . 73.340000000000003 111.262 -171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.518 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.7 m170 -87.55 -9.88 53.17 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.675 0.39 . . . . 73.319999999999993 112.049 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.0 p -88.43 -35.33 17.14 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.98 0.355 . . . . 71.409999999999997 110.114 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 65.8 p -70.28 -46.65 63.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.631 0.372 . . . . 71.129999999999995 111.048 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.745 HG23 ' HB2' ' A' ' 226' ' ' ASP . 22.8 m -132.01 165.14 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.353 0.661 . . . . 52.130000000000003 111.973 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.62 15.41 0.37 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 126.714 2.005 . . . . 64.129999999999995 114.208 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.745 ' HB2' HG23 ' A' ' 224' ' ' VAL . 23.8 t70 -44.65 36.23 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.723 1 C-N-CA 132.429 4.292 . . . . 75.109999999999999 119.561 -157.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 124.1 -7.08 8.73 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.537 -0.727 . . . . 51.439999999999998 112.493 -170.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.4 mt -94.65 162.45 13.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.116 1.366 . . . . 74.209999999999994 110.059 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.76 -35.26 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.604 0.24 . . . . 72.109999999999999 110.786 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.5 t -159.06 -179.22 7.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.996 0.519 . . . . 72.310000000000002 110.677 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.2 p -66.13 137.24 56.9 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.622 1.169 . . . . 73.219999999999999 112.311 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.44 96.69 1.19 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.75 0.82 . . . . 42.229999999999997 109.051 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -97.53 -82.61 0.41 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.818 -0.551 . . . . 53.200000000000003 111.99 -170.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -75.22 120.72 82.99 Favored Pre-proline 0 C--N 1.351 0.647 0 N-CA-C 108.857 -0.794 . . . . 74.219999999999999 108.857 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.88 127.7 7.97 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.038 1.825 . . . . 73.120000000000005 111.275 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.95 140.94 88.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 108.851 -0.796 . . . . 74.409999999999997 108.851 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.76 176.58 9.34 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.488 2.125 . . . . 74.140000000000001 113.051 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -63.53 140.7 58.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.897 0.879 . . . . 75.109999999999999 109.654 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.6 ' HE ' HG22 ' A' ' 151' ' ' VAL . 20.8 ptt85 -90.49 -61.31 1.71 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.524 0.935 . . . . 75.310000000000002 113.524 -165.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.453 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.8 t30 -109.08 128.84 55.32 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.595 0.758 . . . . 64.150000000000006 109.614 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -76.94 113.26 28.6 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.092 -1.447 . . . . 74.340000000000003 107.092 164.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -63.15 132.65 37.31 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.534 2.156 . . . . 74.239999999999995 112.46 -172.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 89.5 m -69.25 123.84 22.22 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.404 0.682 . . . . 63.329999999999998 110.284 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.65 111.74 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.405 -0.961 . . . . 73.239999999999995 108.405 172.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.56 112.37 25.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.303 0.641 . . . . 72.319999999999993 111.917 -169.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 69.34 -38.18 0.34 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 117.366 1.706 . . . . 61.049999999999997 117.366 165.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.33 129.33 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 117.833 0.817 . . . . 73.219999999999999 112.771 -158.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.9 t -83.35 135.82 43.7 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 107.339 -1.356 . . . . 75.409999999999997 107.339 168.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 C--N 1.387 2.562 0 C-N-CA 122.126 1.884 . . . . 75.129999999999995 115.265 -156.246 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.1 t90 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 74.299999999999997 109.625 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 26.2 p-10 -66.97 -33.95 76.7 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.419 -0.81 . . . . 72.340000000000003 110.826 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 p -72.0 6.21 2.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.698 1.199 . . . . 64.450000000000003 112.72 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 83.5 tttt -70.28 -21.24 62.98 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.75 0.42 . . . . 64.439999999999998 111.13 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.608 ' HG3' HD22 ' A' ' 72' ' ' ASN . 13.3 pt-20 -73.0 -38.11 66.72 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.474 -0.565 . . . . 72.340000000000003 109.474 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.608 HD22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -77.43 -13.59 59.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.23 0.612 . . . . 74.329999999999998 111.075 176.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.461 HD13 ' HE1' ' A' ' 146' ' ' TRP . 60.3 tp -59.14 -50.32 74.5 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.684 0.794 . . . . 71.0 110.692 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 mt -108.06 23.8 13.94 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.78 -0.645 . . . . 42.100000000000001 110.922 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 123.073 0.549 . . . . 70.319999999999993 111.533 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.933 0.397 . . . . 73.010000000000005 111.681 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.5 tp -100.11 139.52 35.66 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.65 -0.656 . . . . 72.239999999999995 110.315 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -116.5 172.3 7.29 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.362 1.065 . . . . 73.319999999999993 109.101 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.08 139.99 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.732 1.213 . . . . 74.430000000000007 109.538 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.32 117.26 20.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.207 1.003 . . . . 41.32 110.249 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.07 -31.7 34.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.09 0.956 . . . . 50.219999999999999 111.564 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.43 141.61 51.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.036 0.934 . . . . 74.540000000000006 108.921 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.99 120.2 24.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.158 -0.682 . . . . 71.409999999999997 109.158 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.525 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.2 t80 -115.43 142.87 46.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.786 0.834 . . . . 64.109999999999999 109.469 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.72 135.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.737 -0.838 . . . . 63.109999999999999 108.737 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.42 119.22 10.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.701 0.8 . . . . 64.040000000000006 111.035 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.3 p -94.4 10.94 32.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.428 1.091 . . . . 74.409999999999997 111.324 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.78 179.45 43.47 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.108 -0.496 . . . . 73.310000000000002 112.034 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.14 -34.81 63.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.892 0.877 . . . . 74.430000000000007 110.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.519 ' ND2' ' HD2' ' A' ' 249' ' ' PRO . 32.4 p-10 -90.37 -4.05 57.33 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.043 -0.981 . . . . 75.400000000000006 112.262 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.9 p -96.76 168.51 10.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.457 0.703 . . . . 72.150000000000006 109.936 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.576 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 66.1 tp -135.93 136.29 40.33 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.084 0.553 . . . . 60.240000000000002 111.38 -172.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -83.9 120.14 25.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.573 0.749 . . . . 70.239999999999995 110.073 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.784 HG22 HG21 ' A' ' 123' ' ' THR . 20.2 pt -117.43 152.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 123.171 0.588 . . . . 75.450000000000003 111.614 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -98.53 146.44 25.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.362 1.065 . . . . 72.310000000000002 109.601 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -70.17 118.59 13.19 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.907 0.483 . . . . 71.450000000000003 109.701 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.78 -11.5 56.21 Favored Glycine 0 N--CA 1.472 1.052 0 C-N-CA 123.197 0.427 . . . . 71.319999999999993 112.845 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.11 135.65 44.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.65 0.78 . . . . 73.150000000000006 110.97 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -85.92 142.46 28.83 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.572 -0.899 . . . . 71.319999999999993 108.572 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.677 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.15 150.4 34.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.25 0.62 . . . . 51.310000000000002 111.119 -176.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -95.4 106.41 18.46 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.687 -0.688 . . . . 73.150000000000006 109.287 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.652 HG13 ' HB1' ' A' ' 119' ' ' ALA . 42.1 t -86.75 107.88 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.621 -0.511 . . . . 74.040000000000006 109.621 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.613 HD21 ' HG3' ' A' ' 122' ' ' GLN . 2.1 mm? -69.52 -23.22 63.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.349 1.059 . . . . 32.329999999999998 110.935 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.7 166.42 13.61 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.276 -0.42 . . . . 75.140000000000001 112.46 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.593 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 61.1 m-85 -86.6 173.12 9.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.841 0.829 . . . . 74.140000000000001 111.794 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -90.05 -178.66 5.49 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.208 -1.36 . . . . 64.25 110.97 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -53.26 -34.3 56.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.611 1.165 . . . . 71.030000000000001 113.11 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -105.35 -19.67 13.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 119.183 -0.436 . . . . 74.25 111.368 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.21 34.68 22.9 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.548 0.579 . . . . 71.109999999999999 114.548 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.55 -29.82 14.7 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.023 0.412 . . . . 62.350000000000001 111.057 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 60.6 m95 -128.75 156.02 44.2 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.16 0.984 . . . . 74.25 111.15 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.652 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.22 141.31 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.305 1.042 . . . . 25.440000000000001 110.263 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 110' ' ' LEU . 40.7 tt0 -74.82 118.43 17.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.859 -1.163 . . . . 63.350000000000001 107.859 170.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.52 151.33 48.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.25 0.62 . . . . 75.430000000000007 111.307 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.613 ' HG3' HD21 ' A' ' 110' ' ' LEU . 56.4 mt-30 -115.05 116.43 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.148 0.979 . . . . 74.400000000000006 108.95 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.784 HG21 HG22 ' A' ' 101' ' ' ILE . 67.0 p -114.6 -178.51 3.39 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.349 1.059 . . . . 71.150000000000006 110.885 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -68.66 -16.53 63.86 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.553 -0.748 . . . . 74.129999999999995 110.29 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -84.33 -20.46 32.01 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.202 1.001 . . . . 73.120000000000005 111.074 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.31 -168.43 14.84 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.096 -0.402 . . . . 55.240000000000002 112.096 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.27 145.45 28.83 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.35 0.575 . . . . 71.349999999999994 111.593 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.39 -161.91 27.65 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.713 -0.955 . . . . 21.25 110.713 177.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -110.94 136.24 50.25 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.797 0.798 . . . . 72.510000000000005 111.463 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.484 HG11 ' CG2' ' A' ' 101' ' ' ILE . 34.2 m -137.8 140.28 29.13 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.063 1.345 . . . . 73.109999999999999 109.252 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 8.8 Cg_exo -72.85 146.4 42.33 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.44 2.093 . . . . 74.120000000000005 114.38 -172.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 m -38.09 -50.96 1.4 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.469 1.907 . . . . 44.539999999999999 114.194 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 131' ' ' PRO . 12.7 p-10 -73.3 -3.65 28.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.375 1.07 . . . . 74.519999999999996 113.103 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -106.73 -9.39 16.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.858 0.863 . . . . 75.120000000000005 111.313 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 109' ' ' VAL . 18.0 pt -130.8 168.59 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.137 0.975 . . . . 73.329999999999998 111.832 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 t -163.06 155.9 16.29 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 124.08 0.952 . . . . 62.340000000000003 108.672 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.74 142.71 91.65 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 121.795 1.663 . . . . 72.040000000000006 111.442 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.4 t -69.72 -11.37 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.796 0.807 . . . . 75.409999999999997 109.848 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -73.8 -18.36 60.97 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.523 1.129 . . . . 51.130000000000003 112.568 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.6 p -92.69 -178.25 4.8 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.318 0.858 . . . . 51.340000000000003 113.318 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.8 mt -83.5 -21.19 32.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.257 1.023 . . . . 61.009999999999998 111.689 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.54 -20.95 63.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.684 0.394 . . . . 73.200000000000003 111.792 -172.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 72' ' ' ASN . 21.8 pttm -65.33 -15.99 63.12 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 112.266 0.469 . . . . 74.420000000000002 112.266 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -83.22 138.47 33.6 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.401 0.68 . . . . 75.319999999999993 109.28 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 p -65.11 -39.88 93.76 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.611 0.765 . . . . 63.219999999999999 112.203 -177.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.461 ' HE1' HD13 ' A' ' 73' ' ' LEU . 32.2 p-90 -67.78 -30.16 69.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.848 0.859 . . . . 61.520000000000003 112.87 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -80.58 102.99 10.13 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.742 -0.466 . . . . 71.219999999999999 109.742 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -99.72 -4.1 31.47 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.992 0.517 . . . . 75.439999999999998 111.788 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.8 -139.79 26.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 118.708 -1.051 . . . . 60.130000000000003 112.793 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.92 101.51 0.39 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.813 2.342 . . . . 74.010000000000005 112.399 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 76.7 t -132.3 141.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.77 0.828 . . . . 74.319999999999993 109.801 -175.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.6 p -87.72 172.65 9.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.924 0.89 . . . . 73.25 110.369 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 68.8 ttt180 -61.71 -45.51 93.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.243 -0.28 . . . . 54.409999999999997 110.243 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.5 -45.56 80.94 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.042 0.838 . . . . 64.299999999999997 111.019 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.624 ' HB1' HH12 ' A' ' 239' ' ' ARG . . . -71.65 -26.45 62.55 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.289 -0.869 . . . . 71.230000000000004 111.699 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.27 -43.27 52.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.27 0.628 . . . . 74.310000000000002 111.243 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 26.7 mm-40 -60.79 -36.19 78.38 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.722 0.809 . . . . 74.129999999999995 110.059 174.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -67.75 -47.29 69.67 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.704 -1.134 . . . . 73.209999999999994 111.205 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.33 -38.44 68.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.284 0.634 . . . . 55.200000000000003 111.307 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.9 mt -100.93 6.79 43.75 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.952 0.723 . . . . 73.109999999999999 112.952 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 90.6 p -59.17 -35.31 73.32 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 119.075 0.852 . . . . 70.5 111.166 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -102.86 18.92 20.37 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.495 1.118 . . . . 54.299999999999997 110.89 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.11 133.29 11.68 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 123.644 0.64 . . . . 74.109999999999999 113.057 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -79.54 -177.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.946 0.898 . . . . 41.210000000000001 111.837 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.96 116.43 3.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.601 0.761 . . . . 63.32 110.656 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.16 11.8 55.7 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.629 -0.714 . . . . 73.019999999999996 113.094 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.1 m -76.38 135.24 39.48 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 118.082 0.941 . . . . 73.209999999999994 110.622 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 183' ' ' SER . 33.6 p90 -142.22 168.13 20.47 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 118.782 0.719 . . . . 55.549999999999997 111.34 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 pp -159.29 152.67 22.52 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.337 -0.986 . . . . 50.009999999999998 108.337 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.689 HG22 HG12 ' A' ' 182' ' ' ILE . 89.4 t -110.91 142.05 24.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 N-CA-C 109.092 -0.707 . . . . 70.409999999999997 109.092 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.467 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.3 ptt85 -135.37 159.21 42.3 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.288 -1.323 . . . . 74.439999999999998 108.95 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.658 ' HG2' ' HG2' ' A' ' 180' ' ' ARG . 10.7 mt-10 -113.93 162.14 16.76 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.523 -0.918 . . . . 64.319999999999993 108.523 164.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -84.02 133.79 34.65 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.99 -0.744 . . . . 74.409999999999997 108.99 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -71.17 -43.73 66.89 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.722 -0.473 . . . . 74.450000000000003 109.722 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.5 p -76.25 -15.76 59.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.112 0.565 . . . . 71.420000000000002 112.145 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.5 m -139.54 82.99 17.57 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.141 0.577 . . . . 64.230000000000004 109.865 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.64 125.94 18.57 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.958 2.439 . . . . 62.340000000000003 111.531 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.42 -29.58 8.98 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.752 -0.539 . . . . 53.0 111.752 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -75.77 116.89 16.94 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.02 -0.733 . . . . 72.049999999999997 109.02 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.658 ' HG2' ' HG2' ' A' ' 172' ' ' GLU . 98.3 mtt180 -124.01 145.89 48.9 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 123.954 0.902 . . . . 71.329999999999998 110.121 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 64.3 m -142.27 146.46 35.14 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.221 -0.9 . . . . 71.319999999999993 109.668 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.689 HG12 HG22 ' A' ' 170' ' ' VAL . 34.6 mt -103.32 150.17 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.084 -1.45 . . . . 34.240000000000002 107.084 169.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.1 m -125.45 108.09 11.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.661 -1.237 . . . . 55.530000000000001 107.661 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 25.5 tp -107.72 110.16 21.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.658 0.663 . . . . 55.219999999999999 110.216 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.514 ' HB2' HG22 ' A' ' 190' ' ' VAL . 20.5 ttt180 -79.95 120.89 24.77 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.673 0.749 . . . . 75.299999999999997 110.773 168.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -140.59 135.51 31.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 113.816 -1.538 . . . . 70.319999999999993 107.446 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 60.14 22.4 11.67 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.799 0.84 . . . . 50.32 112.087 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.15 -10.77 73.05 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.142 0.417 . . . . 42.329999999999998 114.142 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -103.5 139.04 39.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.314 0.646 . . . . 70.430000000000007 109.908 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 185' ' ' ARG . 48.1 t -99.3 110.33 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.897 0.479 . . . . 73.329999999999998 110.433 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -95.05 117.03 29.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.979 1.311 . . . . 73.030000000000001 109.133 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -96.54 122.94 39.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.947 0.499 . . . . 74.400000000000006 110.723 -172.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.46 ' HE1' HD21 ' A' ' 232' ' ' LEU . 8.2 m-30 -94.82 147.36 23.43 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.097 0.959 . . . . 75.040000000000006 109.795 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -99.24 117.65 34.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.132 -1.062 . . . . 74.239999999999995 108.132 173.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.531 HD12 ' HB3' ' A' ' 180' ' ' ARG . 56.8 mt -82.4 100.59 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 107.649 -1.241 . . . . 73.439999999999998 107.649 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 196' ' ' ASN . 0.8 OUTLIER -71.28 119.81 15.96 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.051 -0.977 . . . . 52.219999999999999 109.206 176.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 m -87.71 110.47 20.46 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.677 -0.692 . . . . 73.200000000000003 109.16 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.25 157.3 10.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.167 0.987 . . . . 53.43 111.383 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.6 p -64.43 -31.79 73.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.641 0.776 . . . . 73.200000000000003 112.101 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -82.58 -13.92 55.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.319 0.648 . . . . 71.109999999999999 111.316 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.32 9.77 19.04 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.401 0.52 . . . . 64.030000000000001 114.401 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -79.66 164.09 24.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.686 0.743 . . . . 72.530000000000001 110.735 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -115.73 147.36 41.0 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.601 0.761 . . . . 73.209999999999994 109.172 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.608 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.6 p90 -170.3 140.06 1.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.027 0.829 . . . . 62.240000000000002 111.728 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 217' ' ' LEU . 98.9 t -85.35 -44.38 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.733 -0.84 . . . . 43.450000000000003 108.733 165.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 43.1 m -92.7 130.83 38.2 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.941 -1.027 . . . . 71.140000000000001 109.992 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -72.27 -17.11 61.91 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.416 0.686 . . . . 74.099999999999994 111.884 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.47 -1.51 57.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.038 0.535 . . . . 61.030000000000001 111.399 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.36 101.86 3.53 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.769 0.428 . . . . 73.519999999999996 111.426 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.608 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 74.2 mtt180 -101.36 153.68 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.219 0.608 . . . . 72.530000000000001 110.32 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.4 154.72 47.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.411 0.684 . . . . 75.329999999999998 109.952 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -72.21 -44.74 62.48 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.233 -0.655 . . . . 63.240000000000002 109.233 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 156.41 31.39 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-O 121.938 0.875 . . . . 75.450000000000003 111.564 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.426 HD23 HD23 ' A' ' 217' ' ' LEU . 0.8 OUTLIER -64.55 -26.6 68.49 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-N 114.012 -1.449 . . . . 52.140000000000001 110.065 175.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.26 96.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.576 0.75 . . . . 61.450000000000003 111.331 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.84 -33.19 70.4 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.375 0.67 . . . . 72.5 111.154 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.451 HD11 HG23 ' A' ' 205' ' ' VAL . 15.3 tp -53.36 -57.23 11.31 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.729 0.643 . . . . 64.099999999999994 110.034 171.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 53.4 t -63.88 -37.83 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 O-C-N 123.802 0.689 . . . . 74.219999999999999 112.035 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -65.14 -51.89 58.46 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.853 0.358 . . . . 61.299999999999997 111.189 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -64.23 -35.11 79.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 75.150000000000006 110.776 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.652 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.5 m170 -85.72 -9.33 57.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.284 0.476 . . . . 72.430000000000007 112.284 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.4 p -90.93 -29.73 17.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.727 0.411 . . . . 71.430000000000007 110.761 170.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.7 p -75.48 -49.51 18.57 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.852 0.358 . . . . 75.140000000000001 110.735 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.3 m -125.7 154.23 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.979 0.895 . . . . 73.420000000000002 111.694 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.62 13.88 7.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.627 1.971 . . . . 71.150000000000006 113.694 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -46.77 34.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 131.182 3.793 . . . . 55.25 119.855 -159.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.58 -0.67 6.37 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 119.28 0.945 . . . . 52.32 112.941 -167.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.2 mt -92.33 161.92 14.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.434 1.094 . . . . 75.230000000000004 110.52 163.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.83 -42.19 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 122.564 0.345 . . . . 71.030000000000001 110.432 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -161.69 170.9 18.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.665 0.786 . . . . 55.039999999999999 110.102 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.3 p -61.29 139.36 58.17 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.456 1.102 . . . . 63.530000000000001 112.687 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.46 HD21 ' HE1' ' A' ' 193' ' ' TYR . 79.5 mt -68.17 99.55 0.91 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.033 0.933 . . . . 74.510000000000005 109.161 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -94.44 -50.24 5.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.329 0.492 . . . . 61.329999999999998 112.329 -163.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 167' ' ' SER . 15.5 t80 -130.77 124.16 20.62 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.936 1.294 . . . . 62.530000000000001 108.127 -171.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -84.95 146.91 10.4 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.256 1.97 . . . . 72.420000000000002 112.17 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -74.63 130.15 82.25 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.437 -1.32 . . . . 54.219999999999999 107.437 172.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.35 173.8 12.77 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.076 1.85 . . . . 73.310000000000002 112.5 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -68.19 109.12 3.42 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.882 -0.784 . . . . 74.340000000000003 108.882 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.637 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 8.7 ptt180 -75.51 -68.3 0.58 Allowed 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.559 0.948 . . . . 64.109999999999999 113.559 -158.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.637 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 66.8 t30 -111.29 137.75 48.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.788 -0.57 . . . . 70.219999999999999 110.128 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -74.49 112.69 18.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 106.3 -1.741 . . . . 71.420000000000002 106.3 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.23 127.28 16.4 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.346 2.031 . . . . 63.130000000000003 111.568 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 84.8 m -61.53 110.76 1.56 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.969 0.907 . . . . 74.230000000000004 111.182 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.22 106.96 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 107.685 -1.228 . . . . 53.520000000000003 107.685 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.73 120.77 43.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.128 0.971 . . . . 43.509999999999998 112.777 -163.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.07 63.74 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 116.352 1.301 . . . . 64.409999999999997 116.352 161.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.63 122.42 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 123.187 0.595 . . . . 72.239999999999995 110.874 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.9 t -81.3 116.73 64.65 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 104.834 -2.284 . . . . 72.439999999999998 104.834 161.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.519 ' HD2' ' ND2' ' A' ' 97' ' ' ASN . 99.3 Cg_exo . . . . . 0 C--N 1.378 2.11 0 C-N-CA 122.677 2.252 . . . . 74.349999999999994 116.226 -148.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.8 t90 . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 108.51 -0.922 . . . . 74.409999999999997 108.51 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.41 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 30.1 p-10 -94.38 -34.01 12.94 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.888 0.475 . . . . 74.409999999999997 110.68 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.3 p -71.25 2.94 4.05 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.959 0.903 . . . . 60.210000000000001 113.3 -171.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.08 -22.07 64.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.658 . . . . 72.209999999999994 110.636 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 10.9 pt-20 -65.76 -30.79 71.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.688 0.795 . . . . 73.519999999999996 110.673 172.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -84.17 -10.34 57.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.128 0.971 . . . . 54.020000000000003 110.928 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.5 tp -65.12 -48.91 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.807 0.843 . . . . 73.420000000000002 111.686 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.51 12.39 29.6 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 73.540000000000006 110.971 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 123.179 0.591 . . . . 63.0 111.471 179.792 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 111.754 0.279 . . . . 63.119999999999997 111.754 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.0 tp -84.23 127.29 33.86 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 121.258 0.552 . . . . 64.120000000000005 110.035 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -110.49 174.95 5.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.625 1.57 . . . . 74.049999999999997 108.652 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.66 141.56 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.744 1.218 . . . . 71.420000000000002 109.46 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.4 137.03 38.47 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.609 0.763 . . . . 50.350000000000001 110.079 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.526 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 73.1 mt -103.97 -20.85 13.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.942 0.897 . . . . 72.219999999999999 111.475 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.98 149.19 49.99 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.021 0.928 . . . . 73.430000000000007 109.552 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.4 119.58 19.69 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.515 -0.92 . . . . 74.349999999999994 108.515 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -129.8 133.6 47.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.222 -0.659 . . . . 73.549999999999997 109.222 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.9 136.23 37.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.534 -1.284 . . . . 74.200000000000003 107.534 169.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.65 136.07 50.81 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.349 1.06 . . . . 62.219999999999999 111.218 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -131.33 26.88 4.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.014 0.925 . . . . 65.430000000000007 112.254 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.46 -165.74 26.36 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.071 -0.513 . . . . 73.230000000000004 112.014 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.73 -42.51 19.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.143 0.577 . . . . 75.430000000000007 112.304 -172.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -101.05 5.07 42.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.632 0.373 . . . . 72.239999999999995 111.767 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -76.27 172.31 13.09 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.698 0.799 . . . . 73.519999999999996 112.044 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.433 ' HB3' HG13 ' A' ' 130' ' ' VAL . 39.5 tp -147.02 130.54 16.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 73.299999999999997 110.138 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -80.77 127.79 32.91 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.336 0.654 . . . . 62.219999999999999 109.86 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.665 HG22 HG21 ' A' ' 123' ' ' THR . 19.5 pt -126.72 154.22 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.549 0.74 . . . . 74.219999999999999 111.684 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -100.68 147.33 26.13 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.616 -1.175 . . . . 73.310000000000002 108.743 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.67 114.16 4.78 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.551 -0.537 . . . . 75.230000000000004 109.551 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.84 -1.34 44.99 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 115.924 -0.58 . . . . 74.109999999999999 113.124 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -79.65 127.18 31.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.951 0.501 . . . . 74.120000000000005 110.493 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -79.3 135.35 36.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.484 0.714 . . . . 61.539999999999999 109.435 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.705 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.64 147.87 30.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.651 0.78 . . . . 52.43 111.26 -174.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -104.93 109.51 21.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.854 0.461 . . . . 72.140000000000001 110.731 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.645 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.4 t -73.05 125.23 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.608 0.363 . . . . 72.239999999999995 110.162 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.9 mt -96.28 -36.76 10.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.877 1.271 . . . . 75.109999999999999 110.237 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.1 144.68 6.89 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.76 -0.655 . . . . 73.200000000000003 111.982 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 29.5 m-85 -89.62 171.11 9.91 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.853 0.835 . . . . 63.100000000000001 111.616 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -68.98 161.02 29.81 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 113.784 -1.553 . . . . 74.099999999999994 108.021 169.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -54.29 -28.52 42.62 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.998 0.919 . . . . 64.420000000000002 113.141 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -106.11 -3.62 21.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.078 0.951 . . . . 73.299999999999997 111.847 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.72 33.38 58.05 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-O 119.818 -0.434 . . . . 72.319999999999993 113.981 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.651 ' HB3' ' HD1' ' A' ' 118' ' ' TRP . 37.6 mt-10 -70.23 -65.69 0.69 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.261 0.531 . . . . 71.219999999999999 110.544 171.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 23.5 m95 -119.65 167.09 12.37 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.277 1.031 . . . . 74.430000000000007 110.176 -171.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.645 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -141.7 131.56 24.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.462 1.105 . . . . 73.040000000000006 109.95 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.76 101.8 4.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -104.64 144.69 31.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.35 0.66 . . . . 73.329999999999998 110.586 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -95.6 105.17 17.13 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.109 -1.071 . . . . 75.040000000000006 108.109 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.705 HG22 ' HB3' ' A' ' 107' ' ' LEU . 62.3 p -97.94 173.53 7.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.618 1.167 . . . . 62.240000000000002 110.152 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -68.69 -21.79 64.4 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.503 -0.772 . . . . 62.439999999999998 109.777 174.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.979 1.312 . . . . 75.299999999999997 111.474 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.11 -170.48 24.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.139 -0.384 . . . . 71.150000000000006 112.139 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -102.33 135.05 44.62 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.415 0.686 . . . . 74.129999999999995 110.554 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 172.34 -175.38 45.54 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 111.261 -0.735 . . . . 34.340000000000003 111.261 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -94.84 132.67 39.4 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.268 0.627 . . . . 74.299999999999997 112.023 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 135' ' ' ILE . 36.0 m -137.72 139.98 28.41 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.75 1.62 . . . . 52.350000000000001 108.816 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 7.7 Cg_exo -71.21 145.35 48.73 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.598 2.198 . . . . 75.540000000000006 113.953 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -38.2 -50.75 1.44 Allowed 'General case' 0 C--N 1.369 1.444 0 C-N-CA 125.405 1.482 . . . . 72.230000000000004 112.763 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -80.66 12.38 3.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.442 1.097 . . . . 74.299999999999997 112.882 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -115.58 -16.13 11.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.36 1.064 . . . . 74.430000000000007 111.481 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 130' ' ' VAL . 21.3 pt -128.91 171.69 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.766 0.826 . . . . 73.109999999999999 111.511 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.8 t -161.71 153.24 15.75 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.649 -0.871 . . . . 71.430000000000007 108.649 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 36.8 Cg_endo -64.08 154.53 69.99 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.685 1.59 . . . . 73.430000000000007 112.067 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.4 t -72.59 -6.96 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-O 121.937 0.875 . . . . 74.450000000000003 110.382 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.54 -19.78 35.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.826 0.85 . . . . 60.350000000000001 111.401 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.6 p -88.42 171.84 9.81 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.338 0.655 . . . . 54.340000000000003 111.738 -172.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.41 -21.55 30.75 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.001 0.92 . . . . 73.049999999999997 110.668 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.86 -17.12 63.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.471 1.108 . . . . 74.109999999999999 111.761 -172.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.418 ' HA ' HD21 ' A' ' 88' ' ' LEU . 23.4 pttm -62.46 -12.53 22.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.66 0.784 . . . . 74.420000000000002 112.371 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -96.68 150.89 20.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.112 0.965 . . . . 74.310000000000002 110.303 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 p -67.33 -43.86 80.52 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.097 0.959 . . . . 72.129999999999995 111.5 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -57.85 -39.77 78.52 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 124.281 0.988 . . . . 74.319999999999993 111.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -77.83 112.67 14.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.062 -0.718 . . . . 73.099999999999994 109.062 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.401 ' HB2' HG21 ' A' ' 151' ' ' VAL . 70.8 m80 -108.53 -2.71 18.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.024 0.53 . . . . 64.010000000000005 111.695 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.41 -145.69 25.51 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 118.88 -0.955 . . . . 53.420000000000002 113.22 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.74 91.75 0.3 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.357 2.705 . . . . 71.140000000000001 111.85 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 148' ' ' HIS . 61.2 t -121.21 144.14 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.724 1.21 . . . . 74.120000000000005 109.005 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.4 p -88.2 167.25 13.75 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.575 0.75 . . . . 74.450000000000003 109.835 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -60.05 -46.79 88.38 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.901 0.48 . . . . 64.109999999999999 111.702 -173.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -65.53 -35.31 80.49 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 123.754 0.659 . . . . 44.210000000000001 111.115 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.33 67.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.091 0.556 . . . . 64.319999999999993 110.87 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 159' ' ' LEU . . . -68.35 -43.86 76.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.604 0.716 . . . . 33.350000000000001 110.885 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.24 -21.31 60.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.2 -0.909 . . . . 60.109999999999999 110.647 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -72.48 -42.35 65.01 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.594 0.757 . . . . 75.219999999999999 110.353 170.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.612 HD12 ' HA ' ' A' ' 156' ' ' ALA . 21.5 mt -56.66 -37.33 70.66 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.276 0.631 . . . . 75.540000000000006 110.674 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 19.6 17.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.415 -0.811 . . . . 75.200000000000003 112.602 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 -35.86 51.22 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.759 -0.83 . . . . 72.239999999999995 108.759 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.5 p -94.54 -15.16 24.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.67 1.188 . . . . 74.219999999999999 111.586 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.18 148.65 50.28 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 123.267 0.355 . . . . 42.350000000000001 113.455 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.4 -178.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.767 . . . . 72.230000000000004 111.398 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.26 123.2 19.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.146 -0.479 . . . . 62.399999999999999 109.88 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.31 7.89 61.73 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.311 -0.716 . . . . 62.310000000000002 113.052 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.5 m -83.71 133.46 34.8 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 118.26 1.03 . . . . 75.239999999999995 110.479 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -139.37 166.34 24.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.095 0.474 . . . . 74.120000000000005 111.146 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -158.5 150.62 21.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.906 -1.043 . . . . 75.409999999999997 109.17 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 182' ' ' ILE . 99.6 t -110.33 140.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 108.596 -0.89 . . . . 64.239999999999995 108.596 167.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 156' ' ' ALA . 52.2 ptt85 -142.6 161.43 38.08 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.045 -0.979 . . . . 74.109999999999999 109.621 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.48 154.67 27.79 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.196 -1.409 . . . . 74.400000000000006 107.196 165.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -79.63 119.2 22.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 62.109999999999999 109.649 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.46 -37.02 85.69 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.609 -0.723 . . . . 73.510000000000005 109.886 168.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 -40.52 97.9 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.273 1.029 . . . . 75.120000000000005 111.659 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.4 m -143.47 94.84 6.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.648 0.779 . . . . 63.130000000000003 109.598 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -59.19 146.91 92.98 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.217 2.611 . . . . 73.129999999999995 112.812 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.06 -30.62 8.3 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.49 -0.777 . . . . 64.409999999999997 112.268 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.82 115.16 15.22 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 109.451 -0.574 . . . . 65.019999999999996 109.451 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -119.68 140.93 49.88 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.292 0.637 . . . . 74.430000000000007 109.441 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 71.1 m -145.24 147.39 32.36 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.065 0.946 . . . . 73.430000000000007 109.864 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.642 HG12 HG22 ' A' ' 170' ' ' VAL . 38.0 mt -102.74 147.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.221 -1.4 . . . . 63.229999999999997 107.221 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.6 m -124.3 113.0 17.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.519 -1.289 . . . . 52.329999999999998 107.519 172.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.0 112.34 24.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.048 0.539 . . . . 74.109999999999999 109.871 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.441 ' HB2' HG22 ' A' ' 190' ' ' VAL . 54.3 ttt180 -79.73 116.5 19.94 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 109.43 -0.581 . . . . 72.140000000000001 109.43 166.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -142.11 141.44 32.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.144 1.377 . . . . 65.420000000000002 107.938 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 54.55 31.05 14.19 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.403 1.081 . . . . 55.32 111.603 -173.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.24 -11.25 50.74 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-N 115.466 -0.788 . . . . 45.399999999999999 114.228 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -104.72 139.5 39.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.585 0.754 . . . . 74.040000000000006 110.129 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 185' ' ' ARG . 51.7 t -95.68 107.26 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.848 0.459 . . . . 71.219999999999999 110.511 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -93.1 132.38 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.471 1.108 . . . . 73.109999999999999 109.211 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -107.52 119.8 40.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.14 0.576 . . . . 71.219999999999999 110.636 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.495 ' HE1' HD21 ' A' ' 232' ' ' LEU . 7.8 m-85 -94.55 146.65 23.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.411 1.084 . . . . 73.120000000000005 109.192 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -100.38 114.72 28.47 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.217 -0.66 . . . . 71.049999999999997 109.217 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mt -85.15 101.06 9.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.198 -1.038 . . . . 53.43 108.198 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.93 121.27 23.94 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.948 -1.024 . . . . 55.340000000000003 108.641 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.7 m -94.23 118.7 31.95 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.343 -0.984 . . . . 70.430000000000007 108.343 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.9 169.54 14.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.867 0.867 . . . . 72.530000000000001 110.621 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.7 p -66.3 -28.51 68.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.839 0.456 . . . . 64.150000000000006 110.918 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.79 -11.3 42.54 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.542 0.737 . . . . 63.25 110.946 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.27 -0.31 25.21 Favored Glycine 0 C--N 1.356 1.683 0 CA-C-O 119.104 -0.831 . . . . 64.409999999999997 115.166 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.412 ' HE2' ' OD1' ' A' ' 212' ' ' ASN . 98.3 mttt -69.36 131.94 45.6 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.398 1.099 . . . . 60.119999999999997 112.155 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -89.22 142.94 27.21 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.037 -1.097 . . . . 62.5 108.037 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.505 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.1 p90 -167.48 138.0 2.92 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.57 0.543 . . . . 73.409999999999997 111.993 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.46 HG23 HD11 ' A' ' 217' ' ' LEU . 68.0 t -89.17 -30.8 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.583 -0.895 . . . . 72.230000000000004 108.583 163.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 14.7 m -93.2 115.58 28.2 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.26 -1.015 . . . . 74.430000000000007 108.26 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.3 t -56.98 -38.14 72.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.481 0.712 . . . . 74.099999999999994 111.863 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.34 -29.6 30.91 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.751 0.82 . . . . 64.430000000000007 111.15 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 58.9 m -102.2 91.28 4.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.062 0.545 . . . . 74.540000000000006 110.289 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.505 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 87.1 mtt180 -91.1 140.62 29.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.511 0.724 . . . . 62.25 109.688 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.2 m-85 -125.75 141.87 51.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.878 -0.786 . . . . 64.129999999999995 108.878 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' A' ' 202' ' ' LYS . 71.4 m-20 -64.75 -38.83 92.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.533 0.521 . . . . 72.319999999999993 110.132 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 63.7 p -123.88 155.33 38.26 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.072 0.939 . . . . 73.209999999999994 111.757 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.02 -24.29 66.72 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 113.869 -1.514 . . . . 74.510000000000005 109.496 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.65 94.83 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.857 0.863 . . . . 65.200000000000003 110.964 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 47.4 mt-10 -72.52 -36.8 68.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.489 0.716 . . . . 75.129999999999995 111.263 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.46 HD11 HG23 ' A' ' 205' ' ' VAL . 14.2 tp -53.91 -57.1 12.22 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.584 0.553 . . . . 72.439999999999998 110.492 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.64 -37.48 80.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 O-C-N 123.736 0.648 . . . . 74.209999999999994 111.413 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.981 0.355 . . . . 75.340000000000003 111.163 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -57.34 -36.83 71.66 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.142 0.901 . . . . 73.129999999999995 109.988 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.693 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.9 m170 -87.29 -12.28 47.04 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 112.513 0.56 . . . . 73.129999999999995 112.513 -175.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.6 p -98.16 -11.12 23.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.89 0.476 . . . . 74.329999999999998 110.575 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.8 p -87.66 -43.16 12.15 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 110.1 -0.334 . . . . 72.319999999999993 110.1 171.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 226' ' ' ASP . 29.1 m -137.46 172.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.461 0.648 . . . . 72.540000000000006 112.71 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.97 14.51 1.37 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.866 2.066 . . . . 63.009999999999998 114.106 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.594 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.0 t70 -42.66 29.8 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 1 C-N-CA 131.799 4.039 . . . . 73.340000000000003 120.073 -152.249 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.49 1.1 10.13 Favored Glycine 0 N--CA 1.483 1.825 0 O-C-N 120.071 -1.643 . . . . 72.129999999999995 112.192 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -92.83 161.96 14.3 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.082 1.353 . . . . 65.120000000000005 109.525 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.52 -37.4 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 N-CA-C 110.177 -0.305 . . . . 72.340000000000003 110.177 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -161.28 169.2 22.58 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.79 0.836 . . . . 70.439999999999998 110.388 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 27.8 m -61.31 135.9 57.87 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.372 1.069 . . . . 74.510000000000005 111.266 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.495 HD21 ' HE1' ' A' ' 193' ' ' TYR . 74.9 mt -69.5 128.11 35.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 74.0 109.701 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -113.39 -78.71 0.58 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.921 0.489 . . . . 53.020000000000003 111.765 -171.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 167' ' ' SER . 33.2 t80 -94.03 124.92 54.74 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.387 1.075 . . . . 63.329999999999998 109.444 -173.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.99 127.56 4.76 Favored 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 122.272 1.981 . . . . 73.129999999999995 111.477 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -65.59 124.52 87.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.273 0.629 . . . . 50.340000000000003 109.499 178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 14.9 Cg_exo -71.33 175.47 9.3 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.975 2.45 . . . . 74.230000000000004 113.11 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.526 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 72.1 mmtt -69.1 130.33 42.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.371 -0.831 . . . . 64.540000000000006 109.106 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -83.47 -59.13 2.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.518 0.562 . . . . 72.25 112.518 -168.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -108.6 132.75 53.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.784 1.234 . . . . 74.420000000000002 110.136 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -81.32 114.92 53.02 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 106.77 -1.567 . . . . 55.229999999999997 106.77 163.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.33 123.64 14.09 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.782 2.322 . . . . 65.239999999999995 111.897 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 20.8 m -74.73 100.21 3.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.818 0.447 . . . . 73.329999999999998 110.071 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.32 106.54 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 107.245 -1.391 . . . . 64.120000000000005 107.245 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.3 107.54 19.12 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.395 -0.224 . . . . 64.329999999999998 110.395 -161.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.27 11.74 7.18 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.76 1.464 . . . . 72.219999999999999 116.76 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -75.32 130.06 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 118.465 1.133 . . . . 72.099999999999994 112.722 -164.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 m -87.65 115.55 63.29 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.378 -2.082 . . . . 31.420000000000002 105.378 144.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 C--N 1.367 1.509 0 C-N-CA 121.006 1.138 . . . . 72.400000000000006 114.952 -169.503 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 1.2 t90 . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 121.967 0.889 . . . . 74.519999999999996 110.931 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -69.78 -31.75 69.85 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.218 -1.355 . . . . 65.230000000000004 109.428 166.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.9 p -80.21 6.28 12.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.921 1.288 . . . . 74.140000000000001 113.048 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.3 -48.16 82.66 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.871 0.468 . . . . 71.400000000000006 110.983 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -71.78 -24.97 61.84 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.217 0.607 . . . . 70.329999999999998 111.172 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 15.6 m120 -88.38 -2.46 58.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.706 0.802 . . . . 54.420000000000002 111.671 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.402 HD13 ' HE1' ' A' ' 146' ' ' TRP . 29.1 tp -61.84 -47.98 82.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.012 0.925 . . . . 65.329999999999998 111.304 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.02 36.1 2.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.142 0.977 . . . . 63.520000000000003 109.87 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 123.529 0.731 . . . . 72.049999999999997 110.938 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.3 p30 . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 112.073 0.397 . . . . 64.230000000000004 112.073 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.1 tp -83.54 120.07 25.48 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.827 -0.805 . . . . 71.239999999999995 108.827 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -109.06 175.2 5.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.33 1.452 . . . . 65.420000000000002 108.717 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.34 135.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.756 1.222 . . . . 44.149999999999999 109.213 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.72 112.98 9.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.98 0.912 . . . . 73.239999999999995 110.404 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.19 -31.55 38.76 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.249 0.62 . . . . 75.049999999999997 111.32 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 55.3 m-85 -126.34 141.71 51.8 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.33 1.052 . . . . 74.030000000000001 108.758 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.96 122.98 27.38 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.83 -0.804 . . . . 72.140000000000001 108.83 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.461 ' HB3' HG12 ' A' ' 101' ' ' ILE . 78.5 t80 -111.66 135.47 52.2 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.524 -0.917 . . . . 71.120000000000005 108.524 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.95 130.17 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.278 -1.379 . . . . 62.100000000000001 107.278 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.96 132.62 53.29 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.119 0.887 . . . . 72.420000000000002 111.669 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -95.34 13.29 26.19 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.34 1.056 . . . . 62.539999999999999 111.189 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.21 -171.65 44.05 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.1 -0.5 . . . . 70.219999999999999 112.014 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -69.93 -41.85 74.06 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.736 0.814 . . . . 74.430000000000007 112.759 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -82.99 -25.92 31.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.951 0.9 . . . . 73.430000000000007 111.522 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -75.72 158.37 32.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.297 0.639 . . . . 74.319999999999993 109.733 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.414 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 53.2 tp -127.82 137.37 52.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.807 0.443 . . . . 70.200000000000003 111.49 -169.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -86.61 118.02 25.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.881 0.872 . . . . 74.420000000000002 110.168 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.629 HG22 HG21 ' A' ' 123' ' ' THR . 31.7 pt -122.12 162.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.812 0.845 . . . . 71.439999999999998 110.349 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -129.16 152.52 48.66 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 72.140000000000001 109.358 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -57.67 136.87 56.89 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.858 0.863 . . . . 72.010000000000005 112.143 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.5 67.77 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 123.586 0.612 . . . . 22.030000000000001 113.993 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.09 130.24 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.284 0.542 . . . . 73.099999999999994 111.237 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.13 123.21 28.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.141 0.977 . . . . 71.420000000000002 109.107 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.791 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -133.69 146.34 50.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.519 0.728 . . . . 72.409999999999997 110.857 -175.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -96.96 112.62 24.29 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.199 0.6 . . . . 71.25 110.447 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.615 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.5 t -79.9 117.33 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.447 0.641 . . . . 65.049999999999997 109.671 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.462 HD12 ' HG3' ' A' ' 120' ' ' GLU . 29.6 mt -89.64 -19.35 24.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.069 1.348 . . . . 71.430000000000007 110.88 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.51 147.42 5.05 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.146 -0.934 . . . . 63.109999999999999 111.375 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.635 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 23.3 m-85 -87.42 178.58 6.78 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.561 0.745 . . . . 74.140000000000001 111.033 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.66 HD21 ' HB2' ' A' ' 117' ' ' GLU . 9.9 p30 -90.54 -174.0 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 70.099999999999994 110.918 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -44.75 -45.31 9.87 Favored 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 126.318 1.847 . . . . 73.340000000000003 114.389 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -115.86 7.81 14.6 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.15 0.58 . . . . 61.5 111.92 174.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.635 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 71.74 30.77 65.7 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 116.939 1.536 . . . . 50.039999999999999 116.939 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.66 ' HB2' HD21 ' A' ' 113' ' ' ASN . 22.4 mt-10 -68.48 -42.96 77.92 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 119.028 1.414 . . . . 61.43 109.972 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.58 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 51.4 m95 -123.05 159.57 28.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 75.099999999999994 110.204 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.615 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.37 138.52 43.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.185 0.994 . . . . 74.109999999999999 110.022 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.1 tp10 -69.36 98.06 1.03 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 106.786 -1.561 . . . . 75.120000000000005 106.786 168.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.91 140.65 38.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.486 0.714 . . . . 73.239999999999995 110.854 -173.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -114.5 107.66 15.81 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.178 -0.919 . . . . 74.329999999999998 108.748 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.791 HG22 ' HB3' ' A' ' 107' ' ' LEU . 72.4 p -116.15 175.52 5.51 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.101 1.361 . . . . 74.0 110.491 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -75.6 -10.4 59.41 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.6 -0.727 . . . . 72.549999999999997 110.466 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -76.93 -22.74 52.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.819 0.848 . . . . 74.530000000000001 110.355 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.78 -160.48 23.24 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 112.233 -0.347 . . . . 31.52 112.233 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -104.09 137.82 41.49 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.983 0.913 . . . . 63.539999999999999 109.625 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 164.46 178.08 37.62 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 121.083 -0.579 . . . . 54.109999999999999 112.971 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -90.24 128.54 36.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.862 0.865 . . . . 71.140000000000001 112.19 -170.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 m -132.17 143.62 49.69 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.137 0.975 . . . . 74.5 108.936 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 6.2 Cg_exo -76.14 146.4 28.68 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 C-N-CA 122.685 2.257 . . . . 65.400000000000006 113.977 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -41.52 -46.92 3.66 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.882 1.673 . . . . 60.210000000000001 113.173 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 9.2 p-10 -75.35 2.52 11.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.661 0.784 . . . . 52.439999999999998 112.871 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.418 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -109.21 -9.63 15.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.681 0.792 . . . . 64.340000000000003 111.507 171.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.2 pt -132.26 175.86 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.904 0.882 . . . . 65.310000000000002 110.782 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 142' ' ' GLU . 9.0 t -162.54 151.7 12.88 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.562 -0.903 . . . . 54.310000000000002 108.562 170.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.7 Cg_endo -60.11 149.56 84.07 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 121.636 1.557 . . . . 72.150000000000006 111.414 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.5 t -73.41 -7.05 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.465 0 CA-C-O 121.617 0.722 . . . . 60.140000000000001 110.119 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -79.49 -8.32 59.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.274 1.03 . . . . 74.450000000000003 112.173 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.2 p -95.6 171.45 8.67 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.499 0.666 . . . . 63.020000000000003 112.612 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.2 mt -85.28 -20.11 30.55 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.806 -1.088 . . . . 74.329999999999998 111.365 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.403 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.6 mp0 -65.82 -21.44 66.48 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.684 0.794 . . . . 73.519999999999996 112.008 -172.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.58 -13.59 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.241 0.616 . . . . 72.319999999999993 112.5 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -90.71 141.75 28.47 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.403 0.681 . . . . 65.549999999999997 109.969 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.6 m -58.5 -39.96 81.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.722 1.209 . . . . 73.109999999999999 112.39 -175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.402 ' HE1' HD13 ' A' ' 73' ' ' LEU . 39.8 p-90 -70.11 -30.51 67.73 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 74.430000000000007 112.811 -175.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -82.55 117.65 22.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.558 -0.534 . . . . 74.209999999999994 109.558 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -112.12 -6.48 14.14 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.272 0.629 . . . . 74.530000000000001 111.681 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.83 -141.22 34.36 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 118.345 -1.253 . . . . 73.239999999999995 112.89 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -59.65 94.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.561 2.841 . . . . 72.319999999999993 113.144 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.652 HG22 HH12 ' A' ' 239' ' ' ARG . 85.6 t -133.93 132.02 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 44.520000000000003 108.905 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.4 p -78.57 173.01 12.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.446 0.699 . . . . 63.210000000000001 110.408 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -60.41 -43.6 96.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.299 0.639 . . . . 75.129999999999995 109.964 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.9 -46.59 88.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.925 0.89 . . . . 61.219999999999999 111.091 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.39 -26.4 63.69 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.028 0.531 . . . . 70.510000000000005 111.441 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.32 62.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.911 0.484 . . . . 51.229999999999997 110.671 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.08 -21.61 61.48 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.764 -0.653 . . . . 61.140000000000001 110.597 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.64 -49.06 72.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.499 0.719 . . . . 72.420000000000002 109.728 170.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.401 HD21 ' HD3' ' A' ' 239' ' ' ARG . 73.9 mt -58.85 -39.22 80.65 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.595 -0.73 . . . . 74.010000000000005 110.947 175.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.8 -3.71 55.8 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.823 1.046 . . . . 63.539999999999999 113.823 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 61.3 p -69.47 -34.21 74.03 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.767 1.167 . . . . 65.420000000000002 110.239 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 p -90.02 9.1 29.3 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.234 1.014 . . . . 70.519999999999996 110.867 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -105.45 156.61 16.61 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 123.996 0.808 . . . . 55.229999999999997 111.723 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 26.8 pt -103.83 -176.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 124.955 1.302 . . . . 62.310000000000002 112.006 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.53 121.25 11.07 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.65 -0.705 . . . . 74.439999999999998 110.02 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.31 10.36 58.36 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 119.394 -0.67 . . . . 63.119999999999997 113.343 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.7 m -86.09 128.71 34.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.713 1.256 . . . . 73.200000000000003 111.148 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 183' ' ' SER . 13.3 p90 -135.52 167.24 21.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.077 0.551 . . . . 71.530000000000001 111.458 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.4 pp -164.22 143.54 7.62 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.008 -0.996 . . . . 73.329999999999998 108.926 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.666 HG22 HG12 ' A' ' 182' ' ' ILE . 90.8 t -98.13 137.86 24.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.439 -0.948 . . . . 72.319999999999993 108.439 167.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.501 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.8 ptt85 -134.3 160.67 37.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.962 1.305 . . . . 70.510000000000005 109.108 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.33 151.42 33.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.977 -1.49 . . . . 62.25 106.977 165.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 t -84.98 123.21 30.27 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.703 -0.851 . . . . 53.439999999999998 108.703 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.59 -35.6 73.11 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.565 -0.531 . . . . 61.5 109.565 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 p -71.64 -34.86 70.14 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.402 -0.817 . . . . 52.43 111.111 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.3 m -124.25 90.66 50.54 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 123.405 0.682 . . . . 62.43 109.943 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.28 127.56 24.43 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.499 2.8 . . . . 75.140000000000001 112.947 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.51 -28.32 15.45 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.915 -0.584 . . . . 75.340000000000003 112.969 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.426 ' HB3' ' NH1' ' A' ' 194' ' ' ARG . 79.2 mm-40 -69.03 115.03 7.86 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.293 -0.632 . . . . 75.299999999999997 109.293 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -119.82 149.22 42.42 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 109.882 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.2 m -148.0 152.12 36.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.806 -1.088 . . . . 64.219999999999999 109.704 -172.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.666 HG12 HG22 ' A' ' 170' ' ' VAL . 23.6 mt -102.47 150.05 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 106.511 -1.663 . . . . 52.530000000000001 106.511 166.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -125.93 107.1 10.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.708 -1.219 . . . . 63.329999999999998 107.708 171.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 168' ' ' PHE . 56.9 tp -107.5 110.91 22.95 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.538 0.608 . . . . 63.5 109.785 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 190' ' ' VAL . 59.1 ttt180 -80.66 121.36 25.76 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.054 0.542 . . . . 71.430000000000007 109.799 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.1 145.73 31.53 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.506 1.522 . . . . 74.549999999999997 107.688 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 57.97 22.39 8.75 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.931 0.892 . . . . 62.43 112.333 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.94 -9.4 72.33 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.333 -0.704 . . . . 72.200000000000003 114.538 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -113.35 150.37 32.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.291 1.045 . . . . 74.129999999999995 109.99 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . 41.8 t -99.08 111.24 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.851 0.46 . . . . 63.509999999999998 110.672 -177.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -93.73 112.22 24.05 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.278 -1.008 . . . . 54.32 108.278 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -89.64 124.49 34.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.714 -0.676 . . . . 75.209999999999994 109.209 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.417 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.0 m-85 -93.65 146.37 23.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.371 -0.974 . . . . 75.239999999999995 108.371 172.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 179' ' ' GLN . 6.8 tpp180 -106.41 120.64 42.42 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.994 -1.113 . . . . 72.099999999999994 107.994 175.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mt -79.03 100.3 3.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.05 -1.092 . . . . 53.25 108.05 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.427 ' N ' HD22 ' A' ' 196' ' ' ASN . 0.8 OUTLIER -80.37 145.34 32.08 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.476 -0.935 . . . . 74.519999999999996 108.476 177.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.6 m -105.87 136.78 44.9 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.122 0.969 . . . . 75.420000000000002 109.355 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.96 178.23 8.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.073 0.949 . . . . 75.200000000000003 110.15 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 p -65.68 -33.48 75.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.128 0.571 . . . . 75.209999999999994 111.706 -174.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.24 -13.53 28.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.643 0.377 . . . . 71.5 111.086 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 115.57 15.12 7.7 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 115.886 1.115 . . . . 42.0 115.886 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -68.99 141.51 54.89 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.291 1.045 . . . . 74.439999999999998 111.654 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.47 141.58 28.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.66 0.784 . . . . 74.030000000000001 109.153 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.572 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.1 p90 -164.98 148.01 8.39 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.54 0.525 . . . . 64.099999999999994 111.72 175.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.423 HG23 HD11 ' A' ' 217' ' ' LEU . 91.4 t -93.43 -40.36 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.174 -1.047 . . . . 75.340000000000003 108.174 164.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.0 m -99.9 125.13 45.84 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.011 -0.995 . . . . 71.430000000000007 108.831 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -62.81 -28.23 69.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.481 0.712 . . . . 54.140000000000001 111.41 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.87 -25.17 62.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.633 1.173 . . . . 74.129999999999995 110.55 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.5 m -129.45 89.94 2.92 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.58 0.752 . . . . 75.519999999999996 110.328 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.572 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 94.3 mtt180 -103.3 134.31 46.91 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.328 -0.619 . . . . 63.409999999999997 109.328 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -119.38 151.15 38.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.97 0.908 . . . . 74.5 108.602 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -74.04 -28.09 61.25 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.573 0.546 . . . . 74.349999999999994 110.468 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.8 p -132.74 156.01 47.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.876 0.87 . . . . 73.549999999999997 112.144 -177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -69.14 -25.88 64.6 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 114.272 -1.331 . . . . 73.349999999999994 109.427 172.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.14 96.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.4 0.68 . . . . 63.310000000000002 110.675 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.71 -41.88 87.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.47 0.708 . . . . 34.030000000000001 111.336 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.423 HD11 HG23 ' A' ' 205' ' ' VAL . 16.7 tp -52.49 -57.13 10.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 123.52 0.512 . . . . 71.209999999999994 111.157 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.84 -46.39 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.641 0.588 . . . . 72.340000000000003 111.415 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -55.72 -55.68 29.34 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.56 0.744 . . . . 75.310000000000002 111.447 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -67.82 -37.84 82.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.991 -1.004 . . . . 75.409999999999997 110.622 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.631 ' HB3' HD11 ' A' ' 228' ' ' LEU . 15.9 m170 -86.63 -4.41 59.17 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.544 0.572 . . . . 74.400000000000006 112.544 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.7 p -93.95 -35.11 12.8 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.595 0.358 . . . . 73.400000000000006 110.706 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 47.5 p -74.81 -42.13 58.64 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 116.061 -0.518 . . . . 74.040000000000006 111.855 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.76 HG23 ' HB2' ' A' ' 226' ' ' ASP . 31.6 m -128.35 158.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.334 0.654 . . . . 60.43 111.131 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.14 15.34 0.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.46 1.904 . . . . 74.439999999999998 114.027 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.76 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.9 t70 -44.47 33.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 1 C-N-CA 132.556 4.343 . . . . 64.329999999999998 119.386 -153.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.34 -0.82 9.61 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 120.07 -1.644 . . . . 51.009999999999998 112.049 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 221' ' ' HIS . 15.4 mt -92.19 161.65 14.64 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.725 1.21 . . . . 74.349999999999994 109.768 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.9 tt -57.61 -37.01 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 O-C-N 123.419 0.449 . . . . 63.039999999999999 110.673 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -161.5 176.23 11.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.162 0.985 . . . . 65.310000000000002 109.682 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -64.29 145.47 55.96 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.853 0.861 . . . . 72.329999999999998 111.931 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.417 HD21 ' HE1' ' A' ' 193' ' ' TYR . 66.8 mt -75.54 119.48 19.65 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 108.606 -0.887 . . . . 70.109999999999999 108.606 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -113.19 -80.05 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.514 0.597 . . . . 72.430000000000007 112.206 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.7 t80 -87.14 120.0 71.22 Favored Pre-proline 0 C--O 1.208 -1.124 0 C-N-CA 124.266 1.027 . . . . 73.140000000000001 108.438 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.33 136.03 9.79 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 121.632 1.555 . . . . 74.140000000000001 110.947 171.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.87 136.6 96.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 108.9 -0.778 . . . . 70.439999999999998 108.9 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.49 171.94 16.03 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.01 1.807 . . . . 73.439999999999998 112.987 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.521 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 73.7 mmtt -70.33 108.54 4.26 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.053 -1.091 . . . . 72.040000000000006 108.053 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.652 HH12 HG22 ' A' ' 151' ' ' VAL . 15.6 ptt-85 -68.83 -62.92 1.18 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.838 1.051 . . . . 72.209999999999994 113.838 -160.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.434 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 63.1 t30 -110.29 154.58 23.26 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.923 0.889 . . . . 75.450000000000003 109.814 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.21 112.66 27.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 106.188 -1.782 . . . . 64.140000000000001 106.188 158.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.482 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 39.3 Cg_exo -60.52 124.54 15.3 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.752 2.301 . . . . 63.539999999999999 112.965 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 16.6 m -65.46 123.56 19.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.502 0.721 . . . . 34.119999999999997 111.179 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.37 124.5 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 108.356 -0.979 . . . . 74.400000000000006 108.356 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -102.46 114.89 29.48 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.462 0.542 . . . . 75.140000000000001 112.462 -164.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.74 44.08 91.7 Favored Glycine 0 N--CA 1.482 1.712 0 O-C-N 124.046 0.841 . . . . 61.509999999999998 115.124 163.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -103.45 124.36 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 114.228 1.196 . . . . 55.109999999999999 114.228 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.3 t -86.09 119.09 71.48 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 104.057 -2.572 . . . . 63.240000000000002 104.057 143.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--N 1.389 2.692 0 CA-C-N 120.965 1.38 . . . . 74.219999999999999 113.0 -158.707 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.9 t90 . . . . . 0 CA--C 1.543 0.704 0 CA-C-O 121.894 0.855 . . . . 71.540000000000006 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.9 p30 -72.51 -14.84 61.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.158 -0.928 . . . . 73.340000000000003 110.848 174.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.6 p -84.0 4.92 27.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.959 0.904 . . . . 72.200000000000003 112.073 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -67.21 -22.71 65.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.764 0.425 . . . . 73.120000000000005 111.021 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.7 pt-20 -68.49 -39.65 81.22 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.161 0.505 . . . . 53.210000000000001 109.837 168.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 8.8 m120 -75.2 -10.24 59.29 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.198 -0.91 . . . . 63.240000000000002 110.972 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.28 -50.93 69.75 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.045 0.938 . . . . 72.319999999999993 110.572 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.62 23.79 13.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.369 0.668 . . . . 74.140000000000001 110.639 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 122.842 0.457 . . . . 73.340000000000003 111.355 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 112.055 0.391 . . . . 75.140000000000001 112.055 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.414 HD21 ' HD3' ' A' ' 106' ' ' LYS . 30.5 tp -81.85 128.13 33.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.22 -0.659 . . . . 75.0 109.22 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -111.66 172.96 6.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.819 1.247 . . . . 73.530000000000001 108.684 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.75 138.21 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.279 1.032 . . . . 62.030000000000001 109.434 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.87 131.28 41.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 63.109999999999999 110.336 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.497 HD13 ' NZ ' ' A' ' 238' ' ' LYS . 77.5 mt -98.7 -26.56 14.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 65.109999999999999 111.329 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.424 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 48.6 m-85 -125.53 148.66 48.82 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.966 0.906 . . . . 74.340000000000003 108.739 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.2 136.33 46.37 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.61 -0.885 . . . . 74.230000000000004 108.61 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HB3' HG12 ' A' ' 101' ' ' ILE . 82.3 t80 -129.79 133.36 46.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.534 -1.284 . . . . 63.43 107.534 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -103.65 137.14 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 107.248 -1.39 . . . . 34.420000000000002 107.248 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.28 114.23 3.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.242 0.617 . . . . 74.040000000000006 110.942 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -86.91 -51.44 6.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.852 0.861 . . . . 63.43 109.64 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.92 -177.14 38.04 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 115.279 -0.873 . . . . 71.019999999999996 112.261 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.62 -32.88 60.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.772 0.829 . . . . 71.099999999999994 111.645 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.462 HD21 ' HG2' ' A' ' 249' ' ' PRO . 29.3 p-10 -92.32 -20.43 21.1 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.034 0.534 . . . . 71.129999999999995 111.689 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 78.0 p -71.1 154.16 41.97 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.549 0.53 . . . . 75.319999999999993 109.834 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 128' ' ' GLY . 49.5 tp -128.28 124.36 36.4 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.731 0.412 . . . . 55.240000000000002 111.417 -164.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 m -68.36 117.71 10.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.566 0.746 . . . . 74.349999999999994 110.848 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -119.24 154.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.475 0.71 . . . . 65.25 111.739 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 21.6 m -99.18 147.87 24.67 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.333 -1.303 . . . . 74.200000000000003 109.108 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.93 125.77 26.45 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.74 -0.467 . . . . 74.340000000000003 109.74 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.0 1.66 79.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 116.1 -0.5 . . . . 54.229999999999997 113.278 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 80.9 tt0 -84.9 121.24 27.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.381 0.59 . . . . 74.329999999999998 110.071 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.414 ' HD3' HD21 ' A' ' 84' ' ' LEU . 56.8 mttp -73.87 142.82 46.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.379 0.672 . . . . 74.120000000000005 110.155 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.33 150.01 32.85 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.452 1.101 . . . . 73.319999999999993 110.142 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -100.15 108.36 20.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.039 -0.726 . . . . 65.209999999999994 109.039 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.489 HG13 ' HB1' ' A' ' 119' ' ' ALA . 69.7 t -74.84 119.99 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.174 -0.676 . . . . 63.340000000000003 109.174 174.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.712 HD11 ' HG3' ' A' ' 122' ' ' GLN . 14.2 mt -82.07 -54.08 5.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.267 -1.333 . . . . 63.539999999999999 108.019 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.38 152.92 22.68 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.886 -1.052 . . . . 74.510000000000005 112.978 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.781 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 44.9 m-85 -89.29 174.72 7.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.903 0.881 . . . . 62.340000000000003 111.609 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.35 -173.59 4.8 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.13 0.972 . . . . 75.030000000000001 110.389 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -50.7 -39.47 51.43 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 113.741 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -111.16 2.08 17.62 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.453 0.701 . . . . 51.409999999999997 111.563 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.781 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.18 30.35 73.71 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.421 0.928 . . . . 65.340000000000003 115.421 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.48 -27.49 14.86 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.81 0.805 . . . . 75.319999999999993 110.889 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 28.2 m95 -114.38 152.18 31.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.317 1.047 . . . . 63.43 109.81 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.489 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.22 148.21 46.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.262 0.625 . . . . 55.140000000000001 111.26 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -96.64 118.86 34.03 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.434 -1.321 . . . . 73.209999999999994 107.434 166.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -132.8 151.12 52.07 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.141 0.976 . . . . 64.439999999999998 111.026 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.712 ' HG3' HD11 ' A' ' 110' ' ' LEU . 98.4 mt-30 -100.58 105.23 16.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.828 0.851 . . . . 75.099999999999994 109.243 175.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 107' ' ' LEU . 40.9 p -98.4 176.5 5.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.743 1.217 . . . . 73.340000000000003 110.649 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -64.76 -20.32 66.29 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.588 -0.733 . . . . 70.010000000000005 110.728 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -80.49 -32.1 37.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.882 0.873 . . . . 63.240000000000002 111.185 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 144.73 -168.78 26.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.829 -0.428 . . . . 51.100000000000001 112.153 -171.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -104.32 132.25 50.77 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.268 0.627 . . . . 63.5 110.414 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.47 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 177.83 -165.49 35.12 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 111.775 -0.53 . . . . 72.129999999999995 111.775 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -100.12 121.75 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.598 0.962 . . . . 72.549999999999997 113.598 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 101' ' ' ILE . 18.1 m -132.69 136.76 28.36 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.246 1.418 . . . . 53.530000000000001 108.487 170.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 81.8 Cg_endo -85.45 155.21 10.65 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 122.074 1.85 . . . . 72.120000000000005 114.887 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -38.77 -47.23 1.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 126.199 1.8 . . . . 74.430000000000007 114.443 173.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -77.58 0.02 24.65 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.794 0.838 . . . . 72.129999999999995 112.665 -172.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 12.1 m-85 -105.6 -18.54 14.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.16 0.984 . . . . 74.25 111.459 171.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 109' ' ' VAL . 12.7 pt -123.97 175.67 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.889 0.876 . . . . 61.329999999999998 111.672 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 142' ' ' GLU . 12.0 t -161.41 150.82 13.69 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 123.797 0.839 . . . . 72.409999999999997 109.818 172.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.26 145.48 96.07 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.667 1.578 . . . . 73.349999999999994 111.853 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 41.7 t -73.78 -4.63 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 124.018 0.927 . . . . 73.420000000000002 110.797 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -91.26 -18.61 24.11 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 62.43 111.905 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 99.6 p -91.71 179.09 5.73 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.866 0.467 . . . . 61.210000000000001 111.607 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.0 mt -84.45 -22.75 30.22 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.812 0.845 . . . . 71.109999999999999 111.665 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.402 ' HB2' ' OG1' ' A' ' 136' ' ' THR . 2.0 mp0 -66.97 -17.98 65.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.508 0.723 . . . . 72.310000000000002 112.173 -171.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -64.09 -13.56 48.43 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.272 0.629 . . . . 72.329999999999998 112.104 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -97.53 148.58 23.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.163 0.985 . . . . 73.400000000000006 109.859 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.2 p -64.98 -41.41 95.45 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.094 0.871 . . . . 72.209999999999994 111.582 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -60.92 -38.44 85.78 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.023 0.749 . . . . 54.420000000000002 113.023 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.93 100.51 11.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.529 -0.915 . . . . 74.430000000000007 108.529 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.479 ' HB2' HG21 ' A' ' 151' ' ' VAL . 77.1 m80 -96.41 8.78 43.17 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.277 0.473 . . . . 74.549999999999997 112.277 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.459 ' O ' HG23 ' A' ' 151' ' ' VAL . . . 69.27 -145.54 42.83 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 118.631 -1.094 . . . . 74.299999999999997 112.498 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.92 106.17 0.91 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.801 2.334 . . . . 51.420000000000002 111.963 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.634 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 14.5 t -123.12 131.96 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.642 0.777 . . . . 75.109999999999999 110.236 -177.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 151' ' ' VAL . 66.2 p -77.83 152.75 33.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.827 -0.805 . . . . 74.219999999999999 108.827 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -55.81 -38.63 70.23 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.124 0.416 . . . . 73.219999999999999 112.124 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -58.08 -45.21 87.53 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.966 0.791 . . . . 74.129999999999995 111.138 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.82 75.75 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.677 -0.692 . . . . 55.030000000000001 111.179 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.15 68.95 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.463 0.649 . . . . 72.200000000000003 111.524 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -75.83 -19.72 58.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.306 0.642 . . . . 52.539999999999999 110.926 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -67.21 -44.3 79.92 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.653 0.781 . . . . 73.519999999999996 110.28 168.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.648 HD21 ' HB3' ' A' ' 239' ' ' ARG . 53.5 mt -60.19 -38.08 82.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.34 0.656 . . . . 74.310000000000002 111.187 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.98 20.72 10.74 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.464 -0.789 . . . . 74.010000000000005 112.321 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.0 p -66.35 -40.96 90.15 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.926 0.393 . . . . 65.439999999999998 110.977 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.4 p -104.96 14.61 29.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.277 1.031 . . . . 73.209999999999994 111.399 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.63 163.91 50.25 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 114.404 0.522 . . . . 53.210000000000001 114.404 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 17.9 pt -109.18 -175.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.618 1.167 . . . . 74.150000000000006 111.223 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 4.5 m-20 -56.64 123.81 16.16 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.295 -0.866 . . . . 72.519999999999996 110.432 171.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.454 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 88.01 10.98 68.3 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.755 -0.657 . . . . 54.409999999999997 113.393 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.7 m -81.0 118.13 22.21 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.434 1.117 . . . . 72.340000000000003 110.296 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.512 ' HB3' HD13 ' A' ' 184' ' ' LEU . 13.7 p90 -129.6 171.45 12.6 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.391 0.615 . . . . 74.230000000000004 112.557 -168.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.74 146.7 6.93 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 113.884 -1.507 . . . . 73.109999999999999 109.336 171.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.697 HG22 HG12 ' A' ' 182' ' ' ILE . 93.7 t -100.39 131.87 47.09 Favored 'Isoleucine or valine' 0 C--O 1.261 1.659 0 N-CA-C 108.567 -0.901 . . . . 64.239999999999995 108.567 167.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.634 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt85 -116.5 133.83 55.56 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.645 -1.161 . . . . 72.200000000000003 109.115 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.6 tp10 -84.95 145.72 27.61 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.4 1.08 . . . . 71.340000000000003 108.2 166.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.5 t -83.02 126.69 32.82 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.339 -0.615 . . . . 61.119999999999997 109.339 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.47 -40.99 93.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.028 0.531 . . . . 71.239999999999995 109.929 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.8 p -70.09 -25.76 63.66 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 50.130000000000003 111.307 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 66.5 m -145.43 91.88 5.69 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 122.678 0.391 . . . . 73.230000000000004 111.68 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.79 136.18 68.59 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.44 2.093 . . . . 45.210000000000001 111.625 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.23 -24.7 31.2 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 112.127 -173.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -95.78 114.76 26.52 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.743 -0.836 . . . . 71.129999999999995 108.743 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.635 HH11 HD12 ' A' ' 214' ' ' LEU . 94.4 mtt180 -131.29 157.15 44.07 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.221 0.608 . . . . 64.439999999999998 110.947 -171.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.5 m -145.36 147.85 32.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.636 0.774 . . . . 74.299999999999997 109.227 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.697 HG12 HG22 ' A' ' 170' ' ' VAL . 24.6 mt -103.96 125.84 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.923 -0.769 . . . . 75.200000000000003 108.923 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 14.5 m -96.72 110.21 22.7 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.691 -1.226 . . . . 63.439999999999998 107.691 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 168' ' ' PHE . 54.8 tp -116.54 111.79 20.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.22 1.008 . . . . 71.5 109.739 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -81.59 127.69 33.14 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.178 0.991 . . . . 73.329999999999998 111.087 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 88.5 t80 -143.03 136.76 28.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.258 1.423 . . . . 72.109999999999999 107.947 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 53.78 29.18 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.208 1.003 . . . . 75.25 112.499 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.34 -12.6 64.28 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.035 -0.869 . . . . 73.099999999999994 114.669 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -97.81 146.43 25.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.212 1.006 . . . . 65.329999999999998 109.608 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.99 112.69 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 122.572 0.349 . . . . 71.319999999999993 110.1 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -97.94 143.87 28.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.716 1.207 . . . . 74.450000000000003 109.11 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -130.13 118.29 21.24 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.354 0.524 . . . . 72.430000000000007 110.227 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.584 ' CE1' HD22 ' A' ' 228' ' ' LEU . 0.6 OUTLIER -121.24 131.72 54.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.497 0.719 . . . . 75.109999999999999 111.045 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 21.4 tpp85 -70.72 131.27 43.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.428 1.091 . . . . 70.25 111.519 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.58 104.95 11.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.184 -1.043 . . . . 61.299999999999997 108.184 166.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -78.35 138.05 38.35 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.908 -0.775 . . . . 43.109999999999999 108.908 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -111.05 117.25 32.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.66 -0.867 . . . . 71.400000000000006 108.66 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.66 171.49 11.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.537 0.735 . . . . 74.049999999999997 111.258 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 12.8 p -64.52 -26.62 68.5 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.928 0.891 . . . . 74.230000000000004 112.639 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -81.75 -14.47 56.41 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.567 0.747 . . . . 74.140000000000001 111.828 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.44 11.19 39.33 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 119.802 -0.443 . . . . 72.310000000000002 113.432 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.403 ' HE2' ' OD1' ' A' ' 212' ' ' ASN . 98.2 mttt -79.39 132.61 36.45 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 116.901 0.35 . . . . 75.209999999999994 110.922 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.24 146.92 26.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.537 -0.912 . . . . 73.340000000000003 108.537 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.2 p90 -170.27 142.77 2.26 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.379 0.425 . . . . 75.209999999999994 111.128 176.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -89.49 -35.85 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.469 -0.937 . . . . 72.549999999999997 108.469 163.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.6 m -105.5 124.34 49.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.062 0.945 . . . . 73.409999999999997 109.474 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.4 t -65.03 -21.9 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.367 0.667 . . . . 64.209999999999994 111.435 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -66.18 -26.6 67.48 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.275 1.43 . . . . 64.310000000000002 111.459 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.3 m -144.22 106.67 4.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.192 0.597 . . . . 51.43 110.248 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 84.5 mtt180 -104.23 143.37 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.347 1.059 . . . . 55.229999999999997 109.206 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.641 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 6.3 m-85 -125.84 136.34 52.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.05 0.54 . . . . 71.040000000000006 110.073 -167.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.403 ' OD1' ' HE2' ' A' ' 202' ' ' LYS . 78.8 m-20 -57.51 -34.34 68.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.956 0.902 . . . . 71.430000000000007 111.031 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.3 p -131.2 154.4 48.45 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 122.016 0.912 . . . . 71.150000000000006 111.582 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.635 HD12 HH11 ' A' ' 180' ' ' ARG . 0.8 OUTLIER -62.65 -23.98 67.38 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.008 -1.451 . . . . 64.340000000000003 109.309 170.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.92 94.21 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.753 0.821 . . . . 55.210000000000001 111.005 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 53.9 mt-10 -72.92 -35.01 66.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.999 0.519 . . . . 60.329999999999998 111.021 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.35 -57.31 11.75 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.414 0.446 . . . . 74.319999999999993 110.053 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.88 -37.72 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 123.839 0.712 . . . . 64.239999999999995 111.54 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -63.32 -59.22 5.0 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.081 0.238 . . . . 74.239999999999995 111.572 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -63.47 -33.02 74.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.352 0.408 . . . . 73.129999999999995 110.942 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.645 ' HB3' HD11 ' A' ' 228' ' ' LEU . 16.5 m170 -88.96 -7.19 56.5 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.433 0.531 . . . . 63.329999999999998 112.433 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -88.23 -35.77 17.13 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.199 0.454 . . . . 70.400000000000006 110.273 168.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 54.0 p -68.98 -47.45 65.57 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.503 -0.771 . . . . 25.41 110.765 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -131.67 164.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.835 0.826 . . . . 63.299999999999997 112.445 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.33 13.87 1.08 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.864 2.066 . . . . 54.43 114.69 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.549 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.5 t70 -42.18 30.57 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 131.56 3.944 . . . . 64.439999999999998 119.409 -152.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.37 1.49 9.26 Favored Glycine 0 N--CA 1.486 2.031 0 O-C-N 120.065 -1.647 . . . . 61.210000000000001 112.354 -170.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 221' ' ' HIS . 9.6 mt -91.87 163.97 13.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.174 1.389 . . . . 73.340000000000003 108.839 169.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 11.4 tt -61.57 -35.98 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-O 120.67 0.271 . . . . 61.140000000000001 110.808 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -157.48 -179.07 7.82 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.513 0.725 . . . . 71.420000000000002 110.322 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.8 p -67.32 146.94 53.59 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.748 0.819 . . . . 72.0 111.68 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 80.8 mt -79.03 92.44 4.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 108.874 -0.788 . . . . 74.420000000000002 108.874 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -88.93 -65.1 1.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.686 0.795 . . . . 74.420000000000002 112.231 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -108.75 120.9 44.79 Favored Pre-proline 0 C--O 1.216 -0.68 0 C-N-CA 124.749 1.22 . . . . 74.439999999999998 109.451 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.51 129.96 4.39 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.009 1.806 . . . . 73.439999999999998 111.965 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -69.22 135.71 89.09 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.058 0.543 . . . . 64.450000000000003 110.664 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 10.6 Cg_exo -72.27 172.74 14.26 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.825 2.35 . . . . 75.109999999999999 111.999 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.497 ' NZ ' HD13 ' A' ' 88' ' ' LEU . 33.7 mmtp -71.27 145.59 49.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.02 0.528 . . . . 72.430000000000007 111.478 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.648 ' HB3' HD21 ' A' ' 159' ' ' LEU . 20.8 ptt-85 -82.68 -63.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.248 0.833 . . . . 71.140000000000001 113.248 -163.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.533 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.0 t30 -113.39 130.51 56.28 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.015 0.926 . . . . 73.230000000000004 110.707 -174.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.73 113.41 32.12 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 107.484 -1.302 . . . . 73.439999999999998 107.484 164.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.65 124.44 13.68 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.892 2.394 . . . . 65.400000000000006 113.556 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 88.2 m -76.9 123.4 26.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.983 -0.747 . . . . 75.439999999999998 108.983 173.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.411 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 47.9 t -92.58 114.54 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.384 -0.969 . . . . 71.420000000000002 108.384 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -95.2 112.33 24.05 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.565 -0.255 . . . . 75.209999999999994 111.306 -167.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.68 5.92 2.23 Favored Glycine 0 CA--C 1.542 1.773 0 N-CA-C 118.28 2.072 . . . . 53.310000000000002 118.28 161.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.43 143.81 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.63 1.715 . . . . 65.030000000000001 111.615 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.6 t -77.54 128.91 78.7 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.592 -1.262 . . . . 62.119999999999997 107.592 167.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.462 ' HG2' HD21 ' A' ' 97' ' ' ASN . 78.5 Cg_exo . . . . . 0 C--N 1.385 2.483 0 C-N-CA 122.703 2.269 . . . . 74.340000000000003 113.737 -167.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.9 t90 . . . . . 0 C--O 1.242 0.678 0 N-CA-C 108.932 -0.766 . . . . 73.329999999999998 108.932 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -65.93 -25.13 67.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.853 -1.067 . . . . 63.009999999999998 110.419 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.5 m -75.3 4.45 7.11 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.967 1.307 . . . . 74.5 113.155 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -69.99 -33.82 72.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.332 0.515 . . . . 73.439999999999998 110.902 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.75 -36.12 43.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.947 0.499 . . . . 63.420000000000002 110.126 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -74.03 -7.28 51.89 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.626 0.77 . . . . 52.439999999999998 111.523 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.75 -23.95 67.57 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.63 1.172 . . . . 74.129999999999995 111.322 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.55 14.3 20.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.927 0.891 . . . . 61.020000000000003 110.968 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.156 0.582 . . . . 73.019999999999996 111.307 177.691 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 CA--C 1.565 1.528 0 CA-C-O 121.59 0.709 . . . . 72.340000000000003 111.156 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.547 HD21 ' HD3' ' A' ' 106' ' ' LYS . 36.4 tp -85.07 131.41 34.46 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.368 -0.833 . . . . 74.299999999999997 110.339 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.0 m-85 -111.24 172.64 6.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.507 1.123 . . . . 71.420000000000002 108.443 173.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.41 137.22 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.215 1.006 . . . . 73.519999999999996 109.376 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.75 122.17 21.97 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.515 0.726 . . . . 74.349999999999994 110.8 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.4 mt -76.69 -35.87 57.6 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.708 0.803 . . . . 72.519999999999996 110.811 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.452 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 20.1 m-85 -124.31 168.21 13.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.2 -0.909 . . . . 72.030000000000001 109.888 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.65 117.71 24.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.207 -1.035 . . . . 75.150000000000006 108.207 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.662 ' HB3' HG12 ' A' ' 101' ' ' ILE . 61.3 t80 -106.46 131.55 53.51 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.374 -1.343 . . . . 64.420000000000002 107.374 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.14 133.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.871 -0.788 . . . . 65.109999999999999 108.871 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.33 123.2 20.56 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.279 0.631 . . . . 44.409999999999997 109.871 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 p -86.23 -16.31 38.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.601 0.76 . . . . 65.099999999999994 110.997 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -158.83 -173.7 27.58 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.621 -0.718 . . . . 75.400000000000006 111.483 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -69.46 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.964 0.905 . . . . 63.030000000000001 111.669 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -73.68 -27.5 61.26 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.58 1.152 . . . . 71.129999999999995 112.131 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.2 p -93.36 169.11 10.62 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.723 0.809 . . . . 65.409999999999997 109.744 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 65.6 tp -136.06 128.8 30.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.696 0.398 . . . . 72.209999999999994 111.424 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 m -72.79 116.61 13.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.708 HG22 HG21 ' A' ' 123' ' ' THR . 27.1 pt -120.72 149.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.356 0.662 . . . . 71.349999999999994 110.04 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.4 m -102.12 142.2 33.75 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.306 -0.861 . . . . 63.130000000000003 110.256 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -59.2 114.45 2.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.735 0.814 . . . . 50.310000000000002 110.291 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.83 0.12 39.2 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.688 -0.687 . . . . 72.430000000000007 112.78 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.17 121.16 27.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.287 0.544 . . . . 44.450000000000003 111.294 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HD3' HD21 ' A' ' 84' ' ' LEU . 62.7 mttp -70.83 130.39 41.56 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.797 0.839 . . . . 74.219999999999999 109.009 169.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.739 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.14 138.38 31.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.392 0.677 . . . . 74.409999999999997 110.464 -176.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 40.9 ttm180 -89.49 108.56 19.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.928 0.491 . . . . 64.140000000000001 110.068 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.663 HG13 ' HB1' ' A' ' 119' ' ' ALA . 4.6 t -78.61 117.88 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.347 0.659 . . . . 63.119999999999997 110.099 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.3 mt -90.3 -49.12 6.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.101 0.96 . . . . 73.230000000000004 110.229 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.67 144.56 9.47 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 115.38 -0.827 . . . . 71.450000000000003 111.606 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 25.0 m-85 -87.86 168.77 12.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.655 0.782 . . . . 74.540000000000006 111.252 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -88.71 -172.19 3.62 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.681 -1.145 . . . . 73.150000000000006 110.982 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -41.95 -44.72 3.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.838 1.655 . . . . 73.109999999999999 114.506 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -114.34 6.42 16.07 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.174 0.805 . . . . 73.310000000000002 113.174 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.56 16.14 80.59 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.252 -0.749 . . . . 54.530000000000001 114.711 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.77 -66.85 0.81 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.92 0.86 . . . . 74.299999999999997 109.668 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -90.68 131.91 36.1 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.926 0.49 . . . . 70.319999999999993 111.187 -168.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.663 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -124.5 139.14 54.16 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.208 1.003 . . . . 62.520000000000003 109.7 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.659 ' HG2' HE21 ' A' ' 127' ' ' GLN . 25.4 tt0 -73.44 110.41 7.7 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.115 -1.069 . . . . 74.209999999999994 108.115 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -101.61 143.78 31.15 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.591 0.756 . . . . 74.450000000000003 109.513 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 35.4 tt0 -102.66 104.5 14.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.138 -1.392 . . . . 74.430000000000007 107.504 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.739 HG22 ' HB3' ' A' ' 107' ' ' LEU . 58.7 p -112.17 166.83 10.91 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.282 1.033 . . . . 75.329999999999998 110.391 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -72.51 -17.49 61.73 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.796 -1.093 . . . . 72.409999999999997 109.536 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -75.23 -27.44 59.51 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.632 1.173 . . . . 75.510000000000005 111.088 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.16 -155.06 25.37 Favored Glycine 0 C--N 1.358 1.799 0 CA-C-O 120.246 -0.197 . . . . 75.540000000000006 112.969 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.659 HE21 ' HG2' ' A' ' 120' ' ' GLU . 56.8 tp60 -116.29 137.66 51.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.425 0.613 . . . . 72.319999999999993 110.516 -174.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 161.98 170.87 27.33 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 120.249 -0.976 . . . . 74.319999999999993 114.215 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -87.49 129.87 34.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.418 0.687 . . . . 64.040000000000006 111.783 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -137.68 145.2 47.75 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 74.310000000000002 109.106 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.47 151.81 7.75 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 122.402 2.068 . . . . 52.32 114.917 -170.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.0 m -40.47 -30.79 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.133 2.173 . . . . 74.400000000000006 114.69 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.523 HD21 HG22 ' A' ' 244' ' ' VAL . 29.6 p30 -78.97 -27.02 43.42 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.111 0.565 . . . . 74.120000000000005 112.191 -175.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.452 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -91.4 -16.23 27.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.542 0.737 . . . . 75.010000000000005 112.05 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.6 pt -122.8 176.32 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.724 0.81 . . . . 72.510000000000005 111.122 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.0 m -160.03 136.67 6.54 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.649 1.18 . . . . 63.119999999999997 109.083 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 29.1 Cg_endo -59.98 134.9 59.42 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 121.942 1.762 . . . . 72.450000000000003 111.488 173.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.04 -7.33 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.557 0.743 . . . . 35.329999999999998 110.637 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -75.93 -23.44 55.45 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.292 0.637 . . . . 72.150000000000006 111.811 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.3 p -94.59 173.92 7.37 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.173 0.511 . . . . 74.239999999999995 111.91 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 mt -82.79 -19.51 37.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.341 1.056 . . . . 73.209999999999994 111.37 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.66 -18.89 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.207 1.003 . . . . 65.310000000000002 112.19 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -62.58 -25.55 68.13 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.174 0.589 . . . . 72.030000000000001 111.772 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -78.04 136.97 38.02 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.504 -0.771 . . . . 73.510000000000005 110.226 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 m -57.36 -36.58 71.38 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.212 1.005 . . . . 75.239999999999995 112.311 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -67.72 -28.8 67.97 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.917 0.761 . . . . 70.439999999999998 112.621 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.411 ' O ' ' HE2' ' A' ' 238' ' ' LYS . 20.9 t80 -89.14 98.59 11.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.774 -0.824 . . . . 65.140000000000001 108.774 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.541 ' HB2' HG21 ' A' ' 151' ' ' VAL . 65.8 m80 -91.69 -9.04 45.3 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.752 0.421 . . . . 74.439999999999998 111.788 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 150' ' ' PRO . . . 75.04 -126.91 9.02 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 118.317 -1.269 . . . . 44.329999999999998 113.175 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 149' ' ' GLY . 10.1 Cg_exo -69.24 88.31 0.48 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 123.25 2.633 . . . . 60.32 112.185 -175.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 43.4 t -126.95 133.46 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.946 0.898 . . . . 74.430000000000007 109.494 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 p -86.46 171.1 11.36 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.025 0.93 . . . . 72.099999999999994 109.808 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -62.16 -42.31 99.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 110.002 -0.37 . . . . 72.439999999999998 110.002 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.27 -48.26 76.94 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.235 0.959 . . . . 73.409999999999997 110.867 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.3 69.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.236 0.614 . . . . 71.340000000000003 111.735 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.39 75.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 63.450000000000003 111.311 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.97 -20.98 47.81 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.544 -0.753 . . . . 71.230000000000004 110.677 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -37.12 81.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.111 0.964 . . . . 71.0 110.084 170.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 239' ' ' ARG . 67.4 mt -68.97 -51.69 36.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.99 0.516 . . . . 75.530000000000001 110.673 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.464 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 80.7 mt -83.75 11.95 6.69 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.563 0.579 . . . . 64.409999999999997 112.563 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.7 p -62.05 -37.47 85.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.904 0.482 . . . . 75.519999999999996 111.663 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.5 m -111.28 18.62 19.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.678 0.791 . . . . 74.420000000000002 110.739 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 152.06 41.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 112.818 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.8 pt -87.74 -177.67 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.313 0.645 . . . . 53.340000000000003 110.533 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -62.48 125.68 24.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.899 -0.591 . . . . 61.329999999999998 110.472 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 233' ' ' HIS . . . 84.22 10.92 79.45 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.05 -0.977 . . . . 44.530000000000001 113.29 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.6 m -67.67 139.16 56.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.272 1.036 . . . . 63.229999999999997 109.703 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.474 ' HB3' HD12 ' A' ' 184' ' ' LEU . 18.1 p90 -149.17 166.49 28.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.804 0.729 . . . . 73.549999999999997 111.76 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.1 pp -161.84 135.6 6.53 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.841 -1.072 . . . . 75.099999999999994 109.724 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.668 HG22 HG12 ' A' ' 182' ' ' ILE . 74.5 t -91.66 141.55 14.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 N-CA-C 108.3 -1.0 . . . . 75.129999999999995 108.3 167.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.568 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 46.0 ptt85 -144.95 153.38 41.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.242 -0.89 . . . . 71.200000000000003 109.983 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -115.2 148.45 39.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.224 1.009 . . . . 70.319999999999993 108.393 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.8 t -78.67 125.4 29.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.07 0.548 . . . . 74.25 110.103 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.12 -41.77 88.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.172 0.989 . . . . 71.5 110.489 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 57.8 p -80.53 -25.17 38.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.496 0.718 . . . . 71.549999999999997 111.806 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.7 m -124.6 95.63 42.47 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.511 0.724 . . . . 72.519999999999996 110.668 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.81 139.61 81.09 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.211 2.608 . . . . 74.25 112.215 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.64 -28.38 4.9 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.279 -0.419 . . . . 71.450000000000003 113.06 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -75.67 116.18 16.11 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 117.062 0.431 . . . . 50.409999999999997 110.345 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.667 HH11 HD12 ' A' ' 214' ' ' LEU . 89.5 mtt180 -126.12 150.75 48.01 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.087 0.955 . . . . 72.299999999999997 109.281 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.4 m -149.41 153.75 37.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.098 0.959 . . . . 63.420000000000002 109.494 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.668 HG12 HG22 ' A' ' 170' ' ' VAL . 26.7 mt -110.9 149.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.107 -1.071 . . . . 71.510000000000005 108.107 172.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 55.0 m -121.75 115.4 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.34 -1.355 . . . . 41.030000000000001 107.34 169.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 168' ' ' PHE . 14.7 tp -108.45 112.76 25.33 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.569 0.622 . . . . 73.140000000000001 109.956 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 23.3 ttt180 -81.68 112.02 18.48 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 109.752 -0.462 . . . . 65.439999999999998 109.752 165.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -136.36 143.96 44.35 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 106.85 -1.537 . . . . 74.230000000000004 106.85 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 61.38 21.21 11.8 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.178 0.991 . . . . 74.439999999999998 111.815 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.07 1.35 68.22 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.976 -0.347 . . . . 71.019999999999996 113.759 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 71.6 mtp180 -105.66 139.31 40.45 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.683 1.193 . . . . 62.439999999999998 109.251 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.9 t -100.13 105.61 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.051 0.453 . . . . 62.210000000000001 110.147 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -90.98 120.15 31.74 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.862 1.265 . . . . 74.219999999999999 109.229 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -95.32 120.69 36.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.62 0.368 . . . . 70.120000000000005 110.462 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -96.95 147.28 24.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.739 1.215 . . . . 65.239999999999995 109.854 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 19.7 tpp180 -101.84 113.17 26.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.323 0.649 . . . . 72.310000000000002 109.277 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.1 mt -82.63 102.12 8.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.828 -1.175 . . . . 41.32 107.828 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -78.34 107.86 11.27 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.799 -1.091 . . . . 60.450000000000003 108.513 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.8 m -79.44 109.11 13.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.301 -1.0 . . . . 74.239999999999995 108.301 170.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.64 167.7 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.383 0.673 . . . . 64.209999999999994 110.731 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 21.7 p -60.83 -26.3 67.25 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.27 1.028 . . . . 62.109999999999999 113.186 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -94.29 -18.08 22.0 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.482 0.713 . . . . 63.420000000000002 111.502 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.5 10.78 16.39 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-O 119.535 -0.591 . . . . 61.539999999999999 113.662 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.631 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 96.3 mttt -76.68 127.26 32.45 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.643 0.721 . . . . 72.349999999999994 110.239 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.24 145.53 24.93 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.679 -0.86 . . . . 74.230000000000004 108.679 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.596 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 43.8 p90 -163.36 129.81 3.3 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.421 0.45 . . . . 62.149999999999999 111.162 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 60.1 t -72.87 -41.79 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.807 -0.812 . . . . 74.200000000000003 108.807 164.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.403 ' OG ' ' HA3' ' A' ' 227' ' ' GLY . 13.4 m -107.48 129.24 54.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.73 -1.123 . . . . 52.100000000000001 110.049 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.1 t -61.58 -26.88 68.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.54 0.736 . . . . 72.219999999999999 111.654 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -70.39 -27.91 64.68 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.764 1.225 . . . . 75.420000000000002 110.873 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.8 m -134.13 100.35 4.68 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.38 0.672 . . . . 51.049999999999997 109.766 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.596 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 58.2 mtt180 -105.93 128.72 53.98 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.97 0.908 . . . . 75.040000000000006 108.801 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.524 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 7.2 m-85 -115.13 139.68 49.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.698 0.799 . . . . 74.049999999999997 109.921 -167.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.631 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 6.7 m-80 -67.03 -31.28 71.71 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.167 0.917 . . . . 73.129999999999995 110.267 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.7 p -132.29 156.66 46.16 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.155 0.982 . . . . 74.140000000000001 111.497 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.667 HD12 HH11 ' A' ' 180' ' ' ARG . 0.7 OUTLIER -66.77 -24.37 66.19 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 114.916 -1.038 . . . . 73.430000000000007 109.772 173.023 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.39 79.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.621 0.768 . . . . 54.310000000000002 110.496 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 35.5 mt-10 -70.25 -36.93 74.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.059 0.943 . . . . 73.099999999999994 111.536 177.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.411 HD11 HG23 ' A' ' 205' ' ' VAL . 12.6 tp -54.91 -61.3 2.4 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.508 0.505 . . . . 75.099999999999994 110.956 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.2 -38.93 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.827 0.451 . . . . 73.519999999999996 111.093 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -61.51 -57.08 13.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.811 0.445 . . . . 70.409999999999997 111.146 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -67.88 -29.74 68.93 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.243 -0.435 . . . . 65.439999999999998 111.016 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.654 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.9 m170 -87.6 -11.51 48.39 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.26 0.467 . . . . 71.420000000000002 112.26 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.4 p -93.78 -27.14 16.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.742 0.417 . . . . 52.240000000000002 110.967 173.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.6 p -77.81 -48.25 16.98 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.831 -0.622 . . . . 75.209999999999994 110.535 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 226' ' ' ASP . 15.8 m -129.77 163.89 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.566 0.698 . . . . 70.150000000000006 111.797 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.21 16.65 0.23 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 127.373 2.269 . . . . 45.439999999999998 114.236 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.656 ' HB2' HG23 ' A' ' 224' ' ' VAL . 36.1 t70 -43.84 33.81 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.606 1 C-N-CA 132.645 4.378 . . . . 54.350000000000001 119.231 -159.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.403 ' HA3' ' OG ' ' A' ' 206' ' ' SER . . . 122.41 -0.9 10.43 Favored Glycine 0 N--CA 1.474 1.199 0 O-C-N 120.741 -1.224 . . . . 52.5 112.335 -171.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.654 HD11 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -94.71 164.75 12.82 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.759 1.624 . . . . 74.310000000000002 109.878 169.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 9.6 tt -66.5 -39.35 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.036 0.446 . . . . 72.310000000000002 109.921 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.4 m -151.7 154.73 36.9 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 74.019999999999996 110.377 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.1 p -57.38 139.58 52.63 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.79 1.236 . . . . 63.240000000000002 112.475 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.444 HD23 HD13 ' A' ' 184' ' ' LEU . 86.8 mt -68.14 100.1 0.97 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.557 0.743 . . . . 73.439999999999998 109.007 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.532 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 24.3 t60 -96.45 -78.39 0.47 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.898 0.879 . . . . 61.439999999999998 111.643 -165.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -94.0 123.64 58.67 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.385 0.674 . . . . 74.310000000000002 110.11 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.4 130.88 8.24 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.539 2.159 . . . . 75.150000000000006 111.765 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.59 82.48 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 109.063 -0.717 . . . . 71.219999999999999 109.063 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.21 167.01 16.07 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.409 2.073 . . . . 64.349999999999994 112.261 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 32.4 mmtp -63.45 138.12 58.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.494 0.718 . . . . 74.319999999999993 110.252 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.581 ' HB3' HD21 ' A' ' 159' ' ' LEU . 14.7 ptt-85 -72.73 -63.28 1.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.341 1.237 . . . . 73.040000000000006 114.341 -160.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.556 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 53.6 t30 -112.87 146.48 38.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.992 0.917 . . . . 64.319999999999993 110.314 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 94.8 mttt -77.82 114.45 41.61 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 107.638 -1.245 . . . . 74.430000000000007 107.638 161.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 26.2 Cg_exo -64.44 127.41 18.94 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.16 2.573 . . . . 63.130000000000003 113.181 -171.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.4 m -76.87 117.2 18.24 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.102 0.561 . . . . 72.439999999999998 109.537 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.523 HG22 HD21 ' A' ' 133' ' ' ASN . 4.0 t -96.91 112.85 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.268 -1.012 . . . . 75.030000000000001 108.268 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -88.07 114.2 24.45 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.743 0.646 . . . . 73.019999999999996 112.743 -160.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.74 42.41 94.39 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 124.577 1.173 . . . . 74.319999999999993 114.438 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m -104.23 132.72 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 113.29 0.848 . . . . 60.210000000000001 113.29 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.8 t -83.98 120.11 74.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 105.083 -2.192 . . . . 70.439999999999998 105.083 148.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--N 1.373 1.851 0 C-N-CA 122.525 2.15 . . . . 64.310000000000002 113.996 -162.667 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.43 ' HH2' HD22 ' A' ' 73' ' ' LEU . 20.6 t90 . . . . . 0 C--O 1.244 0.801 0 CA-C-O 121.518 0.675 . . . . 73.5 110.315 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -77.8 -31.11 51.63 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.455 -1.248 . . . . 64.230000000000004 111.135 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.7 p -76.14 9.42 2.53 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.555 1.142 . . . . 75.230000000000004 111.98 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -41.61 -43.32 2.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.429 1.492 . . . . 73.129999999999995 113.302 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.64 -27.77 68.63 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.746 0.818 . . . . 72.120000000000005 112.703 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.509 ' HB2' ' HE1' ' A' ' 144' ' ' HIS . 12.8 m120 -86.11 -0.92 56.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.98 0.912 . . . . 53.32 111.373 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.43 HD22 ' HH2' ' A' ' 67' ' ' TRP . 59.3 tp -57.51 -52.91 63.49 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 122.604 0.362 . . . . 74.140000000000001 110.396 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.55 45.14 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.019 0.927 . . . . 72.129999999999995 110.18 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.889 0 C-N-CA 123.249 0.619 . . . . 52.439999999999998 110.779 -177.938 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 112.975 0.732 . . . . 74.150000000000006 112.975 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 tp -100.37 123.65 44.86 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.805 0.812 . . . . 70.420000000000002 109.751 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -113.19 173.1 6.56 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.516 1.526 . . . . 53.100000000000001 109.491 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 p -136.72 132.44 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.069 1.347 . . . . 75.040000000000006 108.805 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.06 116.69 9.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.291 1.036 . . . . 74.420000000000002 110.025 173.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.6 mt -81.48 -36.07 29.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.76 0.824 . . . . 72.209999999999994 110.638 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 36.8 m-85 -122.85 143.91 49.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.967 -1.015 . . . . 65.329999999999998 108.819 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -74.23 134.3 42.68 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.843 -0.799 . . . . 63.439999999999998 108.843 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.619 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.0 t80 -134.87 138.33 44.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.093 0.957 . . . . 63.43 109.015 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.8 134.16 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.006 -1.479 . . . . 64.209999999999994 107.006 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.1 128.27 36.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.865 0.866 . . . . 74.340000000000003 110.996 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 p -110.1 8.96 24.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.799 0.84 . . . . 42.210000000000001 111.725 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.9 -179.46 32.81 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.8 -0.52 . . . . 64.409999999999997 111.8 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.34 -21.49 39.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.575 0.75 . . . . 55.210000000000001 112.767 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -107.12 -7.92 16.68 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 111.852 0.315 . . . . 63.229999999999997 111.852 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.6 p -75.97 177.96 6.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.873 0.469 . . . . 62.43 111.217 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.0 tp -142.65 145.53 33.55 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.825 -0.547 . . . . 64.420000000000002 110.985 -176.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 m -94.11 120.49 34.43 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.936 0.895 . . . . 73.420000000000002 109.304 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.628 HG22 HG21 ' A' ' 123' ' ' THR . 15.8 pt -113.82 148.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.629 0.771 . . . . 53.140000000000001 111.079 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.9 m -94.92 143.96 26.05 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.714 0.806 . . . . 73.230000000000004 109.312 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.01 120.75 11.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.54 0.736 . . . . 70.200000000000003 109.923 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.95 -9.23 68.1 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.643 -0.532 . . . . 52.210000000000001 113.607 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.7 143.44 51.33 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.591 0.757 . . . . 60.039999999999999 111.461 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.33 134.88 35.09 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.87 0.868 . . . . 72.340000000000003 109.192 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.499 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -145.33 142.79 29.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 75.319999999999993 109.847 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -97.08 109.66 22.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.188 -0.671 . . . . 73.430000000000007 109.188 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.591 HG13 ' HB1' ' A' ' 119' ' ' ALA . 19.1 t -72.67 126.4 33.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-O 121.699 0.761 . . . . 63.229999999999997 109.363 171.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.5 mt -88.63 -59.13 2.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.456 -1.702 . . . . 72.400000000000006 109.203 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.63 142.93 8.79 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.359 -0.382 . . . . 35.109999999999999 112.531 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.606 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 30.8 m-85 -86.4 168.12 14.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.513 1.125 . . . . 74.200000000000003 111.25 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -94.09 -171.58 2.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.088 1.355 . . . . 74.109999999999999 111.002 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -47.22 -36.35 8.75 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.924 1.689 . . . . 65.230000000000004 115.025 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -109.57 -6.18 15.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.543 0.337 . . . . 43.439999999999998 111.357 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.72 25.2 75.81 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.392 0.433 . . . . 53.009999999999998 113.451 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.47 -7.15 21.14 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.44 0.696 . . . . 72.150000000000006 112.296 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 33.4 m95 -140.48 134.33 30.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.67 0.788 . . . . 75.140000000000001 109.57 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.591 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -134.0 148.24 51.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 74.310000000000002 110.639 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.86 113.63 19.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.857 -1.164 . . . . 64.129999999999995 107.857 167.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.59 145.36 45.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.262 0.625 . . . . 62.119999999999997 110.95 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.44 103.53 15.49 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 109.03 -0.73 . . . . 73.25 109.03 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.628 HG21 HG22 ' A' ' 101' ' ' ILE . 75.7 p -86.36 168.44 13.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.356 0.662 . . . . 65.430000000000007 109.248 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -74.1 -11.2 60.24 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.671 -0.695 . . . . 35.530000000000001 110.57 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -79.99 -33.08 39.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.731 0.812 . . . . 72.019999999999996 110.19 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.58 -161.52 31.83 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 111.415 -0.674 . . . . 13.550000000000001 111.415 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -128.91 149.28 50.84 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.786 0.793 . . . . 73.120000000000005 110.597 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.06 178.35 35.87 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.706 0.629 . . . . 32.149999999999999 111.576 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -84.3 122.93 29.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.614 0.766 . . . . 73.099999999999994 111.989 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.411 HG11 ' CG2' ' A' ' 101' ' ' ILE . 19.8 m -128.61 145.21 55.16 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 124.992 1.317 . . . . 61.140000000000001 109.361 173.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.2 Cg_endo -84.3 146.61 11.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.287 1.991 . . . . 72.530000000000001 114.705 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 m -40.03 -41.85 1.29 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.191 1.796 . . . . 63.240000000000002 113.968 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -76.39 -17.91 59.13 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.175 -0.921 . . . . 74.219999999999999 112.657 -170.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.476 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 24.7 m-85 -92.28 -18.4 23.44 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.19 0.596 . . . . 61.030000000000001 111.713 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 130' ' ' VAL . 19.4 pt -120.24 -179.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.553 1.141 . . . . 63.530000000000001 110.408 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.9 t -162.5 151.08 12.35 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 118.428 -0.796 . . . . 70.549999999999997 108.872 166.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.72 145.71 97.21 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 121.49 1.46 . . . . 74.209999999999994 109.831 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.55 -4.38 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 121.778 0.799 . . . . 44.549999999999997 111.462 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.88 -22.74 49.31 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.777 0.831 . . . . 60.409999999999997 111.186 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.5 p -81.32 176.43 9.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.832 0.825 . . . . 72.120000000000005 111.705 -167.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 214' ' ' LEU . 38.8 mt -85.78 -26.32 25.86 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.847 -1.07 . . . . 70.140000000000001 110.605 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.525 ' HG3' ' HD2' ' A' ' 147' ' ' TYR . 1.6 mp0 -64.47 -20.41 66.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.79 1.236 . . . . 75.319999999999993 111.966 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -63.75 -4.69 3.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.732 0.813 . . . . 73.239999999999995 113.095 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.509 ' HE1' ' HB2' ' A' ' 72' ' ' ASN . 42.4 m-70 -117.73 159.29 23.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.998 0.919 . . . . 73.120000000000005 110.728 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -42.94 89.29 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.447 1.099 . . . . 71.219999999999999 112.14 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.402 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 56.3 p-90 -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.364 0.875 . . . . 72.329999999999998 113.364 -172.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.525 ' HD2' ' HG3' ' A' ' 142' ' ' GLU . 21.0 t80 -85.34 106.76 16.97 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.705 0.684 . . . . 75.140000000000001 110.356 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.513 ' HB3' HG21 ' A' ' 151' ' ' VAL . 3.2 m80 -89.27 -14.04 36.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.982 0.913 . . . . 62.299999999999997 112.0 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.48 -140.62 23.79 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.035 -1.425 . . . . 71.329999999999998 112.197 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.62 88.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.535 2.823 . . . . 71.109999999999999 112.891 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 155' ' ' ALA . 37.6 t -140.14 128.05 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.849 1.659 . . . . 73.549999999999997 108.807 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.1 p -84.27 175.13 9.62 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 124.061 0.945 . . . . 70.409999999999997 109.997 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -60.08 -40.95 91.32 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.984 -0.531 . . . . 73.420000000000002 111.158 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -53.26 -51.33 62.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.199 0.937 . . . . 75.120000000000005 110.317 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -62.57 -46.35 88.72 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.057 -1.429 . . . . 52.130000000000003 111.168 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 171' ' ' ARG . . . -56.86 -37.13 70.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.453 0.701 . . . . 31.440000000000001 112.184 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -68.83 -43.8 74.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.176 0.99 . . . . 74.219999999999999 111.155 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.42 ' OH ' ' HD2' ' A' ' 239' ' ' ARG . 0.1 OUTLIER -71.74 -22.83 61.56 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.328 0.585 . . . . 72.540000000000006 112.214 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 239' ' ' ARG . 55.8 mt -75.67 -43.59 46.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.872 -1.058 . . . . 73.329999999999998 112.579 174.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.539 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 96.4 mt -83.21 -20.65 34.22 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.045 -0.525 . . . . 62.240000000000002 111.466 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.425 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 86.6 p -64.3 -27.77 69.26 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 108.599 -0.889 . . . . 73.109999999999999 108.599 167.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.5 m -90.41 16.63 8.46 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.516 1.127 . . . . 44.100000000000001 111.468 175.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.29 178.52 17.3 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.381 0.515 . . . . 72.439999999999998 112.688 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.3 pt -100.17 175.77 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.479 1.111 . . . . 73.340000000000003 112.241 -176.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -72.22 116.1 12.25 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.663 -0.698 . . . . 73.450000000000003 109.549 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.07 6.18 34.47 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.508 -0.769 . . . . 73.329999999999998 112.534 -167.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 66.1 m -85.26 135.36 33.96 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 117.979 0.889 . . . . 65.129999999999995 111.124 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.8 p90 -139.46 158.31 44.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.747 0.419 . . . . 73.230000000000004 110.661 -176.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.2 pp -153.69 137.11 15.83 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.871 -0.788 . . . . 72.340000000000003 108.871 170.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 182' ' ' ILE . 59.9 t -92.28 136.5 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.791 -1.189 . . . . 71.019999999999996 107.791 168.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 156' ' ' ALA . 41.2 ptt85 -136.36 143.21 43.93 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.012 0.925 . . . . 63.399999999999999 108.643 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.89 117.11 30.4 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.764 -1.569 . . . . 51.439999999999998 106.764 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -53.44 120.58 6.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.197 0.999 . . . . 70.329999999999998 111.409 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.6 -29.3 69.88 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.684 0.754 . . . . 75.310000000000002 109.665 168.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -67.55 -32.61 73.5 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.678 -1.146 . . . . 73.329999999999998 111.446 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -148.09 94.77 4.24 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 123.929 0.892 . . . . 72.310000000000002 109.829 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.27 146.6 88.45 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.845 2.363 . . . . 75.439999999999998 111.899 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.15 -28.72 3.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.491 -0.616 . . . . 72.450000000000003 114.104 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -76.24 115.85 16.37 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 117.665 0.733 . . . . 73.010000000000005 110.078 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -113.93 140.5 48.34 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.006 0.922 . . . . 65.349999999999994 109.29 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.1 m -145.92 148.61 32.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.344 1.057 . . . . 71.420000000000002 108.977 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.711 HG12 HG22 ' A' ' 170' ' ' VAL . 14.2 mt -101.03 144.3 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.745 -1.576 . . . . 75.310000000000002 106.745 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -124.68 109.24 12.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.968 -1.493 . . . . 75.219999999999999 106.968 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.7 tp -106.59 113.96 27.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.038 0.535 . . . . 74.340000000000003 110.361 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 18.0 ttt180 -76.4 117.85 18.48 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.442 -0.947 . . . . 74.299999999999997 108.442 162.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -140.77 139.8 34.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 107.448 -1.315 . . . . 54.25 107.448 168.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 62.01 22.12 12.85 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.356 1.062 . . . . 74.129999999999995 112.472 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 1.91 89.66 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.331 -0.395 . . . . 65.140000000000001 113.369 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -111.96 140.12 46.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.152 0.981 . . . . 74.219999999999999 108.463 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.33 106.77 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-O 121.371 0.605 . . . . 64.329999999999998 110.657 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -90.86 145.69 24.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 72.239999999999995 108.805 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -125.02 117.92 25.07 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.083 0.468 . . . . 71.219999999999999 110.265 -173.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.572 ' HE1' HD21 ' A' ' 232' ' ' LEU . 3.0 m-85 -95.31 137.0 34.97 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.974 -1.121 . . . . 64.099999999999994 107.974 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -94.77 122.17 37.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.03 -1.1 . . . . 71.329999999999998 108.03 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 59.4 mt -84.65 101.99 9.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.583 -0.895 . . . . 75.340000000000003 108.583 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -76.18 139.52 41.27 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.856 -1.065 . . . . 71.010000000000005 109.094 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -118.39 117.3 28.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.639 0.776 . . . . 73.329999999999998 109.514 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.97 161.05 16.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.748 1.219 . . . . 63.009999999999998 110.464 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 70.0 p -64.41 -27.16 68.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.726 0.81 . . . . 52.340000000000003 112.258 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -83.84 -19.1 35.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.001 0.52 . . . . 45.509999999999998 111.032 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.48 14.3 10.72 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-O 119.014 -0.881 . . . . 64.319999999999993 115.004 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 34.7 mtmm -71.82 129.87 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.218 1.009 . . . . 71.430000000000007 111.09 173.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.93 142.85 26.91 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 71.230000000000004 108.294 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.9 p90 -169.76 137.73 1.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.097 0.873 . . . . 74.319999999999993 110.756 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -78.66 -46.02 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.435 -0.95 . . . . 75.549999999999997 108.435 164.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.1 m -98.56 124.58 43.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.437 -1.256 . . . . 74.030000000000001 108.764 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 31.4 t -65.97 -21.58 66.42 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.766 0.826 . . . . 65.340000000000003 112.051 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.13 -26.63 53.38 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.97 0.908 . . . . 71.340000000000003 110.163 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -125.42 98.41 5.6 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.798 0.839 . . . . 74.5 109.272 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 70.5 mtt180 -111.47 118.91 37.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.843 0.857 . . . . 74.219999999999999 110.179 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.421 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.5 OUTLIER -111.87 147.84 34.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.703 0.801 . . . . 72.530000000000001 109.166 -169.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.536 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 7.9 m-80 -66.41 -38.88 88.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.265 0.626 . . . . 74.239999999999995 110.341 -175.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.8 p -124.32 154.57 40.1 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.652 0.781 . . . . 61.450000000000003 111.28 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 141' ' ' LEU . 1.8 tt -65.21 -23.84 67.19 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.129 0.972 . . . . 63.530000000000001 109.377 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.57 80.36 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.789 0.836 . . . . 74.450000000000003 111.242 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.52 -30.74 64.75 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.378 -0.828 . . . . 72.329999999999998 111.551 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.21 -53.54 56.96 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 123.507 0.505 . . . . 73.409999999999997 110.744 171.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.77 -43.3 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.111 0.565 . . . . 63.210000000000001 110.475 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -55.15 -56.75 16.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.957 0.903 . . . . 73.030000000000001 111.248 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -65.58 -33.16 75.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.688 -1.142 . . . . 62.25 111.047 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.666 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.1 m170 -92.21 -10.58 38.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.015 0.526 . . . . 72.439999999999998 112.024 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 77.2 p -97.75 -11.68 23.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.279 0.632 . . . . 63.310000000000002 110.747 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 35.8 p -87.31 -52.07 5.6 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 122.399 0.28 . . . . 74.219999999999999 110.636 167.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.9 162.95 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 122.135 0.969 . . . . 65.319999999999993 113.204 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.84 11.76 17.01 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.616 1.966 . . . . 73.439999999999998 114.42 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -47.73 32.07 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 130.729 3.611 . . . . 75.430000000000007 120.065 -157.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.07 6.38 4.91 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.649 -1.282 . . . . 60.409999999999997 112.911 -167.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.9 mt -94.11 161.9 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.722 1.209 . . . . 74.010000000000005 109.067 161.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.4 tt -59.46 -40.09 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-O 120.736 0.303 . . . . 52.130000000000003 110.239 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -159.37 171.96 18.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.851 0.861 . . . . 64.430000000000007 109.904 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 34.0 m -68.73 138.38 54.84 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.144 0.978 . . . . 73.340000000000003 111.606 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.572 HD21 ' HE1' ' A' ' 193' ' ' TYR . 63.8 mt -71.9 131.41 42.94 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.199 0.999 . . . . 61.539999999999999 109.412 177.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -121.4 -77.98 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 118.65 0.659 . . . . 53.420000000000002 111.223 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -85.92 121.48 72.99 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 123.531 0.733 . . . . 73.329999999999998 109.366 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.61 126.95 4.82 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.181 1.921 . . . . 72.329999999999998 111.519 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . . . -66.73 145.7 98.97 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.813 0.845 . . . . 72.239999999999995 110.159 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.44 167.17 17.48 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.524 2.15 . . . . 72.540000000000006 112.015 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -69.45 150.12 47.56 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.442 0.697 . . . . 74.140000000000001 110.118 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.719 ' HB3' HD21 ' A' ' 159' ' ' LEU . 13.7 ptt180 -91.38 -64.18 1.16 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.249 0.833 . . . . 73.120000000000005 113.249 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.512 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 61.7 t30 -111.31 134.27 53.02 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.713 0.805 . . . . 73.040000000000006 109.743 -175.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -75.58 110.97 12.03 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 105.457 -2.053 . . . . 74.150000000000006 105.457 160.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.2 146.66 38.42 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.429 2.752 . . . . 74.430000000000007 115.732 -166.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.8 m -80.55 120.69 24.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.22 0.608 . . . . 75.299999999999997 110.78 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.41 108.01 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 108.023 -1.102 . . . . 73.549999999999997 108.023 170.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -108.33 111.75 23.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.192 0.597 . . . . 61.32 109.879 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 61.46 24.07 63.37 Favored Glycine 0 C--N 1.355 1.639 0 O-C-N 124.187 0.93 . . . . 70.420000000000002 114.871 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.4 116.99 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.328 0.651 . . . . 75.310000000000002 110.676 -174.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.9 t -87.99 120.44 70.74 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 105.829 -1.915 . . . . 71.109999999999999 105.829 151.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 N--CA 1.497 1.686 0 C-N-CA 121.771 1.647 . . . . 75.329999999999998 114.793 -159.919 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.2 t90 . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.411 0.624 . . . . 65.129999999999995 109.995 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -83.32 -31.52 26.78 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.627 -1.169 . . . . 52.210000000000001 109.805 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.6 p -69.58 3.48 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.153 0.981 . . . . 61.439999999999998 112.712 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.76 -25.04 67.09 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.419 0.688 . . . . 50.140000000000001 110.329 169.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.603 ' HG3' HD22 ' A' ' 72' ' ' ASN . 17.0 pt-20 -58.82 -36.81 75.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.588 0.755 . . . . 74.409999999999997 110.248 171.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.603 HD22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -86.15 -7.04 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.945 1.298 . . . . 45.530000000000001 111.569 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.81 -49.42 70.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.246 0.618 . . . . 64.340000000000003 110.157 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.2 mt -112.84 18.45 18.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.384 0.674 . . . . 72.319999999999993 110.906 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.119 0 C-N-CA 122.906 0.482 . . . . 30.34 110.842 177.819 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 112.205 0.446 . . . . 60.439999999999998 112.205 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 106' ' ' LYS . 51.0 tp -82.34 120.15 25.04 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.93 -0.767 . . . . 75.299999999999997 108.93 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.1 m-85 -106.91 174.22 5.98 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.758 1.223 . . . . 74.239999999999995 109.066 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.32 138.41 40.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.97 1.308 . . . . 54.549999999999997 108.66 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.49 116.84 18.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 74.319999999999993 109.968 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 69.6 mt -79.4 -29.98 42.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.283 0.633 . . . . 71.430000000000007 110.864 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 87.4 m-85 -126.64 140.82 52.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.867 -1.06 . . . . 75.030000000000001 108.529 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -72.84 134.19 44.77 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.176 -1.046 . . . . 65.019999999999996 108.176 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.9 t80 -131.22 111.23 11.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.316 -0.994 . . . . 73.430000000000007 108.316 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.99 137.15 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.542 -1.281 . . . . 74.430000000000007 107.542 172.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.01 117.12 2.96 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.129 0.972 . . . . 75.340000000000003 112.497 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.8 p -88.5 4.99 44.67 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.918 0.887 . . . . 72.329999999999998 111.646 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.85 -175.39 33.84 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.245 -0.742 . . . . 72.209999999999994 111.245 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -79.39 -38.21 35.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.22 0.608 . . . . 72.099999999999994 110.508 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -83.25 -15.46 50.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.24 1.016 . . . . 70.439999999999998 111.458 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.455 ' HA ' ' H ' ' A' ' 129' ' ' TRP . 71.7 p -77.24 177.24 8.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.967 0.507 . . . . 53.130000000000003 111.183 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.497 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 56.3 tp -134.31 132.22 39.3 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.814 0.446 . . . . 54.409999999999997 111.154 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 58.0 m -77.9 116.9 18.76 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.864 -0.607 . . . . 61.100000000000001 109.771 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 91' ' ' PHE . 15.2 pt -119.9 153.89 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.951 0.901 . . . . 75.219999999999999 110.137 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -106.9 145.87 31.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.106 0.562 . . . . 72.450000000000003 109.506 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -67.34 109.68 3.24 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 122.857 0.463 . . . . 63.140000000000001 110.156 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.18 -11.93 33.94 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 116.371 -0.377 . . . . 71.230000000000004 112.358 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -77.52 137.73 38.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.331 0.652 . . . . 71.409999999999997 110.443 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.41 ' HB3' HD11 ' A' ' 84' ' ' LEU . 42.0 mmtm -84.55 145.23 28.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.816 0.847 . . . . 71.420000000000002 109.371 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.33 146.74 32.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.337 0.655 . . . . 71.439999999999998 110.301 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -92.49 109.65 21.05 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.112 -1.069 . . . . 73.239999999999995 108.112 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.582 HG13 ' HB1' ' A' ' 119' ' ' ALA . 74.8 t -85.21 122.92 38.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.979 -0.748 . . . . 74.120000000000005 108.979 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.473 HD11 HE21 ' A' ' 122' ' ' GLN . 17.3 mt -90.87 -21.91 21.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.814 1.246 . . . . 74.099999999999994 109.959 -174.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.92 152.69 6.39 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.639 -0.534 . . . . 62.030000000000001 112.668 174.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 47.1 m-85 -86.56 165.22 16.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.372 0.606 . . . . 63.140000000000001 110.81 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -86.91 -172.3 3.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.609 1.164 . . . . 64.400000000000006 111.077 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -58.61 -34.12 70.77 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.886 0.875 . . . . 72.409999999999997 112.53 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -102.5 -4.09 25.89 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.239 0.616 . . . . 74.450000000000003 111.741 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 63.49 26.84 70.02 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.59 -0.561 . . . . 71.540000000000006 114.44 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.19 -12.98 19.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.34 0.57 . . . . 72.329999999999998 111.49 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.464 ' HE1' HG23 ' A' ' 247' ' ' VAL . 79.6 m95 -137.65 151.43 48.27 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.984 0.914 . . . . 71.209999999999994 109.967 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 112' ' ' TYR . . . -135.35 140.22 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.581 0.752 . . . . 61.420000000000002 110.312 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.432 ' HG2' ' NE2' ' A' ' 127' ' ' GLN . 40.7 tt0 -77.19 99.87 5.59 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.684 -1.598 . . . . 72.319999999999993 106.684 169.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.98 161.7 24.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.275 0.63 . . . . 74.120000000000005 110.668 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.473 HE21 HD11 ' A' ' 110' ' ' LEU . 8.5 pt20 -132.11 123.64 27.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.25 0.548 . . . . 73.109999999999999 111.929 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.2 p -98.05 -176.95 3.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.958 1.303 . . . . 64.5 109.853 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 11.0 mptt -66.91 -22.27 65.96 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.762 -1.108 . . . . 61.450000000000003 109.514 172.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -75.96 -19.69 58.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.931 1.293 . . . . 74.310000000000002 110.9 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.62 -160.85 24.16 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.076 0.235 . . . . 23.43 112.873 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.432 ' NE2' ' HG2' ' A' ' 120' ' ' GLU . 64.7 tp60 -98.59 158.34 15.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.917 0.887 . . . . 71.209999999999994 110.378 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 166.29 -163.42 36.86 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.234 -0.439 . . . . 35.140000000000001 112.416 169.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.455 ' H ' ' HA ' ' A' ' 98' ' ' THR . 87.0 m95 -102.76 131.64 49.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.906 0.882 . . . . 70.109999999999999 110.618 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 8.8 m -130.66 139.37 35.41 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.196 0.998 . . . . 64.219999999999999 108.947 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 130' ' ' VAL . 3.8 Cg_exo -78.94 141.32 16.67 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.522 2.148 . . . . 50.329999999999998 113.577 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.5 m -42.6 -44.74 4.34 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.614 1.566 . . . . 72.120000000000005 113.981 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.57 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 26.5 p-10 -78.25 6.09 8.95 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.895 0.878 . . . . 64.239999999999995 112.329 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.4 -14.29 12.2 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.3 1.04 . . . . 65.230000000000004 111.274 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.46 173.2 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.507 0.723 . . . . 72.129999999999995 112.034 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.415 HG21 ' HB2' ' A' ' 142' ' ' GLU . 5.8 t -161.56 153.33 16.1 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.602 1.161 . . . . 74.150000000000006 107.889 170.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 28.3 Cg_endo -60.71 148.4 91.81 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.507 1.472 . . . . 74.510000000000005 111.634 172.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.2 t -73.46 -4.01 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 CA-C-O 121.711 0.767 . . . . 73.430000000000007 110.179 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -80.02 -19.99 46.41 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.697 0.799 . . . . 74.239999999999995 111.49 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.0 p -86.41 174.52 8.95 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.172 0.589 . . . . 64.129999999999995 112.129 -171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.59 -22.38 30.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.738 0.815 . . . . 60.329999999999998 111.516 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.415 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.9 mp0 -68.47 -18.1 64.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.74 0.816 . . . . 75.349999999999994 111.611 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -60.74 -12.94 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.412 0.685 . . . . 73.010000000000005 112.744 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -95.44 158.18 15.57 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.029 0.931 . . . . 71.25 110.535 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.5 p -70.11 -42.79 72.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.588 0.755 . . . . 62.32 111.254 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.487 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 48.9 p-90 -61.98 -39.61 92.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.051 0.76 . . . . 74.530000000000001 113.051 -176.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -82.83 105.78 14.12 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.956 -0.387 . . . . 61.329999999999998 109.956 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -99.32 -3.55 33.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.292 0.637 . . . . 53.130000000000003 111.952 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.13 -148.86 33.45 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.754 -1.025 . . . . 73.409999999999997 113.102 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.34 106.76 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.792 2.328 . . . . 52.439999999999998 112.042 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.7 t -135.79 139.63 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.533 1.533 . . . . 72.439999999999998 109.152 -174.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.6 p -90.23 170.33 10.38 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 65.430000000000007 109.873 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.19 -29.81 70.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.795 0.27 . . . . 74.040000000000006 110.583 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -55.94 -53.84 51.98 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.275 0.63 . . . . 71.25 110.125 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.536 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -72.5 -27.88 62.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.844 -1.071 . . . . 71.540000000000006 111.725 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.41 61.97 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.111 0.564 . . . . 74.25 111.586 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -63.71 -38.17 90.09 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.731 . . . . 72.349999999999994 110.433 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.46 -45.81 92.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.903 -1.044 . . . . 70.340000000000003 110.753 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.67 -48.82 79.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.597 0.759 . . . . 75.400000000000006 111.772 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.17 11.18 24.15 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.709 1.003 . . . . 70.030000000000001 113.709 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.8 p -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.725 0.693 . . . . 54.409999999999997 109.991 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.1 p -94.0 10.1 34.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.57 0.748 . . . . 70.140000000000001 111.145 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -76.52 157.92 48.3 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.21 -0.45 . . . . 72.140000000000001 113.274 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.2 pt -100.74 176.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.878 0.871 . . . . 60.310000000000002 111.074 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.99 110.08 5.48 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.089 -0.708 . . . . 75.319999999999993 109.089 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.62 7.96 23.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.505 -0.608 . . . . 63.539999999999999 112.723 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.3 m -83.86 122.43 28.7 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.463 0.632 . . . . 54.020000000000003 111.014 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -129.53 164.82 22.95 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.475 0.579 . . . . 74.239999999999995 111.16 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.94 138.65 14.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.478 -0.934 . . . . 74.030000000000001 108.478 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.663 HG22 HG12 ' A' ' 182' ' ' ILE . 72.5 t -98.27 138.8 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.136 -1.061 . . . . 72.239999999999995 108.136 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.595 ' HE ' ' HB2' ' A' ' 181' ' ' SER . 2.1 ppt_? -146.7 162.38 38.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.881 0.873 . . . . 72.340000000000003 108.83 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -107.57 150.0 27.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.427 -1.323 . . . . 54.439999999999998 107.427 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t -68.33 125.1 25.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.454 -0.573 . . . . 60.130000000000003 109.454 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.25 -38.93 71.78 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.479 1.112 . . . . 73.219999999999999 111.154 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.3 m -102.88 5.92 38.81 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.605 0.762 . . . . 31.129999999999999 112.254 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.7 m -148.1 88.77 5.39 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 122.888 0.475 . . . . 61.32 110.532 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.55 134.47 35.67 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.69 2.26 . . . . 73.340000000000003 111.961 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.27 -28.54 13.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.934 -0.575 . . . . 31.34 112.378 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -88.91 116.98 27.58 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.844 -0.798 . . . . 75.400000000000006 108.844 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 77.5 mtt180 -119.16 159.35 24.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.284 0.564 . . . . 73.120000000000005 110.525 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.595 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 40.2 m -148.4 152.43 36.97 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.266 -0.879 . . . . 72.310000000000002 110.278 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.663 HG12 HG22 ' A' ' 170' ' ' VAL . 33.9 mt -104.18 150.48 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.373 -1.343 . . . . 72.450000000000003 107.373 170.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.0 m -122.94 108.18 12.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.186 -1.412 . . . . 64.549999999999997 107.186 170.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.95 110.49 22.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.319 -0.623 . . . . 72.129999999999995 109.319 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.505 ' HB2' HG22 ' A' ' 190' ' ' VAL . 35.6 ttt180 -78.3 115.68 18.19 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.982 -0.747 . . . . 75.319999999999993 108.982 166.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -140.34 138.25 34.74 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.552 1.158 . . . . 52.009999999999998 108.446 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 56.08 30.89 17.12 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.297 1.039 . . . . 72.409999999999997 112.033 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 75.96 12.95 83.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.87 -0.605 . . . . 74.140000000000001 114.264 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -122.0 136.56 54.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 73.530000000000001 109.391 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 185' ' ' ARG . 60.3 t -96.54 106.47 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 122.921 0.488 . . . . 75.120000000000005 110.252 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.02 136.48 33.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.593 1.157 . . . . 71.409999999999997 109.381 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -112.51 119.0 36.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.132 0.491 . . . . 64.319999999999993 110.231 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.505 ' HE1' HD21 ' A' ' 232' ' ' LEU . 10.6 m-30 -95.63 142.2 28.23 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.994 -1.003 . . . . 65.530000000000001 109.053 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 7.1 tpp180 -93.88 109.79 21.48 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.121 -0.696 . . . . 71.439999999999998 109.121 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 54.9 mt -85.7 101.95 10.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.079 -1.082 . . . . 62.539999999999999 108.079 170.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.06 116.46 19.37 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.051 -0.722 . . . . 75.400000000000006 109.051 170.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 m -87.66 112.92 22.85 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.786 -0.82 . . . . 73.439999999999998 108.786 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -67.13 157.65 33.13 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.232 0.613 . . . . 51.439999999999998 110.401 174.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.8 p -65.61 -20.93 66.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.005 0.922 . . . . 72.209999999999994 113.122 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.37 -14.96 39.25 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.1 0.56 . . . . 54.100000000000001 110.891 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.23 11.99 14.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.508 -0.607 . . . . 33.229999999999997 113.868 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 67.9 mttm -71.56 155.36 40.64 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.873 0.837 . . . . 74.439999999999998 110.563 171.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.43 143.41 49.25 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.011 -1.107 . . . . 64.230000000000004 108.011 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 52.9 p90 -162.83 133.79 4.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.403 0.44 . . . . 73.450000000000003 111.994 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 52.9 t -82.14 -36.32 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.466 -0.788 . . . . 61.219999999999999 109.432 168.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 16.0 m -105.47 124.64 49.89 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.006 -1.109 . . . . 75.040000000000006 108.006 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.2 m -62.25 -25.62 67.93 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 60.32 112.771 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -80.69 -31.32 36.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.876 . . . . 73.510000000000005 110.775 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 50.6 m -109.47 88.47 2.75 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.484 0.713 . . . . 63.549999999999997 109.933 -173.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.592 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 64.8 mtt180 -100.67 127.11 47.18 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.873 -0.788 . . . . 73.340000000000003 108.873 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.95 148.55 38.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.476 -0.935 . . . . 70.219999999999999 108.476 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -68.06 -37.45 81.32 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.555 0.534 . . . . 64.409999999999997 110.146 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 67.0 p -127.98 158.68 37.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.829 0.852 . . . . 74.109999999999999 112.031 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.9 -22.23 62.29 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.879 -1.055 . . . . 75.140000000000001 109.917 175.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.39 97.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.392 0.677 . . . . 74.150000000000006 110.348 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.28 -37.06 71.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.103 -0.953 . . . . 73.519999999999996 111.403 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.422 HD11 HG23 ' A' ' 205' ' ' VAL . 15.2 tp -55.04 -57.87 9.96 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.366 0.416 . . . . 45.420000000000002 110.963 173.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.46 -48.76 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.226 0.61 . . . . 71.239999999999995 110.976 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -57.84 -55.04 39.99 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.012 0.82 . . . . 74.329999999999998 111.071 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -65.13 -33.43 75.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.093 0.557 . . . . 54.420000000000002 111.576 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.737 ' HB3' HD11 ' A' ' 228' ' ' LEU . 14.0 m170 -89.76 -8.54 51.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.095 0.406 . . . . 73.140000000000001 112.095 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 84.5 p -93.59 -24.81 17.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.764 0.426 . . . . 43.399999999999999 110.209 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.9 p -81.31 -47.11 13.75 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.769 0.428 . . . . 51.039999999999999 110.856 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.613 HG23 ' HB2' ' A' ' 226' ' ' ASP . 23.5 m -128.17 164.37 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.043 0.925 . . . . 74.150000000000006 112.356 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.95 14.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 127.184 2.194 . . . . 71.099999999999994 114.125 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.613 ' HB2' HG23 ' A' ' 224' ' ' VAL . 35.4 t70 -45.41 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.356 1 C-N-CA 131.816 4.046 . . . . 74.040000000000006 119.614 -158.219 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 124.52 -1.79 8.77 Favored Glycine 0 N--CA 1.486 1.977 0 O-C-N 120.808 -1.183 . . . . 71.340000000000003 112.48 -169.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.737 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.7 mt -93.9 163.15 13.62 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.753 1.221 . . . . 64.450000000000003 110.016 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.7 tt -56.96 -40.45 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 120.824 0.345 . . . . 64.129999999999995 110.369 166.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -162.76 177.33 9.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.595 0.758 . . . . 70.409999999999997 110.69 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -66.15 136.24 55.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 54.32 111.686 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.505 HD21 ' HE1' ' A' ' 193' ' ' TYR . 49.2 mt -69.36 138.73 53.94 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 108.332 -0.988 . . . . 72.510000000000005 108.332 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -132.25 -77.63 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.962 1.255 . . . . 73.420000000000002 111.675 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 167' ' ' SER . 17.9 t80 -80.7 123.0 82.82 Favored Pre-proline 0 C--O 1.209 -1.049 0 CA-C-O 118.307 -0.854 . . . . 72.019999999999996 108.753 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 146' ' ' TRP . 8.3 Cg_endo -88.36 132.89 2.68 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.288 1.992 . . . . 51.210000000000001 111.609 171.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.77 131.94 93.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.484 0.714 . . . . 74.340000000000003 109.782 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.92 177.76 7.99 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.674 2.249 . . . . 71.439999999999998 113.116 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 32.7 mmtp -79.0 126.6 30.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.463 0.705 . . . . 73.430000000000007 109.349 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.522 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 15.3 ptt180 -93.14 -62.45 1.38 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.545 0.943 . . . . 74.540000000000006 113.545 -160.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.522 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 57.4 t30 -109.26 132.31 54.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.235 0.614 . . . . 73.340000000000003 111.09 -167.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -68.84 112.4 11.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 107.179 -1.415 . . . . 61.229999999999997 107.179 163.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.57 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 8.0 Cg_exo -74.61 124.59 8.93 Favored 'Trans proline' 0 C--N 1.364 1.395 0 C-N-CA 122.218 1.946 . . . . 74.030000000000001 112.098 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 87.7 m -64.96 123.27 19.0 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.318 0.647 . . . . 74.439999999999998 110.744 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.438 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 64.1 t -79.69 125.95 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 108.658 -0.868 . . . . 72.530000000000001 108.658 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -98.17 113.0 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 117.711 0.232 . . . . 64.230000000000004 111.096 -168.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 58.1 6.37 2.92 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 118.675 2.23 . . . . 75.340000000000003 118.675 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.464 HG23 ' HE1' ' A' ' 118' ' ' TRP . 17.1 m -106.53 123.07 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.943 1.371 . . . . 72.329999999999998 113.781 -170.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 t -82.89 122.94 78.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 106.326 -1.731 . . . . 50.130000000000003 106.326 157.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 118' ' ' TRP . 41.0 Cg_endo . . . . . 0 C--N 1.367 1.534 0 C-N-CA 121.423 1.415 . . . . 74.140000000000001 115.212 -157.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.422 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 6.7 t90 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.274 -0.639 . . . . 73.420000000000002 109.274 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -76.84 -29.48 55.93 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 116.229 -0.441 . . . . 71.420000000000002 110.519 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -73.21 5.03 3.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.019 1.328 . . . . 74.129999999999995 113.095 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.53 -17.71 64.96 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.676 1.19 . . . . 73.140000000000001 112.922 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -26.84 19.51 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.255 0.622 . . . . 74.129999999999995 110.957 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.92 -5.63 55.94 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.62 0.768 . . . . 73.430000000000007 110.4 169.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.447 HD13 ' HE1' ' A' ' 146' ' ' TRP . 62.4 tp -60.72 -54.09 49.48 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.961 0.505 . . . . 71.349999999999994 109.869 174.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.02 84.3 1.9 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.98 -1.119 . . . . 71.109999999999999 107.98 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.725 0 CA-C-N 115.378 -0.828 . . . . 72.319999999999993 111.774 -173.41 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.447 0.642 . . . . 73.099999999999994 110.073 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 106' ' ' LYS . 38.5 tp -88.46 121.37 30.77 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 114.636 -1.165 . . . . 63.539999999999999 108.084 171.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.56 173.19 6.42 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.5 1.12 . . . . 71.120000000000005 108.704 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -131.18 135.81 58.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 124.424 1.089 . . . . 63.539999999999999 108.109 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.69 107.06 6.55 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.062 0.945 . . . . 70.239999999999995 109.405 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.521 HD22 ' HZ2' ' A' ' 238' ' ' LYS . 79.0 mt -69.29 -23.92 63.89 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.475 0.71 . . . . 74.209999999999994 111.528 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 77.0 m-85 -135.77 155.67 50.0 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 75.140000000000001 109.954 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 241' ' ' LYS . 10.9 m-20 -70.87 156.09 40.0 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.908 -0.775 . . . . 71.25 108.908 167.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.586 ' HB3' HG12 ' A' ' 101' ' ' ILE . 71.1 t80 -149.3 124.32 10.03 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.133 -1.432 . . . . 72.319999999999993 107.133 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.4 135.34 27.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.789 -1.56 . . . . 62.409999999999997 106.789 169.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.48 117.46 3.11 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.964 0.79 . . . . 41.509999999999998 111.475 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.2 p -88.03 15.14 7.72 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.159 0.984 . . . . 60.350000000000001 110.991 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.47 179.54 46.06 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.912 -0.875 . . . . 74.319999999999993 110.912 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.09 -24.97 58.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.215 0.606 . . . . 72.319999999999993 111.444 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.484 HD21 ' HD2' ' A' ' 249' ' ' PRO . 43.6 p-10 -89.06 -17.56 29.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.724 0.809 . . . . 74.150000000000006 111.561 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.7 p -88.97 158.96 17.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.187 0.595 . . . . 65.549999999999997 110.508 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -121.63 134.15 54.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.215 0.606 . . . . 61.509999999999998 110.98 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.8 m -79.94 132.6 36.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.628 0.771 . . . . 71.450000000000003 110.512 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.696 HG22 HG21 ' A' ' 123' ' ' THR . 6.7 pt -129.22 154.49 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.617 0.767 . . . . 45.140000000000001 111.098 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.5 m -102.93 145.87 29.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.726 1.21 . . . . 34.299999999999997 109.922 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 88' ' ' LEU . 42.3 tttt -70.63 108.15 4.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.252 0.621 . . . . 71.0 109.75 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.95 29.24 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-N 115.832 -0.622 . . . . 64.219999999999999 112.559 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 54.0 tt0 -74.2 144.99 44.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.787 0.835 . . . . 61.140000000000001 111.314 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.449 ' HB3' HD11 ' A' ' 84' ' ' LEU . 43.0 mmtm -92.74 129.61 38.61 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.36 0.664 . . . . 64.430000000000007 109.843 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.606 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.3 OUTLIER -132.18 136.13 46.84 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.835 0.854 . . . . 75.129999999999995 109.505 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -95.15 109.66 21.72 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.902 -0.777 . . . . 44.299999999999997 108.902 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.608 HG13 ' HB1' ' A' ' 119' ' ' ALA . 42.5 t -77.22 134.35 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 123.644 0.59 . . . . 63.149999999999999 110.278 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.4 mt -102.75 -31.21 10.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.943 1.297 . . . . 74.530000000000001 109.906 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.32 142.94 3.93 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.5 -0.611 . . . . 63.439999999999998 113.331 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 33.6 m-85 -86.92 167.34 14.38 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.944 0.898 . . . . 45.329999999999998 110.857 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -88.49 -178.79 5.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.839 . . . . 71.530000000000001 110.565 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -55.42 -34.58 64.54 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.949 1.3 . . . . 63.130000000000003 113.625 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -111.38 9.29 21.5 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.071 0.548 . . . . 74.120000000000005 112.051 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.62 33.11 86.37 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 115.134 0.813 . . . . 62.130000000000003 115.134 172.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.65 -38.68 12.3 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.088 0.444 . . . . 73.549999999999997 111.924 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 66.9 m95 -129.9 147.37 51.65 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.44 0.696 . . . . 72.219999999999999 111.174 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.608 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -128.58 150.82 50.04 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.027 1.331 . . . . 73.299999999999997 109.3 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -87.21 115.76 24.83 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.952 -1.129 . . . . 64.299999999999997 107.952 166.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.51 168.68 10.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.432 0.693 . . . . 72.129999999999995 110.918 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -120.95 110.84 16.77 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.647 0.779 . . . . 73.430000000000007 110.364 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.696 HG21 HG22 ' A' ' 101' ' ' ILE . 82.7 p -100.63 177.58 4.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.347 1.059 . . . . 72.420000000000002 109.933 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.01 -18.3 64.02 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 110.753 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.79 -24.69 55.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.163 0.985 . . . . 73.219999999999999 111.035 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.34 -146.9 17.63 Favored Glycine 0 C--N 1.363 2.055 0 CA-C-N 117.706 0.23 . . . . 72.409999999999997 112.906 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -130.59 139.82 50.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.498 0.719 . . . . 71.109999999999999 109.946 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.21 -174.03 41.05 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.257 -0.737 . . . . 74.540000000000006 111.257 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -87.83 121.81 30.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.344 0.658 . . . . 61.229999999999997 112.41 -170.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.511 HG23 HD13 ' A' ' 135' ' ' ILE . 5.2 m -122.7 142.72 38.33 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.13 1.372 . . . . 63.340000000000003 108.726 173.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 10.6 Cg_endo -88.48 146.91 6.15 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 C-N-CA 122.241 1.961 . . . . 74.430000000000007 114.767 -172.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.4 m -41.35 -44.3 2.73 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.512 1.925 . . . . 74.420000000000002 114.551 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.635 HD22 ' HB2' ' A' ' 242' ' ' PRO . 22.4 p-10 -73.28 -4.16 31.41 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.012 0.525 . . . . 63.340000000000003 112.192 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.455 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 9.7 m-85 -106.44 -22.57 12.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.787 0.835 . . . . 73.120000000000005 111.475 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.511 HD13 HG23 ' A' ' 130' ' ' VAL . 27.6 pt -123.28 164.65 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.325 0.65 . . . . 74.030000000000001 112.442 -172.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.2 t -160.41 149.55 13.91 Favored Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.126 -0.94 . . . . 73.420000000000002 109.166 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.12 145.98 40.5 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.517 2.145 . . . . 62.350000000000001 112.377 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 t -75.68 -3.73 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.576 0.703 . . . . 63.200000000000003 111.149 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.84 -2.78 43.34 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.601 -0.687 . . . . 63.43 112.297 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.8 p -78.25 171.58 14.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.2 0.524 . . . . 64.019999999999996 111.828 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.38 -27.71 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.882 -0.599 . . . . 74.239999999999995 109.66 165.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.6 -16.21 64.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.311 1.044 . . . . 73.129999999999995 112.139 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.512 ' HA ' HD21 ' A' ' 88' ' ' LEU . 16.7 pttm -69.49 -31.71 70.15 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.815 0.446 . . . . 52.409999999999997 111.742 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.01 133.8 51.57 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.721 0.809 . . . . 74.430000000000007 110.23 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.0 p -55.59 -32.55 63.16 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 74.420000000000002 112.702 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.447 ' HE1' HD13 ' A' ' 73' ' ' LEU . 25.7 p-90 -81.13 -32.42 33.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.222 0.609 . . . . 73.310000000000002 112.59 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -84.24 107.6 16.64 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.3 -0.63 . . . . 73.310000000000002 109.3 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.77 -5.57 24.73 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.494 0.717 . . . . 71.239999999999995 111.51 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.24 -130.62 21.72 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 118.065 -1.408 . . . . 75.430000000000007 112.941 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.617 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 32.2 Cg_exo -58.63 86.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.821 3.014 . . . . 74.230000000000004 113.603 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.97 132.48 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.285 1.034 . . . . 74.349999999999994 109.681 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.0 p -87.68 175.07 8.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.755 1.222 . . . . 70.129999999999995 110.193 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -61.85 -44.94 95.83 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.483 0.313 . . . . 74.5 110.508 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.23 -48.46 80.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.978 0.911 . . . . 74.140000000000001 110.295 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.3 77.95 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.853 -1.067 . . . . 72.340000000000003 111.419 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.95 -52.47 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.278 0.631 . . . . 72.310000000000002 111.935 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.524 ' HG2' HG11 ' A' ' 190' ' ' VAL . 43.2 mt-10 -68.8 -25.89 64.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.646 0.779 . . . . 75.310000000000002 110.677 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.23 -43.68 90.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.884 0.874 . . . . 70.120000000000005 111.373 170.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.3 mt -65.0 -34.6 78.83 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.285 0.564 . . . . 75.400000000000006 110.532 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 90.0 mt -89.72 2.23 55.08 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.324 -0.853 . . . . 74.310000000000002 112.807 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -61.98 -34.42 76.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.841 0.746 . . . . 71.349999999999994 111.471 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.6 p -101.73 11.08 39.4 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.631 0.772 . . . . 72.420000000000002 111.065 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.04 153.98 40.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.183 -0.462 . . . . 63.0 113.094 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.59 -176.89 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 124.259 1.024 . . . . 75.209999999999994 111.599 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 108.14 1.66 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.574 -0.739 . . . . 54.420000000000002 110.403 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 105.54 12.32 26.91 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.475 -0.625 . . . . 75.209999999999994 112.429 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.483 ' HG ' ' HD1' ' A' ' 234' ' ' TYR . 74.2 m -71.21 144.85 49.98 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 117.519 0.659 . . . . 72.140000000000001 111.209 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.2 p90 -157.52 164.35 37.45 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 122.799 0.44 . . . . 73.439999999999998 110.423 -174.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.07 146.4 12.44 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.647 -0.871 . . . . 61.219999999999999 108.647 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.658 HG22 HG12 ' A' ' 182' ' ' ILE . 91.4 t -96.62 126.67 49.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 108.889 -0.782 . . . . 61.450000000000003 108.889 167.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -116.08 143.4 45.52 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.959 1.303 . . . . 70.030000000000001 107.883 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.76 149.29 38.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.755 0.822 . . . . 75.5 108.922 171.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 t -83.76 125.47 31.95 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.242 -0.651 . . . . 63.100000000000001 109.242 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 150' ' ' PRO . 18.4 tp10 -77.71 -34.31 52.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.195 0.598 . . . . 64.049999999999997 109.392 172.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.0 p -75.22 -16.36 60.48 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.549 0.74 . . . . 52.509999999999998 111.186 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -147.37 79.16 9.84 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 123.768 0.827 . . . . 74.409999999999997 109.185 172.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.65 133.57 55.11 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.169 2.579 . . . . 72.209999999999994 112.406 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.73 -29.59 10.66 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.885 -0.598 . . . . 73.349999999999994 111.92 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -73.64 115.02 12.56 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 108.632 -0.877 . . . . 71.140000000000001 108.632 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.7 mtt85 -128.47 146.17 50.89 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.725 0.81 . . . . 72.120000000000005 109.098 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.9 m -140.51 148.84 41.69 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.385 1.074 . . . . 70.439999999999998 109.009 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 170' ' ' VAL . 34.4 mt -101.51 148.44 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 106.734 -1.58 . . . . 75.5 106.734 168.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 24.6 m -123.46 109.35 13.73 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.203 -1.406 . . . . 71.319999999999993 107.203 171.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 167' ' ' SER . 20.5 tp -103.59 112.39 25.29 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.808 0.731 . . . . 65.219999999999999 109.614 177.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 23.8 ttt180 -80.47 111.17 16.62 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.471 0.653 . . . . 72.25 109.482 165.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -137.25 134.71 36.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.214 -1.357 . . . . 74.430000000000007 107.433 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 61.91 22.48 13.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.538 1.135 . . . . 73.530000000000001 111.547 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.34 85.94 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.938 -0.573 . . . . 64.310000000000002 113.006 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -105.01 130.77 53.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.132 0.973 . . . . 73.549999999999997 108.798 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.524 HG11 ' HG2' ' A' ' 157' ' ' GLU . 58.7 t -96.46 115.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.897 -0.409 . . . . 74.310000000000002 109.897 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -100.08 148.82 24.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.953 1.301 . . . . 65.439999999999998 107.747 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -119.63 116.41 25.95 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.377 0.535 . . . . 73.519999999999996 110.608 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 8.6 m-30 -93.89 149.48 21.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.434 1.094 . . . . 75.129999999999995 108.216 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 15.3 tpp180 -106.29 114.05 27.94 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.896 -0.409 . . . . 64.319999999999993 109.896 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.446 HD13 HD21 ' A' ' 214' ' ' LEU . 48.2 mt -87.42 102.75 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.315 -0.994 . . . . 70.209999999999994 108.315 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -87.17 132.52 33.84 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.101 -0.954 . . . . 63.299999999999997 108.72 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.6 m -100.76 106.77 18.21 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.979 -1.119 . . . . 75.299999999999997 107.979 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.07 159.56 3.29 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.686 0.794 . . . . 64.409999999999997 110.525 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.5 p -63.3 -22.31 66.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.063 0.945 . . . . 64.109999999999999 113.236 -172.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -93.79 -0.62 55.78 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.692 0.797 . . . . 61.039999999999999 111.44 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 100.17 14.05 34.55 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.601 -0.555 . . . . 74.219999999999999 114.068 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -88.15 127.03 35.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 117.852 0.826 . . . . 54.229999999999997 111.426 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -87.03 146.18 26.2 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.339 1.056 . . . . 52.329999999999998 108.545 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -165.43 140.41 5.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.374 0.421 . . . . 61.439999999999998 110.648 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.506 HG23 HD11 ' A' ' 217' ' ' LEU . 76.1 t -85.18 -43.04 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.229 -1.026 . . . . 74.299999999999997 108.229 163.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.2 m -104.79 129.95 52.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.526 -1.216 . . . . 73.329999999999998 109.099 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.5 t -67.66 -14.65 63.12 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.07 0.948 . . . . 64.129999999999995 112.693 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.44 -17.0 59.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.695 1.198 . . . . 43.420000000000002 111.729 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.2 m -149.57 112.17 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.902 0.481 . . . . 44.350000000000001 110.638 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -102.97 124.17 47.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.06 0.944 . . . . 75.510000000000005 109.021 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -106.87 145.95 31.56 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.071 0.948 . . . . 65.319999999999993 109.284 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.49 -39.77 88.9 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.733 0.645 . . . . 75.540000000000006 110.159 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 69.2 p -126.49 151.62 47.57 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.985 -1.007 . . . . 71.030000000000001 111.482 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 195' ' ' ILE . 0.7 OUTLIER -62.94 -24.63 67.96 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.333 -1.303 . . . . 75.25 109.842 172.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.34 86.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.215 1.006 . . . . 51.409999999999997 111.602 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.37 -35.86 71.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.363 0.665 . . . . 74.120000000000005 111.274 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.506 HD11 HG23 ' A' ' 205' ' ' VAL . 12.4 tp -55.15 -56.18 22.8 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.635 0.584 . . . . 62.140000000000001 110.762 174.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.6 -39.44 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.81 -0.632 . . . . 64.439999999999998 111.041 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -61.26 -53.12 60.89 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.287 0.367 . . . . 71.120000000000005 110.661 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -62.03 -38.6 89.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.413 -0.812 . . . . 75.430000000000007 110.643 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.708 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.0 m170 -88.17 -5.18 58.56 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.112 -0.494 . . . . 74.099999999999994 112.258 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.7 p -95.31 -24.28 16.82 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.819 0.448 . . . . 72.010000000000005 110.837 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.7 p -81.74 -38.86 25.04 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 122.749 0.42 . . . . 72.219999999999999 111.274 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.4 m -135.52 162.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.984 0.897 . . . . 62.100000000000001 112.142 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.69 15.07 1.11 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.71 2.004 . . . . 54.149999999999999 114.231 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.623 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.7 t70 -43.36 33.65 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 131.634 3.974 . . . . 63.399999999999999 119.145 -156.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.55 -5.35 9.28 Favored Glycine 0 N--CA 1.478 1.459 0 O-C-N 120.738 -1.226 . . . . 65.340000000000003 112.846 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 221' ' ' HIS . 10.6 mt -91.3 162.23 14.7 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.121 1.368 . . . . 75.400000000000006 109.785 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -61.25 -36.07 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-O 120.843 0.354 . . . . 75.519999999999996 110.075 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -162.33 175.42 11.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.953 0.901 . . . . 62.409999999999997 109.427 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.6 p -61.88 148.42 43.49 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.454 1.102 . . . . 75.230000000000004 112.202 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.433 HD23 HD13 ' A' ' 184' ' ' LEU . 52.7 mt -75.13 145.93 41.78 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.873 0.869 . . . . 65.109999999999999 108.689 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -137.35 -72.29 0.43 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.799 0.727 . . . . 75.010000000000005 111.949 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.483 ' HD1' ' HG ' ' A' ' 167' ' ' SER . 62.2 t80 -95.26 122.85 58.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.401 0.68 . . . . 73.340000000000003 109.775 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 71.1 Cg_endo -82.1 139.33 10.63 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.538 2.159 . . . . 53.539999999999999 111.058 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.19 141.79 95.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.061 0.545 . . . . 52.310000000000002 110.426 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.49 136.37 12.38 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.339 2.026 . . . . 75.239999999999995 111.852 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.521 ' HZ2' HD22 ' A' ' 88' ' ' LEU . 97.4 mttt -70.24 102.73 2.18 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.563 -1.273 . . . . 73.340000000000003 107.563 172.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.643 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 17.7 ptt180 -73.38 -66.93 0.63 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 115.182 1.549 . . . . 52.240000000000002 115.182 -154.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.643 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 25.2 t-20 -113.75 150.14 33.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.039 0.536 . . . . 74.140000000000001 110.495 -172.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 90' ' ' ASP . 85.5 mttt -70.12 115.71 36.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.098 -1.075 . . . . 63.100000000000001 108.098 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.635 ' HB2' HD22 ' A' ' 133' ' ' ASN . 23.6 Cg_exo -63.78 137.58 59.19 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.643 2.228 . . . . 54.049999999999997 111.933 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 25.5 m -68.81 122.29 18.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.151 0.58 . . . . 45.299999999999997 111.547 -172.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.427 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 58.0 t -92.34 128.27 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.594 -1.261 . . . . 74.200000000000003 107.594 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -104.01 112.48 25.48 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.214 0.461 . . . . 74.430000000000007 111.159 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.71 8.28 3.99 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 118.366 2.106 . . . . 74.0 118.366 159.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.66 129.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 119.256 1.528 . . . . 65.140000000000001 111.865 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 t -73.5 121.67 85.72 Favored Pre-proline 0 C--N 1.355 0.818 0 N-CA-C 106.431 -1.692 . . . . 65.430000000000007 106.431 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.484 ' HD2' HD21 ' A' ' 97' ' ' ASN . 82.0 Cg_exo . . . . . 0 C--N 1.374 1.872 0 C-N-CA 122.791 2.327 . . . . 73.310000000000002 116.452 -153.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.609 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 12.0 t90 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 120.799 0.333 . . . . 72.0 110.464 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -64.97 -17.06 64.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.568 0.747 . . . . 73.349999999999994 110.823 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 72' ' ' ASN . 20.0 m -77.49 4.0 12.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.524 1.129 . . . . 74.219999999999999 112.169 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -75.52 -47.78 25.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.708 0.803 . . . . 70.510000000000005 110.358 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.9 -24.55 64.32 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 120.836 0.351 . . . . 64.099999999999994 110.424 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 69' ' ' SER . 10.7 m120 -89.43 -6.43 56.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.007 0.923 . . . . 75.209999999999994 111.634 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.22 -52.15 64.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.346 1.058 . . . . 60.549999999999997 112.219 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.91 16.14 26.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.605 0.762 . . . . 71.239999999999995 110.36 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 C-N-CA 123.35 0.66 . . . . 61.350000000000001 112.035 -177.248 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 CA--C 1.553 1.066 0 CA-C-O 120.658 0.266 . . . . 74.540000000000006 111.099 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 106' ' ' LYS . 26.2 tp -96.16 126.83 41.65 Favored 'General case' 0 C--N 1.357 0.917 0 CA-C-O 121.65 0.738 . . . . 62.420000000000002 110.085 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -113.95 173.71 6.3 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.417 1.487 . . . . 75.230000000000004 108.257 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.47 139.19 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.088 0.955 . . . . 60.310000000000002 109.04 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.478 ' HA ' HG22 ' A' ' 135' ' ' ILE . . . -74.4 120.4 19.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.213 0.605 . . . . 70.430000000000007 110.137 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 143' ' ' LYS . 83.8 mt -86.03 -34.97 20.6 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.462 0.705 . . . . 73.040000000000006 110.704 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -123.78 146.19 48.5 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.131 -0.941 . . . . 74.219999999999999 108.879 -175.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.1 144.76 44.83 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.734 0.646 . . . . 71.150000000000006 109.409 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.592 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.6 t80 -142.18 140.5 32.4 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.437 -0.949 . . . . 61.43 108.437 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 68.0 t -110.99 134.82 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 108.209 -1.034 . . . . 62.119999999999997 108.209 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.68 116.27 2.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.167 0.987 . . . . 72.109999999999999 111.239 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.8 p -107.91 26.03 10.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.227 1.011 . . . . 55.100000000000001 110.209 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.27 177.52 43.49 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.086 -0.961 . . . . 51.329999999999998 110.929 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.71 -38.18 54.78 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.007 0.523 . . . . 72.239999999999995 111.254 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -84.32 -23.33 30.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.966 0.506 . . . . 71.319999999999993 111.152 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.6 p -72.92 153.99 40.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.151 0.58 . . . . 71.140000000000001 111.521 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.8 tp -127.06 129.05 47.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.388 0.675 . . . . 65.200000000000003 110.968 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -69.66 130.56 42.71 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.692 0.797 . . . . 73.310000000000002 109.997 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.657 HG22 HG21 ' A' ' 123' ' ' THR . 22.0 pt -129.25 147.5 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 72.019999999999996 110.67 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -106.93 140.58 39.52 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.84 -1.17 . . . . 65.439999999999998 107.84 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -62.45 147.43 48.71 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 123.5 0.5 . . . . 73.310000000000002 110.271 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.74 -28.74 10.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.984 -0.342 . . . . 61.130000000000003 112.794 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.3 146.01 33.19 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.229 0.515 . . . . 74.299999999999997 111.04 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HB3' HD11 ' A' ' 84' ' ' LEU . 39.9 mmtm -90.02 142.68 27.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.129 0.971 . . . . 71.530000000000001 109.696 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.586 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -145.57 146.1 31.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.861 0.865 . . . . 73.040000000000006 110.115 -178.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -99.65 107.06 19.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.811 0.444 . . . . 65.200000000000003 110.063 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.538 HG13 ' HB1' ' A' ' 119' ' ' ALA . 53.5 t -79.02 119.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.873 -0.788 . . . . 62.439999999999998 108.873 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -116.8 -8.68 11.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.055 -175.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.83 140.74 6.48 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 121.263 -0.494 . . . . 43.119999999999997 112.885 171.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.404 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 74.4 m-85 -97.03 174.92 6.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.918 0.887 . . . . 74.439999999999998 110.439 172.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -96.09 -173.16 2.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.987 -1.006 . . . . 54.140000000000001 110.445 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -52.44 -39.38 60.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.657 1.183 . . . . 51.420000000000002 114.115 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -108.14 6.62 27.0 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.814 0.446 . . . . 72.209999999999994 112.092 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 63.66 12.15 45.73 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 115.361 0.904 . . . . 53.219999999999999 115.361 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.76 -7.71 33.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.6 0.76 . . . . 75.310000000000002 111.636 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.5 ' HZ2' HG11 ' A' ' 244' ' ' VAL . 39.2 m95 -127.52 145.38 50.87 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.97 -1.122 . . . . 65.239999999999995 107.97 167.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.538 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -148.02 125.78 11.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.274 -0.876 . . . . 51.109999999999999 109.219 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 37.9 tt0 -67.34 123.29 19.95 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 108.268 -1.012 . . . . 71.409999999999997 108.268 171.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -126.98 145.71 50.6 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.76 0.824 . . . . 65.549999999999997 110.215 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -101.92 100.31 10.59 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.12 -1.067 . . . . 60.219999999999999 108.12 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.657 HG21 HG22 ' A' ' 101' ' ' ILE . 67.0 p -82.27 165.85 20.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.309 0.644 . . . . 73.109999999999999 109.831 173.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -20.45 66.09 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 121.462 0.649 . . . . 65.519999999999996 109.445 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -79.38 -29.94 42.3 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.087 1.355 . . . . 74.099999999999994 112.297 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.33 -165.3 36.59 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 119.872 -0.405 . . . . 62.109999999999999 112.588 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -128.03 144.75 51.11 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.033 0.916 . . . . 72.549999999999997 110.367 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.13 178.42 36.0 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 112.589 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 75.1 m95 -75.07 118.4 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.324 1.05 . . . . 73.209999999999994 112.49 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.2 m -118.14 152.47 50.53 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 124.23 1.012 . . . . 35.32 108.428 174.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.12 129.07 17.59 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 121.772 1.648 . . . . 53.020000000000003 111.206 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 m -64.4 -25.84 68.19 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.099 0.96 . . . . 64.420000000000002 112.295 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -80.41 -5.48 56.57 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.236 1.015 . . . . 74.209999999999994 111.875 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -96.87 -13.98 22.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.072 0.949 . . . . 74.420000000000002 110.944 173.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 87' ' ' ALA . 16.1 pt -125.83 172.34 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.752 0.821 . . . . 73.040000000000006 110.585 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.417 HG21 ' HB2' ' A' ' 142' ' ' GLU . 2.5 m -159.63 142.35 10.15 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.403 1.081 . . . . 64.409999999999997 108.959 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.72 139.64 58.1 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.161 1.908 . . . . 70.219999999999999 112.237 170.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.8 t -70.19 -6.05 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 121.603 0.716 . . . . 73.200000000000003 109.966 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -85.85 -21.16 28.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.831 0.852 . . . . 71.319999999999993 112.756 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.3 p -102.11 179.01 4.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.383 0.673 . . . . 53.299999999999997 112.576 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.74 -22.24 37.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.429 1.092 . . . . 73.140000000000001 112.177 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.417 ' HB2' HG21 ' A' ' 136' ' ' THR . 3.1 mp0 -69.5 -13.87 62.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.075 0.95 . . . . 71.0 112.223 -172.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.534 ' HA ' HD21 ' A' ' 88' ' ' LEU . 22.2 pttm -69.88 -11.38 60.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.49 0.716 . . . . 70.140000000000001 112.175 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -87.05 143.37 27.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.293 0.637 . . . . 62.340000000000003 110.582 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 p -68.13 -33.29 74.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.29 1.036 . . . . 75.530000000000001 112.765 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -71.17 -33.28 69.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 74.25 111.46 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -78.43 112.79 15.82 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.52 -0.918 . . . . 74.400000000000006 108.52 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.46 -20.13 13.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.5 0.72 . . . . 71.409999999999997 111.345 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.95 -150.27 42.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 118.545 -1.142 . . . . 72.209999999999994 111.974 -174.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.03 100.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.66 2.907 . . . . 73.319999999999993 113.437 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.9 t -131.93 150.13 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.954 1.302 . . . . 72.140000000000001 108.94 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.3 p -90.95 175.19 7.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.368 0.667 . . . . 53.210000000000001 111.434 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -60.69 3.13 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.494 1.117 . . . . 63.140000000000001 110.886 -177.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.1 -29.03 70.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.936 0.895 . . . . 75.120000000000005 111.255 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.59 83.35 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 123.786 0.679 . . . . 64.099999999999994 110.944 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.78 -44.41 93.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.807 0.692 . . . . 64.510000000000005 110.84 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.99 -44.58 82.84 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.538 -0.755 . . . . 74.340000000000003 111.337 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.11 -44.46 88.68 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.592 -1.186 . . . . 74.030000000000001 111.888 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 237' ' ' PRO . 87.0 mt -59.8 -39.5 85.2 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.19 0.996 . . . . 73.129999999999995 111.571 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 90.8 mt -81.05 -27.53 35.71 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.283 -0.871 . . . . 70.329999999999998 112.074 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.9 p -68.39 -10.02 52.22 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 118.379 0.536 . . . . 51.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.9 p -103.55 21.16 16.57 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.62 1.168 . . . . 71.310000000000002 111.122 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.71 -178.15 15.19 Favored Glycine 0 C--N 1.353 1.499 0 C-N-CA 123.347 0.499 . . . . 51.149999999999999 113.79 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.4 pt -96.79 178.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.381 1.072 . . . . 74.439999999999998 112.06 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.47 112.46 5.31 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.158 -1.052 . . . . 71.319999999999993 108.158 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.59 24.89 Favored Glycine 0 CA--C 1.528 0.89 0 O-C-N 123.742 0.651 . . . . 61.399999999999999 112.746 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 184' ' ' LEU . 73.3 m -76.56 139.96 40.9 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.567 0.684 . . . . 75.430000000000007 110.868 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.2 p90 -148.78 163.53 37.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.068 0.461 . . . . 75.109999999999999 110.538 -175.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.1 pp -157.73 149.71 22.16 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.359 -0.837 . . . . 64.510000000000005 108.961 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.734 HG22 HG12 ' A' ' 182' ' ' ILE . 93.9 t -109.0 120.78 61.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.114 -1.069 . . . . 44.009999999999998 108.114 168.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.504 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 24.2 ptt85 -114.54 164.51 13.9 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.651 1.18 . . . . 71.25 108.452 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.16 160.84 20.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.98 0.912 . . . . 72.219999999999999 108.697 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.7 t -79.68 124.18 28.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.498 -0.556 . . . . 62.43 109.498 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.52 -36.24 83.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.85 0.86 . . . . 71.400000000000006 110.54 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.1 p -69.75 -31.27 69.14 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.897 0.879 . . . . 53.119999999999997 112.071 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 m -150.91 119.43 3.5 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.034 0.534 . . . . 64.519999999999996 110.305 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.8 154.4 74.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.832 2.355 . . . . 61.100000000000001 112.198 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.16 -31.22 8.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.004 -0.543 . . . . 65.230000000000004 112.316 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.59 112.19 17.72 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.93 -1.137 . . . . 72.129999999999995 107.93 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.572 ' H ' ' NH2' ' A' ' 194' ' ' ARG . 98.4 mtt180 -124.28 127.32 47.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.553 0.741 . . . . 73.310000000000002 110.068 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.1 m -125.28 145.51 49.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.74 0.816 . . . . 52.229999999999997 110.206 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.734 HG12 HG22 ' A' ' 170' ' ' VAL . 20.9 mt -100.12 143.93 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 107.696 -1.224 . . . . 65.340000000000003 107.696 173.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.2 m -125.61 109.84 13.12 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 176.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 167' ' ' SER . 32.0 tp -105.35 112.91 26.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.956 0.503 . . . . 51.149999999999999 110.994 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 76.1 ttt180 -78.25 110.97 13.73 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.54 -0.911 . . . . 71.030000000000001 108.54 163.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -133.1 125.88 30.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.009 1.324 . . . . 75.329999999999998 108.718 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 58.54 30.84 20.33 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.339 1.055 . . . . 60.350000000000001 110.433 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.482 ' HA2' ' HE ' ' A' ' 185' ' ' ARG . . . 79.84 -13.23 25.47 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-N 114.678 -1.146 . . . . 43.210000000000001 113.824 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 58.0 mtp85 -93.63 125.53 38.3 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.289 0.636 . . . . 62.420000000000002 109.406 -171.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.93 106.56 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.104 0.562 . . . . 64.030000000000001 110.847 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -96.51 131.99 42.56 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.586 1.154 . . . . 71.400000000000006 108.796 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -110.39 117.82 34.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.213 0.53 . . . . 62.32 111.439 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.453 ' HE1' HD21 ' A' ' 232' ' ' LEU . 2.8 m-30 -95.33 138.71 32.64 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 124.767 1.227 . . . . 70.140000000000001 108.768 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.572 ' NH2' ' H ' ' A' ' 180' ' ' ARG . 1.8 tpm_? -112.0 109.04 18.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 106.873 -1.528 . . . . 52.409999999999997 106.873 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -68.8 103.56 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 123.55 0.531 . . . . 73.409999999999997 110.759 -171.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -68.85 143.44 54.55 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.671 0.788 . . . . 75.340000000000003 110.414 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.6 m -119.99 118.78 31.57 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.506 0.722 . . . . 71.430000000000007 109.702 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.35 159.83 33.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.668 0.787 . . . . 55.399999999999999 109.907 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.5 m -62.24 -22.83 66.28 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.632 0.975 . . . . 75.230000000000004 113.632 -170.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -90.24 -13.98 34.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.96 0.904 . . . . 51.109999999999999 112.03 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.42 12.9 12.48 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 114.501 0.561 . . . . 63.329999999999998 114.501 176.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -74.16 146.45 43.46 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.941 0.87 . . . . 62.32 111.254 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.4 150.3 24.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.931 0.892 . . . . 73.109999999999999 109.269 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.521 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 28.7 p90 -173.14 130.16 0.47 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.993 0.808 . . . . 74.420000000000002 109.492 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.482 HG23 HD11 ' A' ' 217' ' ' LEU . 79.2 t -70.8 -53.78 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.092 -1.077 . . . . 72.299999999999997 108.092 163.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.6 m -103.08 138.99 39.19 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.674 -1.603 . . . . 65.439999999999998 110.147 -170.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.0 t -68.55 -10.46 55.86 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.041 0.936 . . . . 73.340000000000003 112.45 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.0 -29.36 61.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.306 1.042 . . . . 71.040000000000006 112.423 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.31 116.56 7.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.611 0.364 . . . . 73.030000000000001 110.219 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.521 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 95.7 mtt180 -97.98 132.2 43.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.696 0.798 . . . . 73.310000000000002 109.305 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -113.11 156.67 22.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.196 0.998 . . . . 72.329999999999998 109.371 -173.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -78.43 -29.83 47.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.726 -0.67 . . . . 71.439999999999998 109.844 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 35.2 p -137.34 159.15 42.76 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.852 0.834 . . . . 61.109999999999999 112.153 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.465 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -64.14 -31.64 72.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.809 1.243 . . . . 75.420000000000002 110.099 177.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.88 -37.83 80.47 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.09 0.556 . . . . 53.409999999999997 111.299 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -77.79 -32.17 52.3 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.706 -0.679 . . . . 70.430000000000007 111.335 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.482 HD11 HG23 ' A' ' 205' ' ' VAL . 18.3 tp -54.69 -55.52 28.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.894 -0.41 . . . . 71.329999999999998 109.894 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.72 -44.38 98.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 O-C-N 124.251 0.969 . . . . 65.0 110.453 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -61.09 -57.7 11.46 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 123.451 0.469 . . . . 73.409999999999997 111.982 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -62.32 -38.75 90.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.052 -0.522 . . . . 55.100000000000001 110.967 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.655 ' HB3' HD11 ' A' ' 228' ' ' LEU . 16.2 m170 -84.84 -6.59 59.35 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.518 0.562 . . . . 63.039999999999999 112.518 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 86.7 p -95.75 -29.25 14.36 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.742 0.417 . . . . 75.310000000000002 111.16 172.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 38.0 p -81.55 -43.19 19.06 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.323 -0.398 . . . . 62.229999999999997 110.72 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 226' ' ' ASP . 28.9 m -126.65 160.84 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.405 0.682 . . . . 73.400000000000006 111.644 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.78 13.83 1.55 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.372 1.869 . . . . 64.239999999999995 114.624 -170.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.528 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.2 t70 -41.95 29.63 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 131.207 3.803 . . . . 74.109999999999999 120.148 -151.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.14 9.97 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 120.573 -1.329 . . . . 75.329999999999998 112.579 -169.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -90.56 162.56 14.95 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.762 1.225 . . . . 72.530000000000001 108.79 166.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.83 -36.57 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.474 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.2 t -159.84 -178.71 7.25 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.562 0.745 . . . . 64.310000000000002 110.483 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.5 p -66.99 143.34 56.85 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.114 0.965 . . . . 65.219999999999999 111.844 175.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.453 HD21 ' HE1' ' A' ' 193' ' ' TYR . 41.8 mt -74.89 146.44 41.88 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 107.802 -1.184 . . . . 73.209999999999994 107.802 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -147.72 -45.68 0.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 120.134 1.334 . . . . 72.209999999999994 113.833 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -112.55 133.31 21.87 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.323 0.649 . . . . 74.25 109.445 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 67.5 Cg_endo -87.39 124.45 2.01 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.388 2.059 . . . . 71.219999999999999 110.259 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.447 ' HB2' HD23 ' A' ' 160' ' ' LEU . . . -62.39 144.36 95.29 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.002 -0.74 . . . . 71.099999999999994 109.002 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.486 ' O ' HD22 ' A' ' 159' ' ' LEU . 86.8 Cg_endo -75.81 -178.82 4.61 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.242 1.961 . . . . 73.239999999999995 112.718 -177.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -85.48 138.12 32.44 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.637 -1.245 . . . . 73.400000000000006 107.637 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.463 ' HB3' HD21 ' A' ' 159' ' ' LEU . 15.0 ptt180 -90.42 -57.33 2.87 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.351 0.978 . . . . 74.299999999999997 111.257 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -106.78 136.68 46.18 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.156 0.583 . . . . 72.439999999999998 110.443 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -82.85 116.96 66.92 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.076 -1.453 . . . . 71.329999999999998 107.076 162.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.03 127.63 15.21 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.896 3.064 . . . . 71.450000000000003 113.901 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.5 m -75.1 122.01 22.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.939 0.495 . . . . 74.010000000000005 111.13 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.5 HG11 ' HZ2' ' A' ' 118' ' ' TRP . 95.2 t -94.2 120.99 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.281 -1.007 . . . . 73.120000000000005 108.281 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -105.17 112.53 25.69 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.608 -0.516 . . . . 71.150000000000006 109.608 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.54 -28.44 0.22 Allowed Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.514 2.166 . . . . 54.140000000000001 118.514 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.1 m -72.03 132.0 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 118.856 1.328 . . . . 72.349999999999994 114.359 -160.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.8 t -73.45 122.99 88.99 Favored Pre-proline 0 C--N 1.355 0.83 0 N-CA-C 106.288 -1.745 . . . . 70.040000000000006 106.288 160.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 C--N 1.375 1.944 0 C-N-CA 121.833 1.688 . . . . 62.020000000000003 113.838 -158.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.2 t90 . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.167 0.508 . . . . 64.510000000000005 111.376 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 29.7 p-10 -88.09 -22.66 24.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.684 -0.689 . . . . 71.540000000000006 109.264 165.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.4 m -67.64 2.85 1.63 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.776 1.23 . . . . 74.329999999999998 113.381 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -70.01 -26.96 64.3 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.995 0.518 . . . . 72.310000000000002 110.997 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 13.2 pt-20 -77.54 -21.64 52.27 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.095 0.474 . . . . 74.040000000000006 110.327 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -91.66 -2.34 57.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.818 1.247 . . . . 41.310000000000002 110.827 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.31 -47.76 80.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.241 1.017 . . . . 63.530000000000001 111.733 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.1 mt -99.15 26.6 5.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.421 0.688 . . . . 72.340000000000003 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.19 0.596 . . . . 74.209999999999994 111.724 178.408 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.036 0.446 . . . . 65.409999999999997 111.47 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 tp -89.55 122.12 32.41 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.734 -0.839 . . . . 73.239999999999995 108.734 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.7 m-85 -108.87 174.52 5.83 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.811 1.244 . . . . 71.439999999999998 109.099 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.96 138.88 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.109 1.364 . . . . 45.210000000000001 108.957 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.02 114.18 14.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 50.109999999999999 110.517 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.24 -35.62 66.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.288 0.635 . . . . 71.420000000000002 111.071 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.446 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 32.5 m-85 -122.96 143.96 49.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.512 -0.921 . . . . 75.510000000000005 108.512 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 6.3 p-10 -70.42 148.05 48.79 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 109.178 -0.675 . . . . 74.549999999999997 109.178 167.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.563 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.6 t80 -147.17 141.57 26.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.127 -1.064 . . . . 72.219999999999999 108.127 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.7 139.97 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.236 -1.024 . . . . 72.019999999999996 108.236 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.22 115.72 3.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.536 0.734 . . . . 75.209999999999994 111.009 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -93.24 -55.93 3.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.328 1.051 . . . . 75.430000000000007 109.704 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.54 -173.44 38.32 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.398 -0.819 . . . . 65.030000000000001 113.452 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.68 -38.94 80.73 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.278 1.031 . . . . 75.239999999999995 111.759 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -98.95 -12.85 20.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.906 0.882 . . . . 74.319999999999993 112.036 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.4 p -72.33 135.04 45.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.784 -0.451 . . . . 54.140000000000001 109.784 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.6 ' HB3' HG13 ' A' ' 130' ' ' VAL . 66.4 tp -103.42 130.91 50.85 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.411 0.684 . . . . 73.319999999999993 110.394 -174.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -70.94 125.74 27.67 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.722 -0.844 . . . . 62.340000000000003 108.722 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.612 HG22 HG21 ' A' ' 123' ' ' THR . 22.8 pt -125.47 144.86 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.604 0.762 . . . . 65.25 110.08 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 10.1 m -88.72 144.94 25.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.676 -0.861 . . . . 64.239999999999995 108.676 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 62.5 tttp -65.69 110.97 2.97 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.796 0.438 . . . . 61.119999999999997 110.616 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.13 -10.88 55.28 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.013 -0.54 . . . . 61.409999999999997 112.931 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.645 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.5 tt0 -71.27 130.84 42.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.784 0.834 . . . . 74.349999999999994 110.533 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -77.27 147.63 36.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.953 -0.758 . . . . 65.409999999999997 108.953 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.614 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -147.98 142.2 26.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.798 0.439 . . . . 51.229999999999997 111.222 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 19.6 tpp180 -89.12 107.26 18.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.526 -0.761 . . . . 54.219999999999999 109.214 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.6 HG13 ' HB1' ' A' ' 119' ' ' ALA . 77.7 t -88.81 102.59 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.443 -0.577 . . . . 64.319999999999993 109.443 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 122' ' ' GLN . 2.2 mm? -67.53 -41.06 84.96 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.17 -0.923 . . . . 71.450000000000003 110.153 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.45 151.15 11.6 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.321 -0.854 . . . . 64.319999999999993 112.201 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 56.7 m-85 -88.35 174.45 8.15 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.791 0.836 . . . . 71.239999999999995 110.633 174.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -80.22 -176.34 5.54 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.614 -0.721 . . . . 71.0 109.217 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -54.63 -36.59 64.68 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.043 0.937 . . . . 71.25 113.296 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -112.48 10.46 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.077 0.769 . . . . 63.030000000000001 113.077 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.52 26.14 74.52 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.978 0.751 . . . . 70.310000000000002 114.978 171.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -80.81 -65.74 0.97 Allowed 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 109.027 -0.731 . . . . 71.329999999999998 109.027 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.416 ' HB3' ' HE3' ' A' ' 129' ' ' TRP . 73.8 m95 -90.59 150.94 21.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.015 0.926 . . . . 53.399999999999999 111.082 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.6 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.64 132.2 32.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.959 0.903 . . . . 71.120000000000005 110.641 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -76.85 107.48 9.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.889 -0.782 . . . . 70.219999999999999 108.889 167.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -112.52 149.71 32.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.989 0.916 . . . . 61.229999999999997 110.89 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.536 ' HG3' HD21 ' A' ' 110' ' ' LEU . 56.1 mt-30 -112.39 123.15 49.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.899 0.879 . . . . 74.120000000000005 109.498 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.612 HG21 HG22 ' A' ' 101' ' ' ILE . 44.1 p -124.01 174.78 7.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.716 1.207 . . . . 60.439999999999998 110.824 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -58.05 -27.31 63.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.68 1.192 . . . . 73.400000000000006 110.696 167.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.79 -30.87 59.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.525 1.13 . . . . 72.120000000000005 111.299 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 138.03 -177.23 20.16 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.188 -0.229 . . . . 51.229999999999997 112.921 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -86.79 138.9 31.21 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.921 0.488 . . . . 63.409999999999997 109.948 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -178.33 -173.48 43.75 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.243 -0.743 . . . . 63.210000000000001 111.243 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.416 ' HE3' ' HB3' ' A' ' 118' ' ' TRP . 32.7 m95 -110.76 120.79 43.57 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.513 0.725 . . . . 74.0 111.426 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.6 HG13 ' HB3' ' A' ' 99' ' ' LEU . 31.0 m -127.99 143.33 47.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 125.207 1.403 . . . . 73.209999999999994 108.969 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 4.6 Cg_endo -86.07 156.25 9.84 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.385 2.057 . . . . 72.319999999999993 114.39 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.3 m -36.5 -40.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 127.038 2.135 . . . . 54.130000000000003 114.691 170.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.407 HD22 ' HB2' ' A' ' 242' ' ' PRO . 35.6 p-10 -65.98 -22.21 66.45 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.326 0.65 . . . . 71.400000000000006 111.977 -172.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 38.1 m-85 -98.6 -20.04 17.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.806 0.842 . . . . 64.099999999999994 112.387 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -122.8 171.11 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.332 0.653 . . . . 63.119999999999997 112.249 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.4 t -161.3 153.9 17.19 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.353 -0.98 . . . . 72.010000000000005 108.353 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 54.3 Cg_exo -55.23 149.36 45.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 121.743 1.629 . . . . 72.140000000000001 112.351 172.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.88 -12.63 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.94 0.876 . . . . 72.400000000000006 109.852 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -87.22 -6.15 58.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.082 0.953 . . . . 73.25 111.516 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.3 p -89.11 174.26 7.98 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.924 0.489 . . . . 70.239999999999995 111.553 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.17 -23.63 30.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.507 -0.77 . . . . 62.030000000000001 110.849 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.64 -22.19 64.42 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.828 0.851 . . . . 65.340000000000003 111.929 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -59.55 -22.14 61.27 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.054 0.541 . . . . 72.049999999999997 111.91 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -82.55 139.59 33.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.522 0.729 . . . . 74.340000000000003 110.399 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.6 p -60.02 -42.17 93.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.695 1.198 . . . . 64.439999999999998 112.353 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -65.99 -38.42 88.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.734 0.813 . . . . 75.439999999999998 112.568 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.12 109.96 15.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.386 -0.598 . . . . 64.040000000000006 109.386 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.413 ' HB2' HG21 ' A' ' 151' ' ' VAL . 28.5 m170 -104.71 -9.78 17.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.009 0.524 . . . . 73.439999999999998 111.832 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.54 -132.26 27.14 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 118.208 -1.329 . . . . 52.240000000000002 112.294 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.88 95.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.254 2.636 . . . . 73.230000000000004 112.764 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.619 HG22 ' HE ' ' A' ' 239' ' ' ARG . 46.9 t -136.95 126.94 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.431 1.093 . . . . 61.520000000000003 108.956 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.6 p -76.29 172.51 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.307 0.643 . . . . 71.530000000000001 110.762 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -62.8 -48.46 79.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.739 0.416 . . . . 73.299999999999997 109.903 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -59.17 -35.88 74.32 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.113 0.883 . . . . 72.230000000000004 111.089 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -67.64 -47.84 68.41 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.602 -0.726 . . . . 72.450000000000003 111.182 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.36 86.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.409 -0.814 . . . . 73.319999999999993 110.798 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -81.94 -20.27 39.01 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.154 -0.93 . . . . 51.350000000000001 111.914 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -81.03 -24.7 37.7 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.156 0.889 . . . . 74.340000000000003 111.063 174.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.59 HD21 ' HB3' ' A' ' 239' ' ' ARG . 65.4 mt -71.35 -46.24 60.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 51.329999999999998 110.12 168.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 40.4 mt -92.47 20.33 6.33 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.128 -0.942 . . . . 74.129999999999995 111.935 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.6 p -90.4 -37.66 13.83 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.392 -0.596 . . . . 43.399999999999999 109.392 166.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.0 p -96.38 -11.64 25.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.458 0.703 . . . . 54.25 111.179 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.67 166.21 35.66 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 123.439 0.462 . . . . 64.340000000000003 113.89 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 pt -98.35 -178.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.83 0.852 . . . . 73.349999999999994 111.703 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -68.03 125.66 27.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.97 -0.559 . . . . 61.439999999999998 109.98 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.93 9.65 65.66 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-O 119.084 -0.842 . . . . 73.219999999999999 112.794 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.8 m -75.56 135.76 40.56 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 118.093 0.947 . . . . 73.120000000000005 110.396 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 183' ' ' SER . 17.1 p90 -147.28 162.96 37.88 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.708 0.403 . . . . 72.5 110.63 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -160.51 148.33 16.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.537 -0.756 . . . . 71.400000000000006 109.324 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.652 HG22 HG12 ' A' ' 182' ' ' ILE . 70.8 t -101.55 125.17 55.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.168 -1.049 . . . . 72.340000000000003 108.168 169.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.59 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt180 -115.67 151.11 35.66 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.255 1.022 . . . . 71.329999999999998 108.418 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.96 149.96 36.51 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.573 -1.269 . . . . 72.340000000000003 107.573 165.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.6 t -81.04 120.85 25.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.111 0.564 . . . . 63.149999999999999 110.37 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.72 -36.03 77.82 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.152 0.981 . . . . 72.340000000000003 109.862 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.3 m -68.47 -34.04 75.24 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.631 0.773 . . . . 64.530000000000001 111.642 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.5 m -140.98 91.6 8.93 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.381 0.673 . . . . 72.420000000000002 110.969 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.1 124.93 17.46 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.158 2.572 . . . . 72.219999999999999 112.545 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.58 -28.92 11.84 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.815 -0.436 . . . . 63.310000000000002 112.76 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -74.38 116.69 15.34 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.844 -0.799 . . . . 75.129999999999995 108.844 173.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.515 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 72.3 mtt85 -123.84 144.35 49.79 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.462 0.705 . . . . 71.5 109.252 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.1 m -138.26 146.28 42.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.063 -0.971 . . . . 72.349999999999994 108.561 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.652 HG12 HG22 ' A' ' 170' ' ' VAL . 28.5 mt -100.41 149.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 106.589 -1.634 . . . . 72.310000000000002 106.589 168.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.1 m -124.52 120.07 30.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.474 -1.306 . . . . 73.219999999999999 107.474 170.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.6 tp -114.07 112.01 22.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.828 0.74 . . . . 71.510000000000005 110.399 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.546 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 32.9 ttt85 -78.07 114.44 16.96 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 109.258 -0.645 . . . . 71.319999999999993 109.258 165.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -136.9 132.3 34.31 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.08 -1.082 . . . . 71.049999999999997 108.08 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 59.36 28.59 17.98 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.7 1.2 . . . . 64.540000000000006 111.488 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.19 -9.81 56.14 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.889 -0.596 . . . . 72.120000000000005 114.034 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -96.49 124.1 40.37 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.085 0.954 . . . . 74.150000000000006 108.781 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.82 108.08 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 120.913 0.387 . . . . 74.120000000000005 110.104 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.99 151.07 21.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.56 1.144 . . . . 70.239999999999995 108.706 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -128.15 116.75 20.42 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.593 -0.521 . . . . 72.319999999999993 109.593 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.487 ' HE1' HD21 ' A' ' 232' ' ' LEU . 4.5 m-85 -95.74 149.59 21.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.412 1.085 . . . . 62.329999999999998 108.74 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -107.26 116.12 31.38 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.039 0.536 . . . . 74.409999999999997 109.577 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 45.3 mt -81.92 105.28 11.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.564 -0.902 . . . . 61.119999999999997 108.564 172.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -90.57 144.62 25.59 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.918 0.887 . . . . 64.209999999999994 109.288 173.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.8 m -98.39 128.97 45.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.903 0.881 . . . . 51.520000000000003 109.163 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 160.56 31.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.619 0.768 . . . . 71.420000000000002 109.951 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 40.9 p -62.64 -24.44 67.6 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.864 0.69 . . . . 64.140000000000001 112.864 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.07 -17.31 27.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.416 0.686 . . . . 65.439999999999998 111.372 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.55 14.02 9.17 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.451 0.94 . . . . 75.319999999999993 115.451 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -68.87 156.05 39.14 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.244 1.022 . . . . 74.439999999999998 110.492 170.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 146.8 34.2 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.413 -0.958 . . . . 63.109999999999999 108.413 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 30.7 p90 -167.97 141.52 3.32 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.681 0.613 . . . . 73.230000000000004 112.069 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.448 HG23 HD11 ' A' ' 217' ' ' LEU . 75.4 t -88.89 -31.87 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.186 -0.915 . . . . 71.219999999999999 108.87 162.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.7 m -105.54 123.04 47.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.301 1.04 . . . . 73.420000000000002 109.383 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -66.54 -24.7 66.41 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.163 0.585 . . . . 72.530000000000001 111.735 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.72 -15.18 57.15 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.41 1.084 . . . . 75.439999999999998 110.577 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.5 m -133.67 89.42 2.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.772 0.829 . . . . 70.409999999999997 109.338 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.469 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 52.9 mtt180 -97.11 120.04 36.71 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.725 0.81 . . . . 73.230000000000004 109.288 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.22 146.86 32.19 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.642 -0.873 . . . . 75.329999999999998 108.642 -174.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.21 -30.2 70.61 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 123.764 0.665 . . . . 72.209999999999994 111.622 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 75.2 p -132.08 158.79 40.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.32 0.648 . . . . 74.319999999999993 111.902 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.77 -28.56 67.71 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.471 1.108 . . . . 54.439999999999998 109.688 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.47 83.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.312 0.645 . . . . 73.310000000000002 110.668 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -77.33 -28.3 53.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.677 0.791 . . . . 72.209999999999994 111.666 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 205' ' ' VAL . 12.4 tp -58.33 -57.64 12.02 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.541 0.336 . . . . 72.519999999999996 110.254 170.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.54 -38.28 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.892 0.745 . . . . 63.32 110.739 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.15 -56.33 23.49 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.789 0.681 . . . . 73.019999999999996 111.301 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -65.21 -33.54 76.25 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.406 0.682 . . . . 73.140000000000001 110.844 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.697 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.6 m170 -89.29 -8.39 53.46 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.138 -0.483 . . . . 64.319999999999993 112.115 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.6 p -97.52 -22.89 16.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.041 0.537 . . . . 55.340000000000003 110.775 170.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 44.6 p -82.25 -43.2 17.9 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.796 0.439 . . . . 54.340000000000003 111.051 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' A' ' 226' ' ' ASP . 32.0 m -130.32 167.71 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.844 0.83 . . . . 64.340000000000003 111.57 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -80.48 13.93 2.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.839 2.056 . . . . 52.420000000000002 114.549 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.552 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.6 t70 -40.98 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 131.18 3.792 . . . . 73.530000000000001 119.82 -150.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.48 -3.94 10.22 Favored Glycine 0 N--CA 1.481 1.639 0 O-C-N 119.438 -2.039 . . . . 44.020000000000003 112.133 -166.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 221' ' ' HIS . 9.8 mt -89.59 162.49 15.62 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 125.139 1.375 . . . . 75.099999999999994 109.285 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.8 tt -57.5 -39.17 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-O 120.588 0.232 . . . . 75.219999999999999 110.499 168.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -162.64 175.62 11.2 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.492 0.717 . . . . 64.200000000000003 110.906 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.8 p -60.42 144.55 50.76 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.613 1.165 . . . . 65.129999999999995 112.209 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.487 HD21 ' HE1' ' A' ' 193' ' ' TYR . 78.4 mt -77.65 116.4 18.17 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.692 0.797 . . . . 61.210000000000001 109.353 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -104.94 -79.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.787 0.435 . . . . 74.450000000000003 111.308 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 167' ' ' SER . 46.3 t80 -90.39 121.52 68.38 Favored Pre-proline 0 C--O 1.213 -0.844 0 C-N-CA 123.7 0.8 . . . . 41.32 109.486 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.21 134.32 10.26 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.001 1.8 . . . . 71.219999999999999 111.228 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.17 151.35 92.42 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.492 0.717 . . . . 64.120000000000005 109.573 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -85.45 169.15 9.74 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.446 2.097 . . . . 60.340000000000003 113.873 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -59.05 119.19 6.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.006 0.922 . . . . 71.420000000000002 109.041 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.619 ' HE ' HG22 ' A' ' 151' ' ' VAL . 22.9 ptt85 -78.94 -59.67 2.69 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.794 1.035 . . . . 74.140000000000001 113.794 -161.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.415 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 49.2 t30 -106.98 122.0 45.58 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.84 0.856 . . . . 65.209999999999994 109.0 -176.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.69 113.75 22.57 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 106.953 -1.499 . . . . 74.209999999999994 106.953 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.407 ' HB2' HD22 ' A' ' 133' ' ' ASN . 60.0 Cg_endo -69.58 129.32 17.58 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.812 2.341 . . . . 44.409999999999997 112.521 -166.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.8 m -68.81 113.5 6.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.312 -0.858 . . . . 61.109999999999999 110.667 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.56 117.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.601 -1.259 . . . . 71.120000000000005 107.601 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -96.03 110.39 22.64 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 118.927 -0.558 . . . . 71.120000000000005 110.707 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 63.42 -38.19 0.08 OUTLIER Glycine 0 CA--C 1.55 2.26 0 N-CA-C 118.639 2.216 . . . . 60.200000000000003 118.639 166.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.96 125.51 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.809 0.844 . . . . 75.25 113.226 -154.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.4 t -86.83 142.66 34.51 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 107.389 -1.338 . . . . 72.049999999999997 107.389 150.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 C--N 1.375 1.968 0 CA-C-N 120.834 1.334 . . . . 75.299999999999997 114.019 -167.561 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 5.4 t90 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 121.585 0.707 . . . . 73.439999999999998 109.611 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -85.65 -17.79 35.08 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.966 -1.015 . . . . 74.540000000000006 110.249 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.0 p -87.42 5.42 38.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.952 0.901 . . . . 74.239999999999995 111.684 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -64.34 -30.32 71.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.745 0.418 . . . . 64.0 111.553 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.608 ' HG3' HD22 ' A' ' 72' ' ' ASN . 11.6 pt-20 -65.24 -33.16 75.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.166 -0.47 . . . . 75.310000000000002 110.482 172.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.608 HD22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -75.97 -17.95 59.51 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.575 0.75 . . . . 74.319999999999993 111.369 177.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.4 tp -55.48 -51.66 66.22 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.093 0.557 . . . . 74.109999999999999 110.73 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.11 14.84 23.71 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.448 0.699 . . . . 74.409999999999997 111.213 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 C-N-CA 122.477 0.311 . . . . 71.430000000000007 111.261 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.429 0.157 . . . . 71.450000000000003 110.945 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -86.6 130.85 34.33 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 109.202 -0.666 . . . . 74.310000000000002 109.202 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -108.82 174.12 6.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.568 1.147 . . . . 72.439999999999998 108.975 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.44 139.36 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.666 1.186 . . . . 61.43 108.616 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.5 127.51 32.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.515 0.726 . . . . 71.340000000000003 110.739 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 143' ' ' LYS . 91.2 mt -83.55 -32.82 25.64 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.773 0.829 . . . . 62.539999999999999 111.916 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.43 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 25.8 m-85 -125.05 157.18 36.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.253 0.621 . . . . 65.200000000000003 109.485 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.62 119.16 23.93 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.384 -0.969 . . . . 61.329999999999998 108.384 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.606 ' HB3' HG12 ' A' ' 101' ' ' ILE . 79.7 t80 -119.03 138.62 52.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.532 -0.914 . . . . 72.040000000000006 108.532 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -104.95 131.08 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.437 -0.949 . . . . 63.020000000000003 108.437 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.26 56.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.23 0.612 . . . . 62.43 111.092 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -86.83 -42.94 12.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.414 0.686 . . . . 52.109999999999999 109.689 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.76 -167.77 11.17 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.584 -0.734 . . . . 71.099999999999994 112.561 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.92 -37.87 85.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.129 0.972 . . . . 71.239999999999995 110.835 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -66.91 -21.01 66.01 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.259 -1.337 . . . . 74.340000000000003 112.222 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.0 p -100.39 -179.15 4.03 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.842 0.857 . . . . 64.150000000000006 110.484 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.637 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 62.9 tp -144.31 139.69 28.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.917 0.487 . . . . 44.130000000000003 111.073 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 m -85.35 132.9 34.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.442 0.697 . . . . 74.430000000000007 109.7 174.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -133.01 148.8 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 120.953 0.406 . . . . 72.109999999999999 111.621 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.8 m -99.3 150.23 22.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.076 0.95 . . . . 51.509999999999998 108.73 174.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -64.84 126.92 29.47 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.739 -0.467 . . . . 73.129999999999995 109.739 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.02 -14.13 64.19 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.127 -0.488 . . . . 75.120000000000005 112.575 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 39.2 tt0 -74.76 128.0 34.5 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.794 0.838 . . . . 62.530000000000001 110.774 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.88 134.68 35.08 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.412 0.685 . . . . 71.120000000000005 110.325 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.4 OUTLIER -146.21 136.86 24.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.817 0.847 . . . . 74.319999999999993 110.631 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -96.65 115.12 26.9 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.506 0.323 . . . . 72.420000000000002 110.602 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.644 HG13 ' HB1' ' A' ' 119' ' ' ALA . 52.7 t -74.58 110.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.424 0.63 . . . . 75.5 109.707 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.67 -32.13 60.04 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.246 -1.343 . . . . 74.099999999999994 110.044 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.54 155.34 11.17 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.231 -0.895 . . . . 63.100000000000001 111.878 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.61 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 43.0 m-85 -87.47 175.5 7.93 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.472 0.654 . . . . 72.219999999999999 111.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -85.38 -173.05 4.47 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.935 -1.029 . . . . 74.219999999999999 110.928 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -44.38 -44.17 8.12 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.472 1.509 . . . . 74.200000000000003 114.296 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -112.61 0.28 15.37 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.911 0.708 . . . . 74.230000000000004 112.911 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.61 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 81.83 22.69 59.24 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 115.313 0.885 . . . . 71.299999999999997 115.313 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.48 -65.44 1.0 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.98 0.89 . . . . 71.030000000000001 110.012 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 49.2 m95 -92.3 150.4 20.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.194 0.598 . . . . 74.510000000000005 111.369 -174.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.644 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -133.3 137.34 45.94 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.438 1.095 . . . . 30.43 110.193 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -78.37 98.8 6.11 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.292 -1.003 . . . . 73.409999999999997 108.292 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -105.42 139.98 39.23 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.414 0.685 . . . . 64.129999999999995 110.339 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -102.27 105.7 16.39 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.216 -0.661 . . . . 71.310000000000002 109.216 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.462 HG21 HG22 ' A' ' 101' ' ' ILE . 69.4 p -80.4 168.42 19.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.952 0.783 . . . . 75.450000000000003 109.731 171.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -67.33 -8.19 30.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.607 -0.724 . . . . 75.420000000000002 111.537 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -91.4 -30.78 16.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.937 0.895 . . . . 74.019999999999996 110.958 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.28 174.68 24.64 Favored Glycine 0 C--N 1.36 1.886 0 N-CA-C 114.204 0.442 . . . . 44.130000000000003 114.204 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -86.62 142.49 28.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.809 0.843 . . . . 71.219999999999999 110.99 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.637 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -176.81 -170.01 38.8 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-N 114.945 -1.025 . . . . 53.310000000000002 110.646 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -109.77 129.34 55.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.817 0.808 . . . . 74.030000000000001 111.41 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' A' ' 99' ' ' LEU . 27.6 m -136.07 145.21 51.43 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 124.698 1.199 . . . . 65.349999999999994 109.188 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 47.4 Cg_endo -88.44 156.35 6.57 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 122.541 2.161 . . . . 65.319999999999993 114.312 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 m -38.33 -43.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.611 1.964 . . . . 64.540000000000006 114.137 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.54 HD22 ' HB2' ' A' ' 242' ' ' PRO . 36.4 p-10 -72.23 -11.33 60.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.097 0.559 . . . . 70.409999999999997 112.057 -174.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 28.7 m-85 -105.9 -13.5 15.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.983 0.913 . . . . 74.310000000000002 112.581 176.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 130' ' ' VAL . 16.8 pt -130.98 172.83 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.373 0.669 . . . . 71.439999999999998 111.696 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -162.01 152.02 14.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 108.428 -0.953 . . . . 71.540000000000006 108.428 172.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.23 149.52 44.73 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.04 1.826 . . . . 71.420000000000002 112.065 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.17 -23.36 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.093 0.473 . . . . 64.150000000000006 110.531 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -69.69 -18.61 63.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.941 0.896 . . . . 64.409999999999997 112.291 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.2 p -77.93 166.16 23.21 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.157 0.799 . . . . 74.340000000000003 113.157 -167.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -84.52 -19.73 32.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.815 -1.084 . . . . 72.25 110.663 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -71.13 -24.15 62.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.294 1.037 . . . . 72.409999999999997 111.35 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.529 ' HA ' HD21 ' A' ' 88' ' ' LEU . 21.3 pttm -62.08 -18.64 61.37 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.44 0.696 . . . . 74.340000000000003 112.868 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -76.7 149.28 36.42 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.472 0.709 . . . . 72.310000000000002 110.418 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.4 p -61.72 -43.24 99.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.95 0.9 . . . . 73.230000000000004 111.456 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -68.89 -34.56 75.61 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.062 0.851 . . . . 74.299999999999997 113.103 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.92 113.92 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.148 -0.686 . . . . 74.019999999999996 109.148 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.425 ' HD2' ' HD3' ' A' ' 238' ' ' LYS . 29.8 m170 -110.94 3.59 18.93 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.633 0.605 . . . . 75.209999999999994 112.633 -175.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.58 -148.04 38.03 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-O 118.861 -0.966 . . . . 64.150000000000006 112.771 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.81 97.54 0.23 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.02 2.48 . . . . 74.319999999999993 111.952 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 61.0 t -131.89 129.28 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.666 0.787 . . . . 61.049999999999997 110.003 -175.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -79.36 172.34 13.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.55 0.74 . . . . 35.340000000000003 110.392 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -60.35 -47.62 85.27 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.645 0.378 . . . . 71.219999999999999 110.803 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -57.09 -41.59 79.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.652 0.781 . . . . 64.519999999999996 111.89 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -72.14 -34.25 68.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.763 0.425 . . . . 71.439999999999998 111.325 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.25 91.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.484 0.659 . . . . 75.540000000000006 110.915 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -79.6 -21.23 45.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.418 -0.81 . . . . 54.009999999999998 110.88 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -64.61 -42.06 95.78 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.221 0.608 . . . . 71.420000000000002 109.623 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 239' ' ' ARG . 85.8 mt -64.76 -44.51 89.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.521 0.728 . . . . 70.219999999999999 111.692 174.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.5 13.72 13.15 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.959 -0.564 . . . . 63.409999999999997 112.17 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -65.39 -42.11 92.99 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.476 0.655 . . . . 72.209999999999994 110.002 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.3 p -102.58 19.61 18.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.59 1.156 . . . . 65.109999999999999 110.494 176.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.35 152.95 36.65 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.883 -0.599 . . . . 51.539999999999999 112.269 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 pt -102.31 -177.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.147 0.979 . . . . 74.200000000000003 110.709 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.41 120.95 10.29 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.176 0.59 . . . . 61.130000000000003 110.247 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.17 10.52 62.34 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.795 -0.639 . . . . 34.310000000000002 113.168 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 73.9 m -77.73 128.4 33.99 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.782 0.791 . . . . 72.319999999999993 110.044 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -139.69 164.34 30.2 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.381 0.61 . . . . 64.420000000000002 111.454 -170.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.5 pp -160.2 154.92 24.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.464 -1.244 . . . . 75.549999999999997 108.968 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 182' ' ' ILE . 87.5 t -110.14 127.93 66.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.533 -0.914 . . . . 63.32 108.533 168.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.574 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 20.4 ptt85 -115.66 155.36 27.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.41 -1.268 . . . . 65.120000000000005 108.514 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.52 147.46 40.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.257 -1.016 . . . . 74.439999999999998 108.257 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -87.33 129.08 35.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.687 -0.486 . . . . 70.239999999999995 109.687 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -80.7 -40.06 26.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.485 -0.779 . . . . 71.310000000000002 109.518 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.7 m -66.54 -33.07 74.85 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.999 0.92 . . . . 62.310000000000002 111.097 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -118.51 95.53 48.9 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 123.764 0.826 . . . . 41.310000000000002 109.529 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -58.14 126.55 21.89 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.322 2.681 . . . . 74.430000000000007 113.278 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.62 -27.52 8.66 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 116.242 -0.435 . . . . 54.130000000000003 113.152 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -66.65 136.3 55.35 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.353 0.661 . . . . 74.019999999999996 110.548 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -135.17 158.29 44.75 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.717 0.807 . . . . 72.230000000000004 109.793 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.4 m -147.37 150.1 34.05 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.432 1.093 . . . . 72.019999999999996 108.93 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.611 HG12 HG22 ' A' ' 170' ' ' VAL . 35.8 mt -103.93 149.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.954 -1.128 . . . . 73.420000000000002 107.954 173.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.2 m -125.09 110.85 14.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.286 -1.005 . . . . 72.25 108.286 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.1 tp -110.0 112.85 25.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.152 0.581 . . . . 52.109999999999999 110.104 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.503 ' HB2' HG22 ' A' ' 190' ' ' VAL . 39.1 ttt180 -78.47 114.79 17.69 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.268 0.556 . . . . 75.420000000000002 110.048 165.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.44 141.62 37.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.153 -1.385 . . . . 54.119999999999997 107.763 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 57.07 28.67 15.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.922 0.889 . . . . 75.099999999999994 111.575 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.42 -9.46 54.78 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-N 115.797 -0.638 . . . . 72.420000000000002 114.043 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -104.5 140.05 38.53 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.834 0.854 . . . . 73.230000000000004 109.839 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 185' ' ' ARG . 48.9 t -98.77 106.51 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.852 0.461 . . . . 63.409999999999997 110.457 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -91.16 141.62 28.62 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.016 0.926 . . . . 74.219999999999999 109.115 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -114.88 118.58 33.9 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.713 0.405 . . . . 74.310000000000002 110.019 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.425 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.4 m-30 -94.02 149.78 20.93 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.05 0.94 . . . . 74.5 108.738 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -101.07 127.45 47.6 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.792 -0.818 . . . . 74.430000000000007 108.792 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 101.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.826 -1.176 . . . . 63.43 107.826 171.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -79.02 132.92 36.81 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.501 -0.772 . . . . 61.119999999999997 109.045 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.8 m -93.76 113.74 25.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.293 -1.003 . . . . 72.430000000000007 108.293 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.11 159.17 33.43 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.559 0.537 . . . . 71.120000000000005 111.257 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.5 p -66.8 -27.91 67.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.578 -0.737 . . . . 71.329999999999998 110.94 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.3 -1.05 48.33 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.985 0.914 . . . . 72.329999999999998 111.343 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 98.26 -7.92 62.36 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.822 -0.432 . . . . 75.310000000000002 114.116 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.33 133.49 34.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.652 0.726 . . . . 55.240000000000002 111.745 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.416 ' H ' HD22 ' A' ' 203' ' ' LEU . 1.3 mm? -83.6 147.87 27.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.855 0.862 . . . . 75.019999999999996 108.913 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.554 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.3 p90 -166.53 151.46 7.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.967 0.413 . . . . 64.340000000000003 111.876 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.438 ' HB ' ' HE1' ' A' ' 221' ' ' HIS . 59.8 t -99.19 -35.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.577 -0.897 . . . . 63.100000000000001 108.577 165.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -103.78 125.76 50.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.095 0.958 . . . . 72.209999999999994 109.252 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.9 t -63.01 -30.15 71.38 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 71.299999999999997 112.207 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.58 -26.9 61.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.624 0.769 . . . . 72.030000000000001 111.099 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.1 m -121.85 96.68 5.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 74.340000000000003 110.063 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.554 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.0 mtt180 -100.02 140.66 33.93 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.789 0.836 . . . . 75.150000000000006 109.195 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 3.1 m-85 -127.0 140.55 52.23 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.374 0.67 . . . . 72.230000000000004 109.818 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.19 -27.03 63.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.241 0.616 . . . . 74.329999999999998 110.289 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -133.29 153.72 51.32 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.813 0.845 . . . . 64.209999999999994 110.745 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.498 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -67.54 -21.52 65.46 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.128 -0.942 . . . . 74.439999999999998 109.708 172.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.01 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.9 0.88 . . . . 71.219999999999999 110.398 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.3 mt-10 -69.42 -37.04 77.25 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.289 -0.868 . . . . 74.420000000000002 111.338 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 205' ' ' VAL . 13.8 tp -55.17 -57.86 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.374 0.421 . . . . 71.310000000000002 111.152 176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.9 -40.3 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.892 0.477 . . . . 51.43 111.355 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -59.15 -54.44 46.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.381 0.672 . . . . 74.340000000000003 111.004 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.423 ' O ' HG22 ' A' ' 224' ' ' VAL . 45.4 t60 -63.76 -38.21 90.25 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.797 0.839 . . . . 72.450000000000003 110.925 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.71 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.0 m-70 -85.8 -8.24 58.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.922 0.489 . . . . 64.040000000000006 112.002 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.8 p -93.66 -28.9 15.72 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.627 0.371 . . . . 54.450000000000003 110.308 169.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.6 p -77.65 -40.71 40.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.322 0.249 . . . . 73.209999999999994 111.113 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 220' ' ' HIS . 32.6 m -131.58 157.56 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.72 . . . . 74.340000000000003 111.487 -176.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.59 10.24 18.57 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.08 1.752 . . . . 62.43 113.874 -173.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -45.96 32.78 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 130.799 3.64 . . . . 75.430000000000007 120.428 -155.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 127.84 -1.11 6.8 Favored Glycine 0 N--CA 1.464 0.564 0 O-C-N 120.925 -1.109 . . . . 50.100000000000001 112.788 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.5 mt -91.58 161.38 14.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.51 1.124 . . . . 64.099999999999994 109.753 165.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -60.77 -36.37 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 120.816 0.341 . . . . 61.229999999999997 110.485 171.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.2 t -162.77 178.77 8.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.885 0.874 . . . . 75.530000000000001 109.471 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.5 p -63.78 143.77 57.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.24 0.616 . . . . 72.219999999999999 112.039 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.425 HD21 ' HE1' ' A' ' 193' ' ' TYR . 54.4 mt -69.5 138.15 53.12 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 108.159 -1.052 . . . . 70.25 108.159 169.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -135.95 -76.7 0.43 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.85 0.75 . . . . 75.120000000000005 112.238 -170.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -84.21 122.43 75.62 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.912 -0.773 . . . . 64.120000000000005 108.912 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.05 126.4 6.37 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 122.251 1.968 . . . . 64.420000000000002 111.918 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . . . -74.11 135.8 76.47 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.891 -0.781 . . . . 74.340000000000003 108.891 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.5 177.76 8.36 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.632 2.222 . . . . 52.5 112.322 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HD3' ' HD2' ' A' ' 148' ' ' HIS . 72.5 mmtt -63.52 157.12 24.41 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.752 0.821 . . . . 63.219999999999999 109.971 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 29.3 ptt180 -91.13 -62.56 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.06 0.763 . . . . 54.200000000000003 113.06 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.564 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 24.8 t-20 -110.68 158.56 18.47 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.821 0.848 . . . . 64.319999999999993 108.794 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 114.55 57.37 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 106.131 -1.803 . . . . 71.530000000000001 106.131 156.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.54 ' HB2' HD22 ' A' ' 133' ' ' ASN . 36.6 Cg_endo -62.79 124.9 14.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.41 2.074 . . . . 54.420000000000002 112.19 -169.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 33.8 m -71.29 117.8 13.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.819 0.847 . . . . 75.420000000000002 110.646 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.44 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 24.6 t -98.62 125.17 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.077 -1.083 . . . . 70.430000000000007 108.077 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.18 115.55 30.45 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.573 -0.251 . . . . 74.230000000000004 110.563 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.63 -3.36 0.25 Allowed Glycine 0 CA--C 1.54 1.626 0 N-CA-C 118.409 2.123 . . . . 63.409999999999997 118.409 161.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 11.9 m -91.53 122.99 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.372 1.586 . . . . 75.239999999999995 112.222 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 25.3 t -72.97 123.88 90.09 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 106.874 -1.528 . . . . 75.209999999999994 106.874 165.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo . . . . . 0 C--N 1.378 2.092 0 C-N-CA 122.321 2.014 . . . . 52.5 115.104 -153.795 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.3 t90 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 109.962 -0.385 . . . . 75.239999999999995 109.962 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -84.2 -36.08 23.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.314 0.646 . . . . 74.349999999999994 111.355 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.9 p -77.53 7.26 5.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.954 0.902 . . . . 52.219999999999999 112.702 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -62.04 -39.49 92.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.766 1.226 . . . . 64.420000000000002 111.21 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.0 -34.13 71.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 110.274 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -73.28 -12.86 61.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.398 0.679 . . . . 65.209999999999994 110.989 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.1 tp -67.29 -51.68 49.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.801 0.84 . . . . 52.210000000000001 111.868 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.4 mt -112.46 22.04 15.06 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.741 0.416 . . . . 72.219999999999999 110.133 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 62.409999999999997 112.036 177.071 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.7 t30 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.057 0.456 . . . . 73.319999999999993 110.744 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.9 tp -77.34 131.56 38.16 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.634 -0.666 . . . . 71.439999999999998 109.527 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -115.54 173.12 6.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.446 1.099 . . . . 74.329999999999998 109.84 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.73 138.96 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.003 1.321 . . . . 43.240000000000002 108.84 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -79.72 138.23 37.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.511 0.724 . . . . 64.040000000000006 110.349 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 143' ' ' LYS . 82.7 mt -104.01 -35.48 8.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.728 0.811 . . . . 75.299999999999997 110.987 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.462 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 44.0 m-85 -122.48 140.93 52.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.194 -0.912 . . . . 74.5 108.874 -173.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 3.5 m-20 -68.5 124.87 24.75 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.984 -0.747 . . . . 73.400000000000006 108.984 171.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.637 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.2 t80 -114.24 139.45 49.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.261 -1.015 . . . . 74.310000000000002 108.261 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.97 131.82 59.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.523 -1.288 . . . . 74.340000000000003 107.523 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.71 119.13 4.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.839 0.855 . . . . 70.310000000000002 111.709 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.5 p -84.28 -27.31 27.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.498 0.719 . . . . 74.129999999999995 111.158 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -141.38 -169.62 11.96 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.805 -0.918 . . . . 61.130000000000003 110.805 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.68 -44.63 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.005 0.431 . . . . 65.329999999999998 111.257 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.549 HD21 ' HD2' ' A' ' 249' ' ' PRO . 26.5 p-10 -71.47 -24.68 62.04 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.151 -0.931 . . . . 63.439999999999998 111.657 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.0 p -79.99 160.28 25.96 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.332 0.653 . . . . 64.400000000000006 110.775 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.7 tp -133.44 136.4 45.16 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.968 0.507 . . . . 61.439999999999998 111.371 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 m -75.48 134.0 40.93 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.544 0.738 . . . . 63.340000000000003 111.312 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.637 HG12 ' HB3' ' A' ' 91' ' ' PHE . 21.8 pt -127.22 166.77 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.167 0.587 . . . . 72.409999999999997 111.818 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.0 m -126.42 157.19 39.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.727 -1.124 . . . . 62.240000000000002 110.479 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -47.29 119.57 2.71 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.227 1.011 . . . . 73.219999999999999 111.808 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.91 8.61 78.29 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 115.129 0.811 . . . . 71.239999999999995 115.129 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -68.53 122.24 18.06 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.268 0.627 . . . . 44.539999999999999 110.764 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -75.92 128.76 35.75 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.128 -0.693 . . . . 65.400000000000006 109.128 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -147.91 166.94 26.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.71 0.804 . . . . 75.329999999999998 110.783 -173.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -122.72 117.44 25.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.927 0.491 . . . . 75.230000000000004 110.151 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.606 HG13 ' HB1' ' A' ' 119' ' ' ALA . 41.6 t -81.05 112.38 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.196 0.598 . . . . 74.120000000000005 110.139 175.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.5 -35.17 40.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.442 -0.799 . . . . 62.329999999999998 109.965 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.98 147.56 6.09 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.437 0.461 . . . . 44.140000000000001 112.87 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.531 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 47.2 m-85 -86.95 162.78 17.49 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.381 0.672 . . . . 74.450000000000003 111.458 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -81.69 -173.73 4.6 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.302 -0.863 . . . . 64.510000000000005 110.361 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -52.5 -36.95 56.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.28 1.432 . . . . 72.340000000000003 113.838 -170.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -112.17 -3.76 14.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.471 0.708 . . . . 62.350000000000001 111.853 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 72.61 33.97 60.34 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.54 -0.589 . . . . 71.329999999999998 114.566 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -84.91 -38.39 19.44 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.402 0.601 . . . . 74.400000000000006 110.717 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 70.3 m95 -123.0 154.13 38.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.57 0.748 . . . . 73.519999999999996 110.561 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.606 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -134.35 132.4 39.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.027 0.931 . . . . 74.219999999999999 109.991 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.4 114.22 7.44 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 106.172 -1.788 . . . . 73.310000000000002 106.172 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.31 150.85 49.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 63.229999999999997 111.028 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -106.38 116.38 31.83 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.522 -1.288 . . . . 74.040000000000006 107.522 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.536 HG21 HG22 ' A' ' 101' ' ' ILE . 22.9 p -116.96 174.43 6.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.434 0.694 . . . . 73.040000000000006 110.167 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -62.85 -24.24 67.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.311 0.645 . . . . 54.210000000000001 110.22 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.06 -27.57 60.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.497 0.719 . . . . 74.519999999999996 111.608 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.75 -125.1 2.21 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 121.408 -0.425 . . . . 75.049999999999997 113.538 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -134.94 140.42 45.71 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.757 0.823 . . . . 34.210000000000001 110.499 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.51 176.87 23.09 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 113.709 0.243 . . . . 75.219999999999999 113.709 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -80.87 120.6 24.91 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.127 0.971 . . . . 74.030000000000001 112.28 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.431 HG23 HD13 ' A' ' 135' ' ' ILE . 4.2 m -121.79 139.63 30.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.312 1.045 . . . . 54.350000000000001 108.638 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 3.1 Cg_exo -76.05 143.45 25.86 Favored 'Trans proline' 0 CA--C 1.561 1.863 0 C-N-CA 122.631 2.221 . . . . 74.310000000000002 114.46 -172.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -39.54 -49.61 2.14 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.85 1.66 . . . . 42.439999999999998 113.469 168.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 18.6 p-10 -76.3 7.18 4.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.777 0.831 . . . . 63.32 112.581 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.514 ' HB3' HD11 ' A' ' 101' ' ' ILE . 16.5 m-85 -115.87 -9.12 11.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.349 1.06 . . . . 74.349999999999994 111.568 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.431 HD13 HG23 ' A' ' 130' ' ' VAL . 10.8 pt -132.37 171.43 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.96 0.904 . . . . 72.450000000000003 111.215 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -164.17 152.18 10.91 Favored Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.479 -0.772 . . . . 74.150000000000006 109.151 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -58.15 157.85 24.02 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.441 2.094 . . . . 73.209999999999994 113.791 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.55 -8.28 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 123.271 0.628 . . . . 53.439999999999998 111.783 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -102.11 0.82 35.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 72.040000000000006 111.866 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.9 p -77.1 168.11 20.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.13 0.572 . . . . 63.109999999999999 112.197 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.22 -24.65 27.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.149 -0.478 . . . . 71.319999999999993 110.352 167.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.4 -23.59 66.34 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.366 0.666 . . . . 73.019999999999996 111.599 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.66 ' HA ' HD21 ' A' ' 88' ' ' LEU . 20.9 pttm -62.49 -18.21 61.38 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.761 0.663 . . . . 50.039999999999999 112.522 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.99 141.98 30.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.648 -0.705 . . . . 75.430000000000007 110.512 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 p -62.67 -40.14 96.14 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.379 1.049 . . . . 73.319999999999993 111.13 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -66.14 -37.58 86.05 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.163 0.801 . . . . 75.409999999999997 113.163 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 38.9 t80 -76.41 113.6 14.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.854 -0.424 . . . . 75.239999999999995 109.854 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -109.23 -5.24 15.98 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.086 0.554 . . . . 74.049999999999997 112.473 -177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.67 -145.68 42.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 118.652 -1.082 . . . . 65.329999999999998 112.843 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.35 94.88 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.06 2.507 . . . . 71.129999999999995 112.996 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 49.0 t -135.74 126.98 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.994 1.318 . . . . 74.319999999999993 109.257 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.9 p -83.92 175.44 9.58 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.912 0.885 . . . . 71.209999999999994 110.323 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -60.75 -40.4 92.29 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 119.467 -0.301 . . . . 75.239999999999995 110.934 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -53.54 -49.88 66.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.183 0.593 . . . . 64.230000000000004 110.923 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.504 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -71.0 -26.18 63.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.224 -0.898 . . . . 53.0 111.634 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.4 -46.45 60.22 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.067 0.547 . . . . 34.32 111.821 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.6 mm-40 -68.72 -32.91 73.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.559 -0.534 . . . . 73.420000000000002 109.559 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.08 -47.82 82.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.115 0.966 . . . . 72.209999999999994 110.664 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.43 HD13 HD22 ' A' ' 169' ' ' LEU . 12.9 mt -58.54 -45.43 88.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.875 0.87 . . . . 72.329999999999998 111.487 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 97.9 mt -92.99 8.0 41.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.749 0.648 . . . . 72.140000000000001 112.749 -176.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.4 p -64.05 -37.26 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 118.713 0.688 . . . . 70.409999999999997 110.377 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.4 p -101.93 18.44 20.6 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.138 0.975 . . . . 60.009999999999998 111.504 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.21 165.26 32.68 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.285 -0.416 . . . . 53.25 112.409 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.34 -179.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.58 0.752 . . . . 73.329999999999998 111.213 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.57 125.81 24.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.316 -0.856 . . . . 74.549999999999997 110.026 169.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 90.02 9.67 65.46 Favored Glycine 0 C--O 1.242 0.651 0 CA-C-O 119.192 -0.782 . . . . 50.240000000000002 113.022 -177.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.8 m -87.68 116.87 26.11 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 117.669 0.734 . . . . 75.120000000000005 110.526 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.426 ' HB3' HD13 ' A' ' 184' ' ' LEU . 21.0 p90 -128.24 167.92 16.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.936 0.495 . . . . 75.019999999999996 111.118 -172.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.43 HD22 HD13 ' A' ' 159' ' ' LEU . 4.3 pp -159.56 142.35 13.95 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.579 -0.737 . . . . 72.420000000000002 109.622 174.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 182' ' ' ILE . 74.2 t -100.27 115.3 41.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.988 -1.116 . . . . 75.040000000000006 107.988 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.609 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 41.9 ptt85 -115.91 143.1 45.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.566 0.746 . . . . 74.25 109.074 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -94.1 149.15 21.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.534 -0.913 . . . . 72.400000000000006 108.534 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 t -76.28 127.5 33.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.176 0.59 . . . . 71.230000000000004 109.585 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.0 -31.46 70.3 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.685 -0.689 . . . . 75.25 109.419 171.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 34.0 m -66.17 -34.81 78.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.924 0.89 . . . . 73.510000000000005 111.132 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.9 p -148.21 93.41 4.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.084 0.553 . . . . 71.120000000000005 110.841 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.14 138.23 85.35 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.895 2.396 . . . . 73.400000000000006 112.379 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.84 -29.93 10.74 Favored Glycine 0 C--N 1.345 1.029 0 C-N-CA 123.324 0.488 . . . . 72.450000000000003 111.959 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -82.72 117.72 22.85 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.822 -0.807 . . . . 74.340000000000003 108.822 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.505 0.669 . . . . 74.299999999999997 110.446 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 61.4 m -140.52 149.28 42.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.775 1.23 . . . . 71.120000000000005 108.588 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 170' ' ' VAL . 25.9 mt -102.42 146.3 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.684 -1.228 . . . . 65.019999999999996 107.684 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 46.3 m -124.29 107.98 11.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.881 -1.155 . . . . 71.219999999999999 107.881 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.426 HD13 ' HB3' ' A' ' 168' ' ' PHE . 45.5 tp -105.45 114.25 28.31 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.087 0.555 . . . . 53.409999999999997 110.507 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -76.92 116.72 17.84 Favored 'General case' 0 C--O 1.254 1.321 0 CA-C-O 121.43 0.633 . . . . 62.219999999999999 109.946 166.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -139.59 138.52 36.27 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.498 1.519 . . . . 73.549999999999997 107.462 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 59.67 22.02 10.74 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.927 0.891 . . . . 62.329999999999998 111.887 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.61 -12.63 55.69 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.345 -0.389 . . . . 72.420000000000002 113.869 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -98.99 144.93 27.59 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.547 0.739 . . . . 74.209999999999994 109.463 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.8 t -103.31 110.19 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.066 0.46 . . . . 71.430000000000007 110.532 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -96.94 124.51 40.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.849 1.259 . . . . 74.109999999999999 109.513 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -98.66 119.09 36.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.31 0.644 . . . . 73.450000000000003 111.286 -172.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.539 ' HE1' HD21 ' A' ' 232' ' ' LEU . 4.9 m-85 -95.42 150.72 19.98 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.574 -0.899 . . . . 64.349999999999994 108.574 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -106.81 125.3 50.83 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.276 -0.639 . . . . 72.230000000000004 109.276 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.4 mt -85.39 102.41 11.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.428 -0.953 . . . . 61.119999999999997 108.428 172.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -85.38 147.14 26.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.823 -1.08 . . . . 64.319999999999993 109.666 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -108.68 135.69 49.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.475 0.71 . . . . 75.450000000000003 109.648 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.9 176.88 7.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.578 0.751 . . . . 72.150000000000006 110.227 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.0 p -65.7 -28.91 69.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.208 0.603 . . . . 72.129999999999995 112.379 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -91.85 -17.34 25.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 75.319999999999993 110.243 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.11 9.21 16.1 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.914 -0.937 . . . . 72.219999999999999 114.847 175.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.72 130.21 45.36 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.3 1.05 . . . . 73.140000000000001 111.58 176.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -86.54 141.12 29.28 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.876 -1.157 . . . . 41.509999999999998 107.876 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.615 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.1 p90 -167.44 132.11 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.579 0.55 . . . . 73.209999999999994 110.961 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.525 HG23 HD11 ' A' ' 217' ' ' LEU . 70.6 t -77.62 -38.0 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.688 -0.856 . . . . 74.329999999999998 108.688 164.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.7 m -105.54 123.38 47.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.625 -1.17 . . . . 61.240000000000002 109.513 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -64.24 -25.16 67.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.488 0.715 . . . . 73.439999999999998 112.489 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -77.3 -24.38 50.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.625 0.77 . . . . 75.409999999999997 110.946 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.8 m -129.68 100.43 5.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.186 0.594 . . . . 75.340000000000003 109.679 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.615 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 77.7 mtt180 -107.22 138.8 42.73 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 64.150000000000006 109.209 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -124.34 146.65 48.7 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.303 -0.629 . . . . 63.240000000000002 109.303 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.85 -37.56 87.84 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.933 0.771 . . . . 73.5 110.381 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -127.81 157.43 40.45 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.738 0.815 . . . . 65.230000000000004 111.609 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.81 -25.32 67.18 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.689 -1.141 . . . . 63.240000000000002 109.741 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.85 97.35 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.447 0.699 . . . . 71.340000000000003 111.019 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.38 -34.42 67.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.438 0.695 . . . . 75.010000000000005 111.48 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.525 HD11 HG23 ' A' ' 205' ' ' VAL . 14.9 tp -56.48 -54.57 44.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.815 0.446 . . . . 62.299999999999997 111.141 174.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.68 -38.41 82.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 O-C-N 123.776 0.673 . . . . 53.32 110.677 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -58.29 -57.31 13.46 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 62.32 111.253 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -63.14 -39.61 95.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.722 -0.672 . . . . 70.340000000000003 111.1 -176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.719 ' HB3' HD11 ' A' ' 228' ' ' LEU . 41.8 m80 -85.45 -6.09 59.24 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.323 0.49 . . . . 65.230000000000004 112.323 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 91.6 p -98.07 -14.42 20.49 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.027 0.376 . . . . 64.200000000000003 111.12 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 50.7 p -83.63 -40.05 19.49 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 110.23 -0.285 . . . . 72.439999999999998 110.23 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.1 m -138.6 167.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 113.36 0.874 . . . . 63.100000000000001 113.36 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -81.53 13.24 3.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.983 2.113 . . . . 74.329999999999998 113.659 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 224' ' ' VAL . 35.8 t70 -41.95 33.67 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 1 C-N-CA 132.091 4.156 . . . . 63.439999999999998 118.744 -158.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 126.35 -5.52 7.67 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 120.068 -1.645 . . . . 63.009999999999998 112.986 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.1 mt -90.45 161.09 15.7 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.447 1.099 . . . . 62.450000000000003 109.484 174.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.7 tt -56.74 -36.36 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-O 120.958 0.409 . . . . 72.140000000000001 110.418 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.3 t -161.03 170.9 19.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.292 0.637 . . . . 65.349999999999994 110.189 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 29.5 m -63.1 138.33 58.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.513 1.125 . . . . 51.450000000000003 111.889 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.539 HD21 ' HE1' ' A' ' 193' ' ' TYR . 65.1 mt -73.43 135.06 44.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.263 -0.643 . . . . 73.209999999999994 109.263 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.82 -76.16 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.524 0.602 . . . . 41.32 110.809 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 167' ' ' SER . 19.9 t80 -85.4 121.39 73.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 108.393 -0.966 . . . . 75.129999999999995 108.393 -177.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.05 125.06 3.98 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.364 2.043 . . . . 75.519999999999996 111.396 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.1 134.53 94.5 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.773 -0.649 . . . . 54.149999999999999 110.076 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.67 -179.15 4.85 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.603 2.202 . . . . 74.439999999999998 111.988 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.34 152.07 45.96 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.151 0.58 . . . . 54.340000000000003 109.587 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.401 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 10.9 ptt180 -88.92 -62.21 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.532 0.567 . . . . 74.409999999999997 112.532 -172.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.401 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 66.1 t30 -111.24 149.05 31.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.283 0.633 . . . . 74.349999999999994 110.74 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.452 ' NZ ' ' HB2' ' A' ' 90' ' ' ASP . 99.9 mttt -83.57 114.88 56.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 106.807 -1.553 . . . . 75.010000000000005 106.807 160.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.525 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 19.5 Cg_exo -65.27 122.52 10.26 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.085 1.857 . . . . 61.509999999999998 111.817 -168.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.0 m -72.24 112.43 8.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.948 0.499 . . . . 74.140000000000001 110.233 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.29 106.69 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.571 -1.27 . . . . 51.109999999999999 107.571 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -85.5 114.82 22.82 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.702 0.401 . . . . 64.129999999999995 111.776 -161.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.12 0.42 0.71 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.645 1.818 . . . . 73.420000000000002 117.645 164.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.52 HG23 ' HE1' ' A' ' 118' ' ' TRP . 24.1 m -96.99 122.82 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.174 1.487 . . . . 61.039999999999999 112.801 -169.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.4 t -78.66 135.33 60.23 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 113.793 -1.549 . . . . 73.25 107.377 160.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.549 ' HD2' HD21 ' A' ' 97' ' ' ASN . 33.1 Cg_exo . . . . . 0 C--N 1.379 2.177 0 C-N-CA 121.137 1.225 . . . . 73.019999999999996 112.645 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 t90 . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 121.348 0.594 . . . . 73.219999999999999 110.516 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -82.76 -20.73 35.34 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.755 -0.657 . . . . 71.230000000000004 110.074 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 m -70.79 3.15 3.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.306 1.443 . . . . 75.120000000000005 112.886 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.89 -24.4 66.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.794 0.838 . . . . 74.430000000000007 111.612 175.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -81.85 -36.58 28.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.034 0.534 . . . . 71.209999999999994 110.126 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.81 -5.81 49.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.949 0.9 . . . . 62.409999999999997 110.528 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.418 HD13 ' HE1' ' A' ' 146' ' ' TRP . 27.3 tp -58.96 -51.01 71.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.685 1.194 . . . . 75.329999999999998 111.522 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.75 -53.2 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.014 0.526 . . . . 50.350000000000001 110.37 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.625 0.77 . . . . 75.25 111.897 -173.962 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.612 -0.144 . . . . 74.329999999999998 110.612 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -57.53 148.38 24.05 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 73.140000000000001 111.295 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -111.88 163.87 13.73 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.52 0.728 . . . . 72.430000000000007 109.653 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 138.58 46.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 124.423 1.089 . . . . 73.030000000000001 108.619 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -76.33 115.27 15.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.776 0.83 . . . . 60.100000000000001 109.481 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.8 mt -71.98 -38.52 69.69 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.272 0.558 . . . . 64.209999999999994 110.698 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.554 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 6.0 m-85 -125.18 151.81 45.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.981 -1.008 . . . . 74.030000000000001 108.769 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.46 125.49 29.43 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.973 -0.751 . . . . 61.43 108.973 166.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.614 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.5 t80 -106.35 135.01 48.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.797 -1.186 . . . . 64.230000000000004 107.797 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -102.04 134.96 41.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.23 -1.026 . . . . 73.040000000000006 108.23 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.8 134.88 57.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.02 0.928 . . . . 62.229999999999997 111.822 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.5 p -98.82 -53.22 3.35 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.022 0.929 . . . . 72.120000000000005 109.071 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.73 176.28 33.45 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.116 -0.947 . . . . 61.119999999999997 111.747 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.59 -21.41 57.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.839 0.855 . . . . 72.439999999999998 111.521 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -93.55 -26.09 17.28 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.763 0.825 . . . . 72.420000000000002 111.656 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.3 p -73.03 134.83 44.78 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.111 -0.7 . . . . 74.409999999999997 109.111 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.636 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 63.6 tp -104.55 125.72 50.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.453 0.701 . . . . 63.229999999999997 110.561 -167.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -70.35 132.25 45.36 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.952 0.783 . . . . 74.329999999999998 109.842 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.77 HG22 HG21 ' A' ' 123' ' ' THR . 9.8 pt -119.13 148.82 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.728 -0.471 . . . . 71.239999999999995 109.728 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.615 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -86.3 149.48 25.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.625 0.77 . . . . 74.430000000000007 109.354 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.73 113.35 6.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.71 0.404 . . . . 72.030000000000001 110.318 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.79 61.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.379 -0.373 . . . . 33.039999999999999 112.927 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 36.6 tt0 -73.09 135.48 44.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.708 0.803 . . . . 62.43 111.801 -175.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -80.03 126.54 31.18 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.554 -0.906 . . . . 70.129999999999995 108.554 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -148.16 153.59 39.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.244 0.545 . . . . 64.129999999999995 110.8 -174.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -108.56 130.23 55.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.833 0.853 . . . . 72.140000000000001 108.965 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.525 HG13 ' HB1' ' A' ' 119' ' ' ALA . 53.3 t -88.03 130.52 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.213 -1.032 . . . . 71.540000000000006 108.213 168.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.462 HD12 ' HG2' ' A' ' 120' ' ' GLU . 36.0 mt -92.67 -29.19 16.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.221 1.009 . . . . 74.209999999999994 109.623 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.54 145.36 4.44 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.207 -0.906 . . . . 74.109999999999999 111.547 175.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.694 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 62.3 m-85 -86.23 160.34 19.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.212 0.506 . . . . 64.450000000000003 110.033 173.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -83.34 -172.43 4.14 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 73.230000000000004 110.539 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -52.34 -41.46 63.04 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.268 1.027 . . . . 73.109999999999999 113.504 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -95.46 -2.41 48.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.407 0.683 . . . . 70.209999999999994 111.341 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 60.51 22.5 59.17 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.029 0.772 . . . . 61.100000000000001 115.029 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.02 -16.54 18.66 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.396 0.679 . . . . 61.530000000000001 110.82 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 56.2 m95 -131.53 143.4 50.35 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.068 0.947 . . . . 73.530000000000001 110.026 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.525 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -123.28 149.04 45.29 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.462 1.105 . . . . 72.200000000000003 110.042 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HG2' HD12 ' A' ' 110' ' ' LEU . 38.6 tt0 -82.85 107.73 15.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.469 -1.678 . . . . 72.329999999999998 106.469 164.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.45 152.53 40.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.419 0.628 . . . . 71.299999999999997 112.141 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -112.57 103.98 12.05 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.346 -1.297 . . . . 71.310000000000002 108.171 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.77 HG21 HG22 ' A' ' 101' ' ' ILE . 39.5 p -101.62 176.25 5.29 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.111 0.964 . . . . 43.240000000000002 110.206 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -71.56 -14.29 62.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.943 0.497 . . . . 64.019999999999996 110.265 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -85.28 -18.05 35.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.321 1.049 . . . . 73.340000000000003 111.187 172.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.25 -165.23 23.2 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-O 120.3 -0.167 . . . . 44.140000000000001 113.347 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.416 ' NE2' ' HG2' ' A' ' 120' ' ' GLU . 68.3 tp60 -92.22 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.203 0.601 . . . . 70.140000000000001 111.393 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 176.01 -161.12 29.51 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.52 0.512 . . . . 54.350000000000001 112.443 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -112.11 120.46 41.9 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.34 0.656 . . . . 73.140000000000001 111.635 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.76 143.5 47.84 Favored Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 124.015 0.926 . . . . 71.0 109.923 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 83.1 Cg_endo -84.69 145.44 10.31 Favored 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 121.943 1.762 . . . . 70.430000000000007 114.827 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -38.68 -46.48 1.23 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.281 1.832 . . . . 71.230000000000004 114.526 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.554 HD22 ' HB2' ' A' ' 242' ' ' PRO . 30.0 p-10 -75.03 -7.66 54.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.857 0.863 . . . . 74.200000000000003 113.014 -169.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 29.4 m-85 -103.64 -10.61 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.388 0.675 . . . . 61.340000000000003 111.904 174.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.0 pt -123.78 170.84 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.92 0.888 . . . . 74.420000000000002 110.636 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 3.4 m -158.45 137.98 8.46 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.721 0.808 . . . . 61.409999999999997 109.941 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.53 136.71 47.55 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 121.686 1.591 . . . . 72.219999999999999 110.897 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.29 -11.79 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.167 0.987 . . . . 75.140000000000001 110.378 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -21.19 63.29 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.166 0.987 . . . . 71.299999999999997 112.177 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 91.7 p -109.61 -179.63 3.87 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.867 0.867 . . . . 64.129999999999995 111.852 -173.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.94 -22.84 36.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.535 1.134 . . . . 63.399999999999999 112.32 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.78 -12.4 61.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.943 0.897 . . . . 70.340000000000003 112.245 -173.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 140' ' ' SER . 20.8 pttm -63.82 -11.68 29.31 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.818 0.847 . . . . 72.209999999999994 111.911 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.402 ' CE1' ' HA ' ' A' ' 73' ' ' LEU . 48.2 m-70 -99.63 146.64 26.24 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.867 0.867 . . . . 71.209999999999994 110.895 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -64.64 -33.94 77.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.156 -0.929 . . . . 53.340000000000003 112.517 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.418 ' HE1' HD13 ' A' ' 73' ' ' LEU . 41.9 p-90 -72.93 -35.13 66.95 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.569 0.747 . . . . 75.400000000000006 112.471 -176.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HE2' ' A' ' 238' ' ' LYS . 23.1 t80 -80.29 103.02 9.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.825 -0.806 . . . . 73.200000000000003 108.825 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.455 ' HB2' HG21 ' A' ' 151' ' ' VAL . 52.8 m170 -95.59 -9.18 32.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.06 0.544 . . . . 72.230000000000004 112.056 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 -135.06 17.88 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-O 118.273 -1.293 . . . . 65.219999999999999 112.727 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.33 93.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.697 2.931 . . . . 63.25 113.127 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 75.4 t -139.64 132.39 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.915 1.286 . . . . 64.099999999999994 109.252 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.1 p -89.86 175.8 7.07 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.263 1.025 . . . . 74.340000000000003 109.896 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -58.2 -50.14 74.59 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.289 0.236 . . . . 74.329999999999998 111.111 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -55.49 -44.96 77.02 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.845 0.858 . . . . 50.219999999999999 111.145 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.58 84.33 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.397 -0.82 . . . . 55.32 110.751 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.0 80.41 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.946 0.898 . . . . 43.340000000000003 112.052 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -83.83 -21.16 32.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.757 -0.656 . . . . 75.209999999999994 111.759 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.409 ' OH ' ' HD2' ' A' ' 239' ' ' ARG . 0.1 OUTLIER -82.8 -19.36 37.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.27 0.557 . . . . 73.420000000000002 111.311 172.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' A' ' 239' ' ' ARG . 51.6 mt -74.96 -42.97 56.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.344 -0.843 . . . . 34.130000000000003 110.669 168.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.548 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 89.0 mt -92.67 20.69 6.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.281 -0.872 . . . . 75.209999999999994 111.451 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 92.5 p -72.55 -40.19 66.9 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.679 -0.489 . . . . 65.030000000000001 109.679 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.4 p -100.63 3.65 42.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.201 1.0 . . . . 75.530000000000001 112.271 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.11 159.05 53.04 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.124 0.265 . . . . 72.040000000000006 113.469 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.77 -178.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 63.25 110.799 174.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -61.92 118.49 7.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.367 0.667 . . . . 72.340000000000003 109.814 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.78 12.03 59.75 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.292 -0.726 . . . . 73.430000000000007 113.444 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.0 m -76.06 133.04 40.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.182 0.991 . . . . 71.140000000000001 110.184 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.489 ' HB3' HD13 ' A' ' 184' ' ' LEU . 27.0 p90 -141.81 166.44 24.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.237 0.541 . . . . 73.030000000000001 111.187 -171.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -162.6 151.29 14.75 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.617 -1.174 . . . . 63.130000000000003 108.135 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.662 HG22 HG12 ' A' ' 182' ' ' ILE . 85.9 t -103.51 128.9 56.24 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 N-CA-C 108.101 -1.074 . . . . 61.200000000000003 108.101 169.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.651 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.0 ptt85 -114.97 143.26 45.44 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.731 -1.122 . . . . 71.040000000000006 108.313 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -114.95 130.21 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.329 -1.36 . . . . 62.420000000000002 107.329 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -62.67 127.56 31.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.66 0.384 . . . . 71.099999999999994 110.409 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.86 -43.5 98.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.173 0.589 . . . . 73.120000000000005 110.004 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.0 p -68.71 -27.09 65.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.838 0.855 . . . . 74.129999999999995 111.409 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.3 m -137.19 79.5 37.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.043 0.537 . . . . 64.400000000000006 110.582 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.42 137.32 73.53 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.629 2.219 . . . . 53.549999999999997 111.529 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.14 -29.57 12.23 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.809 -0.632 . . . . 64.099999999999994 111.668 -174.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -81.38 114.93 20.48 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.95 -0.759 . . . . 60.299999999999997 108.95 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -129.29 147.77 51.16 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.847 0.859 . . . . 73.200000000000003 109.465 -173.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -148.54 150.97 34.3 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.142 0.977 . . . . 63.439999999999998 108.542 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 170' ' ' VAL . 16.8 mt -103.23 121.87 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.224 -1.028 . . . . 72.129999999999995 108.224 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -93.82 127.25 39.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.646 -1.242 . . . . 74.109999999999999 107.646 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 168' ' ' PHE . 61.9 tp -131.96 110.36 10.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.173 0.589 . . . . 71.019999999999996 109.511 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 21.7 ttt180 -79.7 113.81 18.14 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.076 0.55 . . . . 72.129999999999995 109.829 168.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -139.72 137.0 34.77 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.219 -1.4 . . . . 64.420000000000002 107.219 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 62.14 21.44 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.17 0.988 . . . . 74.239999999999995 111.624 -174.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 9.98 86.58 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.91 -0.586 . . . . 71.409999999999997 113.677 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -117.66 134.45 54.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.415 1.086 . . . . 73.019999999999996 109.487 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.58 115.56 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.735 0.414 . . . . 72.120000000000005 110.592 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -102.94 128.79 49.6 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.624 1.17 . . . . 75.109999999999999 108.696 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -110.37 110.13 20.8 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.316 0.646 . . . . 70.140000000000001 109.393 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.601 ' CE1' HD22 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -115.23 122.89 47.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.553 0.741 . . . . 73.120000000000005 110.545 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.76 135.04 53.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.55 1.14 . . . . 72.239999999999995 111.301 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.49 103.44 12.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.303 -0.999 . . . . 71.25 108.303 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -66.16 112.73 4.07 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.59 0.756 . . . . 64.439999999999998 109.172 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.8 m -97.45 105.46 17.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.436 0.695 . . . . 54.329999999999998 109.133 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.1 155.75 26.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.033 0.933 . . . . 72.519999999999996 110.771 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.8 p -69.19 -13.73 62.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.489 0.922 . . . . 74.120000000000005 113.489 -170.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.11 -16.42 31.52 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.391 0.676 . . . . 71.409999999999997 111.141 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 111.72 14.45 11.33 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.72 -0.489 . . . . 73.510000000000005 113.763 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -78.52 138.71 38.54 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.167 0.484 . . . . 61.340000000000003 110.89 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.29 143.76 32.24 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.977 -1.12 . . . . 63.310000000000002 107.977 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.6 p90 -170.81 136.45 1.17 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.546 0.529 . . . . 75.239999999999995 111.525 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.436 HG21 ' HD1' ' A' ' 193' ' ' TYR . 63.7 t -79.89 -42.06 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.639 -0.875 . . . . 74.450000000000003 108.639 166.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.2 m -100.17 126.98 46.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.24 1.016 . . . . 74.310000000000002 109.605 -174.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -63.16 -24.73 68.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.559 0.743 . . . . 64.140000000000001 112.12 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -77.09 -30.68 55.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.674 1.19 . . . . 62.149999999999999 111.233 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -120.87 100.62 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.575 0.75 . . . . 54.119999999999997 109.157 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.523 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.3 mtt180 -110.13 126.01 53.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.011 0.924 . . . . 74.010000000000005 109.514 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.557 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.5 m-85 -116.03 149.33 39.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.537 0.735 . . . . 75.129999999999995 110.043 -168.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.03 -44.33 72.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.403 -0.591 . . . . 75.239999999999995 109.403 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.1 p -117.93 154.95 31.05 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.955 0.883 . . . . 73.239999999999995 111.722 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.493 HD11 HG11 ' A' ' 170' ' ' VAL . 1.1 tt -65.47 -23.23 66.86 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.723 -1.126 . . . . 74.099999999999994 109.899 174.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.07 93.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.383 0.673 . . . . 61.299999999999997 110.662 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.2 mt-10 -68.04 -36.8 80.5 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 110.82 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 tp -54.04 -57.88 9.4 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.767 0.667 . . . . 74.120000000000005 110.407 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.01 -38.4 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 123.755 0.659 . . . . 72.329999999999998 110.716 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -62.94 -59.05 5.37 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.921 0.488 . . . . 72.019999999999996 111.55 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.26 -32.94 74.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.028 0.531 . . . . 73.450000000000003 111.063 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.671 ' HB3' HD11 ' A' ' 228' ' ' LEU . 17.4 m170 -89.44 -4.72 57.87 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.629 0.603 . . . . 70.120000000000005 112.629 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.2 p -96.24 -28.07 14.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.868 0.467 . . . . 63.229999999999997 110.807 168.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 52.7 p -77.29 -40.36 44.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.356 -0.384 . . . . 74.239999999999995 110.504 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.561 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.5 m -134.5 161.44 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.304 1.049 . . . . 73.319999999999993 112.437 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.23 16.62 0.74 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.26 2.224 . . . . 55.439999999999998 114.442 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.1 t70 -44.37 25.31 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.617 1 C-N-CA 132.266 4.227 . . . . 32.119999999999997 119.821 -155.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.95 6.22 7.16 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 120.114 -1.616 . . . . 64.310000000000002 111.823 -165.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 221' ' ' HIS . 6.7 mt -95.23 163.67 13.17 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.749 1.22 . . . . 63.039999999999999 109.363 167.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 8.4 tt -65.89 -34.0 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-O 121.229 0.537 . . . . 72.109999999999999 109.834 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.4 t -159.67 170.67 21.08 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.592 0.757 . . . . 74.129999999999995 109.664 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.2 p -63.96 142.09 58.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.363 0.665 . . . . 62.140000000000001 111.385 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.42 112.21 4.5 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 108.686 -0.857 . . . . 72.439999999999998 108.686 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -104.75 -57.88 1.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.140000000000001 112.007 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -119.27 122.77 29.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.789 0.836 . . . . 74.420000000000002 109.54 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.2 123.33 4.99 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.449 2.099 . . . . 72.510000000000005 111.132 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -68.32 142.06 94.25 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 109.072 -0.714 . . . . 74.099999999999994 109.072 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.66 176.35 7.12 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.605 2.203 . . . . 65.329999999999998 112.943 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 33.1 mmtp -71.41 155.7 40.33 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.394 -0.821 . . . . 64.409999999999997 109.974 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.855 ' HB3' HD21 ' A' ' 159' ' ' LEU . 16.7 ptt-85 -91.89 -60.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.578 0.584 . . . . 62.149999999999999 112.578 -167.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -110.89 155.06 23.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.348 1.059 . . . . 65.140000000000001 109.872 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.67 114.77 59.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.663 -1.606 . . . . 50.32 106.663 156.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.554 ' HB2' HD22 ' A' ' 133' ' ' ASN . 27.9 Cg_endo -61.59 124.88 15.49 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.595 2.197 . . . . 74.420000000000002 112.352 -171.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.4 m -72.4 112.83 8.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.543 -0.753 . . . . 72.400000000000006 110.833 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.07 111.77 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 107.416 -1.327 . . . . 72.040000000000006 107.416 171.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.74 111.05 22.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.157 -0.312 . . . . 73.150000000000006 110.157 -166.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 60.22 -14.13 0.04 OUTLIER Glycine 0 CA--C 1.542 1.764 0 N-CA-C 118.185 2.034 . . . . 32.200000000000003 118.185 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.3 m -89.52 122.96 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.376 1.588 . . . . 74.25 112.882 -164.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 36.4 t -82.61 140.02 44.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 106.928 -1.508 . . . . 63.549999999999997 106.928 159.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo . . . . . 0 C--N 1.382 2.325 0 CA-C-N 120.723 1.294 . . . . 74.340000000000003 112.793 -163.193 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.1 ttm . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 108.976 -0.75 . . . . 74.150000000000006 108.976 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.7 66.05 3.67 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.337 0.398 . . . . 54.229999999999997 112.787 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -113.74 140.5 48.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.882 0.873 . . . . 73.010000000000005 109.617 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -95.8 106.01 24.82 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.607 0.763 . . . . 62.229999999999997 109.163 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.01 155.32 22.95 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.952 2.435 . . . . 73.549999999999997 112.73 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.54 73.73 2.56 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.148 -0.781 . . . . 65.430000000000007 111.148 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -65.95 -58.2 6.09 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.91 0.884 . . . . 65.450000000000003 113.072 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -159.7 129.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.32 0.648 . . . . 53.229999999999997 109.758 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.8 tt -75.99 -67.93 0.63 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.916 0.886 . . . . 73.340000000000003 109.493 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.35 -141.57 7.32 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 121.573 -0.346 . . . . 72.299999999999997 112.622 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.429 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 10.9 t70 -83.98 129.22 34.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.6 0.76 . . . . 74.109999999999999 108.978 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -127.88 -175.55 3.51 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.736 0.815 . . . . 72.530000000000001 110.964 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.57 177.82 6.45 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.942 0.897 . . . . 72.219999999999999 109.76 173.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 1.8 mpt_? -106.27 113.02 63.8 Favored Pre-proline 0 N--CA 1.477 0.875 0 C-N-CA 124.043 0.937 . . . . 61.439999999999998 109.488 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -82.22 174.68 9.77 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.924 2.416 . . . . 64.409999999999997 111.913 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.0 p -122.18 75.35 1.22 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.025 0.53 . . . . 62.32 111.001 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.54 105.83 55.78 Favored Pre-proline 0 N--CA 1.483 1.196 0 N-CA-C 108.981 -0.748 . . . . 71.439999999999998 108.981 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -80.43 92.81 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.614 2.209 . . . . 64.200000000000003 111.774 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.09 124.4 24.9 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.354 0.662 . . . . 72.450000000000003 109.914 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.4 tp -141.75 134.12 28.03 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.627 0.771 . . . . 64.329999999999998 109.713 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -160.14 136.83 9.05 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.903 0.881 . . . . 75.319999999999993 110.231 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.06 149.92 47.72 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.902 0.881 . . . . 64.340000000000003 109.681 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.416 ' H ' HG21 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -169.57 148.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 107.506 -1.294 . . . . 73.099999999999994 107.506 176.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.406 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -78.31 94.11 4.78 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.433 -0.58 . . . . 73.019999999999996 109.433 -178.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.52 79.24 0.34 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.685 -0.689 . . . . 62.100000000000001 112.201 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.65 166.18 25.91 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.941 0.896 . . . . 64.129999999999995 110.048 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.96 90.95 0.46 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.875 -0.49 . . . . 72.319999999999993 111.875 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -144.53 138.24 27.4 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.483 0.713 . . . . 74.5 110.247 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -115.06 92.07 3.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.233 1.013 . . . . 72.25 109.747 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.74 88.08 3.31 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 105.976 -1.861 . . . . 61.399999999999999 105.976 159.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.1 m -133.75 143.09 48.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.716 0.807 . . . . 72.030000000000001 111.161 -164.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.6 t -156.96 -172.43 4.04 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.336 1.054 . . . . 75.329999999999998 108.959 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -125.21 148.01 48.82 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.306 1.042 . . . . 72.109999999999999 110.349 -173.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -128.87 -41.87 1.44 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.54 0.336 . . . . 75.329999999999998 110.729 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.84 -167.37 34.79 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.532 -0.758 . . . . 74.450000000000003 113.441 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.44 67.6 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.729 -1.348 . . . . 60.109999999999999 109.729 -175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -63.27 128.51 22.86 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 123.589 2.859 . . . . 61.409999999999997 114.604 -165.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -176.66 -159.55 0.06 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.547 1.139 . . . . 73.140000000000001 109.872 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.3 m -45.41 156.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.698 1.599 . . . . 64.519999999999996 114.156 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -97.1 170.18 9.3 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.658 0.783 . . . . 60.409999999999997 111.049 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.0 t -123.74 -97.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 108.153 -1.055 . . . . 74.019999999999996 108.153 165.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.1 t80 179.38 69.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.569 -0.9 . . . . 64.349999999999994 108.569 -172.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 p -161.42 161.4 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 124.401 1.08 . . . . 61.450000000000003 108.855 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.485 ' HA ' HG23 ' A' ' 52' ' ' VAL . 10.8 pt-20 -128.03 134.69 49.24 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.9 1.074 . . . . 75.019999999999996 113.9 -171.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.01 -157.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.769 1.627 . . . . 74.400000000000006 109.093 168.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -91.22 -175.55 4.31 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.365 0.666 . . . . 65.310000000000002 110.431 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . 74.79 118.88 0.05 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.364 1.466 . . . . 70.230000000000004 112.618 170.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.09 82.59 6.99 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.64 0.776 . . . . 72.129999999999995 110.434 -169.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.516 ' HG2' ' HD3' ' A' ' 50' ' ' ARG . 7.5 tt0 -115.63 -66.18 1.11 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.435 -0.95 . . . . 73.129999999999995 108.435 169.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.516 ' HD3' ' HG2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -114.06 120.67 38.21 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 106.709 -1.589 . . . . 64.219999999999999 106.709 174.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -49.01 156.53 2.12 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.996 2.464 . . . . 73.219999999999999 113.553 165.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 44' ' ' GLU . 9.6 p -70.8 159.5 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 123.935 0.894 . . . . 73.310000000000002 111.625 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.63 115.17 5.53 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.814 -1.18 . . . . 55.539999999999999 107.814 165.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.2 t -61.1 -9.92 5.4 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.662 1.356 . . . . 71.129999999999995 114.662 -165.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.43 -48.57 74.83 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.472 0.654 . . . . 74.329999999999998 110.489 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.13 137.47 51.99 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.897 0.879 . . . . 72.439999999999998 109.017 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.8 78.31 30.75 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.886 -1.153 . . . . 71.409999999999997 107.886 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -84.58 -24.07 2.49 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.519 2.146 . . . . 73.239999999999995 112.424 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -142.48 -36.54 0.4 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.809 1.244 . . . . 72.420000000000002 109.728 -174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.53 -14.66 29.98 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 114.381 0.513 . . . . 65.549999999999997 114.381 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -125.96 -161.1 1.02 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.327 0.651 . . . . 72.129999999999995 110.284 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 p -169.6 119.3 0.65 Allowed 'General case' 0 C--O 1.246 0.899 0 C-N-CA 124.016 0.927 . . . . 73.150000000000006 110.537 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 27.6 tt0 -161.6 -48.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.255 1.022 . . . . 65.420000000000002 110.061 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.01 -15.58 56.91 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.781 1.03 . . . . 73.109999999999999 113.781 -172.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.51 -15.82 55.77 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.32 0.648 . . . . 45.299999999999997 112.327 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' NH2' ' HA ' ' A' ' 63' ' ' GLU . 33.8 mtm105 -118.64 -35.34 3.74 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.085 0.954 . . . . 74.329999999999998 110.274 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -159.69 89.67 0.9 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.9 0.88 . . . . 75.120000000000005 109.804 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.51 -22.69 34.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.889 0.876 . . . . 71.030000000000001 111.104 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 m -78.95 7.32 7.42 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.241 1.416 . . . . 54.420000000000002 113.021 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.39 -18.18 65.02 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.464 1.106 . . . . 72.310000000000002 112.315 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -20.35 26.2 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.319 0.648 . . . . 72.310000000000002 110.916 174.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.453 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 12.7 m120 -78.45 -12.31 60.0 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.322 0.649 . . . . 55.119999999999997 110.377 170.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.05 -50.45 70.59 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.679 0.792 . . . . 74.140000000000001 110.623 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.438 HD11 ' CG ' ' A' ' 219' ' ' HIS . 84.8 mt -112.12 30.15 7.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.486 0.714 . . . . 75.450000000000003 110.063 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . -72.05 -25.78 61.93 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.663 0.385 . . . . 75.140000000000001 110.562 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.31 -136.24 16.96 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 118.96 -0.911 . . . . 54.229999999999997 110.869 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.13 175.6 0.32 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.551 2.167 . . . . 63.32 112.406 166.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 1.7 m -71.46 175.64 5.34 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 116.267 -0.424 . . . . 64.409999999999997 111.227 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.77 -48.95 66.44 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.089 0.956 . . . . 63.450000000000003 112.981 -164.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -132.76 -41.08 0.94 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.91 0.484 . . . . 60.539999999999999 110.598 169.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 78' ' ' SER . 18.1 t70 -92.19 118.69 68.26 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 115.345 -0.843 . . . . 72.239999999999995 110.922 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.24 -13.3 39.05 Favored 'Trans proline' 0 CA--C 1.559 1.736 0 C-N-CA 122.937 2.425 . . . . 72.239999999999995 114.832 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -110.69 20.42 17.64 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.435 0.694 . . . . 70.299999999999997 110.848 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.7 tp -76.78 138.42 39.88 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.75 -0.594 . . . . 52.539999999999999 109.455 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.7 m-85 -108.11 173.45 6.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.588 1.155 . . . . 72.109999999999999 110.06 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.6 147.55 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 125.221 1.409 . . . . 60.409999999999997 109.64 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.21 120.15 25.45 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.219 1.008 . . . . 51.219999999999999 110.205 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.3 -42.26 68.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.329 0.651 . . . . 63.32 111.161 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.511 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.8 m-85 -124.54 158.4 33.05 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.41 -0.813 . . . . 75.129999999999995 109.223 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 120.71 24.27 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.502 -1.296 . . . . 72.25 107.502 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.8 t80 -123.01 138.28 54.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.903 0.881 . . . . 72.340000000000003 108.712 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.416 HG21 ' H ' ' A' ' 23' ' ' ILE . 40.8 t -97.48 134.18 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.76 -0.83 . . . . 75.120000000000005 108.76 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.6 117.18 4.62 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.078 0.862 . . . . 74.319999999999993 110.631 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 p -67.82 -38.33 83.12 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.654 0.782 . . . . 64.129999999999995 110.887 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.72 -175.95 14.28 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-N 115.717 -0.674 . . . . 65.040000000000006 111.826 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.79 -31.85 67.02 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.546 0.739 . . . . 71.129999999999995 110.661 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.445 HD22 ' HB3' ' A' ' 251' ' ' TYR . 35.5 p-10 -75.52 -18.06 59.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.803 1.241 . . . . 52.32 112.115 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 57.2 p -95.63 171.25 8.79 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.48 -0.563 . . . . 74.140000000000001 109.48 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.9 tp -126.94 136.7 52.64 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.275 0.56 . . . . 63.32 111.735 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -82.25 117.03 22.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.726 -1.125 . . . . 62.130000000000003 109.042 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.594 HG12 ' HB3' ' A' ' 91' ' ' PHE . 20.7 pt -110.08 144.26 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.388 0.675 . . . . 72.219999999999999 110.104 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.3 m -95.76 140.23 30.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.424 -0.807 . . . . 65.040000000000006 108.845 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.29 125.99 25.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.318 0.647 . . . . 60.020000000000003 111.356 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.45 76.67 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 123.88 0.738 . . . . 60.049999999999997 113.605 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -82.11 138.34 34.79 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.46 0.63 . . . . 74.109999999999999 111.434 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -79.95 112.81 17.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.837 -0.801 . . . . 71.019999999999996 108.837 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -122.83 167.78 13.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.951 0.9 . . . . 74.230000000000004 110.024 -177.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -121.74 119.43 31.72 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.935 -0.478 . . . . 63.439999999999998 111.035 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.65 HG13 ' HB1' ' A' ' 119' ' ' ALA . 43.5 t -86.54 134.55 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.246 1.018 . . . . 75.230000000000004 109.881 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.556 HD12 ' HG3' ' A' ' 120' ' ' GLU . 46.1 mt -105.89 -31.49 8.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.467 1.107 . . . . 75.140000000000001 110.126 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.01 145.48 4.71 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 115.835 -0.62 . . . . 61.119999999999997 112.375 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 45.5 m-85 -85.68 169.74 13.17 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.436 0.694 . . . . 63.25 110.886 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -85.66 -176.26 5.97 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.213 -0.903 . . . . 70.230000000000004 110.694 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -52.83 -35.18 56.79 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.754 1.221 . . . . 74.430000000000007 114.17 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -112.12 2.63 16.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.855 0.462 . . . . 70.310000000000002 112.171 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.79 30.56 72.59 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.398 0.919 . . . . 54.5 115.398 173.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.03 -35.96 18.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.285 0.543 . . . . 74.510000000000005 110.716 173.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 35.3 m95 -131.0 151.66 51.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.743 0.817 . . . . 73.519999999999996 111.72 -171.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -133.54 137.09 45.39 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.534 1.134 . . . . 72.040000000000006 111.026 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.556 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.8 tp10 -66.81 114.45 5.68 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 106.854 -1.536 . . . . 75.030000000000001 106.854 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.15 162.13 33.8 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.184 0.516 . . . . 53.420000000000002 111.299 -170.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.468 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . 9.8 pt20 -132.8 128.96 37.9 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.414 -0.812 . . . . 64.129999999999995 111.122 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 107' ' ' LEU . 45.8 p -116.61 179.1 4.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 74.319999999999993 109.757 173.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -70.68 -16.35 62.79 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 109.513 -0.551 . . . . 72.340000000000003 109.513 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -78.78 -20.16 50.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.918 1.287 . . . . 71.530000000000001 110.984 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.68 -140.4 10.15 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 122.051 -0.118 . . . . 74.439999999999998 112.941 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' A' ' 122' ' ' GLN . 61.6 tp60 -128.67 155.83 44.4 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.348 1.059 . . . . 74.329999999999998 109.667 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.56 169.4 15.36 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.025 -0.43 . . . . 73.120000000000005 112.025 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -77.75 134.53 38.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.241 0.616 . . . . 75.310000000000002 111.668 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG23 HD13 ' A' ' 135' ' ' ILE . 5.9 m -132.0 143.26 48.26 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 124.308 1.043 . . . . 74.010000000000005 108.807 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 92.9 Cg_endo -80.4 143.04 15.19 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 C-N-CA 122.018 1.812 . . . . 41.350000000000001 114.075 -173.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -39.61 -44.73 1.52 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.583 1.953 . . . . 52.049999999999997 114.229 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 38.1 p-10 -79.04 -1.91 37.89 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.198 0.999 . . . . 74.25 113.132 -171.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.511 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 28.8 m-85 -113.14 -0.63 14.61 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.026 0.93 . . . . 73.129999999999995 111.308 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.487 HD13 HG23 ' A' ' 130' ' ' VAL . 21.0 pt -135.37 170.48 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.182 0.993 . . . . 63.030000000000001 110.667 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -163.4 155.39 15.14 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.812 -1.181 . . . . 64.430000000000007 107.812 170.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.8 Cg_endo -60.44 153.53 59.88 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.679 1.586 . . . . 73.310000000000002 111.632 171.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 143' ' ' LYS . 38.2 t -73.1 -8.44 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.107 0.956 . . . . 53.340000000000003 110.356 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.94 -18.61 55.86 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.336 1.054 . . . . 73.129999999999995 111.248 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.2 p -87.01 170.43 11.57 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.853 0.835 . . . . 65.530000000000001 113.024 -170.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.36 -23.79 26.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.512 -1.222 . . . . 55.119999999999997 110.931 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.64 -29.81 70.3 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.322 1.049 . . . . 75.140000000000001 111.447 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 138' ' ' VAL . 24.2 pttm -60.08 -19.28 52.34 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.614 0.765 . . . . 71.209999999999994 112.904 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -86.66 141.86 28.64 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.544 0.737 . . . . 72.329999999999998 109.749 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.1 m -58.9 -40.64 85.1 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.07 0.856 . . . . 64.430000000000007 112.182 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -62.53 -38.5 90.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.122 0.889 . . . . 73.140000000000001 112.336 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -76.6 112.37 13.07 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.728 -0.841 . . . . 73.219999999999999 108.728 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -109.07 -14.83 14.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.073 0.549 . . . . 70.400000000000006 111.517 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.78 -127.25 15.49 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 118.18 -1.344 . . . . 43.119999999999997 112.3 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.55 95.2 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.984 2.456 . . . . 62.030000000000001 112.591 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 77.3 t -137.78 119.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.605 0.762 . . . . 63.509999999999998 109.575 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.8 m -71.78 159.35 34.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.289 0.635 . . . . 71.329999999999998 109.32 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 78.0 ttt180 -59.04 -38.07 78.46 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 119.435 -0.317 . . . . 73.549999999999997 111.415 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -63.49 -36.88 85.21 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.362 0.665 . . . . 71.409999999999997 111.209 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.36 -30.27 67.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.16 0.584 . . . . 70.120000000000005 110.408 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.26 63.18 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 51.509999999999998 111.647 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 22.5 mm-40 -65.66 -43.11 90.38 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.119 -0.697 . . . . 74.310000000000002 109.119 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.489 ' HE1' ' HB2' ' A' ' 239' ' ' ARG . 17.0 t80 -62.73 -41.47 99.19 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.315 -1.311 . . . . 73.239999999999995 111.201 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.442 HD21 ' HB3' ' A' ' 239' ' ' ARG . 28.7 mt -61.48 -44.13 97.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.59 0.756 . . . . 52.340000000000003 111.478 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.0 mt -98.3 17.96 17.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.199 0.6 . . . . 62.5 112.59 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.0 p -69.35 -36.24 76.68 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.444 0.64 . . . . 74.219999999999999 110.694 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 p -106.42 15.81 25.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.342 1.057 . . . . 71.200000000000003 110.8 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.86 140.48 23.3 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.37 -0.377 . . . . 63.119999999999997 112.379 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.7 pt -86.81 -179.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.405 0.682 . . . . 74.0 111.431 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.6 112.33 3.13 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.679 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.6 10.88 39.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.392 -0.822 . . . . 72.209999999999994 112.94 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.4 m -75.54 143.31 42.52 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.634 0.717 . . . . 62.140000000000001 110.619 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -149.72 163.78 37.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.063 0.459 . . . . 71.409999999999997 111.937 -171.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 183' ' ' SER . 4.0 pp -161.72 152.69 18.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.873 -1.058 . . . . 73.540000000000006 109.482 175.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.612 HG22 HG12 ' A' ' 182' ' ' ILE . 59.5 t -107.64 126.73 63.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.424 -0.954 . . . . 55.210000000000001 108.424 168.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.543 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 13.1 ptt180 -114.97 147.29 40.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.182 -1.044 . . . . 71.340000000000003 108.182 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.89 145.99 40.68 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 107.741 -1.207 . . . . 72.340000000000003 107.741 166.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.4 t -78.55 121.64 24.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.169 -0.678 . . . . 74.109999999999999 109.169 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.25 -34.3 77.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.306 1.042 . . . . 73.109999999999999 110.485 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 p -83.18 -15.87 48.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.72 0.808 . . . . 72.340000000000003 111.788 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.8 m -142.2 86.03 10.43 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.423 0.689 . . . . 60.119999999999997 110.079 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.09 135.54 69.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.33 2.687 . . . . 73.239999999999995 112.529 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.15 -28.86 12.07 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.472 -0.331 . . . . 61.509999999999998 112.594 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -81.41 117.11 21.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.182 0.491 . . . . 74.329999999999998 110.193 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.628 HH11 HD12 ' A' ' 214' ' ' LEU . 99.4 mtt180 -130.03 157.6 41.9 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.908 0.883 . . . . 75.400000000000006 110.974 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.4 m -143.61 146.24 33.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.944 -1.026 . . . . 61.310000000000002 109.454 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.612 HG12 HG22 ' A' ' 170' ' ' VAL . 42.8 mt -100.81 108.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 107.394 -1.335 . . . . 72.219999999999999 107.394 169.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.428 ' HB2' ' HG ' ' A' ' 169' ' ' LEU . 14.9 m -87.38 106.81 18.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.243 -1.391 . . . . 65.310000000000002 107.243 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 193' ' ' TYR . 62.4 tp -115.47 110.95 20.03 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.78 -0.822 . . . . 74.5 108.78 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.444 ' HB2' HG22 ' A' ' 190' ' ' VAL . 75.9 ttt180 -89.61 122.77 33.07 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.316 0.646 . . . . 75.209999999999994 110.486 173.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -143.7 144.13 31.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.655 1.182 . . . . 70.109999999999999 108.352 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 61.11 21.93 12.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.422 1.089 . . . . 62.520000000000003 112.358 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.29 11.45 82.17 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 114.358 0.503 . . . . 60.219999999999999 114.358 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -120.14 134.5 55.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.49 0.716 . . . . 74.040000000000006 109.744 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 185' ' ' ARG . 91.0 t -88.65 118.24 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.304 -0.628 . . . . 74.439999999999998 109.304 174.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.37 157.42 16.92 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.147 0.979 . . . . 55.350000000000001 108.564 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -132.76 124.15 27.55 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.976 -0.75 . . . . 74.140000000000001 108.976 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' A' ' 184' ' ' LEU . 89.8 m-85 -113.83 141.24 47.56 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.415 1.086 . . . . 72.310000000000002 108.714 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 9.1 tpp180 -85.21 124.36 31.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.398 0.279 . . . . 73.129999999999995 110.391 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.2 mt -84.71 99.6 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.132 -1.433 . . . . 73.040000000000006 107.132 166.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -78.46 119.71 22.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.963 -1.017 . . . . 72.450000000000003 108.37 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -94.15 108.5 20.35 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.908 -0.775 . . . . 75.0 108.908 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.48 157.57 16.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.952 0.901 . . . . 52.240000000000002 110.886 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -61.85 -30.94 71.19 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.293 1.037 . . . . 75.129999999999995 113.395 -170.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -85.0 -11.5 55.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.803 0.841 . . . . 73.299999999999997 111.925 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.0 11.15 14.38 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.451 -0.638 . . . . 74.310000000000002 114.352 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -75.5 152.16 37.88 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 118.082 0.941 . . . . 62.0 110.983 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -113.56 142.6 45.76 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.327 -0.99 . . . . 71.120000000000005 108.327 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.613 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.8 p90 -165.0 137.0 4.31 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.52 0.512 . . . . 73.349999999999994 110.872 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 54.3 t -79.12 -45.73 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.832 -0.803 . . . . 72.099999999999994 108.832 166.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -101.29 135.93 41.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.763 -1.108 . . . . 71.219999999999999 110.696 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.5 t -64.14 -22.46 66.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.287 1.035 . . . . 74.219999999999999 112.267 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -81.47 -29.98 33.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.941 0.896 . . . . 73.109999999999999 111.176 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 17.1 m -123.17 99.01 6.14 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.026 0.53 . . . . 65.200000000000003 110.176 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.613 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 47.3 mtt180 -112.35 120.29 41.19 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.818 0.847 . . . . 65.420000000000002 109.632 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.62 156.0 20.75 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.083 0.953 . . . . 65.25 109.085 -171.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -69.32 -42.74 74.98 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 70.5 p -120.95 155.04 35.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.92 0.867 . . . . 75.420000000000002 111.904 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.628 HD12 HH11 ' A' ' 180' ' ' ARG . 1.3 tt -65.38 -24.61 67.28 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 114.352 -1.295 . . . . 75.230000000000004 109.559 172.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.33 93.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.41 0.684 . . . . 75.439999999999998 110.766 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.19 -34.81 75.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.83 0.852 . . . . 71.319999999999993 111.15 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.04 -54.92 39.08 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.09 0.556 . . . . 73.140000000000001 111.025 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.61 -41.09 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 123.655 0.597 . . . . 52.200000000000003 111.011 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.438 ' CG ' HD11 ' A' ' 74' ' ' LEU . 17.0 t-80 -55.63 -58.0 9.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.441 0.696 . . . . 61.340000000000003 111.362 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -64.17 -33.7 76.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.125 -0.943 . . . . 74.239999999999995 110.813 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.543 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.1 m-70 -88.28 -10.78 48.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.797 -0.638 . . . . 73.5 112.081 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 232' ' ' LEU . 89.1 p -93.92 -20.28 20.16 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.756 0.423 . . . . 61.420000000000002 111.255 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 37.7 p -81.98 -48.12 11.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.873 -0.417 . . . . 51.420000000000002 109.873 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 226' ' ' ASP . 33.2 m -128.72 158.92 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.636 0.732 . . . . 74.209999999999994 112.303 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.97 16.0 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.759 2.024 . . . . 61.119999999999997 115.217 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.9 t70 -42.64 31.69 0.0 OUTLIER 'General case' 0 CA--C 1.601 2.925 1 C-N-CA 131.88 4.072 . . . . 71.5 119.351 -157.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.86 -1.94 9.25 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 119.486 -2.009 . . . . 74.120000000000005 112.604 -168.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' A' ' 221' ' ' HIS . 45.1 mt -95.59 160.3 14.57 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.584 1.153 . . . . 70.420000000000002 110.216 168.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.11 -35.55 72.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 120.895 0.379 . . . . 72.120000000000005 110.322 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -149.18 173.52 13.35 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.506 0.722 . . . . 44.340000000000003 110.094 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -67.42 143.17 56.41 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.172 0.589 . . . . 72.319999999999993 110.675 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 222' ' ' SER . 90.2 mt -63.58 96.56 0.12 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.74 0.816 . . . . 64.329999999999998 109.275 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -89.45 -66.14 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.184 -0.916 . . . . 63.310000000000002 110.681 -169.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 167' ' ' SER . 43.0 t80 -114.81 121.77 34.92 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 123.852 0.861 . . . . 73.519999999999996 109.725 -170.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.36 123.71 5.61 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.09 1.86 . . . . 75.219999999999999 111.722 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.02 130.95 95.06 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.971 -0.751 . . . . 75.150000000000006 108.971 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.03 179.78 6.18 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.833 2.355 . . . . 75.400000000000006 112.413 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.78 150.92 48.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 52.329999999999998 109.575 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.489 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . 13.7 ptt180 -92.51 -60.49 1.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 111.838 0.31 . . . . 72.120000000000005 111.838 -174.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.42 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 55.5 t30 -109.47 138.45 45.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 73.530000000000001 110.482 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.1 113.64 47.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.256 -1.757 . . . . 71.549999999999997 106.256 159.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.506 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 35.8 Cg_exo -61.01 123.87 13.76 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.51 2.14 . . . . 62.439999999999998 112.709 -173.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 61.2 m -73.47 119.1 17.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.827 0.451 . . . . 71.519999999999996 110.558 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.3 t -98.62 127.04 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.281 1.032 . . . . 62.399999999999999 108.38 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.08 114.52 28.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.095 0.407 . . . . 74.310000000000002 111.51 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.8 21.89 38.57 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 116.426 1.331 . . . . 71.030000000000001 116.426 160.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.489 HG21 ' NE1' ' A' ' 118' ' ' TRP . 27.2 m -82.3 127.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 117.732 0.766 . . . . 74.420000000000002 111.913 -173.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 t -85.18 117.83 69.59 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 104.85 -2.278 . . . . 72.540000000000006 104.85 152.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.99 -59.23 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 120.92 1.08 . . . . 70.420000000000002 113.917 -159.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -128.86 -18.53 3.79 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.368 0.667 . . . . 74.439999999999998 109.576 159.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.445 ' HB3' HD22 ' A' ' 97' ' ' ASN . 0.9 OUTLIER -77.62 105.99 9.13 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 115.192 -0.913 . . . . 72.049999999999997 111.164 -158.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -117.71 -43.59 2.78 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.549 -1.278 . . . . 74.319999999999993 107.549 157.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 11' ' ' ASP . 29.3 ttmt -112.65 -15.98 12.9 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.767 1.227 . . . . 72.310000000000002 111.295 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -50.42 135.45 22.17 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.632 1.173 . . . . 64.329999999999998 113.555 -163.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.251 1.164 0 N-CA-C 108.457 -0.942 . . . . 74.25 108.457 -179.905 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.494 -0.558 . . . . 74.129999999999995 109.494 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.55 106.41 0.2 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.102 -0.799 . . . . 73.329999999999998 111.102 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -69.58 110.77 4.99 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.251 0.621 . . . . 74.329999999999998 110.246 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -113.12 154.29 45.16 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 124.183 0.993 . . . . 74.040000000000006 109.602 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -68.38 -164.12 0.1 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.107 2.538 . . . . 74.040000000000006 112.483 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.06 90.25 0.02 OUTLIER Glycine 0 C--N 1.354 1.569 0 C-N-CA 123.137 0.399 . . . . 73.310000000000002 112.838 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 1.3 tpmt? -75.29 116.26 15.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.61 0.764 . . . . 73.310000000000002 110.474 -171.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.31 124.89 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.041 0.536 . . . . 74.219999999999999 109.74 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.4 119.46 27.69 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.076 -1.083 . . . . 75.319999999999993 108.076 173.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.38 111.22 3.93 Favored Glycine 0 C--N 1.345 1.03 0 O-C-N 123.56 0.537 . . . . 72.319999999999993 113.303 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.69 156.71 22.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.569 1.147 . . . . 71.219999999999999 109.773 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -54.19 118.25 3.91 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.198 0.599 . . . . 74.319999999999993 111.934 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -145.15 -169.57 3.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.386 0.674 . . . . 62.119999999999997 111.52 -166.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -55.42 139.0 67.54 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.824 1.25 . . . . 75.450000000000003 112.903 -173.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 49.7 Cg_exo -59.73 127.3 23.07 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.69 2.927 . . . . 64.0 114.084 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.0 t -101.22 -8.84 21.82 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.008 0.923 . . . . 73.109999999999999 110.254 173.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 mp 47.72 65.9 6.39 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.098 1.359 . . . . 74.329999999999998 110.762 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.63 -23.98 2.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.619 2.213 . . . . 62.399999999999999 114.072 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 62.56 175.07 0.14 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.947 1.299 . . . . 64.030000000000001 112.316 -170.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -156.99 -54.06 0.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.887 -1.153 . . . . 75.349999999999994 107.887 176.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 71.66 -68.97 0.2 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.008 1.323 . . . . 72.430000000000007 111.2 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.525 ' HB2' HD22 ' A' ' 20' ' ' LEU . 9.1 t80 57.74 -71.5 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 126.404 1.882 . . . . 70.450000000000003 114.732 166.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.411 HG12 ' HA2' ' A' ' 111' ' ' GLY . 36.5 mt 76.13 112.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.705 2.002 . . . . 74.109999999999999 111.214 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.598 ' H ' ' HB2' ' A' ' 112' ' ' TYR . 24.1 mmtm -140.3 160.83 39.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.909 0.883 . . . . 71.030000000000001 110.02 168.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.2 104.23 1.41 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.688 -0.687 . . . . 65.400000000000006 111.604 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -141.36 -176.92 4.9 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.725 0.81 . . . . 74.25 109.633 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.86 -169.96 42.97 Favored Glycine 0 C--O 1.241 0.549 0 N-CA-C 111.082 -0.807 . . . . 61.219999999999999 111.082 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -143.32 137.23 28.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.439 -0.578 . . . . 72.239999999999995 109.439 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HD2' ' HG2' ' A' ' 150' ' ' PRO . 19.5 mmt85 -86.69 168.34 13.66 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.1 0.96 . . . . 75.109999999999999 110.045 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 52.99 87.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.072 0.949 . . . . 72.340000000000003 113.217 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 p -72.35 164.47 26.27 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.128 -0.693 . . . . 43.100000000000001 109.128 167.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.553 ' HA ' HH21 ' A' ' 33' ' ' ARG . 15.1 m -68.68 166.88 16.39 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 121.092 0.472 . . . . 73.430000000000007 111.656 -176.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.553 HH21 ' HA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -108.79 78.98 1.18 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.909 0.385 . . . . 75.209999999999994 111.34 -177.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -163.68 131.54 3.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.043 0.937 . . . . 53.439999999999998 108.833 165.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.07 -143.7 5.89 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.524 -0.63 . . . . 61.539999999999999 111.524 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.58 132.48 1.52 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-O 118.863 -0.965 . . . . 75.299999999999997 112.292 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.63 178.55 6.9 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.611 2.207 . . . . 61.350000000000001 112.392 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -132.57 147.03 52.34 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.809 -0.811 . . . . 73.340000000000003 108.809 174.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.409 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 71.7 m -127.38 95.72 4.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.341 0.656 . . . . 73.310000000000002 111.007 -177.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.614 ' H ' ' HA ' ' A' ' 65' ' ' ALA . 15.5 m120 -81.55 -179.08 7.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.277 1.031 . . . . 63.5 111.042 169.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.6 m -97.23 -169.43 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.985 0.914 . . . . 75.230000000000004 111.077 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 83.24 118.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 126.334 1.854 . . . . 73.5 112.741 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.594 HG23 ' HG3' ' A' ' 63' ' ' GLU . 8.6 p -156.73 143.27 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.944 1.298 . . . . 72.25 109.452 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -165.69 153.08 10.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.869 0.467 . . . . 74.25 110.451 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 83.1 t60 77.57 -50.14 0.52 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.558 1.943 . . . . 73.409999999999997 111.961 177.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.39 136.61 58.03 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.113 -1.069 . . . . 74.219999999999999 108.113 172.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.89 110.39 10.77 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.445 0.906 . . . . 71.219999999999999 113.445 -164.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.9 tt -138.78 120.79 15.59 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.375 -1.343 . . . . 63.140000000000001 107.375 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -67.73 103.99 1.54 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.428 1.091 . . . . 52.530000000000001 112.144 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.5 ' HB3' ' HD2' ' A' ' 51' ' ' PRO . 80.6 mtt85 -126.1 177.75 1.81 Allowed Pre-proline 0 CA--C 1.565 1.526 0 C-N-CA 125.065 1.346 . . . . 65.540000000000006 109.297 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 50' ' ' ARG . 21.1 Cg_exo -37.61 132.94 0.65 Allowed 'Trans proline' 0 C--N 1.398 3.177 0 C-N-CA 123.944 3.096 . . . . 71.349999999999994 114.621 171.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -67.15 148.67 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 113.635 0.976 . . . . 73.230000000000004 113.635 -169.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.5 -161.16 0.81 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.271 1.028 . . . . 74.530000000000001 110.093 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -72.22 -52.36 16.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.032 0.533 . . . . 71.510000000000005 111.4 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -110.46 -83.21 0.57 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.525 -0.546 . . . . 50.520000000000003 109.525 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -95.19 146.77 24.09 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.931 0.492 . . . . 75.209999999999994 109.856 172.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.03 103.85 10.3 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 106.564 -1.643 . . . . 73.209999999999994 106.564 173.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.58 -52.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 121.962 1.774 . . . . 33.549999999999997 112.735 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.41 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 25.6 mm-40 -159.28 -43.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.883 0.873 . . . . 63.439999999999998 110.166 -168.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.91 18.03 79.22 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.525 0.515 . . . . 71.019999999999996 112.5 -170.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -161.37 131.81 5.08 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 106.94 -1.504 . . . . 52.399999999999999 106.94 -176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.577 ' HA ' ' HB ' ' A' ' 43' ' ' VAL . 20.2 m -90.52 147.03 23.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.757 0.823 . . . . 71.439999999999998 113.218 -166.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.594 ' HG3' HG23 ' A' ' 43' ' ' VAL . 32.5 mt-10 -101.94 -28.58 12.31 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.797 0.839 . . . . 75.310000000000002 111.212 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.67 21.23 0.4 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.255 0.622 . . . . 62.039999999999999 112.023 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.614 ' HA ' ' H ' ' A' ' 40' ' ' ASN . . . -48.98 -52.89 22.36 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.736 1.614 . . . . 75.400000000000006 111.589 174.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -166.84 19.94 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 O-C-N 124.549 1.156 . . . . 64.310000000000002 109.229 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -93.45 70.94 4.33 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 122.151 0.977 . . . . 75.409999999999997 109.272 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -79.14 -23.92 43.68 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.24 -1.345 . . . . 71.400000000000006 109.426 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.6 p -78.03 4.54 12.0 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.967 0.907 . . . . 74.430000000000007 112.337 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.96 -37.62 78.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.949 0.5 . . . . 75.340000000000003 110.987 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.49 -31.16 62.1 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.072 0.463 . . . . 63.109999999999999 109.943 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.51 -5.81 57.24 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.042 0.937 . . . . 72.5 111.06 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.418 HD13 ' HE1' ' A' ' 146' ' ' TRP . 21.0 tp -66.19 -49.71 66.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.296 1.038 . . . . 74.230000000000004 111.36 -173.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -103.61 20.97 16.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.999 0.52 . . . . 54.119999999999997 110.661 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.46 -22.27 25.04 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.65 0.38 . . . . 64.239999999999995 110.854 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.03 -134.27 21.48 Favored Glycine 0 C--N 1.356 1.684 0 CA-C-O 119.014 -0.881 . . . . 61.219999999999999 112.349 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.458 ' HB3' ' ND2' ' A' ' 139' ' ' ASN . 36.2 Cg_exo -60.52 -174.67 0.1 Allowed 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.831 3.02 . . . . 74.200000000000003 113.558 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 m -64.11 169.72 4.2 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.93 -0.577 . . . . 71.099999999999994 109.725 166.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.91 -41.84 88.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 122.978 0.511 . . . . 60.43 111.557 -173.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -127.81 -35.18 2.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.049 0.54 . . . . 71.430000000000007 111.928 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -88.92 122.38 69.03 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.124 0.787 . . . . 75.209999999999994 113.124 -167.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.492 ' HA ' HD21 ' A' ' 139' ' ' ASN . 92.9 Cg_endo -81.42 -8.54 12.67 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.567 2.178 . . . . 74.230000000000004 111.653 164.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -109.52 6.81 24.38 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.081 0.953 . . . . 71.340000000000003 111.524 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.6 tp -86.59 133.37 33.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.467 -0.938 . . . . 72.140000000000001 108.467 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -110.42 171.51 7.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.777 0.831 . . . . 75.239999999999995 109.14 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.19 138.71 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.473 1.109 . . . . 54.420000000000002 109.273 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 135' ' ' ILE . . . -82.68 111.14 18.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.966 0.906 . . . . 64.040000000000006 109.594 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.46 -38.06 68.34 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.699 0.799 . . . . 52.420000000000002 110.937 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 37.1 m-85 -122.54 140.91 52.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.341 -1.3 . . . . 72.209999999999994 107.574 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -84.34 150.07 25.63 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.734 -0.469 . . . . 72.239999999999995 109.734 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.626 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.9 t80 -139.84 143.52 36.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.051 0.94 . . . . 64.329999999999998 108.642 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.97 133.2 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.564 -1.273 . . . . 52.140000000000001 107.564 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 129.8 41.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.319 0.648 . . . . 52.520000000000003 111.345 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 p -88.35 -38.96 14.7 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.776 0.83 . . . . 71.439999999999998 109.678 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.76 -170.32 12.66 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.344 -0.844 . . . . 45.200000000000003 112.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.74 -35.1 60.3 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.682 0.793 . . . . 65.510000000000005 110.581 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.457 ' HA ' ' HE3' ' A' ' 254' ' ' TRP . 24.2 p-10 -63.07 -29.32 70.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.054 0.942 . . . . 64.439999999999998 111.871 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.5 p -90.38 154.43 19.68 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.845 0.858 . . . . 61.43 109.491 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.661 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 58.6 tp -125.12 136.9 54.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.003 0.521 . . . . 64.140000000000001 110.467 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -75.23 131.39 40.35 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.958 0.503 . . . . 74.540000000000006 110.063 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.734 HG22 HG21 ' A' ' 123' ' ' THR . 19.3 pt -128.47 167.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.77 0.828 . . . . 53.219999999999999 111.215 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -123.11 152.36 41.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.363 1.065 . . . . 71.540000000000006 109.568 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.72 122.37 16.22 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.429 -0.582 . . . . 75.329999999999998 109.429 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.4 72.03 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-O 119.537 -0.591 . . . . 73.329999999999998 113.894 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -83.76 125.4 31.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.678 0.739 . . . . 53.009999999999998 110.745 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -78.3 133.86 37.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.277 -0.638 . . . . 71.540000000000006 109.277 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.673 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.77 147.03 34.86 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.574 0.75 . . . . 72.150000000000006 110.715 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -94.81 105.58 17.52 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.961 -0.755 . . . . 73.319999999999993 108.961 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.635 HG13 ' HB1' ' A' ' 119' ' ' ALA . 60.6 t -82.67 105.18 12.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.517 -0.92 . . . . 44.240000000000002 108.517 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.528 HD23 ' HG2' ' A' ' 120' ' ' GLU . 2.6 mm? -65.68 -52.88 48.06 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.162 0.914 . . . . 52.450000000000003 108.594 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.411 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . -173.7 155.69 22.53 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.605 -0.725 . . . . 65.239999999999995 114.104 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 96.9 m-85 -88.15 163.54 16.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.801 0.84 . . . . 74.510000000000005 109.786 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -71.43 -172.57 0.77 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 120.803 0.335 . . . . 70.319999999999993 111.338 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -47.71 -41.1 22.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.858 1.263 . . . . 74.099999999999994 114.144 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -114.52 3.62 14.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.306 0.854 . . . . 74.439999999999998 113.306 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.14 32.86 47.02 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.921 0.728 . . . . 44.539999999999999 114.921 174.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.85 -65.65 0.71 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.437 0.695 . . . . 61.399999999999999 110.736 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 34.4 m95 -114.4 165.86 12.28 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 75.109999999999999 109.33 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.08 131.08 36.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.764 1.226 . . . . 74.049999999999997 111.384 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HG2' HD23 ' A' ' 110' ' ' LEU . 24.0 tt0 -68.6 103.05 1.61 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.198 -1.038 . . . . 71.400000000000006 108.198 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.4 140.52 48.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.979 0.912 . . . . 73.099999999999994 109.85 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.491 ' HG3' HD21 ' A' ' 110' ' ' LEU . 55.8 mt-30 -105.51 105.39 15.41 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.575 -0.898 . . . . 71.109999999999999 108.575 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.734 HG21 HG22 ' A' ' 101' ' ' ILE . 68.5 p -99.88 -176.37 3.23 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.816 1.246 . . . . 74.310000000000002 110.357 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.88 -18.37 64.12 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.529 -0.76 . . . . 62.329999999999998 110.231 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.64 -3.46 59.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.664 1.186 . . . . 72.109999999999999 111.714 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.53 -138.39 13.27 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-O 119.513 -0.604 . . . . 74.450000000000003 111.815 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -129.73 143.51 50.85 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.724 0.762 . . . . 75.329999999999998 110.096 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.661 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.5 -172.28 43.46 Favored Glycine 0 C--O 1.225 -0.428 0 N-CA-C 110.972 -0.851 . . . . 64.420000000000002 110.972 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 40.9 m95 -107.34 125.19 50.88 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.323 0.561 . . . . 74.239999999999995 110.505 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.52 140.42 38.6 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.433 1.493 . . . . 64.310000000000002 109.091 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 9.3 Cg_exo -72.15 147.96 49.25 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 122.731 2.287 . . . . 44.5 114.414 -171.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 m -37.2 -51.59 1.02 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.415 1.886 . . . . 64.239999999999995 114.189 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -75.11 -3.18 31.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.546 0.738 . . . . 73.209999999999994 112.809 -171.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -94.47 -23.21 17.82 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.493 0.717 . . . . 74.450000000000003 111.577 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 109' ' ' VAL . 11.4 pt -123.32 173.77 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.794 0.838 . . . . 71.420000000000002 111.346 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.3 t -160.97 153.63 17.43 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.039 -1.097 . . . . 73.319999999999993 108.039 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.24 147.76 93.61 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 121.59 1.527 . . . . 62.119999999999997 110.981 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.82 -6.9 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 CA-C-O 121.499 0.666 . . . . 64.409999999999997 110.885 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.492 HD21 ' HA ' ' A' ' 82' ' ' PRO . 5.1 m120 -79.29 -13.15 59.84 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.346 0.658 . . . . 73.329999999999998 112.076 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.0 p -88.53 174.82 7.87 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.336 0.588 . . . . 63.32 112.418 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -84.03 -22.68 31.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.047 -0.979 . . . . 72.019999999999996 110.475 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.23 -22.09 66.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.964 0.905 . . . . 75.099999999999994 112.121 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -63.28 -13.74 41.76 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.529 0.566 . . . . 53.450000000000003 112.529 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -94.25 150.65 20.1 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.76 0.824 . . . . 72.319999999999993 110.425 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.8 p -67.66 -38.82 84.3 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 124.272 0.983 . . . . 74.319999999999993 111.635 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.475 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 41.9 p-90 -60.38 -48.96 79.48 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.82 0.7 . . . . 72.239999999999995 111.958 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.48 96.88 2.99 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.125 -0.694 . . . . 73.420000000000002 109.125 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -91.57 -2.38 57.15 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.616 -0.72 . . . . 74.010000000000005 111.078 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.54 -161.82 42.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.158 -0.801 . . . . 51.049999999999997 112.588 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.449 ' HG2' ' HD2' ' A' ' 29' ' ' ARG . 52.2 Cg_exo -58.33 98.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.4 2.733 . . . . 70.420000000000002 112.564 174.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 53.5 t -122.94 135.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 114.674 -1.148 . . . . 75.420000000000002 109.9 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.7 p -75.37 156.72 35.17 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.366 0.666 . . . . 62.130000000000003 109.489 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 71.1 ttt180 -62.71 -36.92 84.52 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 118.78 -0.629 . . . . 63.100000000000001 111.361 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -55.42 -43.94 75.8 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.559 0.695 . . . . 73.140000000000001 110.484 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.43 70.22 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.406 -1.27 . . . . 70.439999999999998 111.321 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.5 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.084 0.554 . . . . 74.510000000000005 111.402 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.2 mm-40 -68.98 -30.17 68.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.146 0.578 . . . . 71.209999999999994 110.009 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.73 -47.32 84.09 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.202 0.601 . . . . 73.439999999999998 110.329 171.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.6 mt -60.48 -35.33 75.65 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.987 0.515 . . . . 62.119999999999997 110.679 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 73.9 mt -105.74 21.32 17.45 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.539 -0.755 . . . . 71.140000000000001 113.036 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.8 p -88.61 -35.13 17.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.453 -0.943 . . . . 72.230000000000004 108.453 165.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.7 p -95.97 12.89 28.82 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.94 -1.027 . . . . 64.019999999999996 111.702 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.0 -175.59 40.97 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 112.493 -0.243 . . . . 73.140000000000001 112.493 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.439 HD11 ' HE2' ' A' ' 234' ' ' TYR . 32.3 pt -131.18 -174.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.363 1.065 . . . . 61.140000000000001 110.036 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -58.72 122.32 13.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 74.030000000000001 110.799 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.78 9.57 68.25 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.84 -0.618 . . . . 51.420000000000002 113.66 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 48.8 m -88.9 127.85 35.66 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.975 0.887 . . . . 61.149999999999999 110.035 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -132.41 -178.33 4.87 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.772 0.714 . . . . 62.100000000000001 112.793 -172.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.418 HD23 ' HG ' ' A' ' 160' ' ' LEU . 4.0 pp -164.69 155.97 15.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.048 0.939 . . . . 73.010000000000005 109.633 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.679 HG22 HG12 ' A' ' 182' ' ' ILE . 88.1 t -116.37 134.36 60.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.356 -0.979 . . . . 72.420000000000002 108.356 167.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.437 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 15.4 ptt180 -130.26 149.39 51.98 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.522 -0.763 . . . . 62.32 110.077 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -93.11 150.44 20.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.076 1.35 . . . . 74.439999999999998 108.036 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.8 t -79.5 123.51 27.63 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.819 -0.437 . . . . 64.310000000000002 109.819 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.98 -36.14 72.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.284 1.033 . . . . 74.409999999999997 111.2 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.0 p -78.39 -31.09 48.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.409 0.683 . . . . 71.420000000000002 111.566 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.4 m -140.04 89.43 11.19 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.192 0.597 . . . . 75.120000000000005 109.764 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.38 132.7 53.44 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.068 2.512 . . . . 71.420000000000002 112.819 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.52 -27.82 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.842 0.734 . . . . 62.210000000000001 112.388 -175.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -86.87 114.56 23.62 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.817 -0.808 . . . . 73.519999999999996 108.817 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -125.96 148.45 49.25 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.235 0.54 . . . . 63.109999999999999 110.914 -172.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.6 p -144.42 148.88 35.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.782 -1.099 . . . . 54.32 109.923 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.679 HG12 HG22 ' A' ' 170' ' ' VAL . 41.6 mt -102.25 149.71 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.264 -1.384 . . . . 71.129999999999995 107.264 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -125.29 120.85 32.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.105 -1.443 . . . . 54.420000000000002 107.105 170.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 67.7 tp -114.04 114.11 25.69 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.921 0.782 . . . . 73.420000000000002 110.52 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 29.3 ttt85 -77.48 113.85 15.71 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 109.761 -0.459 . . . . 74.209999999999994 109.761 166.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -142.06 138.68 31.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.206 1.402 . . . . 71.150000000000006 107.477 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 58.74 22.14 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.426 1.09 . . . . 72.310000000000002 111.984 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.93 86.7 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 114.226 0.45 . . . . 72.030000000000001 114.226 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -108.17 147.62 31.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.925 0.89 . . . . 73.019999999999996 108.685 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.32 105.58 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.384 0.674 . . . . 72.109999999999999 109.827 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.35 116.46 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.486 1.115 . . . . 74.040000000000006 109.333 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -91.59 118.95 31.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.826 0.451 . . . . 52.109999999999999 110.751 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.56 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.4 m-85 -94.77 151.17 19.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.185 0.994 . . . . 52.409999999999997 108.782 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -104.71 122.72 46.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.415 -0.587 . . . . 74.420000000000002 109.415 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.2 mt -90.98 105.87 16.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.084 -0.71 . . . . 63.219999999999999 109.084 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.91 140.3 29.63 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.412 0.685 . . . . 52.140000000000001 110.033 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 42.6 m -98.36 119.05 36.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.655 1.182 . . . . 70.019999999999996 107.854 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 174.45 6.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.978 0.911 . . . . 71.120000000000005 110.569 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 61.0 p -66.01 -25.63 67.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.373 0.669 . . . . 53.119999999999997 111.937 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.36 -17.21 29.29 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.143 0.577 . . . . 74.040000000000006 111.0 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.55 6.0 23.81 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-O 119.352 -0.693 . . . . 74.209999999999994 114.493 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -70.96 128.6 36.54 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.915 0.857 . . . . 74.540000000000006 112.097 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.21 143.12 34.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.783 0.833 . . . . 70.510000000000005 108.924 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.518 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.2 p90 -165.9 146.84 6.79 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.506 0.504 . . . . 71.329999999999998 111.624 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.528 HG23 HD11 ' A' ' 217' ' ' LEU . 78.0 t -89.39 -42.44 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.561 -0.903 . . . . 73.030000000000001 108.561 165.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.2 m -104.87 129.32 53.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.95 -1.023 . . . . 73.310000000000002 109.155 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -67.14 -18.54 65.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.305 0.642 . . . . 60.229999999999997 111.739 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -70.29 -26.56 63.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.608 1.163 . . . . 63.32 110.942 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 51.1 p -137.46 107.66 6.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.535 0.734 . . . . 72.400000000000006 109.93 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.2 mtt180 -116.56 133.82 55.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.303 1.041 . . . . 74.329999999999998 108.881 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.409 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.2 OUTLIER -128.78 143.67 50.97 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.365 0.666 . . . . 75.040000000000006 109.945 -170.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -67.91 -22.29 65.09 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.974 0.51 . . . . 73.329999999999998 112.066 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.2 p -130.89 155.14 47.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.121 0.962 . . . . 45.310000000000002 112.05 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -28.19 69.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 113.631 -1.622 . . . . 73.439999999999998 109.327 173.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.79 94.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.733 0.813 . . . . 72.439999999999998 110.945 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.407 0.683 . . . . 73.219999999999999 111.15 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.528 HD11 HG23 ' A' ' 205' ' ' VAL . 17.8 tp -55.2 -54.37 44.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 123.552 0.533 . . . . 50.200000000000003 111.158 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.88 -46.79 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 124.038 0.836 . . . . 74.140000000000001 110.703 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -61.74 -48.05 82.45 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.544 0.527 . . . . 61.329999999999998 111.968 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.02 -47.04 78.86 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.939 -0.573 . . . . 75.150000000000006 109.609 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.671 ' HB3' HD11 ' A' ' 228' ' ' LEU . 15.9 m-70 -82.76 -1.45 51.59 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 112.296 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.8 p -94.14 -40.83 9.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.919 0.488 . . . . 74.349999999999994 110.913 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.7 p -69.63 -38.3 77.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.321 -0.399 . . . . 71.450000000000003 111.019 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.651 HG23 ' HB2' ' A' ' 226' ' ' ASP . 17.6 m -132.97 162.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.669 0.747 . . . . 54.350000000000001 112.237 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.34 15.71 0.92 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 127.219 2.208 . . . . 54.549999999999997 113.988 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.651 ' HB2' HG23 ' A' ' 224' ' ' VAL . 23.4 t70 -44.2 33.44 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.464 1 C-N-CA 132.357 4.263 . . . . 74.329999999999998 119.519 -156.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.28 2.14 9.16 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.243 -1.536 . . . . 72.349999999999994 112.63 -171.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.5 mt -94.5 165.58 12.47 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 125.701 1.6 . . . . 74.109999999999999 109.972 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 12.1 tt -56.38 -42.05 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 109.982 -0.377 . . . . 63.43 109.982 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.9 t -160.91 177.39 10.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.995 0.918 . . . . 70.540000000000006 109.693 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 68.3 p -61.85 150.12 38.26 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.451 1.1 . . . . 75.530000000000001 113.106 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.56 HD21 ' HE1' ' A' ' 193' ' ' TYR . 86.5 mt -83.65 92.44 7.68 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.384 -0.969 . . . . 62.140000000000001 108.384 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -78.76 -51.32 9.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.504 0.557 . . . . 72.329999999999998 112.504 -161.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.4 OUTLIER -148.16 150.22 34.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.843 -1.169 . . . . 71.230000000000004 107.843 169.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.413 ' HB3' ' HB3' ' A' ' 146' ' ' TRP . 11.6 Cg_endo -96.0 153.29 1.41 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.384 2.722 . . . . 73.109999999999999 114.149 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -60.51 128.38 88.1 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 114.653 -1.158 . . . . 71.439999999999998 109.53 168.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 11.2 Cg_exo -73.58 -173.79 1.45 Allowed 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 123.006 2.47 . . . . 74.319999999999993 113.31 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 74.1 mmtt -67.3 133.27 49.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.867 0.867 . . . . 73.099999999999994 109.523 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.482 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 13.5 ptt180 -86.49 -66.72 0.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.538 0.94 . . . . 62.43 113.538 -167.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.482 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 9.1 t30 -114.98 158.03 22.61 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.984 0.514 . . . . 64.549999999999997 111.323 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.91 114.62 41.09 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 108.115 -1.068 . . . . 71.25 108.115 166.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.56 123.12 12.87 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.018 2.478 . . . . 74.409999999999997 112.167 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 5.1 m -72.95 103.64 3.82 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.651 -0.704 . . . . 72.420000000000002 111.268 -167.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.488 HG21 ' HG2' ' A' ' 131' ' ' PRO . 25.0 t -93.39 127.92 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.261 -1.014 . . . . 75.209999999999994 108.261 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -104.44 111.18 23.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.426 -0.321 . . . . 71.099999999999994 110.331 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.84 -39.39 0.24 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 118.245 2.058 . . . . 43.310000000000002 118.245 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.3 123.55 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.818 1.044 . . . . 74.439999999999998 113.818 -157.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.1 t -82.04 129.31 64.84 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 106.01 -1.848 . . . . 70.299999999999997 106.01 157.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.08 -55.61 0.98 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.484 1.456 . . . . 73.129999999999995 113.957 -154.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -129.46 -17.3 3.75 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.943 0.897 . . . . 74.340000000000003 111.243 161.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.42 ' CD1' ' HB2' ' A' ' 254' ' ' TRP . 73.7 m-85 -86.39 108.97 18.71 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.0 1.111 . . . . 75.209999999999994 114.0 -158.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -104.41 -23.53 13.17 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.225 -0.898 . . . . 63.329999999999998 108.764 159.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -94.04 9.38 37.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.05 0.94 . . . . 65.439999999999998 112.247 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.457 ' HE3' ' HA ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -94.38 157.88 15.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.493 0.588 . . . . 75.430000000000007 110.008 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 C--O 1.25 1.117 0 N-CA-C 107.49 -1.3 . . . . 63.009999999999998 107.49 173.693 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.139 -0.689 . . . . 72.519999999999996 109.139 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.8 78.06 0.51 Allowed Glycine 0 C--N 1.353 1.526 0 O-C-N 123.645 0.59 . . . . 54.299999999999997 112.732 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -132.86 175.74 9.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.837 1.255 . . . . 73.329999999999998 109.319 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -71.32 136.3 84.15 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 109.162 -0.681 . . . . 73.439999999999998 109.162 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -52.69 108.28 0.25 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.029 2.486 . . . . 71.010000000000005 112.615 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.61 134.92 35.64 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.303 -0.862 . . . . 65.340000000000003 112.036 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -82.48 67.71 8.64 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.825 0.85 . . . . 72.439999999999998 108.903 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.6 m -87.64 130.77 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.761 -1.108 . . . . 51.43 109.514 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.79 150.71 23.21 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.336 -0.986 . . . . 62.100000000000001 108.336 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.79 114.53 0.62 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.064 -0.814 . . . . 72.25 111.064 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -151.94 111.24 3.92 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.636 -0.875 . . . . 74.409999999999997 108.636 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -136.32 -179.23 5.55 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.047 0.939 . . . . 51.409999999999997 108.931 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 164.0 39.07 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.993 -0.743 . . . . 75.019999999999996 108.993 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.43 142.84 25.13 Favored Pre-proline 0 N--CA 1.487 1.375 0 CA-C-N 118.088 0.404 . . . . 74.5 110.802 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.49 93.11 0.58 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.951 2.434 . . . . 54.43 111.714 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.2 p -81.49 116.53 21.32 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.225 0.61 . . . . 74.549999999999997 110.19 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -155.48 113.35 2.24 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.638 -1.245 . . . . 71.099999999999994 107.638 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.12 155.77 59.13 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 123.377 2.718 . . . . 74.549999999999997 112.977 -172.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -127.14 153.69 45.7 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.354 0.662 . . . . 64.239999999999995 111.621 -170.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.3 mt -101.83 131.36 48.2 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.893 0.877 . . . . 50.100000000000001 110.011 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.496 ' HA ' ' OH ' ' A' ' 251' ' ' TYR . 0.6 OUTLIER -80.4 147.64 30.91 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 117.575 0.17 . . . . 73.439999999999998 110.845 177.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -112.92 149.26 33.44 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.4 0.68 . . . . 75.230000000000004 109.685 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.55 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 37.7 pt -112.96 177.29 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.43 0.692 . . . . 74.25 110.879 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt 78.31 142.35 0.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 126.243 1.817 . . . . 72.120000000000005 112.29 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.48 ' HA3' ' HD1' ' A' ' 112' ' ' TYR . . . 137.66 150.63 5.74 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.097 -0.956 . . . . 52.130000000000003 111.97 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.727 ' HA ' ' HZ ' ' A' ' 85' ' ' PHE . . . -147.44 98.43 2.99 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.197 0.599 . . . . 71.109999999999999 111.414 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.35 -179.3 3.56 Favored Glycine 0 C--N 1.364 2.104 0 O-C-N 123.662 0.601 . . . . 74.450000000000003 113.33 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -162.08 -104.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.762 1.225 . . . . 73.310000000000002 109.102 169.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.72 90.94 3.46 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.462 -0.94 . . . . 72.239999999999995 108.462 -175.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -81.42 63.77 5.87 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.306 1.051 . . . . 63.109999999999999 108.264 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.2 p -84.86 156.71 21.17 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 114.052 -1.431 . . . . 53.43 111.291 -170.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.7 m -76.27 179.44 5.76 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.028 -0.987 . . . . 54.25 111.551 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 240' ' ' ASN . 0.2 OUTLIER -161.41 142.25 11.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.526 -1.657 . . . . 51.039999999999999 106.526 178.246 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -86.98 119.74 27.51 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.416 0.553 . . . . 61.420000000000002 109.776 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.38 -152.15 6.84 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.241 -0.436 . . . . 74.5 113.079 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.4 96.03 0.21 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.363 -0.687 . . . . 62.329999999999998 111.865 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -83.9 156.84 13.55 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.062 2.508 . . . . 74.140000000000001 112.029 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -147.28 145.33 29.35 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.702 0.401 . . . . 75.120000000000005 110.37 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 237' ' ' PRO . 94.7 m -131.21 155.74 46.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.105 0.962 . . . . 72.049999999999997 111.014 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -150.48 -176.9 5.67 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 107.479 -1.304 . . . . 73.019999999999996 107.479 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.5 t 79.66 118.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 125.09 1.356 . . . . 63.409999999999997 110.243 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -77.42 172.52 13.2 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.372 0.669 . . . . 74.439999999999998 110.389 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.603 HG22 ' HB3' ' A' ' 65' ' ' ALA . 43.6 t -121.52 -174.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.816 1.246 . . . . 44.030000000000001 107.957 -175.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' H ' HG12 ' A' ' 43' ' ' VAL . 9.6 tp10 -133.9 138.4 45.53 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.331 0.652 . . . . 75.109999999999999 110.292 168.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -164.15 -93.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.654 0.782 . . . . 72.209999999999994 110.434 166.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 162.48 153.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.473 1.509 . . . . 71.019999999999996 108.07 -166.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.14 158.8 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.178 1.391 . . . . 73.319999999999993 113.027 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -157.34 173.03 17.55 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.375 0.67 . . . . 75.25 110.225 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.08 -55.46 0.45 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.946 -1.131 . . . . 44.420000000000002 107.946 174.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.608 ' HD2' HD21 ' A' ' 165' ' ' ASN . 0.0 OUTLIER -119.9 86.69 36.82 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 106.989 -1.486 . . . . 64.049999999999997 106.989 170.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.56 141.89 51.92 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.88 2.387 . . . . 64.510000000000005 112.99 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 m -82.36 -14.7 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-O 121.149 0.5 . . . . 64.219999999999999 110.583 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.53 101.28 3.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.52 1.128 . . . . 75.549999999999997 108.209 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.0 m -85.71 71.81 10.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.919 0.888 . . . . 72.430000000000007 109.918 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -173.81 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.264 1.425 . . . . 71.209999999999994 108.676 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -167.98 124.94 1.11 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 124.441 1.096 . . . . 64.439999999999998 108.458 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.69 105.92 56.33 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.607 0.763 . . . . 75.409999999999997 109.333 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.99 -36.64 58.58 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.489 2.126 . . . . 64.150000000000006 111.501 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.485 ' HB3' ' H ' ' A' ' 43' ' ' VAL . 5.0 pm0 -91.77 -45.87 8.19 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.863 -1.062 . . . . 74.340000000000003 111.091 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.56 -107.58 1.45 Allowed Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.695 -0.962 . . . . 73.319999999999993 110.695 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.431 ' HB3' ' CE1' ' A' ' 233' ' ' HIS . 96.3 mt -77.41 90.22 3.82 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 109.303 -0.629 . . . . 74.120000000000005 109.303 168.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.5 t -67.51 105.35 1.81 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.945 1.298 . . . . 74.450000000000003 111.606 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.542 ' H ' HG11 ' A' ' 43' ' ' VAL . 11.1 pt-20 -144.19 -48.01 0.27 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.103 1.149 . . . . 73.129999999999995 114.103 -171.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.7 -48.61 80.97 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.399 0.888 . . . . 73.420000000000002 113.399 -168.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.603 ' HB3' HG22 ' A' ' 43' ' ' VAL . . . -86.52 -9.79 55.43 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.16 0.584 . . . . 62.420000000000002 112.219 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HG2' HG21 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -102.08 -63.74 1.13 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.358 0.663 . . . . 74.409999999999997 109.62 -176.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.42 46.12 1.19 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.372 1.069 . . . . 65.349999999999994 109.615 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.6 p-10 -63.98 -24.18 67.62 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.355 1.062 . . . . 71.010000000000005 110.236 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.5 m -67.34 3.04 1.37 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.871 1.269 . . . . 75.299999999999997 112.796 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.8 -40.28 83.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.401 1.08 . . . . 63.539999999999999 111.508 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 7.9 pt-20 -68.53 -39.14 81.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.829 0.452 . . . . 75.109999999999999 110.146 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.495 HD22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -81.12 -10.29 59.68 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.254 -0.884 . . . . 61.539999999999999 111.025 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.3 tp -62.78 -52.75 61.98 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.313 0.645 . . . . 73.140000000000001 110.122 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.9 mt -104.34 20.92 17.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.04 0.536 . . . . 72.010000000000005 110.624 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.72 -32.75 70.06 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.94 0.496 . . . . 44.119999999999997 111.278 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.6 -134.44 22.4 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-O 118.785 -1.008 . . . . 43.450000000000003 110.856 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 31.3 Cg_exo -58.63 -175.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.85 2.367 . . . . 74.310000000000002 113.096 167.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.44 ' OG ' ' HB ' ' A' ' 138' ' ' VAL . 7.0 m -72.94 170.74 14.15 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 122.808 0.443 . . . . 74.019999999999996 110.406 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.65 -50.57 29.4 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 111.92 0.341 . . . . 63.310000000000002 111.92 -170.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -131.2 -38.46 1.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.278 0.631 . . . . 75.230000000000004 110.883 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 24.0 m-20 -91.35 111.03 46.76 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 117.972 -1.013 . . . . 63.140000000000001 112.003 -174.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -58.31 -26.69 78.17 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.439 2.093 . . . . 62.329999999999998 112.217 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -96.41 20.45 10.53 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.386 0.674 . . . . 73.420000000000002 110.767 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.2 tp -84.14 135.28 34.45 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.699 -0.625 . . . . 53.409999999999997 109.462 175.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.727 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 5.3 m-85 -119.22 174.23 6.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.238 1.415 . . . . 75.349999999999994 109.734 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.62 139.41 35.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.959 1.303 . . . . 53.32 108.338 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.416 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -76.09 130.8 38.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.619 0.768 . . . . 23.420000000000002 109.344 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 136' ' ' THR . 72.0 mt -91.26 -26.91 18.77 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.395 0.678 . . . . 63.43 110.728 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.14 165.64 21.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.504 0.721 . . . . 75.019999999999996 110.362 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 3.4 m-20 -89.18 120.21 30.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.191 -0.913 . . . . 70.549999999999997 108.915 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.542 ' HB3' HG12 ' A' ' 101' ' ' ILE . 75.5 t80 -114.96 148.14 39.13 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.282 -1.007 . . . . 61.32 108.282 173.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.6 t -122.92 134.54 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.19 -1.041 . . . . 70.230000000000004 108.19 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.3 124.54 22.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.804 . . . . 74.450000000000003 111.573 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 p -141.32 18.56 2.24 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.076 0.95 . . . . 72.409999999999997 111.213 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.25 -179.28 24.08 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.944 -0.863 . . . . 44.439999999999998 110.944 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.93 -38.84 76.33 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.985 0.514 . . . . 64.200000000000003 111.516 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.511 HD21 ' HG2' ' A' ' 249' ' ' PRO . 27.0 p-10 -105.47 -3.19 22.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.977 0.511 . . . . 75.310000000000002 112.305 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.416 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 73.6 p -72.47 164.57 26.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.728 0.64 . . . . 72.340000000000003 112.728 -170.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.445 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 67.3 tp -147.18 136.31 22.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.022 0.529 . . . . 70.120000000000005 110.744 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.4 m -80.0 117.6 20.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.307 0.643 . . . . 42.020000000000003 110.615 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.658 HG22 HG21 ' A' ' 123' ' ' THR . 22.6 pt -117.72 157.04 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.167 0.587 . . . . 74.109999999999999 111.009 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.8 m -111.31 151.54 28.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.566 1.146 . . . . 75.200000000000003 109.064 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -60.05 125.62 24.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.231 0.612 . . . . 71.310000000000002 110.414 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.62 -7.23 82.41 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.611 . . . . 51.409999999999997 113.751 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -69.57 124.39 23.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.366 0.583 . . . . 71.129999999999995 111.058 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -73.86 134.94 43.35 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.348 -0.612 . . . . 54.039999999999999 109.348 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.662 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.0 159.05 44.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.8 0.84 . . . . 52.140000000000001 110.457 -175.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.509 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 56.7 ttm-85 -115.43 109.97 18.64 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.881 0.472 . . . . 72.439999999999998 110.578 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.695 HG13 ' HB1' ' A' ' 119' ' ' ALA . 25.5 t -70.61 112.18 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.56 0.695 . . . . 73.150000000000006 109.127 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.08 -41.83 58.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.042 -0.981 . . . . 70.140000000000001 108.364 175.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 23' ' ' ILE . . . 172.77 158.33 16.79 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.843 0.714 . . . . 50.119999999999997 113.639 171.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.783 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 59.9 m-85 -88.16 164.89 15.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 70.209999999999994 111.666 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.7 -172.56 3.37 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.972 0.909 . . . . 70.25 111.162 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.24 -35.43 11.97 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 115.158 1.54 . . . . 73.540000000000006 115.158 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -110.5 -15.43 13.9 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.136 0.574 . . . . 74.299999999999997 111.791 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.783 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 87.97 30.19 18.26 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 114.631 0.613 . . . . 60.219999999999999 114.631 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.45 -38.05 17.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.516 0.658 . . . . 65.129999999999995 111.79 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 18.1 m95 -125.52 146.25 49.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.163 0.585 . . . . 74.129999999999995 110.559 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.695 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -129.72 136.5 49.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 74.129999999999995 110.927 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.728 ' HG2' HE21 ' A' ' 127' ' ' GLN . 27.1 tt0 -69.41 103.79 2.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.11 -1.07 . . . . 74.409999999999997 108.11 173.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.7 138.42 39.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.108 0.563 . . . . 54.219999999999999 111.135 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 61.3 tt0 -97.75 104.89 16.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.903 -1.147 . . . . 74.310000000000002 107.903 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 107' ' ' LEU . 68.5 p -111.09 172.07 7.1 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.753 0.821 . . . . 71.439999999999998 110.86 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -14.53 62.97 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 114.718 -1.128 . . . . 73.319999999999993 110.031 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.1 -26.66 30.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.18 0.992 . . . . 64.439999999999998 111.539 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 136.22 -158.68 24.07 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 120.158 -0.245 . . . . 75.019999999999996 112.533 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.728 HE21 ' HG2' ' A' ' 120' ' ' GLU . 66.5 tp60 -101.82 137.39 40.18 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.208 0.504 . . . . 74.010000000000005 111.377 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 165.9 162.67 17.76 Favored Glycine 0 C--N 1.347 1.143 0 C-N-CA 121.403 -0.427 . . . . 63.520000000000003 113.399 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 43.1 m95 -77.15 133.69 38.9 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.319 1.047 . . . . 70.510000000000005 112.19 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.3 m -136.28 146.32 55.64 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 125.108 1.363 . . . . 70.530000000000001 108.552 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 73.4 Cg_endo -76.06 150.05 33.25 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.1 1.867 . . . . 64.519999999999996 114.888 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -39.23 -49.06 1.87 Allowed 'General case' 0 C--N 1.366 1.308 0 C-N-CA 126.243 1.817 . . . . 61.299999999999997 113.516 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -79.22 -0.85 33.78 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.082 0.771 . . . . 73.219999999999999 113.082 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -98.76 -13.38 20.22 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.85 0.86 . . . . 74.519999999999996 111.487 170.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.73 177.25 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.26 1.024 . . . . 71.129999999999995 110.451 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.426 HG22 HD21 ' A' ' 88' ' ' LEU . 6.4 t -161.75 151.91 14.3 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 108.463 -0.939 . . . . 73.450000000000003 108.463 170.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.03 148.15 86.69 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.705 1.603 . . . . 61.310000000000002 111.679 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.44 ' HB ' ' OG ' ' A' ' 78' ' ' SER . 36.9 t -71.27 -7.76 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-O 121.688 0.756 . . . . 62.210000000000001 109.893 173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.639 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 5.3 m120 -75.45 -20.26 58.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.078 0.951 . . . . 71.209999999999994 111.746 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.5 p -91.83 174.41 7.35 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.448 0.699 . . . . 75.25 111.607 -172.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.28 -20.04 32.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 61.420000000000002 110.569 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.5 -19.13 65.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.086 0.955 . . . . 75.299999999999997 111.992 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -62.68 -21.43 65.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.499 0.72 . . . . 74.340000000000003 112.658 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -78.47 139.75 38.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.285 0.634 . . . . 75.420000000000002 110.143 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.9 p -59.65 -41.94 91.66 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.187 0.995 . . . . 61.399999999999999 111.906 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -67.01 -38.66 86.35 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.834 0.709 . . . . 72.439999999999998 112.229 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.5 118.51 20.71 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.179 -0.674 . . . . 74.140000000000001 109.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -112.63 -1.46 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.122 0.569 . . . . 73.530000000000001 112.273 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.55 -162.23 49.0 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 118.807 -0.996 . . . . 75.099999999999994 112.794 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.38 95.9 0.15 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.988 2.459 . . . . 71.329999999999998 112.721 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 82.3 t -119.93 149.72 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.996 1.318 . . . . 53.0 109.002 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 45.6 m -85.66 166.8 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.525 0.73 . . . . 54.240000000000002 110.598 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -60.04 -50.92 71.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.988 0.515 . . . . 73.150000000000006 110.975 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -58.24 -39.75 79.95 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.0 0.92 . . . . 74.430000000000007 111.7 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.4 75.48 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.907 -0.588 . . . . 73.319999999999993 110.801 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 159' ' ' LEU . . . -57.34 -39.21 75.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.585 0.707 . . . . 65.530000000000001 111.505 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -83.7 -19.04 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.254 -0.884 . . . . 73.5 111.971 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -24.69 43.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.839 0.745 . . . . 73.200000000000003 110.936 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.843 HD21 ' HA ' ' A' ' 239' ' ' ARG . 42.7 mt -69.77 -43.66 71.76 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.013 -0.994 . . . . 74.310000000000002 110.007 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.433 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 75.4 mt -94.8 22.77 6.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.844 -1.071 . . . . 70.209999999999994 112.285 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.7 p -74.23 -41.68 60.96 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.099 0.476 . . . . 75.239999999999995 110.152 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 p -111.99 15.06 20.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.183 0.993 . . . . 55.5 112.247 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.29 168.73 52.2 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 121.908 -0.187 . . . . 61.240000000000002 113.235 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 pt -101.8 -176.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.641 0.776 . . . . 65.299999999999997 111.056 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.608 HD21 ' HD2' ' A' ' 50' ' ' ARG . 4.4 m-20 -63.31 125.35 23.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.459 -0.791 . . . . 74.319999999999993 109.853 172.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.438 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 90.56 10.79 63.08 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 119.313 -0.715 . . . . 30.140000000000001 113.181 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 68.4 m -82.17 116.01 21.53 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.364 1.082 . . . . 64.040000000000006 111.627 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 183' ' ' SER . 12.9 p90 -132.25 168.47 17.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.448 0.642 . . . . 73.530000000000001 111.494 -171.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.32 155.88 25.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.355 -1.293 . . . . 52.450000000000003 108.584 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.658 HG22 HG12 ' A' ' 182' ' ' ILE . 77.5 t -112.33 125.04 69.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.028 -1.101 . . . . 74.530000000000001 108.028 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.565 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 36.3 ptt85 -114.81 161.65 17.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.039 -1.097 . . . . 75.340000000000003 108.039 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 155.24 23.11 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.9 t -79.79 126.41 30.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.049 0.54 . . . . 75.209999999999994 109.794 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -63.42 -34.87 78.69 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 123.948 0.78 . . . . 41.329999999999998 110.265 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 p -82.01 -19.38 40.57 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.626 0.77 . . . . 63.119999999999997 111.989 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -143.86 98.78 5.21 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.901 0.48 . . . . 71.209999999999994 111.176 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.53 136.35 75.33 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.089 2.526 . . . . 74.219999999999999 112.638 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.33 -29.53 6.07 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.135 -0.484 . . . . 50.439999999999998 113.546 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -75.83 117.3 17.42 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.384 -0.599 . . . . 74.140000000000001 109.384 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -122.29 145.79 47.9 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.658 0.742 . . . . 73.310000000000002 110.288 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.1 m -132.49 144.52 50.51 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.523 -1.217 . . . . 71.450000000000003 108.291 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 170' ' ' VAL . 31.9 mt -99.68 148.56 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.787 -1.56 . . . . 72.109999999999999 106.787 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -123.9 108.71 12.73 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.336 -1.357 . . . . 62.039999999999999 107.336 172.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.438 HD11 ' HA2' ' A' ' 166' ' ' GLY . 67.3 tp -105.93 142.75 35.11 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.367 -0.605 . . . . 73.319999999999993 109.367 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.5 ttt85 -117.53 119.38 34.85 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.525 1.13 . . . . 73.329999999999998 109.486 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -140.97 136.27 32.01 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.061 1.344 . . . . 63.149999999999999 107.84 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 58.18 21.23 7.83 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.637 1.175 . . . . 74.329999999999998 111.62 -170.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.17 -9.5 74.73 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.185 0.434 . . . . 52.409999999999997 114.185 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 57.4 mtp85 -96.18 140.12 31.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.522 0.661 . . . . 75.219999999999999 110.177 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.15 108.42 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.691 0.796 . . . . 72.109999999999999 110.81 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.82 150.6 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.278 1.431 . . . . 74.549999999999997 108.51 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 86.0 m-70 -125.45 127.13 46.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.469 0.307 . . . . 72.120000000000005 110.174 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.41 ' HE1' HD21 ' A' ' 232' ' ' LEU . 5.9 m-85 -101.06 149.29 24.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.899 0.88 . . . . 74.439999999999998 109.287 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -97.99 117.25 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.708 -0.849 . . . . 72.349999999999994 108.708 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.7 mt -82.2 99.83 5.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.299 -1.371 . . . . 74.049999999999997 107.299 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -75.04 110.6 9.47 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.555 -1.276 . . . . 73.099999999999994 107.555 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.7 m -89.28 106.4 18.42 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.956 -0.757 . . . . 63.420000000000002 108.956 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.437 ' HB2' ' HE1' ' A' ' 204' ' ' TYR . . . -63.06 148.68 47.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.909 0.884 . . . . 75.049999999999997 110.743 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.3 p -65.5 -23.81 66.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.255 0.622 . . . . 73.319999999999993 112.13 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -78.24 -18.6 55.16 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.862 0.465 . . . . 72.439999999999998 110.986 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.61 14.77 12.06 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.869 -0.406 . . . . 62.310000000000002 114.012 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -92.15 139.0 31.07 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.779 0.789 . . . . 74.25 110.949 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.13 143.03 29.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.956 -1.128 . . . . 62.200000000000003 107.956 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.509 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.5 p90 -163.39 135.45 5.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.221 0.326 . . . . 74.019999999999996 111.675 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.423 HG23 HD11 ' A' ' 217' ' ' LEU . 87.4 t -82.94 -34.02 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.315 -0.995 . . . . 64.299999999999997 108.315 161.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 35.9 m -99.48 119.91 38.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.446 1.099 . . . . 71.549999999999997 110.344 -175.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.6 t -59.12 -34.15 71.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.805 1.242 . . . . 75.340000000000003 112.634 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.22 -2.86 58.85 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.968 0.907 . . . . 52.310000000000002 111.836 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 15.5 m -135.05 85.63 2.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.068 0.547 . . . . 73.319999999999993 109.527 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.509 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 43.5 mtt180 -93.59 120.49 33.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.929 0.891 . . . . 72.010000000000005 109.286 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -107.44 149.68 27.64 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.533 0.733 . . . . 74.450000000000003 109.351 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -62.36 -44.13 97.18 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.523 0.514 . . . . 70.420000000000002 110.161 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.4 p -125.68 160.5 29.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.637 0.732 . . . . 60.439999999999998 111.785 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.24 -25.92 68.27 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.728 -1.124 . . . . 71.200000000000003 109.317 171.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.13 86.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.039 0.936 . . . . 34.210000000000001 111.395 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -72.02 -30.71 65.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.131 -0.94 . . . . 74.049999999999997 111.346 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.423 HD11 HG23 ' A' ' 205' ' ' VAL . 14.8 tp -57.12 -55.49 34.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.306 0.379 . . . . 75.299999999999997 110.351 171.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.2 -41.96 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.752 0.658 . . . . 53.340000000000003 111.254 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -61.87 -55.1 33.24 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.452 0.47 . . . . 75.420000000000002 111.445 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -61.52 -38.08 86.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.443 0.697 . . . . 73.230000000000004 110.866 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.76 ' HB3' HD11 ' A' ' 228' ' ' LEU . 18.6 m170 -88.65 -6.41 57.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.793 -0.639 . . . . 73.510000000000005 112.386 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.0 p -91.07 -31.89 16.09 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 110.22 -0.289 . . . . 62.240000000000002 110.22 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 40.4 p -76.71 -40.63 48.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.206 -0.452 . . . . 72.439999999999998 111.351 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.644 HG23 ' HB2' ' A' ' 226' ' ' ASP . 18.3 m -134.84 158.45 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.331 0.652 . . . . 71.540000000000006 111.623 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.45 14.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 126.932 2.093 . . . . 71.219999999999999 114.424 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.644 ' HB2' HG23 ' A' ' 224' ' ' VAL . 36.4 t70 -42.92 32.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.78 1 C-N-CA 132.07 4.148 . . . . 73.319999999999993 119.761 -155.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.22 -1.8 9.71 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.22 -1.55 . . . . 71.299999999999997 112.112 -168.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.76 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.2 mt -92.07 162.8 14.21 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.691 1.196 . . . . 74.040000000000006 109.434 168.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.49 -42.57 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 121.046 0.45 . . . . 74.340000000000003 110.42 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -161.36 -179.23 7.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.106 0.962 . . . . 63.329999999999998 109.127 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 49.0 p -70.08 143.99 52.27 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.471 0.708 . . . . 65.140000000000001 112.346 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.41 HD21 ' HE1' ' A' ' 193' ' ' TYR . 49.3 mt -72.21 145.66 47.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.649 -1.241 . . . . 72.340000000000003 107.649 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.431 ' CE1' ' HB3' ' A' ' 61' ' ' LEU . 15.8 t60 -147.26 -78.66 0.16 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.323 0.965 . . . . 73.129999999999995 111.534 -175.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 167' ' ' SER . 11.5 t80 -83.41 124.06 76.17 Favored Pre-proline 0 C--O 1.208 -1.09 0 C-N-CA 124.284 1.034 . . . . 73.129999999999995 108.445 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -86.6 139.3 5.69 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.291 1.994 . . . . 71.400000000000006 112.122 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.25 151.9 90.14 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.408 0.683 . . . . 74.219999999999999 109.778 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.463 ' HG3' ' SG ' ' A' ' 39' ' ' CYS . 92.6 Cg_endo -76.06 176.83 9.52 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.508 2.139 . . . . 72.209999999999994 112.118 177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.62 154.57 40.2 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.129 0.572 . . . . 72.329999999999998 110.285 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.843 ' HA ' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -69.9 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.723 1.008 . . . . 74.109999999999999 113.723 -158.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 33' ' ' ARG . 65.3 t30 -120.45 159.33 25.34 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.012 -1.055 . . . . 75.200000000000003 108.561 159.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.458 ' NZ ' ' HB2' ' A' ' 90' ' ' ASP . 98.6 mttt -73.43 115.64 43.33 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 107.686 -1.227 . . . . 65.219999999999999 107.686 160.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.49 127.44 21.83 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.042 2.495 . . . . 53.43 112.587 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 26.0 m -80.49 116.43 20.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.84 -0.43 . . . . 52.409999999999997 109.84 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.37 111.89 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.643 0.777 . . . . 72.409999999999997 108.964 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.9 112.8 20.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.541 -0.299 . . . . 75.140000000000001 110.692 -166.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 70.47 -41.51 0.51 Allowed Glycine 0 CA--C 1.542 1.737 0 N-CA-C 117.436 1.735 . . . . 71.239999999999995 117.436 163.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.61 135.4 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 117.687 0.743 . . . . 64.150000000000006 112.667 -157.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -82.8 130.08 59.47 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 105.757 -1.942 . . . . 73.010000000000005 105.757 157.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.511 ' HG2' HD21 ' A' ' 97' ' ' ASN . 12.2 Cg_exo -68.55 -57.21 0.15 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 121.575 1.516 . . . . 54.130000000000003 113.829 -153.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -129.76 -24.41 2.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.054 0.454 . . . . 71.400000000000006 110.437 164.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 21' ' ' HIS . 82.2 m-85 -99.79 139.81 34.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.807 1.039 . . . . 70.340000000000003 113.807 -159.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 253' ' ' LYS . 19.1 t70 -119.45 -31.99 4.46 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.922 1.289 . . . . 74.120000000000005 110.614 166.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.446 ' HD2' ' HB3' ' A' ' 252' ' ' ASP . 1.2 mptp? -110.73 13.81 22.35 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.169 0.803 . . . . 74.340000000000003 113.169 -168.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.447 ' CE3' ' HA ' ' A' ' 97' ' ' ASN . 68.3 t90 -70.91 111.74 6.55 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.208 0.913 . . . . 73.299999999999997 110.766 -171.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 CA--C 1.558 1.284 0 C-N-CA 125.803 1.641 . . . . 53.420000000000002 112.468 179.747 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.542 0.21 . . . . 61.229999999999997 110.565 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.88 153.77 5.96 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.349 -0.387 . . . . 64.540000000000006 112.207 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -80.71 68.75 7.05 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.995 0.902 . . . . 72.010000000000005 109.677 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -141.14 140.68 21.52 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.582 1.553 . . . . 64.450000000000003 107.34 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.61 136.65 77.21 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.453 2.102 . . . . 64.450000000000003 112.175 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.13 110.14 3.37 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.219 -0.352 . . . . 71.519999999999996 112.219 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.22 112.18 23.15 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.86 -0.793 . . . . 74.010000000000005 108.86 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -64.94 -27.32 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 122.875 0.47 . . . . 61.409999999999997 111.404 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.4 mt 62.0 -176.23 0.13 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.752 1.221 . . . . 71.430000000000007 112.157 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.74 -142.96 10.13 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.768 -0.933 . . . . 70.129999999999995 110.768 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.94 141.49 40.46 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.352 -0.61 . . . . 63.509999999999998 109.352 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -78.18 149.34 33.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.172 0.589 . . . . 73.099999999999994 110.292 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -76.64 179.28 6.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.757 0.823 . . . . 74.319999999999993 111.94 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -56.94 168.04 0.94 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 124.821 1.248 . . . . 74.310000000000002 113.367 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 253' ' ' LYS . 1.2 Cg_exo -32.01 119.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 124.565 3.51 . . . . 63.439999999999998 116.477 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.0 m -108.45 20.73 18.23 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.834 -1.075 . . . . 71.340000000000003 109.817 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 255' ' ' GLU . 0.6 OUTLIER 37.26 85.67 0.15 Allowed Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 127.027 2.131 . . . . 74.049999999999997 115.918 173.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HD2' ' HA ' ' A' ' 254' ' ' TRP . 75.6 Cg_exo -56.42 152.49 39.5 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.846 2.364 . . . . 62.130000000000003 112.4 159.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.76 85.62 7.29 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.217 0.607 . . . . 53.43 111.326 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HA ' ' HZ2' ' A' ' 254' ' ' TRP . 10.5 mp 53.17 -87.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.695 1.598 . . . . 73.340000000000003 114.128 169.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 86.37 145.92 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 126.707 2.003 . . . . 72.049999999999997 111.364 -168.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -140.67 126.32 19.1 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.627 0.771 . . . . 71.409999999999997 109.923 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.4 pt -147.8 -171.45 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 124.99 1.316 . . . . 71.430000000000007 108.268 172.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -130.0 128.23 41.6 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 123.226 0.61 . . . . 74.530000000000001 109.848 171.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.3 166.07 26.51 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.63 -0.588 . . . . 52.310000000000002 111.63 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.492 ' HA ' ' HZ ' ' A' ' 85' ' ' PHE . . . -144.92 156.25 43.88 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.802 0.441 . . . . 73.129999999999995 111.831 -176.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.26 -177.55 36.67 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-N 116.151 -0.477 . . . . 43.350000000000001 112.401 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' HE3' ' HD2' ' A' ' 137' ' ' PRO . 9.2 ptpp? -171.6 169.28 6.09 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.965 0.906 . . . . 75.329999999999998 110.358 176.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.625 ' HG2' ' HB2' ' A' ' 132' ' ' SER . 9.4 ptm180 -165.76 -171.17 1.99 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.106 0.963 . . . . 71.530000000000001 109.646 165.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.77 -171.74 2.64 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.825 0.85 . . . . 73.530000000000001 111.505 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.9 t -163.28 159.44 22.67 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.514 1.126 . . . . 63.240000000000002 108.6 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.5 p -140.41 110.65 6.62 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.074 0.55 . . . . 72.319999999999993 111.122 -168.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -133.11 -149.46 0.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.584 1.154 . . . . 74.019999999999996 108.602 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -151.94 130.94 12.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.209 0.604 . . . . 72.209999999999994 110.077 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.26 -115.28 0.33 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.171 -1.171 . . . . 45.439999999999998 110.171 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.7 81.47 0.04 OUTLIER Glycine 0 C--N 1.346 1.134 0 CA-C-O 119.411 -0.661 . . . . 45.25 112.114 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.56 159.87 35.36 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.679 2.252 . . . . 73.400000000000006 112.599 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -133.76 150.81 51.47 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.696 1.198 . . . . 75.109999999999999 109.828 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.0 t -152.85 141.83 21.23 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.423 0.689 . . . . 64.540000000000006 109.887 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.447 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.0 OUTLIER -160.62 126.5 3.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.787 0.835 . . . . 52.109999999999999 110.005 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.76 -159.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.331 1.052 . . . . 51.130000000000003 108.915 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -60.52 143.31 53.91 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.326 0.651 . . . . 73.140000000000001 111.49 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.2 m -85.08 -177.63 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.756 0.822 . . . . 73.340000000000003 109.777 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.3 -74.05 0.24 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.568 0.622 . . . . 73.519999999999996 111.867 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -158.88 -160.6 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 122.162 -0.336 . . . . 75.510000000000005 111.368 -166.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 70.84 -177.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.241 1.016 . . . . 75.340000000000003 112.94 172.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.71 167.46 13.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.28 1.032 . . . . 72.219999999999999 110.185 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.92 -174.32 2.52 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.739 0.816 . . . . 73.349999999999994 109.921 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.598 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -117.09 6.97 12.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.815 0.846 . . . . 45.210000000000001 110.22 169.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 165' ' ' ASN . 48.9 ttt85 -173.29 106.51 0.31 Allowed Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.938 1.295 . . . . 71.319999999999993 107.935 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.54 153.66 30.7 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.809 2.339 . . . . 54.140000000000001 110.784 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.17 -175.88 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.892 0 C-N-CA 122.785 0.434 . . . . 73.0 110.527 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.1 116.91 3.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.276 0.63 . . . . 63.509999999999998 109.803 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 m -63.57 -23.47 67.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.261 1.025 . . . . 71.439999999999998 112.134 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.08 -30.38 70.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.613 1.165 . . . . 71.120000000000005 111.429 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.473 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 59.8 m-85 -128.65 39.18 3.85 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.887 0.875 . . . . 74.420000000000002 110.164 -174.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.84 97.51 17.76 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 123.504 0.722 . . . . 62.219999999999999 110.071 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 56' ' ' PHE . 4.6 Cg_exo -88.95 -50.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.317 2.678 . . . . 74.340000000000003 112.866 169.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -84.42 -58.32 2.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.595 0.758 . . . . 74.540000000000006 110.496 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.27 -79.6 0.9 Allowed Glycine 0 C--N 1.35 1.331 0 N-CA-C 111.002 -0.839 . . . . 63.43 111.002 -173.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.52 127.25 32.03 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.859 -0.793 . . . . 63.210000000000001 108.859 171.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.4 m -143.98 31.77 1.26 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.465 0.706 . . . . 71.450000000000003 109.756 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -48.5 74.4 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.356 -0.838 . . . . 73.019999999999996 110.488 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.72 -24.16 53.09 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.035 0.534 . . . . 42.509999999999998 111.213 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.9 -26.87 67.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.225 0.536 . . . . 34.149999999999999 111.129 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.549 HH22 ' HD3' ' A' ' 237' ' ' PRO . 15.7 mmm180 -114.46 -15.46 12.06 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.535 1.134 . . . . 54.030000000000001 111.768 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.799 ' HB2' ' HG3' ' A' ' 235' ' ' PRO . 11.6 t90 -150.6 53.04 0.88 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.949 0.881 . . . . 73.319999999999993 109.021 -169.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.7 p-10 -64.53 -24.18 67.52 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.367 -0.833 . . . . 64.439999999999998 110.012 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.7 p -69.69 3.67 2.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.863 1.265 . . . . 45.450000000000003 112.775 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.6 -20.96 66.13 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.816 0.446 . . . . 62.32 110.664 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 14.4 pt-20 -63.33 -42.46 98.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.056 0.542 . . . . 75.239999999999995 109.816 168.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -72.39 -16.5 61.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.469 1.108 . . . . 71.109999999999999 110.924 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 tp -63.53 -51.4 65.61 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.675 0.79 . . . . 62.109999999999999 110.632 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.6 mt -103.13 4.17 36.68 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 111.41 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.61 -30.27 62.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.667 0.387 . . . . 60.43 110.93 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.75 -136.51 27.65 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.118 -0.823 . . . . 70.120000000000005 111.59 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.442 ' HA ' HD22 ' A' ' 139' ' ' ASN . 15.5 Cg_exo -67.02 151.36 82.11 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.57 2.18 . . . . 74.510000000000005 111.636 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 20.2 m -66.96 141.01 57.76 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.716 -0.475 . . . . 73.439999999999998 109.716 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -57.61 -44.5 85.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.483 1.113 . . . . 73.230000000000004 113.357 -168.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -113.11 -38.87 4.34 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.548 0.214 . . . . 62.25 111.424 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 78' ' ' SER . 57.4 m-20 -94.07 107.04 25.64 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 123.451 0.7 . . . . 74.150000000000006 111.607 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.28 -11.64 7.22 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.689 2.259 . . . . 60.420000000000002 112.477 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -110.73 19.58 18.48 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.822 0.849 . . . . 71.409999999999997 110.069 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.6 tp -79.4 139.12 37.81 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.327 -0.397 . . . . 71.219999999999999 110.033 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.492 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 7.2 m-85 -118.62 171.54 8.12 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.729 1.212 . . . . 73.200000000000003 109.723 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.35 131.48 22.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.502 1.121 . . . . 53.109999999999999 109.406 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.74 114.11 6.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.542 1.137 . . . . 65.5 109.889 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 78.0 mt -73.92 -32.63 63.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.516 0.726 . . . . 62.310000000000002 110.496 173.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.53 163.78 21.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.606 -1.179 . . . . 61.140000000000001 108.69 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.15 149.69 23.75 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.803 -0.814 . . . . 75.200000000000003 108.803 166.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.624 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.2 t80 -132.96 141.52 48.38 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.809 -1.182 . . . . 63.32 107.809 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.24 133.47 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.321 -0.992 . . . . 72.329999999999998 108.321 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.25 132.51 53.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.51 0.724 . . . . 52.229999999999997 111.108 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 p -129.39 -41.12 1.4 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.186 0.995 . . . . 65.409999999999997 111.065 -172.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.88 23.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.307 -0.406 . . . . 55.439999999999998 112.524 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.26 -43.57 10.88 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.638 0.719 . . . . 65.230000000000004 111.067 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.484 ' HB2' ' HE3' ' A' ' 254' ' ' TRP . 6.6 p30 -108.24 10.84 27.73 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.613 0.765 . . . . 70.230000000000004 112.123 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.0 p -73.14 150.35 42.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.347 0.659 . . . . 74.200000000000003 110.122 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 128' ' ' GLY . 58.1 tp -130.32 127.73 40.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.089 0.556 . . . . 64.420000000000002 110.824 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -74.27 133.14 42.62 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.221 0.609 . . . . 71.230000000000004 111.619 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.624 HG12 ' HB3' ' A' ' 91' ' ' PHE . 11.4 pt -130.28 166.84 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.208 1.003 . . . . 74.140000000000001 111.1 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 26.9 m -109.84 155.89 21.08 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.577 1.151 . . . . 74.430000000000007 110.329 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -58.95 127.84 34.24 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.162 0.585 . . . . 64.519999999999996 110.196 171.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.83 3.88 84.68 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.388 0.515 . . . . 45.43 114.388 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' HB ' ' A' ' 123' ' ' THR . 38.1 tt0 -73.45 142.48 46.86 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.053 0.541 . . . . 64.420000000000002 110.516 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -93.1 132.28 37.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.454 -0.573 . . . . 72.439999999999998 109.454 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -143.46 163.44 33.11 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.012 0.925 . . . . 72.450000000000003 110.511 -177.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -123.79 108.05 12.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.771 0.428 . . . . 72.409999999999997 110.345 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.658 HG13 ' HB1' ' A' ' 119' ' ' ALA . 41.3 t -73.65 117.86 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.197 0.522 . . . . 72.430000000000007 110.47 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.8 mt -84.08 -60.3 2.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.822 -1.081 . . . . 73.549999999999997 109.079 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.4 141.1 9.01 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 120.853 -0.689 . . . . 42.219999999999999 112.942 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.64 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 20.5 m-85 -88.41 154.54 20.29 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.413 0.685 . . . . 65.140000000000001 109.781 171.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -78.54 -174.9 4.06 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.527 -1.215 . . . . 71.420000000000002 111.857 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -50.01 -31.65 13.36 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.185 1.394 . . . . 71.25 114.253 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -112.8 3.08 16.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.836 0.68 . . . . 60.149999999999999 112.836 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.49 19.65 74.74 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.974 0.75 . . . . 73.549999999999997 114.974 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.46 -12.13 18.79 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.453 0.701 . . . . 65.049999999999997 112.806 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 44.7 m95 -134.34 144.87 48.52 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.535 0.734 . . . . 72.010000000000005 110.248 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -132.98 129.7 38.55 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.716 0.807 . . . . 63.439999999999998 110.962 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.83 97.43 2.24 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 106.814 -1.55 . . . . 74.239999999999995 106.814 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.08 144.49 33.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.393 0.677 . . . . 43.119999999999997 111.434 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -93.76 103.37 15.51 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.78 -1.192 . . . . 62.439999999999998 107.78 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 107' ' ' LEU . 38.5 p -97.36 174.56 6.63 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.003 0.921 . . . . 74.129999999999995 109.979 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -63.83 -23.21 67.26 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.189 0.518 . . . . 74.5 110.187 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -79.19 -29.35 42.87 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.598 1.159 . . . . 74.209999999999994 111.036 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 139.86 -170.03 24.43 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 112.282 -0.327 . . . . 50.32 112.282 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -97.33 135.93 38.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.463 0.632 . . . . 63.200000000000003 111.224 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.463 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 170.6 172.28 36.79 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.328 -0.709 . . . . 63.149999999999999 111.328 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -85.19 124.02 31.35 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.344 0.572 . . . . 70.5 112.076 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.52 HG23 HD13 ' A' ' 135' ' ' ILE . 17.2 m -126.99 143.39 46.71 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.09 1.356 . . . . 72.510000000000005 108.445 170.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 66.2 Cg_endo -88.13 149.61 6.82 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.257 1.971 . . . . 73.219999999999999 115.33 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.625 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 2.4 m -46.67 -28.09 1.37 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.607 1.963 . . . . 70.129999999999995 115.592 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.572 HD21 HG22 ' A' ' 244' ' ' VAL . 32.0 p-10 -81.95 -16.32 50.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.478 0.311 . . . . 73.349999999999994 111.769 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 30.1 m-85 -94.48 -23.53 17.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 72.109999999999999 111.688 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.52 HD13 HG23 ' A' ' 130' ' ' VAL . 20.4 pt -123.56 168.01 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.071 0.549 . . . . 72.099999999999994 112.282 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.3 t -159.75 151.3 16.54 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.964 0.906 . . . . 72.349999999999994 108.643 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.434 ' HD2' ' HE3' ' A' ' 28' ' ' LYS . 24.3 Cg_endo -60.7 147.24 95.53 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 121.745 1.63 . . . . 73.230000000000004 111.724 174.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.29 -11.56 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.738 0.78 . . . . 52.25 110.767 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 77' ' ' PRO . 10.2 m120 -80.26 -13.53 59.13 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.146 0.578 . . . . 73.099999999999994 111.648 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.2 p -89.16 165.16 14.65 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.253 0.621 . . . . 44.43 110.973 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.9 mt -80.35 -21.35 42.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.804 0.842 . . . . 60.140000000000001 110.817 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.83 -17.16 62.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.843 1.257 . . . . 74.409999999999997 111.68 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.417 ' HA ' HD21 ' A' ' 88' ' ' LEU . 22.0 pttm -61.54 -20.22 63.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.957 0.903 . . . . 51.439999999999998 112.976 176.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.47 144.55 25.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.167 0.587 . . . . 70.430000000000007 111.276 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -60.95 -41.5 96.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.596 1.158 . . . . 72.040000000000006 111.869 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -67.26 -33.07 74.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.649 0.779 . . . . 72.209999999999994 112.556 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -77.59 116.31 18.05 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.69 -0.856 . . . . 73.209999999999994 108.69 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.405 ' ND1' HD13 ' A' ' 159' ' ' LEU . 33.0 m170 -113.33 -2.71 13.94 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.36 0.504 . . . . 50.140000000000001 112.36 -175.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.9 -136.25 25.43 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 118.543 -1.143 . . . . 72.519999999999996 113.091 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.79 90.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.53 2.82 . . . . 54.229999999999997 112.71 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.646 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.6 t -132.31 133.73 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 74.209999999999994 108.963 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -89.79 175.53 7.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.862 0.865 . . . . 73.409999999999997 109.87 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 2.6 tmt_? -58.75 -45.92 88.6 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.76 0.424 . . . . 64.150000000000006 110.261 175.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -63.44 -35.12 79.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.714 0.805 . . . . 72.209999999999994 111.547 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.83 -30.34 62.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.058 -0.519 . . . . 65.310000000000002 110.95 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.7 71.23 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.009 0.524 . . . . 73.140000000000001 111.063 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 12.0 mm-40 -62.86 -48.28 79.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.251 0.62 . . . . 70.340000000000003 109.503 170.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.54 -41.21 69.45 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.077 1.751 . . . . 63.119999999999997 111.669 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 239' ' ' ARG . 59.0 mt -68.1 -55.43 12.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.036 0.934 . . . . 65.319999999999993 111.684 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -84.89 16.02 3.62 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.576 0.584 . . . . 71.530000000000001 112.576 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.6 p -65.0 -40.34 94.8 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.405 0.621 . . . . 74.150000000000006 110.397 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.9 p -98.29 18.89 15.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.34 1.056 . . . . 54.409999999999997 111.0 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.46 162.97 32.31 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.243 -0.435 . . . . 73.299999999999997 112.56 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.1 -176.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.39 1.076 . . . . 54.420000000000002 110.039 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 50' ' ' ARG . 40.2 m-20 -67.47 123.2 19.75 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.422 -0.585 . . . . 74.340000000000003 109.422 175.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.78 5.98 57.36 Favored Glycine 0 C--O 1.25 1.155 0 CA-C-O 119.555 -0.581 . . . . 75.299999999999997 113.187 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 52.6 m -83.88 131.69 34.85 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 119.188 -0.434 . . . . 71.329999999999998 110.5 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.58 168.07 20.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.409 0.623 . . . . 65.340000000000003 111.557 -172.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.16 158.72 27.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 114.326 -1.306 . . . . 74.140000000000001 108.979 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.594 HG22 HG12 ' A' ' 182' ' ' ILE . 98.9 t -119.31 137.69 52.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 N-CA-C 108.338 -0.986 . . . . 72.519999999999996 108.338 168.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.646 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 0.4 OUTLIER -122.26 146.86 46.89 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.009 -0.996 . . . . 63.329999999999998 109.634 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.1 tp10 -97.15 139.64 32.84 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.005 1.322 . . . . 71.310000000000002 108.207 164.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.4 t -83.82 123.14 29.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 72.519999999999996 109.093 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -81.88 -26.55 34.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.28 0.562 . . . . 65.239999999999995 109.799 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.8 m -64.49 -39.12 93.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.281 1.033 . . . . 71.409999999999997 110.213 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 47.5 m -137.51 91.3 14.19 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.035 -1.098 . . . . 54.549999999999997 108.035 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.68 134.38 60.31 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.98 2.453 . . . . 63.140000000000001 112.679 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.06 -27.23 21.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.483 -0.78 . . . . 24.309999999999999 112.549 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -85.22 116.9 23.84 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.538 -0.912 . . . . 64.319999999999993 108.538 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 99.4 mtt180 -123.38 159.5 28.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.477 0.656 . . . . 63.009999999999998 111.668 -170.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.444 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 18.8 m -149.0 152.51 36.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.914 -1.039 . . . . 71.120000000000005 109.516 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.594 HG12 HG22 ' A' ' 170' ' ' VAL . 25.3 mt -102.72 149.08 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.389 -1.337 . . . . 72.400000000000006 107.389 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.2 m -126.43 114.6 18.39 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.311 -0.996 . . . . 52.200000000000003 108.311 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.7 tp -113.03 113.5 25.54 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.088 0.404 . . . . 73.040000000000006 109.911 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.435 ' HE ' ' HA2' ' A' ' 188' ' ' GLY . 44.4 ttt180 -77.82 115.3 17.46 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.324 0.583 . . . . 72.25 110.013 166.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -139.03 144.65 38.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.613 1.565 . . . . 61.219999999999999 107.361 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 58.3 21.07 7.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.04 0.936 . . . . 75.209999999999994 111.919 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.435 ' HA2' ' HE ' ' A' ' 185' ' ' ARG . . . 82.82 -0.37 89.62 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 119.418 -0.657 . . . . 43.149999999999999 114.535 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 55.8 mtp180 -115.36 150.42 36.35 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 117.893 0.846 . . . . 75.010000000000005 109.672 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 62.0 t -100.82 118.94 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.146 0.578 . . . . 73.519999999999996 110.541 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -108.21 117.47 34.23 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.184 0.993 . . . . 71.109999999999999 108.634 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -91.42 122.32 33.91 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.022 0.529 . . . . 75.510000000000005 110.503 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.488 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.6 m-85 -94.36 149.08 21.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.43 1.092 . . . . 74.209999999999994 108.291 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -101.21 127.5 47.75 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.087 -0.708 . . . . 73.120000000000005 109.087 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.51 101.05 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.83 -1.174 . . . . 71.209999999999994 107.83 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -88.11 144.51 26.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.934 1.294 . . . . 73.230000000000004 109.062 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -111.46 116.86 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.55 -0.537 . . . . 75.010000000000005 109.55 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.34 168.15 13.09 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.715 0.806 . . . . 71.129999999999995 110.652 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.6 m -62.81 -28.02 69.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.931 0.892 . . . . 70.530000000000001 112.368 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -90.19 -0.04 57.42 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.063 0.945 . . . . 75.209999999999994 111.969 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 92.09 12.74 58.53 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 114.081 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -83.23 128.09 34.2 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.453 0.627 . . . . 73.450000000000003 111.016 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -81.45 148.14 29.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.648 0.779 . . . . 75.439999999999998 109.288 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 47.3 p90 -168.21 147.11 4.51 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.361 0.413 . . . . 64.319999999999993 111.115 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.522 HG23 HD11 ' A' ' 217' ' ' LEU . 66.0 t -89.65 -41.05 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.38 -0.97 . . . . 74.400000000000006 108.38 164.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 46.6 m -104.94 130.17 53.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.091 0.956 . . . . 65.400000000000006 110.029 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.5 t -66.03 -20.59 66.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 73.510000000000005 112.959 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -76.87 -28.64 55.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.615 0.766 . . . . 73.019999999999996 110.666 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.4 m -124.6 98.09 5.58 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.233 0.613 . . . . 60.32 110.137 -172.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 92.4 mtt180 -112.08 144.36 41.58 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.973 0.909 . . . . 71.420000000000002 109.284 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.95 151.7 52.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.773 0.829 . . . . 65.430000000000007 108.985 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.33 -40.6 77.49 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.988 -0.375 . . . . 72.140000000000001 109.988 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -121.42 160.69 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.042 0.925 . . . . 64.230000000000004 112.353 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.469 HD11 HG11 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -66.8 -27.74 67.81 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.714 -1.584 . . . . 72.549999999999997 109.431 171.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.76 96.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.492 0.717 . . . . 44.43 110.782 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -68.78 -38.78 80.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.068 0.947 . . . . 65.129999999999995 111.165 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.522 HD11 HG23 ' A' ' 205' ' ' VAL . 16.6 tp -55.12 -56.9 14.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.037 0.535 . . . . 65.439999999999998 110.712 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.62 -38.22 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.545 0.738 . . . . 73.040000000000006 111.774 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -61.37 -57.96 10.17 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.784 0.326 . . . . 75.129999999999995 111.177 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -64.14 -28.15 69.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.805 -0.634 . . . . 75.099999999999994 111.028 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.673 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.6 m170 -91.13 -10.85 40.41 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.88 0.472 . . . . 62.149999999999999 112.186 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 98.3 p -87.62 -29.19 21.4 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 110.181 -0.303 . . . . 70.25 110.181 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 59.0 p -77.27 -50.38 12.99 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.021 0.528 . . . . 74.329999999999998 110.74 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.614 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.7 m -126.4 157.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 121.667 0.746 . . . . 62.030000000000001 111.942 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.63 17.74 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 127.552 2.341 . . . . 74.310000000000002 114.538 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.614 ' HB2' HG23 ' A' ' 224' ' ' VAL . 32.0 t70 -42.47 28.66 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.581 1 C-N-CA 132.619 4.368 . . . . 63.049999999999997 119.497 -152.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.11 -5.4 9.55 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 119.835 -1.79 . . . . 42.450000000000003 112.169 -165.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -89.62 160.87 16.43 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.831 1.252 . . . . 41.32 109.792 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.07 -34.35 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 116.272 -0.422 . . . . 73.200000000000003 110.855 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.8 t -162.3 178.49 8.65 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.865 0.866 . . . . 73.209999999999994 109.796 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 50.1 p -73.07 142.39 47.59 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.873 0.469 . . . . 71.109999999999999 111.184 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.488 HD21 ' HE1' ' A' ' 193' ' ' TYR . 46.8 mt -73.36 134.74 44.19 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.474 -0.935 . . . . 70.239999999999995 108.474 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -140.26 -68.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 119.982 1.264 . . . . 73.430000000000007 112.508 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 167' ' ' SER . 16.6 t80 -80.1 120.82 80.89 Favored Pre-proline 0 C--O 1.212 -0.915 0 N-CA-C 107.861 -1.162 . . . . 74.340000000000003 107.861 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.799 ' HG3' ' HB2' ' A' ' 67' ' ' TRP . 58.5 Cg_endo -86.69 144.02 7.42 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.012 1.808 . . . . 62.140000000000001 112.736 173.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.54 149.09 80.85 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 108.878 -0.786 . . . . 72.530000000000001 108.878 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.549 ' HD3' HH22 ' A' ' 66' ' ' ARG . 44.3 Cg_endo -88.26 174.59 4.34 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.359 2.039 . . . . 71.239999999999995 111.661 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 75.6 mmtt -59.57 138.1 57.82 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.127 -0.694 . . . . 74.329999999999998 109.127 175.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.605 ' HB3' HD21 ' A' ' 159' ' ' LEU . 15.9 ptt180 -62.69 -67.4 0.42 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.758 1.021 . . . . 71.340000000000003 113.758 -157.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.595 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 7.9 t30 -119.03 165.19 14.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.844 0.747 . . . . 62.43 110.004 164.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 82.4 mttt -65.27 136.19 96.36 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 110.16 -0.311 . . . . 63.109999999999999 110.16 163.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 7.4 Cg_exo -72.58 126.96 11.96 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.945 2.43 . . . . 62.229999999999997 112.901 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 99.1 m -84.6 124.28 31.26 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.833 -0.802 . . . . 74.319999999999993 108.833 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.572 HG22 HD21 ' A' ' 133' ' ' ASN . 4.3 t -99.84 139.21 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.392 -0.966 . . . . 72.409999999999997 108.392 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.3 114.82 28.98 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.712 0.405 . . . . 74.230000000000004 111.822 -161.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.62 62.19 Favored Glycine 0 C--N 1.362 1.997 0 N-CA-C 115.827 1.091 . . . . 64.200000000000003 115.827 163.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.456 HG21 ' NE1' ' A' ' 118' ' ' TRP . 9.3 p -105.6 130.06 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 114.605 1.335 . . . . 63.229999999999997 114.605 -161.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.0 m -86.42 118.89 71.03 Favored Pre-proline 0 N--CA 1.48 1.066 0 N-CA-C 105.236 -2.135 . . . . 73.120000000000005 105.236 148.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.472 ' HD2' HD21 ' A' ' 97' ' ' ASN . 82.9 Cg_exo -50.61 -58.01 1.93 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.115 1.877 . . . . 61.229999999999997 113.97 -162.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -129.37 -27.5 2.42 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.18 -1.044 . . . . 64.200000000000003 108.18 140.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -100.06 149.38 23.55 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 113.518 -1.674 . . . . 75.530000000000001 112.722 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.49 -17.07 12.75 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.611 -1.631 . . . . 63.210000000000001 108.556 161.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.475 ' HB3' ' HZ3' ' A' ' 253' ' ' LYS . 0.1 OUTLIER -111.6 3.51 17.99 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.724 1.379 . . . . 71.219999999999999 114.724 -165.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.553 ' HA ' ' HD2' ' A' ' 18' ' ' PRO . 7.4 t90 -93.65 154.77 17.64 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.41 1.005 . . . . 73.329999999999998 111.269 -176.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 10.1 tp10 . . . . . 0 C--O 1.251 1.157 0 CA-C-N 115.315 -0.857 . . . . 73.129999999999995 109.438 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.818 0.342 . . . . 71.549999999999997 110.825 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.31 117.14 0.7 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.928 -0.578 . . . . 53.399999999999999 111.716 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.47 112.89 15.97 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.468 0.707 . . . . 74.099999999999994 110.092 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.79 120.32 62.0 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.211 0.605 . . . . 62.039999999999999 109.564 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.08 144.02 91.74 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.517 2.145 . . . . 72.439999999999998 111.784 168.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.71 141.49 12.98 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.989 -0.551 . . . . 64.5 112.619 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.558 ' HD2' HG12 ' A' ' 247' ' ' VAL . 15.7 ptpt -80.97 137.28 36.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.531 0.732 . . . . 63.329999999999998 110.156 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.407 HG23 ' HG ' ' A' ' 9' ' ' LEU . 27.4 m -100.73 -42.73 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.237 0.615 . . . . 74.310000000000002 111.099 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' HG ' HG23 ' A' ' 8' ' ' VAL . 2.5 pp -176.68 -178.9 0.93 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.613 1.165 . . . . 71.040000000000006 110.242 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.47 62.85 0.18 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.957 -0.565 . . . . 52.240000000000002 111.921 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.43 106.58 2.57 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.108 -0.701 . . . . 54.329999999999998 109.108 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.477 ' HG2' ' HG3' ' A' ' 13' ' ' ARG . 58.0 tt0 -159.53 145.68 16.19 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.539 1.136 . . . . 74.209999999999994 108.037 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HB2' ' HB3' ' A' ' 96' ' ' ASP . 59.6 mtt180 68.1 159.67 0.16 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.435 1.094 . . . . 71.120000000000005 110.566 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -100.95 156.44 35.14 Favored Pre-proline 0 CA--C 1.556 1.18 0 CA-C-O 118.771 -0.633 . . . . 73.319999999999993 110.452 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -39.65 106.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 124.854 3.702 . . . . 51.509999999999998 114.959 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.7 m -95.2 91.19 6.17 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.831 -0.803 . . . . 51.0 108.831 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.74 112.82 8.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.36 1.064 . . . . 61.109999999999999 110.579 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -83.41 -171.8 1.19 Allowed 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.758 2.305 . . . . 62.109999999999999 112.536 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.02 112.18 9.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.198 0.599 . . . . 61.340000000000003 109.393 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.2 tp -166.09 150.45 7.99 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.083 0.953 . . . . 65.340000000000003 108.964 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.427 ' HA ' HD22 ' A' ' 110' ' ' LEU . 57.4 t-80 -143.41 134.1 25.13 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.898 0.479 . . . . 72.239999999999995 110.511 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -147.39 -166.32 2.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.788 1.235 . . . . 73.409999999999997 109.523 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 tt -143.1 152.27 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.56 1.144 . . . . 73.409999999999997 109.474 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HE2' ' HA2' ' A' ' 111' ' ' GLY . 35.3 mmtm -136.18 173.74 11.38 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.206 1.003 . . . . 71.310000000000002 110.196 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 82' ' ' PRO . . . 166.36 108.85 0.21 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.96 -0.856 . . . . 61.530000000000001 110.96 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.93 155.45 48.9 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.799 0.84 . . . . 72.230000000000004 110.658 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.98 136.04 2.63 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-O 119.747 -0.474 . . . . 51.420000000000002 112.279 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -157.85 158.01 34.31 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.638 0.775 . . . . 63.030000000000001 110.825 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.64 171.21 12.38 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.621 1.169 . . . . 40.030000000000001 109.072 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.65 124.3 9.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.01 -1.107 . . . . 73.109999999999999 108.01 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 t -68.54 114.48 6.98 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.754 0.821 . . . . 62.149999999999999 111.837 -171.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 196' ' ' ASN . 14.6 m -82.98 -168.96 2.28 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.457 1.103 . . . . 64.120000000000005 110.658 171.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -86.76 -152.46 0.18 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.897 0.879 . . . . 75.430000000000007 111.035 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -137.81 112.77 9.07 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.168 -1.049 . . . . 74.150000000000006 108.168 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.79 125.78 1.12 Allowed Glycine 0 C--N 1.346 1.097 0 C-N-CA 121.336 -0.459 . . . . 61.409999999999997 113.292 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 205' ' ' VAL . . . 163.88 155.44 8.27 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.303 -0.72 . . . . 73.510000000000005 111.534 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -90.55 -165.42 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.534 2.822 . . . . 61.140000000000001 113.416 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -149.94 110.0 4.13 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.323 1.049 . . . . 65.319999999999993 109.369 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.0 m -145.97 160.79 41.35 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.98 1.312 . . . . 61.009999999999998 108.729 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.624 ' HA ' ' HB3' ' A' ' 225' ' ' ALA . 24.7 t-20 -156.58 133.65 10.46 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.621 0.646 . . . . 74.219999999999999 111.327 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.534 ' H ' ' HB3' ' A' ' 225' ' ' ALA . 13.8 p -148.89 142.81 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.267 1.427 . . . . 73.420000000000002 107.518 176.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.92 159.11 36.87 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.515 1.126 . . . . 71.540000000000006 109.36 -171.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 44' ' ' GLU . 15.2 t -87.46 173.39 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 C-N-CA 124.892 1.277 . . . . 60.039999999999999 109.65 -176.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 12.9 pt-20 -150.01 148.25 28.82 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.487 0.715 . . . . 55.109999999999999 111.621 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 178.97 -76.76 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.506 1.522 . . . . 72.049999999999997 109.391 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -131.46 159.44 38.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.202 1.001 . . . . 72.349999999999994 109.661 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.73 113.43 20.89 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.154 0.582 . . . . 55.149999999999999 110.908 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.81 97.93 2.41 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.605 -1.628 . . . . 73.310000000000002 106.605 171.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' HG3' ' H ' ' A' ' 50' ' ' ARG . 4.4 tp-100 61.95 -153.96 0.35 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.916 1.287 . . . . 72.209999999999994 109.441 -174.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.638 ' HG2' ' HB3' ' A' ' 57' ' ' GLU . 10.4 mpt_? 69.31 158.89 0.15 Allowed Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 124.88 1.272 . . . . 62.219999999999999 112.526 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.11 -173.36 0.89 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.53 2.153 . . . . 71.25 111.667 163.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -65.55 99.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.718 0.77 . . . . 71.230000000000004 109.098 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.18 -164.98 0.6 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.452 -0.795 . . . . 62.229999999999997 110.825 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -51.34 -44.09 61.94 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.165 0.983 . . . . 64.239999999999995 109.508 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . 16.2 t70 -126.79 -85.89 0.6 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 106.608 -1.627 . . . . 54.130000000000003 106.608 162.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -151.52 120.89 6.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.045 1.338 . . . . 71.409999999999997 107.393 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.638 ' HB3' ' HG2' ' A' ' 50' ' ' ARG . 36.8 tt0 -88.95 125.72 61.56 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 122.463 0.305 . . . . 65.310000000000002 110.373 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -86.36 -34.09 0.16 Allowed 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.726 2.284 . . . . 73.329999999999998 114.23 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -155.5 -38.77 0.09 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.979 0.912 . . . . 74.219999999999999 109.648 -172.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.51 -70.5 2.83 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.646 -0.706 . . . . 72.140000000000001 112.454 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' ' 233' ' ' HIS . 51.3 mt -83.17 153.0 25.0 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.104 0.962 . . . . 72.140000000000001 111.712 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -98.01 42.41 1.09 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.254 1.022 . . . . 75.219999999999999 109.015 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.04 -35.4 81.06 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.367 -1.288 . . . . 54.030000000000001 111.363 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.13 -24.63 67.98 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.646 0.778 . . . . 65.209999999999994 112.042 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.69 -46.14 22.78 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.545 0.738 . . . . 71.450000000000003 111.85 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -125.51 -53.56 1.58 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.831 0.452 . . . . 73.099999999999994 111.782 -173.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -79.2 71.91 5.74 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.405 0.682 . . . . 71.010000000000005 111.344 -169.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -81.45 -20.94 39.24 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.664 -0.698 . . . . 72.209999999999994 110.538 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.8 p -73.21 1.03 10.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.243 0.617 . . . . 75.219999999999999 112.1 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -71.55 -18.9 62.23 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.37 0.668 . . . . 70.230000000000004 111.431 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.87 -32.92 71.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.614 0.721 . . . . 64.450000000000003 110.678 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -85.9 -9.09 57.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.701 -1.136 . . . . 73.019999999999996 110.978 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 215' ' ' ALA . 37.7 tp -70.57 -46.4 63.57 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.467 0.707 . . . . 60.329999999999998 109.457 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.91 52.22 1.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.439 0.638 . . . . 74.010000000000005 110.076 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 78' ' ' SER . . . -95.02 -49.03 5.72 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.245 -0.889 . . . . 72.400000000000006 109.972 175.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.83 -138.33 44.43 Favored Glycine 0 C--N 1.356 1.682 0 N-CA-C 110.418 -1.073 . . . . 71.319999999999993 110.418 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -65.91 116.78 4.17 Favored 'Trans proline' 0 C--N 1.367 1.531 0 CA-C-N 119.628 1.714 . . . . 63.130000000000003 108.459 159.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.545 ' HB2' ' HB1' ' A' ' 75' ' ' ALA . 46.6 t -121.63 176.04 5.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.611 0.764 . . . . 64.019999999999996 110.913 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -72.12 -13.02 61.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.121 0.968 . . . . 71.439999999999998 108.763 167.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -78.7 29.72 0.2 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.441 1.496 . . . . 71.349999999999994 112.18 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' HB2' ' ND2' ' A' ' 83' ' ' ASN . 6.4 m-20 -45.39 149.48 0.99 Allowed Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 126.002 1.721 . . . . 65.019999999999996 112.989 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 57.3 Cg_endo -63.52 -0.26 2.31 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.42 2.746 . . . . 75.310000000000002 115.518 -171.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 81' ' ' ASP . 10.1 p30 -69.89 -23.8 63.3 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.578 0.351 . . . . 73.0 111.109 172.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.53 139.17 44.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 74.140000000000001 108.676 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 11.3 m-85 -118.97 172.95 7.18 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.008 1.323 . . . . 63.119999999999997 109.928 -176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.94 141.54 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 125.246 1.418 . . . . 72.019999999999996 108.985 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -78.33 129.57 35.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.35 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.487 HD21 ' HA ' ' A' ' 143' ' ' LYS . 82.4 mt -87.25 -26.54 23.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.14 0.976 . . . . 63.409999999999997 112.483 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.2 m-85 -134.24 153.19 52.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.011 0.524 . . . . 62.310000000000002 110.227 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.33 119.11 21.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.091 -0.707 . . . . 71.200000000000003 109.091 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.559 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.5 t80 -117.62 126.14 52.0 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.388 -0.967 . . . . 74.400000000000006 108.388 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.45 133.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.857 -1.164 . . . . 54.310000000000002 107.857 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.66 116.46 14.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.719 0.408 . . . . 71.310000000000002 111.304 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.9 p -115.77 77.22 1.07 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.637 0.775 . . . . 73.549999999999997 108.941 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 140.58 -175.89 21.77 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.41 -0.814 . . . . 72.040000000000006 111.535 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 30.9 p-10 -89.31 -42.03 11.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.407 0.683 . . . . 70.040000000000006 112.031 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.6 -26.73 60.94 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.705 0.802 . . . . 72.140000000000001 110.571 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 77.8 p -72.7 143.19 48.15 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.229 0.611 . . . . 64.340000000000003 110.241 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 128' ' ' GLY . 56.1 tp -132.55 132.05 42.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.195 0.598 . . . . 44.030000000000001 109.932 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.3 m -70.81 130.03 40.63 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.468 0.707 . . . . 70.109999999999999 110.914 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 91' ' ' PHE . 23.3 pt -133.6 150.26 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.773 0.829 . . . . 74.439999999999998 110.313 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -102.45 146.82 27.54 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.942 0.897 . . . . 70.239999999999995 109.319 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -67.94 114.37 6.44 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.542 -0.54 . . . . 74.430000000000007 109.542 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.58 -9.62 32.65 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 123.327 0.489 . . . . 15.43 112.382 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 37.5 tt0 -77.9 137.89 38.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.972 0.909 . . . . 71.329999999999998 111.334 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.43 133.39 35.94 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.432 0.693 . . . . 74.239999999999995 110.2 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.6 OUTLIER -149.08 161.59 41.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.667 1.187 . . . . 61.43 110.117 -174.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -120.34 118.74 31.17 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.88 -0.513 . . . . 72.099999999999994 110.256 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.635 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.5 t -73.35 121.34 23.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.56 0.695 . . . . 71.109999999999999 110.02 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 122' ' ' GLN . 23.6 mt -84.58 -51.95 6.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.967 -1.469 . . . . 64.319999999999993 108.874 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.435 ' HA2' ' HE2' ' A' ' 24' ' ' LYS . . . -170.95 149.39 12.35 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.883 -0.599 . . . . 75.209999999999994 112.784 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.55 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 51.6 m-85 -85.3 168.26 14.85 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.399 0.68 . . . . 73.329999999999998 110.605 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -82.21 -172.87 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.379 -0.828 . . . . 41.450000000000003 109.842 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -53.84 -42.32 68.38 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.836 0.854 . . . . 74.430000000000007 112.945 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -112.43 13.6 20.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.933 0.716 . . . . 44.210000000000001 112.933 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.8 21.07 76.45 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 115.685 1.034 . . . . 62.100000000000001 115.685 170.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -77.28 -54.5 6.4 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.611 0.706 . . . . 75.219999999999999 110.571 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.796 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 20.4 m95 -110.95 152.9 26.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.809 0.844 . . . . 70.340000000000003 111.55 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -129.53 140.46 51.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.688 1.195 . . . . 75.209999999999994 109.981 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 38.4 tt0 -75.82 130.04 37.96 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.956 -1.127 . . . . 72.219999999999999 107.956 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.34 144.55 44.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.526 0.731 . . . . 70.230000000000004 110.003 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.428 ' HG3' HD21 ' A' ' 110' ' ' LEU . 47.8 mt-30 -96.51 107.8 20.27 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.763 -1.199 . . . . 72.349999999999994 107.763 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 107' ' ' LEU . 34.6 p -106.42 -177.04 3.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.111 0.964 . . . . 73.430000000000007 111.395 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -71.83 -10.42 59.75 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.504 -0.771 . . . . 71.040000000000006 110.828 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -101.44 16.42 25.7 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.52 1.128 . . . . 63.439999999999998 110.585 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.79 -122.68 7.06 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.218 -0.768 . . . . 74.120000000000005 112.044 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.83 152.45 47.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 118.032 0.916 . . . . 72.209999999999994 110.849 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.496 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 153.8 172.55 21.99 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 111.575 -0.61 . . . . 55.399999999999999 111.575 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 66.0 m95 -80.15 131.81 35.8 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.225 0.61 . . . . 70.400000000000006 112.561 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.426 HG23 HD13 ' A' ' 135' ' ' ILE . 34.3 m -136.8 141.89 36.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 125.645 1.578 . . . . 74.129999999999995 109.215 168.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.796 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.1 Cg_endo -77.92 151.26 27.5 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.438 2.092 . . . . 73.230000000000004 115.284 -172.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -36.63 -50.54 0.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.628 1.971 . . . . 60.32 113.856 170.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -74.22 -7.96 54.53 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.417 0.687 . . . . 52.530000000000001 112.352 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.416 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 13.6 m-85 -104.03 -4.92 22.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.88 0.872 . . . . 63.210000000000001 112.118 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 130' ' ' VAL . 6.3 pt -135.24 168.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 124.003 0.921 . . . . 52.210000000000001 111.826 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.9 t -163.54 155.98 15.46 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 108.334 -0.987 . . . . 52.210000000000001 108.334 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 51.1 Cg_exo -56.55 151.77 44.37 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.108 1.872 . . . . 63.340000000000003 113.029 171.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.51 -5.66 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.166 0.507 . . . . 73.150000000000006 110.209 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.4 -20.21 23.07 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.625 -0.672 . . . . 74.319999999999993 110.881 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.1 p -80.9 172.49 13.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.328 0.585 . . . . 63.200000000000003 111.742 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 214' ' ' LEU . 61.5 mt -84.67 -25.02 28.73 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.785 0.834 . . . . 75.120000000000005 111.291 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.5 -24.01 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.474 1.11 . . . . 75.200000000000003 112.092 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.487 ' HA ' HD21 ' A' ' 88' ' ' LEU . 23.1 pttm -64.2 -26.16 68.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.39 0.676 . . . . 71.430000000000007 112.476 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -75.15 148.35 39.7 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.61 -0.723 . . . . 72.310000000000002 110.159 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 235' ' ' PRO . 16.9 m -60.52 -41.09 93.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.115 0.885 . . . . 63.439999999999998 111.552 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -67.18 -48.32 68.28 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.324 0.65 . . . . 74.400000000000006 112.549 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -75.66 112.53 12.12 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.538 -0.541 . . . . 75.109999999999999 109.538 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.448 ' HB2' HG21 ' A' ' 151' ' ' VAL . 32.6 m170 -102.39 -1.98 29.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.379 0.672 . . . . 71.400000000000006 111.612 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.34 -151.26 36.27 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 118.887 -0.952 . . . . 74.310000000000002 112.232 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.62 114.29 1.93 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.053 2.502 . . . . 62.439999999999998 111.407 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 54.0 t -142.72 137.85 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 125.398 1.479 . . . . 34.32 108.863 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.2 p -82.58 170.22 15.42 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.627 0.771 . . . . 52.299999999999997 110.95 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -59.7 -48.47 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.932 0.893 . . . . 73.349999999999994 110.389 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.35 -44.37 84.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.466 1.107 . . . . 71.129999999999995 111.465 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.78 76.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.973 -1.012 . . . . 51.439999999999998 111.518 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.77 82.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.447 0.699 . . . . 51.420000000000002 111.636 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -78.64 -25.49 45.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.565 -0.743 . . . . 74.409999999999997 112.709 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -24.88 59.71 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.943 0.792 . . . . 74.230000000000004 110.678 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.811 HD21 ' HA ' ' A' ' 239' ' ' ARG . 69.0 mt -71.92 -48.97 41.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.963 -1.017 . . . . 75.109999999999999 110.056 170.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.694 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 63.8 mt -89.23 19.49 4.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.044 -0.98 . . . . 75.120000000000005 112.642 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.3 p -90.42 -34.11 15.76 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.091 -1.077 . . . . 41.32 108.091 157.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.5 m -92.05 2.49 56.53 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.949 1.299 . . . . 70.150000000000006 111.892 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.1 -178.07 40.43 Favored Glycine 0 C--N 1.351 1.386 0 C-N-CA 122.771 0.224 . . . . 74.310000000000002 112.839 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -107.62 177.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.241 1.016 . . . . 63.329999999999998 110.31 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.05 131.26 46.09 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.84 6.42 72.5 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.079 -0.845 . . . . 73.310000000000002 113.695 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.5 m -81.39 136.18 35.7 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.217 1.008 . . . . 73.409999999999997 110.524 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -142.8 163.12 33.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.303 0.573 . . . . 72.420000000000002 111.218 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.64 145.32 22.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.83 -1.077 . . . . 75.5 108.666 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.645 HG22 HG12 ' A' ' 182' ' ' ILE . 83.2 t -103.48 126.73 57.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.947 -1.131 . . . . 54.32 107.947 169.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.63 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.5 ptt85 -115.71 160.98 19.35 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.177 0.991 . . . . 74.409999999999997 109.06 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -114.35 150.29 34.8 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.259 -1.756 . . . . 70.239999999999995 106.259 167.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -67.96 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.299 -0.63 . . . . 73.239999999999995 109.299 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.07 -31.33 71.74 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.822 0.849 . . . . 65.030000000000001 111.176 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.8 p -97.17 -5.31 37.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.135 0.974 . . . . 52.329999999999998 112.008 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -149.88 102.84 3.21 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 122.719 0.408 . . . . 63.409999999999997 111.189 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.23 146.81 70.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.551 2.167 . . . . 55.32 111.833 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.69 -28.36 3.55 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 123.069 0.366 . . . . 73.219999999999999 113.403 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.91 114.45 18.83 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -130.8 156.54 44.83 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.52 0.676 . . . . 75.5 111.12 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.8 m -147.2 150.86 35.73 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.833 -1.076 . . . . 71.239999999999995 109.241 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.645 HG12 HG22 ' A' ' 170' ' ' VAL . 22.6 mt -103.81 151.57 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.54 -1.281 . . . . 75.319999999999993 107.54 170.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -124.73 121.98 36.18 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.678 -1.23 . . . . 62.109999999999999 107.678 168.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.2 tp -115.65 114.36 24.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.36 0.664 . . . . 75.25 110.377 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.694 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 56.1 ttt85 -76.3 111.53 11.84 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.551 0.74 . . . . 51.149999999999999 109.033 164.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -139.44 139.58 37.11 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.991 1.316 . . . . 72.530000000000001 107.791 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 59.7 21.76 10.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.47 1.108 . . . . 51.109999999999999 111.782 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.75 -12.31 59.75 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.628 -0.714 . . . . 42.229999999999997 113.85 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -98.96 146.73 25.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.237 0.615 . . . . 73.150000000000006 110.211 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 115.24 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.08 0.552 . . . . 64.450000000000003 110.405 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -101.47 137.96 39.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.487 1.115 . . . . 63.100000000000001 108.807 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.54 120.04 41.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.889 0.376 . . . . 73.209999999999994 110.74 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.471 ' HE1' HD21 ' A' ' 232' ' ' LEU . 5.8 m-85 -95.59 152.31 18.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.224 1.009 . . . . 74.25 108.738 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -104.7 115.81 30.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.401 -0.592 . . . . 63.039999999999999 109.401 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -85.73 101.96 10.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.849 -1.167 . . . . 64.219999999999999 107.849 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 32' ' ' SER . 22.2 m-80 -84.04 107.21 16.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.403 -1.271 . . . . 65.099999999999994 108.382 176.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -74.52 112.65 10.91 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.862 -1.162 . . . . 75.340000000000003 107.862 164.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.94 160.97 19.45 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.682 0.393 . . . . 54.130000000000003 110.704 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.0 p -62.43 -28.36 69.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.59 0.756 . . . . 74.340000000000003 111.07 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -89.76 -5.2 57.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.245 1.018 . . . . 72.319999999999993 111.128 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 106.58 -6.82 38.79 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 114.787 0.675 . . . . 63.240000000000002 114.787 168.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.13 127.47 32.68 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.887 0.843 . . . . 75.420000000000002 111.646 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.71 142.68 30.55 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.099 0.96 . . . . 73.209999999999994 109.051 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.617 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 39.9 p90 -164.71 139.74 5.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.214 0.321 . . . . 62.149999999999999 111.686 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.467 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 72.0 t -84.64 -37.84 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.559 -0.904 . . . . 73.329999999999998 108.559 163.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 24.2 m -101.23 126.91 48.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 109.771 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.9 t -69.7 -16.72 63.39 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.421 0.689 . . . . 65.430000000000007 112.129 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -92.66 -15.3 26.94 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.776 1.23 . . . . 73.219999999999999 110.99 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.2 m -133.93 95.46 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.746 0.818 . . . . 71.439999999999998 109.116 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.617 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -111.59 134.77 52.94 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.87 0.868 . . . . 73.200000000000003 109.527 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.471 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.2 OUTLIER -124.0 151.97 43.1 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.104 0.961 . . . . 72.109999999999999 108.538 -170.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -69.47 -34.2 74.01 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.601 0.563 . . . . 74.439999999999998 110.692 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.3 p -126.76 152.58 46.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.73 0.812 . . . . 73.420000000000002 111.718 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 141' ' ' LEU . 1.3 tt -63.84 -24.44 67.75 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 114.674 -1.148 . . . . 75.329999999999998 109.215 172.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 73' ' ' LEU . . . -59.16 -49.12 79.06 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.976 0.91 . . . . 52.340000000000003 111.275 173.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -65.33 -36.8 85.14 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.526 0.73 . . . . 75.299999999999997 111.325 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.431 HD11 HG23 ' A' ' 205' ' ' VAL . 15.9 tp -56.43 -56.76 17.22 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.495 0.497 . . . . 74.010000000000005 111.102 176.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.44 -41.5 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.317 0.647 . . . . 74.519999999999996 110.897 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.11 -52.25 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.741 0.416 . . . . 75.409999999999997 111.524 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -65.44 -40.61 93.46 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.203 0.601 . . . . 65.420000000000002 109.85 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.659 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.3 m-70 -86.6 -4.54 59.19 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.446 -0.797 . . . . 74.400000000000006 111.917 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 89.9 p -91.98 -35.31 14.05 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 110.181 -0.303 . . . . 64.519999999999996 110.181 167.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.2 m -68.4 -49.63 58.7 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.306 0.574 . . . . 71.409999999999997 110.216 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -128.18 161.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.006 -0.997 . . . . 72.329999999999998 110.161 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' A' ' 40' ' ' ASN . . . -74.47 19.61 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.377 1.871 . . . . 72.299999999999997 114.637 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 224' ' ' VAL . 10.9 t70 -43.02 31.64 0.0 OUTLIER 'General case' 0 CA--C 1.598 2.8 1 C-N-CA 132.319 4.247 . . . . 75.25 120.203 -153.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 125.22 0.82 8.04 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 121.259 -0.9 . . . . 75.540000000000006 112.583 -167.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.0 mt -95.06 165.61 12.34 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 126.169 1.788 . . . . 51.420000000000002 110.025 168.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.99 -41.92 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-N 116.604 -0.271 . . . . 61.229999999999997 110.314 168.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -157.41 -179.78 8.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.104 0.561 . . . . 71.239999999999995 110.969 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.0 p -63.55 137.1 57.99 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.837 1.255 . . . . 71.219999999999999 112.243 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.471 HD21 ' HE1' ' A' ' 193' ' ' TYR . 75.7 mt -72.62 111.03 7.42 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.949 -0.76 . . . . 72.010000000000005 108.949 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.636 ' HA ' HD22 ' A' ' 61' ' ' LEU . 13.4 t60 -106.87 -44.54 4.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.948 0.722 . . . . 73.439999999999998 112.948 -163.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -130.84 125.24 21.22 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.15 0.98 . . . . 72.450000000000003 109.138 -169.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 145' ' ' SER . 76.1 Cg_endo -81.56 129.17 6.39 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 122.234 1.956 . . . . 71.409999999999997 112.121 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.36 151.94 85.62 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.852 0.861 . . . . 63.119999999999997 110.113 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.71 170.3 17.12 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.966 2.444 . . . . 74.25 112.593 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.9 154.02 35.08 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.044 0.937 . . . . 62.229999999999997 110.917 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.811 ' HA ' HD21 ' A' ' 159' ' ' LEU . 18.8 ptt180 -81.66 -60.34 2.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.541 0.941 . . . . 74.439999999999998 113.541 -168.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.562 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 64.9 t30 -108.69 153.92 22.75 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.701 0.8 . . . . 72.239999999999995 109.122 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 84.2 tttt -87.4 114.77 60.25 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.204 -1.776 . . . . 75.340000000000003 106.204 159.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 31.7 Cg_exo -62.21 144.39 95.52 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.373 2.715 . . . . 63.130000000000003 113.151 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.4 m -94.66 134.72 36.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.283 0.633 . . . . 74.040000000000006 110.86 -172.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -90.43 125.82 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 64.310000000000002 108.664 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -109.81 115.9 30.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.689 0.395 . . . . 75.129999999999995 110.988 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 75.94 -48.27 2.34 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 119.277 2.471 . . . . 50.119999999999997 119.277 155.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.558 HG12 ' HD2' ' A' ' 7' ' ' LYS . 31.2 m -99.48 144.1 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 114.366 1.247 . . . . 61.420000000000002 114.366 -157.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.0 t -82.34 115.83 60.16 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 104.405 -2.443 . . . . 72.340000000000003 104.405 149.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 11.3 Cg_endo -53.78 -53.2 6.85 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.94 2.427 . . . . 71.049999999999997 116.858 -152.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -123.23 -11.46 7.97 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.989 0.916 . . . . 64.450000000000003 110.226 165.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.506 ' HA ' ' HB3' ' A' ' 254' ' ' TRP . 32.1 t80 -85.1 93.11 8.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.681 0.753 . . . . 74.549999999999997 111.444 -154.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -128.85 -45.48 1.29 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.936 1.294 . . . . 74.409999999999997 108.414 146.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -81.17 -34.55 32.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.191 0.597 . . . . 53.240000000000002 109.528 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.506 ' HB3' ' HA ' ' A' ' 251' ' ' TYR . 38.8 t-105 -60.0 147.82 37.64 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 114.692 -1.14 . . . . 64.219999999999999 110.597 -175.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 C--O 1.246 0.902 0 N-CA-C 106.837 -1.542 . . . . 74.150000000000006 106.837 176.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 mtm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.037 -0.727 . . . . 74.099999999999994 109.037 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.93 43.64 0.02 OUTLIER Glycine 0 C--N 1.349 1.28 0 O-C-N 123.343 0.402 . . . . 64.120000000000005 112.234 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -68.05 112.44 5.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.302 0.641 . . . . 70.239999999999995 110.233 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -122.73 90.9 49.83 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 123.307 0.643 . . . . 62.329999999999998 109.889 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.9 177.14 9.24 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.73 2.286 . . . . 71.319999999999993 111.949 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.77 117.88 0.62 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.325 -0.71 . . . . 72.129999999999995 111.325 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.96 135.49 37.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.785 0.834 . . . . 71.129999999999995 109.9 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.02 96.95 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 124.097 0.959 . . . . 73.230000000000004 109.552 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.59 175.22 10.75 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.908 0.883 . . . . 52.409999999999997 110.395 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.0 155.31 17.89 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.314 -0.715 . . . . 63.329999999999998 111.314 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.03 160.02 44.18 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.853 -1.166 . . . . 74.019999999999996 107.853 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -158.43 105.89 1.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.76 0.79 . . . . 73.340000000000003 111.422 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -110.6 138.59 46.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.696 -1.224 . . . . 74.239999999999995 107.696 164.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.576 ' HD2' HD11 ' A' ' 17' ' ' LEU . 33.2 mmt180 -119.21 81.66 21.69 Favored Pre-proline 0 N--CA 1.484 1.273 0 C-N-CA 123.397 0.679 . . . . 73.239999999999995 109.939 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 255' ' ' GLU . 6.4 Cg_exo -75.57 -66.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.797 2.332 . . . . 63.130000000000003 110.706 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.9 m -154.75 116.97 4.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.215 1.006 . . . . 72.209999999999994 108.511 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.576 HD11 ' HD2' ' A' ' 14' ' ' ARG . 5.9 mp -75.2 129.99 81.38 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.955 0.902 . . . . 74.439999999999998 109.653 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.54 160.59 6.85 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.477 2.785 . . . . 72.209999999999994 114.685 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.21 178.11 2.47 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.353 1.061 . . . . 52.329999999999998 112.683 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.409 HD21 ' OD1' ' A' ' 83' ' ' ASN . 7.8 mp -63.3 120.82 12.31 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.603 -0.726 . . . . 75.140000000000001 110.999 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -150.19 121.36 7.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.814 -1.55 . . . . 72.439999999999998 106.814 169.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.702 ' HB3' ' H ' ' A' ' 112' ' ' TYR . 47.2 p90 -161.5 149.56 15.29 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.709 0.633 . . . . 72.5 112.709 -169.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.478 HD11 ' HA ' ' A' ' 115' ' ' ASN . 34.6 pt -131.21 176.74 8.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 115.066 -0.97 . . . . 73.120000000000005 108.816 168.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -94.84 105.8 17.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.608 0.763 . . . . 72.209999999999994 110.1 -174.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.0 168.7 20.64 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.573 -1.011 . . . . 70.150000000000006 110.573 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.95 -177.62 3.45 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 117.495 0.647 . . . . 55.210000000000001 111.338 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' N ' HD22 ' A' ' 133' ' ' ASN . . . -131.67 -178.03 15.25 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 110.799 -0.92 . . . . 61.340000000000003 110.799 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.86 167.45 28.08 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 117.251 0.525 . . . . 71.129999999999995 111.923 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.63 167.97 7.71 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.36 1.464 . . . . 75.329999999999998 108.68 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.99 -92.53 0.13 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.61 0.764 . . . . 70.230000000000004 111.928 -172.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.7 p -89.86 128.63 36.22 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.271 0.628 . . . . 52.0 110.844 -165.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 10.7 p 178.75 148.51 0.2 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.006 1.722 . . . . 73.209999999999994 107.495 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.36 144.58 22.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.09 0.471 . . . . 75.239999999999995 110.122 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -131.32 155.83 46.53 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.413 -0.958 . . . . 75.400000000000006 108.413 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.95 -115.15 1.66 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.347 -1.101 . . . . 73.040000000000006 110.347 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.93 -173.13 31.22 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.895 0.409 . . . . 74.109999999999999 112.095 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -87.1 -165.84 0.27 Allowed 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.208 2.605 . . . . 71.099999999999994 111.283 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -125.87 173.94 8.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.287 0.635 . . . . 73.140000000000001 110.897 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.7 t -155.52 -144.68 0.14 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 108.395 -0.965 . . . . 65.540000000000006 108.395 -171.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -102.22 168.5 9.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.477 0.711 . . . . 70.219999999999999 110.304 173.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.621 HG23 ' HG3' ' A' ' 63' ' ' GLU . 7.5 p -122.74 149.04 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.13 0.972 . . . . 51.240000000000002 109.525 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -68.7 153.33 43.97 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.34 0.656 . . . . 74.319999999999993 110.29 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.4 m -56.42 110.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 123.882 0.873 . . . . 60.0 112.068 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.18 -171.97 2.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.086 0.954 . . . . 65.439999999999998 109.54 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -139.26 139.23 37.34 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.048 0.539 . . . . 75.319999999999993 111.287 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.24 -29.48 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.536 0.734 . . . . 72.230000000000004 109.503 175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 60.24 -152.84 0.39 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.995 0.918 . . . . 75.409999999999997 112.454 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 71.54 171.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.115 1.366 . . . . 73.140000000000001 112.068 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -63.85 114.9 4.35 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.48 0.712 . . . . 72.140000000000001 111.505 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.459 ' HG3' ' HA3' ' A' ' 60' ' ' GLY . 2.6 ptp180 179.25 146.33 0.38 Allowed Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 125.57 1.548 . . . . 75.450000000000003 108.937 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.55 90.25 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.763 2.308 . . . . 73.209999999999994 112.373 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.53 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 27.1 m -81.39 172.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.932 0.893 . . . . 73.299999999999997 111.169 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.81 164.69 16.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.416 0.686 . . . . 74.219999999999999 110.983 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.5 t -67.42 135.64 53.46 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.26 0.624 . . . . 75.430000000000007 110.253 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t70 69.1 -78.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.593 1.183 . . . . 71.409999999999997 111.083 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -79.16 137.3 37.4 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.778 0.431 . . . . 54.409999999999997 110.497 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -104.6 102.55 34.92 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.435 0.694 . . . . 72.209999999999994 109.744 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.62 -68.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 121.833 1.689 . . . . 74.140000000000001 109.653 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -173.58 21.0 0.01 OUTLIER 'General case' 0 C--N 1.36 1.035 0 O-C-N 123.91 0.756 . . . . 74.140000000000001 112.868 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 52' ' ' VAL . . . 72.08 -76.28 0.74 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.888 -0.396 . . . . 51.109999999999999 114.048 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 pp -49.18 129.26 17.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.152 1.381 . . . . 51.329999999999998 111.127 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.487 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 33.2 p -99.81 126.94 45.99 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.378 0.671 . . . . 72.420000000000002 111.177 -170.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.621 ' HG3' HG23 ' A' ' 41' ' ' VAL . 45.4 mt-10 -74.38 -54.17 8.15 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.761 0.663 . . . . 72.329999999999998 109.812 173.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.21 -20.29 6.65 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.326 1.051 . . . . 64.430000000000007 113.544 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.9 -62.99 1.32 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.288 1.035 . . . . 70.299999999999997 111.84 174.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -113.04 7.09 17.95 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.95 0.9 . . . . 64.5 110.945 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -144.45 45.36 1.41 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.917 0.865 . . . . 74.329999999999998 109.213 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 23.8 p-10 -65.43 -21.82 66.7 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.982 -1.008 . . . . 74.010000000000005 109.46 165.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.4 p -77.47 5.41 8.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.573 1.549 . . . . 73.120000000000005 112.782 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.55 -25.4 68.03 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.202 0.456 . . . . 75.030000000000001 111.167 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.5 pt-20 -62.63 -43.45 98.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.26 0.624 . . . . 71.420000000000002 110.502 168.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -82.47 -2.97 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.48 1.112 . . . . 73.0 111.331 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.0 tp -52.33 -49.18 64.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.005 0.922 . . . . 75.150000000000006 110.274 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.5 mt -95.58 83.26 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.779 -1.193 . . . . 71.010000000000005 107.779 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.77 -57.04 3.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.098 -0.956 . . . . 74.430000000000007 113.054 -168.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.11 -137.92 20.56 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.07 -0.85 . . . . 62.409999999999997 111.031 -169.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.76 176.83 5.5 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.636 2.224 . . . . 74.310000000000002 112.349 171.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 m -80.38 178.24 8.44 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.713 0.805 . . . . 63.340000000000003 110.632 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -60.39 -52.12 66.59 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.895 0.702 . . . . 72.329999999999998 112.895 -167.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -136.91 -40.12 0.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.289 0.636 . . . . 71.200000000000003 110.527 163.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 13.7 m-20 -92.05 124.11 60.92 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 115.326 -0.852 . . . . 75.230000000000004 111.785 -176.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.19 -17.15 50.13 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.102 1.868 . . . . 74.439999999999998 111.345 164.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.409 ' OD1' HD21 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -86.44 2.51 47.49 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.109 0.964 . . . . 75.409999999999997 110.862 177.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.609 HD21 ' HD3' ' A' ' 106' ' ' LYS . 35.7 tp -80.65 125.52 30.12 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.22 172.49 6.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.727 1.211 . . . . 73.329999999999998 108.178 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.57 137.22 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.276 1.031 . . . . 72.150000000000006 108.836 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.2 123.66 26.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.62 0.768 . . . . 65.040000000000006 109.968 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.405 HD22 ' HE3' ' A' ' 238' ' ' LYS . 95.1 mt -79.03 -32.86 45.13 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 53.210000000000001 110.982 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.576 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 55.9 m-85 -126.54 160.14 31.47 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.068 0.547 . . . . 71.230000000000004 110.792 -174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.7 120.38 23.93 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.477 -0.934 . . . . 70.530000000000001 108.477 166.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.729 ' HB3' HG12 ' A' ' 101' ' ' ILE . 93.8 t80 -113.14 132.53 55.42 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.71 -0.848 . . . . 65.329999999999998 108.71 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -93.92 128.59 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.328 -0.99 . . . . 71.150000000000006 108.328 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.3 114.56 6.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.408 -0.59 . . . . 50.219999999999999 109.408 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.9 p -98.69 -0.83 42.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.735 0.814 . . . . 73.310000000000002 111.431 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.9 166.26 24.92 Favored Glycine 0 C--O 1.244 0.742 0 N-CA-C 110.703 -0.959 . . . . 60.509999999999998 110.703 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -70.87 -39.16 73.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.103 0.478 . . . . 65.209999999999994 110.45 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -79.95 -24.53 40.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 62.219999999999999 111.809 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 p -76.25 166.7 23.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.678 0.391 . . . . 71.439999999999998 110.829 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -134.96 133.47 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.042 0.537 . . . . 74.409999999999997 110.629 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.6 m -74.61 141.75 44.66 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.793 0.837 . . . . 74.25 110.177 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.729 HG12 ' HB3' ' A' ' 91' ' ' PHE . 14.1 pt -128.5 156.51 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.174 0.59 . . . . 51.130000000000003 110.412 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 7.2 m -108.03 152.45 24.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.159 0.984 . . . . 74.340000000000003 109.938 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -60.04 110.69 1.26 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.636 0.774 . . . . 71.239999999999995 109.13 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.85 8.33 63.64 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.688 -0.507 . . . . 51.25 113.646 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.2 tt0 -76.23 120.89 22.13 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.478 0.639 . . . . 64.540000000000006 110.355 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.609 ' HD3' HD21 ' A' ' 84' ' ' LEU . 64.6 mttp -78.69 127.7 32.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.274 0.629 . . . . 52.32 109.474 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.422 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.45 150.68 40.89 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.364 1.066 . . . . 64.099999999999994 110.351 -171.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -100.99 118.86 37.83 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.056 0.543 . . . . 75.420000000000002 109.939 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.54 HG13 ' HB1' ' A' ' 119' ' ' ALA . 56.5 t -84.97 118.22 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.617 0.722 . . . . 71.209999999999994 109.862 172.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.63 HD12 ' HG3' ' A' ' 120' ' ' GLU . 18.9 mt -85.37 -13.99 47.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.142 1.377 . . . . 72.409999999999997 110.889 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.25 4.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.491 -1.043 . . . . 64.450000000000003 110.491 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.702 ' H ' ' HB3' ' A' ' 22' ' ' PHE . 62.3 m-85 -88.71 173.28 8.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.543 0.687 . . . . 73.540000000000006 110.625 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -78.36 -179.53 6.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.663 -1.153 . . . . 74.310000000000002 110.844 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -45.72 -41.47 10.66 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.167 1.387 . . . . 71.25 113.766 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.478 ' HA ' HD11 ' A' ' 23' ' ' ILE . 31.4 p-10 -114.24 12.07 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.612 0.968 . . . . 73.420000000000002 113.612 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.56 10.63 85.71 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 116.249 1.26 . . . . 74.109999999999999 116.249 168.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.85 -42.21 28.08 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.987 0.894 . . . . 71.329999999999998 111.655 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 21.1 m95 -119.66 157.38 28.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.707 0.803 . . . . 74.219999999999999 110.36 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.54 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.24 145.69 47.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.662 0.785 . . . . 72.329999999999998 110.361 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.63 ' HG3' HD12 ' A' ' 110' ' ' LEU . 13.2 tp10 -79.22 113.55 17.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.578 -1.638 . . . . 64.049999999999997 106.578 164.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -134.08 140.35 46.57 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.08 0.466 . . . . 63.030000000000001 111.233 -171.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -104.11 106.57 17.12 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.363 1.065 . . . . 63.240000000000002 108.705 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.667 HG21 HG22 ' A' ' 101' ' ' ILE . 50.8 p -97.98 175.1 6.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.2 1.0 . . . . 64.010000000000005 109.482 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -65.15 -22.72 66.96 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.84 -0.429 . . . . 74.040000000000006 109.84 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.32 -21.16 56.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.514 1.126 . . . . 74.409999999999997 111.802 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.07 -139.89 9.3 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.311 0.505 . . . . 52.43 113.589 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -130.37 127.86 40.24 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.982 0.913 . . . . 72.439999999999998 109.898 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 169.37 -173.18 43.71 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 123.256 0.347 . . . . 64.109999999999999 112.723 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.519 ' CH2' ' HB3' ' A' ' 250' ' ' ASN . 91.3 m95 -85.56 126.86 34.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.321 0.648 . . . . 74.319999999999993 112.339 -172.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -133.84 144.07 50.2 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.097 0.959 . . . . 73.310000000000002 108.618 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 2.2 Cg_endo -83.04 142.64 11.09 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.532 2.154 . . . . 72.420000000000002 114.385 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.471 ' HB3' ' CE2' ' A' ' 112' ' ' TYR . 69.2 p -40.92 -44.57 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.867 1.667 . . . . 75.329999999999998 113.707 167.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.627 ' HB2' ' HG2' ' A' ' 242' ' ' PRO . 27.8 p30 -77.94 -6.59 54.87 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.243 -0.89 . . . . 63.439999999999998 112.558 -172.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.576 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 30.2 m-85 -103.58 -10.0 18.8 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.371 0.668 . . . . 70.329999999999998 111.719 170.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.9 pt -126.32 178.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 124.099 0.959 . . . . 64.319999999999993 110.812 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.2 t -160.96 149.99 13.57 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.125 0.97 . . . . 65.420000000000002 108.71 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.557 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 24.3 Cg_endo -61.51 150.07 86.88 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.801 1.667 . . . . 64.129999999999995 111.548 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.1 t -71.32 -15.95 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 CA-C-O 120.955 0.407 . . . . 73.219999999999999 110.598 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -76.28 -17.94 59.22 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.449 0.699 . . . . 74.439999999999998 112.326 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.557 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 59.9 p -71.53 163.75 27.15 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.632 0.729 . . . . 61.5 112.648 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.41 -23.43 40.37 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.241 -0.891 . . . . 74.230000000000004 109.261 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.88 -15.48 63.09 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.607 1.163 . . . . 73.519999999999996 112.678 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -66.72 -24.08 66.19 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.919 0.39 . . . . 71.010000000000005 111.187 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -79.09 134.8 36.73 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.375 0.67 . . . . 72.129999999999995 109.788 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.7 p -59.12 -43.8 91.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.514 1.134 . . . . 52.020000000000003 111.745 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -62.88 -39.05 93.27 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.059 0.85 . . . . 44.43 112.467 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -77.76 110.83 12.97 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.128 -0.693 . . . . 75.409999999999997 109.128 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -107.03 -6.68 17.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.196 0.598 . . . . 73.140000000000001 111.155 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.57 -133.08 25.26 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.639 -1.09 . . . . 61.109999999999999 113.041 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.34 100.65 0.22 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.941 2.427 . . . . 74.010000000000005 112.006 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 55.9 t -138.71 131.74 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.747 1.219 . . . . 71.209999999999994 108.912 -175.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.3 p -84.7 171.57 12.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 62.329999999999998 109.987 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -62.07 -43.81 98.04 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 118.95 -0.548 . . . . 60.030000000000001 111.069 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -54.22 -43.44 70.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.731 0.645 . . . . 75.340000000000003 110.938 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.403 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -67.93 -38.45 82.88 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.282 -0.872 . . . . 74.340000000000003 111.155 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.3 -42.45 88.32 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.588 0.755 . . . . 63.329999999999998 111.732 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 67.5 mm-40 -59.85 -46.57 88.86 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.669 0.787 . . . . 74.439999999999998 109.421 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.536 ' HE1' ' HD2' ' A' ' 239' ' ' ARG . 42.3 t80 -62.01 -46.26 89.98 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.308 -1.314 . . . . 73.409999999999997 111.932 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.03 -40.33 84.71 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.912 0.885 . . . . 61.140000000000001 111.142 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.73 18.01 13.89 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.747 -0.661 . . . . 73.549999999999997 112.367 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 96.8 p -63.84 -41.23 97.87 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.083 0.856 . . . . 75.239999999999995 111.167 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 p -100.7 13.32 35.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.439 0.696 . . . . 62.340000000000003 111.299 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 151.87 41.69 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 123.117 0.26 . . . . 75.230000000000004 113.223 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.6 pt -101.96 -175.39 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.968 0.907 . . . . 75.530000000000001 110.898 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -52.7 122.2 8.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.63 0.772 . . . . 72.239999999999995 110.414 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.441 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 88.4 10.25 68.38 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.019 -0.879 . . . . 62.219999999999999 113.528 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 61.7 m -83.76 115.68 22.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.221 1.011 . . . . 54.030000000000001 111.282 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.459 ' HB3' HD13 ' A' ' 184' ' ' LEU . 11.1 p90 -130.22 167.08 19.0 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.202 0.525 . . . . 75.230000000000004 112.083 -170.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.27 146.79 24.06 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.717 -1.129 . . . . 74.340000000000003 108.609 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 182' ' ' ILE . 78.3 t -107.65 135.56 45.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.152 -1.055 . . . . 73.230000000000004 108.152 171.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.523 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 19.8 ptt85 -134.62 160.22 38.79 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.273 1.029 . . . . 75.430000000000007 109.811 -175.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -117.56 155.35 29.95 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.163 -1.051 . . . . 74.400000000000006 108.163 164.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -80.11 125.75 30.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.14 -0.689 . . . . 40.439999999999998 109.14 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.12 -39.77 65.48 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.339 0.656 . . . . 74.120000000000005 109.619 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.9 p -75.07 -13.29 60.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.41 0.684 . . . . 73.540000000000006 111.74 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 35.3 m -141.72 80.55 15.77 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.511 0.724 . . . . 71.5 109.502 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -59.42 131.26 39.69 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.867 2.378 . . . . 72.319999999999993 112.292 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.45 -29.24 10.77 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.855 -0.611 . . . . 72.430000000000007 112.24 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -80.93 115.89 20.63 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.076 -0.713 . . . . 64.439999999999998 109.076 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -116.26 150.09 38.15 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.55 0.691 . . . . 71.400000000000006 111.077 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.9 m -150.08 153.66 36.8 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.583 -1.19 . . . . 72.010000000000005 109.886 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.605 HG12 HG22 ' A' ' 170' ' ' VAL . 30.0 mt -110.78 149.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.486 -0.931 . . . . 54.32 108.486 172.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 36.3 m -123.11 108.28 12.69 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.666 -1.235 . . . . 73.420000000000002 107.666 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.475 HD23 ' OH ' ' A' ' 193' ' ' TYR . 70.0 tp -106.78 128.04 53.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.915 0.486 . . . . 54.210000000000001 110.069 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -102.36 129.17 48.75 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.098 0.959 . . . . 65.010000000000005 109.085 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -150.17 131.32 14.45 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.602 1.561 . . . . 71.209999999999994 107.174 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 63.72 23.99 13.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.087 0.955 . . . . 70.120000000000005 111.736 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.04 81.04 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.012 0.365 . . . . 51.119999999999997 114.012 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -105.77 128.27 53.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.929 0.892 . . . . 62.009999999999998 109.432 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.2 t -93.63 111.99 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.195 0.598 . . . . 64.310000000000002 110.465 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -96.53 147.81 23.47 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.725 1.21 . . . . 73.540000000000006 109.589 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -121.86 117.48 26.61 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.305 0.574 . . . . 74.209999999999994 110.445 -171.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 9.1 m-30 -96.07 148.21 22.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.76 1.224 . . . . 54.409999999999997 109.42 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.98 117.58 34.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.696 -0.854 . . . . 73.439999999999998 108.696 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 mt -84.08 100.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 N-CA-C 107.304 -1.369 . . . . 63.450000000000003 107.304 172.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -82.95 131.44 35.19 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.077 0.951 . . . . 71.5 108.769 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.7 m -97.33 121.76 39.59 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.767 -0.827 . . . . 62.240000000000002 108.767 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.71 174.31 8.56 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.277 0.631 . . . . 61.32 110.705 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.2 p -62.83 -32.68 73.94 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.655 0.782 . . . . 75.010000000000005 111.737 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.85 -14.9 27.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.742 0.817 . . . . 74.519999999999996 110.891 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.93 13.69 13.42 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 118.983 -0.898 . . . . 72.409999999999997 114.252 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.16 125.69 27.5 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.039 0.92 . . . . 71.420000000000002 110.798 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -84.87 141.16 30.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.51 -0.922 . . . . 60.119999999999997 108.51 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.55 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 31.4 p90 -165.55 137.5 4.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.325 0.391 . . . . 63.109999999999999 111.506 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.475 HG23 HD11 ' A' ' 217' ' ' LEU . 73.1 t -84.19 -36.72 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.573 -0.899 . . . . 51.210000000000001 108.573 163.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.5 m -100.99 127.44 47.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.859 -1.064 . . . . 62.32 109.962 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.2 t -63.67 -22.59 66.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.235 1.014 . . . . 74.140000000000001 111.909 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -82.87 -29.15 29.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.723 1.209 . . . . 73.340000000000003 110.859 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.6 m -126.33 99.02 5.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.33 0.652 . . . . 71.209999999999994 110.531 -175.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 93.6 mtt180 -97.34 133.46 41.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.871 0.868 . . . . 61.520000000000003 109.592 174.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.69 151.49 38.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.684 0.793 . . . . 65.219999999999999 109.327 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -73.09 -42.76 62.65 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.917 -0.401 . . . . 72.409999999999997 109.917 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 44.0 p -118.7 159.05 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.741 0.781 . . . . 75.239999999999995 112.248 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.06 -27.71 68.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.462 -1.245 . . . . 62.329999999999998 109.847 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.88 95.83 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.51 0.724 . . . . 71.219999999999999 110.629 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.11 -39.92 75.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.879 0.871 . . . . 72.109999999999999 110.865 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.475 HD11 HG23 ' A' ' 205' ' ' VAL . 15.3 tp -55.38 -56.07 24.29 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.848 0.718 . . . . 73.430000000000007 111.23 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.1 -42.35 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 123.797 0.686 . . . . 73.209999999999994 111.001 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.84 -55.57 30.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.016 0.823 . . . . 63.25 111.339 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -68.29 -34.77 76.77 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.41 -0.814 . . . . 62.25 111.214 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.61 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.8 m170 -87.64 -9.56 53.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.812 0.445 . . . . 64.409999999999997 112.083 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 90.7 p -90.51 -33.72 15.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.947 0.499 . . . . 71.120000000000005 110.231 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.1 p -72.98 -49.51 28.59 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.717 -0.674 . . . . 71.120000000000005 111.169 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.557 HG23 ' HB2' ' A' ' 226' ' ' ASP . 35.5 m -123.77 159.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.833 0.825 . . . . 61.32 112.459 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.15 16.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 128.205 2.602 . . . . 64.230000000000004 115.246 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.557 ' HB2' HG23 ' A' ' 224' ' ' VAL . 32.6 t70 -40.02 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 131.676 3.99 . . . . 61.539999999999999 119.852 -150.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.06 -3.22 10.68 Favored Glycine 0 N--CA 1.469 0.898 0 O-C-N 118.985 -2.322 . . . . 63.5 112.042 -165.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.1 mt -90.13 163.64 14.77 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.93 1.692 . . . . 74.310000000000002 109.231 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.76 -38.91 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 120.756 0.313 . . . . 71.540000000000006 110.881 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -158.02 -178.0 6.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.099 0.959 . . . . 71.310000000000002 109.938 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.5 p -67.41 144.01 55.99 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.588 0.755 . . . . 71.430000000000007 112.183 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 184' ' ' LEU . 76.8 mt -75.4 90.21 2.67 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 107.565 -1.272 . . . . 63.049999999999997 107.565 169.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -121.71 9.35 10.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.054 -1.029 . . . . 65.310000000000002 113.673 -158.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 167' ' ' SER . 20.2 t80 -159.17 122.95 2.07 Favored Pre-proline 0 C--O 1.22 -0.493 0 N-CA-C 106.957 -1.497 . . . . 74.140000000000001 106.957 174.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.2 139.3 6.06 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 122.214 1.942 . . . . 75.340000000000003 112.592 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -75.46 124.8 89.16 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.181 -1.044 . . . . 13.1 108.181 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.13 -176.98 3.34 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.321 2.014 . . . . 72.439999999999998 113.218 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.405 ' HE3' HD22 ' A' ' 88' ' ' LEU . 73.1 mmtt -76.85 118.74 19.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.034 -0.985 . . . . 73.430000000000007 109.318 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.551 ' HG3' ' N ' ' A' ' 240' ' ' ASN . 6.3 ptt180 -76.53 -53.65 7.79 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.591 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.551 ' N ' ' HG3' ' A' ' 239' ' ' ARG . 10.5 t30 -108.72 122.54 47.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.778 1.029 . . . . 62.340000000000003 113.778 -158.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 89' ' ' TYR . 97.2 mttt -79.8 113.46 37.88 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.183 -1.414 . . . . 54.329999999999998 107.183 159.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.627 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 25.5 Cg_exo -68.84 153.36 73.01 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.789 2.326 . . . . 62.399999999999999 113.601 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 24.5 m -73.44 139.94 46.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.725 -0.671 . . . . 74.319999999999993 110.993 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 52.0 t -95.65 113.51 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.99 -1.115 . . . . 62.049999999999997 107.99 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 247' ' ' VAL . 7.9 m-85 -102.94 110.85 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 119.256 -0.402 . . . . 34.439999999999998 110.414 -173.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.47 25.11 48.82 Favored Glycine 0 N--CA 1.477 1.373 0 N-CA-C 118.078 1.991 . . . . 73.319999999999993 118.078 160.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 245' ' ' TYR . 33.7 m -101.1 134.04 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 119.065 1.433 . . . . 43.020000000000003 113.421 -172.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -83.38 118.35 71.31 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 103.508 -2.775 . . . . 65.540000000000006 103.508 142.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.64 -59.5 0.83 Allowed 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 121.501 1.467 . . . . 63.109999999999999 113.753 -152.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.519 ' HB3' ' CH2' ' A' ' 129' ' ' TRP . 10.2 t30 -129.89 -19.99 3.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.016 0.526 . . . . 60.299999999999997 109.8 151.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -72.9 98.83 2.54 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.977 -0.556 . . . . 74.430000000000007 110.984 -154.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -123.01 -48.95 1.98 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.361 1.064 . . . . 73.400000000000006 108.933 162.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -111.8 -14.99 13.48 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 114.262 -1.336 . . . . 63.240000000000002 110.735 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -56.89 153.35 11.15 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.685 0.794 . . . . 72.510000000000005 110.342 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 7.7 pt-20 . . . . . 0 CA--C 1.56 1.338 0 CA-C-O 117.638 -1.173 . . . . 72.329999999999998 110.288 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 110.107 -0.331 . . . . 74.209999999999994 110.107 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.54 33.94 0.02 OUTLIER Glycine 0 C--N 1.345 1.076 0 CA-C-N 116.409 -0.36 . . . . 44.439999999999998 112.529 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -159.03 132.88 7.52 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.317 0.647 . . . . 73.019999999999996 109.883 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -107.92 106.63 58.97 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.026 0.931 . . . . 72.230000000000004 109.506 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.2 77.93 1.95 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.573 2.182 . . . . 74.129999999999995 111.45 169.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.67 -21.69 79.47 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.508 -0.769 . . . . 61.100000000000001 113.459 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -79.44 3.44 18.5 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.617 0.767 . . . . 75.120000000000005 111.092 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.41 96.78 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 N-CA-C 109.495 -0.557 . . . . 74.310000000000002 109.495 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.59 82.07 7.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.387 0.675 . . . . 71.319999999999993 110.199 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.87 -175.5 35.67 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.976 -0.556 . . . . 64.019999999999996 112.056 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -103.06 142.91 33.3 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.587 0.355 . . . . 72.230000000000004 110.315 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -135.97 21.64 3.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.108 0.963 . . . . 61.350000000000001 110.63 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -70.9 166.5 21.02 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.858 0.463 . . . . 72.310000000000002 109.937 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 59.84 74.86 0.53 Allowed Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.045 0.938 . . . . 75.239999999999995 109.203 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.13 160.07 48.3 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.35 2.033 . . . . 70.329999999999998 112.152 -172.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.1 m -76.08 138.83 41.06 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.371 0.669 . . . . 71.150000000000006 109.901 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 pp -81.54 153.91 71.06 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.038 0.535 . . . . 75.010000000000005 110.251 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.16 162.6 28.56 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.032 1.821 . . . . 64.129999999999995 112.582 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.05 160.26 14.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.793 0.837 . . . . 62.149999999999999 109.665 172.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.57 124.0 48.84 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 109.045 -0.724 . . . . 65.049999999999997 109.045 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -95.26 143.13 26.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.106 0.562 . . . . 63.340000000000003 110.342 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -91.23 154.44 19.28 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.82 0.848 . . . . 74.519999999999996 109.845 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 tt -63.98 146.35 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 124.447 1.099 . . . . 72.340000000000003 112.201 -175.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -125.96 91.97 3.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.918 1.287 . . . . 72.209999999999994 109.262 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.64 -0.09 73.08 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.831 -0.622 . . . . 43.530000000000001 113.781 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.0 102.57 11.04 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 117.727 0.764 . . . . 64.319999999999993 110.37 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.73 149.86 19.75 Favored Glycine 0 C--N 1.348 1.25 0 O-C-N 123.624 0.577 . . . . 44.240000000000002 112.59 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 11.5 mmpt? -91.55 169.93 10.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.471 1.108 . . . . 65.019999999999996 111.244 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -107.74 -76.92 0.6 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.977 0.511 . . . . 62.130000000000003 110.429 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.79 85.96 1.24 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.724 0.81 . . . . 75.310000000000002 109.78 -175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.3 p -169.68 32.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.055 1.742 . . . . 74.120000000000005 106.995 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.6 m -101.96 169.86 8.5 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 113.865 -1.516 . . . . 64.099999999999994 112.343 -164.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.501 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -163.38 160.63 23.8 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.347 -0.842 . . . . 74.310000000000002 109.41 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -96.46 132.85 41.6 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.147 -0.686 . . . . 70.409999999999997 109.147 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.19 -36.64 1.77 Allowed Glycine 0 C--N 1.344 0.987 0 O-C-N 123.886 0.741 . . . . 33.530000000000001 112.091 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.69 135.16 2.53 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 118.461 -1.188 . . . . 74.319999999999993 111.468 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.56 124.5 12.92 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.145 2.563 . . . . 73.430000000000007 112.806 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -117.56 140.98 48.9 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.973 0.909 . . . . 72.329999999999998 110.028 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.9 m -84.28 -178.52 6.96 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.083 0.953 . . . . 72.319999999999993 111.158 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 85.65 156.98 0.09 Allowed 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 126.527 1.931 . . . . 73.420000000000002 111.09 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.584 HG12 HD22 ' A' ' 250' ' ' ASN . 23.4 m -130.93 141.95 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.13 0.972 . . . . 71.239999999999995 110.177 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -127.69 -166.77 1.66 Allowed 'General case' 0 C--O 1.246 0.876 0 C-N-CA 124.688 1.195 . . . . 62.43 108.443 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -167.13 139.93 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.164 0.585 . . . . 62.210000000000001 110.578 172.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -164.25 167.78 19.57 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.611 1.164 . . . . 74.010000000000005 109.745 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -128.35 131.54 48.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.79 0.836 . . . . 73.099999999999994 108.79 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.67 -77.73 0.59 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.128 -1.064 . . . . 63.009999999999998 108.128 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.73 -175.78 0.95 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.602 0.761 . . . . 55.520000000000003 110.661 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.65 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 1.1 pt? -146.26 -175.9 4.95 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.476 1.11 . . . . 62.200000000000003 110.236 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 71.99 142.49 0.06 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.273 1.429 . . . . 73.010000000000005 112.342 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.1 mmt-85 -130.96 143.12 48.12 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.161 0.985 . . . . 75.420000000000002 108.777 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.73 110.46 1.28 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.701 2.267 . . . . 74.209999999999994 111.477 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.3 p -88.33 125.37 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 109.261 -0.644 . . . . 43.210000000000001 109.261 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.25 155.44 28.56 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.197 0.599 . . . . 70.040000000000006 110.303 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.3 p -64.54 -30.18 71.21 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.008 0.818 . . . . 72.140000000000001 109.473 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.83 81.17 4.26 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.178 -0.919 . . . . 73.150000000000006 109.537 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -151.48 159.2 44.28 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.251 1.02 . . . . 74.209999999999994 108.614 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.7 109.87 3.38 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.859 0.864 . . . . 73.310000000000002 108.904 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.2 -32.7 97.53 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.181 2.587 . . . . 73.420000000000002 113.918 -171.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.457 HE22 ' HA ' ' A' ' 159' ' ' LEU . 24.8 tp60 -90.31 -38.52 13.32 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.4 0.68 . . . . 65.420000000000002 110.949 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.56 45.47 22.93 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.02 -1.232 . . . . 61.25 110.02 -163.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.96 136.82 58.2 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.332 1.053 . . . . 62.020000000000003 111.337 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -127.61 175.38 8.31 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.72 0.808 . . . . 73.120000000000005 110.508 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 30.62 0.71 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.86 1.264 . . . . 54.039999999999999 111.82 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.85 10.69 0.65 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.283 1.033 . . . . 73.519999999999996 113.366 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.56 -18.55 64.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.249 1.02 . . . . 65.319999999999993 111.904 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -95.71 125.73 40.49 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.339 0.656 . . . . 70.019999999999996 109.684 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.405 ' NE1' ' HB2' ' A' ' 69' ' ' SER . 11.7 t90 -142.4 86.41 1.96 Allowed 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.007 -0.738 . . . . 74.540000000000006 109.007 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.434 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 24.1 p-10 -84.2 -8.97 58.9 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.718 -0.674 . . . . 53.399999999999999 110.868 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.445 ' HB3' ' HD1' ' A' ' 144' ' ' HIS . 23.8 m -61.17 -4.3 1.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.778 1.399 . . . . 72.430000000000007 114.778 -165.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.51 -34.36 69.0 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.45 0.7 . . . . 62.350000000000001 111.145 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 12.7 pt-20 -65.32 -46.59 79.72 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.444 0.698 . . . . 73.25 110.589 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.04 -5.34 59.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.147 0.979 . . . . 71.219999999999999 111.014 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 tp -76.22 -49.68 16.5 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.429 1.091 . . . . 63.130000000000003 109.111 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.5 mt -104.45 36.7 2.31 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.229 -0.896 . . . . 71.230000000000004 109.529 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.63 92.02 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.412 1.085 . . . . 51.210000000000001 112.677 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.3 -140.37 35.49 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 119.123 -0.821 . . . . 63.409999999999997 111.989 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -67.95 120.09 7.09 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.095 1.863 . . . . 65.140000000000001 109.843 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 m -120.54 157.23 29.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.426 0.69 . . . . 71.030000000000001 111.404 -172.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -65.74 -25.43 67.28 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.421 1.088 . . . . 63.130000000000003 108.687 167.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.32 39.49 0.15 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.03 2.132 . . . . 75.510000000000005 113.018 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -42.59 151.99 0.36 Allowed Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 126.592 1.957 . . . . 64.0 113.523 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -51.96 -25.71 22.79 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.953 3.102 . . . . 63.509999999999998 115.753 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -75.54 -21.63 57.77 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.158 0.504 . . . . 71.400000000000006 110.607 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.402 ' HB2' ' NH2' ' A' ' 108' ' ' ARG . 26.1 tp -79.67 127.54 32.3 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.714 -0.847 . . . . 61.210000000000001 108.714 165.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.4 174.9 5.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.028 1.331 . . . . 71.5 109.165 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.12 135.12 32.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.726 0.81 . . . . 63.350000000000001 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.07 5.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.967 0.907 . . . . 22.199999999999999 110.373 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.9 -30.71 64.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.688 0.795 . . . . 73.310000000000002 110.735 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 45.0 m-85 -123.91 141.23 52.22 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.922 -1.036 . . . . 73.409999999999997 109.019 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -73.53 146.89 44.49 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.14 0.576 . . . . 64.340000000000003 109.524 168.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.421 ' HE2' ' HB ' ' A' ' 98' ' ' THR . 86.1 t80 -154.14 107.66 2.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.278 0.631 . . . . 74.530000000000001 109.361 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.49 137.03 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.111 -1.07 . . . . 62.219999999999999 108.111 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 115.53 10.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.035 0.534 . . . . 75.420000000000002 110.528 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.1 p -88.63 -25.5 22.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.288 0.635 . . . . 71.420000000000002 109.654 171.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.19 157.84 15.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-N 115.227 -0.897 . . . . 72.5 111.242 173.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 255' ' ' GLU . 4.2 m-20 -69.1 -34.69 75.49 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.722 0.809 . . . . 51.039999999999999 109.735 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -76.51 -26.91 55.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.356 -1.293 . . . . 74.0 112.3 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.421 ' HB ' ' HE2' ' A' ' 91' ' ' PHE . 67.0 p -82.77 155.36 24.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.425 -0.583 . . . . 55.329999999999998 109.425 173.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.548 ' HB3' HG13 ' A' ' 130' ' ' VAL . 67.2 tp -113.65 136.21 53.08 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.9 0.48 . . . . 71.239999999999995 111.741 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.7 m -74.55 117.09 15.97 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.794 0.837 . . . . 53.039999999999999 110.482 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.653 HG22 HG21 ' A' ' 123' ' ' THR . 22.0 pt -124.53 147.22 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.714 0.805 . . . . 74.439999999999998 111.343 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 57.5 m -89.88 145.65 24.99 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.262 1.025 . . . . 74.420000000000002 109.474 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -62.08 114.34 3.35 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.985 0.514 . . . . 72.030000000000001 109.749 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 7.05 61.68 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 119.648 -0.529 . . . . 61.539999999999999 113.457 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 88.4 tt0 -83.85 135.09 34.64 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.437 0.618 . . . . 55.240000000000002 110.371 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -85.02 138.59 32.35 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.225 0.61 . . . . 74.420000000000002 109.617 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.61 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.3 OUTLIER -147.6 135.11 20.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.238 1.015 . . . . 62.310000000000002 109.935 -174.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.402 ' NH2' ' HB2' ' A' ' 84' ' ' LEU . 53.0 ttm-85 -99.15 115.9 30.12 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 122.306 -0.246 . . . . 73.450000000000003 110.624 -172.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.628 HG13 ' HB1' ' A' ' 119' ' ' ALA . 74.0 t -76.36 122.97 31.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.8 0.687 . . . . 64.209999999999994 110.39 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 122' ' ' GLN . 20.9 mt -90.81 -36.96 13.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.927 1.291 . . . . 75.140000000000001 109.448 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.46 148.77 9.66 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.421 -0.809 . . . . 72.450000000000003 112.373 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 22.0 m-85 -95.37 156.92 16.12 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 73.120000000000005 110.839 176.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -70.83 -178.39 1.87 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.434 -0.803 . . . . 72.420000000000002 110.791 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -55.29 -27.72 48.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.959 1.096 . . . . 64.299999999999997 113.959 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.02 -2.69 15.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.144 0.578 . . . . 74.319999999999993 112.436 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 76.63 20.98 75.85 Favored Glycine 0 C--N 1.349 1.305 0 N-CA-C 114.478 0.551 . . . . 51.100000000000001 114.478 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.49 -61.42 1.72 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 117.381 0.591 . . . . 72.310000000000002 110.152 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -92.3 145.48 24.45 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.735 0.414 . . . . 63.100000000000001 110.896 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -130.66 139.19 50.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.667 1.187 . . . . 62.109999999999999 110.679 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.2 98.75 5.97 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 107.779 -1.193 . . . . 72.230000000000004 107.779 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -105.46 134.8 47.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.678 0.791 . . . . 40.149999999999999 109.694 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.448 ' HG3' HD11 ' A' ' 110' ' ' LEU . 90.2 mt-30 -93.59 113.14 25.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.945 -0.761 . . . . 71.129999999999995 108.945 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.653 HG21 HG22 ' A' ' 101' ' ' ILE . 57.4 p -98.22 179.5 4.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.144 0.978 . . . . 75.329999999999998 110.589 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -72.51 -18.76 61.63 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.908 -1.042 . . . . 72.340000000000003 110.005 170.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -80.38 -12.5 59.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.384 1.073 . . . . 73.030000000000001 111.278 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.72 -172.75 14.48 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.618 -0.193 . . . . 63.109999999999999 112.618 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -85.67 136.29 33.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.255 0.622 . . . . 74.239999999999995 110.756 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -173.38 -177.77 42.86 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.99 -0.55 . . . . 72.219999999999999 112.49 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -107.2 125.21 50.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.837 0.455 . . . . 71.420000000000002 111.58 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.595 HG23 HD13 ' A' ' 135' ' ' ILE . 26.8 m -138.6 148.9 60.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 125.129 1.372 . . . . 75.030000000000001 109.461 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -95.0 151.91 1.71 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.956 2.437 . . . . 63.32 115.538 -170.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.1 m -41.54 -38.5 1.34 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.424 1.89 . . . . 74.219999999999999 115.133 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -71.78 -13.37 61.68 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 122.113 -0.367 . . . . 52.450000000000003 111.175 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.433 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 15.5 m-85 -104.08 -25.26 13.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.007 0.923 . . . . 70.400000000000006 112.363 170.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.595 HD13 HG23 ' A' ' 130' ' ' VAL . 32.7 pt -128.21 144.95 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 118.669 0.668 . . . . 74.329999999999998 112.486 -173.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -137.5 148.57 62.11 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 108.866 -0.79 . . . . 54.399999999999999 108.866 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.25 141.2 88.55 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.532 2.155 . . . . 72.439999999999998 110.948 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.05 -3.26 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.425 0 CA-C-O 121.056 0.455 . . . . 73.329999999999998 111.355 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.425 HD22 ' N ' ' A' ' 139' ' ' ASN . 0.9 OUTLIER -90.77 -8.54 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.379 0.672 . . . . 72.140000000000001 112.11 174.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.7 p -75.97 -177.27 3.8 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.155 0.582 . . . . 72.430000000000007 111.901 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.7 mt -86.85 -30.93 21.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.828 0.451 . . . . 64.519999999999996 110.082 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -64.34 -23.83 67.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.403 1.081 . . . . 75.430000000000007 111.8 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -6.17 9.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.911 0.884 . . . . 64.140000000000001 112.425 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.445 ' HD1' ' HB3' ' A' ' 69' ' ' SER . 85.1 m-70 -97.21 155.47 16.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.887 0.875 . . . . 74.140000000000001 110.585 171.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.5 p -66.99 -41.51 86.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.501 1.12 . . . . 73.239999999999995 111.745 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -66.04 -41.67 90.56 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.113 0.783 . . . . 74.140000000000001 113.113 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 26.4 t80 -78.06 112.55 15.11 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.955 -0.387 . . . . 73.430000000000007 109.955 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.456 ' HB2' HG21 ' A' ' 151' ' ' VAL . 30.6 m170 -104.41 -5.29 21.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.376 0.51 . . . . 34.340000000000003 112.376 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.34 -141.73 30.37 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 118.506 -1.163 . . . . 73.310000000000002 112.673 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.59 94.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.596 2.864 . . . . 64.310000000000002 112.919 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.8 t -138.53 137.09 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.916 1.286 . . . . 61.310000000000002 109.702 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.4 p -89.4 176.26 6.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.394 1.078 . . . . 65.530000000000001 110.882 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -60.1 -49.29 78.21 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.984 0.513 . . . . 73.430000000000007 110.122 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -59.56 -41.56 90.43 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.194 0.934 . . . . 73.120000000000005 111.192 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -65.84 -44.82 84.36 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.307 -0.86 . . . . 63.25 111.522 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.56 89.63 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.56 -0.745 . . . . 75.310000000000002 111.123 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -80.68 -21.6 41.16 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.47 -0.786 . . . . 63.450000000000003 111.977 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -78.23 -25.63 47.03 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.992 0.814 . . . . 70.230000000000004 110.388 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 239' ' ' ARG . 62.2 mt -70.74 -42.48 70.45 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.518 0.675 . . . . 72.549999999999997 110.484 169.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 66.9 mt -94.37 22.44 6.05 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.757 -1.11 . . . . 75.430000000000007 111.388 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 99.1 p -74.06 -43.8 56.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.148 0.499 . . . . 71.540000000000006 110.164 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.7 p -112.05 19.56 17.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.633 0.773 . . . . 64.430000000000007 110.464 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.96 149.8 48.2 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.98 -0.555 . . . . 74.230000000000004 111.724 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.7 pt -87.35 169.82 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-O 121.166 0.508 . . . . 74.519999999999996 110.527 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -70.96 109.25 4.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.077 -0.511 . . . . 75.219999999999999 109.632 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.87 10.07 19.42 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.087 0.851 . . . . 72.349999999999994 112.863 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.0 m -86.22 131.99 34.11 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.089 0.944 . . . . 62.409999999999997 110.583 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 183' ' ' SER . 8.6 p90 -139.29 166.95 23.18 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.385 0.539 . . . . 74.439999999999998 111.569 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -162.62 147.63 12.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.916 -1.038 . . . . 72.310000000000002 108.483 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 182' ' ' ILE . 99.2 t -105.32 124.53 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.56 -1.274 . . . . 62.240000000000002 107.56 169.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.685 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 44.7 ptt85 -114.68 159.99 19.86 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.456 1.102 . . . . 65.319999999999993 108.663 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.65 141.79 47.73 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.757 -1.201 . . . . 62.149999999999999 107.757 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.0 t -83.51 130.73 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.26 0.624 . . . . 71.230000000000004 110.003 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.05 -33.01 33.79 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.718 0.636 . . . . 74.430000000000007 109.973 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.8 p -72.45 -31.81 65.76 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.494 -0.775 . . . . 55.119999999999997 110.955 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.6 m -121.8 95.1 48.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.476 0.71 . . . . 64.010000000000005 109.293 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.57 114.44 2.54 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.39 2.727 . . . . 55.509999999999998 113.31 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.16 -15.15 61.83 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.755 -0.657 . . . . 75.219999999999999 112.964 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -79.16 116.6 19.53 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.505 0.653 . . . . 72.439999999999998 109.975 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -110.22 144.65 38.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.477 0.656 . . . . 72.140000000000001 110.46 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.6 m -138.43 150.67 46.71 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.834 0.854 . . . . 74.409999999999997 109.043 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.707 HG12 HG22 ' A' ' 170' ' ' VAL . 22.3 mt -101.87 150.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.54 -1.282 . . . . 74.340000000000003 107.54 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -124.87 108.24 11.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.778 -1.193 . . . . 73.400000000000006 107.778 168.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.425 HD23 ' OH ' ' A' ' 193' ' ' TYR . 56.7 tp -107.49 111.12 23.26 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.325 -0.62 . . . . 73.430000000000007 109.325 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.454 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -79.55 122.37 26.4 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.521 -0.548 . . . . 72.010000000000005 109.521 168.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -149.92 145.25 26.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.848 1.659 . . . . 73.040000000000006 107.458 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 59.45 21.79 10.23 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 124.255 1.022 . . . . 62.420000000000002 111.557 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.47 -7.15 62.11 Favored Glycine 0 C--N 1.358 1.765 0 CA-C-N 116.176 -0.465 . . . . 75.030000000000001 113.956 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -104.49 138.64 40.56 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.196 0.999 . . . . 71.299999999999997 108.581 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.33 103.81 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.397 0.544 . . . . 73.310000000000002 110.395 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.26 115.47 27.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.885 0.874 . . . . 74.530000000000001 109.65 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.63 118.25 30.84 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.194 0.598 . . . . 73.439999999999998 110.371 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 11.1 m-85 -94.33 148.49 22.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.447 1.099 . . . . 72.239999999999995 109.532 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -107.02 112.93 26.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 74.310000000000002 108.727 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.18 101.49 8.82 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 N-CA-C 108.8 -0.815 . . . . 40.229999999999997 108.8 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -80.79 121.81 26.39 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.662 -1.154 . . . . 52.450000000000003 108.931 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.2 m -93.39 113.88 26.15 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.917 0.887 . . . . 32.149999999999999 108.78 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.25 167.32 14.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.7 0.8 . . . . 74.019999999999996 110.799 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.9 p -62.45 -24.69 67.57 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.881 0.872 . . . . 74.049999999999997 112.195 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -96.87 -16.66 20.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.62 0.768 . . . . 74.230000000000004 111.516 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.87 9.94 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.217 -0.768 . . . . 70.409999999999997 114.81 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.72 124.71 26.54 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.32 1.06 . . . . 70.040000000000006 110.551 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -88.26 140.88 29.03 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.846 -0.798 . . . . 74.340000000000003 108.846 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.585 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 44.8 p90 -162.63 135.59 5.8 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.769 0.668 . . . . 75.400000000000006 110.516 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.504 HG23 HD11 ' A' ' 217' ' ' LEU . 53.9 t -70.81 -53.28 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.902 -0.777 . . . . 73.409999999999997 108.902 165.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.3 m -107.06 136.15 47.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.629 -1.168 . . . . 74.439999999999998 109.744 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.8 t -60.4 -26.59 66.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.45 1.1 . . . . 71.230000000000004 112.942 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.39 -23.3 61.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.747 0.819 . . . . 73.409999999999997 111.479 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.2 m -134.4 101.17 4.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.182 0.593 . . . . 71.310000000000002 110.364 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.585 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.1 mtm180 -110.07 138.07 46.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.162 0.985 . . . . 72.430000000000007 110.197 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.87 149.22 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.623 -0.88 . . . . 71.120000000000005 108.623 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -68.66 -31.96 71.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 72.319999999999993 110.76 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -132.1 157.36 44.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 112.074 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -27.55 69.03 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.731 -1.122 . . . . 74.019999999999996 109.506 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.99 -45.44 86.79 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.553 0.741 . . . . 71.040000000000006 110.898 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.6 -34.83 72.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.527 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 205' ' ' VAL . 16.0 tp -56.98 -58.64 7.27 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.752 0.421 . . . . 64.239999999999995 110.873 174.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.22 -40.65 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.246 0.618 . . . . 74.239999999999995 111.165 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -57.13 -61.47 2.44 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.822 0.701 . . . . 74.340000000000003 111.566 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -71.9 -29.16 64.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.849 -0.614 . . . . 73.340000000000003 111.262 -171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.518 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.7 m170 -87.55 -9.88 53.17 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.675 0.39 . . . . 73.319999999999993 112.049 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.0 p -88.43 -35.33 17.14 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.98 0.355 . . . . 71.409999999999997 110.114 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 65.8 p -70.28 -46.65 63.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.631 0.372 . . . . 71.129999999999995 111.048 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.745 HG23 ' HB2' ' A' ' 226' ' ' ASP . 22.8 m -132.01 165.14 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.353 0.661 . . . . 52.130000000000003 111.973 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.62 15.41 0.37 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 126.714 2.005 . . . . 64.129999999999995 114.208 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.745 ' HB2' HG23 ' A' ' 224' ' ' VAL . 23.8 t70 -44.65 36.23 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.723 1 C-N-CA 132.429 4.292 . . . . 75.109999999999999 119.561 -157.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 124.1 -7.08 8.73 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.537 -0.727 . . . . 51.439999999999998 112.493 -170.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.4 mt -94.65 162.45 13.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.116 1.366 . . . . 74.209999999999994 110.059 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.76 -35.26 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.604 0.24 . . . . 72.109999999999999 110.786 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.5 t -159.06 -179.22 7.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.996 0.519 . . . . 72.310000000000002 110.677 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.2 p -66.13 137.24 56.9 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.622 1.169 . . . . 73.219999999999999 112.311 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.44 96.69 1.19 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.75 0.82 . . . . 42.229999999999997 109.051 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -97.53 -82.61 0.41 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.818 -0.551 . . . . 53.200000000000003 111.99 -170.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -75.22 120.72 82.99 Favored Pre-proline 0 C--N 1.351 0.647 0 N-CA-C 108.857 -0.794 . . . . 74.219999999999999 108.857 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.88 127.7 7.97 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.038 1.825 . . . . 73.120000000000005 111.275 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.95 140.94 88.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 108.851 -0.796 . . . . 74.409999999999997 108.851 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.76 176.58 9.34 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.488 2.125 . . . . 74.140000000000001 113.051 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -63.53 140.7 58.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.897 0.879 . . . . 75.109999999999999 109.654 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.6 ' HE ' HG22 ' A' ' 151' ' ' VAL . 20.8 ptt85 -90.49 -61.31 1.71 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.524 0.935 . . . . 75.310000000000002 113.524 -165.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.453 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.8 t30 -109.08 128.84 55.32 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.595 0.758 . . . . 64.150000000000006 109.614 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -76.94 113.26 28.6 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.092 -1.447 . . . . 74.340000000000003 107.092 164.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -63.15 132.65 37.31 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.534 2.156 . . . . 74.239999999999995 112.46 -172.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 89.5 m -69.25 123.84 22.22 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.404 0.682 . . . . 63.329999999999998 110.284 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.65 111.74 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.405 -0.961 . . . . 73.239999999999995 108.405 172.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.65 ' HA ' ' HB3' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -106.56 112.37 25.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.303 0.641 . . . . 72.319999999999993 111.917 -169.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 69.34 -38.18 0.34 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 117.366 1.706 . . . . 61.049999999999997 117.366 165.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.33 129.33 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 117.833 0.817 . . . . 73.219999999999999 112.771 -158.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.9 t -83.35 135.82 43.7 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 107.339 -1.356 . . . . 75.409999999999997 107.339 168.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.92 -60.46 0.39 Allowed 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 122.126 1.884 . . . . 75.129999999999995 115.265 -156.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.584 HD22 HG12 ' A' ' 41' ' ' VAL . 25.8 p-10 -128.98 -31.58 2.13 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-O 121.734 0.778 . . . . 70.340000000000003 109.841 153.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.482 ' CG ' ' HB2' ' A' ' 254' ' ' TRP . 0.2 OUTLIER -104.33 150.19 24.69 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.071 -0.968 . . . . 75.519999999999996 111.905 -162.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -103.02 -44.99 5.08 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.029 0.531 . . . . 65.409999999999997 110.251 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -110.78 13.45 22.33 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.604 0.965 . . . . 62.219999999999999 113.604 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.498 ' HH2' ' HA2' ' A' ' 128' ' ' GLY . 25.9 t90 -71.25 145.92 49.29 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.119 0.418 . . . . 74.25 111.255 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 32.0 tt0 . . . . . 0 C--O 1.259 1.591 0 C-N-CA 125.683 1.593 . . . . 73.530000000000001 106.998 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.256 -0.646 . . . . 74.209999999999994 109.256 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.61 -119.86 15.27 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 124.1 0.875 . . . . 74.329999999999998 112.191 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -76.81 117.9 18.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.387 0.675 . . . . 43.420000000000002 109.251 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.01 144.41 47.49 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.466 0.706 . . . . 55.240000000000002 110.537 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -53.76 98.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 123.939 3.093 . . . . 64.25 114.498 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.87 -152.01 13.26 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.32 -0.4 . . . . 71.140000000000001 112.621 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.01 82.58 4.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.476 0.655 . . . . 72.400000000000006 109.346 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.07 -35.69 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.048 0.939 . . . . 54.109999999999999 110.425 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.7 mt 58.94 -165.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.78 1.232 . . . . 73.299999999999997 111.197 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.18 -178.62 11.01 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 112.274 -0.33 . . . . 71.329999999999998 112.274 170.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -134.35 -67.27 0.58 Allowed 'General case' 0 CA--C 1.55 0.967 0 O-C-N 122.043 -0.68 . . . . 54.450000000000003 112.009 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -126.1 168.99 13.24 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.584 0.629 . . . . 72.510000000000005 111.362 -170.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -73.95 93.3 2.19 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.023 -0.99 . . . . 61.25 111.401 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -141.04 -55.5 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 CA-C-O 118.057 -0.973 . . . . 71.040000000000006 112.509 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HB2' HD21 ' A' ' 250' ' ' ASN . 24.2 Cg_exo -62.11 127.88 22.46 Favored 'Trans proline' 0 C--N 1.401 3.309 0 C-N-CA 122.054 1.836 . . . . 63.109999999999999 113.18 -169.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.2 t -135.53 -78.95 0.43 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.59 -1.263 . . . . 61.310000000000002 107.59 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.4 mt 51.25 71.71 1.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 C-N-CA 124.416 1.087 . . . . 74.099999999999994 112.219 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.23 141.19 60.21 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.765 2.976 . . . . 72.230000000000004 114.526 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.67 -163.24 1.73 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.324 1.05 . . . . 33.340000000000003 109.105 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -136.9 125.06 23.01 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.697 0.799 . . . . 72.530000000000001 108.934 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -126.88 127.67 45.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.822 -0.807 . . . . 75.439999999999998 108.822 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -80.56 149.03 30.1 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.284 0.633 . . . . 73.129999999999995 111.453 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.94 -179.83 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.44 1.496 . . . . 65.209999999999994 109.524 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -139.08 155.89 47.58 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.266 0.626 . . . . 73.150000000000006 109.958 171.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.99 110.12 0.24 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.854 -0.612 . . . . 63.32 112.589 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.57 139.71 14.38 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.309 1.044 . . . . 63.329999999999998 109.176 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.94 -27.86 0.46 Allowed Glycine 0 C--N 1.352 1.443 0 C-N-CA 121.903 -0.189 . . . . 73.319999999999993 113.083 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -117.24 167.25 11.38 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.928 0.891 . . . . 74.099999999999994 110.092 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 120.28 18.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.53 0.732 . . . . 74.299999999999997 109.601 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -99.29 134.15 42.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.127 0.571 . . . . 73.209999999999994 111.634 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.6 m -67.46 130.23 42.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.042 0.937 . . . . 74.299999999999997 110.082 176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -134.78 99.11 4.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.695 0.398 . . . . 61.240000000000002 111.101 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.445 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -161.64 148.62 14.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.115 0.566 . . . . 72.200000000000003 111.328 169.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -178.57 89.49 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.534 1.534 . . . . 45.100000000000001 108.361 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.86 -126.91 7.57 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.785 -0.453 . . . . 35.530000000000001 112.874 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . 92.87 137.98 8.42 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.179 -0.789 . . . . 65.519999999999996 112.545 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HB2' ' H ' ' A' ' 38' ' ' HIS . 3.3 Cg_exo -79.38 -120.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.244 2.629 . . . . 51.509999999999998 111.609 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.554 ' HB2' HD21 ' A' ' 61' ' ' LEU . 56.2 p-80 -162.55 130.07 3.79 Favored 'General case' 0 C--N 1.366 1.305 0 CA-C-N 118.917 0.78 . . . . 65.340000000000003 112.049 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.1 m -152.58 157.14 40.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.153 0.981 . . . . 61.140000000000001 109.644 170.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -79.27 94.76 5.51 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.669 0.788 . . . . 65.140000000000001 109.62 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.33 96.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 N-CA-C 107.199 -1.408 . . . . 73.120000000000005 107.199 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -102.39 133.78 46.76 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 114.84 1.422 . . . . 65.219999999999999 114.84 -157.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 m -150.8 -38.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 126.244 1.818 . . . . 74.140000000000001 108.28 161.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -149.25 173.07 13.87 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.434 0.693 . . . . 73.310000000000002 110.703 -167.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 46.9 t60 85.21 133.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.509 1.924 . . . . 72.109999999999999 111.511 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -110.81 148.27 32.74 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.846 1.259 . . . . 74.329999999999998 111.025 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.85 -72.32 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.657 1.583 . . . . 74.109999999999999 108.786 166.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 tt -171.19 94.46 0.18 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.712 0.405 . . . . 64.230000000000004 110.032 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -163.57 176.7 9.44 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 126.094 1.757 . . . . 63.039999999999999 108.326 165.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -121.67 89.3 47.53 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 123.43 0.692 . . . . 70.310000000000002 110.364 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 76.1 Cg_endo -79.32 163.98 24.47 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.786 2.324 . . . . 74.150000000000006 112.033 169.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.66 90.45 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.688 -0.856 . . . . 74.129999999999995 108.688 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.62 -171.95 1.97 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.089 0.956 . . . . 53.119999999999997 110.149 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.1 p -74.97 -62.57 1.5 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.036 0.534 . . . . 71.549999999999997 111.876 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.63 -77.26 0.58 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.713 -0.847 . . . . 64.430000000000007 108.713 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -94.12 128.69 40.66 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.743 0.817 . . . . 74.430000000000007 108.915 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -110.38 129.43 23.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.009 0.524 . . . . 74.120000000000005 110.012 -175.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.78 -137.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.968 2.445 . . . . 74.140000000000001 111.618 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -90.57 -52.98 4.62 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.076 0.551 . . . . 62.109999999999999 109.856 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.76 30.37 9.69 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.187 -0.46 . . . . 74.040000000000006 112.754 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -95.37 74.42 3.32 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.695 -1.595 . . . . 75.319999999999993 106.695 174.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m -88.95 -19.62 25.53 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 114.497 1.295 . . . . 73.310000000000002 114.497 -158.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 1.4 pm0 -76.76 -37.36 56.04 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 118.656 0.662 . . . . 64.150000000000006 109.94 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.55 -18.03 64.48 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 120.765 0.317 . . . . 54.229999999999997 111.094 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.34 -24.35 39.93 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.059 0.944 . . . . 64.349999999999994 112.325 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.445 ' HA ' ' HB3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -152.45 -44.01 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.096 0.776 . . . . 75.010000000000005 113.096 -176.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 63' ' ' GLU . 8.1 t90 -83.89 67.23 9.51 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 74.299999999999997 109.625 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 26.2 p-10 -66.97 -33.95 76.7 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.419 -0.81 . . . . 72.340000000000003 110.826 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 p -72.0 6.21 2.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.698 1.199 . . . . 64.450000000000003 112.72 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HD3' ' HG3' ' A' ' 63' ' ' GLU . 83.5 tttt -70.28 -21.24 62.98 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.75 0.42 . . . . 64.439999999999998 111.13 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.608 ' HG3' HD22 ' A' ' 72' ' ' ASN . 13.3 pt-20 -73.0 -38.11 66.72 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.474 -0.565 . . . . 72.340000000000003 109.474 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.608 HD22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -77.43 -13.59 59.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.23 0.612 . . . . 74.329999999999998 111.075 176.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.461 HD13 ' HE1' ' A' ' 146' ' ' TRP . 60.3 tp -59.14 -50.32 74.5 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.684 0.794 . . . . 71.0 110.692 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 mt -108.06 23.8 13.94 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.78 -0.645 . . . . 42.100000000000001 110.922 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . -75.62 -28.92 59.02 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.073 0.549 . . . . 70.319999999999993 111.533 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.91 -137.71 30.43 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-O 119.141 -0.81 . . . . 74.349999999999994 111.712 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 86.6 Cg_exo -50.81 -177.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.892 0 C-N-CA 123.483 2.789 . . . . 55.009999999999998 114.817 166.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 2.8 m -67.98 167.74 13.2 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.934 -0.575 . . . . 64.129999999999995 109.854 171.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -63.75 -43.65 95.82 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.961 0.504 . . . . 74.519999999999996 111.587 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -127.1 -33.44 2.42 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.348 0.659 . . . . 72.349999999999994 111.035 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.505 ' HB3' ' H ' ' A' ' 83' ' ' ASN . 25.6 m-20 -90.04 149.4 41.56 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 113.653 0.983 . . . . 74.140000000000001 113.653 -174.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -89.42 -9.77 4.09 Favored 'Trans proline' 0 CA--C 1.561 1.85 0 C-N-CA 122.717 2.278 . . . . 75.319999999999993 111.956 149.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.505 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 60.1 t30 -109.85 16.78 21.77 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.229 1.011 . . . . 73.010000000000005 111.681 -169.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.5 tp -100.11 139.52 35.66 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.65 -0.656 . . . . 72.239999999999995 110.315 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -116.5 172.3 7.29 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.362 1.065 . . . . 73.319999999999993 109.101 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.08 139.99 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.732 1.213 . . . . 74.430000000000007 109.538 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.32 117.26 20.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.207 1.003 . . . . 41.32 110.249 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.07 -31.7 34.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.09 0.956 . . . . 50.219999999999999 111.564 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.43 141.61 51.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.036 0.934 . . . . 74.540000000000006 108.921 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.99 120.2 24.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.158 -0.682 . . . . 71.409999999999997 109.158 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.525 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.2 t80 -115.43 142.87 46.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.786 0.834 . . . . 64.109999999999999 109.469 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.72 135.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.737 -0.838 . . . . 63.109999999999999 108.737 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.42 119.22 10.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.701 0.8 . . . . 64.040000000000006 111.035 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.3 p -94.4 10.94 32.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.428 1.091 . . . . 74.409999999999997 111.324 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.78 179.45 43.47 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.108 -0.496 . . . . 73.310000000000002 112.034 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.14 -34.81 63.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.892 0.877 . . . . 74.430000000000007 110.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.519 ' ND2' ' HD2' ' A' ' 249' ' ' PRO . 32.4 p-10 -90.37 -4.05 57.33 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.043 -0.981 . . . . 75.400000000000006 112.262 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.9 p -96.76 168.51 10.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.457 0.703 . . . . 72.150000000000006 109.936 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.576 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 66.1 tp -135.93 136.29 40.33 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.084 0.553 . . . . 60.240000000000002 111.38 -172.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -83.9 120.14 25.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.573 0.749 . . . . 70.239999999999995 110.073 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.784 HG22 HG21 ' A' ' 123' ' ' THR . 20.2 pt -117.43 152.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 123.171 0.588 . . . . 75.450000000000003 111.614 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -98.53 146.44 25.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.362 1.065 . . . . 72.310000000000002 109.601 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -70.17 118.59 13.19 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.907 0.483 . . . . 71.450000000000003 109.701 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.78 -11.5 56.21 Favored Glycine 0 N--CA 1.472 1.052 0 C-N-CA 123.197 0.427 . . . . 71.319999999999993 112.845 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.11 135.65 44.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.65 0.78 . . . . 73.150000000000006 110.97 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -85.92 142.46 28.83 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.572 -0.899 . . . . 71.319999999999993 108.572 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.677 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.15 150.4 34.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.25 0.62 . . . . 51.310000000000002 111.119 -176.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -95.4 106.41 18.46 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.687 -0.688 . . . . 73.150000000000006 109.287 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.652 HG13 ' HB1' ' A' ' 119' ' ' ALA . 42.1 t -86.75 107.88 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.621 -0.511 . . . . 74.040000000000006 109.621 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.613 HD21 ' HG3' ' A' ' 122' ' ' GLN . 2.1 mm? -69.52 -23.22 63.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.349 1.059 . . . . 32.329999999999998 110.935 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.7 166.42 13.61 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.276 -0.42 . . . . 75.140000000000001 112.46 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.593 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 61.1 m-85 -86.6 173.12 9.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.841 0.829 . . . . 74.140000000000001 111.794 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 250' ' ' ASN . 31.2 p-10 -90.05 -178.66 5.49 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.208 -1.36 . . . . 64.25 110.97 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -53.26 -34.3 56.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.611 1.165 . . . . 71.030000000000001 113.11 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -105.35 -19.67 13.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 119.183 -0.436 . . . . 74.25 111.368 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.21 34.68 22.9 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.548 0.579 . . . . 71.109999999999999 114.548 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.55 -29.82 14.7 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.023 0.412 . . . . 62.350000000000001 111.057 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 60.6 m95 -128.75 156.02 44.2 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.16 0.984 . . . . 74.25 111.15 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.652 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.22 141.31 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.305 1.042 . . . . 25.440000000000001 110.263 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 110' ' ' LEU . 40.7 tt0 -74.82 118.43 17.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.859 -1.163 . . . . 63.350000000000001 107.859 170.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.52 151.33 48.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.25 0.62 . . . . 75.430000000000007 111.307 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.613 ' HG3' HD21 ' A' ' 110' ' ' LEU . 56.4 mt-30 -115.05 116.43 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.148 0.979 . . . . 74.400000000000006 108.95 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.784 HG21 HG22 ' A' ' 101' ' ' ILE . 67.0 p -114.6 -178.51 3.39 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.349 1.059 . . . . 71.150000000000006 110.885 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -68.66 -16.53 63.86 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.553 -0.748 . . . . 74.129999999999995 110.29 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -84.33 -20.46 32.01 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.202 1.001 . . . . 73.120000000000005 111.074 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.31 -168.43 14.84 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 112.096 -0.402 . . . . 55.240000000000002 112.096 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.27 145.45 28.83 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.35 0.575 . . . . 71.349999999999994 111.593 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -179.39 -161.91 27.65 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.713 -0.955 . . . . 21.25 110.713 177.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -110.94 136.24 50.25 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.797 0.798 . . . . 72.510000000000005 111.463 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.484 HG11 ' CG2' ' A' ' 101' ' ' ILE . 34.2 m -137.8 140.28 29.13 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.063 1.345 . . . . 73.109999999999999 109.252 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 8.8 Cg_exo -72.85 146.4 42.33 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.44 2.093 . . . . 74.120000000000005 114.38 -172.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 m -38.09 -50.96 1.4 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.469 1.907 . . . . 44.539999999999999 114.194 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 131' ' ' PRO . 12.7 p-10 -73.3 -3.65 28.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.375 1.07 . . . . 74.519999999999996 113.103 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -106.73 -9.39 16.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.858 0.863 . . . . 75.120000000000005 111.313 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 109' ' ' VAL . 18.0 pt -130.8 168.59 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.137 0.975 . . . . 73.329999999999998 111.832 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 t -163.06 155.9 16.29 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 124.08 0.952 . . . . 62.340000000000003 108.672 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.74 142.71 91.65 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 121.795 1.663 . . . . 72.040000000000006 111.442 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.4 t -69.72 -11.37 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.796 0.807 . . . . 75.409999999999997 109.848 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 11.6 m120 -73.8 -18.36 60.97 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.523 1.129 . . . . 51.130000000000003 112.568 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.6 p -92.69 -178.25 4.8 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.318 0.858 . . . . 51.340000000000003 113.318 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.8 mt -83.5 -21.19 32.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.257 1.023 . . . . 61.009999999999998 111.689 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.54 -20.95 63.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.684 0.394 . . . . 73.200000000000003 111.792 -172.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 72' ' ' ASN . 21.8 pttm -65.33 -15.99 63.12 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 112.266 0.469 . . . . 74.420000000000002 112.266 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -83.22 138.47 33.6 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.401 0.68 . . . . 75.319999999999993 109.28 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 p -65.11 -39.88 93.76 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.611 0.765 . . . . 63.219999999999999 112.203 -177.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.461 ' HE1' HD13 ' A' ' 73' ' ' LEU . 32.2 p-90 -67.78 -30.16 69.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.848 0.859 . . . . 61.520000000000003 112.87 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -80.58 102.99 10.13 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.742 -0.466 . . . . 71.219999999999999 109.742 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -99.72 -4.1 31.47 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.992 0.517 . . . . 75.439999999999998 111.788 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.8 -139.79 26.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 118.708 -1.051 . . . . 60.130000000000003 112.793 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.92 101.51 0.39 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.813 2.342 . . . . 74.010000000000005 112.399 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 76.7 t -132.3 141.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.77 0.828 . . . . 74.319999999999993 109.801 -175.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.6 p -87.72 172.65 9.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.924 0.89 . . . . 73.25 110.369 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 68.8 ttt180 -61.71 -45.51 93.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.243 -0.28 . . . . 54.409999999999997 110.243 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.5 -45.56 80.94 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.042 0.838 . . . . 64.299999999999997 111.019 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.624 ' HB1' HH12 ' A' ' 239' ' ' ARG . . . -71.65 -26.45 62.55 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.289 -0.869 . . . . 71.230000000000004 111.699 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.27 -43.27 52.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.27 0.628 . . . . 74.310000000000002 111.243 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 26.7 mm-40 -60.79 -36.19 78.38 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.722 0.809 . . . . 74.129999999999995 110.059 174.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -67.75 -47.29 69.67 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.704 -1.134 . . . . 73.209999999999994 111.205 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.33 -38.44 68.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.284 0.634 . . . . 55.200000000000003 111.307 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.9 mt -100.93 6.79 43.75 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.952 0.723 . . . . 73.109999999999999 112.952 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 90.6 p -59.17 -35.31 73.32 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 119.075 0.852 . . . . 70.5 111.166 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -102.86 18.92 20.37 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.495 1.118 . . . . 54.299999999999997 110.89 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.11 133.29 11.68 Favored Glycine 0 C--N 1.351 1.361 0 C-N-CA 123.644 0.64 . . . . 74.109999999999999 113.057 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -79.54 -177.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.946 0.898 . . . . 41.210000000000001 111.837 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.96 116.43 3.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.601 0.761 . . . . 63.32 110.656 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.16 11.8 55.7 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.629 -0.714 . . . . 73.019999999999996 113.094 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.1 m -76.38 135.24 39.48 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 118.082 0.941 . . . . 73.209999999999994 110.622 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 183' ' ' SER . 33.6 p90 -142.22 168.13 20.47 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 118.782 0.719 . . . . 55.549999999999997 111.34 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 pp -159.29 152.67 22.52 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.337 -0.986 . . . . 50.009999999999998 108.337 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.689 HG22 HG12 ' A' ' 182' ' ' ILE . 89.4 t -110.91 142.05 24.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 N-CA-C 109.092 -0.707 . . . . 70.409999999999997 109.092 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.467 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.3 ptt85 -135.37 159.21 42.3 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.288 -1.323 . . . . 74.439999999999998 108.95 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.658 ' HG2' ' HG2' ' A' ' 180' ' ' ARG . 10.7 mt-10 -113.93 162.14 16.76 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.523 -0.918 . . . . 64.319999999999993 108.523 164.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -84.02 133.79 34.65 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.99 -0.744 . . . . 74.409999999999997 108.99 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -71.17 -43.73 66.89 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.722 -0.473 . . . . 74.450000000000003 109.722 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.5 p -76.25 -15.76 59.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.112 0.565 . . . . 71.420000000000002 112.145 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.5 m -139.54 82.99 17.57 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.141 0.577 . . . . 64.230000000000004 109.865 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.64 125.94 18.57 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.958 2.439 . . . . 62.340000000000003 111.531 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.42 -29.58 8.98 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.752 -0.539 . . . . 53.0 111.752 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -75.77 116.89 16.94 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.02 -0.733 . . . . 72.049999999999997 109.02 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.658 ' HG2' ' HG2' ' A' ' 172' ' ' GLU . 98.3 mtt180 -124.01 145.89 48.9 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 123.954 0.902 . . . . 71.329999999999998 110.121 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 64.3 m -142.27 146.46 35.14 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.221 -0.9 . . . . 71.319999999999993 109.668 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.689 HG12 HG22 ' A' ' 170' ' ' VAL . 34.6 mt -103.32 150.17 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.084 -1.45 . . . . 34.240000000000002 107.084 169.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.1 m -125.45 108.09 11.29 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.661 -1.237 . . . . 55.530000000000001 107.661 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 25.5 tp -107.72 110.16 21.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.658 0.663 . . . . 55.219999999999999 110.216 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.514 ' HB2' HG22 ' A' ' 190' ' ' VAL . 20.5 ttt180 -79.95 120.89 24.77 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.673 0.749 . . . . 75.299999999999997 110.773 168.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -140.59 135.51 31.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 113.816 -1.538 . . . . 70.319999999999993 107.446 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 60.14 22.4 11.67 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.799 0.84 . . . . 50.32 112.087 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.15 -10.77 73.05 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.142 0.417 . . . . 42.329999999999998 114.142 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -103.5 139.04 39.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.314 0.646 . . . . 70.430000000000007 109.908 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 185' ' ' ARG . 48.1 t -99.3 110.33 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.897 0.479 . . . . 73.329999999999998 110.433 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -95.05 117.03 29.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.979 1.311 . . . . 73.030000000000001 109.133 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -96.54 122.94 39.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.947 0.499 . . . . 74.400000000000006 110.723 -172.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.46 ' HE1' HD21 ' A' ' 232' ' ' LEU . 8.2 m-30 -94.82 147.36 23.43 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.097 0.959 . . . . 75.040000000000006 109.795 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -99.24 117.65 34.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.132 -1.062 . . . . 74.239999999999995 108.132 173.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.531 HD12 ' HB3' ' A' ' 180' ' ' ARG . 56.8 mt -82.4 100.59 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 107.649 -1.241 . . . . 73.439999999999998 107.649 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 196' ' ' ASN . 0.8 OUTLIER -71.28 119.81 15.96 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.051 -0.977 . . . . 52.219999999999999 109.206 176.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 m -87.71 110.47 20.46 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.677 -0.692 . . . . 73.200000000000003 109.16 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.25 157.3 10.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.167 0.987 . . . . 53.43 111.383 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.6 p -64.43 -31.79 73.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.641 0.776 . . . . 73.200000000000003 112.101 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -82.58 -13.92 55.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.319 0.648 . . . . 71.109999999999999 111.316 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.32 9.77 19.04 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.401 0.52 . . . . 64.030000000000001 114.401 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -79.66 164.09 24.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.686 0.743 . . . . 72.530000000000001 110.735 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -115.73 147.36 41.0 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.601 0.761 . . . . 73.209999999999994 109.172 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.608 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 42.6 p90 -170.3 140.06 1.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.027 0.829 . . . . 62.240000000000002 111.728 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 217' ' ' LEU . 98.9 t -85.35 -44.38 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.733 -0.84 . . . . 43.450000000000003 108.733 165.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 43.1 m -92.7 130.83 38.2 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.941 -1.027 . . . . 71.140000000000001 109.992 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -72.27 -17.11 61.91 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.416 0.686 . . . . 74.099999999999994 111.884 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.47 -1.51 57.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.038 0.535 . . . . 61.030000000000001 111.399 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.36 101.86 3.53 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.769 0.428 . . . . 73.519999999999996 111.426 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.608 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 74.2 mtt180 -101.36 153.68 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.219 0.608 . . . . 72.530000000000001 110.32 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.4 154.72 47.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.411 0.684 . . . . 75.329999999999998 109.952 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -72.21 -44.74 62.48 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.233 -0.655 . . . . 63.240000000000002 109.233 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 156.41 31.39 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-O 121.938 0.875 . . . . 75.450000000000003 111.564 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.426 HD23 HD23 ' A' ' 217' ' ' LEU . 0.8 OUTLIER -64.55 -26.6 68.49 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-N 114.012 -1.449 . . . . 52.140000000000001 110.065 175.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.26 96.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.576 0.75 . . . . 61.450000000000003 111.331 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.84 -33.19 70.4 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.375 0.67 . . . . 72.5 111.154 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.451 HD11 HG23 ' A' ' 205' ' ' VAL . 15.3 tp -53.36 -57.23 11.31 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.729 0.643 . . . . 64.099999999999994 110.034 171.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 53.4 t -63.88 -37.83 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 O-C-N 123.802 0.689 . . . . 74.219999999999999 112.035 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -65.14 -51.89 58.46 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.853 0.358 . . . . 61.299999999999997 111.189 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -64.23 -35.11 79.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 75.150000000000006 110.776 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.652 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.5 m170 -85.72 -9.33 57.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.284 0.476 . . . . 72.430000000000007 112.284 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.4 p -90.93 -29.73 17.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.727 0.411 . . . . 71.430000000000007 110.761 170.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.7 p -75.48 -49.51 18.57 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.852 0.358 . . . . 75.140000000000001 110.735 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.3 m -125.7 154.23 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.979 0.895 . . . . 73.420000000000002 111.694 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.62 13.88 7.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.627 1.971 . . . . 71.150000000000006 113.694 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -46.77 34.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 131.182 3.793 . . . . 55.25 119.855 -159.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.58 -0.67 6.37 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 119.28 0.945 . . . . 52.32 112.941 -167.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.2 mt -92.33 161.92 14.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.434 1.094 . . . . 75.230000000000004 110.52 163.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.83 -42.19 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 122.564 0.345 . . . . 71.030000000000001 110.432 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -161.69 170.9 18.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.665 0.786 . . . . 55.039999999999999 110.102 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.3 p -61.29 139.36 58.17 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.456 1.102 . . . . 63.530000000000001 112.687 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.46 HD21 ' HE1' ' A' ' 193' ' ' TYR . 79.5 mt -68.17 99.55 0.91 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.033 0.933 . . . . 74.510000000000005 109.161 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -94.44 -50.24 5.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.329 0.492 . . . . 61.329999999999998 112.329 -163.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 167' ' ' SER . 15.5 t80 -130.77 124.16 20.62 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.936 1.294 . . . . 62.530000000000001 108.127 -171.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -84.95 146.91 10.4 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.256 1.97 . . . . 72.420000000000002 112.17 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -74.63 130.15 82.25 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.437 -1.32 . . . . 54.219999999999999 107.437 172.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.35 173.8 12.77 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.076 1.85 . . . . 73.310000000000002 112.5 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -68.19 109.12 3.42 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.882 -0.784 . . . . 74.340000000000003 108.882 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.637 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 8.7 ptt180 -75.51 -68.3 0.58 Allowed 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.559 0.948 . . . . 64.109999999999999 113.559 -158.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.637 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 66.8 t30 -111.29 137.75 48.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.788 -0.57 . . . . 70.219999999999999 110.128 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -74.49 112.69 18.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 106.3 -1.741 . . . . 71.420000000000002 106.3 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.23 127.28 16.4 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.346 2.031 . . . . 63.130000000000003 111.568 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 84.8 m -61.53 110.76 1.56 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.969 0.907 . . . . 74.230000000000004 111.182 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.22 106.96 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 107.685 -1.228 . . . . 53.520000000000003 107.685 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.73 120.77 43.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.128 0.971 . . . . 43.509999999999998 112.777 -163.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.07 63.74 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 116.352 1.301 . . . . 64.409999999999997 116.352 161.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.63 122.42 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 123.187 0.595 . . . . 72.239999999999995 110.874 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.9 t -81.3 116.73 64.65 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 104.834 -2.284 . . . . 72.439999999999998 104.834 161.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.519 ' HD2' ' ND2' ' A' ' 97' ' ' ASN . 99.3 Cg_exo -47.51 -62.95 0.36 Allowed 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.677 2.252 . . . . 74.349999999999994 116.226 -148.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.619 HD21 ' HB2' ' A' ' 15' ' ' PRO . 2.9 t30 -129.4 -32.73 1.95 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 122.213 1.006 . . . . 72.219999999999999 109.783 162.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.517 ' HD2' ' HB3' ' A' ' 250' ' ' ASN . 6.6 m-85 -100.24 150.08 22.91 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 113.512 -1.676 . . . . 72.150000000000006 110.175 -169.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -113.24 -42.4 3.52 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.072 0.858 . . . . 73.109999999999999 109.973 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -94.33 11.78 29.25 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.611 0.765 . . . . 74.150000000000006 112.366 -174.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -92.14 141.83 28.16 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.828 0.451 . . . . 72.430000000000007 111.235 -172.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 106.993 -1.484 . . . . 75.400000000000006 106.993 178.155 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.21 -0.292 . . . . 73.310000000000002 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.12 122.15 23.06 Favored Glycine 0 C--N 1.357 1.709 0 O-C-N 123.81 0.694 . . . . 71.299999999999997 111.985 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -120.73 -60.54 1.65 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.181 0.992 . . . . 74.420000000000002 109.264 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 174.74 131.94 0.13 Allowed Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.194 1.397 . . . . 71.319999999999993 108.275 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.87 109.39 1.67 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.222 1.948 . . . . 74.439999999999998 111.717 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.89 -28.22 73.7 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.573 -0.739 . . . . 72.099999999999994 112.023 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 65.21 14.41 9.38 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.193 1.397 . . . . 70.109999999999999 112.667 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.03 118.99 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.987 0.915 . . . . 64.420000000000002 109.639 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.7 155.68 29.31 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.551 0.34 . . . . 74.420000000000002 110.197 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.4 84.74 0.06 OUTLIER Glycine 0 C--N 1.338 0.642 0 N-CA-C 112.024 -0.43 . . . . 72.150000000000006 112.024 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -158.07 153.54 26.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.031 0.532 . . . . 73.019999999999996 109.855 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -141.0 113.7 8.25 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.869 0.868 . . . . 74.430000000000007 109.191 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -77.06 90.26 3.6 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.188 0.595 . . . . 75.329999999999998 110.257 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 91.83 4.21 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.45 1.1 . . . . 70.209999999999994 108.644 170.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -87.74 126.82 2.2 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.11 1.873 . . . . 75.439999999999998 112.42 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.0 m -107.92 156.8 18.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.717 0.807 . . . . 72.310000000000002 108.978 172.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.73 82.48 13.87 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.48 0.712 . . . . 73.230000000000004 111.142 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.89 114.51 3.18 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.356 2.037 . . . . 72.239999999999995 111.02 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.41 132.04 40.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.393 0.677 . . . . 70.329999999999998 110.386 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.8 mt -142.32 -172.26 3.57 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.041 1.337 . . . . 74.099999999999994 109.35 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -156.2 110.81 2.84 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.792 -0.818 . . . . 64.099999999999994 108.792 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -134.62 -168.76 2.21 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.554 -0.906 . . . . 71.430000000000007 108.554 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.0 mm 73.55 100.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.055 1.342 . . . . 64.450000000000003 110.122 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -82.93 -51.37 7.66 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.285 -0.871 . . . . 74.219999999999999 109.176 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.4 ' HA3' HE22 ' A' ' 49' ' ' GLN . . . 75.83 7.66 83.91 Favored Glycine 0 C--N 1.355 1.637 0 CA-C-N 115.397 -0.819 . . . . 72.019999999999996 113.366 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.92 100.31 2.9 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.662 0.785 . . . . 71.5 110.118 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' ' 48' ' ' LEU . . . -166.09 156.56 28.56 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.089 -0.804 . . . . 74.010000000000005 111.089 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.89 152.94 37.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.505 0.722 . . . . 52.329999999999998 110.369 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -95.59 95.52 8.43 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.373 -0.973 . . . . 73.340000000000003 108.373 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -79.15 133.11 36.74 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.695 -0.684 . . . . 54.5 111.407 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.508 ' HA ' ' HB3' ' A' ' 93' ' ' ALA . 58.9 m -99.47 23.55 9.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.82 0.848 . . . . 75.530000000000001 110.424 172.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.0 m -67.59 133.07 48.75 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 124.084 0.954 . . . . 63.420000000000002 110.224 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -116.5 100.32 7.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.027 0.931 . . . . 73.120000000000005 109.607 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -120.34 134.15 55.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.433 0.693 . . . . 63.219999999999999 109.649 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.19 161.06 29.49 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.844 -0.616 . . . . 53.229999999999997 112.332 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.63 96.46 0.13 Allowed Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.326 -1.11 . . . . 71.019999999999996 110.326 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 254' ' ' TRP . 2.8 Cg_exo -70.05 87.92 0.58 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.033 2.489 . . . . 74.019999999999996 111.788 -173.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -145.93 149.0 33.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.47 0.708 . . . . 75.129999999999995 110.228 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.2 p 55.45 102.47 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.51 1.924 . . . . 62.43 112.599 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -75.14 -3.63 33.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.258 1.023 . . . . 74.439999999999998 112.54 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.3 m -85.11 120.87 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.307 0.643 . . . . 74.129999999999995 110.745 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -163.92 140.31 6.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 71.329999999999998 110.772 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -160.69 96.23 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.946 0.898 . . . . 71.439999999999998 109.959 174.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 252' ' ' ASP . 9.8 tp10 -163.2 147.28 10.95 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.928 -0.578 . . . . 73.040000000000006 110.224 172.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -155.28 92.47 1.42 Allowed 'General case' 0 CA--C 1.547 0.851 0 O-C-N 123.808 0.693 . . . . 74.439999999999998 109.388 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -74.04 166.27 23.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.423 0.689 . . . . 72.129999999999995 110.982 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.17 65.64 1.29 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 75.049999999999997 110.012 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.597 ' HB3' ' HA3' ' A' ' 27' ' ' GLY . 63.7 mt -122.99 117.29 25.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.617 0.767 . . . . 72.030000000000001 109.629 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.4 HE22 ' HA3' ' A' ' 25' ' ' GLY . 4.7 pm0 -141.89 176.51 8.87 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.331 0.653 . . . . 73.510000000000005 110.067 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -130.1 156.91 78.51 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.68 0.792 . . . . 73.519999999999996 110.009 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.69 -176.63 2.1 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.31 2.007 . . . . 63.240000000000002 111.469 168.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.43 131.11 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-N 116.406 -0.361 . . . . 33.340000000000003 110.244 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.76 -173.67 4.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.813 0.845 . . . . 63.119999999999997 111.032 -177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.9 p -78.17 -0.66 29.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.256 1.023 . . . . 75.329999999999998 111.833 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.57 126.37 55.28 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.173 0.989 . . . . 54.329999999999998 108.858 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -129.56 178.18 6.67 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.231 1.013 . . . . 73.319999999999993 109.946 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.68 93.0 5.55 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.042 -1.096 . . . . 72.409999999999997 108.042 168.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.42 -45.03 5.64 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.985 2.456 . . . . 74.209999999999994 113.858 -167.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 pm0 -73.14 -39.78 65.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.714 0.406 . . . . 72.319999999999993 111.368 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.81 47.34 65.5 Favored Glycine 0 C--N 1.359 1.807 0 O-C-N 123.705 0.628 . . . . 51.409999999999997 113.486 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.29 140.26 58.01 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.475 0.71 . . . . 75.510000000000005 112.127 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.0 m -77.28 -167.6 0.94 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.077 0.951 . . . . 74.230000000000004 110.935 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -72.76 90.16 1.4 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.363 1.065 . . . . 73.519999999999996 109.424 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 68.56 -76.65 0.06 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.132 1.773 . . . . 63.43 110.878 -173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.56 -42.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.035 0.534 . . . . 60.229999999999997 111.485 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -142.09 -44.21 0.34 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.994 0.518 . . . . 62.140000000000001 110.823 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -174.47 104.38 0.1 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.158 0.983 . . . . 74.409999999999997 108.51 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.41 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 30.1 p-10 -94.38 -34.01 12.94 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.888 0.475 . . . . 74.409999999999997 110.68 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.3 p -71.25 2.94 4.05 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.959 0.903 . . . . 60.210000000000001 113.3 -171.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.08 -22.07 64.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.658 . . . . 72.209999999999994 110.636 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 10.9 pt-20 -65.76 -30.79 71.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.688 0.795 . . . . 73.519999999999996 110.673 172.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -84.17 -10.34 57.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.128 0.971 . . . . 54.020000000000003 110.928 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.5 tp -65.12 -48.91 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.807 0.843 . . . . 73.420000000000002 111.686 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.51 12.39 29.6 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 73.540000000000006 110.971 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.3 -19.78 65.52 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.179 0.591 . . . . 63.0 111.471 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.62 -136.03 21.46 Favored Glycine 0 C--N 1.358 1.789 0 CA-C-O 118.879 -0.956 . . . . 74.400000000000006 111.73 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.26 -176.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.432 2.754 . . . . 74.439999999999998 113.638 170.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -66.36 172.36 4.06 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.607 -0.724 . . . . 64.329999999999998 110.953 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.04 -48.85 19.33 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.932 0.345 . . . . 73.549999999999997 111.932 -169.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -133.45 -40.0 0.9 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.118 0.567 . . . . 63.119999999999997 110.639 171.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 8.6 m-20 -91.21 112.7 55.29 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 114.992 -1.004 . . . . 70.129999999999995 110.802 -169.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.24 -24.26 72.36 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.436 2.091 . . . . 73.219999999999999 112.228 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -96.64 19.54 12.2 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.451 1.101 . . . . 63.119999999999997 111.754 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 35.0 tp -84.23 127.29 33.86 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 121.258 0.552 . . . . 64.120000000000005 110.035 176.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -110.49 174.95 5.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.625 1.57 . . . . 74.049999999999997 108.652 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.66 141.56 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.744 1.218 . . . . 71.420000000000002 109.46 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.4 137.03 38.47 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.609 0.763 . . . . 50.350000000000001 110.079 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.526 ' HB3' ' HE3' ' A' ' 238' ' ' LYS . 73.1 mt -103.97 -20.85 13.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.942 0.897 . . . . 72.219999999999999 111.475 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.98 149.19 49.99 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.021 0.928 . . . . 73.430000000000007 109.552 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.4 119.58 19.69 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.515 -0.92 . . . . 74.349999999999994 108.515 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -129.8 133.6 47.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.222 -0.659 . . . . 73.549999999999997 109.222 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.9 136.23 37.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.534 -1.284 . . . . 74.200000000000003 107.534 169.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.508 ' HB3' ' HA ' ' A' ' 31' ' ' SER . . . -55.65 136.07 50.81 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.349 1.06 . . . . 62.219999999999999 111.218 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -131.33 26.88 4.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.014 0.925 . . . . 65.430000000000007 112.254 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.46 -165.74 26.36 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.071 -0.513 . . . . 73.230000000000004 112.014 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.73 -42.51 19.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.143 0.577 . . . . 75.430000000000007 112.304 -172.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.68 ' HB3' ' HD2' ' A' ' 251' ' ' TYR . 25.5 p-10 -101.05 5.07 42.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.632 0.373 . . . . 72.239999999999995 111.767 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -76.27 172.31 13.09 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.698 0.799 . . . . 73.519999999999996 112.044 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.433 ' HB3' HG13 ' A' ' 130' ' ' VAL . 39.5 tp -147.02 130.54 16.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 73.299999999999997 110.138 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -80.77 127.79 32.91 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.336 0.654 . . . . 62.219999999999999 109.86 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.665 HG22 HG21 ' A' ' 123' ' ' THR . 19.5 pt -126.72 154.22 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.549 0.74 . . . . 74.219999999999999 111.684 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -100.68 147.33 26.13 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.616 -1.175 . . . . 73.310000000000002 108.743 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.67 114.16 4.78 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.551 -0.537 . . . . 75.230000000000004 109.551 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.84 -1.34 44.99 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 115.924 -0.58 . . . . 74.109999999999999 113.124 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -79.65 127.18 31.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.951 0.501 . . . . 74.120000000000005 110.493 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -79.3 135.35 36.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.484 0.714 . . . . 61.539999999999999 109.435 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.705 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -147.64 147.87 30.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.651 0.78 . . . . 52.43 111.26 -174.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -104.93 109.51 21.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.854 0.461 . . . . 72.140000000000001 110.731 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.645 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.4 t -73.05 125.23 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.608 0.363 . . . . 72.239999999999995 110.162 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.9 mt -96.28 -36.76 10.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.877 1.271 . . . . 75.109999999999999 110.237 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.1 144.68 6.89 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.76 -0.655 . . . . 73.200000000000003 111.982 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 29.5 m-85 -89.62 171.11 9.91 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.853 0.835 . . . . 63.100000000000001 111.616 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -68.98 161.02 29.81 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 113.784 -1.553 . . . . 74.099999999999994 108.021 169.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -54.29 -28.52 42.62 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.998 0.919 . . . . 64.420000000000002 113.141 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -106.11 -3.62 21.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.078 0.951 . . . . 73.299999999999997 111.847 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.72 33.38 58.05 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-O 119.818 -0.434 . . . . 72.319999999999993 113.981 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.651 ' HB3' ' HD1' ' A' ' 118' ' ' TRP . 37.6 mt-10 -70.23 -65.69 0.69 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.261 0.531 . . . . 71.219999999999999 110.544 171.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 23.5 m95 -119.65 167.09 12.37 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.277 1.031 . . . . 74.430000000000007 110.176 -171.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.645 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -141.7 131.56 24.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.462 1.105 . . . . 73.040000000000006 109.95 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.76 101.8 4.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -104.64 144.69 31.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.35 0.66 . . . . 73.329999999999998 110.586 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -95.6 105.17 17.13 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.109 -1.071 . . . . 75.040000000000006 108.109 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.705 HG22 ' HB3' ' A' ' 107' ' ' LEU . 62.3 p -97.94 173.53 7.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.618 1.167 . . . . 62.240000000000002 110.152 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -68.69 -21.79 64.4 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.503 -0.772 . . . . 62.439999999999998 109.777 174.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.979 1.312 . . . . 75.299999999999997 111.474 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.11 -170.48 24.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.139 -0.384 . . . . 71.150000000000006 112.139 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -102.33 135.05 44.62 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.415 0.686 . . . . 74.129999999999995 110.554 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 172.34 -175.38 45.54 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 111.261 -0.735 . . . . 34.340000000000003 111.261 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -94.84 132.67 39.4 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.268 0.627 . . . . 74.299999999999997 112.023 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 135' ' ' ILE . 36.0 m -137.72 139.98 28.41 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.75 1.62 . . . . 52.350000000000001 108.816 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 7.7 Cg_exo -71.21 145.35 48.73 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.598 2.198 . . . . 75.540000000000006 113.953 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -38.2 -50.75 1.44 Allowed 'General case' 0 C--N 1.369 1.444 0 C-N-CA 125.405 1.482 . . . . 72.230000000000004 112.763 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -80.66 12.38 3.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.442 1.097 . . . . 74.299999999999997 112.882 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -115.58 -16.13 11.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.36 1.064 . . . . 74.430000000000007 111.481 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 130' ' ' VAL . 21.3 pt -128.91 171.69 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.766 0.826 . . . . 73.109999999999999 111.511 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.8 t -161.71 153.24 15.75 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.649 -0.871 . . . . 71.430000000000007 108.649 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 36.8 Cg_endo -64.08 154.53 69.99 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.685 1.59 . . . . 73.430000000000007 112.067 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.4 t -72.59 -6.96 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-O 121.937 0.875 . . . . 74.450000000000003 110.382 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.54 -19.78 35.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.826 0.85 . . . . 60.350000000000001 111.401 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.6 p -88.42 171.84 9.81 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.338 0.655 . . . . 54.340000000000003 111.738 -172.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.41 -21.55 30.75 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.001 0.92 . . . . 73.049999999999997 110.668 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.86 -17.12 63.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.471 1.108 . . . . 74.109999999999999 111.761 -172.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.418 ' HA ' HD21 ' A' ' 88' ' ' LEU . 23.4 pttm -62.46 -12.53 22.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.66 0.784 . . . . 74.420000000000002 112.371 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -96.68 150.89 20.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.112 0.965 . . . . 74.310000000000002 110.303 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 p -67.33 -43.86 80.52 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.097 0.959 . . . . 72.129999999999995 111.5 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -57.85 -39.77 78.52 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 124.281 0.988 . . . . 74.319999999999993 111.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -77.83 112.67 14.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.062 -0.718 . . . . 73.099999999999994 109.062 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.401 ' HB2' HG21 ' A' ' 151' ' ' VAL . 70.8 m80 -108.53 -2.71 18.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.024 0.53 . . . . 64.010000000000005 111.695 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.41 -145.69 25.51 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 118.88 -0.955 . . . . 53.420000000000002 113.22 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.74 91.75 0.3 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.357 2.705 . . . . 71.140000000000001 111.85 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 148' ' ' HIS . 61.2 t -121.21 144.14 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.724 1.21 . . . . 74.120000000000005 109.005 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.4 p -88.2 167.25 13.75 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.575 0.75 . . . . 74.450000000000003 109.835 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -60.05 -46.79 88.38 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.901 0.48 . . . . 64.109999999999999 111.702 -173.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -65.53 -35.31 80.49 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 123.754 0.659 . . . . 44.210000000000001 111.115 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.33 67.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.091 0.556 . . . . 64.319999999999993 110.87 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 159' ' ' LEU . . . -68.35 -43.86 76.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.604 0.716 . . . . 33.350000000000001 110.885 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.24 -21.31 60.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.2 -0.909 . . . . 60.109999999999999 110.647 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -72.48 -42.35 65.01 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.594 0.757 . . . . 75.219999999999999 110.353 170.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.612 HD12 ' HA ' ' A' ' 156' ' ' ALA . 21.5 mt -56.66 -37.33 70.66 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.276 0.631 . . . . 75.540000000000006 110.674 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 19.6 17.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.415 -0.811 . . . . 75.200000000000003 112.602 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 -35.86 51.22 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.759 -0.83 . . . . 72.239999999999995 108.759 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.5 p -94.54 -15.16 24.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.67 1.188 . . . . 74.219999999999999 111.586 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.18 148.65 50.28 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 123.267 0.355 . . . . 42.350000000000001 113.455 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.4 -178.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.767 . . . . 72.230000000000004 111.398 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.26 123.2 19.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.146 -0.479 . . . . 62.399999999999999 109.88 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.31 7.89 61.73 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.311 -0.716 . . . . 62.310000000000002 113.052 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.5 m -83.71 133.46 34.8 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 118.26 1.03 . . . . 75.239999999999995 110.479 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -139.37 166.34 24.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.095 0.474 . . . . 74.120000000000005 111.146 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -158.5 150.62 21.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.906 -1.043 . . . . 75.409999999999997 109.17 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 182' ' ' ILE . 99.6 t -110.33 140.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 108.596 -0.89 . . . . 64.239999999999995 108.596 167.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 156' ' ' ALA . 52.2 ptt85 -142.6 161.43 38.08 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.045 -0.979 . . . . 74.109999999999999 109.621 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.48 154.67 27.79 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.196 -1.409 . . . . 74.400000000000006 107.196 165.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -79.63 119.2 22.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 62.109999999999999 109.649 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.46 -37.02 85.69 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.609 -0.723 . . . . 73.510000000000005 109.886 168.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 -40.52 97.9 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.273 1.029 . . . . 75.120000000000005 111.659 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.4 m -143.47 94.84 6.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.648 0.779 . . . . 63.130000000000003 109.598 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -59.19 146.91 92.98 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.217 2.611 . . . . 73.129999999999995 112.812 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.06 -30.62 8.3 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.49 -0.777 . . . . 64.409999999999997 112.268 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.82 115.16 15.22 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 109.451 -0.574 . . . . 65.019999999999996 109.451 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -119.68 140.93 49.88 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.292 0.637 . . . . 74.430000000000007 109.441 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 71.1 m -145.24 147.39 32.36 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.065 0.946 . . . . 73.430000000000007 109.864 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.642 HG12 HG22 ' A' ' 170' ' ' VAL . 38.0 mt -102.74 147.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.221 -1.4 . . . . 63.229999999999997 107.221 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.6 m -124.3 113.0 17.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.519 -1.289 . . . . 52.329999999999998 107.519 172.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 51.9 tp -109.0 112.34 24.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.048 0.539 . . . . 74.109999999999999 109.871 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.441 ' HB2' HG22 ' A' ' 190' ' ' VAL . 54.3 ttt180 -79.73 116.5 19.94 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 109.43 -0.581 . . . . 72.140000000000001 109.43 166.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -142.11 141.44 32.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.144 1.377 . . . . 65.420000000000002 107.938 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 54.55 31.05 14.19 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.403 1.081 . . . . 55.32 111.603 -173.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.24 -11.25 50.74 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-N 115.466 -0.788 . . . . 45.399999999999999 114.228 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -104.72 139.5 39.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.585 0.754 . . . . 74.040000000000006 110.129 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 185' ' ' ARG . 51.7 t -95.68 107.26 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.848 0.459 . . . . 71.219999999999999 110.511 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -93.1 132.38 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.471 1.108 . . . . 73.109999999999999 109.211 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -107.52 119.8 40.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.14 0.576 . . . . 71.219999999999999 110.636 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.495 ' HE1' HD21 ' A' ' 232' ' ' LEU . 7.8 m-85 -94.55 146.65 23.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.411 1.084 . . . . 73.120000000000005 109.192 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -100.38 114.72 28.47 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.217 -0.66 . . . . 71.049999999999997 109.217 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mt -85.15 101.06 9.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.198 -1.038 . . . . 53.43 108.198 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.93 121.27 23.94 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.948 -1.024 . . . . 55.340000000000003 108.641 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.7 m -94.23 118.7 31.95 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.343 -0.984 . . . . 70.430000000000007 108.343 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.9 169.54 14.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.867 0.867 . . . . 72.530000000000001 110.621 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.7 p -66.3 -28.51 68.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.839 0.456 . . . . 64.150000000000006 110.918 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.79 -11.3 42.54 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.542 0.737 . . . . 63.25 110.946 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.27 -0.31 25.21 Favored Glycine 0 C--N 1.356 1.683 0 CA-C-O 119.104 -0.831 . . . . 64.409999999999997 115.166 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.412 ' HE2' ' OD1' ' A' ' 212' ' ' ASN . 98.3 mttt -69.36 131.94 45.6 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.398 1.099 . . . . 60.119999999999997 112.155 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -89.22 142.94 27.21 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.037 -1.097 . . . . 62.5 108.037 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.505 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.1 p90 -167.48 138.0 2.92 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.57 0.543 . . . . 73.409999999999997 111.993 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.46 HG23 HD11 ' A' ' 217' ' ' LEU . 68.0 t -89.17 -30.8 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.583 -0.895 . . . . 72.230000000000004 108.583 163.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 14.7 m -93.2 115.58 28.2 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.26 -1.015 . . . . 74.430000000000007 108.26 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.3 t -56.98 -38.14 72.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.481 0.712 . . . . 74.099999999999994 111.863 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.34 -29.6 30.91 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.751 0.82 . . . . 64.430000000000007 111.15 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 58.9 m -102.2 91.28 4.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.062 0.545 . . . . 74.540000000000006 110.289 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.505 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 87.1 mtt180 -91.1 140.62 29.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.511 0.724 . . . . 62.25 109.688 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.2 m-85 -125.75 141.87 51.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.878 -0.786 . . . . 64.129999999999995 108.878 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' A' ' 202' ' ' LYS . 71.4 m-20 -64.75 -38.83 92.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.533 0.521 . . . . 72.319999999999993 110.132 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 63.7 p -123.88 155.33 38.26 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.072 0.939 . . . . 73.209999999999994 111.757 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.02 -24.29 66.72 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 113.869 -1.514 . . . . 74.510000000000005 109.496 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.65 94.83 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.857 0.863 . . . . 65.200000000000003 110.964 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 47.4 mt-10 -72.52 -36.8 68.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.489 0.716 . . . . 75.129999999999995 111.263 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.46 HD11 HG23 ' A' ' 205' ' ' VAL . 14.2 tp -53.91 -57.1 12.22 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.584 0.553 . . . . 72.439999999999998 110.492 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.64 -37.48 80.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 O-C-N 123.736 0.648 . . . . 74.209999999999994 111.413 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.981 0.355 . . . . 75.340000000000003 111.163 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -57.34 -36.83 71.66 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.142 0.901 . . . . 73.129999999999995 109.988 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.693 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.9 m170 -87.29 -12.28 47.04 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 112.513 0.56 . . . . 73.129999999999995 112.513 -175.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.6 p -98.16 -11.12 23.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.89 0.476 . . . . 74.329999999999998 110.575 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.8 p -87.66 -43.16 12.15 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 110.1 -0.334 . . . . 72.319999999999993 110.1 171.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 226' ' ' ASP . 29.1 m -137.46 172.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.461 0.648 . . . . 72.540000000000006 112.71 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.97 14.51 1.37 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.866 2.066 . . . . 63.009999999999998 114.106 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.594 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.0 t70 -42.66 29.8 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 1 C-N-CA 131.799 4.039 . . . . 73.340000000000003 120.073 -152.249 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.49 1.1 10.13 Favored Glycine 0 N--CA 1.483 1.825 0 O-C-N 120.071 -1.643 . . . . 72.129999999999995 112.192 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.3 mt -92.83 161.96 14.3 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.082 1.353 . . . . 65.120000000000005 109.525 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.8 tt -55.52 -37.4 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 N-CA-C 110.177 -0.305 . . . . 72.340000000000003 110.177 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -161.28 169.2 22.58 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.79 0.836 . . . . 70.439999999999998 110.388 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 27.8 m -61.31 135.9 57.87 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.372 1.069 . . . . 74.510000000000005 111.266 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.495 HD21 ' HE1' ' A' ' 193' ' ' TYR . 74.9 mt -69.5 128.11 35.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 74.0 109.701 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -113.39 -78.71 0.58 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.921 0.489 . . . . 53.020000000000003 111.765 -171.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 167' ' ' SER . 33.2 t80 -94.03 124.92 54.74 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.387 1.075 . . . . 63.329999999999998 109.444 -173.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.99 127.56 4.76 Favored 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 122.272 1.981 . . . . 73.129999999999995 111.477 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -65.59 124.52 87.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.273 0.629 . . . . 50.340000000000003 109.499 178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 14.9 Cg_exo -71.33 175.47 9.3 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.975 2.45 . . . . 74.230000000000004 113.11 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.526 ' HE3' ' HB3' ' A' ' 88' ' ' LEU . 72.1 mmtt -69.1 130.33 42.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.371 -0.831 . . . . 64.540000000000006 109.106 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -83.47 -59.13 2.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.518 0.562 . . . . 72.25 112.518 -168.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -108.6 132.75 53.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.784 1.234 . . . . 74.420000000000002 110.136 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -81.32 114.92 53.02 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 106.77 -1.567 . . . . 55.229999999999997 106.77 163.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.33 123.64 14.09 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.782 2.322 . . . . 65.239999999999995 111.897 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 20.8 m -74.73 100.21 3.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.818 0.447 . . . . 73.329999999999998 110.071 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.32 106.54 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 107.245 -1.391 . . . . 64.120000000000005 107.245 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.3 107.54 19.12 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.395 -0.224 . . . . 64.329999999999998 110.395 -161.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.27 11.74 7.18 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.76 1.464 . . . . 72.219999999999999 116.76 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -75.32 130.06 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 118.465 1.133 . . . . 72.099999999999994 112.722 -164.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 m -87.65 115.55 63.29 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.378 -2.082 . . . . 31.420000000000002 105.378 144.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.13 -51.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 121.006 1.138 . . . . 72.400000000000006 114.952 -169.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -123.01 -20.11 5.87 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.561 0.578 . . . . 71.0 112.561 -171.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.68 ' HD2' ' HB3' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -85.05 102.77 13.49 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.095 0.474 . . . . 72.310000000000002 109.979 -169.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.556 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 17.7 t70 -120.22 -51.55 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.492 1.139 . . . . 53.340000000000003 108.734 156.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -112.63 8.87 19.25 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.212 -1.813 . . . . 72.420000000000002 110.262 -174.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.469 ' CZ2' ' HA ' ' A' ' 37' ' ' PRO . 44.6 t-105 -58.51 121.89 12.03 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.03 0.532 . . . . 71.349999999999994 110.144 -172.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--O 1.254 1.32 0 O-C-N 125.207 1.567 . . . . 71.230000000000004 109.373 -161.373 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 108.189 -1.041 . . . . 74.439999999999998 108.189 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.26 106.18 3.37 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.306 -0.719 . . . . 43.039999999999999 111.581 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -63.0 103.61 0.47 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.096 -1.076 . . . . 74.340000000000003 108.096 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -95.2 -47.48 0.26 Allowed Pre-proline 0 CA--C 1.569 1.691 0 C-N-CA 124.022 0.929 . . . . 71.120000000000005 111.881 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -82.52 -177.97 3.72 Favored 'Trans proline' 0 C--N 1.389 2.67 0 C-N-CA 122.1 1.867 . . . . 64.329999999999998 112.736 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 173.83 -86.89 0.08 OUTLIER Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.754 -0.657 . . . . 61.450000000000003 112.017 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mptt 65.24 146.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.417 1.487 . . . . 73.010000000000005 112.737 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m -107.98 165.51 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.692 0.797 . . . . 74.099999999999994 109.152 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.43 117.13 33.97 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.589 -0.893 . . . . 74.200000000000003 108.589 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.42 114.28 4.03 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 111.554 -0.619 . . . . 73.120000000000005 111.554 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.72 123.43 31.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.963 0.905 . . . . 70.109999999999999 110.223 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -91.54 -163.62 1.06 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 108.422 -0.955 . . . . 73.319999999999993 108.422 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.518 ' HG2' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -143.46 161.14 39.18 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.126 0.488 . . . . 70.329999999999998 111.664 -173.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -124.35 96.23 41.98 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.28 1.032 . . . . 62.25 108.937 173.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HD3' ' HG2' ' A' ' 13' ' ' ARG . 50.4 Cg_exo -60.8 -175.6 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.11 2.54 . . . . 75.540000000000006 113.116 163.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.5 p -146.74 91.99 2.09 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.808 0.443 . . . . 73.349999999999994 111.215 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -149.14 114.61 3.64 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 107.006 -1.479 . . . . 71.519999999999996 107.006 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.2 93.48 0.19 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.985 2.457 . . . . 72.420000000000002 112.187 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.16 -58.26 3.41 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.684 0.394 . . . . 64.209999999999994 110.029 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 47.68 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.426 1.49 . . . . 75.349999999999994 113.351 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -142.75 123.3 14.06 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.624 -1.25 . . . . 74.400000000000006 107.624 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -88.42 -131.28 0.08 Allowed 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.667 0.787 . . . . 74.25 111.165 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.3 mt 75.79 151.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 124.976 1.31 . . . . 71.439999999999998 109.015 -163.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.12 145.32 48.68 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.781 0.832 . . . . 72.109999999999999 109.849 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.36 141.34 7.46 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.899 0.761 . . . . 61.340000000000003 111.367 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 133' ' ' ASN . . . -147.39 154.28 40.67 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.386 0.593 . . . . 71.0 112.165 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.71 153.17 16.75 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 110.93 -0.868 . . . . 75.109999999999999 110.93 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.7 -0.63 0.15 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 118.008 0.904 . . . . 60.43 113.352 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -86.19 107.11 17.74 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.528 0.331 . . . . 75.200000000000003 111.587 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.521 ' HB3' ' ND2' ' A' ' 240' ' ' ASN . 2.1 tm-20 -171.7 -69.49 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.325 1.05 . . . . 74.420000000000002 108.305 167.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.4 m 75.82 128.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.607 1.563 . . . . 71.540000000000006 113.366 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.1 p -153.01 165.85 34.28 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.294 1.038 . . . . 64.510000000000005 109.313 173.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -85.33 124.01 31.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.175 0.59 . . . . 72.450000000000003 110.626 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -143.73 139.65 29.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.85 0.86 . . . . 52.530000000000001 110.072 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.4 173.25 41.13 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.139 -0.784 . . . . 62.340000000000003 111.139 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.94 122.71 0.99 Allowed Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.711 -1.05 . . . . 43.030000000000001 111.418 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.9 157.93 50.72 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.392 2.061 . . . . 70.25 111.915 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -146.57 -72.29 0.23 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.38 0.672 . . . . 75.439999999999998 109.492 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.6 t -163.67 169.04 19.07 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.37 0.605 . . . . 52.520000000000003 110.477 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -126.05 -170.07 2.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.599 1.159 . . . . 72.430000000000007 109.557 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 42' ' ' PHE . 4.2 p -145.05 172.0 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.981 -0.748 . . . . 73.409999999999997 108.981 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.488 ' H ' HG22 ' A' ' 41' ' ' VAL . 97.0 m-85 -67.27 -139.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.888 1.275 . . . . 73.019999999999996 113.143 -171.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.445 ' HB ' HD22 ' A' ' 61' ' ' LEU . 73.1 t 76.44 -76.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.068 0 C-N-CA 125.11 1.364 . . . . 74.319999999999993 111.007 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -171.81 158.67 4.96 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 111.875 0.324 . . . . 73.129999999999995 111.875 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -150.1 112.35 4.65 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.819 1.248 . . . . 64.409999999999997 108.302 167.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -104.92 -172.73 2.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.424 0.69 . . . . 74.109999999999999 109.739 176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.33 133.69 49.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.24 0.616 . . . . 73.25 110.309 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.11 -60.43 2.36 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.899 -0.778 . . . . 64.099999999999994 108.899 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -175.89 -71.71 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.797 1.239 . . . . 71.099999999999994 108.063 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -156.16 61.71 2.77 Favored Pre-proline 0 CA--C 1.562 1.438 0 C-N-CA 123.787 0.835 . . . . 72.409999999999997 110.405 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -90.93 -154.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.161 2.574 . . . . 64.150000000000006 111.615 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.25 169.19 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.435 0 C-N-CA 124.15 0.98 . . . . 52.100000000000001 110.041 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.46 109.08 0.31 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.099 0.96 . . . . 72.209999999999994 110.96 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.7 m -94.85 17.97 12.7 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.588 1.155 . . . . 72.340000000000003 112.433 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -58.51 -43.02 88.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.443 1.097 . . . . 63.409999999999997 112.587 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -128.7 120.11 25.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.734 0.814 . . . . 73.230000000000004 110.325 -174.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.79 101.27 3.95 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 106.63 -1.618 . . . . 74.120000000000005 106.63 175.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.49 -52.44 8.47 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 124.126 3.217 . . . . 54.140000000000001 114.044 -164.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -112.45 -43.68 3.47 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.886 -0.783 . . . . 75.129999999999995 108.886 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.74 -50.1 1.06 Allowed Glycine 0 CA--C 1.537 1.442 0 N-CA-C 116.34 1.296 . . . . 42.130000000000003 116.34 166.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.445 HD22 ' HB ' ' A' ' 43' ' ' VAL . 18.2 tp -68.53 90.59 0.39 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.989 0.894 . . . . 73.099999999999994 110.665 -173.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.1 p -72.33 83.24 1.05 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.746 1.218 . . . . 72.340000000000003 112.998 -171.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.58 -53.36 3.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.294 0.638 . . . . 65.120000000000005 109.658 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.07 -10.93 16.3 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.454 0.909 . . . . 74.120000000000005 113.454 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.37 96.48 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.615 0.766 . . . . 71.420000000000002 111.697 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -125.95 -40.43 2.03 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.247 0.619 . . . . 55.450000000000003 110.919 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -84.78 66.67 9.76 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.967 0.889 . . . . 74.519999999999996 110.931 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -69.78 -31.75 69.85 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.218 -1.355 . . . . 65.230000000000004 109.428 166.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.9 p -80.21 6.28 12.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.921 1.288 . . . . 74.140000000000001 113.048 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.3 -48.16 82.66 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.871 0.468 . . . . 71.400000000000006 110.983 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -71.78 -24.97 61.84 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.217 0.607 . . . . 70.329999999999998 111.172 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 15.6 m120 -88.38 -2.46 58.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.706 0.802 . . . . 54.420000000000002 111.671 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.402 HD13 ' HE1' ' A' ' 146' ' ' TRP . 29.1 tp -61.84 -47.98 82.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.012 0.925 . . . . 65.329999999999998 111.304 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.02 36.1 2.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.142 0.977 . . . . 63.520000000000003 109.87 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . -76.58 -20.69 56.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.529 0.731 . . . . 72.049999999999997 110.938 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.11 -150.45 23.87 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.435 -0.647 . . . . 74.420000000000002 112.951 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.73 -173.09 1.65 Allowed 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.869 3.046 . . . . 75.420000000000002 112.796 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.2 m -55.48 136.99 49.36 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.531 -0.759 . . . . 63.210000000000001 110.914 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.03 -47.17 75.28 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.503 0.927 . . . . 75.310000000000002 113.503 -165.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -132.49 -40.75 0.98 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.476 0.655 . . . . 73.409999999999997 111.013 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.712 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 6.3 m-20 -93.67 122.61 62.08 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 114.63 -1.168 . . . . 74.319999999999993 110.243 -171.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.59 -21.36 59.6 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.3 2.0 . . . . 70.430000000000007 111.608 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -98.01 16.58 20.62 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.528 1.131 . . . . 64.230000000000004 112.073 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.712 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 30.1 tp -83.54 120.07 25.48 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.827 -0.805 . . . . 71.239999999999995 108.827 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.8 m-85 -109.06 175.2 5.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.33 1.452 . . . . 65.420000000000002 108.717 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.34 135.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.756 1.222 . . . . 44.149999999999999 109.213 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.72 112.98 9.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.98 0.912 . . . . 73.239999999999995 110.404 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.19 -31.55 38.76 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.249 0.62 . . . . 75.049999999999997 111.32 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 55.3 m-85 -126.34 141.71 51.8 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.33 1.052 . . . . 74.030000000000001 108.758 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.96 122.98 27.38 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.83 -0.804 . . . . 72.140000000000001 108.83 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.461 ' HB3' HG12 ' A' ' 101' ' ' ILE . 78.5 t80 -111.66 135.47 52.2 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.524 -0.917 . . . . 71.120000000000005 108.524 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.95 130.17 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.278 -1.379 . . . . 62.100000000000001 107.278 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.96 132.62 53.29 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.119 0.887 . . . . 72.420000000000002 111.669 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -95.34 13.29 26.19 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.34 1.056 . . . . 62.539999999999999 111.189 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.21 -171.65 44.05 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.1 -0.5 . . . . 70.219999999999999 112.014 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -69.93 -41.85 74.06 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.736 0.814 . . . . 74.430000000000007 112.759 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -82.99 -25.92 31.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.951 0.9 . . . . 73.430000000000007 111.522 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -75.72 158.37 32.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.297 0.639 . . . . 74.319999999999993 109.733 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.414 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 53.2 tp -127.82 137.37 52.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.807 0.443 . . . . 70.200000000000003 111.49 -169.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -86.61 118.02 25.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.881 0.872 . . . . 74.420000000000002 110.168 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.629 HG22 HG21 ' A' ' 123' ' ' THR . 31.7 pt -122.12 162.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.812 0.845 . . . . 71.439999999999998 110.349 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -129.16 152.52 48.66 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 72.140000000000001 109.358 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -57.67 136.87 56.89 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.858 0.863 . . . . 72.010000000000005 112.143 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.5 67.77 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 123.586 0.612 . . . . 22.030000000000001 113.993 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.09 130.24 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.284 0.542 . . . . 73.099999999999994 111.237 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.13 123.21 28.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.141 0.977 . . . . 71.420000000000002 109.107 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.791 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -133.69 146.34 50.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.519 0.728 . . . . 72.409999999999997 110.857 -175.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -96.96 112.62 24.29 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.199 0.6 . . . . 71.25 110.447 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.615 HG13 ' HB1' ' A' ' 119' ' ' ALA . 55.5 t -79.9 117.33 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.447 0.641 . . . . 65.049999999999997 109.671 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.462 HD12 ' HG3' ' A' ' 120' ' ' GLU . 29.6 mt -89.64 -19.35 24.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.069 1.348 . . . . 71.430000000000007 110.88 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.51 147.42 5.05 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.146 -0.934 . . . . 63.109999999999999 111.375 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.635 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 23.3 m-85 -87.42 178.58 6.78 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.561 0.745 . . . . 74.140000000000001 111.033 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.66 HD21 ' HB2' ' A' ' 117' ' ' GLU . 9.9 p30 -90.54 -174.0 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 70.099999999999994 110.918 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -44.75 -45.31 9.87 Favored 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 126.318 1.847 . . . . 73.340000000000003 114.389 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -115.86 7.81 14.6 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.15 0.58 . . . . 61.5 111.92 174.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.635 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 71.74 30.77 65.7 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 116.939 1.536 . . . . 50.039999999999999 116.939 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.66 ' HB2' HD21 ' A' ' 113' ' ' ASN . 22.4 mt-10 -68.48 -42.96 77.92 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 119.028 1.414 . . . . 61.43 109.972 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.58 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 51.4 m95 -123.05 159.57 28.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 75.099999999999994 110.204 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.615 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -135.37 138.52 43.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.185 0.994 . . . . 74.109999999999999 110.022 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.1 tp10 -69.36 98.06 1.03 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 106.786 -1.561 . . . . 75.120000000000005 106.786 168.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.91 140.65 38.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.486 0.714 . . . . 73.239999999999995 110.854 -173.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -114.5 107.66 15.81 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.178 -0.919 . . . . 74.329999999999998 108.748 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.791 HG22 ' HB3' ' A' ' 107' ' ' LEU . 72.4 p -116.15 175.52 5.51 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.101 1.361 . . . . 74.0 110.491 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -75.6 -10.4 59.41 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.6 -0.727 . . . . 72.549999999999997 110.466 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -76.93 -22.74 52.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.819 0.848 . . . . 74.530000000000001 110.355 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.78 -160.48 23.24 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 112.233 -0.347 . . . . 31.52 112.233 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -104.09 137.82 41.49 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.983 0.913 . . . . 63.539999999999999 109.625 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 164.46 178.08 37.62 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 121.083 -0.579 . . . . 54.109999999999999 112.971 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -90.24 128.54 36.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.862 0.865 . . . . 71.140000000000001 112.19 -170.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 m -132.17 143.62 49.69 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.137 0.975 . . . . 74.5 108.936 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 6.2 Cg_exo -76.14 146.4 28.68 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 C-N-CA 122.685 2.257 . . . . 65.400000000000006 113.977 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -41.52 -46.92 3.66 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.882 1.673 . . . . 60.210000000000001 113.173 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.498 ' HB3' ' HB1' ' A' ' 26' ' ' ALA . 9.2 p-10 -75.35 2.52 11.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.661 0.784 . . . . 52.439999999999998 112.871 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.418 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -109.21 -9.63 15.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.681 0.792 . . . . 64.340000000000003 111.507 171.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.2 pt -132.26 175.86 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.904 0.882 . . . . 65.310000000000002 110.782 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 142' ' ' GLU . 9.0 t -162.54 151.7 12.88 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.562 -0.903 . . . . 54.310000000000002 108.562 170.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 24.7 Cg_endo -60.11 149.56 84.07 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 121.636 1.557 . . . . 72.150000000000006 111.414 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.5 t -73.41 -7.05 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.465 0 CA-C-O 121.617 0.722 . . . . 60.140000000000001 110.119 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -79.49 -8.32 59.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.274 1.03 . . . . 74.450000000000003 112.173 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.2 p -95.6 171.45 8.67 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.499 0.666 . . . . 63.020000000000003 112.612 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.2 mt -85.28 -20.11 30.55 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.806 -1.088 . . . . 74.329999999999998 111.365 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.403 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.6 mp0 -65.82 -21.44 66.48 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.684 0.794 . . . . 73.519999999999996 112.008 -172.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.58 -13.59 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.241 0.616 . . . . 72.319999999999993 112.5 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -90.71 141.75 28.47 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.403 0.681 . . . . 65.549999999999997 109.969 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.6 m -58.5 -39.96 81.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.722 1.209 . . . . 73.109999999999999 112.39 -175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.402 ' HE1' HD13 ' A' ' 73' ' ' LEU . 39.8 p-90 -70.11 -30.51 67.73 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 74.430000000000007 112.811 -175.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -82.55 117.65 22.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.558 -0.534 . . . . 74.209999999999994 109.558 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -112.12 -6.48 14.14 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.272 0.629 . . . . 74.530000000000001 111.681 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.83 -141.22 34.36 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 118.345 -1.253 . . . . 73.239999999999995 112.89 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -59.65 94.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.561 2.841 . . . . 72.319999999999993 113.144 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.652 HG22 HH12 ' A' ' 239' ' ' ARG . 85.6 t -133.93 132.02 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 44.520000000000003 108.905 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.4 p -78.57 173.01 12.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.446 0.699 . . . . 63.210000000000001 110.408 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -60.41 -43.6 96.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.299 0.639 . . . . 75.129999999999995 109.964 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.9 -46.59 88.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.925 0.89 . . . . 61.219999999999999 111.091 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.39 -26.4 63.69 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.028 0.531 . . . . 70.510000000000005 111.441 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.32 62.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.911 0.484 . . . . 51.229999999999997 110.671 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.08 -21.61 61.48 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.764 -0.653 . . . . 61.140000000000001 110.597 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -64.64 -49.06 72.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.499 0.719 . . . . 72.420000000000002 109.728 170.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.401 HD21 ' HD3' ' A' ' 239' ' ' ARG . 73.9 mt -58.85 -39.22 80.65 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.595 -0.73 . . . . 74.010000000000005 110.947 175.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.8 -3.71 55.8 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.823 1.046 . . . . 63.539999999999999 113.823 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 61.3 p -69.47 -34.21 74.03 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.767 1.167 . . . . 65.420000000000002 110.239 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 p -90.02 9.1 29.3 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.234 1.014 . . . . 70.519999999999996 110.867 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -105.45 156.61 16.61 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 123.996 0.808 . . . . 55.229999999999997 111.723 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 26.8 pt -103.83 -176.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 124.955 1.302 . . . . 62.310000000000002 112.006 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.53 121.25 11.07 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.65 -0.705 . . . . 74.439999999999998 110.02 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.31 10.36 58.36 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 119.394 -0.67 . . . . 63.119999999999997 113.343 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 69.7 m -86.09 128.71 34.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.713 1.256 . . . . 73.200000000000003 111.148 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 183' ' ' SER . 13.3 p90 -135.52 167.24 21.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.077 0.551 . . . . 71.530000000000001 111.458 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.4 pp -164.22 143.54 7.62 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.008 -0.996 . . . . 73.329999999999998 108.926 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.666 HG22 HG12 ' A' ' 182' ' ' ILE . 90.8 t -98.13 137.86 24.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.439 -0.948 . . . . 72.319999999999993 108.439 167.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.501 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 34.8 ptt85 -134.3 160.67 37.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.962 1.305 . . . . 70.510000000000005 109.108 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.33 151.42 33.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.977 -1.49 . . . . 62.25 106.977 165.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 t -84.98 123.21 30.27 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.703 -0.851 . . . . 53.439999999999998 108.703 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.59 -35.6 73.11 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.565 -0.531 . . . . 61.5 109.565 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 p -71.64 -34.86 70.14 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.402 -0.817 . . . . 52.43 111.111 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.3 m -124.25 90.66 50.54 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 123.405 0.682 . . . . 62.43 109.943 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.28 127.56 24.43 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.499 2.8 . . . . 75.140000000000001 112.947 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.51 -28.32 15.45 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.915 -0.584 . . . . 75.340000000000003 112.969 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.426 ' HB3' ' NH1' ' A' ' 194' ' ' ARG . 79.2 mm-40 -69.03 115.03 7.86 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.293 -0.632 . . . . 75.299999999999997 109.293 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -119.82 149.22 42.42 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 109.882 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.2 m -148.0 152.12 36.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.806 -1.088 . . . . 64.219999999999999 109.704 -172.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.666 HG12 HG22 ' A' ' 170' ' ' VAL . 23.6 mt -102.47 150.05 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 106.511 -1.663 . . . . 52.530000000000001 106.511 166.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.7 m -125.93 107.1 10.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.708 -1.219 . . . . 63.329999999999998 107.708 171.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 168' ' ' PHE . 56.9 tp -107.5 110.91 22.95 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.538 0.608 . . . . 63.5 109.785 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 190' ' ' VAL . 59.1 ttt180 -80.66 121.36 25.76 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.054 0.542 . . . . 71.430000000000007 109.799 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.1 145.73 31.53 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.506 1.522 . . . . 74.549999999999997 107.688 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 57.97 22.39 8.75 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.931 0.892 . . . . 62.43 112.333 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.94 -9.4 72.33 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.333 -0.704 . . . . 72.200000000000003 114.538 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -113.35 150.37 32.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.291 1.045 . . . . 74.129999999999995 109.99 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . 41.8 t -99.08 111.24 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.851 0.46 . . . . 63.509999999999998 110.672 -177.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -93.73 112.22 24.05 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.278 -1.008 . . . . 54.32 108.278 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -89.64 124.49 34.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.714 -0.676 . . . . 75.209999999999994 109.209 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.417 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.0 m-85 -93.65 146.37 23.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.371 -0.974 . . . . 75.239999999999995 108.371 172.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 179' ' ' GLN . 6.8 tpp180 -106.41 120.64 42.42 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.994 -1.113 . . . . 72.099999999999994 107.994 175.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mt -79.03 100.3 3.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.05 -1.092 . . . . 53.25 108.05 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.427 ' N ' HD22 ' A' ' 196' ' ' ASN . 0.8 OUTLIER -80.37 145.34 32.08 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.476 -0.935 . . . . 74.519999999999996 108.476 177.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.6 m -105.87 136.78 44.9 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.122 0.969 . . . . 75.420000000000002 109.355 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.96 178.23 8.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.073 0.949 . . . . 75.200000000000003 110.15 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 p -65.68 -33.48 75.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.128 0.571 . . . . 75.209999999999994 111.706 -174.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.24 -13.53 28.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.643 0.377 . . . . 71.5 111.086 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 115.57 15.12 7.7 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 115.886 1.115 . . . . 42.0 115.886 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -68.99 141.51 54.89 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.291 1.045 . . . . 74.439999999999998 111.654 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.47 141.58 28.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.66 0.784 . . . . 74.030000000000001 109.153 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.572 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 45.1 p90 -164.98 148.01 8.39 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.54 0.525 . . . . 64.099999999999994 111.72 175.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.423 HG23 HD11 ' A' ' 217' ' ' LEU . 91.4 t -93.43 -40.36 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.174 -1.047 . . . . 75.340000000000003 108.174 164.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.0 m -99.9 125.13 45.84 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.011 -0.995 . . . . 71.430000000000007 108.831 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.8 t -62.81 -28.23 69.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.481 0.712 . . . . 54.140000000000001 111.41 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.87 -25.17 62.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.633 1.173 . . . . 74.129999999999995 110.55 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.5 m -129.45 89.94 2.92 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.58 0.752 . . . . 75.519999999999996 110.328 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.572 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 94.3 mtt180 -103.3 134.31 46.91 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.328 -0.619 . . . . 63.409999999999997 109.328 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -119.38 151.15 38.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.97 0.908 . . . . 74.5 108.602 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -74.04 -28.09 61.25 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.573 0.546 . . . . 74.349999999999994 110.468 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.8 p -132.74 156.01 47.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.876 0.87 . . . . 73.549999999999997 112.144 -177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -69.14 -25.88 64.6 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 114.272 -1.331 . . . . 73.349999999999994 109.427 172.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.14 96.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.4 0.68 . . . . 63.310000000000002 110.675 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.71 -41.88 87.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.47 0.708 . . . . 34.030000000000001 111.336 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.423 HD11 HG23 ' A' ' 205' ' ' VAL . 16.7 tp -52.49 -57.13 10.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 123.52 0.512 . . . . 71.209999999999994 111.157 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.84 -46.39 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.641 0.588 . . . . 72.340000000000003 111.415 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -55.72 -55.68 29.34 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.56 0.744 . . . . 75.310000000000002 111.447 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -67.82 -37.84 82.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.991 -1.004 . . . . 75.409999999999997 110.622 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.631 ' HB3' HD11 ' A' ' 228' ' ' LEU . 15.9 m170 -86.63 -4.41 59.17 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.544 0.572 . . . . 74.400000000000006 112.544 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.7 p -93.95 -35.11 12.8 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.595 0.358 . . . . 73.400000000000006 110.706 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 47.5 p -74.81 -42.13 58.64 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 116.061 -0.518 . . . . 74.040000000000006 111.855 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.76 HG23 ' HB2' ' A' ' 226' ' ' ASP . 31.6 m -128.35 158.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.334 0.654 . . . . 60.43 111.131 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.14 15.34 0.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.46 1.904 . . . . 74.439999999999998 114.027 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.76 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.9 t70 -44.47 33.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 1 C-N-CA 132.556 4.343 . . . . 64.329999999999998 119.386 -153.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.34 -0.82 9.61 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 120.07 -1.644 . . . . 51.009999999999998 112.049 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 221' ' ' HIS . 15.4 mt -92.19 161.65 14.64 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.725 1.21 . . . . 74.349999999999994 109.768 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.9 tt -57.61 -37.01 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 O-C-N 123.419 0.449 . . . . 63.039999999999999 110.673 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.6 t -161.5 176.23 11.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.162 0.985 . . . . 65.310000000000002 109.682 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -64.29 145.47 55.96 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.853 0.861 . . . . 72.329999999999998 111.931 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.417 HD21 ' HE1' ' A' ' 193' ' ' TYR . 66.8 mt -75.54 119.48 19.65 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 108.606 -0.887 . . . . 70.109999999999999 108.606 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -113.19 -80.05 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.514 0.597 . . . . 72.430000000000007 112.206 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.7 t80 -87.14 120.0 71.22 Favored Pre-proline 0 C--O 1.208 -1.124 0 C-N-CA 124.266 1.027 . . . . 73.140000000000001 108.438 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.33 136.03 9.79 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 121.632 1.555 . . . . 74.140000000000001 110.947 171.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.87 136.6 96.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 108.9 -0.778 . . . . 70.439999999999998 108.9 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.49 171.94 16.03 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.01 1.807 . . . . 73.439999999999998 112.987 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.521 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 73.7 mmtt -70.33 108.54 4.26 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.053 -1.091 . . . . 72.040000000000006 108.053 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.652 HH12 HG22 ' A' ' 151' ' ' VAL . 15.6 ptt-85 -68.83 -62.92 1.18 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.838 1.051 . . . . 72.209999999999994 113.838 -160.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.521 ' ND2' ' HB3' ' A' ' 30' ' ' GLU . 63.1 t30 -110.29 154.58 23.26 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.923 0.889 . . . . 75.450000000000003 109.814 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.21 112.66 27.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 106.188 -1.782 . . . . 64.140000000000001 106.188 158.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.482 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 39.3 Cg_exo -60.52 124.54 15.3 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.752 2.301 . . . . 63.539999999999999 112.965 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 16.6 m -65.46 123.56 19.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.502 0.721 . . . . 34.119999999999997 111.179 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.37 124.5 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 108.356 -0.979 . . . . 74.400000000000006 108.356 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -102.46 114.89 29.48 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.462 0.542 . . . . 75.140000000000001 112.462 -164.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 56.74 44.08 91.7 Favored Glycine 0 N--CA 1.482 1.712 0 O-C-N 124.046 0.841 . . . . 61.509999999999998 115.124 163.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -103.45 124.36 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 114.228 1.196 . . . . 55.109999999999999 114.228 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.3 t -86.09 119.09 71.48 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 104.057 -2.572 . . . . 63.240000000000002 104.057 143.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.02 -62.11 0.23 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 120.965 1.38 . . . . 74.219999999999999 113.0 -158.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -129.26 -13.34 4.44 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.506 -0.924 . . . . 74.439999999999998 108.506 148.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.51 103.2 13.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.419 -1.264 . . . . 74.310000000000002 111.109 -149.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -119.59 -44.96 2.53 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.235 -1.024 . . . . 74.040000000000006 108.235 158.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -109.25 -17.2 13.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.329 1.052 . . . . 73.319999999999993 112.073 -175.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -50.34 155.14 1.08 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.978 1.311 . . . . 72.030000000000001 113.772 -161.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.036 0.935 . . . . 75.400000000000006 108.7 178.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.819 -0.067 . . . . 71.430000000000007 110.819 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.35 78.83 0.55 Allowed Glycine 0 C--N 1.356 1.692 0 O-C-N 123.166 0.291 . . . . 63.240000000000002 113.356 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -176.05 100.04 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.597 1.559 . . . . 65.409999999999997 107.632 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.428 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -82.71 -53.33 0.63 Allowed Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.62 0.768 . . . . 71.450000000000003 110.636 173.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 4' ' ' GLN . 51.5 Cg_endo -90.42 70.89 1.44 Allowed 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.205 1.937 . . . . 51.32 112.364 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.55 -59.25 6.85 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.419 -0.81 . . . . 74.420000000000002 112.169 171.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.31 -27.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.5 1.12 . . . . 74.409999999999997 110.473 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.5 t 61.84 -84.87 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 125.407 1.483 . . . . 74.450000000000003 110.588 -169.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.2 mt 56.86 -163.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.549 1.14 . . . . 71.109999999999999 111.718 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.12 -176.34 37.94 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 112.305 -0.318 . . . . 53.039999999999999 112.305 176.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.25 16.01 26.41 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.526 0.73 . . . . 72.230000000000004 111.073 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -64.04 168.98 4.72 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.421 0.688 . . . . 74.109999999999999 110.759 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -154.85 88.31 1.18 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.781 -0.822 . . . . 72.519999999999996 108.781 -168.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -96.88 101.5 9.56 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.65 0.78 . . . . 70.510000000000005 110.496 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.541 ' HB3' HD13 ' A' ' 110' ' ' LEU . 62.1 Cg_endo -69.22 80.43 0.73 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.061 2.507 . . . . 73.230000000000004 113.162 -178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -74.79 156.57 36.38 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.662 -0.699 . . . . 65.299999999999997 109.883 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.5 mt -123.68 80.57 55.27 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 123.149 0.58 . . . . 74.319999999999993 110.939 -174.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -79.99 -46.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.01 2.473 . . . . 74.120000000000005 112.849 169.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 64.51 162.19 0.12 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.225 1.41 . . . . 65.140000000000001 112.625 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.68 HD11 ' HA3' ' A' ' 116' ' ' GLY . 66.1 mt -143.21 154.45 43.86 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.527 0.731 . . . . 55.350000000000001 110.773 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -160.88 114.09 2.0 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.539 1.135 . . . . 71.299999999999997 108.594 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HE2' HD13 ' A' ' 20' ' ' LEU . 45.4 p90 -165.41 160.95 18.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.719 0.808 . . . . 75.219999999999999 110.021 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.03 -33.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.858 0.863 . . . . 53.210000000000001 109.955 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 66.0 -170.41 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.875 1.27 . . . . 73.219999999999999 111.333 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.01 144.49 6.82 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.658 -0.247 . . . . 62.140000000000001 112.738 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB3' ' HA ' ' A' ' 176' ' ' SER . . . -160.26 177.97 10.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.398 1.079 . . . . 62.030000000000001 109.966 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.54 61.41 0.37 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.128 -0.487 . . . . 72.549999999999997 112.161 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -103.82 95.2 5.86 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.48 -1.304 . . . . 72.319999999999993 107.48 171.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.72 130.74 39.57 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.485 -0.561 . . . . 73.120000000000005 109.485 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.93 135.65 31.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.848 -1.167 . . . . 74.120000000000005 107.848 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.0 t -70.58 163.68 26.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.649 0.779 . . . . 71.519999999999996 111.53 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.535 ' OG ' ' HD2' ' A' ' 153' ' ' ARG . 9.5 t -155.76 130.13 8.91 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.517 -0.549 . . . . 72.209999999999994 109.517 -170.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -137.49 124.85 21.88 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.337 0.655 . . . . 72.129999999999995 110.844 -174.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.483 ' HB3' ' HE ' ' A' ' 153' ' ' ARG . 39.0 t-80 176.82 179.32 0.21 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.025 1.33 . . . . 74.219999999999999 108.171 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.87 89.74 0.95 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 121.882 -0.512 . . . . 53.530000000000001 113.04 169.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.76 51.84 0.39 Allowed Glycine 0 CA--C 1.541 1.704 0 CA-C-O 118.668 -1.073 . . . . 73.140000000000001 113.781 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.45 -178.37 4.41 Favored 'Trans proline' 0 C--N 1.387 2.563 0 CA-C-N 120.53 2.165 . . . . 71.319999999999993 112.495 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -149.57 129.2 13.16 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.435 0.694 . . . . 73.319999999999993 110.094 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' N ' HH22 ' A' ' 185' ' ' ARG . 35.7 t 173.18 171.33 0.14 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.239 1.416 . . . . 73.450000000000003 109.338 177.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -158.23 148.03 19.83 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.701 -0.481 . . . . 75.200000000000003 109.701 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -144.68 150.87 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.058 0.943 . . . . 63.240000000000002 109.392 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -102.34 156.28 17.69 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.198 0.599 . . . . 75.540000000000006 109.923 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 21.3 t -131.89 176.24 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.027 -1.101 . . . . 71.120000000000005 108.027 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.8 OUTLIER -82.92 158.58 22.57 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.512 1.125 . . . . 74.019999999999996 109.579 172.597 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.482 ' O ' ' HB3' ' A' ' 59' ' ' GLN . 71.7 m80 78.99 132.39 0.05 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 126.084 1.754 . . . . 64.219999999999999 111.29 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.411 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 10.4 pt-20 -131.66 146.83 52.39 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.512 0.725 . . . . 73.310000000000002 112.449 -168.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.66 -71.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.638 1.175 . . . . 70.209999999999994 108.278 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.1 tp -172.68 104.26 0.15 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 108.562 -0.903 . . . . 74.129999999999995 108.562 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -141.17 -163.19 1.5 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.249 1.019 . . . . 64.540000000000006 109.613 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -99.57 101.1 12.29 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.716 0.806 . . . . 71.129999999999995 109.557 170.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.758 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 38.4 Cg_endo -98.36 -161.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.874 2.383 . . . . 54.439999999999998 110.267 163.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.8 -159.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 C-N-CA 122.786 0.434 . . . . 71.219999999999999 111.212 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.09 119.48 2.94 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.695 0.798 . . . . 74.409999999999997 110.903 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 t -65.49 -9.96 30.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.889 1.275 . . . . 74.430000000000007 112.913 -171.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -51.35 -49.19 61.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.486 1.115 . . . . 52.149999999999999 111.017 171.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -125.95 69.01 1.19 Allowed 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.915 -1.513 . . . . 74.209999999999994 106.915 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.8 118.66 63.04 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 115.438 -0.801 . . . . 73.099999999999994 110.703 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 6.0 Cg_exo -81.33 -164.66 0.29 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.752 2.301 . . . . 71.420000000000002 111.039 167.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' A' ' 45' ' ' HIS . 23.1 mp0 -72.49 -75.1 0.14 Allowed 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.26 1.024 . . . . 72.200000000000003 111.399 -172.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.47 -7.13 81.91 Favored Glycine 0 N--CA 1.479 1.521 0 N-CA-C 115.971 1.149 . . . . 43.039999999999999 115.971 167.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.7 tt -92.48 88.25 6.29 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.232 1.016 . . . . 71.120000000000005 110.155 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.444 ' HB2' HG21 ' A' ' 43' ' ' VAL . 35.1 t -68.41 114.8 7.16 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.937 0.895 . . . . 54.0 111.629 174.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.03 -117.15 0.1 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.164 1.386 . . . . 73.439999999999998 108.484 173.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.98 -12.74 61.84 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.451 1.023 . . . . 71.299999999999997 113.314 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.02 -39.69 95.5 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.628 0.371 . . . . 74.340000000000003 111.557 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -112.19 -52.02 2.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.606 0.762 . . . . 74.400000000000006 109.548 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -90.86 64.32 5.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.894 0.855 . . . . 71.540000000000006 109.463 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 27.9 p30 -72.51 -14.84 61.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.158 -0.928 . . . . 73.340000000000003 110.848 174.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.6 p -84.0 4.92 27.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.959 0.904 . . . . 72.200000000000003 112.073 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -67.21 -22.71 65.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.764 0.425 . . . . 73.120000000000005 111.021 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 8.7 pt-20 -68.49 -39.65 81.22 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.161 0.505 . . . . 53.210000000000001 109.837 168.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 8.8 m120 -75.2 -10.24 59.29 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.198 -0.91 . . . . 63.240000000000002 110.972 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.28 -50.93 69.75 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.045 0.938 . . . . 72.319999999999993 110.572 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.62 23.79 13.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.369 0.668 . . . . 74.140000000000001 110.639 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 72' ' ' ASN . . . -71.56 -38.12 71.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.842 0.457 . . . . 73.340000000000003 111.355 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.57 -134.91 21.39 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.193 -0.782 . . . . 74.420000000000002 111.27 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.414 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 54.5 Cg_exo -53.73 154.16 17.2 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 123.07 2.514 . . . . 64.230000000000004 113.447 171.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -75.03 169.47 17.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.356 0.662 . . . . 74.049999999999997 109.965 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -58.38 -45.47 88.24 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.674 0.79 . . . . 52.119999999999997 112.925 -169.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.44 -34.23 1.83 Allowed 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.335 0.588 . . . . 50.299999999999997 111.056 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 4.6 m-20 -90.84 123.62 64.4 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 115.237 -0.892 . . . . 74.439999999999998 112.755 -163.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.2 -19.89 5.34 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.483 2.122 . . . . 71.120000000000005 112.379 167.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -110.21 19.36 18.99 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.067 0.947 . . . . 75.140000000000001 112.055 -172.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 30.5 tp -81.85 128.13 33.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.22 -0.659 . . . . 75.0 109.22 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -111.66 172.96 6.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.819 1.247 . . . . 73.530000000000001 108.684 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.75 138.21 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.279 1.032 . . . . 62.030000000000001 109.434 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.87 131.28 41.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 63.109999999999999 110.336 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.497 HD13 ' NZ ' ' A' ' 238' ' ' LYS . 77.5 mt -98.7 -26.56 14.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 65.109999999999999 111.329 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.424 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 48.6 m-85 -125.53 148.66 48.82 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.966 0.906 . . . . 74.340000000000003 108.739 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.2 136.33 46.37 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.61 -0.885 . . . . 74.230000000000004 108.61 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HB3' HG12 ' A' ' 101' ' ' ILE . 82.3 t80 -129.79 133.36 46.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.534 -1.284 . . . . 63.43 107.534 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -103.65 137.14 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 107.248 -1.39 . . . . 34.420000000000002 107.248 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.28 114.23 3.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.242 0.617 . . . . 74.040000000000006 110.942 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -86.91 -51.44 6.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.852 0.861 . . . . 63.43 109.64 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.92 -177.14 38.04 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 115.279 -0.873 . . . . 71.019999999999996 112.261 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.62 -32.88 60.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.772 0.829 . . . . 71.099999999999994 111.645 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.462 HD21 ' HG2' ' A' ' 249' ' ' PRO . 29.3 p-10 -92.32 -20.43 21.1 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.034 0.534 . . . . 71.129999999999995 111.689 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 78.0 p -71.1 154.16 41.97 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.549 0.53 . . . . 75.319999999999993 109.834 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 128' ' ' GLY . 49.5 tp -128.28 124.36 36.4 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.731 0.412 . . . . 55.240000000000002 111.417 -164.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 m -68.36 117.71 10.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.566 0.746 . . . . 74.349999999999994 110.848 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -119.24 154.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.475 0.71 . . . . 65.25 111.739 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 21.6 m -99.18 147.87 24.67 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.333 -1.303 . . . . 74.200000000000003 109.108 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.93 125.77 26.45 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.74 -0.467 . . . . 74.340000000000003 109.74 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.0 1.66 79.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 116.1 -0.5 . . . . 54.229999999999997 113.278 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 80.9 tt0 -84.9 121.24 27.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.381 0.59 . . . . 74.329999999999998 110.071 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.414 ' HD3' HD21 ' A' ' 84' ' ' LEU . 56.8 mttp -73.87 142.82 46.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.379 0.672 . . . . 74.120000000000005 110.155 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -148.33 150.01 32.85 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.452 1.101 . . . . 73.319999999999993 110.142 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -100.15 108.36 20.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.039 -0.726 . . . . 65.209999999999994 109.039 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.489 HG13 ' HB1' ' A' ' 119' ' ' ALA . 69.7 t -74.84 119.99 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.174 -0.676 . . . . 63.340000000000003 109.174 174.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.712 HD11 ' HG3' ' A' ' 122' ' ' GLN . 14.2 mt -82.07 -54.08 5.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.267 -1.333 . . . . 63.539999999999999 108.019 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.38 152.92 22.68 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.886 -1.052 . . . . 74.510000000000005 112.978 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.781 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 44.9 m-85 -89.29 174.72 7.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.903 0.881 . . . . 62.340000000000003 111.609 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.35 -173.59 4.8 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.13 0.972 . . . . 75.030000000000001 110.389 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -50.7 -39.47 51.43 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 113.741 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -111.16 2.08 17.62 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.453 0.701 . . . . 51.409999999999997 111.563 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.781 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.18 30.35 73.71 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.421 0.928 . . . . 65.340000000000003 115.421 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.48 -27.49 14.86 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.81 0.805 . . . . 75.319999999999993 110.889 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 28.2 m95 -114.38 152.18 31.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.317 1.047 . . . . 63.43 109.81 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.489 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.22 148.21 46.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.262 0.625 . . . . 55.140000000000001 111.26 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -96.64 118.86 34.03 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.434 -1.321 . . . . 73.209999999999994 107.434 166.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -132.8 151.12 52.07 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.141 0.976 . . . . 64.439999999999998 111.026 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.712 ' HG3' HD11 ' A' ' 110' ' ' LEU . 98.4 mt-30 -100.58 105.23 16.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.828 0.851 . . . . 75.099999999999994 109.243 175.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 107' ' ' LEU . 40.9 p -98.4 176.5 5.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.743 1.217 . . . . 73.340000000000003 110.649 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -64.76 -20.32 66.29 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.588 -0.733 . . . . 70.010000000000005 110.728 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -80.49 -32.1 37.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.882 0.873 . . . . 63.240000000000002 111.185 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 144.73 -168.78 26.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.829 -0.428 . . . . 51.100000000000001 112.153 -171.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -104.32 132.25 50.77 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.268 0.627 . . . . 63.5 110.414 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.47 ' N ' HD22 ' A' ' 99' ' ' LEU . . . 177.83 -165.49 35.12 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 111.775 -0.53 . . . . 72.129999999999995 111.775 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -100.12 121.75 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.598 0.962 . . . . 72.549999999999997 113.598 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 101' ' ' ILE . 18.1 m -132.69 136.76 28.36 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.246 1.418 . . . . 53.530000000000001 108.487 170.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 81.8 Cg_endo -85.45 155.21 10.65 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 122.074 1.85 . . . . 72.120000000000005 114.887 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 m -38.77 -47.23 1.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 126.199 1.8 . . . . 74.430000000000007 114.443 173.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -77.58 0.02 24.65 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.794 0.838 . . . . 72.129999999999995 112.665 -172.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 12.1 m-85 -105.6 -18.54 14.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.16 0.984 . . . . 74.25 111.459 171.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 109' ' ' VAL . 12.7 pt -123.97 175.67 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.889 0.876 . . . . 61.329999999999998 111.672 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 142' ' ' GLU . 12.0 t -161.41 150.82 13.69 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 123.797 0.839 . . . . 72.409999999999997 109.818 172.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.26 145.48 96.07 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.667 1.578 . . . . 73.349999999999994 111.853 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 41.7 t -73.78 -4.63 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 124.018 0.927 . . . . 73.420000000000002 110.797 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 77' ' ' PRO . 13.3 m120 -91.26 -18.61 24.11 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 62.43 111.905 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 99.6 p -91.71 179.09 5.73 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.866 0.467 . . . . 61.210000000000001 111.607 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.0 mt -84.45 -22.75 30.22 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.812 0.845 . . . . 71.109999999999999 111.665 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.402 ' HB2' ' OG1' ' A' ' 136' ' ' THR . 2.0 mp0 -66.97 -17.98 65.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.508 0.723 . . . . 72.310000000000002 112.173 -171.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -64.09 -13.56 48.43 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.272 0.629 . . . . 72.329999999999998 112.104 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -97.53 148.58 23.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.163 0.985 . . . . 73.400000000000006 109.859 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.2 p -64.98 -41.41 95.45 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.094 0.871 . . . . 72.209999999999994 111.582 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -60.92 -38.44 85.78 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.023 0.749 . . . . 54.420000000000002 113.023 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.93 100.51 11.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.529 -0.915 . . . . 74.430000000000007 108.529 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.479 ' HB2' HG21 ' A' ' 151' ' ' VAL . 77.1 m80 -96.41 8.78 43.17 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.277 0.473 . . . . 74.549999999999997 112.277 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.459 ' O ' HG23 ' A' ' 151' ' ' VAL . . . 69.27 -145.54 42.83 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 118.631 -1.094 . . . . 74.299999999999997 112.498 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.92 106.17 0.91 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.801 2.334 . . . . 51.420000000000002 111.963 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.634 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 14.5 t -123.12 131.96 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.642 0.777 . . . . 75.109999999999999 110.236 -177.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 151' ' ' VAL . 66.2 p -77.83 152.75 33.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.827 -0.805 . . . . 74.219999999999999 108.827 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.535 ' HD2' ' OG ' ' A' ' 32' ' ' SER . 34.6 ttt85 -55.81 -38.63 70.23 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.124 0.416 . . . . 73.219999999999999 112.124 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -58.08 -45.21 87.53 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.966 0.791 . . . . 74.129999999999995 111.138 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.82 75.75 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.677 -0.692 . . . . 55.030000000000001 111.179 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.15 68.95 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.463 0.649 . . . . 72.200000000000003 111.524 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -75.83 -19.72 58.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.306 0.642 . . . . 52.539999999999999 110.926 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -67.21 -44.3 79.92 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.653 0.781 . . . . 73.519999999999996 110.28 168.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.648 HD21 ' HB3' ' A' ' 239' ' ' ARG . 53.5 mt -60.19 -38.08 82.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.34 0.656 . . . . 74.310000000000002 111.187 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.98 20.72 10.74 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.464 -0.789 . . . . 74.010000000000005 112.321 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.0 p -66.35 -40.96 90.15 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.926 0.393 . . . . 65.439999999999998 110.977 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.4 p -104.96 14.61 29.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.277 1.031 . . . . 73.209999999999994 111.399 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.63 163.91 50.25 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 114.404 0.522 . . . . 53.210000000000001 114.404 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 17.9 pt -109.18 -175.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.618 1.167 . . . . 74.150000000000006 111.223 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 4.5 m-20 -56.64 123.81 16.16 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.295 -0.866 . . . . 72.519999999999996 110.432 171.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.454 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 88.01 10.98 68.3 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.755 -0.657 . . . . 54.409999999999997 113.393 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.7 m -81.0 118.13 22.21 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.434 1.117 . . . . 72.340000000000003 110.296 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.512 ' HB3' HD13 ' A' ' 184' ' ' LEU . 13.7 p90 -129.6 171.45 12.6 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.391 0.615 . . . . 74.230000000000004 112.557 -168.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.74 146.7 6.93 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 113.884 -1.507 . . . . 73.109999999999999 109.336 171.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.697 HG22 HG12 ' A' ' 182' ' ' ILE . 93.7 t -100.39 131.87 47.09 Favored 'Isoleucine or valine' 0 C--O 1.261 1.659 0 N-CA-C 108.567 -0.901 . . . . 64.239999999999995 108.567 167.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.634 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt85 -116.5 133.83 55.56 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.645 -1.161 . . . . 72.200000000000003 109.115 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 180' ' ' ARG . 8.6 tp10 -84.95 145.72 27.61 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.4 1.08 . . . . 71.340000000000003 108.2 166.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.5 t -83.02 126.69 32.82 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.339 -0.615 . . . . 61.119999999999997 109.339 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.47 -40.99 93.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.028 0.531 . . . . 71.239999999999995 109.929 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.8 p -70.09 -25.76 63.66 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 50.130000000000003 111.307 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.664 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 66.5 m -145.43 91.88 5.69 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 122.678 0.391 . . . . 73.230000000000004 111.68 -176.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.79 136.18 68.59 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.44 2.093 . . . . 45.210000000000001 111.625 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.23 -24.7 31.2 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 112.127 -173.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -95.78 114.76 26.52 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.743 -0.836 . . . . 71.129999999999995 108.743 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.635 HH11 HD12 ' A' ' 214' ' ' LEU . 94.4 mtt180 -131.29 157.15 44.07 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.221 0.608 . . . . 64.439999999999998 110.947 -171.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.5 m -145.36 147.85 32.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.636 0.774 . . . . 74.299999999999997 109.227 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.697 HG12 HG22 ' A' ' 170' ' ' VAL . 24.6 mt -103.96 125.84 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.923 -0.769 . . . . 75.200000000000003 108.923 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 14.5 m -96.72 110.21 22.7 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.691 -1.226 . . . . 63.439999999999998 107.691 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 168' ' ' PHE . 54.8 tp -116.54 111.79 20.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.22 1.008 . . . . 71.5 109.739 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.46 HH22 ' N ' ' A' ' 39' ' ' CYS . 41.5 ttt180 -81.59 127.69 33.14 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.178 0.991 . . . . 73.329999999999998 111.087 172.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 88.5 t80 -143.03 136.76 28.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.258 1.423 . . . . 72.109999999999999 107.947 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 53.78 29.18 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.208 1.003 . . . . 75.25 112.499 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.34 -12.6 64.28 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.035 -0.869 . . . . 73.099999999999994 114.669 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -97.81 146.43 25.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.212 1.006 . . . . 65.329999999999998 109.608 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.99 112.69 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 122.572 0.349 . . . . 71.319999999999993 110.1 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -97.94 143.87 28.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.716 1.207 . . . . 74.450000000000003 109.11 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -130.13 118.29 21.24 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.354 0.524 . . . . 72.430000000000007 110.227 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.584 ' CE1' HD22 ' A' ' 228' ' ' LEU . 0.6 OUTLIER -121.24 131.72 54.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.497 0.719 . . . . 75.109999999999999 111.045 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 21.4 tpp85 -70.72 131.27 43.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.428 1.091 . . . . 70.25 111.519 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.58 104.95 11.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.184 -1.043 . . . . 61.299999999999997 108.184 166.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -78.35 138.05 38.35 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.908 -0.775 . . . . 43.109999999999999 108.908 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -111.05 117.25 32.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.66 -0.867 . . . . 71.400000000000006 108.66 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.66 171.49 11.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.537 0.735 . . . . 74.049999999999997 111.258 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 12.8 p -64.52 -26.62 68.5 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.928 0.891 . . . . 74.230000000000004 112.639 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -81.75 -14.47 56.41 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.567 0.747 . . . . 74.140000000000001 111.828 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.44 11.19 39.33 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 119.802 -0.443 . . . . 72.310000000000002 113.432 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.403 ' HE2' ' OD1' ' A' ' 212' ' ' ASN . 98.2 mttt -79.39 132.61 36.45 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 116.901 0.35 . . . . 75.209999999999994 110.922 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.24 146.92 26.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.537 -0.912 . . . . 73.340000000000003 108.537 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.2 p90 -170.27 142.77 2.26 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.379 0.425 . . . . 75.209999999999994 111.128 176.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -89.49 -35.85 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.469 -0.937 . . . . 72.549999999999997 108.469 163.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.6 m -105.5 124.34 49.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.062 0.945 . . . . 73.409999999999997 109.474 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.4 t -65.03 -21.9 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.367 0.667 . . . . 64.209999999999994 111.435 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -66.18 -26.6 67.48 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.275 1.43 . . . . 64.310000000000002 111.459 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.3 m -144.22 106.67 4.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.192 0.597 . . . . 51.43 110.248 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 84.5 mtt180 -104.23 143.37 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.347 1.059 . . . . 55.229999999999997 109.206 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.641 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 6.3 m-85 -125.84 136.34 52.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.05 0.54 . . . . 71.040000000000006 110.073 -167.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.403 ' OD1' ' HE2' ' A' ' 202' ' ' LYS . 78.8 m-20 -57.51 -34.34 68.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.956 0.902 . . . . 71.430000000000007 111.031 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.3 p -131.2 154.4 48.45 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 122.016 0.912 . . . . 71.150000000000006 111.582 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.635 HD12 HH11 ' A' ' 180' ' ' ARG . 0.8 OUTLIER -62.65 -23.98 67.38 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.008 -1.451 . . . . 64.340000000000003 109.309 170.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.92 94.21 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.753 0.821 . . . . 55.210000000000001 111.005 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 53.9 mt-10 -72.92 -35.01 66.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.999 0.519 . . . . 60.329999999999998 111.021 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.35 -57.31 11.75 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.414 0.446 . . . . 74.319999999999993 110.053 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.88 -37.72 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 123.839 0.712 . . . . 64.239999999999995 111.54 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -63.32 -59.22 5.0 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.081 0.238 . . . . 74.239999999999995 111.572 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -63.47 -33.02 74.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.352 0.408 . . . . 73.129999999999995 110.942 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.645 ' HB3' HD11 ' A' ' 228' ' ' LEU . 16.5 m170 -88.96 -7.19 56.5 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.433 0.531 . . . . 63.329999999999998 112.433 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -88.23 -35.77 17.13 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.199 0.454 . . . . 70.400000000000006 110.273 168.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 54.0 p -68.98 -47.45 65.57 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.503 -0.771 . . . . 25.41 110.765 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.5 m -131.67 164.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.835 0.826 . . . . 63.299999999999997 112.445 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.33 13.87 1.08 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.864 2.066 . . . . 54.43 114.69 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.549 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.5 t70 -42.18 30.57 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 131.56 3.944 . . . . 64.439999999999998 119.409 -152.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.37 1.49 9.26 Favored Glycine 0 N--CA 1.486 2.031 0 O-C-N 120.065 -1.647 . . . . 61.210000000000001 112.354 -170.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 221' ' ' HIS . 9.6 mt -91.87 163.97 13.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.174 1.389 . . . . 73.340000000000003 108.839 169.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 11.4 tt -61.57 -35.98 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-O 120.67 0.271 . . . . 61.140000000000001 110.808 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -157.48 -179.07 7.82 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.513 0.725 . . . . 71.420000000000002 110.322 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 44.8 p -67.32 146.94 53.59 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.748 0.819 . . . . 72.0 111.68 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 80.8 mt -79.03 92.44 4.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 108.874 -0.788 . . . . 74.420000000000002 108.874 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -88.93 -65.1 1.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.686 0.795 . . . . 74.420000000000002 112.231 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -108.75 120.9 44.79 Favored Pre-proline 0 C--O 1.216 -0.68 0 C-N-CA 124.749 1.22 . . . . 74.439999999999998 109.451 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.51 129.96 4.39 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.009 1.806 . . . . 73.439999999999998 111.965 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . . . -69.22 135.71 89.09 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.058 0.543 . . . . 64.450000000000003 110.664 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 10.6 Cg_exo -72.27 172.74 14.26 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.825 2.35 . . . . 75.109999999999999 111.999 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.497 ' NZ ' HD13 ' A' ' 88' ' ' LEU . 33.7 mmtp -71.27 145.59 49.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.02 0.528 . . . . 72.430000000000007 111.478 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.648 ' HB3' HD21 ' A' ' 159' ' ' LEU . 20.8 ptt-85 -82.68 -63.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.248 0.833 . . . . 71.140000000000001 113.248 -163.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.533 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 48.0 t30 -113.39 130.51 56.28 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.015 0.926 . . . . 73.230000000000004 110.707 -174.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.73 113.41 32.12 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 107.484 -1.302 . . . . 73.439999999999998 107.484 164.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.65 124.44 13.68 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.892 2.394 . . . . 65.400000000000006 113.556 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 88.2 m -76.9 123.4 26.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.983 -0.747 . . . . 75.439999999999998 108.983 173.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.411 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 47.9 t -92.58 114.54 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.384 -0.969 . . . . 71.420000000000002 108.384 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -95.2 112.33 24.05 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.565 -0.255 . . . . 75.209999999999994 111.306 -167.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.68 5.92 2.23 Favored Glycine 0 CA--C 1.542 1.773 0 N-CA-C 118.28 2.072 . . . . 53.310000000000002 118.28 161.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.43 143.81 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.63 1.715 . . . . 65.030000000000001 111.615 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.6 t -77.54 128.91 78.7 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.592 -1.262 . . . . 62.119999999999997 107.592 167.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.462 ' HG2' HD21 ' A' ' 97' ' ' ASN . 78.5 Cg_exo -51.37 -52.21 9.54 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.703 2.269 . . . . 74.340000000000003 113.737 -167.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.687 HD22 ' HB2' ' A' ' 254' ' ' TRP . 65.7 t30 -128.38 -20.19 3.72 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.375 0.534 . . . . 70.140000000000001 111.13 154.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -69.17 98.01 0.97 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.731 0.777 . . . . 72.430000000000007 113.038 -145.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.532 ' HB2' ' HD2' ' A' ' 253' ' ' LYS . 4.3 m-20 -120.91 -46.24 2.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.503 -1.665 . . . . 60.340000000000003 106.503 152.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.532 ' HD2' ' HB2' ' A' ' 252' ' ' ASP . 2.1 mptp? -106.56 -39.21 5.92 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.543 -1.208 . . . . 72.430000000000007 110.499 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.687 ' HB2' HD22 ' A' ' 250' ' ' ASN . 3.1 t-105 -60.67 125.16 22.66 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.057 0.943 . . . . 75.310000000000002 110.605 -174.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.258 1.547 0 N-CA-C 107.715 -1.217 . . . . 71.200000000000003 107.715 175.446 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.253 -0.277 . . . . 74.430000000000007 110.253 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.24 -174.23 43.06 Favored Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.7 -0.56 . . . . 71.340000000000003 111.7 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 63.33 12.11 5.98 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.512 0.725 . . . . 73.109999999999999 112.228 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -135.86 100.26 11.03 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 123.831 0.852 . . . . 75.129999999999995 111.153 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -85.79 -165.2 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.284 2.656 . . . . 74.439999999999998 111.776 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.57 82.59 1.58 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.352 -0.299 . . . . 71.129999999999995 112.352 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.3 -38.63 11.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.915 0.886 . . . . 63.43 109.721 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 m 53.83 175.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 C-N-CA 126.525 1.93 . . . . 50.509999999999998 113.818 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.37 164.87 11.83 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.892 0.877 . . . . 74.439999999999998 109.219 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.58 123.24 0.89 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.44 -1.064 . . . . 71.120000000000005 110.44 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.53 142.26 20.97 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.477 0.639 . . . . 74.299999999999997 110.58 -174.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -169.13 124.74 0.88 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.123 0.969 . . . . 73.010000000000005 110.487 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -81.13 115.6 20.64 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.261 0.624 . . . . 75.430000000000007 109.332 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 53.7 mmt-85 -126.54 107.65 23.42 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.007 0.923 . . . . 75.340000000000003 110.109 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 14' ' ' ARG . 25.4 Cg_endo -60.44 117.15 3.87 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.346 2.698 . . . . 63.119999999999997 112.309 175.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -77.71 156.09 30.86 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.503 0.721 . . . . 62.43 110.855 175.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 mp -85.59 150.56 54.07 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.282 0.633 . . . . 72.209999999999994 109.749 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.599 ' HG3' ' HB3' ' A' ' 252' ' ' ASP . 73.3 Cg_endo -71.65 156.71 57.12 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.978 2.452 . . . . 70.310000000000002 112.449 176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.25 154.26 39.06 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.77 -0.65 . . . . 43.119999999999997 111.167 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -97.94 -179.85 4.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.292 1.037 . . . . 75.120000000000005 112.233 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -71.2 172.88 8.47 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.575 1.15 . . . . 63.420000000000002 111.8 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 59.2 t80 54.41 78.98 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.756 1.622 . . . . 75.150000000000006 112.464 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 10.8 tt -179.28 149.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.233 1.413 . . . . 54.310000000000002 108.759 174.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -104.46 167.19 9.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.225 0.61 . . . . 53.210000000000001 110.469 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.18 164.94 33.97 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 116.176 -0.465 . . . . 53.140000000000001 113.034 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.47 138.58 34.75 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.669 0.788 . . . . 54.409999999999997 109.936 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.06 -162.44 24.72 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 116.572 -0.285 . . . . 73.239999999999995 112.635 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -138.01 164.37 29.22 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.359 1.064 . . . . 74.209999999999994 109.756 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HG2' ' NE ' ' A' ' 239' ' ' ARG . 89.0 mtm180 -124.95 -175.39 3.28 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.774 1.23 . . . . 64.530000000000001 109.4 173.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 69.41 131.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.179 1.392 . . . . 74.049999999999997 111.996 -173.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.8 t -173.54 175.23 3.05 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 125.443 1.497 . . . . 62.149999999999999 108.169 174.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.1 m -95.07 145.52 24.92 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.319 0.648 . . . . 51.229999999999997 109.487 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -85.04 152.46 23.41 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.607 0.763 . . . . 52.140000000000001 109.585 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -160.85 105.2 1.37 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.868 0.467 . . . . 51.030000000000001 110.394 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.87 -140.83 5.74 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 123.788 0.68 . . . . 43.149999999999999 111.577 168.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.95 -167.08 27.11 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 117.127 0.464 . . . . 44.450000000000003 113.391 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.56 153.91 74.79 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 123.543 2.828 . . . . 75.140000000000001 112.198 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -83.43 132.33 34.98 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.778 0.323 . . . . 71.109999999999999 110.197 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.4 p -164.51 99.18 0.81 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.441 0.697 . . . . 43.329999999999998 109.659 -173.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 172.14 147.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.46 1.504 . . . . 61.039999999999999 109.207 170.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -56.29 160.26 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.989 1.315 . . . . 62.32 112.873 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -77.98 149.61 34.07 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.424 1.089 . . . . 72.319999999999993 112.193 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.9 p -173.01 -38.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 125.161 1.384 . . . . 71.299999999999997 109.845 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.649 ' H ' HD21 ' A' ' 61' ' ' LEU . 10.4 tp10 -133.7 140.3 46.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.1 0.96 . . . . 53.240000000000002 109.441 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -75.79 124.06 26.65 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.606 0.362 . . . . 74.439999999999998 110.935 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 165' ' ' ASN . 4.8 mm-40 -87.67 142.3 27.94 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.88 0.872 . . . . 75.200000000000003 109.502 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.71 99.33 0.79 Allowed 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.236 -1.024 . . . . 41.350000000000001 108.236 172.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.85 90.52 0.13 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.554 0.742 . . . . 72.319999999999993 110.236 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 7.9 tt0 -167.21 124.95 1.26 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 125.915 1.686 . . . . 72.230000000000004 107.053 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 98.19 -55.95 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 C-N-CA 128.013 2.525 . . . . 53.439999999999998 110.944 -171.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 49' ' ' GLN . 23.9 Cg_endo -63.85 94.63 0.19 Allowed 'Trans proline' 0 C--N 1.397 3.079 0 CA-C-N 122.26 1.843 . . . . 72.120000000000005 110.145 157.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -69.55 95.81 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 CA-C-O 121.797 0.808 . . . . 40.420000000000002 111.332 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.52 93.82 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.468 1.507 . . . . 74.439999999999998 111.464 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 m -87.22 41.8 1.0 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.546 0.738 . . . . 74.450000000000003 110.25 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.93 -53.93 38.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.543 1.137 . . . . 62.009999999999998 111.623 -172.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -78.46 -6.72 56.13 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.655 0.782 . . . . 75.349999999999994 112.399 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -65.43 122.0 77.91 Favored Pre-proline 0 N--CA 1.475 0.803 0 N-CA-C 112.988 0.736 . . . . 72.219999999999999 112.988 -171.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -86.73 0.93 7.7 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.938 2.425 . . . . 71.150000000000006 110.893 162.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -113.27 -79.35 0.58 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.606 1.162 . . . . 72.430000000000007 109.354 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.53 -48.72 4.03 Favored Glycine 0 C--N 1.361 1.949 0 CA-C-N 116.16 -0.473 . . . . 75.5 113.863 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.649 HD21 ' H ' ' A' ' 44' ' ' GLU . 8.5 mp -85.99 -177.67 6.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.643 1.177 . . . . 72.409999999999997 112.824 -167.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 m -148.0 41.98 1.02 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.518 1.127 . . . . 53.450000000000003 110.625 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 233' ' ' HIS . 31.7 tt0 -86.62 -90.86 0.11 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 119.207 -0.425 . . . . 62.549999999999997 111.179 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.38 -24.74 64.81 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.374 1.069 . . . . 75.519999999999996 113.818 -164.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.44 -26.42 60.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.68 0.276 . . . . 73.049999999999997 110.974 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -89.5 -42.64 11.35 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.552 0.692 . . . . 72.329999999999998 109.5 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -94.11 69.89 3.83 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.096 -0.956 . . . . 73.329999999999998 108.932 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -65.93 -25.13 67.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.853 -1.067 . . . . 63.009999999999998 110.419 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.5 m -75.3 4.45 7.11 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.967 1.307 . . . . 74.5 113.155 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -69.99 -33.82 72.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.332 0.515 . . . . 73.439999999999998 110.902 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.75 -36.12 43.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.947 0.499 . . . . 63.420000000000002 110.126 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -74.03 -7.28 51.89 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.626 0.77 . . . . 52.439999999999998 111.523 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.75 -23.95 67.57 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.63 1.172 . . . . 74.129999999999995 111.322 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.55 14.3 20.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.927 0.891 . . . . 61.020000000000003 110.968 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.6 -27.04 67.39 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.156 0.582 . . . . 73.019999999999996 111.307 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.17 -137.79 22.53 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.281 -0.733 . . . . 75.310000000000002 111.908 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.766 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 25.5 Cg_endo -59.96 -176.94 0.13 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.342 2.694 . . . . 71.450000000000003 114.109 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 m -58.2 155.76 10.87 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.729 -1.123 . . . . 73.019999999999996 111.913 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -65.16 -50.32 66.43 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.475 0.546 . . . . 74.200000000000003 112.475 -163.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -133.54 -36.58 0.96 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.84 0.456 . . . . 72.230000000000004 111.324 171.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.772 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 7.2 m-20 -89.45 111.84 48.0 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-O 117.822 -1.085 . . . . 54.310000000000002 110.793 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.93 -27.83 46.38 Favored 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.791 2.327 . . . . 63.130000000000003 113.715 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -98.45 18.5 16.42 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 124.878 1.271 . . . . 72.340000000000003 111.156 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.772 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 36.4 tp -85.07 131.41 34.46 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.368 -0.833 . . . . 74.299999999999997 110.339 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.0 m-85 -111.24 172.64 6.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.507 1.123 . . . . 71.420000000000002 108.443 173.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.41 137.22 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.215 1.006 . . . . 73.519999999999996 109.376 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.75 122.17 21.97 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.515 0.726 . . . . 74.349999999999994 110.8 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.4 mt -76.69 -35.87 57.6 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.708 0.803 . . . . 72.519999999999996 110.811 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.452 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 20.1 m-85 -124.31 168.21 13.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.2 -0.909 . . . . 72.030000000000001 109.888 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.65 117.71 24.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.207 -1.035 . . . . 75.150000000000006 108.207 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.662 ' HB3' HG12 ' A' ' 101' ' ' ILE . 61.3 t80 -106.46 131.55 53.51 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.374 -1.343 . . . . 64.420000000000002 107.374 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.14 133.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.871 -0.788 . . . . 65.109999999999999 108.871 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.33 123.2 20.56 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.279 0.631 . . . . 44.409999999999997 109.871 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 p -86.23 -16.31 38.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.601 0.76 . . . . 65.099999999999994 110.997 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -158.83 -173.7 27.58 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.621 -0.718 . . . . 75.400000000000006 111.483 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -69.46 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.964 0.905 . . . . 63.030000000000001 111.669 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -73.68 -27.5 61.26 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.58 1.152 . . . . 71.129999999999995 112.131 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.2 p -93.36 169.11 10.62 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.723 0.809 . . . . 65.409999999999997 109.744 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 65.6 tp -136.06 128.8 30.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.696 0.398 . . . . 72.209999999999994 111.424 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 m -72.79 116.61 13.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.696 -0.483 . . . . 75.230000000000004 109.696 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.708 HG22 HG21 ' A' ' 123' ' ' THR . 27.1 pt -120.72 149.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.356 0.662 . . . . 71.349999999999994 110.04 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.4 m -102.12 142.2 33.75 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.306 -0.861 . . . . 63.130000000000003 110.256 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -59.2 114.45 2.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.735 0.814 . . . . 50.310000000000002 110.291 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.83 0.12 39.2 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.688 -0.687 . . . . 72.430000000000007 112.78 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.17 121.16 27.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.287 0.544 . . . . 44.450000000000003 111.294 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HD3' HD21 ' A' ' 84' ' ' LEU . 62.7 mttp -70.83 130.39 41.56 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.797 0.839 . . . . 74.219999999999999 109.009 169.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.739 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -142.14 138.38 31.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.392 0.677 . . . . 74.409999999999997 110.464 -176.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' A' ' 122' ' ' GLN . 40.9 ttm180 -89.49 108.56 19.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.928 0.491 . . . . 64.140000000000001 110.068 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.663 HG13 ' HB1' ' A' ' 119' ' ' ALA . 4.6 t -78.61 117.88 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.347 0.659 . . . . 63.119999999999997 110.099 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.3 mt -90.3 -49.12 6.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.101 0.96 . . . . 73.230000000000004 110.229 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.67 144.56 9.47 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 115.38 -0.827 . . . . 71.450000000000003 111.606 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 25.0 m-85 -87.86 168.77 12.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.655 0.782 . . . . 74.540000000000006 111.252 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -88.71 -172.19 3.62 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.681 -1.145 . . . . 73.150000000000006 110.982 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -41.95 -44.72 3.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.838 1.655 . . . . 73.109999999999999 114.506 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 31.4 p-10 -114.34 6.42 16.07 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.174 0.805 . . . . 73.310000000000002 113.174 -174.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 77.56 16.14 80.59 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.252 -0.749 . . . . 54.530000000000001 114.711 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.77 -66.85 0.81 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.92 0.86 . . . . 74.299999999999997 109.668 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -90.68 131.91 36.1 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.926 0.49 . . . . 70.319999999999993 111.187 -168.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.663 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -124.5 139.14 54.16 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.208 1.003 . . . . 62.520000000000003 109.7 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.659 ' HG2' HE21 ' A' ' 127' ' ' GLN . 25.4 tt0 -73.44 110.41 7.7 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.115 -1.069 . . . . 74.209999999999994 108.115 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -101.61 143.78 31.15 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.591 0.756 . . . . 74.450000000000003 109.513 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 35.4 tt0 -102.66 104.5 14.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.138 -1.392 . . . . 74.430000000000007 107.504 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.739 HG22 ' HB3' ' A' ' 107' ' ' LEU . 58.7 p -112.17 166.83 10.91 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.282 1.033 . . . . 75.329999999999998 110.391 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -72.51 -17.49 61.73 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.796 -1.093 . . . . 72.409999999999997 109.536 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -75.23 -27.44 59.51 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.632 1.173 . . . . 75.510000000000005 111.088 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.16 -155.06 25.37 Favored Glycine 0 C--N 1.358 1.799 0 CA-C-O 120.246 -0.197 . . . . 75.540000000000006 112.969 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.659 HE21 ' HG2' ' A' ' 120' ' ' GLU . 56.8 tp60 -116.29 137.66 51.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.425 0.613 . . . . 72.319999999999993 110.516 -174.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 161.98 170.87 27.33 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 120.249 -0.976 . . . . 74.319999999999993 114.215 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -87.49 129.87 34.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.418 0.687 . . . . 64.040000000000006 111.783 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -137.68 145.2 47.75 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 74.310000000000002 109.106 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.47 151.81 7.75 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 122.402 2.068 . . . . 52.32 114.917 -170.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.0 m -40.47 -30.79 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.133 2.173 . . . . 74.400000000000006 114.69 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.523 HD21 HG22 ' A' ' 244' ' ' VAL . 29.6 p30 -78.97 -27.02 43.42 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.111 0.565 . . . . 74.120000000000005 112.191 -175.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.452 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 25.7 m-85 -91.4 -16.23 27.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.542 0.737 . . . . 75.010000000000005 112.05 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.6 pt -122.8 176.32 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.724 0.81 . . . . 72.510000000000005 111.122 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.0 m -160.03 136.67 6.54 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.649 1.18 . . . . 63.119999999999997 109.083 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 29.1 Cg_endo -59.98 134.9 59.42 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 121.942 1.762 . . . . 72.450000000000003 111.488 173.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.04 -7.33 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.557 0.743 . . . . 35.329999999999998 110.637 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.766 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 7.2 t30 -75.93 -23.44 55.45 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.292 0.637 . . . . 72.150000000000006 111.811 175.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.3 p -94.59 173.92 7.37 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.173 0.511 . . . . 74.239999999999995 111.91 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 mt -82.79 -19.51 37.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.341 1.056 . . . . 73.209999999999994 111.37 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.66 -18.89 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.207 1.003 . . . . 65.310000000000002 112.19 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -62.58 -25.55 68.13 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.174 0.589 . . . . 72.030000000000001 111.772 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -78.04 136.97 38.02 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.504 -0.771 . . . . 73.510000000000005 110.226 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 m -57.36 -36.58 71.38 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.212 1.005 . . . . 75.239999999999995 112.311 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -67.72 -28.8 67.97 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.917 0.761 . . . . 70.439999999999998 112.621 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.411 ' O ' ' HE2' ' A' ' 238' ' ' LYS . 20.9 t80 -89.14 98.59 11.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.774 -0.824 . . . . 65.140000000000001 108.774 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.541 ' HB2' HG21 ' A' ' 151' ' ' VAL . 65.8 m80 -91.69 -9.04 45.3 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.752 0.421 . . . . 74.439999999999998 111.788 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 150' ' ' PRO . . . 75.04 -126.91 9.02 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 118.317 -1.269 . . . . 44.329999999999998 113.175 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 149' ' ' GLY . 10.1 Cg_exo -69.24 88.31 0.48 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 123.25 2.633 . . . . 60.32 112.185 -175.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 43.4 t -126.95 133.46 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.946 0.898 . . . . 74.430000000000007 109.494 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 p -86.46 171.1 11.36 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.025 0.93 . . . . 72.099999999999994 109.808 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -62.16 -42.31 99.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 110.002 -0.37 . . . . 72.439999999999998 110.002 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.27 -48.26 76.94 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.235 0.959 . . . . 73.409999999999997 110.867 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.3 69.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.236 0.614 . . . . 71.340000000000003 111.735 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.39 75.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 63.450000000000003 111.311 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.97 -20.98 47.81 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.544 -0.753 . . . . 71.230000000000004 110.677 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -37.12 81.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.111 0.964 . . . . 71.0 110.084 170.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 239' ' ' ARG . 67.4 mt -68.97 -51.69 36.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.99 0.516 . . . . 75.530000000000001 110.673 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.464 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 80.7 mt -83.75 11.95 6.69 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.563 0.579 . . . . 64.409999999999997 112.563 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.7 p -62.05 -37.47 85.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.904 0.482 . . . . 75.519999999999996 111.663 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.5 m -111.28 18.62 19.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.678 0.791 . . . . 74.420000000000002 110.739 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.78 152.06 41.97 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 112.818 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.8 pt -87.74 -177.67 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.313 0.645 . . . . 53.340000000000003 110.533 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 5.1 m-20 -62.48 125.68 24.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.899 -0.591 . . . . 61.329999999999998 110.472 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 233' ' ' HIS . . . 84.22 10.92 79.45 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.05 -0.977 . . . . 44.530000000000001 113.29 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.6 m -67.67 139.16 56.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.272 1.036 . . . . 63.229999999999997 109.703 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.474 ' HB3' HD12 ' A' ' 184' ' ' LEU . 18.1 p90 -149.17 166.49 28.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.804 0.729 . . . . 73.549999999999997 111.76 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.1 pp -161.84 135.6 6.53 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.841 -1.072 . . . . 75.099999999999994 109.724 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.668 HG22 HG12 ' A' ' 182' ' ' ILE . 74.5 t -91.66 141.55 14.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 N-CA-C 108.3 -1.0 . . . . 75.129999999999995 108.3 167.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.568 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 46.0 ptt85 -144.95 153.38 41.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.242 -0.89 . . . . 71.200000000000003 109.983 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -115.2 148.45 39.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.224 1.009 . . . . 70.319999999999993 108.393 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.8 t -78.67 125.4 29.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.07 0.548 . . . . 74.25 110.103 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.12 -41.77 88.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.172 0.989 . . . . 71.5 110.489 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 57.8 p -80.53 -25.17 38.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.496 0.718 . . . . 71.549999999999997 111.806 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.7 m -124.6 95.63 42.47 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.511 0.724 . . . . 72.519999999999996 110.668 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.81 139.61 81.09 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.211 2.608 . . . . 74.25 112.215 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.64 -28.38 4.9 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.279 -0.419 . . . . 71.450000000000003 113.06 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -75.67 116.18 16.11 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 117.062 0.431 . . . . 50.409999999999997 110.345 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.667 HH11 HD12 ' A' ' 214' ' ' LEU . 89.5 mtt180 -126.12 150.75 48.01 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.087 0.955 . . . . 72.299999999999997 109.281 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.4 m -149.41 153.75 37.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.098 0.959 . . . . 63.420000000000002 109.494 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.668 HG12 HG22 ' A' ' 170' ' ' VAL . 26.7 mt -110.9 149.98 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.107 -1.071 . . . . 71.510000000000005 108.107 172.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 55.0 m -121.75 115.4 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.34 -1.355 . . . . 41.030000000000001 107.34 169.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 168' ' ' PHE . 14.7 tp -108.45 112.76 25.33 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.569 0.622 . . . . 73.140000000000001 109.956 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 23.3 ttt180 -81.68 112.02 18.48 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 109.752 -0.462 . . . . 65.439999999999998 109.752 165.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -136.36 143.96 44.35 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 106.85 -1.537 . . . . 74.230000000000004 106.85 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 61.38 21.21 11.8 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.178 0.991 . . . . 74.439999999999998 111.815 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.07 1.35 68.22 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.976 -0.347 . . . . 71.019999999999996 113.759 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 71.6 mtp180 -105.66 139.31 40.45 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.683 1.193 . . . . 62.439999999999998 109.251 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.9 t -100.13 105.61 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.051 0.453 . . . . 62.210000000000001 110.147 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -90.98 120.15 31.74 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.862 1.265 . . . . 74.219999999999999 109.229 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -95.32 120.69 36.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.62 0.368 . . . . 70.120000000000005 110.462 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -96.95 147.28 24.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.739 1.215 . . . . 65.239999999999995 109.854 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 19.7 tpp180 -101.84 113.17 26.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.323 0.649 . . . . 72.310000000000002 109.277 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.1 mt -82.63 102.12 8.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.828 -1.175 . . . . 41.32 107.828 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -78.34 107.86 11.27 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.799 -1.091 . . . . 60.450000000000003 108.513 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.8 m -79.44 109.11 13.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.301 -1.0 . . . . 74.239999999999995 108.301 170.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.64 167.7 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.383 0.673 . . . . 64.209999999999994 110.731 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 21.7 p -60.83 -26.3 67.25 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.27 1.028 . . . . 62.109999999999999 113.186 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -94.29 -18.08 22.0 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.482 0.713 . . . . 63.420000000000002 111.502 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.5 10.78 16.39 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-O 119.535 -0.591 . . . . 61.539999999999999 113.662 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.631 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 96.3 mttt -76.68 127.26 32.45 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.643 0.721 . . . . 72.349999999999994 110.239 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.24 145.53 24.93 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.679 -0.86 . . . . 74.230000000000004 108.679 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.596 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 43.8 p90 -163.36 129.81 3.3 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.421 0.45 . . . . 62.149999999999999 111.162 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 60.1 t -72.87 -41.79 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.807 -0.812 . . . . 74.200000000000003 108.807 164.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.403 ' OG ' ' HA3' ' A' ' 227' ' ' GLY . 13.4 m -107.48 129.24 54.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.73 -1.123 . . . . 52.100000000000001 110.049 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.1 t -61.58 -26.88 68.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.54 0.736 . . . . 72.219999999999999 111.654 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -70.39 -27.91 64.68 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.764 1.225 . . . . 75.420000000000002 110.873 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.8 m -134.13 100.35 4.68 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.38 0.672 . . . . 51.049999999999997 109.766 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.596 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 58.2 mtt180 -105.93 128.72 53.98 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.97 0.908 . . . . 75.040000000000006 108.801 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.524 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 7.2 m-85 -115.13 139.68 49.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.698 0.799 . . . . 74.049999999999997 109.921 -167.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.631 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 6.7 m-80 -67.03 -31.28 71.71 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.167 0.917 . . . . 73.129999999999995 110.267 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.7 p -132.29 156.66 46.16 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.155 0.982 . . . . 74.140000000000001 111.497 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.667 HD12 HH11 ' A' ' 180' ' ' ARG . 0.7 OUTLIER -66.77 -24.37 66.19 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 114.916 -1.038 . . . . 73.430000000000007 109.772 173.023 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.39 79.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.621 0.768 . . . . 54.310000000000002 110.496 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 35.5 mt-10 -70.25 -36.93 74.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.059 0.943 . . . . 73.099999999999994 111.536 177.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.411 HD11 HG23 ' A' ' 205' ' ' VAL . 12.6 tp -54.91 -61.3 2.4 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.508 0.505 . . . . 75.099999999999994 110.956 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.2 -38.93 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.827 0.451 . . . . 73.519999999999996 111.093 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -61.51 -57.08 13.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.811 0.445 . . . . 70.409999999999997 111.146 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -67.88 -29.74 68.93 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.243 -0.435 . . . . 65.439999999999998 111.016 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.654 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.9 m170 -87.6 -11.51 48.39 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.26 0.467 . . . . 71.420000000000002 112.26 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.4 p -93.78 -27.14 16.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.742 0.417 . . . . 52.240000000000002 110.967 173.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.6 p -77.81 -48.25 16.98 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.831 -0.622 . . . . 75.209999999999994 110.535 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 226' ' ' ASP . 15.8 m -129.77 163.89 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.566 0.698 . . . . 70.150000000000006 111.797 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.21 16.65 0.23 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 127.373 2.269 . . . . 45.439999999999998 114.236 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.656 ' HB2' HG23 ' A' ' 224' ' ' VAL . 36.1 t70 -43.84 33.81 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.606 1 C-N-CA 132.645 4.378 . . . . 54.350000000000001 119.231 -159.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.403 ' HA3' ' OG ' ' A' ' 206' ' ' SER . . . 122.41 -0.9 10.43 Favored Glycine 0 N--CA 1.474 1.199 0 O-C-N 120.741 -1.224 . . . . 52.5 112.335 -171.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.654 HD11 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -94.71 164.75 12.82 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.759 1.624 . . . . 74.310000000000002 109.878 169.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 9.6 tt -66.5 -39.35 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.036 0.446 . . . . 72.310000000000002 109.921 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.4 m -151.7 154.73 36.9 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 74.019999999999996 110.377 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.1 p -57.38 139.58 52.63 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.79 1.236 . . . . 63.240000000000002 112.475 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.444 HD23 HD13 ' A' ' 184' ' ' LEU . 86.8 mt -68.14 100.1 0.97 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.557 0.743 . . . . 73.439999999999998 109.007 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.556 ' HE1' HD23 ' A' ' 61' ' ' LEU . 24.3 t60 -96.45 -78.39 0.47 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.898 0.879 . . . . 61.439999999999998 111.643 -165.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -94.0 123.64 58.67 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.385 0.674 . . . . 74.310000000000002 110.11 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.4 130.88 8.24 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.539 2.159 . . . . 75.150000000000006 111.765 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.59 82.48 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 109.063 -0.717 . . . . 71.219999999999999 109.063 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.21 167.01 16.07 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.409 2.073 . . . . 64.349999999999994 112.261 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 32.4 mmtp -63.45 138.12 58.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.494 0.718 . . . . 74.319999999999993 110.252 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.581 ' HB3' HD21 ' A' ' 159' ' ' LEU . 14.7 ptt-85 -72.73 -63.28 1.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.341 1.237 . . . . 73.040000000000006 114.341 -160.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.556 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 53.6 t30 -112.87 146.48 38.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.992 0.917 . . . . 64.319999999999993 110.314 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 94.8 mttt -77.82 114.45 41.61 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 107.638 -1.245 . . . . 74.430000000000007 107.638 161.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 133' ' ' ASN . 26.2 Cg_exo -64.44 127.41 18.94 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.16 2.573 . . . . 63.130000000000003 113.181 -171.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.4 m -76.87 117.2 18.24 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.102 0.561 . . . . 72.439999999999998 109.537 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.523 HG22 HD21 ' A' ' 133' ' ' ASN . 4.0 t -96.91 112.85 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.268 -1.012 . . . . 75.030000000000001 108.268 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -88.07 114.2 24.45 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.743 0.646 . . . . 73.019999999999996 112.743 -160.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.74 42.41 94.39 Favored Glycine 0 C--N 1.354 1.58 0 O-C-N 124.577 1.173 . . . . 74.319999999999993 114.438 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m -104.23 132.72 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 113.29 0.848 . . . . 60.210000000000001 113.29 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.8 t -83.98 120.11 74.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 105.083 -2.192 . . . . 70.439999999999998 105.083 148.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -54.94 -53.65 5.67 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.525 2.15 . . . . 64.310000000000002 113.996 -162.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -125.75 -21.53 4.4 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.156 0.503 . . . . 64.340000000000003 111.449 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -82.63 101.86 11.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.883 1.068 . . . . 74.150000000000006 113.883 -149.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' A' ' 18' ' ' PRO . 8.2 p-10 -122.22 -45.69 2.22 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.14 -0.936 . . . . 63.020000000000003 109.573 152.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER -103.34 -28.31 11.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.476 -0.783 . . . . 70.25 110.523 -171.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -72.4 109.89 6.42 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.416 -0.811 . . . . 74.340000000000003 112.042 -156.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 C--O 1.254 1.303 0 C-N-CA 125.616 1.566 . . . . 74.109999999999999 111.361 176.271 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.404 -0.591 . . . . 75.25 109.404 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.0 -44.94 3.0 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 123.825 0.703 . . . . 63.109999999999999 112.324 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 58.28 75.78 0.37 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 124.857 1.263 . . . . 73.109999999999999 109.631 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -81.14 114.2 47.11 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 115.425 -0.807 . . . . 72.549999999999997 110.817 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.84 149.67 60.39 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.381 2.054 . . . . 70.5 111.147 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.29 93.51 0.14 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.445 -0.662 . . . . 73.230000000000004 111.445 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.26 165.04 21.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.353 0.661 . . . . 51.520000000000003 109.536 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -160.91 146.34 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.375 0.67 . . . . 71.230000000000004 109.894 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.77 147.83 33.38 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.56 0.744 . . . . 54.399999999999999 109.523 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.29 158.16 14.87 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.474 -0.651 . . . . 30.52 111.474 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -115.63 169.6 9.07 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.383 0.592 . . . . 54.310000000000002 110.712 -173.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -81.97 150.9 27.43 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.144 0.978 . . . . 72.329999999999998 110.71 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -104.26 178.98 4.4 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.095 0.958 . . . . 75.209999999999994 109.586 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -76.41 151.41 83.16 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.432 0.693 . . . . 74.439999999999998 110.899 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.04 171.39 5.06 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.03 2.487 . . . . 72.420000000000002 113.079 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 33.9 p -72.44 98.3 2.24 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.08 0.952 . . . . 75.239999999999995 111.644 -176.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.33 150.37 49.33 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 108.848 -0.797 . . . . 72.129999999999995 108.848 169.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.33 175.83 9.28 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.894 2.396 . . . . 61.109999999999999 112.101 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.02 96.83 3.28 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.714 0.806 . . . . 62.539999999999999 110.031 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -89.81 101.3 14.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.612 0.765 . . . . 63.439999999999998 108.974 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -130.8 -143.87 0.25 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.286 -1.375 . . . . 75.319999999999993 107.286 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -172.67 110.24 0.22 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.995 0.816 . . . . 75.219999999999999 109.979 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 11.1 pt -120.5 175.09 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.747 0.819 . . . . 62.450000000000003 109.22 172.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -145.15 139.08 27.02 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.578 0.751 . . . . 54.240000000000002 110.059 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.65 -164.85 32.73 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.501 -0.772 . . . . 63.299999999999997 111.454 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.14 175.45 14.04 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.703 0.801 . . . . 55.310000000000002 110.537 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.77 132.16 2.52 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.3 -0.32 . . . . 62.32 112.3 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -131.66 144.59 51.14 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.471 1.108 . . . . 64.120000000000005 109.405 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -133.76 131.97 39.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.59 0.756 . . . . 74.329999999999998 110.722 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -152.58 119.36 5.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.845 -1.169 . . . . 61.43 107.845 170.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -125.22 44.24 2.85 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.736 1.215 . . . . 72.310000000000002 108.611 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.711 ' HA ' ' HA3' ' A' ' 178' ' ' GLY . 22.8 t -59.06 94.91 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.341 1.056 . . . . 62.32 112.522 -174.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.2 mmt-85 -111.69 -170.03 1.57 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.914 1.285 . . . . 70.319999999999993 109.168 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -128.86 156.83 43.04 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.256 1.022 . . . . 55.43 110.048 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.35 -123.72 1.88 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 110.837 -0.905 . . . . 72.109999999999999 110.837 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.75 -137.56 4.71 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 117.689 0.745 . . . . 74.319999999999993 113.562 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.73 -152.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 124.263 3.309 . . . . 71.019999999999996 113.476 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -148.48 -68.8 0.23 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 123.535 0.734 . . . . 75.310000000000002 110.041 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.9 t -152.59 -167.53 2.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.1 0.56 . . . . 75.329999999999998 110.094 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -135.62 140.6 44.69 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.508 0.723 . . . . 72.340000000000003 110.488 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 158' ' ' TYR . 35.8 m -136.45 142.38 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.992 0.917 . . . . 34.130000000000003 108.84 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -129.19 137.63 51.26 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.826 0.851 . . . . 72.030000000000001 110.279 -173.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 158' ' ' TYR . 47.7 t -117.93 -41.77 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.176 0.591 . . . . 43.439999999999998 110.335 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 161' ' ' SER . 0.4 OUTLIER 73.67 119.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.405 1.482 . . . . 71.340000000000003 110.989 -178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -152.25 151.01 30.41 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.3 1.04 . . . . 52.200000000000003 109.212 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -115.51 82.56 1.78 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.823 -1.177 . . . . 64.430000000000007 107.823 173.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.81 119.86 27.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.763 0.825 . . . . 51.329999999999998 108.873 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tt -156.26 108.08 2.52 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 107.027 -1.472 . . . . 61.329999999999998 107.027 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 66.55 160.74 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.8 1.24 . . . . 75.040000000000006 112.044 -176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -143.76 -53.75 0.02 OUTLIER Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.828 1.251 . . . . 63.43 110.488 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -72.0 97.1 0.81 Allowed 'Trans proline' 0 C--N 1.397 3.096 0 CA-C-N 121.092 1.426 . . . . 63.549999999999997 110.837 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -88.13 177.21 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.766 0.826 . . . . 70.299999999999997 108.772 174.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.83 164.89 23.26 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.554 0.342 . . . . 61.130000000000003 111.521 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.6 t -76.49 -20.94 56.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.821 0.849 . . . . 54.450000000000003 111.611 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -152.62 -81.95 0.09 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.958 0.503 . . . . 70.010000000000005 109.828 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -98.61 137.56 37.07 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.673 -0.862 . . . . 71.030000000000001 108.673 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -87.31 111.8 43.73 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.195 -0.669 . . . . 72.439999999999998 109.195 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.03 -28.54 80.48 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.329 2.019 . . . . 72.510000000000005 111.586 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -145.59 -58.66 0.33 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.131 -0.941 . . . . 53.310000000000002 110.803 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.23 -26.01 4.63 Favored Glycine 0 C--N 1.35 1.344 0 C-N-CA 122.888 0.28 . . . . 62.509999999999998 113.528 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.7 mt -110.49 161.44 15.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.738 1.215 . . . . 72.200000000000003 108.936 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.8 p -102.92 87.88 3.04 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.337 -0.616 . . . . 75.109999999999999 109.337 175.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 55.4 -83.78 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.496 1.918 . . . . 73.109999999999999 113.655 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.36 -51.19 64.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.293 0.637 . . . . 61.030000000000001 110.261 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 176.88 -55.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.326 1.45 . . . . 72.430000000000007 107.989 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -140.61 43.62 1.85 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.01 -1.45 . . . . 73.409999999999997 107.958 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.43 ' HH2' HD22 ' A' ' 73' ' ' LEU . 20.6 t90 -158.88 92.23 1.09 Allowed 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.939 -1.028 . . . . 73.5 110.315 -171.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -77.8 -31.11 51.63 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.455 -1.248 . . . . 64.230000000000004 111.135 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.7 p -76.14 9.42 2.53 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.555 1.142 . . . . 75.230000000000004 111.98 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -41.61 -43.32 2.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.429 1.492 . . . . 73.129999999999995 113.302 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.64 -27.77 68.63 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.746 0.818 . . . . 72.120000000000005 112.703 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.509 ' HB2' ' HE1' ' A' ' 144' ' ' HIS . 12.8 m120 -86.11 -0.92 56.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.98 0.912 . . . . 53.32 111.373 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.43 HD22 ' HH2' ' A' ' 67' ' ' TRP . 59.3 tp -57.51 -52.91 63.49 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 122.604 0.362 . . . . 74.140000000000001 110.396 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.55 45.14 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.019 0.927 . . . . 72.129999999999995 110.18 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.38 -48.97 73.43 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.249 0.619 . . . . 52.439999999999998 110.779 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 65.56 -137.33 37.05 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 118.794 -1.003 . . . . 61.350000000000001 111.37 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.49 121.51 7.5 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.013 1.809 . . . . 60.43 109.64 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.3 t -120.34 164.81 15.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.506 0.323 . . . . 74.349999999999994 111.403 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.17 -21.9 66.84 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.06 0.944 . . . . 73.430000000000007 108.612 166.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.516 ' N ' HD22 ' A' ' 80' ' ' ASN . 0.7 OUTLIER -79.05 33.18 0.22 Allowed 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 126.01 1.724 . . . . 72.040000000000006 111.445 175.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -44.61 140.72 3.09 Favored Pre-proline 0 CA--C 1.567 1.606 0 C-N-CA 127.439 2.295 . . . . 74.329999999999998 111.9 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -15.88 -43.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.399 3.228 1 C-N-CA 127.795 5.663 . . . . 73.030000000000001 120.492 -165.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -67.53 -13.85 62.42 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.683 0.793 . . . . 74.150000000000006 112.975 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 tp -100.37 123.65 44.86 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.805 0.812 . . . . 70.420000000000002 109.751 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -113.19 173.1 6.56 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.516 1.526 . . . . 53.100000000000001 109.491 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 p -136.72 132.44 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.069 1.347 . . . . 75.040000000000006 108.805 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.06 116.69 9.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.291 1.036 . . . . 74.420000000000002 110.025 173.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.6 mt -81.48 -36.07 29.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.76 0.824 . . . . 72.209999999999994 110.638 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 36.8 m-85 -122.85 143.91 49.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.967 -1.015 . . . . 65.329999999999998 108.819 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -74.23 134.3 42.68 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.843 -0.799 . . . . 63.439999999999998 108.843 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.619 ' HB3' HG12 ' A' ' 101' ' ' ILE . 83.0 t80 -134.87 138.33 44.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.093 0.957 . . . . 63.43 109.015 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.8 134.16 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.006 -1.479 . . . . 64.209999999999994 107.006 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 16' ' ' SER . . . -57.1 128.27 36.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.865 0.866 . . . . 74.340000000000003 110.996 -178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 p -110.1 8.96 24.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.799 0.84 . . . . 42.210000000000001 111.725 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.9 -179.46 32.81 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.8 -0.52 . . . . 64.409999999999997 111.8 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.34 -21.49 39.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.575 0.75 . . . . 55.210000000000001 112.767 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -107.12 -7.92 16.68 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 111.852 0.315 . . . . 63.229999999999997 111.852 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.6 p -75.97 177.96 6.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.873 0.469 . . . . 62.43 111.217 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.0 tp -142.65 145.53 33.55 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.825 -0.547 . . . . 64.420000000000002 110.985 -176.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 m -94.11 120.49 34.43 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.936 0.895 . . . . 73.420000000000002 109.304 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.628 HG22 HG21 ' A' ' 123' ' ' THR . 15.8 pt -113.82 148.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.629 0.771 . . . . 53.140000000000001 111.079 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.9 m -94.92 143.96 26.05 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.714 0.806 . . . . 73.230000000000004 109.312 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.01 120.75 11.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.54 0.736 . . . . 70.200000000000003 109.923 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.95 -9.23 68.1 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.643 -0.532 . . . . 52.210000000000001 113.607 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.7 143.44 51.33 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.591 0.757 . . . . 60.039999999999999 111.461 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.33 134.88 35.09 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.87 0.868 . . . . 72.340000000000003 109.192 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.499 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -145.33 142.79 29.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 75.319999999999993 109.847 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -97.08 109.66 22.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.188 -0.671 . . . . 73.430000000000007 109.188 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.591 HG13 ' HB1' ' A' ' 119' ' ' ALA . 19.1 t -72.67 126.4 33.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-O 121.699 0.761 . . . . 63.229999999999997 109.363 171.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 23' ' ' ILE . 79.5 mt -88.63 -59.13 2.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.456 -1.702 . . . . 72.400000000000006 109.203 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.63 142.93 8.79 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.359 -0.382 . . . . 35.109999999999999 112.531 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.606 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 30.8 m-85 -86.4 168.12 14.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.513 1.125 . . . . 74.200000000000003 111.25 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -94.09 -171.58 2.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.088 1.355 . . . . 74.109999999999999 111.002 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -47.22 -36.35 8.75 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.924 1.689 . . . . 65.230000000000004 115.025 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -109.57 -6.18 15.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.543 0.337 . . . . 43.439999999999998 111.357 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 69.72 25.2 75.81 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.392 0.433 . . . . 53.009999999999998 113.451 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.47 -7.15 21.14 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.44 0.696 . . . . 72.150000000000006 112.296 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 33.4 m95 -140.48 134.33 30.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.67 0.788 . . . . 75.140000000000001 109.57 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.591 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -134.0 148.24 51.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 74.310000000000002 110.639 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.86 113.63 19.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.857 -1.164 . . . . 64.129999999999995 107.857 167.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.59 145.36 45.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.262 0.625 . . . . 62.119999999999997 110.95 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.44 103.53 15.49 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 109.03 -0.73 . . . . 73.25 109.03 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.628 HG21 HG22 ' A' ' 101' ' ' ILE . 75.7 p -86.36 168.44 13.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.356 0.662 . . . . 65.430000000000007 109.248 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -74.1 -11.2 60.24 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.671 -0.695 . . . . 35.530000000000001 110.57 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -79.99 -33.08 39.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.731 0.812 . . . . 72.019999999999996 110.19 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.58 -161.52 31.83 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 111.415 -0.674 . . . . 13.550000000000001 111.415 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -128.91 149.28 50.84 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.786 0.793 . . . . 73.120000000000005 110.597 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.06 178.35 35.87 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.706 0.629 . . . . 32.149999999999999 111.576 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -84.3 122.93 29.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.614 0.766 . . . . 73.099999999999994 111.989 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.411 HG11 ' CG2' ' A' ' 101' ' ' ILE . 19.8 m -128.61 145.21 55.16 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 124.992 1.317 . . . . 61.140000000000001 109.361 173.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 72.2 Cg_endo -84.3 146.61 11.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.287 1.991 . . . . 72.530000000000001 114.705 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 m -40.03 -41.85 1.29 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.191 1.796 . . . . 63.240000000000002 113.968 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -76.39 -17.91 59.13 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.175 -0.921 . . . . 74.219999999999999 112.657 -170.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.476 ' HD1' ' HG2' ' A' ' 131' ' ' PRO . 24.7 m-85 -92.28 -18.4 23.44 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.19 0.596 . . . . 61.030000000000001 111.713 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 130' ' ' VAL . 19.4 pt -120.24 -179.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.553 1.141 . . . . 63.530000000000001 110.408 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.9 t -162.5 151.08 12.35 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 118.428 -0.796 . . . . 70.549999999999997 108.872 166.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.72 145.71 97.21 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 121.49 1.46 . . . . 74.209999999999994 109.831 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.55 -4.38 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 121.778 0.799 . . . . 44.549999999999997 111.462 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.88 -22.74 49.31 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.777 0.831 . . . . 60.409999999999997 111.186 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 86.5 p -81.32 176.43 9.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.832 0.825 . . . . 72.120000000000005 111.705 -167.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 214' ' ' LEU . 38.8 mt -85.78 -26.32 25.86 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.847 -1.07 . . . . 70.140000000000001 110.605 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.525 ' HG3' ' HD2' ' A' ' 147' ' ' TYR . 1.6 mp0 -64.47 -20.41 66.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.79 1.236 . . . . 75.319999999999993 111.966 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -63.75 -4.69 3.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.732 0.813 . . . . 73.239999999999995 113.095 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.509 ' HE1' ' HB2' ' A' ' 72' ' ' ASN . 42.4 m-70 -117.73 159.29 23.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.998 0.919 . . . . 73.120000000000005 110.728 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -42.94 89.29 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.447 1.099 . . . . 71.219999999999999 112.14 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.402 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 56.3 p-90 -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.364 0.875 . . . . 72.329999999999998 113.364 -172.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.525 ' HD2' ' HG3' ' A' ' 142' ' ' GLU . 21.0 t80 -85.34 106.76 16.97 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.705 0.684 . . . . 75.140000000000001 110.356 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.513 ' HB3' HG21 ' A' ' 151' ' ' VAL . 3.2 m80 -89.27 -14.04 36.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.982 0.913 . . . . 62.299999999999997 112.0 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.48 -140.62 23.79 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.035 -1.425 . . . . 71.329999999999998 112.197 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.62 88.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.535 2.823 . . . . 71.109999999999999 112.891 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 155' ' ' ALA . 37.6 t -140.14 128.05 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.849 1.659 . . . . 73.549999999999997 108.807 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.1 p -84.27 175.13 9.62 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 124.061 0.945 . . . . 70.409999999999997 109.997 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -60.08 -40.95 91.32 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 118.984 -0.531 . . . . 73.420000000000002 111.158 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -53.26 -51.33 62.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.199 0.937 . . . . 75.120000000000005 110.317 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -62.57 -46.35 88.72 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.057 -1.429 . . . . 52.130000000000003 111.168 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 171' ' ' ARG . . . -56.86 -37.13 70.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.453 0.701 . . . . 31.440000000000001 112.184 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -68.83 -43.8 74.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.176 0.99 . . . . 74.219999999999999 111.155 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -71.74 -22.83 61.56 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.328 0.585 . . . . 72.540000000000006 112.214 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 239' ' ' ARG . 55.8 mt -75.67 -43.59 46.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.872 -1.058 . . . . 73.329999999999998 112.579 174.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.539 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 96.4 mt -83.21 -20.65 34.22 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.045 -0.525 . . . . 62.240000000000002 111.466 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.425 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 86.6 p -64.3 -27.77 69.26 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 108.599 -0.889 . . . . 73.109999999999999 108.599 167.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.5 m -90.41 16.63 8.46 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.516 1.127 . . . . 44.100000000000001 111.468 175.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.29 178.52 17.3 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.381 0.515 . . . . 72.439999999999998 112.688 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.3 pt -100.17 175.77 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.479 1.111 . . . . 73.340000000000003 112.241 -176.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -72.22 116.1 12.25 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.663 -0.698 . . . . 73.450000000000003 109.549 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.07 6.18 34.47 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.508 -0.769 . . . . 73.329999999999998 112.534 -167.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 66.1 m -85.26 135.36 33.96 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 117.979 0.889 . . . . 65.129999999999995 111.124 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.8 p90 -139.46 158.31 44.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.747 0.419 . . . . 73.230000000000004 110.661 -176.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.2 pp -153.69 137.11 15.83 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.871 -0.788 . . . . 72.340000000000003 108.871 170.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 182' ' ' ILE . 59.9 t -92.28 136.5 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.791 -1.189 . . . . 71.019999999999996 107.791 168.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 156' ' ' ALA . 41.2 ptt85 -136.36 143.21 43.93 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.012 0.925 . . . . 63.399999999999999 108.643 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.89 117.11 30.4 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.764 -1.569 . . . . 51.439999999999998 106.764 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -53.44 120.58 6.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.197 0.999 . . . . 70.329999999999998 111.409 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.6 -29.3 69.88 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.684 0.754 . . . . 75.310000000000002 109.665 168.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -67.55 -32.61 73.5 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.678 -1.146 . . . . 73.329999999999998 111.446 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -148.09 94.77 4.24 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 123.929 0.892 . . . . 72.310000000000002 109.829 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.27 146.6 88.45 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.845 2.363 . . . . 75.439999999999998 111.899 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.711 ' HA3' ' HA ' ' A' ' 32' ' ' SER . . . 83.15 -28.72 3.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.491 -0.616 . . . . 72.450000000000003 114.104 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -76.24 115.85 16.37 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 117.665 0.733 . . . . 73.010000000000005 110.078 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -113.93 140.5 48.34 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.006 0.922 . . . . 65.349999999999994 109.29 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.1 m -145.92 148.61 32.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.344 1.057 . . . . 71.420000000000002 108.977 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.711 HG12 HG22 ' A' ' 170' ' ' VAL . 14.2 mt -101.03 144.3 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.745 -1.576 . . . . 75.310000000000002 106.745 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -124.68 109.24 12.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.968 -1.493 . . . . 75.219999999999999 106.968 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.7 tp -106.59 113.96 27.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.038 0.535 . . . . 74.340000000000003 110.361 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 18.0 ttt180 -76.4 117.85 18.48 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.442 -0.947 . . . . 74.299999999999997 108.442 162.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -140.77 139.8 34.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 107.448 -1.315 . . . . 54.25 107.448 168.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 62.01 22.12 12.85 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.356 1.062 . . . . 74.129999999999995 112.472 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 1.91 89.66 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.331 -0.395 . . . . 65.140000000000001 113.369 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -111.96 140.12 46.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.152 0.981 . . . . 74.219999999999999 108.463 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.33 106.77 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-O 121.371 0.605 . . . . 64.329999999999998 110.657 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -90.86 145.69 24.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 72.239999999999995 108.805 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -125.02 117.92 25.07 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.083 0.468 . . . . 71.219999999999999 110.265 -173.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.572 ' HE1' HD21 ' A' ' 232' ' ' LEU . 3.0 m-85 -95.31 137.0 34.97 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.974 -1.121 . . . . 64.099999999999994 107.974 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -94.77 122.17 37.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.03 -1.1 . . . . 71.329999999999998 108.03 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 59.4 mt -84.65 101.99 9.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.583 -0.895 . . . . 75.340000000000003 108.583 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -76.18 139.52 41.27 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.856 -1.065 . . . . 71.010000000000005 109.094 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.2 m -118.39 117.3 28.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.639 0.776 . . . . 73.329999999999998 109.514 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.97 161.05 16.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.748 1.219 . . . . 63.009999999999998 110.464 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 70.0 p -64.41 -27.16 68.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.726 0.81 . . . . 52.340000000000003 112.258 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -83.84 -19.1 35.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.001 0.52 . . . . 45.509999999999998 111.032 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.48 14.3 10.72 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-O 119.014 -0.881 . . . . 64.319999999999993 115.004 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 212' ' ' ASN . 34.7 mtmm -71.82 129.87 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.218 1.009 . . . . 71.430000000000007 111.09 173.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.93 142.85 26.91 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 71.230000000000004 108.294 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 36.9 p90 -169.76 137.73 1.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.097 0.873 . . . . 74.319999999999993 110.756 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -78.66 -46.02 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.435 -0.95 . . . . 75.549999999999997 108.435 164.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 16.1 m -98.56 124.58 43.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.437 -1.256 . . . . 74.030000000000001 108.764 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 31.4 t -65.97 -21.58 66.42 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.766 0.826 . . . . 65.340000000000003 112.051 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.13 -26.63 53.38 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.97 0.908 . . . . 71.340000000000003 110.163 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -125.42 98.41 5.6 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.798 0.839 . . . . 74.5 109.272 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 70.5 mtt180 -111.47 118.91 37.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.843 0.857 . . . . 74.219999999999999 110.179 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.421 ' HZ ' ' HE2' ' A' ' 221' ' ' HIS . 0.5 OUTLIER -111.87 147.84 34.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.703 0.801 . . . . 72.530000000000001 109.166 -169.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.536 ' HA ' ' HG2' ' A' ' 202' ' ' LYS . 7.9 m-80 -66.41 -38.88 88.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.265 0.626 . . . . 74.239999999999995 110.341 -175.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.8 p -124.32 154.57 40.1 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.652 0.781 . . . . 61.450000000000003 111.28 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 141' ' ' LEU . 1.8 tt -65.21 -23.84 67.19 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.129 0.972 . . . . 63.530000000000001 109.377 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.57 80.36 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.789 0.836 . . . . 74.450000000000003 111.242 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.52 -30.74 64.75 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.378 -0.828 . . . . 72.329999999999998 111.551 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.21 -53.54 56.96 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 123.507 0.505 . . . . 73.409999999999997 110.744 171.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.77 -43.3 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.111 0.565 . . . . 63.210000000000001 110.475 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -55.15 -56.75 16.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.957 0.903 . . . . 73.030000000000001 111.248 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -65.58 -33.16 75.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.688 -1.142 . . . . 62.25 111.047 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.666 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.1 m170 -92.21 -10.58 38.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.015 0.526 . . . . 72.439999999999998 112.024 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 77.2 p -97.75 -11.68 23.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.279 0.632 . . . . 63.310000000000002 110.747 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 35.8 p -87.31 -52.07 5.6 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 122.399 0.28 . . . . 74.219999999999999 110.636 167.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.9 162.95 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 122.135 0.969 . . . . 65.319999999999993 113.204 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.84 11.76 17.01 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.616 1.966 . . . . 73.439999999999998 114.42 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -47.73 32.07 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 130.729 3.611 . . . . 75.430000000000007 120.065 -157.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.07 6.38 4.91 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.649 -1.282 . . . . 60.409999999999997 112.911 -167.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.9 mt -94.11 161.9 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.722 1.209 . . . . 74.010000000000005 109.067 161.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 13.4 tt -59.46 -40.09 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-O 120.736 0.303 . . . . 52.130000000000003 110.239 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -159.37 171.96 18.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.851 0.861 . . . . 64.430000000000007 109.904 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 34.0 m -68.73 138.38 54.84 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.144 0.978 . . . . 73.340000000000003 111.606 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.572 HD21 ' HE1' ' A' ' 193' ' ' TYR . 63.8 mt -71.9 131.41 42.94 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.199 0.999 . . . . 61.539999999999999 109.412 177.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -121.4 -77.98 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 118.65 0.659 . . . . 53.420000000000002 111.223 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -85.92 121.48 72.99 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 123.531 0.733 . . . . 73.329999999999998 109.366 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.61 126.95 4.82 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.181 1.921 . . . . 72.329999999999998 111.519 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . . . -66.73 145.7 98.97 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.813 0.845 . . . . 72.239999999999995 110.159 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.44 167.17 17.48 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.524 2.15 . . . . 72.540000000000006 112.015 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -69.45 150.12 47.56 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.442 0.697 . . . . 74.140000000000001 110.118 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.719 ' HB3' HD21 ' A' ' 159' ' ' LEU . 13.7 ptt180 -91.38 -64.18 1.16 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.249 0.833 . . . . 73.120000000000005 113.249 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.512 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 61.7 t30 -111.31 134.27 53.02 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.713 0.805 . . . . 73.040000000000006 109.743 -175.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -75.58 110.97 12.03 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 105.457 -2.053 . . . . 74.150000000000006 105.457 160.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.2 146.66 38.42 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.429 2.752 . . . . 74.430000000000007 115.732 -166.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.8 m -80.55 120.69 24.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.22 0.608 . . . . 75.299999999999997 110.78 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.41 108.01 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 108.023 -1.102 . . . . 73.549999999999997 108.023 170.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -108.33 111.75 23.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.192 0.597 . . . . 61.32 109.879 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 61.46 24.07 63.37 Favored Glycine 0 C--N 1.355 1.639 0 O-C-N 124.187 0.93 . . . . 70.420000000000002 114.871 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.4 116.99 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.328 0.651 . . . . 75.310000000000002 110.676 -174.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.9 t -87.99 120.44 70.74 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 105.829 -1.915 . . . . 71.109999999999999 105.829 151.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.28 -58.39 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.771 1.647 . . . . 75.329999999999998 114.793 -159.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -126.83 -12.58 5.93 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.458 0.703 . . . . 70.310000000000002 110.437 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -85.81 104.21 15.28 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.764 -0.653 . . . . 75.209999999999994 110.637 -156.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -120.88 -47.33 2.3 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.194 0.598 . . . . 73.010000000000005 110.262 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.71 -40.11 4.4 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.354 -0.61 . . . . 74.25 109.354 167.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -55.98 119.75 6.35 Favored 'General case' 0 C--N 1.361 1.074 0 O-C-N 124.691 1.244 . . . . 75.340000000000003 112.083 -164.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--O 1.251 1.138 0 N-CA-C 106.355 -1.72 . . . . 75.219999999999999 106.355 168.293 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.587 0.232 . . . . 72.25 110.762 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.48 -179.57 41.93 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.162 -0.375 . . . . 74.239999999999995 112.162 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -100.44 110.85 23.06 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.554 -0.536 . . . . 75.010000000000005 109.554 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -118.47 128.37 26.02 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.828 0.851 . . . . 73.019999999999996 109.117 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.97 104.38 1.84 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.404 2.069 . . . . 71.409999999999997 112.288 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.32 125.13 11.63 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 110.744 -0.942 . . . . 71.510000000000005 110.744 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -65.77 117.01 7.58 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.687 0.395 . . . . 75.200000000000003 110.913 -174.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 m -76.72 -173.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.003 0.921 . . . . 73.129999999999995 111.059 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.4 mt 73.55 161.73 0.25 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.806 1.242 . . . . 73.310000000000002 111.207 -176.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.78 179.45 35.6 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.633 -0.712 . . . . 42.210000000000001 113.864 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -145.81 124.72 12.71 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.628 -1.249 . . . . 73.200000000000003 107.628 171.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -76.41 -53.33 8.3 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.94 0.896 . . . . 72.129999999999995 111.272 -172.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.63 86.21 6.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.967 -0.56 . . . . 73.140000000000001 110.744 -170.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -97.14 106.7 33.32 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.158 -0.928 . . . . 74.340000000000003 109.997 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.56 114.58 3.72 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.491 2.127 . . . . 72.439999999999998 110.817 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -71.05 88.97 0.79 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 107.827 -1.175 . . . . 74.430000000000007 107.827 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.07 147.78 93.89 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.17 0.988 . . . . 71.140000000000001 111.278 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.9 173.86 12.29 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.792 2.328 . . . . 71.239999999999995 111.62 175.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 64.65 19.0 11.68 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.38 1.072 . . . . 73.400000000000006 112.479 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.5 mt -86.48 96.57 10.09 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.962 -0.755 . . . . 74.510000000000005 108.962 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -140.75 108.62 5.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.396 -0.82 . . . . 62.109999999999999 108.87 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -133.06 101.0 5.05 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.621 -0.881 . . . . 74.030000000000001 108.621 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -66.24 97.72 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 109.139 -0.689 . . . . 74.319999999999993 109.139 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -143.98 -86.66 0.13 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.097 -0.501 . . . . 72.120000000000005 109.98 -173.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.47 98.43 0.04 OUTLIER Glycine 0 C--N 1.351 1.375 0 O-C-N 123.026 0.203 . . . . 72.340000000000003 113.467 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.02 -78.43 0.58 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.402 0.681 . . . . 64.200000000000003 109.34 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.97 -72.64 0.89 Allowed Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.368 -0.378 . . . . 73.109999999999999 112.696 -175.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.2 mttm 64.87 29.22 12.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.157 1.383 . . . . 74.239999999999995 112.819 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -109.82 178.08 4.52 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.068 0.947 . . . . 63.399999999999999 109.908 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -162.67 150.16 13.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.961 0.505 . . . . 75.219999999999999 110.491 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.2 t -119.06 146.88 44.7 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.618 0.767 . . . . 51.350000000000001 110.299 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 p -80.1 170.35 16.56 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.243 0.617 . . . . 51.240000000000002 110.227 170.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -114.68 -179.5 3.65 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.125 0.57 . . . . 61.439999999999998 109.815 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -133.12 137.18 46.21 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.319 0.648 . . . . 71.409999999999997 109.444 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.46 89.84 0.13 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 112.08 -0.408 . . . . 35.520000000000003 112.08 -174.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.16 123.42 6.32 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 119.403 -0.665 . . . . 43.130000000000003 112.689 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -72.05 -178.82 3.42 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.955 2.437 . . . . 72.209999999999994 113.076 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.0 t60 66.8 12.79 9.09 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.782 1.233 . . . . 75.25 112.371 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.6 m -146.82 15.33 1.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.439 0.695 . . . . 75.319999999999993 111.061 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -68.24 148.87 50.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.89 0.476 . . . . 55.399999999999999 110.196 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.05 138.43 53.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.402 0.681 . . . . 65.310000000000002 109.328 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -75.18 113.87 13.03 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.025 -0.731 . . . . 72.150000000000006 109.025 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.5 m -82.04 167.55 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.019 0.528 . . . . 61.420000000000002 109.812 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.14 151.91 38.4 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.77 0.828 . . . . 75.340000000000003 109.648 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -106.41 -40.17 5.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.788 0.835 . . . . 74.129999999999995 109.623 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 64.21 179.32 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.894 1.278 . . . . 53.420000000000002 112.157 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.02 115.41 8.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.368 0.667 . . . . 74.510000000000005 109.607 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.36 155.82 16.6 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.734 -0.839 . . . . 63.450000000000003 108.734 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -79.59 109.86 14.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.675 -0.491 . . . . 53.219999999999999 109.675 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.6 140.04 7.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 123.701 0.8 . . . . 64.200000000000003 109.227 170.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 117.61 5.2 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.383 2.055 . . . . 64.5 111.115 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 53' ' ' ALA . 9.6 p -73.13 176.91 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.298 0 C-N-CA 123.808 0.843 . . . . 71.340000000000003 109.262 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.418 ' H ' HG22 ' A' ' 52' ' ' VAL . . . -64.17 165.37 9.38 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 118.185 0.448 . . . . 74.120000000000005 111.265 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 p -52.76 -30.2 31.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.667 1.187 . . . . 71.310000000000002 113.876 -168.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.98 -50.68 0.26 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.448 0.699 . . . . 54.039999999999999 109.716 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -82.83 -176.84 6.51 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.973 -1.012 . . . . 61.210000000000001 111.122 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 146.1 57.6 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.683 0.793 . . . . 64.25 109.452 174.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.59 -75.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.715 2.276 . . . . 71.109999999999999 112.573 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -145.86 3.8 0.96 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.79 0.836 . . . . 73.019999999999996 111.135 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.42 -48.85 3.15 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.446 -0.662 . . . . 71.010000000000005 111.446 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.6 120.19 14.23 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.385 0.674 . . . . 75.439999999999998 109.911 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.2 p -164.88 40.11 0.07 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.171 0.988 . . . . 64.439999999999998 109.464 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -66.57 -34.72 78.53 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 114.617 -1.174 . . . . 74.120000000000005 111.025 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.22 -76.28 0.58 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.553 0.741 . . . . 53.119999999999997 109.649 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.62 -82.15 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.047 0.939 . . . . 60.039999999999999 108.543 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -88.84 -30.16 19.15 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.052 -0.722 . . . . 54.200000000000003 109.052 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -75.73 84.58 2.72 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.375 -0.83 . . . . 65.129999999999995 109.995 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -83.32 -31.52 26.78 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.627 -1.169 . . . . 52.210000000000001 109.805 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.6 p -69.58 3.48 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.153 0.981 . . . . 61.439999999999998 112.712 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.76 -25.04 67.09 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.419 0.688 . . . . 50.140000000000001 110.329 169.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.603 ' HG3' HD22 ' A' ' 72' ' ' ASN . 17.0 pt-20 -58.82 -36.81 75.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.588 0.755 . . . . 74.409999999999997 110.248 171.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.603 HD22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -86.15 -7.04 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.945 1.298 . . . . 45.530000000000001 111.569 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.81 -49.42 70.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.246 0.618 . . . . 64.340000000000003 110.157 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.2 mt -112.84 18.45 18.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.384 0.674 . . . . 72.319999999999993 110.906 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.49 -46.68 21.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.906 0.482 . . . . 30.34 110.842 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.69 -135.35 12.8 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.19 -0.783 . . . . 52.020000000000003 111.746 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.56 -172.72 0.83 Allowed 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 123.799 2.999 . . . . 73.319999999999993 113.396 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 14.4 m -60.06 170.35 1.26 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.417 1.087 . . . . 44.140000000000001 112.466 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.75 -52.11 65.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.079 0.551 . . . . 54.340000000000003 112.39 -168.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -135.93 -38.4 0.71 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.198 0.523 . . . . 72.239999999999995 111.412 171.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 78' ' ' SER . 7.7 m-20 -90.02 143.65 30.2 Favored Pre-proline 0 N--CA 1.48 1.07 0 CA-C-N 115.607 -0.724 . . . . 73.510000000000005 112.105 -170.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.62 -35.79 27.78 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.977 2.451 . . . . 54.350000000000001 112.244 171.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -95.62 18.31 13.13 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.579 0.752 . . . . 60.439999999999998 112.205 -173.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 51.0 tp -82.34 120.15 25.04 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.93 -0.767 . . . . 75.299999999999997 108.93 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.1 m-85 -106.91 174.22 5.98 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.758 1.223 . . . . 74.239999999999995 109.066 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.32 138.41 40.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.97 1.308 . . . . 54.549999999999997 108.66 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.49 116.84 18.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 74.319999999999993 109.968 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 69.6 mt -79.4 -29.98 42.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.283 0.633 . . . . 71.430000000000007 110.864 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 238' ' ' LYS . 87.4 m-85 -126.64 140.82 52.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.867 -1.06 . . . . 75.030000000000001 108.529 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -72.84 134.19 44.77 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.176 -1.046 . . . . 65.019999999999996 108.176 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HB3' HG12 ' A' ' 101' ' ' ILE . 80.9 t80 -131.22 111.23 11.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.316 -0.994 . . . . 73.430000000000007 108.316 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.99 137.15 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.542 -1.281 . . . . 74.430000000000007 107.542 172.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.01 117.12 2.96 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.129 0.972 . . . . 75.340000000000003 112.497 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.8 p -88.5 4.99 44.67 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.918 0.887 . . . . 72.329999999999998 111.646 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.85 -175.39 33.84 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.245 -0.742 . . . . 72.209999999999994 111.245 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -79.39 -38.21 35.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.22 0.608 . . . . 72.099999999999994 110.508 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -83.25 -15.46 50.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.24 1.016 . . . . 70.439999999999998 111.458 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.455 ' HA ' ' H ' ' A' ' 129' ' ' TRP . 71.7 p -77.24 177.24 8.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.967 0.507 . . . . 53.130000000000003 111.183 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.497 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 56.3 tp -134.31 132.22 39.3 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.814 0.446 . . . . 54.409999999999997 111.154 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 58.0 m -77.9 116.9 18.76 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.864 -0.607 . . . . 61.100000000000001 109.771 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 91' ' ' PHE . 15.2 pt -119.9 153.89 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.951 0.901 . . . . 75.219999999999999 110.137 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 m -106.9 145.87 31.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.106 0.562 . . . . 72.450000000000003 109.506 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -67.34 109.68 3.24 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 122.857 0.463 . . . . 63.140000000000001 110.156 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.18 -11.93 33.94 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 116.371 -0.377 . . . . 71.230000000000004 112.358 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -77.52 137.73 38.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.331 0.652 . . . . 71.409999999999997 110.443 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.41 ' HB3' HD11 ' A' ' 84' ' ' LEU . 42.0 mmtm -84.55 145.23 28.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.816 0.847 . . . . 71.420000000000002 109.371 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.33 146.74 32.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.337 0.655 . . . . 71.439999999999998 110.301 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -92.49 109.65 21.05 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.112 -1.069 . . . . 73.239999999999995 108.112 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.582 HG13 ' HB1' ' A' ' 119' ' ' ALA . 74.8 t -85.21 122.92 38.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.979 -0.748 . . . . 74.120000000000005 108.979 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.473 HD11 HE21 ' A' ' 122' ' ' GLN . 17.3 mt -90.87 -21.91 21.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.814 1.246 . . . . 74.099999999999994 109.959 -174.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.92 152.69 6.39 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.639 -0.534 . . . . 62.030000000000001 112.668 174.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 47.1 m-85 -86.56 165.22 16.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.372 0.606 . . . . 63.140000000000001 110.81 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -86.91 -172.3 3.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.609 1.164 . . . . 64.400000000000006 111.077 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -58.61 -34.12 70.77 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.886 0.875 . . . . 72.409999999999997 112.53 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -102.5 -4.09 25.89 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.239 0.616 . . . . 74.450000000000003 111.741 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 63.49 26.84 70.02 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.59 -0.561 . . . . 71.540000000000006 114.44 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.19 -12.98 19.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.34 0.57 . . . . 72.329999999999998 111.49 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.464 ' HE1' HG23 ' A' ' 247' ' ' VAL . 79.6 m95 -137.65 151.43 48.27 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.984 0.914 . . . . 71.209999999999994 109.967 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 112' ' ' TYR . . . -135.35 140.22 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.581 0.752 . . . . 61.420000000000002 110.312 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.432 ' HG2' ' NE2' ' A' ' 127' ' ' GLN . 40.7 tt0 -77.19 99.87 5.59 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.684 -1.598 . . . . 72.319999999999993 106.684 169.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.98 161.7 24.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.275 0.63 . . . . 74.120000000000005 110.668 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.473 HE21 HD11 ' A' ' 110' ' ' LEU . 8.5 pt20 -132.11 123.64 27.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.25 0.548 . . . . 73.109999999999999 111.929 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.2 p -98.05 -176.95 3.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.958 1.303 . . . . 64.5 109.853 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 11.0 mptt -66.91 -22.27 65.96 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.762 -1.108 . . . . 61.450000000000003 109.514 172.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -75.96 -19.69 58.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.931 1.293 . . . . 74.310000000000002 110.9 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.62 -160.85 24.16 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.076 0.235 . . . . 23.43 112.873 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.432 ' NE2' ' HG2' ' A' ' 120' ' ' GLU . 64.7 tp60 -98.59 158.34 15.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.917 0.887 . . . . 71.209999999999994 110.378 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 166.29 -163.42 36.86 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.234 -0.439 . . . . 35.140000000000001 112.416 169.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.455 ' H ' ' HA ' ' A' ' 98' ' ' THR . 87.0 m95 -102.76 131.64 49.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.906 0.882 . . . . 70.109999999999999 110.618 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 8.8 m -130.66 139.37 35.41 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.196 0.998 . . . . 64.219999999999999 108.947 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 130' ' ' VAL . 3.8 Cg_exo -78.94 141.32 16.67 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.522 2.148 . . . . 50.329999999999998 113.577 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.5 m -42.6 -44.74 4.34 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.614 1.566 . . . . 72.120000000000005 113.981 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.57 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 26.5 p-10 -78.25 6.09 8.95 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.895 0.878 . . . . 64.239999999999995 112.329 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.4 -14.29 12.2 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.3 1.04 . . . . 65.230000000000004 111.274 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.46 173.2 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.507 0.723 . . . . 72.129999999999995 112.034 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.415 HG21 ' HB2' ' A' ' 142' ' ' GLU . 5.8 t -161.56 153.33 16.1 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.602 1.161 . . . . 74.150000000000006 107.889 170.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 28.3 Cg_endo -60.71 148.4 91.81 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.507 1.472 . . . . 74.510000000000005 111.634 172.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.2 t -73.46 -4.01 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 CA-C-O 121.711 0.767 . . . . 73.430000000000007 110.179 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 78' ' ' SER . 8.4 m120 -80.02 -19.99 46.41 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.697 0.799 . . . . 74.239999999999995 111.49 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.0 p -86.41 174.52 8.95 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.172 0.589 . . . . 64.129999999999995 112.129 -171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.59 -22.38 30.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.738 0.815 . . . . 60.329999999999998 111.516 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.415 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.9 mp0 -68.47 -18.1 64.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.74 0.816 . . . . 75.349999999999994 111.611 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -60.74 -12.94 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.412 0.685 . . . . 73.010000000000005 112.744 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -95.44 158.18 15.57 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.029 0.931 . . . . 71.25 110.535 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.5 p -70.11 -42.79 72.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.588 0.755 . . . . 62.32 111.254 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.487 ' HE3' ' HB ' ' A' ' 170' ' ' VAL . 48.9 p-90 -61.98 -39.61 92.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.051 0.76 . . . . 74.530000000000001 113.051 -176.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -82.83 105.78 14.12 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.956 -0.387 . . . . 61.329999999999998 109.956 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -99.32 -3.55 33.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.292 0.637 . . . . 53.130000000000003 111.952 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.13 -148.86 33.45 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.754 -1.025 . . . . 73.409999999999997 113.102 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.34 106.76 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.792 2.328 . . . . 52.439999999999998 112.042 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 79.7 t -135.79 139.63 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.533 1.533 . . . . 72.439999999999998 109.152 -174.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.6 p -90.23 170.33 10.38 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 65.430000000000007 109.873 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.19 -29.81 70.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.795 0.27 . . . . 74.040000000000006 110.583 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -55.94 -53.84 51.98 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.275 0.63 . . . . 71.25 110.125 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.536 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -72.5 -27.88 62.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.844 -1.071 . . . . 71.540000000000006 111.725 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.41 61.97 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.111 0.564 . . . . 74.25 111.586 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -63.71 -38.17 90.09 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.731 . . . . 72.349999999999994 110.433 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.46 -45.81 92.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.903 -1.044 . . . . 70.340000000000003 110.753 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.67 -48.82 79.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.597 0.759 . . . . 75.400000000000006 111.772 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.17 11.18 24.15 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.709 1.003 . . . . 70.030000000000001 113.709 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.8 p -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.725 0.693 . . . . 54.409999999999997 109.991 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.1 p -94.0 10.1 34.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.57 0.748 . . . . 70.140000000000001 111.145 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -76.52 157.92 48.3 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.21 -0.45 . . . . 72.140000000000001 113.274 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.2 pt -100.74 176.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.878 0.871 . . . . 60.310000000000002 111.074 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.99 110.08 5.48 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.089 -0.708 . . . . 75.319999999999993 109.089 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.62 7.96 23.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.505 -0.608 . . . . 63.539999999999999 112.723 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.3 m -83.86 122.43 28.7 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.463 0.632 . . . . 54.020000000000003 111.014 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -129.53 164.82 22.95 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.475 0.579 . . . . 74.239999999999995 111.16 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.94 138.65 14.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.478 -0.934 . . . . 74.030000000000001 108.478 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.663 HG22 HG12 ' A' ' 182' ' ' ILE . 72.5 t -98.27 138.8 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.136 -1.061 . . . . 72.239999999999995 108.136 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.595 ' HE ' ' HB2' ' A' ' 181' ' ' SER . 2.1 ppt_? -146.7 162.38 38.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.881 0.873 . . . . 72.340000000000003 108.83 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -107.57 150.0 27.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.427 -1.323 . . . . 54.439999999999998 107.427 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t -68.33 125.1 25.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.454 -0.573 . . . . 60.130000000000003 109.454 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.25 -38.93 71.78 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.479 1.112 . . . . 73.219999999999999 111.154 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.3 m -102.88 5.92 38.81 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.605 0.762 . . . . 31.129999999999999 112.254 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.7 m -148.1 88.77 5.39 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 122.888 0.475 . . . . 61.32 110.532 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.55 134.47 35.67 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.69 2.26 . . . . 73.340000000000003 111.961 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.27 -28.54 13.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.934 -0.575 . . . . 31.34 112.378 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -88.91 116.98 27.58 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.844 -0.798 . . . . 75.400000000000006 108.844 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 77.5 mtt180 -119.16 159.35 24.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.284 0.564 . . . . 73.120000000000005 110.525 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.595 ' HB2' ' HE ' ' A' ' 171' ' ' ARG . 40.2 m -148.4 152.43 36.97 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.266 -0.879 . . . . 72.310000000000002 110.278 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.663 HG12 HG22 ' A' ' 170' ' ' VAL . 33.9 mt -104.18 150.48 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.373 -1.343 . . . . 72.450000000000003 107.373 170.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.0 m -122.94 108.18 12.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.186 -1.412 . . . . 64.549999999999997 107.186 170.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.95 110.49 22.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.319 -0.623 . . . . 72.129999999999995 109.319 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.505 ' HB2' HG22 ' A' ' 190' ' ' VAL . 35.6 ttt180 -78.3 115.68 18.19 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.982 -0.747 . . . . 75.319999999999993 108.982 166.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -140.34 138.25 34.74 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.552 1.158 . . . . 52.009999999999998 108.446 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 56.08 30.89 17.12 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.297 1.039 . . . . 72.409999999999997 112.033 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 75.96 12.95 83.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.87 -0.605 . . . . 74.140000000000001 114.264 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -122.0 136.56 54.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 73.530000000000001 109.391 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 185' ' ' ARG . 60.3 t -96.54 106.47 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 122.921 0.488 . . . . 75.120000000000005 110.252 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.02 136.48 33.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.593 1.157 . . . . 71.409999999999997 109.381 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -112.51 119.0 36.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.132 0.491 . . . . 64.319999999999993 110.231 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.505 ' HE1' HD21 ' A' ' 232' ' ' LEU . 10.6 m-30 -95.63 142.2 28.23 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.994 -1.003 . . . . 65.530000000000001 109.053 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 7.1 tpp180 -93.88 109.79 21.48 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.121 -0.696 . . . . 71.439999999999998 109.121 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 54.9 mt -85.7 101.95 10.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.079 -1.082 . . . . 62.539999999999999 108.079 170.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.06 116.46 19.37 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.051 -0.722 . . . . 75.400000000000006 109.051 170.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 m -87.66 112.92 22.85 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.786 -0.82 . . . . 73.439999999999998 108.786 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -67.13 157.65 33.13 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.232 0.613 . . . . 51.439999999999998 110.401 174.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.8 p -65.61 -20.93 66.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.005 0.922 . . . . 72.209999999999994 113.122 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.37 -14.96 39.25 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.1 0.56 . . . . 54.100000000000001 110.891 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.23 11.99 14.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.508 -0.607 . . . . 33.229999999999997 113.868 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 67.9 mttm -71.56 155.36 40.64 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.873 0.837 . . . . 74.439999999999998 110.563 171.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.43 143.41 49.25 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.011 -1.107 . . . . 64.230000000000004 108.011 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 52.9 p90 -162.83 133.79 4.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.403 0.44 . . . . 73.450000000000003 111.994 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 194' ' ' ARG . 52.9 t -82.14 -36.32 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.466 -0.788 . . . . 61.219999999999999 109.432 168.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 209' ' ' SER . 16.0 m -105.47 124.64 49.89 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.006 -1.109 . . . . 75.040000000000006 108.006 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.2 m -62.25 -25.62 67.93 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 60.32 112.771 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -80.69 -31.32 36.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.876 . . . . 73.510000000000005 110.775 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 50.6 m -109.47 88.47 2.75 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.484 0.713 . . . . 63.549999999999997 109.933 -173.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.592 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 64.8 mtt180 -100.67 127.11 47.18 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.873 -0.788 . . . . 73.340000000000003 108.873 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.95 148.55 38.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.476 -0.935 . . . . 70.219999999999999 108.476 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -68.06 -37.45 81.32 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.555 0.534 . . . . 64.409999999999997 110.146 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 67.0 p -127.98 158.68 37.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.829 0.852 . . . . 74.109999999999999 112.031 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.9 -22.23 62.29 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.879 -1.055 . . . . 75.140000000000001 109.917 175.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.39 97.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.392 0.677 . . . . 74.150000000000006 110.348 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.28 -37.06 71.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.103 -0.953 . . . . 73.519999999999996 111.403 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.422 HD11 HG23 ' A' ' 205' ' ' VAL . 15.2 tp -55.04 -57.87 9.96 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.366 0.416 . . . . 45.420000000000002 110.963 173.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.46 -48.76 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.226 0.61 . . . . 71.239999999999995 110.976 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -57.84 -55.04 39.99 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.012 0.82 . . . . 74.329999999999998 111.071 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -65.13 -33.43 75.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.093 0.557 . . . . 54.420000000000002 111.576 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.737 ' HB3' HD11 ' A' ' 228' ' ' LEU . 14.0 m170 -89.76 -8.54 51.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.095 0.406 . . . . 73.140000000000001 112.095 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 84.5 p -93.59 -24.81 17.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.764 0.426 . . . . 43.399999999999999 110.209 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.9 p -81.31 -47.11 13.75 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.769 0.428 . . . . 51.039999999999999 110.856 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.613 HG23 ' HB2' ' A' ' 226' ' ' ASP . 23.5 m -128.17 164.37 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.043 0.925 . . . . 74.150000000000006 112.356 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.95 14.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 127.184 2.194 . . . . 71.099999999999994 114.125 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.613 ' HB2' HG23 ' A' ' 224' ' ' VAL . 35.4 t70 -45.41 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.356 1 C-N-CA 131.816 4.046 . . . . 74.040000000000006 119.614 -158.219 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 124.52 -1.79 8.77 Favored Glycine 0 N--CA 1.486 1.977 0 O-C-N 120.808 -1.183 . . . . 71.340000000000003 112.48 -169.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.737 HD11 ' HB3' ' A' ' 221' ' ' HIS . 11.7 mt -93.9 163.15 13.62 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.753 1.221 . . . . 64.450000000000003 110.016 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.7 tt -56.96 -40.45 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 120.824 0.345 . . . . 64.129999999999995 110.369 166.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -162.76 177.33 9.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.595 0.758 . . . . 70.409999999999997 110.69 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -66.15 136.24 55.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 54.32 111.686 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.505 HD21 ' HE1' ' A' ' 193' ' ' TYR . 49.2 mt -69.36 138.73 53.94 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 108.332 -0.988 . . . . 72.510000000000005 108.332 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -132.25 -77.63 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.962 1.255 . . . . 73.420000000000002 111.675 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 167' ' ' SER . 17.9 t80 -80.7 123.0 82.82 Favored Pre-proline 0 C--O 1.209 -1.049 0 CA-C-O 118.307 -0.854 . . . . 72.019999999999996 108.753 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 146' ' ' TRP . 8.3 Cg_endo -88.36 132.89 2.68 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.288 1.992 . . . . 51.210000000000001 111.609 171.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.77 131.94 93.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.484 0.714 . . . . 74.340000000000003 109.782 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.92 177.76 7.99 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.674 2.249 . . . . 71.439999999999998 113.116 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 89' ' ' TYR . 32.7 mmtp -79.0 126.6 30.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.463 0.705 . . . . 73.430000000000007 109.349 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.522 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 15.3 ptt180 -93.14 -62.45 1.38 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.545 0.943 . . . . 74.540000000000006 113.545 -160.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.522 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 57.4 t30 -109.26 132.31 54.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.235 0.614 . . . . 73.340000000000003 111.09 -167.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -68.84 112.4 11.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 107.179 -1.415 . . . . 61.229999999999997 107.179 163.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.57 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 8.0 Cg_exo -74.61 124.59 8.93 Favored 'Trans proline' 0 C--N 1.364 1.395 0 C-N-CA 122.218 1.946 . . . . 74.030000000000001 112.098 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 87.7 m -64.96 123.27 19.0 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.318 0.647 . . . . 74.439999999999998 110.744 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.438 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 64.1 t -79.69 125.95 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 108.658 -0.868 . . . . 72.530000000000001 108.658 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -98.17 113.0 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 117.711 0.232 . . . . 64.230000000000004 111.096 -168.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 58.1 6.37 2.92 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 118.675 2.23 . . . . 75.340000000000003 118.675 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.464 HG23 ' HE1' ' A' ' 118' ' ' TRP . 17.1 m -106.53 123.07 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.943 1.371 . . . . 72.329999999999998 113.781 -170.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 t -82.89 122.94 78.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 106.326 -1.731 . . . . 50.130000000000003 106.326 157.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 118' ' ' TRP . 41.0 Cg_endo -64.7 -57.64 0.28 Allowed 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.423 1.415 . . . . 74.140000000000001 115.212 -157.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -126.78 -26.04 3.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.794 0.438 . . . . 72.099999999999994 110.803 164.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -69.03 99.43 1.09 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.767 0.794 . . . . 74.439999999999998 112.804 -142.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -123.81 -46.27 1.99 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 113.999 -1.455 . . . . 62.140000000000001 108.297 156.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -111.37 -43.14 3.74 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.786 -1.097 . . . . 73.340000000000003 113.372 -169.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -71.95 114.49 10.1 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.848 0.684 . . . . 65.230000000000004 112.848 -153.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.26 1.636 0 C-N-CA 125.359 1.464 . . . . 73.329999999999998 108.123 172.316 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.031 -0.359 . . . . 75.219999999999999 110.031 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.04 149.38 49.09 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 115.825 -0.625 . . . . 44.100000000000001 112.043 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -143.44 148.11 35.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.474 0.71 . . . . 63.200000000000003 110.081 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -100.19 110.11 58.69 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.772 -0.825 . . . . 73.219999999999999 108.772 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.37 111.59 2.97 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.801 2.334 . . . . 72.120000000000005 112.987 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.47 123.94 6.29 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 116.072 -0.513 . . . . 73.530000000000001 111.846 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.5 79.65 8.88 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.746 -0.835 . . . . 64.319999999999993 108.746 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m -83.32 177.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.772 0.829 . . . . 60.140000000000001 111.053 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.5 115.65 31.02 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.687 0.795 . . . . 72.409999999999997 109.024 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.44 84.77 0.95 Allowed Glycine 0 C--N 1.344 1.009 0 N-CA-C 110.273 -1.131 . . . . 75.099999999999994 110.273 170.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.85 152.91 25.99 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.519 0.728 . . . . 63.219999999999999 111.098 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -60.96 105.28 0.45 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.858 0.837 . . . . 73.5 110.574 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -108.29 162.55 13.98 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.553 1.141 . . . . 62.32 109.235 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -60.47 139.49 92.37 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.096 0.958 . . . . 74.430000000000007 111.068 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.59 -171.04 0.84 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.987 2.458 . . . . 61.439999999999998 112.886 -176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 t -146.43 -176.9 5.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.555 0.742 . . . . 62.399999999999999 109.723 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -69.59 116.67 45.47 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.548 0.739 . . . . 70.109999999999999 109.78 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.95 106.55 2.29 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.298 1.999 . . . . 74.010000000000005 110.7 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.04 136.81 32.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.133 0.573 . . . . 70.109999999999999 110.947 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.7 pt? -79.61 156.24 27.75 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.173 0.589 . . . . 73.140000000000001 110.342 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.48 171.14 14.87 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.444 0.698 . . . . 61.299999999999997 110.504 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -77.49 107.94 10.29 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.368 0.667 . . . . 73.439999999999998 109.485 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.495 ' HB ' ' ND2' ' A' ' 240' ' ' ASN . 7.0 pt -140.38 127.1 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.833 0.853 . . . . 71.140000000000001 109.501 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.09 153.09 19.6 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.804 0.842 . . . . 75.319999999999993 111.468 -171.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 178.68 -156.58 19.25 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 123.485 0.49 . . . . 54.240000000000002 112.184 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.1 176.86 8.79 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.147 0.979 . . . . 64.400000000000006 110.391 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.62 97.29 0.26 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.247 0.451 . . . . 71.150000000000006 112.297 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -62.49 -73.24 0.11 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.64 0.776 . . . . 61.310000000000002 110.523 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HB3' HD21 ' A' ' 68' ' ' ASN . 60.8 mtm180 71.92 149.44 0.09 Allowed 'General case' 0 C--N 1.37 1.472 0 C-N-CA 125.348 1.459 . . . . 74.230000000000004 110.729 -174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -82.56 18.34 1.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.868 1.433 . . . . 74.400000000000006 114.868 -165.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.7 t 69.39 145.23 0.05 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.582 1.153 . . . . 63.409999999999997 112.914 172.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 68' ' ' ASN . 28.6 t 178.61 175.88 0.55 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.531 1.533 . . . . 52.25 108.748 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.08 175.45 13.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.777 0.831 . . . . 62.039999999999999 109.719 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -155.19 -72.09 0.12 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 120.995 0.426 . . . . 74.439999999999998 110.695 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.37 135.67 2.35 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.003 -1.239 . . . . 61.240000000000002 110.003 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.11 137.33 5.22 Favored Glycine 0 C--N 1.358 1.753 0 CA-C-N 118.113 0.957 . . . . 70.109999999999999 113.158 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.04 -47.56 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.226 2.617 . . . . 73.129999999999995 114.028 -173.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -76.79 113.16 14.15 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 109.806 -0.442 . . . . 72.400000000000006 109.806 -176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.586 ' SG ' ' HG3' ' A' ' 51' ' ' PRO . 5.9 p -89.05 -178.37 5.67 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.049 0.939 . . . . 73.239999999999995 111.438 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.477 HD22 HG22 ' A' ' 41' ' ' VAL . 9.4 p-10 -153.69 -75.12 0.12 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.883 0.873 . . . . 75.030000000000001 109.911 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.477 HG22 HD22 ' A' ' 40' ' ' ASN . 8.5 m -149.12 159.19 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 124.98 1.312 . . . . 75.310000000000002 109.537 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 t80 80.53 157.62 0.15 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.316 1.447 . . . . 60.329999999999998 112.267 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.1 t 68.0 94.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.334 1.453 . . . . 54.0 110.344 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -66.34 119.41 11.52 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.584 1.153 . . . . 75.120000000000005 111.922 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.574 ' HB2' ' NE2' ' A' ' 59' ' ' GLN . 3.2 m170 -170.92 -165.37 0.42 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.887 1.675 . . . . 64.219999999999999 107.636 170.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -114.14 117.7 31.96 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.906 0.482 . . . . 70.200000000000003 109.874 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.78 133.06 0.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.362 1.465 . . . . 74.120000000000005 108.28 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -147.6 163.27 37.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.187 0.518 . . . . 62.229999999999997 110.571 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.62 -93.53 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.255 -1.758 . . . . 71.150000000000006 106.255 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -133.76 73.1 72.4 Favored Pre-proline 0 N--CA 1.477 0.912 0 N-CA-C 107.068 -1.456 . . . . 71.129999999999995 107.068 162.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HG3' ' SG ' ' A' ' 39' ' ' CYS . 15.1 Cg_exo -70.24 -81.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.339 2.693 . . . . 62.299999999999997 112.457 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.7 m -143.6 -58.22 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.789 0.436 . . . . 63.140000000000001 112.057 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.38 91.79 2.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.692 0.797 . . . . 53.210000000000001 109.356 -170.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.0 m -62.56 -9.3 8.32 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.135 1.161 . . . . 70.409999999999997 114.135 -168.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -62.55 -52.45 63.38 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.974 0.51 . . . . 73.219999999999999 110.649 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -144.87 114.43 7.19 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.672 -0.862 . . . . 63.520000000000003 108.672 -176.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -118.11 120.59 32.25 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 109.254 -0.647 . . . . 74.129999999999995 109.254 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.59 59.44 7.25 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.836 2.357 . . . . 73.430000000000007 110.781 173.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.574 ' NE2' ' HB2' ' A' ' 45' ' ' HIS . 3.8 tt0 60.89 -83.1 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.8 1.64 . . . . 75.319999999999993 110.187 -167.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.27 23.94 3.99 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 115.103 0.801 . . . . 74.209999999999994 115.103 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.415 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . 1.0 OUTLIER -74.52 85.16 2.04 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.255 -1.017 . . . . 71.030000000000001 108.255 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -123.06 89.8 3.17 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.65 -0.87 . . . . 71.340000000000003 108.65 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.643 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 6.4 pt-20 -143.15 -22.4 0.62 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.923 -1.035 . . . . 74.540000000000006 110.841 174.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.8 66.75 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.04 0.448 . . . . 73.450000000000003 111.409 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.35 11.01 17.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.404 1.081 . . . . 73.209999999999994 111.211 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.643 ' HB2' ' HA ' ' A' ' 63' ' ' GLU . 58.3 mmt-85 -126.08 -60.25 1.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.88 0.872 . . . . 74.129999999999995 110.702 -174.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.422 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 6.7 t90 -119.97 81.38 1.73 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.969 0.908 . . . . 73.420000000000002 109.274 176.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 19.7 p-10 -76.84 -29.48 55.93 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 116.229 -0.441 . . . . 71.420000000000002 110.519 177.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -73.21 5.03 3.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.019 1.328 . . . . 74.129999999999995 113.095 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.53 -17.71 64.96 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.676 1.19 . . . . 73.140000000000001 112.922 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -26.84 19.51 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.255 0.622 . . . . 74.129999999999995 110.957 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.92 -5.63 55.94 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.62 0.768 . . . . 73.430000000000007 110.4 169.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.447 HD13 ' HE1' ' A' ' 146' ' ' TRP . 62.4 tp -60.72 -54.09 49.48 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.961 0.505 . . . . 71.349999999999994 109.869 174.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.02 84.3 1.9 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.98 -1.119 . . . . 71.109999999999999 107.98 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.53 -36.86 21.88 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.378 -0.828 . . . . 72.319999999999993 111.774 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.49 -153.13 43.9 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-O 118.874 -0.959 . . . . 71.519999999999996 112.599 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -83.92 112.79 1.8 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 CA-C-N 119.937 1.869 . . . . 74.439999999999998 110.154 165.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.44 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 33.5 t -127.55 177.18 6.94 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.034 0.933 . . . . 54.240000000000002 110.988 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -75.4 3.39 9.24 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 124.527 1.131 . . . . 70.349999999999994 110.87 173.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 78' ' ' SER . 32.4 p-10 -82.67 31.34 0.42 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.058 1.343 . . . . 73.430000000000007 112.111 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.28 148.44 0.84 Allowed Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 126.298 1.839 . . . . 75.329999999999998 112.673 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.58 0.12 4.53 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.444 2.762 . . . . 73.319999999999993 115.813 -162.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.58 -24.24 45.63 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.447 0.642 . . . . 73.099999999999994 110.073 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 106' ' ' LYS . 38.5 tp -88.46 121.37 30.77 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 114.636 -1.165 . . . . 63.539999999999999 108.084 171.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.56 173.19 6.42 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.5 1.12 . . . . 71.120000000000005 108.704 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -131.18 135.81 58.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 124.424 1.089 . . . . 63.539999999999999 108.109 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.69 107.06 6.55 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.062 0.945 . . . . 70.239999999999995 109.405 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.521 HD22 ' HZ2' ' A' ' 238' ' ' LYS . 79.0 mt -69.29 -23.92 63.89 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.475 0.71 . . . . 74.209999999999994 111.528 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 77.0 m-85 -135.77 155.67 50.0 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 75.140000000000001 109.954 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 241' ' ' LYS . 10.9 m-20 -70.87 156.09 40.0 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.908 -0.775 . . . . 71.25 108.908 167.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.586 ' HB3' HG12 ' A' ' 101' ' ' ILE . 71.1 t80 -149.3 124.32 10.03 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.133 -1.432 . . . . 72.319999999999993 107.133 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.4 135.34 27.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.789 -1.56 . . . . 62.409999999999997 106.789 169.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.48 117.46 3.11 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.964 0.79 . . . . 41.509999999999998 111.475 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.2 p -88.03 15.14 7.72 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.159 0.984 . . . . 60.350000000000001 110.991 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.47 179.54 46.06 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.912 -0.875 . . . . 74.319999999999993 110.912 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.09 -24.97 58.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.215 0.606 . . . . 72.319999999999993 111.444 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.683 HD22 ' HB3' ' A' ' 251' ' ' TYR . 43.6 p-10 -89.06 -17.56 29.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.724 0.809 . . . . 74.150000000000006 111.561 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.7 p -88.97 158.96 17.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.187 0.595 . . . . 65.549999999999997 110.508 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -121.63 134.15 54.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.215 0.606 . . . . 61.509999999999998 110.98 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.8 m -79.94 132.6 36.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.628 0.771 . . . . 71.450000000000003 110.512 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.696 HG22 HG21 ' A' ' 123' ' ' THR . 6.7 pt -129.22 154.49 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.617 0.767 . . . . 45.140000000000001 111.098 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.5 m -102.93 145.87 29.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.726 1.21 . . . . 34.299999999999997 109.922 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 88' ' ' LEU . 42.3 tttt -70.63 108.15 4.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.252 0.621 . . . . 71.0 109.75 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.95 29.24 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-N 115.832 -0.622 . . . . 64.219999999999999 112.559 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 54.0 tt0 -74.2 144.99 44.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.787 0.835 . . . . 61.140000000000001 111.314 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.449 ' HB3' HD11 ' A' ' 84' ' ' LEU . 43.0 mmtm -92.74 129.61 38.61 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.36 0.664 . . . . 64.430000000000007 109.843 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.606 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.3 OUTLIER -132.18 136.13 46.84 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.835 0.854 . . . . 75.129999999999995 109.505 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -95.15 109.66 21.72 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.902 -0.777 . . . . 44.299999999999997 108.902 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.608 HG13 ' HB1' ' A' ' 119' ' ' ALA . 42.5 t -77.22 134.35 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 123.644 0.59 . . . . 63.149999999999999 110.278 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.4 mt -102.75 -31.21 10.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.943 1.297 . . . . 74.530000000000001 109.906 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.32 142.94 3.93 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.5 -0.611 . . . . 63.439999999999998 113.331 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 119' ' ' ALA . 33.6 m-85 -86.92 167.34 14.38 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.944 0.898 . . . . 45.329999999999998 110.857 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -88.49 -178.79 5.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.839 . . . . 71.530000000000001 110.565 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -55.42 -34.58 64.54 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.949 1.3 . . . . 63.130000000000003 113.625 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -111.38 9.29 21.5 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.071 0.548 . . . . 74.120000000000005 112.051 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.62 33.11 86.37 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 115.134 0.813 . . . . 62.130000000000003 115.134 172.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.65 -38.68 12.3 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.088 0.444 . . . . 73.549999999999997 111.924 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 66.9 m95 -129.9 147.37 51.65 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.44 0.696 . . . . 72.219999999999999 111.174 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.608 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -128.58 150.82 50.04 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.027 1.331 . . . . 73.299999999999997 109.3 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -87.21 115.76 24.83 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.952 -1.129 . . . . 64.299999999999997 107.952 166.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.51 168.68 10.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.432 0.693 . . . . 72.129999999999995 110.918 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -120.95 110.84 16.77 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.647 0.779 . . . . 73.430000000000007 110.364 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.696 HG21 HG22 ' A' ' 101' ' ' ILE . 82.7 p -100.63 177.58 4.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.347 1.059 . . . . 72.420000000000002 109.933 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.01 -18.3 64.02 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 110.753 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.79 -24.69 55.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.163 0.985 . . . . 73.219999999999999 111.035 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.34 -146.9 17.63 Favored Glycine 0 C--N 1.363 2.055 0 CA-C-N 117.706 0.23 . . . . 72.409999999999997 112.906 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -130.59 139.82 50.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.498 0.719 . . . . 71.109999999999999 109.946 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.21 -174.03 41.05 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.257 -0.737 . . . . 74.540000000000006 111.257 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -87.83 121.81 30.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.344 0.658 . . . . 61.229999999999997 112.41 -170.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.511 HG23 HD13 ' A' ' 135' ' ' ILE . 5.2 m -122.7 142.72 38.33 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.13 1.372 . . . . 63.340000000000003 108.726 173.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 10.6 Cg_endo -88.48 146.91 6.15 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 C-N-CA 122.241 1.961 . . . . 74.430000000000007 114.767 -172.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.4 m -41.35 -44.3 2.73 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.512 1.925 . . . . 74.420000000000002 114.551 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.635 HD22 ' HB2' ' A' ' 242' ' ' PRO . 22.4 p-10 -73.28 -4.16 31.41 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.012 0.525 . . . . 63.340000000000003 112.192 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.455 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 9.7 m-85 -106.44 -22.57 12.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.787 0.835 . . . . 73.120000000000005 111.475 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.511 HD13 HG23 ' A' ' 130' ' ' VAL . 27.6 pt -123.28 164.65 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.325 0.65 . . . . 74.030000000000001 112.442 -172.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.2 t -160.41 149.55 13.91 Favored Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.126 -0.94 . . . . 73.420000000000002 109.166 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.12 145.98 40.5 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.517 2.145 . . . . 62.350000000000001 112.377 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.431 HG12 HD22 ' A' ' 80' ' ' ASN . 3.9 t -75.68 -3.73 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.576 0.703 . . . . 63.200000000000003 111.149 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.84 -2.78 43.34 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.601 -0.687 . . . . 63.43 112.297 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.8 p -78.25 171.58 14.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.2 0.524 . . . . 64.019999999999996 111.828 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.38 -27.71 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.882 -0.599 . . . . 74.239999999999995 109.66 165.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.6 -16.21 64.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.311 1.044 . . . . 73.129999999999995 112.139 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.512 ' HA ' HD21 ' A' ' 88' ' ' LEU . 16.7 pttm -69.49 -31.71 70.15 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.815 0.446 . . . . 52.409999999999997 111.742 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.01 133.8 51.57 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.721 0.809 . . . . 74.430000000000007 110.23 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.0 p -55.59 -32.55 63.16 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 74.420000000000002 112.702 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.447 ' HE1' HD13 ' A' ' 73' ' ' LEU . 25.7 p-90 -81.13 -32.42 33.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.222 0.609 . . . . 73.310000000000002 112.59 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -84.24 107.6 16.64 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.3 -0.63 . . . . 73.310000000000002 109.3 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.77 -5.57 24.73 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.494 0.717 . . . . 71.239999999999995 111.51 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.24 -130.62 21.72 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 118.065 -1.408 . . . . 75.430000000000007 112.941 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.617 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 32.2 Cg_exo -58.63 86.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.821 3.014 . . . . 74.230000000000004 113.603 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.97 132.48 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.285 1.034 . . . . 74.349999999999994 109.681 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.0 p -87.68 175.07 8.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.755 1.222 . . . . 70.129999999999995 110.193 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -61.85 -44.94 95.83 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.483 0.313 . . . . 74.5 110.508 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.23 -48.46 80.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.978 0.911 . . . . 74.140000000000001 110.295 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.3 77.95 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.853 -1.067 . . . . 72.340000000000003 111.419 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.95 -52.47 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.278 0.631 . . . . 72.310000000000002 111.935 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.524 ' HG2' HG11 ' A' ' 190' ' ' VAL . 43.2 mt-10 -68.8 -25.89 64.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.646 0.779 . . . . 75.310000000000002 110.677 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.23 -43.68 90.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.884 0.874 . . . . 70.120000000000005 111.373 170.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.3 mt -65.0 -34.6 78.83 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.285 0.564 . . . . 75.400000000000006 110.532 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 90.0 mt -89.72 2.23 55.08 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.324 -0.853 . . . . 74.310000000000002 112.807 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -61.98 -34.42 76.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.841 0.746 . . . . 71.349999999999994 111.471 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.6 p -101.73 11.08 39.4 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.631 0.772 . . . . 72.420000000000002 111.065 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.04 153.98 40.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.183 -0.462 . . . . 63.0 113.094 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.59 -176.89 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 124.259 1.024 . . . . 75.209999999999994 111.599 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 108.14 1.66 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.574 -0.739 . . . . 54.420000000000002 110.403 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 105.54 12.32 26.91 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.475 -0.625 . . . . 75.209999999999994 112.429 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.483 ' HG ' ' HD1' ' A' ' 234' ' ' TYR . 74.2 m -71.21 144.85 49.98 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 117.519 0.659 . . . . 72.140000000000001 111.209 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.2 p90 -157.52 164.35 37.45 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 122.799 0.44 . . . . 73.439999999999998 110.423 -174.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.07 146.4 12.44 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.647 -0.871 . . . . 61.219999999999999 108.647 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.658 HG22 HG12 ' A' ' 182' ' ' ILE . 91.4 t -96.62 126.67 49.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 108.889 -0.782 . . . . 61.450000000000003 108.889 167.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -116.08 143.4 45.52 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.959 1.303 . . . . 70.030000000000001 107.883 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.76 149.29 38.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.755 0.822 . . . . 75.5 108.922 171.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 t -83.76 125.47 31.95 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.242 -0.651 . . . . 63.100000000000001 109.242 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 150' ' ' PRO . 18.4 tp10 -77.71 -34.31 52.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.195 0.598 . . . . 64.049999999999997 109.392 172.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.0 p -75.22 -16.36 60.48 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.549 0.74 . . . . 52.509999999999998 111.186 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.8 m -147.37 79.16 9.84 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 123.768 0.827 . . . . 74.409999999999997 109.185 172.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.65 133.57 55.11 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.169 2.579 . . . . 72.209999999999994 112.406 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.73 -29.59 10.66 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.885 -0.598 . . . . 73.349999999999994 111.92 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -73.64 115.02 12.56 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 108.632 -0.877 . . . . 71.140000000000001 108.632 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.7 mtt85 -128.47 146.17 50.89 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.725 0.81 . . . . 72.120000000000005 109.098 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.9 m -140.51 148.84 41.69 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.385 1.074 . . . . 70.439999999999998 109.009 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 170' ' ' VAL . 34.4 mt -101.51 148.44 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 106.734 -1.58 . . . . 75.5 106.734 168.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 24.6 m -123.46 109.35 13.73 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.203 -1.406 . . . . 71.319999999999993 107.203 171.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 167' ' ' SER . 20.5 tp -103.59 112.39 25.29 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.808 0.731 . . . . 65.219999999999999 109.614 177.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 23.8 ttt180 -80.47 111.17 16.62 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.471 0.653 . . . . 72.25 109.482 165.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -137.25 134.71 36.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.214 -1.357 . . . . 74.430000000000007 107.433 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 61.91 22.48 13.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.538 1.135 . . . . 73.530000000000001 111.547 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.34 85.94 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.938 -0.573 . . . . 64.310000000000002 113.006 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -105.01 130.77 53.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.132 0.973 . . . . 73.549999999999997 108.798 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.524 HG11 ' HG2' ' A' ' 157' ' ' GLU . 58.7 t -96.46 115.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.897 -0.409 . . . . 74.310000000000002 109.897 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -100.08 148.82 24.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.953 1.301 . . . . 65.439999999999998 107.747 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -119.63 116.41 25.95 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.377 0.535 . . . . 73.519999999999996 110.608 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 182' ' ' ILE . 8.6 m-30 -93.89 149.48 21.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.434 1.094 . . . . 75.129999999999995 108.216 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 205' ' ' VAL . 15.3 tpp180 -106.29 114.05 27.94 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.896 -0.409 . . . . 64.319999999999993 109.896 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.446 HD13 HD21 ' A' ' 214' ' ' LEU . 48.2 mt -87.42 102.75 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.315 -0.994 . . . . 70.209999999999994 108.315 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -87.17 132.52 33.84 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.101 -0.954 . . . . 63.299999999999997 108.72 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.6 m -100.76 106.77 18.21 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.979 -1.119 . . . . 75.299999999999997 107.979 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.07 159.56 3.29 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.686 0.794 . . . . 64.409999999999997 110.525 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.5 p -63.3 -22.31 66.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.063 0.945 . . . . 64.109999999999999 113.236 -172.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -93.79 -0.62 55.78 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.692 0.797 . . . . 61.039999999999999 111.44 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 100.17 14.05 34.55 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.601 -0.555 . . . . 74.219999999999999 114.068 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -88.15 127.03 35.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 117.852 0.826 . . . . 54.229999999999997 111.426 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -87.03 146.18 26.2 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.339 1.056 . . . . 52.329999999999998 108.545 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -165.43 140.41 5.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.374 0.421 . . . . 61.439999999999998 110.648 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.506 HG23 HD11 ' A' ' 217' ' ' LEU . 76.1 t -85.18 -43.04 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.229 -1.026 . . . . 74.299999999999997 108.229 163.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 20.2 m -104.79 129.95 52.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.526 -1.216 . . . . 73.329999999999998 109.099 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.5 t -67.66 -14.65 63.12 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.07 0.948 . . . . 64.129999999999995 112.693 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.44 -17.0 59.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.695 1.198 . . . . 43.420000000000002 111.729 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.2 m -149.57 112.17 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.902 0.481 . . . . 44.350000000000001 110.638 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -102.97 124.17 47.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.06 0.944 . . . . 75.510000000000005 109.021 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -106.87 145.95 31.56 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.071 0.948 . . . . 65.319999999999993 109.284 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.49 -39.77 88.9 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.733 0.645 . . . . 75.540000000000006 110.159 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 69.2 p -126.49 151.62 47.57 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.985 -1.007 . . . . 71.030000000000001 111.482 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 195' ' ' ILE . 0.7 OUTLIER -62.94 -24.63 67.96 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.333 -1.303 . . . . 75.25 109.842 172.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.34 86.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.215 1.006 . . . . 51.409999999999997 111.602 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.37 -35.86 71.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.363 0.665 . . . . 74.120000000000005 111.274 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.506 HD11 HG23 ' A' ' 205' ' ' VAL . 12.4 tp -55.15 -56.18 22.8 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.635 0.584 . . . . 62.140000000000001 110.762 174.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.6 -39.44 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.81 -0.632 . . . . 64.439999999999998 111.041 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -61.26 -53.12 60.89 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.287 0.367 . . . . 71.120000000000005 110.661 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -62.03 -38.6 89.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.413 -0.812 . . . . 75.430000000000007 110.643 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.708 ' HB3' HD11 ' A' ' 228' ' ' LEU . 12.0 m170 -88.17 -5.18 58.56 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.112 -0.494 . . . . 74.099999999999994 112.258 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.7 p -95.31 -24.28 16.82 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.819 0.448 . . . . 72.010000000000005 110.837 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.7 p -81.74 -38.86 25.04 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 122.749 0.42 . . . . 72.219999999999999 111.274 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 226' ' ' ASP . 27.4 m -135.52 162.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.984 0.897 . . . . 62.100000000000001 112.142 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.69 15.07 1.11 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.71 2.004 . . . . 54.149999999999999 114.231 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.623 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.7 t70 -43.36 33.65 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 131.634 3.974 . . . . 63.399999999999999 119.145 -156.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.55 -5.35 9.28 Favored Glycine 0 N--CA 1.478 1.459 0 O-C-N 120.738 -1.226 . . . . 65.340000000000003 112.846 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 221' ' ' HIS . 10.6 mt -91.3 162.23 14.7 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.121 1.368 . . . . 75.400000000000006 109.785 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -61.25 -36.07 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-O 120.843 0.354 . . . . 75.519999999999996 110.075 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.0 t -162.33 175.42 11.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.953 0.901 . . . . 62.409999999999997 109.427 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.6 p -61.88 148.42 43.49 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.454 1.102 . . . . 75.230000000000004 112.202 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.433 HD23 HD13 ' A' ' 184' ' ' LEU . 52.7 mt -75.13 145.93 41.78 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.873 0.869 . . . . 65.109999999999999 108.689 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -137.35 -72.29 0.43 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.799 0.727 . . . . 75.010000000000005 111.949 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.532 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 62.2 t80 -95.26 122.85 58.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.401 0.68 . . . . 73.340000000000003 109.775 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 71.1 Cg_endo -82.1 139.33 10.63 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.538 2.159 . . . . 53.539999999999999 111.058 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.19 141.79 95.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.061 0.545 . . . . 52.310000000000002 110.426 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.49 136.37 12.38 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.339 2.026 . . . . 75.239999999999995 111.852 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.521 ' HZ2' HD22 ' A' ' 88' ' ' LEU . 97.4 mttt -70.24 102.73 2.18 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.563 -1.273 . . . . 73.340000000000003 107.563 172.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.643 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 17.7 ptt180 -73.38 -66.93 0.63 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 115.182 1.549 . . . . 52.240000000000002 115.182 -154.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.643 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 25.2 t-20 -113.75 150.14 33.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.039 0.536 . . . . 74.140000000000001 110.495 -172.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 90' ' ' ASP . 85.5 mttt -70.12 115.71 36.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.098 -1.075 . . . . 63.100000000000001 108.098 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.635 ' HB2' HD22 ' A' ' 133' ' ' ASN . 23.6 Cg_exo -63.78 137.58 59.19 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.643 2.228 . . . . 54.049999999999997 111.933 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 25.5 m -68.81 122.29 18.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.151 0.58 . . . . 45.299999999999997 111.547 -172.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.427 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 58.0 t -92.34 128.27 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.594 -1.261 . . . . 74.200000000000003 107.594 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -104.01 112.48 25.48 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.214 0.461 . . . . 74.430000000000007 111.159 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 57.71 8.28 3.99 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 118.366 2.106 . . . . 74.0 118.366 159.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.66 129.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 119.256 1.528 . . . . 65.140000000000001 111.865 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.7 t -73.5 121.67 85.72 Favored Pre-proline 0 C--N 1.355 0.818 0 N-CA-C 106.431 -1.692 . . . . 65.430000000000007 106.431 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.484 ' HD2' HD21 ' A' ' 97' ' ' ASN . 82.0 Cg_exo -46.09 -63.07 0.36 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.791 2.327 . . . . 73.310000000000002 116.452 -153.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -130.92 -22.06 2.64 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.904 1.282 . . . . 72.400000000000006 108.122 139.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.683 ' HB3' HD22 ' A' ' 97' ' ' ASN . 17.5 t80 -81.87 101.8 10.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.08 -1.418 . . . . 73.230000000000004 109.69 -153.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -119.84 -45.87 2.47 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.174 0.989 . . . . 72.319999999999993 109.382 169.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -114.69 -26.4 7.87 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.389 1.475 . . . . 64.150000000000006 112.088 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -60.6 150.15 32.68 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.715 0.634 . . . . 73.019999999999996 111.269 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.005 0.922 . . . . 54.409999999999997 108.676 -177.1 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 tpt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 108.855 -0.794 . . . . 72.319999999999993 108.855 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.51 -32.36 3.22 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.356 -0.384 . . . . 63.409999999999997 112.742 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -82.06 74.28 9.05 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.643 0.735 . . . . 53.509999999999998 110.883 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -86.79 141.35 33.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 115.045 -0.98 . . . . 70.120000000000005 109.817 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.58 157.42 56.04 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.272 1.981 . . . . 64.239999999999995 111.879 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.54 126.42 27.54 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 112.526 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -91.05 -70.24 0.69 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.294 0.638 . . . . 65.200000000000003 110.907 -176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 m -143.5 147.47 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.196 0.598 . . . . 64.230000000000004 111.444 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.79 162.25 14.36 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.723 1.209 . . . . 72.019999999999996 108.131 171.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.64 -77.33 0.02 OUTLIER Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.12 -0.792 . . . . 41.329999999999998 111.12 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -174.84 132.27 0.33 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.562 1.145 . . . . 63.420000000000002 108.975 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.636 HE21 ' HG3' ' A' ' 255' ' ' GLU . 71.5 mm-40 -135.71 166.66 22.75 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.575 0.75 . . . . 72.239999999999995 111.81 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -68.47 141.83 55.5 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 114.577 -1.192 . . . . 74.340000000000003 110.034 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -104.82 129.84 24.2 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.483 0.713 . . . . 71.329999999999998 110.177 -166.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.91 162.97 36.41 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.682 2.255 . . . . 72.239999999999995 112.214 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.2 t -71.89 160.82 31.9 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.741 -0.663 . . . . 73.409999999999997 109.773 175.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.7 mt -93.21 142.9 25.9 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.956 -0.757 . . . . 73.219999999999999 108.956 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -72.36 156.84 54.26 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.512 2.141 . . . . 71.519999999999996 112.064 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.8 160.52 32.04 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.267 0.627 . . . . 72.519999999999996 111.2 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.55 -174.55 4.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.703 0.801 . . . . 64.299999999999997 109.449 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -125.44 158.23 34.92 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.101 0.56 . . . . 75.120000000000005 110.283 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -79.46 179.88 7.2 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.581 -0.736 . . . . 70.329999999999998 110.931 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 203' ' ' LEU . 4.1 pt -124.18 152.43 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.511 1.124 . . . . 73.230000000000004 109.401 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.571 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -153.08 138.76 17.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.615 0.766 . . . . 75.209999999999994 109.497 -178.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 196' ' ' ASN . . . -128.39 167.41 20.6 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 123.452 0.47 . . . . 74.120000000000005 114.201 -174.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.71 -179.29 8.02 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.369 1.068 . . . . 54.43 110.073 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.92 157.84 53.48 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.284 0.365 . . . . 73.540000000000006 113.454 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.49 ' HB3' ' H ' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -131.95 146.29 52.01 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.314 0.646 . . . . 74.129999999999995 111.343 -176.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.64 121.11 0.14 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.149 1.38 . . . . 74.109999999999999 108.509 168.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -172.1 132.55 0.67 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.689 0.796 . . . . 70.310000000000002 109.717 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.4 t -128.77 68.83 1.38 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.019 0.928 . . . . 61.240000000000002 109.026 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.531 ' HB2' HH22 ' A' ' 153' ' ' ARG . 23.2 t -76.71 173.08 12.05 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.053 -0.976 . . . . 74.439999999999998 109.613 175.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 189' ' ' ARG . 0.0 OUTLIER -156.99 134.81 10.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.146 0.578 . . . . 74.530000000000001 110.137 -177.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -152.54 -170.3 3.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.246 1.418 . . . . 73.450000000000003 109.012 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.1 -168.19 25.76 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 121.68 -0.295 . . . . 71.349999999999994 113.122 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 127.73 -173.12 18.82 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.198 -0.779 . . . . 63.0 111.78 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -83.53 -161.17 0.14 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.4 2.734 . . . . 75.030000000000001 113.321 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -160.66 179.83 8.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.478 1.111 . . . . 75.310000000000002 110.899 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.6 m -153.47 130.55 11.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.281 1.032 . . . . 74.129999999999995 109.011 172.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -148.61 100.57 3.13 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.118 0.567 . . . . 74.120000000000005 110.221 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.0 t -142.73 136.61 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.663 1.185 . . . . 73.340000000000003 108.041 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -161.29 -128.9 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 108.436 -0.95 . . . . 71.209999999999994 108.436 171.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.648 HG12 ' HG3' ' A' ' 44' ' ' GLU . 48.2 t -145.03 134.48 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.289 1.036 . . . . 74.439999999999998 108.987 -169.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.677 ' H ' ' HB3' ' A' ' 59' ' ' GLN . 45.0 mt-10 79.01 92.39 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.309 1.843 . . . . 54.009999999999998 112.118 174.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.41 ' ND1' ' HG2' ' A' ' 46' ' ' GLU . 18.7 t-80 -158.07 -82.26 0.06 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.368 0.667 . . . . 72.349999999999994 109.235 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 48' ' ' LEU . 14.5 pt-20 -176.21 18.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.437 1.095 . . . . 74.340000000000003 110.375 -177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.672 ' HA ' ' HA3' ' A' ' 60' ' ' GLY . . . 59.08 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.577 1.151 . . . . 70.329999999999998 110.703 -164.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.692 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 48.0 tp 74.5 -71.99 0.12 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.271 1.428 . . . . 70.209999999999994 112.568 170.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' HG2' ' HG2' ' A' ' 50' ' ' ARG . 9.7 tt0 -146.26 158.81 43.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.759 0.823 . . . . 75.200000000000003 109.754 -169.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.461 ' HA ' ' NE ' ' A' ' 50' ' ' ARG . 4.7 mmp_? 81.63 147.47 0.1 Allowed Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 125.806 1.643 . . . . 73.109999999999999 112.979 171.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -48.16 102.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.398 3.17 0 C-N-CA 124.589 3.526 . . . . 74.530000000000001 114.203 -170.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 57' ' ' GLU . 34.0 m -81.55 177.38 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.716 -1.129 . . . . 52.030000000000001 109.307 167.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.677 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -79.45 177.56 8.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.519 0.328 . . . . 72.409999999999997 111.44 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.5 p -62.15 -62.87 1.47 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.13 0.972 . . . . 53.350000000000001 112.211 -170.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.98 -72.05 0.71 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.25 -0.648 . . . . 72.450000000000003 109.25 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -76.85 86.02 3.42 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 108.809 -0.811 . . . . 75.120000000000005 108.809 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HA ' ' HB3' ' A' ' 53' ' ' ALA . 12.5 pt-20 -66.38 148.89 98.39 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 114.988 -1.006 . . . . 72.140000000000001 110.174 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.14 -64.9 0.13 Allowed 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 122.319 2.012 . . . . 73.209999999999994 111.198 -173.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.677 ' HB3' ' H ' ' A' ' 44' ' ' GLU . 5.0 tp-100 176.13 -22.94 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.887 1.275 . . . . 74.409999999999997 108.713 176.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . 130.02 -101.29 0.51 Allowed Glycine 0 C--N 1.362 1.986 0 CA-C-N 116.222 -0.445 . . . . 21.510000000000002 112.75 165.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.8 mt -103.13 176.07 5.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.012 0.925 . . . . 64.209999999999994 109.131 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.1 p -76.99 -175.15 3.42 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.84 -0.43 . . . . 63.229999999999997 109.84 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.32 -30.67 62.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.174 0.59 . . . . 71.209999999999994 110.959 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.1 -63.94 1.08 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.274 1.03 . . . . 73.140000000000001 109.936 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.53 -54.39 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.38 1.072 . . . . 63.229999999999997 109.565 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -145.38 -8.3 0.59 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 114.412 -1.267 . . . . 70.439999999999998 109.158 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.609 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 12.0 t90 -86.17 65.55 9.14 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.162 0.585 . . . . 72.0 110.464 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -64.97 -17.06 64.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.568 0.747 . . . . 73.349999999999994 110.823 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 72' ' ' ASN . 20.0 m -77.49 4.0 12.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.524 1.129 . . . . 74.219999999999999 112.169 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -75.52 -47.78 25.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.708 0.803 . . . . 70.510000000000005 110.358 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.9 -24.55 64.32 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 120.836 0.351 . . . . 64.099999999999994 110.424 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 69' ' ' SER . 10.7 m120 -89.43 -6.43 56.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.007 0.923 . . . . 75.209999999999994 111.634 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.22 -52.15 64.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.346 1.058 . . . . 60.549999999999997 112.219 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.91 16.14 26.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.605 0.762 . . . . 71.239999999999995 110.36 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.88 -20.17 64.88 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.35 0.66 . . . . 61.350000000000001 112.035 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.32 -138.67 25.58 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.178 -0.79 . . . . 54.329999999999998 112.224 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 93.4 Cg_endo -79.0 -174.81 2.44 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.753 2.302 . . . . 75.319999999999993 112.586 175.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.482 ' OG ' ' HB ' ' A' ' 138' ' ' VAL . 1.9 m -68.01 173.99 4.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.426 0.69 . . . . 62.219999999999999 110.489 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -72.64 -44.97 61.19 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 116.72 -0.218 . . . . 72.5 111.533 -174.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.55 -37.51 1.2 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 122.208 -0.308 . . . . 62.030000000000001 111.493 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 10.6 m-20 -90.64 113.52 58.05 Favored Pre-proline 0 N--CA 1.485 1.286 0 N-CA-C 113.415 0.894 . . . . 63.140000000000001 113.415 -170.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.0 -17.47 46.17 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.868 1.712 . . . . 75.420000000000002 111.175 163.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -89.6 9.67 25.96 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.65 1.18 . . . . 74.540000000000006 111.099 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 26.2 tp -96.16 126.83 41.65 Favored 'General case' 0 C--N 1.357 0.917 0 CA-C-O 121.65 0.738 . . . . 62.420000000000002 110.085 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -113.95 173.71 6.3 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.417 1.487 . . . . 75.230000000000004 108.257 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.47 139.19 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.088 0.955 . . . . 60.310000000000002 109.04 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.478 ' HA ' HG22 ' A' ' 135' ' ' ILE . . . -74.4 120.4 19.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.213 0.605 . . . . 70.430000000000007 110.137 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 143' ' ' LYS . 83.8 mt -86.03 -34.97 20.6 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.462 0.705 . . . . 73.040000000000006 110.704 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -123.78 146.19 48.5 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.131 -0.941 . . . . 74.219999999999999 108.879 -175.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.1 144.76 44.83 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.734 0.646 . . . . 71.150000000000006 109.409 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.592 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.6 t80 -142.18 140.5 32.4 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.437 -0.949 . . . . 61.43 108.437 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 68.0 t -110.99 134.82 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 108.209 -1.034 . . . . 62.119999999999997 108.209 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.68 116.27 2.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.167 0.987 . . . . 72.109999999999999 111.239 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.8 p -107.91 26.03 10.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.227 1.011 . . . . 55.100000000000001 110.209 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.27 177.52 43.49 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.086 -0.961 . . . . 51.329999999999998 110.929 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.71 -38.18 54.78 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.007 0.523 . . . . 72.239999999999995 111.254 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -84.32 -23.33 30.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.966 0.506 . . . . 71.319999999999993 111.152 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.6 p -72.92 153.99 40.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.151 0.58 . . . . 71.140000000000001 111.521 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.8 tp -127.06 129.05 47.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.388 0.675 . . . . 65.200000000000003 110.968 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.7 m -69.66 130.56 42.71 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.692 0.797 . . . . 73.310000000000002 109.997 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.657 HG22 HG21 ' A' ' 123' ' ' THR . 22.0 pt -129.25 147.5 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 72.019999999999996 110.67 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -106.93 140.58 39.52 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.84 -1.17 . . . . 65.439999999999998 107.84 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -62.45 147.43 48.71 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 123.5 0.5 . . . . 73.310000000000002 110.271 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.74 -28.74 10.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.984 -0.342 . . . . 61.130000000000003 112.794 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.3 146.01 33.19 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.229 0.515 . . . . 74.299999999999997 111.04 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HB3' HD11 ' A' ' 84' ' ' LEU . 39.9 mmtm -90.02 142.68 27.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.129 0.971 . . . . 71.530000000000001 109.696 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.586 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -145.57 146.1 31.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.861 0.865 . . . . 73.040000000000006 110.115 -178.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -99.65 107.06 19.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.811 0.444 . . . . 65.200000000000003 110.063 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.538 HG13 ' HB1' ' A' ' 119' ' ' ALA . 53.5 t -79.02 119.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.873 -0.788 . . . . 62.439999999999998 108.873 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -116.8 -8.68 11.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.055 -175.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.83 140.74 6.48 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 121.263 -0.494 . . . . 43.119999999999997 112.885 171.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.404 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 74.4 m-85 -97.03 174.92 6.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.918 0.887 . . . . 74.439999999999998 110.439 172.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -96.09 -173.16 2.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.987 -1.006 . . . . 54.140000000000001 110.445 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -52.44 -39.38 60.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.657 1.183 . . . . 51.420000000000002 114.115 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -108.14 6.62 27.0 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.814 0.446 . . . . 72.209999999999994 112.092 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 63.66 12.15 45.73 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 115.361 0.904 . . . . 53.219999999999999 115.361 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.76 -7.71 33.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.6 0.76 . . . . 75.310000000000002 111.636 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.5 ' HZ2' HG11 ' A' ' 244' ' ' VAL . 39.2 m95 -127.52 145.38 50.87 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.97 -1.122 . . . . 65.239999999999995 107.97 167.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.538 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -148.02 125.78 11.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.274 -0.876 . . . . 51.109999999999999 109.219 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 129' ' ' TRP . 37.9 tt0 -67.34 123.29 19.95 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 108.268 -1.012 . . . . 71.409999999999997 108.268 171.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -126.98 145.71 50.6 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.76 0.824 . . . . 65.549999999999997 110.215 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -101.92 100.31 10.59 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.12 -1.067 . . . . 60.219999999999999 108.12 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.657 HG21 HG22 ' A' ' 101' ' ' ILE . 67.0 p -82.27 165.85 20.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.309 0.644 . . . . 73.109999999999999 109.831 173.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -20.45 66.09 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 121.462 0.649 . . . . 65.519999999999996 109.445 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -79.38 -29.94 42.3 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.087 1.355 . . . . 74.099999999999994 112.297 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.33 -165.3 36.59 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 119.872 -0.405 . . . . 62.109999999999999 112.588 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -128.03 144.75 51.11 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.033 0.916 . . . . 72.549999999999997 110.367 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.13 178.42 36.0 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 112.589 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 120' ' ' GLU . 75.1 m95 -75.07 118.4 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.324 1.05 . . . . 73.209999999999994 112.49 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.2 m -118.14 152.47 50.53 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 124.23 1.012 . . . . 35.32 108.428 174.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.12 129.07 17.59 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 121.772 1.648 . . . . 53.020000000000003 111.206 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 m -64.4 -25.84 68.19 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.099 0.96 . . . . 64.420000000000002 112.295 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -80.41 -5.48 56.57 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.236 1.015 . . . . 74.209999999999994 111.875 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -96.87 -13.98 22.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.072 0.949 . . . . 74.420000000000002 110.944 173.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 87' ' ' ALA . 16.1 pt -125.83 172.34 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.752 0.821 . . . . 73.040000000000006 110.585 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.417 HG21 ' HB2' ' A' ' 142' ' ' GLU . 2.5 m -159.63 142.35 10.15 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.403 1.081 . . . . 64.409999999999997 108.959 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.72 139.64 58.1 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.161 1.908 . . . . 70.219999999999999 112.237 170.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.482 ' HB ' ' OG ' ' A' ' 78' ' ' SER . 13.8 t -70.19 -6.05 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 121.603 0.716 . . . . 73.200000000000003 109.966 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.769 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 5.2 m120 -85.85 -21.16 28.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.831 0.852 . . . . 71.319999999999993 112.756 -176.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.3 p -102.11 179.01 4.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.383 0.673 . . . . 53.299999999999997 112.576 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.74 -22.24 37.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.429 1.092 . . . . 73.140000000000001 112.177 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.417 ' HB2' HG21 ' A' ' 136' ' ' THR . 3.1 mp0 -69.5 -13.87 62.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.075 0.95 . . . . 71.0 112.223 -172.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.534 ' HA ' HD21 ' A' ' 88' ' ' LEU . 22.2 pttm -69.88 -11.38 60.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.49 0.716 . . . . 70.140000000000001 112.175 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -87.05 143.37 27.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.293 0.637 . . . . 62.340000000000003 110.582 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 p -68.13 -33.29 74.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.29 1.036 . . . . 75.530000000000001 112.765 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -71.17 -33.28 69.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 74.25 111.46 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -78.43 112.79 15.82 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.52 -0.918 . . . . 74.400000000000006 108.52 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.46 -20.13 13.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.5 0.72 . . . . 71.409999999999997 111.345 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.95 -150.27 42.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 118.545 -1.142 . . . . 72.209999999999994 111.974 -174.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.03 100.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.66 2.907 . . . . 73.319999999999993 113.437 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 41.9 t -131.93 150.13 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.954 1.302 . . . . 72.140000000000001 108.94 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.3 p -90.95 175.19 7.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.368 0.667 . . . . 53.210000000000001 111.434 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.531 HH22 ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -62.92 -60.69 3.13 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.494 1.117 . . . . 63.140000000000001 110.886 -177.261 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.1 -29.03 70.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.936 0.895 . . . . 75.120000000000005 111.255 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.59 83.35 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 123.786 0.679 . . . . 64.099999999999994 110.944 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.78 -44.41 93.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.807 0.692 . . . . 64.510000000000005 110.84 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.99 -44.58 82.84 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.538 -0.755 . . . . 74.340000000000003 111.337 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.11 -44.46 88.68 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.592 -1.186 . . . . 74.030000000000001 111.888 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 237' ' ' PRO . 87.0 mt -59.8 -39.5 85.2 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.19 0.996 . . . . 73.129999999999995 111.571 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 90.8 mt -81.05 -27.53 35.71 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.283 -0.871 . . . . 70.329999999999998 112.074 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.9 p -68.39 -10.02 52.22 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 118.379 0.536 . . . . 51.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.9 p -103.55 21.16 16.57 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.62 1.168 . . . . 71.310000000000002 111.122 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.71 -178.15 15.19 Favored Glycine 0 C--N 1.353 1.499 0 C-N-CA 123.347 0.499 . . . . 51.149999999999999 113.79 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.4 pt -96.79 178.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.381 1.072 . . . . 74.439999999999998 112.06 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.47 112.46 5.31 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.158 -1.052 . . . . 71.319999999999993 108.158 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.59 24.89 Favored Glycine 0 CA--C 1.528 0.89 0 O-C-N 123.742 0.651 . . . . 61.399999999999999 112.746 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 184' ' ' LEU . 73.3 m -76.56 139.96 40.9 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.567 0.684 . . . . 75.430000000000007 110.868 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.2 p90 -148.78 163.53 37.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.068 0.461 . . . . 75.109999999999999 110.538 -175.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.1 pp -157.73 149.71 22.16 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.359 -0.837 . . . . 64.510000000000005 108.961 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.734 HG22 HG12 ' A' ' 182' ' ' ILE . 93.9 t -109.0 120.78 61.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.114 -1.069 . . . . 44.009999999999998 108.114 168.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.504 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 24.2 ptt85 -114.54 164.51 13.9 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.651 1.18 . . . . 71.25 108.452 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.16 160.84 20.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.98 0.912 . . . . 72.219999999999999 108.697 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.7 t -79.68 124.18 28.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.498 -0.556 . . . . 62.43 109.498 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.52 -36.24 83.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.85 0.86 . . . . 71.400000000000006 110.54 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.1 p -69.75 -31.27 69.14 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.897 0.879 . . . . 53.119999999999997 112.071 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 m -150.91 119.43 3.5 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.034 0.534 . . . . 64.519999999999996 110.305 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.8 154.4 74.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.832 2.355 . . . . 61.100000000000001 112.198 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.16 -31.22 8.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.004 -0.543 . . . . 65.230000000000004 112.316 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.59 112.19 17.72 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.93 -1.137 . . . . 72.129999999999995 107.93 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.572 ' H ' ' NH2' ' A' ' 194' ' ' ARG . 98.4 mtt180 -124.28 127.32 47.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.553 0.741 . . . . 73.310000000000002 110.068 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.1 m -125.28 145.51 49.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.74 0.816 . . . . 52.229999999999997 110.206 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.734 HG12 HG22 ' A' ' 170' ' ' VAL . 20.9 mt -100.12 143.93 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 107.696 -1.224 . . . . 65.340000000000003 107.696 173.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.2 m -125.61 109.84 13.12 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 176.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 167' ' ' SER . 32.0 tp -105.35 112.91 26.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.956 0.503 . . . . 51.149999999999999 110.994 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 76.1 ttt180 -78.25 110.97 13.73 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.54 -0.911 . . . . 71.030000000000001 108.54 163.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -133.1 125.88 30.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.009 1.324 . . . . 75.329999999999998 108.718 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 58.54 30.84 20.33 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.339 1.055 . . . . 60.350000000000001 110.433 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.482 ' HA2' ' HE ' ' A' ' 185' ' ' ARG . . . 79.84 -13.23 25.47 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-N 114.678 -1.146 . . . . 43.210000000000001 113.824 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 58.0 mtp85 -93.63 125.53 38.3 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.289 0.636 . . . . 62.420000000000002 109.406 -171.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.93 106.56 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.104 0.562 . . . . 64.030000000000001 110.847 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -96.51 131.99 42.56 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.586 1.154 . . . . 71.400000000000006 108.796 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -110.39 117.82 34.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.213 0.53 . . . . 62.32 111.439 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.453 ' HE1' HD21 ' A' ' 232' ' ' LEU . 2.8 m-30 -95.33 138.71 32.64 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 124.767 1.227 . . . . 70.140000000000001 108.768 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.572 ' NH2' ' H ' ' A' ' 180' ' ' ARG . 1.8 tpm_? -112.0 109.04 18.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 106.873 -1.528 . . . . 52.409999999999997 106.873 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -68.8 103.56 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 123.55 0.531 . . . . 73.409999999999997 110.759 -171.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.522 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 2.2 m-80 -68.85 143.44 54.55 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.671 0.788 . . . . 75.340000000000003 110.414 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.6 m -119.99 118.78 31.57 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.506 0.722 . . . . 71.430000000000007 109.702 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.35 159.83 33.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.668 0.787 . . . . 55.399999999999999 109.907 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.5 m -62.24 -22.83 66.28 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.632 0.975 . . . . 75.230000000000004 113.632 -170.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -90.24 -13.98 34.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.96 0.904 . . . . 51.109999999999999 112.03 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.42 12.9 12.48 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 114.501 0.561 . . . . 63.329999999999998 114.501 176.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -74.16 146.45 43.46 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.941 0.87 . . . . 62.32 111.254 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.532 HD11 HD12 ' A' ' 23' ' ' ILE . 2.9 mm? -104.4 150.3 24.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.931 0.892 . . . . 73.109999999999999 109.269 175.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.521 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 28.7 p90 -173.14 130.16 0.47 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.993 0.808 . . . . 74.420000000000002 109.492 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.482 HG23 HD11 ' A' ' 217' ' ' LEU . 79.2 t -70.8 -53.78 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.092 -1.077 . . . . 72.299999999999997 108.092 163.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.6 m -103.08 138.99 39.19 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.674 -1.603 . . . . 65.439999999999998 110.147 -170.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.0 t -68.55 -10.46 55.86 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.041 0.936 . . . . 73.340000000000003 112.45 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.0 -29.36 61.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.306 1.042 . . . . 71.040000000000006 112.423 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.6 m -146.31 116.56 7.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.611 0.364 . . . . 73.030000000000001 110.219 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.521 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 95.7 mtt180 -97.98 132.2 43.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.696 0.798 . . . . 73.310000000000002 109.305 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -113.11 156.67 22.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.196 0.998 . . . . 72.329999999999998 109.371 -173.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -78.43 -29.83 47.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.726 -0.67 . . . . 71.439999999999998 109.844 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 35.2 p -137.34 159.15 42.76 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.852 0.834 . . . . 61.109999999999999 112.153 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.465 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -64.14 -31.64 72.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.809 1.243 . . . . 75.420000000000002 110.099 177.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.88 -37.83 80.47 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.09 0.556 . . . . 53.409999999999997 111.299 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -77.79 -32.17 52.3 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.706 -0.679 . . . . 70.430000000000007 111.335 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.482 HD11 HG23 ' A' ' 205' ' ' VAL . 18.3 tp -54.69 -55.52 28.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.894 -0.41 . . . . 71.329999999999998 109.894 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.72 -44.38 98.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 O-C-N 124.251 0.969 . . . . 65.0 110.453 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -61.09 -57.7 11.46 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 123.451 0.469 . . . . 73.409999999999997 111.982 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -62.32 -38.75 90.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.052 -0.522 . . . . 55.100000000000001 110.967 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.655 ' HB3' HD11 ' A' ' 228' ' ' LEU . 16.2 m170 -84.84 -6.59 59.35 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.518 0.562 . . . . 63.039999999999999 112.518 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 86.7 p -95.75 -29.25 14.36 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.742 0.417 . . . . 75.310000000000002 111.16 172.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 38.0 p -81.55 -43.19 19.06 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.323 -0.398 . . . . 62.229999999999997 110.72 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 226' ' ' ASP . 28.9 m -126.65 160.84 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.405 0.682 . . . . 73.400000000000006 111.644 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.78 13.83 1.55 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 126.372 1.869 . . . . 64.239999999999995 114.624 -170.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.528 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.2 t70 -41.95 29.63 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 131.207 3.803 . . . . 74.109999999999999 120.148 -151.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.14 9.97 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 120.573 -1.329 . . . . 75.329999999999998 112.579 -169.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 221' ' ' HIS . 13.4 mt -90.56 162.56 14.95 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.762 1.225 . . . . 72.530000000000001 108.79 166.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.83 -36.57 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.474 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.2 t -159.84 -178.71 7.25 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.562 0.745 . . . . 64.310000000000002 110.483 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 70.5 p -66.99 143.34 56.85 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.114 0.965 . . . . 65.219999999999999 111.844 175.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.453 HD21 ' HE1' ' A' ' 193' ' ' TYR . 41.8 mt -74.89 146.44 41.88 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 107.802 -1.184 . . . . 73.209999999999994 107.802 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -147.72 -45.68 0.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 120.134 1.334 . . . . 72.209999999999994 113.833 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -112.55 133.31 21.87 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.323 0.649 . . . . 74.25 109.445 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 67' ' ' TRP . 67.5 Cg_endo -87.39 124.45 2.01 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.388 2.059 . . . . 71.219999999999999 110.259 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.447 ' HB2' HD23 ' A' ' 160' ' ' LEU . . . -62.39 144.36 95.29 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.002 -0.74 . . . . 71.099999999999994 109.002 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.486 ' O ' HD22 ' A' ' 159' ' ' LEU . 86.8 Cg_endo -75.81 -178.82 4.61 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.242 1.961 . . . . 73.239999999999995 112.718 -177.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -85.48 138.12 32.44 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.637 -1.245 . . . . 73.400000000000006 107.637 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.463 ' HB3' HD21 ' A' ' 159' ' ' LEU . 15.0 ptt180 -90.42 -57.33 2.87 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.351 0.978 . . . . 74.299999999999997 111.257 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -106.78 136.68 46.18 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.156 0.583 . . . . 72.439999999999998 110.443 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -82.85 116.96 66.92 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.076 -1.453 . . . . 71.329999999999998 107.076 162.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.03 127.63 15.21 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.896 3.064 . . . . 71.450000000000003 113.901 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.5 m -75.1 122.01 22.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.939 0.495 . . . . 74.010000000000005 111.13 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.5 HG11 ' HZ2' ' A' ' 118' ' ' TRP . 95.2 t -94.2 120.99 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.281 -1.007 . . . . 73.120000000000005 108.281 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -105.17 112.53 25.69 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.608 -0.516 . . . . 71.150000000000006 109.608 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 67.54 -28.44 0.22 Allowed Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.514 2.166 . . . . 54.140000000000001 118.514 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.1 m -72.03 132.0 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 118.856 1.328 . . . . 72.349999999999994 114.359 -160.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.8 t -73.45 122.99 88.99 Favored Pre-proline 0 C--N 1.355 0.83 0 N-CA-C 106.288 -1.745 . . . . 70.040000000000006 106.288 160.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.8 -57.42 1.74 Allowed 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 121.833 1.688 . . . . 62.020000000000003 113.838 -158.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -124.1 -21.82 4.95 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.38 0.672 . . . . 72.230000000000004 110.288 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -78.34 98.47 5.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.031 0.92 . . . . 71.450000000000003 111.702 -147.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.553 ' HB2' ' HD2' ' A' ' 253' ' ' LYS . 14.8 m-20 -121.76 -46.08 2.25 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 113.828 -1.533 . . . . 71.439999999999998 107.118 151.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.553 ' HD2' ' HB2' ' A' ' 252' ' ' ASP . 2.1 mptp? -109.15 -6.64 15.51 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 114.566 -1.197 . . . . 74.310000000000002 111.766 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -64.01 135.38 56.41 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 122.422 0.289 . . . . 73.420000000000002 110.863 -172.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.636 ' HG3' HE21 ' A' ' 12' ' ' GLN . 11.0 pt-20 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.643 1.177 . . . . 64.5 108.654 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.784 0.326 . . . . 41.119999999999997 110.334 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.21 -167.08 40.2 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.719 -0.553 . . . . 61.009999999999998 111.719 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -22.92 64.12 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.051 0.425 . . . . 65.129999999999995 111.568 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -117.65 109.65 41.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.793 0.837 . . . . 74.510000000000005 109.087 172.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.8 100.2 0.29 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.765 2.31 . . . . 72.209999999999994 112.294 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.03 -169.51 41.73 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.081 -0.509 . . . . 60.020000000000003 112.62 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -128.14 -63.13 1.02 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.306 0.643 . . . . 60.020000000000003 109.439 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -156.94 133.51 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.656 0.782 . . . . 64.319999999999993 109.765 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -128.44 137.07 51.66 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 106.48 -1.674 . . . . 73.340000000000003 106.48 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.77 132.29 46.67 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 123.382 0.426 . . . . 70.219999999999999 113.344 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.8 160.63 20.19 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.031 0.932 . . . . 75.349999999999994 111.432 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -78.19 152.54 32.63 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.049 0.939 . . . . 73.530000000000001 111.658 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.12 -57.05 2.64 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.3 1.04 . . . . 74.439999999999998 110.197 175.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 59.24 82.02 0.24 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.487 1.115 . . . . 64.209999999999994 110.926 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.68 -54.69 4.15 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.181 2.587 . . . . 72.030000000000001 112.89 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.4 p -179.15 -178.3 0.51 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.788 1.235 . . . . 61.310000000000002 109.956 176.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -146.13 123.48 6.06 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.976 0.91 . . . . 64.209999999999994 109.018 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.03 140.9 11.51 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.555 2.17 . . . . 75.349999999999994 112.293 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.92 116.68 29.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.514 0.726 . . . . 73.310000000000002 109.286 176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.49 -170.66 3.52 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.768 0.827 . . . . 70.0 110.073 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -69.34 170.46 10.3 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.444 0.64 . . . . 64.150000000000006 111.999 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 33' ' ' ARG . 35.3 t80 -147.58 165.04 31.58 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.951 -1.022 . . . . 64.540000000000006 109.153 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 tp -85.94 11.54 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 C-N-CA 123.485 0.714 . . . . 74.409999999999997 111.488 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm 64.26 -178.12 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.663 1.185 . . . . 53.509999999999998 111.286 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.03 120.38 1.8 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 116.143 -0.481 . . . . 74.420000000000002 113.196 176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.73 102.08 2.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.243 1.017 . . . . 74.439999999999998 110.045 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.1 -8.37 27.14 Favored Glycine 0 N--CA 1.471 1.017 0 CA-C-O 119.632 -0.538 . . . . 53.350000000000001 113.186 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -62.92 137.49 58.28 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.279 0.632 . . . . 71.030000000000001 111.014 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.2 164.09 14.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.936 0.494 . . . . 65.040000000000006 110.785 172.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.2 -55.51 0.01 OUTLIER 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.027 -1.472 . . . . 55.020000000000003 107.027 169.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.9 m 78.04 -44.97 0.41 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.734 1.613 . . . . 72.25 112.793 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -68.23 -46.39 70.66 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.991 0.517 . . . . 71.140000000000001 109.651 173.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -69.65 147.09 51.09 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.935 -1.135 . . . . 63.240000000000002 107.935 161.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -60.74 98.19 0.07 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.925 0.49 . . . . 53.43 110.567 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.53 76.88 0.37 Allowed Glycine 0 C--N 1.344 0.994 0 O-C-N 124.214 0.947 . . . . 63.409999999999997 113.351 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.84 159.24 27.32 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.081 -0.808 . . . . 53.219999999999999 111.081 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.29 -52.86 6.23 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 123.526 2.817 . . . . 41.020000000000003 113.523 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.7 m80 67.11 -68.11 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.334 1.454 . . . . 55.039999999999999 111.136 -172.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 245' ' ' TYR . 9.2 p -149.14 139.38 22.27 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.913 0.885 . . . . 65.319999999999993 109.331 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -118.79 141.25 48.8 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.214 0.606 . . . . 64.329999999999998 110.695 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.536 HG23 HG13 ' A' ' 43' ' ' VAL . 26.4 m -73.12 179.18 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.397 0.679 . . . . 65.510000000000005 112.821 -173.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -55.61 -65.74 0.54 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 123.963 0.905 . . . . 72.25 112.286 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.536 HG13 HG23 ' A' ' 41' ' ' VAL . 29.9 m 38.72 -157.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 125.681 1.592 . . . . 65.439999999999998 114.353 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.17 124.0 43.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.472 1.109 . . . . 74.430000000000007 108.126 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -167.69 85.16 0.22 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.746 0.784 . . . . 75.310000000000002 109.578 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -94.5 92.74 7.25 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.745 -0.661 . . . . 74.400000000000006 109.396 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.24 6.65 38.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.678 0.791 . . . . 52.130000000000003 111.365 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.41 173.36 12.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.533 0.733 . . . . 71.430000000000007 111.488 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -115.83 128.64 55.97 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.63 -0.878 . . . . 43.030000000000001 108.63 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.407 ' HD2' ' OG ' ' A' ' 161' ' ' SER . 70.4 mtm180 -99.01 -44.11 0.23 Allowed Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 117.951 -1.023 . . . . 74.120000000000005 113.565 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -69.4 83.24 0.64 Allowed 'Trans proline' 0 C--N 1.4 3.268 0 C-N-CA 122.002 1.801 . . . . 63.149999999999999 112.071 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.89 143.69 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.141 0.576 . . . . 74.219999999999999 110.097 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.47 90.17 0.07 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.333 0.653 . . . . 64.439999999999998 110.496 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.4 p -69.09 -12.57 61.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.785 1.234 . . . . 75.5 111.957 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -49.64 -54.36 18.92 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.435 1.094 . . . . 70.150000000000006 110.979 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -100.82 79.84 2.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.049 -0.978 . . . . 75.329999999999998 108.865 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -81.91 113.54 43.76 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 108.91 -0.774 . . . . 65.150000000000006 108.91 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.33 -61.27 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.009 2.472 . . . . 72.010000000000005 114.318 -167.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.46 -19.45 11.68 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.109 0.563 . . . . 64.219999999999999 112.08 -171.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.07 -86.92 0.67 Allowed Glycine 0 C--N 1.344 0.972 0 N-CA-C 112.189 -0.364 . . . . 62.140000000000001 112.189 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -105.97 110.88 23.3 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.835 -0.802 . . . . 74.239999999999995 108.835 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . 18.3 m -114.83 81.4 1.56 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.202 1.001 . . . . 74.040000000000006 108.468 176.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.47 -50.34 73.98 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.27 1.028 . . . . 52.240000000000002 113.142 -166.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.79 -36.22 59.84 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.759 0.424 . . . . 71.310000000000002 110.754 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 62' ' ' SER . . . -68.05 -27.55 66.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.179 0.592 . . . . 65.540000000000006 111.957 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HB2' ' HD2' ' A' ' 234' ' ' TYR . 7.6 ppt_? -83.45 -37.3 23.36 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-O 119.589 -0.244 . . . . 72.420000000000002 110.967 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -161.57 85.44 0.64 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.167 0.508 . . . . 64.510000000000005 111.376 178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 29.7 p-10 -88.09 -22.66 24.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.684 -0.689 . . . . 71.540000000000006 109.264 165.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.4 m -67.64 2.85 1.63 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.776 1.23 . . . . 74.329999999999998 113.381 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -70.01 -26.96 64.3 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.995 0.518 . . . . 72.310000000000002 110.997 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 68' ' ' ASN . 13.2 pt-20 -77.54 -21.64 52.27 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.095 0.474 . . . . 74.040000000000006 110.327 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -91.66 -2.34 57.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.818 1.247 . . . . 41.310000000000002 110.827 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.31 -47.76 80.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.241 1.017 . . . . 63.530000000000001 111.733 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.1 mt -99.15 26.6 5.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.421 0.688 . . . . 72.340000000000003 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.22 64.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.19 0.596 . . . . 74.209999999999994 111.724 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.99 -141.28 44.81 Favored Glycine 0 C--N 1.356 1.642 0 CA-C-O 119.061 -0.855 . . . . 71.530000000000001 113.337 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 11.2 Cg_exo -71.15 -176.38 1.85 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.083 2.522 . . . . 74.540000000000006 112.361 171.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.485 ' H ' ' ND2' ' A' ' 139' ' ' ASN . 6.4 m -73.89 175.29 7.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.283 0.633 . . . . 73.129999999999995 109.542 172.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -69.6 -46.37 66.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 120.705 0.288 . . . . 75.040000000000006 111.091 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.62 -33.19 2.55 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.5 0.72 . . . . 63.100000000000001 110.961 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -89.51 115.61 64.22 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 114.866 1.432 . . . . 62.539999999999999 114.866 -163.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.441 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 74.7 Cg_endo -79.43 -20.44 9.57 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.556 2.171 . . . . 62.210000000000001 113.192 162.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -98.19 8.26 45.06 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.834 0.854 . . . . 65.409999999999997 111.47 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 tp -89.55 122.12 32.41 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.734 -0.839 . . . . 73.239999999999995 108.734 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.7 m-85 -108.87 174.52 5.83 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.811 1.244 . . . . 71.439999999999998 109.099 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.96 138.88 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.109 1.364 . . . . 45.210000000000001 108.957 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.02 114.18 14.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 50.109999999999999 110.517 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.24 -35.62 66.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.288 0.635 . . . . 71.420000000000002 111.071 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.446 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 32.5 m-85 -122.96 143.96 49.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.512 -0.921 . . . . 75.510000000000005 108.512 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 6.3 p-10 -70.42 148.05 48.79 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 109.178 -0.675 . . . . 74.549999999999997 109.178 167.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.563 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.6 t80 -147.17 141.57 26.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.127 -1.064 . . . . 72.219999999999999 108.127 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.7 139.97 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.236 -1.024 . . . . 72.019999999999996 108.236 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.22 115.72 3.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.536 0.734 . . . . 75.209999999999994 111.009 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -93.24 -55.93 3.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.328 1.051 . . . . 75.430000000000007 109.704 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.54 -173.44 38.32 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.398 -0.819 . . . . 65.030000000000001 113.452 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.68 -38.94 80.73 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.278 1.031 . . . . 75.239999999999995 111.759 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -98.95 -12.85 20.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.906 0.882 . . . . 74.319999999999993 112.036 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.4 p -72.33 135.04 45.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.784 -0.451 . . . . 54.140000000000001 109.784 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.6 ' HB3' HG13 ' A' ' 130' ' ' VAL . 66.4 tp -103.42 130.91 50.85 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.411 0.684 . . . . 73.319999999999993 110.394 -174.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -70.94 125.74 27.67 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.722 -0.844 . . . . 62.340000000000003 108.722 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.612 HG22 HG21 ' A' ' 123' ' ' THR . 22.8 pt -125.47 144.86 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.604 0.762 . . . . 65.25 110.08 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 10.1 m -88.72 144.94 25.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.676 -0.861 . . . . 64.239999999999995 108.676 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 62.5 tttp -65.69 110.97 2.97 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.796 0.438 . . . . 61.119999999999997 110.616 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.13 -10.88 55.28 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.013 -0.54 . . . . 61.409999999999997 112.931 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.645 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 43.5 tt0 -71.27 130.84 42.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.784 0.834 . . . . 74.349999999999994 110.533 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -77.27 147.63 36.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.953 -0.758 . . . . 65.409999999999997 108.953 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.614 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -147.98 142.2 26.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.798 0.439 . . . . 51.229999999999997 111.222 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 19.6 tpp180 -89.12 107.26 18.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.526 -0.761 . . . . 54.219999999999999 109.214 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.6 HG13 ' HB1' ' A' ' 119' ' ' ALA . 77.7 t -88.81 102.59 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.443 -0.577 . . . . 64.319999999999993 109.443 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 122' ' ' GLN . 2.2 mm? -67.53 -41.06 84.96 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.17 -0.923 . . . . 71.450000000000003 110.153 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.45 151.15 11.6 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.321 -0.854 . . . . 64.319999999999993 112.201 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 119' ' ' ALA . 56.7 m-85 -88.35 174.45 8.15 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.791 0.836 . . . . 71.239999999999995 110.633 174.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -80.22 -176.34 5.54 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.614 -0.721 . . . . 71.0 109.217 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -54.63 -36.59 64.68 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.043 0.937 . . . . 71.25 113.296 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -112.48 10.46 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.077 0.769 . . . . 63.030000000000001 113.077 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 68.52 26.14 74.52 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.978 0.751 . . . . 70.310000000000002 114.978 171.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -80.81 -65.74 0.97 Allowed 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 109.027 -0.731 . . . . 71.329999999999998 109.027 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.416 ' HB3' ' HE3' ' A' ' 129' ' ' TRP . 73.8 m95 -90.59 150.94 21.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.015 0.926 . . . . 53.399999999999999 111.082 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.6 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -137.64 132.2 32.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.959 0.903 . . . . 71.120000000000005 110.641 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -76.85 107.48 9.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.889 -0.782 . . . . 70.219999999999999 108.889 167.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -112.52 149.71 32.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.989 0.916 . . . . 61.229999999999997 110.89 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.536 ' HG3' HD21 ' A' ' 110' ' ' LEU . 56.1 mt-30 -112.39 123.15 49.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.899 0.879 . . . . 74.120000000000005 109.498 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.612 HG21 HG22 ' A' ' 101' ' ' ILE . 44.1 p -124.01 174.78 7.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.716 1.207 . . . . 60.439999999999998 110.824 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -58.05 -27.31 63.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.68 1.192 . . . . 73.400000000000006 110.696 167.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.79 -30.87 59.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.525 1.13 . . . . 72.120000000000005 111.299 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 138.03 -177.23 20.16 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.188 -0.229 . . . . 51.229999999999997 112.921 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -86.79 138.9 31.21 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.921 0.488 . . . . 63.409999999999997 109.948 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -178.33 -173.48 43.75 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.243 -0.743 . . . . 63.210000000000001 111.243 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.416 ' HE3' ' HB3' ' A' ' 118' ' ' TRP . 32.7 m95 -110.76 120.79 43.57 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.513 0.725 . . . . 74.0 111.426 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.6 HG13 ' HB3' ' A' ' 99' ' ' LEU . 31.0 m -127.99 143.33 47.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 125.207 1.403 . . . . 73.209999999999994 108.969 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 4.6 Cg_endo -86.07 156.25 9.84 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.385 2.057 . . . . 72.319999999999993 114.39 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.3 m -36.5 -40.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 127.038 2.135 . . . . 54.130000000000003 114.691 170.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.407 HD22 ' HB2' ' A' ' 242' ' ' PRO . 35.6 p-10 -65.98 -22.21 66.45 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.326 0.65 . . . . 71.400000000000006 111.977 -172.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 38.1 m-85 -98.6 -20.04 17.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.806 0.842 . . . . 64.099999999999994 112.387 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -122.8 171.11 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.332 0.653 . . . . 63.119999999999997 112.249 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.4 t -161.3 153.9 17.19 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.353 -0.98 . . . . 72.010000000000005 108.353 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 54.3 Cg_exo -55.23 149.36 45.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 121.743 1.629 . . . . 72.140000000000001 112.351 172.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.88 -12.63 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.94 0.876 . . . . 72.400000000000006 109.852 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 1.6 m120 -87.22 -6.15 58.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.082 0.953 . . . . 73.25 111.516 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.3 p -89.11 174.26 7.98 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.924 0.489 . . . . 70.239999999999995 111.553 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.17 -23.63 30.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.507 -0.77 . . . . 62.030000000000001 110.849 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.64 -22.19 64.42 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.828 0.851 . . . . 65.340000000000003 111.929 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -59.55 -22.14 61.27 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.054 0.541 . . . . 72.049999999999997 111.91 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -82.55 139.59 33.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.522 0.729 . . . . 74.340000000000003 110.399 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.6 p -60.02 -42.17 93.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.695 1.198 . . . . 64.439999999999998 112.353 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -65.99 -38.42 88.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.734 0.813 . . . . 75.439999999999998 112.568 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.12 109.96 15.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.386 -0.598 . . . . 64.040000000000006 109.386 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.413 ' HB2' HG21 ' A' ' 151' ' ' VAL . 28.5 m170 -104.71 -9.78 17.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.009 0.524 . . . . 73.439999999999998 111.832 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.54 -132.26 27.14 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 118.208 -1.329 . . . . 52.240000000000002 112.294 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.88 95.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.254 2.636 . . . . 73.230000000000004 112.764 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.619 HG22 ' HE ' ' A' ' 239' ' ' ARG . 46.9 t -136.95 126.94 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.431 1.093 . . . . 61.520000000000003 108.956 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.6 p -76.29 172.51 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.307 0.643 . . . . 71.530000000000001 110.762 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -62.8 -48.46 79.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.739 0.416 . . . . 73.299999999999997 109.903 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -59.17 -35.88 74.32 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.113 0.883 . . . . 72.230000000000004 111.089 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . . . -67.64 -47.84 68.41 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.602 -0.726 . . . . 72.450000000000003 111.182 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.36 86.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.409 -0.814 . . . . 73.319999999999993 110.798 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -81.94 -20.27 39.01 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.154 -0.93 . . . . 51.350000000000001 111.914 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 155' ' ' ALA . 0.1 OUTLIER -81.03 -24.7 37.7 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.156 0.889 . . . . 74.340000000000003 111.063 174.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.59 HD21 ' HB3' ' A' ' 239' ' ' ARG . 65.4 mt -71.35 -46.24 60.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 51.329999999999998 110.12 168.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 185' ' ' ARG . 40.4 mt -92.47 20.33 6.33 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.128 -0.942 . . . . 74.129999999999995 111.935 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.407 ' OG ' ' HD2' ' A' ' 50' ' ' ARG . 83.6 p -90.4 -37.66 13.83 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.392 -0.596 . . . . 43.399999999999999 109.392 166.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.0 p -96.38 -11.64 25.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.458 0.703 . . . . 54.25 111.179 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.67 166.21 35.66 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 123.439 0.462 . . . . 64.340000000000003 113.89 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 pt -98.35 -178.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.83 0.852 . . . . 73.349999999999994 111.703 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -68.03 125.66 27.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.97 -0.559 . . . . 61.439999999999998 109.98 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.93 9.65 65.66 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-O 119.084 -0.842 . . . . 73.219999999999999 112.794 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 72.8 m -75.56 135.76 40.56 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 118.093 0.947 . . . . 73.120000000000005 110.396 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 183' ' ' SER . 17.1 p90 -147.28 162.96 37.88 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.708 0.403 . . . . 72.5 110.63 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 pp -160.51 148.33 16.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.537 -0.756 . . . . 71.400000000000006 109.324 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.652 HG22 HG12 ' A' ' 182' ' ' ILE . 70.8 t -101.55 125.17 55.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.168 -1.049 . . . . 72.340000000000003 108.168 169.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.59 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 17.0 ptt180 -115.67 151.11 35.66 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.255 1.022 . . . . 71.329999999999998 108.418 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.96 149.96 36.51 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.573 -1.269 . . . . 72.340000000000003 107.573 165.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.6 t -81.04 120.85 25.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.111 0.564 . . . . 63.149999999999999 110.37 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.72 -36.03 77.82 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.152 0.981 . . . . 72.340000000000003 109.862 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.3 m -68.47 -34.04 75.24 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.631 0.773 . . . . 64.530000000000001 111.642 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.5 m -140.98 91.6 8.93 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.381 0.673 . . . . 72.420000000000002 110.969 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.1 124.93 17.46 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.158 2.572 . . . . 72.219999999999999 112.545 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.58 -28.92 11.84 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.815 -0.436 . . . . 63.310000000000002 112.76 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -74.38 116.69 15.34 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.844 -0.799 . . . . 75.129999999999995 108.844 173.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.515 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 72.3 mtt85 -123.84 144.35 49.79 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.462 0.705 . . . . 71.5 109.252 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.1 m -138.26 146.28 42.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.063 -0.971 . . . . 72.349999999999994 108.561 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.652 HG12 HG22 ' A' ' 170' ' ' VAL . 28.5 mt -100.41 149.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 106.589 -1.634 . . . . 72.310000000000002 106.589 168.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.1 m -124.52 120.07 30.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.474 -1.306 . . . . 73.219999999999999 107.474 170.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.6 tp -114.07 112.01 22.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.828 0.74 . . . . 71.510000000000005 110.399 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.546 ' HB2' ' HB3' ' A' ' 160' ' ' LEU . 32.9 ttt85 -78.07 114.44 16.96 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 109.258 -0.645 . . . . 71.319999999999993 109.258 165.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -136.9 132.3 34.31 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.08 -1.082 . . . . 71.049999999999997 108.08 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 59.36 28.59 17.98 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.7 1.2 . . . . 64.540000000000006 111.488 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.19 -9.81 56.14 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.889 -0.596 . . . . 72.120000000000005 114.034 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -96.49 124.1 40.37 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.085 0.954 . . . . 74.150000000000006 108.781 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.82 108.08 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 120.913 0.387 . . . . 74.120000000000005 110.104 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.99 151.07 21.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.56 1.144 . . . . 70.239999999999995 108.706 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -128.15 116.75 20.42 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.593 -0.521 . . . . 72.319999999999993 109.593 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.487 ' HE1' HD21 ' A' ' 232' ' ' LEU . 4.5 m-85 -95.74 149.59 21.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.412 1.085 . . . . 62.329999999999998 108.74 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -107.26 116.12 31.38 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.039 0.536 . . . . 74.409999999999997 109.577 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 45.3 mt -81.92 105.28 11.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.564 -0.902 . . . . 61.119999999999997 108.564 172.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -90.57 144.62 25.59 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.918 0.887 . . . . 64.209999999999994 109.288 173.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.8 m -98.39 128.97 45.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.903 0.881 . . . . 51.520000000000003 109.163 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 160.56 31.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.619 0.768 . . . . 71.420000000000002 109.951 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 40.9 p -62.64 -24.44 67.6 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.864 0.69 . . . . 64.140000000000001 112.864 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.07 -17.31 27.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.416 0.686 . . . . 65.439999999999998 111.372 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.55 14.02 9.17 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.451 0.94 . . . . 75.319999999999993 115.451 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -68.87 156.05 39.14 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.244 1.022 . . . . 74.439999999999998 110.492 170.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 146.8 34.2 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.413 -0.958 . . . . 63.109999999999999 108.413 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 30.7 p90 -167.97 141.52 3.32 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.681 0.613 . . . . 73.230000000000004 112.069 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.448 HG23 HD11 ' A' ' 217' ' ' LEU . 75.4 t -88.89 -31.87 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.186 -0.915 . . . . 71.219999999999999 108.87 162.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.7 m -105.54 123.04 47.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.301 1.04 . . . . 73.420000000000002 109.383 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -66.54 -24.7 66.41 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.163 0.585 . . . . 72.530000000000001 111.735 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.72 -15.18 57.15 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.41 1.084 . . . . 75.439999999999998 110.577 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 21.5 m -133.67 89.42 2.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.772 0.829 . . . . 70.409999999999997 109.338 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.469 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 52.9 mtt180 -97.11 120.04 36.71 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.725 0.81 . . . . 73.230000000000004 109.288 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.22 146.86 32.19 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.642 -0.873 . . . . 75.329999999999998 108.642 -174.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.21 -30.2 70.61 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 123.764 0.665 . . . . 72.209999999999994 111.622 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 75.2 p -132.08 158.79 40.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.32 0.648 . . . . 74.319999999999993 111.902 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.77 -28.56 67.71 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.471 1.108 . . . . 54.439999999999998 109.688 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.47 83.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.312 0.645 . . . . 73.310000000000002 110.668 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -77.33 -28.3 53.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.677 0.791 . . . . 72.209999999999994 111.666 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 205' ' ' VAL . 12.4 tp -58.33 -57.64 12.02 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.541 0.336 . . . . 72.519999999999996 110.254 170.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.54 -38.28 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.892 0.745 . . . . 63.32 110.739 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.15 -56.33 23.49 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.789 0.681 . . . . 73.019999999999996 111.301 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -65.21 -33.54 76.25 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.406 0.682 . . . . 73.140000000000001 110.844 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.697 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.6 m170 -89.29 -8.39 53.46 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.138 -0.483 . . . . 64.319999999999993 112.115 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.6 p -97.52 -22.89 16.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.041 0.537 . . . . 55.340000000000003 110.775 170.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 44.6 p -82.25 -43.2 17.9 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.796 0.439 . . . . 54.340000000000003 111.051 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' A' ' 226' ' ' ASP . 32.0 m -130.32 167.71 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.844 0.83 . . . . 64.340000000000003 111.57 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -80.48 13.93 2.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.839 2.056 . . . . 52.420000000000002 114.549 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.552 ' HB2' HG23 ' A' ' 224' ' ' VAL . 33.6 t70 -40.98 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 131.18 3.792 . . . . 73.530000000000001 119.82 -150.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 122.48 -3.94 10.22 Favored Glycine 0 N--CA 1.481 1.639 0 O-C-N 119.438 -2.039 . . . . 44.020000000000003 112.133 -166.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 221' ' ' HIS . 9.8 mt -89.59 162.49 15.62 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 125.139 1.375 . . . . 75.099999999999994 109.285 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 6.8 tt -57.5 -39.17 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-O 120.588 0.232 . . . . 75.219999999999999 110.499 168.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -162.64 175.62 11.2 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.492 0.717 . . . . 64.200000000000003 110.906 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.8 p -60.42 144.55 50.76 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.613 1.165 . . . . 65.129999999999995 112.209 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.487 HD21 ' HE1' ' A' ' 193' ' ' TYR . 78.4 mt -77.65 116.4 18.17 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.692 0.797 . . . . 61.210000000000001 109.353 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -104.94 -79.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.787 0.435 . . . . 74.450000000000003 111.308 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.52 ' HD2' ' HB2' ' A' ' 66' ' ' ARG . 46.3 t80 -90.39 121.52 68.38 Favored Pre-proline 0 C--O 1.213 -0.844 0 C-N-CA 123.7 0.8 . . . . 41.32 109.486 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.21 134.32 10.26 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.001 1.8 . . . . 71.219999999999999 111.228 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.17 151.35 92.42 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.492 0.717 . . . . 64.120000000000005 109.573 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -85.45 169.15 9.74 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.446 2.097 . . . . 60.340000000000003 113.873 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -59.05 119.19 6.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.006 0.922 . . . . 71.420000000000002 109.041 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.619 ' HE ' HG22 ' A' ' 151' ' ' VAL . 22.9 ptt85 -78.94 -59.67 2.69 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.794 1.035 . . . . 74.140000000000001 113.794 -161.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.415 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 49.2 t30 -106.98 122.0 45.58 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.84 0.856 . . . . 65.209999999999994 109.0 -176.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.69 113.75 22.57 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 106.953 -1.499 . . . . 74.209999999999994 106.953 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.407 ' HB2' HD22 ' A' ' 133' ' ' ASN . 60.0 Cg_endo -69.58 129.32 17.58 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.812 2.341 . . . . 44.409999999999997 112.521 -166.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.8 m -68.81 113.5 6.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.312 -0.858 . . . . 61.109999999999999 110.667 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.56 117.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.601 -1.259 . . . . 71.120000000000005 107.601 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 41' ' ' VAL . 8.5 m-85 -96.03 110.39 22.64 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 118.927 -0.558 . . . . 71.120000000000005 110.707 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 63.42 -38.19 0.08 OUTLIER Glycine 0 CA--C 1.55 2.26 0 N-CA-C 118.639 2.216 . . . . 60.200000000000003 118.639 166.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.96 125.51 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.809 0.844 . . . . 75.25 113.226 -154.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.4 t -86.83 142.66 34.51 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 107.389 -1.338 . . . . 72.049999999999997 107.389 150.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.53 -54.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.375 1.968 0 CA-C-N 120.834 1.334 . . . . 75.299999999999997 114.019 -167.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -126.2 -25.59 3.51 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.966 0.728 . . . . 63.009999999999998 112.966 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -98.78 117.76 33.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.989 0.737 . . . . 73.019999999999996 112.989 -166.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -114.71 -37.19 4.3 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.596 0.759 . . . . 74.420000000000002 110.81 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -110.48 17.48 20.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.4 1.08 . . . . 73.450000000000003 111.44 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -86.48 141.96 28.71 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.636 -0.665 . . . . 73.329999999999998 112.665 -167.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.253 1.269 0 O-C-N 124.979 1.424 . . . . 70.450000000000003 107.669 165.775 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.061 -0.718 . . . . 74.239999999999995 109.061 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 147.68 80.59 0.03 OUTLIER Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.519 -0.632 . . . . 61.240000000000002 111.519 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -78.5 149.05 33.23 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 109.788 -0.449 . . . . 74.420000000000002 109.788 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -158.62 96.1 1.81 Allowed Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 108.757 -0.831 . . . . 74.120000000000005 108.757 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.86 -172.72 1.47 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.957 2.438 . . . . 53.020000000000003 112.971 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.55 146.12 8.43 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.909 -0.587 . . . . 74.530000000000001 111.843 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -67.52 162.99 22.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.074 0.95 . . . . 42.420000000000002 111.868 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.62 150.91 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.051 0.94 . . . . 72.040000000000006 109.283 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.5 pt? -115.11 171.37 7.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.576 0.75 . . . . 75.230000000000004 109.152 176.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.04 83.3 0.32 Allowed Glycine 0 C--N 1.346 1.098 0 O-C-N 123.484 0.49 . . . . 71.329999999999998 112.08 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.17 147.5 43.96 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.311 1.044 . . . . 72.010000000000005 110.924 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -61.88 128.91 38.46 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.419 0.688 . . . . 73.439999999999998 111.296 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -70.15 83.88 0.53 Allowed 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 122.366 1.079 . . . . 75.310000000000002 110.628 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -132.31 134.78 25.37 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 115.306 -0.861 . . . . 63.439999999999998 109.195 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.78 111.85 2.28 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.41 2.074 . . . . 60.32 111.282 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 t -61.89 148.37 43.71 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.615 0.766 . . . . 64.140000000000001 110.506 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 mp -65.78 118.63 53.49 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.518 0.727 . . . . 53.340000000000003 109.732 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.94 119.61 6.72 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.461 2.107 . . . . 73.340000000000003 111.184 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -150.43 99.41 2.77 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.379 0.672 . . . . 72.420000000000002 110.363 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.52 155.25 21.6 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.134 0.974 . . . . 73.329999999999998 109.591 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -151.96 129.85 11.72 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.253 0.346 . . . . 75.400000000000006 110.697 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -159.6 87.49 0.82 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.49 0.716 . . . . 75.200000000000003 109.24 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 tt -162.86 139.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.86 0.864 . . . . 51.119999999999997 109.654 177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -153.75 124.62 7.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.674 0.79 . . . . 74.540000000000006 109.372 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.94 158.45 10.43 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 111.482 -0.647 . . . . 22.32 111.482 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.2 85.12 4.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.138 -0.69 . . . . 50.140000000000001 109.138 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.79 -143.85 6.22 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.281 -0.872 . . . . 52.210000000000001 111.938 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.93 105.9 3.31 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.4 -1.333 . . . . 44.140000000000001 107.4 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HG2' ' H ' ' A' ' 30' ' ' GLU . 55.4 ttt180 -85.46 -179.83 7.0 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.515 0.726 . . . . 74.010000000000005 110.137 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.53 ' H ' ' HG2' ' A' ' 29' ' ' ARG . 12.7 mt-10 -41.97 98.25 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.487 1.515 . . . . 73.299999999999997 111.182 170.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.5 p -106.52 168.01 9.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.271 0.628 . . . . 61.439999999999998 110.878 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 54.1 p -74.24 170.36 15.72 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.625 0.77 . . . . 63.299999999999997 109.996 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -61.91 92.26 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.096 0.559 . . . . 74.230000000000004 110.747 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -81.41 153.08 27.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.135 0.574 . . . . 75.140000000000001 110.536 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -132.86 39.1 1.78 Allowed Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.971 -0.852 . . . . 72.430000000000007 110.971 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.39 71.78 0.04 OUTLIER Glycine 0 C--O 1.241 0.581 0 N-CA-C 111.133 -0.787 . . . . 62.039999999999999 111.133 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -91.05 -131.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.217 2.612 . . . . 74.219999999999999 110.12 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.6 m170 65.15 -177.83 0.18 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.728 0.811 . . . . 74.409999999999997 110.674 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 40' ' ' ASN . 53.7 t 67.09 167.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.283 1.033 . . . . 72.349999999999994 112.643 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.417 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 21.8 t-20 -157.47 116.99 3.34 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.251 -1.388 . . . . 70.099999999999994 107.251 171.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.3 p -79.69 132.83 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 122.807 0.443 . . . . 70.040000000000006 110.277 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -75.59 134.41 40.68 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.221 -0.659 . . . . 74.439999999999998 109.221 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.92 138.37 49.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.968 0.907 . . . . 70.120000000000005 108.634 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.22 113.81 10.7 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.004 -0.739 . . . . 63.549999999999997 109.004 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -71.35 162.37 29.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.002 0.921 . . . . 74.430000000000007 111.956 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.28 154.09 42.71 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.6 1.16 . . . . 72.329999999999998 108.702 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.94 34.06 0.1 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.081 0.4 . . . . 73.409999999999997 112.081 -173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.92 133.0 40.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.111 -0.7 . . . . 72.230000000000004 109.111 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -137.9 -88.61 0.25 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.783 -0.821 . . . . 72.409999999999997 108.783 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.41 134.85 0.48 Allowed Pre-proline 0 C--N 1.35 0.625 0 N-CA-C 108.664 -0.865 . . . . 73.439999999999998 108.664 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.8 -173.04 1.7 Allowed 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.427 2.084 . . . . 71.510000000000005 112.187 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -75.06 -165.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.335 0.654 . . . . 64.510000000000005 110.867 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.57 97.04 0.05 OUTLIER 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.457 0.646 . . . . 55.340000000000003 110.153 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 p -86.92 22.59 1.96 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.345 1.058 . . . . 73.310000000000002 111.408 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -89.04 11.46 18.32 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.534 1.133 . . . . 64.340000000000003 110.929 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -128.78 133.91 48.22 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.842 0.857 . . . . 74.219999999999999 110.194 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.26 160.75 77.53 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.926 0.891 . . . . 71.420000000000002 110.641 174.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -40.77 -52.11 3.36 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.963 3.109 . . . . 53.409999999999997 114.816 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.522 ' HG3' HD13 ' A' ' 61' ' ' LEU . 24.1 tp60 -169.05 -42.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.365 0.666 . . . . 61.149999999999999 110.438 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.53 -23.51 35.89 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 116.152 -0.476 . . . . 73.409999999999997 112.625 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.522 HD13 ' HG3' ' A' ' 59' ' ' GLN . 9.4 mp -77.46 165.58 24.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.172 0.511 . . . . 65.120000000000005 111.049 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.0 m -89.59 -161.52 0.78 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.169 -0.923 . . . . 75.0 111.497 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -47.79 -36.52 11.81 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.685 1.594 . . . . 71.040000000000006 113.384 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -150.08 -70.61 0.19 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.376 -0.972 . . . . 63.420000000000002 108.376 172.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.73 -76.47 0.61 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.1 -0.704 . . . . 45.43 109.1 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -137.98 -83.74 0.31 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.64 0.776 . . . . 73.439999999999998 109.016 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -120.01 81.04 1.68 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.585 0.707 . . . . 73.439999999999998 109.611 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -85.65 -17.79 35.08 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.966 -1.015 . . . . 74.540000000000006 110.249 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.0 p -87.42 5.42 38.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.952 0.901 . . . . 74.239999999999995 111.684 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -64.34 -30.32 71.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.745 0.418 . . . . 64.0 111.553 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.608 ' HG3' HD22 ' A' ' 72' ' ' ASN . 11.6 pt-20 -65.24 -33.16 75.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.166 -0.47 . . . . 75.310000000000002 110.482 172.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.608 HD22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -75.97 -17.95 59.51 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.575 0.75 . . . . 74.319999999999993 111.369 177.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.4 tp -55.48 -51.66 66.22 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.093 0.557 . . . . 74.109999999999999 110.73 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.11 14.84 23.71 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.448 0.699 . . . . 74.409999999999997 111.213 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.48 -34.79 72.77 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.477 0.311 . . . . 71.430000000000007 111.261 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.55 -135.61 33.52 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 118.617 -1.102 . . . . 64.25 111.034 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.25 -177.24 3.13 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 122.981 2.454 . . . . 75.400000000000006 112.17 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 m -77.84 172.27 13.71 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.964 -0.562 . . . . 75.349999999999994 109.67 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -70.23 -42.8 71.79 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.73 0.412 . . . . 51.409999999999997 111.412 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -125.65 -34.39 2.65 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.057 0.543 . . . . 72.329999999999998 111.484 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.0 109.35 29.96 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.049 0.54 . . . . 50.229999999999997 111.508 -170.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.11 -12.87 6.75 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.412 2.074 . . . . 61.439999999999998 112.008 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -109.73 16.41 22.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.61 1.164 . . . . 71.450000000000003 110.945 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -86.6 130.85 34.33 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 109.202 -0.666 . . . . 74.310000000000002 109.202 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -108.82 174.12 6.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.568 1.147 . . . . 72.439999999999998 108.975 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.44 139.36 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.666 1.186 . . . . 61.43 108.616 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.5 127.51 32.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.515 0.726 . . . . 71.340000000000003 110.739 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 143' ' ' LYS . 91.2 mt -83.55 -32.82 25.64 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.773 0.829 . . . . 62.539999999999999 111.916 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.43 ' HB2' ' CD2' ' A' ' 134' ' ' TYR . 25.8 m-85 -125.05 157.18 36.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.253 0.621 . . . . 65.200000000000003 109.485 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.62 119.16 23.93 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.384 -0.969 . . . . 61.329999999999998 108.384 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.606 ' HB3' HG12 ' A' ' 101' ' ' ILE . 79.7 t80 -119.03 138.62 52.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.532 -0.914 . . . . 72.040000000000006 108.532 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -104.95 131.08 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.437 -0.949 . . . . 63.020000000000003 108.437 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.26 56.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.23 0.612 . . . . 62.43 111.092 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 p -86.83 -42.94 12.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.414 0.686 . . . . 52.109999999999999 109.689 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.76 -167.77 11.17 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.584 -0.734 . . . . 71.099999999999994 112.561 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' A' ' 255' ' ' GLU . 5.7 m-20 -66.92 -37.87 85.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.129 0.972 . . . . 71.239999999999995 110.835 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.508 ' HA ' ' HE3' ' A' ' 254' ' ' TRP . 26.5 p-10 -66.91 -21.01 66.01 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.259 -1.337 . . . . 74.340000000000003 112.222 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.0 p -100.39 -179.15 4.03 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.842 0.857 . . . . 64.150000000000006 110.484 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.637 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 62.9 tp -144.31 139.69 28.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.917 0.487 . . . . 44.130000000000003 111.073 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 m -85.35 132.9 34.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.442 0.697 . . . . 74.430000000000007 109.7 174.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' A' ' 91' ' ' PHE . 19.3 pt -133.01 148.8 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 120.953 0.406 . . . . 72.109999999999999 111.621 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 24.8 m -99.3 150.23 22.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.076 0.95 . . . . 51.509999999999998 108.73 174.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -64.84 126.92 29.47 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.739 -0.467 . . . . 73.129999999999995 109.739 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.02 -14.13 64.19 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.127 -0.488 . . . . 75.120000000000005 112.575 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 39.2 tt0 -74.76 128.0 34.5 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.794 0.838 . . . . 62.530000000000001 110.774 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.88 134.68 35.08 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.412 0.685 . . . . 71.120000000000005 110.325 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 0.4 OUTLIER -146.21 136.86 24.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.817 0.847 . . . . 74.319999999999993 110.631 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -96.65 115.12 26.9 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.506 0.323 . . . . 72.420000000000002 110.602 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.644 HG13 ' HB1' ' A' ' 119' ' ' ALA . 52.7 t -74.58 110.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.424 0.63 . . . . 75.5 109.707 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.67 -32.13 60.04 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.246 -1.343 . . . . 74.099999999999994 110.044 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.54 155.34 11.17 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.231 -0.895 . . . . 63.100000000000001 111.878 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.61 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 43.0 m-85 -87.47 175.5 7.93 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.472 0.654 . . . . 72.219999999999999 111.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -85.38 -173.05 4.47 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.935 -1.029 . . . . 74.219999999999999 110.928 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -44.38 -44.17 8.12 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.472 1.509 . . . . 74.200000000000003 114.296 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -112.61 0.28 15.37 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.911 0.708 . . . . 74.230000000000004 112.911 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.61 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 81.83 22.69 59.24 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 115.313 0.885 . . . . 71.299999999999997 115.313 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.48 -65.44 1.0 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.98 0.89 . . . . 71.030000000000001 110.012 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 49.2 m95 -92.3 150.4 20.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.194 0.598 . . . . 74.510000000000005 111.369 -174.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.644 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -133.3 137.34 45.94 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.438 1.095 . . . . 30.43 110.193 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -78.37 98.8 6.11 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.292 -1.003 . . . . 73.409999999999997 108.292 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 107' ' ' LEU . . . -105.42 139.98 39.23 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.414 0.685 . . . . 64.129999999999995 110.339 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -102.27 105.7 16.39 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.216 -0.661 . . . . 71.310000000000002 109.216 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.462 HG21 HG22 ' A' ' 101' ' ' ILE . 69.4 p -80.4 168.42 19.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.952 0.783 . . . . 75.450000000000003 109.731 171.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -67.33 -8.19 30.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.607 -0.724 . . . . 75.420000000000002 111.537 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -91.4 -30.78 16.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.937 0.895 . . . . 74.019999999999996 110.958 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.28 174.68 24.64 Favored Glycine 0 C--N 1.36 1.886 0 N-CA-C 114.204 0.442 . . . . 44.130000000000003 114.204 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -86.62 142.49 28.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.809 0.843 . . . . 71.219999999999999 110.99 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.637 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . -176.81 -170.01 38.8 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-N 114.945 -1.025 . . . . 53.310000000000002 110.646 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -109.77 129.34 55.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.817 0.808 . . . . 74.030000000000001 111.41 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' A' ' 99' ' ' LEU . 27.6 m -136.07 145.21 51.43 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 124.698 1.199 . . . . 65.349999999999994 109.188 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 47.4 Cg_endo -88.44 156.35 6.57 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 122.541 2.161 . . . . 65.319999999999993 114.312 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 m -38.33 -43.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.611 1.964 . . . . 64.540000000000006 114.137 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.54 HD22 ' HB2' ' A' ' 242' ' ' PRO . 36.4 p-10 -72.23 -11.33 60.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.097 0.559 . . . . 70.409999999999997 112.057 -174.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 89' ' ' TYR . 28.7 m-85 -105.9 -13.5 15.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.983 0.913 . . . . 74.310000000000002 112.581 176.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 130' ' ' VAL . 16.8 pt -130.98 172.83 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.373 0.669 . . . . 71.439999999999998 111.696 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -162.01 152.02 14.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 108.428 -0.953 . . . . 71.540000000000006 108.428 172.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.23 149.52 44.73 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.04 1.826 . . . . 71.420000000000002 112.065 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.17 -23.36 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.093 0.473 . . . . 64.150000000000006 110.531 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -69.69 -18.61 63.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.941 0.896 . . . . 64.409999999999997 112.291 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.2 p -77.93 166.16 23.21 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.157 0.799 . . . . 74.340000000000003 113.157 -167.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -84.52 -19.73 32.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.815 -1.084 . . . . 72.25 110.663 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -71.13 -24.15 62.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.294 1.037 . . . . 72.409999999999997 111.35 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.529 ' HA ' HD21 ' A' ' 88' ' ' LEU . 21.3 pttm -62.08 -18.64 61.37 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.44 0.696 . . . . 74.340000000000003 112.868 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -76.7 149.28 36.42 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.472 0.709 . . . . 72.310000000000002 110.418 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.4 p -61.72 -43.24 99.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.95 0.9 . . . . 73.230000000000004 111.456 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -68.89 -34.56 75.61 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.062 0.851 . . . . 74.299999999999997 113.103 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.92 113.92 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.148 -0.686 . . . . 74.019999999999996 109.148 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.425 ' HD2' ' HD3' ' A' ' 238' ' ' LYS . 29.8 m170 -110.94 3.59 18.93 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.633 0.605 . . . . 75.209999999999994 112.633 -175.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.58 -148.04 38.03 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-O 118.861 -0.966 . . . . 64.150000000000006 112.771 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.81 97.54 0.23 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.02 2.48 . . . . 74.319999999999993 111.952 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 61.0 t -131.89 129.28 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.666 0.787 . . . . 61.049999999999997 110.003 -175.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -79.36 172.34 13.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.55 0.74 . . . . 35.340000000000003 110.392 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -60.35 -47.62 85.27 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.645 0.378 . . . . 71.219999999999999 110.803 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -57.09 -41.59 79.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.652 0.781 . . . . 64.519999999999996 111.89 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -72.14 -34.25 68.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.763 0.425 . . . . 71.439999999999998 111.325 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.25 91.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.484 0.659 . . . . 75.540000000000006 110.915 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -79.6 -21.23 45.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.418 -0.81 . . . . 54.009999999999998 110.88 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -64.61 -42.06 95.78 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.221 0.608 . . . . 71.420000000000002 109.623 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 239' ' ' ARG . 85.8 mt -64.76 -44.51 89.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.521 0.728 . . . . 70.219999999999999 111.692 174.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.5 13.72 13.15 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.959 -0.564 . . . . 63.409999999999997 112.17 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -65.39 -42.11 92.99 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.476 0.655 . . . . 72.209999999999994 110.002 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.3 p -102.58 19.61 18.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.59 1.156 . . . . 65.109999999999999 110.494 176.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.35 152.95 36.65 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.883 -0.599 . . . . 51.539999999999999 112.269 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 pt -102.31 -177.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.147 0.979 . . . . 74.200000000000003 110.709 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.41 120.95 10.29 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.176 0.59 . . . . 61.130000000000003 110.247 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.17 10.52 62.34 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.795 -0.639 . . . . 34.310000000000002 113.168 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 73.9 m -77.73 128.4 33.99 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.782 0.791 . . . . 72.319999999999993 110.044 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -139.69 164.34 30.2 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.381 0.61 . . . . 64.420000000000002 111.454 -170.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 236' ' ' ALA . 4.5 pp -160.2 154.92 24.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.464 -1.244 . . . . 75.549999999999997 108.968 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 182' ' ' ILE . 87.5 t -110.14 127.93 66.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.533 -0.914 . . . . 63.32 108.533 168.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.574 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 20.4 ptt85 -115.66 155.36 27.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.41 -1.268 . . . . 65.120000000000005 108.514 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.52 147.46 40.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.257 -1.016 . . . . 74.439999999999998 108.257 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t -87.33 129.08 35.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.687 -0.486 . . . . 70.239999999999995 109.687 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -80.7 -40.06 26.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.485 -0.779 . . . . 71.310000000000002 109.518 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.7 m -66.54 -33.07 74.85 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.999 0.92 . . . . 62.310000000000002 111.097 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -118.51 95.53 48.9 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 123.764 0.826 . . . . 41.310000000000002 109.529 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -58.14 126.55 21.89 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.322 2.681 . . . . 74.430000000000007 113.278 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.62 -27.52 8.66 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 116.242 -0.435 . . . . 54.130000000000003 113.152 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -66.65 136.3 55.35 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.353 0.661 . . . . 74.019999999999996 110.548 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -135.17 158.29 44.75 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.717 0.807 . . . . 72.230000000000004 109.793 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.4 m -147.37 150.1 34.05 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.432 1.093 . . . . 72.019999999999996 108.93 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.611 HG12 HG22 ' A' ' 170' ' ' VAL . 35.8 mt -103.93 149.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.954 -1.128 . . . . 73.420000000000002 107.954 173.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.2 m -125.09 110.85 14.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.286 -1.005 . . . . 72.25 108.286 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.1 tp -110.0 112.85 25.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.152 0.581 . . . . 52.109999999999999 110.104 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.503 ' HB2' HG22 ' A' ' 190' ' ' VAL . 39.1 ttt180 -78.47 114.79 17.69 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.268 0.556 . . . . 75.420000000000002 110.048 165.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.44 141.62 37.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.153 -1.385 . . . . 54.119999999999997 107.763 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 57.07 28.67 15.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.922 0.889 . . . . 75.099999999999994 111.575 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.42 -9.46 54.78 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-N 115.797 -0.638 . . . . 72.420000000000002 114.043 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -104.5 140.05 38.53 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.834 0.854 . . . . 73.230000000000004 109.839 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 185' ' ' ARG . 48.9 t -98.77 106.51 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.852 0.461 . . . . 63.409999999999997 110.457 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -91.16 141.62 28.62 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.016 0.926 . . . . 74.219999999999999 109.115 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -114.88 118.58 33.9 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.713 0.405 . . . . 74.310000000000002 110.019 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.425 ' HE1' HD21 ' A' ' 232' ' ' LEU . 6.4 m-30 -94.02 149.78 20.93 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.05 0.94 . . . . 74.5 108.738 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -101.07 127.45 47.6 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.792 -0.818 . . . . 74.430000000000007 108.792 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 101.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.826 -1.176 . . . . 63.43 107.826 171.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -79.02 132.92 36.81 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.501 -0.772 . . . . 61.119999999999997 109.045 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.8 m -93.76 113.74 25.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.293 -1.003 . . . . 72.430000000000007 108.293 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.11 159.17 33.43 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.559 0.537 . . . . 71.120000000000005 111.257 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.5 p -66.8 -27.91 67.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.578 -0.737 . . . . 71.329999999999998 110.94 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.3 -1.05 48.33 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.985 0.914 . . . . 72.329999999999998 111.343 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 98.26 -7.92 62.36 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.822 -0.432 . . . . 75.310000000000002 114.116 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.33 133.49 34.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.652 0.726 . . . . 55.240000000000002 111.745 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.416 ' H ' HD22 ' A' ' 203' ' ' LEU . 1.3 mm? -83.6 147.87 27.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.855 0.862 . . . . 75.019999999999996 108.913 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.554 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 40.3 p90 -166.53 151.46 7.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.967 0.413 . . . . 64.340000000000003 111.876 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.438 ' HB ' ' HE1' ' A' ' 221' ' ' HIS . 59.8 t -99.19 -35.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.577 -0.897 . . . . 63.100000000000001 108.577 165.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -103.78 125.76 50.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.095 0.958 . . . . 72.209999999999994 109.252 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.9 t -63.01 -30.15 71.38 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 71.299999999999997 112.207 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.58 -26.9 61.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.624 0.769 . . . . 72.030000000000001 111.099 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.1 m -121.85 96.68 5.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 74.340000000000003 110.063 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.554 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.0 mtt180 -100.02 140.66 33.93 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.789 0.836 . . . . 75.150000000000006 109.195 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 3.1 m-85 -127.0 140.55 52.23 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.374 0.67 . . . . 72.230000000000004 109.818 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.19 -27.03 63.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.241 0.616 . . . . 74.329999999999998 110.289 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -133.29 153.72 51.32 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.813 0.845 . . . . 64.209999999999994 110.745 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.498 HD11 HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -67.54 -21.52 65.46 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.128 -0.942 . . . . 74.439999999999998 109.708 172.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.01 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.9 0.88 . . . . 71.219999999999999 110.398 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.3 mt-10 -69.42 -37.04 77.25 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.289 -0.868 . . . . 74.420000000000002 111.338 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 205' ' ' VAL . 13.8 tp -55.17 -57.86 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.374 0.421 . . . . 71.310000000000002 111.152 176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.9 -40.3 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.892 0.477 . . . . 51.43 111.355 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -59.15 -54.44 46.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.381 0.672 . . . . 74.340000000000003 111.004 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.423 ' O ' HG22 ' A' ' 224' ' ' VAL . 45.4 t60 -63.76 -38.21 90.25 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.797 0.839 . . . . 72.450000000000003 110.925 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.71 ' HB3' HD11 ' A' ' 228' ' ' LEU . 11.0 m-70 -85.8 -8.24 58.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.922 0.489 . . . . 64.040000000000006 112.002 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.8 p -93.66 -28.9 15.72 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.627 0.371 . . . . 54.450000000000003 110.308 169.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.6 p -77.65 -40.71 40.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.322 0.249 . . . . 73.209999999999994 111.113 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 220' ' ' HIS . 32.6 m -131.58 157.56 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.72 . . . . 74.340000000000003 111.487 -176.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.59 10.24 18.57 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.08 1.752 . . . . 62.43 113.874 -173.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -45.96 32.78 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 130.799 3.64 . . . . 75.430000000000007 120.428 -155.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 127.84 -1.11 6.8 Favored Glycine 0 N--CA 1.464 0.564 0 O-C-N 120.925 -1.109 . . . . 50.100000000000001 112.788 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 221' ' ' HIS . 12.5 mt -91.58 161.38 14.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.51 1.124 . . . . 64.099999999999994 109.753 165.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 10.9 tt -60.77 -36.37 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 120.816 0.341 . . . . 61.229999999999997 110.485 171.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.2 t -162.77 178.77 8.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.885 0.874 . . . . 75.530000000000001 109.471 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.5 p -63.78 143.77 57.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.24 0.616 . . . . 72.219999999999999 112.039 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.425 HD21 ' HE1' ' A' ' 193' ' ' TYR . 54.4 mt -69.5 138.15 53.12 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 108.159 -1.052 . . . . 70.25 108.159 169.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -135.95 -76.7 0.43 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.85 0.75 . . . . 75.120000000000005 112.238 -170.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -84.21 122.43 75.62 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.912 -0.773 . . . . 64.120000000000005 108.912 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.05 126.4 6.37 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 122.251 1.968 . . . . 64.420000000000002 111.918 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . . . -74.11 135.8 76.47 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.891 -0.781 . . . . 74.340000000000003 108.891 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.5 177.76 8.36 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.632 2.222 . . . . 52.5 112.322 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HD3' ' HD2' ' A' ' 148' ' ' HIS . 72.5 mmtt -63.52 157.12 24.41 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.752 0.821 . . . . 63.219999999999999 109.971 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 29.3 ptt180 -91.13 -62.56 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.06 0.763 . . . . 54.200000000000003 113.06 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.564 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 24.8 t-20 -110.68 158.56 18.47 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.821 0.848 . . . . 64.319999999999993 108.794 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 114.55 57.37 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 106.131 -1.803 . . . . 71.530000000000001 106.131 156.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.54 ' HB2' HD22 ' A' ' 133' ' ' ASN . 36.6 Cg_endo -62.79 124.9 14.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.41 2.074 . . . . 54.420000000000002 112.19 -169.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 33.8 m -71.29 117.8 13.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.819 0.847 . . . . 75.420000000000002 110.646 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.44 HG11 ' CZ2' ' A' ' 118' ' ' TRP . 24.6 t -98.62 125.17 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.077 -1.083 . . . . 70.430000000000007 108.077 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.18 115.55 30.45 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.573 -0.251 . . . . 74.230000000000004 110.563 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.63 -3.36 0.25 Allowed Glycine 0 CA--C 1.54 1.626 0 N-CA-C 118.409 2.123 . . . . 63.409999999999997 118.409 161.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 11.9 m -91.53 122.99 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.372 1.586 . . . . 75.239999999999995 112.222 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 25.3 t -72.97 123.88 90.09 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 106.874 -1.528 . . . . 75.209999999999994 106.874 165.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.96 -63.79 0.25 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.321 2.014 . . . . 52.5 115.104 -153.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -131.76 -29.73 1.68 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.597 1.189 . . . . 62.149999999999999 108.321 147.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.455 ' HD1' ' HB2' ' A' ' 254' ' ' TRP . 9.9 m-85 -101.48 139.43 37.15 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 113.191 -1.822 . . . . 73.239999999999995 110.636 -174.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.08 -40.3 3.5 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.353 1.061 . . . . 54.240000000000002 109.397 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -76.74 -20.6 56.34 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.868 0.867 . . . . 73.230000000000004 111.731 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.508 ' HE3' ' HA ' ' A' ' 97' ' ' ASN . 35.3 t90 -67.44 138.32 56.56 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.61 0.596 . . . . 71.219999999999999 112.61 -171.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 6.7 pt-20 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 124.973 1.309 . . . . 70.310000000000002 109.295 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.526 0.203 . . . . 60.030000000000001 110.565 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.06 56.42 0.74 Allowed Glycine 0 C--N 1.347 1.179 0 N-CA-C 110.275 -1.13 . . . . 73.340000000000003 110.275 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -76.51 107.25 8.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.439 0.695 . . . . 74.219999999999999 110.301 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -111.89 102.12 52.98 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.476 0.71 . . . . 64.450000000000003 110.507 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.98 96.43 0.35 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.804 2.336 . . . . 74.400000000000006 110.82 165.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.57 -179.02 51.9 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.824 -0.625 . . . . 34.409999999999997 113.642 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 158.16 19.47 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.468 0.707 . . . . 74.150000000000006 112.327 -175.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.0 t -81.81 136.42 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.938 0.895 . . . . 72.209999999999994 110.145 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.61 174.81 14.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.635 1.174 . . . . 74.109999999999999 109.898 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.62 -158.12 4.05 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-O 119.854 -0.414 . . . . 72.299999999999997 112.635 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -75.35 -72.12 0.32 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.367 0.583 . . . . 75.129999999999995 110.374 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 50.38 33.31 7.42 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.222 1.009 . . . . 74.099999999999994 110.989 -171.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 138.39 58.47 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.3 -0.864 . . . . 75.340000000000003 111.26 -169.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.507 ' H ' ' NE ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -135.03 146.79 59.98 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 123.664 0.786 . . . . 75.129999999999995 109.666 -176.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.23 135.88 68.7 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.499 2.132 . . . . 74.319999999999993 111.29 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.7 t -83.78 -46.08 12.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.835 0.854 . . . . 50.310000000000002 110.272 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.1 mt 56.54 85.87 0.18 Allowed Pre-proline 0 CA--C 1.562 1.409 0 C-N-CA 124.824 1.249 . . . . 74.450000000000003 112.735 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.42 156.39 36.75 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.01 2.473 . . . . 74.030000000000001 112.808 177.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.78 134.28 48.34 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.798 0.839 . . . . 62.210000000000001 109.055 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.3 78.19 9.67 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.3 0.572 . . . . 71.040000000000006 110.382 -175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -92.07 89.93 7.15 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.618 -0.882 . . . . 74.450000000000003 108.618 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -95.03 141.46 28.65 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.062 0.545 . . . . 73.239999999999995 110.244 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.0 tt -102.24 127.7 55.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.023 -0.732 . . . . 71.549999999999997 109.023 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HE2' ' HD2' ' A' ' 28' ' ' LYS . 41.5 tttp -127.44 -92.62 0.48 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.52 -0.918 . . . . 64.140000000000001 108.52 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.63 -51.57 2.65 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 118.141 0.428 . . . . 54.539999999999999 113.683 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.14 100.05 2.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.157 0.583 . . . . 54.509999999999998 110.826 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.99 -176.55 53.24 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 116.463 -0.335 . . . . 65.409999999999997 113.229 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HD2' ' HE2' ' A' ' 24' ' ' LYS . 63.3 tttp 72.49 137.52 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.194 1.398 . . . . 73.219999999999999 111.594 -176.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -73.19 77.9 1.28 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 122.451 1.119 . . . . 74.439999999999998 109.37 170.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.528 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 33.1 tt0 -127.83 133.34 49.39 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.86 -1.064 . . . . 53.229999999999997 109.304 -171.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -64.82 124.54 22.24 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 124.252 0.97 . . . . 74.329999999999998 110.501 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 m 73.93 127.32 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.415 1.486 . . . . 74.329999999999998 112.01 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.528 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -92.57 163.21 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.238 -1.023 . . . . 72.400000000000006 108.238 167.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -79.1 77.03 5.6 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.116 0.484 . . . . 74.120000000000005 111.784 -172.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.1 -171.01 8.02 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 114.753 -1.112 . . . . 72.010000000000005 114.909 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.551 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.47 -38.5 95.85 Favored Glycine 0 CA--C 1.549 2.207 0 CA-C-O 117.703 -1.61 . . . . 55.43 115.647 171.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 8.6 Cg_endo -47.73 -23.95 4.34 Favored 'Trans proline' 0 C--N 1.401 3.325 0 C-N-CA 123.881 3.054 . . . . 45.329999999999998 115.575 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 79.2 t60 70.63 9.87 6.98 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.176 0.99 . . . . 62.450000000000003 112.576 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.5 t 61.9 41.75 11.1 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.253 1.021 . . . . 64.310000000000002 109.833 -170.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 71.08 -177.76 0.21 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.921 1.688 . . . . 64.120000000000005 110.534 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.9 m -56.51 159.28 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 113.284 0.846 . . . . 52.43 113.284 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -76.49 164.59 25.81 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.193 -0.912 . . . . 73.099999999999994 109.968 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.59 153.04 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 123.073 0.549 . . . . 65.430000000000007 110.779 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.17 -152.51 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.729 1.211 . . . . 65.109999999999999 113.787 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -34.94 97.65 0.01 OUTLIER 'General case' 0 C--N 1.368 1.394 0 C-N-CA 126.599 1.96 . . . . 73.140000000000001 113.002 174.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.4 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.852 1.261 . . . . 70.239999999999995 111.979 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.04 163.28 13.19 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.359 0.664 . . . . 75.099999999999994 109.837 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.99 166.15 14.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.022 0.529 . . . . 41.100000000000001 110.556 172.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -54.89 123.14 12.48 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.583 -0.525 . . . . 75.030000000000001 109.583 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -63.5 116.36 25.32 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 124.269 0.98 . . . . 70.439999999999998 109.617 -168.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.69 98.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.857 2.371 . . . . 73.530000000000001 111.741 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.05 135.07 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.236 1.015 . . . . 71.439999999999998 111.134 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.6 -85.74 0.36 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.3 -0.409 . . . . 72.25 111.658 -169.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.1 p -115.94 -11.86 11.44 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.895 0.878 . . . . 75.519999999999996 110.048 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -88.61 8.13 29.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.85 1.26 . . . . 74.239999999999995 112.088 -171.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -58.61 147.58 31.94 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.603 0.761 . . . . 71.040000000000006 111.413 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -57.08 116.87 14.77 Favored Pre-proline 0 CA--C 1.555 1.158 0 O-C-N 123.763 0.664 . . . . 73.010000000000005 110.405 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.59 9.39 3.49 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.615 2.21 . . . . 74.0 112.955 -174.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -79.68 -74.12 0.31 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.336 0.654 . . . . 75.319999999999993 110.345 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.81 -37.56 3.07 Favored Glycine 0 N--CA 1.479 1.565 0 C-N-CA 122.762 0.22 . . . . 52.299999999999997 112.777 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.03 -178.88 7.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.353 1.061 . . . . 70.439999999999998 110.361 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 m -75.03 163.21 27.83 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.143 0.497 . . . . 53.240000000000002 111.039 174.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -30.4 64.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.306 1.042 . . . . 74.340000000000003 113.658 -176.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.47 -64.74 1.05 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.249 -0.648 . . . . 52.509999999999998 109.249 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.89 -77.99 0.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.053 -0.976 . . . . 70.150000000000006 109.871 175.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -125.23 -53.86 1.6 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.461 0.704 . . . . 75.430000000000007 109.289 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -136.24 102.44 4.99 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.947 0.499 . . . . 75.239999999999995 109.962 -173.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -84.2 -36.08 23.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.314 0.646 . . . . 74.349999999999994 111.355 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.9 p -77.53 7.26 5.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.954 0.902 . . . . 52.219999999999999 112.702 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -62.04 -39.49 92.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.766 1.226 . . . . 64.420000000000002 111.21 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.0 -34.13 71.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 110.274 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -73.28 -12.86 61.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.398 0.679 . . . . 65.209999999999994 110.989 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.1 tp -67.29 -51.68 49.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.801 0.84 . . . . 52.210000000000001 111.868 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.4 mt -112.46 22.04 15.06 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.741 0.416 . . . . 72.219999999999999 110.133 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.98 -21.19 65.95 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 62.409999999999997 112.036 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.47 -139.62 20.41 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.103 -0.831 . . . . 64.439999999999998 111.672 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.21 -178.22 3.93 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.561 2.174 . . . . 63.009999999999998 112.72 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 m -67.17 126.9 30.68 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.548 -0.908 . . . . 63.420000000000002 108.548 170.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -64.4 -46.18 84.42 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.057 1.132 . . . . 74.129999999999995 114.057 -161.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.95 -39.73 1.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 118.058 0.39 . . . . 61.32 110.852 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.647 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 20.3 m-20 -93.6 104.45 12.75 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.906 -1.045 . . . . 72.299999999999997 110.35 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.95 -33.47 92.35 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.317 2.012 . . . . 63.450000000000003 113.009 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -94.38 22.03 6.48 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.709 0.804 . . . . 73.319999999999993 110.744 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 23.9 tp -77.34 131.56 38.16 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.634 -0.666 . . . . 71.439999999999998 109.527 174.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -115.54 173.12 6.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.446 1.099 . . . . 74.329999999999998 109.84 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.73 138.96 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.003 1.321 . . . . 43.240000000000002 108.84 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -79.72 138.23 37.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.511 0.724 . . . . 64.040000000000006 110.349 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 143' ' ' LYS . 82.7 mt -104.01 -35.48 8.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.728 0.811 . . . . 75.299999999999997 110.987 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.462 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 44.0 m-85 -122.48 140.93 52.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.194 -0.912 . . . . 74.5 108.874 -173.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 3.5 m-20 -68.5 124.87 24.75 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.984 -0.747 . . . . 73.400000000000006 108.984 171.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.637 ' HB3' HG12 ' A' ' 101' ' ' ILE . 90.2 t80 -114.24 139.45 49.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.261 -1.015 . . . . 74.310000000000002 108.261 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.97 131.82 59.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.523 -1.288 . . . . 74.340000000000003 107.523 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.71 119.13 4.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.839 0.855 . . . . 70.310000000000002 111.709 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.5 p -84.28 -27.31 27.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.498 0.719 . . . . 74.129999999999995 111.158 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -141.38 -169.62 11.96 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.805 -0.918 . . . . 61.130000000000003 110.805 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.68 -44.63 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.005 0.431 . . . . 65.329999999999998 111.257 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.549 HD21 ' HD2' ' A' ' 249' ' ' PRO . 26.5 p-10 -71.47 -24.68 62.04 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.151 -0.931 . . . . 63.439999999999998 111.657 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.0 p -79.99 160.28 25.96 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.332 0.653 . . . . 64.400000000000006 110.775 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.7 tp -133.44 136.4 45.16 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.968 0.507 . . . . 61.439999999999998 111.371 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 m -75.48 134.0 40.93 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.544 0.738 . . . . 63.340000000000003 111.312 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.637 HG12 ' HB3' ' A' ' 91' ' ' PHE . 21.8 pt -127.22 166.77 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.167 0.587 . . . . 72.409999999999997 111.818 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.0 m -126.42 157.19 39.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.727 -1.124 . . . . 62.240000000000002 110.479 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -47.29 119.57 2.71 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.227 1.011 . . . . 73.219999999999999 111.808 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.91 8.61 78.29 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 115.129 0.811 . . . . 71.239999999999995 115.129 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -68.53 122.24 18.06 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.268 0.627 . . . . 44.539999999999999 110.764 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -75.92 128.76 35.75 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.128 -0.693 . . . . 65.400000000000006 109.128 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -147.91 166.94 26.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.71 0.804 . . . . 75.329999999999998 110.783 -173.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -122.72 117.44 25.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.927 0.491 . . . . 75.230000000000004 110.151 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.606 HG13 ' HB1' ' A' ' 119' ' ' ALA . 41.6 t -81.05 112.38 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.196 0.598 . . . . 74.120000000000005 110.139 175.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.5 -35.17 40.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.442 -0.799 . . . . 62.329999999999998 109.965 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.98 147.56 6.09 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.437 0.461 . . . . 44.140000000000001 112.87 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.531 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 47.2 m-85 -86.95 162.78 17.49 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.381 0.672 . . . . 74.450000000000003 111.458 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -81.69 -173.73 4.6 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.302 -0.863 . . . . 64.510000000000005 110.361 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -52.5 -36.95 56.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.28 1.432 . . . . 72.340000000000003 113.838 -170.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -112.17 -3.76 14.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.471 0.708 . . . . 62.350000000000001 111.853 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 72.61 33.97 60.34 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.54 -0.589 . . . . 71.329999999999998 114.566 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -84.91 -38.39 19.44 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.402 0.601 . . . . 74.400000000000006 110.717 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 70.3 m95 -123.0 154.13 38.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.57 0.748 . . . . 73.519999999999996 110.561 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.606 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -134.35 132.4 39.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.027 0.931 . . . . 74.219999999999999 109.991 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.4 114.22 7.44 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 106.172 -1.788 . . . . 73.310000000000002 106.172 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.31 150.85 49.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 63.229999999999997 111.028 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -106.38 116.38 31.83 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.522 -1.288 . . . . 74.040000000000006 107.522 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.536 HG21 HG22 ' A' ' 101' ' ' ILE . 22.9 p -116.96 174.43 6.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.434 0.694 . . . . 73.040000000000006 110.167 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -62.85 -24.24 67.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.311 0.645 . . . . 54.210000000000001 110.22 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.06 -27.57 60.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.497 0.719 . . . . 74.519999999999996 111.608 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.75 -125.1 2.21 Favored Glycine 0 C--N 1.355 1.6 0 C-N-CA 121.408 -0.425 . . . . 75.049999999999997 113.538 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -134.94 140.42 45.71 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.757 0.823 . . . . 34.210000000000001 110.499 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.486 ' HA2' ' HZ3' ' A' ' 254' ' ' TRP . . . 149.51 176.87 23.09 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 113.709 0.243 . . . . 75.219999999999999 113.709 176.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -80.87 120.6 24.91 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.127 0.971 . . . . 74.030000000000001 112.28 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.431 HG23 HD13 ' A' ' 135' ' ' ILE . 4.2 m -121.79 139.63 30.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.312 1.045 . . . . 54.350000000000001 108.638 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 3.1 Cg_exo -76.05 143.45 25.86 Favored 'Trans proline' 0 CA--C 1.561 1.863 0 C-N-CA 122.631 2.221 . . . . 74.310000000000002 114.46 -172.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -39.54 -49.61 2.14 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.85 1.66 . . . . 42.439999999999998 113.469 168.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 242' ' ' PRO . 18.6 p-10 -76.3 7.18 4.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.777 0.831 . . . . 63.32 112.581 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.514 ' HB3' HD11 ' A' ' 101' ' ' ILE . 16.5 m-85 -115.87 -9.12 11.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.349 1.06 . . . . 74.349999999999994 111.568 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.431 HD13 HG23 ' A' ' 130' ' ' VAL . 10.8 pt -132.37 171.43 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.96 0.904 . . . . 72.450000000000003 111.215 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 t -164.17 152.18 10.91 Favored Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.479 -0.772 . . . . 74.150000000000006 109.151 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -58.15 157.85 24.02 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.441 2.094 . . . . 73.209999999999994 113.791 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.55 -8.28 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 123.271 0.628 . . . . 53.439999999999998 111.783 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -102.11 0.82 35.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 72.040000000000006 111.866 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.9 p -77.1 168.11 20.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.13 0.572 . . . . 63.109999999999999 112.197 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.22 -24.65 27.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.149 -0.478 . . . . 71.319999999999993 110.352 167.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.4 -23.59 66.34 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.366 0.666 . . . . 73.019999999999996 111.599 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.66 ' HA ' HD21 ' A' ' 88' ' ' LEU . 20.9 pttm -62.49 -18.21 61.38 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.761 0.663 . . . . 50.039999999999999 112.522 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.99 141.98 30.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.648 -0.705 . . . . 75.430000000000007 110.512 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 p -62.67 -40.14 96.14 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.379 1.049 . . . . 73.319999999999993 111.13 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -66.14 -37.58 86.05 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.163 0.801 . . . . 75.409999999999997 113.163 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 38.9 t80 -76.41 113.6 14.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.854 -0.424 . . . . 75.239999999999995 109.854 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -109.23 -5.24 15.98 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.086 0.554 . . . . 74.049999999999997 112.473 -177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.67 -145.68 42.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 118.652 -1.082 . . . . 65.329999999999998 112.843 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.35 94.88 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.06 2.507 . . . . 71.129999999999995 112.996 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 49.0 t -135.74 126.98 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.994 1.318 . . . . 74.319999999999993 109.257 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 79.9 p -83.92 175.44 9.58 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.912 0.885 . . . . 71.209999999999994 110.323 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 76.0 ttt180 -60.75 -40.4 92.29 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 119.467 -0.301 . . . . 75.239999999999995 110.934 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -53.54 -49.88 66.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.183 0.593 . . . . 64.230000000000004 110.923 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.504 ' HB3' HG13 ' A' ' 151' ' ' VAL . . . -71.0 -26.18 63.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.224 -0.898 . . . . 53.0 111.634 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.4 -46.45 60.22 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.067 0.547 . . . . 34.32 111.821 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 153' ' ' ARG . 3.6 mm-40 -68.72 -32.91 73.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.559 -0.534 . . . . 73.420000000000002 109.559 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.08 -47.82 82.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.115 0.966 . . . . 72.209999999999994 110.664 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.43 HD13 HD22 ' A' ' 169' ' ' LEU . 12.9 mt -58.54 -45.43 88.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.875 0.87 . . . . 72.329999999999998 111.487 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 97.9 mt -92.99 8.0 41.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.749 0.648 . . . . 72.140000000000001 112.749 -176.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.4 p -64.05 -37.26 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 118.713 0.688 . . . . 70.409999999999997 110.377 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.4 p -101.93 18.44 20.6 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.138 0.975 . . . . 60.009999999999998 111.504 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.21 165.26 32.68 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.285 -0.416 . . . . 53.25 112.409 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.34 -179.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.58 0.752 . . . . 73.329999999999998 111.213 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -57.57 125.81 24.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.316 -0.856 . . . . 74.549999999999997 110.026 169.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' A' ' 184' ' ' LEU . . . 90.02 9.67 65.46 Favored Glycine 0 C--O 1.242 0.651 0 CA-C-O 119.192 -0.782 . . . . 50.240000000000002 113.022 -177.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 66.8 m -87.68 116.87 26.11 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 117.669 0.734 . . . . 75.120000000000005 110.526 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.426 ' HB3' HD13 ' A' ' 184' ' ' LEU . 21.0 p90 -128.24 167.92 16.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.936 0.495 . . . . 75.019999999999996 111.118 -172.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.43 HD22 HD13 ' A' ' 159' ' ' LEU . 4.3 pp -159.56 142.35 13.95 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.579 -0.737 . . . . 72.420000000000002 109.622 174.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 182' ' ' ILE . 74.2 t -100.27 115.3 41.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.988 -1.116 . . . . 75.040000000000006 107.988 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.609 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 41.9 ptt85 -115.91 143.1 45.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.566 0.746 . . . . 74.25 109.074 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -94.1 149.15 21.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.534 -0.913 . . . . 72.400000000000006 108.534 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 t -76.28 127.5 33.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.176 0.59 . . . . 71.230000000000004 109.585 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.0 -31.46 70.3 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.685 -0.689 . . . . 75.25 109.419 171.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 34.0 m -66.17 -34.81 78.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.924 0.89 . . . . 73.510000000000005 111.132 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.9 p -148.21 93.41 4.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.084 0.553 . . . . 71.120000000000005 110.841 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.14 138.23 85.35 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.895 2.396 . . . . 73.400000000000006 112.379 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.84 -29.93 10.74 Favored Glycine 0 C--N 1.345 1.029 0 C-N-CA 123.324 0.488 . . . . 72.450000000000003 111.959 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -82.72 117.72 22.85 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.822 -0.807 . . . . 74.340000000000003 108.822 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.505 0.669 . . . . 74.299999999999997 110.446 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 61.4 m -140.52 149.28 42.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.775 1.23 . . . . 71.120000000000005 108.588 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 170' ' ' VAL . 25.9 mt -102.42 146.3 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.684 -1.228 . . . . 65.019999999999996 107.684 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 46.3 m -124.29 107.98 11.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.881 -1.155 . . . . 71.219999999999999 107.881 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.426 HD13 ' HB3' ' A' ' 168' ' ' PHE . 45.5 tp -105.45 114.25 28.31 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.087 0.555 . . . . 53.409999999999997 110.507 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 22.7 ttt180 -76.92 116.72 17.84 Favored 'General case' 0 C--O 1.254 1.321 0 CA-C-O 121.43 0.633 . . . . 62.219999999999999 109.946 166.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -139.59 138.52 36.27 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.498 1.519 . . . . 73.549999999999997 107.462 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 59.67 22.02 10.74 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.927 0.891 . . . . 62.329999999999998 111.887 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.61 -12.63 55.69 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.345 -0.389 . . . . 72.420000000000002 113.869 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -98.99 144.93 27.59 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.547 0.739 . . . . 74.209999999999994 109.463 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.8 t -103.31 110.19 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.066 0.46 . . . . 71.430000000000007 110.532 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -96.94 124.51 40.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.849 1.259 . . . . 74.109999999999999 109.513 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -98.66 119.09 36.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.31 0.644 . . . . 73.450000000000003 111.286 -172.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.539 ' HE1' HD21 ' A' ' 232' ' ' LEU . 4.9 m-85 -95.42 150.72 19.98 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.574 -0.899 . . . . 64.349999999999994 108.574 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -106.81 125.3 50.83 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.276 -0.639 . . . . 72.230000000000004 109.276 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.4 mt -85.39 102.41 11.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.428 -0.953 . . . . 61.119999999999997 108.428 172.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -85.38 147.14 26.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.823 -1.08 . . . . 64.319999999999993 109.666 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -108.68 135.69 49.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.475 0.71 . . . . 75.450000000000003 109.648 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.9 176.88 7.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.578 0.751 . . . . 72.150000000000006 110.227 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.0 p -65.7 -28.91 69.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.208 0.603 . . . . 72.129999999999995 112.379 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -91.85 -17.34 25.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 75.319999999999993 110.243 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 114.11 9.21 16.1 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.914 -0.937 . . . . 72.219999999999999 114.847 175.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.72 130.21 45.36 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.3 1.05 . . . . 73.140000000000001 111.58 176.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -86.54 141.12 29.28 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.876 -1.157 . . . . 41.509999999999998 107.876 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.615 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.1 p90 -167.44 132.11 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.579 0.55 . . . . 73.209999999999994 110.961 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.525 HG23 HD11 ' A' ' 217' ' ' LEU . 70.6 t -77.62 -38.0 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.688 -0.856 . . . . 74.329999999999998 108.688 164.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.7 m -105.54 123.38 47.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.625 -1.17 . . . . 61.240000000000002 109.513 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -64.24 -25.16 67.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.488 0.715 . . . . 73.439999999999998 112.489 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -77.3 -24.38 50.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.625 0.77 . . . . 75.409999999999997 110.946 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.8 m -129.68 100.43 5.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.186 0.594 . . . . 75.340000000000003 109.679 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.615 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 77.7 mtt180 -107.22 138.8 42.73 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 64.150000000000006 109.209 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -124.34 146.65 48.7 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.303 -0.629 . . . . 63.240000000000002 109.303 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.85 -37.56 87.84 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.933 0.771 . . . . 73.5 110.381 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.7 p -127.81 157.43 40.45 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.738 0.815 . . . . 65.230000000000004 111.609 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.81 -25.32 67.18 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.689 -1.141 . . . . 63.240000000000002 109.741 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.85 97.35 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.447 0.699 . . . . 71.340000000000003 111.019 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.38 -34.42 67.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.438 0.695 . . . . 75.010000000000005 111.48 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.525 HD11 HG23 ' A' ' 205' ' ' VAL . 14.9 tp -56.48 -54.57 44.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.815 0.446 . . . . 62.299999999999997 111.141 174.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.68 -38.41 82.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 O-C-N 123.776 0.673 . . . . 53.32 110.677 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -58.29 -57.31 13.46 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 62.32 111.253 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -63.14 -39.61 95.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.722 -0.672 . . . . 70.340000000000003 111.1 -176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.719 ' HB3' HD11 ' A' ' 228' ' ' LEU . 41.8 m80 -85.45 -6.09 59.24 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.323 0.49 . . . . 65.230000000000004 112.323 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 91.6 p -98.07 -14.42 20.49 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.027 0.376 . . . . 64.200000000000003 111.12 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 50.7 p -83.63 -40.05 19.49 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 110.23 -0.285 . . . . 72.439999999999998 110.23 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.1 m -138.6 167.68 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 113.36 0.874 . . . . 63.100000000000001 113.36 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -81.53 13.24 3.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.983 2.113 . . . . 74.329999999999998 113.659 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 224' ' ' VAL . 35.8 t70 -41.95 33.67 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 1 C-N-CA 132.091 4.156 . . . . 63.439999999999998 118.744 -158.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 126.35 -5.52 7.67 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 120.068 -1.645 . . . . 63.009999999999998 112.986 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 221' ' ' HIS . 14.1 mt -90.45 161.09 15.7 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.447 1.099 . . . . 62.450000000000003 109.484 174.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 7.7 tt -56.74 -36.36 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-O 120.958 0.409 . . . . 72.140000000000001 110.418 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.3 t -161.03 170.9 19.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.292 0.637 . . . . 65.349999999999994 110.189 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 29.5 m -63.1 138.33 58.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.513 1.125 . . . . 51.450000000000003 111.889 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.539 HD21 ' HE1' ' A' ' 193' ' ' TYR . 65.1 mt -73.43 135.06 44.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.263 -0.643 . . . . 73.209999999999994 109.263 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.82 -76.16 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.524 0.602 . . . . 41.32 110.809 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 167' ' ' SER . 19.9 t80 -85.4 121.39 73.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 108.393 -0.966 . . . . 75.129999999999995 108.393 -177.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.05 125.06 3.98 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.364 2.043 . . . . 75.519999999999996 111.396 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.1 134.53 94.5 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.773 -0.649 . . . . 54.149999999999999 110.076 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.67 -179.15 4.85 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.603 2.202 . . . . 74.439999999999998 111.988 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.34 152.07 45.96 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.151 0.58 . . . . 54.340000000000003 109.587 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.401 ' HG3' ' H ' ' A' ' 240' ' ' ASN . 10.9 ptt180 -88.92 -62.21 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.532 0.567 . . . . 74.409999999999997 112.532 -172.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.401 ' H ' ' HG3' ' A' ' 239' ' ' ARG . 66.1 t30 -111.24 149.05 31.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.283 0.633 . . . . 74.349999999999994 110.74 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.452 ' NZ ' ' HB2' ' A' ' 90' ' ' ASP . 99.9 mttt -83.57 114.88 56.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 106.807 -1.553 . . . . 75.010000000000005 106.807 160.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.525 ' HB2' ' ND2' ' A' ' 133' ' ' ASN . 19.5 Cg_exo -65.27 122.52 10.26 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.085 1.857 . . . . 61.509999999999998 111.817 -168.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 59.0 m -72.24 112.43 8.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.948 0.499 . . . . 74.140000000000001 110.233 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.29 106.69 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.571 -1.27 . . . . 51.109999999999999 107.571 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -85.5 114.82 22.82 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.702 0.401 . . . . 64.129999999999995 111.776 -161.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 59.12 0.42 0.71 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.645 1.818 . . . . 73.420000000000002 117.645 164.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.52 HG23 ' HE1' ' A' ' 118' ' ' TRP . 24.1 m -96.99 122.82 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.174 1.487 . . . . 61.039999999999999 112.801 -169.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.4 t -78.66 135.33 60.23 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 113.793 -1.549 . . . . 73.25 107.377 160.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.549 ' HD2' HD21 ' A' ' 97' ' ' ASN . 33.1 Cg_exo -61.42 -59.91 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 121.137 1.225 . . . . 73.019999999999996 112.645 -169.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -132.66 -25.93 1.85 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.133 0.973 . . . . 71.510000000000005 109.168 149.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.16 121.31 41.61 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.635 -1.166 . . . . 74.439999999999998 113.427 -156.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -100.93 -27.0 13.54 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.018 -0.734 . . . . 73.140000000000001 109.018 162.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -79.4 -40.92 28.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.696 0.798 . . . . 73.129999999999995 112.444 -175.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.486 ' HZ3' ' HA2' ' A' ' 128' ' ' GLY . 25.8 t90 -59.51 135.69 57.75 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.512 0.507 . . . . 60.020000000000003 112.354 -163.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 CA--C 1.556 1.206 0 CA-C-N 114.159 -1.382 . . . . 74.400000000000006 111.665 179.81 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.451 -0.944 . . . . 74.010000000000005 108.451 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.47 74.07 0.1 OUTLIER Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.424 -0.671 . . . . 71.150000000000006 111.424 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -129.09 -86.83 0.54 Allowed 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.123 -1.066 . . . . 75.209999999999994 108.123 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 173.16 84.79 0.05 OUTLIER Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 125.008 1.323 . . . . 71.349999999999994 108.014 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.85 101.77 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.402 2.068 . . . . 72.450000000000003 111.557 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 -124.79 1.66 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.944 -0.462 . . . . 72.219999999999999 111.944 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -92.37 35.54 1.01 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.205 0.602 . . . . 74.340000000000003 110.466 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.8 m -73.9 80.5 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-O 122.01 0.909 . . . . 54.350000000000001 110.678 175.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -83.22 130.94 35.12 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.552 -1.277 . . . . 75.150000000000006 107.552 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.23 73.35 1.26 Allowed Glycine 0 C--N 1.339 0.749 0 O-C-N 123.604 0.565 . . . . 53.399999999999999 113.017 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -145.04 136.39 25.13 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.004 0.922 . . . . 60.539999999999999 109.598 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -163.06 88.71 0.61 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.586 1.154 . . . . 63.439999999999998 109.199 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -140.3 129.22 23.34 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.033 0.933 . . . . 54.229999999999997 109.718 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -113.22 90.35 16.38 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 124.322 1.049 . . . . 71.120000000000005 109.319 175.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.79 85.0 0.63 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.121 2.547 . . . . 74.010000000000005 111.708 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.2 m -86.0 96.97 10.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.613 0.765 . . . . 73.420000000000002 110.232 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.4 mt -119.8 110.16 37.1 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.933 0.893 . . . . 74.25 109.63 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.36 94.17 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.66 2.24 . . . . 64.209999999999994 111.101 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.38 121.62 26.46 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 122.95 0.5 . . . . 60.439999999999998 110.388 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.72 152.07 37.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.671 0.788 . . . . 73.430000000000007 109.172 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -160.87 173.74 14.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.88 0.872 . . . . 75.430000000000007 109.953 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -84.97 141.8 30.08 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.464 0.706 . . . . 62.329999999999998 110.13 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.2 pt -74.33 157.59 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.445 0.64 . . . . 54.530000000000001 111.51 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -111.56 88.58 2.83 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.379 -1.341 . . . . 74.230000000000004 107.379 171.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.54 47.21 3.79 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.621 -0.544 . . . . 63.210000000000001 113.821 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 63.87 -78.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.349 1.46 . . . . 75.409999999999997 111.448 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.97 -0.29 3.17 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.215 0.436 . . . . 64.5 112.887 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -73.51 88.58 1.64 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.561 0.745 . . . . 74.310000000000002 109.453 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.9 mmm-85 -141.76 86.94 2.02 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.997 0.919 . . . . 75.530000000000001 110.262 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -86.89 -75.11 0.41 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.544 -0.91 . . . . 73.310000000000002 108.544 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.1 m 58.53 -175.28 0.09 Allowed 'General case' 0 C--N 1.36 1.044 0 C-N-CA 124.248 1.019 . . . . 73.450000000000003 112.054 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.8 t -128.92 -21.0 3.4 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 122.017 -0.427 . . . . 71.310000000000002 110.166 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -78.14 -82.28 0.09 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.152 0.581 . . . . 75.109999999999999 109.475 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -155.69 -171.89 3.93 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.753 1.221 . . . . 74.230000000000004 108.543 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.02 -109.44 0.4 Allowed Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.555 -0.618 . . . . 64.329999999999998 111.555 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.39 -82.08 0.15 Allowed Glycine 0 C--N 1.339 0.73 0 CA-C-O 119.368 -0.684 . . . . 43.340000000000003 112.308 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.53 -179.92 5.9 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.792 2.328 . . . . 64.230000000000004 112.461 175.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -115.78 -163.56 0.9 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.788 0.835 . . . . 74.219999999999999 109.745 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.12 115.26 5.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.223 0.609 . . . . 50.509999999999998 111.791 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -76.13 -22.94 54.91 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.071 0.948 . . . . 63.200000000000003 110.985 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.4 t 58.68 -96.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 124.57 1.148 . . . . 64.409999999999997 109.815 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -177.2 -179.21 0.86 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.899 1.28 . . . . 72.099999999999994 109.116 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.85 157.41 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 N-CA-C 108.782 -0.822 . . . . 63.520000000000003 108.782 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 68.41 -169.08 0.19 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.772 1.229 . . . . 30.239999999999998 113.025 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -143.12 169.16 18.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.632 1.173 . . . . 71.530000000000001 109.429 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -75.63 146.47 40.29 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.152 0.581 . . . . 74.319999999999993 111.388 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.8 165.94 18.39 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.513 0.725 . . . . 50.5 110.005 173.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.42 HD22 ' HB3' ' A' ' 162' ' ' SER . 78.1 mt -83.89 170.6 13.88 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.306 0.642 . . . . 75.129999999999995 111.12 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -116.59 159.68 21.8 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.712 0.805 . . . . 74.109999999999999 109.908 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.84 135.72 55.41 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.523 0.729 . . . . 72.510000000000005 110.076 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.96 145.93 96.58 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.347 2.031 . . . . 73.129999999999995 112.386 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.3 m -79.61 172.94 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.49 0.716 . . . . 74.329999999999998 110.277 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.03 92.79 0.54 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.265 0.626 . . . . 74.310000000000002 109.318 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.8 p -100.73 78.48 1.98 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.762 0.825 . . . . 72.450000000000003 109.985 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.59 -67.46 0.47 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.852 -0.613 . . . . 74.209999999999994 109.971 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -94.07 114.56 26.74 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.543 0.737 . . . . 75.319999999999993 109.616 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.13 108.04 10.4 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.158 0.983 . . . . 71.430000000000007 108.448 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.23 -52.85 1.35 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.85 2.367 . . . . 74.299999999999997 114.004 -168.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.58 HE21 ' HA ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -119.95 -27.32 5.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.284 0.476 . . . . 62.140000000000001 112.284 -171.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.33 -82.09 0.68 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.513 -0.635 . . . . 32.299999999999997 111.513 -171.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.9 tp -112.76 145.47 40.49 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.956 0.903 . . . . 72.209999999999994 109.18 175.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.0 p -136.53 168.58 19.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.894 1.278 . . . . 74.439999999999998 108.906 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -113.12 -49.51 2.92 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.127 0.571 . . . . 74.319999999999993 111.706 -172.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' A' ' 68' ' ' ASN . . . -59.61 -71.96 0.11 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 112.994 0.739 . . . . 63.450000000000003 112.994 -168.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.26 16.01 4.77 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.015 0.526 . . . . 71.340000000000003 111.752 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -106.87 -61.08 1.59 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.029 -0.73 . . . . 65.540000000000006 109.029 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -165.76 73.25 0.18 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.348 0.594 . . . . 73.219999999999999 110.516 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 64' ' ' ALA . 33.6 p-10 -82.76 -20.73 35.34 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.755 -0.657 . . . . 71.230000000000004 110.074 169.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 m -70.79 3.15 3.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.306 1.443 . . . . 75.120000000000005 112.886 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.89 -24.4 66.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.794 0.838 . . . . 74.430000000000007 111.612 175.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -81.85 -36.58 28.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.034 0.534 . . . . 71.209999999999994 110.126 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.81 -5.81 49.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.949 0.9 . . . . 62.409999999999997 110.528 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.418 HD13 ' HE1' ' A' ' 146' ' ' TRP . 27.3 tp -58.96 -51.01 71.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.685 1.194 . . . . 75.329999999999998 111.522 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.75 -53.2 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.014 0.526 . . . . 50.350000000000001 110.37 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.66 -55.57 22.51 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.625 0.77 . . . . 75.25 111.897 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.08 140.1 4.37 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.987 -1.006 . . . . 73.450000000000003 111.254 -170.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.59 114.08 2.93 Favored 'Trans proline' 0 C--N 1.371 1.722 0 CA-C-N 119.745 1.772 . . . . 65.129999999999995 111.545 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.5 t -123.18 127.79 49.14 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.746 1.218 . . . . 74.349999999999994 108.444 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.403 ' H ' HD22 ' A' ' 84' ' ' LEU . 9.5 mm-40 -83.76 -52.42 6.42 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.507 -0.553 . . . . 62.130000000000003 109.507 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -135.98 -37.18 0.73 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.828 0.851 . . . . 71.209999999999994 110.512 164.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -89.48 131.26 40.73 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 115.151 -0.931 . . . . 61.109999999999999 112.85 -166.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.29 -5.5 16.26 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.072 2.515 . . . . 63.109999999999999 111.874 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -106.24 7.81 31.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.45 1.1 . . . . 74.329999999999998 110.612 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 79' ' ' GLU . 42.8 tp -57.53 148.38 24.05 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 73.140000000000001 111.295 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -111.88 163.87 13.73 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.52 0.728 . . . . 72.430000000000007 109.653 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 138.58 46.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 124.423 1.089 . . . . 73.030000000000001 108.619 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 107' ' ' LEU . . . -76.33 115.27 15.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.776 0.83 . . . . 60.100000000000001 109.481 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.8 mt -71.98 -38.52 69.69 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.272 0.558 . . . . 64.209999999999994 110.698 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.554 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 6.0 m-85 -125.18 151.81 45.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.981 -1.008 . . . . 74.030000000000001 108.769 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.46 125.49 29.43 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.973 -0.751 . . . . 61.43 108.973 166.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.614 ' HB3' HG12 ' A' ' 101' ' ' ILE . 89.5 t80 -106.35 135.01 48.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.797 -1.186 . . . . 64.230000000000004 107.797 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -102.04 134.96 41.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.23 -1.026 . . . . 73.040000000000006 108.23 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.8 134.88 57.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.02 0.928 . . . . 62.229999999999997 111.822 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.5 p -98.82 -53.22 3.35 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.022 0.929 . . . . 72.120000000000005 109.071 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.73 176.28 33.45 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.116 -0.947 . . . . 61.119999999999997 111.747 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.59 -21.41 57.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.839 0.855 . . . . 72.439999999999998 111.521 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -93.55 -26.09 17.28 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.763 0.825 . . . . 72.420000000000002 111.656 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.3 p -73.03 134.83 44.78 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.111 -0.7 . . . . 74.409999999999997 109.111 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.636 ' HB2' ' HA3' ' A' ' 128' ' ' GLY . 63.6 tp -104.55 125.72 50.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.453 0.701 . . . . 63.229999999999997 110.561 -167.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -70.35 132.25 45.36 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.952 0.783 . . . . 74.329999999999998 109.842 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.77 HG22 HG21 ' A' ' 123' ' ' THR . 9.8 pt -119.13 148.82 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.728 -0.471 . . . . 71.239999999999995 109.728 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.615 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 16.1 m -86.3 149.48 25.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.625 0.77 . . . . 74.430000000000007 109.354 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.73 113.35 6.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.71 0.404 . . . . 72.030000000000001 110.318 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.79 61.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.379 -0.373 . . . . 33.039999999999999 112.927 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 36.6 tt0 -73.09 135.48 44.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.708 0.803 . . . . 62.43 111.801 -175.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -80.03 126.54 31.18 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.554 -0.906 . . . . 70.129999999999995 108.554 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -148.16 153.59 39.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.244 0.545 . . . . 64.129999999999995 110.8 -174.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -108.56 130.23 55.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.833 0.853 . . . . 72.140000000000001 108.965 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.525 HG13 ' HB1' ' A' ' 119' ' ' ALA . 53.3 t -88.03 130.52 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.213 -1.032 . . . . 71.540000000000006 108.213 168.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.462 HD12 ' HG2' ' A' ' 120' ' ' GLU . 36.0 mt -92.67 -29.19 16.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.221 1.009 . . . . 74.209999999999994 109.623 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.54 145.36 4.44 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.207 -0.906 . . . . 74.109999999999999 111.547 175.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.694 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 62.3 m-85 -86.23 160.34 19.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.212 0.506 . . . . 64.450000000000003 110.033 173.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -83.34 -172.43 4.14 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 73.230000000000004 110.539 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -52.34 -41.46 63.04 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.268 1.027 . . . . 73.109999999999999 113.504 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -95.46 -2.41 48.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.407 0.683 . . . . 70.209999999999994 111.341 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 60.51 22.5 59.17 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.029 0.772 . . . . 61.100000000000001 115.029 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.02 -16.54 18.66 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.396 0.679 . . . . 61.530000000000001 110.82 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 56.2 m95 -131.53 143.4 50.35 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.068 0.947 . . . . 73.530000000000001 110.026 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.525 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -123.28 149.04 45.29 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.462 1.105 . . . . 72.200000000000003 110.042 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HG2' HD12 ' A' ' 110' ' ' LEU . 38.6 tt0 -82.85 107.73 15.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.469 -1.678 . . . . 72.329999999999998 106.469 164.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.45 152.53 40.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.419 0.628 . . . . 71.299999999999997 112.141 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -112.57 103.98 12.05 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.346 -1.297 . . . . 71.310000000000002 108.171 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.77 HG21 HG22 ' A' ' 101' ' ' ILE . 39.5 p -101.62 176.25 5.29 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.111 0.964 . . . . 43.240000000000002 110.206 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -71.56 -14.29 62.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.943 0.497 . . . . 64.019999999999996 110.265 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -85.28 -18.05 35.08 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.321 1.049 . . . . 73.340000000000003 111.187 172.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.25 -165.23 23.2 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-O 120.3 -0.167 . . . . 44.140000000000001 113.347 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.416 ' NE2' ' HG2' ' A' ' 120' ' ' GLU . 68.3 tp60 -92.22 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.203 0.601 . . . . 70.140000000000001 111.393 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 99' ' ' LEU . . . 176.01 -161.12 29.51 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.52 0.512 . . . . 54.350000000000001 112.443 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -112.11 120.46 41.9 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.34 0.656 . . . . 73.140000000000001 111.635 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.76 143.5 47.84 Favored Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 124.015 0.926 . . . . 71.0 109.923 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 118' ' ' TRP . 83.1 Cg_endo -84.69 145.44 10.31 Favored 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 121.943 1.762 . . . . 70.430000000000007 114.827 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -38.68 -46.48 1.23 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.281 1.832 . . . . 71.230000000000004 114.526 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.554 HD22 ' HB2' ' A' ' 242' ' ' PRO . 30.0 p-10 -75.03 -7.66 54.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.857 0.863 . . . . 74.200000000000003 113.014 -169.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 29.4 m-85 -103.64 -10.61 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.388 0.675 . . . . 61.340000000000003 111.904 174.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.0 pt -123.78 170.84 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.92 0.888 . . . . 74.420000000000002 110.636 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 3.4 m -158.45 137.98 8.46 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.721 0.808 . . . . 61.409999999999997 109.941 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.53 136.71 47.55 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 121.686 1.591 . . . . 72.219999999999999 110.897 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.29 -11.79 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.167 0.987 . . . . 75.140000000000001 110.378 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -21.19 63.29 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.166 0.987 . . . . 71.299999999999997 112.177 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 91.7 p -109.61 -179.63 3.87 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.867 0.867 . . . . 64.129999999999995 111.852 -173.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.94 -22.84 36.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.535 1.134 . . . . 63.399999999999999 112.32 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.78 -12.4 61.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.943 0.897 . . . . 70.340000000000003 112.245 -173.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 140' ' ' SER . 20.8 pttm -63.82 -11.68 29.31 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.818 0.847 . . . . 72.209999999999994 111.911 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.402 ' CE1' ' HA ' ' A' ' 73' ' ' LEU . 48.2 m-70 -99.63 146.64 26.24 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.867 0.867 . . . . 71.209999999999994 110.895 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -64.64 -33.94 77.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.156 -0.929 . . . . 53.340000000000003 112.517 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.418 ' HE1' HD13 ' A' ' 73' ' ' LEU . 41.9 p-90 -72.93 -35.13 66.95 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.569 0.747 . . . . 75.400000000000006 112.471 -176.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HE2' ' A' ' 238' ' ' LYS . 23.1 t80 -80.29 103.02 9.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.825 -0.806 . . . . 73.200000000000003 108.825 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.455 ' HB2' HG21 ' A' ' 151' ' ' VAL . 52.8 m170 -95.59 -9.18 32.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.06 0.544 . . . . 72.230000000000004 112.056 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 -135.06 17.88 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-O 118.273 -1.293 . . . . 65.219999999999999 112.727 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.33 93.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.697 2.931 . . . . 63.25 113.127 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 171' ' ' ARG . 75.4 t -139.64 132.39 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.915 1.286 . . . . 64.099999999999994 109.252 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.1 p -89.86 175.8 7.07 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.263 1.025 . . . . 74.340000000000003 109.896 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -58.2 -50.14 74.59 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.289 0.236 . . . . 74.329999999999998 111.111 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -55.49 -44.96 77.02 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.845 0.858 . . . . 50.219999999999999 111.145 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.58 84.33 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.397 -0.82 . . . . 55.32 110.751 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.0 80.41 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.946 0.898 . . . . 43.340000000000003 112.052 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -83.83 -21.16 32.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.757 -0.656 . . . . 75.209999999999994 111.759 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.409 ' OH ' ' HD2' ' A' ' 239' ' ' ARG . 0.1 OUTLIER -82.8 -19.36 37.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.27 0.557 . . . . 73.420000000000002 111.311 172.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' A' ' 239' ' ' ARG . 51.6 mt -74.96 -42.97 56.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.344 -0.843 . . . . 34.130000000000003 110.669 168.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.548 ' O ' ' HD2' ' A' ' 185' ' ' ARG . 89.0 mt -92.67 20.69 6.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.281 -0.872 . . . . 75.209999999999994 111.451 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 92.5 p -72.55 -40.19 66.9 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.679 -0.489 . . . . 65.030000000000001 109.679 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.42 ' HB3' HD22 ' A' ' 48' ' ' LEU . 21.4 p -100.63 3.65 42.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.201 1.0 . . . . 75.530000000000001 112.271 -178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.11 159.05 53.04 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.124 0.265 . . . . 72.040000000000006 113.469 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.77 -178.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 63.25 110.799 174.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -61.92 118.49 7.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.367 0.667 . . . . 72.340000000000003 109.814 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.78 12.03 59.75 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.292 -0.726 . . . . 73.430000000000007 113.444 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.0 m -76.06 133.04 40.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.182 0.991 . . . . 71.140000000000001 110.184 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.489 ' HB3' HD13 ' A' ' 184' ' ' LEU . 27.0 p90 -141.81 166.44 24.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.237 0.541 . . . . 73.030000000000001 111.187 -171.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 pp -162.6 151.29 14.75 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.617 -1.174 . . . . 63.130000000000003 108.135 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.662 HG22 HG12 ' A' ' 182' ' ' ILE . 85.9 t -103.51 128.9 56.24 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 N-CA-C 108.101 -1.074 . . . . 61.200000000000003 108.101 169.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.651 ' HB2' ' HB ' ' A' ' 151' ' ' VAL . 38.0 ptt85 -114.97 143.26 45.44 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.731 -1.122 . . . . 71.040000000000006 108.313 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -114.95 130.21 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.329 -1.36 . . . . 62.420000000000002 107.329 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -62.67 127.56 31.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.66 0.384 . . . . 71.099999999999994 110.409 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.86 -43.5 98.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.173 0.589 . . . . 73.120000000000005 110.004 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.0 p -68.71 -27.09 65.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.838 0.855 . . . . 74.129999999999995 111.409 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.3 m -137.19 79.5 37.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.043 0.537 . . . . 64.400000000000006 110.582 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.42 137.32 73.53 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.629 2.219 . . . . 53.549999999999997 111.529 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.14 -29.57 12.23 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.809 -0.632 . . . . 64.099999999999994 111.668 -174.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -81.38 114.93 20.48 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.95 -0.759 . . . . 60.299999999999997 108.95 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -129.29 147.77 51.16 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.847 0.859 . . . . 73.200000000000003 109.465 -173.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -148.54 150.97 34.3 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.142 0.977 . . . . 63.439999999999998 108.542 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 170' ' ' VAL . 16.8 mt -103.23 121.87 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.224 -1.028 . . . . 72.129999999999995 108.224 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -93.82 127.25 39.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.646 -1.242 . . . . 74.109999999999999 107.646 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 168' ' ' PHE . 61.9 tp -131.96 110.36 10.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.173 0.589 . . . . 71.019999999999996 109.511 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 160' ' ' LEU . 21.7 ttt180 -79.7 113.81 18.14 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.076 0.55 . . . . 72.129999999999995 109.829 168.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -139.72 137.0 34.77 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.219 -1.4 . . . . 64.420000000000002 107.219 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 62.14 21.44 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.17 0.988 . . . . 74.239999999999995 111.624 -174.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 9.98 86.58 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.91 -0.586 . . . . 71.409999999999997 113.677 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -117.66 134.45 54.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.415 1.086 . . . . 73.019999999999996 109.487 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.58 115.56 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.735 0.414 . . . . 72.120000000000005 110.592 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -102.94 128.79 49.6 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.624 1.17 . . . . 75.109999999999999 108.696 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -110.37 110.13 20.8 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.316 0.646 . . . . 70.140000000000001 109.393 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.601 ' CE1' HD22 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -115.23 122.89 47.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.553 0.741 . . . . 73.120000000000005 110.545 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.76 135.04 53.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.55 1.14 . . . . 72.239999999999995 111.301 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.49 103.44 12.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.303 -0.999 . . . . 71.25 108.303 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -66.16 112.73 4.07 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.59 0.756 . . . . 64.439999999999998 109.172 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.8 m -97.45 105.46 17.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.436 0.695 . . . . 54.329999999999998 109.133 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.1 155.75 26.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.033 0.933 . . . . 72.519999999999996 110.771 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.8 p -69.19 -13.73 62.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.489 0.922 . . . . 74.120000000000005 113.489 -170.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.11 -16.42 31.52 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.391 0.676 . . . . 71.409999999999997 111.141 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 111.72 14.45 11.33 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.72 -0.489 . . . . 73.510000000000005 113.763 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -78.52 138.71 38.54 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.167 0.484 . . . . 61.340000000000003 110.89 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.29 143.76 32.24 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.977 -1.12 . . . . 63.310000000000002 107.977 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 210' ' ' ARG . 41.6 p90 -170.81 136.45 1.17 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.546 0.529 . . . . 75.239999999999995 111.525 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.436 HG21 ' HD1' ' A' ' 193' ' ' TYR . 63.7 t -79.89 -42.06 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.639 -0.875 . . . . 74.450000000000003 108.639 166.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.2 m -100.17 126.98 46.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.24 1.016 . . . . 74.310000000000002 109.605 -174.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -63.16 -24.73 68.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.559 0.743 . . . . 64.140000000000001 112.12 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -77.09 -30.68 55.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.674 1.19 . . . . 62.149999999999999 111.233 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -120.87 100.62 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.575 0.75 . . . . 54.119999999999997 109.157 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.523 ' HA ' ' HB3' ' A' ' 204' ' ' TYR . 83.3 mtt180 -110.13 126.01 53.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.011 0.924 . . . . 74.010000000000005 109.514 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.557 ' HB3' ' HB2' ' A' ' 216' ' ' GLU . 2.5 m-85 -116.03 149.33 39.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.537 0.735 . . . . 75.129999999999995 110.043 -168.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -69.03 -44.33 72.91 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.403 -0.591 . . . . 75.239999999999995 109.403 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.1 p -117.93 154.95 31.05 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.955 0.883 . . . . 73.239999999999995 111.722 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.493 HD11 HG11 ' A' ' 170' ' ' VAL . 1.1 tt -65.47 -23.23 66.86 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.723 -1.126 . . . . 74.099999999999994 109.899 174.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.07 93.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.383 0.673 . . . . 61.299999999999997 110.662 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 211' ' ' PHE . 41.2 mt-10 -68.04 -36.8 80.5 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 110.82 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 tp -54.04 -57.88 9.4 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.767 0.667 . . . . 74.120000000000005 110.407 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.01 -38.4 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 123.755 0.659 . . . . 72.329999999999998 110.716 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -62.94 -59.05 5.37 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.921 0.488 . . . . 72.019999999999996 111.55 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.26 -32.94 74.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.028 0.531 . . . . 73.450000000000003 111.063 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.671 ' HB3' HD11 ' A' ' 228' ' ' LEU . 17.4 m170 -89.44 -4.72 57.87 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.629 0.603 . . . . 70.120000000000005 112.629 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 79.2 p -96.24 -28.07 14.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.868 0.467 . . . . 63.229999999999997 110.807 168.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 52.7 p -77.29 -40.36 44.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.356 -0.384 . . . . 74.239999999999995 110.504 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.561 HG23 ' HB2' ' A' ' 226' ' ' ASP . 16.5 m -134.5 161.44 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.304 1.049 . . . . 73.319999999999993 112.437 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.23 16.62 0.74 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.26 2.224 . . . . 55.439999999999998 114.442 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' A' ' 224' ' ' VAL . 28.1 t70 -44.37 25.31 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.617 1 C-N-CA 132.266 4.227 . . . . 32.119999999999997 119.821 -155.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 123.95 6.22 7.16 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 120.114 -1.616 . . . . 64.310000000000002 111.823 -165.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 221' ' ' HIS . 6.7 mt -95.23 163.67 13.17 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.749 1.22 . . . . 63.039999999999999 109.363 167.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 8.4 tt -65.89 -34.0 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-O 121.229 0.537 . . . . 72.109999999999999 109.834 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.4 t -159.67 170.67 21.08 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.592 0.757 . . . . 74.129999999999995 109.664 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.2 p -63.96 142.09 58.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.363 0.665 . . . . 62.140000000000001 111.385 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.42 112.21 4.5 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 108.686 -0.857 . . . . 72.439999999999998 108.686 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -104.75 -57.88 1.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.140000000000001 112.007 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -119.27 122.77 29.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.789 0.836 . . . . 74.420000000000002 109.54 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.2 123.33 4.99 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.449 2.099 . . . . 72.510000000000005 111.132 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -68.32 142.06 94.25 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 109.072 -0.714 . . . . 74.099999999999994 109.072 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.66 176.35 7.12 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.605 2.203 . . . . 65.329999999999998 112.943 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 147' ' ' TYR . 33.1 mmtp -71.41 155.7 40.33 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.394 -0.821 . . . . 64.409999999999997 109.974 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.855 ' HB3' HD21 ' A' ' 159' ' ' LEU . 16.7 ptt-85 -91.89 -60.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.578 0.584 . . . . 62.149999999999999 112.578 -167.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -110.89 155.06 23.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.348 1.059 . . . . 65.140000000000001 109.872 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.67 114.77 59.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.663 -1.606 . . . . 50.32 106.663 156.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.554 ' HB2' HD22 ' A' ' 133' ' ' ASN . 27.9 Cg_endo -61.59 124.88 15.49 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.595 2.197 . . . . 74.420000000000002 112.352 -171.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 8.4 m -72.4 112.83 8.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.543 -0.753 . . . . 72.400000000000006 110.833 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.07 111.77 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 107.416 -1.327 . . . . 72.040000000000006 107.416 171.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.74 111.05 22.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.157 -0.312 . . . . 73.150000000000006 110.157 -166.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 60.22 -14.13 0.04 OUTLIER Glycine 0 CA--C 1.542 1.764 0 N-CA-C 118.185 2.034 . . . . 32.200000000000003 118.185 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 15.3 m -89.52 122.96 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.376 1.588 . . . . 74.25 112.882 -164.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 36.4 t -82.61 140.02 44.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 106.928 -1.508 . . . . 63.549999999999997 106.928 159.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -63.67 -58.61 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 CA-C-N 120.723 1.294 . . . . 74.340000000000003 112.793 -163.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -132.85 -21.54 2.15 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.19 0.996 . . . . 62.109999999999999 109.285 152.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.658 ' HB3' ' HB2' ' A' ' 254' ' ' TRP . 59.5 m-85 -97.64 117.93 33.03 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.322 -1.308 . . . . 63.119999999999997 114.3 -152.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -104.36 -41.94 5.62 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.962 0.505 . . . . 61.539999999999999 109.731 170.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -104.31 25.14 10.49 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.626 1.171 . . . . 73.239999999999995 110.508 -172.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.658 ' HB2' ' HB3' ' A' ' 251' ' ' TYR . 54.7 t90 -52.54 119.4 4.46 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.123 0.569 . . . . 74.329999999999998 112.179 -176.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 107.806 -1.183 . . . . 63.0 107.806 177.663 . . . . . . . . 0 0 . 1 stop_ save_